PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lee, HH; Behringer, RR				Lee, Hu-Hui; Behringer, Richard R.			Conditional Expression of Wnt4 during Chondrogenesis Leads to Dwarfism in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR-3; VEGF; PROLIFERATION; ANGIOGENESIS; CHONDROCYTES; PATHWAY; LACKING; KIDNEY; ROLES	Wnts are expressed in the forming long bones, suggesting roles in skeletogenesis. To examine the action of Wnts in skeleton formation, we developed a genetic system to conditionally express Wnt4 in chondrogenic tissues of the mouse. A mouse Wnt4 cDNA was introduced into the ubiquitously expressed Rosa26 (R26) locus by gene targeting in embryonic stem (ES) cells. The expression of Wnt4 from the R26 locus was blocked by a neomycin selection cassette flanked by loxP sites (floxneo) that was positioned between the Rosa26 promoter and the Wnt4 cDNA, creating the allele designated R26(floxneoWnt4). Wnt4 expression was activated during chondrogenesis using Col2a1-Cre transgenic mice that express Cre recombinase in differentiating chondrocytes. R26(floxneoWnt4); Col2a1-Cre double heterozygous mice exhibited a growth deficiency, beginning approximately 7 to 10 days after birth, that resulted in dwarfism. In addition, they also had craniofacial abnormalities, and delayed ossification of the lumbar vertebrae and pelvic bones. Histological analysis revealed a disruption in the organization of the growth plates and a delay in the onset of the primary and secondary ossification centers. Molecular studies showed that Wnt4 overexpression caused decreased proliferation and altered maturation of chondrocytes. In addition, R26(floxneoWnt4); Col2a1-Cre mice had decreased expression of vascular endothelial growth factor (VEGF). These studies demonstrate that Wnt4 overexpression leads to dwarfism in mice. The data indicate that Wnt4 levels must be regulated in chondrocytes for normal growth plate development and skeletogenesis. Decreased VEGF expression suggests that defects in vascularization may contribute to the dwarf phenotype.	[Lee, Hu-Hui; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Behringer, RR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA.	rrb@mdanderson.org			National Institutes of Health (NIH) [AR42919, CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042919] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by National Institutes of Health (NIH) grant AR42919 to R. R. B. Veterinary and DNA sequencing resources were supported by the NIH Cancer Center Support Grant CA16672.	ALBECHT U, 1997, MOL CELLULAR METHODS, P23; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen L, 2001, HUM MOL GENET, V10, P457, DOI 10.1093/hmg/10.5.457; Church V, 2002, J CELL SCI, V115, P4809, DOI 10.1242/jcs.00152; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Jager R, 2004, GENESIS, V38, P145, DOI 10.1002/gene.20014; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawakami Y, 1999, DEV GROWTH DIFFER, V41, P29; Kitagaki J, 2003, OSTEOARTHR CARTILAGE, V11, P36, DOI 10.1053/joca.2002.0863; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; Lim J, 2005, GENESIS, V42, P150, DOI 10.1002/gene.20142; Lin CL, 2006, J AM SOC NEPHROL, V17, P2812, DOI 10.1681/ASN.2005121355; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Nagy A., 2003, MANIPULATING MOUSE E; Naski MC, 1998, DEVELOPMENT, V125, P4977; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Spater D, 2006, EUR CELLS MATER, V12, P71; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wang YC, 1999, P NATL ACAD SCI USA, V96, P4455, DOI 10.1073/pnas.96.8.4455; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; YANG YZ, 1995, CELL, V80, P939, DOI 10.1016/0092-8674(95)90297-X; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zhang XB, 2001, CANCER RES, V61, P6050; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	55	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e450	10.1371/journal.pone.0000450	http://dx.doi.org/10.1371/journal.pone.0000450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505543	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445900009
J	Saiz, L; Vilar, JMG				Saiz, Leonor; Vilar, Jose M. G.			Multilevel Deconstruction of the In Vivo Behavior of Looped DNA-Protein Complexes	PLOS ONE			English	Article							LAC REPRESSOR; CRYSTAL-STRUCTURE; NUCLEOPROTEIN COMPLEXES; BINDING; TRANSCRIPTION; CAP; DEPENDENCE; CHROMATIN; TETRAMER; ELEMENTS	Protein-DNA complexes with loops play a fundamental role in a wide variety of cellular processes, ranging from the regulation of DNA transcription to telomere maintenance. As ubiquitous as they are, their precise in vivo properties and their integration into the cellular function still remain largely unexplored. Here, we present a multilevel approach that efficiently connects in both directions molecular properties with cell physiology and use it to characterize the molecular properties of the looped DNA-lac repressor complex while functioning in vivo. The properties we uncover include the presence of two representative conformations of the complex, the stabilization of one conformation by DNA architectural proteins, and precise values of the underlying twisting elastic constants and bending free energies. Incorporation of all this molecular information into gene-regulation models reveals an unprecedented versatility of looped DNA-protein complexes at shaping the properties of gene expression.	[Saiz, Leonor; Vilar, Jose M. G.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, Integrat Biol Modeling Lab, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Vilar, JMG (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, Integrat Biol Modeling Lab, 1275 York Ave, New York, NY 10021 USA.	vilar@cbio.mskcc.org	Saiz, Leonor/I-3557-2015; Vilar, Jose MG/A-9069-2013	Saiz, Leonor/0000-0002-6866-9400; Vilar, Jose MG/0000-0003-4037-0746				ADHYA S, 1989, ANNU REV GENET, V23, P227, DOI 10.1146/annurev.genet.23.1.227; Balaeff A, 2004, STRUCTURE, V12, P123, DOI 10.1016/j.str.2003.12.004; Bates A. D., 2005, DNA TOPOLOGY; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; BELLOMY GR, 1988, BIOCHEMISTRY-US, V27, P3900, DOI 10.1021/bi00411a002; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Edelman LM, 2003, BIOPHYS J, V84, P1131, DOI 10.1016/S0006-3495(03)74929-7; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; GARTENBERG MR, 1988, NATURE, V333, P824, DOI 10.1038/333824a0; Geanacopoulos M, 2001, NAT STRUCT BIOL, V8, P432, DOI 10.1038/87595; GROSSCHEDL R, 1995, CURR OPIN CELL BIOL, V7, P362, DOI 10.1016/0955-0674(95)80091-3; Halford SE, 2000, NAT STRUCT BIOL, V7, P705, DOI 10.1038/78911; Hill T. L., 2012, INTRO STAT THERMODYN; HUDSON JM, 1990, J MOL BIOL, V214, P381, DOI 10.1016/0022-2836(90)90188-R; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Li QL, 2006, TRENDS GENET, V22, P197, DOI 10.1016/j.tig.2006.02.004; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Olson WK, 2004, PHILOS T R SOC A, V362, P1403, DOI 10.1098/rsta.2004.1380; PTASHNE M, 2002, GENES SIGNALS; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Ruben GC, 1997, MICROSC RES TECHNIQ, V36, P400, DOI 10.1002/(SICI)1097-0029(19970301)36:5<400::AID-JEMT10>3.0.CO;2-W; Saiz L, 2005, P NATL ACAD SCI USA, V102, P17642, DOI 10.1073/pnas.0505693102; Saiz L, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100061; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SEGALL AM, 1994, EMBO J, V13, P4536, DOI 10.1002/j.1460-2075.1994.tb06775.x; Semsey S, 2005, TRENDS BIOCHEM SCI, V30, P334, DOI 10.1016/j.tibs.2005.04.009; Swigon D, 2006, P NATL ACAD SCI USA, V103, P9879, DOI 10.1073/pnas.0603557103; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Vilar JMG, 2005, CURR OPIN GENET DEV, V15, P136, DOI 10.1016/j.gde.2005.02.005; Vilar JMG, 2003, J MOL BIOL, V331, P981, DOI 10.1016/S0022-2836(03)00764-2; Vilar JMG, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238103; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; Watson MA, 2000, J MOL BIOL, V298, P461, DOI 10.1006/jmbi.2000.3676; Werner MH, 1997, CELL, V88, P733, DOI 10.1016/S0092-8674(00)81917-0; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108; Zhang Y, 2006, BIOPHYS J, V90, P1903, DOI 10.1529/biophysj.105.070490	42	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e355	10.1371/journal.pone.0000355	http://dx.doi.org/10.1371/journal.pone.0000355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406679	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445300017
J	Gamm, DM; Wang, SM; Lu, B; Girman, S; Holmes, T; Bischoff, N; Shearer, RL; Sauve, Y; Capowski, E; Svendsen, CN; Lund, RD				Gamm, David M.; Wang, Shaomei; Lu, Bin; Girman, Sergei; Holmes, Toby; Bischoff, Nicholas; Shearer, Rebecca L.; Sauve, Yves; Capowski, Elizabeth; Svendsen, Clive N.; Lund, Raymond D.			Protection of Visual Functions by Human Neural Progenitors in a Rat Model of Retinal Disease	PLOS ONE			English	Article								Background. A promising clinical application for stem and progenitor cell transplantation is in rescue therapy for degenerative diseases. This strategy seeks to preserve rather than restore host tissue function by taking advantage of unique properties often displayed by these versatile cells. In studies using different neurodegenerative disease models, transplanted human neural progenitor cells (hNPC) protected dying host neurons within both the brain and spinal cord. Based on these reports, we explored the potential of hNPC transplantation to rescue visual function in an animal model of retinal degeneration, the Royal College of Surgeons rat. Methodology/ Principal Findings. Animals received unilateral subretinal injections of hNPC or medium alone at an age preceding major photoreceptor loss. Principal outcomes were quantified using electroretinography, visual acuity measurements and luminance threshold recordings from the superior colliculus. At 90100 days postnatal, a time point when untreated rats exhibit little or no retinal or visual function, hNPC-treated eyes retained substantial retinal electrical activity and visual field with near-normal visual acuity. Functional efficacy was further enhanced when hNPC were genetically engineered to secrete glial cell line-derived neurotrophic factor. Histological examination at 150 days postnatal showed hNPC had formed a nearly continuous pigmented layer between the neural retina and retinal pigment epithelium, as well as distributed within the inner retina. A concomitant preservation of host cone photoreceptors was also observed. Conclusions/Significance. Wild type and genetically modified human neural progenitor cells survive for prolonged periods, migrate extensively, secrete growth factors and rescue visual functions following subretinal transplantation in the Royal College of Surgeons rat. These results underscore the potential therapeutic utility of hNPC in the treatment of retinal degenerative diseases and suggest potential mechanisms underlying their effect in vivo.	[Gamm, David M.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Svendsen, Clive N.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; [Svendsen, Clive N.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Gamm, David M.; Shearer, Rebecca L.; Capowski, Elizabeth; Svendsen, Clive N.] Univ Wisconsin, Waisman Ctr Stem Cell Res Program, Madison, WI 53706 USA; [Wang, Shaomei; Lu, Bin; Girman, Sergei; Holmes, Toby; Bischoff, Nicholas; Sauve, Yves; Lund, Raymond D.] Univ Utah, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT USA; [Wang, Shaomei; Lu, Bin; Girman, Sergei; Lund, Raymond D.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA; [Sauve, Yves] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Utah System of Higher Education; University of Utah; Oregon Health & Science University; University of Alberta	Gamm, DM (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	dgamm@wisc.edu			Walsh Foundation; Heckrodt Foundation; Foundation Fighting Blindness; Lincy Foundation; NIH [K08EY015138]; Kinetics Foundation and Department of Defense; NATIONAL EYE INSTITUTE [K08EY015138] Funding Source: NIH RePORTER	Walsh Foundation; Heckrodt Foundation; Foundation Fighting Blindness(European Commission); Lincy Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinetics Foundation and Department of Defense; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	DMG laboratory was supported by grants from Walsh Foundation, Heckrodt Foundation, Foundation Fighting Blindness, Lincy Foundation and NIH K08EY015138. DMG is a recipient of a Research to Prevent Blindness Robert E. McCormick Scholar Award and a Retina Research Foundation Award (Edwin and Dorothy Gamewell Professorship). RDL laboratory was supported by grants from Walsh Foundation, Lincy Foundation, Foundation Fighting Blindness and Wynn Foundation. RDL is a recipient of a Research to Prevent Blindness Senior Scientific Investigator Award. CNS laboratory was supported by Kinetics Foundation and Department of Defense.	Andrieu-Soler C, 2005, MOL VIS, V11; Arnhold S, 2004, INVEST OPHTH VIS SCI, V45, P4251, DOI 10.1167/iovs.03-1108; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Bjorklund A, 1997, NEUROBIOL DIS, V4, P186, DOI 10.1006/nbdi.1997.0151; Blesch A, 2001, J COMP NEUROL, V436, P399, DOI 10.1002/cne.1076; Caffe AR, 2001, INVEST OPHTH VIS SCI, V42, P275; CAPOWSKI EE, J NEUROSCI IN PRESS; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Girman S, 2005, VISION RES, V45, P343, DOI 10.1016/j.visres.2004.08.023; Girman SV, 2003, VISION RES, V43, P1817, DOI 10.1016/S0042-6989(03)00276-1; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Hauck SM, 2006, MOL CELL BIOL, V26, P2746, DOI 10.1128/MCB.26.7.2746-2757.2006; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Jomary C, 2004, INVEST OPHTH VIS SCI, V45, P1240, DOI 10.1167/iovs.03-1122; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Klein SM, 2005, HUM GENE THER, V16, P509, DOI 10.1089/hum.2005.16.509; Kretz A, 2006, BRAIN RES, V1090, P1, DOI 10.1016/j.brainres.2006.01.131; Kurimoto Y, 2001, NEUROSCI LETT, V306, P57, DOI 10.1016/S0304-3940(01)01857-2; LaVail M M, 2001, Prog Brain Res, V131, P617; Lawrence JM, 2004, INVEST OPHTH VIS SCI, V45, P267, DOI 10.1167/iovs.03-0093; Lawrence JM, 2000, INVEST OPHTH VIS SCI, V41, P518; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindqvist N, 2004, EXP NEUROL, V187, P487, DOI 10.1016/j.expneurol.2004.02.002; Lu B, 2002, BRAIN RES, V943, P292, DOI 10.1016/S0006-8993(02)02906-2; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mizumoto H, 2003, VISION RES, V43, P1699, DOI 10.1016/S0042-6989(03)00235-9; Mizumoto H, 2001, CELL TRANSPLANT, V10, P223; Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268; Ogilvie JM, 2000, EXP NEUROL, V161, P676, DOI 10.1006/exnr.1999.7291; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Sanftner LHM, 2001, MOL THER, V4, P622, DOI 10.1006/mthe.2001.0498; Sauve Y, 2006, VISION RES, V46, P1459, DOI 10.1016/j.visres.2005.11.009; Sauve Y, 2002, NEUROSCIENCE, V114, P389, DOI 10.1016/S0306-4522(02)00271-3; Sauve Y, 2001, NEUROSCIENCE, V103, P51, DOI 10.1016/S0306-4522(00)00557-1; Schwartz Philip H, 2006, Expert Rev Neurother, V6, P153, DOI 10.1586/14737175.6.2.153; Seigel G, 2000, MOL VIS, V6, P157; Spencer B, 2001, MOL THER, V3, P746, DOI 10.1006/mthe.2001.0307; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Svendsen CN, 2004, NAT MED, V10, P224, DOI 10.1038/nm0304-224; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Tai YT, 2004, CURR OPIN PHARMACOL, V4, P98, DOI 10.1016/j.coph.2003.09.006; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Taupin P, 2006, CURR OPIN MOL THER, V8, P156; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Wang SM, 2005, INVEST OPHTH VIS SCI, V46, P2552, DOI 10.1167/iovs.05-0279; Wang SM, 2005, J COMP NEUROL, V491, P400, DOI 10.1002/cne.20695; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Wu WC, 2004, MOL VIS, V10, P93; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261	67	112	113	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e338	10.1371/journal.pone.0000338	http://dx.doi.org/10.1371/journal.pone.0000338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17396165	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445200021
J	Gillespie, JJ; Beier, MS; Rahman, MS; Ammerman, NC; Shallom, JM; Purkayastha, A; Sobral, BS; Azad, AF				Gillespie, Joseph J.; Beier, Magda S.; Rahman, M. Sayeedur; Ammerman, Nicole C.; Shallom, Joshua M.; Purkayastha, Anjan; Sobral, Bruno S.; Azad, Abdu F.			Plasmids and Rickettsial Evolution: Insight from Rickettsia felis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; RESTRICTION ENDONUCLEASE ANALYSIS; MULTIPLE SEQUENCE ALIGNMENT; COMPLETE GENOME SEQUENCE; HORIZONTAL GENE-TRANSFER; SPOTTED-FEVER; CHLAMYDIA-TRACHOMATIS; IV SECRETION; YERSINIA-PESTIS; MOLECULAR CHARACTERIZATION	Background. The genome sequence of Rickettsia felis revealed a number of rickettsial genetic anomalies that likely contribute not only to a large genome size relative to other rickettsiae, but also to phenotypic oddities that have confounded the categorization of R. felis as either typhus group (TG) or spotted fever group (SFG) rickettsiae. Most intriguing was the first report from rickettsiae of a conjugative plasmid (pRF) that contains 68 putative open reading frames, several of which are predicted to encode proteins with high similarity to conjugative machinery in other plasmid-containing bacteria. Methodology/Principal Findings. Using phylogeny estimation, we determined the mode of inheritance of pRF genes relative to conserved rickettsial chromosomal genes. Phylogenies of chromosomal genes were in agreement with other published rickettsial trees. However, phylogenies including pRF genes yielded different topologies and suggest a close relationship between pRF and ancestral group (AG) rickettsiae, including the recently completed genome of R. bellii str. RML369-C. This relatedness is further supported by the distribution of pRF genes across other rickettsiae, as 10 pRF genes (or inactive derivatives) also occur in AG (but not SFG) rickettsiae, with five of these genes characteristic of typical plasmids. Detailed characterization of pRF genes resulted in two novel findings: the identification of oriV and replication termination regions, and the likelihood that a second proposed plasmid, pRF delta, is an artifact of the original genome assembly. Conclusion/Significance. Altogether, we propose a new rickettsial classification scheme with the addition of a fourth lineage, transitional group (TRG) rickettsiae, that is unique from TG and SFG rickettsiae and harbors genes from possible exchanges with AG rickettsiae via conjugation. We offer insight into the evolution of a plastic plasmid system in rickettsiae, including the role plasmids may have played in the acquirement of virulence traits in pathogenic strains, and the likely origin of plasmids within the rickettsial tree.	[Gillespie, Joseph J.; Beier, Magda S.; Rahman, M. Sayeedur; Ammerman, Nicole C.; Azad, Abdu F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Gillespie, Joseph J.; Shallom, Joshua M.; Purkayastha, Anjan; Sobral, Bruno S.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	University System of Maryland; University of Maryland Baltimore; Virginia Polytechnic Institute & State University	Azad, AF (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	aazad@umaryland.edu	Sobral, Bruno/GVU-7637-2022	Sobral, Bruno/0000-0003-3908-577X; Gillespie, Joseph/0000-0002-5447-7264; Ammerman, Nicole C./0000-0001-9359-9144	NIH [AI59118, AI17828]; NIAID [HHSN266200400035C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059118, R01AI017828, R37AI017828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded through NIH grants AI59118 and AI17828 to AFA and NIAID contract HHSN266200400035C to BSS.	Abergel C, 2006, MOL BIOL EVOL, V23, P2112, DOI 10.1093/molbev/msl082; Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Andersson S G, 1996, Microb Comp Genomics, V1, P293; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; AZAD AF, 1992, P NATL ACAD SCI USA, V89, P43, DOI 10.1073/pnas.89.1.43; Azad AF, 2003, ANN NY ACAD SCI, V990, P734, DOI 10.1111/j.1749-6632.2003.tb07452.x; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Azuma Y, 2006, DNA RES, V13, P15, DOI 10.1093/dnares/dsi027; Bacon DJ, 2002, INFECT IMMUN, V70, P6242, DOI 10.1128/IAI.70.11.6242-6250.2002; Baron C, 2002, MOL MICROBIOL, V43, P1359, DOI 10.1046/j.1365-2958.2002.02816.x; BININDAEMONDS O, 2006, SEQCONVERTER PL VERS; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Blanc G, 2005, ANN NY ACAD SCI, V1063, P83, DOI 10.1196/annals.1355.012; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bouyer DH, 2001, INT J SYST EVOL MICR, V51, P339, DOI 10.1099/00207713-51-2-339; Brinkman FSL, 2002, GENOME RES, V12, P1159, DOI 10.1101/gr.341802; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; BUTS B, 2006, TRENDS BIOCHEM SCI, V30, P673; CAMPBELL LA, 1987, J CLIN MICROBIOL, V25, P1911, DOI 10.1128/JCM.25.10.1911-1916.1987; Cao TB, 2001, MICROBIOL-SGM, V147, P3201, DOI 10.1099/00221287-147-12-3201; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Caturegli P, 2000, INFECT IMMUN, V68, P5277, DOI 10.1128/IAI.68.9.5277-5283.2000; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x; Chung S, 2003, INFECT IMMUN, V71, P1988, DOI 10.1128/IAI.71.4.1988-1994.2003; COPELAND A, 2006, COMPLETE SEQUENCE CH; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Eremeeva ME, 2005, ANN NY ACAD SCI, V1063, P47, DOI 10.1196/annals.1355.006; EREMEEVA ME, 2006, 20 M AM SOC RICK CON; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenn K, 2006, PLOS PATHOG, V2, P887, DOI 10.1371/journal.ppat.0020094; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Fomenko DE, 2003, ANTIMICROB AGENTS CH, V47, P2868, DOI 10.1128/AAC.47.9.2868-2874.2003; Fournier PE, 2003, J CLIN MICROBIOL, V41, P5456, DOI 10.1128/JCM.41.12.5456-5465.2003; Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Hinnebusch J, 2000, INT J MED MICROBIOL, V290, P483, DOI 10.1016/S1438-4221(00)80070-3; Holden M, 2005, NAT REV MICROBIOL, V3, P912, DOI 10.1038/nrmicro1292; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; HUEBNER RJ, 1946, PUBLIC HEALTH REP, V61, P1677, DOI 10.2307/4585913; HYYPIA T, 1984, J GEN MICROBIOL, V130, P3159; Ishikura M, 2002, MICROBIOL IMMUNOL, V46, P241, DOI 10.1111/j.1348-0421.2002.tb02692.x; Itoh T, 2002, P NATL ACAD SCI USA, V99, P12944, DOI 10.1073/pnas.192449699; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; JOSEPH T, 1986, INFECT IMMUN, V51, P699, DOI 10.1128/IAI.51.2.699-703.1986; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Kill K, 2005, MICROBIOL-SGM, V151, P3147, DOI 10.1099/mic.0.28339-0; Klockgether J, 2004, J BACTERIOL, V186, P518, DOI 10.1128/JB.186.2.518-534.2004; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lawson ET, 2001, HEREDITY, V86, P497, DOI 10.1046/j.1365-2540.2001.00848.x; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Licht TR, 2006, ADV APPL MICROBIOL, V58, P77, DOI 10.1016/S0065-2164(06)58002-X; Liu Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r64; Lovett M, 1980, CURRENT CHEMOTHERAPY, P1250; LUSHER M, 1989, J GEN MICROBIOL, V135, P1145; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; MCCLENAGHAN M, 1988, J GEN MICROBIOL, V134, P559; METZGER S, 1988, J BIOL CHEM, V263, P15699; Miyamoto H, 2003, J BACTERIOL, V185, P6712, DOI 10.1128/JB.185.22.6712-6718.2003; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; NOVICK RP, 1976, BACTERIOL REV, V40, P168, DOI 10.1128/MMBR.40.1.168-189.1976; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; O'Connell CM, 2006, MICROBIOL-SGM, V152, P1601, DOI 10.1099/mic.0.28658-0; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogata H, 2005, ANN NY ACAD SCI, V1063, P26, DOI 10.1196/annals.1355.004; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; PALMER L, 1986, PLASMID, V16, P52, DOI 10.1016/0147-619X(86)90079-X; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; PEARCE BJ, 1991, PLASMID, V26, P116, DOI 10.1016/0147-619X(91)90051-W; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; PETERSON EM, 1988, J CLIN MICROBIOL, V26, P625, DOI 10.1128/JCM.26.4.625-629.1988; PHILIP RN, 1983, INT J SYST BACTERIOL, V33, P94, DOI 10.1099/00207713-33-1-94; Picardeau M, 2000, GENOME RES, V10, P1594, DOI 10.1101/gr.124000; Pickett MA, 2005, MICROBIOL-SGM, V151, P893, DOI 10.1099/mic.0.27625-0; Pornwiroon W, 2006, APPL ENVIRON MICROB, V72, P5589, DOI 10.1128/AEM.00532-06; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2003, GENOME RES, V13, P1800, DOI 10.1101/gr.1474603; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; SAMUEL JE, 1985, INFECT IMMUN, V49, P775, DOI 10.1128/IAI.49.3.775-779.1985; SAMUEL JE, 1983, INFECT IMMUN, V41, P488, DOI 10.1128/IAI.41.2.488-493.1983; SAVINELLI EA, 1990, ANN NY ACAD SCI, V590, P523, DOI 10.1111/j.1749-6632.1990.tb42262.x; Scully LR, 2006, FEMS MICROBIOL LETT, V263, P1, DOI 10.1111/j.1574-6968.2006.00388.x; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sexton JA, 2002, TRAFFIC, V3, P178, DOI 10.1034/j.1600-0854.2002.030303.x; Sikora S, 2005, TRENDS MICROBIOL, V13, P522, DOI 10.1016/j.tim.2005.08.010; SNYDER EE, 2007, NUCL ACIDS IN PRESS; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Stenos J, 2000, INT J SYST EVOL MICR, V50, P1775, DOI 10.1099/00207713-50-5-1775; STOTHARD DR, 1995, SYST APPL MICROBIOL, V18, P52, DOI 10.1016/S0723-2020(11)80448-0; STOTHARD DR, 1994, INT J SYST BACTERIOL, V44, P798, DOI 10.1099/00207713-44-4-798; Strauch E, 2003, MICROBIOL-SGM, V149, P2829, DOI 10.1099/mic.0.26418-0; Sundin GW, 2004, MOL GENET GENOMICS, V270, P462, DOI 10.1007/s00438-003-0945-9; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; van Passel MWJ, 2006, INFECT IMMUN, V74, P4892, DOI 10.1128/IAI.02087-05; van Passel MWJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-26; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Waterfield NR, 2004, NAT REV MICROBIOL, V2, P833, DOI 10.1038/nrmicro1008; WEISBURG WG, 1989, J BACTERIOL, V171, P4202, DOI 10.1128/JB.171.8.4202-4206.1989; Whitworth T, 2005, INFECT IMMUN, V73, P6668, DOI 10.1128/IAI.73.10.6668-6673.2005; Willems H, 1997, J BACTERIOL, V179, P3293, DOI 10.1128/jb.179.10.3293-3297.1997; Wolf YI, 1999, TRENDS GENET, V15, P173, DOI 10.1016/S0168-9525(99)01704-7; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Yin YB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-63; Zavala-Velazquez E, 2002, VECTOR-BORNE ZOONOT, V2, P69, DOI 10.1089/153036602321131869; Zhang YX, 2004, CELL RES, V14, P208, DOI 10.1038/sj.cr.7290221	137	169	177	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e266	10.1371/journal.pone.0000266	http://dx.doi.org/10.1371/journal.pone.0000266			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17342200	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444700001
J	Morgan, MJ; McEwan, W; Solomon, J				Morgan, Michael J.; McEwan, William; Solomon, Joshua			The Lingering Effects of an Artificial Blind Spot	PLOS ONE			English	Article								Background. When steady fixation is maintained on the centre of a large patch of texture, holes in the periphery of the texture rapidly fade from awareness, producing artificial scotomata (i.e., invisible areas of reduced vision, like the natural 'blind spot'). There has been considerable controversy about whether this apparent 'filling in' depends on a low-level or high-level visual process. Evidence for an active process is that when the texture around the scotomata is suddenly removed, phantasms of the texture appear within the previous scotomata. Methodology. To see if these phantasms were equivalent to real low-level signals, we measured contrast discrimination for real dynamic texture patches presented on top of the phantasms. Principal Findings. Phantasm intensity varied with adapting contrast. Contrast discrimination depended on both (real) pedestal contrast and phantasm intensity, in a manner indicative of a common sensory threshold. The phantasms showed inter-ocular transfer, proving that their effects are cortical rather than retinal. Conclusions. We show that this effect is consistent with a tonic spreading of the adapting texture into the scotomata, coupled with some overall loss of sensitivity. Our results support the view that 'filling in' happens at an early stage of visual processing, quite possibly in primary visual cortex (V1).	[Morgan, Michael J.; McEwan, William; Solomon, Joshua] City Univ London, Dept Optometry & Visual Sci, Henry Wellcome Vis Labs, London, England	City University London	Morgan, MJ (corresponding author), City Univ London, Dept Optometry & Visual Sci, Henry Wellcome Vis Labs, London, England.	m.morgan@city.ac.uk		McEwan, William/0000-0002-4408-0407	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The Wellcome Trust (UK registered charity)	BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; BRADLEY A, 1988, VISION RES, V28, P841, DOI 10.1016/0042-6989(88)90031-4; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P437, DOI 10.1113/jphysiol.1966.sp008101; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; LEGGE GE, 1987, J OPT SOC AM A, V4, P391, DOI 10.1364/JOSAA.4.000391; Lou LG, 1999, PERCEPTION, V28, P519, DOI 10.1068/p2816; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; Reich LN, 2000, VISION RES, V40, P805, DOI 10.1016/S0042-6989(99)00215-1; TROXLER D, 1804, OPHTHALMOLOGISCHES B, V2, P51	15	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e256	10.1371/journal.pone.0000256	http://dx.doi.org/10.1371/journal.pone.0000256			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327917	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000207444600016
J	Zhang, GC; Assadi, AH; McNeil, RS; Beffert, U; Wynshaw-Boris, A; Herz, J; Clark, GD; D'Arcangelo, G				Zhang, Guangcheng; Assadi, Amir H.; McNeil, Robert S.; Beffert, Uwe; Wynshaw-Boris, Anthony; Herz, Joachim; Clark, Gary D.; D'Arcangelo, Gabriella			The Pafah1b Complex Interacts with the Reelin Receptor VLDLR	PLOS ONE			English	Article								Reelin is an extracellular protein that directs the organization of cortical structures of the brain through the activation of two receptors, the very low-density lipoprotein receptor (VLDLR) and the apolipoprotein E receptor 2 (ApoER2), and the phosphorylation of Disabled-1 (Dab1). Lis1, the product of the Pafah1b1 gene, is a component of the brain platelet-activating factor acetylhydrolase 1b (Pafah1b) complex, and binds to phosphorylated Dab1 in response to Reelin. Here we investigated the involvement of the whole Pafah1b complex in Reelin signaling and cortical layer formation and found that catalytic subunits of the Pafah1b complex, Pafah1b2 and Pafah1b3, specifically bind to the NPxYL sequence of VLDLR, but not to ApoER2. Compound Pafah1b1(+/-); Apoer2(-/-) mutant mice exhibit a reeler-like phenotype in the forebrain consisting of the inversion of cortical layers and hippocampal disorganization, whereas double Pafah1b1(+/-); Vldlr(-/-) mutants do not. These results suggest that a cross-talk between the Pafah1b complex and Reelin occurs downstream of the VLDLR receptor.	[Zhang, Guangcheng; Assadi, Amir H.; McNeil, Robert S.; Clark, Gary D.; D'Arcangelo, Gabriella] Texas Childrens Hosp, Cain Fdn Labs, Houston, TX 77030 USA; [Zhang, Guangcheng; Assadi, Amir H.; McNeil, Robert S.; Clark, Gary D.; D'Arcangelo, Gabriella] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Clark, Gary D.; D'Arcangelo, Gabriella] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Clark, Gary D.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [D'Arcangelo, Gabriella] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [D'Arcangelo, Gabriella] Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Beffert, Uwe; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Wynshaw-Boris, Anthony] Univ Calif San Diego, Sch Med, Dept Pediat & Med, La Jolla, CA 92093 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	D'Arcangelo, G (corresponding author), Texas Childrens Hosp, Cain Fdn Labs, Houston, TX 77030 USA.	gangelo@bcm.tmc.edu		D'Arcangelo, Gabriella/0000-0003-1575-1010	National Institute of Disorders and Stroke/NIH [R01 NS042616]; NIH [HL20948, HL63762, NS43408]; Perot Family Foundation; Humboldt Foundation; Mental Retardation and Developmental Disabilities Research Center (MRDDRC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762, P01HL020948, R01HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043408, R01NS042616] Funding Source: NIH RePORTER	National Institute of Disorders and Stroke/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; Humboldt Foundation(Alexander von Humboldt Foundation); Mental Retardation and Developmental Disabilities Research Center (MRDDRC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a grant from the National Institute of Disorders and Stroke/NIH R01 NS042616 (G.D.), NIH grants HL20948, HL63762, NS43408, the Perot Family Foundation and the Humboldt Foundation (J.H.) and by the Mental Retardation and Developmental Disabilities Research Center (MRDDRC) at Baylor College of Medicine.	Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; Andersen OM, 2003, J BIOL CHEM, V278, P23989, DOI 10.1074/jbc.M302157200; Assadi AH, 2003, NAT GENET, V35, P270, DOI 10.1038/ng1257; Ballif BA, 2003, MOL BRAIN RES, V117, P152, DOI 10.1016/S0169-328X(03)00295-X; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Benhayon D, 2003, MOL BRAIN RES, V112, P33, DOI 10.1016/S0169-328X(03)00032-9; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 2005, INT REV NEUROBIOL, P383; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Huang YC, 2004, BIOCHEM BIOPH RES CO, V318, P204, DOI 10.1016/j.bbrc.2004.04.023; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Koizumi H, 2003, J BIOL CHEM, V278, P12489, DOI 10.1074/jbc.M211836200; Kuo G, 2005, J NEUROSCI, V25, P8578, DOI 10.1523/JNEUROSCI.1656-05.2005; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Nothwang HG, 2001, HUM MOL GENET, V10, P797, DOI 10.1093/hmg/10.8.797; Pramatarova A, 2003, MOL CELL BIOL, V23, P7210, DOI 10.1128/MCB.23.20.7210-7221.2003; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Suetsugu S, 2004, BIOCHEM J, V384, P1, DOI 10.1042/BJ20041103; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yan W, 2003, P NATL ACAD SCI USA, V100, P7189, DOI 10.1073/pnas.1236145100	42	36	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e252	10.1371/journal.pone.0000252	http://dx.doi.org/10.1371/journal.pone.0000252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17330141	Green Submitted, gold, Green Published			2022-12-27	WOS:000207444600012
J	Baratin, M; Roetynck, S; Pouvelle, B; Lemmers, C; Viebig, NK; Johansson, S; Bierling, P; Scherf, A; Gysin, J; Vivier, E; Ugolini, S				Baratin, Myriam; Roetynck, Sophie; Pouvelle, Bruno; Lemmers, Celine; Viebig, Nicola K.; Johansson, Sofia; Bierling, Philippe; Scherf, Artur; Gysin, Juerg; Vivier, Eric; Ugolini, Sophie			Dissection of the Role of PfEMP1 and ICAM-1 in the Sensing of Plasmodium falciparum-Infected Erythrocytes by Natural Killer Cells	PLOS ONE			English	Article								Background. Host innate immunity contributes to malaria clinical outcome by providing protective inflammatory cytokines such as interferon-gamma, and by shaping the adaptive immune response. Plasmodium falciparum (Pf) is the etiologic agent of the most severe forms of human malaria. Natural Killer (NK) cells are lymphocytes of the innate immune system that are the first effectors to produce interferon-gamma in response to Pf. However, the molecular bases of Pf-NK cell recognition events are unknown. Our study focuses on the role of Pf erythrocyte membrane protein 1 (PfEMP1), a major Pf virulence factor. PfEMP1 is expressed on parasitized-erythrocytes and participates to vascular obstruction through the binding to several host receptors. PfEMP1 is also a pivotal target for host antibody response to Pf infection. Methodology/Principal Findings. Using genetically-engineered parasite mutant strains, a human genetic deficiency, and blocking antibodies, we identified two receptor-ligand pairs involved in two uncoupled events occurring during the sensing of Pf infection by NK cells. First, PfEMP1 interaction with one of its host receptor, chondroitin sulfate A, mediates the cytoadhesion of Pf-infected erythrocytes to human NK cell lines, but is not required for primary NK cell activation. Second, intercellular adhesion molecule-1 (ICAM-1), another host receptor for PfEMP1, is mandatory for NK cell interferon-gamma response. In this case, ICAM-1 acts via its engagement with its host ligand, LFA-1, and not with PfEMP1, consistent with the obligatory cross-talk of NK cells with macrophages for their production of interferon-gamma. Conclusion/Significance. PfEMP1-independent but ICAM-1/LFA-1-dependent events occurring during NK cell activation by Pf highlight the fundamental role of cellular cooperation during innate immune response to malaria.	[Baratin, Myriam; Roetynck, Sophie; Lemmers, Celine; Johansson, Sofia; Vivier, Eric; Ugolini, Sophie] Aix Marseille Univ, Fac Sci Luminy, CIML, Marseille, France; [Baratin, Myriam; Roetynck, Sophie; Lemmers, Celine; Johansson, Sofia; Vivier, Eric; Ugolini, Sophie] INSERM, U631, F-13258 Marseille, France; [Baratin, Myriam; Roetynck, Sophie; Lemmers, Celine; Johansson, Sofia; Vivier, Eric; Ugolini, Sophie] CNRS, UMR6102, Marseille, France; [Pouvelle, Bruno; Gysin, Juerg] Univ Aix Marseille 2, Unite Parasitol Expt, Marseille, France; [Viebig, Nicola K.; Scherf, Artur] Inst Pasteur, Paris, France; [Viebig, Nicola K.; Scherf, Artur] CNRS, Paris, France; [Bierling, Philippe] Etab Francais Sang, Creteil, France; [Vivier, Eric] Hop Conception, AP HM, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vivier, E (corresponding author), Aix Marseille Univ, Fac Sci Luminy, CIML, Marseille, France.	vivier@ciml.univ-mrs.fr; ugolini@ciml.univ-mrs.fr	Vivier, Eric/F-8939-2010; Pouvelle, Bruno/AAA-3968-2022; Scherf, Artur/A-9674-2014; Johansson, Sofia/B-9043-2011	Vivier, Eric/0000-0001-7022-8287; Johansson, Sofia/0000-0002-9295-6266; Ugolini, Sophie/0000-0003-4041-0103; Scherf, Artur/0000-0003-2411-3328	European Union [FP6, LSHB-CT-2004-503319-Allostem]; Ligue Nationale contre le Cancer ("Equipe labellisee La Ligue''); Agence Nationale de la Recherche ("Reseau Innovation Biotechnologies'' and "Microbiologie Immunologie-Maladies Emergentes''); INSERM; CNRS; Ministere de l'Enseignement Superieur et de la Recherche; BioMalPar program [LSHP-CT-2004-503578]; Fond Dedier, Institut Pasteur; Malaria in Pregnancy Initiative of the Melinda and Bill Gates Foundation [2902]	European Union(European Commission); Ligue Nationale contre le Cancer ("Equipe labellisee La Ligue'')(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche ("Reseau Innovation Biotechnologies'' and "Microbiologie Immunologie-Maladies Emergentes'')(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); BioMalPar program; Fond Dedier, Institut Pasteur; Malaria in Pregnancy Initiative of the Melinda and Bill Gates Foundation(Bill & Melinda Gates Foundation)	E. V. lab is supported by European Union FP6, LSHB-CT-2004-503319-Allostem, Ligue Nationale contre le Cancer ("Equipe labellisee La Ligue''), Agence Nationale de la Recherche ("Reseau Innovation Biotechnologies'' and "Microbiologie Immunologie-Maladies Emergentes''), INSERM, CNRS and Ministere de l'Enseignement Superieur et de la Recherche. AS and JG labs are supported by the BioMalPar program (LSHP-CT-2004-503578), a FP6 funded network of excellence and the Fond Dedier, Institut Pasteur. JG lab is also supported by the Malaria Antigen Discovery Program (MADP) Malaria in Pregnancy Initiative of the Melinda and Bill Gates Foundation (grant no. 2902).	Artavanis-Tsakonas K, 2003, J IMMUNOL, V171, P5396, DOI 10.4049/jimmunol.171.10.5396; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Craig A, 2000, HUM MOL GENET, V9, P525, DOI 10.1093/hmg/9.4.525; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Flick K, 2004, MOL BIOCHEM PARASIT, V134, P3, DOI 10.1016/j.molbiopara.2003.09.010; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Frick C, 2005, EUR J IMMUNOL, V35, P3610, DOI 10.1002/eji.200425914; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hargreaves DC, 2005, J CLIN IMMUNOL, V25, P503, DOI 10.1007/s10875-005-8065-4; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Korbel DS, 2005, J IMMUNOL, V175, P7466, DOI 10.4049/jimmunol.175.11.7466; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lee K, 1999, TRANSFUSION, V39, P873, DOI 10.1046/j.1537-2995.1999.39080873.x; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Pouvelle B, 1998, INFECT IMMUN, V66, P4950, DOI 10.1128/IAI.66.10.4950-4956.1998; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Urban BC, 2005, CURR TOP MICROBIOL, V297, P25; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736	41	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e228	10.1371/journal.pone.0000228	http://dx.doi.org/10.1371/journal.pone.0000228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311092	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444500009
J	Perez, JM; Calderon, IL; Arenas, FA; Fuentes, DE; Pradenas, GA; Fuentes, EL; Sandoval, JM; Castro, ME; Elias, AO; Vasquez, CC				Perez, Jose M.; Calderon, Ivan L.; Arenas, Felipe A.; Fuentes, Derie E.; Pradenas, Gonzalo A.; Fuentes, Eugenia L.; Sandoval, Juan M.; Castro, Miguel E.; Elias, Alex O.; Vasquez, Claudio C.			Bacterial Toxicity of Potassium Tellurite: Unveiling an Ancient Enigma	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; GENE-EXPRESSION; RESISTANCE; INACTIVATION; IDENTIFICATION; SENSITIVITY; RESPONSES; ENZYMES; IBPB	Biochemical, genetic, enzymatic and molecular approaches were used to demonstrate, for the first time, that tellurite (TeO32-) toxicity in E. coli involves superoxide formation. This radical is derived, at least in part, from enzymatic TeO32- reduction. This conclusion is supported by the following observations made in K2TeO3-treated E. coli BW25113: i) induction of the ibpA gene encoding for the small heat shock protein IbpA, which has been associated with resistance to superoxide, ii) increase of cytoplasmic reactive oxygen species (ROS) as determined with ROS-specific probe 2'7'-dichlorodihydrofluorescein diacetate (H(2)DCFDA), iii) increase of carbonyl content in cellular proteins, iv) increase in the generation of thiobarbituric acid-reactive substances (TBARs), v) inactivation of oxidative stress-sensitive [Fe-S] enzymes such as aconitase, vi) increase of superoxide dismutase (SOD) activity, vii) increase of sodA, sodB and soxS mRNA transcription, and viii) generation of superoxide radical during in vitro enzymatic reduction of potassium tellurite.	[Perez, Jose M.; Calderon, Ivan L.; Arenas, Felipe A.; Fuentes, Derie E.; Pradenas, Gonzalo A.; Fuentes, Eugenia L.; Sandoval, Juan M.; Castro, Miguel E.; Elias, Alex O.; Vasquez, Claudio C.] Univ Santiago Chile, Mol Microbiol Lab, Fac Quim & Biol, Santiago, Chile	Universidad de Santiago de Chile	Vasquez, CC (corresponding author), Univ Santiago Chile, Mol Microbiol Lab, Fac Quim & Biol, Santiago, Chile.	cvasquez@usach.cl	Pérez-Donoso, José M./G-3668-2013; Fuentes, Derie/GLS-8773-2022	Pérez-Donoso, José M./0000-0002-9506-1716; Fuentes, Derie/0000-0002-8189-8515	MECESUP; CONICYT; FONDECYT [1060022]; Dicyt, Universidad de Santiago de Chile	MECESUP; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Dicyt, Universidad de Santiago de Chile	JMP, DEF and JMS received fellowships from MECESUP and ILC, FAA, MEC received fellowships from CONICYT. This work was supported in part by FONDECYT grant 1060022 to CCV and by Dicyt, Universidad de Santiago de Chile.	Araya MA, 2004, J BIOL INORG CHEM, V9, P609, DOI 10.1007/s00775-004-0554-z; Avazeri C, 1997, MICROBIOL-SGM, V143, P1181, DOI 10.1099/00221287-143-4-1181; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BERGMEYER HU, 1974, METHOD ENZYMAT AN, V1, P485; Bianchi AA, 1999, APPL ENVIRON MICROB, V65, P5023; Borsetti F, 2005, RES MICROBIOL, V156, P807, DOI 10.1016/j.resmic.2005.03.011; Calderon IL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000070; Chen GZ, 2003, ANTIMICROB AGENTS CH, V47, P3485, DOI 10.1128/AAC.47.11.3485-3493.2003; CHIONG M, 1988, J BACTERIOL, V170, P3269, DOI 10.1128/jb.170.7.3269-3273.1988; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEMPLE B, 1991, ANNU REV GENET, V25, P315, DOI 10.1146/annurev.ge.25.120191.001531; Echave P, 2003, J BIOL CHEM, V278, P30193, DOI 10.1074/jbc.M304351200; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Goldenberg D, 1996, MOL MICROBIOL, V19, P241, DOI 10.1046/j.1365-2958.1996.363898.x; GOLDSTEIN J, 1990, P NATL ACAD SCI USA, V87, P283, DOI 10.1073/pnas.87.1.283; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; ITOH M, 1995, J BIOCHEM-TOKYO, V4, P780; Jakubowski W, 2000, FREE RADICAL BIO MED, V28, P659, DOI 10.1016/S0891-5849(99)00266-X; Kitagawa M, 2000, FEMS MICROBIOL LETT, V184, P165, DOI 10.1111/j.1574-6968.2000.tb09009.x; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lohmeier-Vogel EM, 2004, APPL ENVIRON MICROB, V70, P7342, DOI 10.1128/AEM.70.12.7342-7347.2004; Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x; Moscoso H, 1998, RES MICROBIOL, V149, P389, DOI 10.1016/S0923-2508(98)80321-5; OGara JP, 1997, APPL ENVIRON MICROB, V63, P4713, DOI 10.1128/AEM.63.12.4713-4720.1997; Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611; Rice-Evans C, 1991, LAB TECHNIQUES BIOCH, V22, P147; Rojas DM, 2005, RES MICROBIOL, V156, P465, DOI 10.1016/j.resmic.2004.12.010; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHNARR M, 1991, BIOCHIMIE, V73, P423, DOI 10.1016/0300-9084(91)90109-E; SEKO Y, SELENIUM BIOL MED, P70; Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002; Shapiro E, 2002, ANTIMICROB AGENTS CH, V46, P2490, DOI 10.1128/AAC.46.8.2490-2497.2002; Silver S, 1998, J IND MICROBIOL BIOT, V20, P1, DOI 10.1038/sj.jim.2900483; SPALLHOLZ JE, 1994, FREE RADICAL BIO MED, V17, P45, DOI 10.1016/0891-5849(94)90007-8; SUMMERS AO, 1977, J BACTERIOL, V129, P276, DOI 10.1128/JB.129.1.276-281.1977; Tantalean JC, 2003, J BACTERIOL, V185, P5831, DOI 10.1128/JB.185.19.5831-5837.2003; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Tremaroli V, 2007, ARCH MICROBIOL, V187, P127, DOI 10.1007/s00203-006-0179-4; Turner RJ, 1999, MICROBIOL-UK, V145, P2549, DOI 10.1099/00221287-145-9-2549; Vasquez CC, 2001, CURR MICROBIOL, V43, P418, DOI 10.1007/s002840010331; Wang AY, 2005, J BACTERIOL, V187, P3259, DOI 10.1128/JB.187.9.3259-3266.2005; Westenberg DJ, 1997, ADV GENET, V36, P187, DOI 10.1016/S0065-2660(08)60310-7	45	126	130	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e211	10.1371/journal.pone.0000211	http://dx.doi.org/10.1371/journal.pone.0000211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299591	Green Published, gold			2022-12-27	WOS:000207444400012
J	Glisic-Milosavljevic, S; Waukau, J; Jailwala, P; Jana, S; Khoo, HJ; Albertz, H; Woodliff, J; Koppen, M; Alemzadeh, R; Hagopian, W; Ghosh, S				Glisic-Milosavljevic, Sanja; Waukau, Jill; Jailwala, Parthav; Jana, Srikanta; Khoo, Huoy-Jii; Albertz, Hope; Woodliff, Jeffrey; Koppen, Marilyn; Alemzadeh, Ramin; Hagopian, William; Ghosh, Soumitra			At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+(high) T-Cell Fraction	PLOS ONE			English	Article								Background. In experimental models, Type 1 diabetes (T1D) can be prevented by adoptive transfer of CD4+CD25+ (FoxP3+) suppressor or regulatory T cells. Recent studies have found a suppression defect of CD4+CD25+(high) T cells in human disease. In this study we measure apoptosis of CD4+CD25+(high) T cells to see if it could contribute to reduced suppressive activity of these cells. Methods and Findings. T-cell apoptosis was evaluated in children and adolescent (35 females/40 males) subjects comprising recent-onset and long-standing T1D subjects and their first-degree relatives, who are at variable risk to develop T1D. YOPRO1/7AAD and intracellular staining of the active form of caspase 3 were used to evaluate apoptosis. Isolated CD4+CD25+(high) and CD4+CD25- T cells were co-cultured in a suppression assay to assess the function of the former cells. We found that recent-onset T1D subjects show increased apoptosis of CD4+CD25+(high) T cells when compared to both control and long-standing T1D subjects (p<0.0001 for both groups). Subjects at high risk for developing T1D ( 2-3Ab+ve) show a similar trend (p<0.02 and p<0.01, respectively). On the contrary, in long-standing T1D and T2D subjects, CD4+CD25+(high) T cell apoptosis is at the same level as in control subjects (p = NS). Simultaneous intracellular staining of the active form of caspase 3 and FoxP3 confirmed recent-onset FoxP3+ve CD4+CD25+(high) T cells committed to apoptosis at a higher percentage (15.3 +/- 2.2) compared to FoxP3+ve CD4+CD25+(high) T cells in control subjects (6.1 +/- 1.7) (p<0.002). Compared to control subjects, both recent-onset T1D and high at-risk subjects had significantly decreased function of CD4+CD25+(high) T cells (p = 0.0007 and p = 0.007, respectively). Conclusions. There is a higher level of ongoing apoptosis in CD4+CD25+(high) T cells in recent-onset T1D subjects and in subjects at high risk for the disease. This high level of CD4+CD25+(high) T-cell apoptosis could be a contributing factor to markedly decreased suppressive potential of these cells in recent-onset T1D subjects.	[Glisic-Milosavljevic, Sanja; Waukau, Jill; Jailwala, Parthav; Jana, Srikanta; Khoo, Huoy-Jii; Koppen, Marilyn; Ghosh, Soumitra] Med Coll Wisconsin, Max McGee Natl Ctr Juvenile Diabet, Milwaukee, WI 53226 USA; [Glisic-Milosavljevic, Sanja; Waukau, Jill; Jailwala, Parthav; Jana, Srikanta; Khoo, Huoy-Jii; Koppen, Marilyn; Ghosh, Soumitra] Med Coll Wisconsin, Human Mol Genet Ctr, Milwaukee, WI 53226 USA; [Glisic-Milosavljevic, Sanja; Waukau, Jill; Jailwala, Parthav; Jana, Srikanta; Khoo, Huoy-Jii; Koppen, Marilyn; Ghosh, Soumitra] Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53201 USA; [Albertz, Hope] Med Coll Wisconsin, Blood Ctr Wisconsin, Milwaukee, WI 53226 USA; [Woodliff, Jeffrey] Med Coll Wisconsin, Dept Pediat, Flow Cytometry Core Facil, Milwaukee, WI 53226 USA; [Alemzadeh, Ramin] Childrens Hosp Wisconsin, Med Coll Wisconsin, Diabet Ctr Pediat Endocrinol & Metab, Milwaukee, WI 53201 USA; [Hagopian, William] Pacific NW Res Inst, Seattle, WA USA	Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Medical College of Wisconsin	Ghosh, S (corresponding author), Med Coll Wisconsin, Max McGee Natl Ctr Juvenile Diabet, Milwaukee, WI 53226 USA.	sghosh@mcw.edu			Max McGee National Center for Juvenile Diabetes; Children's Research Institute; National Institutes of Health [M01-RR00058]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER	Max McGee National Center for Juvenile Diabetes; Children's Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Part of the study was funded through The Max McGee National Center for Juvenile Diabetes private fund and The Children's Research Institute. The study was also funded through GCRC Grant M01-RR00058 from the National Institutes of Health. The funding source didn't have any role or influence on study design, collection of data, analysis and interpretation of results.	Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Baecher-Allan C, 2005, CLIN IMMUNOL, V115, P10, DOI 10.1016/j.clim.2005.02.018; Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Buckner JH, 2004, ARTHRITIS RES THER, V6, P215, DOI 10.1186/ar1226; Dosch HM, 1999, J IMMUNOL, V163, P6933; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; GIORDANO C, 1995, DIABETOLOGIA, V38, P1449, DOI 10.1007/BF00400606; GIORDANO C, 1995, DIABETOLOGIA, V38, P953, DOI 10.1007/BF00400585; Glisic-Milosavljevic S, 2005, CELL PROLIFERAT, V38, P301, DOI 10.1111/j.1365-2184.2005.00351.x; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Hori S, 2004, MICROBES INFECT, V6, P745, DOI 10.1016/j.micinf.2004.02.020; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liston A, 2004, IMMUNITY, V21, P817, DOI 10.1016/S1074-7613(04)00313-9; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lundsgaard D, 2005, DIABETES, V54, P1040, DOI 10.2337/diabetes.54.4.1040; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Otton R, 2004, J ENDOCRINOL, V182, P145, DOI 10.1677/joe.0.1820145; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Woo W, 2000, J IMMUNOL METHODS, V244, P91, DOI 10.1016/S0022-1759(00)00259-3; World Health Organization, 1999, DIAGN CLASS DIAB MEL	35	51	53	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2007	2	1							e146	10.1371/journal.pone.0000146	http://dx.doi.org/10.1371/journal.pone.0000146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DD	17206281	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443800008
J	Chikhlikar, P; de Arruda, LB; Maciel, M; Silvera, P; Lewis, MG; August, JT; Marques, ETA				Chikhlikar, Priya; de Arruda, Luciana Barros; Maciel, Milton; Silvera, Peter; Lewis, Mark G.; August, J. Thomas; Marques, Ernesto T. A.			DNA Encoding an HIV-1 Gag/Human Lysosome-Associated Membrane Protein-1 Chimera Elicits a Broad Cellular and Humoral Immune Response in Rhesus Macaques	PLOS ONE			English	Article								Previous studies of HIV-1 p55Gag immunization of mice have demonstrated the usefulness of targeting antigens to the cellular compartment containing the major histocompatibility complex type II (MHC II) complex molecules by use of a DNA antigen formulation encoding Gag as a chimera with the mouse lysosome-associated membrane protein (mLAMP/gag). In the present study, we have analyzed the magnitude and breadth of Gag-specific T-lymphocyte and antibody responses elicited in Rhesus macaques after immunization with DNA encoding a human LAMP/gag(hLAMP/gag) chimera. ELISPOT analyses indicated that the average Gag-specific IFN-gamma response elicited by the hLAMP/gag chimera was detectable after only two or three naked DNA immunizations in all five immunized macaques and reached an average of 1000 spot-forming cells (SFC)/10(6) PBMCs. High IFN-gamma ELISPOT responses were detected in CD8(+)-depleted cells, indicating that CD4(+) T-cells play a major role in these responses. The T-cell responses of four of the macaques were also tested by use of ELISPOT to 12 overlapping 15-amino acids (aa) peptide pools containing ten peptides each, encompassing the complete Gag protein sequence. The two Mamu 08 immunized macaques responded to eight and twelve of the pools, the Mamu B01 to six, and the other macaque to five pools indicating that the hLAMP/gag DNA antigen formulation elicits a broad T-cell response against Gag. Additionally, there was a strong HIV-1-specific IgG response. The IgG antibody titers increased after each DNA injection, indicating a strong amnestic B-cell response, and were highly elevated in all the macaques after three immunizations. Moreover, the serum of each macaque recognized 13 of the 49 peptides of a 20-aa peptide library covering the complete Gag amino acid sequence. In addition, HIV-1-specific IgA antibodies were present in the plasma and external secretions, including nasal washes. These data support the findings of increased immunogenicity of genetic vaccines encoded as LAMP chimeras, including the response to DNA vaccines by non-human primates.	[Chikhlikar, Priya; Maciel, Milton; August, J. Thomas; Marques, Ernesto T. A.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA; [de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Silvera, Peter; Lewis, Mark G.] So Res Inst, Frederick, MD USA; [Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, FIOCRUZ, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil; [Marques, Ernesto T. A.] Johns Hopkins Sch Med, Div Infect Dis, Dept Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Johns Hopkins University; Johns Hopkins Medicine	Marques, ETA (corresponding author), Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA.	emarques@jhmi.edu	Marques, Ernesto/L-4514-2013; Marques, Ernesto T. A/L-4967-2013; Arruda, Luciana/B-5806-2014; Arruda, Luciana B/N-9086-2013	Marques, Ernesto/0000-0003-3826-9358; Marques, Ernesto T. A/0000-0003-3826-9358; 	National Institute of Allergy and Infectious Disease, National Institutes of Health, USA [R37-AI41908, R21-AI44317, N01-AI-15429]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI041908, R01AI015429, R21AI044317] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Grants R37-AI41908, R21-AI44317 and N01-AI-15429 "Simian Vaccine Evaluation Unit'' contract from the National Institute of Allergy and Infectious Disease, National Institutes of Health, USA	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Anwar A, 2005, VIROLOGY, V332, P66, DOI 10.1016/j.virol.2004.11.022; Arruda LB, 2006, J IMMUNOL, V177, P2265, DOI 10.4049/jimmunol.177.4.2265; BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; Bonini C, 2001, J IMMUNOL, V166, P5250, DOI 10.4049/jimmunol.166.8.5250; CARPIO E, 1991, AIDS RES HUM RETROV, V7, P97, DOI 10.1089/aid.1991.7.97; Casimiro DR, 2003, J VIROL, V77, P7663, DOI 10.1128/JVI.77.13.7663-7668.2003; Chikhlikar P, 2004, VIROLOGY, V323, P220, DOI 10.1016/j.virol.2004.02.025; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Drake JR, 1999, J IMMUNOL, V162, P1150; DUBEY C, 1995, J IMMUNOL, V155, P45; FUJIHASHI K, 1991, J CLIN INVEST, V88, P248, DOI 10.1172/JCI115284; Geuze HJ, 1998, IMMUNOL TODAY, V19, P282, DOI 10.1016/S0167-5699(98)01269-9; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; GUPTA V, 2005, VIROLOGY; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Kavanagh DG, 2006, BLOOD, V107, P1963, DOI 10.1182/blood-2005-04-1513; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Lu Y, 2003, VACCINE, V21, P2178, DOI 10.1016/S0264-410X(03)00009-4; Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200; MATHIESEN T, 1989, IMMUNOLOGY, V67, P453; MATSUO K, 1992, J GEN VIROL, V73, P2445, DOI 10.1099/0022-1317-73-9-2445; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; MAZANEC MB, 1992, VIRUS RES, V23, P1, DOI 10.1016/0168-1702(92)90063-F; Nair SK, 1998, NAT BIOTECHNOL, V16, P364, DOI 10.1038/nbt0498-364; NIEDRIG M, 1991, J VIROL, V65, P4529, DOI 10.1128/JVI.65.8.4529-4533.1991; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136; Robinson HL, 1995, ANN NY ACAD SCI, V772, P209, DOI 10.1111/j.1749-6632.1995.tb44746.x; ROWELL JF, 1995, J IMMUNOL, V155, P1818; Ruff AL, 1997, J BIOL CHEM, V272, P8671, DOI 10.1074/jbc.272.13.8671; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sedegah M, 1998, P NATL ACAD SCI USA, V95, P7648, DOI 10.1073/pnas.95.13.7648; Su Z, 2002, CANCER RES, V62, P5041; Su Z, 2005, J IMMUNOL, V174, P3798, DOI 10.4049/jimmunol.174.6.3798; SUNDQVIST VA, 1989, J MED VIROL, V29, P170, DOI 10.1002/jmv.1890290305; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Wu L, 2005, J VIROL, V79, P8024, DOI 10.1128/JVI.79.13.8024-8031.2005; WU TC, 1995, P NATL ACAD SCI USA, V92, P11671, DOI 10.1073/pnas.92.25.11671	44	27	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e135	10.1371/journal.pone.0000135	http://dx.doi.org/10.1371/journal.pone.0000135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205139	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700029
J	Maurer, K; Cooper, J; Caraballo, M; Crye, J; Suciu, D; Ghindilis, A; Leonetti, JA; Wang, W; Rossi, FM; Stover, AG; Larson, C; Gao, H; Dill, K; McShea, A				Maurer, Karl; Cooper, John; Caraballo, Marcelo; Crye, James; Suciu, Dominic; Ghindilis, Andrey; Leonetti, Joseph A.; Wang, Wei; Rossi, Francis M.; Stoever, Axel G.; Larson, Christopher; Gao, Hetian; Dill, Kilian; McShea, Andy			Electrochemically Generated Acid and Its Containment to 100 Micron Reaction Areas for the Production of DNA Microarrays	PLOS ONE			English	Article								An addressable electrode array was used for the production of acid at sufficient concentration to allow deprotection of the dimethoxytrityl (DMT) protecting group from an overlaying substrate bound to a porous reaction layer. Containment of the generated acid to an active electrode of 100 micron diameter was achieved by the presence of an organic base. This procedure was then used for the production of a DNA array, in which synthesis was directed by the electrochemical removal of the DMT group during synthesis. The product array was found to have a detection sensitivity to as low as 0.5 pM DNA in a complex background sample.	[Maurer, Karl; Cooper, John; Caraballo, Marcelo; Crye, James; Suciu, Dominic; Ghindilis, Andrey; Leonetti, Joseph A.; Wang, Wei; Rossi, Francis M.; Stoever, Axel G.; Larson, Christopher; Gao, Hetian; Dill, Kilian; McShea, Andy] CombiMatrix Corp, Mukilteo, WA USA		Maurer, K (corresponding author), CombiMatrix Corp, Mukilteo, WA USA.	kmaurer@combima-trix.com	Ghindilis, Andrey/AAT-6810-2021	Rossi, Francis/0000-0002-8997-720X; Gindilis, Andrei/0000-0002-1931-6422	CombiMatrix	CombiMatrix	Funding: This work was performed by employees of CombiMatrix Corporation as part of research and development efforts funded by CombiMatrix.	BAIZER LH, 1991, ORGANIC ELECTROCHEMI; CARUTHERS MH, 1991, ACCOUNTS CHEM RES, V24, P278, DOI 10.1021/ar00009a005; CARUTHERS MH, SCIENCE, V230, P281; Dill K, 2001, ANAL CHIM ACTA, V444, P69, DOI 10.1016/S0003-2670(01)01155-2; Egeland RD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni117; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Gao XL, 2001, NUCLEIC ACIDS RES, V29, P4744, DOI 10.1093/nar/29.22.4744; Maurer K, 2005, J COMB CHEM, V7, P637, DOI 10.1021/cc0498175; MAURER K, 2006, Patent No. 20060054511; Maurer K., 2006, U.S. Patent, Patent No. [2006/0102471A1, 20060102471]; Montgomery D. D., 2001, U.S. Patent, Patent No. [6280595, 6280595B1]; Montgomery D. D., 2000, U.S. Patent, Patent No. [6093302, 6,093,302]; SOUTHERN EM, 2003, Patent No. 03020415; Tesfu E, 2006, ORG LETT, V8, P709, DOI 10.1021/ol052891r; Tesfu E, 2006, J AM CHEM SOC, V128, P70, DOI 10.1021/ja057155x; Tesfu E, 2004, J AM CHEM SOC, V126, P6212, DOI 10.1021/ja0489036; Tian J, 2005, J AM CHEM SOC, V127, P1392, DOI 10.1021/ja042448w; Volke J., 1994, ELECTROCHEMISTRY ORG	19	38	57	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e34	10.1371/journal.pone.0000034	http://dx.doi.org/10.1371/journal.pone.0000034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183662	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600034
J	Milton, CC; Ulane, CM; Rutherford, S				Milton, Claire C.; Ulane, Christina M.; Rutherford, Suzannah			Control of Canalization and Evolvability by Hsp90	PLOS ONE			English	Article								Partial reduction of Hsp90 increases expression of morphological novelty in qualitative traits of Drosophila and Arabidopsis, but the extent to which the Hsp90 chaperone also controls smaller and more likely adaptive changes in natural quantitative traits has been unclear. To determine the effect of Hsp90 on quantitative trait variability we deconstructed genetic, stochastic and environmental components of variation in Drosophila wing and bristle traits of genetically matched flies, differing only by Hsp90 loss-of-function or wild-type alleles. Unexpectedly, Hsp90 buffering was remarkably specific to certain normally invariant and highly discrete quantitative traits. Like the qualitative trait phenotypes controlled by Hsp90, highly discrete quantitative traits such as scutellor and thoracic bristle number are threshold traits. When tested across genotypes sampled from a wild population or in laboratory strains, the sensitivity of these traits to many types of variation was coordinately controlled, while continuously variable bristle types and wing size, and critically invariant left-right wing asymmetry, remained relatively unaffected. Although increased environmental variation and developmental noise would impede many types of selection response, in replicate populations in which Hsp90 was specifically impaired, heritability and 'extrinsic evolvability', the expected response to selection, were also markedly increased. However, despite the overall buffering effect of Hsp90 on variation in populations, for any particular individual or genotype in which Hsp90 was impaired, the size and direction of its effects were unpredictable. The trait and genetic-background dependence of Hsp90 effects and its remarkable bias toward invariant or canalized traits support the idea that traits evolve independent and trait-specific mechanisms of canalization and evolvability through their evolution of non-linearity and thresholds. Highly non-linear responses would buffer variation in Hsp90-dependent signaling over a wide range, while over a narrow range of signaling near trait thresholds become more variable with increasing probability of triggering all-or-none developmental responses.	[Rutherford, Suzannah] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Milton, Claire C.] Univ Melbourne, Ctr Environm Stress & Adaptat Res, Melbourne, Vic, Australia	Fred Hutchinson Cancer Center; University of Melbourne	Rutherford, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	srutherf@fhcrc.org	Rutherford, Suzannah/L-7355-2019	Rutherford, Suzannah/0000-0002-7809-3337	Damon Runyon-Walter Winchel Foundation; NIH [R01 GM068873]; Australian Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068873] Funding Source: NIH RePORTER	Damon Runyon-Walter Winchel Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Scholar Award of the Damon Runyon-Walter Winchel Foundation and by NIH R01 GM068873 ( S. R.) and by the Australian Research Council ( C. C. M.).	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Bishop CD, 2002, DEV GENES EVOL, V212, P70, DOI 10.1007/s00427-002-0212-9; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; DEBAT V, 2006, EVOLUTION IN PRESS; Dickinson WJ, 1999, NATURE, V399, P30, DOI 10.1038/19894; DING D, 1993, MOL CELL BIOL, V13, P3773, DOI 10.1128/MCB.13.6.3773; Eshel I, 1998, GENETICS, V149, P2119; FALCONER DS, 1996, INTRO QUANTITATIVE G, pR13; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Frankel J, 2001, J EUKARYOT MICROBIOL, V48, P147, DOI 10.1111/j.1550-7408.2001.tb00297.x; Frankel J, 2001, J EUKARYOT MICROBIOL, V48, P135, DOI 10.1111/j.1550-7408.2001.tb00296.x; Fry JD, 1998, GENETICS, V148, P1171; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gilchrist GW, 2001, GENETICA, V112, P273, DOI 10.1023/A:1013358931816; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; HOULE D, 1992, GENETICS, V130, P195; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Judd EM, 2000, BIOESSAYS, V22, P507, DOI 10.1002/(SICI)1521-1878(200006)22:6<507::AID-BIES3>3.0.CO;2-0; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Loubradou G, 1997, GENETICS, V147, P581; Loubradou G, 1999, GENETICS, V152, P519; Lynch Michael, 1998; MARKOW T.A., 1994, DEV INSTABILITY ITS; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Milton CC, 2003, P NATL ACAD SCI USA, V100, P13396, DOI 10.1073/pnas.1835613100; MOHLER JD, 1965, GENETICS, V51, P329; Nijhout HF, 2003, EVOL DEV, V5, P281, DOI 10.1046/j.1525-142X.2003.03035.x; Nollen EAA, 2002, J CELL SCI, V115, P2809; PALMER RA, 1994, FLUCTUATING ASYMMETR; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; PINEIRO R, 1992, J HERED, V83, P445, DOI 10.1093/oxfordjournals.jhered.a111249; Powell J. R., 1997, PROGR PROSPECTS EVOL; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rendel J. M., 1967, CANALISATION GENE CO; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Roberts SP, 1999, OECOLOGIA, V121, P323, DOI 10.1007/s004420050935; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; RUTHERFORD SL, 1994, CELL, V79, P1129, DOI 10.1016/0092-8674(94)90003-5; SCHARLOO W, 1991, ANNU REV ECOL SYST, V22, P65, DOI 10.1146/annurev.es.22.110191.000433; SCHMALHAUSEN, 1986, FACTORS EVOLUTION TH; Simpson P, 1999, DEVELOPMENT, V126, P1349; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; vanderStraten A, 1997, EMBO J, V16, P1961, DOI 10.1093/emboj/16.8.1961; WADDINGTON C. H., 1957, The strategy of the genes. A discussion of some aspects of theoretical biology. With an appendix by H. Kacser.; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Wagner GP, 1999, J EXP ZOOL, V285, P116, DOI 10.1002/(SICI)1097-010X(19990815)285:2<116::AID-JEZ3>3.0.CO;2-P; Wiesgigl M, 2001, MOL BIOL CELL, V12, P3307, DOI 10.1091/mbc.12.11.3307; Wright S, 1934, GENETICS, V19, P0506	55	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e75	10.1371/journal.pone.0000075	http://dx.doi.org/10.1371/journal.pone.0000075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183707	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600075
J	Schillaci, MA				Schillaci, Michael A.			Sexual Selection and the Evolution of Brain Size in Primates	PLOS ONE			English	Article							SPERM COMPETITION; SOCIAL BRAIN; BODY-WEIGHT; DIMORPHISM; TESTIS; RATIO	Reproductive competition among males has long been considered a powerful force in the evolution of primates. The evolution of brain size and complexity in the Order Primates has been widely regarded as the hallmark of primate evolutionary history. Despite their importance to our understanding of primate evolution, the relationship between sexual selection and the evolutionary development of brain size is not well studied. The present research examines the evolutionary relationship between brain size and two components of primate sexual selection, sperm competition and male competition for mates. Results indicate that there is not a significant relationship between relative brain size and sperm competition as measured by relative testis size in primates, suggesting sperm competition has not played an important role in the evolution of brain size in the primate order. There is, however, a significant negative evolutionary relationship between relative brain size and the level of male competition for mates. The present study shows that the largest relative brain sizes among primate species are associated with monogamous mating systems, suggesting primate monogamy may require greater social acuity and abilities of deception.	Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada	University of Toronto	Schillaci, MA (corresponding author), Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada.	schillaci@utsc.utoronto.ca		Grant, Seth/0000-0001-8732-8735	University of Toronto's Connaught Fund	University of Toronto's Connaught Fund(University of Toronto)	This research was funded in part by the University of Toronto's Connaught Fund.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Byrne R.W., 1997, MACHIAVELLIAN INTELL, VII, P1, DOI DOI 10.1017/CBO9780511525636; CLUTTONBROCK TH, 1977, NATURE, V269, P797, DOI 10.1038/269797a0; Darwin C., 1871, P423; DUNBAR RIM, 1995, J HUM EVOL, V28, P287, DOI 10.1006/jhev.1995.1021; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Harvey P.H., 1984, P589; Harvey P.H., 1987, P181; MADDISON WP, 2005, MESQUITE MODULAR SYS; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; Parker GA, 2005, BIOL LETTERS, V1, P235, DOI 10.1098/rsbl.2004.0273; Pitnick S, 2006, P ROY SOC B-BIOL SCI, V273, P719, DOI 10.1098/rspb.2005.3367; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; REEVE J, 2003, PHYLOGENETIC INDEPEN; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; [No title captured]	21	64	64	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e62	10.1371/journal.pone.0000062	http://dx.doi.org/10.1371/journal.pone.0000062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183693	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600062
J	Moreno, CS; Matyunina, L; Dickerson, EB; Schubert, N; Bowen, NJ; Logani, S; Benigno, BB; McDonald, JF				Moreno, Carlos S.; Matyunina, Lilya; Dickerson, Erin B.; Schubert, Nina; Bowen, Nathan J.; Logani, Sanjay; Benigno, Benedict B.; McDonald, John F.			Evidence that p53-Mediated Cell-Cycle-Arrest Inhibits Chemotherapeutic Treatment of Ovarian Carcinomas	PLOS ONE			English	Article							WILD-TYPE P53; PATHOLOGICAL RESPONSE; TUMOR-CELLS; GENE; EXPRESSION; MUTATIONS; RESISTANCE; CANCER; IDENTIFICATION; SURVIVAL	Gene expression profiles of malignant tumors surgically removed from ovarian cancer patients pre-treated with chemotherapy (neo-adjuvant) prior to surgery group into two distinct clusters. One group clusters with carcinomas from patients not pre-treated with chemotherapy prior to surgery (C-L), while the other clusters with non-malignant adenomas (A-L). We show here that although the C-L cluster is preferentially associated with p53 loss-of-function (LOF) mutations, the C-L cluster cancer patients display a more favorable clinical response to chemotherapy as evidenced by enhanced long-term survivorships. Our results support a model whereby p53 mediated cell-cycle-arrest/DNA repair serves as a barrier to optimal chemotherapeutic treatment of ovarian and perhaps other carcinomas and suggest that inhibition of p53 during chemotherapy may enhance clinical outcome.	[Matyunina, Lilya; Dickerson, Erin B.; Schubert, Nina; Bowen, Nathan J.; McDonald, John F.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Moreno, Carlos S.; Logani, Sanjay] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Moreno, Carlos S.] Winship Canc Inst, Atlanta, GA USA; [Matyunina, Lilya; Dickerson, Erin B.; Schubert, Nina; Bowen, Nathan J.; Benigno, Benedict B.; McDonald, John F.] Ovarian Canc Inst, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Emory University	McDonald, JF (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	john.mcdonald@biology.gatech.edu	Bowen, Nathan J./M-3202-2019; Bowen, Nathan/F-3132-2010; Benigno, Benedict/GPW-8134-2022; Moreno, Carlos S/B-3863-2009	Bowen, Nathan J./0000-0002-1609-6698; Bowen, Nathan/0000-0002-1609-6698; Moreno, Carlos S/0000-0002-5582-0028; McDonald, John F/0000-0002-4263-8155	Georgia Cancer Coalition; Georgia Tech Research Foundation; Robinson Family Foundation; Larry and Beth Lawrence Foundation; Department of Pathology and Laboratory Medicine, Emory University;  [R01 CA106826]; NATIONAL CANCER INSTITUTE [R01CA106826] Funding Source: NIH RePORTER	Georgia Cancer Coalition; Georgia Tech Research Foundation; Robinson Family Foundation; Larry and Beth Lawrence Foundation; Department of Pathology and Laboratory Medicine, Emory University; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants to JM from the Georgia Cancer Coalition, the Georgia Tech Research Foundation, the Robinson Family Foundation and the Larry and Beth Lawrence Foundation. CSM received support from R01 CA106826 and the Department of Pathology and Laboratory Medicine, Emory University.	Ameyar M, 1999, ONCOGENE, V18, P5464, DOI 10.1038/sj.onc.1202919; Andrews GA, 2004, HEAD NECK-J SCI SPEC, V26, P870, DOI 10.1002/hed.20029; Banks E, 2000, METH MOLEC MED, V39, P3; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BERCHUCK A, 1994, AM J OBSTET GYNECOL, V170, P246; Berns A, 2006, NATURE, V443, P153, DOI 10.1038/443153a; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Coukos G, 1998, OBSTET GYNECOL, V91, P783, DOI 10.1016/S0029-7844(98)00054-4; Daoud SS, 2003, CANCER RES, V63, P2782; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erenpreisa J, 2005, CELL BIOL INT, V29, P1012, DOI 10.1016/j.cellbi.2005.10.005; Feki A, 2004, CRIT REV ONCOL HEMAT, V52, P103, DOI 10.1016/j.critrevonc.2004.07.002; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katabuchi H, 1998, INT J GYNECOL PATHOL, V17, P54, DOI 10.1097/00004347-199801000-00010; Keshelava N, 2000, MED PEDIATR ONCOL, V35, P563, DOI 10.1002/1096-911X(20001201)35:6<563::AID-MPO15>3.0.CO;2-J; Komarova EA, 1998, ONCOGENE, V17, P1089, DOI 10.1038/sj.onc.1202303; Lambert HE, 2004, INT J GYNECOL CANCER, V14, P772, DOI 10.1111/j.1048-891X.2004.014507.x; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YX, 2006, ANTI-CANCER DRUG, V17, P733, DOI 10.1097/01.cad.0000217429.67455.18; MALOAS JS, 1979, J ROY SOC MED, V72, P357; MERCER WE, 1991, P NATL ACAD SCI USA, V88, P1958, DOI 10.1073/pnas.88.5.1958; Meyer E, 2005, CANCER RES, V65, P4261, DOI 10.1158/0008-5472.CAN-04-2908; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; NIMEUSMALMSTROM E, 2006, EUR J CANC IN PRESS; Osugi H, 2002, INT J ONCOL, V21, P637; PESTELL KE, 2004, MOL PHARM, V57, P503; Razani B, 2000, BIOCHEMISTRY-US, V39, P13916, DOI 10.1021/bi001489b; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reles A, 2001, CLIN CANCER RES, V7, P2984; Ribeiro U, 1998, CANCER, V83, P7, DOI 10.1002/(SICI)1097-0142(19980701)83:1<7::AID-CNCR2>3.0.CO;2-R; Sakamoto M, 2001, Hum Cell, V14, P305; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scholl FA, 2000, J CELL BIOL, V151, P495, DOI 10.1083/jcb.151.3.495; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tan MJ, 1999, FEBS LETT, V445, P265, DOI 10.1016/S0014-5793(99)00135-0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Warrenfeltz S, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-27; Yamaguchi A, 2002, J BIOL CHEM, V277, P623, DOI 10.1074/jbc.M107435200	45	47	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e441	10.1371/journal.pone.0000441	http://dx.doi.org/10.1371/journal.pone.0000441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505532	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445900001
J	Boer, U; Alejel, T; Beimesche, S; Cierny, I; Krause, D; Knepel, W; Flugge, G				Boeer, Ulrike; Alejel, Tahseen; Beimesche, Stephan; Cierny, Irmgard; Krause, Doris; Knepel, Willhart; Fluegge, Gabriele			CRE/CREB-Driven Up-Regulation of Gene Expression by Chronic Social Stress in CRE-Luciferase Transgenic Mice: Reversal by Antidepressant Treatment	PLOS ONE			English	Article								Background. It has been suggested that stress provokes neuropathological changes and may thus contribute to the precipitation of affective disorders such as depression. Likewise, the pharmacological therapy of depression requires chronic treatment and is thought to induce a positive neuronal adaptation, presumably based on changes in gene transcription. The transcription factor cAMP-responsive element binding protein (CREB) and its binding site (CRE) have been suggested to play a major role in both the development of depression and antidepressive therapy. Methodology/Principle Findings. To investigate the impact of stress and antidepressant treatment on CRE/CREB transcriptional activity, we generated a transgenic mouse line in which expression of the luciferase reporter gene is controlled by four copies of CRE. In this transgene, luciferase enzyme activity and protein were detected throughout the brain, e. g., in the hippocampal formation. Chronic social stress significantly increased (by 45 to 120%) CRE/CREB-driven gene expression measured as luciferase activity in several brain regions. This was also reflected by increased CREB-phosphorylation determined by immunoblotting. Treatment of the stressed mice with the antidepressant imipramine normalized luciferase expression to control levels in all brain regions and likewise reduced CREB-phosphorylation. In non-stressed animals, chronic (21 d) but not acute (24 h) treatment with imipramine (2 x 10 mg/kg/d) reduced luciferase expression in the hippocampus by 40-50%. Conclusions/Significance. Our results emphasize a role of CREB in stress-regulated gene expression and support the view that the therapeutic actions of antidepressants are mediated via CRE/CREB-directed transcription.	[Boeer, Ulrike; Alejel, Tahseen; Beimesche, Stephan; Cierny, Irmgard; Krause, Doris; Knepel, Willhart] Univ Gottingen, Dept Mol Pharmacol, Gottingen, Germany; [Fluegge, Gabriele] DFG Res Ctr Mol Physiol Brain CMPB, Gottingen, Germany; [Fluegge, Gabriele] German Primate Ctr, Lab Clin Neurobiol, Gottingen, Germany	University of Gottingen; German Research Foundation (DFG); Deutsches Primatenzentrum (DPZ)	Boer, U (corresponding author), Univ Gottingen, Dept Mol Pharmacol, Gottingen, Germany.	uboeer1@gwdg.de			Deutsche Forschungsgemeinschaft [SFB 402 (A3)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a grant from the Deutsche Forschungsgemeinschaft SFB 402 (A3).	Abumaria N, 2006, CELL MOL NEUROBIOL, V26, P145, DOI 10.1007/s10571-006-9024-1; Aktories K, 2004, INT J MED MICROBIOL, V293, P557, DOI 10.1078/1438-4221-00305; Alfonso J, 2005, REV NEUROSCIENCE, V16, P43; BANERJEE SP, 1977, NATURE, V268, P455, DOI 10.1038/268455a0; Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Beimesche S, 1999, MOL ENDOCRINOL, V13, P718, DOI 10.1210/me.13.5.718; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Blendy JA, 1998, J MOL MED-JMM, V76, P104, DOI 10.1007/s001090050197; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandao ML, 2003, EUR J PHARMACOL, V463, P225, DOI 10.1016/S0014-2999(03)01284-6; Butterweck V, 2001, MOL PSYCHIATR, V6, P547, DOI 10.1038/sj.mp.4000937; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; DEKLOET ER, 1990, J STEROID BIOCHEM, V37, P387, DOI 10.1016/0960-0760(90)90489-8; Fuchs E, 2002, PHARMACOL BIOCHEM BE, V73, P247, DOI 10.1016/S0091-3057(02)00795-5; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HENINGER GR, 1988, ACTA PSYCHIAT SCAND, V77, P138, DOI 10.1111/j.1600-0447.1988.tb08559.x; Holoubek G, 2004, PHARMACOPSYCHIATRY, V37, pS113, DOI 10.1055/s-2004-832664; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Kuipers SD, 2003, J NEUROCHEM, V85, P1312, DOI 10.1046/j.1471-4159.2003.01770.x; Laifenfeld D, 2005, NEUROBIOL DIS, V20, P432, DOI 10.1016/j.nbd.2005.03.023; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Manier DH, 2002, J NEURAL TRANSM, V109, P91, DOI 10.1007/s702-002-8239-6; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; Meyer H, 2000, BRAIN RES, V880, P147, DOI 10.1016/S0006-8993(00)02787-6; MEYERSON LR, 1980, PHARMACOL BIOCHEM BE, V12, P943, DOI 10.1016/0091-3057(80)90457-8; Moore AN, 1996, J BIOL CHEM, V271, P14214, DOI 10.1074/jbc.271.24.14214; NAIR A, 2006, NEUROPSYCHOPHARMACOL; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NESTLER EJ, 1990, P NATL ACAD SCI USA, V87, P7522, DOI 10.1073/pnas.87.19.7522; Nibuya M, 1996, J NEUROSCI, V16, P2365; NIBUYA M, 1995, J NEUROSCI, V15, P7539; OETJEN E, 1994, J BIOL CHEM, V269, P27036; Pardon MC, 2005, NEUROSCIENCE, V132, P561, DOI 10.1016/j.neuroscience.2005.01.033; PAXINOS G, 1972, J COMP PHYSIOL PSYCH, V79, P219, DOI 10.1037/h0032530; POST RM, 1992, AM J PSYCHIAT, V149, P999; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; SCHWANINGER M, 1995, MOL PHARMACOL, V47, P1112; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Stanford SC, 1995, PHARMACOL THERAPEUT, V68, P297, DOI 10.1016/0163-7258(95)02010-1; STERNBERGER LA, 1979, J HISTOCHEM CYTOCHEM, V27, P1424, DOI 10.1177/27.11.92498; Suzuki S, 2004, J COMP NEUROL, V479, P70, DOI 10.1002/cne.20310; Swank MW, 2000, NEUROREPORT, V11, P1625, DOI 10.1097/00001756-200006050-00006; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Thome J, 2000, J NEUROSCI, V20, P4030; VETULANI J, 1975, NATURE, V257, P495, DOI 10.1038/257495a0; Zhu MY, 2005, MOL BRAIN RES, V133, P167, DOI 10.1016/j.molbrainres.2004.10.009	52	35	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e431	10.1371/journal.pone.0000431	http://dx.doi.org/10.1371/journal.pone.0000431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487276	gold, Green Published			2022-12-27	WOS:000207445800013
J	Dahlberg, J; Nilsson, LO; von Wowern, F; Melander, O				Dahlberg, Jonas; Nilsson, Lars-Olof; von Wowern, Fredrik; Melander, Olle			Polymorphism in NEDD4L Is Associated with Increased Salt Sensitivity, Reduced Levels of P-renin and Increased Levels of Nt-proANP	PLOS ONE			English	Article								Objective. Neuronal precursor cell expressed developmentally down-regulated 4-like (NEDD4L) is a regulator of the amiloride-sensitive epithelial sodium channel (ENaC), thus a candidate gene for salt sensitivity. Carriers of an intact NEDD4L C2-domain, encoded by the NEDD4L rs4149601 (G/A) GG genotype, together with the C-allele of the NEDD4L rs2288774 (C/T) polymorphism have previously been shown to have increased blood pressure. Our aim was to test if genetic variation in NEDD4L is associated with increased salt sensitivity. Methods. 39 normotensive subjects were studied. The difference in 24-hour systolic blood pressure after four weeks on 150 mmol/day NaCl intake and four weeks on 50 mmol/day NaCl was defined as salt sensitivity. The rs4149601 and rs2288774 polymorphisms were genotyped using PCR-based techniques. Results. Carriers of the rs4149601 GG-genotype together with the rs2288774 CC-genotype had significantly higher salt sensitivity (median, IQR) (18.0, 7.5-20.0 mmHg vs 6.0, 0.0-10.0 mmHg, P = 0.007) and lower plasma renin concentration (P-renin) (6.0, 2.0-9.5 mU/L vs 15.0, 9.0-24.0 mU/L, P = 0.005) as compared to non-carriers of these genotypes. In carriers of the rs4149601 GG-genotype together with the rs2288774 CC-or CT-genotype, as compared to non-carriers, salt sensitivity was (8.0, 6.0-18.0 mmHg vs 5.0, 0.0-10.0 mmHg, P = 0.07) and P-renin (9.0, 6.0-16.0 mU/L vs 15.0, 9.0-28.0 mU/L, P = 0.03). Conclusion. Genetic NEDD4L variation seems to affect salt sensitivity and P-renin in normotensive subjects, suggesting that genotyping of NEDD4L may be clinically useful in order to identify subjects who benefit from dietary salt restriction in the prevention of hypertension.	[Dahlberg, Jonas] Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden; Lund Univ, Malmo, Sweden	Lund University; Skane University Hospital; Lund University	Dahlberg, J (corresponding author), Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden.	jonas.dahlberg@med.lu.se		Melander, Olle/0000-0002-2581-484X	Swedish Medical Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University, Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane, Hulda; Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University, Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane, Hulda; Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation	This study supported by grants from the Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, Malmo University Hospital, the Albert Pahlsson Research Foundation, the Crafoord Foundation, the Ernhold Lundstroms Research Foundation, the Region Skane, Hulda and Conrad Mossfelt Foundation and King Gustaf V and Queen Victoria Foundation The sponsors had no role in the study design, collection, analysis, interpretation of data or the writing and submission of the manuscript.	Dunn DM, 2002, J HUM GENET, V47, P665, DOI 10.1007/s100380200102; Fava C, 2006, KIDNEY INT, V70, P562, DOI 10.1038/sj.ki.5001590; Fava C, 2004, J HYPERTENS, V22, P1717, DOI 10.1097/00004872-200409000-00015; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; GUYTON AC, 1987, HYPERTENSION, V10, P1, DOI 10.1161/01.HYP.10.1.1; GUYTON AC, 1989, AM J HYPERTENS, V2, P575, DOI 10.1093/ajh/2.7.575; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Melander O, 2003, AM J HYPERTENS, V16, P729, DOI 10.1016/S0895-7061(03)00981-6; Melander O, 2002, HYPERTENSION, V39, P996, DOI 10.1161/01.HYP.0000017552.91014.2A; Melander O, 2001, BLOOD PRESSURE, V10, P254, DOI 10.1080/080370501753400575; Melander O, 2007, J HYPERTENS, V25, P619, DOI 10.1097/HJH.0b013e328013cd50; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; SBU, 2004, MOD EL BLOOD PRESS; Sharma A M, 1996, Blood Press Suppl, V1, P59; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Svetkey LP, 1996, HYPERTENSION, V28, P854, DOI 10.1161/01.HYP.28.5.854; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; WEINBERGER MH, 1986, HYPERTENSION, V8, P127, DOI 10.1161/01.HYP.8.6_Pt_2.II127; Zeggini E, 2007, DIABETOLOGIA, V50, P1, DOI 10.1007/s00125-006-0507-x	25	57	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e432	10.1371/journal.pone.0000432	http://dx.doi.org/10.1371/journal.pone.0000432			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487281	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445800014
J	Efroni, S; Schaefer, CF; Buetow, KH				Efroni, Sol; Schaefer, Carl F.; Buetow, Kenneth H.			Identification of Key Processes Underlying Cancer Phenotypes Using Biologic Pathway Analysis	PLOS ONE			English	Article								Cancer is recognized to be a family of gene-based diseases whose causes are to be found in disruptions of basic biologic processes. An increasingly deep catalogue of canonical networks details the specific molecular interaction of genes and their products. However, mapping of disease phenotypes to alterations of these networks of interactions is accomplished indirectly and non-systematically. Here we objectively identify pathways associated with malignancy, staging, and outcome in cancer through application of an analytic approach that systematically evaluates differences in the activity and consistency of interactions within canonical biologic processes. Using large collections of publicly accessible genome-wide gene expression, we identify small, common sets of pathways - Trka Receptor, Apoptosis response to DNA Damage, Ceramide, Telomerase, CD40L and Calcineurin - whose differences robustly distinguish diverse tumor types from corresponding normal samples, predict tumor grade, and distinguish phenotypes such as estrogen receptor status and p53 mutation state. Pathways identified through this analysis perform as well or better than phenotypes used in the original studies in predicting cancer outcome. This approach provides a means to use genome-wide characterizations to map key biological processes to important clinical features in disease.	[Efroni, Sol; Schaefer, Carl F.; Buetow, Kenneth H.] NCI, Ctr Bioinformat, Rockville, MD USA; [Buetow, Kenneth H.] NCI, Lab Populat Genet, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Buetow, KH (corresponding author), NCI, Ctr Bioinformat, Rockville, MD USA.	buetowk@mail.nih.gov	Efroni, Sol/I-6752-2012	Efroni, Sol/0000-0001-7927-6349	NIH, National Cancer Institute	NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the intramural research program of the NIH, National Cancer Institute.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bianco RB, 2006, EUR J CANCER, V42, P290, DOI 10.1016/j.ejca.2005.07.034; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; BITTNER M, 2006, INT GENOMICS CONSORT; Bonnaud S, 2007, CANCER RES, V67, P1803, DOI 10.1158/0008-5472.CAN-06-2802; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Buetow KH, 2002, CANCER CELL, V1, P315, DOI 10.1016/S1535-6108(02)00065-X; Claus R., 2000, Current Drug Targets, V1, P185, DOI 10.2174/1389450003349272; Dolle L, 2004, CURR CANCER DRUG TAR, V4, P463, DOI 10.2174/1568009043332853; DUDA RO, 2001, PATTERN CLASSIFICATI, pR20; Gielen SCJP, 2005, ENDOCR-RELAT CANCER, V12, P1037, DOI 10.1677/erc.1.01046; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HASTIE T, 2001, ELEMENTS STAT LEARNI, pR16; Hiscox S, 2006, INT J CANCER, V118, P290, DOI 10.1002/ijc.21355; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Lin CF, 2006, CURR MED CHEM, V13, P1609, DOI 10.2174/092986706777441986; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; *NAT CANC I CTR BI, NAT CANC I CTR BIOIN; Padron JM, 2006, CURR MED CHEM, V13, P755, DOI 10.2174/092986706776055553; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Regev A, 2002, NATURE, V419, P343, DOI 10.1038/419343a; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; ROTH RB, 2006, NEUROGENETICS; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Schaefer CF, 2004, ANN NY ACAD SCI, V1020, P77, DOI 10.1196/annals.1310.009; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sharma S, 2003, HUM GENE THER, V14, P1511, DOI 10.1089/104303403322495025; Stepulak A, 2005, P NATL ACAD SCI USA, V102, P15605, DOI 10.1073/pnas.0507679102; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; THEODORIDIS S, 2003, PATTERN RECOGN, pR14; Thevissen K, 2006, MINI-REV MED CHEM, V6, P699, DOI 10.2174/138955706777435643; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Watters JW, 2006, MOL CANCER THER, V5, P2444, DOI 10.1158/1535-7163.MCT-06-0340; WEBB AR, 2002, STAT PATTERN RECOGNI, pR18; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	47	91	92	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e425	10.1371/journal.pone.0000425	http://dx.doi.org/10.1371/journal.pone.0000425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487280	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445800007
J	Ferdinands, JM; Mannino, DM; Gwinn, ML; Bray, MS				Ferdinands, Jill M.; Mannino, David M.; Gwinn, Marta L.; Bray, Molly S.			ADRB2 Arg16Gly Polymorphism, Lung Function, and Mortality: Results from the Atherosclerosis Risk in Communities Study	PLOS ONE			English	Article							BETA-AGONIST USE; BETA(2)-ADRENERGIC RECEPTOR; ASTHMA; ASSOCIATION; ALBUTEROL; GENOTYPE; METAANALYSIS; HAPLOTYPE; DEATH	Background. Growing evidence suggests that the Arg16Arg genotype of the beta-2 adrenergic receptor gene may be associated with adverse effects of beta-agonist therapy. We sought to examine the association of beta-agonist use and the Arg16Gly polymorphism with lung function and mortality among participants in the Atherosclerosis Risk in Communities study. Methodology and Principal Findings. We genotyped study participants and analyzed the association of the Arg16Gly polymorphism and beta-agonist use with lung function at baseline and clinical examination three years later and with all-cause mortality during 10 years of follow-up. Lung function was characterized by percent-predicted forced expiratory volume in 1 second. Associations were examined separately for blacks and whites. Black beta-agonist users with the Arg/Arg genotype had better lung function at baseline and at the second clinical visit than those with Arg/Gly and Gly/Gly genotypes. Adjusted mean percent-predicted FEV1 was 21% higher in Arg/Arg subjects compared to Gly/Gly at baseline (p = 0.01) and 20% higher than Gly/Gly at visit 2 (p = 0.01). Arg/Gly subjects had adjusted percent-predicted FEV1 17% lower than Arg/Arg at baseline but were similar to Arg/Arg subjects at visit 2. Although black beta-agonist users with the Arg/Arg genotype appeared to have better crude survival rates, the association between genotype and all-cause mortality was inconclusive. We found no difference in lung function or mortality by genotype among blacks who did not use beta-agonists or among whites, regardless of beta-agonist use. Conclusions. Black beta-agonist users with the ADRB2 Arg16Arg genotype had better lung function, and, possibly, better overall survival compared to black beta-agonist users with the Gly16Gly genotype. Our findings highlight the need for additional studies of sufficient size and statistical power to allow examination of outcomes among beta-agonist users of different races and genotypes.	[Ferdinands, Jill M.] Ctr Dis Control & Prevent, Air Pollut & Resp Hlth Branch, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA; [Mannino, David M.] Univ Kentucky, Coll Med, Div Pulm Crit Care & Sleep Med, Lexington, KY USA; [Gwinn, Marta L.] Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, Atlanta, GA USA; [Bray, Molly S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Centers for Disease Control & Prevention - USA; University of Kentucky; Centers for Disease Control & Prevention - USA; Baylor College of Medicine	Ferdinands, JM (corresponding author), Ctr Dis Control & Prevent, Air Pollut & Resp Hlth Branch, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.	zdn5@cdc.gov		Mannino, David/0000-0003-3646-7828	National Heart, Lung, and Blood Institute [1R01HL073366-01, N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC55020, N01-HC-55021, N01-HC-55022]; Centers for Disease Control and Prevention [UR6/CCU617218]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055021, N01HC055020, N01HC055019, N01HC055015, N01HC055022, N01HC055016, N01HC055018] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055019, R42HL055018, R41HL055018, R01HL073366] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants 1R01HL073366-01 from the National Heart, Lung, and Blood Institute and UR6/CCU617218 from the Centers for Disease Control and Prevention. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC55020, N01-HC-55021, and N01-HC-55022.	Belfer I, 2005, EUR J HUM GENET, V13, P341, DOI 10.1038/sj.ejhg.5201313; Contopoulos-Ioannidis DG, 2005, J ALLERGY CLIN IMMUN, V115, P963, DOI 10.1016/j.jaci.2004.12.1119; Dewar JC, 1998, CLIN EXP ALLERGY, V28, P442; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; Israel E, 2005, J ALLERGY CLIN IMMUN, V115, pS532, DOI 10.1016/j.jaci.2005.01.029; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Joos L, 2002, CURR OPIN PULM MED, V8, P9, DOI 10.1097/00063198-200201000-00003; Kelly EAB, 2003, J ALLERGY CLIN IMMUN, V111, P79, DOI 10.1067/mai.2003.28; Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874; MULLEN M, 1993, JAMA-J AM MED ASSOC, V270, P1842, DOI 10.1001/jama.270.15.1842; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ortega AN, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e1; PAUWELS RA, 2001, AM J RESP CRIT CARE, V163, P1276; Raby BA, 2001, CURR OPIN MOL THER, V3, P554; Ramsay CE, 1999, CLIN EXP ALLERGY, V29, P1195; SEARS MR, 1994, DRUG SAFETY, V11, P259, DOI 10.2165/00002018-199411040-00005; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Summerhill E, 2000, AM J RESP CRIT CARE, V162, P599, DOI 10.1164/ajrccm.162.2.9910108; Tantisira KG, 2005, CURR OPIN MOL THER, V7, P209; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; Taylor DR, 2000, J ASTHMA, V37, P691, DOI 10.3109/02770900009087308; TAYLOR M, 2006, PHARMACOGENOMICS J, P1; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Turner SW, 2004, CLIN EXP ALLERGY, V34, P1043, DOI 10.1111/j.1365-2222.2004.02001.x; Wechsler ME, 2005, AM J RESP CRIT CARE, V172, P12, DOI 10.1164/rccm.200412-1635OE; WEISS ST, 2006, PHARMACOGENOMICS J; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; ARCH INTERN MED, V158, P1855	32	12	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e289	10.1371/journal.pone.0000289	http://dx.doi.org/10.1371/journal.pone.0000289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356698	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444800012
J	Hullin, R; Matthes, J; von Vietinghoff, S; Bodi, I; Rubio, M; D'Souza, K; Khan, IF; Rottlander, D; Hoppe, UC; Mohacsi, P; Schmitteckert, E; Gilsbach, R; Bunemann, M; Hein, L; Schwartz, A; Herzig, S				Hullin, Roger; Matthes, Jan; von Vietinghoff, Sibylle; Bodi, Ilona; Rubio, Marta; D'Souza, Karen; Khan, Ismail Friedrich; Rottlaender, Dennis; Hoppe, Uta C.; Mohacsi, Paul; Schmitteckert, Eva; Gilsbach, Ralf; Buenemann, Moritz; Hein, Lutz; Schwartz, Arnold; Herzig, Stefan			Increased Expression of the Auxiliary beta(2)-subunit of Ventricular L-type Ca(2+) Channels Leads to Single-Channel Activity Characteristic of Heart Failure	PLOS ONE			English	Article								Background. Increased activity of single ventricular L-type Ca(2+)-channels (L-VDCC) is a hallmark in human heart failure. Recent findings suggest differential modulation by several auxiliary beta-subunits as a possible explanation. Methods and Results. By molecular and functional analyses of human and murine ventricles, we find that enhanced L-VDCC activity is accompanied by altered expression pattern of auxiliary L-VDCC beta-subunit gene products. In HEK293-cells we show differential modulation of single L-VDCC activity by coexpression of several human cardiac beta-subunits: Unlike beta(1) or beta(3) isoforms, beta(2a) and beta(2b) induce a high-activity channel behavior typical of failing myocytes. In accordance, beta(2)-subunit mRNA and protein are up-regulated in failing human myocardium. In a model of heart failure we find that mice overexpressing the human cardiac Ca(V)1.2 also reveal increased single-channel activity and sarcolemmal beta(2) expression when entering into the maladaptive stage of heart failure. Interestingly, these animals, when still young and non-failing ("Adaptive Phase''), reveal the opposite phenotype, viz: reduced single-channel activity accompanied by lowered beta(2) expression. Additional evidence for the cause-effect relationship between beta(2)-subunit expression and single L-VDCC activity is provided by newly engineered, double-transgenic mice bearing both constitutive Ca(V)1.2 and inducible beta(2) cardiac overexpression. Here in non-failing hearts induction of beta(2)-subunit overexpression mimicked the increase of single L-VDCC activity observed in murine and human chronic heart failure. Conclusions. Our study presents evidence of the pathobiochemical relevance of beta(2)-subunits for the electrophysiological phenotype of cardiac L-VDCC and thus provides an explanation for the single L-VDCC gating observed in human and murine heart failure.	[Hullin, Roger; Mohacsi, Paul] Univ Hosp Bern, Swiss Heart Ctr Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Matthes, Jan; Khan, Ismail Friedrich; Rottlaender, Dennis; Herzig, Stefan] Univ Cologne, Dept Pharmacol, Cologne, Germany; [von Vietinghoff, Sibylle; Schmitteckert, Eva; Buenemann, Moritz; Hein, Lutz] Univ Wurzburg, Dept Pharmacol, Wurzburg, Germany; [von Vietinghoff, Sibylle] Fac Med Charite, Franz Volhard Clin, Nephrol Hypertens Sect, Berlin, Germany; [Bodi, Ilona; Rubio, Marta; D'Souza, Karen; Schwartz, Arnold] Univ Cincinnati, Coll Med, Inst Mol Pharmacol & Biophys, Cincinnati, OH USA; [Khan, Ismail Friedrich; Hoppe, Uta C.; Herzig, Stefan] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Gilsbach, Ralf; Hein, Lutz] Univ Freiburg, Dept Expt & Clin Pharmacol & Toxicol, Freiburg, Germany	University of Bern; University Hospital of Bern; University of Cologne; University of Wurzburg; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University System of Ohio; University of Cincinnati; University of Cologne; University of Freiburg	Hullin, R (corresponding author), Univ Hosp Bern, Swiss Heart Ctr Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	roger.hullin@insel.ch; schwara@email.uc.edu; stefan.herzig@uni-koeln.de	Matthes, Jan/AAF-1229-2020; Hein, Lutz/GRJ-8644-2022	Matthes, Jan/0000-0003-2754-1555; Gilsbach, Ralf/0000-0002-0895-1535; Herzig, Stefan/0000-0001-8107-5204	DFG [HE1578/13-1, SFB355 TPC10]; ZMMK [A5]; NIH (NHLBI) [R01 HL079599-01, T32-HL07382-30]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079599, T32HL007382] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); ZMMK; NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: Herzig S, DFG HE1578/13-1, ZMMK A5; Schwartz A, NIH (NHLBI), R01 HL079599-01; Schwartz A., Bodi I. T32-HL07382-30; Hullin R, Schweizer Herzstiftung, Katharina Huber-Steiner Stiftung; Hein L, DFG SFB355 TPC10.	Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Chen XW, 2005, CIRC RES, V97, P1009, DOI 10.1161/01.RES.0000189270.72915.D1; Chen XW, 2002, CIRC RES, V91, P517, DOI 10.1161/01.RES.0000033988.13062.7C; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; COLLIN T, 1993, CIRC RES, V72, P1337, DOI 10.1161/01.RES.72.6.1337; Dalton S, 2005, J PHYSIOL-LONDON, V567, P757, DOI 10.1113/jphysiol.2005.093195; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Erhardt JA, 1998, J BIOL CHEM, V273, P35222, DOI 10.1074/jbc.273.52.35222; Figulla HR, 1996, CIRCULATION, V94, P346, DOI 10.1161/01.CIR.94.3.346; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Foerster K, 2003, P NATL ACAD SCI USA, V100, P14475, DOI 10.1073/pnas.1936026100; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Groner F, 2004, BIOCHEM BIOPH RES CO, V314, P878, DOI 10.1016/j.bbrc.2003.12.174; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Haase H, 2000, J CELL BIOCHEM, V76, P695, DOI 10.1002/(SICI)1097-4644(20000315)76:4<695::AID-JCB17>3.0.CO;2-Q; Haase H, 1996, J MOL MED-JMM, V74, P99; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; Hullin R, 2003, J BIOL CHEM, V278, P21623, DOI 10.1074/jbc.M211164200; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Hullin R, 1999, CIRCULATION, V100, P155, DOI 10.1161/01.CIR.100.2.155; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kamp TJ, 2000, AM J PHYSIOL-HEART C, V278, pH126, DOI 10.1152/ajpheart.2000.278.1.H126; Keef KD, 2001, AM J PHYSIOL-CELL PH, V281, pC1743; Klugbauer N, 1999, J NEUROSCI, V19, P684; Matthes J, 2004, J MOL CELL CARDIOL, V36, P241, DOI 10.1016/j.yjmcc.2003.11.013; Mukherjee R, 1998, J MOL CELL CARDIOL, V30, P1899, DOI 10.1006/jmcc.1998.0755; Murakami M, 2003, J BIOL CHEM, V278, P43261, DOI 10.1074/jbc.M211380200; Muth JN, 1999, J BIOL CHEM, V274, P21503, DOI 10.1074/jbc.274.31.21503; Muth JN, 2001, CIRCULATION, V103, P140; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Richard S, 1998, CARDIOVASC RES, V37, P300, DOI 10.1016/S0008-6363(97)00273-3; Schotten U, 2003, J MOL CELL CARDIOL, V35, P437, DOI 10.1016/S0022-2828(03)00012-9; Schroder F, 1998, CIRCULATION, V98, P969, DOI 10.1161/01.CIR.98.10.969; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; Serikov V, 2002, BIOCHEM BIOPH RES CO, V293, P1405, DOI 10.1016/S0006-291X(02)00396-0; Shannon TR, 2004, ANN NY ACAD SCI, V1015, P28, DOI 10.1196/annals.1302.003; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Song LS, 2002, CIRC RES, V90, P174, DOI 10.1161/hh0202.103230; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Wei S, 2000, CIRC RES, V86, P175, DOI 10.1161/01.RES.86.2.175	44	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e292	10.1371/journal.pone.0000292	http://dx.doi.org/10.1371/journal.pone.0000292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356701	gold, Green Published, Green Accepted			2022-12-27	WOS:000207444800015
J	Gilbert, MTP; Moore, W; Melchior, L; Worobey, M				Gilbert, M. Thomas P.; Moore, Wendy; Melchior, Linea; Worobey, Michael			DNA Extraction from Dry Museum Beetles without Conferring External Morphological Damage	PLOS ONE			English	Article							COLEOPTERA	Background. A large number of dry-preserved insect specimens exist in collections around the world that might be useful for genetic analyses. However, until now, the recovery of nucleic acids from such specimens has involved at least the partial destruction of the specimen. This is clearly undesirable when dealing with rare species or otherwise important specimens, such as type specimens. Methodology. We describe a method for the extraction of PCR-amplifiable mitochondrial and nuclear DNA from dry insects without causing external morphological damage. Using PCR to amplify approximate to 220 bp of the mitochondrial gene cytochrome c oxidase I, and 250-345 bp fragments of the multi-copy, nuclear 28s ribosomal DNA gene, we demonstrate the efficacy of this method on beetles collected up to 50 years ago. Conclusions. This method offers a means of obtaining useful genetic information from rare insects without conferring external morphological damage.	[Gilbert, M. Thomas P.; Melchior, Linea; Worobey, Michael] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Gilbert, M. Thomas P.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Moore, Wendy] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Melchior, Linea] Univ Copenhagen, Inst Forens Med, Res Lab, Copenhagen, Denmark	University of Arizona; University of Copenhagen; Niels Bohr Institute; California Academy of Sciences; University of Copenhagen	Gilbert, MTP (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	mtpgilbert@gmail.com	Gilbert, Marcus TP/A-8936-2013	Gilbert, Marcus TP/0000-0002-5805-7195; Moore, Wendy/0000-0003-4441-6203	University of Arizona	University of Arizona	The University of Arizona is acknowledged for funding the research.	Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hillis David M., 1996, P321; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maddison DR, 1999, SYST ENTOMOL, V24, P103, DOI 10.1046/j.1365-3113.1999.00088.x; Pfeiffer I, 2004, FORENSIC SCI INT, V141, P149, DOI 10.1016/j.forsciint.2004.01.016; PHILLIPS AJ, 1995, ANN ENTOMOL SOC AM, V88, P281, DOI 10.1093/aesa/88.3.281; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; VOGLER AP, 1993, ANN ENTOMOL SOC AM, V86, P142, DOI 10.1093/aesa/86.2.142	10	180	197	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e272	10.1371/journal.pone.0000272	http://dx.doi.org/10.1371/journal.pone.0000272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17342206	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444700007
J	Tsujiuchi, S; Sivan-Loukianova, E; Eberl, DF; Kitagawa, Y; Kadowaki, T				Tsujiuchi, Seiya; Sivan-Loukianova, Elena; Eberl, Daniel F.; Kitagawa, Yasuo; Kadowaki, Tatsuhiko			Dynamic Range Compression in the Honey Bee Auditory System toward Waggle Dance Sounds	PLOS ONE			English	Article							NEAR-FIELD; HEARING; COMMUNICATION; DIRECTION; ANTENNA; SIGNALS; SENSE	Honey bee foragers use a "waggle dance'' to inform nestmates about direction and distance to locations of attractive food. The sound and air flows generated by dancer's wing and abdominal vibrations have been implicated as important cues, but the decoding mechanisms for these dance messages are poorly understood. To understand the neural mechanisms of honey bee dance communication, we analyzed the anatomy of antenna and Johnston's organ (JO) in the pedicel of the antenna, as well as the mechanical and neural response characteristics of antenna and JO to acoustic stimuli, respectively. The honey bee JO consists of about 300-320 scolopidia connected with about 48 cuticular "knobs'' around the circumference of the pedicel. Each scolopidium contains bipolar sensory neurons with both type I and II cilia. The mechanical sensitivities of the antennal flagellum are specifically high in response to low but not high intensity stimuli of 265-350 Hz frequencies. The structural characteristics of antenna but not JO neurons seem to be responsible for the non-linear responses of the flagellum in contrast to mosquito and fruit fly. The honey bee flagellum is a sensitive movement detector responding to 20 nm tip displacement, which is comparable to female mosquito. Furthermore, the JO neurons have the ability to preserve both frequency and temporal information of acoustic stimuli including the "waggle dance'' sound. Intriguingly, the response of JO neurons was found to be age-dependent, demonstrating that the dance communication is only possible between aged foragers. These results suggest that the matured honey bee antennae and JO neurons are best tuned to detect 250-300 Hz sound generated during "waggle dance'' from the distance in a dark hive, and that sufficient responses of the JO neurons are obtained by reducing the mechanical sensitivity of the flagellum in a near-field of dancer. This nonlinear effect brings about dynamic range compression in the honey bee auditory system.	[Tsujiuchi, Seiya; Kitagawa, Yasuo; Kadowaki, Tatsuhiko] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Sivan-Loukianova, Elena; Eberl, Daniel F.] Univ Iowa, Dept Biol Sci, Iowa City, IA USA	Nagoya University; University of Iowa	Tsujiuchi, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	emi@nuagr1.agr.nagoya-u.ac.jp	Eberl, Daniel F./AAN-3359-2020	Eberl, Daniel F./0000-0001-9982-9895	Japan Society for the Promotion of Science and a joint research grant of Nagoya University-Mitsubishi Heavy Industries, LTD; NIH [DC04848]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004848] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science and a joint research grant of Nagoya University-Mitsubishi Heavy Industries, LTD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and a joint research grant of Nagoya University-Mitsubishi Heavy Industries, LTD to TK, and NIH grant DC04848 to DFE.	BENNETCLARK HC, 1971, NATURE, V234, P255, DOI 10.1038/234255a0; BOO K S, 1975, International Journal of Insect Morphology and Embryology, V4, P549, DOI 10.1016/0020-7322(75)90031-8; BOO KS, 1975, J INSECT PHYSIOL, V21, P1129, DOI 10.1016/0022-1910(75)90126-2; DRELLER C, 1993, J COMP PHYSIOL A, V173, P275, DOI 10.1007/BF00212691; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Erber J, 2000, J COMP PHYSIOL A, V186, P557, DOI 10.1007/s003590000111; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Fahrbach SE, 1995, LEARN MEMORY, V2, P199, DOI 10.1101/lm.2.5.199; Field LH, 1998, ADV INSECT PHYSIOL, V27, P1, DOI 10.1016/S0065-2806(08)60013-2; Gopfert MC, 2001, P ROY SOC B-BIOL SCI, V268, P333, DOI 10.1098/rspb.2000.1376; Gopfert MC, 2005, P NATL ACAD SCI USA, V102, P325, DOI 10.1073/pnas.0405741102; Gopfert MC, 2000, P ROY SOC B-BIOL SCI, V267, P453, DOI 10.1098/rspb.2000.1021; Gopfert MC, 2002, J EXP BIOL, V205, P1199; KIRCHNER WH, 1994, J COMP PHYSIOL A, V175, P261, DOI 10.1007/BF00192985; KIRCHNER WH, 1988, NATURWISSENSCHAFTEN, V75, P629, DOI 10.1007/BF00366482; KIRCHNER WH, 1991, J COMP PHYSIOL A, V168, P85, DOI 10.1007/BF00217106; KLOPPENBURG P, 1995, J COMP NEUROL, V363, P333, DOI 10.1002/cne.903630213; McIndoo NE, 1922, J COMP NEUROL, V34, P173, DOI 10.1002/cne.900340202; MICHELSEN A, 1987, J COMP PHYSIOL A, V161, P633, DOI 10.1007/BF00605005; Michelsen A, 2003, J COMP PHYSIOL A, V189, P165, DOI 10.1007/s00359-003-0398-y; MICHELSEN A, 1986, BEHAV ECOL SOCIOBIOL, V18, P207, DOI 10.1007/BF00290824; Nieh JC, 2000, J EXP BIOL, V203, P1573; Rohrseitz K, 1999, J COMP PHYSIOL A, V184, P463, DOI 10.1007/s003590050346; Sasagawa H, 2003, EUR J NEUROSCI, V17, P963, DOI 10.1046/j.1460-9568.2003.02528.x; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; STABENTHEINER A, 1991, NATURWISSENSCHAFTEN, V78, P471, DOI 10.1007/BF01134389; Todi SV, 2004, MICROSC RES TECHNIQ, V63, P388, DOI 10.1002/jemt.20053; TOWNE WF, 1989, SCIENCE, V244, P686, DOI 10.1126/science.244.4905.686; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051	30	34	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e234	10.1371/journal.pone.0000234	http://dx.doi.org/10.1371/journal.pone.0000234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311102	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444500015
J	Voutilainen, S; Tuomainen, TP; Korhonen, M; Mursu, J; Virtanen, JK; Happonen, P; Alfthan, G; Erlund, I; North, KE; Mosher, MJ; Kauhanen, J; Tiihonen, J; Kaplan, GA; Salonen, JT				Voutilainen, Sari; Tuomainen, Tomi-Pekka; Korhonen, Maarit; Mursu, Jaakko; Virtanen, Jyrki K.; Happonen, Pertti; Alfthan, Georg; Erlund, Iris; North, Kari E.; Mosher, M. J.; Kauhanen, Jussi; Tiihonen, Jari; Kaplan, George A.; Salonen, Jukka T.			Functional COMT Val158Met Polymorphism, Risk of Acute Coronary Events and Serum Homocysteine: The Kuopio Ischaemic Heart Disease Risk Factor Study	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; MYOCARDIAL-INFARCTION; ASSOCIATION; PATHOPHYSIOLOGY; GENOTYPE; VARIANT; GENE	Background. The role of circulating levels of total homocysteine tHcy in the development of coronary heart disease (CHD) is still under debate. One reason for conflicting results between previous studies on homocysteine and heart diseases could be consequence of different interactions between homocysteine and genes in different study populations. Many genetic factors play a role in folate-homocysteine metabolism, like functional polymorphism (Val108Met) in the Catechol-O-methyltransferase (COMT) gene. Methodology and Findings. Our aim was to examine the role of COMT Val158Met polymorphism and interaction of this polymorphism with serum tHcy and folate concentration on the risk of acute coronary and events in middle-aged men from eastern Finland. A population-based prospective cohort of 792 men aged 46-64 years was examined as part of the Kuopio Ischaemic Heart Disease Risk Factor Study. During an average follow-up of 9.3 years, there were 69 acute coronary events in men with no previous history of CHD. When comparing the COMT low activity genotype with the others, we found an age and examination year adjusted hazard rate ratio (HRR) of 1.73 (95% confidence interval (CI), 1.07-2.79), and an age, examination year, serum LDL and HDL cholesterol, and triglyceride concentration, systolic blood pressure and smoking adjusted HRR of 1.77 (95% CI, 1.05-2.77). Although serum tHcy concentration was not statistically significantly associated with acute coronary events (HRR for the highest third versus others 1.52, 95% CI, 0.93-2.49), subjects with both high serum tHcy and the COMT low activity genotype had an additionally increased adjusted risk of HRR 2.94 (95% CI 1.50-5.76) as compared with other men. Conclusions. This prospective cohort study suggests that the functional COMT Val158Met polymorphism is associated with increased risk of acute coronary events and it may interact with high serum tHcy levels.	[Voutilainen, Sari; Tuomainen, Tomi-Pekka; Mursu, Jaakko; Virtanen, Jyrki K.; Salonen, Jukka T.] Univ Kuopio, Publ Hlth Res Inst, FIN-70211 Kuopio, Finland; [Tuomainen, Tomi-Pekka] Univ Kuopio, Atherosclerosis Res Unit, FIN-70211 Kuopio, Finland; [Korhonen, Maarit; Happonen, Pertti; Kauhanen, Jussi; Salonen, Jukka T.] Univ Kuopio, Dept Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland; [Alfthan, Georg; Erlund, Iris] Natl Publ Hlth Inst, Biomarker Lab, Helsinki, Finland; [North, Kari E.; Mosher, M. J.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Tiihonen, Jari] Univ Kuopio, Dept Forens Psychiat, FIN-70211 Kuopio, Finland; [Kaplan, George A.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Salonen, Jukka T.] Oy Jurilab Ltd, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Finland National Institute for Health & Welfare; University of North Carolina; University of North Carolina Chapel Hill; University of Eastern Finland; University of Michigan System; University of Michigan	Voutilainen, S (corresponding author), Univ Kuopio, Publ Hlth Res Inst, FIN-70211 Kuopio, Finland.	sari.voutilainen@uku.fi	Kauhanen, Jussi/ABC-4064-2021; Kaplan, George/AAJ-2398-2020; Erlund, Iris/AAA-4108-2019; Virtanen, Jyrki/G-5149-2013; Tiihonen, Jari/G-3078-2012; Virtanen, Jyrki/AAC-8945-2020	Virtanen, Jyrki/0000-0002-0648-999X; Tiihonen, Jari/0000-0002-0400-6798; Virtanen, Jyrki/0000-0002-0648-999X; Korhonen, Maarit/0000-0002-2953-4757	Academy of Finland [201688, 80185, 200942, 41471, 1041086, 2041022]; National Heart, Lung and Blood Institute of the USA Juho Vainio Foundation [HL44199]; Yrjo Jahnsson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R24HD047861] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044199] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); National Heart, Lung and Blood Institute of the USA Juho Vainio Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Yrjo Jahnsson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by Academy of Finland (grants 201688 and 80185 to SV, 200942 to JK), Juho Vainio Foundation and Yrjo Jahnsson Foundation. The KIHD study was supported by grants from the Academy of Finland (grants 41471, 1041086 and 2041022 to JTS) and the National Heart, Lung and Blood Institute of the USA (grant HL44199 to GAK).	ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Eriksson AL, 2004, EUR HEART J, V25, P386, DOI 10.1016/j.ehj.2003.12.026; Hallikainen T, 2000, AM J MED GENET, V96, P348, DOI 10.1002/1096-8628(20000612)96:3<348::AID-AJMG22>3.0.CO;2-Z; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Knekt P, 2001, ARCH INTERN MED, V161, P1589, DOI 10.1001/archinte.161.13.1589; Lachman HM, 1998, AM J PSYCHIAT, V155, P835; Lievers KJA, 2003, ANN CLIN BIOCHEM, V40, P46, DOI 10.1258/000456303321016169; Norio R., 1981, BIOCULTURAL ASPECTS, P359; Nygard O, 1999, J INTERN MED, V246, P425, DOI 10.1046/j.1365-2796.1999.00512.x; SALONEN JT, 1995, BRIT MED J, V311, P1124, DOI 10.1136/bmj.311.7013.1124; SALONEN JT, 1988, ANN CLIN RES, V20, P46; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; Schwab U, 2002, AM J CLIN NUTR, V76, P961, DOI 10.1093/ajcn/76.5.961; Tiihonen J, 1999, MOL PSYCHIATR, V4, P286, DOI 10.1038/sj.mp.4000509; TUOMILEHTO J, 1992, EUR HEART J, V13, P577, DOI 10.1093/oxfordjournals.eurheartj.a060219; Voutilainen S, 2000, J INTERN MED, V248, P217, DOI 10.1046/j.1365-2796.2000.00741.x; Voutilainen S, 2004, AM J CLIN NUTR, V80, P317, DOI 10.1093/ajcn/80.2.317; Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674; Voutilainen S, 2000, EUR J CLIN NUTR, V54, P424, DOI 10.1038/sj.ejcn.1600991; Zhu BT, 2002, HISTOL HISTOPATHOL, V17, P1283, DOI 10.14670/HH-17.1283; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	23	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e181	10.1371/journal.pone.0000181	http://dx.doi.org/10.1371/journal.pone.0000181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17264883	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444200005
J	Clarke, SL; Betts, GJ; Plant, A; Wright, KL; El-Shanawany, TM; Harrop, R; Torkington, J; Rees, BI; Williams, GT; Gallimore, AM; Godkin, AJ				Clarke, Sarah L.; Betts, Gareth J.; Plant, Andrea; Wright, Kate L.; El-Shanawany, Tariq M.; Harrop, Richard; Torkington, Jared; Rees, Brian I.; Williams, Geraint T.; Gallimore, Awen M.; Godkin, Andrew J.			CD4(+) CD25(+) FOXP3(+) Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer	PLOS ONE			English	Article								Background. A wealth of evidence obtained using mouse models indicates that CD4(+) CD25(+) FOXP3(+) regulatory T cells (Treg) maintain peripheral tolerance to self-antigens and also inhibit anti-tumor immune responses. To date there is limited information about CD4(+) T cell responses in patients with colorectal cancer (CRC). We set out to measure T cell responses to a tumor-associated antigen and examine whether Treg impinge on those anti-tumor immune responses in CRC patients. Methodology and Principal Findings. Treg were identified and characterized as CD4(+) CD25(+) FOXP3(+) using flow cytometry. An increased frequency of Treg was demonstrated in both peripheral blood and mesenteric lymph nodes of patients with colorectal cancer (CRC) compared with either healthy controls or patients with inflammatory bowel disease (IBD). Depletion of Treg from peripheral blood mononuclear cells (PBMC) of CRC patients unmasked CD4(+) T cell responses, as observed by IFN gamma release, to the tumor associated antigen 5T4, whereas no effect was observed in a healthy age-matched control group. Conclusions/Significance. Collectively, these data demonstrate that Treg capable of inhibiting tumor associated antigen-specific immune responses are enriched in patients with CRC. These results support a rationale for manipulating Treg to enhance cancer immunotherapy.	[Clarke, Sarah L.; Betts, Gareth J.; Plant, Andrea; Wright, Kate L.; El-Shanawany, Tariq M.; Gallimore, Awen M.; Godkin, Andrew J.] Cardiff Univ, Dept Med Biochem & Immunol, Cardiff, Wales; [Harrop, Richard] Oxford Biomedica, Oxford, England; [Torkington, Jared; Rees, Brian I.] Univ Wales Hosp, Dept Surg, Cardiff, Wales; [Williams, Geraint T.] Cardiff Univ, Dept Pathol, Cardiff, Wales	Cardiff University; Oxford Biomedica (UK) Ltd; Cardiff University; Cardiff University	Clarke, SL (corresponding author), Cardiff Univ, Dept Med Biochem & Immunol, Cardiff, Wales.	godkinaj@cf.ac.uk		Godkin, Andrew/0000-0002-1910-7567; Gallimore, Awen/0000-0001-6675-7004	Tenovus Cancer Charity, Cardiff; Cardiff and Vale NHS Trust; Wellcome Trust project; Association of International Cancer Research; MRC senior research fellow; MRC [G0500617, G117/488] Funding Source: UKRI; Medical Research Council [G117/488, G0500617] Funding Source: researchfish	Tenovus Cancer Charity, Cardiff; Cardiff and Vale NHS Trust; Wellcome Trust project(Wellcome Trust); Association of International Cancer Research; MRC senior research fellow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from the Tenovus Cancer Charity, Cardiff, and a small grant award from Cardiff and Vale NHS Trust. KLW was funded by a Wellcome Trust project grant and the Association of International Cancer Research. AMG is an MRC senior research fellow.	Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; GODKIN A, 2006, MICROBES IN IN PRESS; Godkin AJ, 1998, J IMMUNOL, V161, P850; Golgher D, 2002, EUR J IMMUNOL, V32, P3267, DOI 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1; Griffiths RW, 2005, BRIT J CANCER, V93, P670, DOI 10.1038/sj.bjc.6602776; Harris R., 2005, CANC IMMUNOL IM 1126, P1; HOLE N, 1988, BRIT J CANCER, V57, P239, DOI 10.1038/bjc.1988.53; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Jones Emma, 2002, Cancer Immun, V2, P1; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; MYERS KA, 1994, J BIOL CHEM, V269, P9319; Naito Y, 1998, CANCER RES, V58, P3491; Newcombe RG, 2001, STAT MED, V20, P2885, DOI 10.1002/sim.925; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; PARKIN DM, 2002, IARC SCI PUB, P1; Penn I, 1999, TRANSPLANT P, V31, P1260, DOI 10.1016/S0041-1345(98)01987-3; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; STARZYNSKA T, 1992, BRIT J CANCER, V66, P867, DOI 10.1038/bjc.1992.375; STARZYNSKA T, 1994, BRIT J CANCER, V69, P899, DOI 10.1038/bjc.1994.173; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Wang HY, 2005, J IMMUNOL, V174, P2661, DOI 10.4049/jimmunol.174.5.2661; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5; WRIGLEY E, 1995, INT J GYNECOL CANCER, V5, P269, DOI 10.1046/j.1525-1438.1995.05040269.x	29	178	186	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e129	10.1371/journal.pone.0000129	http://dx.doi.org/10.1371/journal.pone.0000129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205133	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700023
J	Zhang, YL; McEwen, AE; Crothers, DM; Levene, SD				Zhang, Yongli; McEwen, Abbye E.; Crothers, Donald M.; Levene, Stephen D.			Analysis of In-Vivo LacR-Mediated Gene Repression Based on the Mechanics of DNA Looping	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; CRYSTAL-STRUCTURE; HELICAL REPEAT; PROTEIN; FLEXIBILITY; BINDING; DYNAMICS; HU; COMPLEXES; OPERATORS	Interactions of E. coli lac repressor (LacR) with a pair of operator sites on the same DNA molecule can lead to the formation of looped nucleoprotein complexes both in vitro and in vivo. As a major paradigm for loop-mediated gene regulation, parameters such as operator affinity and spacing, repressor concentration, and DNA bending induced by specific or non-specific DNA-binding proteins (e.g., HU), have been examined extensively. However, a complete and rigorous model that integrates all of these aspects in a systematic and quantitative treatment of experimental data has not been available. Applying our recent statistical-mechanical theory for DNA looping, we calculated repression as a function of operator spacing (58-156 bp) from first principles and obtained excellent agreement with independent sets of in-vivo data. The results suggest that a linear extended, as opposed to a closed v-shaped, LacR conformation is the dominant form of the tetramer in vivo. Moreover, loop-mediated repression in wild-type E. coli strains is facilitated by decreased DNA rigidity and high levels of flexibility in the LacR tetramer. In contrast, repression data for strains lacking HU gave a near-normal value of the DNA persistence length. These findings underscore the importance of both protein conformation and elasticity in the formation of small DNA loops widely observed in vivo, and demonstrate the utility of quantitatively analyzing gene regulation based on the mechanics of nucleoprotein complexes.	[Zhang, Yongli; Crothers, Donald M.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Zhang, Yongli; Crothers, Donald M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [McEwen, Abbye E.; Levene, Stephen D.] Univ Texas Dallas, Inst Biomed Sci & Technol, Richardson, TX 75083 USA; [Levene, Stephen D.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA	Yale University; Yale University; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Zhang, YL (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.	ylzhang@lbl.gov; sdlevene@utdallas.edu	Levene, Stephen/G-3100-2010	Levene, Stephen/0000-0003-2778-5162	NIH [GM 67242, GM 21966]; National Foundation for Cancer Research through the Yale-NFCR Center for Protein and Nucleic Acid Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021966, R01GM067242, R01GM021966] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research through the Yale-NFCR Center for Protein and Nucleic Acid Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Joint DMS/NIGMS Mathematical Biology Initiative (NIH GM 67242 to SDL and I. K. Darcy), by NIH grant GM 21966 to DMC, and by the National Foundation for Cancer Research through the Yale-NFCR Center for Protein and Nucleic Acid Chemistry.	[Anonymous], 1987, LINEAR AGGREGATION T; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; BLISKA JB, 1987, J MOL BIOL, V194, P205, DOI 10.1016/0022-2836(87)90369-X; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Cloutier TE, 2004, MOL CELL, V14, P355, DOI 10.1016/S1097-2765(04)00210-2; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P3; CROTHERS DM, 1972, IMMUNOCHEMISTRY, V9, P341, DOI 10.1016/0019-2791(72)90097-3; ECHOLS H, 1986, SCIENCE, V233, P1050, DOI 10.1126/science.2943018; Edelman LM, 2003, BIOPHYS J, V84, P1131, DOI 10.1016/S0006-3495(03)74929-7; Espeli O, 2004, MOL MICROBIOL, V52, P925, DOI 10.1111/j.1365-2958.2004.04047.x; FINZI L, 1995, SCIENCE, V267, P378, DOI 10.1126/science.7824935; FLASHNER Y, 1988, CELL, V54, P713, DOI 10.1016/S0092-8674(88)80016-3; Fried MG, 2001, J BIOL CHEM, V276, P11226, DOI 10.1074/jbc.M009087200; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Geanacopoulos M, 2001, NAT STRUCT BIOL, V8, P432, DOI 10.1038/87595; Gemmen GJ, 2006, NUCLEIC ACIDS RES, V34, P2864, DOI 10.1093/nar/gkl382; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; HAYKINSON MJ, 1993, EMBO J, V12, P2503, DOI 10.1002/j.1460-2075.1993.tb05905.x; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547; LAW SM, 1993, J MOL BIOL, V230, P161, DOI 10.1006/jmbi.1993.1133; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; LEVENE SD, 2001, NATURE ENCY LIFE SCI; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; Mehta RA, 1999, J MOL BIOL, V294, P67, DOI 10.1006/jmbi.1999.3244; MOSSING MC, 1986, SCIENCE, V233, P889, DOI 10.1126/science.3090685; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; Pastre D, 2006, EUR BIOPHYS J BIOPHY, V35, P214, DOI 10.1007/s00249-005-0025-7; PORSCHKE D, 1991, BIOPHYS CHEM, V40, P169, DOI 10.1016/0301-4622(91)87006-Q; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Ross ED, 2001, MOL CELL BIOL, V21, P6598, DOI 10.1128/MCB.21.19.6598-6605.2001; Ruben GC, 1997, MICROSC RES TECHNIQ, V36, P400, DOI 10.1002/(SICI)1097-0029(19970301)36:5<400::AID-JEMT10>3.0.CO;2-W; Saiz L, 2005, P NATL ACAD SCI USA, V102, P17642, DOI 10.1073/pnas.0505693102; SAIZ L, IN VIVO EVIDENCE ALT; SASSEDWIGHT S, 1988, J MOL BIOL, V202, P107, DOI 10.1016/0022-2836(88)90523-2; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; Skoko D, 2004, BIOCHEMISTRY-US, V43, P13867, DOI 10.1021/bi048428o; Swigon D, 2006, P NATL ACAD SCI USA, V103, P9879, DOI 10.1073/pnas.0603557103; van den Broek B, 2006, NUCLEIC ACIDS RES, V34, P167, DOI 10.1093/nar/gkj432; van Noort J, 2004, P NATL ACAD SCI USA, V101, P6969, DOI 10.1073/pnas.0308230101; Vilar JMG, 2005, CURR OPIN GENET DEV, V15, P136, DOI 10.1016/j.gde.2005.02.005; Vilar JMG, 2003, J MOL BIOL, V331, P981, DOI 10.1016/S0022-2836(03)00764-2; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; von Hippel P. H, 1979, BIOL REGULATION DEV, V1, P279; Vossen KM, 1996, J MOL BIOL, V255, P44, DOI 10.1006/jmbi.1996.0005; WASSERMAN SA, 1988, NATURE, V334, P448, DOI 10.1038/334448a0; Watson MA, 2000, J MOL BIOL, V298, P461, DOI 10.1006/jmbi.2000.3676; Wiggins PA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021909; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Yan J, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061905; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhang Y, 2006, BIOPHYS J, V90, P1903, DOI 10.1529/biophysj.105.070490; Zhang YL, 2004, P NATL ACAD SCI USA, V101, P8337, DOI 10.1073/pnas.0402319101; Zhang YL, 2003, P NATL ACAD SCI USA, V100, P3161, DOI 10.1073/pnas.0530189100; Zhang YL, 2003, BIOPHYS J, V84, P136, DOI 10.1016/S0006-3495(03)74838-3; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P15069, DOI 10.1021/bi015795g	69	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e136	10.1371/journal.pone.0000136	http://dx.doi.org/10.1371/journal.pone.0000136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205140	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443700030
J	Gutierrez, F; Padilla, S; Masia, M; Iribarren, JA; Moreno, S; Viciana, P; Munoz, L; Sirvent, JLG; Vidal, F; Lopez-Aldeguer, J; Blanco, JR; Leal, M; Rodriguez-Arenas, MA; Hoyos, SP				Gutierrez, Felix; Padilla, Sergio; Masia, Mar; Iribarren, Jose A.; Moreno, Santiago; Viciana, Pompeyo; Munoz, Leopoldo; Gomez Sirvent, Jose L.; Vidal, Francesc; Lopez-Aldeguer, Jose; Blanco, Jose R.; Leal, Manuel; Angeles Rodriguez-Arenas, Maria; Perez Hoyos, Santiago		CoRIS-MD	Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort	PLOS ONE			English	Article								Background. Limited information exists on long-term prognosis of patients with sustained virologic response to antiretroviral therapy. We aimed to assess predictors of unfavorable clinical outcome in patients who maintain viral suppression with HAART. Methods. Using data collected from ten clinic-based cohorts in Spain, we selected all antiretroviral-naive adults who initiated HAART and maintained plasma HIV-1 RNA levels,500 copies/mL throughout follow-up. Factors associated with disease progression were determined by Cox proportional-hazards models. Results. Of 2,613 patients who started HAART, 757 fulfilled the inclusion criteria. 61% of them initiated a protease inhibitor-based HAART regimen, 29.7% a nonnucleoside reverse-transcriptase inhibitor-based regimen, and 7.8% a triple-nucleoside regimen. During 2,556 person-years of follow-up, 22 (2.9%) patients died (mortality rate 0.86 per 100 person-years), and 40 (5.3%) died or developed a new AIDS-defining event. The most common causes of death were neoplasias and liver failure. Mortality was independently associated with a CD4-T cell response,50 cells/L after 12 months of HAART (adjusted hazard ratio [AHR], 4.26 [95% confidence interval {CI}, 1.68-10.83]; P = .002), and age at initiation of HAART (AHR, 1.06 per year; 95% CI, 1.02-1.09; P = .001). Initial antiretroviral regimen chosen was not associated with different risk of clinical progression. Conclusions. Patients with sustained virologic response on HAART have a low mortality rate over time. Long-term outcome of these patients is driven by immunologic response at the end of the first year of therapy and age at the time of HAART initiation, but not by the initial antiretroviral regimen selected.	[Gutierrez, Felix; Padilla, Sergio; Masia, Mar] Univ Miguel Hernandez, Univ Elche, Gen Hosp, Unidad Enfermedades Infecciosas, Alicante, Spain; [Iribarren, Jose A.] Hosp Donostia, Unidad Enfermedades Infecciosas, San Sebastian, Spain; [Moreno, Santiago] Hosp Ramon & Cajal, Serv Enfermedades Infecciosas, E-28034 Madrid, Spain; [Viciana, Pompeyo; Leal, Manuel] Hosp Univ Virgen Rodo, Serv Enfermedades Infecciosas, Seville, Spain; [Munoz, Leopoldo] Hosp Univ San Cecilio, Unidad Enfermedades Infecciosas, Granada, Spain; [Gomez Sirvent, Jose L.] Hosp Univ Canarias, Unidad Enfermedades Infecciosas, Santa Cruz de Tenerife, Spain; [Vidal, Francesc] Univ Rovira & Virgili, Hosp Univ Tarragona Joan XXIII, Unidad Enfermedades Infecciosas, Tarragona, Spain; [Lopez-Aldeguer, Jose] Hosp La Fe, Unidad Enfermedades Infecciosas, E-46009 Valencia, Spain; [Blanco, Jose R.] Hosp La Rioja, Area Enfermedades Infecciosas, Logrono, La Rioja, Spain; [Angeles Rodriguez-Arenas, Maria] Univ Miguel Hernandez, Dept Salud Publ, Alicante, Spain; [Perez Hoyos, Santiago] EVES, Valencia, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; University Hospital Donostia; Hospital Universitario Ramon y Cajal; Hospital Universitario San Cecilio; Universidad de la Laguna; Universitat Rovira i Virgili; Hospital Universitari De Tarragona Joan XXIII; Hospital Universitari i Politecnic La Fe; Universidad Miguel Hernandez de Elche	Gutierrez, F (corresponding author), Univ Miguel Hernandez, Univ Elche, Gen Hosp, Unidad Enfermedades Infecciosas, Alicante, Spain.	gutierrez_fel@gva.es	Padilla, Sergio/U-7682-2017; Iribarren, José/AAK-5528-2021; DEL AMO VALERO, JULIA/M-7020-2015; Rodriguez-Arenas, M. Angeles/AAE-2705-2021; Blanco, Jose-Ramon/L-6768-2018; IBIS, VIH/O-8856-2015; Leal, Manuel/C-8458-2015; Oteo, Jose A./AAB-3134-2020; Perez Hoyos, Santiago/O-1075-2019; Lopez.Cortes, Luis Fernando/S-5625-2018; Masia, Mar/U-7510-2017	DEL AMO VALERO, JULIA/0000-0002-3104-540X; Rodriguez-Arenas, M. Angeles/0000-0002-8115-054X; Blanco, Jose-Ramon/0000-0002-4268-0150; Oteo, Jose A./0000-0001-7080-6542; Perez Hoyos, Santiago/0000-0001-9797-4917; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Perez Elias/0000-0001-5700-5257; Masia, Mar/0000-0001-9878-2458; Padilla, Sergio/0000-0002-8420-7310; Vidal, Francesc/0000-0002-6692-6186; Bernal, Enrique/0000-0002-4041-0579	Red Tematica Cooperativa de Investigacion en SIDA del Fondo de Investigacion Sanitaria (FISss) [PI051338]	Red Tematica Cooperativa de Investigacion en SIDA del Fondo de Investigacion Sanitaria (FISss)	Supported in part by the "Red Tematica Cooperativa de Investigacion en SIDA (Red de Grupos 173 y Expte: PI051338; RIS)'' del Fondo de Investigacion Sanitaria (FISss).	Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Binquet C, 2001, AM J EPIDEMIOL, V153, P386, DOI 10.1093/aje/153.4.386; Bonnet F, 2005, HIV MED, V6, P198, DOI 10.1111/j.1468-1293.2005.00290.x; Braitstein P, 2006, J INFECT DIS, V193, P259, DOI 10.1086/498908; DeGruttola V, 1997, J INFECT DIS, V175, P237, DOI 10.1093/infdis/175.2.237; Demeter LM, 2001, ANN INTERN MED, V135, P954, DOI 10.7326/0003-4819-135-11-200112040-00007; *DHHS PAN CLIN PRA, 2006, GUID US ANT AG HIV 1; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Gebhardt M, 1998, AIDS, V12, P1195, DOI 10.1097/00002030-199810000-00012; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Grabar S, 2005, JAIDS-J ACQ IMM DEF, V39, P284, DOI 10.1097/01.qai.0000160925.33935.72; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Hortelano CME, 2004, MED CLIN-BARCELONA, V122, P1; Li QS, 2004, J INFECT DIS, V189, P572, DOI 10.1086/381396; Marimoutou C, 2001, J ACQ IMMUN DEF SYND, V27, P161, DOI 10.1097/00126334-200106010-00011; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Moore DM, 2006, AIDS, V20, P371, DOI 10.1097/01.aids.0000196180.11293.9a; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Olsen CH, 2005, AIDS, V19, P319; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Perez-Hoyos S, 2003, AIDS, V17, P353, DOI 10.1097/00002030-200302140-00009; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Puoti M, 2000, J ACQ IMMUN DEF SYND, V24, P211; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rodriguez-Arenas MA, 2006, AIDS RES HUM RETROV, V22, P715, DOI 10.1089/aid.2006.22.715; Schechter M, 2006, J ANTIMICROB CHEMOTH, V58, P506, DOI 10.1093/jac/dkl263; Staszewski S, 1998, AIDS, V12, P1991, DOI 10.1097/00002030-199815000-00010; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Valdez H, 2001, CLIN INFECT DIS, V32, P1487, DOI 10.1086/320164; Weber R, 2005, 12 C RETR OPP INF 22; Welch K, 2002, AIDS PATIENT CARE ST, V16, P75, DOI 10.1089/10872910252806126; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	36	41	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e89	10.1371/journal.pone.0000089	http://dx.doi.org/10.1371/journal.pone.0000089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183720	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600088
J	Pourmand, N; Diamond, L; Garten, R; Erickson, JP; Kumm, J; Donis, RO; Davis, RW				Pourmand, Nader; Diamond, Lisa; Garten, Rebecca; Erickson, Julianna P.; Kumm, Jochen; Donis, Ruben O.; Davis, Ronald W.			Rapid and Highly Informative Diagnostic Assay for H5N1 Influenza Viruses	PLOS ONE			English	Article								A highly discriminative and information-rich diagnostic assay for H5N1 avian influenza would meet immediate patient care needs and provide valuable information for public health interventions, e. g., tracking of new and more dangerous variants by geographic area as well as avian-to-human or human-to-human transmission. In the present study, we have designed a rapid assay based on multilocus nucleic acid sequencing that focuses on the biologically significant regions of the H5N1 hemagglutinin gene. This allows the prediction of viral strain, clade, receptor binding properties, low-or high-pathogenicity cleavage site and glycosylation status. H5 HA genes were selected from nine known high-pathogenicity avian influenza subtype H5N1 viruses, based on their diversity in biologically significant regions of hemagglutinin and/or their ability to cause infection in humans. We devised a consensus pre-programmed pyrosequencing strategy, which may be used as a faster, more accurate alternative to de novo sequencing. The available data suggest that the assay described here is a reliable, rapid, information-rich and cost-effective approach for definitive diagnosis of H5N1 avian influenza. Knowledge of the predicted functional sequences of the HA will enhance H5N1 avian influenza surveillance efforts.	[Pourmand, Nader; Diamond, Lisa; Erickson, Julianna P.; Kumm, Jochen; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Garten, Rebecca; Donis, Ruben O.] Ctr Dis Control & Prevent, Mol Virol & Vaccines Branch, Influenza Div, Atlanta, GA USA	Stanford University; Centers for Disease Control & Prevention - USA	Pourmand, N (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	pourmand@stanford.edu		Pourmand, Nader/0000-0003-0251-9060	National Institutes of Health [1R21 A1059499- 01, PO1-HG000205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	National Institutes of Health, 1R21 A1059499- 01 and PO1-HG000205	Banks J, 2003, AVIAN DIS, V47, P942, DOI 10.1637/0005-2086-47.s3.942; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; *CDC, 2006, MMWR-MORBID MORTAL W, V10, P127; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Cover TM, 1991, ELEMENTS INFORM THEO, Vxxii; Cristianini N, 2000, INTRO SUPPORT VECTOR, pxiii; DUDA RO, 2001, PATTERN CLASSIFICATI, pR25; Effler PV, 2002, EMERG INFECT DIS, V8, P23, DOI 10.3201/eid0801.010067; Fan J, 1998, CLIN INFECT DIS, V26, P1397, DOI 10.1086/516357; Gharizadeh B, 2005, INT J ANTIMICROB AG, V26, P486, DOI 10.1016/j.ijantimicag.2005.08.017; Gharizadeh B, 2006, MOL CELL PROBE, V20, P230, DOI 10.1016/j.mcp.2006.01.002; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Habib-Bein NF, 2003, J CLIN MICROBIOL, V41, P3597, DOI 10.1128/JCM.41.8.3597-3601.2003; Hatta M, 2000, ARCH VIROL, V145, P1947, DOI 10.1007/s007050070068; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; MEYER D, 2006, SUPPORT VECTOR MACHI, pE1071; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; OHUCHI M, 1989, VIROLOGY, V168, P274, DOI 10.1016/0042-6822(89)90267-5; PAULSON JC, 1985, RECEPTORS; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Scheffner M, 1998, PHARMACOL THERAPEUT, V78, P129, DOI 10.1016/S0163-7258(98)00003-5; SCHMIDT NJ, 1989, DIAGNOSTIC PROCEDURE, pR15; Shinya K, 2005, J VIROL, V79, P9926, DOI 10.1128/JVI.79.15.9926-9932.2005; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; WHILEY DM, 2005, DIAGN MICROBIOL INFE; *WHO, 2005, EMERG INFECT DIS, V11; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; R STAT PACKAGE	38	29	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e95	10.1371/journal.pone.0000095	http://dx.doi.org/10.1371/journal.pone.0000095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183727	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600094
J	Yu, LL; Tucci, V; Kishi, S; Zhdanova, IV				Yu, Lili; Tucci, Valter; Kishi, Shuji; Zhdanova, Irina V.			Cognitive Aging in Zebrafish	PLOS ONE			English	Article								Background. Age-related impairments in cognitive functions represent a growing clinical and social issue. Genetic and behavioral characterization of animal models can provide critical information on the intrinsic and environmental factors that determine the deterioration or preservation of cognitive abilities throughout life. Methodology/Principal Findings. Behavior of wild-type, mutant and gamma-irradiated zebrafish (Danio rerio) was documented using image-analysis technique. Conditioned responses to spatial, visual and temporal cues were investigated in young, middle-aged and old animals. The results demonstrate that zebrafish aging is associated with changes in cognitive responses to emotionally positive and negative experiences, reduced generalization of adaptive associations, increased stereotypic and reduced exploratory behavior and altered temporal entrainment. Genetic upregulation of cholinergic transmission attenuates cognitive decline in middle-aged achesb55/+ mutants, compared to wild-type siblings. In contrast, the genotoxic stress of gamma-irradiation accelerates the onset of cognitive impairment in young zebrafish. Conclusions/Significance. These findings would allow the use of powerful molecular biological resources accumulated in the zebrafish field to address the mechanisms of cognitive senescence, and promote the search for therapeutic strategies which may attenuate age-related cognitive decline.	[Yu, Lili; Tucci, Valter; Zhdanova, Irina V.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Kishi, Shuji] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Boston University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Zhdanova, IV (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	zhdanova@bu.edu		Tucci, Valter/0000-0002-3796-3826; Zhdanova, Irina/0000-0002-8401-9571	NIH [MH065528, AG02264]; Chaikin-Wile foundation; Ellison Medical Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065528] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chaikin-Wile foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the grants awarded by NIH (MH065528; to IZ), (AG02264, to SK), Chaikin-Wile foundation (IZ), and Ellison Medical Foundation (SK).	Bartus RT, 2000, EXP NEUROL, V163, P495, DOI 10.1006/exnr.2000.7397; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Behra M, 2002, NAT NEUROSCI, V5, P111, DOI 10.1038/nn788; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P290, DOI 10.1037/h0022308; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; Delaney M, 2002, BIOL BULL, V203, P240, DOI 10.2307/1543418; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Gerhard GS, 2003, EXP GERONTOL, V38, P1333, DOI 10.1016/j.exger.2003.10.022; Gerhard GS, 2002, AGING CELL, V1, P104, DOI 10.1046/j.1474-9728.2002.00012.x; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; GREENWOOD B, 1995, AM J PHYSIOL-GASTR L, V268, pG514, DOI 10.1152/ajpgi.1995.268.3.G514; INGLIS FM, 1994, NEUROSCIENCE, V62, P1049, DOI 10.1016/0306-4522(94)90342-5; Keller ET, 2004, COMP BIOCHEM PHYS C, V138, P335, DOI 10.1016/j.cca.2004.04.001; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; MISTLBERGER RE, 1990, NEUROBIOL AGING, V11, P619, DOI 10.1016/0197-4580(90)90027-W; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mueller T, 2004, BRAIN RES, V1011, P156, DOI 10.1016/j.brainres.2004.02.073; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Ninkovic J, 2006, J NEUROBIOL, V66, P463, DOI 10.1002/neu.20231; ONO M, 1995, PHYSIOL BEHAV, V57, P189, DOI 10.1016/0031-9384(94)00248-4; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; RAZA A, 1994, HEARING RES, V77, P221, DOI 10.1016/0378-5955(94)90270-4; ROBINSON J, 1993, P NATL ACAD SCI USA, V90, P6009, DOI 10.1073/pnas.90.13.6009; Sarter M, 2004, NEUROBIOL AGING, V25, P1127, DOI 10.1016/j.neurobiolaging.2003.11.011; Schaffitzel E, 2006, EXP GERONTOL, V41, P557, DOI 10.1016/j.exger.2006.02.008; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Tanaka Y, 2000, PHARMACOL BIOCHEM BE, V66, P827, DOI 10.1016/S0091-3057(00)00288-4; TSAI SB, 2006, AGING CELL IN PRESS; Walcott EC, 1996, PHYSIOL BEHAV, V60, P1205, DOI 10.1016/S0031-9384(96)00215-6; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1	33	107	108	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e14	10.1371/journal.pone.0000014	http://dx.doi.org/10.1371/journal.pone.0000014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183640	gold, Green Published			2022-12-27	WOS:000207443600014
J	Absalon, S; Kohl, L; Branche, C; Blisnick, T; Toutirais, G; Rusconi, F; Cosson, J; Bonhivers, M; Robinson, D; Bastin, P				Absalon, Sabrina; Kohl, Linda; Branche, Carole; Blisnick, Thierry; Toutirais, Geraldine; Rusconi, Filippo; Cosson, Jacky; Bonhivers, Melanie; Robinson, Derrick; Bastin, Philippe			Basal Body Positioning Is Controlled by Flagellum Formation in Trypanosoma brucei	PLOS ONE			English	Article								To perform their multiple functions, cilia and flagella are precisely positioned at the cell surface by mechanisms that remain poorly understood. The protist Trypanosoma brucei possesses a single flagellum that adheres to the cell body where a specific cytoskeletal structure is localised, the flagellum attachment zone (FAZ). Trypanosomes build a new flagellum whose distal tip is connected to the side of the old flagellum by a discrete structure, the flagella connector. During this process, the basal body of the new flagellum migrates towards the posterior end of the cell. We show that separate inhibition of flagellum assembly, base-to-tip motility or flagella connection leads to reduced basal body migration, demonstrating that the flagellum contributes to its own positioning. We propose a model where pressure applied by movements of the growing new flagellum on the flagella connector leads to a reacting force that in turn contributes to migration of the basal body at the proximal end of the flagellum.	[Absalon, Sabrina; Kohl, Linda; Branche, Carole; Toutirais, Geraldine; Rusconi, Filippo; Bastin, Philippe] Museum Natl Hist Nat, INSERM, F-75231 Paris, France; [Absalon, Sabrina; Kohl, Linda; Branche, Carole; Blisnick, Thierry; Toutirais, Geraldine; Rusconi, Filippo; Bastin, Philippe] CNRS, Paris, France; [Absalon, Sabrina; Branche, Carole; Blisnick, Thierry; Bastin, Philippe] Inst Pasteur, Trypanosome Cell Biol Unit, Paris, France; [Bonhivers, Melanie; Robinson, Derrick] CNRS, Bordeaux, France; [Bonhivers, Melanie; Robinson, Derrick] Univ Bordeaux 2, F-33076 Bordeaux, France; [Cosson, Jacky] CNRS, Stn Zool, Villefranche Sur Mer, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Bastin, P (corresponding author), Museum Natl Hist Nat, INSERM, F-75231 Paris, France.	pbastin@pasteur.fr	Bastin, Philippe/E-6688-2017; Bastin, Philippe/B-1402-2014; Bonhivers, Melanie/Z-5889-2019; Bastin, Philippe/O-4230-2019	Bonhivers, Melanie/0000-0001-9179-8473; Bastin, Philippe/0000-0002-3042-8679; Absalon, Sabrina/0000-0003-2468-8156; Rusconi, Filippo Matteo/0000-0003-1822-0397; Absalon, Sabrina/0000-0002-4167-3071	CNRS; ACI; Programme Proteomique et Genie des Proteines; GIS; MRT; FRM; European Science Foundation	CNRS(Centre National de la Recherche Scientifique (CNRS)); ACI; Programme Proteomique et Genie des Proteines; GIS; MRT; FRM(Fondation pour la Recherche Medicale); European Science Foundation(European Science Foundation (ESF)European Commission)	This work was funded by the CNRS, an ACI grant "Dynamique et Reactivite des Assemblages Biologiques'' (PB & DR), by a Programme Proteomique et Genie des Proteines (DR & PB), an ACI grant in Development Biology and by a GIS grant on rare genetic diseases (PB). S. A. was funded by a MRT fellowship and by a FRM doctoral fellowship; C. B. was funded by a European Science Foundation fellowship.	Adhiambo C, 2005, MOL BIOCHEM PARASIT, V143, P216, DOI 10.1016/j.molbiopara.2005.04.017; Bastin P, 1999, MOL CELL BIOL, V19, P8191; Bastin P, 1996, PARASITOL TODAY, V12, P302, DOI 10.1016/0169-4758(96)10031-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2000, J CELL SCI, V113, P3321; Beisson J, 2003, CURR OPIN CELL BIOL, V15, P96, DOI 10.1016/S0955-0674(02)00017-0; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; BRUGEROLLE G, 1992, BIOSYSTEMS, V28, P203, DOI 10.1016/0303-2647(92)90021-P; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Davidge JA, 2006, J CELL SCI, V119, P3935, DOI 10.1242/jcs.03203; Dawe HR, 2005, J CELL SCI, V118, P5421, DOI 10.1242/jcs.02659; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Dilbeck V, 1999, J CELL SCI, V112, P4687; Durand-Dubief M, 2003, MOL BIOCHEM PARASIT, V129, P11, DOI 10.1016/S0166-6851(03)00071-9; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Hagiwara H, 2004, INT REV CYTOL, V234, P101, DOI 10.1016/S0074-7696(04)34003-9; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; Kohl L, 1998, MOL BIOCHEM PARASIT, V93, P1, DOI 10.1016/S0166-6851(98)00014-0; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Noel C, 2003, PARASITOL RES, V89, P487, DOI 10.1007/s00436-002-0811-4; Nohynkova E, 2006, EUKARYOT CELL, V5, P753, DOI 10.1128/EC.5.4.753-761.2006; Pradel LC, 2006, J CELL SCI, V119, P1852, DOI 10.1242/jcs.02900; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; SHERWIN T, 1987, J CELL BIOL, V104, P439, DOI 10.1083/jcb.104.3.439; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Simons M, 2006, KIDNEY INT, V70, P854, DOI 10.1038/sj.ki.5001534; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491	44	66	66	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e437	10.1371/journal.pone.0000437	http://dx.doi.org/10.1371/journal.pone.0000437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487282	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445800019
J	Rock, F; Hadeler, KP; Rammensee, HG; Overath, P				Roeck, Frank; Hadeler, Karl-Peter; Rammensee, Hans-Georg; Overath, Peter			Quantitative Analysis of Mouse Urine Volatiles: In Search of MHC-ependent Differences	PLOS ONE			English	Article								Genes of the major histocompatibility complex (MHC), which play a critical role in immune recognition, influence mating preference and other social behaviors in mice. Training experiments using urine scent from mice differing only in the MHC complex, from MHC class I mutants or from knock-out mice lacking functional MHC class I molecules (beta 2m-deficient), suggest that these behavioral effects are mediated by differences in MHC-dependent volatile components. In search for the physical basis of these behavioral studies, we have conducted a comparison of urinary volatiles in three sub-strains of C57BL/6 mice, a beta 2m-deficient mutant lacking functional MHC class I expression and two unrelated inbred strains, using the technique of sorptive extraction with polydimethylsiloxan and subsequent analysis by gas chromatography/mass spectrometry. We show (i) that qualitative differences occur between different inbred strains but not in mice with the C57BL/6 background, (ii) that the individual variability in abundance in the same mouse strain is strongly component-dependent, (iii) that C57BL/6 sub-strains obtained from different provenance show a higher fraction of quantitative differences than a sub-strain and its beta 2m-mutant obtained from the same source and (iv) that comparison of the spectra of beta 2m mice and the corresponding wild type reveals no qualitative differences in close to 200 major and minor components and only minimal differences in a few substances from an ensemble of 69 selected for quantitative analysis. Our data suggest that odor is shaped by ontogenetic, environmental and genetic factors, and the gestalt of this scent may identify a mouse on the individual and population level; but, within the limits of the ensemble of components analysed, the results do not support the notion that functional MHC class I molecules influence the urinary volatile composition.	[Roeck, Frank] Univ Tubingen, Inst Phys Chem, Interfak Inst Zellbiol, Tubingen, Germany; [Rammensee, Hans-Georg; Overath, Peter] Univ Tubingen, Interfak Inst Zellbiol, Immunol Abt, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Overath, P (corresponding author), Univ Tubingen, Interfak Inst Zellbiol, Immunol Abt, Tubingen, Germany.	peter.overath@tuebingen.mpg.de			Max-Planck-Gesellschaft; Fonds der Chemischen Industrie	Max-Planck-Gesellschaft(Max Planck Society); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was funded in part by the Max-Planck-Gesellschaft and the Fonds der Chemischen Industrie.	Baltussen E, 2002, ANAL BIOANAL CHEM, V373, P3, DOI 10.1007/s00216-002-1266-2; Bard J, 2000, IMMUNOGENETICS, V51, P514, DOI 10.1007/s002510000165; Beauchamp GK, 2003, BIOCHEM SOC T, V31, P147; Boehm T, 2006, TRENDS NEUROSCI, V29, P100, DOI 10.1016/j.tins.2005.11.006; BROWN RE, 1989, BEHAV GENET, V19, P658, DOI 10.1007/BF01066029; Carroll LS, 2002, P NATL ACAD SCI USA, V99, P2187, DOI 10.1073/pnas.042244899; Curran AM, 2005, J CHEM ECOL, V31, P1607, DOI 10.1007/s10886-005-5801-4; Eggert Frank, 1996, Physiology and Behavior, V59, P57, DOI 10.1016/0031-9384(95)02029-2; Harvey LM, 2006, J FORENSIC SCI, V51, P1109, DOI 10.1111/j.1556-4029.2006.00231.x; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Kelliher KR, 2003, P NATL ACAD SCI USA, V100, P4299, DOI 10.1073/pnas.0736071100; KLEIN J, 1982, IMMUNOLOGY SCI SELF, P47; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Montag S, 2001, P NATL ACAD SCI USA, V98, P9249, DOI 10.1073/pnas.161266398; Novotny MV, 2007, J CHEM ECOL, V33, P417, DOI 10.1007/s10886-006-9230-9; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Penn D, 1998, PHYSIOL BEHAV, V64, P235, DOI 10.1016/S0031-9384(98)00052-3; Penn DJ, 2007, J R SOC INTERFACE, V4, P331, DOI 10.1098/rsif.2006.0182; Rock F, 2006, J CHEM ECOL, V32, P1333, DOI 10.1007/s10886-006-9091-2; Santos PSC, 2005, HORM BEHAV, V47, P384, DOI 10.1016/j.yhbeh.2004.11.005; Schaefer ML, 2002, J NEUROSCI, V22, P9513; SCHWENDE FJ, 1984, J CHEM ECOL, V10, P1603, DOI 10.1007/BF00988428; Singer AG, 1997, P NATL ACAD SCI USA, V94, P2210, DOI 10.1073/pnas.94.6.2210; Soini HA, 2005, J CHEM ECOL, V31, P377, DOI 10.1007/s10886-005-1347-8; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; THOMAS L, 1975, IMMUNE SYSTEM INFECT, P2; Wedekind C, 2000, NEPHROL DIAL TRANSPL, V15, P1269, DOI 10.1093/ndt/15.9.1269; Willse A, 2005, ANAL CHEM, V77, P2348, DOI 10.1021/ac048711t; Willse A, 2006, IMMUNOGENETICS, V58, P967, DOI 10.1007/s00251-006-0162-x; Wysocki CJ, 2004, HORM BEHAV, V46, P241, DOI 10.1016/j.yhbeh.2004.02.010; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; YAMAZAKI K, 1983, P NATL ACAD SCI-BIOL, V80, P5685, DOI 10.1073/pnas.80.18.5685; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1979, J EXP MED, V150, P755, DOI 10.1084/jem.150.4.755; Yamazaki K, 2005, CHEM SENSES, V30, pI142, DOI 10.1093/chemse/bjh154; YAMAZAKI K, 1982, P NATL ACAD SCI-BIOL, V79, P7828, DOI 10.1073/pnas.79.24.7828	39	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e429	10.1371/journal.pone.0000429	http://dx.doi.org/10.1371/journal.pone.0000429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487279	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445800011
J	Zhang, YL; Wada, J; Yasuhara, A; Iseda, I; Eguchi, J; Fukui, K; Yang, Q; Yamagata, K; Hiesberger, T; Igarashi, P; Zhang, H; Wang, HY; Akagi, S; Kanwar, YS; Makino, H				Zhang, Yanling; Wada, Jun; Yasuhara, Akihiro; Iseda, Izumi; Eguchi, Jun; Fukui, Kenji; Yang, Qin; Yamagata, Kazuya; Hiesberger, Thomas; Igarashi, Peter; Zhang, Hong; Wang, Haiyan; Akagi, Shigeru; Kanwar, Yashpal S.; Makino, Hirofumi			The Role for HNF-1 beta-Targeted Collectrin in Maintenance of Primary Cilia and Cell Polarity in Collecting Duct Cells	PLOS ONE			English	Article								Collectrin, a homologue of angiotensin converting enzyme 2 (ACE2), is a type I transmembrane protein, and we originally reported its localization to the cytoplasm and apical membrane of collecting duct cells. Recently, two independent studies of targeted disruption of collectrin in mice resulted in severe and general defects in renal amino acid uptake. Collectrin has been reported to be under the transcriptional regulation by HNF-1 alpha, which is exclusively expressed in proximal tubules and localized at the luminal side of brush border membranes. The deficiency of collectrin was associated with reduction of multiple amino acid transporters on luminal membranes. In the current study, we describe that collectrin is a target of HNF-1 beta and heavily expressed in the primary cilium of renal collecting duct cells. Collectrin is also localized in the vesicles near the peri-basal body region and binds to gamma-actin-myosin II-A, SNARE, and polycystin-2-polaris complexes, and all of these are involved in intracellular and ciliary movement of vesicles and membrane proteins. Treatment of mIMCD3 cells with collectrin siRNA resulted in defective cilium formation, increased cell proliferation and apoptosis, and disappearance of polycystin-2 in the primary cilium. Suppression of collectrin mRNA in metanephric culture resulted in the formation of multiple longitudinal cysts in ureteric bud branches. Taken together, the cystic change and formation of defective cilium with the interference in the collectrin functions would suggest that it is necessary for recycling of the primary cilia-specific membrane proteins, the maintenance of the primary cilia and cell polarity of collecting duct cells. The transcriptional hierarchy between HNF-1 beta and PKD (polycystic kidney disease) genes expressed in the primary cilia of collecting duct cells has been suggested, and collectrin is one of such HNF-1 beta regulated genes.	[Zhang, Yanling; Wada, Jun; Yasuhara, Akihiro; Iseda, Izumi; Eguchi, Jun; Makino, Hirofumi] Okayama Univ, Grad Sch Med, Dept Med & Clin Sci, Okayama, Japan; [Zhang, Yanling] Hebei Med Univ, Hosp 3, Dept Nephrol, Shijiazhuang, Peoples R China; [Fukui, Kenji; Yang, Qin; Yamagata, Kazuya] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan; [Yang, Qin] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Hiesberger, Thomas; Igarashi, Peter] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Hiesberger, Thomas; Igarashi, Peter] Univ Texas SW Med Ctr Dallas, Div Basic Sci, Dallas, TX 75390 USA; [Zhang, Hong; Wang, Haiyan] Peking Univ, Hosp 1, Inst Nephrol, Div Renal, Beijing 100871, Peoples R China; [Akagi, Shigeru; Kanwar, Yashpal S.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Okayama University; Hebei Medical University; Osaka University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Peking University; Northwestern University; Feinberg School of Medicine	Wada, J (corresponding author), Okayama Univ, Grad Sch Med, Dept Med & Clin Sci, Okayama, Japan.	junwada@md.okayama-u.ac.jp	WADA, Jun/B-2023-2011	WADA, Jun/0000-0003-1468-5170; Igarashi, Peter/0000-0001-8698-1185	JSPS (Japan Society for the Promotion of Science); Ministry of Education, Science and Culture, Japan [17590829]; Uehara Memorial Foundation; Scientific Research, Ministry of Education, Science and Culture, Japan [18390249]; NIH [R01DK42921, R01DK67565, DK28492, DK60635];  [1604241]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060635, R37DK028492, R01DK067565, R01DK042921, R01DK028492] Funding Source: NIH RePORTER	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Scientific Research, Ministry of Education, Science and Culture, Japan; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant-in-Aid for Scientific Research (1604241) to Y. Z and Y. Z. is a recipient of JSPS (Japan Society for the Promotion of Science) fellow. Grant-in-Aid for Scientific Research, Ministry of Education, Science and Culture, Japan (17590829) to J. W. and Uehara Memorial Foundation, Grant-in-Aid for Scientific Research, Ministry of Education, Science and Culture, Japan (18390249) to H. M., NIH grants (R01DK42921 and R01DK67565) to P. I. and NIH grants (DK28492 and DK60635) to Y. S. K. We thank Dr. Bradley K. Yoder in University of Alabama at Birmingham for the Polaris antibody.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; Eguchi J, 2005, BIOCHEM J, V387, P343, DOI 10.1042/BJ20041709; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; FUKUI K, CELL METAB IN PRESS; Gouraud S, 2002, J CELL SCI, V115, P3667, DOI 10.1242/jcs.00053; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Hidaka S, 2004, J BIOL CHEM, V279, P35009, DOI 10.1074/jbc.M314206200; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Hiesberger T, 2005, J BIOL CHEM, V280, P10578, DOI 10.1074/jbc.M414121200; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Jerdeva GV, 2005, J CELL SCI, V118, P4797, DOI 10.1242/jcs.02573; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; KOTTGEN M, 2005, PFLUGERS ARCH; Linz-McGillem LA, 2003, EXP EYE RES, V76, P543, DOI 10.1016/S0014-4835(03)00031-9; MALAKAUSKAS SM, 2006, AM J PHYSL RENAL PHY; Mandon B, 1996, J CLIN INVEST, V98, P906, DOI 10.1172/JCI118873; MILLER M, 1992, NEURON, V8, P25, DOI 10.1016/0896-6273(92)90106-N; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Neco P, 2002, BIOCHEM J, V368, P405, DOI 10.1042/BJ20021090; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; ROSENBAUM JL, 1967, J CELL BIOL, V34, P345, DOI 10.1083/jcb.34.1.345; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scheffers MS, 2002, HUM MOL GENET, V11, P59, DOI 10.1093/hmg/11.1.59; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Veizis IE, 2005, AM J PHYSIOL-RENAL, V288, pF474, DOI 10.1152/ajprenal.00227.2004; Wada J, 1996, J CELL BIOL, V132, P1161, DOI 10.1083/jcb.132.6.1161; Wada J, 1998, P NATL ACAD SCI USA, V95, P144, DOI 10.1073/pnas.95.1.144; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Witzgall R, 2005, N-S ARCH PHARMACOL, V371, P342, DOI 10.1007/s00210-005-1027-9; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhang H, 1999, KIDNEY INT, V56, P549, DOI 10.1046/j.1523-1755.1999.00561.x; Zhang H, 2001, J BIOL CHEM, V276, P17132, DOI 10.1074/jbc.M006723200; [张志强 Zhang Zhiqiang], 2004, [自然资源学报, Journal of Natural Resources], V19, P230	51	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e414	10.1371/journal.pone.0000414	http://dx.doi.org/10.1371/journal.pone.0000414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476336	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445700016
J	Fuchs, BB; Tang, RJ; Mylonakis, E				Fuchs, Beth Burgwyn; Tang, Robin J.; Mylonakis, Eleftherios			The Temperature-Sensitive Role of Cryptococcus neoformans ROM2 in Cell Morphogenesis	PLOS ONE			English	Article								ROM2 is associated with Cryptococcus neoformans virulence. We examined additional roles of ROM2 in C. neoformans and found that ROM2 plays a role in several cell functions specifically at high temperature conditions. Morphologically rom2 mutant cells demonstrated a "tear"-like shape and clustered together. A sub-population of cells had a hyperelongated phenotype at restrictive growth conditions. Altered morphology was associated with defects in actin that was concentrated at the cell periphery and with abnormalities in microtubule organization. Interestingly, the ROM2 associated defects in cell morphology, location of nuclei, and actin and microtubule organization were not observed in cells grown at temperatures below 37 degrees C. These results indicate that in C. neoformans, ROM2 is important at restrictive temperature conditions and is involved in several cell maintenance functions.	[Fuchs, Beth Burgwyn; Tang, Robin J.; Mylonakis, Eleftherios] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Mylonakis, E (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	emylonakis@partners.org			NIH [AI63084-01]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI063084] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: A K08 award AI63084-01 from the NIH and a New Scholar Award in Global Infectious Diseases from the Ellison Medical Foundation, to EM, supported this work.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Arellano M, 1997, J CELL SCI, V110, P2547; Bussey H, 1996, SCIENCE, V272, P224, DOI 10.1126/science.272.5259.224; Cabib E, 1998, ANNU REV BIOCHEM, V67, P307, DOI 10.1146/annurev.biochem.67.1.307; Calonge TM, 2003, MOL MICROBIOL, V47, P507, DOI 10.1046/j.1365-2958.2003.03312.x; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Fujiwara T, 1999, MOL CELL BIOL, V19, P8016; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; Gumbo T, 2002, PEDIATR INFECT DIS J, V21, P54, DOI 10.1097/00006454-200201000-00012; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Helling H., 1998, J LIE THEORY, V8, P1; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; Jacoby JJ, 1998, MOL GEN GENET, V258, P148, DOI 10.1007/s004380050717; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Kopecka M, 2001, EUR J CELL BIOL, V80, P303, DOI 10.1078/0171-9335-00157; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Manning BD, 1997, MOL BIOL CELL, V8, P1829, DOI 10.1091/mbc.8.10.1829; Mazur P, 1996, J BIOL CHEM, V271, P14604, DOI 10.1074/jbc.271.24.14604; NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x; Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Perfect JR, 2002, INFECT DIS CLIN N AM, V16, P837, DOI 10.1016/S0891-5520(02)00064-8; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Pruyne D, 2000, J CELL SCI, V113, P365; Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Tang RJ, 2005, INFECT IMMUN, V73, P8219, DOI 10.1128/IAI.73.12.8219-8225.2005; Thomas CJ, 1998, ANN EPIDEMIOL, V8, P212, DOI 10.1016/S1047-2797(97)00234-2; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Waugh MS, 2002, MICROBIOL-SGM, V148, P191, DOI 10.1099/00221287-148-1-191; WOODS A, 1989, J CELL SCI, V93, P491	39	12	13	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2007	2	4							e368	10.1371/journal.pone.0000368	http://dx.doi.org/10.1371/journal.pone.0000368			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DT	17426816	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445400008
J	Kobiler, O; Rokney, A; Oppenheim, AB				Kobiler, Oren; Rokney, Assaf; Oppenheim, Amos B.			Phage Lambda CIII: A Protease Inhibitor Regulating the Lysis-Lysogeny Decision	PLOS ONE			English	Article								The ATP-dependent protease FtsH (HflB) complexed with HflKC participates in post-translational control of the lysis-lysogeny decision of bacteriophage lambda by rapid degradation of lambda CII. Both phage-encoded proteins, the CII transcription activator and the CIII polypeptide, are required for efficient lysogenic response. The conserved CIII is both an inhibitor and substrate of FtsH. Here we show that the protease inhibitor CIII is present as oligomeric amphipathic alpha helical structures and functions as a competitive inhibitor of FtsH by preventing binding of the CII substrate. We identified single alanine substitutions in CIII that abolish its activity. We characterize a dominant negative effect of a CIII mutant. Thus, we suggest that CIII oligomrization is required for its function. Real-time analysis of CII activity demonstrates that the effect of CIII is not seen in the absence of either FtsH or HflKC. When CIII is provided ectopically, CII activity increases linearly as a function of the multiplicity of infection, suggesting that CIII enhances CII stability and the lysogenic response. FtsH function is essential for cellular viability as it regulates the balance in the synthesis of phospholipids and lipopolysaccharides. Genetic experiments confirmed that the CIII bacteriostatic effects are due to inhibition of FtsH. Thus, the early presence of CIII following infection stimulates the lysogenic response, while its degradation at later times ensures the reactivation of FtsH allowing the growth of the established lysogenic cell.	[Kobiler, Oren; Rokney, Assaf; Oppenheim, Amos B.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Genet & Biotechnol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Kobiler, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Genet & Biotechnol, IL-91010 Jerusalem, Israel.	orenk@ekmd.huji.ac.il	Kobiler, Oren/J-2268-2012	Kobiler, Oren/0000-0001-9914-3770	Israel Science Foundation [489/01-1, 340/04]; NIH [R21A I071240-01]	Israel Science Foundation(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This research was supported in part by the Israel Science Foundation (grant # 489/01-1 and 340/04) and by an NIH grant R21A I071240-01.	Ades SE, 2004, CURR BIOL, V14, pR924, DOI 10.1016/j.cub.2004.10.015; ALTUVIA S, 1986, J BACTERIOL, V167, P415, DOI 10.1128/jb.167.1.415-419.1986; BELFORT M, 1975, VIROLOGY, V63, P147, DOI 10.1016/0042-6822(75)90380-3; Cutting S, 1997, J BACTERIOL, V179, P5534, DOI 10.1128/jb.179.17.5534-5542.1997; Dougan DA, 2002, CELL MOL LIFE SCI, V59, P1607, DOI 10.1007/PL00012487; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Herman C, 1997, J BACTERIOL, V179, P358, DOI 10.1128/jb.179.2.358-363.1997; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; HERSKOWITZ I, 1980, ANNU REV GENET, V14, P399, DOI 10.1146/annurev.ge.14.120180.002151; Hilliard JJ, 1998, J BIOL CHEM, V273, P524, DOI 10.1074/jbc.273.1.524; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; KAISER AD, 1957, VIROLOGY, V3, P42, DOI 10.1016/0042-6822(57)90022-3; Kanemori M, 1999, J BIOL CHEM, V274, P22002, DOI 10.1074/jbc.274.31.22002; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Kihara A, 1998, J MOL BIOL, V279, P175, DOI 10.1006/jmbi.1998.1781; Kobiler O, 2005, P NATL ACAD SCI USA, V102, P4470, DOI 10.1073/pnas.0500670102; Kobiler O, 2004, J STRUCT BIOL, V146, P72, DOI 10.1016/j.jsb.2003.10.021; Kobiler O, 2002, P NATL ACAD SCI USA, V99, P14964, DOI 10.1073/pnas.222172499; KORNITZER D, 1991, P NATL ACAD SCI USA, V88, P5217, DOI 10.1073/pnas.88.12.5217; KOURILSKY P, 1974, BIOCHIMIE, V56, P1517; OBERTO J, 1989, J MOL BIOL, V207, P675, DOI 10.1016/0022-2836(89)90237-4; Obuchowski M, 1997, J BACTERIOL, V179, P5987, DOI 10.1128/jb.179.19.5987-5991.1997; Obuchowski M, 1997, MOL GEN GENET, V254, P304, DOI 10.1007/s004380050420; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Oppenheim AB, 2004, VIROLOGY, V319, P185, DOI 10.1016/j.virol.2003.11.007; Prajapati RS, 2000, BBA-GEN SUBJECTS, V1475, P353, DOI 10.1016/S0304-4165(00)00089-1; Ptashne M, 2004, GENETIC SWITCH PHAGE; REICHARDT L, 1971, P NATL ACAD SCI USA, V68, P2185, DOI 10.1073/pnas.68.9.2185; Shotland Y, 1997, MOL MICROBIOL, V24, P1303, DOI 10.1046/j.1365-2958.1997.4231796.x; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Tyler JS, 2004, J BACTERIOL, V186, P7670, DOI 10.1128/JB.186.22.7670-7679.2004; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003	35	29	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2007	2	4							e363	10.1371/journal.pone.0000363	http://dx.doi.org/10.1371/journal.pone.0000363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DT	17426811	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445400003
J	Fredriksson, J; Anevski, D; Almgren, P; Sjogren, M; Lyssenko, V; Carlson, J; Isomaa, B; Taskinen, MR; Groop, L; Orho-Melander, M				Fredriksson, Jenny; Anevski, Dragi; Almgren, Peter; Sjogren, Marketa; Lyssenko, Valeriya; Carlson, Joyce; Isomaa, Bo; Taskinen, Marja-Riitta; Groop, Leif; Orho-Melander, Marju		Botnia Study Grp	Variation in GYS1 Interacts with Exercise and Gender to Predict Cardiovascular Mortality	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE GENE; APOLIPOPROTEIN-E POLYMORPHISM; WIDE LINKAGE SCANS; SUSCEPTIBILITY LOCUS; INSULIN-RESISTANCE; DIABETES-MELLITUS; GENOME SCAN; TRAITS; RISK; METAANALYSIS	Background. The muscle glycogen synthase gene (GYS1) has been associated with type 2 diabetes (T2D), the metabolic syndrome (MetS), male myocardial infarction and a defective increase in muscle glycogen synthase protein in response to exercise. We addressed the questions whether polymorphism in GYS1 can predict cardiovascular (CV) mortality in a high-risk population, if this risk is influenced by gender or physical activity, and if the association is independent of genetic variation in nearby apolipoprotein E gene (APOE). Methodology/Principal Findings. Polymorphisms in GYS1 (XbaIC>T) and APOE (-219G>T, epsilon 2/epsilon 3/epsilon 4) were genotyped in 4,654 subjects participating in the Botnia T2D-family study and followed for a median of eight years. Mortality analyses were performed using Cox proportional-hazards regression. During the follow-up period, 749 individuals died, 409 due to CV causes. In males the GYS1 XbaI T-allele (hazard ratio (HR) 1.9 [1.2-2.9]), T2D (2.5 [1.7-3.8]), earlier CV events (1.7 [1.2-2.5]), physical inactivity (1.9 [1.2-2.9]) and smoking (1.5 [1.0-2.3]) predicted CV mortality. The GYS1 XbaI T-allele predicted CV mortality particularly in physically active males (HR 1.7 [1.3-2.0]). Association of GYS1 with CV mortality was independent of APOE (219TT/epsilon 4), which by its own exerted an effect on CV mortality risk in females (2.9 [1.9-4.4]). Other independent predictors of CV mortality in females were fasting plasma glucose (1.2 [1.1-1.2]), high body mass index (BMI) (1.0 [1.0-1.1]), hypertension (1.9 [1.2-3.1]), earlier CV events (1.9 [1.3-2.8]) and physical inactivity (1.9 [1.2-2.8]). Conclusions/Significance. Polymorphisms in GYS1 and APOE predict CV mortality in T2D families in a gender-specific fashion and independently of each other. Physical exercise seems to unmask the effect associated with the GYS1 polymorphism, rendering carriers of the variant allele less susceptible to the protective effect of exercise on the risk of CV death, which finding could be compatible with a previous demonstration of defective increase in the glycogen synthase protein in carriers of this polymorphism.	[Fredriksson, Jenny; Anevski, Dragi; Almgren, Peter; Sjogren, Marketa; Lyssenko, Valeriya; Carlson, Joyce; Groop, Leif; Orho-Melander, Marju] Lund Univ, Dept Clin Sci Malmo, Clin Res Ctr, Malmo, Sweden; [Anevski, Dragi] Chalmers Univ Technol, Dept Math Sci, S-41296 Gothenburg, Sweden; [Isomaa, Bo] Helsinki & Malmska Municipal Hlth Care Ctr & Hosp, Biomedicum, Folkhalsan Res Ctr, Folkhalsan Inst Genet, Pietarsaari, Finland; [Taskinen, Marja-Riitta; Groop, Leif] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland; [Groop, Leif] Univ Helsinki, Res Program Mol Med, Helsinki, Finland	Lund University; Chalmers University of Technology; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Orho-Melander, M (corresponding author), Lund Univ, Dept Clin Sci Malmo, Clin Res Ctr, Malmo, Sweden.	marju.orho-melander@med.lu.se	Taskinen, Marja-Riitta/AAN-5432-2020	Taskinen, Marja-Riitta/0000-0002-6229-3588	Diabetes Program at Lund University (DPLU); Foundation for Strategic Research through the National Network for Cardiovascular Research; Swedish Medical Research Council; Swedish Foundation for the Study of Diabetes; Albert Pahlssons Foundation; Malmo University Hospital Foundation; Crafoord Foundation; Lundberg Foundation; Novo Nordisk Foundation; Swedish Heart and Lung Foundation; Medical Faculty of Lund University; EXGENESIS [CT-2004-005272]; Sigrid Juselius Foundation; Academy of Finland; Finnish Diabetes Research Foundation; Folkhalsan Research Foundation; Viktor Ollqvist Foundation	Diabetes Program at Lund University (DPLU); Foundation for Strategic Research through the National Network for Cardiovascular Research; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Foundation for the Study of Diabetes; Albert Pahlssons Foundation; Malmo University Hospital Foundation; Crafoord Foundation; Lundberg Foundation(European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; EXGENESIS(European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Folkhalsan Research Foundation; Viktor Ollqvist Foundation	This work was supported by grants from the Diabetes Program at Lund University (DPLU), the Foundation for Strategic Research through the National Network for Cardiovascular Research, the Swedish Medical Research Council, the Swedish Foundation for the Study of Diabetes, the Albert Pahlssons Foundation, Malmo University Hospital Foundation, Crafoord Foundation, the Lundberg Foundation, the Novo Nordisk Foundation, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University and EXGENESIS CT-2004-005272. The Botnia Study is principally supported by the Sigrid Juselius Foundation, the Academy of Finland, the Finnish Diabetes Research Foundation, the Folkhalsan Research Foundation, and the Viktor Ollqvist Foundation.	Adeyemo AA, 2005, ATHEROSCLEROSIS, V181, P389, DOI 10.1016/j.atherosclerosis.2004.12.049; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; An P, 2005, DIABETOLOGIA, V48, P1142, DOI 10.1007/s00125-005-1769-4; An P, 2005, DIABETES, V54, P909, DOI 10.2337/diabetes.54.3.909; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beekman M, 2003, EUR J HUM GENET, V11, P845, DOI 10.1038/sj.ejhg.5201053; Bell CG, 2004, DIABETES, V53, P1857, DOI 10.2337/diabetes.53.7.1857; Bosse Y, 2004, J LIPID RES, V45, P419, DOI 10.1194/jlr.M300401-JLR200; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; CASELLA G, 1990, STAT INFERENCE, P360; DUPONT W, POWER SAMPLE SIZE CA; EHNHOLM C, 1986, J LIPID RES, V27, P227; FEITOSA MF, 2005, ATHEROSCLEROSIS; Fenger M, 2000, DIABETIC MED, V17, P735, DOI 10.1046/j.1464-5491.2000.00377.x; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; GROOP LC, 1993, NEW ENGL J MED, V328, P10, DOI 10.1056/NEJM199301073280102; Heijmans BT, 2005, EUR J HUM GENET, V13, P1143, DOI 10.1038/sj.ejhg.5201466; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; KADOWAKI T, 1993, NEW ENGL J MED, V328, P1568; Lambert JC, 2000, HUM MOL GENET, V9, P57, DOI 10.1093/hmg/9.1.57; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mori Y, 2002, DIABETES, V51, P1247, DOI 10.2337/diabetes.51.4.1247; *NAT HEART LUNG BL, 2002, NHLBI MORB MORT CHAR; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Orho-Melander M, 1999, DIABETOLOGIA, V42, P1138, DOI 10.1007/s001250051282; Panhuysen CIM, 2003, DIABETOLOGIA, V46, P579, DOI 10.1007/s00125-003-1066-z; Pollin TI, 2004, ATHEROSCLEROSIS, V173, P89, DOI 10.1016/j.atherosclerosis.2003.11.012; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Rissanen J, 1997, DIABETOLOGIA, V40, P1313, DOI 10.1007/s001250050826; SchalinJantti C, 1996, HYPERTENSION, V27, P67, DOI 10.1161/01.HYP.27.1.67; SCHALINJANTTI C, 1992, DIABETES, V41, P598, DOI 10.2337/diabetes.41.5.598; Shephard RJ, 2000, CAN J APPL PHYSIOL, V25, P19, DOI 10.1139/h00-002; SING CF, 1985, AM J HUM GENET, V37, P268; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; St-Onge J, 2001, DIABETES, V50, P195, DOI 10.2337/diabetes.50.1.195; van Tilburg JHO, 2003, J CLIN ENDOCR METAB, V88, P2223, DOI 10.1210/jc.2002-021252; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Ye S, 2003, EUR J HUM GENET, V11, P437, DOI 10.1038/sj.ejhg.5200983; ZOUALI H, 1993, NEW ENGL J MED, V328, P1568; 1999, JAMA, V269, P3015	44	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e285	10.1371/journal.pone.0000285	http://dx.doi.org/10.1371/journal.pone.0000285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356695	Green Submitted, gold, Green Published			2022-12-27	WOS:000207444800008
J	Kumar, R; Qiu, J; Joshi, T; Valliyodan, B; Xu, D; Nguyen, HT				Kumar, Rajesh; Qiu, Jing; Joshi, Trupti; Valliyodan, Babu; Xu, Dong; Nguyen, Henry T.			Single Feature Polymorphism Discovery in Rice	PLOS ONE			English	Article								The discovery of nucleotide diversity captured as single feature polymorphism (SFP) by using the expression array is a high-throughput and effective method in detecting genome-wide polymorphism. The efficacy of such method was tested in rice, and the results presented in the paper indicate high sensitivity in predicting SFP. The sensitivity of polymorphism detection was further demonstrated by the fact that no biasness was observed in detecting SFP with either single or multiple nucleotide polymorphisms. The high density SFP data that can be generated quite effectively by the current method has promise for high resolution genetic mapping studies, as physical location of features are well-defined on rice genome.	[Kumar, Rajesh; Valliyodan, Babu; Nguyen, Henry T.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Qiu, Jing] Univ Missouri, Dept Stat, Columbia, MO 65211 USA; [Joshi, Trupti; Xu, Dong] Univ Missouri, Dept Comp Sci, Columbia, MO USA; [Joshi, Trupti; Xu, Dong] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kumar, R (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	kumarr@missouri.edu; nguyenhenry@missouri.edu		Joshi, Trupti/0000-0001-8944-4924; Valliyodan, Babu/0000-0001-9457-9508	USDA-NRI; USDA-CSREES [2004-35317-14867]	USDA-NRI(United States Department of Agriculture (USDA)); USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was conducted under RiceCAP project (www.uark.edu/ua/ricecap/) entitled "A coordinated research, education, and extension project for the application of genomics discoveries to improve rice in the United States.'' The multi-institutional RiceCAP project was supported by the USDA-NRI Competitive Grants Program and funding was from the USDA-CSREES (2004-35317-14867) to HTN.	Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; Bevan M, 1999, TRENDS GENET, V15, P211, DOI 10.1016/S0168-9525(99)01744-8; BOREVITZ J, 2005, ARRAY GENOTYPING MAP; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Cui XP, 2005, BIOINFORMATICS, V21, P3852, DOI 10.1093/bioinformatics/bti640; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Hazen SP, 2003, TRENDS PLANT SCI, V8, P413, DOI 10.1016/S1360-1385(03)00186-9; Hazen SP, 2005, PLANT PHYSIOL, V138, P990, DOI 10.1104/pp.105.061408; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Kim S, 2006, GENETICS, V173, P1125, DOI 10.1534/genetics.105.052720; Lu H, 2005, CROP SCI, V45, P66, DOI 10.2135/cropsci2005.0066; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Ni J, 2002, CROP SCI, V42, P601, DOI 10.2135/cropsci2002.0601; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Werner JD, 2005, GENETICS, V170, P1197, DOI 10.1534/genetics.104.036533; Winzeler EA, 2003, GENETICS, V163, P79; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; 2005, IRGSP RELEASES BUILD; 2003, SUPERSCAFFOLD STAT O; SUPPLEMENTARY DATA S	25	52	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e284	10.1371/journal.pone.0000284	http://dx.doi.org/10.1371/journal.pone.0000284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17372626	gold, Green Published			2022-12-27	WOS:000207444800007
J	Traulsen, A; Nowak, MA				Traulsen, Arne; Nowak, Martin A.			Chromodynamics of Cooperation in Finite Populations	PLOS ONE			English	Article							EVOLUTIONARY GAME DYNAMICS; INDIRECT RECIPROCITY; KIN-SELECTION; GREEN BEARD; ALTRUISM; LATTICE; NETWORKS; SIGNALS; CYCLES; RULES	Background. The basic idea of tag-based models for cooperation is that individuals recognize each other via arbitrary signals, so-called tags. If there are tags of different colors, then cooperators can always establish new signals of recognition. The resulting "chromodynamics'' is a mechanism for the evolution of cooperation. Cooperators use a secret tag until they are discovered by defectors who then destroy cooperation based on this tag. Subsequently, a fraction of the population manages to establish cooperation based on a new tag. Methodology/Principal Findings. We derive a mathematical description of stochastic evolutionary dynamics of tag-based cooperation in populations of finite size. Benefit and cost of cooperation are given by b and c. We find that cooperators are more abundant than defectors if b/c > 1+2u/v, where u is the mutation rate changing only the strategy and v is the mutation rate changing strategy and tag. We study specific assumptions for u and v in two genetic models and one cultural model. Conclusions/Significance. In a genetic model, tag-based cooperation only evolves if a gene encodes both strategy and tag. In a cultural model with equal mutation rates between all possible phenotypes (tags and behaviors), the crucial condition is b/c > (K+1)/(K21), where K is the number of tags. A larger number of tags requires a smaller benefit-to-cost ratio. In the limit of many different tags, the condition for cooperators to have a higher average abundance than defectors becomes b > c.	[Traulsen, Arne; Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Dept Math, Program Evolutionary Dynam, Cambridge, MA 02138 USA	Harvard University	Traulsen, A (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Dept Math, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	traulsen@fas.harvard.edu	Nowak, Martin A/A-6977-2008; Traulsen, Arne/A-4955-2009	Traulsen, Arne/0000-0002-0669-5267	Deutsche Akademie der Naturforscher Leopoldina [BMBF-LPD 9901/8-134]; John Templeton foundation; NSF/NIH [1R01GM078986-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	Deutsche Akademie der Naturforscher Leopoldina; John Templeton foundation; NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support from the Deutsche Akademie der Naturforscher Leopoldina (Grant No. BMBF-LPD 9901/8-134), the John Templeton foundation and the NSF/NIH joint program in mathematical biology (NIH grant 1R01GM078986-01) is gratefully acknowledged. The Program for Evolutionary Dynamics at Harvard University is sponsored by Jeffrey Epstein.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R, 2004, EVOLUTION, V58, P1833; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Binmore K., 2007, PLAYING REAL TEXT GA, DOI [10.1093/acprof:oso/9780195300574.001.0001, DOI 10.1093/ACPROF:OSO/9780195300574.001.0001]; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Brandt H, 2004, J THEOR BIOL, V231, P475, DOI 10.1016/j.jtbi.2004.06.032; Dawkins Richard, 1976, SELFISH GENE; Durrett R, 2005, J ECON BEHAV ORGAN, V57, P267, DOI 10.1016/j.jebo.2003.09.017; Frank, 1998, FDN SOCIAL EVOLUTION; Fudenberg D, 2006, THEOR POPUL BIOL, V70, P352, DOI 10.1016/j.tpb.2006.07.006; GRAFEN A, 1990, ANIM BEHAV, V39, P42, DOI 10.1016/S0003-3472(05)80724-9; Grafen A, 2006, J THEOR BIOL, V238, P541, DOI 10.1016/j.jtbi.2005.06.009; Haig D, 1996, P NATL ACAD SCI USA, V93, P6547, DOI 10.1073/pnas.93.13.6547; Hales D, 2005, IEEE T SYST MAN CY A, V35, P385, DOI 10.1109/TSMCA.2005.846399; HALES D, 2004, LECT NOTES ARTIF INT, V3415, P89; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hartvigsen G., 2000, Complexity, V5, P14, DOI 10.1002/(SICI)1099-0526(200001/02)5:3<14::AID-CPLX3>3.0.CO;2-Q; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Killingback T, 1998, J THEOR BIOL, V191, P335, DOI 10.1006/jtbi.1997.0602; MASUDA N, 2006, P ROY SOC LOND B BIO, V274, P689; MAYNARDSMITH J, 1976, Q REV BIOL, V51, P277; Nakamaru M, 2005, EVOL ECOL RES, V7, P853; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pfeiffer T, 2006, CURR BIOL, V16, pR946, DOI 10.1016/j.cub.2006.10.011; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; Roberts G, 2002, NATURE, V418, P499, DOI 10.1038/418499b; Rousset F, 2000, J EVOLUTION BIOL, V13, P814, DOI 10.1046/j.1420-9101.2000.00219.x; Sigmund K, 2001, NATURE, V414, P403, DOI 10.1038/35106672; Sinervo B, 2006, P NATL ACAD SCI USA, V103, P7372, DOI 10.1073/pnas.0510260103; SLATKIN M, 1978, P NATL ACAD SCI USA, V75, P3531, DOI 10.1073/pnas.75.7.3531; Summers K, 2005, P ROY SOC B-BIOL SCI, V272, P643, DOI 10.1098/rspb.2004.2890; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Taylor C, 2004, B MATH BIOL, V66, P1621, DOI 10.1016/j.bulm.2004.03.004; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; Traulsen A, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046129; Traulsen A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046128; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021905; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730; van Baalen M, 2003, P ROY SOC B-BIOL SCI, V270, P69, DOI 10.1098/rspb.2002.2151; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; West SA, 2001, NATURE, V409, P510, DOI 10.1038/35054057; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	58	84	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e270	10.1371/journal.pone.0000270	http://dx.doi.org/10.1371/journal.pone.0000270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17342204	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444700005
J	George, RE; Attiyeh, EF; Li, SL; Moreau, LA; Neuberg, D; Li, C; Fox, EA; Meyerson, M; Diller, L; Fortina, P; Look, AT; Maris, JM				George, Rani E.; Attiyeh, Edward F.; Li, Shuli; Moreau, Lisa A.; Neuberg, Donna; Li, Cheng; Fox, Edward A.; Meyerson, Matthew; Diller, Lisa; Fortina, Paolo; Look, A. Thomas; Maris, John M.			Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays	PLOS ONE			English	Article								Background. Neuroblastomas are characterized by chromosomal alterations with biological and clinical significance. We analyzed paired blood and primary tumor samples from 22 children with high-risk neuroblastoma for loss of heterozygosity (LOH) and DNA copy number change using the Affymetrix 10K single nucleotide polymorphism (SNP) array. Findings. Multiple areas of LOH and copy number gain were seen. The most commonly observed area of LOH was on chromosome arm 11q (15/22 samples; 68%). Chromosome 11q LOH was highly associated with occurrence of chromosome 3p LOH: 9 of the 15 samples with 11q LOH had concomitant 3p LOH (P = 0.016). Chromosome 1p LOH was seen in one-third of cases. LOH events on chromosomes 11q and 1p were generally accompanied by copy number loss, indicating hemizygous deletion within these regions. The one exception was on chromosome 11p, where LOH in all four cases was accompanied by normal copy number or diploidy, implying uniparental disomy. Gain of copy number was most frequently observed on chromosome arm 17q (21/22 samples; 95%) and was associated with allelic imbalance in six samples. Amplification of MYCN was also noted, and also amplification of a second gene, ALK, in a single case. Conclusions. This analysis demonstrates the power of SNP arrays for high-resolution determination of LOH and DNA copy number change in neuroblastoma, a tumor in which specific allelic changes drive clinical outcome and selection of therapy.	[George, Rani E.; Moreau, Lisa A.; Diller, Lisa; Look, A. Thomas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Attiyeh, Edward F.; Maris, John M.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Oncol, Philadelphia, PA 19104 USA; [Li, Shuli; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Li, Cheng] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Fox, Edward A.] Dana Farber Canc Inst, Microarray Core Facil, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fortina, Paolo] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA	Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Jefferson University	George, RE (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	rani_george@dfci.harvard.edu	Fortina, Paolo/ABE-8350-2020; George, Rani/AAG-7635-2019; Meyerson, Matthew L/E-7123-2012	Fortina, Paolo/0000-0002-5898-2081	NIH/NINDS [K08NS047983]; Young Investigator Awards; American Society of Clinical Oncology; Children's Oncology Group; NIH [R01 CA104605, R33-CA83220, R01-CA87847, U01-CA98543]; NATIONAL CANCER INSTITUTE [R01CA104605, R01CA087847, U10CA098543, R33CA083220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047983] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Young Investigator Awards; American Society of Clinical Oncology; Children's Oncology Group; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS Grant K08NS047983 (to R. E. G.), Young Investigator Awards, American Society of Clinical Oncology and Children's Oncology Group (to R. E. G.), NIH R01 CA104605 (A. T. L.), R33-CA83220 (to P. F., J.M.M.), R01-CA87847 (to J.M.M.) and U01-CA98543 (to the Children's Oncology Group).	Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; Breen CJ, 2000, CANCER GENET CYTOGEN, V120, P44, DOI 10.1016/S0165-4608(99)00252-6; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; ELBADRY OM, 1991, J CLIN INVEST, V87, P648, DOI 10.1172/JCI115042; Janne PA, 2004, ONCOGENE, V23, P2716, DOI 10.1038/sj.onc.1207329; Janoueix-Lerosey I, 2000, GENE CHROMOSOME CANC, V28, P276, DOI 10.1002/1098-2264(200007)28:3<276::AID-GCC5>3.0.CO;2-P; Lieberfarb ME, 2003, CANCER RES, V63, P4781; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Maris JM, 2005, GENOME RES, V15, P1168, DOI 10.1101/gr.3865305; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; Morowitz M, 2003, MODERN PATHOL, V16, P1248, DOI 10.1097/01.MP.0000097364.64566.81; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Murthy SK, 2002, MODERN PATHOL, V15, P1241, DOI 10.1097/01.MP.0000032535.62750.D1; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Plantaz D, 1997, AM J PATHOL, V150, P81; Raghavan M, 2005, CANCER RES, V65, P375; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; SRIVATSAN ES, 1993, GENE CHROMOSOME CANC, V7, P32, DOI 10.1002/gcc.2870070106; Stallings RL, 2003, CANCER GENET CYTOGEN, V140, P133, DOI 10.1016/S0165-4608(02)00681-7; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; WONG KK, 2004, NUCLEIC ACIDS RES, V32, P69; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	33	91	98	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e255	10.1371/journal.pone.0000255	http://dx.doi.org/10.1371/journal.pone.0000255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327916	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444600015
J	van der Kuyl, AC; van den Burg, R; Zorgdrager, F; Groot, F; Berkhout, B; Cornelissen, M				van der Kuyl, Antoinette C.; van den Burg, Remco; Zorgdrager, Fokla; Groot, Fedde; Berkhout, Ben; Cornelissen, Marion			Sialoadhesin (CD169) Expression in CD14+Cells Is Upregulated Early after HIV-1 Infection and Increases during Disease Progression	PLOS ONE			English	Article								Background. Sialoadhesin (CD169, siglec-1 or Sn) is an activation marker seen on macrophages in chronic inflammatory diseases and in tumours, and on subsets of tissue macrophages. CD169 is highly expressed by macrophages present in AIDS-related Kaposi's sarcoma lesions. It is also increased on blood monocytes of HIV-1 infected patients with a high viral load despite antiretroviral treatment. Methodology/Principal Findings. We investigated expression of sialoadhesin in untreated HIV-1 and HHV-8 infected patients, by real-time PCR and FACS analysis to establish its expression in relation to infection and disease progression. Patients analysed were either HIV-1 seroconverters (n = 7), in the chronic phase of HIV-1 infection (n = 21), or in the AIDS stage (n = 58). Controls were HHV-8 infected, but otherwise healthy individuals (n = 20), and uninfected men having sex with men (n = 24). Sialoadhesin mRNA was significantly elevated after HIV-1, but not HHV-8 infection, and a further increase was seen in AIDS patients. Samples obtained around HIV-1 seroconversion indicated that sialoadhesin levels go up early in infection. FACS analysis of PBMCs showed that sialoadhesin protein was expressed at high levels by approximately 90% of CD14(+) and CD14(+)CD16(+) cells of HIV-1(+) patients with a concomitant 10-fold increase in sialoadhesin protein/cell compared with uninfected controls. Conclusions/Significance. We have shown that sialoadhesin is induced to high levels on CD14(+) cells early after HIV-1 infection in vivo. The phenotype of the cells is maintained during disease progression, suggesting that it could serve as a marker for infection and probably contributes to the severe dysregulation of the immune system seen in AIDS.	[van der Kuyl, Antoinette C.; van den Burg, Remco; Zorgdrager, Fokla; Groot, Fedde; Berkhout, Ben; Cornelissen, Marion] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van der Kuyl, AC (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol,Lab Expt Virol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.c.vanderkuyl@amc.uva.nl	Van der Kuyl, Antoinette/T-9369-2019					ABEL PM, 1992, FEMS MICROBIOL IMMUN, V105, P317; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Avril T, 2006, BIOCHEM SOC T, V34, P1024, DOI 10.1042/BST0341024; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Cornelissen M, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-7; CROCKER PR, 1989, J EXP MED, V169, P1333, DOI 10.1084/jem.169.4.1333; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; Crocker PR, 1997, GLYCOCONJUGATE J, V14, P601, DOI 10.1023/A:1018588526788; CROCKER PR, 1994, EMBO J, V13, P4490, DOI 10.1002/j.1460-2075.1994.tb06771.x; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Decrion AZ, 2005, CURR HIV RES, V3, P243, DOI 10.2174/1570162054368057; Delputte PL, 2004, J VIROL, V78, P8094, DOI 10.1128/JVI.78.15.8094-8101.2004; Draude G, 1999, AM J PHYSIOL-HEART C, V276, pH1144, DOI 10.1152/ajpheart.1999.276.4.H1144; FEIZI T, 1990, Glycobiology, V1, P17, DOI 10.1093/glycob/1.1.17; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; GEYER H, 1988, J BIOL CHEM, V263, P11760; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Kirchberger S, 2005, J IMMUNOL, V175, P1145, DOI 10.4049/jimmunol.175.2.1145; LOCHER C, 1994, CLIN EXP IMMUNOL, V98, P115, DOI 10.1111/j.1365-2249.1994.tb06616.x; Lozano JM, 2002, AIDS, V16, P347, DOI 10.1097/00002030-200202150-00005; Meroni L, 2005, JAIDS-J ACQ IMM DEF, V38, P310; Miller LS, 2001, AIDS RES HUM RETROV, V17, P443, DOI 10.1089/088922201750102544; Munday J, 1999, J LEUKOCYTE BIOL, V66, P705, DOI 10.1002/jlb.66.5.705; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V98, P369, DOI 10.1111/j.1365-2249.1994.tb05499.x; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Polstra AM, 2003, J CLIN MICROBIOL, V41, P5488, DOI 10.1128/JCM.41.12.5488-5491.2003; Pulliam L, 2004, J NEUROIMMUNOL, V157, P93, DOI 10.1016/j.jneuroim.2004.08.039; Renwick N, 1998, AIDS, V12, P2481, DOI 10.1097/00002030-199818000-00018; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; van der Meijden M, 1998, CELL IMMUNOL, V190, P156, DOI 10.1006/cimm.1998.1387; Vanderheijden N, 2003, J VIROL, V77, P8207, DOI 10.1128/JVI.77.15.8207-8215.2003; Weeks BS, 1998, INT J MOL MED, V1, P361	33	57	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e257	10.1371/journal.pone.0000257	http://dx.doi.org/10.1371/journal.pone.0000257			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17330143	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444600017
J	Brockhurst, MA; Colegrave, N; Hodgson, DJ; Buckling, A				Brockhurst, Michael A.; Colegrave, Nick; Hodgson, David J.; Buckling, Angus			Niche Occupation Limits Adaptive Radiation in Experimental Microcosms	PLOS ONE			English	Article								Adaptive radiations have played a key role in the evolution of biological diversity. The breadth of adaptive radiation in an invading lineage is likely to be influenced by the availability of ecological niches, which will be determined to some extent by the diversity of the resident community. High resident diversity may result in existing ecological niches being filled, inhibiting subsequent adaptive radiation. Conversely, high resident diversity could result in the creation of novel ecological niches or an increase in within niche competition driving niche partitioning, thus promoting subsequent diversification. We tested the role of resident diversity on adaptive radiations in experimental populations of the bacterium Pseudomonas fluorescens that readily diversify into a range of niche specialists when grown in a heterogeneous environment. We allowed an undiversified strain to invade resident communities that varied in the number of niche specialists. The breadth of adaptive radiation attainable by an invading lineage decreased with increasing niche occupation of the resident community. Our results highlight the importance of niche occupation as a constraint on adaptive radiation.	[Brockhurst, Michael A.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Colegrave, Nick] Univ Edinburgh, Inst Evolutionary Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Hodgson, David J.] Univ Exeter Cornwall, Sch Biol & Chem Sci, Ctr Ecol & Conservat, Penryn, England; [Buckling, Angus] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Liverpool; University of Edinburgh; University of Exeter; University of Oxford	Brockhurst, MA (corresponding author), Univ Liverpool, Sch Biol Sci, Crown St,Biosci Bldg, Liverpool L69 3BX, Merseyside, England.	michael.brockhurst@liv.ac.uk	Colegrave, Nick/F-3916-2010; Brockhurst, Michael A/A-6247-2009	Brockhurst, Michael/0000-0003-0362-820X; Buckling, Angus/0000-0003-1170-4604	Royal Society (UK); Leverhulme Trust (UK)	Royal Society (UK)(Royal Society of London); Leverhulme Trust (UK)(Leverhulme Trust)	Royal Society (UK) Leverhulme Trust (UK)	Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Barrett RDH, 2006, EVOLUTION, V60, P484; Brockhurst MA, 2004, P ROY SOC B-BIOL SCI, V271, P107, DOI 10.1098/rspb.2003.2556; Brockhurst MA, 2006, CURR BIOL, V16, P2030, DOI 10.1016/j.cub.2006.08.068; Buckling A, 2003, SCIENCE, V302, P2107, DOI 10.1126/science.1088848; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Crawley M.J., 1993, GLIM ECOLOGISTS; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Hall AR, 2007, P ROY SOC B-BIOL SCI, V274, P73, DOI 10.1098/rspb.2006.3703; Harrison F, 2005, CURR BIOL, V15, P1968, DOI 10.1016/j.cub.2005.09.048; HELLING RB, 1987, GENETICS, V116, P349; Hodgson DJ, 2002, P ROY SOC B-BIOL SCI, V269, P2277, DOI 10.1098/rspb.2002.2146; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kassen R, 2004, NATURE, V431, P984, DOI 10.1038/nature02923; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MacLean R. Craig, 2005, Ecology Letters, V8, P38; MacLean RC, 2005, J EVOLUTION BIOL, V18, P1376, DOI 10.1111/j.1420-9101.2005.00931.x; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Spiers AJ, 2002, GENETICS, V161, P33	26	54	55	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e193	10.1371/journal.pone.0000193	http://dx.doi.org/10.1371/journal.pone.0000193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17285146	Green Published, gold			2022-12-27	WOS:000207444300006
J	Pulliam, JRC; Dushoff, JG; Levin, SA; Dobson, AP				Pulliam, Juliet R. C.; Dushoff, Jonathan G.; Levin, Simon A.; Dobson, Andrew P.			Epidemic Enhancement in Partially Immune Populations	PLOS ONE			English	Article							INFECTIOUS-DISEASES; SPREAD	We observe that a pathogen introduced into a population containing individuals with acquired immunity can result in an epidemic longer in duration and/or larger in size than if the pathogen were introduced into a naive population. We call this phenomenon "epidemic enhancement,'' and use simple dynamical models to show that it is a realistic scenario within the parameter ranges of many common infectious diseases. This finding implies that repeated pathogen introduction or intermediate levels of vaccine coverage can lead to pathogen persistence in populations where extinction would otherwise be expected.	[Pulliam, Juliet R. C.; Dushoff, Jonathan G.; Levin, Simon A.; Dobson, Andrew P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Dushoff, Jonathan G.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Pulliam, JRC (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	pulliam@princeton.edu	Levin, Simon A/J-1218-2014; Pulliam, Juliet RC/A-6516-2008	Levin, Simon A/0000-0002-8216-5639; Pulliam, Juliet RC/0000-0003-3314-8223	NIH/NSF [R01-TW05869]; NIH [P50 GM071508]; Pew Charitable Trusts; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NIH/NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by an NIH/NSF "Ecology of Infectious Disease'' grant (R01-TW05869), by an NIH grant to the Center for Quantitative Biology at Princeton University (P50 GM071508), and by a grant from the Pew Charitable Trusts (2000-002558). The funding bodies have had no role in the conception or performance of the study nor in the preparation of the manuscript.	ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; Savill NJ, 2006, NATURE, V442, P757, DOI 10.1038/442757a	7	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e165	10.1371/journal.pone.0000165	http://dx.doi.org/10.1371/journal.pone.0000165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225866	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444000015
J	Coleman, SW; Rosenthal, GG				Coleman, Seth W.; Rosenthal, Gil G.			Swordtail Fry Attend to Chemical and Visual Cues in Detecting Predators and Conspecifics	PLOS ONE			English	Article							XIPHOPHORUS; RESPONSES; RISK	Predation pressure and energy requirements present particularly salient opposing selective pressures on young fish. Thus, fry are expected to possess sophisticated means of detecting predators and resources. Here we tested the hypotheses that fry of the swordtail fish Xiphophorus birchmanni use chemical and visual cues in detection of predators and conspecifics. To test these hypotheses we presented young (<7 day-old) fry with combinations of visual and chemical stimuli from adult conspecifics and predators. We found that exposure to predator odors resulted in shoal tightening similar to that observed when fry were presented with visual cues alone. In trials with conspecific stimuli, fry were particularly attracted to adult conspecifics when presented simultaneous visual and chemical stimuli compared to the visual stimulus alone. These results show that fry attend to the odors of adult conspecifics, whose presence in a particular area may signal the location of resources as well as an absence of predators. This is one of the first studies to show that such young fish use chemical and visual cues in predator detection and in interactions with conspecifics. Previous research in X. birchmanni has shown that anthropogenic alteration of the chemical environment disrupts intraspecific chemical communication among adults; we suggest that because fry use the same chemosensory pathways to detect predators and conspecifics, alteration of the chemical environment may critically disrupt predator and resource detection.	[Coleman, Seth W.; Rosenthal, Gil G.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Coleman, Seth W.; Rosenthal, Gil G.] Ctr Invest Cient Huastecas Aguazarca, Calnali, Hidalgo, Mexico	Texas A&M University System; Texas A&M University College Station	Coleman, SW (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	sethcoleman@tamu.edu	Rosenthal, Gil/E-6924-2015	Rosenthal, Gil/0000-0003-0342-9024	National Institutes of Health, USA; National Science Foundation, USA [IOB-063712]	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation, USA(National Science Foundation (NSF))	SWC is supported by an individual National Research Service Award from the National Institutes of Health, USA. GGR is supported by a grant (IOB-063712) from the National Science Foundation, USA.	Curio E., 1976, ETHOLOGY PREDATION; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Endler J.A., 1991, P169; Endler J.A., 1986, Monographs in Population Biology, pviii; Ferrari MCO, 2006, BEHAV ECOL SOCIOBIOL, V60, P522, DOI 10.1007/s00265-006-0195-z; Fisher HS, 2006, ANIM BEHAV, V72, P721, DOI 10.1016/j.anbehav.2006.02.009; Fisher HS, 2006, P ROY SOC B-BIOL SCI, V273, P1187, DOI 10.1098/rspb.2005.3406; FREISEN RG, 2005, ETHOL, V112, P339; Hirvonen H, 2000, OIKOS, V88, P191, DOI 10.1034/j.1600-0706.2000.880121.x; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mikheev VN, 2006, ECOL FRESHW FISH, V15, P111, DOI 10.1111/j.1600-0633.2006.00140.x; Morris MR, 2001, COPEIA, P65, DOI 10.1643/0045-8511(2001)001[0065:PRAPON]2.0.CO;2; NEILL SRS, 1974, J ZOOL, V172, P549, DOI 10.1111/j.1469-7998.1974.tb04385.x; RAUCHENBERGER M, 1990, AM MUS NOVIT, P1; Rosenthal GG, 2001, AM NAT, V158, P146, DOI 10.1086/321309; Rosenthal GG, 2003, COPEIA, P299, DOI 10.1643/0045-8511(2003)003[0299:DOSSCI]2.0.CO;2; ROSENTHAL GG, 2000, THESIS U TEXAS AUSTI; Smith R.J.F., 1992, Reviews in Fish Biology and Fisheries, V2, P33, DOI 10.1007/BF00042916; Smith R. Jan F., 1997, P163; Sokal RR, 1995, BIOMETRY; TAMARU CS, 2001, MANUAL COMMERCIAL PR; Utne-Palm AC, 2001, MAR ECOL PROG SER, V218, P267, DOI 10.3354/meps218267; Wong BBM, 2006, AM NAT, V167, P136, DOI 10.1086/498278; Wong BBM, 2005, BEHAV ECOL, V16, P818, DOI 10.1093/beheco/ari058; WYATT TD, 2003, PHEROMONES ANIMAL BE, P410	27	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e118	10.1371/journal.pone.0000118	http://dx.doi.org/10.1371/journal.pone.0000118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205122	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700012
J	Crone, TJ; Wilcock, WSD; Barclay, AH; Parsons, JD				Crone, Timothy J.; Wilcock, William S. D.; Barclay, Andrew H.; Parsons, Jeffrey D.			The Sound Generated by Mid-Ocean Ridge Black Smoker Hydrothermal Vents	PLOS ONE			English	Article								Hydrothermal flow through seafloor black smoker vents is typically turbulent and vigorous, with speeds often exceeding 1 m/s. Although theory predicts that these flows will generate sound, the prevailing view has been that black smokers are essentially silent. Here we present the first unambiguous field recordings showing that these vents radiate significant acoustic energy. The sounds contain a broadband component and narrowband tones which are indicative of resonance. The amplitude of the broadband component shows tidal modulation which is indicative of discharge rate variations related to the mechanics of tidal loading. Vent sounds will provide researchers with new ways to study flow through sulfide structures, and may provide some local organisms with behavioral or navigational cues.	[Crone, Timothy J.; Wilcock, William S. D.; Barclay, Andrew H.; Parsons, Jeffrey D.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Crone, TJ (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	tjc@ocean.washing-ton.edu	Crone, Timothy/A-9360-2009	Crone, Timothy/0000-0002-8100-5633; Wilcock, William/0000-0001-7224-7246	University of Washington Royalty Research Fund; W. M. Keck Foundation	University of Washington Royalty Research Fund(University of Washington); W. M. Keck Foundation(W.M. Keck Foundation)	This work was supported by the University of Washington Royalty Research Fund, and by a grant from the W. M. Keck Foundation.	BAKER ET, 1994, J GEOPHYS RES-SOL EA, V99, P4889, DOI 10.1029/93JB01030; BIBEE LD, 1986, GEOPHYS RES LETT, V13, P957, DOI 10.1029/GL013i009p00957; BISCHOFF JL, 1985, AM J SCI, V285, P725, DOI 10.2475/ajs.285.8.725; Blake W.K., 1986, MECH FLOW INDUCED SO; Blake W.K., 1986, MECH FLOW INDUCED SO, V2; Butterfield DA, 1997, PHILOS T R SOC A, V355, P369, DOI 10.1098/rsta.1997.0013; CONVERSE DR, 1984, EARTH PLANET SC LETT, V69, P159, DOI 10.1016/0012-821X(84)90080-3; Crone TJ, 2005, GEOCHEM GEOPHY GEOSY, V6, P1, DOI 10.1029/2004GC000905; Delaney JR, 1998, SCIENCE, V281, P222, DOI 10.1126/science.281.5374.222; DELANEY JR, 1992, J GEOPHYS RES-SOL EA, V97, P19663, DOI 10.1029/92JB00174; Desbruyeres D, 2006, DENISIA; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; Fornari DJ, 1998, EARTH PLANET SC LETT, V160, P419, DOI 10.1016/S0012-821X(98)00101-0; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Howe M., 1998, ACOUSTICS FLUID STRU; Johnson HP, 2000, NATURE, V407, P174, DOI 10.1038/35025040; Jupp TE, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002583; KOSKI RA, 1994, J GEOPHYS RES-SOL EA, V99, P4813, DOI 10.1029/93JB02871; LIGHTHILL MJ, 1952, PROC R SOC LON SER-A, V211, P564, DOI 10.1098/rspa.1952.0060; Lilley MD, 2003, NATURE, V422, P878, DOI 10.1038/nature01569; LITTLE SA, 1990, J GEOPHYS RES-SOLID, V95, P12927, DOI 10.1029/JB095iB08p12927; LITTLE SA, 1987, J GEOPHYS RES-SOLID, V92, P2587, DOI 10.1029/JB092iB03p02587; Melchior P. J. O., 1983, TIDES PLANET EARTH; MOFJELD HO, 1995, J GEOPHYS RES-OCEANS, V100, P10789, DOI 10.1029/95JC00687; MORFEY CL, 1973, J SOUND VIB, V31, P391, DOI 10.1016/S0022-460X(73)80255-X; PACKARD A, 1990, J COMP PHYSIOL A, V166, P501; PLETT EG, 1975, J ACOUST SOC AM, V57, P755, DOI 10.1121/1.380630; PLETT EG, 1974, J ACOUST SOC AM, V56, P516, DOI 10.1121/1.1903285; Popper AN, 2001, J COMP PHYSIOL A, V187, P83, DOI 10.1007/s003590100184; POWELL A, 1990, J VIB ACOUST, V112, P145, DOI 10.1115/1.2930107; Pruis MJ, 2004, EARTH PLANET SC LETT, V217, P379, DOI 10.1016/S0012-821X(03)00607-1; RIEDESEL M, 1982, J GEOPHYS RES, V87, P613, DOI 10.1029/JB087iB13p10613; ROCKWELL D, 1979, ANNU REV FLUID MECH, V11, P67, DOI 10.1146/annurev.fl.11.010179.000435; ROCKWELL D, 1978, J FLUID ENG-T ASME, V100, P152, DOI 10.1115/1.3448624; Ross D., 1976, MECH UNDERWATER NOIS; SCHUIJF A, 1976, DEV AQUACULTURE FISH, V5; Schultz A, 1996, GEOPHYS RES LETT, V23, P3471, DOI 10.1029/96GL02081; THOMSON RE, 1990, J GEOPHYS RES-OCEANS, V95, P7261, DOI 10.1029/JC095iC05p07261; Thomson RE, 2003, NATURE, V424, P545, DOI 10.1038/nature01824; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; VANDOVER CL, 1989, NATURE, V337, P458, DOI 10.1038/337458a0; von Frisch Karl., 1923, BIOL ZBL, V43, P439; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wolff T, 2005, CAH BIOL MAR, V46, P97; YE IN, 1991, FLUID MECH SOV RES, V20, P108	45	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e133	10.1371/journal.pone.0000133	http://dx.doi.org/10.1371/journal.pone.0000133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205137	Green Submitted, gold, Green Published			2022-12-27	WOS:000207443700027
J	Kaphzan, H; O'Riordan, KJ; Mangan, KP; Levenson, JM; Rosenblum, K				Kaphzan, Hanoch; O'Riordan, Kenneth J.; Mangan, Kile P.; Levenson, Jonathan M.; Rosenblum, Kobi			NMDA and Dopamine Converge on the NMDA-Receptor to Induce ERK Activation and Synaptic Depression in Mature Hippocampus	PLOS ONE			English	Article								The formation of enduring internal representation of sensory information demands, in many cases, convergence in time and space of two different stimuli. The first conveys the sensory input, mediated via fast neurotransmission. The second conveys the meaning of the input, hypothesized to be mediated via slow neurotransmission. We tested the biochemical conditions and feasibility for fast (NMDA) and slow (dopamine) neurotransmission to converge on the Mitogen Activated Protein Kinase signaling pathways, crucial in several forms of synaptic plasticity, and recorded its effects upon synaptic transmission. We detected differing kinetics of ERK2 activation and synaptic strength changes in the CA1 for low and high doses of neurotransmitters in hippocampal slices. Moreover, when weak fast and slow inputs are given together, they converge on ERK2, but not on p38 or JNK, and induce strong short-term synaptic depression. Surprisingly, pharmacological analysis revealed that a probable site of such convergence is the NMDA receptor itself, suggesting it serves as a detector and integrator of fast and slow neurotransmission in the mature mammalian brain, as revealed by ERK2 activation and synaptic function.	[Kaphzan, Hanoch; Rosenblum, Kobi] Univ Haifa, Dept Neurobiol & Ethol, Ctr Brain & Behav, IL-31999 Haifa, Israel; [O'Riordan, Kenneth J.; Mangan, Kile P.; Levenson, Jonathan M.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [O'Riordan, Kenneth J.; Mangan, Kile P.; Levenson, Jonathan M.] Univ Wisconsin, Waisman Ctr, Sch Med & Publ Hlth, Madison, WI 53705 USA	University of Haifa; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rosenblum, K (corresponding author), Univ Haifa, Dept Neurobiol & Ethol, Ctr Brain & Behav, IL-31999 Haifa, Israel.	kobir@psy.haifa.ac.il	O'Riordan, Kenneth J./H-6467-2019	O'Riordan, Kenneth J./0000-0003-0081-6010	ISF; Psychobiology	ISF(Israel Science Foundation); Psychobiology	This research was supported by ISF and Psychobiology grants to KR.	Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Ajay SM, 2004, EUR J NEUROSCI, V20, P2671, DOI 10.1111/j.1460-9568.2004.03725.x; Ambrosini A, 2000, MOL BRAIN RES, V75, P54, DOI 10.1016/S0169-328X(99)00294-6; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Belelovsky K, 2005, EUR J NEUROSCI, V22, P2560, DOI 10.1111/j.1460-9568.2005.04428.x; Berman DE, 1998, J NEUROSCI, V18, P10037; Borsello T, 2004, TRENDS MOL MED, V10, P239, DOI 10.1016/j.molmed.2004.03.008; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; BULLER AL, 1994, J NEUROSCI, V14, P5471; Chan ASL, 2005, J NEUROCHEM, V94, P1457, DOI 10.1111/j.1471-4159.2005.03304.x; Chan GCK, 2005, J NEUROSCI, V25, P9913, DOI 10.1523/JNEUROSCI.2376-05.2005; Chang Anne B, 2005, Cough, V1, P7; Chen J, 2004, J BIOL CHEM, V279, P39317, DOI 10.1074/jbc.M403891200; COYLE JT, 2006, CELL MOL NEUROBIOL; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Derkinderen P, 1999, NEUROREPORT, V10, pR24; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; Gisabella B, 2003, NEUROSCIENCE, V121, P297, DOI 10.1016/S0306-4522(03)00440-8; Gomez-Santos C, 2003, J NEUROSCI RES, V73, P341, DOI 10.1002/jnr.10663; Guerrero C, 2002, AM J PHYSIOL-LUNG C, V282, pL1099, DOI 10.1152/ajplung.00178.2001; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Ho OH, 2004, J NEUROCHEM, V91, P1344, DOI 10.1111/j.1471-4159.2004.02815.x; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Ko HW, 1998, J NEUROCHEM, V71, P1390; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; Lee MY, 2006, J CELL PHYSIOL, V208, P399, DOI 10.1002/jcp.20674; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Luo YQ, 1998, J NEUROCHEM, V71, P980; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; Matthies H, 1997, NEUROREPORT, V8, P3533, DOI 10.1097/00001756-199711100-00023; MURPHY BP, 2006, SCHIZOPHR RES; Opazo P, 2003, J NEUROSCI, V23, P3679; Papadeas ST, 2004, J NEUROSCI, V24, P5863, DOI 10.1523/JNEUROSCI.0528-04.2004; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rosenblum K, 2002, J NEUROSCI, V22, P5432; Rosenblum K, 1997, J NEUROSCI, V17, P5129; Rubinfeld Hadara, 2004, Methods Mol Biol, V250, P1; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Scott L, 2006, P NATL ACAD SCI USA, V103, P762, DOI 10.1073/pnas.0505557103; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Waxman EA, 2005, J BIOL CHEM, V280, P29322, DOI 10.1074/jbc.M502080200; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; Zhao ML, 2005, J NEUROSCI, V25, P7032, DOI 10.1523/JNEUROSCI.1579-05.2005; Zhen XC, 1998, MOL PHARMACOL, V54, P453, DOI 10.1124/mol.54.3.453; Zhen XC, 2001, J NEUROSCI, V21, P5513, DOI 10.1523/JNEUROSCI.21-15-05513.2001; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	68	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e138	10.1371/journal.pone.0000138	http://dx.doi.org/10.1371/journal.pone.0000138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205142	Green Submitted, gold, Green Published			2022-12-27	WOS:000207443700032
J	Maqbool, T; Soler, C; Jagla, T; Daczewska, M; Lodha, N; Palliyil, S; VijayRaghavan, K; Jagla, K				Maqbool, Tariq; Soler, Cedric; Jagla, Teresa; Daczewska, Malgorzata; Lodha, Neha; Palliyil, Sudhir; VijayRaghavan, K.; Jagla, Krzysztof			Shaping Leg Muscles in Drosophila: Role of ladybird, a Conserved Regulator of Appendicular Myogenesis	PLOS ONE			English	Article								Legs are locomotor appendages used by a variety of evolutionarily distant vertebrates and invertebrates. The primary biological leg function, locomotion, requires the formation of a specialised appendicular musculature. Here we report evidence that ladybird, an orthologue of the Lbx1 gene recognised as a hallmark of appendicular myogenesis in vertebrates, is expressed in leg myoblasts, and regulates the shape, ultrastructure and functional properties of leg muscles in Drosophila. ladybird expression is progressively activated in myoblasts associated with the imaginal leg disc and precedes that of the founder cell marker dumbfounded. The RNAi-mediated attenuation of ladybird expression alters properties of developing myotubes, impairing their ability to grow and interact with the internal tendons and epithelial attachment sites. It also affects sarcomeric ultrastructure, resulting in reduced leg muscle performance and impaired mobility in surviving flies. The overexpression of ladybird also results in an abnormal pattern of dorsally located leg muscles, indicating different requirements for ladybird in dorsal versus ventral muscles. This differential effect is consistent with the higher level of Ladybird in ventrally located myoblasts and with positive ladybird regulation by extrinsic Wingless signalling from the ventral epithelium. In addition, ladybird expression correlates with that of FGF receptor Heartless and the read-out of FGF signalling downstream of FGF. FGF signals regulate the number of leg disc associated myoblasts and are able to accelerate myogenic differentiation by activating ladybird, leading to ectopic muscle fibre formation. A key role for ladybird in leg myogenesis is further supported by its capacity to repress vestigial and to down-regulate the vestigial-governed flight muscle developmental programme. Thus in Drosophila like in vertebrates, appendicular muscles develop from a specialised pool of myoblasts expressing ladybird/Lbx1. The ladybird/Lbx1 gene family appears as a part of an ancient genetic circuitry determining leg-specific properties of myoblasts and making an appendage adapted for locomotion.	[Maqbool, Tariq; Soler, Cedric; Jagla, Teresa; Daczewska, Malgorzata; Lodha, Neha; Palliyil, Sudhir; VijayRaghavan, K.; Jagla, Krzysztof] Fac Med, U384, INSERM, Clermont Ferrand, France; [Lodha, Neha; Palliyil, Sudhir; VijayRaghavan, K.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Daczewska, Malgorzata] Univ Wroclaw, Dept Gen Zool, PL-50138 Wroclaw, Poland	Institut National de la Sante et de la Recherche Medicale (Inserm); Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Wroclaw	Jagla, K (corresponding author), Fac Med, U384, INSERM, Clermont Ferrand, France.	christophe.jagla@u-clermont1.fr	Jagla, Krzysztof/E-4144-2016; Daczewska, Małgorzata/E-9383-2017; Lodha, Neha/AAG-9581-2020	Jagla, Krzysztof/0000-0003-4965-8818; Daczewska, Małgorzata/0000-0001-7208-1012; soler, cedric/0000-0002-2312-5370; Teresa, Jagla/0000-0002-9277-6089	Institut National de la Sante et da la Recherche Medicale; Association Francaise contre les Myopathies; Association pour la Recherche sur le Cancer; Department of Biotechnology, Govt. Of India; Indo-French research programme (CEFIPRA);  [LSHG-CT2004-511978]	Institut National de la Sante et da la Recherche Medicale; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Department of Biotechnology, Govt. Of India(Department of Biotechnology (DBT) India); Indo-French research programme (CEFIPRA)(French National Research Agency (ANR)); 	This work was supported by the Institut National de la Sante et da la Recherche Medicale, the Association Francaise contre les Myopathies, the Association pour la Recherche sur le Cancer, and European Grant LSHG-CT2004-511978 to the MYORES Network of Excellence. Research support from the Department of Biotechnology, Govt. Of India and the Indo-French research programme (CEFIPRA) are gratefully acknowledged.	Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; BATE M, 1991, DEVELOPMENT, V113, P79; Bernard F, 2003, DEV BIOL, V260, P391, DOI 10.1016/S0012-1606(03)00255-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brohmann H, 2000, DEVELOPMENT, V127, P437; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; CONDIC ML, 1991, DEVELOPMENT, V111, P23; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; COSTELLO WJ, 1996, DEV BIOL, V118, P247; De Graeve F, 2004, DEV BIOL, V270, P122, DOI 10.1016/j.ydbio.2004.02.014; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Dutta D, 2005, PLOS BIOL, V3, P1789, DOI 10.1371/journal.pbio.0030337; Dutta D, 2004, DEVELOPMENT, V131, P3761, DOI 10.1242/dev.01249; FERNANDES J, 1991, DEVELOPMENT, V113, P67; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; Fristrom Dianne, 1993, P843; Ghazi A, 2000, DEVELOPMENT, V127, P5309; GonzalezCrespo S, 1996, DEVELOPMENT, V122, P3921; Gross MK, 2000, DEVELOPMENT, V127, P413; Hollway GE, 2003, EMBO REP, V4, P855, DOI 10.1038/sj.embor.embor920; Jagla K, 1997, DEVELOPMENT, V124, P3471; Jagla K, 1997, DEVELOPMENT, V124, P91; Jagla K, 2001, BIOESSAYS, V23, P125, DOI 10.1002/1521-1878(200102)23:2<125::AID-BIES1019>3.3.CO;2-3; Jagla T, 1998, DEVELOPMENT, V125, P3699; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; Kojima T, 2004, DEV GROWTH DIFFER, V46, P115; Kraus P, 2006, AM J MED GENET A, V140A, P1366, DOI 10.1002/ajmg.a.31252; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; MARCELLE C, 1995, DEV BIOL, V172, P100, DOI 10.1006/dbio.1995.0008; Marics I, 2002, DEVELOPMENT, V129, P4559; Neyt C, 2000, NATURE, V408, P82, DOI 10.1038/35040549; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Panganiban G, 2000, DEV DYNAM, V218, P554, DOI 10.1002/1097-0177(200008)218:4<554::AID-DVDY1023>3.0.CO;2-#; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Roy S, 1999, BIOESSAYS, V21, P486, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;486::AID-BIES5&gt;3.0.CO;2-M; Soler C, 2004, DEVELOPMENT, V131, P6041, DOI 10.1242/dev.01527; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Sudarsan V, 2001, DEV CELL, V1, P829, DOI 10.1016/S1534-5807(01)00089-2; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Weigmann K, 1999, DEVELOPMENT, V126, P3823	48	43	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e122	10.1371/journal.pone.0000122	http://dx.doi.org/10.1371/journal.pone.0000122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205126	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443700016
J	Baens, M; Noels, H; Broeckx, V; Hagens, S; Fevery, S; Billiau, AD; Vankelecom, H; Marynen, P				Baens, Mathijs; Noels, Heidi; Broeckx, Vicky; Hagens, Sofie; Fevery, Sabine; Billiau, An D.; Vankelecom, Hugo; Marynen, Peter			The Dark Side of EGFP: Defective Polyubiquitination	PLOS ONE			English	Article							KAPPA-B ACTIVATION; EXPRESSION; PROTEIN; TRAF6; MICE; CELL; APOPTOSIS; PROMOTES; MYOSIN; GAMMA	Enhanced Green Fluorescent Protein (EGFP) is the most commonly used live cell reporter despite a number of conflicting reports that it can affect cell physiology. Thus far, the precise mechanism of GFP-associated defects remained unclear. Here we demonstrate that EGFP and EGFP fusion proteins inhibit polyubiquitination, a posttranslational modification that controls a wide variety of cellular processes, like activation of kinase signalling or protein degradation by the proteasome. As a consequence, the NF-kappa B and JNK signalling pathways are less responsive to activation, and the stability of the p53 tumour suppressor is enhanced in cell lines and in vivo. In view of the emerging role of polyubiquitination in the regulation of numerous cellular processes, the use of EGFP as a live cell reporter should be carefully considered.	[Baens, Mathijs; Noels, Heidi; Broeckx, Vicky; Hagens, Sofie; Marynen, Peter] Univ Leuven VIB, Ctr Human Genet, Mol Genet, Louvain, Belgium; [Fevery, Sabine; Billiau, An D.] Univ Leuven, Lab Expt Transplantat, Leuven, Belgium; [Vankelecom, Hugo] Univ Leuven, Lab Cell Pharmacol, Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven	Baens, M (corresponding author), Univ Leuven VIB, Ctr Human Genet, Mol Genet, Louvain, Belgium.	Mathijs.Baens@Med.KULeuven.be	Noels, Heidi/AAQ-2622-2020	Vankelecom, Hugo/0000-0002-2251-7284	Belgische Federatie tegen Kanker [SCIE2003-09]; Association for International Cancer Research [04-149]; Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen [1.5.145.04]	Belgische Federatie tegen Kanker; Association for International Cancer Research; Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen(FWO)	This work was supported by grant SCIE2003-09 of the "Belgische Federatie tegen Kanker" to PM, by grant 04-149 of the "Association for International Cancer Research" to PM and a "Krediet aan Navorsers" (1.5.145.04) from the "Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen" to MB. HN is an "aspirant" from the "FWO - Vlaanderen".	Agbulut O, 2006, NAT METHODS, V3, P331, DOI 10.1038/nmeth0506-331; Baens M, 2006, CANCER RES, V66, P5270, DOI 10.1158/0008-5472.CAN-05-4590; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Fei PW, 2002, CANCER RES, V62, P7316; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krestel HE, 2004, NEUROBIOL DIS, V17, P310, DOI 10.1016/j.nbd.2004.05.012; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; LEUNG TKC, 1990, BIOCHEM J, V267, P125, DOI 10.1042/bj2670125; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; [孙雪涛 Sun Xuetao], 2004, [中国工程科学, Engineering science], V6, P1; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zhang F, 2003, BLOOD, V102, P2115, DOI 10.1182/blood-2003-01-0049; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012	28	119	120	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e54	10.1371/journal.pone.0000054	http://dx.doi.org/10.1371/journal.pone.0000054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183684	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600054
J	Nagaev, I; Bokarewa, M; Tarkowski, A; Smith, U				Nagaev, Ivan; Bokarewa, Maria; Tarkowski, Andrej; Smith, Ulf			Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; BINDING-PROTEIN-EPSILON; C/EBP-EPSILON; FUNCTIONAL-CHARACTERIZATION; MESSENGER-RNA; EXPRESSION; GENE; OBESITY; CELLS; DIFFERENTIATION	The characteristics of human resistin (RETN) are unclear and controversial despite intensive adipose-focused research. Its transcriptional and functional similarity with the murine myeloid-specific and CCAAT/enhancer binding protein epsilon (Cebpe)-dependent gene, resistin-like gamma (Retnlg), is unexplored. We examined the human CEBPE-regulatory pathway by unbiased reference and custom gene expression assays. Real-time RT-PCR analysis demonstrated lack of both the transcriptional factor CEBPE and RETN expression in adipose and muscle cells. In contrast, primary myelocytic samples revealed a concerted CEBPE-RETN transcription that was significantly elevated in inflammatory synoviocytes relative to intact peripheral blood mononuclear cells (PBMC). Mouse Cebpe and Retnlg were predictably expressed in macrophages, whereas Retn was abundant in adipocytes. Quite the opposite, a low and inconsistent RETN transcription was seen in some human white adipose tissue (WAT) biopsies without any relationship to body mass index, insulin sensitivity, or fat depot. However, in these cases, RETN was co-detected with CEBPE and the leukocyte-specific marker, EMR1, indicating the presence of inflammatory cells and their possible resistin-mediated effect on adipocytes. Indeed, addition of human resistin to WAT in culture induced, like in PBMC, the inflammatory cytokines IL6, IL8 and TNF. Importantly, the expression of the adipose-specific markers CEBPA, FABP4 and SLC2A4 was unchanged, while the expected inhibitory effect was seen with TNF. Both cytokines increased the mRNA level of CCL2 and MMP3, which may further promote inflammation in WAT. Thus, the myeloid-restricted nature of CEBPE precludes the expression of RETN in human adipocytes which, however, are targeted by this innate immune-derived proinflammatory cytokine.	[Nagaev, Ivan; Smith, Ulf] Gothenburg Univ, Sahlgrenska Acad, Dept Internal Med, Lundberg Lab Diabet Res, Gothenburg, Sweden; [Bokarewa, Maria; Tarkowski, Andrej] Gothenburg Univ, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Nagaev, I (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Dept Internal Med, Lundberg Lab Diabet Res, Gothenburg, Sweden.	ivan.nagaev@.gu.se	Bokarewa, Maria I/A-8114-2019	Bokarewa, Maria I/0000-0001-9424-5145	Swedish Research Council [K 2004-72x-03506-33A, K2004-74P-15176-01A, K2004-06X-08674-16A]; European Community [LSHM-CT-2004-512013]; Swedish Diabetes Association; Novo Nordisk Foundation; Torsten and Ragnar Soderberg's Foundation; National Inflammation Network; Swedish Association against Rheumatism; King Gustaf V's Foundation; Nanna Svartz's Foundation; Goteborg Medical Society; Borje Dahlin's Foundation; Goteborg University	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission); Swedish Diabetes Association; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Torsten and Ragnar Soderberg's Foundation; National Inflammation Network; Swedish Association against Rheumatism; King Gustaf V's Foundation; Nanna Svartz's Foundation; Goteborg Medical Society; Borje Dahlin's Foundation; Goteborg University	Funding: The Swedish Research Council (K 2004-72x-03506-33A, K2004-74P-15176-01A, K2004-06X-08674-16A), the European Community's FP6 EUGENE2 (LSHM-CT-2004-512013), the Swedish Diabetes Association, the Novo Nordisk Foundation, the Torsten and Ragnar Soderberg's Foundation, National Inflammation Network, Swedish Association against Rheumatism, King Gustaf V's Foundation, Nanna Svartz's Foundation, Goteborg Medical Society, Borje Dahlin's Foundation, and the Goteborg University.	Antonson P, 1996, GENOMICS, V35, P30, DOI 10.1006/geno.1996.0319; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Chen XD, 2004, DIABETES OBES METAB, V6, P271, DOI 10.1111/j.1462-8902.2004.0346.x; Chih DY, 2004, EXP HEMATOL, V32, P1173, DOI 10.1016/j.exphem.2004.08.014; Chumakov AM, 1997, MOL CELL BIOL, V17, P1375, DOI 10.1128/MCB.17.3.1375; Chumakov AM, 2004, ONCOGENE, V23, P3414, DOI 10.1038/sj.onc.1207126; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; Dai MH, 2006, DOMEST ANIM ENDOCRIN, V30, P88, DOI 10.1016/j.domaniend.2005.06.003; Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808; Fain JN, 2003, BIOCHEM BIOPH RES CO, V300, P674, DOI 10.1016/S0006-291X(02)02864-4; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Jonke J, 2002, OBES RES, V10, P1; Jung HS, 2006, CARDIOVASC RES, V69, P76, DOI 10.1016/j.cardiores.2005.09.015; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Kawanami D, 2004, BIOCHEM BIOPH RES CO, V314, P415, DOI 10.1016/j.bbrc.2003.12.104; Khazen W, 2005, FEBS LETT, V579, P5631, DOI 10.1016/j.febslet.2005.09.032; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Korner A, 2005, BIOCHEM BIOPH RES CO, V337, P540, DOI 10.1016/j.bbrc.2005.09.064; Kubota T, 2000, BLOOD, V96, P3953, DOI 10.1182/blood.V96.12.3953.h8003953_3953_3957; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Lu SC, 2002, FEBS LETT, V530, P158, DOI 10.1016/S0014-5793(02)03450-6; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; McTernan PG, 2003, J CLIN ENDOCR METAB, V88, P6098, DOI 10.1210/jc.2003-030898; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P2407, DOI 10.1210/jc.87.5.2407; Morosetti R, 1997, BLOOD, V90, P2591, DOI 10.1182/blood.V90.7.2591.2591_2591_2600; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Nohira T, 2004, EUR J ENDOCRINOL, V151, P151, DOI 10.1530/eje.0.1510151; Ort T, 2005, ENDOCRINOLOGY, V146, P2200, DOI 10.1210/en.2004-1421; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Schinke T, 2004, BIOCHEM BIOPH RES CO, V314, P356, DOI 10.1016/j.bbrc.2003.12.100; Seo JB, 2003, MOL ENDOCRINOL, V17, P1522, DOI 10.1210/me.2003-0028; Shojima N, 2005, DIABETOLOGIA, V48, P984, DOI 10.1007/s00125-005-1735-1; Sopasakis VR, 2005, INT J OBESITY, V29, P1144, DOI 10.1038/sj.ijo.0803002; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Williamson EA, 2005, BLOOD, V105, P3841, DOI 10.1182/blood-2004-09-3708; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093	45	115	117	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e31	10.1371/journal.pone.0000031	http://dx.doi.org/10.1371/journal.pone.0000031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183659	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600031
J	Zhou, Y; Wu, H; Li, SA; Chen, Q; Cheng, XW; Zheng, J; Takemori, H; Xiong, ZQ				Zhou, Yang; Wu, Hao; Li, Shuai; Chen, Qian; Cheng, Xue-Wen; Zheng, Jing; Takemori, Hiroshi; Xiong, Zhi-Qi			Requirement of TORC1 for Late-Phase Long-Term Potentiation in the Hippocampus	PLOS ONE			English	Article								Late-phase long-term potentiation (L-LTP) and long-term memory depend on the transcription of mRNA of CRE-driven genes and synthesis of proteins. However, how synaptic signals propagate to the nucleus is unclear. Here we report that the CREB coactivator TORC1 (transducer of regulated CREB activity 1) undergoes neuronal activity-induced translocation from the cytoplasm to the nucleus, a process required for CRE-dependent gene expression and L-LTP. Overexpressing a dominant-negative form of TORC1 or down-regulating TORC1 expression prevented activity-dependent transcription of CREB target genes in cultured hippocampal neurons, while overexpressing a wild-type form of TORC1 facilitated basal and activity-induced transcription of CREB target genes. Furthermore, overexpressing the dominant-negative form of TORC1 suppressed the maintenance of L-LTP without affecting early-phase LTP, while overexpressing the wild-type form of TORC1 facilitated the induction of L-LTP in hippocampal slices. Our results indicate that TORC1 is essential for CRE-driven gene expression and maintenance of long-term synaptic potentiation.	[Zhou, Yang; Wu, Hao; Li, Shuai; Chen, Qian; Cheng, Xue-Wen; Zheng, Jing; Xiong, Zhi-Qi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Zhou, Yang; Wu, Hao; Li, Shuai; Chen, Qian; Cheng, Xue-Wen; Zheng, Jing; Xiong, Zhi-Qi] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai, Peoples R China; [Zhou, Yang; Wu, Hao; Li, Shuai; Chen, Qian; Cheng, Xue-Wen; Zheng, Jing; Xiong, Zhi-Qi] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signal & Metab, Osaka, Japan	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; National Institute of Health Sciences - Japan	Xiong, ZQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China.	xiongzhiqi@ion.ac.cn	Cheng, Xuewen/L-7124-2019; Li, Shuai/ABD-5132-2021	Li, Shuai/0000-0002-9574-9609; cheng, xue wen/0000-0001-9898-4404	Major State Basic Research Program of China [2006CB806600]; Chinese Academy of Sciences; Shanghai Pujiang Program	Major State Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by grants from Major State Basic Research Program of China (2006CB806600) and "Hundreds Talents Plan'' of the Chinese Academy of Sciences and Shanghai Pujiang Program to Z.Q.X.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Balschun D, 2003, J NEUROSCI, V23, P6304; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dzeja PP, 2002, P NATL ACAD SCI USA, V99, P10156, DOI 10.1073/pnas.152259999; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Gass P, 1998, LEARN MEMORY, V5, P274; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu YF, 1999, J NEUROSCI, V19, P10250; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhu DY, 2003, J NEUROSCI, V23, P223	54	88	94	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e16	10.1371/journal.pone.0000016	http://dx.doi.org/10.1371/journal.pone.0000016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183642	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600016
J	Zhang, W; Liu, WQ; Innocenti, F; Ratain, MJ				Zhang, Wei; Liu, Wanqing; Innocenti, Federico; Ratain, Mark J.			Searching for Tissue-Specific Expression Pattern-Linked Nucleotides of UGT1A Isoforms	PLOS ONE			English	Article								UDP-glucuronosyltransferases 1A isoforms belong to a superfamily of microsomal enzymes responsible for glucuronidation of numerous endogenous and exogenous compounds. The nine functional UGT1A isoforms are encoded by a single UGT1A gene locus with multiple first exons. The expression of the UGT1A transcripts was measured by quantitative RT-PCR in 23 normal human tissues. The tissue-specific expression patterns were observed in 13 tissues. To understand the regulation mechanism that is responsible for the tissue-specific expression patterns, we scanned the DNA sequence alignments of the putative promoter regions, exon 1 sequences and intron 1 sequences for those expression-pattern-linked nucleotides. Using one of the expression-pattern-linked nucleotides for livers as an example, we showed that a database comprised of these expression-pattern-linked nucleotides could be used to generate focused hypotheses on the problem of tissue-specific expression, which is critical for tissue-specific pharmacodynamics of anticancer drugs.	[Zhang, Wei; Liu, Wanqing; Innocenti, Federico; Ratain, Mark J.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Innocenti, Federico; Ratain, Mark J.] Univ Chicago, Comm Clin Pharmacol & Pharmacogenom, Chicago, IL 60637 USA; [Innocenti, Federico; Ratain, Mark J.] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Ratain, MJ (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA.	mratain@medicine.bsd.uchicago.edu		Liu, Wanqing/0000-0001-7727-6900	NIH/NIGMS [U01GM61393, U01GM61374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374, U01GM061393] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This Pharmacogenetics of Anticancer Agents Research (PAAR) Group (http://pharmacogenetics.org) study was supported by the NIH/NIGMS grant U01GM61393. Data will be deposited into PharmGKB (supported by NIH/NIGMS Pharmacogenetics Research Network and Database grant U01GM61374, http://pharmgkb.org/).	Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; BUCKLEY DB, 2006, DRUG METAB DISPOS; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Desai AA, 2003, PHARMACOGENETICS, V13, P517, DOI 10.1097/00008571-200308000-00010; Dutton G.F., 1980, GLUCURONIDATION DRUG; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Green MD, 1996, DRUG METAB DISPOS, V24, P356; HARDING D, 1988, P NATL ACAD SCI USA, V85, P8381, DOI 10.1073/pnas.85.22.8381; HARDING D, 1990, ANN HUM GENET, V54, P17, DOI 10.1111/j.1469-1809.1990.tb00356.x; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mojarrabi B, 1996, BIOCHEM BIOPH RES CO, V225, P785, DOI 10.1006/bbrc.1996.1251; RITTER JK, 1992, J BIOL CHEM, V267, P3257; Strassburg CP, 1997, MOL PHARMACOL, V52, P212, DOI 10.1124/mol.52.2.212; Strassburg CP, 1998, J BIOL CHEM, V273, P8719, DOI 10.1074/jbc.273.15.8719; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; WOOSTER R, 1991, BIOCHEM J, V278, P465, DOI 10.1042/bj2780465	18	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e396	10.1371/journal.pone.0000396	http://dx.doi.org/10.1371/journal.pone.0000396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460763	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445600010
J	Strid, J; Tan, LA; Strobel, S; Londei, M; Callard, R				Strid, Jessica; Tan, Lee Aun; Strobel, Stephan; Londei, Marco; Callard, Robin			Epicutaneous Immunization with Type II Collagen Inhibits both Onset and Progression of Chronic Collagen-Induced Arthritis	PLOS ONE			English	Article								Epicutaneous immunization is a potential non-invasive technique for antigen-specific immune-modulation. Topical application of protein antigens to barrier-disrupted skin induces potent antigen-specific immunity with a strong Th2-bias. In this study, we investigate whether the autoimmune inflammatory response of chronic collagen-induced arthritis (CCIA) in DBA/1-TCR-beta Tg mice can be modified by epicutaneous immunization. We show that epicutaneous immunization with type II collagen (CII) inhibited development and progression of CCIA and, importantly, also ameliorated ongoing disease as indicated by clinical scores of disease severity, paw swelling and joints histology. Treated mice show reduced CII-driven T cell proliferation and IFN-gamma production, as well as significantly lower levels of CII-specific IgG2a serum antibodies. In contrast, CII-driven IL-4 production and IgE antibody levels were increased consistent with skewing of the CII response from Th1 to Th2 in treated mice. IL-4 production in treated mice was inversely correlated with disease severity. Moreover, T cells from treated mice inhibited proliferation and IFN-gamma production by T cells from CCIA mice, suggesting induction of regulatory T cells that actively inhibit effector responses in arthritic mice. The levels of CD4(+)CD25(+) T cells were however not increased following epicutaneous CII treatment. Together, these results suggest that epicutaneous immunization may be used as an immune-modulating procedure to actively re-programme pathogenic Th1 responses, and could have potential as a novel specific and simple treatment for chronic autoimmune inflammatory diseases such as rheumatoid arthritis.	[Strid, Jessica; Callard, Robin] UCL, Inst Child Hlth, Immunobiol Unit, London, England; [Tan, Lee Aun; Londei, Marco] UCL, Inst Child Hlth, Autoimmun & Gastroenterol Unit, London, England; [Strobel, Stephan] Peninsula Postgrad Hlth Inst, Plymouth, Devon, England	University of London; University College London; University of London; University College London; University of Plymouth	Strid, J (corresponding author), UCL, Inst Child Hlth, Immunobiol Unit, London, England.	jessica.strid@kcl.ac.uk		Strid, Jessica/0000-0003-3690-2201	UK NHS Executive; Arthritis Research Campaign (ARC) UK	UK NHS Executive; Arthritis Research Campaign (ARC) UK(Versus Arthritis)	Research at the Institute of Child Health and Great Ormond Street Hospital for Children National Health Service (NHS) Trust benefits from research and development funding received from the UK NHS Executive. This work was additionally funded by the Arthritis Research Campaign (ARC) UK. Nothing to disclose.	Butler DM, 1999, EUR J IMMUNOL, V29, P2205, DOI 10.1002/(SICI)1521-4141(199907)29:07<2205::AID-IMMU2205>3.0.CO;2-Z; Bynoe MS, 2003, IMMUNITY, V19, P317, DOI 10.1016/S1074-7613(03)00239-5; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Feldmann M, 2001, NAT IMMUNOL, V2, P771, DOI 10.1038/ni0901-771; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Glenn GM, 2000, NAT MED, V6, P1403, DOI 10.1038/82225; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Herrick CA, 2003, J IMMUNOL, V170, P2488, DOI 10.4049/jimmunol.170.5.2488; Horsfall AC, 1997, J IMMUNOL, V159, P5687; Itoh M, 1999, J IMMUNOL, V162, P5317; Kondo H, 1998, EUR J IMMUNOL, V28, P769, DOI 10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H; Malfait AM, 1998, CLIN EXP IMMUNOL, V111, P377; Mauri C, 1997, J IMMUNOL, V159, P5032; Mauri C, 1996, EUR J IMMUNOL, V26, P1511, DOI 10.1002/eji.1830260716; MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P4903, DOI 10.1021/bi00776a005; Miossec P, 1997, ARTHRITIS RHEUM-US, V40, P2105, DOI 10.1002/art.1780401203; MORI L, 1992, J EXP MED, V176, P381, DOI 10.1084/jem.176.2.381; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Partidos CD, 2004, VACCINE, V22, P2385, DOI 10.1016/j.vaccine.2003.11.063; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Strid J, 2004, EUR J IMMUNOL, V34, P2100, DOI 10.1002/eji.200425196; Strid J, 2006, IMMUNOLOGY, V119, P27, DOI 10.1111/j.1365-2567.2006.02401.x; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szczepanik M, 2005, J NEUROIMMUNOL, V164, P105, DOI 10.1016/j.jneuroim.2005.04.007; Szczepanik M, 2005, IMMUNOLOGY, V115, P42, DOI 10.1111/j.1365-2567.2005.02127.x; von Herrath MG, 1997, RES IMMUNOL, V148, P541, DOI 10.1016/S0923-2494(98)80148-X; von Herrath MG, 2003, NAT REV IMMUNOL, V3, P223, DOI 10.1038/nri1029; Wang LF, 1996, J IMMUNOL, V156, P4079; Wing K, 2006, INT IMMUNOL, V18, P991, DOI 10.1093/intimm/dxl044; Yates A, 2004, J THEOR BIOL, V231, P181, DOI 10.1016/j.jtbi.2004.06.013; YOSHINO S, 1995, ARTHRITIS RHEUM, V38, P1092, DOI 10.1002/art.1780380811; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zivny JH, 2001, CLIN IMMUNOL, V101, P158, DOI 10.1006/clim.2001.5103	39	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e387	10.1371/journal.pone.0000387	http://dx.doi.org/10.1371/journal.pone.0000387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440622	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445500017
J	Wile, D; Balaban, E				Wile, Daryl; Balaban, Evan			An Auditory Neural Correlate Suggests a Mechanism Underlying Holistic Pitch Perception	PLOS ONE			English	Article							FREQUENCY-FOLLOWING RESPONSES; DISTORTION PRODUCTS; ORIGINS	Current theories of auditory pitch perception propose that cochlear place (spectral) and activity timing pattern (temporal) information are somehow combined within the brain to produce holistic pitch percepts, yet the neural mechanisms for integrating these two kinds of information remain obscure. To examine this process in more detail, stimuli made up of three pure tones whose components are individually resolved by the peripheral auditory system, but that nonetheless elicit a holistic, "missing fundamental" pitch percept, were played to human listeners. A technique was used to separate neural timing activity related to individual components of the tone complexes from timing activity related to an emergent feature of the complex (the envelope), and the region of the tonotopic map where information could originate from was simultaneously restricted by masking noise. Pitch percepts were mirrored to a very high degree by a simple combination of component-related and envelope-related neural responses with similar timing that originate within higher-frequency regions of the tonotopic map where stimulus components interact. These results suggest a coding scheme for holistic pitches whereby limited regions of the tonotopic map (spectral places) carrying envelope- and component-related activity with similar timing patterns selectively provide a key source of neural pitch information. A similar mechanism of integration between local and emergent object properties may contribute to holistic percepts in a variety of sensory systems.	[Wile, Daryl; Balaban, Evan] McGill Univ, Behav Neurosci Program, Montreal, PQ, Canada; [Balaban, Evan] Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, Trieste, Italy	McGill University; International School for Advanced Studies (SISSA)	Balaban, E (corresponding author), McGill Univ, Behav Neurosci Program, Montreal, PQ, Canada.	evan.balaban@mcgill.ca	Balaban, Evan/AAV-2353-2020	Balaban, Evan/0000-0002-0391-3433	Natural Sciences and Engineering Research Council of Canada; Canadian Fund for Innovation; Scuola Internazionale Superiore di Studi Avanzati (SISSA)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Fund for Innovation; Scuola Internazionale Superiore di Studi Avanzati (SISSA)	Funding: This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Canadian Fund for Innovation, and the Scuola Internazionale Superiore di Studi Avanzati (SISSA).	Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bhagat SP, 2004, HEARING RES, V193, P51, DOI 10.1016/j.heares.2004.04.005; BOER ED, 1969, J ACOUST SOC AM, V46, P1579, DOI 10.1121/1.1911906; Chialvo DR, 2003, CHAOS, V13, P1226, DOI 10.1063/1.1617771; De Cheveigne A, 2005, PITCH NEURAL CODING, P169; GALBRAITH GC, 1994, ELECTROEN CLIN NEURO, V92, P321, DOI 10.1016/0168-5597(94)90100-7; GARDI J, 1979, AUDIOLOGY, V18, P353; GOBLICK TJ, 1969, J ACOUST SOC AM, V46, P924, DOI 10.1121/1.1911812; GOLDSTEI.JL, 1968, PR INST ELECTR ELECT, V56, P981, DOI 10.1109/PROC.1968.6449; GOLDSTEIN JL, 1967, J ACOUST SOC AM, V41, P676, DOI 10.1121/1.1910396; GREENBERG S, 1987, HEARING RES, V25, P91, DOI 10.1016/0378-5955(87)90083-9; JARAMILLO F, 1993, NATURE, V364, P527, DOI 10.1038/364527a0; Julicher F, 2001, P NATL ACAD SCI USA, V98, P9080, DOI 10.1073/pnas.151257898; McAlpine D, 2004, J NEUROPHYSIOL, V92, P1295, DOI 10.1152/jn.00034.2004; Pandya Pritesh K, 2004, J Am Acad Audiol, V15, P184, DOI 10.3766/jaaa.15.3.2; PATTERSON RD, 1973, J ACOUST SOC AM, V53, P1565, DOI 10.1121/1.1913504; Plack CJ, 2005, PITCH NEURAL CODING, P7, DOI 10.1007/0-387-28958-5_2; RICKMAN MD, 1991, J ACOUST SOC AM, V89, P2818, DOI 10.1121/1.400720; RITSMA RJ, 1964, J ACOUST SOC AM, V36, P1637, DOI 10.1121/1.1919257; ROBLES L, 1991, NATURE, V349, P413, DOI 10.1038/349413a0; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SMITH JC, 1975, ELECTROEN CLIN NEURO, V39, P465, DOI 10.1016/0013-4694(75)90047-4; SMOORENBURG GF, 1976, J ACOUST SOC AM, V59, P945, DOI 10.1121/1.380954; SOHMER H, 1977, ELECTROEN CLIN NEURO, V42, P656, DOI 10.1016/0013-4694(77)90282-6; TURNER RS, 1977, BRIT J HIST SCI, V10, P1, DOI 10.1017/S0007087400015089; WORDEN FG, 1968, ELECTROEN CLIN NEURO, V25, P42, DOI 10.1016/0013-4694(68)90085-0; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	31	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2007	2	4							e369	10.1371/journal.pone.0000369	http://dx.doi.org/10.1371/journal.pone.0000369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DT	17426817	Green Submitted, gold, Green Published			2022-12-27	WOS:000207445400009
J	Carter, O; Cavanagh, P				Carter, Olivia; Cavanagh, Patrick			Onset Rivalry: Brief Presentation Isolates an Early Independent Phase of Perceptual Competition	PLOS ONE			English	Article							BINOCULAR-RIVALRY; DOMINANCE; SUPPRESSION; ATTENTION; MOTION	When the left and right eyes are simultaneously presented with different images, observers typically report exclusive awareness of only one image. This phenomenon is termed binocular rivalry, reflecting the fact that the dominant image alternates every few seconds in a cycle of perceptual competition that continues indefinitely. Despite the apparent continuity in perceptual switching, we now demonstrate that the initial "onset" period is fundamentally different to all subsequent rivalry epochs. Using brief intermittent presentations, rivalry dominance shows strong biases such that the same target is perceived with each successive stimulus onset. These biases remain consistent within any given location, but vary across the visual field in a distribution that is stable over multiple weeks but highly idiosyncratic across observers. If the presentation exceeds, similar to 1sec at any location, however, the very different and much more balanced alternations of sustained binocular rivalry become apparent. These powerful onset biases are observed with brief intermittent presentations at a single location or with continual smooth motion of the targets. Periods of adaptation to one of the rivaling targets induced local switches in dominance to the non-adapted target. However, these effects were generally limited to the spatial site of adaptation and had less influence over each subsequent cycle of the target. We conclude that onset rivalry is independent of sustained rivalry and cannot be explained by local regions of monocular dominance or memory of past perceptual history, but rather reflects low-level, spatially localized factors that are stable over periods of weeks. These findings suggest that brief presentation paradigms are inappropriate for their current use in studies of the mechanisms underlying sustained rivalry. However, brief presentations are ideal for investigating early stages of perceptual competition.	[Carter, Olivia; Cavanagh, Patrick] Harvard Univ, Vis Sci Lab, Cambridge, MA 02138 USA; [Carter, Olivia] Brain Res Inst, Melbourne, Vic, Australia; [Cavanagh, Patrick] Univ Paris 05, Lab Psychol Percept, Paris, France	Harvard University; Florey Institute of Neuroscience & Mental Health; UDICE-French Research Universities; Universite Paris Cite	Carter, O (corresponding author), Harvard Univ, Vis Sci Lab, Cambridge, MA 02138 USA.	ocarter@wjh.harvard.edu		Carter, Olivia/0000-0001-7708-6154	NHMRC(Aust) [368525]; NIH [R01 EY-09258]; NATIONAL EYE INSTITUTE [R01EY009258] Funding Source: NIH RePORTER	NHMRC(Aust)(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a NHMRC(Aust) CJ Martin Fellowship: 368525 to OC and a NIH grant: R01 EY-09258 to PC.	Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 2003, NEURON, V39, P869, DOI 10.1016/S0896-6273(03)00495-1; BREITMEYER BG, 1984, VISUAL MASKING; CARNEY T, 1987, NATURE, V328, P647, DOI 10.1038/328647a0; Chen XC, 2004, CURR BIOL, V14, P1013, DOI 10.1016/j.cub.2004.05.042; Chen XC, 2003, VISION RES, V43, P2207, DOI 10.1016/S0042-6989(03)00359-6; Chong SC, 2006, VISION RES, V46, P1794, DOI 10.1016/j.visres.2005.10.031; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Hupe JM, 2003, VISION RES, V43, P531, DOI 10.1016/S0042-6989(02)00593-X; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LEVELT WJM, 1967, BRIT J PSYCHOL, V58, P143, DOI 10.1111/j.2044-8295.1967.tb01068.x; Levelt WJM, 1965, BINOCULAR RIVALRY; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Maier A, 2003, CURR BIOL, V13, P1076, DOI 10.1016/S0960-9822(03)00414-7; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; O'Shea R. P., 2001, BRAIN MIND, V2, P151; Pearson J, 2004, J VISION, V4, P196, DOI 10.1167/4.3.6; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Wheatstone C., 1838, PHILOS T ROY SOC LON, V128, P371, DOI DOI 10.1098/RSTL.1838.0019; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447	22	114	114	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e343	10.1371/journal.pone.0000343	http://dx.doi.org/10.1371/journal.pone.0000343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406667	Green Published, gold			2022-12-27	WOS:000207445300005
J	Tam, CC; O'Brien, SJ; Petersen, I; Islam, A; Hayward, A; Rodrigues, LC				Tam, Clarence C.; O'Brien, Sarah J.; Petersen, Irene; Islam, Amir; Hayward, Andrew; Rodrigues, Laura C.			Guillain-Barre Syndrome and Preceding Infection with Campylobacter, Influenza and Epstein-Barr Virus in the General Practice Research Database	PLOS ONE			English	Article							JEJUNI INFECTION; ANTIBODY-RESPONSES; ASSOCIATION; GALACTOCEREBROSIDE; NEUROPATHY; SPECTRUM; FEATURES; ENGLAND; RATES	Background. A number of infectious agents have previously been suggested as risk factors for the development of Guillain-Barre syndrome (GBS), but robust epidemiologic evidence for these associations is lacking. Methods and Findings. We conducted a nested case-control study using data from the United Kingdom General Practice Research Database between 1991 and 2001. Controls were matched to cases on general practice clinic, sex, year of birth and date of outcome diagnosis in their matched case. We found positive associations between GBS and infection with Campylobacter, Epstein-Barr virus and influenza-like illness in the previous two months, as well as evidence of a protective effect of influenza vaccination. After correction for under-ascertainment of Campylobacter infection, the excess risk of GBS following Campylobacter enteritis was 60-fold and 20% of GBS cases were attributable to this pathogen. Conclusions. Our findings indicate a far greater excess risk of GBS among Campylobacter enteritis patients than previously reported by retrospective serological studies. In addition, they confirm previously suggested associations between infection due to Epstein-Barr virus infection and influenza-like illness and GBS. Finally, we report evidence of a protective effect of influenza vaccination on GBS risk, which may be mediated through protection against influenza disease, or result from a lower likelihood of vaccination among those with recent infection. Cohort studies of GBS incidence in this population would help to clarify the burden of GBS due to influenza, and any potential protective effect of influenza vaccination.	[Tam, Clarence C.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London WC1, England; [Tam, Clarence C.] Hlth Protect Agcy Ctr Infect, Environm & Enter Dis Dept, London, England; [O'Brien, Sarah J.] Univ Manchester, Sch Med, Div Med & Neurosci, Salford, Lancs, England; [Petersen, Irene; Islam, Amir; Hayward, Andrew] UCL, Dept Primary Care & Populat Sci, London, England	University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency; University of Manchester; University of London; University College London	Tam, CC (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London WC1, England.	clarence.tam@lshtm.ac.uk	Hayward, Andrew C/C-3268-2013; RODRIGUES, LAURA CUNHA/AAO-4130-2021; Petersen, Irene/I-2751-2012; Petersen, Irene/C-5702-2009	Hayward, Andrew C/0000-0002-3549-6232; Petersen, Irene/0000-0002-0037-7524; O'Brien, Sarah Jane/0000-0003-2896-8999; Rodrigues, Laura Cunha/0000-0001-9008-660X; Tam, Clarence/0000-0003-1697-286X	Medical Research Council [G0601726] Funding Source: Medline; MRC [G0601726] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ang CW, 2002, J NEUROIMMUNOL, V130, P179, DOI 10.1016/S0165-5728(02)00209-6; BERTRAND A, 1971, PRESSE MED, V79, P2328; Bogliun G, 2004, ACTA NEUROL SCAND, V110, P100, DOI 10.1111/j.1600-0404.2004.00272.x; Cawthraw SA, 2002, CLIN EXP IMMUNOL, V130, P101, DOI 10.1046/j.1365-2249.2002.01966.x; COUGHLIN SS, 1994, EPIDEMIOL REV, V16, P51, DOI 10.1093/oxfordjournals.epirev.a036144; ENDERS U, 1993, ANN NEUROL, V34, P136, DOI 10.1002/ana.410340208; FLEGAL KM, 1986, AM J EPIDEMIOL, V123, P736, DOI 10.1093/oxfordjournals.aje.a114294; Guarino M, 1998, Neuroepidemiology, V17, P296; Hao Q, 1998, J NEUROIMMUNOL, V81, P116, DOI 10.1016/S0165-5728(97)00166-5; HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Hughes RA, 2006, ARCH INTERN MED, V166, P1301, DOI 10.1001/archinte.166.12.1301; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Ju YY, 2004, J NEUROIMMUNOL, V149, P160, DOI 10.1016/j.jneuroim.2003.12.011; KALDOR J, 1984, BRIT MED J, V288, P1867, DOI 10.1136/bmj.288.6434.1867; Kinnunen E, 1998, AM J EPIDEMIOL, V147, P69; Koga M, 1998, J NEUROIMMUNOL, V81, P138, DOI 10.1016/S0165-5728(97)00168-9; Kruger H, 1974, Psychiatr Neurol Med Psychol (Leipz), V26, P513; KUROKI S, 1993, ANN NEUROL, V33, P243, DOI 10.1002/ana.410330304; KUROKI S, 1991, PEDIATR INFECT DIS J, V10, P149, DOI 10.1097/00006454-199102000-00014; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610; Migita M, 2001, Eur J Paediatr Neurol, V5, P83, DOI 10.1053/ejpn.2001.0470; MISHU B, 1993, ANN INTERN MED, V118, P947, DOI 10.7326/0003-4819-118-12-199306150-00006; Novak M, 1975, Cesk Neurol Neurochir, V38, P314; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; SAFRANEK TJ, 1991, AM J EPIDEMIOL, V133, P940, DOI 10.1093/oxfordjournals.aje.a115973; Strid MA, 2001, CLIN DIAGN LAB IMMUN, V8, P314, DOI 10.1128/CDLI.8.2.314-319.2001; Susuki K, 2004, NEUROLOGY, V62, P949, DOI 10.1212/01.WNL.0000115123.42929.FD; Tam CC, 2003, CLIN INFECT DIS, V37, P307, DOI 10.1086/375845; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; Tam CC, 2006, EMERG INFECT DIS, V12, P1880; Taylor BV, 2004, INTERN MED J, V34, P250, DOI 10.1111/j.1444-0903.2004.00517.x; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; WELLS CEC, 1959, ARCH NEURO PSYCHIATR, V81, P699, DOI 10.1001/archneurpsyc.1959.02340180033005; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; WINER JB, 1988, J NEUROL NEUROSUR PS, V51, P613, DOI 10.1136/jnnp.51.5.613	37	129	140	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e344	10.1371/journal.pone.0000344	http://dx.doi.org/10.1371/journal.pone.0000344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406668	Green Published, gold, Green Accepted			2022-12-27	WOS:000207445300006
J	Plumet, S; Herschke, F; Bourhis, JM; Valentin, H; Longhi, S; Gerlier, D				Plumet, Sebastien; Herschke, Florence; Bourhis, Jean-Marie; Valentin, Helene; Longhi, Sonia; Gerlier, Denis			Cytosolic 5 '-Triphosphate Ended Viral Leader Transcript of Measles Virus as Activator of the RIG I-Mediated Interferon Response	PLOS ONE			English	Article								Background. Double stranded RNA (dsRNA) is widely accepted as an RNA motif recognized as a danger signal by the cellular sentries. However, the biology of non-segmented negative strand RNA viruses, or Mononegavirales, is hardly compatible with the production of such dsRNA. Methodology and Principal Findings. During measles virus infection, the IFN-beta gene transcription was found to be paralleled by the virus transcription, but not by the virus replication. Since the expression of every individual viral mRNA failed to activate the IFN-beta gene, we postulated the involvement of the leader RNA, which is a small not capped and not polyadenylated RNA firstly transcribed by Mononegavirales. The measles virus leader RNA, synthesized both in vitro and in vivo, was efficient in inducing the IFN-beta expression, provided that it was delivered into the cytosol as a 5'-trisphosphate ended RNA. The use of a human cell line expressing a debilitated RIG-I molecule, together with overexpression studies of wild type RIG-I, showed that the IFN-beta induction by virus infection or by leader RNA required RIG-I to be functional. RIG-I binds to leader RNA independently from being 5-trisphosphate ended; while a point mutant, Q299A, predicted to establish contacts with the RNA, fails to bind to leader RNA. Since the 5'-triphosphate is required for optimal RIG-I activation but not for leader RNA binding, our data support that RIG-I is activated upon recognition of the 5'-triphosphate RNA end. Conclusions/Significance. RIG-I is proposed to recognize Mononegavirales transcription, which occurs in the cytosol, while scanning cytosolic RNAs, and to trigger an IFN response when encountering a free 5'-triphosphate RNA resulting from a mislocated transcription activity, which is therefore considered as the hallmark of a foreign invader.	[Plumet, Sebastien; Herschke, Florence; Gerlier, Denis] Univ Lyon 1, CNRS, Fac Med, RTH Laennec, F-69365 Lyon, France; [Bourhis, Jean-Marie; Longhi, Sonia] Univ Aix Marseille 1, CNRS, UMR 6098, Marseille, France; [Bourhis, Jean-Marie; Longhi, Sonia] Univ Aix Marseille 2, F-13284 Marseille 07, France; [Valentin, Helene] Univ Lyon 1, INSERM, Immunol Fondamentale & Clin, Biosci Lyon Gerland IFR128,UMR 6098, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gerlier, D (corresponding author), Univ Lyon 1, CNRS, Fac Med, RTH Laennec, F-69365 Lyon, France.	denis.gerlier@univ-lyon1.fr	Gerlier, Denis/L-6094-2014; LONGHI, Sonia/M-5305-2014; Valentin, Helene/AAA-4265-2020	Gerlier, Denis/0000-0001-5539-456X; LONGHI, Sonia/0000-0002-6829-6771; 	Delegation Generale de l'Armement; MNERT; ANR-MIME	Delegation Generale de l'Armement; MNERT; ANR-MIME(French National Research Agency (ANR))	S. P. is an engineer supported by the Delegation Generale de l'Armement and F. H. is supported by an MNERT fellowship. The work was supported by a grant from ANR-MIME.	ABRAHAM G, 1975, CELL, V5, P51, DOI 10.1016/0092-8674(75)90091-4; Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDREAZZOLI M, 1991, EMBO J, V10, P767, DOI 10.1002/j.1460-2075.1991.tb08008.x; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; CASTANEDA SJ, 1990, J VIROL, V64, P222, DOI 10.1128/JVI.64.1.222-230.1990; CASTANEDA SJ, 1989, J VIROL, V63, P2977, DOI 10.1128/JVI.63.7.2977-2986.1989; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Cortay JC, 2006, J VIROL METHODS, V131, P16, DOI 10.1016/j.jviromet.2005.06.021; Dhib-Jalbut S, 1999, J IMMUNOL, V162, P4024; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Garcin D, 2004, J VIROL, V78, P8799, DOI 10.1128/JVI.78.16.8799-8811.2004; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; HEFTI E, 1975, J VIROL, V15, P90, DOI 10.1128/JVI.15.1.90-96.1975; Helin E, 2001, VIROLOGY, V290, P1, DOI 10.1006/viro.2001.1174; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; HORIKAMI SM, 1991, J VIROL, V65, P5342, DOI 10.1128/JVI.65.10.5342-5347.1991; Hornung V, 2006, SCIENCE; Iseni F, 2002, EMBO J, V21, P5141, DOI 10.1093/emboj/cdf513; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KAWAI T, 2005, NAT IMMUNOL; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kolakofsky D, 2004, VIROLOGY, V318, P463, DOI 10.1016/j.virol.2003.10.031; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LEPPERT M, 1978, J VIROL, V25, P427, DOI 10.1128/JVI.25.1.427-432.1978; LYNCH S, 1978, J VIROL, V28, P584, DOI 10.1128/JVI.28.2.584-589.1978; Marians KJ, 1997, STRUCTURE, V5, P1129, DOI 10.1016/S0969-2126(97)00263-3; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MOYER SA, 1975, CELL, V5, P59, DOI 10.1016/0092-8674(75)90092-6; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; PERRY RP, 1981, J CELL BIOL, V91, pS28, DOI 10.1083/jcb.91.3.28s; Plumet S, 2005, J VIROL METHODS, V128, P79, DOI 10.1016/j.jviromet.2005.03.020; Plumet S, 2005, J VIROL, V79, P6900, DOI 10.1128/JVI.79.11.6900-6908.2005; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Reis e Sousa A, 2006, SCIENCE; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SINGH R, 1989, P NATL ACAD SCI USA, V86, P8280, DOI 10.1073/pnas.86.21.8280; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; VIDAL S, 1989, J VIROL, V63, P1951, DOI 10.1128/JVI.63.5.1951-1958.1989; Vidalain PO, 2002, J VIROL, V76, P6415, DOI 10.1128/JVI.76.13.6415-6424.2002; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	55	153	161	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e279	10.1371/journal.pone.0000279	http://dx.doi.org/10.1371/journal.pone.0000279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356690	gold, Green Published			2022-12-27	WOS:000207444800002
J	Perez-Tris, J; Hellgren, O; Krizanauskiene, A; Waldenstrom, J; Secondi, J; Bonneaud, C; Fjeldsa, J; Hasselquist, D; Bensch, S				Perez-Tris, Javier; Hellgren, Olof; Krizanauskiene, Asta; Waldenstrom, Jonas; Secondi, Jean; Bonneaud, Camille; Fjeldsa, Jon; Hasselquist, Dennis; Bensch, Staffan			Within-Host Speciation of Malaria Parasites	PLOS ONE			English	Article							POPULATION-STRUCTURE; BLOOD PARASITES; HAEMOPROTEUS; PLASMODIUM; TRANSMISSION; INFECTIONS; ECOLOGY	Background. Sympatric speciation-the divergence of populations into new species in absence of geographic barriers to hybridization-is the most debated mode of diversification of life forms. Parasitic organisms are prominent models for sympatric speciation, because they may colonise new hosts within the same geographic area and diverge through host specialization. However, it has been argued that this mode of parasite divergence is not strict sympatric speciation, because host shifts likely cause the sudden effective isolation of parasites, particularly if these are transmitted by vectors and therefore cannot select their hosts. Strict sympatric speciation would involve parasite lineages diverging within a single host species, without any population subdivision. Methodology/Principal Findings. Here we report a case of extraordinary divergence of sympatric, ecologically distinct, and reproductively isolated malaria parasites within a single avian host species, which apparently occurred without historical or extant subdivision of parasite or host populations. Conclusions/Significance. This discovery of within-host speciation changes our current view on the diversification potential of malaria parasites, because neither geographic isolation of host populations nor colonization of new host species are any longer necessary conditions to the formation of new parasite species.	[Perez-Tris, Javier; Hellgren, Olof; Waldenstrom, Jonas; Hasselquist, Dennis; Bensch, Staffan] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Perez-Tris, Javier] Univ Complutense, Dept Zool & Phys Anthropol, E-28040 Madrid, Spain; [Krizanauskiene, Asta] Vilnius State Univ, Inst Ecol, Vilnius, Lithuania; [Secondi, Jean] Univ Angers, Anim Ecol Lab, Angers, France; [Bonneaud, Camille] Univ Paris 06, Lab Parasitol Evolut, Paris, France; [Fjeldsa, Jon] Univ Copenhagen, Zool Museum, DK-2100 Copenhagen, Denmark	Lund University; Complutense University of Madrid; Vilnius University; Universite d'Angers; UDICE-French Research Universities; Sorbonne Universite; University of Copenhagen	Perez-Tris, J (corresponding author), Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden.	jperez@bio.ucm.es	Križanauskienė, Asta/CAF-5095-2022; Hasselquist, Dennis/M-5223-2014; Hellgren, Olof/C-7420-2014; Waldenström, Jonas/E-4460-2013; Fjeldså, Jon/A-9699-2013; Pérez-Tris, Javier/D-4087-2012	Hasselquist, Dennis/0000-0002-0056-6616; Hellgren, Olof/0000-0002-4062-7276; Waldenström, Jonas/0000-0002-1152-4235; Fjeldså, Jon/0000-0003-0790-3600; Pérez-Tris, Javier/0000-0001-5535-3100; Secondi, Jean/0000-0001-8130-1195	EU; Spanish Ramon y Cajal programme; Swedish Research Council; Carl Trygger Foundation; Ministere de la Recherche	EU(European Commission); Spanish Ramon y Cajal programme(Spanish Government); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	The study was funded by EU Marie Curie grants (to J.P. and J.S.), the Spanish Ramon y Cajal programme (J.P.), the Swedish Research Council and Carl Trygger Foundation (D. H. and S. B.), and the Ministere de la Recherche (C. B.). None of these funding bodies played any role in the experimental design, execution or writing of the paper.	Bensch S, 1999, BIOL J LINN SOC, V66, P171, DOI 10.1006/bijl.1998.0261; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Bohning-Gaese K, 2003, J EVOLUTION BIOL, V16, P956, DOI 10.1046/j.1420-9101.2003.00605.x; Coyne J.A., 2004, SPECIATION; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Meeus T, 1998, PARASITOL TODAY, V14, P10, DOI 10.1016/S0169-4758(97)01163-0; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2003, TRENDS ECOL EVOL, V18, P60, DOI 10.1016/S0169-5347(02)00058-7; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; HELLGREN O, 2007, MOL ECOL IN PRESS; KREIER JP, 1994, PARASITIC PROTOZOA; McCoy KD, 2003, TRENDS PARASITOL, V19, P400, DOI 10.1016/S1471-4922(03)00194-6; PAGE RDM, 1993, COMPONENT VER 2 00A; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Perez-Tris J, 2005, TRENDS PARASITOL, V21, P209, DOI 10.1016/j.pt.2005.03.001; Perez-Tris J, 2004, EVOLUTION, V58, P1819, DOI 10.1554/03-731; Perez-Tris J, 2005, PARASITOLOGY, V131, P15, DOI 10.1017/S003118200500733X; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Razakandrainibe FG, 2005, P NATL ACAD SCI USA, V102, P17388, DOI 10.1073/pnas.0508871102; Reullier J, 2006, MOL ECOL, V15, P753, DOI 10.1111/j.1365-294X.2005.02826.x; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schneider S., 2000, ARLEQUIN SOFTWARE PO; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Valkiunas G, 2004, J PARASITOL, V90, P196, DOI 10.1645/GE-3223RN; VALKIUNAS G, 2007, J PARASITOL IN PRESS; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN	32	91	93	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e235	10.1371/journal.pone.0000235	http://dx.doi.org/10.1371/journal.pone.0000235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311104	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444500016
J	Lloyd-Smith, JO				Lloyd-Smith, James O.			Maximum Likelihood Estimation of the Negative Binomial Dispersion Parameter for Highly Overdispersed Data, with Applications to Infectious Diseases	PLOS ONE			English	Article							AGGREGATION; CURVES	Background. The negative binomial distribution is used commonly throughout biology as a model for overdispersed count data, with attention focused on the negative binomial dispersion parameter, k. A substantial literature exists on the estimation of k, but most attention has focused on datasets that are not highly overdispersed (i.e., those with k >= 1), and the accuracy of confidence intervals estimated for k is typically not explored. Methodology. This article presents a simulation study exploring the bias, precision, and confidence interval coverage of maximum-likelihood estimates of k from highly overdispersed distributions. In addition to exploring small-sample bias on negative binomial estimates, the study addresses estimation from datasets influenced by two types of event under-counting, and from disease transmission data subject to selection bias for successful outbreaks. Conclusions. Results show that maximum likelihood estimates of k can be biased upward by small sample size or under-reporting of zero-class events, but are not biased downward by any of the factors considered. Confidence intervals estimated from the asymptotic sampling variance tend to exhibit coverage below the nominal level, with overestimates of k comprising the great majority of coverage errors. Estimation from outbreak datasets does not increase the bias of k estimates, but can add significant upward bias to estimates of the mean. Because k varies inversely with the degree of overdispersion, these findings show that overestimation of the degree of overdispersion is very rare for these datasets.	Penn State Univ, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lloyd-Smith, JO (corresponding author), Penn State Univ, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	jlloydsmith@psu.edu	/K-4080-2012; Lloyd-Smith, James/AAG-4463-2021	/0000-0001-7941-502X; 	NIH-NIDA [R01-DA10135]; Center for Infectious Disease Dynamics	NIH-NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Center for Infectious Disease Dynamics	This research was performed as a postdoctoral researcher supported by NIH-NIDA (R01-DA10135) and a Center for Infectious Disease Dynamics Postdoctoral Fellowship. None of the sponsors played any role in the research.	Alexander N, 2000, Biostatistics, V1, P453, DOI 10.1093/biostatistics/1.4.453; ANDERSON R M, 1991; ANSCOMBE FJ, 1950, BIOMETRIKA, V37, P358, DOI 10.1093/biomet/37.3-4.358; Blaker H, 2000, CAN J STAT, V28, P783, DOI 10.2307/3315916; BLISS CI, 1953, BIOMETRICS, V9, P176, DOI 10.2307/3001850; Boswell M., 1970, RANDOM COUNTS SCI WO, V1, P3; CLARK SJ, 1989, BIOMETRICS, V45, P309, DOI 10.2307/2532055; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Donnelly CA, 2004, LANCET INFECT DIS, V4, P672, DOI 10.1016/S1473-3099(04)01173-9; Ferrari MJ, 2005, MATH BIOSCI, V198, P14, DOI 10.1016/j.mbs.2005.08.002; Gray BR, 2005, ECOL MODEL, V185, P1, DOI 10.1016/j.ecolmodel.2004.11.006; GREGORY RD, 1993, ACTA TROP, V54, P131, DOI 10.1016/0001-706X(93)90059-K; Harris TE, 1989, THEORY BRANCHING PRO; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; PIEGORSCH WW, 1990, BIOMETRICS, V46, P863, DOI 10.2307/2532104; PIELOU E C, 1969, P286; PIETERS EP, 1977, BIOMETRICS, V33, P718, DOI 10.2307/2529470; Power JH, 1999, CAN J FISH AQUAT SCI, V56, P191, DOI 10.1139/cjfas-56-2-191; Rice J., 1995, MATH STAT DATA ANAL; Ridout M, 1998, INT BIOM C, V19, P179; Saha K, 2005, BIOMETRICS, V61, P179, DOI 10.1111/j.0006-341X.2005.030833.x; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Walther BA, 1998, PARASITOLOGY, V116, P395, DOI 10.1017/S0031182097002230; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; WILLSON LJ, 1984, BIOMETRICS, V40, P109, DOI 10.2307/2530749; Wilson K., 2001, ECOLOGY WILDLIFE DIS, P6; [No title captured]	29	110	112	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e180	10.1371/journal.pone.0000180	http://dx.doi.org/10.1371/journal.pone.0000180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299582	Green Published, gold			2022-12-27	WOS:000207444400001
J	Yoshihama, M; Nguyen, HD; Kenmochi, N				Yoshihama, Maki; Nguyen, Hung D.; Kenmochi, Naoya			Intron Dynamics in Ribosomal Protein Genes	PLOS ONE			English	Article							SPLICEOSOMAL INTRON; EVOLUTION; GAIN; POSITIONS; ORIGIN; GENOME	The role of spliceosomal introns in eukaryotic genomes remains obscure. A large scale analysis of intron presence/absence patterns in many gene families and species is a necessary step to clarify the role of these introns. In this analysis, we used a maximum likelihood method to reconstruct the evolution of 2,961 introns in a dataset of 76 ribosomal protein genes from 22 eukaryotes and validated the results by a maximum parsimony method. Our results show that the trends of intron gain and loss differed across species in a given kingdom but appeared to be consistent within subphyla. Most subphyla in the dataset diverged around 1 billion years ago, when the "Big Bang" radiation occurred. We speculate that spliceosomal introns may play a role in the explosion of many eukaryotes at the Big Bang radiation.	[Yoshihama, Maki; Nguyen, Hung D.; Kenmochi, Naoya] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan	University of Miyazaki	Kenmochi, N (corresponding author), Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan.	kenmochi@med.miyazaki-u.ac.jp	Kenmochi, Naoya/ABF-3564-2021		Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [14035103, 17770207, 188093]; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research (14035103, 17770207, and 188093) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS). HDN is a research fellow of the JSPS (17-05174).	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Csuros M, 2005, LECT NOTES COMPUT SC, V3678, P47; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; KENMOCHI N, 2003, NATURE ENCY HUMAN GE, P77; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; Nakao A, 2004, NUCLEIC ACIDS RES, V32, pD168, DOI 10.1093/nar/gkh004; Nguyen HD, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-69; Nguyen HD, 2005, PLOS COMPUT BIOL, V1, P631, DOI 10.1371/journal.pcbi.0010079; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Philippe H, 2000, CURR OPIN GENET DEV, V10, P596, DOI 10.1016/S0959-437X(00)00137-4; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Roy SW, 2003, P NATL ACAD SCI USA, V100, P7158, DOI 10.1073/pnas.1232297100; Russell AG, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-45; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202; Yoshihama M, 2006, PLOS GENET, V2, P237, DOI 10.1371/journal.pgen.0020025; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	28	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2007	2	1							e141	10.1371/journal.pone.0000141	http://dx.doi.org/10.1371/journal.pone.0000141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DD	17206276	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443800003
J	Puccini, GD; Compte, A; Maravall, M				Puccini, Gabriel D.; Compte, Albert; Maravall, Miguel			Stimulus Dependence of Barrel Cortex Directional Selectivity	PLOS ONE			English	Article								Neurons throughout the rat vibrissa somatosensory pathway are sensitive to the angular direction of whisker movement. Could this sensitivity help rats discriminate stimuli? Here we use a simple computational model of cortical neurons to analyze the robustness of directional selectivity. In the model, directional preference emerges from tuning of synaptic conductance amplitude and latency, as in recent experimental findings. We find that directional selectivity during stimulation with random deflection sequences is strongly dependent on the mean deflection frequency: Selectivity is weakened at high frequencies even when each individual deflection evokes strong directional tuning. This variability of directional selectivity is due to generic properties of synaptic integration by the neuronal membrane, and is therefore likely to hold under very general physiological conditions. Our results suggest that directional selectivity depends on stimulus context. It may participate in tasks involving brief whisker contact, such as detection of object position, but is likely to be weakened in tasks involving sustained whisker exploration (e.g., texture discrimination).	[Puccini, Gabriel D.; Compte, Albert; Maravall, Miguel] UMH, Inst Neurociencias Alicante, CSIC, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Maravall, M (corresponding author), UMH, Inst Neurociencias Alicante, CSIC, Campus San Juan, Alicante, Spain.	mmaravall@umh.es	Maravall, Miguel/AAW-4328-2021; Compte, Albert/A-2491-2009	Maravall, Miguel/0000-0002-8869-7206; Compte, Albert/0000-0001-6594-6946	Human Frontier Science Program [RG0043/2004-C]; European Community Marie Curie International Reintegration [MIRG-CT-2004-511273]; Royal Society Joint Project; Spanish Ministry of Education [BFI2002-02378]; Volkswagen-Stiftung; European Regional Development Fund	Human Frontier Science Program(Human Frontier Science Program); European Community Marie Curie International Reintegration(European Commission); Royal Society Joint Project; Spanish Ministry of Education(Spanish Government); Volkswagen-Stiftung(Volkswagen); European Regional Development Fund(European Commission)	This work was supported by: Human Frontier Science Program Grant RG0043/2004-C (to M.M.), European Community Marie Curie International Reintegration Grant MIRG-CT-2004-511273 (to M.M.), Royal Society Joint Project Grant (to M.M.), Spanish Ministry of Education Grant BFI2002-02378 (to A.C.), Volkswagen-Stiftung (to A.C.) and European Regional Development Fund (to M.M. and A.C.). M.M. and A.C. are Ramon y Cajal Research Fellows (Spanish Ministry of Education and Science). Funders played no role in the research presented.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Andermann ML, 2006, NAT NEUROSCI, V9, P543, DOI 10.1038/nn1671; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2003, J NEUROSCI, V23, P9565; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Erchova IA, 2004, J NEUROSCI, V24, P5931, DOI 10.1523/JNEUROSCI.1202-04.2004; Erchova IA, 2002, EUR J NEUROSCI, V15, P744, DOI 10.1046/j.0953-816x.2002.01898.x; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Hentschke H, 2006, CEREB CORTEX, V16, P1142, DOI 10.1093/cercor/bhj056; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Hipp J, 2006, J NEUROPHYSIOL, V95, P1792, DOI 10.1152/jn.01104.2005; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Lee SH, 2004, J NEUROPHYSIOL, V91, P223, DOI 10.1152/jn.00541.2003; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; MARAVALL M, 2007, PLOS BIOL IN PRESS; Minnery BS, 2003, J NEUROPHYSIOL, V90, P1556, DOI 10.1152/jn.00111.2003; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Polley DB, 2005, NEUROBIOL LEARN MEM, V83, P134, DOI 10.1016/j.nlm.2004.10.005; Shoykhet M, 2003, J NEUROPHYSIOL, V90, P1432, DOI 10.1152/jn.00419.2003; SIMONS DJ, 1983, BRAIN RES, V276, P178, DOI 10.1016/0006-8993(83)90561-9; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Temereanca S, 2003, J NEUROPHYSIOL, V89, P2137, DOI 10.1152/jn.00582.2002; Timofeeva E, 2003, J NEUROSCI, V23, P10717; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004	35	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e137	10.1371/journal.pone.0000137	http://dx.doi.org/10.1371/journal.pone.0000137			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205141	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443700031
J	Rangrez, AY; Dayananda, KM; Atanur, S; Joshi, R; Patole, MS; Shouche, YS				Rangrez, Ashraf Yusuf; Dayananda, Kannayakanahalli Maheshwarappa; Atanur, Santosh; Joshi, Rajendra; Patole, Milind S.; Shouche, Yogesh S.			Detection of Conjugation Related Type Four Secretion Machinery in Aeromonas culicicola	PLOS ONE			English	Article							IV SECRETION; AGROBACTERIUM-TUMEFACIENS; DNA; SYSTEMS; TRANSPORT; VIRB9; PROTEINS; SUBSTRATE; VIRULENCE; MEMBRANES	Background. Aeromonas sp. can now be considered relatively common enteropathogens due to the increase of diseases in humans. Aeromonas culicicola is a gram negative rod-shaped bacterium isolated for the first time from the mosquito mid-gut, but subsequently detected in other insects and waters also. Our previous study discovered that A. culicicola harbors three plasmids, which we designated as pAc3249A, pAc3249B and pAc3249C. We investigated and report here the existence and genetic organization of a Conjugal Type IV Secretion System (TFSS) in pAc3249A. Methodology/Principle Finding. The complete operon is 11,061 bp in length and has G+C content of 47.20% code for 12 ORFs. The gene order and orientation were similar to those found in other bacteria with some differences. We have designated this system as AcTra for Aeromonas culicicola transfer system. BLAST results of ORFs and phylogenetic analysis showed significant similarity towards the respective proteins of the IncI2 plasmid R721 of E. coli. Other bioinformatics studies have been performed to predict conserved motifs/domains, signal peptides, transmembrane helices, etc. of the ORFs. Conclusions/Significance. BLAST results of ORFs and phylogenetic analysis showed significant similarity towards the respective proteins of the IncI2 plasmid R721 of E. coli.	[Rangrez, Ashraf Yusuf; Dayananda, Kannayakanahalli Maheshwarappa; Patole, Milind S.; Shouche, Yogesh S.] Natl Ctr Cell Sci, Mol Biol Unit, Pune, Maharashtra, India; [Atanur, Santosh; Joshi, Rajendra] Ctr Dev & Adv Comp, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Centre for Development of Advanced Computing (C-DAC)	Shouche, YS (corresponding author), Natl Ctr Cell Sci, Mol Biol Unit, Pune Univ Campus, Pune, Maharashtra, India.	yogesh@nccs.res.in	Rangrez, Ashraf/H-4988-2016	Rangrez, Ashraf/0000-0003-2630-9754	CSIR (Council of Scientific and Industrial Research), India	CSIR (Council of Scientific and Industrial Research), India(Council of Scientific & Industrial Research (CSIR) - India)	We are kindly thankful to CSIR (Council of Scientific and Industrial Research), India for providing research fellowship to Dayananda KM.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baron C, 1997, J BACTERIOL, V179, P1211, DOI 10.1128/jb.179.4.1211-1218.1997; Baron C, 2002, MOL MICROBIOL, V43, P1359, DOI 10.1046/j.1365-2958.2002.02816.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayer M, 2001, J BACTERIOL, V183, P3176, DOI 10.1128/JB.183.10.3176-3183.2001; Beaupre CE, 1997, J BACTERIOL, V179, P78, DOI 10.1128/jb.179.1.78-89.1997; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Boschiroli ML, 2002, VET MICROBIOL, V90, P341, DOI 10.1016/S0378-1135(02)00219-5; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Cao TB, 2001, MICROBIOL-SGM, V147, P3201, DOI 10.1099/00221287-147-12-3201; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Das A, 2000, J BACTERIOL, V182, P758, DOI 10.1128/JB.182.3.758-763.2000; Figueras MJ, 2000, CLIN INFECT DIS, V30, P988, DOI 10.1086/313839; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JANDA JM, 2001, MOL MED MICROBIOLOGY, P1237; Joseph SW, 2000, ASM NEWS, V66, P218; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Krause S, 2000, J BACTERIOL, V182, P2761, DOI 10.1128/JB.182.10.2761-2770.2000; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Maniatis T, MOL CLONING LAB MANU; Rhodes G, 2004, APPL ENVIRON MICROB, V70, P7497, DOI 10.1128/AEM.70.12.7497-7510.2004; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Roy CR, 2002, J CELL BIOL, V158, P415, DOI 10.1083/jcb.200205011; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; Shamaei-Tousi A, 2004, J BACTERIOL, V186, P4796, DOI 10.1128/JB.186.14.4796-4801.2004; SONNHAMMER ELL, 1994, PROTEIN SCI, V3, P482; Spudich GM, 1996, P NATL ACAD SCI USA, V93, P7512, DOI 10.1073/pnas.93.15.7512; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	37	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e115	10.1371/journal.pone.0000115	http://dx.doi.org/10.1371/journal.pone.0000115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205119	Green Published, gold			2022-12-27	WOS:000207443700009
J	Arce, C; Perez-Plasencia, C; Gonzalez-Fierro, A; de la Cruz-Hernandez, E; Revilla-Vazquez, A; Chavez-Blanco, A; Trejo-Becerril, C; Perez-Cardenas, E; Taja-Chayeb, L; Bargallo, E; Villarreal, P; Ramirez, T; Vela, T; Candelaria, M; Camargo, MF; Robles, E; Duenas-Gonzalez, A				Arce, Claudia; Perez-Plasencia, Carlos; Gonzalez-Fierro, Aurora; de la Cruz-Hernandez, Erick; Revilla-Vazquez, Alma; Chavez-Blanco, Alma; Trejo-Becerril, Catalina; Perez-Cardenas, Enrique; Taja-Chayeb, Lucia; Bargallo, Enrique; Villarreal, Patricia; Ramirez, Teresa; Vela, Teresa; Candelaria, Myrna; Camargo, Maria F.; Robles, Elizabeth; Duenas-Gonzalez, Alfonso			A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer	PLOS ONE			English	Article								Background. Aberrant DNA methylation and histone deacetylation participate in cancer development and progression; hence, their reversal by inhibitors of DNA methylation and histone deacetylases (HDACs) is at present undergoing clinical testing in cancer therapy. As epigenetic alterations are common to breast cancer, in this proof-of-concept study demethylating hydralazine, plus the HDAC inhibitor magnesium valproate, were added to neoadjuvant doxorubicin and cyclophosphamide in locally advanced breast cancer to assess their safety and biological efficacy. Methodology. This was a single-arm interventional trial on breast cancer patients (ClinicalTrials.gov Identifier: NCT00395655). After signing informed consent, patients were typed for acetylator phenotype and then treated with hydralazine at 182 mg for rapid-, or 83 mg for slow-acetylators, and magnesium valproate at 30 mg/kg, starting from day -7 until chemotherapy ended, the latter consisting of four cycles of doxorubicin 60 mg/m(2) and cyclophosphamide 600 mg/m(2) every 21 days. Core-needle biopsies were taken from primary breast tumors at diagnosis and at day 8 of treatment with hydralazine and valproate. Main Findings. 16 patients were included and received treatment as planned. All were evaluated for clinical response and toxicity and 15 for pathological response. Treatment was well-tolerated. The most common toxicity was drowsiness grades 1-2. Five (31%) patients had clinical CR and eight (50%) PR for an ORR of 81%. No patient progressed. One of 15 operated patients (6.6%) had pathological CR and 70% had residual disease <3 cm. There was a statistically significant decrease in global 5(m)C content and HDAC activity. Hydralazine and magnesium valproate up- and down-regulated at least 3-fold, 1,091 and 89 genes, respectively. Conclusions. Hydralazine and magnesium valproate produce DNA demethylation, HDAC inhibition, and gene reactivation in primary tumors. Doxorubicin and cyclophosphamide treatment is safe, well-tolerated, and appears to increase the efficacy of chemotherapy. A randomized phase III study is ongoing to support the efficacy of so-called epigenetic or transcriptional cancer therapy.	[Perez-Plasencia, Carlos; Gonzalez-Fierro, Aurora; de la Cruz-Hernandez, Erick; Chavez-Blanco, Alma; Trejo-Becerril, Catalina; Perez-Cardenas, Enrique; Taja-Chayeb, Lucia; Camargo, Maria F.; Duenas-Gonzalez, Alfonso] Univ Nacl Autonoma Mexico, Inst Nacl Cancerol INCAN, Inst Invest Biomed, Unidad Invest Biomed Canc, Mexico City 04510, DF, Mexico; [Arce, Claudia; Candelaria, Myrna; Robles, Elizabeth] Inst Nacl Cancerol INCAN, Div Invest Clin, Mexico City, DF, Mexico; [Revilla-Vazquez, Alma] Univ Nacl Autonoma Mexico, Lab Desarrollo Metodos Analit, FES Cuautitlan, Cuautitlan, Estado Mexico, Mexico; [Bargallo, Enrique; Villarreal, Patricia; Ramirez, Teresa] Inst Nacl Cancerol INCAN, Dept Tumores Mamarios, Mexico City, DF, Mexico; [Vela, Teresa] Inst Nacl Cancerol INCAN, Dept Patol, Mexico City, DF, Mexico	Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN)	Duenas-Gonzalez, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Nacl Cancerol INCAN, Inst Invest Biomed, Unidad Invest Biomed Canc, Mexico City 04510, DF, Mexico.	alfonso_duenasg@yahoo.com	Perez-Plasencia, Carlos/P-2372-2019; De la Cruz-Hernandez, Erick/E-1487-2019	Perez-Plasencia, Carlos/0000-0002-8593-8211; De la Cruz-Hernandez, Erick/0000-0001-5236-7347; Revilla Vazquez, Alma Luisa/0000-0002-4714-0866	CONACyT [SALUD-2002-C01-6579, AVANCE C01-294]; Psicofarma; S. A. de C. V., Mexico	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Psicofarma; S. A. de C. V., Mexico	This work was supported by CONACyT grants SALUD-2002-C01-6579 and AVANCE C01-294, and by Psicofarma, S. A. de C. V., Mexico. Sponsors did not participate in study design; collection, analysis, and interpretation of data; writing of the paper; nor decision to submit it for publication.	Acharya S, 2000, J PEDIAT HEMATOL ONC, V22, P62, DOI 10.1097/00043426-200001000-00012; Angeles E, 2005, LETT DRUG DES DISCOV, V2, P282, DOI 10.2174/1570180054038413; Blagosklonny MV, 2005, CANCER RES, V65, P7386, DOI 10.1158/0008-5472.CAN-04-3433; Bonadonna G, 1998, J CLIN ONCOL, V16, P93, DOI 10.1200/JCO.1998.16.1.93; Bourg V, 2001, ANN ONCOL, V12, P217, DOI 10.1023/A:1008331708395; Bovenzi V, 2001, CANCER CHEMOTH PHARM, V48, P71, DOI 10.1007/s002800100294; Brain E, 1997, BRIT J CANCER, V75, P1360, DOI 10.1038/bjc.1997.230; Buchholz TA, 2002, CANCER J, V8, P461, DOI 10.1097/00130404-200211000-00010; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Castaneda-Hernandez G., 1995, Am J Ther, V2, P57, DOI 10.1097/00045391-199501000-00011; Chavez-Blanco A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-2; Chavez-Blanco A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-22; Claus R, 2005, SEMIN ONCOL, V32, P511, DOI 10.1053/j.seminoncol.2005.07.024; Cristofanilli M, 2006, CANCER-AM CANCER SOC, V107, P935, DOI 10.1002/cncr.22080; FERNANDEZSANCHE.M, 1998, MED ONCOL, V23, P171; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Gagnon J, 2003, ANTI-CANCER DRUG, V14, P193, DOI 10.1097/00001813-200303000-00002; GARCIAMANERO G, 2006, BLOOD           0801; Goffin J, 2002, ANN ONCOL, V13, P1699, DOI 10.1093/annonc/mdf314; Gollob JA, 2006, CLIN CANCER RES, V12, P4619, DOI 10.1158/1078-0432.CCR-06-0883; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Guerrero KS, 2005, ELECTROPHORESIS, V26, P1057, DOI 10.1002/elps.200410040; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Hartsough MT, 2001, CANCER RES, V61, P2320; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Huang THM, 1999, HUM MOL GENET, V8, P459, DOI 10.1093/hmg/8.3.459; Karagiannis TC, 2006, ONCOGENE, V25, P3885, DOI 10.1038/sj.onc.1209417; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; Kaufmann M, 2006, J CLIN ONCOL, V24, P1940, DOI 10.1200/JCO.2005.02.6187; Kim MS, 2003, CANCER RES, V63, P7291; Kitazono M, 2002, CANCER BIOL THER, V1, P665, DOI 10.4161/cbt.317; Klisovic MI, 2003, LEUKEMIA, V17, P350, DOI 10.1038/sj.leu.2402776; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; LESSER JM, 1974, DRUG METAB DISPOS, V2, P351; Li L, 2005, J COMPUT BIOL, V12, P370, DOI 10.1089/cmb.2005.12.370; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Mamelak AJ, 2005, EXP DERMATOL, V14, P336, DOI 10.1111/j.0906-6705.2005.00278.x; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Mielnicki LM, 2001, J MAMMARY GLAND BIOL, V6, P169, DOI 10.1023/A:1011356623442; Modlich O, 2004, CLIN CANCER RES, V10, P6418, DOI 10.1158/1078-0432.CCR-04-1031; Morrell LE, 1998, CANCER-AM CANCER SOC, V82, P503, DOI 10.1002/(SICI)1097-0142(19980201)82:3<503::AID-CNCR12>3.0.CO;2-5; Perez-Plasencia C, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-27; POWLES TJ, 1995, J CLIN ONCOL, V13, P547, DOI 10.1200/JCO.1995.13.3.547; Primeau M, 2003, INT J CANCER, V103, P177, DOI 10.1002/ijc.10789; REECE PA, 1980, J CHROMATOGR, V181, P427, DOI 10.1016/S0378-4347(00)81145-7; Rouzier R, 2005, J CLIN ONCOL, V23, P8331, DOI 10.1200/JCO.2005.01.2898; Rouzier R, 2002, J CLIN ONCOL, V20, P1304, DOI 10.1200/JCO.20.5.1304; Samlowski WE, 2005, J CLIN ONCOL, V23, P3897, DOI 10.1200/JCO.2005.06.118; Scholl SM, 1995, EUR J CANCER, V31A, P1969, DOI 10.1016/0959-8049(95)00454-8; Schover LR, 1994, J PSYCHOL HUMAN SEXU, V6, P5; SCHWARTZ GF, 1994, CANCER, V73, P362, DOI 10.1002/1097-0142(19940115)73:2<362::AID-CNCR2820730221>3.0.CO;2-L; Segura-Pacheco B, 2003, CLIN CANCER RES, V9, P1596; Selivanova G, 1998, SEMIN CANCER BIOL, V8, P369, DOI 10.1006/scbi.1998.0099; Shi HD, 2003, CANCER RES, V63, P2164; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Sonnemann J, 2006, INT J ONCOL, V28, P755; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Tang Bo, 2005, Zhonghua Bing Li Xue Za Zhi, V34, P283; Tomasi TB, 2006, CANCER IMMUNOL IMMUN, V55, P1159, DOI 10.1007/s00262-006-0164-4; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; Wong TWL, 2000, LIFE SCI, V67, pPL1111; Yan PS, 2001, CANCER RES, V61, P8375; Yang X, 2001, ENDOCR-RELAT CANCER, V8, P115, DOI 10.1677/erc.0.0080115; Zambrano P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-44; Zhu Wei-Guo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P187, DOI 10.2174/1568011033482440; Zhu WG, 2001, CANCER RES, V61, P1327	70	113	123	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e98	10.1371/journal.pone.0000098	http://dx.doi.org/10.1371/journal.pone.0000098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183730	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600097
J	Chau, BN; Pan, CW; Wang, JYJ				Chau, B. Nelson; Pan, Chris W.; Wang, Jean Y. J.			Separation of Anti-Proliferation and Anti-Apoptotic Functions of Retinoblastoma Protein through Targeted Mutations of Its A/B Domain	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; BINDING DOMAIN; CELL-DEATH; RB; E2F; INHIBITION; PRB; PHOSPHORYLATION; ARREST; GENE	Background. The human retinoblastoma susceptibility gene encodes a nuclear phosphoprotein RB, which is a negative regulator of cell proliferation. The growth suppression function of RB requires an evolutionarily conserved A/B domain that contains two distinct peptide-binding pockets. At the A/B interface is a binding site for the C-terminal trans-activation domain of E2F. Within the B-domain is a binding site for proteins containing the LxCxE peptide motif. Methodology/Principle Findings. Based on the crystal structure of the A/B domain, we have constructed an RB-K530A/N757F (KN) mutant to disrupt the E2F- and LxCxE-binding pockets. The RB-K530A (K) mutant is sufficient to inactivate the E2F-binding pocket, whereas the RB-N757F (N) mutant is sufficient to inactivate the LxCxE-binding pocket. Each single mutant inhibits cell proliferation, but the RB-KN double mutant is defective in growth suppression. Nevertheless, the RB-KN mutant is capable of reducing etoposide-induced apoptosis. Conclusion/Significance. Previous studies have established that RB-dependent G1-arrest can confer resistance to DNA damage-induced apoptosis. Results from this study demonstrate that RB can also inhibit apoptosis independent of growth suppression.	[Chau, B. Nelson; Pan, Chris W.; Wang, Jean Y. J.] Univ Calif San Diego, Dept Med, Div Hematol Oncol, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, JYJ (corresponding author), Univ Calif San Diego, Dept Med, Div Hematol Oncol, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	jywang@ucsd.edu			NIH-NCI (USA) [CA58320]; Damon Runyon Medical Research Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA058320] Funding Source: NIH RePORTER	NIH-NCI (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Medical Research Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH-NCI (USA) CA58320 to JYJW; Damon Runyon Medical Research Foundation Postdoctoral Fellowship (BNC)	Angus SP, 2002, EXP CELL RES, V276, P201, DOI 10.1006/excr.2002.5510; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; CAVENEE W, 1984, AM J HUM GENET, V36, P10; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Chen TT, 2000, MOL CELL BIOL, V20, P5571, DOI 10.1128/MCB.20.15.5571-5580.2000; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Goodrich DW, 2006, ONCOGENE, V25, P5233, DOI 10.1038/sj.onc.1209616; HAASKOGAN DA, 1995, EMBO J, V14, P461, DOI 10.1002/j.1460-2075.1995.tb07022.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Masselli A, 2006, ONCOGENE, V25, P1290, DOI 10.1038/sj.onc.1209161; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Ross JF, 2001, GENE DEV, V15, P392, DOI 10.1101/gad.858501; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; Wang JYJ, 2005, CELL RES, V15, P43, DOI 10.1038/sj.cr.7290263; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Whitaker LL, 1998, MOL CELL BIOL, V18, P4032, DOI 10.1128/MCB.18.7.4032; Xiao B, 2003, P NATL ACAD SCI USA, V100, P2363, DOI 10.1073/pnas.0436813100; Xiao H, 2005, ONCOGENE, V24, P8105, DOI 10.1038/sj.onc.1208958	34	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e82	10.1371/journal.pone.0000082	http://dx.doi.org/10.1371/journal.pone.0000082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183714	Green Published, gold			2022-12-27	WOS:000207443600082
J	Drake, JM; Chew, SK; Ma, S				Drake, John M.; Chew, Suok Kai; Ma, Stefan			Societal Learning in Epidemics: Intervention Effectiveness during the 2003 SARS Outbreak in Singapore	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; TRANSMISSION DYNAMICS; SPREAD; MODELS; AGENT	Background. Rapid response to outbreaks of emerging infectious diseases is impeded by uncertain diagnoses and delayed communication. Understanding the effect of inefficient response is a potentially important contribution of epidemic theory. To develop this understanding we studied societal learning during emerging outbreaks wherein patient removal accelerates as information is gathered and disseminated. Methods and Findings. We developed an extension of a standard outbreak model, the simple stochastic epidemic, which accounts for societal learning. We obtained expressions for the expected outbreak size and the distribution of epidemic duration. We found that rapid learning noticeably affects the final outbreak size even when learning exhibits diminishing returns (relaxation). As an example, we estimated the learning rate for the 2003 outbreak of severe acute respiratory syndrome (SARS) in Singapore. Evidence for relaxation during the first eight weeks of the outbreak was inconclusive. We estimated that if societal learning had occurred at half the actual rate, the expected final size of the outbreak would have reached nearly 800 cases, more than three times the observed number of infections. By contrast, the expected outbreak size for societal learning twice as effective was 116 cases. Conclusion. These results show that the rate of societal learning can greatly affect the final size of disease outbreaks, justifying investment in early warning systems and attentiveness to disease outbreak by both government authorities and the public. We submit that the burden of emerging infections, including the risk of a global pandemic, could be efficiently reduced by improving procedures for rapid detection of outbreaks, alerting public health officials, and aggressively educating the public at the start of an outbreak.	[Drake, John M.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Chew, Suok Kai; Ma, Stefan] Minist Hlth, Singapore, Singapore	National Center for Ecological Analysis & Synthesis; Ministry of Health-Singapore	Drake, JM (corresponding author), Univ Georgia, Inst Ecol, Athens, GA 30602 USA.	jdrake@uga.edu	Drake, John/D-6622-2012	Drake, John/0000-0003-4646-1235	NSF [DEB0072909]; University of California; Santa Barbara campus	NSF(National Science Foundation (NSF)); University of California(University of California System); Santa Barbara campus	This work was conducted while J. M. D was a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant#DEB0072909), the University of California, and the Santa Barbara campus.	ANDERSON R M, 1991; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; [Anonymous], 1999, EPIDEMIC MODELLING I; [Anonymous], 2013, WHOCDSCSRGAR2003; Bailey N. T. J., 1964, ELEMENTS STOCHASTIC; Barnett DJ, 2005, PLOS MED, V2, P1235, DOI 10.1371/journal.pmed.0020359; Dodd SC, 1952, AM SOCIOL REV, V17, P167, DOI 10.2307/2087656; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Drake JM, 2006, PLOS MED, V3, P57, DOI 10.1371/journal.pmed.0030003; Ferrari MJ, 2005, MATH BIOSCI, V198, P14, DOI 10.1016/j.mbs.2005.08.002; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Hartley DM, 2003, LANCET, V362, P170, DOI 10.1016/S0140-6736(03)13875-5; Holmes EC, 2005, SCIENCE, V309, P989, DOI 10.1126/science.1117128; Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023; James L, 2006, PUBLIC HEALTH, V120, P20, DOI 10.1016/j.puhe.2005.10.005; KENDALL DG, 1949, J R STAT SOC B, V11, P230; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Kuk AYC, 2005, STAT MED, V24, P2525, DOI 10.1002/sim.2123; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; O'Toole Tara, 2003, Biosecur Bioterror, V1, P1, DOI 10.1089/15387130360514760; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Razum O, 2003, LANCET, V361, P1739, DOI 10.1016/S0140-6736(03)13335-1; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Trapman P, 2004, J MATH BIOL, V49, P553, DOI 10.1007/s00285-004-0267-5; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; WHO, 2005, SUMM PROB SARS CAS O; Zhou GF, 2004, EMERG INFECT DIS, V10, P1167; Zhou GF, 2003, EMERG INFECT DIS, V9, P1608	32	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e20	10.1371/journal.pone.0000020	http://dx.doi.org/10.1371/journal.pone.0000020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183647	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600020
J	Dimitrov, D; He, Y; Mutoh, H; Baker, BJ; Cohen, L; Akemann, W; Knopfel, T				Dimitrov, Dimitar; He, You; Mutoh, Hiroki; Baker, Bradley J.; Cohen, Lawrence; Akemann, Walther; Knopfel, Thomas			Engineering and Characterization of an Enhanced Fluorescent Protein Voltage Sensor	PLOS ONE			English	Article								Background. Fluorescent proteins have been used to generate a variety of biosensors to optically monitor biological phenomena in living cells. Among this class of genetically encoded biosensors, reporters for membrane potential have been a particular challenge. The use of presently known voltage sensor proteins is limited by incorrect subcellular localization and small or absent voltage responses in mammalian cells. Results. Here we report on a fluorescent protein voltage sensor with superior targeting to the mammalian plasma membrane and high responsiveness to membrane potential signaling in excitable cells. Conclusions and Significance. This biosensor, which we termed VSFP2.1, is likely to lead to new methods of monitoring electrically active cells with cell type specificity, non-invasively and in large numbers, simultaneously.	[Dimitrov, Dimitar; He, You; Mutoh, Hiroki; Akemann, Walther; Knopfel, Thomas] RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dynam, Saitama, Japan; [Baker, Bradley J.; Cohen, Lawrence] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	RIKEN; Yale University	Knopfel, T (corresponding author), RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dynam, Saitama, Japan.	tknopfel@brain.riken.jp	Mutoh, Hiroki/D-5240-2009; Akemann, Walther/A-7593-2011; Knöpfel, Thomas/B-1128-2008; Baker, Bradley/P-5047-2016	Akemann, Walther/0000-0002-4978-4665; Knöpfel, Thomas/0000-0002-5718-0765; Baker, Bradley/0000-0003-4652-5585	RIKEN Brain Science Institute	RIKEN Brain Science Institute	This work was supported by intramural funds of the RIKEN Brain Science Institute.	Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baker BJ, 2007, J NEUROSCI METH, V161, P32, DOI 10.1016/j.jneumeth.2006.10.005; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Diez-Garcia J, 2007, NEUROIMAGE, V34, P859, DOI 10.1016/j.neuroimage.2006.10.021; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Knopfel T, 2006, TRENDS NEUROSCI, V29, P160, DOI 10.1016/j.tins.2006.01.004; Knopfel T, 2003, METHODS, V30, P42, DOI 10.1016/S1046-2023(03)00006-9; Kosolapov A, 2004, NEURON, V44, P295, DOI 10.1016/j.neuron.2004.09.011; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Mutoh H, 2005, J NEUROSCI, V25, P4252, DOI 10.1523/JNEUROSCI.4721-04.2005; Ottschytsch N, 2005, J PHYSIOL-LONDON, V568, P737, DOI 10.1113/jphysiol.2005.090142; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Yuan Q, 2006, J NEUROPHYSIOL, V95, P3097, DOI 10.1152/jn.00001.2006; Yuan Q, 2006, J NEUROPHYSIOL, V95, P2417, DOI 10.1152/jn.00964.2005; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	19	162	164	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e440	10.1371/journal.pone.0000440	http://dx.doi.org/10.1371/journal.pone.0000440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487283	Green Published, gold			2022-12-27	WOS:000207445800022
J	Guiyedi, V; Chanseaud, Y; Fesel, C; Snounou, G; Rousselle, JC; Lim, P; Koko, J; Namane, A; Cazenave, PA; Kombila, M; Pied, S				Guiyedi, Vincent; Chanseaud, Youri; Fesel, Constantin; Snounou, Georges; Rousselle, Jean-Claude; Lim, Pharat; Koko, Jean; Namane, Abdelkader; Cazenave, Pierre-Andre; Kombila, Maryvonne; Pied, Sylviane			Self-Reactivities to the Non-Erythroid Alpha Spectrin Correlate with Cerebral Malaria in Gabonese Children	PLOS ONE			English	Article								Background. Hypergammaglobulinemia and polyclonal B-cell activation commonly occur in Plasmodium sp. infections. Some of the antibodies produced recognize self-components and are correlated with disease severity in P. falciparum malaria. However, it is not known whether some self-reactive antibodies produced during P. falciparum infection contribute to the events leading to cerebral malaria (CM). We show here a correlation between self-antibody responses to a human brain protein and high levels of circulating TNF alpha (TNF alpha), with the manifestation of CM in Gabonese children. Methodology. To study the role of self-reactive antibodies associated to the development of P. falciparum cerebral malaria, we used a combination of quantitative immunoblotting and multivariate analysis to analyse correlation between the reactivity of circulating IgG with a human brain protein extract and TNF alpha concentrations in cohorts of uninfected controls (UI) and P. falciparum-infected Gabonese children developing uncomplicated malaria (UM), severe non-cerebral malaria (SNCM), or CM. Results/Conclusion. The repertoire of brain antigens recognized by plasma IgGs was more diverse in infected than in UI individuals. Anti-brain reactivity was significantly higher in the CM group than in the UM and SNCM groups. IgG self-reactivity to brain antigens was also correlated with plasma IgG levels and age. We found that 90% of CM patients displayed reactivity to a high-molecular mass band containing the spectrin non-erythroid alpha chain. Reactivity with this band was correlated with high TNFa concentrations in CM patients. These results strongly suggest that an antibody response to brain antigens induced by P. falciparum infection may be associated with pathogenic mechanisms in patients developing CM.	[Guiyedi, Vincent; Chanseaud, Youri; Lim, Pharat; Cazenave, Pierre-Andre; Pied, Sylviane] Univ Paris 06, CNRS, Inst Pasteur, Unite Immunophysiopathol,URA 1961, Paris, France; [Guiyedi, Vincent; Kombila, Maryvonne; Pied, Sylviane] Univ Sci Sante, Fac Med, Dept Parasitol Mycol Med Trop, Libreville, Gabon; [Chanseaud, Youri; Fesel, Constantin; Pied, Sylviane] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Snounou, Georges] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, F-75231 Paris, France; [Koko, Jean] Hop Pediat Owendo, Libreville, Gabon	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Instituto Gulbenkian de Ciencia; Museum National d'Histoire Naturelle (MNHN)	Pied, S (corresponding author), Univ Paris 06, CNRS, Inst Pasteur, Unite Immunophysiopathol,URA 1961, Paris, France.	spied@pasteur.fr	Namane, Abdelkader/O-1857-2013; Snounou, Georges/F-3352-2011; Lim, Pharath/AAF-6699-2020	Namane, Abdelkader/0000-0001-7180-7619; Snounou, Georges/0000-0002-6133-6398; Lim, Pharath/0000-0002-1012-2461; Cazenave, Pierre-Andre/0000-0002-1345-8526; Fesel, Constantin/0000-0003-3537-5243; Pied, Sylviane/0000-0003-0642-1423	French Ministry of Research; Fundacao para a Ciencia e Tecnologia (Portugal); Agence Universitaire de la Francophonie (AUF); Institut Pasteur and Pasteur-Genopole-Ile-de-France	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Agence Universitaire de la Francophonie (AUF); Institut Pasteur and Pasteur-Genopole-Ile-de-France	This work was part of the CNRS-IGC LEA "Genetique et developpement de la tolerance naturelle'' program. It was supported by the PAL+ program of the French Ministry of Research. Y-C and C-F received a post-doctoral fellowship and S-P a visiting scientist fellowship from the Fundacao para a Ciencia e Tecnologia (Portugal). V-G holds a fellowship from the Agence Universitaire de la Francophonie (AUF). This work was also supported by grants from the Institut Pasteur and Pasteur-Genopole-Ile-de-France.	ADU D, 1982, CLIN EXP IMMUNOL, V49, P310; Akanmori BD, 2000, EUR CYTOKINE NETW, V11, P113; Ballok DA, 2004, J NEUROIMMUNOL, V152, P83, DOI 10.1016/j.jneuroim.2004.04.003; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Chikkamuniyappa Shylashree, 2004, Dermatol Online J, V10, P7; COHEN IR, 1992, IMMUNOL TODAY, V13, P490, DOI 10.1016/0167-5699(92)90024-2; COHEN IR, 1991, IMMUNOL TODAY, V12, P105, DOI 10.1016/0167-5699(91)90093-9; Consigny PH, 2002, CLIN EXP IMMUNOL, V127, P158, DOI 10.1046/j.1365-2249.2002.01722.x; Cooke SP, 1998, ANN MED INTERNE, V149, P30; Daniel-Ribeiro C, 1991, J Clin Lab Immunol, V35, P109; Daniel-Ribeiro CT, 2000, MEM I OSWALDO CRUZ, V95, P199, DOI 10.1590/S0074-02762000000200011; DANIELRIBEIRO C, 1983, T ROY SOC TROP MED H, V77, P185, DOI 10.1016/0035-9203(83)90064-0; Ebringer A, 2000, J MED MICROBIOL, V49, P305, DOI 10.1099/0022-1317-49-4-305; FACER CA, 1994, CLIN EXP IMMUNOL, V95, P304, DOI 10.1111/j.1365-2249.1994.tb06528.x; FREEMAN RR, 1978, CLIN EXP IMMUNOL, V32, P41; GALLIEN S, 2007, J INFECTION, V54, P1; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Guyton MK, 2005, J NEUROSCI RES, V81, P53, DOI 10.1002/jnr.20470; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; HAURY M, 1994, SCAND J IMMUNOL, V39, P79, DOI 10.1111/j.1365-3083.1994.tb03343.x; He XP, 1998, NEURON, V20, P153, DOI 10.1016/S0896-6273(00)80443-2; HOLMBERG D, 1984, EUR J IMMUNOL, V14, P435, DOI 10.1002/eji.1830140510; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Issifou S, 2003, EUR CYTOKINE NETW, V14, P238; JAKOBSEN PH, 1993, IMMUNOLOGY, V79, P653; KENNEDY PGE, 1994, Q J MED, V87, P523; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Krams SM, 1996, CLIN IMMUNOL IMMUNOP, V80, P311, DOI 10.1006/clin.1996.0129; LACROIXDESMAZES S, 1995, EUR J IMMUNOL, V25, P2598, DOI 10.1002/eji.1830250929; Lang B, 2005, J INFECT DIS, V191, P117, DOI 10.1086/426512; Lima MRD, 1996, SCAND J IMMUNOL, V43, P263; Lopez-Escribano H, 2002, ARTHRITIS RHEUM, V46, P3290, DOI 10.1002/art.10684; MALANCHERE E, 1995, EUR J IMMUNOL, V25, P1358, DOI 10.1002/eji.1830250534; Matsumoto J, 2000, INFECT IMMUN, V68, P1183, DOI 10.1128/IAI.68.3.1183-1188.2000; McKnight K, 2005, NEUROLOGY, V65, P1730, DOI 10.1212/01.wnl.0000187129.66353.13; Medana IM, 2007, J INFECT DIS, V195, P921, DOI 10.1086/512089; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mirilas P, 1999, J CLIN IMMUNOL, V19, P109, DOI 10.1023/A:1020554500266; Mouthon L, 1996, SCAND J IMMUNOL, V44, P243, DOI 10.1046/j.1365-3083.1996.d01-306.x; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Newton CRJC, 1996, PEDIATR NEUROL, V15, P41, DOI 10.1016/0887-8994(96)00115-4; NOBREGA A, 1993, EUR J IMMUNOL, V23, P2851, DOI 10.1002/eji.1830231119; Ohno T, 2005, IMMUNOGENETICS, V57, P293, DOI 10.1007/s00251-005-0791-5; Penet MF, 2005, J NEUROSCI, V25, P7352, DOI 10.1523/JNEUROSCI.1002-05.2005; Potter SM, 2006, J NEUROIMMUNOL, V173, P96, DOI 10.1016/j.jneuroim.2005.12.004; Quintana FJ, 2006, LUPUS, V15, P428, DOI 10.1191/0961203306lu2328oa; RALPH C, 2004, ARTHRITIS RHEUMATISM, V50, P1239; Rami A, 2003, NEUROSCI RES, V47, P373, DOI 10.1016/j.neures.2003.07.002; Rami A, 2003, NEUROBIOL DIS, V13, P75, DOI 10.1016/S0969-9961(03)00018-4; RITTER K, 1993, LANCET, V342, P1333, DOI 10.1016/0140-6736(93)92248-R; Rudehill S, 2006, ACTA NEUROCHIR, V148, P199, DOI 10.1007/s00701-005-0673-5; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Schutzer SE, 2003, J NEUROIMMUNOL, V138, P156, DOI 10.1016/S0165-5728(03)00120-6; SHAPER AG, 1968, LANCET, V1, P1342; SHUKLA M, 2005, NEUROCHEM INT, V14, P14; SONI PN, 1993, S AFR MED J, V83, P660; Stankova I, 1999, PHYSIOL RES, V48, P383; STEENS SCA, 2006, ARTHRITIS RES THERAP, V8, P1186; Stoute JA, 2003, J INFECT DIS, V187, P522, DOI 10.1086/367712; VARITEK VA, 1981, J NEUROIMMUNOL, V1, P27, DOI 10.1016/0165-5728(81)90005-9; Vuong PN, 1999, PARASITOLOGY, V119, P543, DOI 10.1017/S0031182099005120; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Zephir H, 2006, J NEUROIMMUNOL, V179, P53, DOI 10.1016/j.jneuroim.2006.06.016	64	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e389	10.1371/journal.pone.0000389	http://dx.doi.org/10.1371/journal.pone.0000389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460756	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445600003
J	Abbasi, AA; Paparidis, Z; Malik, S; Goode, DK; Callaway, H; Elgar, G; Grzeschik, KH				Abbasi, Amir Ali; Paparidis, Zissis; Malik, Sajid; Goode, Debbie K.; Callaway, Heather; Elgar, Greg; Grzeschik, Karl-Heinz			Human GLI3 Intragenic Conserved Non-Coding Sequences Are Tissue-Specific Enhancers	PLOS ONE			English	Article							CIS-REGULATORY ELEMENTS; SONIC HEDGEHOG; PHENOTYPE PREDICTION; POINT MUTATIONS; GREIG SYNDROME; DNA-SEQUENCE; FLOOR PLATE; GENE; EXPRESSION; MUTANT	The zinc-finger transcription factor GLI3 is a key regulator of development, acting as a primary transducer of Sonic hedgehog (SHH) signaling in a combinatorial context dependent fashion controlling multiple patterning steps in different tissues/organs. A tight temporal and spatial control of gene expression is indispensable, however, cis-acting sequence elements regulating GLI3 expression have not yet been reported. We show that 11 ancient genomic DNA signatures, conserved from the pufferfish Takifugu (Fugu) rubripes to man, are distributed throughout the introns of human GLI3. They map within larger conserved non-coding elements (CNEs) that are found in the tetrapod lineage. Full length CNEs transiently transfected into human cell cultures acted as cell type specific enhancers of gene transcription. The regulatory potential of these elements is conserved and was exploited to direct tissue specific expression of a reporter gene in zebrafish embryos. Assays of deletion constructs revealed that the human-Fugu conserved sequences within the GLI3 intronic CNEs were essential but not sufficient for full-scale transcriptional activation. The enhancer activity of the CNEs is determined by a combinatorial effect of a core sequence conserved between human and teleosts (Fugu) and flanking tetrapod-specific sequences, suggesting that successive clustering of sequences with regulatory potential around an ancient, highly conserved nucleus might be a possible mechanism for the evolution of cis-acting regulatory elements.	[Abbasi, Amir Ali; Paparidis, Zissis; Malik, Sajid; Grzeschik, Karl-Heinz] Univ Marburg, Inst Human Genet, Marburg, Germany; [Goode, Debbie K.; Callaway, Heather; Elgar, Greg] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	Philipps University Marburg; University of London; Queen Mary University London	Grzeschik, KH (corresponding author), Univ Marburg, Inst Human Genet, Marburg, Germany.	grzeschi@staff.uni-marburg.de	Malik, Sajid/H-7816-2019	Malik, Sajid/0000-0001-5563-9053; Elgar, Greg/0000-0001-7323-1596	Deutsche Forschungsgemeinschaft [Gr373-21, GRK 767]; Stiftung P. E. Kempkes, Marburg, Germany; Higher Education Commission of Pakistan; MRC [G0401138] Funding Source: UKRI; Medical Research Council [G0401138] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Stiftung P. E. Kempkes, Marburg, Germany; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This work was funded by Deutsche Forschungsgemeinschaft (Gr373-21; GRK 767) and Stiftung P. E. Kempkes, Marburg, Germany. A. A. A. holds a fellowship of Higher Education Commission of Pakistan.	Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Bejerano G, 2005, NAT METHODS, V2, P535, DOI 10.1038/nmeth0705-535; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Biesecker LG, 1998, OTOLARYNG HEAD NECK, V119, P556, DOI 10.1016/S0194-5998(98)70126-3; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Brewster R, 2000, DEVELOPMENT, V127, P4395; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Ding Q, 1998, DEVELOPMENT, V125, P2533; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Gomez-Skarmeta JL, 2006, DEV DYNAM, V235, P870, DOI 10.1002/dvdy.20659; Goode DK, 2005, GENOMICS, V86, P172, DOI 10.1016/j.ygeno.2005.04.006; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; Holstege FCP, 2006, CELL, V124, P21, DOI 10.1016/j.cell.2005.12.026; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Johnston JJ, 2005, AM J HUM GENET, V76, P609, DOI 10.1086/429346; Kalff-Suske M, 1999, HUM MOL GENET, V8, P1769, DOI 10.1093/hmg/8.9.1769; KANG S, 1997, NAT GENET, V266, P3; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; KRUGER G, 1989, AM J MED GENET, V32, P411, DOI 10.1002/ajmg.1320320329; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Moens CB, 1999, METHODS CELL BIOL, V59, P253; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Muller F, 1999, DEVELOPMENT, V126, P2103; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; POHL TM, 1990, DEVELOPMENT, V110, P1153; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Pu YB, 2004, DEV BIOL, V273, P257, DOI 10.1016/j.ydbio.2004.06.002; Radhakrishna U, 1999, AM J HUM GENET, V65, P645, DOI 10.1086/302557; Radhakrishna U, 1997, NAT GENET, V17, P269, DOI 10.1038/ng1197-269; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Robert B, 2006, DEV DYNAM, V235, P2337, DOI 10.1002/dvdy.20890; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sanges R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r56; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; SCHIMMANG T, 1994, MAMM GENOME, V5, P384, DOI 10.1007/BF00356560; SCHIMMANG T, 1992, DEVELOPMENT, V116, P799; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Ueta Etsuko, 2004, Congenital Anomalies, V44, P27, DOI 10.1111/j.1741-4520.2003.00005.x; VANDERHOEVEN F, 1993, MAMM GENOME, V4, P276, DOI 10.1007/BF00417435; Vanderlaan G, 2005, DEV BIOL, V282, P550, DOI 10.1016/j.ydbio.2005.04.010; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	58	37	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2007	2	4							e366	10.1371/journal.pone.0000366	http://dx.doi.org/10.1371/journal.pone.0000366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DT	17426814	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445400006
J	Lusseau, D				Lusseau, David			Why Are Male Social Relationships Complex in the Doubtful Sound Bottlenose Dolphin Population?	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; GENETIC-ANALYSIS; KINSHIP; STABILITY; EVOLUTION; COMMUNITY; PATTERNS; BEHAVIOR; MODEL; SP.	Background. Access to oestrus females tends to be the main driver of male sociality. This factor can lead to complex behavioural interactions between males and groups of males. Male bottlenose dolphins may form alliances to consort females and to compete with other males. In some populations these alliances may form temporary coalitions when competing for females. I examined the role of dyadic and group interactions in the association patterns of male bottlenose dolphins in Doubtful Sound, New Zealand. There is no apparent mating competition in this population and no consortship has been observed, yet agonistic interactions between males occur regularly. Methodology/Principal Findings. By comparing the network of male interactions in several social dimensions (affiliative, agonistic, and associative) I show that while agonistic interactions relate to dyadic association patterns, affiliative interactions seem to relate to group association patterns. Some evidence suggests that groups of males also formed temporary coalitions during agonistic interactions. While different groups of males had similar relationships with non-oestrus females, the time they spent with oestrus females and mothers of newborns differed greatly. Conclusions/Significance. After considering several hypotheses, I propose that the evolution of these complex relationships was driven by sexual competition probably to out-compete other males for female choice.	[Lusseau, David] Univ Otago, Dept Zool, Dunedin, New Zealand; [Lusseau, David] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	University of Otago; Dalhousie University	Lusseau, D (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	d.lusseau@dal.ca	Lusseau, David/A-8501-2012; Lusseau, David/AAV-9295-2021	Lusseau, David/0000-0003-1245-3747	Killam Postdoctoral Fellowship; New Zealand Whale and Dolphin Trust; Real Journeys Ltd; University of Otago	Killam Postdoctoral Fellowship; New Zealand Whale and Dolphin Trust; Real Journeys Ltd; University of Otago	Analyses were funded by a Killam Postdoctoral Fellowship. Data collection was funded by the New Zealand Whale and Dolphin Trust, Real Journeys Ltd, and the University of Otago. These also provided logistic support during the study.	Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; CARO TM, 1987, ETHOLOGY, V74, P52; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Connor R, 2006, ETHOLOGY, V112, P631, DOI 10.1111/j.1439-0310.2006.01203.x; CONNOR RC, 1982, AM NAT, V119, P358, DOI 10.1086/283915; Connor RC, 2001, P ROY SOC B-BIOL SCI, V268, P263, DOI 10.1098/rspb.2000.1357; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; Dugatkin LA, 1998, P ROY SOC B-BIOL SCI, V265, P2121, DOI 10.1098/rspb.1998.0548; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Gazda SK, 2005, P ROY SOC B-BIOL SCI, V272, P135, DOI 10.1098/rspb.2004.2937; Griffin AS, 2003, BEHAV ECOL, V14, P472, DOI 10.1093/beheco/arg040; Haase PA, 2001, NEW ZEAL J MAR FRESH, V35, P675, DOI 10.1080/00288330.2001.9517034; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; Krutzen M, 2003, P ROY SOC B-BIOL SCI, V270, P497, DOI 10.1098/rspb.2002.2229; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Lusseau D, 2003, J EVOLUTION BIOL, V16, P531, DOI 10.1046/j.1420-9101.2003.00541.x; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Lusseau D, 2006, BEHAV PROCESS, V73, P257, DOI 10.1016/j.beproc.2006.06.006; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; Mitani JC, 2003, BEHAVIOUR, V140, P869, DOI 10.1163/156853903770238355; Moller LM, 2001, P ROY SOC B-BIOL SCI, V268, P1941, DOI 10.1098/rspb.2001.1756; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; ODELL DK, 1975, J FISH RES BOARD CAN, V32, P1055, DOI 10.1139/f75-124; Ostman J., 1991, P305; Owen ECG, 2002, CAN J ZOOL, V80, P2072, DOI 10.1139/z02-195; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Parsons KM, 2003, ANIM BEHAV, V66, P185, DOI 10.1006/anbe.2003.2186; Patterson IAP, 1998, P ROY SOC B-BIOL SCI, V265, P1167, DOI 10.1098/rspb.1998.0414; Puente A.E, 1976, Cetology, VNo. 21, P1; Sakai M, 2006, MAR MAMMAL SCI, V22, P966, DOI 10.1111/j.1748-7692.2006.00082.x; SCHNEIDER K, 1999, BEHAV ECOLOGY BOTTLE, P200; Tyack PL, 2000, CETACEAN SOCIETIES, P270; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Watts DP, 2002, BEHAVIOUR, V139, P343, DOI 10.1163/156853902760102708; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755	40	48	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e348	10.1371/journal.pone.0000348	http://dx.doi.org/10.1371/journal.pone.0000348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406672	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445300010
J	Glaser, T; Pollard, SM; Smith, A; Brustle, O				Glaser, Tamara; Pollard, Steven M.; Smith, Austin; Bruestle, Oliver			Tripotential Differentiation of Adherently Expandable Neural Stem (NS) Cells	PLOS ONE			English	Article								Background. A recent study has shown that pure neural stem cells can be derived from embryonic stem (ES) cells and primary brain tissue. In the presence of fibroblast growth factor 2 (FGF2) and epidermal growth factor (EGF), this population can be continuously expanded in adherent conditions. In analogy to continuously self-renewing ES cells, these cells were termed 'NS' cells (Conti et al., PLoS Biol 3: e283, 2005). While NS cells have been shown to readily generate neurons and astrocytes, their differentiation into oligodendrocytes has remained enigmatic, raising concerns as to whether they truly represent tripotential neural stem cells. Methodology/Principal Findings. Here we provide evidence that NS cells are indeed tripotent. Upon proliferation with FGF2, platelet-derived growth factor (PDGF) and forskolin, followed by differentiation in the presence of thyroid hormone (T3) and ascorbic acid NS cells efficiently generate oligodendrocytes (similar to 20%) alongside astrocytes (similar to 40%) and neurons (similar to 10%). Mature oligodendroglial differentiation was confirmed by transplantation data showing that NS cell-derived oligodendrocytes ensheath host axons in the brain of myelin-deficient rats. Conclusions/Significance. In addition to delineating NS cells as a potential donor source for myelin repair, our data strongly support the view that these adherently expandable cells represent bona fide tripotential neural stem cells.	[Glaser, Tamara; Bruestle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, LIFE & BRAIN Ctr, D-5300 Bonn, Germany; [Glaser, Tamara; Bruestle, Oliver] Hertie Fdn, Bonn, Germany; [Pollard, Steven M.; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England	University of Bonn; University of Cambridge	Brustle, O (corresponding author), Univ Bonn, Inst Reconstruct Neurobiol, LIFE & BRAIN Ctr, D-5300 Bonn, Germany.	brustle@uni-bonn.de	; Pollard, Steven/B-7966-2010	Smith, Austin/0000-0002-3029-4682; Pollard, Steven/0000-0001-6428-0492	EuroStemCell; BBRSC; Institute of Multiple Sclerosis Research (IMSF); Hertie Foundation; Biotechnology and Biological Sciences Research Council [G15381/2] Funding Source: researchfish; Medical Research Council [G9806702] Funding Source: researchfish; MRC [G9806702] Funding Source: UKRI	EuroStemCell(European Commission); BBRSC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute of Multiple Sclerosis Research (IMSF); Hertie Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by EuroStemCell, the BBRSC, the Institute of Multiple Sclerosis Research (IMSF) in Gottingen and the Hertie Foundation.	BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BOISON D, 1989, EMBO J, V8, P3295, DOI 10.1002/j.1460-2075.1989.tb08490.x; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Glaser T, 2004, FASEB J, V18, P112, DOI 10.1096/fj.04-1931fje; Goldman S, 2003, TRENDS NEUROSCI, V26, P590, DOI 10.1016/j.tins.2003.09.011; Gotz M, 2003, GLIA, V43, P1, DOI 10.1002/glia.10251; Gotz M, 2003, NEUROSCIENTIST, V9, P379, DOI 10.1177/1073858403257138; Gritti A, 1999, J NEUROSCI, V19, P3287; Gritti A, 1996, J NEUROSCI, V16, P1091; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; Klein D, 2006, GENE THER, V13, P1686, DOI 10.1038/sj.gt.3302834; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mori T, 2005, CURR TOP DEV BIOL, V69, P67, DOI 10.1016/S0070-2153(05)69004-7; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Watanabe M, 2006, J NEUROSCI RES, V84, P525, DOI 10.1002/jnr.20950; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weiss S, 1996, J NEUROSCI, V16, P7599; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	41	86	88	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e298	10.1371/journal.pone.0000298	http://dx.doi.org/10.1371/journal.pone.0000298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356704	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444800021
J	Kandil, FI; Lappe, M				Kandil, Farid I.; Lappe, Markus			Spatio-Temporal Interpolation Is Accomplished by Binocular Form and Motion Mechanisms	PLOS ONE			English	Article								Spatio-temporal interpolation describes the ability of the visual system to perceive shapes as whole figures (Gestalts), even if they are moving behind narrow apertures, so that only thin slices of them meet the eye at any given point in time. The interpolation process requires registration of the form slices, as well as perception of the shape's global motion, in order to reassemble the slices in the correct order. The commonly proposed mechanism is a spatio-temporal motion detector with a receptive field, for which spatial distance and temporal delays are interchangeable, and which has generally been regarded as monocular. Here we investigate separately the nature of the motion and the form detection involved in spatio-temporal interpolation, using dichoptic masking and interocular presentation tasks. The results clearly demonstrate that the associated mechanisms for both motion and form are binocular rather than monocular. Hence, we question the traditional view according to which spatio-temporal interpolation is achieved by monocular first-order motion-energy detectors in favour of models featuring binocular motion and form detection.	[Kandil, Farid I.; Lappe, Markus] Univ Munster, Dept Gen Psychol, Munster, Germany	University of Munster	Kandil, FI (corresponding author), Univ Munster, Dept Gen Psychol, Munster, Germany.	kandil@uni-muenster.de			German Science Foundation; German Federal Ministry of Education and Research; EC	German Science Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EC(European CommissionEuropean Commission Joint Research Centre)	M. L. is supported by the German Science Foundation, the German Federal Ministry of Education and Research, and the EC Project Drivsco. None of these interfered with the design and conduct of the study, the collection, analysis, and interpretation of the data, and the preparation, review, or approval of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; [Anonymous], 1862, ANN PHYS-BERLIN, DOI DOI 10.1002/ANDP.18621931108; ANSTIS SM, 1967, AM J PSYCHOL, V80, P572, DOI 10.2307/1421189; Breitmeyer B., 2006, VISUAL MASKING; BURR D, 1986, TRENDS NEUROSCI, V9, P304, DOI 10.1016/0166-2236(86)90088-3; BURR DC, 1979, VISION RES, V19, P835, DOI 10.1016/0042-6989(79)90162-7; BURR DC, 1986, PROC R SOC SER B-BIO, V227, P249, DOI 10.1098/rspb.1986.0022; BURR DC, 1979, VISION RES, V19, P523, DOI 10.1016/0042-6989(79)90137-8; Carney T, 1997, VISION RES, V37, P2361, DOI 10.1016/S0042-6989(97)00053-9; FAHLE M, 1981, PROC R SOC SER B-BIO, V213, P451, DOI 10.1098/rspb.1981.0075; FAHLE M, 1994, VISION RES, V34, P343, DOI 10.1016/0042-6989(94)90092-2; Georgeson MA, 1999, VISION RES, V39, P4393, DOI 10.1016/S0042-6989(99)00147-9; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; MORGAN MJ, 1975, PERCEPTION, V4, P3, DOI 10.1068/p040003; MORGAN MJ, 1979, VISION RES, V19, P491, DOI 10.1016/0042-6989(79)90133-0; MORGAN MJ, 1983, VISION RES, V23, P997, DOI 10.1016/0042-6989(83)90010-X; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Nishida S, 2004, CURR BIOL, V14, P830, DOI 10.1016/j.cub.2004.04.044; Paffen CLE, 2005, VISION RES, V45, P2642, DOI 10.1016/j.visres.2005.04.018; PARKS TE, 1965, AM J PSYCHOL, V78, P145, DOI 10.2307/1421101; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; Zanker JM, 1996, PHILOS T ROY SOC B, V351, P1725, DOI 10.1098/rstb.1996.0154	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e264	10.1371/journal.pone.0000264	http://dx.doi.org/10.1371/journal.pone.0000264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327923	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444600024
J	Horii, A; Wang, XM; Gelain, F; Zhang, SG				Horii, Akihiro; Wang, Xiumei; Gelain, Fabrizio; Zhang, Shuguang			Biological Designer Self-Assembling Peptide Nanofiber Scaffolds Significantly Enhance Osteoblast Proliferation, Differentiation and 3-D Migration	PLOS ONE			English	Article							STEM-CELLS; COMPLEMENTARY OLIGOPEPTIDE; TERMINAL PENTAPEPTIDE; PROGENITOR CELLS; IN-VITRO; BONE; GROWTH; HYDROGELS; ATTACHMENT; ADHESION	A class of self-assembling peptide nanofiber scaffolds has been shown to be an excellent biological material for 3-dimension cell culture and stimulating cell migration into the scaffold, as well as for repairing tissue defects in animals. We report here the development of several peptide nanofiber scaffolds designed specifically for osteoblasts. We designed one of the pure self-assembling peptide scaffolds RADA16-I through direct coupling to short biologically active motifs. The motifs included osteogenic growth peptide ALK (ALKRQGRTLYGF) bone-cell secreted-signal peptide, osteopontin cell adhesion motif DGR (DGRGDSVAYG) and 2-unit RGD binding sequence PGR (PRGDSGYRGDS). We made the new peptide scaffolds by mixing the pure RAD16 and designer-peptide solutions, and we examined the molecular integration of the mixed nanofiber scaffolds using AFM. Compared to pure RAD16 scaffold, we found that these designer peptide scaffolds significantly promoted mouse pre-osteoblast MC3T3-E1 cell proliferation. Moreover, alkaline phosphatase (ALP) activity and osteocalcin secretion, which are early and late markers for osteoblastic differentiation, were also significantly increased. We demonstrated that the designer, self-assembling peptide scaffolds promoted the proliferation and osteogenic differentiation of MC3T3-E1. Under the identical culture medium condition, confocal images unequivocally demonstrated that the designer PRG peptide scaffold stimulated cell migration into the 3-D scaffold. Our results suggest that these designer peptide scaffolds may be very useful for promoting bone tissue regeneration.	[Horii, Akihiro; Wang, Xiumei; Gelain, Fabrizio; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Horii, Akihiro] Olympus Amer Inc, Center Valley, PA USA; [Gelain, Fabrizio] Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy	Massachusetts Institute of Technology (MIT); Olympus Corporation; University of Milano-Bicocca	Zhang, SG (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	Shuguang@mit.edu	Gelain, Fabrizio G/K-5069-2012	Gelain, Fabrizio G/0000-0002-2624-5853; Zhang, Shuguang/0000-0002-3856-3752	Olympus Corp	Olympus Corp	Akihiro Horii is from Olympus Corp. Dr. Xiumei Wang is supported by Olympus Corp. Fabrizio Gelain was from CARIPLO and Hospital S. Raffaele, Milano, Italy but supported by Olympus Corp.	Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501; BAB I, 1992, EMBO J, V11, P1867, DOI 10.1002/j.1460-2075.1992.tb05238.x; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040; Chen YC, 2002, J MED CHEM, V45, P1624, DOI 10.1021/jm010479l; Cornish J, 1998, AM J PHYSIOL-ENDOC M, V275, pE694, DOI 10.1152/ajpendo.1998.275.4.E694; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386; Fazzi R, 2002, LEUKEMIA RES, V26, P19, DOI 10.1016/S0145-2126(01)00091-1; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Haubner R, 1997, ANGEW CHEM INT EDIT, V36, P1375; Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721; Hayashibara T, 2004, J BONE MINER RES, V19, P455, DOI 10.1359/JBMR.0301263; Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374; Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030; Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.0.CO;2-4; Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; KREIS TVR, 1999, GUIDE BOOK EXTRACELL, P457; Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192; Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b; Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o; Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027; Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Weinand C, 2006, BONE, V38, P555, DOI 10.1016/j.bone.2005.10.016; ZHANG S, 2005, PURAMATRIX SELF ASSE, P218; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128	32	361	397	3	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e190	10.1371/journal.pone.0000190	http://dx.doi.org/10.1371/journal.pone.0000190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17285144	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444300003
J	Levine, RS; Peterson, AT; Yorita, KL; Carroll, D; Damon, IK; Reynolds, MG				Levine, Rebecca S.; Peterson, A. Townsend; Yorita, Krista L.; Carroll, Darin; Damon, Inger K.; Reynolds, Mary G.			Ecological Niche and Geographic Distribution of Human Monkeypox in Africa	PLOS ONE			English	Article							DISEASE; VIRUS; CONGO	Monkeypox virus, a zoonotic member of the genus Orthopoxviridae, can cause a severe, smallpox-like illness in humans. Monkeypox virus is thought to be endemic to forested areas of western and Central Africa. Considerably more is known about human monkeypox disease occurrence than about natural sylvatic cycles of this virus in non-human animal hosts. We use human monkeypox case data from Africa for 1970-2003 in an ecological niche modeling framework to construct predictive models of the ecological requirements and geographic distribution of monkeypox virus across West and Central Africa. Tests of internal predictive ability using different subsets of input data show the model to be highly robust and suggest that the distinct phylogenetic lineages of monkeypox in West Africa and Central Africa occupy similar ecological niches. High mean annual precipitation and low elevations were shown to be highly correlated with human monkeypox disease occurrence. The synthetic picture of the potential geographic distribution of human monkeypox in Africa resulting from this study should support ongoing epidemiologic and ecological studies, as well as help to guide public health intervention strategies to areas at highest risk for human monkeypox.	[Levine, Rebecca S.; Carroll, Darin; Damon, Inger K.; Reynolds, Mary G.] Ctr Dis Control & Prevent, Poxvirus Program, Atlanta, GA 30333 USA; [Peterson, A. Townsend] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; [Peterson, A. Townsend] Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA; [Yorita, Krista L.] Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; University of Kansas; University of Kansas; Centers for Disease Control & Prevention - USA	Reynolds, MG (corresponding author), Ctr Dis Control & Prevent, Poxvirus Program, Atlanta, GA 30333 USA.	nzr6@cdc.gov	Levine, Rebecca/ABB-9551-2020; Peterson, A. Townsend/I-5697-2013	Levine, Rebecca/0000-0001-6525-1132; Peterson, A. Townsend/0000-0003-0243-2379; Christensen, Krista/0000-0003-4431-336X; Reynolds, Mary/0000-0001-7882-4614	US Centers for Disease Control and Prevention	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded entirely by the US Centers for Disease Control and Prevention.	ARITA I, 1985, AM J TROP MED HYG, V34, P781, DOI 10.4269/ajtmh.1985.34.781; BREMAN JG, 1980, B WORLD HEALTH ORGAN, V58, P165; Breman JG, 2000, EMERGING INFECTIONS 4, P45; BREMAN JG, 1977, AM J TROP MED HYG, V26, P273, DOI 10.4269/ajtmh.1977.26.273; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; FOSTER SO, 1972, B WORLD HEALTH ORGAN, V46, P569; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; JANSEGHERS L, 1984, ANN SOC BELG MED TR, V64, P295; JEZEK Z, 1986, J INFECT DIS, V154, P551, DOI 10.1093/infdis/154.4.551; Jezek Z, 1983, J Hyg Epidemiol Microbiol Immunol, V27, P13; KHODAKEVICH L, 1986, LANCET, V1, P98; LADNYJ ID, 1972, B WORLD HEALTH ORGAN, V46, P593; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Meyer A, 1991, Med Trop (Mars), V51, P53; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2004, EMERG INFECT DIS, V10, P2073, DOI 10.3201/eid1012.040346; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; 1991, WKLY EPIDEMIOL REC, V67, P101	28	68	72	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e176	10.1371/journal.pone.0000176	http://dx.doi.org/10.1371/journal.pone.0000176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17268575	Green Submitted, gold, Green Published			2022-12-27	WOS:000207444200001
J	Endicott, P; Metspalu, M; Stringer, C; Macaulay, V; Cooper, A; Sanchez, JJ				Endicott, Phillip; Metspalu, Mait; Stringer, Chris; Macaulay, Vincent; Cooper, Alan; Sanchez, Juan J.			Multiplexed SNP Typing of Ancient DNA Clarifies the Origin of Andaman mtDNA Haplogroups amongst South Asian Tribal Populations	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MITOCHONDRIAL-DNA; AMPLIFICATION; SETTLEMENT; MUTATIONS; DISPERSAL; EVOLUTION; SEQUENCES; AMERICAN; HUMANS	The issue of errors in genetic data sets is of growing concern, particularly in population genetics where whole genome mtDNA sequence data is coming under increased scrutiny. Multiplexed PCR reactions, combined with SNP typing, are currently under-exploited in this context, but have the potential to genotype whole populations rapidly and accurately, significantly reducing the amount of errors appearing in published data sets. To show the sensitivity of this technique for screening mtDNA genomic sequence data, 20 historic samples of the enigmatic Andaman Islanders and 12 modern samples from three Indian tribal populations (Chenchu, Lambadi and Lodha) were genotyped for 20 coding region sites after provisional haplogroup assignment with control region sequences. The genotype data from the historic samples significantly revise the topologies for the Andaman M31 and M32 mtDNA lineages by rectifying conflicts in published data sets. The new Indian data extend the distribution of the M31a lineage to South Asia, challenging previous interpretations of mtDNA phylogeography. This genetic connection between the ancestors of the Andamanese and South Asian tribal groups similar to 30 kya has important implications for the debate concerning migration routes and settlement patterns of humans leaving Africa during the late Pleistocene, and indicates the need for more detailed genotyping strategies. The methodology serves as a low-cost, high-throughput model for the production and authentication of data from modern or ancient DNA, and demonstrates the value of museum collections as important records of human genetic diversity.	[Endicott, Phillip] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Metspalu, Mait] Univ Tartu, Dept Evolutionary Biol, Estonian Bioctr, EE-50090 Tartu, Estonia; [Stringer, Chris] Nat Hist Museum London, London, England; [Macaulay, Vincent] Univ Glasgow, Dept Stat, Glasgow, Lanark, Scotland; [Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA, Australia; [Sanchez, Juan J.] Inst Nacl Toxicol, Dept Canarias, Santa Cruz de Tenerife, Spain	University of Oxford; Estonian Biocentre; University of Tartu; Natural History Museum London; University of Glasgow; University of Adelaide	Endicott, P (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	phillip.endicott@zoo.ox.ac.uk	Metspalu, Mait/G-8671-2015; Cooper, Alan/E-8171-2012	Metspalu, Mait/0000-0003-3099-9161; Cooper, Alan/0000-0002-7738-7851; Endicott, Phillip/0000-0003-2452-8507				Bandelt HJ, 2006, ANN HUM GENET, V70, P314, DOI 10.1111/j.1469-1809.2005.00234.x; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; Bandelt HJ, 2005, EUR J HUM GENET, V13, P1106, DOI 10.1038/sj.ejhg.5201476; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2004, AM J HUM GENET, V75, P919, DOI 10.1086/425180; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Barnard R, 1998, BIOTECHNIQUES, V25, P684, DOI 10.2144/98254dt08; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Bower MA, 2005, NUCLEIC ACIDS RES, V33, P2549, DOI 10.1093/nar/gki550; Brandstatter A, 2003, INT J LEGAL MED, V117, P180, DOI 10.1007/s00414-002-0350-7; BRANDSTATTER A, 2006, ELECTROPHORESIS; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Cooper A, 2000, SCIENCE, V289, P1139; Cordaux R, 2003, AM J HUM GENET, V72, P1586, DOI 10.1086/375407; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; Field JS, 2005, J WORLD PREHIST, V19, P1, DOI 10.1007/s10963-005-9000-6; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haff LA, 1997, NUCLEIC ACIDS RES, V25, P3749, DOI 10.1093/nar/25.18.3749; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Man E., 1932, ABORIGINAL INHABITAN; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Norton N, 2002, HUM GENET, V110, P471, DOI 10.1007/s00439-002-0706-6; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Palanichamy MG, 2006, SCIENCE, V311, DOI 10.1126/science.1120176; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; PORTMAN MV, 1990, HIST OUR RELATIONS A; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; SANCHEZ JJ, 2006, NATURE PROT IN PRESS; Sanchez Juan J., 2005, V297, P209; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Syvanen AC, 1999, HUM MUTAT, V13, P1; SYVANEN AC, 1993, EXS, V67, P275; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; THANGARAJ K, 2006, FORENSIC SCI INT; TORRONI A, 2006, TRENDS GENE IN PRESS; Umetsu K, 2005, ELECTROPHORESIS, V26, P91, DOI 10.1002/elps.200406129; Vallone PM, 2004, J FORENSIC SCI, V49, P723; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Yao YG, 2003, AM J HUM GENET, V72, P1341, DOI 10.1086/375119	55	30	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e81	10.1371/journal.pone.0000081	http://dx.doi.org/10.1371/journal.pone.0000081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17218991	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600081
J	Laaksonen, R; Katajamaa, M; Paiva, H; Sysi-Aho, M; Saarinen, L; Junni, P; Lutjohann, D; Smet, J; Van Coster, R; Seppanen-Laakso, T; Lehtimaki, T; Soini, J; Oresic, M				Laaksonen, Reijo; Katajamaa, Mikko; Paiva, Hannu; Sysi-Aho, Marko; Saarinen, Lilli; Junni, Paivi; Lutjohann, Dieter; Smet, Joel; Van Coster, Rudy; Seppanen-Laakso, Tuulikki; Lehtimaki, Terho; Soini, Juhani; Oresic, Matej			A Systems Biology Strategy Reveals Biological Pathways and Plasma Biomarker Candidates for Potentially Toxic Statin-Induced Changes in Muscle	PLOS ONE			English	Article								Background. Aggressive lipid lowering with high doses of statins increases the risk of statin-induced myopathy. However, the cellular mechanisms leading to muscle damage are not known and sensitive biomarkers are needed to identify patients at risk of developing statin-induced serious side effects. Methodology. We performed bioinformatics analysis of whole genome expression profiling of muscle specimens and UPLC/MS based lipidomics analyses of plasma samples obtained in an earlier randomized trial from patients either on high dose simvastatin (80 mg), atorvastatin (40 mg), or placebo. Principal Findings. High dose simvastatin treatment resulted in 111 differentially expressed genes (1.5-fold change and p-value < 0.05), while expression of only one and five genes was altered in the placebo and atorvastatin groups, respectively. The Gene Set Enrichment Analysis identified several affected pathways (23 gene lists with False Discovery Rate q-value < 0.1) in muscle following high dose simvastatin, including eicosanoid synthesis and Phospholipase C pathways. Using lipidomic analysis we identified previously uncharacterized drug-specific changes in the plasma lipid profile despite similar statin-induced changes in plasma LDL-cholesterol. We also found that the plasma lipidomic changes following simvastatin treatment correlate with the muscle expression of the arachidonate 5-lipoxygenase-activating protein. Conclusions. High dose simvastatin affects multiple metabolic and signaling pathways in skeletal muscle, including the pro-inflammatory pathways. Thus, our results demonstrate that clinically used high statin dosages may lead to unexpected metabolic effects in non-hepatic tissues. The lipidomic profiles may serve as highly sensitive biomarkers of statin-induced metabolic alterations in muscle and may thus allow us to identify patients who should be treated with a lower dose to prevent a possible toxicity.	[Laaksonen, Reijo] Tampere Univ Hosp, Res Unit, Tampere, Finland; [Katajamaa, Mikko; Saarinen, Lilli; Junni, Paivi; Soini, Juhani] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Katajamaa, Mikko; Saarinen, Lilli; Junni, Paivi; Soini, Juhani] Abo Akad Univ, Turku, Finland; [Paiva, Hannu] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Sysi-Aho, Marko; Seppanen-Laakso, Tuulikki; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Lutjohann, Dieter] Univ Bonn, Dept Clin Pharmacol, D-5300 Bonn, Germany; [Smet, Joel; Van Coster, Rudy] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Lab Atherosclerosis Genet, FIN-33521 Tampere, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Ctr Lab Med, FIN-33521 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland	Tampere University; Tampere University Hospital; University of Turku; Abo Akademi University; Tampere University; Tampere University Hospital; VTT Technical Research Center Finland; University of Bonn; Ghent University; Ghent University Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University	Laaksonen, R (corresponding author), Tampere Univ Hosp, Res Unit, Tampere, Finland.	reijo.laaksonen@helsinki.fi; matej.oresic@vtt.fi	Oresic, Matej/AAV-3978-2020; Lehtimäki, Terho/AAD-1094-2022; Laaksonen, Reijo/D-6323-2014; Oresic, Matej/K-7673-2016; Smet, Joel/B-7428-2013	Lehtimäki, Terho/0000-0002-2555-4427; Oresic, Matej/0000-0002-2856-9165; Smet, Joel/0000-0002-9551-6282; Soini, Juhani/0000-0002-5574-0650	Future Forum Research; Tampere University Hospital Research Fund; Academy of Finland SYSBIO [8207492]; Tekes MASI program	Future Forum Research; Tampere University Hospital Research Fund; Academy of Finland SYSBIO(Academy of Finland); Tekes MASI program(Finnish Funding Agency for Technology & Innovation (TEKES))	This study was supported by the Future Forum Research Grant, the Tampere University Hospital Research Fund, Academy of Finland SYSBIO program (grant #8207492), and the Tekes MASI program.	Antons KA, 2006, AM J MED, V119, P400, DOI 10.1016/j.amjmed.2006.02.007; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Brentani H, 2003, P NATL ACAD SCI USA, V100, P13418, DOI 10.1073/pnas.1233632100; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Burke JR, 1997, BBA-MOL CELL RES, V1359, P80, DOI 10.1016/S0167-4889(97)00094-3; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Engelmann B, 2004, BIOCHEM SOC T, V32, P147, DOI 10.1042/BST0320147; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Mukhtar RYA, 2005, CURR OPIN LIPIDOL, V16, P640; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Oresic M, 2006, EXPERT REV MOL DIAGN, V6, P575, DOI 10.1586/14737159.6.4.575; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; PEDERSEN TR, 1994, LANCET, V344, P1383; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Pindyck R.S., 2013, ECONOMETRIC MODELS E; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Urso ML, 2005, ARTERIOSCL THROM VAS, V25, P2560, DOI 10.1161/01.ATV.0000190608.28704.71; VLADUTIU GD, 2006, MUSCLE NERVE; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wise B., 2005, PLS TOOLBOX 3 5 USE; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769	31	182	190	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e97	10.1371/journal.pone.0000097	http://dx.doi.org/10.1371/journal.pone.0000097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183729	Green Published, gold			2022-12-27	WOS:000207443600096
J	Kim, TW; Christy, JH; Choe, JC				Kim, Tae Won; Christy, John H.; Choe, Jae C.			A Preference for a Sexual Signal Keeps Females Safe	PLOS ONE			English	Article							MALE FIDDLER-CRABS; SENSORY TRAP HYPOTHESIS; PREDATION RISK; MATE CHOICE; MATING-BEHAVIOR; SELECTION; BENEFITS; ATTRACTIVENESS; COURTSHIP; COSTS	Predation is generally thought to constrain sexual selection by female choice and limit the evolution of conspicuous sexual signals. Under high predation risk, females usually become less choosy, because they reduce their exposure to their predators by reducing the extent of their mate searching. However, predation need not weaken sexual selection if, under high predation risk, females exhibit stronger preferences for males that use conspicuous signals that help females avoid their predators. We tested this prediction in the fiddler crab Uca terpsichores by increasing females' perceived predation risk from crab-eating birds and measuring the attractiveness of a courtship signal that females use to find mates. The sexual signal is an arching mound of sand that males build at the openings of their burrows to which they attract females for mating. We found that the greater the risk, the more attractive were males with those structures. The benefits of mate preferences for sexual signals are usually thought to be linked to males' reproductive contributions to females or their young. Our study provides the first evidence that a female preference for a sexual signal can yield direct survival benefits by keeping females safe as they search for mates.	[Choe, Jae C.] Ewha Womans Univ, Grad Program EcoSci, Seoul, South Korea; [Kim, Tae Won] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Christy, John H.] Smithsonian Trop Res Inst, Naos Lab, Balboa, Ancon, Panama	Ewha Womans University; Seoul National University (SNU); Smithsonian Institution; Smithsonian Tropical Research Institute	Choe, JC (corresponding author), Ewha Womans Univ, Grad Program EcoSci, Seoul, South Korea.	jaechoe@ewha.ac.kr			Korean Government (MOEHRD) [KRF-2005-213-D00043]; Ewha Womans University	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Ewha Womans University	This research was supported by a Korean Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2005-213-D00043). Jae C. Choe was funded by the Ewha Womans University Research Grant of 2006. The Smithsonian Tropical Research Institute provided space and logistical support.	ALATALO RV, 1990, ANIM BEHAV, V39, P601, DOI 10.1016/S0003-3472(05)80430-0; BREDEN F, 1987, NATURE, V329, P831, DOI 10.1038/329831a0; Choe J.C., 1997, EVOLUTION MATING SYS; Christy JH, 2003, ANIM BEHAV, V66, P89, DOI 10.1006/anbe.2003.2196; CHRISTY JH, 1995, AM NAT, V146, P171, DOI 10.1086/285793; Christy JH, 2003, BEHAV ECOL SOCIOBIOL, V53, P84, DOI 10.1007/s00265-002-0553-4; Christy JH, 2002, BEHAV ECOL, V13, P366, DOI 10.1093/beheco/13.3.366; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; CROWLEY PH, 1991, AM NAT, V137, P567, DOI 10.1086/285184; Derivera CE, 2005, ANIM BEHAV, V70, P289, DOI 10.1016/j.anbehav.2004.10.027; FORSGREN E, 1992, AM NAT, V140, P1041, DOI 10.1086/285455; Godin JGJ, 1996, ANIM BEHAV, V51, P117, DOI 10.1006/anbe.1996.0010; Head ML, 2005, PLOS BIOL, V3, P289, DOI 10.1371/journal.pbio.0030033; HUBBELL SP, 1987, AM NAT, V130, P91, DOI 10.1086/284700; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johnson JB, 2003, BEHAV ECOL, V14, P619, DOI 10.1093/beheco/arg046; Koga T, 1998, P ROY SOC B-BIOL SCI, V265, P1385, DOI 10.1098/rspb.1998.0446; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; POMIANKOWSKI A, 1987, J THEOR BIOL, V128, P195, DOI 10.1016/S0022-5193(87)80169-8; SIH A, 1990, AM NAT, V135, P284, DOI 10.1086/285044; Warner RR, 2000, BEHAV ECOL, V11, P444, DOI 10.1093/beheco/11.4.444; Zeil J, 2002, CRUSTACEAN EXPERIMENTAL SYSTEMS IN NEUROBIOLOGY, P227; Zeil J, 1998, J COMP PHYSIOL A, V183, P367, DOI 10.1007/s003590050263	24	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e422	10.1371/journal.pone.0000422	http://dx.doi.org/10.1371/journal.pone.0000422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487270	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445800004
J	Calhim, S; Immler, S; Birkhead, TR				Calhim, Sara; Immler, Simone; Birkhead, Tim R.			Postcopulatory Sexual Selection Is Associated with Reduced Variation in Sperm Morphology	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; RELATIVE TESTIS SIZE; COMPETITION GAMES; MAMMALIAN SPERM; MATING SYSTEMS; NO EVIDENCE; EVOLUTION; COEVOLUTION; MIDPIECE; LENGTH	Background. The evolutionary role of postcopulatory sexual selection in shaping male reproductive traits, including sperm morphology, is well documented in several taxa. However, previous studies have focused almost exclusively on the influence of sperm competition on variation among species. In this study we tested the hypothesis that intraspecific variation in sperm morphology is driven by the level of postcopulatory sexual selection in passerine birds. Methodology/Findings. Using two proxy measures of sperm competition level, (i) relative testes size and (ii) extrapair paternity level, we found strong evidence that intermale variation in sperm morphology is negatively associated with the degree of postcopulatory sexual selection, independently of phylogeny. Conclusions/Significance. Our results show that the role of postcopulatory sexual selection in the evolution of sperm morphology extends to an intraspecific level, reducing the variation towards what might be a species-specific 'optimum' sperm phenotype. This finding suggests that while postcopulatory selection is generally directional (e.g., favouring longer sperm) across avian species, it also acts as a stabilising evolutionary force within species under intense selection, resulting in reduced variation in sperm morphology traits. We discuss some potential evolutionary mechanisms for this pattern.	[Calhim, Sara; Immler, Simone; Birkhead, Tim R.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Calhim, S (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	s.calhim@sheffield.ac.uk	Calhim, Sara/D-5335-2009; Immler, Simone/A-1707-2014; Immler, Simone/F-8708-2014		FCT Portugal; Roche Research Foundation; Leverhulme Trust	FCT Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); Roche Research Foundation; Leverhulme Trust(Leverhulme Trust)	This study was funded by FCT Portugal (SC), Roche Research Foundation (SI), and the Leverhulme Trust (TRB).	ALATALO RV, 1988, BIOL J LINN SOC, V34, P363, DOI 10.1111/j.1095-8312.1988.tb01969.x; Anderson MJ, 2006, J ZOOL, V270, P682, DOI 10.1111/j.1469-7998.2006.00173.x; Anderson MJ, 2005, J ZOOL, V267, P135, DOI 10.1017/S0952836905007284; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Andersson Malte, 1994; [Anonymous], [No title captured]; Bakst M. R., 1994, Poultry Science Reviews, V5, P117; Balshine S, 2001, BEHAV ECOL, V12, P726, DOI 10.1093/beheco/12.6.726; Beatty R. A., 1972, The genetics of the spermatozoon. Proceedings, International Symposium, Edinburgh, 16-20 August, 1971., P97; BEATTY RA, 1970, BIOL REV, V45, P73, DOI 10.1111/j.1469-185X.1970.tb01076.x; Birkhead TR, 2006, AUK, V123, P383, DOI 10.1642/0004-8038(2006)123[383:USMITE]2.0.CO;2; BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; Birkhead TR, 2005, NATURE, V434, P383, DOI 10.1038/nature03374; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Birkhead TR, 1992, SPERM COMPETITION BI; BIRKHEAD TR, 2006, SPERMATOLOGY S, V65; Birkhead TR, 1998, SPERM COMPETITION SE; BIRKHEAD TR, 2007, TRENDS ECOL IN PRESS; Breed WG, 2000, J MAMMAL, V81, P758, DOI 10.1644/1545-1542(2000)081&lt;0758:BMTMAS&gt;2.3.CO;2; Briskie JV, 1997, EVOLUTION, V51, P937, DOI 10.1111/j.1558-5646.1997.tb03674.x; BRISKIE JV, 1992, P ROY SOC B-BIOL SCI, V247, P89, DOI 10.1098/rspb.1992.0013; BRISKIE JV, 1993, CONDOR, V95, P442, DOI 10.2307/1369366; Byrne PG, 2003, P ROY SOC B-BIOL SCI, V270, P2079, DOI 10.1098/rspb.2003.2433; Calhim S, 2007, BEHAV ECOL, V18, P271, DOI 10.1093/beheco/arl076; CARDULLO RA, 1991, CELL MOTIL CYTOSKEL, V19, P180, DOI 10.1002/cm.970190306; CARTAR RV, 1985, NATURWISSENSCHAFTEN, V72, P157, DOI 10.1007/BF00490407; Charlesworth B, 1987, SEXUAL SELECTION TES, P21; COHEN J, 1977, REPRODUCTION; Double M, 2000, P ROY SOC B-BIOL SCI, V267, P465, DOI 10.1098/rspb.2000.1023; Dunn PO, 2001, EVOLUTION, V55, P161; DYBAS LK, 1981, EVOLUTION, V35, P168, DOI 10.1111/j.1558-5646.1981.tb04869.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Froman DP, 2005, BIOL REPROD, V72, P562, DOI 10.1095/biolreprod.104.035113; GAGE MJG, 1994, P ROY SOC B-BIOL SCI, V258, P247, DOI 10.1098/rspb.1994.0169; Gage MJG, 2003, P ROY SOC B-BIOL SCI, V270, P625, DOI 10.1098/rspb.2002.2258; Garamszegi LZ, 2005, HORM BEHAV, V47, P389, DOI 10.1016/j.yhbeh.2004.11.008; GOMENDIO M, 1993, P ROY SOC B-BIOL SCI, V252, P7, DOI 10.1098/rspb.1993.0039; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; HARCOURT AH, 1991, EVOLUTION, V45, P314, DOI [10.2307/2409666, 10.1111/j.1558-5646.1991.tb04406.x]; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; HUNTER FM, 1992, ANIM BEHAV, V44, P149, DOI 10.1016/S0003-3472(05)80764-X; Immler S, 2005, IBIS, V147, P827, DOI 10.1111/j.1474-919x.2005.00456.x; Immler S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000170; Immler S, 2007, P ROY SOC B-BIOL SCI, V274, P561, DOI 10.1098/rspb.2006.3752; Katz D.F., 1990, P125; LaMunyon CW, 1999, P ROY SOC B-BIOL SCI, V266, P263, DOI 10.1098/rspb.1999.0631; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Minder AM, 2005, J EVOLUTION BIOL, V18, P60, DOI 10.1111/j.1420-9101.2004.00799.x; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; MOLLER AP, 1995, BEHAV ECOL SOCIOBIOL, V36, P357, DOI 10.1007/BF00167797; Morrow EH, 2001, HEREDITY, V87, P356, DOI 10.1046/j.1365-2540.2001.00921.x; Morrow EH, 2000, P ROY SOC B-BIOL SCI, V267, P307, DOI 10.1098/rspb.2000.1001; Morrow EH, 2003, ECOL LETT, V6, P228, DOI 10.1046/j.1461-0248.2003.00418.x; Morrow EH, 2001, J ZOOL, V254, P147, DOI 10.1017/S0952836901000656; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P245, DOI 10.1098/rspb.1993.0110; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P255, DOI 10.1098/rspb.1993.0111; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PESGRAVES DC, 1999, P ROY SOC LOND B BIO, V266, P1041; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Pitnick S, 2001, P ROY SOC B-BIOL SCI, V268, P1071, DOI 10.1098/rspb.2001.1621; R Development Core Team, 2006, R LANG ENV STAT COMP; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Simmons L. W., 2001, MG BEH ECOL; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Stockley P, 1997, AM NAT, V149, P933, DOI 10.1086/286031; STUTCHBURY BJ, 1995, BEHAVIOUR, V132, P675, DOI 10.1163/156853995X00081; SUTTLE JM, 1988, J EXP ZOOL, V247, P166, DOI 10.1002/jez.1402470208; VANVALEN L, 2005, VARIATION; Ward PI, 1998, HEREDITY, V80, P655, DOI 10.1046/j.1365-2540.1998.00401.x	76	130	131	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e413	10.1371/journal.pone.0000413	http://dx.doi.org/10.1371/journal.pone.0000413			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476335	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000207445700015
J	Yoda, M; Eguchi, K; Terada, TP; Sasai, M				Yoda, Mitsumasa; Eguchi, Kohei; Terada, Tomoki P.; Sasai, Masaki			Monomer-Shuffling and Allosteric Transition in KaiC Circadian Oscillation	PLOS ONE			English	Article							CLOCK PROTEIN KAIB; PHOSPHORYLATION CYCLE; CRYSTAL-STRUCTURE; RHYTHMS; EXPRESSION; BINDING; SYSTEM; MODEL; SASA	Circadian rhythms in living organisms have long been attributed solely to a transcription-translation loop comprising a negative or positive feedback. The rhythms in cyanobacteria are known to be modulated by kaiC, kaiA and kaiB genes. It was recently shown, however, that their product proteins KaiC, KaiA and KaiB are sufficient to reconstitute the circadian rhythm in the phosphorylation level of KaiC in vitro. It has since been unclear why such an oscillatory behavior can occur in the absence of the apparent transcription-translation feedback. In the meantime, it has been reported that the monomer exchange between KaiC hexamers occurs in a phosphorylation-dependent manner, which suggests that the monomer shuffling is also involved in the circadian rhythm (H. Kageyama et al., Mol. Cell, 23, 161 (2006)). To further clarify the role of the monomer shuffling, we have performed a computational modeling of interactions among Kai proteins assuming the allosteric transition of KaiC hexamer as well as the monomer shuffling. The results show that the existence of both monomer shuffling and allosteric transition can synchronize the phosphorylation level of the KaiC hexamers, and stabilizes its oscillation.	[Yoda, Mitsumasa; Eguchi, Kohei; Terada, Tomoki P.; Sasai, Masaki] Nagoya Univ, Dept Computat Sci & Engn, Nagoya, Aichi 4648601, Japan; [Sasai, Masaki] CREST Japan Sci & Technol Agcy, Nagoya, Aichi, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Sasai, M (corresponding author), Nagoya Univ, Dept Computat Sci & Engn, Nagoya, Aichi 4648601, Japan.	sasai@cse.nagoya-u.ac.jp	Terada, Tomoki P./I-6671-2014	Terada, Tomoki P./0000-0001-8231-9274	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and from Japan Society for Promotion of Science and by grants for the 21st century COE program for Frontiers of Computational Science.	Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Emberly E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.038303; Garces RG, 2004, EMBO J, V23, P1688, DOI 10.1038/sj.emboj.7600190; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Horovitz A, 1998, CURR OPIN STRUC BIOL, V8, P93, DOI 10.1016/S0959-440X(98)80015-8; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwase R, 2005, J BIOL CHEM, V280, P43141, DOI 10.1074/jbc.M503360200; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Kondo T, 1997, SCIENCE, V275, P224, DOI 10.1126/science.275.5297.224; Kurosawa G, 2006, BIOPHYS J, V91, P2015, DOI 10.1529/biophysj.105.076554; Mehra A, 2006, PLOS COMPUT BIOL, V2, P816, DOI 10.1371/journal.pcbi.0020096; Miyoshi F, 2007, J BIOL RHYTHM, V22, P69, DOI 10.1177/0748730406295749; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Naef F, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100002; Nakahira Y, 2004, P NATL ACAD SCI USA, V101, P881, DOI 10.1073/pnas.0307411100; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Pattanayek R, 2006, EMBO J, V25, P2017, DOI 10.1038/sj.emboj.7601086; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Takigawa-Imamura H, 2006, J BIOL RHYTHM, V21, P405, DOI 10.1177/0748730406291329; Uzumaki T, 2004, NAT STRUCT MOL BIOL, V11, P623, DOI 10.1038/nsmb781; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	34	39	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e408	10.1371/journal.pone.0000408	http://dx.doi.org/10.1371/journal.pone.0000408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476330	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445700010
J	Garske, T; Clarke, P; Ghani, AC				Garske, Tini; Clarke, Paul; Ghani, Azra C.			The Transmissibility of Highly Pathogenic Avian Influenza in Commercial Poultry in Industrialised Countries	PLOS ONE			English	Article								Background. With the increased occurrence of outbreaks of H5N1 worldwide there is concern that the virus could enter commercial poultry farms with severe economic consequences. Methodology/Principal Findings. We analyse data from four recent outbreaks of highly pathogenic avian influenza (HPAI) in commercial poultry to estimate the farm-to-farm reproductive number for HPAI. The reproductive number is a key measure of the transmissibility of HPAI at the farm level because it can be used to evaluate the effectiveness of the control measures. In these outbreaks the mean farm-to-farm reproductive number prior to controls ranged from 1.1 to 2.4, with the maximum farm-based reproductive number in the range 2.2 to 3.2. Enhanced bio-security, movement restrictions and prompt isolation of the infected farms in all four outbreaks substantially reduced the reproductive number, but it remained close to the threshold value 1 necessary to ensure the disease will be eradicated. Conclusions/Significance. Our results show that depending on the particular situation in which an outbreak of avian influenza occurs, current controls might not be enough to eradicate the disease, and therefore a close monitoring of the outbreak is required. The method we used for estimating the reproductive number is straightforward to implement and can be used in real-time. It therefore can be a useful tool to inform policy decisions.	[Garske, Tini; Clarke, Paul; Ghani, Azra C.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Garske, Tini] Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Garske, T (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	t.garske@imperial.ac.uk	Ghani, Azra/B-8560-2009	Ghani, Azra/0000-0002-0007-4910	UK Department for Environment, Food and Rural Affairs	UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by research funding from the UK Department for Environment, Food and Rural Affairs. The views expressed in the paper are those of the authors.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; *CAN FOOD INSP AG, 2004, SHORT SUMM 2004 OUTB; Capua I, 2000, AVIAN PATHOL, V29, P289, DOI 10.1080/03079450050118403; Capua I, 2004, AVIAN PATHOL, V33, P393, DOI 10.1080/03079450410001724085; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Capua I, 1999, AVIAN PATHOL, V28, P455, DOI 10.1080/03079459994470; Capua I, 2006, EMERG INFECT DIS, V12, P1319, DOI 10.3201/eid1209.060430; *COUNC EUR UN, 2005, OFFICIAL J EUROPEAN, P16; Davison AC, 1997, BOOTSTRAP METHODS TH; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; Elbers ARW, 2004, AVIAN DIS, V48, P691, DOI 10.1637/7149; Ellis TM, 2004, AVIAN PATHOL, V33, P405, DOI 10.1080/03079450410001724012; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; MANNELLI A, 2004, MARTIGNY, P13; MARANGON S, 2003, CONTROL AVIAN INFLUE, P1997; Press W. H., 1992, ART SCI COMPUTING; SANCO DG, 2003, AVIAN INFLUENZA AI N; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; STEGEMAN A, 2006, AVIAN INFLUENZA H7N7; Tian GB, 2005, VIROLOGY, V341, P153, DOI 10.1016/j.virol.2005.07.011; Tumpey TM, 2004, AVIAN DIS, V48, P167, DOI 10.1637/7103; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255	26	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e349	10.1371/journal.pone.0000349	http://dx.doi.org/10.1371/journal.pone.0000349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406673	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000207445300011
J	Kasehagen, LJ; Mueller, I; Kiniboro, B; Bockarie, MJ; Reeder, JC; Kazura, JW; Kastens, W; McNamara, DT; King, CH; Whalen, CC; Zimmerman, PA				Kasehagen, Laurin J.; Mueller, Ivo; Kiniboro, Benson; Bockarie, Moses J.; Reeder, John C.; Kazura, James W.; Kastens, Will; McNamara, David T.; King, Charles H.; Whalen, Christopher C.; Zimmerman, Peter A.			Reduced Plasmodium vivax Erythrocyte Infection in PNG Duffy-Negative Heterozygotes	PLOS ONE			English	Article								Background. Erythrocyte Duffy blood group negativity reaches fixation in African populations where Plasmodium vivax (Pv) is uncommon. While it is known that Duffy-negative individuals are highly resistant to Pv erythrocyte infection, little is known regarding Pv susceptibility among heterozygous carriers of a Duffy-negative allele(+/-). Our limited knowledge of the selective advantages or disadvantages associated with this genotype constrains our understanding of the effect that interventions against Pv may have on the health of people living in malaria-endemic regions. Methods and Findings. We conducted cross-sectional malaria prevalence surveys in Papua New Guinea (PNG), where we have previously identified a new Duffy-negative allele among individuals living in a region endemic for all four human malaria parasite species. We evaluated infection status by conventional blood smear light microscopy and semi-quantitative PCR-based strategies. Analysis of a longitudinal cohort constructed from our surveys showed that Duffy heterozygous (+/-) individuals were protected from Pv erythrocyte infection compared to those homozygous for wild-type alleles (+/+) (log-rank tests: LM, p = 0.049; PCR, p = 0.065). Evaluation of Pv parasitemia, determined by semi-quantitative PCR-based methods, was significantly lower in Duffy +/-vs. +/+ individuals (Mann-Whitney U: p = 0.023). Overall, we observed no association between susceptibility to P. falciparum erythrocyte infection and Duffy genotype. Conclusions. Our findings provide the first evidence that Duffy-negative heterozygosity reduces erythrocyte susceptibility to Pv infection. As this reduction was not associated with greater susceptibility to Pf malaria, our in vivo observations provide evidence that Pv-targeted control measures can be developed safely.	[Kasehagen, Laurin J.; Kazura, James W.; Kastens, Will; McNamara, David T.; King, Charles H.; Zimmerman, Peter A.] Case Western Reserve Univ, Sch Med, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Mueller, Ivo; Kiniboro, Benson; Bockarie, Moses J.; Reeder, John C.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Whalen, Christopher C.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Case Western Reserve University; PNG Institute Of Medical Research; Case Western Reserve University	Zimmerman, PA (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA.	paz@case.edu	Bockarie, Moses/AAV-4578-2020; Mueller, Ivo/C-7251-2013; Bockarie, Moses/AAW-3130-2021	Mueller, Ivo/0000-0001-6554-6889; King, Charles/0000-0001-8349-9270; Reeder, John/0000-0003-1395-1289	National Institutes of Health [AI36478-04S1, AI46919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036478, U01AI036478, R01AI046919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institutes of Health (AI36478-04S1 and AI46919). The funding agency played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg MA, 2002, AM J TROP MED HYG, V67, P230, DOI 10.4269/ajtmh.2002.67.230; Boyd MF., 1949, MALARIOLOGY, P3; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; GENTON B, 1995, ANN TROP MED PARASIT, V89, P359, DOI 10.1080/00034983.1995.11812965; Haldane J.B.S., 1949, HEREDITAS, V35, P267; Iwamoto S, 1996, BIOCHEM BIOPH RES CO, V222, P852, DOI 10.1006/bbrc.1996.0833; Kasehagen LJ, 2006, AM J TROP MED HYG, V75, P588, DOI 10.4269/ajtmh.2006.75.588; Kish L, 1965, SURVEY SAMPLING; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; McNamara DT, 2006, AM J TROP MED HYG, V74, P413, DOI 10.4269/ajtmh.2006.74.413; McNamara DT, 2004, J CLIN MICROBIOL, V42, P2403, DOI 10.1128/JCM.42.6.2403-2410.2004; Mehlotra RK, 2002, AM J TROP MED HYG, V67, P555, DOI 10.4269/ajtmh.2002.67.555; Mgone CS, 1996, T ROY SOC TROP MED H, V90, P228, DOI 10.1016/S0035-9203(96)90223-0; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Oron-Karni V, 1998, AM J HEMATOL, V58, P306, DOI 10.1002/(SICI)1096-8652(199808)58:4<306::AID-AJH10>3.0.CO;2-5; Patel SS, 2001, BLOOD, V98, P3489, DOI 10.1182/blood.V98.12.3489; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; Rothman K, 1986, MODERN EPIDEMIOLOGY; Smith T, 2001, AM J TROP MED HYG, V64, P262, DOI 10.4269/ajtmh.2001.64.262; Snounou G, 2004, TRENDS PARASITOL, V20, P262, DOI 10.1016/j.pt.2004.03.008; TOURNAMILLE C, 1995, HUM GENET, V95, P407, DOI 10.1007/BF00208965; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Twisk JWR, 2003, APPL LONGITUDINAL DA; WEATHERALL DJ, 1987, ANN TROP MED PARASIT, V81, P539, DOI 10.1080/00034983.1987.11812155; Williams TN, 1996, NATURE, V383, P522, DOI 10.1038/383522a0; ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973; Zimmerman PA, 2004, TRENDS PARASITOL, V20, P440, DOI 10.1016/j.pt.2004.07.004; Zimmerman PA, 2004, INFECTIOUS DISEASE AND HOST-PATHOGEN EVOLUTION, P141, DOI 10.1017/CBO9780511546259.007; 2000, PAPUA NEW GUINEA MIN	38	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e336	10.1371/journal.pone.0000336	http://dx.doi.org/10.1371/journal.pone.0000336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389925	Green Published, gold			2022-12-27	WOS:000207445200019
J	Clausen, T; Ribbeck, K				Clausen, Thomas; Ribbeck, Katharina			Self-Organization of Anastral Spindles by Synergy of Dynamic Instability, Autocatalytic Microtubule Production, and a Spatial Signaling Gradient	PLOS ONE			English	Article								Assembly of the mitotic spindle is a classic example of macromolecular self-organization. During spindle assembly, microtubules (MTs) accumulate around chromatin. In centrosomal spindles, centrosomes at the spindle poles are the dominating source of MT production. However, many systems assemble anastral spindles, i.e., spindles without centrosomes at the poles. How anastral spindles produce and maintain a high concentration of MTs in the absence of centrosome-catalyzed MT production is unknown. With a combined biochemistry-computer simulation approach, we show that the concerted activity of three components can efficiently concentrate microtubules (MTs) at chromatin: (1) an external stimulus in form of a RanGTP gradient centered on chromatin, (2) a feed-back loop where MTs induce production of new MTs, and (3) continuous reorganization of MT structures by dynamic instability. The mechanism proposed here can generate and maintain a dissipative MT super-structure within a RanGTP gradient.	[Clausen, Thomas; Ribbeck, Katharina] European Mol Biol Lab, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Ribbeck, K (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	Katharina_Ribbeck@hms.harvard.edu			EMBL; BioMS	EMBL; BioMS	This project was funded by EMBL and BioMS.	BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BRINKLEY BR, 1985, ANNU REV CELL BIOL, V1, P145, DOI 10.1146/annurev.cellbio.1.1.145; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Cramer J.S, 2003, LOGIT MODELS EC OTHE, DOI 10.1017/CBO9780511615412.002; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; Desai A, 1997, P NATL ACAD SCI USA, V94, P12378, DOI 10.1073/pnas.94.23.12378; Desai A, 1999, METHOD CELL BIOL, V61, P385; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; McNally FJ, 1996, CURR OPIN CELL BIOL, V8, P23, DOI 10.1016/S0955-0674(96)80044-5; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Pearl R, 1920, P NATL ACAD SCI USA, V6, P275, DOI 10.1073/pnas.6.6.275; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; ZHENG Y, 2004, ANN REV CELL DEV BIO	25	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e244	10.1371/journal.pone.0000244	http://dx.doi.org/10.1371/journal.pone.0000244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17330139	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444600004
J	Schonenberger, E; Schnapauff, D; Teige, F; Laule, M; Hamm, B; Dewey, M				Schoenenberger, Eva; Schnapauff, Dirk; Teige, Florian; Laule, Michael; Hamm, Bernd; Dewey, Marc			Patient Acceptance of Noninvasive and Invasive Coronary Angiography	PLOS ONE			English	Article								Background. Noninvasive angiography using multislice computed tomography (MSCT) is superior to magnetic resonance imaging (MRI) for detection of coronary stenoses. We compared patient acceptance of these two noninvasive diagnostic tests and invasive conventional coronary angiography (Angio). Methods and Findings. A total of 111 consecutive patients with suspected coronary artery disease underwent MSCT, MRI, and Angio. Subsequently, patient acceptance of the three tests was evaluated with questionnaires in all patients. The main acceptance variables were preparation and information prior to the test, degree of concern, comfort, degree of helplessness, pain (on visual analog scales), willingness to undergo the test again, and overall satisfaction. Preparation for each test was not rated significantly differently, whereas patients were significantly more concerned about Angio than the two noninvasive tests (p < 0.001). No pain during MSCT, MRI, and Angio as assessed on visual analog scales (0 to 100) was reported by 99, 93, and 31 patients, respectively. Among the 82 patients who felt pain during at least one procedure, both CT (0.9 +/- 4.5) and MRI (5.2 +/- 16.6) were significantly less painful than Angio (24.6 +/- 23.4, both p < 0.001). MSCT was considered significantly more comfortable (1.49 +/- 0.64) than MRI (1.75 +/- 0.81, p < 0.001). In both the no-revascularization (55 patients) and the revascularization group (56 patients), the majority of the patients (73 and 71%) would prefer MSCT to MRI and Angio for future imaging of the coronary arteries. None of the patients indicated to be unwilling to undergo MSCT again. The major advantages patients attributed to MSCT were its fast, uncomplicated, noninvasive, and painless nature. Conclusions. Noninvasive coronary angiography with MSCT is considered more comfortable than MRI and both MSCT and MRI are less painful than Angio. Patient preference for MSCT might tip the scales in favor of this test provided that the diagnostic accuracy of MSCT can be shown to be high enough for clinical application.	[Schnapauff, Dirk; Teige, Florian; Hamm, Bernd; Dewey, Marc] Humboldt Univ, Charite, Dept Radiol, Berlin, Germany; [Schoenenberger, Eva] Hannover Med Sch, Dept Med, D-30623 Hannover, Germany; [Laule, Michael] Humboldt Univ, Charite, Dept Cardiol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dewey, M (corresponding author), Humboldt Univ, Charite, Dept Radiol, Berlin, Germany.	marc.dewey@charite.de	Laule, Michael E/A-6548-2013	Dewey, Marc/0000-0002-4402-2733; Laule, Michael/0000-0002-7579-295X	GE Healthcare Biosciences	GE Healthcare Biosciences(General Electric)	Dr. Dewey and Dr. Hamm have received grant support from GE Healthcare Biosciences ( formerly: Amersham Buchler) for this study. The funding source had no role in the collection, analysis, or interpretation of the data or in the decision to submit the manuscript for publication.	*AM HEART ASS, 2004, HEART DIS STROK STAT; Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833; Bogaert J, 2003, RADIOLOGY, V226, P707, DOI 10.1148/radiol.2263011750; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Coles DR, 2006, J AM COLL CARDIOL, V47, P1840, DOI 10.1016/j.jacc.2005.11.078; Cooper R, 2000, CIRCULATION, V102, P3137; Dewey M, 2006, ROFO-FORTSCHR RONTG, V178, P600, DOI 10.1055/s-2006-926755; Dewey M, 2006, J MAGN RESON IMAGING, V23, P674, DOI 10.1002/jmri.20568; Dewey M, 2006, INVEST RADIOL, V41, P400, DOI 10.1097/01.rli.0000201233.42994.9b; Dewey M, 2004, INVEST RADIOL, V39, P223, DOI 10.1097/01.rli.0000115201.27096.6e; DEWEY M, 2006, EUR RADIOL; Dewey M, 2006, ANN INTERN MED, V145, P407, DOI 10.7326/0003-4819-145-6-200609190-00004; Garcia MJ, 2006, JAMA-J AM MED ASSOC, V296, P403, DOI 10.1001/jama.296.4.403; Gerber TC, 2005, INVEST RADIOL, V40, P556, DOI 10.1097/01.rli.0000170628.69792.cb; Greenland P, 2006, ANN INTERN MED, V145, P466, DOI 10.7326/0003-4819-145-6-200609190-00012; Herborn CU, 2003, RADIOLOGY, V229, P217, DOI 10.1148/radiol.2291021033; Hoffmann MHK, 2005, JAMA-J AM MED ASSOC, V293, P2471, DOI 10.1001/jama.293.20.2471; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Kondo C, 2005, J COMPUT ASSIST TOMO, V29, P694, DOI 10.1097/01.rct.0000173844.89988.37; Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071; Lefere PA, 2002, RADIOLOGY, V224, P393, DOI 10.1148/radiol.2241011222; Leschka S, 2005, EUR HEART J, V26, P1482, DOI 10.1093/eurheartj/ehi261; Martuscelli E, 2004, EUR HEART J, V25, P1043, DOI 10.1016/j.ehj.2004.03.024; Menon K, 2001, AM J GASTROENTEROL, V96, P2646; Mollet NR, 2004, J AM COLL CARDIOL, V43, P2265, DOI 10.1016/j.jacc.2004.03.032; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Nieman K, 2002, CIRCULATION, V106, P2051, DOI 10.1161/01.CIR.0000037222.58317.3D; Niendorf T, 2006, ROFO-FORTSCHR RONTG, V178, P15, DOI 10.1055/s-2005-858686; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Ropers D, 2006, AM J CARDIOL, V97, P343, DOI 10.1016/j.amjcard.2005.08.050; Ropers D, 2003, CIRCULATION, V107, P664, DOI 10.1161/01.CIR.0000055738.31551.A9; Schoenhagen P, 2004, RADIOLOGY, V232, P7, DOI 10.1148/radiol.2321021803; Schoepf UJ, 2004, RADIOLOGY, V232, P18, DOI 10.1148/radiol.2321030636; Schuijf JD, 2006, AM HEART J, V151, P404, DOI 10.1016/j.ahj.2005.03.022; Schuijf JD, 2006, AM J CARDIOL, V98, P145, DOI 10.1016/j.amjcard.2006.01.092; Stamm G, 2002, ROFO-FORTSCHR RONTG, V174, P1570, DOI 10.1055/s-2002-35937; Stiebellehner L, 2002, WIEN KLIN WOCHENSCHR, V114, P847; Svensson MH, 2002, RADIOLOGY, V222, P337, DOI 10.1148/radiol.2222010669; Taupitz M, 2001, MAGN RESON MED, V46, P932, DOI 10.1002/mrm.1279; Trabold T, 2003, ROFO-FORTSCHR RONTG, V175, P1051; U-King-Im JM, 2004, CLIN RADIOL, V59, P358, DOI 10.1016/j.crad.2003.08.015; van Gelder RE, 2004, RADIOLOGY, V233, P328, DOI 10.1148/radiol.2331031208	43	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e246	10.1371/journal.pone.0000246	http://dx.doi.org/10.1371/journal.pone.0000246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327910	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444600006
J	Touchman, JW; Wagner, DM; Hao, JC; Mastrian, SD; Shah, MK; Vogler, AJ; Allender, CJ; Clark, EA; Benitez, DS; Youngkin, DJ; Girard, JM; Auerbach, RK; Beckstrom-Sternberg, SM; Keim, P				Touchman, Jeffrey W.; Wagner, David M.; Hao, Jicheng; Mastrian, Stephen D.; Shah, Maulik K.; Vogler, Amy J.; Allender, Christopher J.; Clark, Erin A.; Benitez, Debbie S.; Youngkin, David J.; Girard, Jessica M.; Auerbach, Raymond K.; Beckstrom-Sternberg, Stephen M.; Keim, Paul			A North American Yersinia pestis Draft Genome Sequence: SNPs and Phylogenetic Analysis	PLOS ONE			English	Article								Background. Yersinia pestis, the causative agent of plague, is responsible for some of the greatest epidemic scourges of mankind. It is widespread in the western United States, although it has only been present there for just over 100 years. As a result, there has been very little time for diversity to accumulate in this region. Much of the diversity that has been detected among North American isolates is at loci that mutate too quickly to accurately reconstruct large-scale phylogenetic patterns. Slowly-evolving but stable markers such as SNPs could be useful for this purpose, but are difficult to identify due to the monomorphic nature of North American isolates. Methodology/Principal Findings. To identify SNPs that are polymorphic among North American populations of Y. pestis, a gapped genome sequence of Y. pestis strain FV-1 was generated. Sequence comparison of FV-1 with another North American strain, CO92, identified 19 new SNP loci that differ among North American isolates. Conclusions/Significance. The 19 SNP loci identified in this study should facilitate additional studies of the genetic population structure of Y. pestis across North America.	[Touchman, Jeffrey W.; Hao, Jicheng; Mastrian, Stephen D.; Shah, Maulik K.; Clark, Erin A.; Benitez, Debbie S.; Youngkin, David J.; Beckstrom-Sternberg, Stephen M.; Keim, Paul] Translat Genom Res Inst, Phoenix, AZ USA; [Touchman, Jeffrey W.] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Wagner, David M.; Vogler, Amy J.; Allender, Christopher J.; Girard, Jessica M.; Auerbach, Raymond K.; Beckstrom-Sternberg, Stephen M.; Keim, Paul] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA	Translational Genomics Research Institute; Arizona State University; Arizona State University-Tempe; Northern Arizona University	Touchman, JW (corresponding author), Translat Genom Res Inst, Phoenix, AZ USA.	jtouchman@tgen.org	Wagner, David M/A-5125-2010; Keim, Paul S/A-2269-2010	Wagner, David/0000-0003-2684-6007				Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; ACHTMAN M, 2004, YERSINIA MOL CELLULA, P432; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Cully JF, 2001, J MAMMAL, V82, P894, DOI 10.1644/1545-1542(2001)082&lt;0894:ICOSPI&gt;2.0.CO;2; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Enscore RE, 2002, AM J TROP MED HYG, V66, P186, DOI 10.4269/ajtmh.2002.66.186; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; LINK V B, 1955, Public Health Monogr, V26, P1; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Parmenter RR, 1999, AM J TROP MED HYG, V61, P814, DOI 10.4269/ajtmh.1999.61.814; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; SCHWARTZ S, 2003, NUCLEIC ACIDS RES, V31, P1; Thorstenson YR, 1998, GENOME RES, V8, P848, DOI 10.1101/gr.8.8.848	23	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e220	10.1371/journal.pone.0000220	http://dx.doi.org/10.1371/journal.pone.0000220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311096	gold, Green Published			2022-12-27	WOS:000207444500001
J	Franco, MD; Bohbot, J; Fernandez, K; Hanna, J; Poppy, J; Vogt, R				Franco, Marie-dominique; Bohbot, Jonathan; Fernandez, Kenny; Hanna, Jayd; Poppy, James; Vogt, Richard			Sensory Cell Proliferation within the Olfactory Epithelium of Developing Adult Manduca sexta (Lepidoptera)	PLOS ONE			English	Article								Background. Insects detect a multitude of odors using a broad array of phenotypically distinct olfactory organs referred to as olfactory sensilla. Each sensillum contains one to several sensory neurons and at least three support cells; these cells arise from mitotic activities from one or a small group of defined precursor cells. Sensilla phenotypes are defined by distinct morphologies, and specificities to specific odors; these are the consequence of developmental programs expressed by associated neurons and support cells, and by selection and expression of subpopulations of olfactory genes encoding such proteins as odor receptors, odorant binding proteins, and odor degrading enzymes. Methodology/Principal Findings. We are investigating development of the olfactory epithelium of adult M. sexta, identifying events which might establish sensilla phenotypes. In the present study, antennal tissue was examined during the first three days of an 18 day development, a period when sensory mitotic activity was previously reported to occur. Each antenna develops as a cylinder with an outward facing sensory epithelium divided into approximately 80 repeat units or annuli. Mitotic proliferation of sensory cells initiated about 20-24 hrs after pupation (a. p.), in pre-existing zones of high density cells lining the proximal and distal borders of each annulus. These high density zones were observed as early as two hr. a. p., and expanded with mitotic activity to fill the mid-annular regions by about 72 hrs a. p. Mitotic activity initiated at a low rate, increasing dramatically after 40-48 hrs a. p.; this activity was enhanced by ecdysteroids, but did not occur in animals entering pupal diapause (which is also ecdysteroid sensitive). Conclusions/Significance. Sensory proliferation initiates in narrow zones along the proximal and distal borders of each annulus; these zones rapidly expand to fill the mid-annular regions. These zones exist prior to any mitotic activity as regions of high density cells which form either at or prior to pupation. Mitotic sensitivity to ecdysteroids may be a regulatory mechanism coordinating olfactory development with the developmental choice of diapause entry.	[Franco, Marie-dominique; Bohbot, Jonathan; Fernandez, Kenny; Hanna, Jayd; Poppy, James; Vogt, Richard] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Vogt, R (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	vogt@biol.sc.edu			National Science Foundation [IBN9731005, IBN0212510]; National Institutes of Health [NICDC DC-00588]; Department of Agriculture [CRGP 94-37302-0615]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000588] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Agriculture; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the National Science Foundation (IBN9731005, IBN0212510) the National Institutes of Health (NICDC DC-00588) and the Department of Agriculture (CRGP 94-37302-0615) for various support throughout this study.	BELL RA, 1975, J INSECT PHYSIOL, V21, P1471, DOI 10.1016/0022-1910(75)90210-3; BOWEN MF, 1985, J INSECT PHYSIOL, V31, P83, DOI 10.1016/0022-1910(85)90012-5; BOWEN MF, 1984, J EXP BIOL, V108, P9; BRADFIELD JY, 1980, GEN COMP ENDOCR, V41, P101, DOI 10.1016/0016-6480(80)90038-6; Byrd CA, 1996, J NEUROBIOL, V29, P445, DOI 10.1002/(SICI)1097-4695(199604)29:4<445::AID-NEU3>3.0.CO;2-8; Champlin DT, 1998, DEVELOPMENT, V125, P269; Champlin DT, 1998, DEVELOPMENT, V125, P2009; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Denlinger D.L., 1985, P353; EASSA Y. E. E., 1953, TRANS ROY ENT SOC LONDON, V104, P39; GILBERT LI, 1996, METAMORPHOSIS POSTEM, V2, P59; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; HANSON FE, 1973, J INSECT PHYSIOL, V19, P1019, DOI 10.1016/0022-1910(73)90028-0; Hansson BS, 2003, J COMP PHYSIOL A, V189, P301, DOI 10.1007/s00359-003-0403-5; Hiruma K, 1997, GEN COMP ENDOCR, V107, P84, DOI 10.1006/gcen.1997.6901; Kalinova B, 2001, CHEM SENSES, V26, P1175, DOI 10.1093/chemse/26.9.1175; KEIL TA, 1990, TISSUE CELL, V22, P319, DOI 10.1016/0040-8166(90)90007-V; KEIL TA, 1992, MICROSC RES TECHNIQ, V22, P351, DOI 10.1002/jemt.1070220405; KEIL TA, 1990, TISSUE CELL, V22, P705, DOI 10.1016/0040-8166(90)90066-I; KEIL TA, 1989, TISSUE CELL, V21, P139, DOI 10.1016/0040-8166(89)90028-1; KEIL TA, 1990, TISSUE CELL, V22, P821; KENT KS, 1987, PHILOS T ROY SOC B, V315, P3; KIRSCHENBAUM SR, 1995, J NEUROBIOL, V28, P234, DOI 10.1002/neu.480280209; LAFONT R, 1992, ECDYSONE HDB; Lage PIZ, 2003, DEVELOPMENT, V130, P4683, DOI 10.1242/dev.00680; Laue M, 2000, ARTHROPOD STRUCT DEV, V29, P57, DOI 10.1016/S1467-8039(00)00013-X; LEE JK, 1990, J NEUROCYTOL, V19, P519, DOI 10.1007/BF01257241; Levine Richard B., 1995, Current Opinion in Neurobiology, V5, P28, DOI 10.1016/0959-4388(95)80083-2; MacWhinnie SGB, 2005, DEV BIOL, V285, P285, DOI 10.1016/j.ydbio.2005.06.021; Monsma SA, 1996, J COMP NEUROL, V367, P10, DOI 10.1002/(SICI)1096-9861(19960325)367:1<10::AID-CNE2>3.0.CO;2-M; OLAND LA, 1988, J NEUROSCI, V8, P353; OLAND LA, 1993, J NEUROBIOL, V24, P1170, DOI 10.1002/neu.480240905; RAY K, 1995, DEV BIOL, V167, P426, DOI 10.1006/dbio.1995.1039; Reddy GV, 1997, DEVELOPMENT, V124, P703; Riddiford L.M., 1979, TCA (TISSUE CULTURE ASSOCIATION) MANUAL, V5, P975, DOI 10.1007/BF00919715; RIDDIFORD LM, 1993, AM ZOOL, V33, P340; RIDDIFORD LM, 1993, DEV DROSOPHILA MELAN, V2, P889; Riddiford Lynn M., 1995, P293, DOI 10.1017/CBO9780511529931.012; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Rossler W, 1999, J NEUROSCI, V19, P9865; SANES JR, 1976, DEV BIOL, V51, P282, DOI 10.1016/0012-1606(76)90144-5; SANES JR, 1976, DEV BIOL, V51, P300, DOI 10.1016/0012-1606(76)90145-7; SCHWARTZ LM, 1983, DEV BIOL, V99, P103, DOI 10.1016/0012-1606(83)90257-9; Sen A, 2004, MECH DEVELOP, V121, P65, DOI 10.1016/j.mod.2003.10.002; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shields VDC, 1999, CAN J ZOOL, V77, P302, DOI 10.1139/cjz-77-2-302; Shields VDC, 1999, CAN J ZOOL, V77, P290, DOI 10.1139/cjz-77-2-290; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; STEINBRECHT RA, 1980, TISSUE CELL, V12, P73, DOI 10.1016/0040-8166(80)90053-1; Steinbrecht Rudolf Alexander, 1999, P155; SVACHA P, 1992, DEV BIOL, V154, P101, DOI 10.1016/0012-1606(92)90052-I; TAUBER MJ, 1978, ANNU REV ENTOMOL, V21, P81; Tissot M, 2000, PROG NEUROBIOL, V62, P89, DOI 10.1016/S0301-0082(99)00069-6; TOMIOKA K, 1995, ZOOL SCI, V12, P165, DOI 10.2108/zsj.12.165; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; VOGT RG, 1993, J NEUROBIOL, V24, P581, DOI 10.1002/neu.480240505; Vogt RG, 2002, J EXP BIOL, V205, P719; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; WAKU Y, 1991, J MORPHOL, V207, P253, DOI 10.1002/jmor.1052070304; WARREN JT, 1986, INSECT BIOCHEM, V16, P65, DOI 10.1016/0020-1790(86)90080-6; Weeks JC, 1995, CURR OPIN NEUROBIOL, V5, P809, DOI 10.1016/0959-4388(95)80110-3; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	65	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e215	10.1371/journal.pone.0000215	http://dx.doi.org/10.1371/journal.pone.0000215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299595	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444400016
J	Bain, MB; Haley, N; Peterson, DL; Arend, KK; Mills, KE; Sullivan, PJ				Bain, Mark B.; Haley, Nancy; Peterson, Douglas L.; Arend, Kristin K.; Mills, Kathy E.; Sullivan, Patrick J.			Recovery of a US Endangered Fish	PLOS ONE			English	Article							STURGEON ACIPENSER-BREVIROSTRUM; SPECIES-ACT; SHORTNOSE STURGEON; LIFE-HISTORY; CLASSIFICATION; CRITERIA; RIVER	Background. More fish have been afforded US Endangered Species Act protection than any other vertebrate taxonomic group, and none has been designated as recovered. Shortnose sturgeon (Acipenser brevirostrum) occupy large rivers and estuaries along the Atlantic coast of North America, and the species has been protected by the US Endangered Species Act since its enactment. Methodology/Principal Findings. Data on the shortnose sturgeon in the Hudson River (New York to Albany, NY, USA) were obtained from a 1970s population study, a population and fish distribution study we conducted in the late 1990s, and a fish monitoring program during the 1980s and 1990s. Population estimates indicate a late 1990s abundance of about 60,000 fish, dominated by adults. The Hudson River population has increased by more than 400% since the 1970s, appears healthy, and has attributes typical for a long-lived species. Our population estimates exceed the government and scientific population recovery criteria by more than 500%, we found a positive trend in population abundance, and key habitats have remained intact despite heavy human river use. Conclusions/Significance. Scientists and legislators have called for changes in the US Endangered Species Act, the Act is being debated in the US Congress, and the Act has been characterized as failing to recover species. Recovery of the Hudson River population of shortnose sturgeon suggests the combination of species and habitat protection with patience can yield successful species recovery, even near one of the world's largest human population centers.	[Bain, Mark B.; Haley, Nancy; Peterson, Douglas L.; Arend, Kristin K.; Mills, Kathy E.; Sullivan, Patrick J.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA	Cornell University	Bain, MB (corresponding author), Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA.	Mark.Bain@Cornell.edu		Arend, Kristin/0000-0003-1115-1050	Hudson River Foundation; US Army Corps of Engineers via the National Marine Fisheries Service; US Geological Survey	Hudson River Foundation; US Army Corps of Engineers via the National Marine Fisheries Service; US Geological Survey(United States Geological Survey)	Supported by grants to MBB from the Hudson River Foundation and the New York District of the US Army Corps of Engineers via the National Marine Fisheries Service and the US Geological Survey. None of the sponsors specified or influenced the study design, findings, and interpretations. The conclusions do not imply agency concurrence or policy positions.	*APPL SCI ASS, 1999, 1996 YEAR CLASS REP; Bain MB, 1997, ENVIRON BIOL FISH, V48, P347, DOI 10.1023/A:1007325814893; Bean MJ, 2006, BIOSCIENCE, V56, P98, DOI 10.1641/0006-3568(2006)056[0098:TESAUT]2.0.CO;2; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; BUCKLEY J, 1981, PROG FISH CULT, V43, P74, DOI 10.1577/1548-8659(1981)43[74:SAROSS]2.0.CO;2; Campbell SP, 2002, ECOL APPL, V12, P674, DOI 10.1890/1051-0761(2002)012[0674:AAOMEI]2.0.CO;2; Carroll R, 1996, ECOL APPL, V6, P1; COCH NK, 1986, NE GEOL, V8, P96; *CONN DEP ENV PROT, 2003, WORK NAT SHORTN STUR; Cooper J.C., 1988, AM FISHERIES SOC MON, V4, P11; CROCKER J, 2006, COMMUNICATION    NOV; Curran H.W., 1937, BIOL SURVEY LOWER HU, P124; Dadswell M. J., 1984, 14 NMFS NAT OC ATM A; Doremus H, 2001, CONSERV BIOL, V15, P1258, DOI 10.1046/j.1523-1739.2001.00178.x; Dovel W. L., 1981, ENDANGERED SHORTNOSE; DOVEL WL, 1992, ESTUARINE RESEARCH IN THE 1980S, P187; Foin TC, 1998, BIOSCIENCE, V48, P177, DOI 10.2307/1313263; Franklin I., 1980, CONSERVATION BIOL EV; FRIEDLAND KD, 2004, 2006 IUCN RED LIST T; GEOGHEGAN P, 1992, ESTUARINE RESEARCH IN THE 1980S, P217; Gerber LR, 2002, ECOL APPL, V12, P668; Gerber LR, 1999, CONSERV BIOL, V13, P1203, DOI 10.1046/j.1523-1739.1999.98277.x; GIBBONS A, 1992, SCIENCE, V256, P1386, DOI 10.1126/science.256.5062.1386; Hoekstra JM, 2002, ECOL APPL, V12, P630, DOI 10.1890/1051-0761(2002)012[0630:ACROES]2.0.CO;2; Hoff T.B., 1988, P171; JOHNSON L, 1976, J FISH RES BOARD CAN, V33, P2459, DOI 10.1139/f76-293; Klauda R.J., 1988, P7; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Kynard B, 1997, ENVIRON BIOL FISH, V48, P319, DOI 10.1023/A:1007372913578; LANDE R, 1995, CONSERV BIOL, V9, P782, DOI 10.1046/j.1523-1739.1995.09040782.x; LIMBURG K E, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P265; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; Manly BFJ, 1997, RANDOMIZATION BOOTST; MCDOWALL RM, 1987, AM FISH SOC S, V1, P1; MILLER RR, 1989, FISHERIES, V14, P22, DOI 10.1577/1548-8446(1989)014<0022:EONAFD>2.0.CO;2; *NAT MAR FISH SERV, 2002, C REC PROGR THREAT E; *NAT MAR FISH SERV, 1987, STAT REV SHORTN STUR; *NAT MAR FISH SERV, 2004, C REC PROGR THREAT E; *NOAA NAT MAR FISH, 1998, FIN REC PLAN SHORTN; *NOAA NAT MAR FISH, 1996, STAT REV SHORTN STUR; PEKOVITCH AW, 1979, DISTRIBUTION SOME LI; Ralls K, 1996, CONSERV BIOL, V10, P1528, DOI 10.1046/j.1523-1739.1996.10061528.x; RICKER W E, 1975, P382; Scott JM, 2005, FRONT ECOL ENVIRON, V3, P383, DOI 10.1890/1540-9295(2005)003[0383:ROISUT]2.0.CO;2; Shelden KEW, 2001, CONSERV BIOL, V15, P1300, DOI 10.1046/j.1523-1739.2001.99380.x; Stokstad E, 2005, SCIENCE, V309, P2150, DOI 10.1126/science.309.5744.2150; TAUBERT BD, 1980, COPEIA, P114; TEAR TH, 1993, SCIENCE, V262, P976, DOI 10.1126/science.262.5136.976; TEAR TH, 1995, CONSERV BIOL, V9, P182, DOI 10.1046/j.1523-1739.1995.09010182.x; THOMAS CD, 1990, CONSERV BIOL, V4, P324, DOI 10.1111/j.1523-1739.1990.tb00295.x; THOMPSON GG, 1991, FNWC198 NMFS NAT OC; TOWNES AK, 1937, BIOL SURVEY LOWER HU, P217; *US FISH WILDL SER, 2002, C REC THREAT END SPE; *US FISH WILDL SER, 2006, THREAT END SPEC SYST; Walsh MG, 2001, ESTUARIES, V24, P41, DOI 10.2307/1352811; WILCOVE DS, 1993, CONSERV BIOL, V7, P87, DOI 10.1046/j.1523-1739.1993.07010087.x; WILLIAMS JE, 1989, FISHERIES, V14, P2, DOI 10.1577/1548-8446(1989)014<0002:FONAET>2.0.CO;2; 1996, FED REG, V61, P53893	59	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e168	10.1371/journal.pone.0000168	http://dx.doi.org/10.1371/journal.pone.0000168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17245444	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444100005
J	Symonds, MRE; Gemmell, NJ; Braisher, TL; Gorringe, KL; Elgar, MA				Symonds, Matthew R. E.; Gemmell, Neil J.; Braisher, Tamsin L.; Gorringe, Kylie L.; Elgar, Mark A.			Gender Differences in Publication Output: Towards an Unbiased Metric of Research Performance	PLOS ONE			English	Article							H-INDEX; BIAS	We examined the publication records of a cohort of 168 life scientists in the field of ecology and evolutionary biology to assess gender differences in research performance. Clear discrepancies in publication rate between men and women appear very early in their careers and this has consequences for the subsequent citation of their work. We show that a recently proposed index designed to rank scientists fairly is in fact strongly biased against female researchers, and advocate a modified index to assess men and women on a more equitable basis.	[Symonds, Matthew R. E.; Elgar, Mark A.] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia; [Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Braisher, Tamsin L.] Landcare Res, Lincoln, New Zealand; [Gorringe, Kylie L.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	University of Melbourne; University of Canterbury; Landcare Research - New Zealand; Peter Maccallum Cancer Center	Symonds, MRE (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia.	symondsm@unimelb.edu.au	Gemmell, Neil J/C-6774-2009; Gorringe, Kylie L/H-3264-2019; Symonds, Matthew R.E./I-6020-2018	Gemmell, Neil J/0000-0003-0671-3637; Gorringe, Kylie L/0000-0001-5681-2022; Symonds, Matthew R.E./0000-0002-9785-6045; Braisher, Tamsin/0000-0002-3407-226X; Elgar, Mark/0000-0003-0861-6064	Faculty of Science at the University of Melbourne	Faculty of Science at the University of Melbourne(University of Melbourne)	The Faculty of Science at the University of Melbourne paid for the analysis.	Ball P, 2005, NATURE, V436, P900, DOI 10.1038/436900a; Barres BA, 2006, NATURE, V442, P133, DOI 10.1038/442133a; Braisher TL, 2005, BIOESSAYS, V27, P858, DOI 10.1002/bies.20272; Cole J. R., 1984, ADV MOTIVATION ACHIE, V2, P217; Ding WW, 2006, SCIENCE, V313, P665, DOI 10.1126/science.1124832; GILBERT JR, 1994, JAMA-J AM MED ASSOC, V272, P139, DOI 10.1001/jama.272.2.139; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Holden C, 2005, SCIENCE, V309, P1800; Kelly CD, 2006, TRENDS ECOL EVOL, V21, P167, DOI 10.1016/j.tree.2006.01.005; Knapp S, 2005, TRENDS ECOL EVOL, V20, P55, DOI 10.1016/j.tree.2004.11.016; Lawler A, 2006, SCIENCE, V313, P1712, DOI 10.1126/science.313.5794.1712; Lawrence PA, 2006, PLOS BIOL, V4, P13, DOI 10.1371/journal.pbio.0040019; LONG JS, 1992, SOC FORCES, V71, P159, DOI 10.2307/2579971; Purvis A, 2006, TRENDS ECOL EVOL, V21, P422, DOI 10.1016/j.tree.2006.05.014; Sax LJ, 2002, RES HIGH EDUC, V43, P423, DOI 10.1023/A:1015575616285; Summers L., 2005, NBER C DIV SCI ENG W; Tregenza T, 2002, TRENDS ECOL EVOL, V17, P349, DOI 10.1016/S0169-5347(02)02545-4; Ward JE, 1998, MED J AUSTRALIA, V169, P623, DOI 10.5694/j.1326-5377.1998.tb123438.x; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; Xie Y, 1998, AM SOCIOL REV, V63, P847, DOI 10.2307/2657505	20	176	181	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e127	10.1371/journal.pone.0000127	http://dx.doi.org/10.1371/journal.pone.0000127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205131	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700021
J	Zhang, C; Carl, TF; Trudeau, ED; Simmet, T; Klymkowsky, MW				Zhang, Chi; Carl, Timothy F.; Trudeau, Evan D.; Simmet, Thomas; Klymkowsky, Michael W.			An NF-kappa B and Slug Regulatory Loop Active in Early Vertebrate Mesoderm	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SLUG; NEURAL CREST DEVELOPMENT; ACETYL-BOSWELLIC ACIDS; EPITHELIAL-MESENCHYMAL TRANSITIONS; E-CADHERIN EXPRESSION; ZINC-FINGER PROTEINS; REPRESSES E-CADHERIN; VIRUS TYPE-1 TAX; GENE-EXPRESSION; XENOPUS HOMOLOG	Background. In both Drosophila and the mouse, the zinc finger transcription factor Snail is required for mesoderm formation; its vertebrate paralog Slug (Snai2) appears to be required for neural crest formation in the chick and the clawed frog Xenopus laevis. Both Slug and Snail act to induce epithelial to mesenchymal transition (EMT) and to suppress apoptosis. Methodology & Principle Findings. Morpholino-based loss of function studies indicate that Slug is required for the normal expression of both mesodermal and neural crest markers in X. laevis. Both phenotypes are rescued by injection of RNA encoding the antiapoptotic protein Bcl-xL; Bcl-xL's effects are dependent upon I kappa B kinase-mediated activation of the bipartite transcription factor NF-kappa B. NF-kappa B, in turn, directly up-regulates levels of Slug and Snail RNAs. Slug indirectly up-regulates levels of RNAs encoding the NF-kappa B subunit proteins RelA, Rel2, and Rel3, and directly down-regulates levels of the pro-apopotic Caspase-9 RNA. Conclusions/Significance. These studies reveal a Slug/Snail-NF-kappa B regulatory circuit, analogous to that present in the early Drosophila embryo, active during mesodermal formation in Xenopus. This is a regulatory interaction of significance both in development and in the course of inflammatory and metastatic disease.	[Zhang, Chi; Carl, Timothy F.; Trudeau, Evan D.; Klymkowsky, Michael W.] Univ Colorado, Boulder, CO 80309 USA; [Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, Ulm, Germany	University of Colorado System; University of Colorado Boulder; Ulm University	Klymkowsky, MW (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	klym@spot.colorado.edu		Syrovets, Tatiana/0000-0002-6751-2233; Klymkowsky, Mike/0000-0001-5816-9771	March of Dimes Birth Defects Foundation, Inc.; National Institutes of Health [GM54001]; American Heart Association; German Cancer Foundation (Deutsche Krebshilfe); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054001] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation, Inc.(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); German Cancer Foundation (Deutsche Krebshilfe)(Deutsche Krebshilfe); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was initiated with support from the March of Dimes Birth Defects Foundation, Inc., and completed with support from the National Institutes of Health (GM54001) and the American Heart Association. TS was supported by the German Cancer Foundation (Deutsche Krebshilfe).	Ashraf SI, 1999, EMBO J, V18, P6426, DOI 10.1093/emboj/18.22.6426; Aybar MJ, 2003, DEVELOPMENT, V130, P483, DOI 10.1242/dev.00238; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Baker CVH, 1997, MECH DEVELOP, V69, P3, DOI 10.1016/S0925-4773(97)00132-9; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beck CW, 1998, INT J DEV BIOL, V42, P67; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bonstein L, 1998, DEV BIOL, V193, P156, DOI 10.1006/dbio.1997.8795; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Campbell KJ, 2006, BIOCHEM SOC SYMP, V73, P165, DOI 10.1042/bss0730165; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carl T, 1999, ADV MOLEC BIOL, P291; Carl TF, 1999, DEV BIOL, V213, P101, DOI 10.1006/dbio.1999.9320; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Catalano A, 2004, J BIOL CHEM, V279, P46706, DOI 10.1074/jbc.M406696200; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Come C, 2004, J MAMMARY GLAND BIOL, V9, P183, DOI 10.1023/B:JOMG.0000037161.91969.de; CRUZREYES J, 1995, GENE, V158, P171, DOI 10.1016/0378-1119(95)00159-4; de Moissac D, 1999, J BIOL CHEM, V274, P29505, DOI 10.1074/jbc.274.41.29505; de Moissac D, 1998, J BIOL CHEM, V273, P23946, DOI 10.1074/jbc.273.37.23946; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; DENT JA, 1989, DEVELOPMENT, V105, P61; Dobrovolskaia MA, 2005, CURR CANCER DRUG TAR, V5, P325, DOI 10.2174/1568009054629645; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; ENTNER N, 1973, J PROTOZOOL, V20, P160, DOI 10.1111/j.1550-7408.1973.tb06025.x; Feng H, 2004, ONCOGENE, V23, P7310, DOI 10.1038/sj.onc.1208041; Finkielstein CV, 2001, P NATL ACAD SCI USA, V98, P1006, DOI 10.1073/pnas.98.3.1006; Fritzenwanker JH, 2004, DEV BIOL, V275, P389, DOI 10.1016/j.ydbio.2004.08.014; Ganguly A, 2005, DEVELOPMENT, V132, P3419, DOI 10.1242/dev.01903; Gilmore T, 2002, CANCER LETT, V181, P1, DOI 10.1016/S0304-3835(01)00795-9; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; GRAU Y, 1984, GENETICS, V108, P347; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Hajra KM, 2002, CANCER RES, V62, P1613; Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1; Hemavathy K, 2004, DEV BIOL, V269, P411, DOI 10.1016/j.ydbio.2004.01.029; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; Hoernlein RF, 1999, J PHARMACOL EXP THER, V288, P613; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; JONAS E, 1985, P NATL ACAD SCI USA, V82, P5413, DOI 10.1073/pnas.82.16.5413; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; KAO KR, 1991, P NATL ACAD SCI USA, V88, P2697, DOI 10.1073/pnas.88.7.2697; Kao KR, 1996, MECH DEVELOP, V58, P129, DOI 10.1016/S0925-4773(96)00565-5; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; KENGAKU M, 1993, DEVELOPMENT, V119, P1067; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kirshenbaum LA, 2000, CLIN INVEST MED, V23, P322; Kishi M, 2000, DEVELOPMENT, V127, P791; KOLM PJ, 1995, DEV BIOL, V171, P267, DOI 10.1006/dbio.1995.1279; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Kumano G, 2002, MECH DEVELOP, V118, P45, DOI 10.1016/S0925-4773(02)00186-7; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; Lake BB, 2001, DEVELOPMENT, V128, P263; Lespinet O, 2002, DEV GENES EVOL, V212, P186, DOI 10.1007/s00427-002-0228-1; Li L, 2004, CANCER-AM CANCER SOC, V101, P2351, DOI 10.1002/cncr.20605; Li LJ, 2003, J CELL SCI, V116, P3687, DOI 10.1242/jcs.00644; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Locascio A, 2002, P NATL ACAD SCI USA, V99, P16841, DOI 10.1073/pnas.262525399; LU PJ, 1995, J CELL BIOL, V129, P1363, DOI 10.1083/jcb.129.5.1363; Manzanares M, 2001, TRENDS GENET, V17, P178, DOI 10.1016/S0168-9525(01)02232-6; Mayor R, 2000, MECH DEVELOP, V97, P47, DOI 10.1016/S0925-4773(00)00412-3; Mayor R, 1999, CURR TOP DEV BIOL, V43, P85; MAYOR R, 1995, DEVELOPMENT, V121, P767; Metzstein MM, 1999, MOL CELL, V4, P309, DOI 10.1016/S1097-2765(00)80333-0; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Nakakura EK, 2001, P NATL ACAD SCI USA, V98, P4010, DOI 10.1073/pnas.051014098; Nakata K, 2000, MECH DEVELOP, V99, P83, DOI 10.1016/S0925-4773(00)00480-9; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Penzel R, 1997, INT J DEV BIOL, V41, P667; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pise-Masison CA, 2000, MOL CELL BIOL, V20, P3377, DOI 10.1128/MCB.20.10.3377-3386.2000; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; READ MA, 1994, J EXP MED, V179, P503, DOI 10.1084/jem.179.2.503; Regula KM, 2002, J BIOL CHEM, V277, P38676, DOI 10.1074/jbc.M206175200; RICHARDSON JC, 1994, MECH DEVELOP, V45, P173, DOI 10.1016/0925-4773(94)90031-0; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; SAFAYHI H, 1995, MOL PHARMACOL, V47, P1212; Saint-Germain N, 2004, DEVELOPMENT, V131, P1755, DOI 10.1242/dev.01066; Sakai D, 2006, DEVELOPMENT, V133, P1323, DOI 10.1242/dev.02297; Sanchez-Martin MS, 2003, AM J MED GENET A, V122A, P125, DOI 10.1002/ajmg.a.20345; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Sefton M, 1998, DEVELOPMENT, V125, P3111; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; SIMPSON P, 1983, GENETICS, V105, P615; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Sitcheran R, 2003, GENE DEV, V17, P2368, DOI 10.1101/gad.1114503; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Spokony RF, 2002, DEVELOPMENT, V129, P421; Stack JH, 1997, DEVELOPMENT, V124, P3185; Stennard F, 1999, MECH DEVELOP, V86, P87, DOI 10.1016/S0925-4773(99)00119-7; Su CC, 2006, ANTICANCER RES, V26, P1281; Suzuki K, 1998, GENE, V206, P1, DOI 10.1016/S0378-1119(97)00561-1; SUZUKI K, 1995, NUCLEIC ACIDS RES, V23, P4664, DOI 10.1093/nar/23.22.4664; Syrovets T, 2005, J BIOL CHEM, V280, P6170, DOI 10.1074/jbc.M409477200; Syrovets T, 2000, MOL PHARMACOL, V58, P71, DOI 10.1124/mol.58.1.71; Syrovets T, 2005, J IMMUNOL, V174, P498, DOI 10.4049/jimmunol.174.1.498; Takada Y, 2006, J IMMUNOL, V176, P3127, DOI 10.4049/jimmunol.176.5.3127; Takayama E, 2004, BIOCHEM BIOPH RES CO, V325, P1367, DOI 10.1016/j.bbrc.2004.10.179; TANNAHILL D, 1995, INT J DEV BIOL, V39, P549; Technau U, 2003, INT J DEV BIOL, V47, P531; Thellmann M, 2003, DEVELOPMENT, V130, P4057, DOI 10.1242/dev.00597; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tribulo C, 2004, DEV BIOL, V275, P325, DOI 10.1016/j.ydbio.2004.07.041; Trisciuoglio D, 2004, J BIOL CHEM, V279, P6737, DOI 10.1074/jbc.M308938200; Tsukahara T, 1999, J VIROL, V73, P7981, DOI 10.1128/JVI.73.10.7981-7987.1999; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vernon AE, 2006, DEVELOPMENT, V133, P3359, DOI 10.1242/dev.02504; Vickaryous MK, 2006, BIOL REV, V81, P425, DOI 10.1017/S1464793106007068; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Webster GA, 1999, MOL CELL BIOL, V19, P3485; WHITELEY M, 1992, MECH DEVELOP, V36, P117, DOI 10.1016/0925-4773(92)90063-P; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yang SS, 1998, J BIOL CHEM, V273, P13746, DOI 10.1074/jbc.273.22.13746; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yeo W, 2004, DEV BIOL, V274, P233, DOI 10.1016/j.ydbio.2004.07.026; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhang C, 2005, DEV DYNAM, V234, P878, DOI 10.1002/dvdy.20565; Zhang C, 2005, DEV BIOL, V278, P526, DOI 10.1016/j.ydbio.2004.11.008; Zhang C, 2003, DEVELOPMENT, V130, P5609, DOI 10.1242/dev.00798; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	143	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e106	10.1371/journal.pone.0000106	http://dx.doi.org/10.1371/journal.pone.0000106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205110	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443700002
J	Kerry, S; TeKippe, M; Gaddis, NC; Aballay, A				Kerry, Samantha; TeKippe, Michael; Gaddis, Nathan C.; Aballay, Alejandro			GATA Transcription Factor Required for Immunity to Bacterial and Fungal Pathogens	PLOS ONE			English	Article								In the past decade, Caenorhabditis elegans has been used to dissect several genetic pathways involved in immunity; however, little is known about transcription factors that regulate the expression of immune effectors. C. elegans does not appear to have a functional homolog of the key immune transcription factor NF-kappa B. Here we show that that the intestinal GATA transcription factor ELT-2 is required for both immunity to Salmonella enterica and expression of a C-type lectin gene, clec-67, which is expressed in the intestinal cells and is a good marker of S. enterica infection. We also found that ELT-2 is required for immunity to Pseudomonas aeruginosa, Enterococcus faecalis, and Cryptococcus neoformans. Lack of immune inhibition by DAF-2, which negatively regulates the FOXO transcription factor DAF-16, rescues the hypersusceptibility to pathogens phenotype of elt-2(RNAi) animals. Our results indicate that ELT-2 is part of a multi-pathogen defense pathway that regulates innate immunity independently of the DAF-2/DAF-16 signaling pathway.	[Kerry, Samantha; TeKippe, Michael; Gaddis, Nathan C.; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	a.aballay@duke.edu	Gaddis, Nathan/GXG-6395-2022; Gaddis, Nathan/GXG-6447-2022	Gaddis, Nathan/0000-0001-5205-7138; Elliott, Samantha/0000-0001-6146-5395	NIH [GM074461, GM070977, AI065641]; Whitehead Scholars Program; DCTR; NIH SERCEB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074461, R37GM070977, R01GM070977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehead Scholars Program; DCTR; NIH SERCEB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S. E. K is funded by the NIH Ruth-Kirschstein postdoctoral fellowship GM074461. A. A. is funded by The Whitehead Scholars Program, DCTR, NIH SERCEB, and NIH grants GM070977 and AI065641.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; BRENNER S, 1974, GENETICS, V77, P71; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cheng TC, 2006, GENOMICS, V87, P356, DOI 10.1016/j.ygeno.2005.11.018; Cheon HM, 2006, J BIOL CHEM, V281, P8426, DOI 10.1074/jbc.M510957200; Franzot SP, 1999, J CLIN MICROBIOL, V37, P838, DOI 10.1128/JCM.37.3.838-840.1999; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukushige T, 1999, P NATL ACAD SCI USA, V96, P11883, DOI 10.1073/pnas.96.21.11883; Fukushige T, 2003, GENETICS, V165, P575; Fukushige T, 2005, DEV BIOL, V279, P446, DOI 10.1016/j.ydbio.2004.12.012; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim T, 2005, J BIOCHEM MOL BIOL, V38, P121; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Nicholas HR, 2004, MOL IMMUNOL, V41, P479, DOI 10.1016/j.molimm.2004.03.037; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Petersen UM, 1999, EMBO J, V18, P4013, DOI 10.1093/emboj/18.14.4013; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Suzuki YJ, 2003, FREE RADICAL BIO MED, V34, P1589, DOI 10.1016/S0891-5849(03)00208-9; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	58	68	80	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e77	10.1371/journal.pone.0000077	http://dx.doi.org/10.1371/journal.pone.0000077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183709	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600077
J	Arai, Y; Mentis, GZ; Wu, JY; O'Donovan, MJ				Arai, Yoshiyasu; Mentis, George Z.; Wu, Jiang-young; O'Donovan, Michael J.			Ventrolateral Origin of Each Cycle of Rhythmic Activity Generated by the Spinal Cord of the Chick Embryo	PLOS ONE			English	Article								Background. The mechanisms responsible for generating rhythmic motor activity in the developing spinal cord of the chick embryo are poorly understood. Here we investigate whether the activity of motoneurons occurs before other neuronal populations at the beginning of each cycle of rhythmic discharge. Methodology/Principal Findings. The spatiotemporal organization of neural activity in transverse slices of the lumbosacral cord of the chick embryo (E8-E11) was investigated using intrinsic and voltage-sensitive dye (VSD) imaging. VSD signals accompanying episodes of activity comprised a rhythmic decrease in light transmission that corresponded to each cycle of electrical activity recorded from the ipsilateral ventral root. The rhythmic signals were widely synchronized across the cord face, and the largest signal amplitude was in the ventrolateral region where motoneurons are located. In unstained slices we recorded two classes of intrinsic signal. In the first, an episode of rhythmic activity was accompanied by a slow decrease in light transmission that peaked in the dorsal horn and decayed dorsoventrally. Superimposed on this signal was a much smaller rhythmic increase in transmission that was coincident with each cycle of discharge and whose amplitude and spatial distribution was similar to that of the VSD signals. At the onset of a spontaneously occurring episode and each subsequent cycle, both the intrinsic and VSD signals originated within the lateral motor column and spread medially and then dorsally. By contrast, following a dorsal root stimulus, the optical signals originated within the dorsal horn and traveled ventrally to reach the lateral motor column. Conclusions/Significance. These findings suggest that motoneuron activity contributes to the initiation of each cycle of rhythmic activity, and that motoneuron and/or R-interneuron synapses are a plausible site for the activity-dependent synaptic depression that modeling studies have identified as a critical mechanism for cycling within an episode.	[Arai, Yoshiyasu; Mentis, George Z.; Wu, Jiang-young; O'Donovan, Michael J.] NINDS, Neural Control Lab, Sect Dev Neurobiol, NIH, Bethesda, MD 20892 USA; [Wu, Jiang-young] Georgetown Univ, Dept Physiol & Biophys, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Georgetown University	O'Donovan, MJ (corresponding author), NINDS, Neural Control Lab, Sect Dev Neurobiol, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	odonovm@ninds.nih.gov	o'donovan, michael/A-2357-2015	o'donovan, michael/0000-0003-2487-7547	National Institute of Neurological Disorders and Stroke; JSPS [2000]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036447, Z01NS003022] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Neurological Disorders and Stroke Intramural Research Program, and a JSPS Postdoctoral Fellowships for Research Abroad (to Y. A. 2000).	Arai Y, 1999, J NEUROPHYSIOL, V81, P1889, DOI 10.1152/jn.1999.81.4.1889; ARAI Y, 2001, 31 SOC NEUR; BEKOFF A, 1976, BRAIN RES, V106, P271, DOI 10.1016/0006-8993(76)91025-8; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Chub N, 2006, J NEUROPHYSIOL, V95, P323, DOI 10.1152/jn.00162.2005; Chub N, 1998, J NEUROSCI, V18, P294; Chub N, 2001, J NEUROPHYSIOL, V85, P2166, DOI 10.1152/jn.2001.85.5.2166; Fayuk D, 2002, J NEUROPHYSIOL, V87, P1924, DOI 10.1152/jn.00231.2001; Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Jin WJ, 2002, J NEUROSCI METH, V115, P13, DOI 10.1016/S0165-0270(01)00511-8; KAMINO K, 1981, NATURE, V290, P595, DOI 10.1038/290595a0; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; LANDMESSER LT, 1984, J PHYSIOL-LONDON, V347, P189, DOI 10.1113/jphysiol.1984.sp015061; LEVIMONTALCINI R, 1950, J MORPHOL, V86, P253, DOI 10.1002/jmor.1050860203; Marchetti C, 2005, J NEUROSCI, V25, P3601, DOI 10.1523/JNEUROSCI.4290-04.2005; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; Mochida H, 2001, EUR J NEUROSCI, V14, P809, DOI 10.1046/j.0953-816x.2001.01692.x; Mochida H, 2001, EUR J NEUROSCI, V13, P1547, DOI 10.1046/j.0953-816x.2001.01528.x; Momose-Sato Y, 1998, J NEUROPHYSIOL, V79, P2208, DOI 10.1152/jn.1998.79.4.2208; MOMOSESATO Y, 1995, J MEMBRANE BIOL, V144, P167, DOI 10.1007/bf00232802; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; ODONOVAN M, 1994, J NEUROSCI, V14, P6354; ODONOVAN MJ, 1989, J NEUROSCI, V9, P943; PERRINS R, 1995, J NEUROPHYSIOL, V73, P1013, DOI 10.1152/jn.1995.73.3.1013; Ren J, 2006, J NEUROPHYSIOL, V95, P527, DOI 10.1152/jn.00735.2005; Ritter A, 1999, J NEUROSCI, V19, P3457; Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x; SALZBERG BM, 1983, NATURE, V306, P36, DOI 10.1038/306036a0; SALZBERG BM, 1985, J GEN PHYSIOL, V86, P395, DOI 10.1085/jgp.86.3.395; Sato K, 1997, NEUROREPORT, V8, P3559, DOI 10.1097/00001756-199711100-00028; Sholomenko GN, 1998, EXP NEUROL, V154, P430, DOI 10.1006/exnr.1998.6944; Tabak J, 2000, J NEUROSCI, V20, P3041; Tabak J, 2001, J NEUROSCI, V21, P8966, DOI 10.1523/JNEUROSCI.21-22-08966.2001; Terni T., 1923, Archivio Italiano di Anatomia e di Embriologia, V20, P433; Wenner P, 2001, J NEUROPHYSIOL, V86, P1481, DOI 10.1152/jn.2001.86.3.1481; Wenner P, 1996, J NEUROSCI METH, V70, P111, DOI 10.1016/S0165-0270(96)00108-2; Wenner P, 1999, J NEUROSCI, V19, P7557, DOI 10.1523/JNEUROSCI.19-17-07557.1999; Wu J.-Y., 1993, FLUORESCENT LUMINESC, P389; Xu HY, 2007, J NEUROPHYSIOL, V97, P2769, DOI 10.1152/jn.01324.2006; Xu HY, 2005, J NEUROPHYSIOL, V93, P2922, DOI 10.1152/jn.01091.2004; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Ziskind-Conhaim L, 2005, J NEUROPHYSIOL, V94, P1952, DOI 10.1152/jn.00209.2005	47	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e417	10.1371/journal.pone.0000417	http://dx.doi.org/10.1371/journal.pone.0000417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17479162	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445700019
J	Chen, C; Tang, JQ; Dong, W; Wang, CJ; Feng, YJ; Wang, J; Zheng, F; Pan, XZ; Liu, D; Li, M; Song, YJ; Zhu, XX; Sun, HB; Feng, T; Guo, ZB; Ju, AP; Ge, JC; Dong, YQ; Sun, W; Jiang, YQ; Wang, J; Yan, JH; Yang, HM; Wang, XN; Gao, GF; Yang, RF; Wang, J; Yu, J				Chen, Chen; Tang, Jiaqi; Dong, Wei; Wang, Changjun; Feng, Youjun; Wang, Jing; Zheng, Feng; Pan, Xiuzhen; Liu, Di; Li, Ming; Song, Yajun; Zhu, Xinxing; Sun, Haibo; Feng, Tao; Guo, Zhaobiao; Ju, Aiping; Ge, Junchao; Dong, Yaqing; Sun, Wen; Jiang, Yongqiang; Wang, Jun; Yan, Jinghua; Yang, Huanming; Wang, Xiaoning; Gao, George F.; Yang, Ruifu; Wang, Jian; Yu, Jun			A Glimpse of Streptococcal Toxic Shock Syndrome from Comparative Genomics of S-suis 2 Chinese Isolates	PLOS ONE			English	Article								Background. Streptococcus suis serotype 2 (SS2) is an important zoonotic pathogen, causing more than 200 cases of severe human infection worldwide, with the hallmarks of meningitis, septicemia, arthritis, etc. Very recently, SS2 has been recognized as an etiological agent for streptococcal toxic shock syndrome (STSS), which was originally associated with Streptococcus pyogenes (GAS) in Streptococci. However, the molecular mechanisms underlying STSS are poorly understood. Methods and Findings. To elucidate the genetic determinants of STSS caused by SS2, whole genome sequencing of 3 different Chinese SS2 strains was undertaken. Comparative genomics accompanied by several lines of experiments, including experimental animal infection, PCR assay, and expression analysis, were utilized to further dissect a candidate pathogenicity island (PAI). Here we show, for the first time, a novel molecular insight into Chinese isolates of highly invasive SS2, which caused two large-scale human STSS outbreaks in China. A candidate PAI of similar to 89 kb in length, which is designated 89K and specific for Chinese SS2 virulent isolates, was investigated at the genomic level. It shares the universal properties of PAIs such as distinct GC content, consistent with its pivotal role in STSS and high virulence. Conclusions. To our knowledge, this is the first PAI candidate from S. suis worldwide. Our finding thus sheds light on STSS triggered by SS2 at the genomic level, facilitates further understanding of its pathogenesis and points to directions of development on some effective strategies to combat highly pathogenic SS2 infections.	[Tang, Jiaqi; Wang, Changjun; Zheng, Feng; Pan, Xiuzhen; Li, Ming; Ju, Aiping; Ge, Junchao; Dong, Yaqing; Sun, Wen] Res Inst Med Nanjing Command, Dept Epidemiol, Nanjing, Peoples R China; [Chen, Chen; Dong, Wei; Wang, Jing; Zhu, Xinxing; Sun, Haibo; Feng, Tao; Wang, Jun; Yang, Huanming; Wang, Jian; Yu, Jun] Chinese Acad Sci, Beijing Genom Inst, Beijing, Peoples R China; [Song, Yajun; Guo, Zhaobiao; Jiang, Yongqiang; Yang, Ruifu] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Feng, Youjun; Liu, Di; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Ctr Mol Immunol, Beijing, Peoples R China; [Chen, Chen; Dong, Wei; Wang, Jing; Zhu, Xinxing; Sun, Haibo; Feng, Tao; Wang, Jun; Yang, Huanming; Wang, Jian; Yu, Jun] Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xiaoning] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Wang, Jun] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Feng, Youjun; Liu, Di; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China; [Feng, Youjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Academy of Military Medical Sciences - China; Chinese Academy of Sciences; Institute of Microbiology, CAS; Zhejiang University; South China University of Technology; Aarhus University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tang, JQ (corresponding author), Res Inst Med Nanjing Command, Dept Epidemiol, Nanjing, Peoples R China.	tjq85@hotmail.com; xnwang@21cn.net; gaof@im.ac.cn; yangrf@nic.bmi.ac.cn; wangjian@genomics.org.cn; junyu@genomics.org.cn	Gao, George Fu/ABD-5229-2021; CHEN, CHEN/HDM-6657-2022; Song, Yajun/F-3714-2011; 郑, 征/C-8514-2011; Song, Yajun/GQQ-0476-2022; Liu, Di/G-6135-2014; chen, chen/AAQ-1805-2021; Feng, Youjun/E-8386-2010; Feng, Youjun/I-4134-2012; Liu, Di/ABD-2729-2021; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747; Liu, Di/0000-0003-3693-2726; chen, chen/0000-0003-1765-8899; Liu, Di/0000-0003-3693-2726; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Beijing Institute of Genomics; Chinese Academy of Sciences, National Basic Research Program (973) of China [KSCX2-SW-331, 2006CB504400]; National Natural Science Foundation of China [30670105, 30600533]; High-Tech Research&Development Project [2005AA219070]; National Basic Research Program (973) of China [2005CB523001]; National Key Technologies RD Program [2006BAD06A04]; Natural Science Foundation of Jiangsu Province, China [BK2006014]; Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology); National Natural Science Foundation of China (NSFC) [30525010]	Beijing Institute of Genomics; Chinese Academy of Sciences, National Basic Research Program (973) of China(National Basic Research Program of ChinaChinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-Tech Research&Development Project; National Basic Research Program (973) of China(National Basic Research Program of China); National Key Technologies RD Program(National Key Technology R&D Program); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by institutional grant at the Beijing Institute of Genomics and a grant to JY (KSCX2-SW-331) from Chinese Academy of Sciences, National Basic Research Program (973) of China (2006CB504400), a grant from National Natural Science Foundation of China (30670105) and High-Tech Research&Development Project 863 (2005AA219070) to JT, National Basic Research Program (973) of China (2005CB523001) to GFG, National Key Technologies R&D Program (2006BAD06A04) to JY, and a grant from National Natural Science Foundation of China (30600533) and a grant from Natural Science Foundation of Jiangsu Province, China (BK2006014) to CW. The China-Japan Joint Laboratory of Molecular Immunology and Molecular Microbiology is, in part, supported by Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology). GFG is a distinguished young investigator of National Natural Science Foundation of China (NSFC) (Grant No. 30525010). The authors declare no competing financial interests.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Bentley SD, 2003, LANCET, V361, P637, DOI 10.1016/S0140-6736(03)12597-4; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Brandt CM, 2005, INT J MED MICROBIOL, V295, P539, DOI 10.1016/j.ijmm.2005.07.013; Brown EJ, 2004, NEW ENGL J MED, V350, P2093, DOI 10.1056/NEJMcibr040657; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Cabello F, 1997, TRENDS MICROBIOL, V5, P431, DOI 10.1016/S0966-842X(97)01150-5; CHESNEY PJ, 1983, INFECTION, V11, P181, DOI 10.1007/BF01641192; Desvaux M, 2006, FEMS MICROBIOL REV, V30, P774, DOI 10.1111/j.1574-6976.2006.00035.x; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Hacker J., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P321, DOI 10.1556/AMicr.50.2003.4.1; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hashikawa S, 2004, J CLIN MICROBIOL, V42, P186, DOI 10.1128/JCM.42.1.186-192.2004; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; Mecsas J, 1996, EMERG INFECT DIS, V2, P271, DOI 10.3201/eid0204.960403; Middendorf B, 2001, J INFECT DIS, V183, pS17, DOI 10.1086/318843; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nallapareddy SR, 2005, J BACTERIOL, V187, P5709, DOI 10.1128/JB.187.16.5709-5718.2005; Ochman H, 1996, INFECT IMMUN, V64, P5410, DOI 10.1128/IAI.64.12.5410-5412.1996; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Sachse S, 2002, FEMS IMMUNOL MED MIC, V34, P159, DOI 10.1016/S0928-8244(02)00373-5; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Sitkiewicz I, 2006, INFECT IMMUN, V74, P1339, DOI 10.1128/IAI.74.2.1339-1351.2006; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Sriskandan S, 2006, PLOS MED, V3, P595, DOI 10.1371/journal.pmed.0030187; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; TANG J, 2006, PLOS MED, V3; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Ubeda C, 2003, MOL MICROBIOL, V49, P193, DOI 10.1046/j.1365-2958.2003.03577.x; WOOD TF, 1993, ANN SURG, V217, P109, DOI 10.1097/00000658-199302000-00003; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	42	217	749	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e315	10.1371/journal.pone.0000315	http://dx.doi.org/10.1371/journal.pone.0000315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375201	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445100017
J	Breban, R; Vardavas, R; Blower, S				Breban, Romulus; Vardavas, Raffaele; Blower, Sally			Theory versus Data: How to Calculate R-0?	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; MODELS	To predict the potential severity of outbreaks of infectious diseases such as SARS, HIV, TB and smallpox, a summary parameter, the basic reproduction number R-0, is generally calculated from a population-level model. R-0 specifies the average number of secondary infections caused by one infected individual during his/her entire infectious period at the start of an outbreak. R-0 is used to assess the severity of the outbreak, as well as the strength of the medical and/or behavioral interventions necessary for control. Conventionally, it is assumed that if R-0>1 the outbreak generates an epidemic, and if R-0<1 the outbreak becomes extinct. Here, we use computational and analytical methods to calculate the average number of secondary infections and to show that it does not necessarily represent an epidemic threshold parameter (as it has been generally assumed). Previously we have constructed a new type of individual-level model (ILM) and linked it with a population-level model. Our ILM generates the same temporal incidence and prevalence patterns as the population-level model; we use our ILM to directly calculate the average number of secondary infections (i.e., R-0). Surprisingly, we find that this value of R-0 calculated from the ILM is very different from the epidemic threshold calculated from the population-level model. This occurs because many different individual-level processes can generate the same incidence and prevalence patterns. We show that obtaining R-0 from empirical contact tracing data collected by epidemiologists and using this R-0 as a threshold parameter for a population-level model could produce extremely misleading estimates of the infectiousness of the pathogen, the severity of an outbreak, and the strength of the medical and/or behavioral interventions necessary for control.	[Breban, Romulus; Vardavas, Raffaele; Blower, Sally] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Blower, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.	sblower@mednet.ucla.edu		Breban, Romulus/0000-0002-5821-8139	NIH [RO1 AI041935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041935] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge financial support from NIH (RO1 AI041935). The funders had no role in the study or in the preparation of the manuscript.	ANDERSON R M, 1991; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Bootsma MCJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.018101; Breban R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046110; Breban R, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.018102; Green DM, 2006, J THEOR BIOL, V239, P289, DOI 10.1016/j.jtbi.2005.07.018; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; Keeling MJ, 2000, J THEOR BIOL, V203, P51, DOI 10.1006/jtbi.1999.1064; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8	12	50	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e282	10.1371/journal.pone.0000282	http://dx.doi.org/10.1371/journal.pone.0000282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356693	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444800005
J	van Opijnen, T; de Ronde, A; Boerlijst, MC; Berkhout, B				van Opijnen, Tim; de Ronde, Anthony; Boerlijst, Maarten C.; Berkhout, Ben			Adaptation of HIV-1 Depends on the Host-Cell Environment	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE MUTATIONS; LONG TERMINAL REPEAT; DELETERIOUS MUTATIONS; REVERSE-TRANSCRIPTASE; EXPERIMENTAL EVOLUTION; BENEFICIAL MUTATIONS; BACKGROUND SELECTION; DIMINISHING RETURNS; TYPE-1 VARIANTS	Many viruses have the ability to rapidly develop resistance against antiviral drugs and escape from the host immune system. To which extent the host environment affects this adaptive potential of viruses is largely unknown. Here we show that for HIV-1, the host-cell environment is key to the adaptive potential of the virus. We performed a large-scale selection experiment with two HIV-1 strains in two different T-cell lines (MT4 and C8166). Over 110 days of culture, both virus strains adapted rapidly to the MT4 T-cell line. In contrast, when cultured on the C8166 T-cell line, the same strains did not show any increase in fitness. By sequence analyses and infections with viruses expressing either yellow or cyan fluorescent protein, we were able to show that the absence of adaptation was linked to a lower recombination rate in the C8166 T-cell line. Our findings suggest that if we can manipulate the host-cellular factors that mediate viral evolution, we may be able to significantly retard viral adaptability.	[van Opijnen, Tim; de Ronde, Anthony; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands; [van Opijnen, Tim; Boerlijst, Maarten C.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Populat Biol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	van Opijnen, T (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.	Tim.van_Opijnen@tufts.edu		van Opijnen, Tim/0000-0001-6895-6795	NWO-ALW [811.35.001]; ZonMw; NWO-CW	NWO-ALW(Netherlands Organization for Scientific Research (NWO)); ZonMw(Netherlands Organization for Health Research and Development); NWO-CW(Netherlands Organization for Scientific Research (NWO))	This research was supported by NWO-ALW, project number 811.35.001, as well as by ZonMw (vici-grant) and NWO-CW (TOP-grant).	Althaus CL, 2005, J VIROL, V79, P13572, DOI 10.1128/JVI.79.21.13572-13578.2005; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; BARTON NH, 1995, GENETICS, V140, P821; Beck Z, 2003, J MED VIROL, V71, P94, DOI 10.1002/jmv.10447; Berkhout B, 1999, J BIOMED SCI, V6, P298, DOI 10.1159/000025401; Bleiber G, 2001, J VIROL, V75, P3291, DOI 10.1128/JVI.75.7.3291-3300.2001; Bocharov G, 2005, J GEN VIROL, V86, P3109, DOI 10.1099/vir.0.81138-0; Boerlijst MC, 1996, P ROY SOC B-BIOL SCI, V263, P1577, DOI 10.1098/rspb.1996.0231; BOUCHER CAB, 1992, J INFECT DIS, V165, P105, DOI 10.1093/infdis/165.1.105; BUTCHER D, 1995, GENETICS, V141, P431; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Charpentier C, 2006, J VIROL, V80, P2472, DOI 10.1128/JVI.80.5.2472-2482.2006; Chen BK, 1997, J VIROL, V71, P5495, DOI 10.1128/JVI.71.7.5495-5504.1997; Clementi M, 2004, MICROBIOLOGICA, V27, P207; Croteau G, 1997, J VIROL, V71, P1089, DOI 10.1128/JVI.71.2.1089-1096.1997; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Doyon L, 1998, J VIROL, V72, P6146, DOI 10.1128/JVI.72.7.6146-6150.1998; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; EIGEN M, 1987, COLD SPRING HARB SYM, V52, P307, DOI 10.1101/SQB.1987.052.01.036; ESHEL I, 1970, Theoretical Population Biology, V1, P88, DOI 10.1016/0040-5809(70)90043-2; Fisher RA, 1930, GENETICAL THEORY NAT; Frenkel LM, 2001, NEW ENGL J MED, V344, P520, DOI 10.1056/NEJM200102153440710; FU YX, 1993, GENETICS, V133, P693; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gessler DDG, 1995, GENET RES, V66, P241, DOI 10.1017/S0016672300034686; Gordo I, 2000, GENETICS, V156, P2137; GU ZX, 1995, J GEN VIROL, V76, P2601, DOI 10.1099/0022-1317-76-10-2601; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hemonnot B, 2004, J BIOL CHEM, V279, P32426, DOI 10.1074/jbc.M313137200; Hey J, 1998, GENETICS, V149, P2089; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Kauffman S.A., 1993, ORIGINS ORDER; KELLAM P, 1995, J VIROL, V69, P669, DOI 10.1128/JVI.69.2.669-674.1995; Keulen W, 1996, ANTIVIR RES, V31, P45, DOI 10.1016/0166-3542(96)00944-8; Kim Y, 2003, GENETICS, V164, P389; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; KORTHALS A, 2006, P BIOL SCI, V273, P1697; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LARDER BA, 1994, J GEN VIROL, V75, P951, DOI 10.1099/0022-1317-75-5-951; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; LEITNER T, 1995, VIROLOGY, V209, P136, DOI 10.1006/viro.1995.1237; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Maree AFM, 2000, J VIROL, V74, P11067, DOI 10.1128/JVI.74.23.11067-11072.2000; Matsuo Yoshinobu, 2004, Hum Cell, V17, P85; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Miralles R, 2000, J VIROL, V74, P3566, DOI 10.1128/JVI.74.8.3566-3571.2000; Mohapatra S, 2003, CANCER RES, V63, P8523; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Negroni M, 2001, ANNU REV GENET, V35, P275, DOI 10.1146/annurev.genet.35.102401.090551; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; NOVELLA IS, 1995, J VIROL, V69, P2869, DOI 10.1128/JVI.69.5.2869-2872.1995; Orr HA, 2000, GENETICS, V155, P961; Otto SP, 1997, GENETICS, V147, P879; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; PECK JR, 1994, GENETICS, V137, P597; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Rice WR, 1998, GENETICA, V102-3, P71, DOI 10.1023/A:1017055429755; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; ROSS EK, 1991, J VIROL, V65, P4350, DOI 10.1128/JVI.65.8.4350-4358.1991; Rouzine IM, 2005, GENETICS, V170, P7, DOI 10.1534/genetics.104.029926; ROZAS J, DNA POLYMORPHISM ANA; SABINO E, 1994, AIDS, V8, P901, DOI 10.1097/00002030-199407000-00006; SERVIENE E, 2005, P NATL ACAD SCI US; SMITH JM, 1968, AM NAT, V102, P469, DOI 10.1086/282559; SMITH JM, 1978, EVOLUTION SEX; SMITH SD, 1984, CANCER RES, V44, P5657; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Valdez H, 2002, AIDS, V16, P1113, DOI 10.1097/00002030-200205240-00004; van Opijnen T, 2005, REV MED VIROL, V15, P219, DOI 10.1002/rmv.472; van Opijnen T, 2004, J VIROL, V78, P3675, DOI 10.1128/JVI.78.7.3675-3683.2004; VANOPIJNEN T, 2006, J VIROL IN PRESS; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Zaccarelli M, 2004, CURR HIV RES, V2, P283, DOI 10.2174/1570162043351192	84	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e271	10.1371/journal.pone.0000271	http://dx.doi.org/10.1371/journal.pone.0000271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17342205	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444700006
J	Fic, W; Juge, F; Soret, J; Tazi, J				Fic, Weronika; Juge, Francois; Soret, Johann; Tazi, Jamal			Eye Development under the control of SRp55/B52-Mediated Alternative Splicing of eyeless	PLOS ONE			English	Article								The genetic programs specifying eye development are highly conserved during evolution and involve the vertebrate Pax-6 gene and its Drosophila melanogaster homolog eyeless(ey). Here we report that the SR protein B52/SRp55 controls a novel developmentally regulated splicing event of eyeless that is crucial for eye growth and specification in Drosophila. B52/SRp55 generates two isoforms of eyeless differing by an alternative exon encoding a 60-amino-acid insert at the beginning of the paired domain. The long isoform has impaired ability to trigger formation of ectopic eyes and to bind efficiently Eyeless target DNA sequences in vitro. When over-produced in the eye imaginal disc, this isoform induces a small eye phenotype, whereas the isoform lacking the alternative exon triggers eye over-growth and strong disorganization. Our results suggest that B52/SRp55 splicing activity is used during normal eye development to control eye organogenesis and size through regulation of eyeless alternative splicing.	[Fic, Weronika; Juge, Francois; Soret, Johann; Tazi, Jamal] Univ Montpellier 2, CNRS, UMR 5535, IGMM, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Tazi, J (corresponding author), Univ Montpellier 2, CNRS, UMR 5535, IGMM, Montpellier, France.	jamal.tazi@igmm.cnrs.fr	Juge, François/P-2371-2017	Juge, Francois/0000-0001-5015-2019; Tazi, Jamal/0000-0002-1949-8748	Association pour la Recherche contre le Cancer (ARC); Association Francaise contre les Myopahties (AFM); Agence Nationale de la Recherche [ANR-05-BLAN-0261-01]; European Alternative Splicing Network of Excellence	Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Association Francaise contre les Myopahties (AFM)(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Alternative Splicing Network of Excellence	W. Fic is a recipient of a fellowship from the Association pour la Recherche contre le Cancer (ARC). F.J. was supported by a post-doctoral fellowship of the Association Francaise contre les Myopahties (AFM). This work was supported by grants from the Agence Nationale de la Recherche (ANR-05-BLAN-0261-01) and the European Alternative Splicing Network of Excellence (EURASNET, FP6 life sciences, genomics and biotechnology for health).	Allemand E, 2001, MOL CELL BIOL, V21, P1345, DOI 10.1128/MCB.21.4.1345-1359.2001; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Curtiss J, 2000, DEVELOPMENT, V127, P1325; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; FU XD, 1995, RNA, V1, P663; Gehring WJ, 2004, INT J DEV BIOL, V48, P707, DOI 10.1387/ijdb.041900wg; Gehring WJ, 1996, GENES CELLS, V1, P11, DOI 10.1046/j.1365-2443.1996.11011.x; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564; Hoffman BE, 2000, MOL CELL BIOL, V20, P181, DOI 10.1128/MCB.20.1.181-186.2000; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; KRAUS ME, 1994, MOL CELL BIOL, V14, P5360, DOI 10.1128/MCB.14.8.5360; Labourier E, 1999, GENE DEV, V13, P740, DOI 10.1101/gad.13.6.740; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYEDA A, 1993, MOL CELL BIOL, V13, P2993, DOI 10.1128/MCB.13.5.2993; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Milan M, 2000, DEVELOPMENT, V127, P3069; Mount SM, 2000, J CELL BIOL, V150, pF37, DOI 10.1083/jcb.150.2.F37; Niimi T, 1999, DEVELOPMENT, V126, P2253; Ostrin EJ, 2006, GENOME RES, V16, P466, DOI 10.1101/gr.4673006; Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; Punzo C, 2002, DEVELOPMENT, V129, P625; Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Rasheva VI, 2006, MOL CELL BIOL, V26, P3468, DOI 10.1128/MCB.26.9.3468-3477.2006; RING HJ, 1994, MOL CELL BIOL, V14, P7499, DOI 10.1128/MCB.14.11.7499; Sanford J R, 2003, Prog Mol Subcell Biol, V31, P33; Seimiya M, 2000, DEVELOPMENT, V127, P1879; Shi H, 1997, MOL CELL BIOL, V17, P2649, DOI 10.1128/MCB.17.5.2649; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Soret J, 2003, Prog Mol Subcell Biol, V31, P89; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; WORBY CA, 2001, SCI STKE, pL1; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; YANG XM, 1994, P NATL ACAD SCI USA, V91, P6924, DOI 10.1073/pnas.91.15.6924; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9; ZUO P, 1994, P NATL ACAD SCI USA, V91, P3363, DOI 10.1073/pnas.91.8.3363	60	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e253	10.1371/journal.pone.0000253	http://dx.doi.org/10.1371/journal.pone.0000253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327915	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444600013
J	Levy, S; Ihmels, J; Carmi, M; Weinberger, A; Friedlander, G; Barkai, N				Levy, Sagi; Ihmels, Jan; Carmi, Miri; Weinberger, Adina; Friedlander, Gilgi; Barkai, Naama			Strategy of Transcription Regulation in the Budding Yeast	PLOS ONE			English	Article								Cells must adjust their gene expression in order to compete in a constantly changing environment. Two alternative strategies could in principle ensure optimal coordination of gene expression with physiological requirements. First, characters of the internal physiological state, such as growth rate, metabolite levels, or energy availability, could be feedback to tune gene expression. Second, internal needs could be inferred from the external environment, using evolutionary-tuned signaling pathways. Coordination of ribosomal biogenesis with the requirement for protein synthesis is of particular importance, since cells devote a large fraction of their biosynthetic capacity for ribosomal biogenesis. To define the relative contribution of internal vs. external sensing to the regulation of ribosomal biogenesis gene expression in yeast, we subjected S. cerevisiae cells to conditions which decoupled the actual vs. environmentally-expected growth rate. Gene expression followed the environmental signal according to the expected, but not the actual, growth rate. Simultaneous monitoring of gene expression and growth rate in continuous cultures further confirmed that ribosome biogenesis genes responded rapidly to changes in the environments but were oblivious to longer-term changes in growth rate. Our results suggest that the capacity to anticipate and prepare for environmentally-mediated changes in cell growth presented a major selection force during yeast evolution.	[Levy, Sagi; Ihmels, Jan; Carmi, Miri; Weinberger, Adina; Friedlander, Gilgi; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Levy, Sagi; Ihmels, Jan; Carmi, Miri; Weinberger, Adina; Friedlander, Gilgi; Barkai, Naama] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Ihmels, Jan] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Weizmann Institute of Science; Weizmann Institute of Science; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il	Levy, Sagi/AAG-1593-2019		Kahn Fund; Tauber Fund	Kahn Fund; Tauber Fund	This work was supported by a grant from the Kahn Fund for Systems Biology at the Weizmann Institute of Science, and by the Tauber Fund through the Foundations of Cognition Initiative.	Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Jain V, 2006, J MICROBIOL, V44, P1; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Schneider DA, 2002, P NATL ACAD SCI USA, V99, P8602, DOI 10.1073/pnas.132285199; SEGEL LA, 1984, MODELING DYNAMIC PHE, pR20; Walker KA, 2004, J BIOL CHEM, V279, P50818, DOI 10.1074/jbc.M406285200; Wang H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-91; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005	31	60	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e250	10.1371/journal.pone.0000250	http://dx.doi.org/10.1371/journal.pone.0000250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327914	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444600010
J	Sjolinder, H; Jonsson, AB				Sjolinder, Hong; Jonsson, Ann-Beth			Imaging of Disease Dynamics during Meningococcal Sepsis	PLOS ONE			English	Article								Neisseria meningitidis is a human pathogen that causes septicemia and meningitis with high mortality. The disease progression is rapid and much remains unknown about the disease process. The understanding of disease development is crucial for development of novel therapeutic strategies and vaccines against meningococcal disease. The use of bioluminescent imaging combined with a mouse disease model allowed us to investigate the progression of meningococcal sepsis over time. Injection of bacteria in blood demonstrated waves of bacterial clearance and growth, which selected for Opa-expressing bacteria, indicating the importance of this bacterial protein. Further, N. meningitidis accumulated in the thyroid gland, while thyroid hormone T4 levels decreased. Bacteria reached the mucosal surfaces of the upper respiratory tract, which required expression of the meningococcal PilC1 adhesin. Surprisingly, PilC1 was dispensable for meningococcal growth in blood and for crossing of the blood-brain barrier, indicating that the major role of PilC1 is to interact with mucosal surfaces. This in vivo study reveals disease dynamics and organ targeting during meningococcal disease and presents a potent tool for further investigations of meningococcal pathogenesis and vaccines in vivo. This might lead to development of new strategies to improve the outcome of meningococcal disease in human patients.	[Sjolinder, Hong; Jonsson, Ann-Beth] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Jonsson, AB (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Ann-Beth.Jonsson@imbim.uu.se			The Swedish Research Council [2004-4831, 2002-6240, 2006-5073, 2006-4112]; Swedish Cancer Society; Magnus Bergvalls Foundation; Ake Wibergs Stiftelse; Swedish Society for Medicine; Torsten och Ragnar Soderbergs Stiftelse; Knut och Alice Wallenbergs Stiftelse; Laerdal Foundation for Acute Medicine; Uppsala University	The Swedish Research Council(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Magnus Bergvalls Foundation; Ake Wibergs Stiftelse; Swedish Society for Medicine; Torsten och Ragnar Soderbergs Stiftelse; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Laerdal Foundation for Acute Medicine; Uppsala University	This work was supported by grants from The Swedish Research Council (Dnr 2004-4831, 2002-6240, 2006-5073, 2006-4112), Swedish Cancer Society, Magnus Bergvalls Foundation, Ake Wibergs Stiftelse, Swedish Society for Medicine, Torsten och Ragnar Soderbergs Stiftelse, Knut och Alice Wallenbergs Stiftelse, Laerdal Foundation for Acute Medicine, and Uppsala University.	Albiger B, 2003, INFECT IMMUN, V71, P155, DOI 10.1128/IAI.71.1.155-162.2003; Cattaneo R, 2004, J VIROL, V78, P4385, DOI 10.1128/JVI.78.9.4385-4388.2004; Dehio C, 2000, Subcell Biochem, V33, P61; deVries FP, 1996, INFECT IMMUN, V64, P2998, DOI 10.1128/IAI.64.8.2998-3006.1996; Edwards JL, 2005, CELL MICROBIOL, V7, P1197, DOI 10.1111/j.1462-5822.2005.00547.x; Edwards JL, 2002, CELL MICROBIOL, V4, P571, DOI 10.1046/j.1462-5822.2002.t01-1-00215.x; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; Gorringe AR, 2005, VACCINE, V23, P2214, DOI 10.1016/j.vaccine.2005.01.053; Gray-Owen SD, 2003, SCAND J INFECT DIS, V35, P614, DOI 10.1080/00365540310016042; Hackett SJ, 2002, ARCH DIS CHILD, V86, P44, DOI 10.1136/adc.86.1.44; Hobbs MM, 1998, MICROBIOL-UK, V144, P157, DOI 10.1099/00221287-144-1-157; HOLBEIN BE, 1979, INFECT IMMUN, V24, P545, DOI 10.1128/IAI.24.2.545-551.1979; Ilver D, 1998, INFECT IMMUN, V66, P469, DOI 10.1128/IAI.66.2.469-473.1998; Inan M, 2003, SURG TODAY, V33, P24, DOI 10.1007/s005950300004; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Johansson L, 2005, J IMMUNOL, V175, P433, DOI 10.4049/jimmunol.175.1.433; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Kirchner M, 2005, MOL MICROBIOL, V56, P945, DOI 10.1111/j.1365-2958.2005.04600.x; Koomey M, 2001, CURR OPIN MICROBIOL, V4, P53, DOI 10.1016/S1369-5274(00)00164-8; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; MACKINNON FG, 1992, MICROB PATHOGENESIS, V12, P415, DOI 10.1016/0882-4010(92)90004-8; Massari P, 2003, TRENDS MICROBIOL, V11, P87, DOI 10.1016/S0966-842X(02)00037-9; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Mezosi E, 2005, J ENDOCRINOL, V185, P121, DOI 10.1677/joe.1.05968; Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; Riley-Vargas RC, 2004, TRENDS IMMUNOL, V25, P496, DOI 10.1016/j.it.2004.07.004; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rytkonen A, 2004, J INFECT DIS, V189, P402, DOI 10.1086/381271; SALIT IE, 1986, INFECT IMMUN, V51, P648, DOI 10.1128/IAI.51.2.648-652.1986; SAUKKONEN K, 1988, MICROB PATHOGENESIS, V4, P203, DOI 10.1016/0882-4010(88)90070-8; Szychowska Z, 1998, Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw, V4, P19; Tobiason DM, 2006, PLOS BIOL, V4, P1069, DOI 10.1371/journal.pbio.0040185; Toropainen M, 1999, VACCINE, V17, P2677, DOI 10.1016/S0264-410X(99)00049-3; Zhu DZ, 2005, INFECT IMMUN, V73, P6838, DOI 10.1128/IAI.73.10.6838-6845.2005	37	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e241	10.1371/journal.pone.0000241	http://dx.doi.org/10.1371/journal.pone.0000241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311106	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444500020
J	Finn, RN; Kristoffersen, BA				Finn, Roderick Nigel; Kristoffersen, Borge A.			Vertebrate Vitellogenin Gene Duplication in Relation to the "3R Hypothesis": Correlation to the Pelagic Egg and the Oceanic Radiation of Teleosts	PLOS ONE			English	Article							WHOLE-GENOME DUPLICATION; FREE AMINO-ACIDS; YOLK-SAC LARVAE; DEDUCED PRIMARY-STRUCTURE; OOCYTE MATURATION; 2 FORMS; BARFIN FLOUNDER; MARINE TELEOST; HOX CLUSTERS; MULTIPLE VITELLOGENINS	The spiny ray-finned teleost fishes (Acanthomorpha) are the most successful group of vertebrates in terms of species diversity. Their meteoric radiation and speciation in the oceans during the late Cretaceous and Eocene epoch is unprecedented in vertebrate history, occurring in one third of the time for similar diversity to appear in the birds and mammals. The success of marine teleosts is even more remarkable considering their long freshwater ancestry, since it implies solving major physiological challenges when freely broadcasting their eggs in the hyper-osmotic conditions of seawater. Most extant marine teleosts spawn highly hydrated pelagic eggs, due to differential proteolysis of vitellogenin (Vtg)-derived yolk proteins. The maturational degradation of Vtg involves depolymerization of mainly the lipovitellin heavy chain (LvH) of one form of Vtg to generate a large pool of free amino acids (FAA 150-200 m M). This organic osmolyte pool drives hydration of the ooctye while still protected within the maternal ovary. In the present contribution, we have used Bayesian analysis to examine the evolution of vertebrate Vtg genes in relation to the "3R hypothesis'' of whole genome duplication (WGD) and the functional end points of LvH degradation during oocyte maturation. We find that teleost Vtgs have experienced a post-R3 lineage-specific gene duplication to form paralogous clusters that correlate to the pelagic and benthic character of the eggs. Neo-functionalization allowed one paralogue to be proteolyzed to FAA driving hydration of the maturing oocytes, which pre-adapts them to the marine environment and causes them to float. The timing of these events matches the appearance of the Acanthomorpha in the fossil record. We discuss the significance of these adaptations in relation to ancestral physiological features, and propose that the neo-functionalization of duplicated Vtg genes was a key event in the evolution and success of the teleosts in the oceanic environment.	[Finn, Roderick Nigel; Kristoffersen, Borge A.] Univ Bergen, Dept Biol, Bergen, Norway	University of Bergen	Finn, RN (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	nigel.finn@bio.uib.no	Finn, Roderick Nigel/Y-2916-2019	Finn, Roderick Nigel/0000-0002-8776-3945				Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Allendorf F.W., 1984, P1; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2004, GENOME RES, V14, P1, DOI 10.1101/gr.1717804; Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; [Anonymous], 1966, VERTEBRATE PALEONTOL; Babin PJ, 1999, J MOL EVOL, V49, P150, DOI 10.1007/PL00006528; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; Buisine N, 2002, MOL GENET GENOMICS, V268, P535, DOI 10.1007/s00438-002-0771-5; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; Carnevali O, 2006, GEN COMP ENDOCR, V146, P195, DOI 10.1016/j.ygcen.2005.12.007; Carnevali O, 1999, BIOL REPROD, V60, P140, DOI 10.1095/biolreprod60.1.140; Chen JS, 1997, J MOL EVOL, V44, P440, DOI 10.1007/PL00006164; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; CRAIK JCA, 1987, J MAR BIOL ASSOC UK, V67, P169, DOI 10.1017/S0025315400026436; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; de Pinna Mario C.C., 1996, P147; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Evans David H., 2004, P247; Evans David H., 1993, P315; Fabra M, 2005, SCIENCE, V307, P545, DOI 10.1126/science.1106305; Fabra M, 2004, MOL REPROD DEV, V67, P282, DOI 10.1002/mrd.20018; Fabra M, 2006, DEV BIOL, V295, P250, DOI 10.1016/j.ydbio.2006.03.034; Ferrier DE, 2005, CURR BIOL, V15, pR820, DOI 10.1016/j.cub.2005.10.014; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Fink SV, 1996, INTERRELATIONSHIPS F, P251; Finn RN, 1996, COMP BIOCHEM PHYS A, V115, P133, DOI 10.1016/0300-9629(96)00026-6; Finn RN, 1995, MAR BIOL, V124, P355, DOI 10.1007/BF00363909; Finn RN, 2002, MAR ECOL PROG SER, V237, P217, DOI 10.3354/meps237217; Finn RN, 2002, J EXP BIOL, V205, P211; Force A, 2002, J EXP ZOOL, V294, P30, DOI 10.1002/jez.10091; Fujiwara Y, 2005, GEN COMP ENDOCR, V143, P267, DOI 10.1016/j.ygcen.2005.03.014; Fulton T.W., 1898, 16 FISH BOARD SCOT 3, P83; Furlong RF, 2004, BIOL J LINN SOC, V82, P425, DOI 10.1111/j.1095-8312.2004.00329.x; Furlong RF, 2002, PHILOS T R SOC B, V357, P531, DOI 10.1098/rstb.2001.1035; Gardiner BG, 2005, ZOOL J LINN SOC-LOND, V144, P511, DOI 10.1111/j.1096-3642.2005.00181.x; GERBERHUBER S, 1987, NUCLEIC ACIDS RES, V15, P4737, DOI 10.1093/nar/15.12.4737; Glenner H, 2004, CURR BIOL, V14, P1644, DOI 10.1016/j.cub.2004.09.027; Gray J, 1932, J EXP BIOL, V9, P277; GREELEY MS, 1991, COMP BIOCHEM PHYS A, V100, P639, DOI 10.1016/0300-9629(91)90383-N; GRIFFITH RW, 1987, COMP BIOCHEM PHYS A, V87, P523, DOI 10.1016/0300-9629(87)90355-0; Haldane JB., 1990, CAUSES EVOLUTION; Hayakawa H, 2006, BIOCHEM BIOPH RES CO, V344, P173, DOI 10.1016/j.bbrc.2006.03.116; Hiramatsu N, 2005, BIOCH MOLEC, V6, P431; Hiramatsu N, 2002, FISHERIES SCI, V68, P694, DOI 10.2331/fishsci.68.sup1_694; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hughes AL, 1999, J MOL EVOL, V48, P565, DOI 10.1007/PL00006499; Hurley I, 2005, EVOL DEV, V7, P556, DOI 10.1111/j.1525-142X.2005.05059.x; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Inoue JG, 2004, MOL PHYLOGENET EVOL, V32, P274, DOI 10.1016/j.ympev.2003.11.009; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Irvine SQ, 2002, J EXP ZOOL, V294, P47, DOI 10.1002/jez.10090; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JORGENSEN NC, 1984, CELL TISSUE RES, V235, P643; Kamm K, 2006, CURR BIOL, V16, P920, DOI 10.1016/j.cub.2006.03.036; Keller G, 2001, PLANET SPACE SCI, V49, P817, DOI 10.1016/S0032-0633(01)00032-0; Kendall A.W. Jr, 1984, American Society of Ichthyologists and Herpetologists Special Publication, P11; KORMANIK GA, 1993, ENVIRON BIOL FISH, V38, P233, DOI 10.1007/BF00842919; Krogh A, 1937, J EXP BIOL, V14, P35; Kumazawa Y, 2000, MOL BIOL EVOL, V17, P1869, DOI 10.1093/oxfordjournals.molbev.a026288; Kumazawa Y, 1999, BIOL BIODIVERSITY, P35; LAFLEUR GJ, 1991, J EXP ZOOL, V258, P126, DOI 10.1002/jez.1402580114; LAFLEUR GJ, 1995, J MOL EVOL, V41, P505, DOI 10.1007/BF00160323; LaFleur GJ, 2005, BIOL REPROD, V73, P815, DOI 10.1095/biolreprod.105.041335; Liberles DA, 2001, MOL BIOL EVOL, V18, P2040, DOI 10.1093/oxfordjournals.molbev.a003745; LOEFFLER CA, 1970, J EXP BIOL, V52, P291; LONG JA, 1995, RISE FISHES 500 MILL; Lynch M, 2001, GENETICS, V159, P1789; Marshall William S., 2006, P177; Matsubara T, 2003, FISH PHYSIOL BIOCHEM, V28, P295, DOI 10.1023/B:FISH.0000030559.71954.37; Matsubara T, 1997, J EXP ZOOL, V278, P189, DOI 10.1002/(SICI)1097-010X(19970615)278:3<189::AID-JEZ8>3.0.CO;2-K; Matsubara T, 1999, DEV BIOL, V213, P18, DOI 10.1006/dbio.1999.9365; McInerney JO, 2006, TRENDS ECOL EVOL, V21, P230, DOI 10.1016/j.tree.2006.03.008; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Meyer A, 1999, CURR BIOL, V9, pR210, DOI 10.1016/S0960-9822(99)80131-6; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Mikawa N, 2006, COMP BIOCHEM PHYS B, V143, P404, DOI 10.1016/j.cbpb.2005.12.013; Milroy T. H., 1898, 16th Rep Fish Board Scotland, P135; Miracle A, 2006, ECOTOX ENVIRON SAFE, V63, P337, DOI 10.1016/j.ecoenv.2005.12.002; Mossel E, 2005, SCIENCE, V309, P2207, DOI 10.1126/science.1115493; Mulley J, 2004, NATURE, V431, P916, DOI 10.1038/431916a; Needham J, 1930, J EXP BIOL, V7, P7; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Ohkubo N, 2004, GEN COMP ENDOCR, V137, P19, DOI 10.1016/j.ygcen.2004.02.019; Ohkubo N, 2002, MAR BIOL, V140, P187, DOI 10.1007/s002270100647; Ohkubo N, 2003, GEN COMP ENDOCR, V131, P353, DOI 10.1016/S0016-6480(03)00035-2; Ohkubo N, 2006, FISHERIES SCI, V72, P620, DOI 10.1111/j.1444-2906.2006.01192.x; Ohno S, 1999, CELL MOL LIFE SCI, V55, P824, DOI 10.1007/s000180050336; Ohno S., 1970, EVOLUTION GENE DUPLI; OKUMURA H, 1995, FISHERIES SCI, V61, P529, DOI 10.2331/fishsci.61.529; PEREZ LE, 1991, COMP BIOCHEM PHYS B, V100, P821, DOI 10.1016/0305-0491(91)90297-Q; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; POTTS WTW, 1969, J EXP BIOL, V50, P223; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Raldua D, 2006, AM J PHYSIOL-REG I, V290, pR456, DOI 10.1152/ajpregu.00528.2005; Reith M, 2001, J EXP ZOOL, V291, P58, DOI 10.1002/jez.5; Robinson-Rechavi M, 2001, CURR BIOL, V11, pR458, DOI 10.1016/S0960-9822(01)00280-9; Romano M, 2004, MOL REPROD DEV, V69, P109, DOI 10.1002/mrd.20146; RONNESTAD I, 1992, MAR ECOL PROG SER, V88, P195, DOI 10.3354/meps088195; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Sawaguchi S, 2006, MOL REPROD DEV, V73, P719, DOI 10.1002/mrd.20446; Sawaguchi S, 2005, BIOL REPROD, V72, P1045, DOI 10.1095/biolreprod.104.037895; SCHMIDTKE J, 1977, NATURE, V266, P532, DOI 10.1038/266532a0; Selman K, 2001, J EXP ZOOL, V290, P265, DOI 10.1002/jez.1057; Seoka M, 2003, AQUACULTURE, V216, P355, DOI 10.1016/S0044-8486(02)00459-3; Siltberg J, 2002, J EVOLUTION BIOL, V15, P588, DOI 10.1046/j.1420-9101.2002.00416.x; SILVA R, 1989, MOL CELL BIOL, V9, P3557, DOI 10.1128/MCB.9.8.3557; Skibinski DOF, 2004, MOL BIOL EVOL, V21, P1753, DOI 10.1093/molbev/msh193; Skrabanek L, 1998, CURR OPIN GENET DEV, V8, P694, DOI 10.1016/S0959-437X(98)80039-7; Smith HW, 1953, FISH PHILOS STORY OU; Steele SL, 2004, J EXP BIOL, V207, P2021, DOI 10.1242/jeb.00959; Steinke D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-20; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; STEINMANN G, 1906, BER NATF GES FREIBUR, V16, P1; Swafford D. L., 2002, PAUP PHYLOGENETIC AN; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tauber E, 2004, J BIOL RHYTHM, V19, P445, DOI 10.1177/0748730404268775; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Thompson JR, 2002, BIOCHEMISTRY-US, V41, P9398, DOI 10.1021/bi025674w; Thorsen A, 1996, J FISH BIOL, V48, P1195; Thorsen Anders, 1993, P94; Tingaud-Sequeira A, 2007, GENE, V386, P98, DOI 10.1016/j.gene.2006.08.018; Van de Peer Yves, 2003, Journal of Structural and Functional Genomics, V3, P65, DOI 10.1023/A:1022652814749; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Venkatesh B, 2003, CURR OPIN GENET DEV, V13, P588, DOI 10.1016/j.gde.2003.09.001; von Schantz M, 2006, J MOL EVOL, V62, P701, DOI 10.1007/s00239-005-0185-1; WALLACE RA, 1992, J COMP PHYSIOL B, V162, P241, DOI 10.1007/BF00357530; Wang H, 2000, GENE, V256, P303, DOI 10.1016/S0378-1119(00)00376-0; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; WATANABE WO, 1986, J FISH BIOL, V28, P425, DOI 10.1111/j.1095-8649.1986.tb05180.x; Wilkie MP, 2002, J EXP ZOOL, V293, P284, DOI 10.1002/jez.10123; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Wright P.A., 2001, Fish Physiology, V20, P149; Yoshitome S, 2003, DEV GROWTH DIFFER, V45, P283; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383; Zmasek CM, 2001, BIOINFORMATICS, V17, P821, DOI 10.1093/bioinformatics/17.9.821; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	158	165	172	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e169	10.1371/journal.pone.0000169	http://dx.doi.org/10.1371/journal.pone.0000169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17245445	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000207444100006
J	Krystkowiak, P; Gaura, V; Labalette, M; Rialland, A; Remy, P; Peschanski, M; Bachoud-Levi, AC				Krystkowiak, Pierre; Gaura, Veronique; Labalette, Myriam; Rialland, Amandine; Remy, Philippe; Peschanski, Marc; Bachoud-Levi, Anne-Catherine			Alloimmunisation to Donor Antigens and Immune Rejection Following Foetal Neural Grafts to the Brain in Patients with Huntington's Disease	PLOS ONE			English	Article								Background. The brain is deemed "immunologically privileged'' due to sparse professional antigen-presenting cells and lymphatic drainage, and to the blood-brain barrier. Although the actual extent of this privilege is controversial, there is general consensus about the limited need in intracerebral neural grafts for immunosuppressive regimens comparable to those used in other cases of allotransplantation. This has led over the past fifteen years to the use of either short-term or even no immunosuppression in most clinical trials with foetal neural transplant in patients with Parkinson's and Huntington's disease. Methodology/Principal Findings. We report biological demonstration of alloimmunisation without signs of rejection in four grafted patients out of 13 studied during the course of a clinical trial involving fetal neural transplantation in patients with Huntington's Disease. Biological, radiological and clinical demonstration of an ongoing rejection process was observed in a fifth transplanted patient. The rejection process was, however, fully reversible under immunosuppressive treatment and graft activity recovered within six months. Conclusions/Significance. There had been, up to date, no report of documented cases that could have cast a doubt on those procedures. Our results underline the need for a reconsideration of the extent of the so-called immune privilege of the brain and of the follow-up protocols of patients with intracerebral grafts. It also suggests that some of the results obtained in past studies with foetal neural transplants may have been biased by an unrecognized immune response to donor cells.	[Krystkowiak, Pierre] Ctr Hosp Reg & Univ Lille, Hosp R Salengro, Equipe Associee 2683, Dept Neurol & Movement Disorders, F-59037 Lille, France; [Gaura, Veronique; Remy, Philippe] CEA, Serv Hosp Frederic Joliot, CNRS, Unite Rech Associee 2210, F-91406 Orsay, France; [Labalette, Myriam] Fac Med Lille, Serv Immunol, F-59045 Lille, France; [Rialland, Amandine; Remy, Philippe; Bachoud-Levi, Anne-Catherine] CHU Henri Mondor, AP HP, Serv Neurol, F-94010 Creteil, France; [Rialland, Amandine; Remy, Philippe; Bachoud-Levi, Anne-Catherine] CHU Henri Mondor, Fac Med Paris 12, F-94010 Creteil, France; [Peschanski, Marc; Bachoud-Levi, Anne-Catherine] Hop Henri Mondor, INSERM, Fac Med Creteil, U421, F-94010 Creteil, France	Universite de Lille - ISITE; CHU Lille; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Peschanski, M (corresponding author), Inst Stem Cell Therapy & Explorat Monogen Dis I S, Evry, France.	mpeschanski@istem.genethon.fr	Peschanski, Marc/N-5769-2017; Bachoud-Lévi, Anne-Catherine/GYU-8680-2022; LABALETTE, Myriam/M-4203-2018	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; LABALETTE, Myriam/0000-0002-1524-9891; Remy, Philippe/0000-0003-2150-2563	Assistance-Publique/Hopitaux de Paris [NCT00190450]; Association Francaise contre les Myopathies; INSERM	Assistance-Publique/Hopitaux de Paris; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	These results have been obtained as an ancillary study to the MIG-HD clinical trial (Multicentric Intracerebral Grafting in Huntington's Disease, NCT00190450) sponsored by Assistance-Publique/Hopitaux de Paris, with additional support from Association Francaise contre les Myopathies and INSERM. The study sponsors have had no role either in study design, collection, analysis and interpretation of data, writing of the paper nor in decision to submit.	Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Bachoud-Levi AC, 2006, LANCET NEUROL, V5, P303, DOI 10.1016/S1474-4422(06)70381-7; Barker Roger A, 2004, NeuroRx, V1, P472, DOI 10.1007/BF03206631; DEFER GL, 1994, BRAIN, V119, P41; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gaura V, 2004, BRAIN, V127, P65, DOI 10.1093/brain/awh003; HANTRAYE P, 1992, P NATL ACAD SCI USA, V89, P4187, DOI 10.1073/pnas.89.9.4187; Hourmant M, 2005, J AM SOC NEPHROL, V16, P2804, DOI 10.1681/ASN.2004121130; Lee PC, 2002, TRANSPLANTATION, V74, P1192, DOI 10.1097/00007890-200210270-00025; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; McKenna RM, 2000, TRANSPLANTATION, V69, P319, DOI 10.1097/00007890-200002150-00001; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203; Wood MJA, 1996, TRENDS NEUROSCI, V19, P497, DOI 10.1016/S0166-2236(96)10060-6	14	97	102	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e166	10.1371/journal.pone.0000166	http://dx.doi.org/10.1371/journal.pone.0000166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17245442	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444100003
J	Williams, KT; Young, SP; Negus, A; Young, LS; Adams, DH; Afford, SC				Williams, Kevin T.; Young, Steven P.; Negus, Alison; Young, Lawrence S.; Adams, David H.; Afford, Simon C.			C4b Binding Protein Binds to CD154 Preventing CD40 Mediated Cholangiocyte Apoptosis: A Novel Link between Complement and Epithelial Cell Survival	PLOS ONE			English	Article								Activation of CD40 on hepatocytes and cholangiocytes is critical for amplifying Fas-mediated apoptosis in the human liver. C4b-Binding Protein (C4BP) has been reported to act as a potential surrogate ligand for CD40, suggesting that it could be involved in modulating liver epithelial cell survival. Using surface plasmon resonance (BiaCore) analysis supported by gel filtration we have shown that C4BP does not bind CD40, but it forms stable high molecular weight complexes with soluble CD40 ligand (sCD154). These C4BP/sCD154 complexes bound efficiently to immobilised CD40, but when applied to cholangiocytes they failed to induce apoptosis or proliferation or to activate NFkB, AP-1 or STAT 3, which are activated by sCD154 alone. Thus C4BP can modulate CD40/sCD154 interactions by presenting a high molecular weight multimeric sCD154/C4BP complex that suppresses critical intracellular signalling pathways, permitting cell survival without inducing proliferation. Immunohistochemistry demonstrated co-localisation and enhanced expression of C4BP and CD40 in human liver cancers. These findings suggest a novel pathway whereby components of the complement system and TNF ligands and receptors might be involved in modulating epithelial cell survival in chronic inflammation and malignant disease.	[Williams, Kevin T.; Negus, Alison; Adams, David H.; Afford, Simon C.] Univ Birmingham, Liver Res Grp, Birmingham, W Midlands, England; [Williams, Kevin T.; Negus, Alison; Adams, David H.; Afford, Simon C.] Univ Birmingham, MRC Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England; [Young, Steven P.] Univ Birmingham, Sch Med, Dept Rheumatol, Birmingham, W Midlands, England; [Young, Lawrence S.] Univ Birmingham, Sch Med, Canc Res UK Inst Canc Studies, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; Cancer Research UK; University of Birmingham	Afford, SC (corresponding author), Univ Birmingham, Liver Res Grp, Birmingham, W Midlands, England.	s.c.afford@bham.ac.uk	Young, Lawrence S/B-7213-2009; Adams, David H/C-9092-2009; Young, Stephen P/A-7380-2008	Young, Lawrence S/0000-0003-3919-4298; Adams, David H/0000-0001-6776-0336; Young, Stephen P/0000-0002-6355-3361	Biotechnology and Biological Science Research Council; Medical Research Council [G9818340B] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support was received in the form of a project grant (Ref 6/C19953) from the Biotechnology and Biological Science Research Council. The sponsor played no role in the design or conduct of the study and BBSRC approval to submit the manuscript was a precondition of accepting the award.	Adams DH, 2005, SEMIN LIVER DIS, V25, P281, DOI 10.1055/s-2005-916320; Adams DH, 2002, FRONT BIOSCI-LANDMRK, V7, pE276; Afford SC, 1999, J EXP MED, V189, P441, DOI 10.1084/jem.189.2.441; AFFORD SC, 1995, J PATHOL, V176, P373, DOI 10.1002/path.1711760408; Afford SC, 2001, FASEB J, V15, P2345, DOI 10.1096/fj.01-0088com; Ahmed-Choudhury J, 2006, CELL SIGNAL, V18, P456, DOI 10.1016/j.cellsig.2005.05.015; Armitage R J, 1993, Semin Immunol, V5, P401; Baxendale AJ, 2005, ONCOGENE, V24, P7913, DOI 10.1038/sj.onc.1208929; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Brodeur SR, 2003, IMMUNITY, V18, P837, DOI 10.1016/S1074-7613(03)00149-3; Choudhury JA, 2003, MOL BIOL CELL, V14, P1334, DOI 10.1091/mbc.E02-07-0378; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DE FRUTOS PG, 1995, J BIOL CHEM, V270, P26950, DOI 10.1074/jbc.270.45.26950; Eliopoulos AG, 2000, MOL CELL BIOL, V20, P5503, DOI 10.1128/MCB.20.15.5503-5515.2000; Hayward AR, 1997, J IMMUNOL, V158, P977; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; HESSING M, 1990, J IMMUNOL, V144, P204; Hill SC, 2005, J IMMUNOL, V174, P41, DOI 10.4049/jimmunol.174.1.41; HOLLENBAUGH D, 1995, J EXP MED, V182, P33, DOI 10.1084/jem.182.1.33; Johnsson E, 1996, J IMMUNOL, V157, P3021; Komichi D, 2003, DIGEST DIS SCI, V48, P2315, DOI 10.1023/B:DDAS.0000007869.67105.27; KUSADAFUNAKOSHI M, 1991, BIOCHEM MED METAB B, V45, P350, DOI 10.1016/0885-4505(91)90040-R; LANE P, 1992, EUR J IMMUNOL, V22, P2573, DOI 10.1002/eji.1830221016; LAPPIN DF, 1990, BIOCHEM J, V271, P767, DOI 10.1042/bj2710767; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; MOFFAT GJ, 1992, BIOCHEMISTRY-US, V31, P12376, DOI 10.1021/bi00164a012; MOFFAT GJ, 1992, J BIOL CHEM, V267, P20400; Murakami K, 1999, J IMMUNOL, V163, P2667; Pound JD, 1999, INT IMMUNOL, V11, P11, DOI 10.1093/intimm/11.1.11; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; SHAKIR A, 2005, LIVER DIS BIOCH MECH; Shudo K, 2001, EUR J IMMUNOL, V31, P2504, DOI 10.1002/1521-4141(200108)31:8<2504::AID-IMMU2504>3.0.CO;2-C; Stephens J, 1999, HEPATOLOGY, V30, P27, DOI 10.1002/hep.510300138; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330, DOI 10.1016/S0952-7915(97)80078-7; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; YELLIN MJ, 1995, J LEUKOCYTE BIOL, V58, P209, DOI 10.1002/jlb.58.2.209	36	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e159	10.1371/journal.pone.0000159	http://dx.doi.org/10.1371/journal.pone.0000159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225862	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444000010
J	Malpica, JM; Sacristan, S; Fraile, A; Garcia-Arenal, F				Malpica, Jose M.; Sacristan, Soledad; Fraile, Aurora; Garcia-Arenal, Fernando			Association and Host Selectivity in Multi-Host Pathogens	PLOS ONE			English	Article							POPULATION-DYNAMICS; MOSAIC-VIRUS; EVOLUTION; RECOMBINATION; INFLUENZA; INFECTION; VIRULENCE; PATTERNS; COMPLEMENTATION; SPECIALIZATION	The distribution of multi-host pathogens over their host range conditions their population dynamics and structure. Also, host co-infection by different pathogens may have important consequences for the evolution of hosts and pathogens, and host-pathogen co-evolution. Hence it is of interest to know if the distribution of pathogens over their host range is random, or if there are associations between hosts and pathogens, or between pathogens sharing a host. To analyse these issues we propose indices for the observed patterns of host infection by pathogens, and for the observed patterns of co-infection, and tests to analyse if these patterns conform to randomness or reflect associations. Applying these tests to the prevalence of five plant viruses on 21 wild plant species evidenced host-virus associations: most hosts and viruses were selective for viruses and hosts, respectively. Interestingly, the more host-selective viruses were the more prevalent ones, suggesting that host specialisation is a successful strategy for multi-host pathogens. Analyses also showed that viruses tended to associate positively in co-infected hosts. The developed indices and tests provide the tools to analyse how strong and common are these associations among different groups of pathogens, which will help to understand and model the population biology of multi-host pathogens.	[Sacristan, Soledad; Fraile, Aurora; Garcia-Arenal, Fernando] Univ Politecn Madrid, Dept Biotecnol, Madrid, Spain; [Sacristan, Soledad; Fraile, Aurora; Garcia-Arenal, Fernando] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain; [Malpica, Jose M.] Inst Nacl Invest Agr & Alimentaria, Dept Biotecnol, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Garcia-Arenal, F (corresponding author), Univ Politecn Madrid, Dept Biotecnol, Madrid, Spain.	fernando.garcia-arenal@upm.es	Garcia-Arenal, Fernando/H-1603-2015; Fraile, Aurora/H-1532-2015; SACRISTAN, SOLEDAD/H-1062-2015	GARCIA-ARENAL RODRIGUEZ, FERNANDO/0000-0002-5327-3200; FRAILE PEREZ, AURORA/0000-0002-2785-7931; SACRISTAN, SOLEDAD/0000-0002-5753-2644	Ministerio de Educacion y Ciencia, Spain [AGL2004-03496]; FPU	Ministerio de Educacion y Ciencia, Spain(Spanish Government); FPU(Spanish Government)	Funding: This work was in part supported by grant AGL2004-03496, Ministerio de Educacion y Ciencia, Spain, to AF. SS was in receipt of a FPU fellowship, Ministerio de Educacion y Ciencia, Spain.	Briddon RW, 2003, MOL PLANT PATHOL, V4, P427, DOI [10.1046/j.1364-3703.2003.00188.x, 10.1046/J.1364-3703.2003.00188.X]; Brockhurst MA, 2006, J EVOLUTION BIOL, V19, P374, DOI 10.1111/j.1420-9101.2005.01026.x; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Cicin-Sain L, 2005, J VIROL, V79, P9492, DOI 10.1128/JVI.79.15.9492-9502.2005; Cleaveland S, 1995, PARASITOLOGY, V111, pS33, DOI 10.1017/S0031182000075806; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Escriu F, 2003, EVOLUTION, V57, P755, DOI 10.1111/j.0014-3820.2003.tb00287.x; Fauquet C. M., 2000, VIRUS TAXONOMY; Foster KR, 2005, SCIENCE, V308, P1269, DOI 10.1126/science.1108158; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; Gandon S, 2001, EVOLUTION, V55, P1056, DOI 10.1554/0014-3820(2001)055[1056:HLHATE]2.0.CO;2; Ganusov VV, 2002, EVOLUTION, V56, P213, DOI 10.1111/j.0014-3820.2002.tb01332.x; Garcia-Arenal F, 2003, PHYTOPATHOLOGY, V93, P941, DOI 10.1094/PHYTO.2003.93.8.941; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Griffiths PD, 2000, REV MED VIROL, V10, P351, DOI 10.1002/1099-1654(200011/12)10:6<351::AID-RMV302>3.0.CO;2-Y; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Hu WS, 2003, FRONT BIOSCI, V8, pD143, DOI 10.2741/940; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; JAVIER RT, 1986, SCIENCE, V234, P746, DOI 10.1126/science.3022376; Karayiannis P, 1998, REV MED VIROL, V8, P13, DOI 10.1002/(SICI)1099-1654(199801/03)8:1&lt;13::AID-RMV208&gt;3.0.CO;2-L; Kawecki TJ, 1998, AM NAT, V152, P635, DOI 10.1086/286195; KENDALL M, ADV THEORY STAT, V2; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Kirchner JW, 2002, EVOL ECOL RES, V4, P27; KONDO A, 1991, J VIROL, V65, P3625, DOI 10.1128/JVI.65.7.3625-3632.1991; Legg JP, 2000, VIRUS RES, V71, P135, DOI 10.1016/S0168-1702(00)00194-5; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Lopez-Ferber M, 2003, P ROY SOC B-BIOL SCI, V270, P2249, DOI 10.1098/rspb.2003.2498; Luis-Arteaga M, 1998, PLANT DIS, V82, P979, DOI 10.1094/PDIS.1998.82.9.979; MANSKY LM, 1995, J PHYTOPATHOL, V143, P247, DOI 10.1111/j.1439-0434.1995.tb00607.x; May Robert M., 1995, Proceedings of the Royal Society of London Series B Biological Sciences, V261, P209, DOI 10.1098/rspb.1995.0138; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Mills JN, 1997, AM J TROP MED HYG, V56, P273; Monci F, 2002, VIROLOGY, V303, P317, DOI 10.1006/viro.2002.1633; Moreno IM, 1997, J VIROL, V71, P9157, DOI 10.1128/JVI.71.12.9157-9162.1997; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; MORIONES E, 1991, PLANT DIS, V75, P930, DOI 10.1094/PD-75-0930; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; Raybould AF, 1999, NEW PHYTOL, V141, P265, DOI 10.1046/j.1469-8137.1999.00339.x; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Regoes RR, 2000, EVOLUTION, V54, P64, DOI 10.1111/j.0014-3820.2000.tb00008.x; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; Rest JS, 2003, INFECT GENET EVOL, V3, P219, DOI 10.1016/j.meegid.2003.08.001; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riley SPD, 2004, J WILDLIFE DIS, V40, P11, DOI 10.7589/0090-3558-40.1.11; Roy BA, 2001, EVOLUTION, V55, P41, DOI 10.1111/j.0014-3820.2001.tb01271.x; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Sacristan S, 2004, PHYTOPATHOLOGY, V94, P992, DOI 10.1094/PHYTO.2004.94.9.992; SCHOENEWEISS DF, 1975, ANNU REV PHYTOPATHOL, V13, P193, DOI 10.1146/annurev.py.13.090175.001205; Simon AE, 2004, ANNU REV PHYTOPATHOL, V42, P415, DOI 10.1146/annurev.phyto.42.040803.140402; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; [No title captured]	60	63	65	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e41	10.1371/journal.pone.0000041	http://dx.doi.org/10.1371/journal.pone.0000041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183670	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600041
J	Shulman, LM; Manor, Y; Sofer, D; Handsher, R; Swartz, T; Delpeyroux, F; Mendelson, E				Shulman, Lester M.; Manor, Yossi; Sofer, Danit; Handsher, Rachel; Swartz, Tiberio; Delpeyroux, Francis; Mendelson, Ella			Neurovirulent Vaccine-Derived Polioviruses in Sewage from Highly Immune Populations	PLOS ONE			English	Article							ORAL POLIOVACCINE; RIVER WATER; POLIO; EVOLUTION; INFECTION; STRAINS; ISRAEL; POLIOMYELITIS; RECOMBINATION; SURVEILLANCE	Background. Vaccine-derived polioviruses (VDPVs) have caused poliomyelitis outbreaks in communities with sub-optimal vaccination. Israeli environmental surveillance of sewage from populations with high (> 95%) documented vaccine coverage of confirmed efficacy identified two separate evolutionary clusters of VDPVs: Group 1 (1998-2005, one system, population 1.6x10(6)) and Group 2 (2006, 2 systems, populations 0.7x10(6) and 5x10(4)). Principal Findings. Molecular analyses support evolution of nine Group 1 VDPVs along five different lineages, starting from a common ancestral type 2 vaccine-derived Sabin-2/Sabin-1 recombinant strain, and independent evolution of three Group 2 VDPVs along one lineage starting from a different recombinant strain. The primary evidence for two independent origins was based on comparison of unique recombination fingerprints, the number and distribution of identical substitutions, and evolutionary rates. Geometric mean titers of neutralizing antibodies against Group 1 VDPVs were significantly lower than against vaccine strains in all age-group cohorts tested. All individuals had neutralizing titers > 1:8 against these VDPVs except 7% of the 20-50 year cohort. Group 1 VDPVs were highly neurovirulent in a transgenic mouse model. Intermediate levels of protective immunity against Group 2 VDPVs correlated with fewer (5.0+1.0) amino acid substitutions in neutralizing antigenic sites than in Group 1 VDPV's (12.1 +/- 1.5). Significance. VDPVs that revert from live oral attenuated vaccines and reacquire characteristics of wild-type polioviruses not only threaten populations with poor immune coverage, but are also a potential source for re-introduction of poliomyelitis into highly immune populations through older individuals with waning immunity. The presence of two independently evolved groups of VDPVs in Israel and the growing number of reports of environmental VDPV elsewhere make it imperative to determine the global frequency of environmental VDPV. Our study underscores the importance of the environmental surveillance and the need to reconsider the global strategies for polio eradication and the proposed cessation of vaccination.	[Shulman, Lester M.; Manor, Yossi; Sofer, Danit; Handsher, Rachel; Mendelson, Ella] Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Publ Hlth Serv, IL-52621 Tel Hashomer, Israel; [Swartz, Tiberio] Chaim Sheba Med Ctr, Israel Ctr Dis Control, Minist Hlth, IL-52621 Tel Hashomer, Israel; [Delpeyroux, Francis] Inst Pasteur, CNRS, FRE 2849, Unit Mol Prevent & Therapy Human Dis, Paris, France; [Mendelson, Ella] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Bar Ilan University	Shulman, LM (corresponding author), Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Publ Hlth Serv, IL-52621 Tel Hashomer, Israel.	cvlsheba@netvision.net.il	Shulman, Lester M./AAU-4372-2021; DELPEYROUX, Francis/ABA-5429-2021; Delpeyroux, Francis/H-8838-2016	Shulman, Lester M./0000-0002-6385-894X; DELPEYROUX, Francis/0000-0002-4895-823X; Delpeyroux, Francis/0000-0002-4895-823X	Israel Ministry of Health	Israel Ministry of Health	We thank the Israel Ministry of Health for supporting this study.	Agol VI, 1997, SEMIN VIROL, V8, P77, DOI 10.1006/smvy.1997.0112; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Buttinelli G, 2003, J GEN VIROL, V84, P1215, DOI 10.1099/vir.0.18974-0; Calderon-Margalit R, 2005, PREV MED, V40, P685, DOI 10.1016/j.ypmed.2004.09.008; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P369; Cherkasova E, 2003, P NATL ACAD SCI USA, V100, P9398, DOI 10.1073/pnas.1633511100; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; DE L, 1995, J CLIN MICROBIOL, V33, P562, DOI 10.1128/JCM.33.3.562-571.1995; DOMINGO E, 1985, GENE, V40, P1, DOI 10.1016/0378-1119(85)90017-4; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; GEORGESCU MM, 1994, J VIROL, V68, P8089, DOI 10.1128/JVI.68.12.8089-8101.1994; Grotto I, 2001, VACCINE, V19, P4162, DOI 10.1016/S0264-410X(01)00165-7; Guillot S, 2000, J VIROL, V74, P8434, DOI 10.1128/JVI.74.18.8434-8443.2000; Halsey NA, 2004, B WORLD HEALTH ORGAN, V82, P3; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kew OM, 1995, SEMIN VIROL, V6, P401, DOI 10.1016/S1044-5773(05)80017-4; KINNUNEN L, 1990, J GEN VIROL, V71, P317, DOI 10.1099/0022-1317-71-2-317; Korotkova EA, 2003, J VIROL, V77, P12460, DOI 10.1128/JVI.77.23.12460-12465.2003; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; Manor Y, 1999, J CLIN MICROBIOL, V37, P1670, DOI 10.1128/JCM.37.6.1670-1675.1999; MCGOLDRICK A, 1995, J VIROL, V69, P7601, DOI 10.1128/JVI.69.12.7601-7605.1995; MENDELSON E, 2002, GLASGOW SCOTLAND J C, V282; Pavlov DN, 2005, WATER RES, V39, P3309, DOI 10.1016/j.watres.2005.05.027; Pertinacova J., 2004, Epidemiologie Mikrobiologie Imunologie, V53, P22; Ranta J, 2001, RISK ANAL, V21, P1087, DOI 10.1111/0272-4332.t01-1-216174; Shulman LM, 2006, ISR MED ASSOC J, V8, P312; Shulman LM, 2000, J CLIN MICROBIOL, V38, P945, DOI 10.1128/JCM.38.3.945-952.2000; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; SHULMAN LM, 1996, 10 INT C VIR JER ISR; SHULMAN LM, 2004, ANN M ISR SOC MICR H; SLATER PE, 1990, LANCET, V335, P1192, DOI 10.1016/0140-6736(90)92705-M; SLATER PE, 1988, LANCET, V335, P1196; Swartz TA, 1998, VACCINE, V16, P2090, DOI 10.1016/S0264-410X(98)00071-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOYODA H, 1984, J MOL BIOL, V174, P561, DOI 10.1016/0022-2836(84)90084-6; Vidor E, 1997, PEDIATR INFECT DIS J, V16, P312, DOI 10.1097/00006454-199703000-00011; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Yakovenko ML, 2006, J VIROL, V80, P2641, DOI 10.1128/JVI.80.6.2641-2653.2006; Yang CF, 2005, J VIROL, V79, P12623, DOI 10.1128/JVI.79.20.12623-12634.2005; Yoshida H, 2000, LANCET, V356, P1461, DOI 10.1016/S0140-6736(00)02868-3; 2005, MMWR, V54, P1053	43	51	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e69	10.1371/journal.pone.0000069	http://dx.doi.org/10.1371/journal.pone.0000069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183700	Green Published, gold			2022-12-27	WOS:000207443600069
J	Mikkelson, GM; Gonzalez, A; Peterson, GD				Mikkelson, Gregory M.; Gonzalez, Andrew; Peterson, Garry D.			Economic Inequality Predicts Biodiversity Loss	PLOS ONE			English	Article								Human activity is causing high rates of biodiversity loss. Yet, surprisingly little is known about the extent to which socioeconomic factors exacerbate or ameliorate our impacts on biological diversity. One such factor, economic inequality, has been shown to affect public health, and has been linked to environmental problems in general. We tested how strongly economic inequality is related to biodiversity loss in particular. We found that among countries, and among US states, the number of species that are threatened or declining increases substantially with the Gini ratio of income inequality. At both levels of analysis, the connection between income inequality and biodiversity loss persists after controlling for biophysical conditions, human population size, and per capita GDP or income. Future research should explore potential mechanisms behind this equality-biodiversity relationship. Our results suggest that economic reforms would go hand in hand with, if not serving as a prerequisite for, effective conservation.	[Mikkelson, Gregory M.; Gonzalez, Andrew; Peterson, Garry D.] McGill Sch Environm, Montreal, PQ, Canada; [Mikkelson, Gregory M.] McGill Univ, Dept Philosophy, Montreal, PQ, Canada; [Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Peterson, Garry D.] McGill Univ, Dept Geog, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Mikkelson, GM (corresponding author), McGill Sch Environm, Montreal, PQ, Canada.	gregory.mikkelson@mcgill.ca	Peterson, Garry D/C-1309-2008; Gonzalez, Andrew/F-2247-2010	Peterson, Garry D/0000-0003-0173-0112; Gonzalez, Andrew/0000-0001-6075-8081	McGill School of Environment for a collaborative research; Canada Research Chair program	McGill School of Environment for a collaborative research; Canada Research Chair program(Canada Research Chairs)	We are grateful to the McGill School of Environment for a collaborative research grant, and to the Canada Research Chair program for support to A. G. and G. D. P.	[Anonymous], 1965, LOGIC COLLECTIVE ACT; Baland JM, 1999, WORLD DEV, V27, P773, DOI 10.1016/S0305-750X(99)00026-1; BERGSTROM T, 1986, J PUBLIC ECON, V29, P25, DOI 10.1016/0047-2727(86)90024-1; BOYCE JK, 1994, ECOL ECON, V11, P169, DOI 10.1016/0921-8009(94)90198-8; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Dayton-Johnson J, 2002, ECON J, V112, P577, DOI 10.1111/1468-0297.00731; *DEP EC SOC AFF UN, 2005, WORLD POP PROSP 2004; *DEV DAT GROUP WOR, 2006, WORLD DEV IND 2006 O; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; *EARTH CHART INT, 2006, EARTH CHART; Itaya J, 1997, ECON LETT, V57, P289, DOI 10.1016/S0165-1765(97)00179-1; Magnani E, 2000, ECOL ECON, V32, P431, DOI 10.1016/S0921-8009(99)00115-9; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; NAESS A, 2006, DEEP ECOLOGY PLATFOR; Naidoo R, 2001, CONSERV BIOL, V15, P1021, DOI 10.1046/j.1523-1739.2001.0150041021.x; Pitt Inequality Project, 2006, STAND INC DISTR DAT; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sauer J. R., 2005, N AM BREEDING BIRD S; U.S. Bureau of the Census, 2005, TABL S4 GIN RAT STAT; U. S. Census Bureau, 2002, DEM TRENDS 20 CENT; *UN ENV PROGR WORL, 2005, KNOWN THREAT SPEC; *US BUR CENS, 2005, TABL S3 PER CAP INC; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; York R, 2003, AM SOCIOL REV, V68, P279, DOI 10.2307/1519769	27	84	85	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e444	10.1371/journal.pone.0000444	http://dx.doi.org/10.1371/journal.pone.0000444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505535	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445900004
J	Narasimhan, S; DePonte, K; Marcantonio, N; Liang, XP; Royce, TE; Nelson, KF; Booth, CJ; Koski, B; Anderson, JF; Kantor, F; Fikrig, E				Narasimhan, Sukanya; DePonte, Kathleen; Marcantonio, Nancy; Liang, Xianping; Royce, Thomas E.; Nelson, Kenneth F.; Booth, Carmen J.; Koski, Benjamin; Anderson, John F.; Kantor, Fred; Fikrig, Erol			Immunity against Ixodes scapularis Salivary Proteins Expressed within 24 Hours of Attachment Thwarts Tick Feeding and Impairs Borrelia Transmission	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; LYME-DISEASE; RICINUS L; RHIPICEPHALUS-APPENDICULATUS; ACQUIRED-RESISTANCE; PASSIVE TRANSFER; AMPLIFIED RNA; GUINEA-PIGS; ANTIGENS; BURGDORFERI	In North America, the black-legged tick, Ixodes scapularis, an obligate haematophagus arthropod, is a vector of several human pathogens including Borrelia burgdorferi, the Lyme disease agent. In this report, we show that the tick salivary gland transcriptome and proteome is dynamic and changes during the process of engorgement. We demonstrate, using a guinea pig model of I. scapularis feeding and B. burgdorferi transmission, that immunity directed against salivary proteins expressed in the first 24 h of tick attachment - and not later - is sufficient to evoke all the hallmarks of acquired tick-immunity, to thwart tick feeding and also to impair Borrelia transmission. Defining this subset of proteins will promote a mechanistic understanding of novel I. scapularis proteins critical for the initiation of tick feeding and for Borrelia transmission.	[Narasimhan, Sukanya; Liang, Xianping; Koski, Benjamin; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA; [DePonte, Kathleen; Marcantonio, Nancy; Kantor, Fred] Yale Univ, Sch Med, Dept Internal Med, Sect Allergy & Clin Immunol, New Haven, CT 06510 USA; [Royce, Thomas E.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Nelson, Kenneth F.] Yale Univ, Dept Biochem & Biophys, New Haven, CT USA; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Anderson, John F.] Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Connecticut Agricultural Experiment Station	Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA.	erol.fikrig@yale.edu			NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065583] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the NIH	Aljamali MN, 2002, EXP APPL ACAROL, V28, P89, DOI 10.1023/A:1025346131903; ALLEN J R, 1973, International Journal for Parasitology, V3, P195, DOI 10.1016/0020-7519(73)90024-6; ALLEN JR, 1989, EXP APPL ACAROL, V7, P5, DOI 10.1007/BF01200448; Almazan C, 2005, VACCINE, V23, P4403, DOI 10.1016/j.vaccine.2005.04.012; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; ASKENASE PW, 1982, IMMUNOLOGY, V45, P501; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; BELL JF, 1979, AM J TROP MED HYG, V28, P876, DOI 10.4269/ajtmh.1979.28.876; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROSSARD M, 1979, EXPERIENTIA, V35, P1395, DOI 10.1007/BF01964030; BROSSARD M, 1982, PARASITOLOGY, V85, P583, DOI 10.1017/S0031182000056365; Burke GS, 2005, EMERG INFECT DIS, V11, P36; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; de la Fuente J, 2006, VACCINE, V24, P4082, DOI 10.1016/j.vaccine.2006.02.046; DESILVA AM, 1995, AM J TROP MED HYG, V53, P397, DOI 10.4269/ajtmh.1995.53.397; DHARAMPAUL S, 1993, J MED ENTOMOL, V30, P262, DOI 10.1093/jmedent/30.1.262; DIZIJ A, 1995, PARASITE IMMUNOL, V17, P177, DOI 10.1111/j.1365-3024.1995.tb00887.x; DVORAK HF, 1970, J EXP MED, V132, P558, DOI 10.1084/jem.132.3.558; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti NMB, 2004, THROMB HAEMOSTASIS, V91, P886, DOI 10.1160/TH03-11-0715; Gillespie RD, 2001, J IMMUNOL, V166, P4319, DOI 10.4049/jimmunol.166.7.4319; Gillespie RD, 2000, PARASITE IMMUNOL, V22, P319, DOI 10.1046/j.1365-3024.2000.00309.x; GORDON JR, 1987, PARASITE IMMUNOL, V9, P337, DOI 10.1111/j.1365-3024.1987.tb00512.x; Hannier S, 2004, IMMUNOLOGY, V113, P401, DOI 10.1111/j.1365-2567.2004.01975.x; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Hodzic E, 1998, J CLIN MICROBIOL, V36, P3574, DOI 10.1128/JCM.36.12.3574-3578.1998; Labuda M, 2006, PLOS PATHOG, V2, P251, DOI 10.1371/journal.ppat.0020027; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATHER TN, 1990, EXP PARASITOL, V70, P55, DOI 10.1016/0014-4894(90)90085-Q; Montgomery RR, 2007, INFECT IMMUN, V75, P613, DOI 10.1128/IAI.00685-06; Mulenga A, 2000, MICROBES INFECT, V2, P1353, DOI 10.1016/S1286-4579(00)01289-2; Narasimhan S, 2002, INSECT MOL BIOL, V11, P641, DOI 10.1046/j.1365-2583.2002.00375.x; Nazario S, 1998, AM J TROP MED HYG, V58, P780, DOI 10.4269/ajtmh.1998.58.780; Nuttall PA, 2006, PARASITE IMMUNOL, V28, P155, DOI 10.1111/j.1365-3024.2006.00806.x; Nuttall PA, 2004, PARASITOLOGY, V129, pS177, DOI 10.1017/S0031182004005633; Park JY, 2004, BIOCHEM BIOPH RES CO, V325, P1346, DOI 10.1016/j.bbrc.2004.10.151; PIESMAN J, 1987, J CLIN MICROBIOL, V25, P557, DOI 10.1128/JCM.25.3.557-558.1987; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Ribeiro JMC, 1998, EXP PARASITOL, V89, P213, DOI 10.1006/expr.1998.4296; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Sauer J. R., 1986, MORPHOLOGY PHYSL BEH; SHAPIRO SZ, 1986, J PARASITOL, V72, P454, DOI 10.2307/3281686; Sonenshine DE., 1991, BIOL TICKS; Telford SR, 1996, P NATL ACAD SCI USA, V93, P6209, DOI 10.1073/pnas.93.12.6209; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209; Thomas V, 2001, INFECT IMMUN, V69, P3359, DOI 10.1128/IAI.69.5.3359-3371.2001; TRAGER WILLIAM, 1939, JOUR PARASITOL, V25, P57, DOI 10.2307/3272160; Trimnell AR, 2005, VACCINE, V23, P4329, DOI 10.1016/j.vaccine.2005.03.041; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wang H, 1999, PARASITOLOGY, V119, P143, DOI 10.1017/S0031182099004540; Wang H, 2001, MED VET ENTOMOL, V15, P403, DOI 10.1046/j.0269-283x.2001.00328.x; WHEELER CM, 1991, J PARASITOL, V77, P965, DOI 10.2307/3282751; WHELEN AC, 1986, J PARASITOL, V72, P155, DOI 10.2307/3281809; WHELEN AC, 1993, J PARASITOL, V79, P908, DOI 10.2307/3283729; WIKEL SK, 1988, VET PARASITOL, V29, P235, DOI 10.1016/0304-4017(88)90127-6; WIKEL SK, 1986, VET PARASITOL, V20, P149, DOI 10.1016/0304-4017(86)90098-1; Wikel SK, 1997, INFECT IMMUN, V65, P335, DOI 10.1128/IAI.65.1.335-338.1997; WIKEL SK, 1976, IMMUNOLOGY, V30, P311; Wikel SK, 1996, ANNU REV ENTOMOL, V41, P1, DOI 10.1146/annurev.en.41.010196.000245; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Willadsen P, 1999, PARASITOL TODAY, V15, P258, DOI 10.1016/S0169-4758(99)01472-6; Willadsen P, 1980, Adv Parasitol, V18, P293, DOI 10.1016/S0065-308X(08)60402-9	67	75	76	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e451	10.1371/journal.pone.0000451	http://dx.doi.org/10.1371/journal.pone.0000451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505544	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445900010
J	Epstein, JM; Goedecke, DM; Yu, F; Morris, RJ; Wagener, DK; Bobashev, GV				Epstein, Joshua M.; Goedecke, D. Michael; Yu, Feng; Morris, Robert J.; Wagener, Diane K.; Bobashev, Georgiy V.			Controlling Pandemic Flu: The Value of International Air Travel Restrictions	PLOS ONE			English	Article							TRANSPORTATION NETWORK; SPREAD; INFLUENZA; STRATEGIES	Background. Planning for a possible influenza pandemic is an extremely high priority, as social and economic effects of an unmitigated pandemic would be devastating. Mathematical models can be used to explore different scenarios and provide insight into potential costs, benefits, and effectiveness of prevention and control strategies under consideration. Methods and Findings. A stochastic, equation-based epidemic model is used to study global transmission of pandemic flu, including the effects of travel restrictions and vaccination. Economic costs of intervention are also considered. The distribution of First Passage Times (FPT) to the United States and the numbers of infected persons in metropolitan areas worldwide are studied assuming various times and locations of the initial outbreak. International air travel restrictions alone provide a small delay in FPT to the U. S. When other containment measures are applied at the source in conjunction with travel restrictions, delays could be much longer. If in addition, control measures are instituted worldwide, there is a significant reduction in cases worldwide and specifically in the U. S. However, if travel restrictions are not combined with other measures, local epidemic severity may increase, because restriction-induced delays can push local outbreaks into high epidemic season. The per annum cost to the U. S. economy of international and major domestic air passenger travel restrictions is minimal: on the order of 0.8% of Gross National Product. Conclusions. International air travel restrictions may provide a small but important delay in the spread of a pandemic, especially if other disease control measures are implemented during the afforded time. However, if other measures are not instituted, delays may worsen regional epidemics by pushing the outbreak into high epidemic season. This important interaction between policy and seasonality is only evident with a global-scale model. Since the benefit of travel restrictions can be substantial while their costs are minimal, dismissal of travel restrictions as an aid in dealing with a global pandemic seems premature.	[Epstein, Joshua M.] Brookings Inst, Econ Studies Program, Washington, DC 20036 USA; [Goedecke, D. Michael; Yu, Feng; Morris, Robert J.; Bobashev, Georgiy V.] RTI Int, Stat & Epidemiol, Res Triangle Pk, NC USA; [Wagener, Diane K.] RTI Int, Stat & Epidemiol, Rockville, MD USA	Brookings Institution; Research Triangle Institute; Research Triangle Institute	Epstein, JM (corresponding author), Brookings Inst, Econ Studies Program, Washington, DC 20036 USA.	jepstein@brookings.edu			NIGMS [1 U01 GM070698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070698] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Pilot Studies of Modeling of Infectious Disease Agents Study (MIDAS) cooperative agreement from NIGMS, (1 U01 GM070698).	ANDERSON R M, 1991; BAROYAN OV, 1981, PROGRAMMING COMPUT S, V6, P272; BRINKHOFF T, 2005, MATO GROSSO CITY POP; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; *BUR TRANSP STAT, 2002, AIR CARR FIN STAT; Colizza V, 2006, B MATH BIOL, V68, P1893, DOI 10.1007/s11538-006-9077-9; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; *DEP EC SOC AFF UN, 2004, WORLD URB PROSP I003; *ESRI, 2005, ARCGIS 9 WORLD EUR C; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; HELDERS S, 2005, WORLD GAZETTER; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; *MONG COM, 2004, WORLD POP FIG; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; *US BUR CENS POP D, 2004, CBSAEST200401 US BUR; *US DEP COMM, 2005, SURV CURR BUS, V85; *US SEN JOINT EC C, 2001, ASS LOSS AIRL IND IT	25	195	204	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e401	10.1371/journal.pone.0000401	http://dx.doi.org/10.1371/journal.pone.0000401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476323	Green Published, gold			2022-12-27	WOS:000207445700003
J	Tzelepis, F; Persechini, PM; Rodrigues, MM				Tzelepis, Fanny; Persechini, Pedro M.; Rodrigues, Mauricio M.			Modulation of CD4(+) T Cell-Dependent Specific Cytotoxic CD8(+) T Cells Differentiation and Proliferation by the Timing of Increase in the Pathogen Load	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; MALARIA LIVER STAGES; LISTERIA-MONOCYTOGENES; ANTIGEN PRESENTATION; TOXOPLASMA-GONDII; CD8-T-CELL MEMORY; VIRAL-INFECTION; CD4-T-CELL HELP; DEFICIENT MICE; 3RD SIGNAL	Background. Following infection with viruses, bacteria or protozoan parasites, naive antigen-specific CD8(+) T cells undergo a process of differentiation and proliferation to generate effector cells. Recent evidences suggest that the timing of generation of specific effector CD8(+) T cells varies widely according to different pathogens. We hypothesized that the timing of increase in the pathogen load could be a critical parameter governing this process. Methodology/Principal Findings. Using increasing doses of the protozoan parasite Trypanosoma cruzi to infect C57BL/6 mice, we observed a significant acceleration in the timing of parasitemia without an increase in mouse susceptibility. In contrast, in CD8 deficient mice, we observed an inverse relationship between the parasite inoculum and the timing of death. These results suggest that in normal mice CD8(+) T cells became protective earlier, following the accelerated development of parasitemia. The evaluation of specific cytotoxic responses in vivo to three distinct epitopes revealed that increasing the parasite inoculum hastened the expansion of specific CD8(+) cytotoxic T cells following infection. The differentiation and expansion of T. cruzi-specific CD8(+) cytotoxic T cells is in fact dependent on parasite multiplication, as radiation-attenuated parasites were unable to activate these cells. We also observed that, in contrast to most pathogens, the activation process of T. cruzi-specific CD8(+) cytotoxic T cells was dependent on MHC class II restricted CD4(+) T cells. Conclusions/Significance. Our results are compatible with our initial hypothesis that the timing of increase in the pathogen load can be a critical parameter governing the kinetics of CD4(+) T cell-dependent expansion of pathogen-specific CD8(+) cytotoxic T cells.	[Tzelepis, Fanny; Rodrigues, Mauricio M.] Univ Fed Sao Paulo, Escola Paulista Med, CINTERGEN, Sao Paulo, Brazil; [Tzelepis, Fanny; Rodrigues, Mauricio M.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Persechini, Pedro M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ilha Fundao, Ctr Ciencias Saude, BR-21941 Rio De Janeiro, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Rodrigues, MM (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, CINTERGEN, Sao Paulo, Brazil.	mrodrigues@ecb.epm.br	Persechini, Pedro/A-9477-2009; Rodrigues, Mauricio M./B-8512-2012	Persechini, Pedro/0000-0002-3278-1951; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Millennium Institute for Vaccine Development and Technology [CNPq - 420067/2005-1]; FAPESP; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Millennium Institute for Vaccine Development and Technology; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, and The Millennium Institute for Vaccine Development and Technology (CNPq - 420067/2005-1). FT is a recipient of a fellowship from FAPESP. PMP and MMR are recipients of fellowships from CNPq.	Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Da Silva APG, 2003, IMMUNOLOGY, V108, P230, DOI 10.1046/j.1365-2567.2003.01571.x; Datta SK, 2006, IMMUNITY, V25, P143, DOI 10.1016/j.immuni.2006.05.013; Denkers EY, 1997, J IMMUNOL, V159, P1903; Hafalla JCR, 2002, P NATL ACAD SCI USA, V99, P11819, DOI 10.1073/pnas.182189999; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Harty JT, 2002, CURR OPIN IMMUNOL, V14, P360, DOI 10.1016/S0952-7915(02)00333-3; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kwok LY, 2003, J IMMUNOL, V170, P1949, DOI 10.4049/jimmunol.170.4.1949; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Lutjen S, 2006, INFECT IMMUN, V74, P5790, DOI 10.1128/IAI.00098-06; Luu RA, 2006, J IMMUNOL, V177, P1516, DOI 10.4049/jimmunol.177.3.1516; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P145; Morrot A, 2005, J EXP MED, V202, P551, DOI 10.1084/jem.20042463; Morrot A, 2004, IMMUNOL REV, V201, P291, DOI 10.1111/j.0105-2896.2004.00175.x; Muller U, 2003, EUR J IMMUNOL, V33, P70, DOI 10.1002/immu.200390009; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Renggli J, 1997, PARASITE IMMUNOL, V19, P145, DOI 10.1046/j.1365-3024.1997.d01-190.x; Riberdy JM, 2000, J VIROL, V74, P9762, DOI 10.1128/JVI.74.20.9762-9765.2000; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; Schmidt CS, 2002, J IMMUNOL, V168, P5521, DOI 10.4049/jimmunol.168.11.5521; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tarleton RL, 1996, INT IMMUNOL, V8, P13, DOI 10.1093/intimm/8.1.13; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; Tzelepis F, 2006, INFECT IMMUN, V74, P2477, DOI 10.1128/IAI.74.4.2477-2481.2006; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004	40	45	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e393	10.1371/journal.pone.0000393	http://dx.doi.org/10.1371/journal.pone.0000393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460760	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445600007
J	Diaz-Martinez, LA; Gimenez-Abian, JF; Clarke, DJ				Diaz-Martinez, Laura A.; Gimenez-Abian, Juan F.; Clarke, Duncan J.			Cohesin Is Dispensable for Centromere Cohesion in Human Cells	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; VERTEBRATE COHESIN; MEDIATED COHESION; CHROMOSOME; TOPOISOMERASE; SEPARATION; ANAPHASE; CHECKPOINT; SHUGOSHIN; COMPLEX	Background. Proper regulation of the cohesion at the centromeres of human chromosomes is essential for accurate genome transmission. Exactly how cohesion is maintained and is then dissolved in anaphase is not understood. Principal Findings. We have investigated the role of the cohesin complex at centromeres in human cells both by depleting cohesin subunits using RNA interference and also by expressing a non-cleavable version of the Rad21 cohesin protein. Rad21 depletion results in aberrant anaphase, during which the sister chromatids separate and segregate in an asynchronous fashion. However, centromere cohesion was maintained before anaphase in Rad21-depleted cells, and the primary constrictions at centromeres were indistinguishable from those in control cells. Expression of non-cleavable Rad21 (NC-Rad21), in which the sites normally cleaved by separase are mutated, resulted in delayed sister chromatid resolution in prophase and prometaphase, and a blockage of chromosome arm separation in anaphase, but did not impede centromere separation. Conclusions. These data indicate that cohesin complexes are dispensable for sister cohesion in early mitosis, yet play an important part in the fidelity of sister separation and segregation during anaphase. Cleavage at the separase-sensitive sites of Rad21 is important for arm separation, but not for centromere separation.	[Diaz-Martinez, Laura A.; Gimenez-Abian, Juan F.; Clarke, Duncan J.] Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Gimenez-Abian, Juan F.] CSIC, Ctr Invest Biol, Madrid, Spain	University of Minnesota System; University of Minnesota Twin Cities; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Clarke, DJ (corresponding author), Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	Duncan.J.Clarke-2@umn.edu	Díaz-Martínez, Laura/A-5357-2010; Abián, Juan F Giménez/E-6372-2015	Abián, Juan F Giménez/0000-0002-9220-286X; Diaz-Martinez, Laura/0000-0002-7226-7068; Clarke, Duncan/0000-0002-7795-3294	NIH [CA099033]; MEC-Spain DGI; CONACyT; NATIONAL CANCER INSTITUTE [R01CA099033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEC-Spain DGI; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH grant CA099033 (D. J. C.) and J. F. G. A was partly supported by MEC-Spain DGI and L. A. D. M. by CONACyT.	Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bailis JM, 2003, CELL CYCLE, V2, P303, DOI 10.4161/cc.2.4.434; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; CLARKE DJ, 1993, J CELL SCI, V105, P563; Clarke DJ, 2006, CELL CYCLE, V5, P1925, DOI 10.4161/cc.5.17.3200; COOK PR, 1991, CELL, V66, P627, DOI 10.1016/0092-8674(91)90109-C; Darwiche N, 1999, GENE, V233, P39, DOI 10.1016/S0378-1119(99)00160-2; Diaz-Martinez LA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000053; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Flemming W., 1882, ZELLSUBSTANZ KERN ZE; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1576, DOI 10.4161/cc.4.11.2147; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1561, DOI 10.4161/cc.4.11.2146; Gimenez-Abian JF, 2002, EUR J CELL BIOL, V81, P9, DOI 10.1078/0171-9335-00226; GIMENEZABIAN JF, 1995, J CELL BIOL, V131, P7, DOI 10.1083/jcb.131.1.7; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Huang JA, 2004, CELL CYCLE, V3, P973; Kenney RD, 2006, J CELL SCI, V119, P5057, DOI 10.1242/jcs.03277; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; LIU LF, 1979, NATURE, V281, P456, DOI 10.1038/281456a0; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Noble D, 2006, CELL CYCLE, V5, P2528, DOI 10.4161/cc.5.21.3405; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; SUMNER AT, 1991, CHROMOSOMA, V100, P410, DOI 10.1007/BF00337519; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Vagnarelli P, 2004, EMBO REP, V5, P167, DOI 10.1038/sj.embor.7400077; Watanabe Y, 2005, PHILOS T ROY SOC B, V360, P515, DOI 10.1098/rstb.2004.1607; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; WOLF F, 2006, EMBO J; Yalon M, 2004, J CELL SCI, V117, P1961, DOI 10.1242/jcs.01032; Yu HT, 2005, CELL CYCLE, V4, P262; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	53	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e318	10.1371/journal.pone.0000318	http://dx.doi.org/10.1371/journal.pone.0000318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389909	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445200001
J	Demeny, MA; Soutoglou, E; Nagy, Z; Scheer, E; Janoshazi, A; Richardot, M; Argentini, M; Kessler, P; Tora, L				Demeny, Mate A.; Soutoglou, Evi; Nagy, Zita; Scheer, Elisabeth; Janoshazi, Agnes; Richardot, Magalie; Argentini, Manuela; Kessler, Pascal; Tora, Laszlo			Identification of a Small TAF Complex and Its Role in the Assembly of TAF-Containing Complexes	PLOS ONE			English	Article							RNA-POLYMERASE-II; HISTONE FOLD; TRANSCRIPTION; COMPONENTS; BINDING; SAGA; DISTINCT; PROTEIN; CHROMATIN; PROMOTER	TFIID plays a role in nucleating RNA polymerase II preinitiation complex assembly on protein-coding genes. TFIID is a multisubunit complex comprised of the TATA box binding protein (TBP) and 14 TBP-associated factors (TAFs). Another class of multiprotein transcriptional regulatory complexes having histone acetyl transferase (HAT) activity, and containing TAFs, includes TFTC, STAGA and the PCAF/GCN5 complex. Looking for as yet undiscovered subunits by a proteomic approach, we had identified TAF8 and SPT7L in human TFTC preparations. Subsequently, however, we demonstrated that TAF8 was not a stable component of TFTC, but that it is present in a small TAF complex (SMAT), containing TAF8, TAF10 and SPT7L, that co-purified with TFTC. Thus, TAF8 is a subunit of both TFIID and SMAT. The latter has to be involved in a pathway of complex formation distinct from the other known TAF complexes, since these three histone fold (HF)-containing proteins (TAF8, TAF10 and SPT7L) can never be found together either in TFIID or in STAGA/TFTC HAT complexes. Here we show that TAF8 is absolutely necessary for the integration of TAF10 in a higher order TFIID core complex containing seven TAFs. TAF8 forms a heterodimer with TAF10 through its HF and proline rich domains, and also interacts with SPT7L through its C-terminal region, and the three proteins form a complex in vitro and in vivo. Thus, the TAF8-TAF10 and TAF10-SPT7L HF pairs, and also the SMAT complex, seem to be important regulators of the composition of different TFIID and/or STAGA/TFTC complexes in the nucleus and consequently may play a role in gene regulation.	[Demeny, Mate A.; Soutoglou, Evi; Nagy, Zita; Scheer, Elisabeth; Janoshazi, Agnes; Richardot, Magalie; Argentini, Manuela; Kessler, Pascal; Tora, Laszlo] Univ Strasbourg, INSERM, U596, IGBMC,CNRS,UMR 7104, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tora, L (corresponding author), Univ Strasbourg, INSERM, U596, IGBMC,CNRS,UMR 7104, Strasbourg, France.	laszlo@igbmc.u-strasbg.fr	Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250; Soutoglou, Evi/0000-0002-3724-5613	European Community [HPRN-CT-2000-00088, PRN-CT 00504228, STREP LSHG-CT-2004-502950]; ARC [05-BLAN-0396-01]; EU-RTN MC [HPRN-CT 00504228]; CNRS; INSERM; Universite Louis Pasteur; Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale; Fond National de La Science ACI; INTAS; AICR [03-084]	European Community(European Commission); ARC(Australian Research Council); EU-RTN MC; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Louis Pasteur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fond National de La Science ACI; INTAS(INTASEuropean Commission); AICR	M. A. Demeny was supported by a fellowship from the European Community grant (HPRN-CT-2000-00088) and a fellowship from the ARC, E. Soutoglou was supported by an EMBO fellowship and Z. Nagy was supported by a EU-RTN MC grant (HPRN-CT 00504228). This work was supported by funds from CNRS, INSERM, Universite Louis Pasteur, Association pour la Recherche sur le Cancer, the Fondation pour la Recherche Medicale, the Fond National de La Science ACI, ANR (05-BLAN-0396-01; Regulome), European Community (HPRN-CT 00504228 and STREP LSHG-CT-2004-502950), INTAS and AICR (03-084) grants.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bell B, 1999, EXP CELL RES, V246, P11, DOI 10.1006/excr.1998.4294; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; BROU C, 1993, NUCLEIC ACIDS RES, V21, P4011, DOI 10.1093/nar/21.17.4011; Cavusoglu N, 2003, PROTEOMICS, V3, P217, DOI 10.1002/pmic.200390030; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Gangloff YG, 2001, MOL CELL BIOL, V21, P1841, DOI 10.1128/MCB.21.5.1841-1853.2001; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Guermah M, 2003, MOL CELL, V12, P991, DOI 10.1016/S1097-2765(03)00396-4; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Hernandez-Hernandez A, 2001, MOL CELL BIOL, V21, P614, DOI 10.1128/MCB.21.2.614-623.2001; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Lebedeva LA, 2005, P NATL ACAD SCI USA, V102, P18087, DOI 10.1073/pnas.0509063102; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; Memedula S, 2003, CURR BIOL, V13, P241, DOI 10.1016/S0960-9822(03)00048-4; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mohan WS, 2003, MOL CELL BIOL, V23, P4307, DOI 10.1128/MCB.23.12.4307-4318.2003; Nishizaka S, 2000, CANCER RES, V60, P4830; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; OSSIPOW V, 1995, CELL, V83, P137, DOI 10.1016/0092-8674(95)90242-2; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Soutoglou E, 2005, MOL CELL BIOL, V25, P4092, DOI 10.1128/MCB.25.10.4092-4104.2005; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; vom Baur E, 1998, GENE DEV, V12, P1278, DOI 10.1101/gad.12.9.1278; Voss AK, 2000, DEVELOPMENT, V127, P5449; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1	47	44	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e316	10.1371/journal.pone.0000316	http://dx.doi.org/10.1371/journal.pone.0000316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375202	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445100018
J	Diaz, S; Amaro, F; Rico, D; Campos, V; Benitez, L; Martin-Gonzalez, A; Hamilton, EP; Orias, E; Gutierrez, JC				Diaz, Silvia; Amaro, Francisco; Rico, Daniel; Campos, Virginia; Benitez, Laura; Martin-Gonzalez, Ana; Hamilton, Eileen P.; Orias, Eduardo; Gutierrez, Juan C.			Tetrahymena Metallothioneins Fall into Two Discrete Subfamilies	PLOS ONE			English	Article							STRESS INDUCIBLE METALLOTHIONEIN; METAL-BINDING FEATURES; IN-VITRO; HEAVY-METALS; ALPHA-DOMAIN; CADMIUM; GENE; PROTEIN; COPPER; EXPRESSION	Background. Metallothioneins are ubiquitous small, cysteine-rich, multifunctional proteins which can bind heavy metals. Methodology/Principal Findings. We report the results of phylogenetic and gene expression analyses that include two new Tetrahymena thermophila metallothionein genes (MTT3 and MTT5). Sequence alignments of all known Tetrahymena metallothioneins have allowed us to rationalize the structure of these proteins. We now formally subdivide the known metallothioneins from the ciliate genus Tetrahymena into two well defined subfamilies, 7a and 7b, based on phylogenetic analysis, on the pattern of clustering of Cys residues, and on the pattern of inducibility by the heavy metals Cd and Cu. Sequence alignment also reveals a remarkably regular, conserved and hierarchical modular structure of all five subfamily 7a MTs, which include MTT3 and MTT5. The former has three modules, while the latter has only two. Induction levels of the three T. thermophila genes were determined using quantitative real time RT-PCR. Various stressors (including heavy metals) brought about dramatically different fold-inductions for each gene; MTT5 showed the highest fold-induction. Conserved DNA motifs with potential regulatory significance were identified, in an unbiased way, upstream of the start codons of subfamily 7a MTs. EST evidence for alternative splicing in the 3' UTR of the MTT5 mRNA with potential regulatory activity is reported. Conclusion/Significance. The small number and remarkably regular structure of Tetrahymena MTs, coupled with the experimental tractability of this model organism for studies of in vivo function, make it an attractive system for the experimental dissection of the roles, structure/function relationships, regulation of gene expression, and adaptive evolution of these proteins, as well as for the development of biotechnological applications for the environmental monitoring of toxic substances.	[Hamilton, Eileen P.; Orias, Eduardo] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Diaz, Silvia; Amaro, Francisco; Rico, Daniel; Campos, Virginia; Benitez, Laura; Martin-Gonzalez, Ana; Gutierrez, Juan C.] Univ Complutense, Fac Biol, Dept Microbiol 3, Madrid, Spain	University of California System; University of California Santa Barbara; Complutense University of Madrid	Hamilton, EP (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.		MARTIN, ANA/ABG-7710-2020; Amaro, Francisco/Y-5610-2019; Rico, Daniel/I-2049-2013	Amaro, Francisco/0000-0002-0061-477X; Rico, Daniel/0000-0002-6561-2310; Gutierrez, Juan Carlos/0000-0003-0909-3349	CAM [07M/0029/2002]; Del AMO project (UCM-University of California); NIH [RR-09231]; Ministerio de Educacion y Ciencia; Complutense University; UC-UCM EAP;  [BOS2002-01067 MCYT (1+ D)];  [CGL2005-00548]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR009231] Funding Source: NIH RePORTER	CAM; Del AMO project (UCM-University of California)(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Educacion y Ciencia(Spanish Government); Complutense University; UC-UCM EAP; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was partially supported by the following grants: BOS2002-01067 MCYT (1+ D) to A. M. G., CAM (07M/0029/2002) and CGL2005-00548 to J.C.G., Del AMO project (UCM-University of California) to J.C.G. and E.O., NIH grant RR-09231 to E.O., Ph.D. scholarship from Ministerio de Educacion y Ciencia to S. D. and V. C., Ph.D. scholarship from Complutense University (UCM) to F. A. and UC-UCM EAP scholarship to D. R.	BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Binz PA, 1999, METALLOTHIONEIN IV, P7; Boldrin F, 2006, EUKARYOT CELL, V5, P422, DOI 10.1128/EC.5.2.422-425.2006; Boldrin F, 2002, PROTIST, V153, P283, DOI 10.1078/1434-4610-00105; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chabanon Herve, 2004, Briefings in Functional Genomics & Proteomics, V3, P240; Cheung, 2005, BBA-GENE STRUCT EXPR, V1731, P191, DOI [10.1016/j.bbaexp.2005.09.006, 10.1016/j.bbaexp.2005.9.006]; CHURCH HJ, 1993, J INORG BIOCHEM, V49, P55, DOI 10.1016/0162-0134(93)80048-E; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; CODY CW, 1994, BIOCHEM BIOPH RES CO, V202, P954, DOI 10.1006/bbrc.1994.2022; COUSINS RJ, 1985, PHYSIOL REV, V65, P238, DOI 10.1152/physrev.1985.65.2.238; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031; Dondero F, 2004, PROTIST, V155, P157, DOI 10.1078/143446104774199565; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; Egli D, 2006, GENES CELLS, V11, P647, DOI 10.1111/j.1365-2443.2006.00971.x; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Emoto T, 1996, BIOCHEM GENET, V34, P239, DOI 10.1007/BF02407022; Erk M, 2001, ANAL CHIM ACTA, V442, P165, DOI 10.1016/S0003-2670(01)01130-8; Fu CJ, 2006, PROTIST, V157, P193, DOI 10.1016/j.protis.2006.02.006; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; Gaertig J, 1999, NAT BIOTECHNOL, V17, P462, DOI 10.1038/8638; Gutierrez JC, 2003, EUR J PROTISTOL, V39, P461, DOI 10.1078/0932-4739-00021; Hamilton EP, 2000, METHOD CELL BIOL, V62, P265; Hamilton EP, 2000, METHOD CELL BIOL, V62, P219; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Henkel G, 2004, CHEM REV, V104, P801, DOI 10.1021/cr020620d; Hughes S, 2007, ENVIRON POLLUT, V145, P395, DOI 10.1016/j.envpol.2006.06.003; IKEBUCHI H, 1986, BIOCHEM J, V233, P541, DOI 10.1042/bj2330541; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; KAGI JHR, 1991, METHOD ENZYMOL, V205, P613; KANEY AR, 1983, EXP CELL RES, V143, P461, DOI 10.1016/0014-4827(83)90074-5; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Klaassen CD, 1998, ENVIRON HEALTH PERSP, V106, P297, DOI 10.2307/3433930; KOJIMA Y, 1976, P NATL ACAD SCI USA, V73, P3413, DOI 10.1073/pnas.73.10.3413; Kondrashov FA, 2006, J THEOR BIOL, V239, P141, DOI 10.1016/j.jtbi.2005.08.033; Kovalchuk I, 2005, MUTAT RES-FUND MOL M, V570, P149, DOI 10.1016/j.mrfmmm.2004.10.004; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Liu J, 1996, FUND APPL TOXICOL, V29, P294, DOI 10.1006/faat.1996.0034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luporini P, 2005, ACTA PROTOZOOL, V44, P89; Martin-Gonzalez A, 2006, RES MICROBIOL, V157, P108, DOI 10.1016/j.resmic.2005.06.005; Martin-Gonzalez A., 1999, Recent Research Developments in Microbiology, V3, P93; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; MICELI C, 1992, P NATL ACAD SCI USA, V89, P1988, DOI 10.1073/pnas.89.5.1988; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; NILSSON JR, 1989, EUR J PROTISTOL, V25, P2, DOI 10.1016/S0932-4739(89)80074-4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nury D, 2005, BIOCHEM J, V387, P419, DOI 10.1042/BJ20040630; Ohno S., 1970, EVOLUTION GENE DUPLI; OLAFSON RW, 1988, BIOCHEM J, V251, P691, DOI 10.1042/bj2510691; PAN PK, 1994, BIOCHEM BIOPH RES CO, V202, P621, DOI 10.1006/bbrc.1994.1973; Park JD, 2001, TOXICOLOGY, V163, P93, DOI 10.1016/S0300-483X(01)00375-4; Penkowa M, 2000, J CEREBR BLOOD F MET, V20, P1174, DOI 10.1097/00004647-200008000-00003; Peterson DS, 2002, MOL BIOCHEM PARASIT, V122, P119, DOI 10.1016/S0166-6851(02)00079-8; Piccinni E, 1999, GENE, V234, P51, DOI 10.1016/S0378-1119(99)00181-X; PICCINNI E, 1994, EUR J BIOCHEM, V226, P853, DOI 10.1111/j.1432-1033.1994.t01-1-00853.x; Robinson NJ, 2001, ADV MICROB PHYSIOL, V44, P183, DOI 10.1016/S0065-2911(01)44014-8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Santovito G, 2001, PROTIST, V152, P219, DOI 10.1078/1434-4610-00061; Santovito G, 2000, EUR J PROTISTOL, V36, P437, DOI 10.1016/S0932-4739(00)80049-8; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Smith JJ, 2004, NUCLEIC ACIDS RES, V32, P4313, DOI 10.1093/nar/gkh771; Tanguy A, 2001, GENE, V273, P123, DOI 10.1016/S0378-1119(01)00577-7; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tio L, 2004, J BIOL CHEM, V279, P24403, DOI 10.1074/jbc.M401346200; Turkewitz AP, 2002, TRENDS GENET, V18, P35, DOI 10.1016/S0168-9525(01)02560-4; Valls M, 2001, J BIOL CHEM, V276, P32835, DOI 10.1074/jbc.M102151200; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Viarengo A, 2000, CELL MOL BIOL, V46, P407; Vidal F, 1993, ZYGOTE, V1, P225, DOI 10.1017/S0967199400001507; Villarreal L, 2006, FEBS J, V273, P523, DOI 10.1111/j.1742-4658.2005.05086.x; WAALKES MP, 1984, TOXICOL LETT, V20, P33, DOI 10.1016/0378-4274(84)90179-6; Wong L, 2000, GENETICS, V155, P1119; WU AL, 1993, J BIOL CHEM, V268, P18850; Wuitschick JD, 1999, J EUKARYOT MICROBIOL, V46, P239, DOI 10.1111/j.1550-7408.1999.tb05120.x; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001	83	68	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e291	10.1371/journal.pone.0000291	http://dx.doi.org/10.1371/journal.pone.0000291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356700	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444800014
J	Popa-Lisseanu, AG; Delgado-Huertas, A; Forero, MG; Rodriguez, A; Arlettaz, R; Ibanez, C				Popa-Lisseanu, Ana G.; Delgado-Huertas, Antonio; Forero, Manuela G.; Rodriguez, Alicia; Arlettaz, Raphael; Ibanez, Carlos			Bats' Conquest of a Formidable Foraging Niche: The Myriads of Nocturnally Migrating Songbirds	PLOS ONE			English	Article								Along food chains, i.e., at different trophic levels, the most abundant taxa often represent exceptional food reservoirs, and are hence the main target of consumers and predators. The capacity of an individual consumer to opportunistically switch towards an abundant food source, for instance, a prey that suddenly becomes available in its environment, may offer such strong selective advantages that ecological innovations may appear and spread rapidly. New predator-prey relationships are likely to evolve even faster when a diet switch involves the exploitation of an unsaturated resource for which few or no other species compete. Using stable isotopes of carbon and nitrogen as dietary tracers, we provide here strong support to the controversial hypothesis that the giant noctule bat Nyctalus lasiopterus feeds on the wing upon the multitude of flying passerines during their nocturnal migratory journeys, a resource which, while showing a predictable distribution in space and time, is only seasonally available. So far, no predator had been reported to exploit this extraordinarily diverse and abundant food reservoir represented by nocturnally migrating passerines.	[Popa-Lisseanu, Ana G.; Forero, Manuela G.; Ibanez, Carlos] CSIC, Estac Biol Donana, E-41080 Seville, Spain; [Delgado-Huertas, Antonio; Rodriguez, Alicia] CSIC, Estac Expt Zaidin, Granada, Spain; [Arlettaz, Raphael] Univ Bern, Inst Zool, Div Conservat Biol, Bern, Switzerland; [Arlettaz, Raphael] Nat Ctr, Valais Field Stn, Swiss Ornithol Inst, Salgesch, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); University of Bern; Swiss Ornithological Institute	Popa-Lisseanu, AG (corresponding author), CSIC, Estac Biol Donana, E-41080 Seville, Spain.	anapopa@ebd.csic.es	Huertas, Antonio Delgado/F-6866-2011; Arlettaz, Raphaël/O-2182-2016; Ibanez, Carlos/H-7577-2015; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Rodríguez Sánchez, Alicia/H-7716-2015	Huertas, Antonio Delgado/0000-0002-7240-1570; Arlettaz, Raphaël/0000-0001-6360-5339; Ibanez, Carlos/0000-0003-1181-7641; Rodríguez Sánchez, Alicia/0000-0002-0028-6120	Organismo Autonomo de Parques Nacionales (MMA) of Spain [021/2002]; MEC of Spain; RyC; FPU	Organismo Autonomo de Parques Nacionales (MMA) of Spain; MEC of Spain(Spanish Government); RyC; FPU(Spanish Government)	This research was funded by the Organismo Autonomo de Parques Nacionales (MMA) of Spain, project 021/2002. MEC of Spain supported M. G. F. with a contract RyC and A. G. P- L. with a predoctoral grant of the program FPU.	Arlettaz R, 2001, OIKOS, V95, P105, DOI 10.1034/j.1600-0706.2001.950112.x; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; BAIRD RW, 1992, OECOLOGIA, V89, P125, DOI 10.1007/BF00319024; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; BenDavid M, 1997, OECOLOGIA, V111, P280, DOI 10.1007/s004420050236; Bontadina F, 2003, FUNCT ECOL, V17, P141, DOI 10.1046/j.1365-2435.2003.00702_1.x; Bruderer B, 1998, J AVIAN BIOL, V29, P499, DOI 10.2307/3677169; BRUDERER B, 1999, P 22 INT ORN C DURB, P1983; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Correia AM, 2001, J ZOOL, V255, P533; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dondini G, 2000, J ZOOL, V251, P233, DOI 10.1111/j.1469-7998.2000.tb00606.x; Hobson KA, 1997, CAN J ZOOL, V75, P1720, DOI 10.1139/z97-799; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Huin N, 1998, BIRD STUDY, V45, P361, DOI 10.1080/00063659809461108; Ibanez C, 2003, FUNCT ECOL, V17, P143, DOI 10.1046/j.1365-2435.2003.00702_2.x; Ibanez C, 2001, P NATL ACAD SCI USA, V98, P9700, DOI 10.1073/pnas.171140598; Ibanez C., 2004, HDB SAUGETIERE EUROP, VII, P695, DOI DOI 10.1080/0964704X.2013.774246; Inger R, 2006, J ANIM ECOL, V75, P1190, DOI 10.1111/j.1365-2656.2006.01142.x; Jones G, 1996, SYM ZOOL S, P111; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kunz T.H., 1988, P277; MACARTHUR RH, 1966, AM NAT, V100, P377; MacAvoy SE, 2005, CAN J ZOOL, V83, P631, DOI 10.1139/Z05-038; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Miron MLL, 2006, J EXP BIOL, V209, P541, DOI 10.1242/jeb.02016; Moreau R., 1972, PALAEARCTIC AFRICAN; Mroz I, 1996, PHYS REV LETT, V76, P3025, DOI 10.1103/PhysRevLett.76.3025; Munday PL, 2004, CURR BIOL, V14, P1498, DOI 10.1016/j.cub.2004.08.029; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; NORBERG UM, 1988, BIOL J LINN SOC, V33, P383, DOI 10.1111/j.1095-8312.1988.tb00451.x; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; ROSENZWEIG ML, 1978, BIOL J LINN SOC, V10, P275, DOI 10.1111/j.1095-8312.1978.tb00016.x; RYDELL J, 1994, P ROY SOC B-BIOL SCI, V257, P175, DOI 10.1098/rspb.1994.0112; Simmons NB, 2005, SCIENCE, V307, P527, DOI 10.1126/science.1108871; Sponheimer M, 2006, RAPID COMMUN MASS SP, V20, P1395, DOI 10.1002/rcm.2454; Sweeting CJ, 2005, FUNCT ECOL, V19, P777, DOI 10.1111/j.1365-2435.2005.01019.x; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; von Helversen O, 2003, BAT ECOLOGY, P346; Walter H., 1979, ELEONORAS FALCON ADA; West AG, 2004, FUNCT ECOL, V18, P616, DOI 10.1111/j.0269-8463.2004.00862.x; WILSON DS, 1986, AM NAT, V127, P835, DOI 10.1086/284528	47	50	50	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e205	10.1371/journal.pone.0000205	http://dx.doi.org/10.1371/journal.pone.0000205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299585	Green Submitted, gold, Green Published			2022-12-27	WOS:000207444400006
J	Hill, PC; Jeffries, DJ; Brookes, RH; Fox, A; Jackson-Sillah, D; Lugos, MD; Donkor, SA; de Jong, BC; Corrah, T; Adegbola, RA; McAdam, KP				Hill, Philip C.; Jeffries, David J.; Brookes, Roger H.; Fox, Annette; Jackson-Sillah, Dolly; Lugos, Moses D.; Donkor, Simon A.; de Jong, Bouke C.; Corrah, Tumani; Adegbola, Richard A.; McAdam, Keith P.			Using ELISPOT to Expose False Positive Skin Test Conversion in Tuberculosis Contacts	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; INFECTION; DIAGNOSIS; SURVEILLANCE; REVERSION; ASSAY	Background. Repeat tuberculin skin tests may be false positive due to boosting of waned immunity to past mycobacterial exposure. We evaluated whether an ELISPOT test could identify tuberculosis (TB) contacts with boosting of immunity to non-tuberculous mycobacterial exposure. Methodology/Principal Findings. We conducted tuberculin and ELISPOT tests in 1665 TB contacts: 799 were tuberculin test negative and were offered a repeat test after three months. Those with tuberculin test conversion had an ELISPOT, chest X-ray and sputum analysis if appropriate. We compared converters with non-converters, assessed the probability of each of four combinations of ELISPOT results over the two time points and estimated boosting with adjustment for ELISPOT sensitivity and specificity. 704 (72%) contacts had a repeat tuberculin test; 176 (25%) had test conversion, which increased with exposure to a case (p = 0.002), increasing age (p = 0.0006) and BCG scar (p = 0.06). 114 tuberculin test converters had ELISPOT results: 16(14%) were recruitment positive/follow-up positive, 9 (8%) positive/negative, 34 (30%) negative/positive, and 55 (48%) were negative/negative. There was a significant non-linear effect of age for ELISPOT results in skin test converters (p = 0.038). Estimates of boosting ranged from 32%-41% of skin test converters with increasing age. Three converters were diagnosed with TB, two had ELISPOT results: both were positive, including one at recruitment. Conclusions/Significance. We estimate that approximately one third of tuberculin skin test conversion in Gambian TB case contacts is due to boosting of immunity to non-tuberculous mycobacterial exposure. Further longitudinal studies are required to confirm whether ELISPOT can reliably identify case contacts with tuberculin test conversion that would benefit most from prophylactic treatment.	[Hill, Philip C.; Jeffries, David J.; Brookes, Roger H.; Fox, Annette; Jackson-Sillah, Dolly; Lugos, Moses D.; Donkor, Simon A.; de Jong, Bouke C.; Corrah, Tumani; Adegbola, Richard A.; McAdam, Keith P.] MRC Unit, Bacterial Dis Programme, Banjul, Gambia	University of London; London School of Hygiene & Tropical Medicine	Hill, PC (corresponding author), MRC Unit, Bacterial Dis Programme, Banjul, Gambia.	phill@mrc.gm	de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675; Lugos, Moses/0000-0002-4921-2691; Brookes, Roger/0000-0002-5361-0617	Medical Research Council (UK); European Commission; Medical Research Council [MC_U190071468, MC_U190081982] Funding Source: researchfish; MRC [MC_U190071468, MC_U190081982] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Medical Research Council (UK) and the European Commission.	Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390; Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; [Anonymous], 1956, Br Med J, V1, P413; COMSTOCK GW, 1969, AM REV RESPIR DIS, V100, P839; EDWARDS LB, 1953, RESPONSE BCG VACCINA; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Jeffries DJ, 2006, INT J TUBERC LUNG D, V10, P192; Jeffries DJ, 2004, INT J TUBERC LUNG D, V8, P1095; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Levy MZ, 2005, INT J TUBERC LUNG D, V9, P771; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; *NAT I HLTH CLIN E, 2006, CLIN GUIDELINE, V33, P1; PALMER CE, 1952, LANCET, V262, P935; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Pouchot J, 1997, ANN INTERN MED, V126, P210, DOI 10.7326/0003-4819-126-3-199702010-00005; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; TUKEY JW, 1950, AM REV TUBERC PULM, V62, P77; van der Loeff MFS, 2003, AIDS, V17, P1841, DOI [10.1097/00002030-200308150-00014, 10.1097/01.aids.0000076303.76477.49]; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vekemans J, 2001, INFECT IMMUN, V69, P6554, DOI 10.1128/IAI.69.10.6554-6557.2001; WASZ-HOCKERT O, 1947, Ann Med Intern Fenn, V36, P764	27	27	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e183	10.1371/journal.pone.0000183	http://dx.doi.org/10.1371/journal.pone.0000183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17264885	Green Published, gold			2022-12-27	WOS:000207444200007
J	Lemaire, F; Mandon, CA; Reboud, J; Papine, A; Angulo, J; Pointu, H; Diaz-Latoud, C; Lajaunie, C; Chatelain, F; Arrigo, AP; Schaack, B				Lemaire, Frederic; Mandon, Celine A.; Reboud, Julien; Papine, Alexandre; Angulo, Jesus; Pointu, Herve; Diaz-Latoud, Chantal; Lajaunie, Christian; Chatelain, Francois; Arrigo, Andre-Patrick; Schaack, Beatrice			Toxicity Assays in Nanodrops Combining Bioassay and Morphometric Endpoints	PLOS ONE			English	Article							CELLULAR-RESPONSE; STRESS; CYTOTOXICITY; ACTIVATION; MICROARRAY; INDUCTION; BIOLOGY; SYSTEMS; CELLS; EXPRESSION	Background. Improved chemical hazard management such as REACH policy objective as well as drug ADMETOX prediction, while limiting the extent of animal testing, requires the development of increasingly high throughput as well as highly pertinent in vitro toxicity assays. Methodology. This report describes a new in vitro method for toxicity testing, combining cell-based assays in nanodrop Cell-on-Chip format with the use of a genetically engineered stress sensitive hepatic cell line. We tested the behavior of a stress inducible fluorescent HepG2 model in which Heat Shock Protein promoters controlled Enhanced-Green Fluorescent Protein expression upon exposure to Cadmium Chloride (CdCl2), Sodium Arsenate (NaAsO2) and Paraquat. In agreement with previous studies based on a micro-well format, we could observe a chemical-specific response, identified through differences in dynamics and amplitude. We especially determined IC50 values for CdCl2 and NaAsO2, in agreement with published data. Individual cell identification via image-based screening allowed us to perform multiparametric analyses. Conclusions. Using pre/sub lethal cell stress instead of cell mortality, we highlighted the high significance and the superior sensitivity of both stress promoter activation reporting and cell morphology parameters in measuring the cell response to a toxicant. These results demonstrate the first generation of high-throughput and high-content assays, capable of assessing chemical hazards in vitro within the REACH policy framework.	[Lemaire, Frederic; Reboud, Julien; Pointu, Herve; Chatelain, Francois; Schaack, Beatrice] CEA, Ctr Grenoble, DSV, DRDC,Lab Biopuces, Grenoble, France; [Mandon, Celine A.; Diaz-Latoud, Chantal; Arrigo, Andre-Patrick] Univ Lyon 1, CNRS, UMR 5534, Lab Stress Oxydant,Ctr Genet Mol & Cellulaire, Villeurbanne, France; [Papine, Alexandre] IMSTAR SA, Paris, France; [Angulo, Jesus] Ecole Mines, Ctr Morphol Math, Fontainebleau, France; [Lajaunie, Christian] Ecole Mines, Ctr Computat Biol, Fontainebleau, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Schaack, B (corresponding author), CEA, Ctr Grenoble, DSV, DRDC,Lab Biopuces, Grenoble, France.	beatrice.schaack@cea.fr	Mandon, Céline/Q-3989-2018; Reboud, Julien/F-1565-2014; Schaack, Beatrice/C-1801-2014	Mandon, Céline/0000-0002-2104-6660; Reboud, Julien/0000-0002-6879-8405; 	European STREP project	European STREP project	This work was supported by the European STREP project TOXDROP 513698. The following organizations are part of TOXDROP consortium: CEA, DSV, DRDC, Laboratoire Biopuces, Commissariat a l'Energie Atomique de Grenoble, Bat 40 20, Laboratoire Biopuces, 17 rue des Martyrs, Grenoble, F-38054 France. CNRS, UMR 5534, Laboratoire du Stress Oxydant, Chaperons, Apoptose, Centre de Genetique Moleculaire et Cellulaire, Universite Claude Bernard, Bat. Gregor Mendel, 16 rue Dubois, Villeurbanne, F-69622 France. IMSTAR S. A., 60 rue Notre-Dame des Champs, Paris, F-75006 France.	Ait-Aissa S, 2000, TOXICOLOGY, V145, P147, DOI 10.1016/S0300-483X(00)00145-1; Ait-Aissa S, 2003, ECOTOX ENVIRON SAFE, V54, P92, DOI 10.1016/S0147-6513(02)00026-X; ALEXANDROVA AY, 2006, EXP CELL RES; Angulo J, 2003, BIOINFORMATICS, V19, P553, DOI 10.1093/bioinformatics/btg057; Arrigo AP, 2000, PATHOL BIOL, V48, P280; Aydin HH, 2003, BIOL TRACE ELEM RES, V95, P139, DOI 10.1385/BTER:95:2:139; Baghdoyan S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh074; Balls M, 1995, ATLA-ALTERN LAB ANIM, V23, P838; David CA, 2002, J BIOMOL SCREEN, V7, P259, DOI 10.1177/108705710200700309; Del Razo LM, 2001, TOXICOL APPL PHARM, V177, P132, DOI 10.1006/taap.2001.9291; Dragin N, 2006, FEBS LETT, V580, P3845, DOI 10.1016/j.febslet.2006.06.006; DUDLEY RE, 1982, TOXICOL APPL PHARM, V65, P302, DOI 10.1016/0041-008X(82)90013-8; Eldar A, 2005, NATURE, V437, P631, DOI 10.1038/437631a; Elez D, 2001, CELL BIOL TOXICOL, V17, P169, DOI 10.1023/A:1011940414419; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Giuliano KA, 2004, J BIOMOL SCREEN, V9, P557, DOI 10.1177/1087057104265387; Giuliano KA, 2005, ASSAY DRUG DEV TECHN, V3, P501, DOI 10.1089/adt.2005.3.501; GOTTSCHALG E, 2006, CHEM BIOL INTERACT; Knasmuller S, 2004, TOXICOLOGY, V198, P315, DOI 10.1016/j.tox.2004.02.008; Kondoh M, 2004, TOXICOL LETT, V148, P133, DOI 10.1016/j.toxlet.2003.12.066; Lee JH, 2005, BIOSENS BIOELECTRON, V21, P500, DOI 10.1016/j.bios.2004.12.015; Lee MY, 2005, P NATL ACAD SCI USA, V102, P983, DOI 10.1073/pnas.0406755102; Mandon CA, 2006, J BIOTECHNOL, V124, P392, DOI 10.1016/j.jbiotec.2006.01.004; Mandon CA, 2005, BIOCHEM BIOPH RES CO, V335, P536, DOI 10.1016/j.bbrc.2005.07.112; Meyer F, 2004, J MATH IMAGING VIS, V20, P59, DOI 10.1023/B:JMIV.0000011319.21884.39; Meyer F, 2001, INT J PATTERN RECOGN, V15, P1089, DOI 10.1142/S0218001401001337; Pourahmad J, 2003, TOXICOL IN VITRO, V17, P803, DOI 10.1016/S0887-2333(03)00123-1; Romero D, 2003, TOXICOL IN VITRO, V17, P293, DOI 10.1016/S0887-2333(03)00017-1; Rossi MR, 2002, ENVIRON HEALTH PERSP, V110, P1225, DOI 10.1289/ehp.021101225; SCHAACK B, 2005, NANOBIOTECHNOLOGY, V1, P166; Scheers EM, 2001, TOXICOL IN VITRO, V15, P153, DOI 10.1016/S0887-2333(00)00062-X; Selinger DW, 2003, TRENDS BIOTECHNOL, V21, P251, DOI 10.1016/S0167-7799(03)00113-6; SERRA J, 1999, COURSE MORPHOLOGICAL; Tencza SB, 2004, J APPL TOXICOL, V24, P371, DOI 10.1002/jat.1025; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Vayssier M, 1998, BIOCHEM BIOPH RES CO, V252, P249, DOI 10.1006/bbrc.1998.9586; Vernhet L, 2001, J PHARMACOL EXP THER, V298, P234; Wilson CJ, 2006, J BIOMOL SCREEN, V11, P21, DOI 10.1177/1087057105280726; Wong HR, 1999, SHOCK, V12, P323, DOI 10.1097/00024382-199910000-00012; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Yu HM, 2005, LAB CHIP, V5, P1089, DOI 10.1039/b504403k; Zingarelli B, 1999, SHOCK, V11, P13, DOI 10.1097/00024382-199906001-00045	43	21	21	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e163	10.1371/journal.pone.0000163	http://dx.doi.org/10.1371/journal.pone.0000163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17235363	gold, Green Published			2022-12-27	WOS:000207444000013
J	Beard, DA; Qian, H				Beard, Daniel A.; Qian, Hong			Relationship between Thermodynamic Driving Force and One-Way Fluxes in Reversible Processes	PLOS ONE			English	Article								Chemical reaction systems operating in nonequilibrium open-system states arise in a great number of contexts, including the study of living organisms, in which chemical reactions, in general, are far from equilibrium. Here we introduce a theorem that relates forward and reverse fluxes and free energy for any chemical process operating in a steady state. This relationship, which is a generalization of equilibrium conditions to the case of a chemical process occurring in a nonequilibrium steady state in dilute solution, provides a novel equivalent definition for chemical reaction free energy. In addition, it is shown that previously unrelated theories introduced by Ussing and Hodgkin and Huxley for transport of ions across membranes, Hill for catalytic cycle fluxes, and Crooks for entropy production in microscopically reversible systems, are united in a common framework based on this relationship.	[Beard, Daniel A.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Qian, Hong] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	Medical College of Wisconsin; University of Washington; University of Washington Seattle	Beard, DA (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	dbeard@mcw.edu			NIH [GM0680610]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant GM0680610.	Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; Frank T, 1996, FOKKER PLANCK EQUATI; GALLAVOTTI G, 1995, PHYS REV LETT, V74, P2694, DOI 10.1103/PhysRevLett.74.2694; Hill T.L., 1977, FREE ENERGY TRANSDUC; HILL TL, 1975, P NATL ACAD SCI USA, V72, P1291, DOI 10.1073/pnas.72.4.1291; HILL TL, 1988, P NATL ACAD SCI USA, V85, P5345, DOI 10.1073/pnas.85.15.5345; HILL TL, 1966, J THEOR BIOL, V10, P442, DOI 10.1016/0022-5193(66)90137-8; Hill TL, 2004, FREE ENERGY TRANSDUC; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; KOHLER HH, 1980, J MATH BIOL, V9, P275, DOI 10.1007/BF00276029; Lewis GN, 1925, P NATL ACAD SCI USA, V11, P179, DOI 10.1073/pnas.11.3.179; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; Onsager L, 1931, PHYS REV, V38, P2265, DOI 10.1103/PhysRev.38.2265; QIAN C, 1981, SCI SINICA, V24, P1431; Qian H, 2005, BIOPHYS CHEM, V114, P213, DOI 10.1016/j.bpc.2004.12.001; Qian H, 2003, EUR J BIOCHEM, V270, P415, DOI 10.1046/j.1432-1033.2003.03357.x; Qian H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.022101; Qian H, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.010902; USSING HH, 1949, ACTA PHYSIOL SCAND, V19, P43, DOI 10.1111/j.1748-1716.1949.tb00633.x; Wiechert W, 1997, BIOTECHNOL BIOENG, V55, P101, DOI 10.1002/(SICI)1097-0290(19970705)55:1<101::AID-BIT12>3.0.CO;2-P	20	112	113	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2007	2	1							e144	10.1371/journal.pone.0000144	http://dx.doi.org/10.1371/journal.pone.0000144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DD	17206279	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443800006
J	Koivusilta, LK; Ojanlatva, A				Koivusilta, Leena K.; Ojanlatva, Ansa			To Have or Not To Have a Pet for Better Health?	PLOS ONE			English	Article								Background. Pet ownership is thought to have health benefits, but not all scientific explorations have been founded on proper applications of representative samples or statistically correct methodologies. Databanks have been too small for proper statistical analyses; or, instead of a random sample, participation has been voluntary. The direction of causality has been evaluated incorrectly or control of relevant factors noted deficient. This study examined the associations of pet ownership with perceived health and disease indicators by taking into account socio-demographic background factors together with health risk factors, including exercise. Methodology/Principal Findings. The present study used baseline data from the 15-year Health and Social Support Study (the HeSSup Study). The Finnish Population Register Centre was used to draw population-based random samples stratified according to gender and four age groups (20-24, 30-34, 40-44, and 50-54 years). A total of 21,101 working-aged Finns responded to the baseline survey questionnaire of the 15-year HeSSup Study in 1998. Ordinal and binary logistic regression was used to analyze the cross-sectional data. Pet ownership was associated with poor rather than good perceived health. BMI surfaced as the risk factor most strongly associated with pet ownership. Conclusions/Significance. Pet owners set in their ways and getting older were found to have a slightly higher BMI than the rest. Additional research is needed for the testing of hypotheses involving effects of pet ownership with various health dimensions within population groups that are composed of different kinds of background characteristics.	[Ojanlatva, Ansa] Univ Turku, Dept Teacher Educ, Turku, Finland; [Ojanlatva, Ansa] Univ Turku, Inst Biomed, Ctr Reprod & Dev Med, Turku, Finland; [Ojanlatva, Ansa] Turku City Hosp, Turku, Finland; [Koivusilta, Leena K.] Univ Turku, Inst & Social Mech IASM Consortium, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Ojanlatva, A (corresponding author), Univ Turku, Dept Teacher Educ, Turku, Finland.	ansa.ojanlatva@utu.fi						ALLEN KM, 1991, J PERS SOC PSYCHOL, V61, P582, DOI 10.1037/0022-3514.61.4.582; ANDERSON WP, 1992, MED J AUSTRALIA, V157, P298, DOI 10.5694/j.1326-5377.1992.tb137178.x; [Anonymous], 1984, BIOPHILIA HUMAN BOND; *APPMA, US PET OWN STAT 2005; Argyle M., 1994, PSYCHOL SOCIAL CLASS; AROMAA A, 2002, HLTH FUNCTIONAL CAPA; Bauman AE, 2001, MED J AUSTRALIA, V175, P632, DOI 10.5694/j.1326-5377.2001.tb143757.x; BECK AM, 1984, J AM VET MED ASSOC, V184, P414; DOBSON A, 1998, AN COMM HLTH PUBL PO; Elo IT, 1996, SOC SCI MED, V42, P47, DOI 10.1016/0277-9536(95)00062-3; Friedmann E, 2003, AM J CARDIOL, V91, P718, DOI 10.1016/S0002-9149(02)03412-4; FRIEDMANN E, 1995, AM J CARDIOL, V76, P1213, DOI 10.1016/S0002-9149(99)80343-9; FRIEDMANN E, 1980, PUBLIC HEALTH REP, V95, P307; Friedmann E., 1995, WALTHAM BOOK HUMAN A; Frumkin P, 2001, AM J PREV MED, V20, P234, DOI 10.1016/S0749-3797(00)00317-2; Headey B, 2003, MED J AUSTRALIA, V179, P460, DOI 10.5694/j.1326-5377.2003.tb05646.x; Headey B, 1999, SOC INDIC RES, V47, P233, DOI 10.1023/A:1006892908532; HEADEY B, 2003, C 20 ANN GERM SOC PA; HEADEY B, 1995, HLTH COST SAVINGS IM; HEADEY B, 1999, DO PET OWNERS ENJOY; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jorm AF, 1997, MED J AUSTRALIA, V166, P376, DOI 10.5694/j.1326-5377.1997.tb123170.x; Kingwell BA, 2001, CLIN AUTON RES, V11, P313, DOI 10.1007/BF02332977; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; KOSKENVUO M, 1986, SOC SCI MED, V23, P605, DOI 10.1016/0277-9536(86)90154-1; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; MANSON JE, 1992, NEW ENGL J MED, V326, P1406, DOI 10.1056/NEJM199205213262107; McHarg M., 1995, NATL PEOPLE PETS SUR; Parslow RA, 2005, GERONTOLOGY, V51, P40, DOI 10.1159/000081433; Parslow RA, 2003, MED J AUSTRALIA, V179, P466, DOI 10.5694/j.1326-5377.2003.tb05649.x; Putnam RD., 2000, BOWLING ALONE COLLAP; Raina P, 1999, J AM GERIATR SOC, V47, P323, DOI 10.1111/j.1532-5415.1999.tb02996.x; RAINA P, 1998, RELATIONSHIP PET OWN; ROWAN AN, 1994, ANTHROZOOS, V7, P85, DOI 10.2752/089279394787001916; SERPELL J, 1991, J ROY SOC MED, V84, P717, DOI 10.1177/014107689108401208; Siegel JM, 1999, AIDS CARE, V11, P157, DOI 10.1080/09540129948054; SIEGEL JM, 1990, J PERS SOC PSYCHOL, V58, P1081, DOI 10.1037/0022-3514.58.6.1081; Simons LA, 1997, MED J AUSTRALIA, V167, P231, DOI 10.5694/j.1326-5377.1997.tb138864.x; *STAT FINL, STAT YB FINL 1998; Virtanen P, 2003, INT J EPIDEMIOL, V32, P1015, DOI 10.1093/ije/dyg319; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; WRIGHT JC, 1982, PUBLIC HEALTH REP, V97, P380; 2000, OUR DOGS MAGAZINE, P16	44	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e109	10.1371/journal.pone.0000109	http://dx.doi.org/10.1371/journal.pone.0000109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205113	gold, Green Published			2022-12-27	WOS:000207443700004
J	Diaz-Martinez, LA; Gimenez-Abian, JF; Azuma, Y; Guacci, V; Gimenez-Martin, G; Lanier, LM; Clarke, DJ				Diaz-Martinez, Laura A.; Gimenez-Abian, Juan F.; Azuma, Yoshiaki; Guacci, Vincent; Gimenez-Martin, Gonzalo; Lanier, Lorene M.; Clarke, Duncan J.			PIAS gamma Is Required for Faithful Chromosome Segregation in Human Cells	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; SISTER-CHROMATID COHESION; TOPOISOMERASE-II-ALPHA; MITOTIC CHROMOSOME; DNA-DAMAGE; CENP-E; CHECKPOINT; SUMOYLATION; SEPARATION; CENTROMERE	Background. The precision of the metaphase-anaphase transition ensures stable genetic inheritance. The spindle checkpoint blocks anaphase onset until the last chromosome biorients at metaphase plate, then the bonds between sister chromatids are removed and disjoined chromatids segregate to the spindle poles. But, how sister separation is triggered is not fully understood. Principal Findings. We identify PIAS gamma as a human E3 sumo ligase required for timely and efficient sister chromatid separation. In cells lacking PIAS gamma, normal metaphase plates form, but the spindle checkpoint is activated, leading to a prolonged metaphase block. Sister chromatids remain cohered even if cohesin is removed by depletion of hSgo1, because DNA catenations persist at centromeres. PIAS gamma-depleted cells cannot properly localize Topoisomerase II at centromeres or in the cores of mitotic chromosomes, providing a functional link between PIAS gamma and Topoisomerase II. Conclusions. PIAS gamma directs Topoisomerase II to specific chromosome regions that require efficient removal of DNA catenations prior to anaphase. The lack of this activity activates the spindle checkpoint, protecting cells from non-disjunction. Because DNA catenations persist without PIAS gamma in the absence of cohesin, removal of catenations and cohesin rings must be regulated in parallel.	[Diaz-Martinez, Laura A.; Gimenez-Abian, Juan F.; Clarke, Duncan J.] Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Gimenez-Abian, Juan F.; Gimenez-Martin, Gonzalo] CSIC, Ctr Invest Biol, Madrid, Spain; [Azuma, Yoshiaki] Univ Kansas, Dept Mol Biosci, Lawrence, KS USA; [Guacci, Vincent] Carnegie Inst, Dept Embryol, Baltimore, MD USA; [Lanier, Lorene M.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Kansas; Carnegie Institution for Science; University of Minnesota System; University of Minnesota Twin Cities	Clarke, DJ (corresponding author), Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	Duncan.J.Clarke-2@umn.edu	Díaz-Martínez, Laura/A-5357-2010; Abián, Juan F Giménez/E-6372-2015	Abián, Juan F Giménez/0000-0002-9220-286X; Clarke, Duncan/0000-0002-7795-3294; Diaz-Martinez, Laura/0000-0002-7226-7068	NIH [CA099033]; MEC-Spain DGI; CONACyT; NATIONAL CANCER INSTITUTE [R01CA099033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEC-Spain DGI; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH grant CA099033 ( DJC). JFGA was partly supported by MEC-Spain DGI and LADM by CONACyT.	Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; CLARKE DJ, 1993, J CELL SCI, V105, P563; Clarke DJ, 2000, BIOESSAYS, V22, P351, DOI 10.1002/(SICI)1521-1878(200004)22:4<351::AID-BIES5>3.0.CO;2-W; Clarke DJ, 2006, CELL CYCLE, V5, P1925, DOI 10.4161/cc.5.17.3200; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1561, DOI 10.4161/cc.4.11.2146; GIMENEZABIAN JF, 1995, J CELL BIOL, V131, P7, DOI 10.1083/jcb.131.1.7; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; KOSHLAND D, 1987, SCIENCE, V238, P1713, DOI 10.1126/science.3317838; Lee KM, 2006, DNA REPAIR, V5, P138, DOI 10.1016/j.dnarep.2005.08.003; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; MURRAY AW, 1985, ANNU REV CELL BIOL, V1, P289, DOI 10.1146/annurev.cellbio.1.1.289; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Nasmyth K, 1999, TRENDS BIOCHEM SCI, V24, P98, DOI 10.1016/S0968-0004(99)01358-4; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; Rankin S, 2005, CELL CYCLE, V4, P1039, DOI 10.4161/cc.4.8.1926; Rattner JB, 1996, J CELL BIOL, V134, P1097, DOI 10.1083/jcb.134.5.1097; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Skoufias DA, 2004, MOL CELL, V15, P977, DOI 10.1016/j.molcel.2004.08.018; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Sumner AT, 1996, CHROMOSOME RES, V4, P5, DOI 10.1007/BF02254938; TAAGEPERA S, 1993, P NATL ACAD SCI USA, V90, P8407, DOI 10.1073/pnas.90.18.8407; Takahashi Y, 2006, GENETICS, V172, P783, DOI 10.1534/genetics.105.047167; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tavormina PA, 2002, J CELL BIOL, V158, P23, DOI 10.1083/jcb.200202053; Warburton PE, 1997, BIOESSAYS, V19, P97, DOI 10.1002/bies.950190203; Wirth KG, 2004, GENE DEV, V18, P88, DOI 10.1101/gad.285404; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; Yu HT, 2005, CELL CYCLE, V4, P262; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201	49	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e53	10.1371/journal.pone.0000053	http://dx.doi.org/10.1371/journal.pone.0000053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183683	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600053
J	Dingli, D; Pacheco, JM				Dingli, David; Pacheco, Jorge M.			Allometric Scaling of the Active Hematopoietic Stem Cell Pool across Mammals	PLOS ONE			English	Article								Background. Many biological processes are characterized by allometric relations of the type Y = Y(0)M(b) between an observable Y and body mass M, which pervade at multiple levels of organization. In what regards the hematopoietic stem cell pool, there is experimental evidence that the size of the hematopoietic stem cell pool is conserved in mammals. However, demands for blood cell formation vary across mammals and thus the size of the active stem cell compartment could vary across species. Methodology/Principle Findings. Here we investigate the allometric scaling of the hematopoietic system in a large group of mammalian species using reticulocyte counts as a marker of the active stem cell pool. Our model predicts that the total number of active stem cells, in an adult mammal, scales with body mass with the exponent L. Conclusion/Significance. The scaling predicted here provides an intuitive justification of the Hayflick hypothesis and supports the current view of a small active stem cell pool supported by a large, quiescent reserve. The present scaling shows excellent agreement with the available (indirect) data for smaller mammals. The small size of the active stem cell pool enhances the role of stochastic effects in the overall dynamics of the hematopoietic system.	[Dingli, David] Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA; [Dingli, David; Pacheco, Jorge M.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Pacheco, Jorge M.] Univ Lisbon, Fac Ciencias, Dept Fis, Lisbon, Portugal; [Pacheco, Jorge M.] Ctr Fis Teor & Computac, Lisbon, Portugal	Mayo Clinic; Harvard University; Universidade de Lisboa; Universidade de Lisboa	Dingli, D (corresponding author), Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA.	dingli@fas.harvard.edu	Pacheco, Jorge M/B-6116-2008; Pacheco, Jorge M./O-8184-2019	Pacheco, Jorge M/0000-0002-2579-8499; Pacheco, Jorge M./0000-0002-2579-8499	FCT, Portugal	FCT, Portugal(Portuguese Foundation for Science and Technology)	JMP acknowledges financial support from FCT, Portugal.	Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; ABKOWITZ JL, 1995, P NATL ACAD SCI USA, V92, P2031, DOI 10.1073/pnas.92.6.2031; ABKOWITZ JL, 1990, P NATL ACAD SCI USA, V87, P9062, DOI 10.1073/pnas.87.22.9062; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; BUESCHER ES, 1985, J CLIN INVEST, V76, P1581, DOI 10.1172/JCI112140; BURKE JD, 1954, PHYSIOL ZOOL, V26, P1; Dick JE, 2003, NATURE, V423, P231, DOI 10.1038/423231a; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; DINGLI D, 2006, STOCHASTIC DYN UNPUB; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; EADIE GS, 1953, BLOOD, V8, P1110, DOI 10.1182/blood.V8.12.1110.1110; Gordon MY, 2002, BLOOD, V100, P4679, DOI 10.1182/blood-2002-08-2517; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huxley J., 1932, PROBLEMS RELATIVE GR; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; McCarthy KF, 1997, BLOOD, V89, P834, DOI 10.1182/blood.V89.3.834; McCarthy KF, 2003, BLOOD, V101, P3431, DOI 10.1182/blood-2002-10-3026; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; NASH R, 1988, BLOOD, V72, P2031; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; WORTON RG, 1969, J EXP MED, V130, P91, DOI 10.1084/jem.130.1.91	32	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e2	10.1371/journal.pone.0000002	http://dx.doi.org/10.1371/journal.pone.0000002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183646	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600002
J	Li, TS; Xie, J; He, YX; Fan, HW; Baril, L; Qiu, ZF; Han, Y; Xu, WB; Zhang, WH; You, H; Zuo, YL; Fang, Q; Yu, J; Chen, ZW; Zhang, LQ				Li, Taisheng; Xie, Jing; He, Yuxian; Fan, Hongwei; Baril, Laurence; Qiu, Zhifeng; Han, Yang; Xu, Wenbing; Zhang, Weihong; You, Hui; Zuo, Yanling; Fang, Qing; Yu, Jian; Chen, Zhiwei; Zhang, Linqi			Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus	PLOS ONE			English	Article								Most of the individuals infected with SARS coronavirus (SARS-CoV) spontaneously recovered without clinical intervention. However, the immunological correlates associated with patients' recovery are currently unknown. In this report, we have sequentially monitored 30 recovered patients over a two-year period to characterize temporal changes in SARS-CoV-specific antibody responses as well as cytotoxic T cell (CTL) responses. We have found persistence of robust antibody and CTL responses in all of the study subjects throughout the study period, with a moderate decline one year after the onset of symptoms. We have also identified two potential major CTL epitopes in N proteins based on ELISPOT analysis of pooled peptides. However, despite the potent immune responses and clinical recovery, peripheral lymphocyte counts in the recovered patients have not yet been restored to normal levels. In summary, our study has, for the first time, characterized the temporal and dynamic changes of humoral and CTL responses in the natural history of SARS-recovered individuals, and strongly supports the notion that high and sustainable levels of immune responses correlate strongly with the disease outcome. Our findings have direct implications for future design and development of effective therapeutic agents and vaccines against SARS-CoV infection.	[Li, Taisheng; Xie, Jing; He, Yuxian; Fan, Hongwei; Qiu, Zhifeng; Han, Yang; Xu, Wenbing; Zhang, Weihong; You, Hui; Zuo, Yanling; Zhang, Linqi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Taisheng; Xie, Jing; He, Yuxian; Fan, Hongwei; Qiu, Zhifeng; Han, Yang; Xu, Wenbing; Zhang, Weihong; You, Hui; Zuo, Yanling; Zhang, Linqi] Chinese Acad Med Sci, AIDS Res Ctr, Beijing 100037, Peoples R China; [Li, Taisheng; Xie, Jing; He, Yuxian; Fan, Hongwei; Qiu, Zhifeng; Han, Yang; Xu, Wenbing; Zhang, Weihong; You, Hui; Zuo, Yanling; Zhang, Linqi] Beijing Union Med Coll Hosp, Dept Infect Dis, Beijing, Peoples R China; [Li, Taisheng; Xie, Jing; He, Yuxian; Fan, Hongwei; Qiu, Zhifeng; Han, Yang; Xu, Wenbing; Zhang, Weihong; You, Hui; Zuo, Yanling; Zhang, Linqi] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100037, Peoples R China; [He, Yuxian] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Baril, Laurence] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Fang, Qing; Yu, Jian; Chen, Zhiwei; Zhang, Linqi] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; New York Blood Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rockefeller University	Li, TS (corresponding author), Beijing Union Med Coll Hosp, Dept Infect Dis, Beijing, Peoples R China.	litsh@263.net; lzhang07@hotmail.com	Chen, Zhiwei/B-7793-2019; ZHANG, LIN/GYD-9123-2022; han, yang/GRS-2388-2022	Chen, Zhiwei/0000-0002-4511-2888; Baril, Laurence/0000-0003-2346-883X	Chinese Ministry of Science and Technology; National Institute of Health (NIH) [U19 AI51915-02]; European Commission [SP22-CT2004-511063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Chinese Ministry of Science and Technology, and partly by National Institute of Health (NIH) CIPRA-SARS Project (NIH U19 AI51915-02) and the European Commission grant EPISARS (SP22-CT2004-511063). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Leung DTM, 2004, J INFECT DIS, V190, P379, DOI 10.1086/422040; Li TS, 2004, J INFECT DIS, V189, P648, DOI 10.1086/381535; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Nie YC, 2004, J INFECT DIS, V190, P1119, DOI 10.1086/423286; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Shi YL, 2004, J CLIN VIROL, V31, P66, DOI 10.1016/j.jcv.2004.05.006; Temperton NJ, 2005, EMERG INFECT DIS, V11, P411, DOI 10.3201/eid1103.040906; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Woo PCY, 2004, CLIN DIAGN LAB IMMUN, V11, P665, DOI 10.1128/CDLI.11.4.665-668.2004; Woo PCY, 2004, J CLIN MICROBIOL, V42, P2306, DOI 10.1128/JCM.42.5.2306-2309.2004; Zhang LQ, 2006, J MED VIROL, V78, P1, DOI 10.1002/jmv.20499	17	51	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e24	10.1371/journal.pone.0000024	http://dx.doi.org/10.1371/journal.pone.0000024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183651	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600024
J	Seitz, AR; Nanez, JE; Holloway, SR; Watanabe, T				Seitz, Aaron R.; Nanez, Jose E., Sr.; Holloway, Steve R.; Watanabe, Takeo			Perceptual Learning of Motion Leads to Faster Flicker Perception	PLOS ONE			English	Article								Critical flicker fusion thresholds (CFFT) describe when quick amplitude modulations of a light source become undetectable as the frequency of the modulation increases. The threshold at which CFF occurs has been shown to remain constant under repeated testing. Additionally, CFF thresholds are correlated with various measures of intelligence, and have been regarded by clinicians as a general measure of cortical processing capacity. For these reasons, CFF is used as a cognitive indicator in drug studies, as a measure of fatigue, and has been suggested as a diagnostic measure for various brain diseases. Here we report that CFFT increases dramatically in subjects who are trained with a motion-direction learning procedure. Control tasks demonstrate that CFFT changes are tightly coupled with improvements in discriminating the direction of motion stimuli, and are likely related to plasticity in low-level visual areas that are specialized to process motion signals. This plasticity is long-lasting and is retained for at least one year after training. Combined, these results show that CFFT relates to a specialized sensory process and bring into question that CFFT is a measure of high-level, or general, processes.	[Seitz, Aaron R.; Watanabe, Takeo] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Nanez, Jose E., Sr.; Holloway, Steve R.] Arizona State Univ, Dept Social & Behav Sci, Phoenix, AZ USA	Boston University; Arizona State University; Arizona State University-Downtown Phoenix	Seitz, AR (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	aseitz@bu.edu	Holloway, Steven R/O-3032-2013	Holloway, Steven R/0000-0001-8900-5315	NSF [BCS-9905914]; NIH [R01EY015980-01]; Human Frontier [RGP18/2004]; NATIONAL EYE INSTITUTE [R01EY015980] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This research was supported by NSF grant (BCS-9905914), NIH grant (R01EY015980-01), and Human Frontier Research grant (RGP18/2004) and NSF (CELEST).	Anderson AJ, 2002, VISION RES, V42, P1149, DOI 10.1016/S0042-6989(02)00033-0; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Battelli L, 2003, NEUROPSYCHOLOGIA, V41, P1808, DOI 10.1016/S0028-3932(03)00182-9; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CAVANAGH P, 1987, J OPT SOC AM A, V4, P1428, DOI 10.1364/JOSAA.4.001428; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Curran S, 2000, HUM PSYCHOPHARM CLIN, V15, P103, DOI 10.1002/(SICI)1099-1077(200003)15:2<103::AID-HUP149>3.0.CO;2-7; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; del Romo GB, 2005, INVEST OPHTH VIS SCI, V46, P1107, DOI 10.1167/iovs.04-1138; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; ERNST W, 1968, VISION RES, V8, P889, DOI 10.1016/0042-6989(68)90138-7; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; HALSTEAD WC, 1947, BRAIN INTELLIGENCE Q, V13; HARVEY LO, 1970, VISION RES, V10, P55, DOI 10.1016/0042-6989(70)90062-3; HINDMARCH I, 1982, PHARMACOPSYCHIATRIA, V15, P44, DOI 10.1055/s-2007-1019549; Hindmarch I, 1988, Psychopharmacol Ser, V6, P79; Hosokawa T, 1997, ERGONOMICS, V40, P887, DOI 10.1080/001401397187720; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; Lisberger SG, 1999, J NEUROSCI, V19, P2224; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; MCCLELLAND GR, 1987, HUM PSYCHOPHARM CLIN, V2, P109; MERIGAN WH, 1991, J NEUROSCI, V11, P3422; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; MISHKIN M, 1959, J COMP PHYSIOL PSYCH, V52, P660, DOI 10.1037/h0038577; Misiak H, 1948, J GEN PSYCHOL, V38, P251, DOI 10.1080/00221309.1948.9711786; MOULDEN B, 1990, PERCEPTION, V19, P79, DOI 10.1068/p190079; Parkin C, 1997, HUM PSYCHOPHARM CLIN, V12, P65, DOI 10.1002/(SICI)1099-1077(199701/02)12:1<65::AID-HUP838>3.0.CO;2-W; PLATEAU J, 1829, CERTAIN PROPERTIES I; Priebe NJ, 2003, J NEUROSCI, V23, P5650; Rota-Bartelink A, 1999, Curr Opin Ophthalmol, V10, P135, DOI 10.1097/00055735-199904000-00010; ROVAMO J, 1984, VISION RES, V24, P1127, DOI 10.1016/0042-6989(84)90166-4; SANDRY M, 1963, PERCEPT MOTOR SKILL, V16, P103, DOI 10.2466/pms.1963.16.1.103; SAUCER RT, 1958, SCIENCE, V127, P698, DOI 10.1126/science.127.3300.698; SCHILLER PH, 1991, NEUROPSYCHOLOGIA, V29, P433, DOI 10.1016/0028-3932(91)90003-Q; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2005, P NATL ACAD SCI USA, V102, P9080, DOI 10.1073/pnas.0501026102; Seitz AR, 2005, HUM PSYCHOPHARM CLIN, V20, P55, DOI 10.1002/hup.661; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; TANNER WP, 1950, SCIENCE, V112, P201, DOI 10.1126/science.112.2903.201; TURNER P, 1968, BRIT J OPHTHALMOL, V52, P245, DOI 10.1136/bjo.52.3.245; Vaina LM, 1998, VISUAL NEUROSCI, V15, P333, DOI 10.1017/S0952523898152082; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Williams PE, 2004, J NEUROSCI, V24, P8278, DOI 10.1523/JNEUROSCI.2716-04.2004; Wooten BR, 1999, INVEST OPHTH VIS SCI, V40, P2481; Yoshiyama KK, 1997, INVEST OPHTH VIS SCI, V38, P2270; ZLODY RL, 1965, AM J PSYCHOL, V78, P596, DOI 10.2307/1420921; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114; ZUBEK JP, 1973, NATURE, V241, P288, DOI 10.1038/241288a0; ZUBEK JP, 1972, SCIENCE, V176, P1045, DOI 10.1126/science.176.4038.1045	56	46	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e28	10.1371/journal.pone.0000028	http://dx.doi.org/10.1371/journal.pone.0000028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183655	Green Published, gold			2022-12-27	WOS:000207443600028
J	Estecio, MRH; Gharibyan, V; Shen, LL; Ibrahim, AEK; Doshi, K; He, R; Jelinek, J; Yang, AS; Yan, PS; Huang, THM; Tajara, EH; Issa, JPJ				Estecio, Marcos R. H.; Gharibyan, Vazganush; Shen, Lanlan; Ibrahim, Ashraf E. K.; Doshi, Ketan; He, Rong; Jelinek, Jaroslav; Yang, Allen S.; Yan, Pearlly S.; Huang, Tim H-M.; Tajara, Eloiza H.; Issa, Jean-Pierre J.			LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability	PLOS ONE			English	Article								Background. Alterations in DNA methylation in cancer include global hypomethylation and gene-specific hypermethylation. It is not clear whether these two epigenetic errors are mechanistically linked or occur independently. This study was performed to determine the relationship between DNA hypomethylation, hypermethylation and microsatellite instability in cancer. Methodology/Principal Findings. We examined 61 cancer cell lines and 60 colorectal carcinomas and their adjacent tissues using LINE-1 bisulfite-PCR as a surrogate for global demethylation. Colorectal carcinomas with sporadic microsatellite instability (MSI), most of which are due to a CpG island methylation phenotype (CIMP) and associated MLH1 promoter methylation, showed in average no difference in LINE-1 methylation between normal adjacent and cancer tissues. Interestingly, some tumor samples in this group showed increase in LINE-1 methylation. In contrast, MSI-showed a significant decrease in LINE-1 methylation between normal adjacent and cancer tissues (P<0.001). Microarray analysis of repetitive element methylation confirmed this observation and showed a high degree of variability in hypomethylation between samples. Additionally, unsupervised hierarchical clustering identified a group of highly hypomethylated tumors, composed mostly of tumors without microsatellite instability. We extended LINE-1 analysis to cancer cell lines from different tissues and found that 50/61 were hypomethylated compared to peripheral blood lymphocytes and normal colon mucosa. Interestingly, these cancer cell lines also exhibited a large variation in demethylation, which was tissue-specific and thus unlikely to be resultant from a stochastic process. Conclusion/Significance. Global hypomethylation is partially reversed in cancers with microsatellite instability and also shows high variability in cancer, which may reflect alternative progression pathways in cancer.	[Estecio, Marcos R. H.; Gharibyan, Vazganush; Shen, Lanlan; He, Rong; Jelinek, Jaroslav; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Ibrahim, Ashraf E. K.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Doshi, Ketan] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Yang, Allen S.] Univ So Calif, Dept Med, Los Angeles, CA USA; [Yan, Pearlly S.; Huang, Tim H-M.] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; [Tajara, Eloiza H.] Fac Med Sao Jose Rio Preto FAMERP, Dept Mol Biol, Sao Paulo, Brazil	University of Texas System; UTMD Anderson Cancer Center; University of Cambridge; University of Minnesota System; University of Minnesota Twin Cities; University of Southern California; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Issa, JPJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	jissa@mdanderson.org	Tajara, Eloiza H/G-7586-2012; Yan, Pearlly S/E-4339-2011; Jelinek, Jaroslav/D-2282-2012; Jelinek, Jaroslav/O-6876-2019	Tajara, Eloiza H/0000-0002-2603-2057; Yan, Pearlly S/0000-0003-1965-4920; Jelinek, Jaroslav/0000-0002-2533-0220; Issa, Jean-Pierre/0000-0003-2258-5030; Estecio, Marcos/0000-0002-6874-7413	National Institutes of Health (USA) [CA098006, CA100632, CA105346]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) [99/09368-1, 00/12361-8]; NATIONAL CANCER INSTITUTE [P50CA100632, R01CA105346, R01CA098006] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (USA) grants CA098006, CA100632 and CA105346 (J-P.J.I.) and from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) grants 99/09368-1 (M. R. H. E.) and 00/12361-8 (E. H. T.)	BAYLIN SB, 1986, CANCER RES, V46, P2917; BAYLIN SB, 1987, BLOOD, V70, P412; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Deng GR, 2006, INT J CANCER, V118, P2999, DOI 10.1002/ijc.21740; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gonzalgo ML, 1997, CANCER RES, V57, P594; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; LU LJW, 1983, CANCER LETT, V19, P231, DOI 10.1016/0304-3835(83)90159-3; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Piotrowski A, 2006, GENE CHROMOSOME CANC, V45, P656, DOI 10.1002/gcc.20331; Smiraglia DJ, 2002, ONCOGENE, V21, P5414, DOI 10.1038/sj.onc.1205608; Sugimura T, 2000, MUTAT RES-REV MUTAT, V462, P235, DOI 10.1016/S1383-5742(00)00005-3; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Toyota M, 2005, SEMIN ONCOL, V32, P521, DOI 10.1053/j.seminoncol.2005.07.003; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; WALKER MS, 1981, CANCER BIOCHEM BIOPH, V5, P169; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	30	211	224	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e399	10.1371/journal.pone.0000399	http://dx.doi.org/10.1371/journal.pone.0000399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476321	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445700001
J	Costedoat, C; Pech, N; Chappaz, R; Gilles, A				Costedoat, Caroline; Pech, Nicolas; Chappaz, Remi; Gilles, Andre			Novelties in Hybrid Zones: Crossroads between Population Genomic and Ecological Approaches	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; INTROGRESSIVE HYBRIDIZATION; GEOMETRIC MORPHOMETRICS; REPRODUCTIVE ISOLATION; GENETIC-VARIATION; MOUNTAIN-HARES; BROWN HARES; EVOLUTION; SIZE; CYPRINIDAE	Background. Interspecific hybridization is widespread, occurring in a taxonomically diverse array of species. The Cyprinidae family, which displays more than 30% hybridization, is a good candidate for studies of processes underlying isolation and speciation, such as genetic exchange between previously isolated lineages. This is particularly relevant in the case of recent hybridization between an invasive species, Chondrostoma nasus nasus (from Eastern Europe), and C. toxostoma toxostoma (a threatened species endemic to southern France), in which bidirectional introgressive hybridization has been demonstrated. Methodology/Principal Findings. We studied 128 specimens from reference populations and 1495 hybrid zone specimens (two years of sampling and four stations), using five molecular markers (one mitochondrial gene, four nuclear introns), morphology (meristic and plastic characters) and life history traits (weight, size, coefficient of condition, sex, age, shoaling). We identified 65 hybrid combinations and visualized spatial and temporal changes in composition. The direction of mitochondrial introgression was density-dependent in favor of the rarer species and we demonstrate that the sexual selection hypothesis is a preponderant explanation in the asymmetry of introgression. Despite genomic evolution in the hybrid zone, convergence was observed for body shape and coefficient of condition, indicating changes in foraging behavior with respect to reference populations, reflecting strong environmental pressure. Conclusions/Significance. The complex rules of hybrid zone dynamics are established very early in the contact zone. We propose "inheritance from the rare species" as a new evolutionary hypothesis for animal models. The endemic species was not assimilated by the invasive species. Survival rates for this species were highest in the middle of the river (the warmest part) due to a trade-off between food availability and fecundity. The environment-independent hybrid combination may result from nuclear-mitochondrial interactions involving the Tpi1b gene or a gene linked to this gene (Chromosome 16). This genomic region is also responsible for shoaling behavior in Danio rerio and is a promising zone for studies of changes in population dynamics and advances in integrated studies of hybrid zones.	[Costedoat, Caroline; Pech, Nicolas; Chappaz, Remi; Gilles, Andre] Univ Aix Marseille 1, Evolut Genome Environm EA EGEE 3781, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Costedoat, C (corresponding author), Univ Aix Marseille 1, Evolut Genome Environm EA EGEE 3781, Marseille, France.	costedoa@up.univ-mrs.fr		Nicolas, Pech/0000-0002-1822-3558	"region PACA"	"region PACA"(Region Provence-Alpes-Cote d'Azur)	This work was partly supported by a grant from "region PACA".	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Andersson M, 1999, P ROY SOC B-BIOL SCI, V266, P1579, DOI 10.1098/rspb.1999.0818; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Avise J, 2004, MOL MARKERS NATURAL; Avise JC, 1997, J HERED, V88, P14, DOI 10.1093/oxfordjournals.jhered.a023049; AVISE JC, 1984, GENETICS, V108, P237; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Carson EW, 2006, MOL ECOL, V15, P667, DOI 10.1111/j.1365-294X.2005.02763.x; CHAPPAZ R, 1989, CR ACAD SCI SERIES 3, V5, P181; Costedoat C, 2005, BIOL J LINN SOC, V85, P135, DOI 10.1111/j.1095-8312.2005.00478.x; Costedoat C, 2004, CYBIUM, V28, P51; Crespin L, 2002, J FISH BIOL, V61, P696, DOI 10.1006/jfbi.2002.2092; Das J, 2006, BIOESSAYS, V28, P890, DOI 10.1002/bies.20463; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; DESALLE R, 1986, HEREDITY, V56, P87, DOI 10.1038/hdy.1986.12; DOWLING TE, 1989, EVOLUTION, V43, P620, DOI 10.1111/j.1558-5646.1989.tb04257.x; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Dowling TE, 1997, EVOLUTION, V51, P1574, DOI 10.1111/j.1558-5646.1997.tb01480.x; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; EDWARDS CA, 1987, MAR BIOL, V94, P547, DOI 10.1007/BF00431401; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; FERRIS SD, 1983, P NATL ACAD SCI-BIOL, V80, P2290, DOI 10.1073/pnas.80.8.2290; Gill FB, 1997, EVOLUTION, V51, P519, DOI 10.1111/j.1558-5646.1997.tb02439.x; Glemet H, 1998, MOL ECOL, V7, P1655, DOI 10.1046/j.1365-294x.1998.00494.x; Good JM, 2003, EVOLUTION, V57, P1900; Gozlan R.E., 1998, ENV BIOL MORPHODYNAM; Gray MA, 2002, WATER QUAL RES J CAN, V37, P195, DOI 10.2166/wqrj.2002.012; HARRISON RG, 1987, MOL BIOL EVOL, V4, P144; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hayashi K, 1991, PCR Methods Appl, V1, P34; Jiggins CD, 1997, HEREDITY, V79, P495, DOI 10.1038/sj.hdy.6882230; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; LAMB T, 1986, P NATL ACAD SCI USA, V83, P2526, DOI 10.1073/pnas.83.8.2526; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; McDonald DB, 2001, EVOLUTION, V55, P1443; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; NELVAPASQUAL A, 1985, BIOGEOGRAPHIE DEMOGR; Orive ME, 2002, GENETICS, V162, P1469; Orti G, 1997, MOL ECOL, V6, P575, DOI 10.1046/j.1365-294X.1997.00212.x; Peacor SD, 2006, PLOS BIOL, V4, P2112, DOI 10.1371/journal.pbio.0040372; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; R Development Core Team, 2005, R LANG ENV STAT COMP; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RIESEBERG LH, 1995, CONSERV BIOL, V9, P199, DOI 10.1046/j.1523-1739.1995.09010199.x; RIESEBERG LH, 1991, AM J BOT, V78, P1218, DOI 10.2307/2444926; Rieseberg LH, 1998, NATO ADV SCI I A-LIF, V306, P243; Rognon X, 2003, MOL ECOL, V12, P435, DOI 10.1046/j.1365-294X.2003.01739.x; Rohlf F. J., 2004, TPSDIG VERSION 1 40; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sandstrom O, 1997, J FISH BIOL, V51, P1015, DOI 10.1006/jfbi.1997.0506; Scribner KT, 2000, REV FISH BIOL FISHER, V10, P293, DOI 10.1023/A:1016642723238; SPOLSKY C, 1986, MOL BIOL EVOL, V3, P44; Steinke D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-16; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; TAYLOR DJ, 1993, P ROY SOC B-BIOL SCI, V254, P163, DOI 10.1098/rspb.1993.0141; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; Thulin CG, 1997, MOL ECOL, V6, P463, DOI 10.1046/j.1365-294X.1997.t01-1-00199.x; Thulin CG, 2003, ANN ZOOL FENN, V40, P45; Thulin CG, 2002, J ZOOL, V258, P299, DOI 10.1017/S0952836902001425; Valentin A, 2002, J FISH BIOL, V60, P857, DOI 10.1006/jfbi.2002.1889; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; Ward AJW, 2001, ANIM BEHAV, V62, P617, DOI 10.1006/anbe.2001.1785; WAYNE RK, 1993, TRENDS GENET, V9, P218, DOI 10.1016/0168-9525(93)90122-X; Willett CS, 2006, GENETICS, V173, P1465, DOI 10.1534/genetics.105.051011; Wilson CC, 1998, MOL ECOL, V7, P127, DOI 10.1046/j.1365-294x.1998.00302.x; WILSON E O, 1992; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Wright D, 2006, BEHAV GENET, V36, P271, DOI 10.1007/s10519-005-9029-4; Wright D, 2003, NATURWISSENSCHAFTEN, V90, P374, DOI 10.1007/s00114-003-0443-2	78	41	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e357	10.1371/journal.pone.0000357	http://dx.doi.org/10.1371/journal.pone.0000357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406681	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445300019
J	Panksepp, JB; Jochman, KA; Kim, JU; Koy, JJ; Wilson, ED; Chen, QL; Wilson, CR; Lahvis, GP				Panksepp, Jules B.; Jochman, Kimberly A.; Kim, Joseph U.; Koy, Jamie J.; Wilson, Ellie D.; Chen, QiLiang; Wilson, Clarinda R.; Lahvis, Garet P.			Affiliative Behavior, Ultrasonic Communication and Social Reward Are Influenced by Genetic Variation in Adolescent Mice	PLOS ONE			English	Article							MUS-MUSCULUS; ADULT MALE; GROUND-SQUIRRELS; FIGHTING BEHAVIOR; DECISION-MAKING; SEXUAL-BEHAVIOR; GUINEA-PIGS; FEMALE RATS; PLAY; MOUSE	Social approach is crucial for establishing relationships among individuals. In rodents, social approach has been studied primarily within the context of behavioral phenomena related to sexual reproduction, such as mating, territory defense and parental care. However, many forms of social interaction occur before the onset of reproductive maturity, which suggests that some processes underlying social approach among juvenile animals are probably distinct from those in adults. We conducted a longitudinal study of social investigation (SI) in mice from two inbred strains to assess the extent to which genetic factors influence the motivation for young mice to approach one another. Early-adolescent C57BL/6J (B6) mice, tested 4-6 days after weaning, investigated former cage mates to a greater degree than BALB/cJ (BALB) mice, irrespective of the sex composition within an interacting pair. This strain difference was not due to variation in maternal care, the phenotypic characteristics of stimulus mice or sensitivity to the length of isolation prior to testing, nor was it attributable to a general difference in appetitive motivation. Ultrasonic vocalization (USV) production was positively correlated with the SI responses of mice from both strains. Interestingly, several USV characteristics segregated with the genetic background of young mice, including a higher average frequency and shorter duration for the USVs emitted by B6 mice. An assessment of conditioned place preference responses indicated that there was a strain-dependent difference in the rewarding nature of social contact. As adolescent mice aged, SI responses gradually became less sensitive to genetic background and more responsive to the particular sex of individuals within an interacting pair. We have thus identified a specific, genetic influence on the motivation of early-adolescent mice to approach one another. Consistent with classical theories of motivation, which propose a functional relationship between behavioral approach and reward, our findings indicate that reward is a proximal mechanism through which genetic factors affect social motivation during early adolescence.	[Panksepp, Jules B.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Jochman, Kimberly A.; Kim, Joseph U.; Lahvis, Garet P.] Univ Wisconsin, Dept Surg, Madison, WI 53706 USA; [Koy, Jamie J.] Univ Wisconsin, Undergrad Program Religious Studies, Madison, WI 53706 USA; [Wilson, Ellie D.; Chen, QiLiang; Wilson, Clarinda R.] Univ Wisconsin, Undergrad Program Biol Sci, Madison, WI 53706 USA; [Lahvis, Garet P.] Univ Wisconsin, Waisman Ctr Dev Disabil, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Panksepp, JB (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.	jbpanksepp@wisc.edu; gplahvis@wisc.edu		Chen, QiLiang/0000-0002-9588-1423; Lahvis, Garet/0000-0002-1986-8251; Kim, Joseph/0000-0003-1539-1991	NIH [R03 HD046716, R01 DA022543, P30 HD03352, U01 MH61971, T32 GM07507, T32 MH018931]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD046716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018931, U01MH061971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was funded by NIH research grants R03 HD046716 and R01 DA022543, a program-project grant (P30 HD03352) to the Waisman Center and an institutional grant (U01 MH61971) to the Tennessee Genome Consortium. JBP was supported by NIH training grants to the Neuroscience Training Program (T32 GM07507) and the Training Program in Emotion Research (T32 MH018931) at the University of Wisconsin - Madison.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; BARASH DP, 1974, SCIENCE, V185, P415, DOI 10.1126/science.185.4149.415; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BERRY RJ, 1992, BIOL REV, V67, P519, DOI 10.1111/j.1469-185X.1992.tb01192.x; Brodkin ES, 2007, BEHAV BRAIN RES, V176, P53, DOI 10.1016/j.bbr.2006.06.025; Brodkin ES, 2004, BRAIN RES, V1002, P151, DOI 10.1016/j.brainres.2003.12.013; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Burgdorf J, 2005, BEHAV GENET, V35, P67, DOI 10.1007/s10519-004-0856-5; BURGHART GM, 2005, GENESIS ANIMAL PLAY, P518; Byrom AE, 1999, CAN J ZOOL, V77, P1048, DOI 10.1139/cjz-77-7-1048; Cameron JL, 2004, ANN NY ACAD SCI, V1021, P110, DOI 10.1196/annals.1308.012; Carpendale JIM, 2004, BEHAV BRAIN SCI, V27, P79; Chambers LK, 2000, J MAMMAL, V81, P59, DOI 10.1644/1545-1542(2000)081&lt;0059:MASOOW&gt;2.0.CO;2; Childress MJ, 2001, ANIM BEHAV, V62, P465, DOI 10.1006/anbe.2001.1760; Clutton-Brock TH, 2001, ANIM BEHAV, V61, P705, DOI 10.1006/anbe.2000.1631; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Crews D, 1997, ANN NY ACAD SCI, V807, P1, DOI 10.1111/j.1749-6632.1997.tb51910.x; D'Amato FR, 2005, BEHAV GENET, V35, P103, DOI 10.1007/s10519-004-0860-9; DEITCHMAN R, 1976, PSYCHOL REP, V39, P27, DOI 10.2466/pr0.1976.39.1.27; Delville Y, 2003, HORM BEHAV, V44, P263, DOI 10.1016/S0018-506X(03)00130-2; Douglas LA, 2004, DEV PSYCHOBIOL, V45, P153, DOI 10.1002/dev.20025; Douglas LA, 2003, PHYSIOL BEHAV, V80, P317, DOI 10.1016/j.physbeh.2003.08.003; Drickamer LC, 2003, AM MIDL NAT, V150, P308, DOI 10.1674/0003-0031(2003)150[0308:DCOHMM]2.0.CO;2; Flack JC, 2004, J COMP PSYCHOL, V118, P149, DOI 10.1037/0735-7036.118.2.149; FREELAND WJ, 1981, SCIENCE, V213, P461, DOI 10.1126/science.7244643; Geissler DB, 2004, EUR J NEUROSCI, V19, P1027, DOI 10.1111/j.1460-9568.2004.03205.x; Gerlach G, 1998, ETHOLOGY, V104, P487; GLICKMAN SE, 1967, PSYCHOL REV, V74, P81, DOI 10.1037/h0024290; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gourbal BEF, 2004, NATURWISSENSCHAFTEN, V91, P381, DOI 10.1007/s00114-004-0543-7; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129, DOI 10.1615/CritRevNeurobiol.v12.i1-2.50; Hare JF, 2004, ETHOL ECOL EVOL, V16, P157; Hennessy MB, 2005, DEV PSYCHOBIOL, V46, P86, DOI 10.1002/dev.20045; Hennessy MB, 2003, J COMP PSYCHOL, V117, P406, DOI 10.1037/0735-7036.117.4.406; HENNESSY MB, 1980, DEV PSYCHOBIOL, V13, P573, DOI 10.1002/dev.420130603; Hol T, 1999, BEHAV BRAIN RES, V100, P91, DOI 10.1016/S0166-4328(98)00116-8; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; HOOGLAND JL, 1979, BEHAVIOUR, V69, P1, DOI 10.1163/156853979X00377; Judge PG, 1997, ANIM BEHAV, V54, P643, DOI 10.1006/anbe.1997.0469; Kaufman J, 2001, BIOL PSYCHIAT, V49, P980, DOI 10.1016/S0006-3223(01)01127-1; Kavaliers M, 2006, P NATL ACAD SCI USA, V103, P4293, DOI 10.1073/pnas.0600410103; KNUTSON B, 2000, PSYCHOL BULL, V128, P961; Laviola G, 1999, NEUROSCI BIOBEHAV R, V23, P993, DOI 10.1016/S0149-7634(99)00032-9; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Loughry WJ, 1998, AM MIDL NAT, V139, P125, DOI 10.1674/0003-0031(1998)139[0125:BIBJNB]2.0.CO;2; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; MCKINNEY TD, 1973, BIOL REPROD, V9, P279, DOI 10.1093/biolreprod/9.3.279; McNew LB, 2005, AM MIDL NAT, V154, P217; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Oyama S., 2000, EVOLUTIONS EYE SYSTE; PANKSEPP J, 1981, DEV PSYCHOBIOL, V14, P327, DOI 10.1002/dev.420140405; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; PANKSEPP JB, 2006, GENES BRAIN BEHAV; PELLIS SM, 1995, BEHAV BRAIN RES, V68, P65, DOI 10.1016/0166-4328(94)00161-8; Pocock MJO, 2005, BIOL J LINN SOC, V84, P565, DOI 10.1111/j.1095-8312.2005.00455.x; Putland DA, 2001, EMU, V101, P265, DOI 10.1071/MU00046; Randall JA, 2005, BEHAV ECOL, V16, P961, DOI 10.1093/beheco/ari078; RITCHIE ME, 1990, OECOLOGIA, V83, P495, DOI 10.1007/BF00317200; Robinson GE, 2004, SCIENCE, V304, P397, DOI 10.1126/science.1095766; Romeo RD, 2003, DEV PSYCHOBIOL, V43, P102, DOI 10.1002/dev.10125; Romeo RD, 2002, NEUROSCI BIOBEHAV R, V26, P381, DOI 10.1016/S0149-7634(02)00009-X; Romeo RD, 2001, PHYSIOL BEHAV, V73, P579, DOI 10.1016/S0031-9384(01)00499-1; Romeo RD, 2001, BRAIN RES, V889, P71, DOI 10.1016/S0006-8993(00)03111-5; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; SCHNEIRLA TC, 1959, NEBR SYM MOTIV, V7, P1; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; SIVIY SM, 1985, PHYSIOL BEHAV, V35, P435, DOI 10.1016/0031-9384(85)90320-8; Sokal RR, 1995, BIOMETRY; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spinka M, 2001, Q REV BIOL, V76, P141, DOI 10.1086/393866; SWANSON HH, 1987, HORM BEHAV, V21, P310, DOI 10.1016/0018-506X(87)90017-1; TAYLOR GT, 1986, J ENDOCRINOL, V110, P533, DOI 10.1677/joe.0.1100533; TERRANOVA ML, 1993, DEV PSYCHOBIOL, V26, P467, DOI 10.1002/dev.420260805; Terranova ML, 2000, J COMP PSYCHOL, V114, P325, DOI 10.1037/0735-7036.114.4.325; Teshiba T, 2001, J NEUROSCI, V21, P4523, DOI 10.1523/JNEUROSCI.21-12-04523.2001; THOR DH, 1982, PHYSIOL BEHAV, V29, P281, DOI 10.1016/0031-9384(82)90016-6; Thornton LM, 2005, BEHAV GENET, V35, P73, DOI 10.1007/s10519-004-0857-4; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; White NR, 1998, PHYSIOL BEHAV, V63, P467, DOI 10.1016/S0031-9384(97)00484-8; WOLFF RJ, 1981, J ZOOL, V195, P405; YOUNG PT, 1959, PSYCHOL REV, V66, P104, DOI 10.1037/h0045997	86	207	209	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e351	10.1371/journal.pone.0000351	http://dx.doi.org/10.1371/journal.pone.0000351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406675	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445300013
J	Lowe, AW; Olsen, M; Hao, Y; Lee, SP; Lee, KT; Chen, X; van de Rijn, M; Brown, PO				Lowe, Anson W.; Olsen, Mari; Hao, Ying; Lee, Sum P.; Lee, Kyu Taek; Chen, Xin; van de Rijn, Matt; Brown, Patrick O.			Gene Expression Patterns in Pancreatic Tumors, Cells and Tissues	PLOS ONE			English	Article								Background. Cancers of the pancreas originate from both the endocrine and exocrine elements of the organ, and represent a major cause of cancer-related death. This study provides a comprehensive assessment of gene expression for pancreatic tumors, the normal pancreas, and nonneoplastic pancreatic disease. Methods/Results. DNA microarrays were used to assess the gene expression for surgically derived pancreatic adenocarcinomas, islet cell tumors, and mesenchymal tumors. The addition of normal pancreata, isolated islets, isolated pancreatic ducts, and pancreatic adenocarcinoma cell lines enhanced subsequent analysis by increasing the diversity in gene expression profiles obtained. Exocrine, endocrine, and mesenchymal tumors displayed unique gene expression profiles. Similarities in gene expression support the pancreatic duct as the origin of adenocarcinomas. In addition, genes highly expressed in other cancers and associated with specific signal transduction pathways were also found in pancreatic tumors. Conclusion. The scope of the present work was enhanced by the inclusion of publicly available datasets that encompass a wide spectrum of human tissues and enabled the identification of candidate genes that may serve diagnostic and therapeutic goals.	[Lowe, Anson W.; Hao, Ying] Stanford Univ, Med Ctr, Dept Med, Stanford, CA 94305 USA; [Brown, Patrick O.] Stanford Univ, Med Ctr, Dept Biochem, Stanford, CA 94305 USA; [van de Rijn, Matt] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Lowe, Anson W.; Brown, Patrick O.] Stanford Univ, Med Ctr, Stanford Digest Dis Ctr, Stanford, CA 94305 USA; [Olsen, Mari; Brown, Patrick O.] Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Lee, Sum P.] Vet Adm Puget Sound Hlth Care Syst, Seattle, WA USA; [Lee, Kyu Taek] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Chen, Xin] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Sungkyunkwan University (SKKU); Samsung Medical Center; University of California System; University of California San Francisco	Lowe, AW (corresponding author), Stanford Univ, Med Ctr, Dept Med, Stanford, CA 94305 USA.	lowe@stanford.edu	Lee, Sum Ping/C-4333-2009	van de Rijn, Matt/0000-0002-1909-9739	Susan E. Riley Family Foundation; Lustgarten Foundation; NCI [CA77097]; HHMI; General Medical Research Service; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER	Susan E. Riley Family Foundation; Lustgarten Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHMI(Howard Hughes Medical Institute); General Medical Research Service; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Susan E. Riley Family Foundation (AWL and POB), The Lustgarten Foundation (AWL), NCI grant CA77097 and HHMI (POB), General Medical Research Service of the Department of Veterans Affairs (SPL). POB is an investigator of the Howard Hughes Medical Institute. The study sponsors had no role in the study design, data collection, analysis, interpretation of the data, writing of the paper, or the decision to submit for publication.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Argani P, 2001, CANCER RES, V61, P4320; Argani P, 2001, CLIN CANCER RES, V7, P3862; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bramhall SR, 1996, BRIT J CANCER, V73, P972, DOI 10.1038/bjc.1996.190; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; DICHN M, 2006, PLOS GENET, V2, pE11; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Dilley WG, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friess H, 1999, ANN SURG, V230, P767, DOI 10.1097/00000658-199912000-00005; Hansel DE, 2004, CLIN CANCER RES, V10, P6152, DOI 10.1158/1078-0432.CCR-04-0285; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P91, DOI 10.1016/S0002-9440(10)64353-2; Ito T, 1999, THYROID, V9, P563, DOI 10.1089/thy.1999.9.563; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kern S, 2001, CANCER RES, V61, P4923; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Leung SY, 2002, P NATL ACAD SCI USA, V99, P16203, DOI 10.1073/pnas.212646299; Logsdon CD, 2003, CANCER RES, V63, P2649; Lowy AM, 2003, ANN SURG ONCOL, V10, P284, DOI 10.1245/ASO.2003.05.003; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maitra A, 2003, CLIN CANCER RES, V9, P5988; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Oda D, 1998, IN VITRO CELL DEV-AN, V34, P211; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ryu B, 2002, CANCER RES, V62, P819; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stumpf E, 2000, GENE CHROMOSOME CANC, V29, P83, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1011>3.0.CO;2-Z; Sun WS, 2003, ANN ONCOL, V14, P898, DOI 10.1093/annonc/mdg257; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Terris B, 1998, GENE CHROMOSOME CANC, V22, P50, DOI 10.1002/(SICI)1098-2264(199805)22:1<50::AID-GCC7>3.0.CO;2-6; Terris B, 2002, AM J PATHOL, V160, P1745, DOI 10.1016/S0002-9440(10)61121-2; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Wang P, 2005, BIOSTATISTICS, V6, P45, DOI 10.1093/biostatistics/kxh017; Wang PW, 1999, GENOMICS, V59, P275, DOI 10.1006/geno.1999.5884; Wang XC, 2004, ENDOCR-RELAT CANCER, V11, P295, DOI 10.1677/erc.0.0110295; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187	46	79	85	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e323	10.1371/journal.pone.0000323	http://dx.doi.org/10.1371/journal.pone.0000323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389914	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445200006
J	Isaac, NJB; Turvey, ST; Collen, B; Waterman, C; Baillie, JEM				Isaac, Nick J. B.; Turvey, Samuel T.; Collen, Ben; Waterman, Carly; Baillie, Jonathan E. M.			Mammals on the EDGE: Conservation Priorities Based on Threat and Phylogeny	PLOS ONE			English	Article							QUANTIFYING BIODIVERSITY; DIVERSITY; EXTINCTION; HOTSPOTS; INFORMATION; MODELS	Conservation priority setting based on phylogenetic diversity has frequently been proposed but rarely implemented. Here, we define a simple index that measures the contribution made by different species to phylogenetic diversity and show how the index might contribute towards species-based conservation priorities. We describe procedures to control for missing species, incomplete phylogenetic resolution and uncertainty in node ages that make it possible to apply the method in poorly known clades. We also show that the index is independent of clade size in phylogenies of more than 100 species, indicating that scores from unrelated taxonomic groups are likely to be comparable. Similar scores are returned under two different species concepts, suggesting that the index is robust to taxonomic changes. The approach is applied to a near-complete species-level phylogeny of the Mammalia to generate a global priority list incorporating both phylogenetic diversity and extinction risk. The 100 highest-ranking species represent a high proportion of total mammalian diversity and include many species not usually recognised as conservation priorities. Many species that are both evolutionarily distinct and globally endangered (EDGE species) do not benefit from existing conservation projects or protected areas. The results suggest that global conservation priorities may have to be reassessed in order to prevent a disproportionately large amount of mammalian evolutionary history becoming extinct in the near future.	[Isaac, Nick J. B.; Turvey, Samuel T.; Collen, Ben; Waterman, Carly; Baillie, Jonathan E. M.] Zool Soc London, Inst Zool, London NW1 4RY, England	Zoological Society of London	Isaac, NJB (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	nick.isaac@ioz.ac.uk	Collen, Ben/F-2543-2016; Isaac, Nick/C-2716-2011; Collen, Ben/D-5055-2011	Collen, Ben/0000-0003-2564-4243; Isaac, Nick/0000-0002-4869-8052; 	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Averianov Alexander O., 2000, Contributions from the Zoological Institute St Petersburg, V3, P1; Barker GM, 2002, BIOL J LINN SOC, V76, P165, DOI 10.1111/j.1095-8312.2002.tb02081.x; Bininda-Emonds ORP, 2004, TRENDS ECOL EVOL, V19, P315, DOI 10.1016/j.tree.2004.03.015; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; BININDAEMONDS ORP, 2007, NATURE IN PRESS, DOI DOI 10.1038/NATURE05634; Briggs DEG, 2001, PALAEOBIOLOGY, VII; Brooks TM, 2005, CONSERV BIOL SER, V8, P267; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; Diniz JAF, 2004, CONSERV BIOL, V18, P698; Dudgeon D, 2005, AQUAT CONSERV, V15, P105, DOI 10.1002/aqc.687; Entwistle A., 2000, HAS PANDA HAD ITS DA; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; Faith DP, 2002, CONSERV BIOL, V16, P248, DOI 10.1046/j.1523-1739.2002.00503.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Flannery TF, 1998, MAMMALIA, V62, P367, DOI 10.1515/mamm.1998.62.3.367; Groves C.P., 2001, PRIMATE TAXONOMY; Hallam A., 1997, MASS EXTINCTIONS THE; Hartmann K, 2007, RECONSTRUCTING EVOLU; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; *IUCN, 2006, 2006 IUCN RED LIST T; IUCN Red List Standards and Petitions Subcommittee, 2006, GUID US IUCN RED LIS; Kemp TS., 1999, FOSSILS EVOLUTION; KRAJEWSKI C, 1991, SCIENCE, V254, P918, DOI 10.1126/science.254.5034.918-a; Leader-Williams N, 2000, HAS PANDA HAD ITS DA, P53; Mace Georgina M., 2002, V7, P61, DOI 10.1017/CBO9780511606304.005; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; MACE GM, 2005, MILLENNIUM ECOSYSTEM, V1, pCH4; MacPhee R.D.E., 1999, P333; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; McKinney ML, 1998, ANIM CONSERV, V1, P159, DOI 10.1111/j.1469-1795.1998.tb00024.x; Musser G G, 1993, MAMMAL SPECIES WORLD; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Owens IPF, 2000, CONSERV BIOL, V14, P1014, DOI 10.1046/j.1523-1739.2000.98509.x; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Peterson AT, 1999, CONSERV BIOL, V13, P427, DOI 10.1046/j.1523-1739.1999.013002427.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Purvis A, 2005, CONSERV BIOL SER, V8, P295; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Soutullo A, 2005, ANIM CONSERV, V8, P249, DOI 10.1017/S136794300500226X; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N	56	598	624	4	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e296	10.1371/journal.pone.0000296	http://dx.doi.org/10.1371/journal.pone.0000296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17375184	Green Submitted, gold, Green Published			2022-12-27	WOS:000207444800019
J	Li, L; Wang, XF; Sasidharan, R; Stolc, V; Deng, W; He, H; Korbel, J; Chen, XW; Tongprasit, W; Ronald, P; Chen, RS; Gerstein, M; Deng, XW				Li, Lei; Wang, Xiangfeng; Sasidharan, Rajkumar; Stolc, Viktor; Deng, Wei; He, Hang; Korbel, Jan; Chen, Xuewei; Tongprasit, Waraporn; Ronald, Pamela; Chen, Runsheng; Gerstein, Mark; Deng, Xing Wang			Global Identification and Characterization of Transcriptionally Active Regions in the Rice Genome	PLOS ONE			English	Article							ANTISENSE TRANSCRIPTS; MESSENGER-RNA; DRAFT SEQUENCE; EXPRESSION; MICROARRAYS; ANNOTATION; PREDICTION; PAIR	Genome tiling microarray studies have consistently documented rich transcriptional activity beyond the annotated genes. However, systematic characterization and transcriptional profiling of the putative novel transcripts on the genome scale are still lacking. We report here the identification of 25,352 and 27,744 transcriptionally active regions (TARs) not encoded by annotated exons in the rice (Oryza. sativa) subspecies japonica and indica, respectively. The non-exonic TARs account for approximately two thirds of the total TARs detected by tiling arrays and represent transcripts likely conserved between japonica and indica. Transcription of 21,018 (83%) japonica non-exonic TARs was verified through expression profiling in 10 tissue types using a re-array in which annotated genes and TARs were each represented by five independent probes. Subsequent analyses indicate that about 80% of the japonica TARs that were not assigned to annotated exons can be assigned to various putatively functional or structural elements of the rice genome, including splice variants, uncharacterized portions of incompletely annotated genes, antisense transcripts, duplicated gene fragments, and potential non-coding RNAs. These results provide a systematic characterization of non-exonic transcripts in rice and thus expand the current view of the complexity and dynamics of the rice transcriptome.	[Li, Lei; Wang, Xiangfeng; Stolc, Viktor; Deng, Xing Wang] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Wang, Xiangfeng; Deng, Wei; He, Hang] Natl Inst Biol Sci, Beijing, Peoples R China; [Wang, Xiangfeng] Peking Univ, Coll Life Sci, Peking Yale Joint Res Ctr Plant Mol Genet & Agrob, Beijing 100871, Peoples R China; [Sasidharan, Rajkumar; Korbel, Jan; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Stolc, Viktor] NASA, Ames Res Ctr, Genome Res Facil, Moffett Field, CA 94035 USA; [Deng, Wei; He, Hang; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Bioinformat Lab, Beijing 100080, Peoples R China; [Chen, Xuewei; Ronald, Pamela] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Tongprasit, Waraporn] Eloret Corp, Sunnyvale, CA USA	Yale University; National Institute of Biological Sciences, Beijing; Peking University; Yale University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of California System; University of California Davis	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	xingwang.deng@yale.edu	Ronald, Pamela/AAK-7664-2020; Korbel, Jan O/G-6470-2012; Deng, Wei/I-1280-2012; Deng, Xing Wang/ABF-4107-2020; He, Hang/ABF-4074-2020; Chen, Runsheng/S-9834-2017	Korbel, Jan O/0000-0002-2798-3794; Chen, Runsheng/0000-0001-6049-8347; Wang, Xiangfeng/0000-0002-6406-5597; He, Hang/0000-0003-3165-283X; Deng, Wei/0000-0001-7561-9172	NSF [DBI-0421675]	NSF(National Science Foundation (NSF))	This work was supported by a grant from the NSF Plant Genome Program (DBI-0421675).	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Deng W, 2006, GENOME RES, V16, P20, DOI 10.1101/gr.4139206; FARRELL CM, 1995, J BIOL CHEM, V270, P3400, DOI 10.1074/jbc.270.7.3400; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jabbari K, 2004, TRENDS PLANT SCI, V9, P281, DOI 10.1016/j.tplants.2004.04.006; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Juretic N, 2005, GENOME RES, V15, P1292, DOI 10.1101/gr.4064205; Juretic N, 2004, BIOINFORMATICS, V20, P155, DOI 10.1093/bioinformatics/bth019; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; KIKUCHI S, 2003, SCIENCE, V300, P1566; Kitagawa N, 2005, BIOINFORMATICS, V21, P1758, DOI 10.1093/bioinformatics/bti253; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Li L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r52; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matsumura H, 1999, PLANT J, V20, P719, DOI 10.1046/j.1365-313X.1999.00640.x; Matsumura H, 2006, NAT METHODS, V3, P469, DOI 10.1038/NMETH882; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; MUNROE SH, 1991, J BIOL CHEM, V266, P22083; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Osato N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2003-5-1-r5; *RIC CHROM 10 SEQ, 2003, SCIENCE NEW YORK NY, V0300; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Royce TE, 2005, TRENDS GENET, V21, P466, DOI 10.1016/j.tig.2005.06.007; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Wang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r92; Wang XF, 2006, BIOINFORMATICS, V22, P2955, DOI 10.1093/bioinformatics/btl525; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan QP, 2005, PLANT PHYSIOL, V138, P17, DOI 10.1104/pp.104.059063	48	60	64	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e294	10.1371/journal.pone.0000294	http://dx.doi.org/10.1371/journal.pone.0000294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17372628	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444800017
J	Estrugo, D; Fischer, A; Hess, F; Scherthan, H; Belka, C; Cordes, N				Estrugo, Doris; Fischer, Alexander; Hess, Franziska; Scherthan, Harry; Belka, Claus; Cordes, Nils			Ligand Bound beta 1 Integrins Inhibit Procaspase-8 for Mediating Cell Adhesion-Mediated Drug and Radiation Resistance in Human Leukemia Cells	PLOS ONE			English	Article								Background. Chemo- and radiotherapeutic responses of leukemia cells are modified by integrin-mediated adhesion to extracellular matrix. To further characterize the molecular mechanisms by which beta 1 integrins confer radiation and chemoresistance, HL60 human acute promyelocytic leukemia cells stably transfected with beta 1 integrin and A3 Jurkat T-lymphoma cells deficient for Fas-associated death domain protein or procaspase-8 were examined. Methodology/Principal Findings. Upon exposure to X-rays, Ara-C or FasL, suspension and adhesion (fibronectin (FN), laminin, collagen-1; 5-100 mu g/cm(2) coating concentration) cultures were processed for measurement of apoptosis, mitochondrial transmembrane potential (MTP), caspase activation, and protein analysis. Overexpression of beta 1 integrins enhanced the cellular sensitivity to X-rays and Ara-C, which was counteracted by increasing concentrations of matrix proteins in association with reduced caspase-3 and -8 activation and MTP breakdown. Usage of stimulatory or inhibitory anti beta 1 integrin antibodies, pharmacological caspase or phosphatidylinositol-3 kinase (PI3K) inhibitors, coprecipitation experiments and siRNA-mediated beta 1 integrin silencing provided further data showing an interaction between FN-ligated beta 1 integrin and PI3K/Akt for inhibiting procaspase-8 cleavage. Conclusions/Significance. The presented data suggest that the ligand status of beta 1 integrins is critical for their antiapoptotic effect in leukemia cells treated with Ara-C, FasL or ionizing radiation. The antiapoptotic actions involve formation of a beta 1 integrin/Akt complex, which signals to prevent procaspase-8-mediated induction of apoptosis in a PI3K-dependent manner. Antagonizing agents targeting beta 1 integrin and PI3K/Akt signaling in conjunction with conventional therapies might effectively reduce radiation-and drug-resistant tumor populations and treatment failure in hematological malignancies.	[Cordes, Nils] Tech Univ Dresden, Med Fac Carl Gustav Carus, OncoRay Ctr Radiat Res Oncol, D-8027 Dresden, Germany; [Estrugo, Doris; Fischer, Alexander; Hess, Franziska; Scherthan, Harry; Cordes, Nils] Bundeswehr Inst Radiobiol, Munich, Germany; [Belka, Claus] Univ Tubingen, Dept Radiat Oncol, Tubingen, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Eberhard Karls University of Tubingen	Cordes, N (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, OncoRay Ctr Radiat Res Oncol, D-8027 Dresden, Germany.	Nils.Cordes@Oncoray.de		Cordes, Nils/0000-0001-5684-629X	Federal Ministry of Education and Research, Germany, BMBF [03ZIK041]	Federal Ministry of Education and Research, Germany, BMBF(Federal Ministry of Education & Research (BMBF))	This research was in part supported by the Federal Ministry of Education and Research, Germany, BMBF contract 03ZIK041 to N.C.	Aoudjit F, 2001, J CELL BIOL, V152, P633, DOI 10.1083/jcb.152.3.633; Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; Belka C, 2006, ONCOGENE, V25, P969, DOI 10.1038/sj.onc.1209175; Belka C, 2000, ONCOGENE, V19, P1181, DOI 10.1038/sj.onc.1203401; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cordes N, 2006, ONCOGENE, V25, P1378, DOI 10.1038/sj.onc.1209164; Cordes N, 2004, INT J RADIAT ONCOL, V58, P453, DOI 10.1016/j.ijrobp.2003.09.069; Cordes N, 2003, BRIT J CANCER, V89, P2122, DOI 10.1038/sj.bjc.6601429; Cordes N, 2003, STRAHLENTHER ONKOL, V179, P337, DOI 10.1007/s00066-003-1074-4; Damiano JS, 2001, LEUKEMIA, V15, P1232, DOI 10.1038/sj.leu.2402179; de la Fuente MT, 2002, J LEUKOCYTE BIOL, V71, P495; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Eke I, 2006, RADIOTHER ONCOL, V80, P178, DOI 10.1016/j.radonc.2006.07.028; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431; GRENMAN R, 1989, INT J CANCER, V44, P131, DOI 10.1002/ijc.2910440123; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hazlehurst LA, 2000, ONCOGENE, V19, P4319, DOI 10.1038/sj.onc.1203782; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; HESS F, 2006, ONCOGENE        0828, DOI DOI 10.1038/SJ.ONC.1209947;2006; Hodkinson PS, 2006, CELL DEATH DIFFER, V13, P1776, DOI 10.1038/sj.cdd.4401849; Ilic D, 1998, J CELL BIOL, V143, P547; Kasahara T, 2002, ANTIOXID REDOX SIGN, V4, P491, DOI 10.1089/15230860260196290; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Lu B, 2006, J IMMUNOL, V176, P6785, DOI 10.4049/jimmunol.176.11.6785; Marini P, 2003, RADIOTHER ONCOL, V68, P189, DOI 10.1016/S0167-8140(03)00186-5; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Varadhachary AS, 1999, J IMMUNOL, V163, P4772; Wu RC, 2004, CELL MOL LIFE SCI, V61, P2071, DOI 10.1007/s00018-004-4165-1; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954	44	57	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e269	10.1371/journal.pone.0000269	http://dx.doi.org/10.1371/journal.pone.0000269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17342203	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444700004
J	Ringach, DL				Ringach, Dario L.			On the Origin of the Functional Architecture of the Cortex	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; OCULAR-DOMINANCE COLUMNS; CYTOCHROME-OXIDASE BLOBS; PRIMATE STRIATE CORTEX; CORTICAL MAGNIFICATION FACTOR; SPATIAL RESOLVING POWER; ISO-ORIENTATION DOMAINS; SIMPLE RECEPTIVE-FIELDS; RETINAL GANGLION-CELLS	The basic structure of receptive fields and functional maps in primary visual cortex is established without exposure to normal sensory experience and before the onset of the critical period. How the brain wires these circuits in the early stages of development remains unknown. Possible explanations include activity-dependent mechanisms driven by spontaneous activity in the retina and thalamus, and molecular guidance orchestrating thalamo-cortical connections on a fine spatial scale. Here I propose an alternative hypothesis: the blueprint for receptive fields, feature maps, and their inter-relationships may reside in the layout of the retinal ganglion cell mosaics along with a simple statistical connectivity scheme dictating the wiring between thalamus and cortex. The model is shown to account for a number of experimental findings, including the relationship between retinotopy, orientation maps, spatial frequency maps and cytochrome oxidase patches. The theory's simplicity, explanatory and predictive power makes it a serious candidate for the origin of the functional architecture of primary visual cortex.	Univ Calif Los Angeles, Dept Psychol & Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Ringach, DL (corresponding author), Univ Calif Los Angeles, Dept Psychol & Neurobiol, Los Angeles, CA 90095 USA.	dario@ucla.edu			NIH [EY-12816]; DARPA [FA8650-06-C-7633]; NATIONAL EYE INSTITUTE [R01EY012816] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work has been supported by NIH EY-12816 and DARPA FA8650-06-C-7633.	Adams DL, 2003, J NEUROSCI, V23, P5984, DOI 10.1523/JNEUROSCI.23-14-05984.2003; Adams DL, 2003, J NEUROSCI, V23, P3771; AHMED B, 1991, EXP BRAIN RES, V84, P676; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Andrade MA, 1997, NEURAL NETWORKS, V10, P1037, DOI 10.1016/S0893-6080(97)00003-8; BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; Bartsch AP, 2001, BIOL CYBERN, V84, P41, DOI 10.1007/s004220170003; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; Bednar JA, 2006, NEUROCOMPUTING, V69, P1272, DOI 10.1016/j.neucom.2005.12.090; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; Blumenfeld B, 2006, J COMPUT NEUROSCI, V20, P219, DOI 10.1007/s10827-006-6307-y; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; BOYCOTT BB, 1974, J PHYSIOL-LONDON, V240, P397, DOI 10.1113/jphysiol.1974.sp010616; Buzas P, 2003, EUR J NEUROSCI, V18, P957, DOI 10.1046/j.1460-9568.2003.02808.x; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chapman B, 2000, J NEUROSCI, V20, P1922; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Chklovskii DB, 2000, PHYSICA A, V284, P318, DOI 10.1016/S0378-4371(00)00219-3; CLELAND BG, 1985, J PHYSIOL-LONDON, V369, P249, DOI 10.1113/jphysiol.1985.sp015899; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; COWEY A, 1979, Q J EXP PSYCHOL, V31, P1, DOI 10.1080/14640747908400703; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 2002, CURR OPIN NEUROBIOL, V12, P104, DOI 10.1016/S0959-4388(02)00297-0; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; Dayan P, 2003, J PHYSIOL-PARIS, V97, P475, DOI 10.1016/j.jphysparis.2004.01.006; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Eglen SJ, 2005, VISUAL NEUROSCI, V22, P859, DOI 10.1017/S0952523805226147; Eglen SJ, 2006, MATH MED BIOL, V23, P79, DOI 10.1093/imammb/dql003; Ernst U, 1999, NEURAL COMPUT, V11, P375, DOI 10.1162/089976699300016692; Ernst UA, 2001, NAT NEUROSCI, V4, P431, DOI 10.1038/86089; Erwin E, 1998, J NEUROSCI, V18, P9870; EVERSON R, 1995, INVEST OPHTH VIS SCI, V36, pS873; FERSTER D, 1978, J COMP NEUROL, V182, P923, DOI 10.1002/cne.901820510; FREGNAC Y, 1984, PHYSIOL REV, V64, P325, DOI 10.1152/physrev.1984.64.1.325; GOODHILL GJ, 1994, NEURAL COMPUT, V6, P615, DOI 10.1162/neco.1994.6.4.615; Goodhill GJ, 1997, P ROY SOC B-BIOL SCI, V264, P649, DOI 10.1098/rspb.1997.0092; Goodhill GJ, 2000, NETWORK-COMP NEURAL, V11, P153, DOI 10.1088/0954-898X/11/2/303; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 2000, EUR J NEUROSCI, V12, P194; Hubener M, 1997, J NEUROSCI, V17, P9270; HUMPHREY AL, 1985, J COMP NEUROL, V233, P190, DOI 10.1002/cne.902330204; IKEDA H, 1978, EXP BRAIN RES, V31, P193; IKEDA H, 1978, ARCH ITAL BIOL, V116, P375; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; JONES DG, 1991, J NEUROSCI, V11, P3794; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Kaschube M, 2002, J NEUROSCI, V22, P7206; Kayser AS, 2002, NEURON, V33, P131, DOI 10.1016/S0896-6273(01)00570-0; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kohonen T, 1985, J OPT SOC AM A, V2, pP16; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3126, DOI 10.1152/jn.2002.87.6.3126; LEVENTHAL AG, 1983, J COMP NEUROL, V220, P465, DOI 10.1002/cne.902200408; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; MALSBURG CV, 1973, KYBERNETIK, V14, P85, DOI 10.1007/BF00288907; MALSBURG CV, 1973, PFLUG ARCH EUR J PHY, V339, P95; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Matsuda Y, 2000, NEUROREPORT, V11, P3337, DOI 10.1097/00001756-200010200-00015; McLaughlin D, 2003, J PHYSIOL-PARIS, V97, P237, DOI 10.1016/j.jphysparis.2003.09.019; MILLER KD, 1992, NEUROREPORT, V3, P73, DOI 10.1097/00001756-199201000-00019; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Miller KD, 2003, CEREB CORTEX, V13, P73, DOI 10.1093/cercor/13.1.73; MILLER KD, 1994, J NEUROSCI, V14, P409; Miller KD, 2001, VISUAL NEUROSCI, V18, P821, DOI 10.1017/S0952523801185159; MILLER KD, 1994, PROG BRAIN RES, V102, P303; Miller KD, 1998, NEURAL COMPUT, V10, P529, DOI 10.1162/089976698300017647; Miller KD, 1999, J NEUROBIOL, V41, P44, DOI 10.1002/(SICI)1097-4695(199910)41:1<44::AID-NEU7>3.0.CO;2-V; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1981, ANNU REV PSYCHOL, V32, P477, DOI 10.1146/annurev.ps.32.020181.002401; Muller T, 2000, NEURAL COMPUT, V12, P2573, DOI 10.1162/089976600300014854; MURPHY KM, 1995, J NEUROSCI, V15, P4196; MURPHY KM, 1991, INVEST OPHTH VIS SCI, V32, P1116; Murphy KM, 2001, CEREB CORTEX, V11, P122, DOI 10.1093/cercor/11.2.122; NAEGELE JR, 1988, J COMP NEUROL, V277, P593, DOI 10.1002/cne.902770411; NIEBUR E, 1994, NEURAL COMPUT, V6, P602, DOI 10.1162/neco.1994.6.4.602; Obermayer K, 1997, NEURAL COMPUT, V9, P555, DOI 10.1162/neco.1997.9.3.555; OBERMAYER K, 1995, BEHAV BRAIN RES, V66, P161, DOI 10.1016/0166-4328(94)00136-4; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Ohshiro T, 2006, NAT NEUROSCI, V9, P1541, DOI 10.1038/nn1799; Ohzawa I, 1996, J NEUROPHYSIOL, V75, P1779, DOI 10.1152/jn.1996.75.5.1779; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; PURVES D, 1992, TRENDS NEUROSCI, V15, P362, DOI 10.1016/0166-2236(92)90180-G; Rao SC, 1997, J COMP NEUROL, V387, P358; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; SAKITT B, 1982, VISION RES, V22, P417, DOI 10.1016/0042-6989(82)90158-4; Sasaki Y, 2006, NEURON, V51, P661, DOI 10.1016/j.neuron.2006.07.021; SCHALL JD, 1986, BRAIN RES, V368, P18, DOI 10.1016/0006-8993(86)91037-1; SCHALL JD, 1987, J COMP NEUROL, V257, P149, DOI 10.1002/cne.902570202; Schmidt KF, 2006, NEUROSCIENCE, V141, P1525, DOI 10.1016/j.neuroscience.2006.04.056; Schmidt KF, 2006, NEUROIMAGE, V29, P439, DOI 10.1016/j.neuroimage.2005.07.031; Schummers J, 2004, J PHYSIOL-PARIS, V98, P429, DOI 10.1016/j.jphysparis.2005.09.017; Schummers J, 2002, NEURON, V36, P969, DOI 10.1016/S0896-6273(02)01012-7; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; SHATZ CJ, 1994, INT J DEV NEUROSCI, V12, P531, DOI 10.1016/0736-5748(94)90061-2; SHERK H, 1976, J NEUROPHYSIOL, V39, P63, DOI 10.1152/jn.1976.39.1.63; Shmuel A, 2000, P NATL ACAD SCI USA, V97, P5568, DOI 10.1073/pnas.97.10.5568; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; Skaliora I, 2000, J NEUROSCI, V20, P3650, DOI 10.1523/JNEUROSCI.20-10-03650.2000; SOODAK RE, 1987, P NATL ACAD SCI USA, V84, P3936, DOI 10.1073/pnas.84.11.3936; SOODAK RE, 1991, VISUAL NEUROSCI, V6, P507, DOI 10.1017/S0952523800001358; Stein JJ, 1996, J COMP NEUROL, V372, P597, DOI 10.1002/(SICI)1096-9861(19960902)372:4<597::AID-CNE8>3.0.CO;2-#; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; SWINDALE NV, 1990, TRENDS NEUROSCI, V13, P487, DOI 10.1016/0166-2236(90)90082-L; Swindale NV, 2000, CEREB CORTEX, V10, P633, DOI 10.1093/cercor/10.7.633; SWINDALE NV, 1991, BIOL CYBERN, V65, P415, DOI 10.1007/BF00204654; Swindale NV, 2004, NETWORK-COMP NEURAL, V15, P217, DOI 10.1088/0954-898X/15/4/001; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Swindale NV, 2003, CEREB CORTEX, V13, P225, DOI 10.1093/cercor/13.3.225; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Thomas PJ, 2006, MATH MED BIOL, V23, P119, DOI 10.1093/imammb/dql006; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P157, DOI 10.1098/rspb.1981.0032; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; Weliky M, 1999, J NEUROBIOL, V41, P25, DOI 10.1002/(SICI)1097-4695(199910)41:1<25::AID-NEU5>3.0.CO;2-#; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; Weng C, 2005, J NEUROPHYSIOL, V93, P3537, DOI 10.1152/jn.00847.2004; Wimbauer S, 1997, BIOL CYBERN, V77, P453, DOI 10.1007/s004220050405; Wolf F, 1996, NATURE, V382, P306, DOI 10.1038/382306a0; Wolf F, 2000, J PHYSIOLOGY-PARIS, V94, P525, DOI 10.1016/S0928-4257(00)01104-9; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Xiao YP, 2003, NATURE, V421, P535, DOI 10.1038/nature01372; Xing DJ, 2004, J PHYSIOL-LONDON, V557, P923, DOI 10.1113/jphysiol.2004.062026; Yeh CI, 2003, J NEUROPHYSIOL, V90, P1852, DOI 10.1152/jn.00417.2003; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; Zhan XJ, 2000, VISUAL NEUROSCI, V17, P23, DOI 10.1017/S0952523800171032	159	53	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e251	10.1371/journal.pone.0000251	http://dx.doi.org/10.1371/journal.pone.0000251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17330140	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444600011
J	Falagas, ME; Karydis, I; Kostogiannou, I				Falagas, Matthew E.; Karydis, Ioannis; Kostogiannou, Ilektra			Percutaneous Exposure Incidents of the Health Care Personnel in a Newly Founded Tertiary Hospital: A Prospective Study	PLOS ONE			English	Article								Background. Percutaneous exposure incidents (PEIs) and blood splashes on the skin of health care workers are a major concern, since they expose susceptible employees to the risk of infectious diseases. We undertook this study in order to estimate the overall incidence of such injuries in a newly founded tertiary hospital, and to evaluate possible changes in their incidence over time. Methodology/Principal Findings. We prospectively studied the PEIs and blood splashes on the skin of employees in a newly founded (October 2000) tertiary hospital in Athens, Greece, while a vaccination program against hepatitis B virus, as well as educational activities for avoidance of injuries, were taking place. The study period ranged from October 1, 2002 to February 28, 2005. Serologic studies for hepatitis B (HBV) and C virus (HCV) as well as human immunodeficiency virus (HIV) were performed in all injured employees and the source patients, when known. High-titer immunoglobulin (250 IU anti-HBs intramuscularly) and HBV vaccination were given to non-vaccinated or previously vaccinated but serologically non-responders after exposure. Statistical analysis of the data was performed using Mc Nemar's and Fisher's tests. 60 needlestick, 11 sharp injuries, and two splashes leading to exposure of the skin or mucosa to blood were reported during the study period in 71 nurses and two members of the cleaning staff. The overall incidence (percutaneous injuries and splashes) per 100 full-time employment-years (100 FTEYs) for high-risk personnel (nursing, medical, and cleaning staff) was 3.48, whereas the incidence of percutaneous injuries (needlestick and sharp injuries) alone per 100 FTEYs was 3.38. A higher incidence of injuries was noted during the first than in the second half of the study period (4.67 versus 2.29 per 100 FTEYs, p = 0.005). No source patient was found positive for HCV or HIV. The use of high-titer immunoglobulin after adjustment for the incidence of injuries was higher in the first than in the second half of the study period, although the difference was not statistically significant [9/49 (18.37%) vs 1/24 (4.17%), p = 0.15]. Conclusions/Significance. Our data show that nurses are the healthcare worker group that reports most of PEIs. Doctors did not report such injuries during the study period in our setting. However, the possibility of even relatively frequent PEIs in doctors cannot be excluded. This is due to underreporting of such events that has been previously described for physicians and surgeons. A decrease of the incidence of PEIs occurred during the operation of this newly founded hospital.	[Falagas, Matthew E.; Karydis, Ioannis] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.] Henry Dunant Hosp, Employee Hlth Clin, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Kostogiannou, Ilektra] Henry Dunant Hosp, Dept Nursing, Athens, Greece	Alfa Institute Of Biomedical Sciences; Henry Dunant Hospital; Tufts University; Henry Dunant Hospital	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr						AGERTON TB, 1995, INFECT CONT HOSP EP, V16, P287; [Anonymous], 1990, MMWR Recomm Rep, V39, P1; Babcock HM, 2003, INFECT CONT HOSP EP, V24, P731, DOI 10.1086/502121; Beekmann SE, 2001, INFECT CONT HOSP EP, V22, P73, DOI 10.1086/501867; BOLYARD E, 2001, INFECT CONTROL REFER, P1105; Dement JM, 2004, AM J IND MED, V46, P637, DOI 10.1002/ajim.20106; Doebbeling BN, 2003, CLIN INFECT DIS, V37, P1006, DOI 10.1086/377535; Foley M, 2004, AM J NURS, V104, P96, DOI 10.1097/00000446-200408000-00049; Lee Jennifer M, 2005, AAOHN J, V53, P117; MALLON DFJ, 1992, MED J AUSTRALIA, V157, P592, DOI 10.5694/j.1326-5377.1992.tb137397.x; Merchant RC, 2006, ANN EMERG MED, V47, P492, DOI 10.1016/j.annemergmed.2006.02.013; Murphy E, 2000, OCCUP MED-OXFORD, V50, P383, DOI 10.1093/occmed/50.6.383; Nash G, 2001, BRIT MED J, V323, P169, DOI 10.1136/bmj.323.7305.169; Pournaras S, 1999, OCCUP MED-OXFORD, V49, P423, DOI 10.1093/occmed/49.7.423; Puro V, 2001, INFECT CONT HOSP EP, V22, P206, DOI 10.1086/501890; ROUDOTTHORAVAL F, 2000, INFECT CONT HOSP EP, V21, P494; Shiao JSC, 1999, AM J INFECT CONTROL, V27, P254, DOI 10.1053/ic.1999.v27.a97006; Tan L, 2001, ARCH INTERN MED, V161, P929, DOI 10.1001/archinte.161.7.929; Trape-Cardoso M, 2004, AM J INFECT CONTROL, V32, P301, DOI 10.1016/j.ajic.2003.12.003; Whitby RM, 2002, MED J AUSTRALIA, V177, P405	20	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e194	10.1371/journal.pone.0000194	http://dx.doi.org/10.1371/journal.pone.0000194			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17332844	Green Published, gold			2022-12-27	WOS:000207444300007
J	Greenstein, RJ; Su, LY; Haroutunian, V; Shahidi, A; Brown, ST				Greenstein, Robert J.; Su, Liya; Haroutunian, Vahram; Shahidi, Azra; Brown, Sheldon T.			On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis	PLOS ONE			English	Article								Background. Clinical improvement in inflammatory bowel disease (IBD) treated with methotrexate and 6-mercaptopurine (6-MP) is associated with a decrease in pro-inflammatory cytokines. This has been presumed to indicate the mechanism of action of methotrexate and 6-MP. Although controversial, there are increasingly compelling data that Mycobacterium avium subspecies paratuberculosis(MAP) may be an etiological agent in some or all of IBD. We hypothesized that the clinical efficacy of methotrexate and 6-MP in IBD may be to simply inhibit the growth of MAP. Methodology. The effect on MAP growth kinetics by methotrexate and 6-MP were evaluated in cell culture of two strains each of MAP and M. avium using a radiometric ((CO2)-C-14 BACTEC (R)) detection system that quantifies mycobacterial growth as arbitrary "growth index units'' (GI). Efficacy data are presented as "percent decrease in cumulative GI'' (% -Delta cGI). Principal Findings. The positive control antibiotic (clarithromycin) has >= 85% -Delta cGI at a concentration of 0.5 mu g/ml. The negative control (ampicillin) has minimal inhibition at 64 mu g/ml. MAP ATCC 19698 shows >= 80% -Delta cGI for both agents by 4 mu g/ml. With the other three isolates, although more effective than ampicillin, 6-MP is consistently less effective than methotrexate. Conclusions. We show that methotrexate and 6-MP inhibit MAP growth in vitro. Each of the four isolates manifests different % -Delta cGI. These data are compatible with the hypothesis that the clinical improvement in patients with IBD treated with methotrexate and 6-MP could be due to treating a MAP infection. The decrease in pro-inflammatory cytokines, thought to be the primary mechanism of action, may simply be a normal, secondary, physiological response. We conclude that henceforth, in clinical studies that evaluate the effect of anti-MAP agents in IBD, the use of methotrexate and 6-MP should be excluded from any control groups.	[Greenstein, Robert J.; Su, Liya] VA Med Ctr, Lab Mol Surg Res, Bronx, NY USA		Greenstein, RJ (corresponding author), VA Med Ctr, Lab Mol Surg Res, Bronx, NY USA.	BGAxis@aol.com						Autschbach F, 2005, GUT, V54, P944, DOI 10.1136/gut.2004.045526; Baumgart DC, 2005, SCAND J GASTROENTERO, V40, P958, DOI 10.1080/00365520510015854; BERNSTEIN CN, 1994, DIGEST DIS SCI, V39, P1638, DOI 10.1007/BF02087769; BERTRAM MA, 1986, J INFECT DIS, V154, P194, DOI 10.1093/infdis/154.1.194; CALABRESI P, 1990, PHARMACOL BASIS THER, P1202; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; COGGIN JH, 1966, J BACTERIOL, V92, P446, DOI 10.1128/JB.92.2.446-454.1966; DAMATO JJ, 1990, VET MICROBIOL, V22, P31, DOI 10.1016/0378-1135(90)90122-C; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; FINDLEY RS, 1996, TXB THERAPEUTICS DRU, P1509; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; GROSS V, 1991, KLIN WOCHENSCHR, V69, P981, DOI 10.1007/BF01645143; Hermon-Taylor J, 2004, PATHOGENIC MYCOBACTE, P74; JOHNE HA, 1895, DTSCH Z TIERMED PATH, V21, P438; Kleinsmith LJ, 2006, PRINCIPLES CANC BIOL; KUNZE ZM, 1991, MOL MICROBIOL, V5, P2265, DOI 10.1111/j.1365-2958.1991.tb02157.x; KUNZE ZM, 1992, J CLIN MICROBIOL, V30, P2366, DOI 10.1128/JCM.30.9.2366-2372.1992; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Peifer C, 2006, CURR TOP MED CHEM, V6, P113, DOI 10.2174/156802606775270323; RASTOGI N, 1992, ANTIMICROB AGENTS CH, V36, P2843, DOI 10.1128/AAC.36.12.2843; *RTI INT, 2006, TUB ANT ACQ COORD FA; URBA W J, 1990, Journal of the National Cancer Institute Monographs, P29; WOLTERS FL, 2005, GUT; ZIMMERMAN EF, 1964, J BIOL CHEM, V239, P293	26	63	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e161	10.1371/journal.pone.0000161	http://dx.doi.org/10.1371/journal.pone.0000161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17252054	Green Published, gold			2022-12-27	WOS:000207444100002
J	Al-Ani, B; Hewett, PW; Ahmed, S; Cudmore, M; Fujisawa, T; Ahmad, S; Ahmed, A				Al-Ani, Bahjat; Hewett, Peter W.; Ahmed, Suborna; Cudmore, Melissa; Fujisawa, Takeshi; Ahmad, Shakil; Ahmed, Asif			The Release of Nitric Oxide from S-Nitrosothiols Promotes Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VITAMIN-C; ASCORBIC-ACID; RELAXING FACTOR; CELL APOPTOSIS; NITROSYLATION; SYNTHASE; VASCULATURE; DYSFUNCTION; ACTIVATION	Background. Free nitric oxide (NO) reacts with sulphydryl residues to form S-nitrosothiols, which act as NO reservoirs. We sought to determine whether thiol-preserving agents and antioxidants, such as dithiothreitol (DTT) and vitamin C, induce NO release from S-nitrosylated proteins in endothelial cell cultures to promote angiogenesis. Methodology/Principal Findings. NO release was measured directly in cell supernatants using a Sievers NO Analyser, and in vitro angiogenesis was assessed by quantifying capillary-like tube network formation of porcine aortic endothelial cells (PAEC) on growth factor-reduced Matrigel. Incubation of PAEC with DTT or vitamin C significantly increased NO release in a concentration-dependent manner. However, the nitric oxide synthase (NOS) inhibitors, L-NNA and L-NIO, had no effect on DTT- or vitamin C-induced NO release, and there was no concomitant increase in the phosphorylation of endothelial NOS at serine-1177 following DTT or vitamin C treatment. DTT and vitamin C increased capillary-like tube network formation by nine-and two-fold, respectively, and the addition of copper ions doubled the effect of vitamin C. Surprisingly, DTT maintained endothelial tube networks for up to one month under serum-free conditions, and selective inhibitors of guanylyl cyclase (ODQ) and PKG (KT-5823) blocked this, demonstrating the requirement of cyclic GMP and PKG in this process. Conclusions/Significance. Both DTT and vitamin C are capable of releasing sufficient NO from S-nitrosothiols to induce capillary morphogenesis. This study provides the first evidence that increased denitrosylation leads to increased bioavailability of NO, independent of NOS activity, to promote sustained angiogenesis.	[Al-Ani, Bahjat; Hewett, Peter W.; Ahmed, Suborna; Cudmore, Melissa; Fujisawa, Takeshi; Ahmad, Shakil; Ahmed, Asif] Univ Birmingham, Sch Med, Inst Biomed Res, Dept Reprod & Vasc Biol,Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Ahmed, Asif] Birmingham Womens Hosp NHS Trust, Birmingham, W Midlands, England	University of Birmingham; Birmingham Women's Hospital	Ahmed, A (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res, Dept Reprod & Vasc Biol,Ctr Cardiovasc Sci, Birmingham, W Midlands, England.	a.s.ahmed@bham.ac.uk	Fujisawa, Takeshi/F-9451-2010; Ahmed, Asif/ABE-9544-2020; Ahmed, Asif/A-7268-2010; Ahmad, Shakil/A-9421-2008; Cudmore, Melissa/B-5714-2008	Ahmed, Asif/0000-0002-8755-8546; Ahmad, Shakil/0000-0002-9294-0475; Goswami, Kaushal/0000-0002-7052-4358	British Heart Foundation; European Vascular Genomics Network; European Community [LSHM-CT-2003-503254]; MRC [G0600270] Funding Source: UKRI; Medical Research Council [G0600270] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); European Vascular Genomics Network; European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the British Heart Foundation and the European Vascular Genomics Network, a network of excellence supported by the European Community's Sixth Framework Programme for Research Priority 1 "Life Sciences, Genomics and Biotechnology for Health'' (contractLSHM-CT-2003-503254).	Ahmed A, 1997, LAB INVEST, V76, P779; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Ashino Hiromi, 2003, Angiogenesis, V6, P259, DOI 10.1023/B:AGEN.0000029390.09354.f8; Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; Bates CJ, 1998, J HYPERTENS, V16, P925, DOI 10.1097/00004872-199816070-00005; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; Chen X, 2001, HYPERTENSION, V38, P606, DOI 10.1161/hy09t1.094005; D'Alessio M, 2003, ANN NY ACAD SCI, V1010, P449, DOI 10.1196/annals.1299.082; Dicks AP, 1996, CHEM BIOL, V3, P655, DOI 10.1016/S1074-5521(96)90133-7; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1; Duvall WL, 2005, MT SINAI J MED, V72, P71; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Foster D C, 1999, Rev Physiol Biochem Pharmacol, V135, P1, DOI 10.1007/BFb0033668; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Gandley RE, 2005, HYPERTENSION, V45, P21, DOI 10.1161/01.HYP.0000150158.42620.3e; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; GHIGO D, 1993, AM J PHYSIOL, V265, pC728, DOI 10.1152/ajpcell.1993.265.3.C728; Gokce N, 1999, CIRCULATION, V99, P3234, DOI 10.1161/01.CIR.99.25.3234; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hasnain BI, 2004, CLEV CLIN J MED, V71, P327, DOI 10.3949/ccjm.71.4.327; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huang AN, 2001, AM J PHYSIOL-CELL PH, V281, pC719, DOI 10.1152/ajpcell.2001.281.2.C719; Jernigan NL, 2004, AM J PHYSIOL-LUNG C, V286, pL947, DOI 10.1152/ajplung.00215.2003; Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013; KashibaIwatsuki M, 1997, J BIOCHEM-TOKYO, V122, P1208; KEANEY JF, 1993, J CLIN INVEST, V91, P1582, DOI 10.1172/JCI116364; KELM M, 1990, CIRC RES, V66, P1561, DOI 10.1161/01.RES.66.6.1561; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Laursen JB, 2001, FREE RADICAL RES, V35, P387, DOI 10.1080/10715760100300901; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liuzzi F, 2003, ANN NY ACAD SCI, V1010, P441, DOI 10.1196/annals.1299.080; Massy ZA, 2004, J AM SOC NEPHROL, V15, P470, DOI 10.1097/01.ASN.0000106716.22153.BB; Matsumoto T, 2003, J PHARMACOL EXP THER, V306, P103, DOI 10.1124/jpet.103.049163; May JM, 2005, ARCH BIOCHEM BIOPHYS, V434, P178, DOI 10.1016/j.abb.2004.10.023; Moncada S, 1997, ANN NY ACAD SCI, V811, P60, DOI 10.1111/j.1749-6632.1997.tb51989.x; Moulton K S, 2001, Curr Atheroscler Rep, V3, P225, DOI 10.1007/s11883-001-0065-0; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; Ness A R, 1996, J Cardiovasc Risk, V3, P373; Ness AR, 1996, J HYPERTENS, V14, P503; NUNES GL, 1995, ARTERIOSCL THROM VAS, V15, P156, DOI 10.1161/01.ATV.15.1.156; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; RAM FS, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000993.PUB2; Rossig L, 2001, CIRCULATION, V104, P2182, DOI 10.1161/hc4301.098284; Sato J, 2000, CARDIOVASC RES, V47, P697, DOI 10.1016/S0008-6363(00)00137-1; Sephel GC, 1996, MATRIX BIOL, V15, P263, DOI 10.1016/S0945-053X(96)90117-1; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Tsuboi H, 2004, J CELL BIOCHEM, V93, P162, DOI 10.1002/jcb.20134; WEDGWOOD S, 2005, AM J PHYSL LUNG CELL; Yang Y, 2005, P NATL ACAD SCI USA, V102, P117, DOI 10.1073/pnas.0405989102	57	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e25	10.1371/journal.pone.0000025	http://dx.doi.org/10.1371/journal.pone.0000025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183652	gold, Green Published, Green Accepted			2022-12-27	WOS:000207443600025
J	Harris, JA; Arabzadeh, E; Fairhall, AL; Benito, C; Diamond, ME				Harris, Justin A.; Arabzadeh, Ehsan; Fairhall, Adrienne L.; Benito, Claire; Diamond, Mathew E.			Factors Affecting Frequency Discrimination of Vibrotactile Stimuli: Implications for Cortical Encoding	PLOS ONE			English	Article								Background. Measuring perceptual judgments about stimuli while manipulating their physical characteristics can uncover the neural algorithms underlying sensory processing. We carried out psychophysical experiments to examine how humans discriminate vibrotactile stimuli. Methodology/Principal Findings. Subjects compared the frequencies of two sinusoidal vibrations applied sequentially to one fingertip. Performance was reduced when (1) the root mean square velocity (or energy) of the vibrations was equated by adjusting their amplitudes, and (2) the vibrations were noisy (their temporal structure was irregular). These effects were super-additive when subjects compared noisy vibrations that had equal velocity, indicating that frequency judgments became more dependent on the vibrations' temporal structure when differential information about velocity was eliminated. To investigate which areas of the somatosensory system use information about velocity and temporal structure, we required subjects to compare vibrations applied sequentially to opposite hands. This paradigm exploits the fact that tactile input to neurons at early levels (e.g., the primary somatosensory cortex, SI) is largely confined to the contralateral side of the body, so these neurons are less able to contribute to vibration comparisons between hands. The subjects' performance was still sensitive to differences in vibration velocity, but became less sensitive to noise. Conclusions/Significance. We conclude that vibration frequency is represented in different ways by different mechanisms distributed across multiple cortical regions. Which mechanisms support the "readout'' of frequency varies according to the information present in the vibration. Overall, the present findings are consistent with a model in which information about vibration velocity is coded in regions beyond SI. While adaptive processes within SI also contribute to the representation of frequency, this adaptation is influenced by the temporal regularity of the vibration.	[Harris, Justin A.; Arabzadeh, Ehsan; Benito, Claire] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Fairhall, Adrienne L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Diamond, Mathew E.] Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, Trieste, Italy	University of Sydney; University of Washington; University of Washington Seattle; International School for Advanced Studies (SISSA)	Harris, JA (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	justinh@psych.usyd.edu.au		Arabzadeh, Ehsan/0000-0001-9632-0735; Harris, Justin/0000-0003-3865-8097; DIAMOND, Mathew Ernest/0000-0003-2286-4566	Australian Research Council [DP0343552, DP0663086]; Telethon Foundation [GGP02459]; James S. McDonnell Foundation; Italian Institute of Technology; Human Frontiers Science Program [RG0043/2004-C]; Burroughs-Wellcome Careers at the Scientific Interface	Australian Research Council(Australian Research Council); Telethon Foundation(Fondazione Telethon); James S. McDonnell Foundation; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Human Frontiers Science Program(Human Frontier Science Program); Burroughs-Wellcome Careers at the Scientific Interface(Burroughs Wellcome Fund)	This work was supported by grants from the Australian Research Council (grants DP0343552 and DP0663086), the Telethon Foundation (grant GGP02459), the James S. McDonnell Foundation, the Italian Institute of Technology, the Human Frontiers Science Program (a postdoctoral fellowship to E. A., and grant RG0043/2004-C), and a Burroughs-Wellcome Careers at the Scientific Interface grant.	Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Burton H, 1999, CEREB CORTEX, V9, P662, DOI 10.1093/cercor/9.7.662; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; GOFF GD, 1967, J EXP PSYCHOL, V74, P294, DOI 10.1037/h0024561; Harris JA, 2002, J NEUROSCI, V22, P8720; Harris JA, 2001, J NEUROSCI, V21, P8262, DOI 10.1523/JNEUROSCI.21-20-08262.2001; HARRIS JA, 2006, PERCEPT DECISION ACT, P238; HEGNER YL, J NEUROPHYS IN PRESS, DOI DOI 10.1152/JN.00617.02006; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; IWAMURA Y, 1993, EXP BRAIN RES, V92, P360; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; LAK A, RETUNING NEURO UNPUB; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Lipton ML, 2006, J NEUROSCI, V26, P180, DOI 10.1523/JNEUROSCI.1073-05.2006; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; MERZENICH MM, 1978, J COMP NEUROL, V181, P41, DOI 10.1002/cne.901810104; MOUNTCAS.VB, 1967, SCIENCE, V155, P597, DOI 10.1126/science.155.3762.597; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Roder B, 2002, EXP BRAIN RES, V143, P453, DOI 10.1007/s00221-002-1019-7; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Shoham D, 2001, J NEUROSCI, V21, P6820, DOI 10.1523/JNEUROSCI.21-17-06820.2001; Tassinari G, 1996, NEUROPSYCHOLOGIA, V34, P235, DOI 10.1016/0028-3932(95)00085-2; THORSON J, 1974, SCIENCE, V183, P161, DOI 10.1126/science.183.4121.161; Tommerdahl M, 2006, J NEUROSCI, V26, P5970, DOI 10.1523/JNEUROSCI.5270-05.2006	34	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e100	10.1371/journal.pone.0000100	http://dx.doi.org/10.1371/journal.pone.0000100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183633	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600099
J	Khanna, R; Li, Q; Stanley, EF				Khanna, Rajesh; Li, Qi; Stanley, Elise F.			'Fractional Recovery' Analysis of a Presynaptic Synaptotagmin 1-Anchored Endocytic Protein Complex	PLOS ONE			English	Article								Background. The integral synaptic vesicle protein and putative calcium sensor, synaptotagmin 1 (STG), has also been implicated in synaptic vesicle (SV) recovery. However, proteins with which STG interacts during SV endocytosis remain poorly understood. We have isolated an STG-associated endocytic complex (SAE) from presynaptic nerve terminals and have used a novel fractional recovery (FR) assay based on electrostatic dissociation to identify SAE components and map the complex structure. The location of SAE in the presynaptic terminal was determined by high-resolution quantitative immunocytochemistry at the chick ciliary ganglion giant calyx-type synapse. Methodology/Principle Findings. The first step in FR analysis was to immunoprecipitate (IP) the complex with an antibody against one protein component (the IP-protein). The immobilized complex was then exposed to a high salt (1150 mM) stress-test that caused shedding of co-immunoprecipitated proteins (coIP-proteins). A Fractional Recovery ratio (FR: recovery after high salt/recovery with control salt as assayed by Western blot) was calculated for each co-IP-protein. These FR values reflect complex structure since an easily dissociated protein, with a low FR value, cannot be intermediary between the IP-protein and a salt-resistant protein. The structure of the complex was mapped and a blueprint generated with a pair of FR analyses generated using two different IP-proteins. The blueprint of SAE contains an AP180/X/STG/stonin 2/intersectin/epsin core (X is unknown and epsin is hypothesized), and an AP2 adaptor, H-/L-clathrin coat and dynamin scission protein perimeter. Quantitative immunocytochemistry (ICA/ICQ method) at an isolated calyx-type presynaptic terminal indicates that this complex is associated with STG at the presynaptic transmitter release face but not with STG on intracellular synaptic vesicles. Conclusions/Significance. We hypothesize that the SAE serves as a recognition site and also as a seed complex for clathrin-mediated synaptic vesicle recovery. The combination of FR analysis with quantitative immunocytochemistry provides a novel and effective strategy for the identification and characterization of biologically-relevant multi-molecular complexes.	[Khanna, Rajesh; Li, Qi; Stanley, Elise F.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Stanley, EF (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	estanley@uhnres.utoronto.ca		Khanna, Rajesh/0000-0002-9066-2969	CIHR [MOP57716]; Canada Research Chair; Tanenbaum chair	CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Tanenbaum chair	CIHR MOP57716, Canada Research Chair, Tanenbaum chair ( all to EFS). No other support, all experiments were carried out independently in the laboratory.	Augustine GJ, 2006, BIOCHEM SOC T, V34, P68, DOI 10.1042/BST0340068; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Gentile L, 2005, EUR J NEUROSCI, V21, P278, DOI 10.1111/j.1460-9568.2004.03841.x; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KEEN JH, 1987, J BIOL CHEM, V262, P3864; Kelly LE, 2005, BIOCHEM J, V388, P195, DOI 10.1042/BJ20041797; KHANNA R, 2006, NEUROSCIENCE; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Lafer EM, 2002, TRAFFIC, V3, P513, DOI 10.1034/j.1600-0854.2002.30801.x; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Mirotznik RR, 2000, J NEUROSCI, V20, P7614; Montesinos ML, 2005, BRAIN RES REV, V49, P416, DOI 10.1016/j.brainresrev.2005.06.002; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; STANLEY EF, 1991, J NEUROSCI, V11, P985; Stanley EF, 1997, NATURE, V385, P340, DOI 10.1038/385340a0; STANLEY EF, 1991, NEURON, V7, P585, DOI 10.1016/0896-6273(91)90371-6; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; von Poser C, 2000, J BIOL CHEM, V275, P30916, DOI 10.1074/jbc.M005559200; Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100; Walther K, 2001, EMBO REP, V2, P634, DOI 10.1093/embo-reports/kve134; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Xiong X, 2006, BIOCHEM BIOPH RES CO, V347, P76, DOI 10.1016/j.bbrc.2006.06.045; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yao PJ, 2005, J COMP NEUROL, V481, P58, DOI 10.1002/cne.20362; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	40	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e67	10.1371/journal.pone.0000067	http://dx.doi.org/10.1371/journal.pone.0000067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183698	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600067
J	Sano, Y; Nakaya, T; Pedrini, S; Takeda, S; Iijima-Ando, K; Iijima, K; Mathews, PM; Itohara, S; Gandy, S; Suzuki, T				Sano, Yoshitake; Nakaya, Tadashi; Pedrini, Steve; Takeda, Shizu; Iijima-Ando, Kanae; Iijima, Koichi; Mathews, Paul M.; Itohara, Shigeyoshi; Gandy, Sam; Suzuki, Toshiharu			Physiological Mouse Brain A beta Levels Are Not Related to the Phosphorylation State of Threonine-668 of Alzheimer's APP	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CYTOPLASMIC DOMAIN; DISEASE; FE65; CLEAVAGE; SITE	Background. Amyloid-beta peptide species ending at positions 40 and 42 (A beta 40, A beta 42) are generated by the proteolytic processing of the Alzheimer's amyloid precursor protein (APP). A beta peptides accumulate in the brain early in the course of Alzheimer's disease (AD), especially A beta 42. The cytoplasmic domain of APP regulates intracellular trafficking and metabolism of APP and its carboxyl-terminal fragments (CTF alpha, CTF beta). The role of protein phosphorylation in general, and that of the phosphorylation state of APP at threonine-668 (Thr(668)) in particular, has been investigated in detail by several laboratories (including our own). Some investigators have recently proposed that the phosphorylation state of Thr(668) plays a pivotal role in governing brain A beta levels, prompting the current study. Methodology. In order to evaluate whether the phosphorylation state of Thr(668) controlled brain A beta levels, we studied the levels and subcellular distributions of holoAPP, sAPP alpha, sAPP beta, CTF alpha, CTF beta, A beta 40 and A beta 42 in brains from "knock-in'' mice in which a non-phosphorylatable alanyl residue had been substituted at position 668, replacing the threonyl residue present in the wild-type protein. Conclusions. The levels and subcellular distributions of holoAPP, sAPP alpha, sAPP beta, CTF alpha, CTF beta, A beta 40 and A beta 42 in the brains of Thr(668)Ala mutant mice were identical to those observed in wild-type mice. These results indicate that, despite speculation to the contrary, the phosphorylation state of APP at Thr(668) does not play an obvious role in governing the physiological levels of brain A beta 40 or A beta 42 in vivo.	[Pedrini, Steve; Iijima-Ando, Kanae; Iijima, Koichi; Gandy, Sam] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Sano, Yoshitake; Takeda, Shizu; Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Nakaya, Tadashi; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Sapporo, Hokkaido, Japan; [Iijima-Ando, Kanae; Iijima, Koichi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Mathews, Paul M.] Nathan S Kline Inst Psychiat Res, Dementia Res Program, Orangeburg, NY 10962 USA	Jefferson University; RIKEN; Hokkaido University; Cold Spring Harbor Laboratory; Nathan Kline Institute for Psychiatric Research	Gandy, S (corresponding author), Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA.	samgandy@earthlink.net; tsuzuki@pharm.hokudai.ac.jp	Itohara, Shigeyoshi/I-8769-2012; Suzuki, Toshiharu/B-5342-2013	Itohara, Shigeyoshi/0000-0002-2410-9989; Mathews, Paul/0000-0003-1742-7687; Pedrini, Steve/0000-0002-6409-8022; Sano, Yoshitake/0000-0001-5188-3104	Ministry of Education, Science, Culture, Sports, Science, and Technology, Japan [17790046, 16029002, 17025002]; The Mitsubishi Foundation; USPHS [AG010491, AG023611, NS41017, NS45357]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS045357, R01NS041017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010491, R01AG023611] Funding Source: NIH RePORTER	Ministry of Education, Science, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Mitsubishi Foundation; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Ministry of Education, Science, Culture, Sports, Science, and Technology, Japan ( T. S., T. N.) including 17790046, 16029002, and 17025002, by a grant from The Mitsubishi Foundation ( T. S.), and by the USPHS ( S. G., P. M., S. P.), including AG010491, AG023611, and NS41017, and NS45357.	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ando K, 1999, J NEUROSCI, V19, P4421; Aplin AE, 1996, J NEUROCHEM, V67, P699; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; KAWASE E, 1994, INT J DEV BIOL, V38, P385; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Maudsley S, 2006, NAT MED, V12, P392, DOI 10.1038/nm0406-392; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ramelot TA, 2000, BIOCHEMISTRY-US, V39, P2714, DOI 10.1021/bi992580m; SCHMIDT S, METHODS MOL BIOL, V299, P267; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; SILVER LM, MOUSE GENETICS CONCE; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; Sunaga S, 1997, MOL REPROD DEV, V46, P109, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;109::AID-MRD1&gt;3.0.CO;2-U; Suzuki T, 2006, J BIOCHEM, V139, P949, DOI 10.1093/jb/mvj121; Taru H, 2004, J BIOL CHEM, V279, P21628, DOI 10.1074/jbc.M312007200; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Vingtdeux V, 2005, NEUROBIOL DIS, V20, P625, DOI 10.1016/j.nbd.2005.05.004; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	36	51	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e51	10.1371/journal.pone.0000051	http://dx.doi.org/10.1371/journal.pone.0000051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183681	Green Submitted, gold, Green Published			2022-12-27	WOS:000207443600051
J	Cavina-Pratesi, C; Goodale, MA; Culham, JC				Cavina-Pratesi, Cristiana; Goodale, Melvyn A.; Culham, Jody C.			FMRI Reveals a Dissociation between Grasping and Perceiving the Size of Real 3D Objects	PLOS ONE			English	Article								Background. Almost 15 years after its formulation, evidence for the neuro-functional dissociation between a dorsal action stream and a ventral perception stream in the human cerebral cortex is still based largely on neuropsychological case studies. To date, there is no unequivocal evidence for separate visual computations of object features for performance of goal-directed actions versus perceptual tasks in the neurologically intact human brain. We used functional magnetic resonance imaging to test explicitly whether or not brain areas mediating size computation for grasping are distinct from those mediating size computation for perception. Methodology/Principal Findings. Subjects were presented with the same real graspable 3D objects and were required to perform a number of different tasks: grasping, reaching, size discrimination, pattern discrimination or passive viewing. As in prior studies, the anterior intraparietal area (AIP) in the dorsal stream was more active during grasping, when object size was relevant for planning the grasp, than during reaching, when object properties were irrelevant for movement planning (grasping > reaching). Activity in AIP showed no modulation, however, when size was computed in the context of a purely perceptual task (size = pattern discrimination). Conversely, the lateral occipital (LO) cortex in the ventral stream was modulated when size was computed for perception (size > pattern discrimination) but not for action (grasping = reaching). Conclusions/Significance. While areas in both the dorsal and ventral streams responded to the simple presentation of 3D objects (passive viewing), these areas were differentially activated depending on whether the task was grasping or perceptual discrimination, respectively. The demonstration of dual coding of an object for the purposes of action on the one hand and perception on the other in the same healthy brains offers a substantial contribution to the current debate about the nature of the neural coding that takes place in the dorsal and ventral streams.	[Cavina-Pratesi, Cristiana; Goodale, Melvyn A.; Culham, Jody C.] Univ Western Ontario, Dept Psychol, London, ON, Canada	Western University (University of Western Ontario)	Culham, JC (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	culham@imaging.robarts.ca	Goodale, Melvyn A/M-5907-2013; Culham, Jody C./A-9863-2013	Goodale, Melvyn A/0000-0001-6748-0561; Culham, Jody C./0000-0003-0754-2999	Canadian Institutes of Health Research; Canadian Foundation for Innovation; Canada Research Chairs Program; Medical Research Council [G0401090] Funding Source: researchfish; MRC [G0401090] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs Program(Canada Research Chairs); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Canadian Institutes of Health Research (JCC and MAG), the Canadian Foundation for Innovation (JCC), and the Canada Research Chairs Program (MAG).	Astafiev SV, 2003, J NEUROSCI, V23, P4689; BEGLIOMINI C, 2007, DIFFERENTIAL CORTICA, P1245; Begliomini C, 2007, EUR J NEUROSCI, V25, P1245, DOI 10.1111/j.1460-9568.2007.05365.x; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Binkofski F, 2003, EXP BRAIN RES, V153, P210, DOI 10.1007/s00221-003-1594-2; Binkofski F, 1999, EXP BRAIN RES, V128, P210, DOI 10.1007/s002210050838; Birn RM, 1999, HUM BRAIN MAPP, V7, P106, DOI 10.1002/(SICI)1097-0193(1999)7:2<106::AID-HBM4>3.0.CO;2-O; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Cabeza R, 2006, HDB FUNCTIONAL NEURO; CANT JS, 2006, CEREB CORTEX; Cavina-Pratesi C, 2006, J NEUROSCI, V26, P2704, DOI 10.1523/JNEUROSCI.3176-05.2006; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Chapman H, 2002, EUR J NEUROSCI, V15, P2037, DOI 10.1046/j.1460-9568.2002.02021.x; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Culham JC, 2004, ATTENTION PERFORMANC; CULHAM JC, EMBODIMENT IN PRESS; DAVARE M, 2007, TEMPORAL DISSOCIATIO, P3974; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; Faillenot I, 2001, EUR J NEUROSCI, V13, P585, DOI 10.1046/j.1460-9568.2001.01399.x; Field AS, 2000, AM J NEURORADIOL, V21, P1388; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Gardner EP, 2002, BEHAV BRAIN RES, V135, P213, DOI 10.1016/S0166-4328(02)00167-5; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Grefkes C, 2004, NEUROIMAGE, V23, P1494, DOI 10.1016/j.neuroimage.2004.08.031; Grefkes C, 2002, NEURON, V35, P173, DOI 10.1016/S0896-6273(02)00741-9; Gregoriou GG, 2001, J CEREBR BLOOD F MET, V21, P671, DOI 10.1097/00004647-200106000-00005; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kalaska JF, 1996, CAN J PHYSIOL PHARM, V74, P483, DOI 10.1139/cjpp-74-4-483; Klassen LM, 2004, MAGN RESON MED, V51, P881, DOI 10.1002/mrm.20094; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; KROLICZAK G, 2006, SOC NEUR ABSTR; KROLICZAK G, J NEUROPHYS IN PRESS; LE S, 2002, SEEING CHILDHOOD VEN, P58; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Marois R, 2000, NEURON, V25, P717, DOI 10.1016/S0896-6273(00)81073-9; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Nakamura K, 2000, J NEUROPHYSIOL, V84, P677, DOI 10.1152/jn.2000.84.2.677; Oakes TR, 2005, NEUROIMAGE, V28, P529, DOI 10.1016/j.neuroimage.2005.05.058; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ONO M, 1990, ATLAS CEREBRAL SULCI, pR14; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; Rice NJ, 2006, J NEUROSCI, V26, P8176, DOI 10.1523/JNEUROSCI.1641-06.2006; ROBERTSON LC, 1988, J NEUROSCI, V8, P3757; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; SAKATA H, 1992, CONTROL ARM MOVEMENT, P185; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Shikata E, 2003, EUR J NEUROSCI, V17, P1105, DOI 10.1046/j.1460-9568.2003.02540.x; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Shmuelof L, 2005, NEURON, V47, P457, DOI 10.1016/j.neuron.2005.06.034; Stanley DA, 2005, J VISION, V5, P690, DOI 10.1167/5.9.4; Taira M, 2001, NEUROIMAGE, V14, P959, DOI 10.1006/nimg.2001.0895; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Talairach J., 1988, COPLANAR STEREOTAXIC; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tunik E, 2005, NAT NEUROSCI, V8, P505, DOI 10.1038/nn1430; Valyear KF, 2006, NEUROPSYCHOLOGIA, V44, P218, DOI 10.1016/j.neuropsychologia.2005.05.004; VALYEAR KF, NEUROIMAGE IN PRESS	83	114	114	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e424	10.1371/journal.pone.0000424	http://dx.doi.org/10.1371/journal.pone.0000424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487272	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000207445800006
J	Mazzoni, A; Broccard, FD; Garcia-Perez, E; Bonifazi, P; Ruaro, ME; Torre, V				Mazzoni, Alberto; Broccard, Frederic D.; Garcia-Perez, Elizabeth; Bonifazi, Paolo; Ruaro, Maria Elisabetta; Torre, Vincent			On the Dynamics of the Spontaneous Activity in Neuronal Networks	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CORTICAL-NEURONS; LEECH; MODULATION; PATTERNS; ORIGIN; MODEL; VARIABILITY; MECHANISMS; AVALANCHES	Most neuronal networks, even in the absence of external stimuli, produce spontaneous bursts of spikes separated by periods of reduced activity. The origin and functional role of these neuronal events are still unclear. The present work shows that the spontaneous activity of two very different networks, intact leech ganglia and dissociated cultures of rat hippocampal neurons, share several features. Indeed, in both networks: i) the inter-spike intervals distribution of the spontaneous firing of single neurons is either regular or periodic or bursting, with the fraction of bursting neurons depending on the network activity; ii) bursts of spontaneous spikes have the same broad distributions of size and duration; iii) the degree of correlated activity increases with the bin width, and the power spectrum of the network firing rate has a 1/f behavior at low frequencies, indicating the existence of long-range temporal correlations; iv) the activity of excitatory synaptic pathways mediated by NMDA receptors is necessary for the onset of the long-range correlations and for the presence of large bursts; v) blockage of inhibitory synaptic pathways mediated by GABA(A) receptors causes instead an increase in the correlation among neurons and leads to a burst distribution composed only of very small and very large bursts. These results suggest that the spontaneous electrical activity in neuronal networks with different architectures and functions can have very similar properties and common dynamics.	[Mazzoni, Alberto; Broccard, Frederic D.; Garcia-Perez, Elizabeth; Bonifazi, Paolo; Ruaro, Maria Elisabetta; Torre, Vincent] Scuola Int Super Studi Avanzati, Trieste, Italy	International School for Advanced Studies (SISSA)	Torre, V (corresponding author), Scuola Int Super Studi Avanzati, Trieste, Italy.	torre@sissa.it	Bonifazi, Paolo/N-9737-2018; Mazzoni, Alberto/A-5433-2018; Mazzoni, Alberto/AGO-5998-2022; Mazzoni, Alberto/N-6960-2016; Bonifazi, Paolo/AAA-8035-2020; Mazzoni, Alberto/C-8523-2009	Bonifazi, Paolo/0000-0001-6374-8997; Mazzoni, Alberto/0000-0002-9632-1831; Mazzoni, Alberto/0000-0002-9632-1831; Mazzoni, Alberto/0000-0002-9632-1831; Bonifazi, Paolo/0000-0001-6374-8997; 	EU; Italian Government; CIPE/FVG	EU(European Commission); Italian Government; CIPE/FVG	This work was supported by the EU grant NEURO, by a FIRB grant from the Italian Government and by the GRAND grant from CIPE/FVG.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Arisi I, 2001, J NEUROPHYSIOL, V86, P2475, DOI 10.1152/jn.2001.86.5.2475; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Azouz R, 1999, J NEUROSCI, V19, P2209; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Baker RE, 2006, BRAIN RES, V1101, P29, DOI 10.1016/j.brainres.2006.05.028; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonifazi P, 2005, EUR J NEUROSCI, V22, P2953, DOI 10.1111/j.1460-9568.2005.04464.x; BRODFUEHRER PD, 1986, J NEUROBIOL, V17, P697, DOI 10.1002/neu.480170612; Brodfuehrer PD, 2001, PROG NEUROBIOL, V63, P371, DOI 10.1016/S0301-0082(00)00048-4; Burrell BD, 2004, J NEUROSCI, V24, P4011, DOI 10.1523/JNEUROSCI.0178-04.2004; Butts DA, 2001, J NEUROSCI, V21, P961, DOI 10.1523/JNEUROSCI.21-03-00961.2001; Cacciatore TW, 2000, J NEUROSCI, V20, P1643; CALABRESE RL, 1995, J NEUROBIOL, V27, P390, DOI 10.1002/neu.480270311; Canepari M, 1997, BIOL CYBERN, V77, P153, DOI 10.1007/s004220050376; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; CLINE HT, 1986, J NEUROSCI, V6, P2848; Crow E.L., 1987, LOGNORMAL DISTRIBUTI; Cymbalyuk GS, 2002, J NEUROSCI, V22, P10580; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Egert U, 2002, J NEUROSCI METH, V117, P33, DOI 10.1016/S0165-0270(02)00045-6; Eisenhart FJ, 2000, J COMP PHYSIOL A, V186, P631, DOI 10.1007/s003590000117; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; FRANKLIN JL, 1992, J NEUROSCI, V12, P1726; Freeman WJ, 2004, CLIN NEUROPHYSIOL, V115, P2089, DOI 10.1016/j.clinph.2004.02.028; Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Jensen H.J., 1998, SELF ORG CRITICALITY; Jones TA, 2000, J NEUROPHYSIOL, V83, P1452, DOI 10.1152/jn.2000.83.3.1452; Koch C., 1999, BIOPHYSICAL COMPUTAT; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; Kudela P, 2003, BIOL CYBERN, V88, P276, DOI 10.1007/s00422-002-0381-7; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; MAEDA E, 1995, J NEUROSCI, V15, P6834; Maimon G, 2006, J NEUROSCI, V26, P2487, DOI 10.1523/JNEUROSCI.3590-05.2006; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2002, NEURAL NETWORKS, V15, P479, DOI 10.1016/S0893-6080(02)00043-6; MULLER KJ, 1981, NEUROBIOLOGY LEECH; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Papoulis A., 2002, PROBABILITY RANDOM V; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Rieke F., 1997, SPIKES EXPLORING NEU; Ruaro ME, 2005, IEEE T BIO-MED ENG, V52, P371, DOI 10.1109/TBME.2004.842975; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Tateno T, 2005, NEUROSCIENCE, V134, P425, DOI 10.1016/j.neuroscience.2005.04.049; Thorogood MSE, 1995, INVERTEBR NEUROSCI, V1, P223, DOI 10.1007/BF02211024; TRAUB RD, 1994, PROG BRAIN RES, V102, P383; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Vespignani A, 1998, PHYS REV E, V57, P6345, DOI 10.1103/PhysRevE.57.6345; Wang XJ, 1999, J NEUROSCI, V19, P9587; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wu Eric, 2002, Invertebrate Neuroscience, V4, P157, DOI 10.1007/s10158-002-0017-6; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	72	184	185	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e439	10.1371/journal.pone.0000439	http://dx.doi.org/10.1371/journal.pone.0000439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17502919	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445800021
J	Sobo, K; Chevallier, J; Parton, RG; Gruenberg, J; van der Goot, FG				Sobo, Komla; Chevallier, Julien; Parton, Robert G.; Gruenberg, Jean; van der Goot, F. Gisou			Diversity of Raft-Like Domains in Late Endosomes	PLOS ONE			English	Article							DETERGENT-RESISTANT MEMBRANES; GPI-ANCHORED PROTEINS; LIPID RAFTS; PLASMA-MEMBRANE; ENDOCYTIC PATHWAY; CELL-MEMBRANES; ENDOPLASMIC-RETICULUM; PRION PROTEIN; CHOLESTEROL; TOXIN	Background. Late endosomes, the last sorting station in the endocytic pathway before lysosomes, are pleiomorphic organelles composed of tubular elements as well as vesicular regions with a characteristic multivesicular appearance, which play a crucial role in intracellular trafficking. Here, we have investigated whether, in addition to these morphologically distinguishable regions, late endosomal membranes are additionally sub-compartmentalized into membrane microdomains. Methodology/Principal Findings. Using sub-organellar fractionation techniques, both with and without detergents, combined with electron microscopy, we found that both the limiting membrane of the organel and the intraluminal vesicles contain raft-type membrane domains. Interestingly, these differentially localized domains vary in protein composition and physico-chemical properties. Conclusions/Significance. In addition to the multivesicular organization, we find that late endosomes contain cholesterol rich microdomains both on their limiting membrane and their intraluminal vesicles that differ in composition and properties. Implications of these findings for late endosomal functions are discussed.	[Sobo, Komla; van der Goot, F. Gisou] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Chevallier, Julien; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Inst Mol Biosci, Brisbane, Qld, Australia; [Parton, Robert G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, SV AI Extens, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Queensland; University of Queensland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van der Goot, FG (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland.	gisou.vandergoot@epfl.ch	Chevallier, Julien/AAY-9567-2020; Parton, Robert G/C-5673-2009; van der Goot, Gisou G/B-2279-2012	Chevallier, Julien/0000-0002-4423-9502; Parton, Robert G/0000-0002-7494-5248; van der Goot, Gisou G/0000-0002-8522-274X	Swiss National Science Foundation; National Health and Medical Research Council of Australia; Howard Hughes Medical Institute	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by a grant from the Swiss National Science Foundation to J. G and to G. v. d. G. and a grant from the National Health and Medical Research Council of Australia to R. P. G. v. d. G is an international Fellow of the Howard Hughes Medical Institute.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Alpy F, 2001, J BIOL CHEM, V276, P4261, DOI 10.1074/jbc.M006279200; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Babiychuk EB, 2006, BIOCHEM J, V397, P407, DOI 10.1042/BJ20060056; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; BUCKLEY JT, 1981, CAN J BIOCHEM CELL B, V59, P430, DOI 10.1139/o81-059; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; COELHO VD, 2004, BMC IMMUNOL, V5, P2; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Eberle HB, 2002, J CELL SCI, V115, P827; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Fullekrug J, 2004, ANN NY ACAD SCI, V1014, P164, DOI 10.1196/annals.1294.017; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gallegos AM, 2006, BIOCHEMISTRY-US, V45, P12100, DOI 10.1021/bi0602720; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; LI X, 2007, MOL BIOL CE IN PRESS; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Magee T, 2002, BIOL RES, V35, P127, DOI 10.4067/S0716-97602002000200003; Mobius W, 2003, TRAFFIC, V4, P222; Morris R, 2004, SUB CELL BIOCHEM, V37, P35; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; Pielsticker LK, 2005, BIOCHEM BIOPH RES CO, V330, P163, DOI 10.1016/j.bbrc.2005.02.136; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sharma P, 2002, SEMIN CELL DEV BIOL, V13, P205, DOI 10.1016/S1084-9521(02)00049-6; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Strauss JF, 2002, STEROIDS, V67, P947, DOI 10.1016/S0039-128X(02)00042-9; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003	67	61	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e391	10.1371/journal.pone.0000391	http://dx.doi.org/10.1371/journal.pone.0000391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460758	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445600005
J	Shaman, J; Day, JF				Shaman, Jeffrey; Day, Jonathan F.			Reproductive Phase Locking of Mosquito Populations in Response to Rainfall Frequency	PLOS ONE			English	Article							ST-LOUIS ENCEPHALITIS; CULEX-NIGRIPALPUS DIPTERA; DROUGHT-INDUCED AMPLIFICATION; INDIAN-RIVER-COUNTY; WEST-NILE-VIRUS; TAMPA BAY AREA; CLIMATE VARIABILITY; EPIDEMIC; CULICIDAE; MALARIA	The frequency of moderate to heavy rainfall events is projected to change in response to global warming. Here we show that these hydrologic changes may have a profound effect on mosquito population dynamics and rates of mosquito-borne disease transmission. We develop a simple model, which treats the mosquito reproductive cycle as a phase oscillator that responds to rainfall frequency forcing. This model reproduces observed mosquito population dynamics and indicates that mosquito-borne disease transmission can be sensitive to rainfall frequency. These findings indicate that changes to the hydrologic cycle, in particular the frequency of moderate to heavy rainfall events, could have a profound effect on the transmission rates of some mosquito-borne diseases.	[Shaman, Jeffrey] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Day, Jonathan F.] Univ Florida, Inst Food & Agr Sci, Florida Med Entomol Lab, Vero Beach, FL 32962 USA	Oregon State University; State University System of Florida; University of Florida	Shaman, J (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	jshaman@coas.oregonstate.edu.edu						CHAMBERLAIN RW, 1964, AM J TROP MED HYG, V13, P456, DOI 10.4269/ajtmh.1964.13.456; CHRISTOPHERS R, 1911, SCI MEMOIRS OFFICERS; CUSHING JM, 1986, THEOR POPUL BIOL, V30, P289, DOI 10.1016/0040-5809(86)90038-9; DAY J F, 1988, Miscellaneous Publications of the Entomological Society of America, V68, P1; Day JF, 1999, J MED ENTOMOL, V36, P176, DOI 10.1093/jmedent/36.2.176; DAY JF, 1993, J AM MOSQUITO CONTR, V9, P249; DAY JF, 1990, J MED ENTOMOL, V27, P43, DOI 10.1093/jmedent/27.1.43; DAY JF, 1989, ANN ENTOMOL SOC AM, V82, P32, DOI 10.1093/aesa/82.1.32; Day Jonathan F., 1994, American Entomologist, V40, P162; DOW RP, 1964, AM J TROP MED HYG, V13, P462, DOI 10.4269/ajtmh.1964.13.462; DOW RP, 1970, ANN ENTOMOL SOC AM, V63, P995, DOI 10.1093/aesa/63.4.995; GILL CA, 1938, SEASONAL PERIODICITY; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; HADDOW AJ, 1945, B ENTOMOL RES, V36, P33, DOI 10.1017/S0007485300023907; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 IMP; Kettle DS, 1995, MED VET ENTOMOL, P248; Mitchell C.J., 1980, ST LOUIS ENCEPHALITI, P313; MONATH TP, 1980, ST LOUIS ENCEPHALITI, P239; NISBET RM, 1976, J THEOR BIOL, V56, P459, DOI 10.1016/S0022-5193(76)80086-0; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; PITTENDRIGH CS, 1950, EVOLUTION, V4, P43, DOI 10.2307/2405533; PLATT RB, 1957, ECOL MONOGR, V27, P303, DOI 10.2307/1942188; Provost M. W., 1973, Florida Scientist, V36, P217; Reisen WK, 2002, J MED ENTOMOL, V39, P793, DOI 10.1603/0022-2585-39.5.793; Rutledge CR, 2003, J MED ENTOMOL, V40, P253, DOI 10.1603/0022-2585-40.3.253; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Shaman J, 2006, ECOL MODEL, V194, P395, DOI 10.1016/j.ecolmodel.2005.10.037; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Shaman J, 2004, AM J TROP MED HYG, V71, P251, DOI 10.4269/ajtmh.2004.71.251; Shaman J, 2004, EMERG INFECT DIS, V10, P802, DOI 10.3201/eid1005.030246; Shaman J, 2003, J MED ENTOMOL, V40, P547, DOI 10.1603/0022-2585-40.4.547; Shaman J, 2002, EMERG INFECT DIS, V8, P575, DOI 10.3201/eid0806.010417; Shanks GD, 2002, EMERG INFECT DIS, V8, P1404, DOI 10.3201/eid0812.020077; Shroyer D. A., 1991, Journal of the Florida Mosquito Control Association, V62, P69; Singh N, 2002, ANN TROP MED PARASIT, V96, P349, DOI 10.1179/000349802125001113; Strogatz S.H., 1998, NONLINEAR DYNAMICS C; Tong SL, 2001, ENVIRON HEALTH PERSP, V109, P1271, DOI 10.2307/3454750; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Wegbreit J, 2000, J AM MOSQUITO CONTR, V16, P22; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100; [No title captured]	43	57	57	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e331	10.1371/journal.pone.0000331	http://dx.doi.org/10.1371/journal.pone.0000331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17396162	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445200014
J	Rathinam, C; Klein, C				Rathinam, Chozhavendan; Klein, Christoph			Transcriptional Repressor Gfi1 Integrates Cytokine-Receptor Signals Controlling B-Cell Differentiation	PLOS ONE			English	Article								Hematopoietic stem cell differentiation is specified by cytokines and transcription factors, but the mechanisms controlling instructive and permissive signalling networks are poorly understood. We provide evidence that CLP1-dependent IL7-receptor mediated B cell differentiation is critically controlled by the transcriptional repressor Gfi1. Gfi1-deficient progenitor B cells show global defects in IL7R alpha-dependent signal cascades. Consequently, IL7-dependent trophic, proliferative and differentiation-inducing responses of progenitor B cells are perturbed. Gfi1 directly regulates expression levels of IL7R alpha and indirectly controls STAT5 signalling via expression of SOCS3. Thus, Gfi1 selectively specifies IL7-dependent development of B cells from CLP1 progenitors, providing clues to the transcriptional networks integrating cytokine signals and lymphoid differentiation.	[Rathinam, Chozhavendan; Klein, Christoph] Hannover Med Sch, Dept Pediat Hematol Oncol, D-3000 Hannover, Germany	Hannover Medical School	Klein, C (corresponding author), Hannover Med Sch, Dept Pediat Hematol Oncol, D-3000 Hannover, Germany.	klein.christoph@mh-hannover.de						Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Doan LL, 2003, J IMMUNOL, V170, P2356, DOI 10.4049/jimmunol.170.5.2356; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Jafar-Nejad H, 2004, MOL CELL BIOL, V24, P8803, DOI 10.1128/MCB.24.20.8803-8812.2004; Jegalian AG, 2002, J BIOL CHEM, V277, P2345, DOI 10.1074/jbc.M105575200; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; Laouar Y, 2004, BLOOD, V103, P1985, DOI 10.1182/blood-2003-06-2126; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Purohit SJ, 2003, EMBO J, V22, P5511, DOI 10.1093/emboj/cdg522; Rathinam C, 2005, IMMUNITY, V22, P717, DOI 10.1016/j.immuni.2005.04.007; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Ye M, 2005, J EXP MED, V202, P1411, DOI 10.1084/jem.20051089; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	45	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e306	10.1371/journal.pone.0000306	http://dx.doi.org/10.1371/journal.pone.0000306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375192	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445100008
J	Fu, N; Drinnenberg, I; Kelso, J; Wu, JR; Paabo, S; Zeng, R; Khaitovich, P				Fu, Ning; Drinnenberg, Ines; Kelso, Janet; Wu, Jia-Rui; Paeaebo, Svante; Zeng, Rong; Khaitovich, Philipp			Comparison of Protein and mRNA Expression Evolution in Humans and Chimpanzees	PLOS ONE			English	Article								Even though mRNA expression levels are commonly used as a proxy for estimating functional differences that occur at the protein level, the relation between mRNA and protein expression is not well established. Further, no study to date has tested whether the evolutionary differences in mRNA expression observed between species reflect those observed in protein expression. Since a large proportion of mRNA expression differences observed between mammalian species appears to have no functional consequences for the phenotype, it is conceivable that many or most mRNA expression differences are not reflected at the protein level. If this is true, then differences in protein expression may largely reflect functional adaptations observed in species phenotypes. In this paper, we present the first direct comparison of mRNA and protein expression differences seen between humans and chimpanzees. We reproducibly find a significant positive correlation between mRNA expression and protein expression differences. This correlation is comparable in magnitude to that found between mRNA and protein expression changes at different developmental stages or in different physiological conditions within one species. Noticeably, this correlation is mainly due to genes with large expression differences between species. Our study opens the door to a new level of understanding of regulatory evolution and poses many new questions that remain to be answered.	[Fu, Ning; Wu, Jia-Rui; Zeng, Rong] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Drinnenberg, Ines; Kelso, Janet; Paeaebo, Svante; Khaitovich, Philipp] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Khaitovich, Philipp] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Computat Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zeng, R (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	zr@sibs.ac.cn; khaitovich@eva.mpg.de	Kelso, Janet/N-1812-2019; Khaitovich, Philipp/HGC-8520-2022	Kelso, Janet/0000-0002-3618-322X; 	Chinese Academy of Sciences; Max Planck Society; Bundesministerium fur Bildung und Forschung; National Natural Science Foundation [30425021]; EU	Chinese Academy of Sciences(Chinese Academy of Sciences); Max Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); EU(European Commission)	This study was financially supported by the Chinese Academy of Sciences, by the Max Planck Society and by the Bundesministerium fur Bildung und Forschung, as well as by the National Natural Science Foundation (grant 30425021) and by the Proteomage Project from FP6 of EU. None of these institutions play any direct or indirect role in in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hack Catherine Jane, 2004, Briefings in Functional Genomics & Proteomics, V3, P212, DOI 10.1093/bfgp/3.3.212; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang XS, 2005, MOL CELL PROTEOMICS, V4, P12, DOI 10.1074/mcp.M400079-MCP200; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Mijalski T, 2005, P NATL ACAD SCI USA, V102, P8621, DOI 10.1073/pnas.0407672102; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100	17	60	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e216	10.1371/journal.pone.0000216	http://dx.doi.org/10.1371/journal.pone.0000216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299596	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444400017
J	Getz, WM; Fortmann-Roe, S; Cross, PC; Lyons, AJ; Ryan, SJ; Wilmers, CC				Getz, Wayne M.; Fortmann-Roe, Scott; Cross, Paul C.; Lyons, Andrew J.; Ryan, Sadie J.; Wilmers, Christopher C.			LoCoH: Nonparameteric Kernel Methods for Constructing Home Ranges and Utilization Distributions	PLOS ONE			English	Article								Parametric kernel methods currently dominate the literature regarding the construction of animal home ranges (HRs) and utilization distributions (UDs). These methods frequently fail to capture the kinds of hard boundaries common to many natural systems. Recently a local convex hull (LoCoH) nonparametric kernel method, which generalizes the minimum convex polygon (MCP) method, was shown to be more appropriate than parametric kernel methods for constructing HRs and UDs, because of its ability to identify hard boundaries (e. g., rivers, cliff edges) and convergence to the true distribution as sample size increases. Here we extend the LoCoH in two ways: "fixed sphere-of-influence,'' or r-LoCoH (kernels constructed from all points within a fixed radius r of each reference point), and an "adaptive sphere-of-influence,'' or a-LoCoH (kernels constructed from all points within a radius a such that the distances of all points within the radius to the reference point sum to a value less than or equal to a), and compare them to the original "fixed-number-of-points,'' or k-LoCoH (all kernels constructed from k-1 nearest neighbors of root points). We also compare these nonparametric LoCoH to parametric kernel methods using manufactured data and data collected from GPS collars on African buffalo in the Kruger National Park, South Africa. Our results demonstrate that LoCoH methods are superior to parametric kernel methods in estimating areas used by animals, excluding unused areas (holes) and, generally, in constructing UDs and HRs arising from the movement of animals influenced by hard boundaries and irregular structures (e. g., rocky outcrops). We also demonstrate that a-LoCoH is generally superior to k- and r-LoCoH (with software for all three methods available at http://locoh.cnr.berkeley.edu).	[Getz, Wayne M.; Fortmann-Roe, Scott; Lyons, Andrew J.; Ryan, Sadie J.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Cross, Paul C.] Montana State Univ, US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT 59717 USA; [Cross, Paul C.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Wilmers, Christopher C.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	University of California System; University of California Berkeley; University of Pretoria; Montana State University System; Montana State University Bozeman; United States Department of the Interior; United States Geological Survey; Montana State University System; Montana State University Bozeman; University of California System; University of California Santa Cruz	Getz, WM (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	getz@nature.berkeley.edu	Ryan, Sadie Jane/H-7488-2019; Lyons, Andrew/AAF-7067-2020; Ryan, Sadie/H-1595-2012; Cross, Paul/K-6987-2012; Getz, Wayne/I-4521-2013	Ryan, Sadie Jane/0000-0002-4308-6321; Cross, Paul/0000-0001-8045-5213; Getz, Wayne/0000-0001-8784-9354	NSF EID; James S McDonnell Foundation; NSF	NSF EID; James S McDonnell Foundation; NSF(National Science Foundation (NSF))	NSF EID and James S McDonnell Foundation Grants to WMG. EPA STAR and NSF Bioinformatics Postdoctoral Grans to SJR.	Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Baker Jack, 2001, Corella, V25, P62; Birk RJ, 2003, REMOTE SENS ENVIRON, V88, P3, DOI 10.1016/j.rse.2003.07.007; Blundell GM, 2001, ECOL MONOGR, V71, P469, DOI 10.1890/0012-9615(2001)071[0469:LHREOS]2.0.CO;2; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Cushman SA, 2005, OIKOS, V109, P331, DOI 10.1111/j.0030-1299.2005.13538.x; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; FORD RG, 1979, J THEOR BIOL, V76, P125, DOI 10.1016/0022-5193(79)90366-7; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Hemson G, 2005, J ANIM ECOL, V74, P455, DOI 10.1111/j.1365-2656.2005.00944.x; Holden C, 2006, SCIENCE, V313, P779, DOI 10.1126/science.313.5788.779; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; JENNRICH RI, 1969, J THEOR BIOL, V22, P227, DOI 10.1016/0022-5193(69)90002-2; Karama M, 2004, SCI ENG COMPOS MATER, V11, P1; Kenward RE, 2001, ECOLOGY, V82, P1905, DOI 10.2307/2680056; Kie J. G., 1994, CALHOME HOME RANGE A; Lawson EJ, 1997, WILDLIFE SOC B, V25, P721; Matosevic M, 2006, IEEE T INSTRUM MEAS, V55, P1677, DOI 10.1109/TIM.2006.880918; Matthiopoulos J, 2003, OIKOS, V102, P367, DOI 10.1034/j.1600-0706.2003.12528.x; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Redfern JV, 2006, OECOLOGIA, V146, P632, DOI 10.1007/s00442-005-0235-9; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Silverman B.W., 1986, DENSITY ESTIMATION S; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Worton BJ, 1995, BIOMETRICS, V51, P1206, DOI 10.2307/2533254; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	33	350	359	5	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e207	10.1371/journal.pone.0000207	http://dx.doi.org/10.1371/journal.pone.0000207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299587	Green Published, gold			2022-12-27	WOS:000207444400008
J	Nizak, C; Fitzhenry, RJ; Kessin, RH				Nizak, Clement; Fitzhenry, Robert J.; Kessin, Richard H.			Exploitation of Other Social Amoebae by Dictyostelium caveatum	PLOS ONE			English	Article								Dictyostelium amoebae faced with starvation trigger a developmental program during which many cells aggregate and form fruiting bodies that consist of a ball of spores held aloft by a thin stalk. This developmental strategy is open to several forms of exploitation, including the remarkable case of Dictyostelium caveatum, which, even when it constitutes 1/10(3) of the cells in an aggregate, can inhibit the development of the host and eventually devour it. We show that it accomplishes this feat by inhibiting a region of cells, called the tip, which organizes the development of the aggregate into a fruiting body. We use live-cell microscopy to define the D. caveatum developmental cycle and to show that D. caveatum amoebae have the capacity to ingest amoebae of other Dictyostelid species, but do not attack each other. The block in development induced by D. caveatum does not affect the expression of specific markers of prespore cell or prestalk cell differentiation, but does stop the coordinated cell movement leading to tip formation. The inhibition mechanism involves the constitutive secretion of a small molecule by D. caveatum and is reversible. Four Dictyostelid species were inhibited in their development, while D. caveatum is not inhibited by its own compound(s). D. caveatum has evolved a predation strategy to exploit other members of its genus, including mechanisms of developmental inhibition and specific phagocytosis.	[Nizak, Clement] Rockefeller Univ, Ctr Phys & Biol, Living Matter Lab, New York, NY 10021 USA; [Fitzhenry, Robert J.; Kessin, Richard H.] Columbia Univ, Dept Anat & Cell Biol, New York, NY USA	Rockefeller University; Columbia University	Nizak, C (corresponding author), CNRS, Spectrometrie Phys Lab, St Martin Dheres, France.	clement.nizak@mail.rockefeller.edu	Nizak, Clement/HGV-1085-2022; Nizak, Clement/L-1334-2013	Nizak, Clement/0000-0002-4591-8240; Nizak, Clement/0000-0002-4591-8240	EMBO; HFSP; Wellcome Trust; Dictyostelium Stock Center; NIH [GM64432-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064432] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); Dictyostelium Stock Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C. N. was supported by EMBO and is currently the recipient of a HFSP postdoctoral fellowship. R. J. F. is the recipient of a Wellcome Trust postdoctoral fellowship. We thank Jakob Franke at the Dictyostelium Stock Center and the NIH for support of this facility (GM64432-05).	ABE T, 1994, CELL, V77, P687, DOI 10.1016/0092-8674(94)90053-1; BONNER JT, 1958, J EMBRYOL EXP MORPH, V6, P346; CANNON GJ, 1992, J CELL SCI, V101, P907; Dormann D, 1998, BIOPHYS CHEM, V72, P21, DOI 10.1016/S0301-4622(98)00120-3; DUFFY KTI, 1988, CURR MICROBIOL, V17, P203, DOI 10.1007/BF01589453; GOMER RH, 1987, SCIENCE, V237, P758, DOI 10.1126/science.3039657; Haspel G, 2005, J COMP PHYSIOL A, V191, P529, DOI 10.1007/s00359-005-0620-1; Kessin RH, 2001, DICTYOSTELIUM EVOLUT, pxiv; LEWIS KE, 1986, CAN J MICROBIOL, V32, P79, DOI 10.1139/m86-017; Moore J., 2002, Parasites and the behavior of animals; NICOL A, 1978, J CELL SCI, V32, P377; OLIVE LS, 1961, J PROTOZOOL, V8, P467, DOI 10.1111/j.1550-7408.1961.tb01243.x; Raper KB, 1940, AM J BOT, V27, P436, DOI 10.2307/2436460; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Thompson CRL, 2004, DEV GROWTH DIFFER, V46, P363; WADDELL DR, 1982, NATURE, V298, P464, DOI 10.1038/298464a0; WADDELL DR, 1985, EXP CELL RES, V159, P323, DOI 10.1016/S0014-4827(85)80006-9; WADDELL DR, 1986, J CELL BIOL, V102, P298, DOI 10.1083/jcb.102.1.298; Zuppinger C, 1997, EUR J PROTISTOL, V33, P396, DOI 10.1016/S0932-4739(97)80051-X	21	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e212	10.1371/journal.pone.0000212	http://dx.doi.org/10.1371/journal.pone.0000212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299592	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444400013
J	Jafa, K; Patel, P; MacKellar, DA; Sullivan, PS; Delaney, KP; Sides, TL; Newman, AP; Paul, SM; Cadoff, EM; Martin, EG; Keenan, PA; Branson, BM				Jafa, Krishna; Patel, Pragna; MacKellar, Duncan A.; Sullivan, Patrick S.; Delaney, Kevin P.; Sides, Tracy L.; Newman, Alexandra P.; Paul, Sindy M.; Cadoff, Evan M.; Martin, Eugene G.; Keenan, Patrick A.; Branson, Bernard M.		OraQuick Study Grp	Investigation of False Positive Results with an Oral Fluid Rapid HIV-1/2 Antibody Test	PLOS ONE			English	Article								Background. In March 2004, the OraQuickH rapid HIV antibody test became the first rapid HIV test approved by the US Food and Drug Administration for use on oral fluid specimens. Test results are available in 20 minutes, and the oral fluid test is non-invasive. From August 2004-June 2005, we investigated a sudden increase in false-positive results occurring in a performance study of OraQuickH oral-fluid rapid HIV tests in Minnesota. Methodology/Principal Findings. In a field investigation, we reviewed performance study data on oral-fluid and whole-blood OraQuickH rapid HIV test device lots and expiration dates and assessed test performance and interpretation with oral-fluid and whole-blood specimens by operators who reported false-positive results. We used multivariate logistic regression to evaluate client demographic and risk characteristics associated with false-positive results. Next, we conducted an incidence study of false-positive OraQuick rapid HIV tests in nine US cities and tested both oral-fluid and finger-stick whole-blood specimens from clients; reactive tests were confirmed with Western blot. Sixteen (4.1%) false-positive oral-fluid results occurred in the performance study from April 15, 2004 through August 31, 2004 with unexpired devices from six test lots among 388 HIV-uninfected clients (specificity, 95.9%; 95% CI: 93.4-97.6). Three test operators who had reported false-positive results performed and interpreted the test according to package-insert instructions. In multivariate analysis, only older age was significantly associated with false-positive results (adjusted odds ratio = 4.5, 95% CI: 1.2-25.7). In the incidence study, all valid oral-fluid and whole-blood results from 2,268 clients were concordant and no false-positive results occurred (100% specificity). Conclusions/Significance. The field investigation did not identify a cause for the increase in false-positive oral-fluid results, and the incidence study detected no false-positive results. The findings suggest this was an isolated cluster; the test's overall performance was as specified by the manufacturer.	[Jafa, Krishna; Patel, Pragna; MacKellar, Duncan A.; Sullivan, Patrick S.; Delaney, Kevin P.; Branson, Bernard M.] Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Sides, Tracy L.] Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN USA; [Newman, Alexandra P.] Wisconsin Div Publ Hlth, Madison, WI USA; [Jafa, Krishna; Newman, Alexandra P.] Ctr Dis Control & Prevent, Off Workforce & Career Dev, Epidemiol Program Off, Atlanta, GA USA; [Paul, Sindy M.] New Jersey Dept Hlth & Senior Serv, Div HIV AIDS Serv, Trenton, NJ USA; [Cadoff, Evan M.; Martin, Eugene G.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, New Brunswick, NJ USA; [Keenan, Patrick A.] Univ Minnesota, Sch Med, Dept Family Med & Community Hlth, Minneapolis, MN 55455 USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Centers for Disease Control & Prevention - USA; New Jersey Department of Health & Senior Services; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Jafa, K (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	kjafa@cdc.gov	Delaney, Kevin/HHS-1060-2022; Martin, Eugene/AAF-2041-2020	Martin, Eugene/0000-0002-9692-0033; Sullivan, Patrick Sean/0000-0002-7728-0587	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the investigation described in the manuscript was provided by the Centers for Disease Control and Prevention.	[Anonymous], 2004, MMWR MORB MORTAL WKL; *CDCP, 2006, HIV COUNS RAP TESTS; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; *CDCP, 2006, CLIA CERT WAIV FACT; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; OraSure Technologies Inc, 2004, ORAQUICK ADV RAP HIV; *US FDA, 2000, BLOOD PROD ADV COMM, V1; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed	9	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e185	10.1371/journal.pone.0000185	http://dx.doi.org/10.1371/journal.pone.0000185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17268576	gold, Green Published			2022-12-27	WOS:000207444200009
J	Viola, A; Saywell, V; Villard, L; Cozzone, PJ; Lutz, NW				Viola, Angele; Saywell, Veronique; Villard, Laurent; Cozzone, Patrick J.; Lutz, Norbert W.			Metabolic Fingerprints of Altered Brain Growth, Osmoregulation and Neurotransmission in a Rett Syndrome Model	PLOS ONE			English	Article								Background. Rett syndrome (RS) is the leading cause of profound mental retardation of genetic origin in girls. Since RS is mostly caused by mutations in the MECP2 gene, transgenic animal models such as the Mecp2-deleted ("Mecp2-null'') mouse have been employed to study neurological symptoms and brain function. However, an interdisciplinary approach drawing from chemistry, biology and neuroscience is needed to elucidate the mechanistic links between the genotype and phenotype of this genetic disorder. Methodology/Principal Findings. We performed, for the first time, a metabolomic study of brain extracts from Mecp2-null mice by using high-resolution magnetic resonance spectroscopy. A large number of individual water-soluble metabolites and phospholipids were quantified without prior selection for specific metabolic pathways. Results were interpreted in terms of Mecp2 gene deletion, brain cell function and brain morphology. This approach provided a "metabolic window'' to brain characteristics in Mecp2-null mice (n = 4), revealing (i) the first metabolic evidence of astrocyte involvement in RS (decreased levels of the astrocyte marker, myo-inositol, vs. wild-type mice; p = 0.034); (ii) reduced choline phospholipid turnover in Mecp2-null vs. wild-type mice, implying a diminished potential of cells to grow, paralleled by globally reduced brain size and perturbed osmoregulation; (iii) alterations of the platelet activating factor (PAF) cycle in Mecp2-null mouse brains, where PAF is a bioactive lipid acting on neuronal growth, glutamate exocytosis and other processes; and (iv) changes in glutamine/glutamate ratios (p = 0.034) in Mecp2-null mouse brains potentially indicating altered neurotransmitter recycling. Conclusions/Significance. This study establishes, for the first time, detailed metabolic fingerprints of perturbed brain growth, osmoregulation and neurotransmission in a mouse model of Rett syndrome. Combined with morphological and neurological findings, these results are crucial elements in providing mechanistic links between genotype and phenotype of Rett syndrome. Ultimately, this information can be used to identify novel molecular targets for pharmacological RS treatment.	[Viola, Angele; Cozzone, Patrick J.; Lutz, Norbert W.] Univ Mediterranee, Fac Med, CNRS, UMR 6612,CRMBM, Marseille, France; [Saywell, Veronique; Villard, Laurent] Fac Med Timone, INSERM, U491, Marseille, France; [Saywell, Veronique; Villard, Laurent] Univ Mediterranee, Fac Med Timone, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Lutz, NW (corresponding author), Univ Mediterranee, Fac Med, CNRS, UMR 6612,CRMBM, Marseille, France.	Norbert.Lutz@medecine.univ-mrs.fr	Villard, Laurent/E-3941-2016	Villard, Laurent/0000-0001-6657-5008	CNRS (Centre National de la Recherche Scientifique); Programme Interdisciplinaire CNRS-CEA Imagerie du Petit Animal, Institut Universitaire de France, ACI 2003	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Programme Interdisciplinaire CNRS-CEA Imagerie du Petit Animal, Institut Universitaire de France, ACI 2003	Financial support from the following institutions is gratefully acknowledged: CNRS (Centre National de la Recherche Scientifique), Programme Interdisciplinaire CNRS-CEA Imagerie du Petit Animal, Institut Universitaire de France, ACI 2003 (Action Concertee Initiative Plates-formes d'explorations fonctionnelles thematisees). These sponsors had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, nor in the preparation, review, or approval of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Armstrong DD, 2001, BRAIN DEV-JPN, V23, pS72, DOI 10.1016/S0387-7604(01)00332-1; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Bazan NG, 2003, J LIPID RES, V44, P2221, DOI 10.1194/jlr.R300013-JLR200; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Gokcay A, 2002, COMPUT MED IMAG GRAP, V26, P271, DOI 10.1016/S0895-6111(02)00016-2; Gotoh H, 2001, BRAIN DEV-JPN, V23, pS118, DOI 10.1016/S0387-7604(01)00355-2; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1986, AM J MED GENET, V24, P47; Hagberg Bengt, 2002, Eur J Paediatr Neurol, V6, P293, DOI 10.1053/ejpn.2002.0612; Hagberg G, 2000, ACTA PAEDIATR, V89, P198, DOI 10.1080/080352500750028834; Ham AL, 2005, J CHILD NEUROL, V20, P768; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; JOHNSTON MV, 1995, NEUROPEDIATRICS, V26, P119, DOI 10.1055/s-2007-979740; Johnston R, 2001, POLIT BEHAV, V23, P1, DOI 10.1023/A:1017684329835; Kimelberg HK, 2004, NEUROCHEM INT, V45, P191, DOI 10.1016/j.neuint.2003.08.015; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Lekman A Y, 1999, Eur J Paediatr Neurol, V3, P119, DOI 10.1016/S1090-3798(99)90099-5; LEKMAN AY, 1991, PEDIATR NEUROL, V7, P186, DOI 10.1016/0887-8994(91)90082-V; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lutz NW, 2005, METABOLOMICS, V1, P251, DOI 10.1007/s11306-005-0005-z; Lutz NW, 2002, NMR BIOMED, V15, P356, DOI 10.1002/nbm.790; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; MACALA LJ, 1995, GLYCOBIOLOGY, V5, P67, DOI 10.1093/glycob/5.1.67; Nagai K, 2005, DEV BRAIN RES, V157, P103, DOI 10.1016/j.devbrainres.2005.03.011; Naidu S, 2001, BRAIN DEV-JPN, V23, pS62, DOI 10.1016/S0387-7604(01)00381-3; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Pan JW, 1999, J CHILD NEUROL, V14, P524, DOI 10.1177/088307389901400808; PAPADIMITRIOU JM, 1988, AM J MED GENET, V29, P365, DOI 10.1002/ajmg.1320290216; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Picker JD, 2006, NEUROREPORT, V17, P541, DOI 10.1097/01.wnr.0000208995.38695.2f; Purves D., 2001, NEUROSCIENCE; REISS AL, 1993, ANN NEUROL, V34, P227, DOI 10.1002/ana.410340220; Rett A, 1966, Wien Med Wochenschr, V116, P723; Rice SQJ, 1998, BIOCHEM J, V330, P1309; Saywell W, 2006, BIOCHEM BIOPH RES CO, V340, P776, DOI 10.1016/j.bbrc.2005.12.080; Segovia G, 1999, NEUROCHEM RES, V24, P779, DOI 10.1023/A:1020787714940; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Shokati T, 2005, NEUROCHEM RES, V30, P1269, DOI 10.1007/s11064-005-8798-8; Sokal RR, 1995, BIOMETRY; Stanimirovic DB, 1997, GLIA, V19, P123, DOI 10.1002/(SICI)1098-1136(199702)19:2<123::AID-GLIA4>3.0.CO;2-1; Subramaniam B, 1997, NEUROLOGY, V48, P399, DOI 10.1212/WNL.48.2.399; Tome ME, 2003, BBA-MOL CELL RES, V1642, P149, DOI 10.1016/j.bbamcr.2003.08.002; Viemari JC, 2005, J NEUROSCI, V25, P11521, DOI 10.1523/JNEUROSCI.4373-05.2005; Viola A, 2002, PEDIATR RES, V52, DOI 10.1023/01.PDR.0000019549.97278.EF; WESTERGAARD N, 1991, J NEUROCHEM, V56, P59, DOI 10.1111/j.1471-4159.1991.tb02562.x; Wu GS, 2005, J NEUROSCI, V25, P11014, DOI 10.1523/JNEUROSCI.3635-05.2005; Zhang XH, 2006, J CELL SCI, V119, P1005, DOI 10.1242/jcs.02821; Zoghbi HY, 2005, J CHILD NEUROL, V20, P736, DOI 10.1177/08830738050200090701; ZWINGMANN C, NEUROCHEM R IN PRESS	55	42	42	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e157	10.1371/journal.pone.0000157	http://dx.doi.org/10.1371/journal.pone.0000157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17237885	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444000008
J	Li, CY; Stanton, JAL; Robertson, TM; Suttie, JM; Sheard, PW; Harris, AJ; Clark, DE				Li, Chunyi; Stanton, Jo-Ann L.; Robertson, Tracy M.; Suttie, James M.; Sheard, Philip W.; Harris, A. John; Clark, Dawn E.			Nerve Growth Factor mRNA Expression in the Regenerating Antler Tip of Red Deer (Cervus elaphus)	PLOS ONE			English	Article								Deer antlers are the only mammalian organs that can fully regenerate each year. During their growth phase, antlers of red deer extend at a rate of approximately 10 mm/day, a growth rate matched by the antler nerves. It was demonstrated in a previous study that extracts from deer velvet antler can promote neurite outgrowth from neural explants, suggesting a possible role for Nerve Growth Factor (NGF) in antler innervation. Here we showed using the techniques of Northern blot analysis, denervation, immunohistochemistry and in situ hybridization that NGF mRNA was expressed in the regenerating antler, principally in the smooth muscle of the arteries and arterioles of the growing antler tip. Regenerating axons followed the route of the major blood vessels, located at the interface between the dermis and the reserve mesenchyme of the antler. Denervation experiments suggested a causal relationship exists between NGF mRNA expression in arterial smooth muscle and sensory axons in the antler tip. We hypothesize that NGF expressed in the smooth muscle of the arteries and arterioles promotes and maintains antler angiogenesis and this role positions NGF ahead of axons during antler growth. As a result, NGF can serve a second role, attracting sensory axons into the antler, and thus it can provide a guidance cue to define the nerve track. This would explain the phenomenon whereby re-innervation of the regenerating antler follows vascular ingrowth. The annual growth of deer antler presents a unique opportunity to better understand the factors involved in rapid nerve regeneration.	[Li, Chunyi; Robertson, Tracy M.; Suttie, James M.; Clark, Dawn E.] AgRes, Invermay Agr Ctr, Mosgiel, New Zealand; [Stanton, Jo-Ann L.] Univ Otago, Dept Anat & Struct Biol, Dunedin, New Zealand; [Robertson, Tracy M.; Sheard, Philip W.; Harris, A. John] Univ Otago, Dept Physiol, Dunedin, New Zealand	AgResearch - New Zealand; University of Otago; University of Otago	Li, CY (corresponding author), AgRes, Invermay Agr Ctr, Mosgiel, New Zealand.	chunyi.li@agresearch.co.nz	Coates, Dawn Elizabeth/B-5134-2012; Stanton, Jo-Ann L/C-6621-2009	Coates, Dawn Elizabeth/0000-0003-4242-6846; Stanton, Jo-Ann L/0000-0001-8139-4694	New Zealand Foundation for Research and Technology [C10X0207]; Department of Physiology, University of Otago, New Zealand	New Zealand Foundation for Research and Technology(New Zealand Foundation for Research, Science and Technology); Department of Physiology, University of Otago, New Zealand	This research was funded by New Zealand Foundation for Research and Technology (Grant number: C10X0207) through AgResearch and the Department of Physiology, University of Otago, New Zealand.	Allen SP, 2002, DEV BIOL, V251, P409, DOI 10.1006/dbio.2002.0816; ANGELETT.RH, 1971, P NATL ACAD SCI USA, V68, P2417, DOI 10.1073/pnas.68.10.2417; BUBENIK GA, 1982, DEER ANTLER DEV CERV, P73; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Clark DE, 1996, HUM REPROD, V11, P1090; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; DISSEN GA, 1995, ENDOCRINOLOGY, V136, P4681, DOI 10.1210/en.136.10.4681; EDWARDS RH, 1986, NATURE, V319, P784, DOI 10.1038/319784a0; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Fiorentini C, 2002, EUR J ENDOCRINOL, V147, P371, DOI 10.1530/eje.0.1470371; Garcia RL, 1997, J MOL ENDOCRINOL, V19, P173, DOI 10.1677/jme.0.0190173; Gibran NS, 2003, SHOCK, V19, P127, DOI 10.1097/00024382-200302000-00007; Goss R.J., 1983, DEER ANTLERS REGENER; GOTZ R, 1994, NATURE, V372, P266, DOI 10.1038/372266a0; GRAY C, 1992, NEUROSCIENCE, V50, P953, DOI 10.1016/0306-4522(92)90218-Q; HUMPHREY MF, 1992, EXP BRAIN RES, V60, P630; Huo Y, 1997, Biomed Sci Instrum, V33, P541; IDE C, 1996, J NEUROSCI RES, V25, P101; Lee JW, 2002, BIOTECHNOL LETT, V24, P2035, DOI 10.1023/A:1021363203406; Li C., 2003, RECENT ADV RES UPDAT, V4, P255; Li CY, 2002, ANAT REC, V268, P125, DOI 10.1002/ar.10120; LI CY, 1993, J EXP ZOOL, V267, P188, DOI 10.1002/jez.1402670212; MEIER R, 1986, EMBO J, V5, P1489, DOI 10.1002/j.1460-2075.1986.tb04387.x; NITHYA M, 2003, BIOCHIM BIOPHYS ACTA, V1620, P23; Reimer MK, 2003, PANCREAS, V26, P392, DOI 10.1097/00006676-200305000-00014; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; SCULLY JL, 1995, CELL BIOL INT, V19, P459, DOI 10.1006/cbir.1995.1089; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SELBY MJ, 1987, MOL CELL BIOL, V7, P3057, DOI 10.1128/MCB.7.9.3057; Takeuchi T, 2003, BIOCHEM PHARMACOL, V65, P1507, DOI 10.1016/S0006-2952(03)00116-3; ULLRICH A, 1983, NATURE, V303, P821, DOI 10.1038/303821a0; WISLOCKI GB, 1946, J COMP NEUROL, V85, P1, DOI 10.1002/cne.900850102	34	39	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2007	2	1							e148	10.1371/journal.pone.0000148	http://dx.doi.org/10.1371/journal.pone.0000148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DE	17215957	Green Submitted, gold, Green Published			2022-12-27	WOS:000207443900002
J	Caley, P; Becker, NG; Philp, DJ				Caley, Peter; Becker, Niels G.; Philp, David J.			The Waiting Time for Inter-Country Spread of Pandemic Influenza	PLOS ONE			English	Article								Background. The time delay between the start of an influenza pandemic and its subsequent initiation in other countries is highly relevant to preparedness planning. We quantify the distribution of this random time in terms of the separate components of this delay, and assess how the delay may be extended by non-pharmaceutical interventions. Methods and Findings. The model constructed for this time delay accounts for: (i) epidemic growth in the source region, (ii) the delay until an infected individual from the source region seeks to travel to an at-risk country, (iii) the chance that infected travelers are detected by screening at exit and entry borders, (iv) the possibility of in-flight transmission, (v) the chance that an infected arrival might not initiate an epidemic, and (vi) the delay until infection in the at-risk country gathers momentum. Efforts that reduce the disease reproduction number in the source region below two and severe travel restrictions are most effective for delaying a local epidemic, and under favourable circumstances, could add several months to the delay. On the other hand, the model predicts that border screening for symptomatic infection, wearing a protective mask during travel, promoting early presentation of cases arising among arriving passengers and moderate reduction in travel volumes increase the delay only by a matter of days or weeks. Elevated in-flight transmission reduces the delay only minimally. Conclusions. The delay until an epidemic of pandemic strain influenza is imported into an at-risk country is largely determined by the course of the epidemic in the source region and the number of travelers attempting to enter the at-risk country, and is little affected by non-pharmaceutical interventions targeting these travelers. Short of preventing international travel altogether, eradicating a nascent pandemic in the source region appears to be the only reliable method of preventing country-to-country spread of a pandemic strain of influenza.	[Caley, Peter; Becker, Niels G.; Philp, David J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	Australian National University	Caley, P (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	Peter.Caley@anu.edu.au	Caley, Peter/D-8638-2011	Caley, Peter/0000-0002-8077-6460	Australian National Health & Medical Research Council [358425, 410224]; Australia Research Council [DP0558357]; Australian Department of Health and Ageing	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council(Australian Research Council); Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	Funding by Australian National Health & Medical Research Council grants (358425, 410224), an Australia Research Council grant (DP0558357) and the Australian Department of Health and Ageing is gratefully acknowledged.	BECKER NG, 1989, ANAL INFECT DIS DATA; Caswell H, 2000, MATRIX POPULATION MO, V2nd; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Harris T. E., 1963, THEORY BRANCHING PRO; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; John RKS, 2005, EMERG INFECT DIS, V11, P6, DOI 10.3201/eid1101.040835; Liao CM, 2005, RISK ANAL, V25, P1097, DOI 10.1111/j.1539-6924.2005.00663.x; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Marsden AG, 2003, MED J AUSTRALIA, V179, P172, DOI 10.5694/j.1326-5377.2003.tb05483.x; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Pitman RJ, 2005, BRIT MED J, V331, P1242, DOI 10.1136/bmj.38573.696100.3A	19	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2007	2	1							e143	10.1371/journal.pone.0000143	http://dx.doi.org/10.1371/journal.pone.0000143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DD	17206278	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443800005
J	Apatoff, A; Kim, E; Kliger, Y				Apatoff, Avihay; Kim, Eddo; Kliger, Yossef			Towards Alignment Independent Quantitative Assessment of Homology Detection	PLOS ONE			English	Article								Identification of homologous proteins provides a basis for protein annotation. Sequence alignment tools reliably identify homologs sharing high sequence similarity. However, identification of homologs that share low sequence similarity remains a challenge. Lowering the cutoff value could enable the identification of diverged homologs, but also introduces numerous false hits. Methods are being continuously developed to minimize this problem. Estimation of the fraction of homologs in a set of protein alignments can help in the assessment and development of such methods, and provides the users with intuitive quantitative assessment of protein alignment results. Herein, we present a computational approach that estimates the amount of homologs in a set of protein pairs. The method requires a prevalent and detectable protein feature that is conserved between homologs. By analyzing the feature prevalence in a set of pairwise protein alignments, the method can estimate the number of homolog pairs in the set independently of the alignments' quality. Using the HomoloGene database as a standard of truth, we implemented this approach in a proteome-wide analysis. The results revealed that this approach, which is independent of the alignments themselves, works well for estimating the number of homologous proteins in a wide range of homology values. In summary, the presented method can accompany homology searches and method development, provides validation to search results, and allows tuning of tools and methods.	[Apatoff, Avihay; Kim, Eddo; Kliger, Yossef] Compugen Ltd, Tel Aviv, Israel; [Apatoff, Avihay; Kim, Eddo] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Kliger, Y (corresponding author), Compugen Ltd, Tel Aviv, Israel.	kliger@compugen.co.il						Alexandrov NN, 1996, PROTEINS, V25, P354, DOI 10.1002/(SICI)1097-0134(199607)25:3<354::AID-PROT7>3.3.CO;2-W; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; FISCHELGHODSIAN F, 1990, PROTEIN ENG, V3, P577, DOI 10.1093/protein/3.7.577; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Hadley C, 1999, STRUCT FOLD DES, V7, P1099, DOI 10.1016/S0969-2126(99)80177-4; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; Kim E, 2005, BIOINFORMATICS, V21, P4216, DOI 10.1093/bioinformatics/bti706; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Orengo CA, 1996, METHOD ENZYMOL, V266, P617; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rost B, 1997, J MOL BIOL, V270, P471, DOI 10.1006/jmbi.1997.1101; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504	22	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e113	10.1371/journal.pone.0000113	http://dx.doi.org/10.1371/journal.pone.0000113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205117	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700007
J	Almeida, MC; Steiner, AA; Branco, LGS; Romanovsky, AA				Almeida, Maria C.; Steiner, Alexandre A.; Branco, Luiz G. S.; Romanovsky, Andrej A.			Neural Substrate of Cold-Seeking Behavior in Endotoxin Shock	PLOS ONE			English	Article								Systemic inflammation is a leading cause of hospital death. Mild systemic inflammation is accompanied by warmth-seeking behavior (and fever), whereas severe inflammation is associated with cold-seeking behavior (and hypothermia). Both behaviors are adaptive. Which brain structures mediate which behavior is unknown. The involvement of hypothalamic structures, namely, the preoptic area (POA), paraventricular nucleus (PVH), or dorsomedial nucleus (DMH), in thermoregulatory behaviors associated with endotoxin (lipopolysaccharide [LPS])-induced systemic inflammation was studied in rats. The rats were allowed to select their thermal environment by freely moving in a thermogradient apparatus. A low intravenous dose of Escherichia coli LPS (10 mu g/kg) caused warmth-seeking behavior, whereas a high, shock-inducing dose (5,000 mu g/kg) caused cold-seeking behavior. Bilateral electrocoagulation of the PVH or DMH, but not of the POA, prevented this cold-seeking response. Lesioning the DMH with ibotenic acid, an excitotoxin that destroys neuronal bodies but spares fibers of passage, also prevented LPS-induced cold-seeking behavior; lesioning the PVH with ibotenate did not affect it. Lesion of no structure affected cold-seeking behavior induced by heat exposure or by pharmacological stimulation of the transient receptor potential (TRP) vanilloid-1 channel ("warmth receptor''). Nor did any lesion affect warmth-seeking behavior induced by a low dose of LPS, cold exposure, or pharmacological stimulation of the TRP melastatin-8 ("cold receptor''). We conclude that LPS-induced cold-seeking response is mediated by neuronal bodies located in the DMH and neural fibers passing through the PVH. These are the first two landmarks on the map of the circuitry of cold-seeking behavior associated with endotoxin shock.	[Almeida, Maria C.; Steiner, Alexandre A.; Romanovsky, Andrej A.] St Josephs Hosp, Syst Inflammat Lab, Phoenix, AZ USA; [Almeida, Maria C.] Univ Sao Paulo, Med Sch Ribeirao Preto, Sao Paulo, Brazil; [Branco, Luiz G. S.] Univ Sao Paulo, Dent Sch Ribeirao Preto, Sao Paulo, Brazil	St. Joseph's Hospital and Medical Center; Universidade de Sao Paulo; Universidade de Sao Paulo	Romanovsky, AA (corresponding author), St Josephs Hosp, Syst Inflammat Lab, Phoenix, AZ USA.	aromano@chw.edu	Branco, Luiz/AAH-7589-2020; Almeida, Maria Camila/F-4443-2012; Branco, Luiz G S/N-6273-2014; Steiner, Alexandre A/G-1288-2012	Branco, Luiz/0000-0003-0292-4947; Almeida, Maria Camila/0000-0002-2012-3169; Steiner, Alexandre A/0000-0002-0802-4619; Romanovsky, Andrej/0000-0003-3772-8575	St. Joseph's Foundation; National Institute of Neurological Disorders and Stroke [NS-41233]; Arizona Disease Control Research Commission [8016]; CAPES Foundation, Brazil; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041233] Funding Source: NIH RePORTER	St. Joseph's Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Arizona Disease Control Research Commission; CAPES Foundation, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by grants from the St. Joseph's Foundation (to A. A. R.), National Institute of Neurological Disorders and Stroke (grant NS-41233 to A. A. R.), and Arizona Disease Control Research Commission (category II grant #8016 to A. A. R.), and by a Visiting Ph. D. Student Fellowship from the CAPES Foundation, Brazil (to M. C. A.). None of the funding bodies had any involvement whatsoever in preparing this manuscript.	ALLEN GV, 1992, J COMP NEUROL, V315, P313, DOI 10.1002/cne.903150307; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; AMIR S, 1990, BRAIN RES, V508, P152, DOI 10.1016/0006-8993(90)91129-5; Bicego KC, 2002, J EXP BIOL, V205, P3513; Caldeira JC, 1998, ANN NY ACAD SCI, V856, P294, DOI 10.1111/j.1749-6632.1998.tb08342.x; CARLISLE HJ, 1969, J COMP PHYSIOL PSYCH, V69, P391, DOI 10.1037/h0028170; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; CRAWSHAW LI, 1975, J PHYSIOL-LONDON, V244, P197, DOI 10.1113/jphysiol.1975.sp010791; de Menezes RCA, 2006, BRAIN RES, V1092, P129, DOI 10.1016/j.brainres.2006.03.080; DiMicco JA, 2002, PHARMACOL BIOCHEM BE, V71, P469, DOI 10.1016/S0091-3057(01)00689-X; Florez-Duquet M, 2001, AM J PHYSIOL-REG I, V280, pR1457, DOI 10.1152/ajpregu.2001.280.5.R1457; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Heimer L, 2006, NEUROSCI BIOBEHAV R, V30, P126, DOI 10.1016/j.neubiorev.2005.06.006; HORN T, 1994, AM J PHYSIOL, V267, pR323, DOI 10.1152/ajpregu.1994.267.1.R323; JARRARD LE, 1989, J NEUROSCI METH, V29, P251, DOI 10.1016/0165-0270(89)90149-0; Jhou T, 2005, J COMP NEUROL, V493, P111, DOI 10.1002/cne.20734; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; KORNEVA EK, 1992, NEUROIMMUNOLOGY FEVE, P145; KRUEGER JM, 1994, CRIT REV IMMUNOL, V14, P355, DOI 10.1615/CritRevImmunol.v14.i3-4.70; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; LIPTON JM, 1974, AM J PHYSIOL, V226, P1356, DOI 10.1152/ajplegacy.1974.226.6.1356; LIPTON JM, 1968, PHYSIOL BEHAV, V3, P165, DOI 10.1016/0031-9384(68)90049-8; LIPTON JM, 1976, AM J PHYSIOL, V231, P1638, DOI 10.1152/ajplegacy.1976.231.6.1638; LOVICK TA, 1993, BEHAV BRAIN RES, V58, P19, DOI 10.1016/0166-4328(93)90087-7; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Madden CJ, 2004, AM J PHYSIOL-REG I, V286, pR320, DOI 10.1152/ajpregu.00515.2003; Maruyama M, 2003, AM J PHYSIOL-REG I, V285, pR1116, DOI 10.1152/ajpregu.00166.2002; MOGA MM, 1990, J COMP NEUROL, V295, P624, DOI 10.1002/cne.902950408; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; NAGEL JA, 1980, SCIENCE, V208, P301, DOI 10.1126/science.7367860; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; Nakamura Y, 2005, EUR J NEUROSCI, V22, P3137, DOI 10.1111/j.1460-9568.2005.04515.x; Oka T, 2000, J COMP NEUROL, V428, P20, DOI 10.1002/1096-9861(20001204)428:1<20::AID-CNE3>3.0.CO;2-X; Onat FY, 2002, CELLS TISSUES ORGANS, V172, P48, DOI 10.1159/000064385; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Petersen, 2006, LECT NOTES HUMAN PHY, P603; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; ROBERTS WW, 1974, J COMP PHYSIOL PSYCH, V86, P470, DOI 10.1037/h0036147; ROBERTS WW, 1977, PHYSIOL BEHAV, V19, P503, DOI 10.1016/0031-9384(77)90226-8; ROBERTS WW, 1988, ANN NY ACAD SCI, V525, P363, DOI 10.1111/j.1749-6632.1988.tb38620.x; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V271, pR244, DOI 10.1152/ajpregu.1996.271.1.R244; Romanovsky AA, 1997, ANN NY ACAD SCI, V813, P733, DOI 10.1111/j.1749-6632.1997.tb51775.x; Romanovsky AA, 2002, J APPL PHYSIOL, V92, P2667, DOI 10.1152/japplphysiol.01173.2001; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V270, pR693, DOI 10.1152/ajpregu.1996.270.4.R693; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SAKAGUCHI T, 1988, BRAIN RES BULL, V20, P461, DOI 10.1016/0361-9230(88)90135-9; SAPER CB, 1994, NEW ENGL J MED, V330, P1880; SAPER CB, 1985, J COMP NEUROL, V237, P21, DOI 10.1002/cne.902370103; SATINOFF E, 1976, BRAIN RES BULL, V1, P553, DOI 10.1016/0361-9230(76)90082-4; SATINOFF E, 1970, J COMP PHYSIOL PSYCH, V71, P77, DOI 10.1037/h0028959; Scammell TE, 1996, J NEUROSCI, V16, P6246; SCHULZE G, 1981, N-S ARCH PHARMACOL, V318, P43, DOI 10.1007/BF00503311; Srividya R, 2006, NEUROSCIENCE, V139, P853, DOI 10.1016/j.neuroscience.2006.01.003; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; SZEKELY M, 1979, ACTA PHYSIOL HUNG, V53, P265; SZYMUSIAK R, 1982, PHYSIOL BEHAV, V28, P161, DOI 10.1016/0031-9384(82)90118-4; TERHORST GJ, 1986, BRAIN RES BULL, V16, P231; Thompson RH, 1998, BRAIN RES REV, V27, P89, DOI 10.1016/S0165-0173(98)00010-1; Thompson RH, 1996, J COMP NEUROL, V376, P143, DOI 10.1002/(SICI)1096-9861(19961202)376:1<143::AID-CNE9>3.0.CO;2-3; VANZOEREN JG, 1976, AM J PHYSIOL, V230, P932, DOI 10.1152/ajplegacy.1976.230.4.932; Yoshida K, 2003, EUR J NEUROSCI, V18, P1848, DOI 10.1046/j.1460-9568.2003.02919.x; YOSHIMATSU H, 1993, BRAIN RES, V601, P121, DOI 10.1016/0006-8993(93)91702-T; Zaretskaia MV, 2003, NEUROSCI LETT, V340, P1, DOI 10.1016/S0304-3940(03)00047-8	70	81	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e1	10.1371/journal.pone.0000001	http://dx.doi.org/10.1371/journal.pone.0000001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183631	Green Published, gold			2022-12-27	WOS:000207443600001
J	Goddard, MR; Leigh, J; Roger, AJ; Pemberton, AJ				Goddard, Matthew R.; Leigh, Jessica; Roger, Andrew J.; Pemberton, Andrew J.			Invasion and Persistence of a Selfish Gene in the Cnidaria	PLOS ONE			English	Article								Background. Homing endonuclease genes (HEGs) are superfluous, but are capable of invading populations that mix alleles by biasing their inheritance patterns through gene conversion. One model suggests that their long-term persistence is achieved through recurrent invasion. This circumvents evolutionary degeneration, but requires reasonable rates of transfer between species to maintain purifying selection. Although HEGs are found in a variety of microbes, we found the previous discovery of this type of selfish genetic element in the mitochondria of a sea anemone surprising. Methods/Principal Findings. We surveyed 29 species of Cnidaria for the presence of the COXIHEG. Statistical analyses provided evidence for HEG invasion. We also found that 96 individuals of Metridium senile, from five different locations in the UK, had identical HEG sequences. This lack of sequence divergence illustrates the stable nature of Anthozoan mitochondria. Our data suggests this HEG conforms to the recurrent invasion model of evolution. Conclusions. Ordinarily such low rates of HEG transfer would likely be insufficient to enable major invasion. However, the slow rate of Anthozoan mitochondrial change lengthens greatly the time to HEG degeneration: this significantly extends the periodicity of the HEG life-cycle. We suggest that a combination of very low substitution rates and rare transfers facilitated metazoan HEG invasion.	[Goddard, Matthew R.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Goddard, Matthew R.] Univ London Imperial Coll Sci Technol & Med, Natl Environm Res Council Ctr Populat Biol, London, England; [Leigh, Jessica; Roger, Andrew J.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Pemberton, Andrew J.] Marine Biol Assoc UK, Plymouth, Devon, England	University of Auckland; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Dalhousie University; Marine Biological Association United Kingdom	Goddard, MR (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	m.goddard@auckland.ac.nz	Goddard, Matthew/C-7462-2014	Goddard, Matthew/0000-0002-7482-4438	Canadian Institutes for Health Research [MOP-62809]; UK Natural Environment Research Council; University of Auckland Research [3606223]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Auckland Research	The contributions of JL and AJR were supported by an operating grant(MOP-62809) from the Canadian Institutes for Health Research. This work was funded by the UK Natural Environment Research Council and a University of Auckland Research grant (3606223) to MG.	Beagley CT, 1996, P NATL ACAD SCI USA, V93, P5619, DOI 10.1073/pnas.93.11.5619; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Bergthorsson U, 2004, P NATL ACAD SCI USA, V101, P17747, DOI 10.1073/pnas.0408336102; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Berntson EA, 1999, MOL PHYLOGENET EVOL, V13, P417, DOI 10.1006/mpev.1999.0649; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Dalgaard JZ, 1997, NUCLEIC ACIDS RES, V25, P4626, DOI 10.1093/nar/25.22.4626; France SC, 2002, HYDROBIOLOGIA, V471, P149, DOI 10.1023/A:1016517724749; Fukami H, 2005, CORAL REEFS, V24, P410, DOI 10.1007/s00338-005-0023-3; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Goddard MR, 2001, P ROY SOC B-BIOL SCI, V268, P2537, DOI 10.1098/rspb.2001.1830; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, MOL BIOL EVOL, V21, P129, DOI 10.1093/molbev/msh005; Huelsenbeck JP, 1996, SYST BIOL, V45, P92, DOI 10.2307/2413514; Koufopanou V, 2002, MOL BIOL EVOL, V19, P239, DOI 10.1093/oxfordjournals.molbev.a004077; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Loreto ELD, 2001, J HERED, V92, P375, DOI 10.1093/jhered/92.5.375; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Nishimura Y, 2002, GENE DEV, V16, P1116, DOI 10.1101/gad.979902; Nylander J. A. A., 2004, MRMODELTEST V2; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pinto SM, 2000, GENET MOL BIOL, V23, P601, DOI 10.1590/S1415-47572000000300017; PONTKINGDOM G, 1997, J MOL EVOL, V46, P419; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waggoner B, 2004, J PALEONTOL, V78, P51, DOI 10.1666/0022-3360(2004)078<0051:RAATTE>2.0.CO;2; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WOLFRAM S, 1996, MATH 5 0; Won JH, 2001, CORAL REEFS, V20, P39	39	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e3	10.1371/journal.pone.0000003	http://dx.doi.org/10.1371/journal.pone.0000003			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183657	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000207443600003
J	Lian, QZ; Yeo, KS; Que, JW; Tan, EKW; Yu, FG; Yin, YJ; Salto-Tellez, M; El Oakley, RM; Lim, SK				Lian, Qizhou; Yeo, Keng Suan; Que, Jianwen; Tan, Eileen Khia Way; Yu, Fenggang; Yin, Yijun; Salto-Tellez, Manuel; El Oakley, Reida Menshawe; Lim, Sai-Kiang			Establishing Clonal Cell Lines with Endothelial-Like Potential from CD9(hi), SSEA-1(-) Cells in Embryonic Stem Cell-Derived Embryoid Bodies	PLOS ONE			English	Article								Background. Differentiation of embryonic stem cells (ESCs) into specific cell types with minimal risk of teratoma formation could be efficiently directed by first reducing the differentiation potential of ESCs through the generation of clonal, self-renewing lineage-restricted stem cell lines. Efforts to isolate these stem cells are, however, mired in an impasse where the lack of purified lineage-restricted stem cells has hindered the identification of defining markers for these rare stem cells and, in turn, their isolation. Methodology/Principal Findings. We describe here a method for the isolation of clonal lineage-restricted cell lines with endothelial potential from ESCs through a combination of empirical and rational evidence-based methods. Using an empirical protocol that we have previously developed to generate embryo-derived RoSH lines with endothelial potential, we first generated E-RoSH lines from mouse ESC-derived embryoid bodies (EBs). Despite originating from different mouse strains, RoSH and E-RoSH lines have similar gene expression profiles (r(2) = 0.93) while that between E-RoSH and ESCs was 0.83. In silico gene expression analysis predicted that like RoSH cells, E-RoSH cells have an increased propensity to differentiate into vasculature. Unlike their parental ESCs, E-RoSH cells did not form teratomas and differentiate efficiently into endothelial-like cells in vivo and in vitro. Gene expression and FACS analysis revealed that RoSH and E-RoSH cells are CD9(hi), SSEA-1(-) while ESCs are CD9(lo), SSEA-1(+). Isolation of CD9(hi), SSEA-1(-) cells that constituted 1%-10% of EB-derived cultures generated an E-RoSH-like culture with an identical E-RoSH-like gene expression profile (r(2) = 0.95) and a propensity to differentiate into endothelial-like cells. Conclusions. By combining empirical and rational evidence-based methods, we identified definitive selectable surface antigens for the isolation and propagation of lineage-restricted stem cells with endothelial-like potential from mouse ESCs.	[Lian, Qizhou; Yeo, Keng Suan; Que, Jianwen; Tan, Eileen Khia Way; El Oakley, Reida Menshawe; Lim, Sai-Kiang] Genome Inst Singapore, Singapore, Singapore; [Lian, Qizhou; Que, Jianwen; Tan, Eileen Khia Way; Yu, Fenggang] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore; [Yin, Yijun] Natl Univ Singapore, Dept Obstet & Gynaecol, Singapore 117548, Singapore; Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Salto-Tellez, Manuel] Natl Univ Singapore, Dept Pathol, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lim, SK (corresponding author), Genome Inst Singapore, Singapore, Singapore.	limsk@gis.a-star.edu.sg	Lim, Sai Kiang/AEN-0252-2022; Lian, Qizhou/Y-1613-2019	Lim, Sai Kiang/0000-0002-5752-3297; Lian, Qizhou/0000-0001-8189-7160; Salto-Tellez, Manuel/0000-0001-8586-282X; El Oakley, Reida M/0000-0003-4101-8998	ASTAR-BMRC (Agency for Science and Technology-Biomedical Research Council) [01/1/21/17/045]	ASTAR-BMRC (Agency for Science and Technology-Biomedical Research Council)(Agency for Science Technology & Research (A*STAR))	This work was funded by an ASTAR-BMRC (Agency for Science and Technology-Biomedical Research Council) grant (BMRC Project No. 01/1/21/17/045) to SKL and RMO. ASTAR-BMRC did not participate in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript	Aberdam D, 2004, INT J DEV BIOL, V48, P203, DOI 10.1387/ijdb.15272386; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Breier G, 1997, THROMB HAEMOSTASIS, V78, P678; BROWN DG, 1993, HISTOCHEM J, V25, P452, DOI 10.1007/BF00157810; Chung S, 2006, J NEUROCHEM, V97, P1467, DOI 10.1111/j.1471-4159.2006.03841.x; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cui L, 2004, J HISTOCHEM CYTOCHEM, V52, P1447, DOI 10.1369/jhc.3A6241.2004; FORSYTH KD, 1991, IMMUNOLOGY, V72, P292; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Greenlee AR, 2005, TOXICOL IN VITRO, V19, P389, DOI 10.1016/j.tiv.2004.11.002; HASHEMI S, 1991, AM J HEMATOL, V38, P293, DOI 10.1002/ajh.2830380408; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hidaka K, 2003, FASEB J, V17, P740, DOI 10.1096/fj.02-0104fje; Hirai H, 2003, BLOOD, V101, P886, DOI 10.1182/blood-2002-02-0655; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lim SK, 1997, BLOOD, V90, P1291, DOI 10.1182/blood.V90.3.1291.1291_1291_1299; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Miyagi T, 2002, EXP HEMATOL, V30, P1444, DOI 10.1016/S0301-472X(02)00961-X; Nagano K, 2005, PROTEOMICS, V5, P1346, DOI 10.1002/pmic.200400990; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Oka M, 2002, MOL BIOL CELL, V13, P1274, DOI 10.1091/mbc.02-01-0600; Otani T, 2005, EXP HEMATOL, V33, P632, DOI 10.1016/j.exphem.2005.03.006; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Rippon HJ, 2006, STEM CELLS, V24, P1389, DOI 10.1634/stemcells.2005-0465; RISAU W, 1988, DEVELOPMENT, V102, P471; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; RUIZARGUELLES GJ, 1994, MAYO CLIN PROC, V69, P684, DOI 10.1016/S0025-6196(12)61350-0; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wynne F, 2006, REPRODUCTION, V131, P721, DOI 10.1530/rep.1.00869; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yin Y, 2002, STEM CELLS, V20, P338, DOI 10.1634/stemcells.20-4-338; Yin YJ, 2004, ARTERIOSCL THROM VAS, V24, P691, DOI 10.1161/01.ATV.0000120375.51196.73; ZHAO Y, 2006, EXP CELL RES; Zola H, 2000, J BIOL REG HOMEOS AG, V14, P218	41	7	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e6	10.1371/journal.pone.0000006	http://dx.doi.org/10.1371/journal.pone.0000006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183690	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600006
J	Scobie, HM; Young, JAT				Scobie, Heather M.; Young, John A. T.			Divalent Metal Ion Coordination by Residue T118 of Anthrax Toxin Receptor 2 Is Not Essential for Protective Antigen Binding	PLOS ONE			English	Article								The protective antigen (PA) subunit of anthrax toxin interacts with the integrin-like I domains of either of two cellular receptors, ANTXR1 or ANTXR2. These I domains contain a metal ion-dependent adhesion site (MIDAS) made up of five nonconsecutive amino acid residues that coordinate a divalent metal ion that is important for PA-binding. The MIDAS residues of integrin I domains shift depending upon whether the domain exists in a closed (ligand-unbound) or open (ligand-bound) conformation. Of relevance to this study, the MIDAS threonine residue coordinates the metal ion only in the open I domain conformation. Previously it was shown that the MIDAS threonine is essential for PA interaction with ANTXR1, a result consistent with the requirement that the I domain of that receptor adopts an open conformation for PA-binding [1]. Here we have tested the requirement for the MIDAS threonine of ANTXR2 for PA-binding. We show that the toxin can bind to a mutant receptor lacking the MIDAS threonine and that it can use that mutant receptor to intoxicate cultured cells. These findings suggest that an open-like configuration of the ANTXR2 MIDAS is not essential for the interaction with PA.	[Scobie, Heather M.; Young, John A. T.] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA	Salk Institute	Young, JAT (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jyoung@salk.edu		Young, John/0000-0003-1824-2561	NIH [A156013]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant A156013.	Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2003, J BIOL CHEM, V278, P49342, DOI 10.1074/jbc.M307900200; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200	14	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e99	10.1371/journal.pone.0000099	http://dx.doi.org/10.1371/journal.pone.0000099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183731	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600098
J	Wolff, T; Guinto, JB; Rawls, AS				Wolff, Tanya; Guinto, Jake B.; Rawls, Amy S.			Screen for Genetic Modifiers of stbm Reveals that Photoreceptor Fate and Rotation Can Be Genetically Uncoupled in the Drosophila Eye	PLOS ONE			English	Article							PLANAR CELL POLARITY; TISSUE POLARITY; OMMATIDIAL ROTATION; PROTEIN; PRICKLE; NOTCH; POLARIZATION; INFORMATION; STRABISMUS; ACTIVATION	Background. Polarity of the Drosophila compound eye arises primarily as a consequence of two events that are tightly linked in time and space: fate specification of two photoreceptor cells, R3 and R4, and the subsequent directional movement of the unit eyes of the compound eye, or ommatidia. While it is thought that these fates dictate the direction of ommatidial rotation, the phenotype of mutants in the genes that set up this polarity led to the hypothesis that these two events could be uncoupled. Methodology/Principal Findings. To definitively demonstrate these events are genetically separable, we conducted a dominant modifier screen to determine if genes, when misexpressed, could selectively enhance subclasses of mutant ommatidia in which the direction of rotation does not follow the R3/R4 cell fates, yet not affect the number of ommatidia in which rotation follows the R3/R4 cell fates. We identified a subset of P element lines that exhibit this selective enhancement. We also identified lines that behave in the opposite manner: They enhance the number of ommatidia that rotate in the right direction, but do not alter the number of ommatidia that rotate incorrectly with respect to the R3/R4 fates. Conclusions/Significance. These results indicate that fate and direction of rotation can be genetically separated, and that there are genes that act between R3/R4 fate specification and direction of ommatidial rotation. These data affirm what has been a long-standing assumption about the genetic control of ommatidial polarity.	[Wolff, Tanya; Guinto, Jake B.; Rawls, Amy S.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Wolff, T (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	twolff@genetics.wustl.edu			Lucille P. Markey Pathway fellowship; NIH [R01 EY13136]; NATIONAL EYE INSTITUTE [R01EY013136] Funding Source: NIH RePORTER	Lucille P. Markey Pathway fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a Lucille P. Markey Pathway fellowship to ASR and NIH grant R01 EY13136 to TW. Funders did not contribute to the design or conduct of the study, nor the collection, analysis, or interpretation of the data, nor in the preparation, review or approval of the manuscript.	Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Brown KE, 2003, DEVELOPMENT, V130, P5401, DOI 10.1242/dev.00773; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Chou YH, 2002, DEV CELL, V3, P839, DOI 10.1016/S1534-5807(02)00362-3; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Gaengel K, 2003, DEVELOPMENT, V130, P5413, DOI 10.1242/dev.00759; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; HAY BA, 1994, DEVELOPMENT, V120, P2121; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Lopez-Schier H, 2006, P NATL ACAD SCI USA, V103, P18615, DOI 10.1073/pnas.0608536103; Mlodzik M, 2005, AD DEV BIOL, V14, P1; Rawls AS, 2002, CURR BIOL, V12, P1021, DOI 10.1016/S0960-9822(02)00893-X; Rawls AS, 2003, DEVELOPMENT, V130, P1877, DOI 10.1242/dev.00411; Strutt H, 2003, CURR BIOL, V13, P1451, DOI 10.1016/S0960-9822(03)00545-1; Taylor J, 1998, GENETICS, V150, P199; THEISEN H, 1994, DEVELOPMENT, V120, P347; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wolff T, 1993, DEV DROSOPHILA MELAN; ZHENG L, 1995, DEVELOPMENT, V121, P3045	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e453	10.1371/journal.pone.0000453	http://dx.doi.org/10.1371/journal.pone.0000453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505545	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445900012
J	Elmqvist, T; Pyykonen, M; Tengo, M; Rakotondrasoa, F; Rabakonandrianina, E; Radimilahy, C				Elmqvist, Thomas; Pyykonen, Markku; Tengo, Maria; Rakotondrasoa, Fanambinantsoa; Rabakonandrianina, Elisabeth; Radimilahy, Chantal			Patterns of Loss and Regeneration of Tropical Dry Forest in Madagascar: The Social Institutional Context	PLOS ONE			English	Article								Loss of tropical forests and changes in land-use/land-cover are of growing concern worldwide. Although knowledge exists about the institutional context in which tropical forest loss is embedded, little is known about the role of social institutions in influencing regeneration of tropical forests. In the present study we used Landsat images from southern Madagascar from three different years (1984, 1993 and 2000) and covering 5500 km(2), and made a time-series analysis of three distinct large-scale patterns: 1) loss of forest cover, 2) increased forest cover, and 3) stable forest cover. Institutional characteristics underlying these three patterns were analyzed, testing the hypothesis that forest cover change is a function of strength and enforcement of local social institutions. The results showed a minor decrease of 7% total forest cover in the study area during the whole period 1984-2000, but an overall net increase of 4% during the period 1993-2000. The highest loss of forest cover occurred in a low human population density area with long distances to markets, while a stable forest cover occurred in the area with highest population density and good market access. Analyses of institutions revealed that loss of forest cover occurred mainly in areas characterized by insecure property rights, while areas with well-defined property rights showed either regenerating or stable forest cover. The results thus corroborate our hypothesis. The large-scale spontaneous regeneration dominated by native endemic species appears to be a result of a combination of changes in precipitation, migration and decreased human population and livestock grazing pressure, but under conditions of maintained and well-defined property rights. Our study emphasizes the large capacity of a semi-arid system to spontaneously regenerate, triggered by decreased pressures, but where existing social institutions mitigate other drivers of deforestation and alternative land-use.	[Elmqvist, Thomas; Pyykonen, Markku; Tengo, Maria] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden; [Elmqvist, Thomas] Stockholm Resilience Ctr, Stockholm, Sweden; [Rakotondrasoa, Fanambinantsoa; Rabakonandrianina, Elisabeth] Univ Antananarivo, Dept Biol & Plant Ecol, Antananarivo, Madagascar; [Radimilahy, Chantal] Univ Antananarivo, Museum Art & Archaeol, Antananarivo, Madagascar	Stockholm University; Stockholm University; University Antananarivo; University Antananarivo	Elmqvist, T (corresponding author), Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden.	thomase@ecology.su.se	Elmqvist, Thomas/AAY-6344-2021; Tengö, Maria/AAC-5698-2020	Elmqvist, Thomas/0000-0002-4617-6197; Tengö, Maria/0000-0002-4776-3748	Sida/Sarec; Formas	Sida/Sarec; Formas(Swedish Research Council Formas)	Grant from Sida/Sarec and Formas. No role in design and conduct of the study.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Barrett CB, 2001, BIOSCIENCE, V51, P497, DOI 10.1641/0006-3568(2001)051[0497:CTBAWI]2.0.CO;2; BATTISTINI R, 1972, BIOGEOGRAPHY ECOLOGY; Bawa KS, 1998, CONSERV BIOL, V12, P46, DOI 10.1046/j.1523-1739.1998.96480.x; Berkes F., 2003, NAVIGATING SOCIAL EC, V1, P30; Berkes F., 1998, LINKING SOCIAL ECOLO, V1st, DOI DOI 10.1017/CBO9780511541957; BERTRAND A, 1999, GESTION CONTRACTUELL; Brown KA, 2004, P NATL ACAD SCI USA, V101, P6045, DOI 10.1073/pnas.0401456101; Casse T, 2004, FOREST POLICY ECON, V6, P33, DOI 10.1016/S1389-9341(02)00084-9; Chazdon RL, 1998, SCIENCE, V281, P1295, DOI 10.1126/science.281.5381.1295; Clark CD, 1998, INT J REMOTE SENS, V19, P1461, DOI 10.1080/014311698215298; Cohen WB, 2004, BIOSCIENCE, V54, P535, DOI 10.1641/0006-3568(2004)054[0535:LRIEAO]2.0.CO;2; Dewar RE, 1999, J CLIMATE, V12, P3457, DOI 10.1175/1520-0442(1999)012<3457:GPOIRV>2.0.CO;2; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; ELMQVIST T, 2004, PLANT TALK, V35, P29; Fairhead J., 1996, Misreading the African landscape: society and ecology in a forest-savanna mosaic.; Fenn M, 2003, NATURAL HIST MADAGAS; Gibson C.C., 2000, PEOPLE FORESTS COMMU, P1; Gibson CC, 2005, WORLD DEV, V33, P273, DOI 10.1016/j.worlddev.2004.07.013; Grau HR, 2003, BIOSCIENCE, V53, P1159, DOI 10.1641/0006-3568(2003)053[1159:TECOSA]2.0.CO;2; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; HANNA SS, 1996, RIGHTS NATURE; Henderson P.A., 2003, PRACTICAL METHODS EC; Heurtebize G., 1986, HIST AFOMAROLAHY EXT; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Horning N.R., 2003, NATURAL HIST MADAGAS; Kaufmann J.C., 2006, CONSERV SOC, V4, P231; Kiefer R.W., 1994, REMOTE SENSING IMAGE; Koechlin J., 1972, BIOGEOGRAPHY ECOLOGY; Kull C., 2004, ISLE FIRE POLITICAL; Kvale S, 1996, INTERVIEWS INTRO QUA; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Leach M, 1999, WORLD DEV, V27, P225, DOI 10.1016/S0305-750X(98)00141-7; LOCATELLI B, 2004, TROPICAL DEFORESTATI, P135; Luck GW, 2004, P NATL ACAD SCI USA, V101, P182, DOI 10.1073/pnas.2237148100; McConnell WJ, 2002, ENVIRONMENT, V44, P10, DOI 10.1080/00139157.2002.10544685; McGarigal K., 2000, MULTIVARIATE STAT WI; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2006, P NATL ACAD SCI USA, V103, P19224, DOI 10.1073/pnas.0607962103; Pascarella JB, 2000, ECOSYSTEMS, V3, P217, DOI 10.1007/s100210000021; RABESANDRATANA R, 1984, MADAGASCAR, P55; Raharison L.-J.R., 1997, CACHIERS SECHERESSE, V8, P129; Ramirez OA, 2002, ENVIRON RESOUR ECON, V21, P23, DOI 10.1023/A:1014533310664; Richard AF, 2002, J ZOOL, V256, P421, DOI 10.1017/S0952836902000468; Rouse Jr. J.W., 1974, MONITORING VERNAL AD; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; *SAP, 2002, DONN STRUCT CONC SEC; Seddon N, 2000, ORYX, V34, P287, DOI 10.1017/S0030605300031355; SHEPERD G, 1992, MANAGING AFRICAS TRO; Silver WL, 1996, CONSERV BIOL, V10, P17, DOI 10.1046/j.1523-1739.1996.10010017.x; Sussman Robert W., 2003, Primate Conservation, V19, P32; SUSSMAN RW, 1994, HUM ECOL, V22, P333, DOI 10.1007/BF02168856; SUSSMAN RW, 1994, BIOTROPICA, V26, P241, DOI 10.2307/2388845; Swift J., 1996, The lie of the land: challenging received wisdom on the African environment., P73; Tengo M., 2004, THESIS STOCKHOLM U S; Tiffen M., 1994, MORE PEOPLE LESS ERO; Tucker C., 2005, CONSERV SOC, V3, P174; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X; Watson RT, 2000, LAND USE LAND USE CH; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991	65	55	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e402	10.1371/journal.pone.0000402	http://dx.doi.org/10.1371/journal.pone.0000402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476324	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445700004
J	Pinyol, R; Haeckel, A; Ritter, A; Qualmann, B; Kessels, MM				Pinyol, Roser; Haeckel, Akvile; Ritter, Anett; Qualmann, Britta; Kessels, Michael Manfred			Regulation of N-WASP and the Arp2/3 Complex by Abp1 Controls Neuronal Morphology	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; ACTIN-DEPOLYMERIZING PROTEIN; BINDING-PROTEIN; MEDIATED ENDOCYTOSIS; SYNDAPIN-I; CYTOSKELETON; ACTIVATION; WAVE; LINKS; REARRANGEMENT	Polymerization and organization of actin filaments into complex superstructures is indispensable for structure and function of neuronal networks. We here report that knock down of the F-actin-binding protein Abp1, which is important for endocytosis and synaptic organization, results in changes in axon development virtually identical to Arp2/3 complex inhibition, i.e., a selective increase of axon length. Our in vitro and in vivo experiments demonstrate that Abp1 interacts directly with N-WASP, an activator of the Arp2/3 complex, and releases the autoinhibition of N-WASP in cooperation with Cdc42 and thereby promotes N-WASP-triggered Arp2/3 complex-mediated actin polymerization. In line with our mechanistical studies and the colocalization of Abp1, N-WASP and Arp2/3 at sites of actin polymerization in neurons, we reveal an essential role of Abp1 and its cooperativity with Cdc42 in N-WASP-induced rearrangements of the neuronal cytoskeleton. We furthermore show that introduction of N-WASP mutants lacking the ability to bind Abp1 or Cdc42, Arp2/3 complex inhibition, Abp1 knock down, N-WASP knock down and Arp3 knock down, all cause identical neuromorphological phenotypes. Our data thus strongly suggest that these proteins and their complex formation are important for cytoskeletal processes underlying neuronal network formation.	[Pinyol, Roser; Haeckel, Akvile; Ritter, Anett; Kessels, Michael Manfred] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Res Grp Membrane Trafficking & Cytoskeleton, Magdeburg, Germany; [Pinyol, Roser; Haeckel, Akvile; Qualmann, Britta] Leibniz Inst Neurobiol, Res Grp Cell Biol, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN)	Kessels, MM (corresponding author), Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Res Grp Membrane Trafficking & Cytoskeleton, Magdeburg, Germany.	kessels@ifn-magde-burg.de	Pinyol, Roser/AAA-4404-2019	Pinyol, Roser/0000-0002-0288-6314	La Caixa/DAAD; Kultusministerium Land Sachsen-Anhalt [XN3571A/0504M]; Deutsche Forschungsgemeinschaft [QU116/4-1, QU116/3-1, KE685/2-1]	La Caixa/DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Kultusministerium Land Sachsen-Anhalt; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a La Caixa/DAAD fellowship (to RP) and the Kultusministerium Land Sachsen-Anhalt XN3571A/0504M (to BQ) as well as by Deutsche Forschungsgemeinschaft grants QU116/4-1 (to BQ), QU116/3-1 and 3-2 (to BQ and MMK) as well as KE685/2-1, 2-2 and 2-3 (to MMK).	Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Connert S, 2006, EMBO J, V25, P1611, DOI 10.1038/sj.emboj.7601053; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Fukuoka M, 2001, J CELL BIOL, V152, P471, DOI 10.1083/jcb.152.3.471; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kessels MM, 2000, MOL BIOL CELL, V11, P393, DOI 10.1091/mbc.11.1.393; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Mise-Omata S, 2003, BIOCHEM BIOPH RES CO, V301, P704, DOI 10.1016/S0006-291X(02)02972-8; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Otsuki M, 2003, J BIOL CHEM, V278, P6461, DOI 10.1074/jbc.M207433200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Qualmann B, 2002, INT REV CYTOL, V220, P93; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; QUALMANN B, 2003, REGULATION ENDOCYTIC; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Soulard A, 2002, MOL CELL BIOL, V22, P7889, DOI 10.1128/MCB.22.22.7889-7906.2002; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Suetsugu S, 2003, INT REV CYTOL, V229, P245, DOI 10.1016/S0074-7696(03)29006-9; Takenawa T, 2001, J CELL SCI, V114, P1801; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; WELCH MD, 2002, BIOCHEM J, V371, P233; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076	46	65	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e400	10.1371/journal.pone.0000400	http://dx.doi.org/10.1371/journal.pone.0000400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476322	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445700002
J	Ball, T; Rahm, B; Eickhoff, SB; Schulze-Bonhage, A; Speck, O; Mutschler, I				Ball, Tonio; Rahm, Benjamin; Eickhoff, Simon B.; Schulze-Bonhage, Andreas; Speck, Oliver; Mutschler, Isabella			Response Properties of Human Amygdala Subregions: Evidence Based on Functional MRI Combined with Probabilistic Anatomical Maps	PLOS ONE			English	Article							NEURAL REPRESENTATIONS; PREFRONTAL CORTEX; MUSIC CORRELATE; ACTIVATION; EMOTION; FEAR; HABITUATION; INTENSITY; CIRCUITS; VALENCE	The human amygdala is thought to play a pivotal role in the processing of emotionally significant sensory information. The major subdivisions of the human amygdala-the laterobasal group (LB), the superficial group (SF), and the centromedial group (CM)-have been anatomically delineated, but the functional response properties of these amygdala subregions in humans are still unclear. We combined functional MRI with cyto-architectonically defined probabilistic maps to analyze the response characteristics of amygdala subregions in subjects presented with auditory stimuli. We found positive auditory stimulation-related signal changes predominantly in probabilistically defined LB, and negative responses predominantly in SF and CM. In the left amygdala, mean response magnitude in the core area of LB with 90-100% assignment probability was significantly larger than in the core areas of SF and CM. These differences were observed for pleasant and unpleasant stimuli. Our findings reveal that the probabilistically defined anatomical subregions of the human amygdala show distinctive fMRI response patterns. The stronger auditory responses in LB as compared with SF and CM may reflect a predominance of auditory inputs to human LB, similar to many animal species in which the majority of sensory, including auditory, afferents project to this subdivision of the amygdala. Our study indicates that the intrinsic functional differentiation of the human amygdala may be probed using fMRI combined with probabilistic anatomical maps.	[Ball, Tonio; Schulze-Bonhage, Andreas; Mutschler, Isabella] Univ Hosp Freiburg, Epilepsy Ctr, Freiburg, Germany; [Ball, Tonio; Mutschler, Isabella] Heidelberg Acad Sci & Humanities, Heidelberg, Germany; [Ball, Tonio; Schulze-Bonhage, Andreas] Bernstein Ctr Computat Neurosci Freiburg, Freiburg, Germany; [Rahm, Benjamin] Univ Basel, Dept Cognit Psychol & Methodol, Basel, Switzerland; [Rahm, Benjamin] Goethe Univ Frankfurt, Inst Med Psychol, Frankfurt, Germany; [Eickhoff, Simon B.] Res Ctr Julich, Inst Med, Julich, Germany; [Eickhoff, Simon B.] Univ Dusseldorf, C&O Inst Brain Res, Dusseldorf, Germany; [Speck, Oliver] Univ Magdeburg, Inst Expt Phys, Dept Biomed Magnet Resonance, D-39106 Magdeburg, Germany	University of Freiburg; University of Basel; Goethe University Frankfurt; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Otto von Guericke University	Ball, T (corresponding author), Univ Hosp Freiburg, Epilepsy Ctr, Freiburg, Germany.	tonio.ball@uniklinik-freiburg.de	Schulze-Bonhage, Andreas/AAJ-3107-2020; Eickhoff, Simon B./K-2061-2013; Speck, Oliver/F-1406-2013	Eickhoff, Simon B./0000-0001-6363-2759; Speck, Oliver/0000-0002-6019-5597; Mutschler Collins, Isabella/0000-0003-2738-5943	Heidelberg Academy of Science and Humanities; University of Freiburg; YAMAHA Stiftung 100 Jahre e. V., Germany	Heidelberg Academy of Science and Humanities; University of Freiburg; YAMAHA Stiftung 100 Jahre e. V., Germany	This research was supported by the Heidelberg Academy of Science and Humanities, the University of Freiburg, and the 'YAMAHA Stiftung 100 Jahre e. V.', Germany.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; [Anonymous], 2000, SER AFFECTIVE SCI; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Birbaumer N, 1998, NEUROREPORT, V9, P1223, DOI 10.1097/00001756-199804200-00048; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; BORDI F, 1992, J NEUROSCI, V12, P2493; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Collins DR, 1999, J NEUROSCI, V19, P836; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; GONZALEZLIMA F, 1986, BRAIN RES, V363, P239, DOI 10.1016/0006-8993(86)91009-7; Heimer L., 1999, PRIMATE NERVOUS SY 3, P57, DOI DOI 10.1016/S0924-8196(99)80024-4; Khalfa S, 2005, NEUROREPORT, V16, P1981, DOI 10.1097/00001756-200512190-00002; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Krishnan S, 2006, NEUROIMAGE, V31, P560, DOI 10.1016/j.neuroimage.2005.12.061; LEDOUX J, 2000, SER AFFECTIVE SCI, P129; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liberzon I, 2003, NEUROPSYCHOPHARMACOL, V28, P726, DOI 10.1038/sj.npp.1300113; McDonald AJ, 2003, ANN NY ACAD SCI, V985, P1; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Merboldt KD, 2001, NEUROIMAGE, V14, P253, DOI 10.1006/nimg.2001.0802; MERKSZ M, 1978, ACTA MORPHOL HUNG, V26, P139; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Phillips ML, 2001, HUM BRAIN MAPP, V12, P193, DOI 10.1002/1097-0193(200104)12:4<193::AID-HBM1015>3.0.CO;2-A; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Robinson S, 2004, NEUROIMAGE, V22, P203, DOI 10.1016/j.neuroimage.2003.12.048; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Sander K, 2005, J COGNITIVE NEUROSCI, V17, P1519, DOI 10.1162/089892905774597227; Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Turner R, 2002, NEUROIMAGE, V16, P1062, DOI 10.1006/nimg.2002.1082; Veit R, 2002, NEUROSCI LETT, V328, P233, DOI 10.1016/S0304-3940(02)00519-0; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	53	123	124	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e307	10.1371/journal.pone.0000307	http://dx.doi.org/10.1371/journal.pone.0000307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375193	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000207445100009
J	Foligne, B; Zoumpopoulou, G; Dewulf, J; Ben Younes, A; Chareyre, F; Sirard, JC; Pot, B; Grangette, C				Foligne, Benoit; Zoumpopoulou, Georgia; Dewulf, Joelle; Ben Younes, Amena; Chareyre, Fabrice; Sirard, Jean-Claude; Pot, Bruno; Grangette, Corinne			A Key Role of Dendritic Cells in Probiotic Functionality	PLOS ONE			English	Article							REGULATORY T-CELLS; MURINE COLITIS; CUTTING EDGE; KAPPA-B; IMMUNE-RESPONSES; INHIBITION; INTERLEUKIN-10; INFLAMMATION; TOLERANCE; BACTERIA	Background. Disruption of the intestinal homeostasis and tolerance towards the resident microbiota is a major mechanism involved in the development of inflammatory bowel disease. While some bacteria are inducers of disease, others, known as probiotics, are able to reduce inflammation. Because dendritic cells (DCs) play a central role in regulating immune responses and in inducing tolerance, we investigated their role in the anti-inflammatory potential of probiotic lactic acid bacteria. Methodology/Principal Findings. Selected LAB strains, while efficiently taken up by DCs in vitro, induced a partial maturation of the cells. Transfer of probiotic-treated DCs conferred protection against 2, 4, 6-trinitrobenzenesulfonic acid (TNBS)-induced colitis. Protection was associated with a reduction of inflammatory scores and colonic expression of proinflammatory genes, while a high local expression of the immunoregulatory enzyme indolamine 2, 3 dioxgenase (IDO) was observed. The preventive effect of probiotic-pulsed DCs required not only MyD88-, TLR2- and NOD2-dependent signaling but also the induction of CD4+ CD25+ regulatory cells in an IL-10-independent pathway. Conclusions/Significance. Altogether, these results suggest that selected probiotics can stimulate DC regulatory functions by targeting specific pattern-recognition receptors and pathways. The results not only emphasize the role of DCs in probiotic immune interactions, but indicate a possible role in immune-intervention therapy for IBD.	[Foligne, Benoit; Zoumpopoulou, Georgia; Dewulf, Joelle; Pot, Bruno; Grangette, Corinne] Inst Biol Lille, Inst Pasteur Lille, Lab Bacteries Lact & Immunite Muqueuses, Lille, France; [Foligne, Benoit; Sirard, Jean-Claude] Inst Biol Lille, Inst Pasteur Lille, INSERM, U801, Lille, France; [Ben Younes, Amena] Inst Biol Lille, Inst Pasteur Lille, IFR142, Lille, France; [Chareyre, Fabrice] CEPH, Fdn Jean Dausset, INSERM, U674, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Grangette, C (corresponding author), Inst Biol Lille, Inst Pasteur Lille, Lab Bacteries Lact & Immunite Muqueuses, Lille, France.	Corinne.grangette@ibl.fr	Zoumpopoulou, Georgia/AAQ-6419-2021; Sirard, Jean-Claude/B-5932-2011; Foligne, Benoit/B-2754-2014; Pot, Bruno DF/I-6645-2012	Sirard, Jean-Claude/0000-0001-9854-4652; Foligne, Benoit/0000-0001-9263-9706; 	Institut Pasteur de Lille; foundation Aupetit, Paris	Institut Pasteur de Lille; foundation Aupetit, Paris	This work was supported by the Institut Pasteur de Lille and the foundation Aupetit, Paris.	Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Braat H, 2004, AM J CLIN NUTR, V80, P1618, DOI 10.1093/ajcn/80.6.1618; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Cong YZ, 2005, J IMMUNOL, V174, P2787, DOI 10.4049/jimmunol.174.5.2787; Corinti S, 1999, J IMMUNOL, V163, P3029; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Duchmann R, 1996, EUR J IMMUNOL, V26, P934, DOI 10.1002/eji.1830260432; Elson CO, 1996, J IMMUNOL, V157, P2174; Fiorucci S, 2004, P NATL ACAD SCI USA, V101, P15736, DOI 10.1073/pnas.0404722101; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Foligne B, 2005, GUT, V54, P727; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; GASSON MJ, 1983, J BACTERIOL, V154, P1; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Lammers KM, 2005, INFLAMM BOWEL DIS, V11, P447, DOI 10.1097/01.mpa.0000160302.40931.7b; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Nishihara T, 2006, GASTROENTEROLOGY, V131, P853, DOI 10.1053/j.gastro.2006.06.015; Noel C, 2003, PARASITOL RES, V89, P487, DOI 10.1007/s00436-002-0811-4; Oldenhove G, 2003, J EXP MED, V198, P259, DOI 10.1084/jem.20030654; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Sheil B, 2004, GUT, V53, P694, DOI 10.1136/gut.2003.027789; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stephens LA, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; van Heel DA, 2005, GUT, V54, P1553, DOI 10.1136/gut.2005.065888; Vandenbroucke K, 2004, GASTROENTEROLOGY, V127, P502, DOI 10.1053/j.gastro.2004.05.020; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wolf AM, 2004, CLIN IMMUNOL, V113, P47, DOI 10.1016/j.clim.2004.05.004; Zelenay S, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036-a; Zhu M, 2003, WORLD J GASTROENTERO, V9, P2509	54	218	231	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e313	10.1371/journal.pone.0000313	http://dx.doi.org/10.1371/journal.pone.0000313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375199	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445100015
J	Chen, L; Shen, RL; Ye, Y; Pu, XA; Liu, XL; Duan, WR; Wen, J; Zimmerer, J; Wang, Y; Liu, Y; Lasky, LC; Heerema, NA; Perrotti, D; Ozato, K; Kuramochi-Miyagawa, S; Nakano, T; Yates, AJ; Carson, WE; Lin, HF; Barsky, SH; Gao, JX				Chen, Li; Shen, Rulong; Ye, Yin; Pu, Xin-An; Liu, Xingluo; Duan, Wenrui; Wen, Jing; Zimmerer, Jason; Wang, Ying; Liu, Yan; Lasky, Larry C.; Heerema, Nyla A.; Perrotti, Danilo; Ozato, Keiko; Kuramochi-Miyagawa, Satomi; Nakano, Toru; Yates, Allen J.; Carson, William E., III; Lin, Haifan; Barsky, Sanford H.; Gao, Jian-Xin			Precancerous Stem Cells Have the Potential for both Benign and Malignant Differentiation	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; SELF-RENEWAL; GENE-EXPRESSION; CANCER; IDENTIFICATION; RECEPTOR; TUMORS; SUBPOPULATION; MAINTENANCE; HIERARCHY	Cancer stem cells (CSCs) have been identified in hematopoietic and solid tumors. However, their precursors-namely, precancerous stem cells (pCSCs) -have not been characterized. Here we experimentally define the pCSCs that have the potential for both benign and malignant differentiation, depending on environmental cues. While clonal pCSCs can develop into various types of tissue cells in immunocompetent mice without developing into cancer, they often develop, however, into leukemic or solid cancers composed of various types of cancer cells in immunodeficient mice. The progress of the pCSCs to cancers is associated with the up-regulation of c-kit and Sca-1, as well as with lineage markers. Mechanistically, the pCSCs are regulated by the PIWI/AGO family gene called piwil2. Our results provide clear evidence that a single clone of pCSCs has the potential for both benign and malignant differentiation, depending on the environmental cues. We anticipate pCSCs to be a novel target for the early detection, prevention, and therapy of cancers.	[Chen, Li; Shen, Rulong; Ye, Yin; Wang, Ying; Liu, Yan; Lasky, Larry C.; Heerema, Nyla A.; Yates, Allen J.; Barsky, Sanford H.; Gao, Jian-Xin] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Liu, Xingluo; Duan, Wenrui; Wen, Jing; Zimmerer, Jason; Heerema, Nyla A.; Perrotti, Danilo; Carson, William E., III; Gao, Jian-Xin] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Pu, Xin-An] Ohio State Univ, Med Ctr, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Lasky, Larry C.] Ctr Stem Cell & Regenerat Med, Cleveland, OH USA; [Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT USA; [Ozato, Keiko] NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; [Kuramochi-Miyagawa, Satomi; Nakano, Toru] Osaka Univ, Microbial Dis Res Inst, Dept Mol Cell Biol, Osaka, Japan	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Yale University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Osaka University	Gao, JX (corresponding author), Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA.	Jian-Xin.Gao@osumc.edu	Carson, William E/E-2846-2011; Perrotti, Danilo/E-3852-2011; Shen, Rulong/E-4079-2011	Carson, III, William E./0000-0001-7024-7533; duan, wenrui/0000-0001-6512-7350	Department of Pathology; Ohio State University (OSU); Strategy Initiative [2005/2006]; American Cancer Society [IRG-112367]; Immunology Program; Davis/Bremer Medical Research; National Cancer Institute [CA095512]; United States Army; Chronic Myelogenous Leukemia (CML) Research Program [DAMD17-03-1-0184]; National Institute of Child and Human Development [HD42012]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008815] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042012, Z01HD008815] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095512] Funding Source: NIH RePORTER	Department of Pathology; Ohio State University (OSU)(Ohio State University); Strategy Initiative; American Cancer Society(American Cancer Society); Immunology Program; Davis/Bremer Medical Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Army(United States Department of DefenseUnited States Army); Chronic Myelogenous Leukemia (CML) Research Program; National Institute of Child and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported from the Grants of Start-up funding, Department of Pathology, Ohio State University (OSU) (JXG); Strategy Initiative Grant (SIG) 2005/2006, OSU (JXG); American Cancer Society grant IRG-112367 (JXG); Immunology Program Award 2007 (OSU) (JXG); Davis/Bremer Medical Research Grant, OSU (RS); Strategy Initiative Grant (SIG) 2006, OSU (SHB); National Cancer Institute CA095512 (D. P.); the United States Army, Chronic Myelogenous Leukemia (CML) Research Program DAMD17-03-1-0184 (D. P.); and National Institute of Child and Human Development HD42012 (H. L.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Baldassarre G, 1997, ONCOGENE, V15, P927, DOI 10.1038/sj.onc.1201260; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Casserly IP, 2002, CELL MOL LIFE SCI, V59, P478, DOI 10.1007/s00018-002-8440-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen CZ, 2002, P NATL ACAD SCI USA, V99, P15468, DOI 10.1073/pnas.202614899; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Constantinescu S, 2003, J CELL MOL MED, V7, P103, DOI 10.1111/j.1582-4934.2003.tb00209.x; Cotter FE, 2004, SEMIN ONCOL, V31, P18, DOI 10.1053/j.seminoncol.2004.10.014; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Demetri GD, 2001, SEMIN ONCOL, V28, P19, DOI 10.1053/sonc.2001.29181; Drexler HG, 2004, GROWTH FACTORS, V22, P71, DOI 10.1080/08977190410001700989; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gao JX, 2003, J IMMUNOL, V170, P5927, DOI 10.4049/jimmunol.170.12.5927; Gao JX, 2000, CELL IMMUNOL, V202, P41, DOI 10.1006/cimm.2000.1656; Geiger H, 1998, CELL, V93, P1055, DOI 10.1016/S0092-8674(00)81210-6; Gurbuxani S, 2005, P NATL ACAD SCI USA, V102, P11480, DOI 10.1073/pnas.0500303102; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hogge DE, 1996, BLOOD, V88, P3765, DOI 10.1182/blood.V88.10.3765.bloodjournal88103765; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Ishikawa T, 2001, DEVELOPMENT, V128, P25; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kawase Y, 2001, CONTEMP TOP LAB ANIM, V40, P31; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lelievre SA, 1998, P NATL ACAD SCI USA, V95, P14711, DOI 10.1073/pnas.95.25.14711; Massung RF, 1998, J CLIN MICROBIOL, V36, P1090, DOI 10.1128/JCM.36.4.1090-1095.1998; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Nagy A., 2003, MANIPULATING MOUSE E; Nakamura Y, 1998, EXP HEMATOL, V26, P1105; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Potti Anil, 2005, J Carcinog, V4, P8, DOI 10.1186/1477-3163-4-8; Raaphorst FM, 2003, TRENDS IMMUNOL, V24, P522, DOI 10.1016/S1471-4906(03)00241-2; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skea D, 1999, J HEMATOTHER, V8, P129, DOI 10.1089/106161299320406; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tagoh H, 2004, EMBO J, V23, P4275, DOI 10.1038/sj.emboj.7600421; Wang HY, 2004, FRONT BIOSCI-LANDMRK, V9, P1043, DOI 10.2741/1310; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; YILMAZ OH, 2006, NATURE	64	94	97	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e293	10.1371/journal.pone.0000293	http://dx.doi.org/10.1371/journal.pone.0000293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356702	Green Published, gold			2022-12-27	WOS:000207444800016
J	Kraeva, RI; Krastev, DB; Roguev, A; Ivanova, A; Nedelcheva-Veleva, MN; Stoynov, SS				Kraeva, Rayna I.; Krastev, Dragomir B.; Roguev, Assen; Ivanova, Anna; Nedelcheva-Veleva, Marina N.; Stoynov, Stoyno S.			Stability of mRNA/DNA and DNA/DNA Duplexes Affects mRNA Transcription	PLOS ONE			English	Article								Nucleic acids, due to their structural and chemical properties, can form double-stranded secondary structures that assist the transfer of genetic information and can modulate gene expression. However, the nucleotide sequence alone is insufficient in explaining phenomena like intron-exon recognition during RNA processing. This raises the question whether nucleic acids are endowed with other attributes that can contribute to their biological functions. In this work, we present a calculation of thermodynamic stability of DNA/DNA and mRNA/DNA duplexes across the genomes of four species in the genus Saccharomyces by nearest-neighbor method. The results show that coding regions are more thermodynamically stable than introns, 3'-untranslated regions and intergenic sequences. Furthermore, open reading frames have more stable sense mRNA/DNA duplexes than the potential antisense duplexes, a property that can aid gene discovery. The lower stability of the DNA/DNA and mRNA/DNA duplexes of 3'-untranslated regions and the higher stability of genes correlates with increased mRNA level. These results suggest that the thermodynamic stability of DNA/DNA and mRNA/DNA duplexes affects mRNA transcription.	[Kraeva, Rayna I.; Nedelcheva-Veleva, Marina N.; Stoynov, Stoyno S.] Bulgarian Acad Sci, Inst Mol Biol, BU-1113 Sofia, Bulgaria	Bulgarian Academy of Sciences	Stoynov, SS (corresponding author), Bulgarian Acad Sci, Inst Mol Biol, BU-1113 Sofia, Bulgaria.	stoynov@obzor.bio21.bas.bg		Krastev, Dragomir/0000-0003-4298-7272; Stoynov, Stoyno/0000-0002-7004-1081	Alexander von Humboldt Foundation; NATO [EAP.RIG.981642]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATO(NATO (North Atlantic Treaty Organisation))	The research of S. S. S. has been supported by an Alexander von Humboldt Foundation Return Fellowship and NATO Grant EAP.RIG.981642.	Ak P, 2005, PLOS COMPUT BIOL, V1, P41, DOI 10.1371/journal.pcbi.0010007; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Benham CJ, 1996, J MOL BIOL, V255, P425, DOI 10.1006/jmbi.1996.0035; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; BORER PN, 1974, J MOL BIOL, V86, P843, DOI 10.1016/0022-2836(74)90357-X; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; DOVE WF, 1962, J MOL BIOL, V5, P467, DOI 10.1016/S0022-2836(62)80119-3; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Graber JH, 2002, NUCLEIC ACIDS RES, V30, P1851, DOI 10.1093/nar/30.8.1851; Graber JH, 1999, NUCLEIC ACIDS RES, V27, P888, DOI 10.1093/nar/27.3.888; Greive SJ, 2005, NAT REV MOL CELL BIO, V6, P221, DOI 10.1038/nrm1588; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huang YL, 2003, NUCLEIC ACIDS RES, V31, P3819, DOI 10.1093/nar/gkg562; Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X; Kellis M, 2004, J COMPUT BIOL, V11, P319, DOI 10.1089/1066527041410319; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; NATALE DA, 1993, NUCLEIC ACIDS RES, V21, P555, DOI 10.1093/nar/21.3.555; NATALE DA, 1992, P NATL ACAD SCI USA, V89, P2654, DOI 10.1073/pnas.89.7.2654; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; RAHMOUNI AR, 1992, J MOL BIOL, V223, P131, DOI 10.1016/0022-2836(92)90721-U; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; van Helden J, 2000, NUCLEIC ACIDS RES, V28, P1000; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032	30	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e290	10.1371/journal.pone.0000290	http://dx.doi.org/10.1371/journal.pone.0000290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356699	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444800013
J	Seo, H; Sonntag, KC; Kim, W; Cattaneo, E; Isacson, O				Seo, Hyemyung; Sonntag, Kai-Christian; Kim, Woori; Cattaneo, Elena; Isacson, Ole			Proteasome Activator Enhances Survival of Huntington's Disease Neuronal Model Cells	PLOS ONE			English	Article								In patients with Huntington's disease (HD), the proteolytic activity of the ubiquitin proteasome system ( UPS) is reduced in the brain and other tissues. The pathological hallmark of HD is the intraneuronal nuclear protein aggregates of mutant huntingtin. We determined how to enhance UPS function and influence catalytic protein degradation and cell survival in HD. Proteasome activators involved in either the ubiquitinated or the non-ubiquitinated proteolysis were overexpressed in HD patients' skin fibroblasts or mutant huntingtin-expressing striatal neurons. Following compromise of the UPS, overexpression of the proteasome activator subunit PA28 gamma, but not subunit S5a, recovered proteasome function in the HD cells. PA28 gamma also improved cell viability in mutant huntingtin-expressing striatal neurons exposed to pathological stressors, such as the excitotoxin quinolinic acid and the reversible proteasome inhibitor MG132. These results demonstrate the specific functional enhancements of the UPS that can provide neuroprotection in HD cells.	[Seo, Hyemyung; Sonntag, Kai-Christian; Isacson, Ole] McLean Hosp, Ctr Neuroregenerat Res, Neuroregenerat Labs, Belmont, MA 02178 USA; [Seo, Hyemyung; Sonntag, Kai-Christian; Isacson, Ole] Harvard Univ, Sch Med, Belmont, MA 02178 USA; [Seo, Hyemyung; Kim, Woori] Hanyang Univ, Dept Mol & Life Sci, Gyeonggi Do, South Korea; [Cattaneo, Elena] Univ Milan, Ctr Neurodegenerat Dis, Milan, Italy	Harvard University; McLean Hospital; Harvard University; Hanyang University; University of Milan	Seo, H (corresponding author), McLean Hosp, Ctr Neuroregenerat Res, Neuroregenerat Labs, 115 Mill St, Belmont, MA 02178 USA.	hseo@hanyang.ac.kr; isacson@hms.harvard.edu	Kim, Woori/AAL-4146-2021; Sonntag, Kai-Christian/AAU-6921-2021	Isacson, Ole/0000-0001-8091-8302; Kim, Woori/0000-0002-7951-9280; CATTANEO, ELENA/0000-0002-0755-4917; Sonntag, Kai-Christian/0000-0001-7979-8171	NIH [NS-30064]; Vaughan Foundation; Korean Government (MOEHRD) [KRF-2005-202-C00230]; Hanyang University [HY-2005]; BK21 fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030064] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vaughan Foundation; Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Hanyang University; BK21 fellowship(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was primarily supported by NIH NS-30064 (to OI), the Vaughan Foundation (to OI), and in part by a KRF Grant funded by the Korean Government (MOEHRD) (KRF-2005-202-C00230) (to HS), Hanyang University (HY-2005) (to HS) and BK21 fellowship (to WK).	Bae Y, 2006, P NATL ACAD SCI USA, V103, P3405, DOI 10.1073/pnas.0511316103; Barton LF, 2004, J IMMUNOL, V172, P3948, DOI 10.4049/jimmunol.172.6.3948; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BEAL MF, 1988, J NEUROSCI, V8, P3901; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Demasi M, 2003, FEBS LETT, V542, P89, DOI 10.1016/S0014-5793(03)00353-3; DEVERAUX Q, 1995, J BIOL CHEM, V270, P29660; DIAZHERNANDEZ M, 2006, J NEUROCHEM; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 2005, METHOD ENZYMOL, V398, P329, DOI 10.1016/S0076-6879(05)98027-0; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Jacquard C, 2006, FASEB J, V20, P1021, DOI 10.1096/fj.05-5085fje; Kaytor MD, 2004, J NEUROCHEM, V89, P962, DOI 10.1111/j.1471-4159.2004.02376.x; Kisselev AF, 2003, J BIOL CHEM, V278, P35869, DOI 10.1074/jbc.M303725200; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kominami K, 1997, MOL BIOL CELL, V8, P171, DOI 10.1091/mbc.8.1.171; Layfield R, 2005, ESSAYS BIOCHEM, V41, P157, DOI 10.1042/EB0410157; Lee HG, 2003, BRAIN PATHOL, V13, P630; Li J, 2001, BIOCHIMIE, V83, P373, DOI 10.1016/S0300-9084(01)01236-6; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; Metere A, 2006, J NEUROCHEM, V97, P1327, DOI 10.1111/j.1471-4159.2006.03814.x; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Rechsteiner M, 2000, BIOCHEM J, V345, P1, DOI 10.1042/0264-6021:3450001; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; ROBERTS RC, 1989, SYNAPSE, V3, P363, DOI 10.1002/syn.890030410; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; SEO H, 2005, ANN C SOC NEUR; SIMPSON JR, 1993, EXP NEUROL, V121, P57, DOI 10.1006/exnr.1993.1071; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; YEE WM, 1993, EXP BRAIN RES, V94, P193; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	50	95	97	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e238	10.1371/journal.pone.0000238	http://dx.doi.org/10.1371/journal.pone.0000238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327906	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444600001
J	Boucard, CC; Hoogduin, JM; van der Grond, J; Cornelissen, FW				Boucard, Christine C.; Hoogduin, Johannes M.; van der Grond, Jeroen; Cornelissen, Frans W.			Occipital Proton Magnetic Resonance Spectroscopy (H-1-MRS) Reveals Normal Metabolite Concentrations in Retinal Visual Field Defects	PLOS ONE			English	Article								Background. Progressive visual field defects, such as age-related macular degeneration and glaucoma, prevent normal stimulation of visual cortex. We investigated whether in the case of visual field defects, concentrations of metabolites such as N-acetylaspartate (NAA), a marker for degenerative processes, are reduced in the occipital brain region. Methodology/ Principal Findings. Participants known with glaucoma, age-related macular degeneration (the two leading causes of visual impairment in the developed world), and controls were examined by proton MR spectroscopic (H-1-MRS) imaging. Absolute NAA, Creatine and Choline concentrations were derived from a single-voxel in the occipital region of each brain hemisphere. No significant differences in metabolites concentrations were found between the three groups. Conclusions/ Significance. We conclude that progressive retinal visual field defects do not affect metabolite concentration in visual brain areas suggesting that there is no ongoing occipital degeneration. We discuss the possibility that metabolite change is too slow to be detectable.	[Boucard, Christine C.; Hoogduin, Johannes M.; Cornelissen, Frans W.] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Boucard, Christine C.; Cornelissen, Frans W.] Univ Groningen, Univ Med Ctr Groningen, Lab Expt Ophthalmol, Groningen, Netherlands; [van der Grond, Jeroen] Univ Med Ctr Leiden, Dept Radiol, Leiden, Netherlands	University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC)	Boucard, CC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands.	joyce@brain.riken.jp		Boucard, Christine Claudia/0000-0003-2634-869X	University of Groningen; Cognition program of the Netherlands Organization for Scientific Research (NWO) [051.02.080]	University of Groningen; Cognition program of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Author CCB was supported by an Ubbo Emmius grant from the University of Groningen. FWC was supported by grant 051.02.080 of the Cognition program of the Netherlands Organization for Scientific Research (NWO).	Bjartmar C, 2002, ANN NEUROL, V51, P51, DOI 10.1002/ana.10052; Block W, 1998, ARCH NEUROL-CHICAGO, V55, P931, DOI 10.1001/archneur.55.7.931; Block W, 2002, AMINO ACIDS, V23, P317, DOI 10.1007/s00726-001-0144-0; Chan YL, 1999, J MAGN RESON IMAGING, V10, P130, DOI 10.1002/(SICI)1522-2586(199908)10:2<130::AID-JMRI4>3.0.CO;2-R; De Stefano N., 2000, Neurological Sciences, V21, pS883, DOI 10.1007/s100720070031; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; ETTL A, 1994, INT OPHTHALMOL, V18, P171, DOI 10.1007/BF00915968; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Gujar SK, 2005, J NEURO-OPHTHALMOL, V25, P217, DOI 10.1097/01.wno.0000177307.21081.81; Hashimoto M, 2004, JPN J OPHTHALMOL, V48, P353, DOI 10.1007/s10384-004-0086-7; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Jansonius NM, 2005, GRAEF ARCH CLIN EXP, V243, P433, DOI 10.1007/s00417-004-1065-x; Johansson Barbro B., 2004, Keio Journal of Medicine, V53, P231, DOI 10.2302/kjm.53.231; Karitzky J, 1999, ARCH NEUROL-CHICAGO, V56, P1465, DOI 10.1001/archneur.56.12.1465; Kuzniecky R, 2004, NEUROIMAG CLIN N AM, V14, P507, DOI 10.1016/j.nic.2004.04.010; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Nickells RW, 1996, J GLAUCOMA, V5, P345; PASSE TJ, 1995, PROG NEURO-PSYCHOPH, V19, P541, DOI 10.1016/0278-5846(95)00101-Z; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Schuff N, 1997, NEUROLOGY, V49, P1513, DOI 10.1212/WNL.49.6.1513; Sijens PE, 2006, EUR RADIOL, V16, P489, DOI 10.1007/s00330-005-2839-1; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Tedeschi G, 1997, BRAIN, V120, P1541, DOI 10.1093/brain/120.9.1541; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	25	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e222	10.1371/journal.pone.0000222	http://dx.doi.org/10.1371/journal.pone.0000222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311099	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444500003
J	Huang, GH; Xie, XJ; Han, Y; Fan, LF; Chen, J; Mou, CY; Guo, L; Liu, H; Zhang, QF; Chen, SW; Dong, ML; Liu, JZ; Xu, AL				Huang, Gonghua; Xie, Xiaojin; Han, Yan; Fan, Lifei; Chen, Jie; Mou, Chunyan; Guo, Lei; Liu, Hui; Zhang, Qinfen; Chen, Shangwu; Dong, Meiling; Liu, Jianzhong; Xu, Anlong			The Identification of Lymphocyte-Like Cells and Lymphoid-Related Genes in Amphioxus Indicates the Twilight for the Emergency of Adaptive Immune System	PLOS ONE			English	Article								To seek evidence of a primitive adaptive immune system (AIS) before vertebrate, we examined whether lymphocytes or lymphocyte-like cells and the related molecules participating in the lymphocyte function existed in amphioxus. Anatomical analysis by electron microscopy revealed the presence of lymphocyte-like cells in gills, and these cells underwent morphological changes in response to microbial pathogens that are reminiscent of those of mammalian lymphocytes executing immune response to microbial challenge. In addition, a systematic comparative analysis of our cDNA database of amphioxus identified a large number of genes whose vertebrate counterparts are involved in lymphocyte function. Among these genes, several genes were found to be expressed in the vicinity of the lymphocyte-like cells by in situ hybridization and up-regulated after exposure to microbial pathogens. Our findings in the amphioxus indicate the twilight for the emergency of AIS before the invertebrate-vertebrate transition during evolution.	[Huang, Gonghua; Xie, Xiaojin; Han, Yan; Fan, Lifei; Chen, Jie; Mou, Chunyan; Guo, Lei; Liu, Hui; Zhang, Qinfen; Chen, Shangwu; Dong, Meiling; Liu, Jianzhong; Xu, Anlong] Sun Yat Sen Univ, Coll Life Sci, Open Lab Marine Funct Genom State High Tech Dev P, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, AL (corresponding author), Sun Yat Sen Univ, Coll Life Sci, Open Lab Marine Funct Genom State High Tech Dev P, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn			Outstanding Young Scientist Award [39725007]; National Natural Science Foundation of China [30300264]; Ministry of Science and Technology of China [2004AA621030, 2003AA626010]; Ministry of Education, and Key Projects of Commission of Science and Technology of Guangdong Province and Guangzhou City [0107]	Outstanding Young Scientist Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education, and Key Projects of Commission of Science and Technology of Guangdong Province and Guangzhou City	"Outstanding Young Scientist Award'' (No. 39725007), and projects (No. 30300264) of National Natural Science Foundation of China, the projects 2004AA621030 and 2003AA626010 of State High-Tech Development Project (863) of the Ministry of Science and Technology of China, Key Project (0107) of Ministry of Education, and Key Projects of Commission of Science and Technology of Guangdong Province and Guangzhou City.	Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Allam A, 2005, IMMUNOL LETT, V97, P7, DOI 10.1016/j.imlet.2004.09.019; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Hagman J, 2005, TRENDS IMMUNOL, V26, P455, DOI 10.1016/j.it.2005.07.001; HAGMAN J, 1991, EMBO J, V10, P3409, DOI 10.1002/j.1460-2075.1991.tb04905.x; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Marshall AJ, 2002, MOL CELL BIOL, V22, P5479, DOI 10.1128/MCB.22.15.5479-5491.2002; Mayer WE, 2002, P NATL ACAD SCI USA, V99, P14350, DOI 10.1073/pnas.212527499; Mayer WE, 2002, SCAND J IMMUNOL, V55, P162, DOI 10.1046/j.1365-3083.2002.01026.x; Minguillon C, 2003, DEVELOPMENT, V130, P5903, DOI 10.1242/dev.00811; Mou CY, 2002, BIOCHEM BIOPH RES CO, V299, P74, DOI 10.1016/S0006-291X(02)02582-2; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; RHODES CP, 1982, SCIENCE, V217, P263, DOI 10.1126/science.7089565; Yu CL, 2005, J IMMUNOL, V174, P3493, DOI 10.4049/jimmunol.174.6.3493	20	39	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e206	10.1371/journal.pone.0000206	http://dx.doi.org/10.1371/journal.pone.0000206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299586	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444400007
J	Pietilainen, KH; Sysi-Aho, M; Rissanen, A; Seppanen-Laakso, T; Yki-Jarvinen, H; Kaprio, J; Oresic, M				Pietilainen, Kirsi H.; Sysi-Aho, Marko; Rissanen, Aila; Seppanen-Laakso, Tuulikki; Yki-Jarvinen, Hannele; Kaprio, Jaakko; Oresic, Matej			Acquired Obesity Is Associated with Changes in the Serum Lipidomic Profile Independent of Genetic Effects - A Monozygotic Twin Study	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; HUMAN ENDOTHELIAL-CELLS; ADIPOSE-TISSUE; LYSOPHOSPHATIDYLCHOLINE INCREASES; INSULIN-RESISTANCE; PLASMA; EXPRESSION; ACTIVATION; GLUCOSE; ALPHA	Both genetic and environmental factors are involved in the etiology of obesity and the associated lipid disturbances. We determined whether acquired obesity is associated with changes in global serum lipid profiles independent of genetic factors in young adult monozygotic (MZ) twins. 14 healthy MZ pairs discordant for obesity (10 to 25 kg weight difference) and ten weight concordant control pairs aged 24-27 years were identified from a large population-based study. Insulin sensitivity was assessed by the euglycemic clamp technique, and body composition by DEXA (% body fat) and by MRI (subcutaneous and intra-abdominal fat). Global characterization of lipid molecular species in serum was performed by a lipidomics strategy using liquid chromatography coupled to mass spectrometry. Obesity, independent of genetic influences, was primarily related to increases in lysophosphatidylcholines, lipids found in proinflammatory and proatherogenic conditions and to decreases in ether phospholipids, which are known to have antioxidant properties. These lipid changes were associated with insulin resistance, a pathogonomic characteristic of acquired obesity in these young adult twins. Our results show that obesity, already in its early stages and independent of genetic influences, is associated with deleterious alterations in the lipid metabolism known to facilitate atherogenesis, inflammation and insulin resistance.	[Sysi-Aho, Marko; Seppanen-Laakso, Tuulikki; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Pietilainen, Kirsi H.; Rissanen, Aila] Univ Helsinki, Dept Psychiat, Cent Hosp, Obes Res Unit, SF-00180 Helsinki, Finland; [Pietilainen, Kirsi H.; Yki-Jarvinen, Hannele] Univ Helsinki, Cent Hosp, Div Diabet, Dept Med, Helsinki, Finland; [Pietilainen, Kirsi H.; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Finnish Twin Cohort Study, Helsinki, Finland; [Kaprio, Jaakko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland	VTT Technical Research Center Finland; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finland National Institute for Health & Welfare	Oresic, M (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	matej.oresic@vtt.fi	Kaprio, Jaakko/A-1820-2008; Oresic, Matej/K-7673-2016; Oresic, Matej/AAV-3978-2020	Kaprio, Jaakko/0000-0002-3716-2455; Oresic, Matej/0000-0002-2856-9165; Pietilainen, Kirsi/0000-0002-8522-1288	National Institute on Alcohol Abuse and Alcoholism [AA-08315, AA-12502]; European Union; Academy of Finland [44069, 100499, 201461]; Academy of Finland Centre of Excellence in Complex Disease Genetics; Helsinki University Central Hospita; European Commission [LSHM-CT-2005-018734]; Yrjo Jahnsson; Jalmari Rauha Ahokas; Juho Vainio; Finnish Cultural; Finnish Medical Foundation; Research Foundation of the Orion Coorporation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012502, R01AA008315, R37AA012502] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); European Union(European Commission); Academy of Finland(Academy of Finland); Academy of Finland Centre of Excellence in Complex Disease Genetics(Academy of Finland); Helsinki University Central Hospita; European Commission(European CommissionEuropean Commission Joint Research Centre); Yrjo Jahnsson; Jalmari Rauha Ahokas; Juho Vainio; Finnish Cultural(Finnish Cultural Foundation); Finnish Medical Foundation; Research Foundation of the Orion Coorporation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by The National Institute on Alcohol Abuse and Alcoholism (grants AA-08315 and AA-12502), the European Union Fifth Framework Program (QLRT-1999-00916, QLG2-CT-2002-01254), the Academy of Finland (Grant 44069, 100499 and 201461), the Academy of Finland Centre of Excellence in Complex Disease Genetics, and Helsinki University Central Hospital grants. This work is part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome'' (HEPADIP, see http://www.hepadip.org/), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme (Contract LSHM-CT-2005-018734). KHP is supported by the following foundations: Yrjo Jahnsson, Jalmari & Rauha Ahokas, Juho Vainio, Finnish Cultural, Finnish Medical Foundation, and Research Foundation of the Orion Coorporation. The funding sources have not been involved in the design, analysis or interpretation of the results.	Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; CHAPKIN RS, 1992, BIOCHEM J, V287, P237, DOI 10.1042/bj2870237; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Damian D, 2007, METABOLOMICS, V3, P69, DOI 10.1007/s11306-006-0045-z; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; DESBUQUOIS B, 1971, J CLIN ENDOCR METAB, V33, P732, DOI 10.1210/jcem-33-5-732; DESPRES JP, 1992, MOL CELL BIOCHEM, V113, P151, DOI 10.1007/BF00231535; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Engelmann B, 2004, BIOCHEM SOC T, V32, P147, DOI 10.1042/BST0320147; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Farooqui AA, 2001, NEUROSCIENTIST, V7, P232, DOI 10.1177/107385840100700308; Ferguson LR, 2006, MOL DIAGN THER, V10, P101, DOI 10.1007/BF03256449; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GALILI O, 2006, AM J PHYSL IN PRESS; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gertow K, 2004, DIABETOLOGIA, V47, P1118, DOI 10.1007/s00125-004-1417-4; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Horrocks LA, 1999, PHARMACOL RES, V40, P211, DOI 10.1006/phrs.1999.0495; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang F, 2005, AM J PHYSIOL-LUNG C, V289, pL176, DOI 10.1152/ajplung.00003.2005; Inoue N, 2001, ATHEROSCLEROSIS, V155, P45, DOI 10.1016/S0021-9150(00)00530-X; KADISH AH, 1968, CLIN CHEM, V14, P116; Kannisto K, 2004, J CLIN ENDOCR METAB, V89, P4414, DOI 10.1210/jc.2004-0153; Kaprio J, 2002, TWIN RES, V5, P366, DOI 10.1375/136905202320906101; Kugiyama K, 1999, ATHEROSCLEROSIS, V143, P201, DOI 10.1016/S0021-9150(98)00288-3; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Lagarde M, 2003, BBA-MOL CELL BIOL L, V1634, P61, DOI 10.1016/j.bbalip.2003.11.002; Lin P, 2005, J IMMUNOL, V174, P2981, DOI 10.4049/jimmunol.174.5.2981; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MA DWL, 2004, FASEB J; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; McIntyre TM, 1999, J BIOL CHEM, V274, P25189, DOI 10.1074/jbc.274.36.25189; Motley ED, 2002, HYPERTENSION, V39, P508, DOI 10.1161/hy02t2.102907; Murohara T, 1996, CIRC RES, V78, P780, DOI 10.1161/01.RES.78.5.780; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; OHLSON LO, 1985, DIABETES, V34, P1055, DOI 10.2337/diabetes.34.10.1055; Oresic M, 2006, EXPERT REV MOL DIAGN, V6, P575, DOI 10.1586/14737159.6.4.575; Oresic Matej, 2004, Appl Bioinformatics, V3, P205; Pietilaien KH, 2004, TWIN RES, V7, P421; Pietilainen KH, 2005, AM J PHYSIOL-ENDOC M, V288, pE768, DOI 10.1152/ajpendo.00381.2004; Pietilainen KH, 2006, J CLIN ENDOCR METAB, V91, P2776, DOI 10.1210/jc.2005-2848; Pietilainen KH, 2006, OBESITY, V14, P826, DOI 10.1038/oby.2006.96; Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, pE941, DOI 10.1152/ajpendo.1996.271.6.E941; PORTMAN OW, 1973, BIOCHIM BIOPHYS ACTA, V326, P34, DOI 10.1016/0005-2760(73)90025-8; POULOS A, 1995, LIPIDS, V30, P1, DOI 10.1007/BF02537036; Qiao J, 2006, AM J PHYSIOL-LUNG C, V291, pL91, DOI 10.1152/ajplung.00508.2005; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; RABINI RA, 1994, DIABETES, V43, P915, DOI 10.2337/diabetes.43.7.915; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; SHALINA S, 2000, GLIA, V30, P92; Takabe W, 2004, ARTERIOSCL THROM VAS, V24, P1640, DOI 10.1161/01.ATV.0000134377.17680.26; Taskinen MR, 2005, CURR MOL MED, V5, P297, DOI 10.2174/1566524053766086; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wise B., 2005, PLS TOOLBOX 3 5 USE; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; YKIJARVINEN H, 1987, J CLIN INVEST, V79, P1713, DOI 10.1172/JCI113011; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769; Zoeller RA, 2002, AM J PHYSIOL-HEART C, V283, pH671, DOI 10.1152/ajpheart.00524.2001	67	316	322	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e218	10.1371/journal.pone.0000218	http://dx.doi.org/10.1371/journal.pone.0000218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299598	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444400019
J	Evangelou, E; Maraganore, DM; Ioannidis, JPA				Evangelou, Evangelos; Maraganore, Demetrius M.; Ioannidis, John P. A.			Meta-Analysis in Genome-Wide Association Datasets: Strategies and Application in Parkinson Disease	PLOS ONE			English	Article								Background. Genome-wide association studies hold substantial promise for identifying common genetic variants that regulate susceptibility to complex diseases. However, for the detection of small genetic effects, single studies may be underpowered. Power may be improved by combining genome-wide datasets with meta-analytic techniques. Methodology/Principal Findings. Both single and two-stage genome-wide data may be combined and there are several possible strategies. In the two-stage framework, we considered the options of (1) enhancement of replication data and (2) enhancement of first-stage data, and then, we also considered (3) joint meta-analyses including all first-stage and second-stage data. These strategies were examined empirically using data from two genome-wide association studies (three datasets) on Parkinson disease. In the three strategies, we derived 12, 5, and 49 single nucleotide polymorphisms that show significant associations at conventional levels of statistical significance. None of these remained significant after conservative adjustment for the number of performed analyses in each strategy. However, some may warrant further consideration: 6 SNPs were identified with at least 2 of the 3 strategies and 3 SNPs [rs1000291 on chromosome 3, rs2241743 on chromosome 4 and rs3018626 on chromosome 11] were identified with all 3 strategies and had no or minimal between-dataset heterogeneity (I-2 = 0, 0 and 15%, respectively). Analyses were primarily limited by the suboptimal overlap of tested polymorphisms across different datasets (e. g., only 31,192 shared polymorphisms between the two tier 1 datasets). Conclusions/Significance. Meta-analysis may be used to improve the power and examine the between-dataset heterogeneity of genome-wide association studies. Prospective designs may be most efficient, if they try to maximize the overlap of genotyping platforms and anticipate the combination of data across many genome-wide association studies.	[Evangelou, Evangelos; Ioannidis, John P. A.] Univ Ioannina, Sch Med, Clin & Mol Epidemiol Unit, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Maraganore, Demetrius M.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Tufts New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	University of Ioannina; Mayo Clinic; Foundation for Research & Technology - Hellas (FORTH); Tufts Medical Center; Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Clin & Mol Epidemiol Unit, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011; Evangelou, Evangelos/C-3033-2013; Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022	Evangelou, Evangelos/0000-0002-5488-2999; 	PENED; European Union	PENED(Greek Ministry of Development-GSRT); European Union(European Commission)	E. E. was funded in part by a PENED grant from the General Secretariat for Research and Technology, Greece and the European Union.	Ackerman SL, 1998, GENOMICS, V52, P205, DOI 10.1006/geno.1998.5425; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Cardon LR, 2006, SCIENCE, V314, P1403, DOI 10.1126/science.1136668; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Daiger SP, 2005, SCIENCE, V308, P362, DOI 10.1126/science.1111655; Elbaz A, 2006, LANCET NEUROL, V5, P917, DOI 10.1016/S1474-4422(06)70579-8; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2005, AM J EPIDEMIOL, V162, P302, DOI 10.1093/aje/kwi201; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ioannidis JPA, 2003, TRENDS MOL MED, V9, P135, DOI 10.1016/S1471-4914(03)00030-3; Jorgenson E, 2006, NAT REV GENET, V7, P885, DOI 10.1038/nrg1962; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Lin L, 2006, STEM CELLS, V24, P2504, DOI 10.1634/stemcells.2006-0119; LITTLE J, HUGENET HUGE REV HDB; Livesey FJ, 1997, MOL CELL NEUROSCI, V8, P417, DOI 10.1006/mcne.1997.0598; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Pettiti D, 1999, METAANALYSIS DECISIO; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; DBGAP DATABASE	35	60	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e196	10.1371/journal.pone.0000196	http://dx.doi.org/10.1371/journal.pone.0000196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17332845	Green Published, gold			2022-12-27	WOS:000207444300009
J	Mols, CMM; Visser, ME				Mols, Christel M. M.; Visser, Marcel E.			Great Tits (Parus major) Reduce Caterpillar Damage in Commercial Apple Orchards	PLOS ONE			English	Article								Alternative ways to control caterpillar pests and reduce the use of pesticides in apple orchards are in the interest of the environment, farmers and the public. Great tits have already been shown to reduce damage under high caterpillar density when breeding in nest boxes in an experimental apple orchard. We tested whether this reduction also occurs under practical conditions of Integrated Pest Management (IPM), as well as Organic Farming (OF), by setting up an area with nest boxes while leaving a comparable area as a control within 12 commercial orchards. We showed that in IPM orchards, but not in OF orchards, in the areas with breeding great tits, apples had 50% of the caterpillar damage of the control areas. Offering nest boxes to attract insectivorous passerines in orchards can thus lead to more limited pesticide use, thereby adding to the natural biological diversity in an agricultural landscape, while also being economically profitable to the fruit growers.	[Mols, Christel M. M.; Visser, Marcel E.] Netherlands Inst Ecol NIOO KNAW, Heteren, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Visser, ME (corresponding author), Netherlands Inst Ecol NIOO KNAW, Heteren, Netherlands.	m.visser@nioo.knaw.nl	Visser, Marcel E/A-9151-2009	Visser, Marcel E/0000-0002-1456-1939	The Technology Foundation STW [3844]	The Technology Foundation STW(Technologiestichting STW)	The Technology Foundation STW (code BBI. 3844), applied science division of NWO and the technology programme of the Ministry of Economic Affairs supported this research. The funders of the research have played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	BETTS MM, 1955, J ANIM ECOL, V24, P282, DOI 10.2307/1715; BLOMMERS LHM, 1994, ANNU REV ENTOMOL, V39, P213, DOI 10.1146/annurev.en.39.010194.001241; BRUNS H, 1960, BIRD STUDY, V7, P193; Cross JV, 1999, BIOCONTROL SCI TECHN, V9, P277, DOI 10.1080/09583159929569; DEREEDE RH, 1985, ENTOMOL EXP APPL, V37, P263, DOI 10.1007/BF00191658; Gosler A, 1993, GREAT TIT; Kirk David A., 1996, Current Ornithology, V13, P175; Mols CMM, 2005, ARDEA, V93, P259; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Naef-Daenzer B, 2000, ANIM BEHAV, V59, P989, DOI 10.1006/anbe.1999.1380; Otvos I. S., 1979, ROLE INSECTIVOROUS B, P341; ROYAMA T, 1966, IBIS, V108, P313, DOI 10.1111/j.1474-919X.1966.tb07348.x; Solomon MG, 2000, BIOCONTROL SCI TECHN, V10, P91, DOI 10.1080/09583150029260; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; VANBALEN JH, 1973, ARDEA, V61, P1	15	43	43	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e202	10.1371/journal.pone.0000202	http://dx.doi.org/10.1371/journal.pone.0000202			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17285148	Green Submitted, gold, Green Published			2022-12-27	WOS:000207444300013
J	Hetzer, C; Bisgrove, D; Cohen, MS; Pedal, A; Kaehlcke, K; Speyerer, A; Bartscherer, K; Taunton, J; Ott, M				Hetzer, Claudia; Bisgrove, Dwayne; Cohen, Michael S.; Pedal, Angelika; Kaehlcke, Katrin; Speyerer, Anja; Bartscherer, Kerstin; Taunton, Jack; Ott, Melanie			Recruitment and Activation of RSK2 by HIV-1 Tat	PLOS ONE			English	Article								The transcriptional activity of the integrated HIV provirus is dependent on the chromatin organization of the viral promoter and the transactivator Tat. Tat recruits the cellular pTEFb complex and interacts with several chromatin-modifying enzymes, including the histone acetyltransferases p300 and PCAF. Here, we examined the interaction of Tat with activation-dependent histone kinases, including the p90 ribosomal S6 kinase 2 (RSK2). Dominant-negative RSK2 and treatment with a small-molecule inhibitor of RSK2 kinase activity inhibited the transcriptional activity of Tat, indicating that RSK2 is important for Tat function. Reconstitution of RSK2 in cells from subjects with a genetic defect in RSK2 expression (Coffin-Lowry syndrome) enhanced Tat transactivation. Tat interacted with RSK2 and activated RSK2 kinase activity in cells. Both properties were lost in a mutant Tat protein (F38A) that is deficient in HIV transactivation. Our data identify a novel reciprocal regulation of Tat and RSK2 function, which might serve to induce early changes in the chromatin organization of the HIV LTR.	[Bisgrove, Dwayne; Pedal, Angelika; Kaehlcke, Katrin; Ott, Melanie] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Hetzer, Claudia; Speyerer, Anja; Bartscherer, Kerstin] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Cohen, Michael S.; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Francisco	Ott, M (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA.	mott@gladstone.ucsf.edu		Ott, Melanie/0000-0002-5697-1274	Searle Scholars Foundation; NIH; Helmholtz-Gemeinschaft deutscher Forschungszentren; Public Health Service [NIAID AI057179-02, NIAID AI065248-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI057179, R21AI065248] Funding Source: NIH RePORTER	Searle Scholars Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmholtz-Gemeinschaft deutscher Forschungszentren(Helmholtz Association); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Searle Scholars Foundation and the NIH to J. T. and grants from the Helmholtz-Gemeinschaft deutscher Forschungszentren and Public Health Service grants (NIAID AI057179-02 and NIAID AI065248-02) to M. O. The sponsors had no role in the study design, collection, analysis, and interpretation of data or the writing and submission of the manuscript.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bres V, 2002, EMBO J, V21, P6811, DOI 10.1093/emboj/cdf669; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Cheng N, 2002, MOL CANCER RES, V1, P2; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Col E, 2001, J BIOL CHEM, V276, P28179, DOI 10.1074/jbc.M101385200; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Davie James R, 2003, Sci STKE, V2003, pPE33; de la Fuente C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-14; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Dorr A, 2002, EMBO J, V21, P2715, DOI 10.1093/emboj/21.11.2715; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Fujinaga K, 1999, P NATL ACAD SCI USA, V96, P1285, DOI 10.1073/pnas.96.4.1285; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hanauer A, 2002, J MED GENET, V39, P705, DOI 10.1136/jmg.39.10.705; HAUBER J, 1987, P NATL ACAD SCI USA, V84, P6364, DOI 10.1073/pnas.84.18.6364; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; HERRMANN CH, 1993, VIROLOGY, V197, P601, DOI 10.1006/viro.1993.1634; Hotttiger MO, 1998, J VIROL, V72, P8252, DOI 10.1128/JVI.72.10.8252-8256.1998; Hsia SCV, 2002, MOL CELL BIOL, V22, P4043, DOI 10.1128/MCB.22.12.4043-4052.2002; Jacquot S, 1998, AM J HUM GENET, V63, P1631, DOI 10.1086/302153; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kaehlcke K, 2003, MOL CELL, V12, P167, DOI 10.1016/S1097-2765(03)00245-4; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Marzio G, 1998, P NATL ACAD SCI USA, V95, P13519, DOI 10.1073/pnas.95.23.13519; Merienne K, 2001, MOL CELL BIOL, V21, P7089, DOI 10.1128/MCB.21.20.7089-7096.2001; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neuveut C, 1996, J VIROL, V70, P5572, DOI 10.1128/JVI.70.8.5572-5581.1996; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; Poteet-Smith CE, 1999, J BIOL CHEM, V274, P22135, DOI 10.1074/jbc.274.32.22135; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; RICE AP, 1990, J VIROL, V64, P1864, DOI 10.1128/JVI.64.4.1864-1868.1990; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Swanson KD, 1999, J BIOL CHEM, V274, P3385, DOI 10.1074/jbc.274.6.3385; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Weissman JD, 1998, P NATL ACAD SCI USA, V95, P11601, DOI 10.1073/pnas.95.20.11601; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; YANG J, 1999, P INT S WEAR COMP SA, V1, P73; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; YOUNG ID, 1988, J MED GENET, V25, P344, DOI 10.1136/jmg.25.5.344; Zhou MS, 2004, J VIROL, V78, P13522, DOI 10.1128/JVI.78.24.13522-13533.2004; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	72	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e151	10.1371/journal.pone.0000151	http://dx.doi.org/10.1371/journal.pone.0000151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225856	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444000003
J	Warsame, M; Kimbute, O; Machinda, Z; Ruddy, P; Melkisedick, M; Peto, T; Ribeiro, I; Kitua, A; Tomson, G; Gomes, M				Warsame, Marian; Kimbute, Omari; Machinda, Zena; Ruddy, Patricia; Melkisedick, Majaha; Peto, Thomas; Ribeiro, Isabela; Kitua, Andrew; Tomson, Goran; Gomes, Melba			Recognition, Perceptions and Treatment Practices for Severe Malaria in Rural Tanzania: Implications for Accessing Rectal Artesunate as a Pre-Referral	PLOS ONE			English	Article							CLINICAL-FEATURES; INTEGRATED MANAGEMENT; PROGNOSTIC INDICATORS; TRADITIONAL HEALERS; CHILDHOOD MALARIA; TREATMENT SEEKING; TECHNICAL BASIS; HEALTH-WORKERS; CHILDREN; DISTRICT	Objectives. Preparatory to a community trial investigating how best to deliver rectal artesunate as pre-referral treatment for severe malaria; local understanding, perceptions of signs/symptoms of severe malaria and treatment-seeking patterns for and barriers to seeking biomedical treatment were investigated. Methodology/Principal Findings. 19 key informant interviews, 12 in-depth interviews and 14 focus group discussions targeting care-givers, opinion leaders, and formal and informal health care providers were conducted. Monthly fever episodes and danger signs or symptoms associated with severe malaria among under-fives were recorded. Respondents recognized convulsions, altered consciousness and coma, and were aware of their risks if not treated. But, these symptoms were perceived to be caused by supernatural forces, and traditional healers were identified as primary care providers. With some delay, mothers eventually visited a health facility when convulsions were part of the illness, despite pressures against this. Although vomiting and failure to eat/suck/drink were associated with malaria, they were not considered as indicators of danger signs unless combined with another more severe symptom. Study communities were familiar with rectal application of medicines. Conclusions/Significance. Communities' recognition and awareness of major symptoms of severe malaria could encourage action, but perceptions of their causes and poor discrimination of other danger signs - vomiting and failure to feed - might impede early treatment. An effective health education targeting parents/guardians, decision-makers/advisors, and formal and informal care providers might be a prerequisite for successful introduction of rectal artemisinins as an emergency treatment. Role of traditional healers in delivering such medication to the community should be explored.	[Warsame, Marian; Tomson, Goran] Karolinska Inst, Div Int Hlth IHCAR, Stockholm, Sweden; [Warsame, Marian; Kimbute, Omari; Machinda, Zena; Melkisedick, Majaha; Peto, Thomas] Natl Inst Med Res, Rectal Artesunate Study Team, Dar Es Salaam, Tanzania; [Ribeiro, Isabela; Gomes, Melba] United Nations Dev Programme UNDP World Bank WHO, Geneva, Switzerland	Karolinska Institutet; National Institute of Medical Research; World Health Organization	Warsame, M (corresponding author), Karolinska Inst, Div Int Hlth IHCAR, Stockholm, Sweden.	dahan2004@hotmail.com		Peto, Thomas/0000-0003-3197-9891; Tomson, Goran/0000-0001-9222-3604; Kimbute, Omari/0000-0002-0067-5783	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) Geneva, Switzerland	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) Geneva, Switzerland	This study received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) Geneva, Switzerland. Melba Gomes and Isabela Ribeiro are employed by this organization. Patricia Ruddy was provided with financial support as an external consultant to the study by the sponsor.	Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; AIKINS MK, 1993, T ROY SOC TROP MED H, V87, P25, DOI 10.1016/0035-9203(93)90172-M; [Anonymous], 2006, PLoS Med, V3, pe83; Armspach D, 2004, J IRAN CHEM SOC, V1, P10, DOI 10.1007/BF03245765; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Comoro C, 2003, ACTA TROP, V87, P305, DOI 10.1016/S0001-706X(03)00113-X; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; Gilroy K, 2004, PATIENT EDUC COUNS, V54, P35, DOI 10.1016/s0738-3991(03)00189-7; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Gove S, 1999, ARCH DIS CHILD, V81, P473, DOI 10.1136/adc.81.6.473; Hardon A.P., 2001, APPL HLTH RES ANTHR, V3rd; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Kaona FAD, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-28; KENGEYAKAYONDO JF, 1994, ACTA TROP, V58, P267, DOI 10.1016/0001-706X(94)90020-5; Makundi EA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-58; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; McCombie SC, 2002, HEALTH POLICY PLANN, V17, P333, DOI 10.1093/heapol/17.4.333; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; MOLYNEUX ME, 1989, Q J MED, V71, P441; *MORB MORT PROJ PH, 1997, POL IMPL AD MORB MOR, P197; MWENESI HA, 1995, J BIOSOC SCI, V27, P235, DOI 10.1017/S0021932000022720; Newton P, 2000, ANTIMICROB AGENTS CH, V44, P972, DOI 10.1128/AAC.44.4.972-977.2000; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Okeke TA, 2006, J BIOSOC SCI, V38, P491, DOI 10.1017/S002193200502660X; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; WALLER D, 1995, CLIN INFECT DIS, V21, P577, DOI 10.1093/clinids/21.3.577; WARRELL DA, 1989, J ROY SOC MED, V82, P44; *WHO, 2006, WHOHTMMAL20061108; Winch PJ, 2005, HEALTH POLICY PLANN, V20, P199, DOI 10.1093/heapol/czi027; Winch PJ, 1996, SOC SCI MED, V42, P1057, DOI 10.1016/0277-9536(95)00293-6; Winch PJ, 2002, HEALTH POLICY PLANN, V17, P345, DOI 10.1093/heapol/17.4.345; Zucker JR, 1997, B WORLD HEALTH ORGAN, V75, P97	35	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e149	10.1371/journal.pone.0000149	http://dx.doi.org/10.1371/journal.pone.0000149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225854	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000207444000001
J	Bacac, M; Provero, P; Mayran, N; Stehle, JC; Fusco, C; Stamenkovic, I				Bacac, Marina; Provero, Paolo; Mayran, Nathalie; Stehle, Jean-Christophe; Fusco, Carlo; Stamenkovic, Ivan			A Mouse Stromal Response to Tumor Invasion Predicts Prostate and Breast Cancer Patient Survival	PLOS ONE			English	Article								Primary and metastatic tumor growth induces host tissue responses that are believed to support tumor progression. Understanding the molecular changes within the tumor microenvironment during tumor progression may therefore be relevant not only for discovering potential therapeutic targets, but also for identifying putative molecular signatures that may improve tumor classification and predict clinical outcome. To selectively address stromal gene expression changes during cancer progression, we performed cDNA microarray analysis of laser-microdissected stromal cells derived from prostate intraepithelial neoplasia (PIN) and invasive cancer in a multistage model of prostate carcinogenesis. Human orthologs of genes identified in the stromal reaction to tumor progression in this mouse model were observed to be expressed in several human cancers, and to cluster prostate and breast cancer patients into groups with statistically different clinical outcomes. Univariate Cox analysis showed that overexpression of these genes is associated with shorter survival and recurrence-free periods. Taken together, our observations provide evidence that the expression signature of the stromal response to tumor invasion in a mouse tumor model can be used to probe human cancer, and to provide a powerful prognostic indicator for some of the most frequent human malignancies.	[Bacac, Marina; Mayran, Nathalie; Stehle, Jean-Christophe; Fusco, Carlo; Stamenkovic, Ivan] Inst Univ Pathol, Div Expt Pathol, Lausanne, Switzerland; [Provero, Paolo] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	University of Turin	Stamenkovic, I (corresponding author), Inst Univ Pathol, Div Expt Pathol, Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.hospvd.ch	Provero, Paolo/AAC-1930-2019; Fusco, Carlo/AAC-7332-2022		Swiss National Science Foundation (SNSF) [3100-65090.01]; Molecular Oncology National Centre of Competence in Research (NCCR)	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Molecular Oncology National Centre of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	Funding: This work was supported by the Swiss National Science Foundation (SNSF) grant 3100-65090.01 and a Molecular Oncology National Centre of Competence in Research (NCCR) grant. P. P. is a Lagrange Fellow of the CRT Foundation, Turin.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Garabedian EM, 1998, P NATL ACAD SCI USA, V95, P15382, DOI 10.1073/pnas.95.26.15382; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Hu Y, 2002, J BIOL CHEM, V277, P44462, DOI 10.1074/jbc.M205784200; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; Ippolito JE, 2005, P NATL ACAD SCI USA, V102, P9901, DOI 10.1073/pnas.0500756102; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Laurent-Matha V, 2005, J CELL BIOL, V168, P489, DOI 10.1083/jcb.200403078; Leung SY, 2002, P NATL ACAD SCI USA, V99, P16203, DOI 10.1073/pnas.212646299; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Littlepage LE, 2005, CANCER CELL, V7, P499, DOI 10.1016/j.ccr.2005.05.019; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nadji M, 1996, HUM PATHOL, V27, P890, DOI 10.1016/S0046-8177(96)90214-2; Nomura T, 2005, J MED INVESTIG, V52, P1, DOI 10.2152/jmi.52.1; Peeper D, 2006, CELL, V125, P1230, DOI 10.1016/j.cell.2006.06.018; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Skrzydlewska E, 2005, WORLD J GASTROENTERO, V11, P1251, DOI 10.3748/wjg.v11.i9.1251; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; Tfelt-Hansen J, 2006, CLIN MED RES, V4, P130, DOI 10.3121/cmr.4.2.130; Tinker AV, 2006, CANCER CELL, V9, P333, DOI 10.1016/j.ccr.2006.05.001; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	47	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e32	10.1371/journal.pone.0000032	http://dx.doi.org/10.1371/journal.pone.0000032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183660	Green Published, gold			2022-12-27	WOS:000207443600032
J	de Groot, P; Veldhuizen, RW				de Groot, Paul; Veldhuizen, R. W.			Human Coronary Artery Remodeling, Beginning and End of the Atherosclerotic Process	PLOS ONE			English	Article								Background, Aims of the Study. The objective of the study was to relate the progress of coronary artery remodeling to the earliest stages of the atherosclerotic process. For this purpose, a mathematical model for description of dimensional change of the coronary artery wall and its constituent components was developed and applied. Materials and Methods. The study used coronary artery samples randomly taken from each of 83 consecutive, unselected postmortems. All samples were routinely fixed and processed to paraffin for the preparation of right-angled, 5-micron sections, routinely stained and mounted for subsequent analysis. Computer assisted image analysis, using 32 systematic random, radial sampling lines, was used for interactive measurements of distance from centre of lumen to points defining intima, media and adventitia thickness along the radial intercept, which were subsequently tabled for analysis of variance, calculations of (group-vessel) means, and related to stage of pathology. Results. Pre-atherosclerotic changes, before any localised changes in especially intima dimensions, are found, consisting of a process of gradual vascular widening, associated with temporally at least partly dissociated increases in width, which as a fraction of total vessel radius show a phased process. In these, the intima first increases, subsequently remains stable, and finally reduces in width proportionally to the increasing diameter. The media shows a similar initial increase, on average stabilising in the third phase after reaching a plateau value in the second. The adventitia, already increasing in phase 1, continues to increase in phase 2, accelerating in phase 3. The complex process, as found, occurs systematically in all vessels, is distributed circumferentially, and precedes the development of localised lesions of the intima. Conclusions. The findings suggest the existence of a diffuse complex of changes, consisting of a gradual vascular widening followed by narrowing, with associated mural changes reflecting the atherosclerotic process.	[de Groot, Paul] MCH Hosp, Dept Cardiol, The Hague, Netherlands; [Veldhuizen, R. W.] MCH Hosp, Dept Pathol, The Hague, Netherlands		de Groot, P (corresponding author), MCH Hosp, Dept Cardiol, The Hague, Netherlands.	legrands@planet.nl						BOND MG, 1981, ARTERY, V9, P21; Clarijs JAGM, 1997, ARTERIOSCL THROM VAS, V17, P2617, DOI 10.1161/01.ATV.17.11.2617; DEGROOT P, 1994, THESIS LEIDEN U; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Herity NA, 1999, J CARDIOVASC ELECTR, V10, P1016, DOI 10.1111/j.1540-8167.1999.tb01273.x; Labropoulos N, 1998, AM J SURG, V176, P140, DOI 10.1016/S0002-9610(98)00135-4; Varnava AM, 2001, HEART, V86, P207, DOI 10.1136/heart.86.2.207; ZARINS CK, 1988, J VASC SURG, V7, P386, DOI 10.1067/mva.1988.avs0070386	8	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e91	10.1371/journal.pone.0000091	http://dx.doi.org/10.1371/journal.pone.0000091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183723	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600090
J	Martinez-Diez, M; Santamaria, G; Ortega, AD; Cuezva, JM				Martinez-Diez, Marta; Santamaria, Gema; Ortega, Alvaro D.; Cuezva, Jose M.			Biogenesis and Dynamics of Mitochondria during the Cell Cycle: Significance of 3 ' UTRs	PLOS ONE			English	Article								Nowadays, we are facing a renaissance of mitochondria in cancer biology. However, our knowledge of the basic cell biology and on the timing and mechanisms that control the biosynthesis of mitochondrial constituents during progression through the cell cycle of mammalian cells remain largely unknown. Herein, we document the in vivo changes on mitochondrial morphology and dynamics that accompany cellular mitosis, and illustrate the following key points of the biogenesis of mitochondria during progression of liver cells through the cycle: (i) the replication of nuclear and mitochondrial genomes is synchronized during cellular proliferation, (ii) the accretion of OXPHOS proteins is asynchronously regulated during proliferation being the synthesis of beta-F1-ATPase and Hsp60 carried out also at G2/M and, (iii) the biosynthesis of cardiolipin is achieved during the S phase, although full development of the mitochondrial membrane potential (Delta Psi m) is attained at G2/M. Furthermore, we demonstrate using reporter constructs that the mechanism regulating the accretion of beta-F1-ATPase during cellular proliferation is controlled at the level of mRNA translation by the 3'UTR of the transcript. The 3'UTR-driven synthesis of the protein at G2/M is essential for conferring to the daughter cells the original phenotype of the parental cell. Our findings suggest that alterations on this process may promote deregulated beta-F1-ATPase expression in human cancer.	[Martinez-Diez, Marta; Santamaria, Gema; Ortega, Alvaro D.; Cuezva, Jose M.] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Cuezva, JM (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jmcuezva@cbm.uam.es	Ortega, Alvaro Dario/K-5394-2018; Cuezva, Jose M/F-8381-2011; Cuezva, Jose M/AAR-5392-2020	Ortega, Alvaro Dario/0000-0003-0691-7154; Martinez Diez, Marta/0000-0001-5410-7207; Santamaria, Gema/0000-0002-5455-2754; Cuezva Marcos, Jose Manuel/0000-0003-1118-248X; Martinez-Diez, Marta/0000-0002-4095-8673	Ministerio de Sanidad [Pl041255]; Educacion y Ciencia [SAF-2005-4001, BMC2001-0710]; Fundacion Mutua Madrilena, Spain; Fundacion Ramon Areces	Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); Educacion y Ciencia; Fundacion Mutua Madrilena, Spain; Fundacion Ramon Areces	M-D, G. S. and A. D. O are/were recipients of predoctoral fellowships from the Ministerio de Educacion/Ciencia, Spain. This work was supported by grants from the Ministerio de Sanidad (Pl041255), Educacion y Ciencia SAF-2005-4001 and BMC2001-0710) and Fundacion Mutua Madrilena, Spain. The CBMSO is the recipient of an institutional grant from Fundacion Ramon Areces.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 1997, J BIOENERG BIOMEMBR, V29, P365, DOI 10.1023/A:1022450831360; Cuezva JM, 2002, CANCER RES, V62, P6674; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; de Heredia ML, 2000, J BIOL CHEM, V275, P7430, DOI 10.1074/jbc.275.10.7430; de Mena IR, 2000, J BIOL CHEM, V275, P13628, DOI 10.1074/jbc.275.18.13628; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Di Liegro CM, 2000, BIOCHEM J, V352, P109, DOI 10.1042/0264-6021:3520109; Egea G, 1997, BIOCHEM J, V322, P557, DOI 10.1042/bj3220557; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Isidoro A, 2004, BIOCHEM J, V378, P17, DOI 10.1042/BJ20031541; Izquierdo JM, 2005, ARCH BIOCHEM BIOPHYS, V433, P481, DOI 10.1016/j.abb.2004.10.007; Izquierdo JM, 2000, BIOCHEM J, V346, P849, DOI 10.1042/0264-6021:3460849; Izquierdo JM, 1997, MOL CELL BIOL, V17, P5255, DOI 10.1128/MCB.17.9.5255; IZQUIERDO JM, 1995, J BIOL CHEM, V270, P10342, DOI 10.1074/jbc.270.17.10342; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kim H, 2001, EXP CELL RES, V265, P339, DOI 10.1006/excr.2001.5207; KINDY MS, 1991, J CELL BIOCHEM, V46, P345, DOI 10.1002/jcb.240460409; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200; Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lithgow T, 1997, TRENDS BIOCHEM SCI, V22, P110, DOI 10.1016/S0968-0004(97)01007-4; LUCIAKOVA K, 1992, EUR J BIOCHEM, V207, P253, DOI 10.1111/j.1432-1033.1992.tb17045.x; LUIS AM, 1993, J BIOL CHEM, V268, P1868; LUNARDI J, 1991, J BIOL CHEM, V266, P16534; Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Margeot A, 2002, EMBO J, V21, P6893, DOI 10.1093/emboj/cdf690; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; Nishida K, 2005, MOL BIOL CELL, V16, P2493, DOI 10.1091/mbc.e05-01-0068; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Ostrander DB, 2001, J BIOL CHEM, V276, P25262, DOI 10.1074/jbc.M103689200; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; RADSAK K, 1978, EUR J BIOCHEM, V89, P3, DOI 10.1111/j.1432-1033.1978.tb20889.x; Reinke H, 2006, TRENDS BIOCHEM SCI, V31, P189, DOI 10.1016/j.tibs.2006.02.001; Ricart J, 1997, BIOCHEM J, V324, P635, DOI 10.1042/bj3240635; Ricart J, 2002, BIOCHEM J, V365, P417, DOI 10.1042/BJ20011726; Rojo G, 1998, J VIROL, V72, P7583, DOI 10.1128/JVI.72.9.7583-7588.1998; Sakamaki T, 2006, MOL CELL BIOL, V26, P5449, DOI 10.1128/MCB.02074-05; Santamaria G, 2006, CARCINOGENESIS, V27, P925, DOI 10.1093/carcin/bgi315; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Sweet S, 1999, J CELL PHYSIOL, V180, P91, DOI 10.1002/(SICI)1097-4652(199907)180:1<91::AID-JCP10>3.0.CO;2-6; Sylvestre J, 2003, MOL BIOL CELL, V14, P3848, DOI 10.1091/mbc.E03-02-0074; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; TVRDIK P, 1992, FEBS LETT, V313, P23, DOI 10.1016/0014-5793(92)81175-L; VALCARCE C, 1988, J BIOL CHEM, V263, P7767; VANDENBOGERT C, 1988, EXP CELL RES, V178, P143, DOI 10.1016/0014-4827(88)90385-0; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang CG, 2006, P NATL ACAD SCI USA, V103, P11567, DOI 10.1073/pnas.0603363103; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	77	89	93	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e107	10.1371/journal.pone.0000107	http://dx.doi.org/10.1371/journal.pone.0000107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17205111	Green Published, gold			2022-12-27	WOS:000207443600104
J	Matoba, R; Niwa, H; Masui, S; Ohtsuka, S; Carter, MG; Sharov, AA; Ko, MSH				Matoba, Ryo; Niwa, Hitoshi; Masui, Shinji; Ohtsuka, Satoshi; Carter, Mark G.; Sharov, Alexei A.; Ko, Minoru S. H.			Dissecting Oct3/4-Regulated Gene Networks in Embryonic Stem Cells by Expression Profiling	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SELF-RENEWAL; MOUSE EMBRYOS; AKT KINASE; POU-DOMAIN; ES CELLS; OCT-4; DIFFERENTIATION; PLURIPOTENCY; NANOG	POU transcription factor Pou5f1 (Oct3/4) is required to maintain ES cells in an undifferentiated state. Here we show that global expression profiling of Oct3/4-manipulated ES cells delineates the downstream target genes of Oct3/4. Combined with data from genome-wide chromatin-immunoprecipitation (ChIP) assays, this analysis identifies not only primary downstream targets of Oct3/4, but also secondary or tertiary targets. Furthermore, the analysis also reveals that downstream target genes are regulated either positively or negatively by Oct3/4. Identification of a group of genes that show both activation and repression depending on Oct3/4 expression levels provides a possible mechanism for the requirement of appropriate Oct3/4 expression to maintain undifferentiated ES cells. As a proof-of-principle study, one of the downstream genes, Tcl1, has been analyzed in detail. We show that Oct3/4 binds to the promoter region of Tcl1 and activates its transcription. We also show that Tcl1 is involved in the regulation of proliferation, but not differentiation, in ES cells. These findings suggest that the global expression profiling of gene-manipulated ES cells can help to delineate the structure and dynamics of gene regulatory networks.	[Matoba, Ryo; Carter, Mark G.; Sharov, Alexei A.; Ko, Minoru S. H.] NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA; [Niwa, Hitoshi; Masui, Shinji; Ohtsuka, Satoshi] RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Kobe, Hyogo, Japan	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); RIKEN	Ko, MSH (corresponding author), NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA.	kom@mail.nih.gov	Carter, Mark/B-5089-2010; Ko, Minoru S. H./B-7969-2009	Ko, Minoru S. H./0000-0002-3530-3015; Masui, Shinji/0000-0001-7417-0019	Intramural Research Program of the National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING [Z01AG000656, ZIAAG000656] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institute on Aging, NIH.	Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carter MG, 2003, GENOME RES, V13, P1011, DOI 10.1101/gr.878903; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; CAVALERI F, 2004, HDB STEM CELLS, P27; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Kang SM, 2005, BLOOD, V105, P1288, DOI 10.1182/blood-2004-04-1453; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kishimoto H, 2003, CELL STRUCT FUNCT, V28, P11; Kraft HJ, 1996, J BIOL CHEM, V271, P12873, DOI 10.1074/jbc.271.22.12873; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Narducci MG, 1997, ONCOGENE, V15, P919, DOI 10.1038/sj.onc.1201246; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 2003, BIOCHEM BIOPH RES CO, V302, P581, DOI 10.1016/S0006-291X(03)00218-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; PONGUBALA JMR, 1995, J BIOL CHEM, V270, P10304, DOI 10.1074/jbc.270.17.10304; Ramos-Mejia V, 2005, DEV DYNAM, V232, P180, DOI 10.1002/dvdy.20211; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Saijoh Y, 1996, GENES CELLS, V1, P239, DOI 10.1046/j.1365-2443.1996.d01-237.x; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; SHAROV AA, 2005, BIOINFORMATICS; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stewart C. L., 2002, Gene expression at the beginning of animal development, P205; SUDA Y, 1987, J CELL PHYSIOL, V133, P197, DOI 10.1002/jcp.1041330127; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; TAKEUCHI T, 2006, DEV DYN; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang GX, 2003, MOL CELL BIOL, V23, P6507, DOI 10.1128/MCB.23.18.6507-6519.2003	71	143	148	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e26	10.1371/journal.pone.0000026	http://dx.doi.org/10.1371/journal.pone.0000026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183653	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600026
J	Vigne, P; Frelin, C				Vigne, Paul; Frelin, Christian			A Low Protein Diet Increases the Hypoxic Tolerance in Drosophila	PLOS ONE			English	Article								Dietary restriction is well known to increase the life span of a variety of organisms from yeast to mammals, but the relationships between nutrition and the hypoxic tolerance have not yet been considered. Hypoxia is a major cause of cell death in myocardial infarction and stroke. Here we forced hypoxia-related death by exposing one-day-old male Drosophila to chronic hypoxia (5% O-2) and analysed their survival. Chronic hypoxia reduced the average life span from 33.6 days to 6.3 days when flies were fed on a rich diet. A demographic analysis indicated that chronic hypoxia increased the slope of the mortality trajectory and not the short-term risk of death. Dietary restriction produced by food dilution, by yeast restriction, or by amino acid restriction partially reversed the deleterious action of hypoxia. It increased the life span of hypoxic flies up to seven days, which represented about 25% of the life time of an hypoxic fly. Maximum survival of hypoxic flies required only dietary sucrose, and it was insensitive to drugs such as rapamycin and resveratrol, which increase longevity of normoxic animals. The results thus uncover a new link between protein nutrition, nutrient signalling, and resistance to hypoxic stresses.	[Vigne, Paul; Frelin, Christian] Fac Med Nice, INSERM, F-06034 Nice, France; [Vigne, Paul; Frelin, Christian] Univ Nice Sophia Antipolis, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Frelin, C (corresponding author), Fac Med Nice, INSERM, U210, F-06034 Nice, France.	cfrelin@unice.fr			Institut National de la Sante et de la Recherche Medicale; Federation pour la Recherche sur le Cerveau; University of Nice Sophia Antipolis	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Federation pour la Recherche sur le Cerveau; University of Nice Sophia Antipolis	This work was supported by the Institut National de la Sante et de la Recherche Medicale, Federation pour la Recherche sur le Cerveau, and the University of Nice Sophia Antipolis.	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Arquier N, 2006, BIOCHEM J, V393, P471, DOI 10.1042/BJ20050675; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; CARVALHO GB, 2005, NAT METH, V2, P755; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; HOLLINGS.MJ, 1970, J INSECT PHYSIOL, V16, P1017, DOI 10.1016/0022-1910(70)90195-2; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mattson Mark P, 2004, NeuroRx, V1, P111, DOI 10.1007/BF03206571; Min KJ, 2006, MECH AGEING DEV, V127, P93, DOI 10.1016/j.mad.2005.09.004; Min KJ, 2006, MECH AGEING DEV, V127, P643, DOI 10.1016/j.mad.2006.02.005; O'Farrell PH, 2001, J CLIN INVEST, V107, P671, DOI 10.1172/JCI12562; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; VANHERREWEGE J, 1974, EXP GERONTOL, V9, P191; Walker DW, 2006, CURR BIOL, V16, P674, DOI 10.1016/j.cub.2006.01.057; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	27	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e56	10.1371/journal.pone.0000056	http://dx.doi.org/10.1371/journal.pone.0000056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183686	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600056
J	Boucher, P; Li, WP; Matz, RL; Takayama, Y; Auwerx, J; Anderson, RGW; Herz, J				Boucher, Philippe; Li, Wei-Ping; Matz, Rachel L.; Takayama, Yoshiharu; Auwerx, Johan; Anderson, Richard G. W.; Herz, Joachim			LRP1 Functions as an Atheroprotective Integrator of TGF beta and PDGF Signals in the Vascular Wall: Implications for Marfan Syndrome	PLOS ONE			English	Article								Background. The multifunctional receptor LRP1 controls expression, activity and trafficking of the PDGF receptor-beta in vascular smooth muscle cells (VSMC). LRP1 is also a receptor for TGF beta 1 and is required for TGF beta mediated inhibition of cell proliferation. Methods and Principal Findings. We show that loss of LRP1 in VSMC (smLRP(-)) in vivo results in a Marfan-like syndrome with nuclear accumulation of phosphorylated Smad2/3, disruption of elastic layers, tortuous aorta, and increased expression of the TGFb target genes thrombospondin-1 (TSP1) and PDGFR beta in the vascular wall. Treatment of smLRP1(-) animals with the PPAR gamma agonist rosiglitazone abolished nuclear pSmad accumulation, reversed the Marfan-like phenotype, and markedly reduced smooth muscle proliferation, fibrosis and atherosclerosis independent of plasma cholesterol levels. Conclusions and Significance. Our findings are consistent with an activation of TGF beta signals in the LRP1-deficient vascular wall. LRP1 may function as an integrator of proliferative and anti-proliferative signals that control physiological mechanisms common to the pathogenesis of Marfan syndrome and atherosclerosis, and this is essential for maintaining vascular wall integrity.	[Boucher, Philippe; Takayama, Yoshiharu; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Boucher, Philippe; Matz, Rachel L.] Inst Gilbert Laustriat, UMR 7175, LC 1, Dept Pharmacol, Illkirch Graffenstaden, France; [Li, Wei-Ping; Anderson, Richard G. W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Auwerx, Johan] Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Herz, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	joachim.herz@utsouthwestern.edu	Takayama, Yoshiharu/M-8826-2019; 黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022; Auwerx, Johan/ABE-9307-2021; Takayama, Yoshiharu/E-3662-2010	Takayama, Yoshiharu/0000-0003-4532-7114; Takayama, Yoshiharu/0000-0003-4532-7114; Auwerx, Johan/0000-0002-5065-5393; MATZ, Rachel/0000-0001-5832-7063; Boucher, Philippe/0000-0002-3928-9812	Fondation pour la Recherche Medicale, Fondation de France; Conseil Scientifique de l'Universite Louis Pasteur de Strasbourg; National Institutes of Health [HL20948, HL63762, NS43408]; Perot Family Foundation; Humboldt Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, P01HL020948, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043408] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale, Fondation de France(Fondation de FranceFondation pour la Recherche Medicale); Conseil Scientifique de l'Universite Louis Pasteur de Strasbourg; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from, Fondation pour la Recherche Medicale, Fondation de France, Conseil Scientifique de l'Universite Louis Pasteur de Strasbourg, the National Institutes of Health (HL20948, HL63762, NS43408), and the Perot Family Foundation. J.H. is an Established Investigator of the American Heart Association and Parke-Davis and is the recipient of a Wolfgang-Paul Award from the Humboldt Foundation. None of the sponsors has placed any restrictions on the work or its publication.	BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; Boileau C, 2005, CURR OPIN CARDIOL, V20, P194, DOI 10.1097/01.hco.0000162398.21972.cd; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Fan WH, 2000, EUR J CELL BIOL, V79, P915, DOI 10.1078/0171-9335-00122; Fu MG, 2001, J BIOL CHEM, V276, P45888, DOI 10.1074/jbc.M105490200; Gao BB, 2006, BIOCHEM J, V397, P337, DOI 10.1042/BJ20060095; Ghosh AK, 2004, ARTHRITIS RHEUM-US, V50, P1305, DOI 10.1002/art.20104; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Ikuno Y, 2002, INVEST OPHTH VIS SCI, V43, P41; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kaartinen V, 2003, NAT GENET, V33, P331, DOI 10.1038/ng0303-331; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Law RE, 1996, J CLIN INVEST, V98, P1897, DOI 10.1172/JCI118991; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Liu QJ, 1997, J BIOL CHEM, V272, P18891, DOI 10.1074/jbc.272.30.18891; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Morosetti R, 2004, INT J ONCOL, V25, P493; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Taylor LM, 2000, J BIOL CHEM, V275, P16709, DOI 10.1074/jbc.275.22.16709; Tseng WF, 2004, FEBS LETT, V562, P71, DOI 10.1016/S0014-5793(04)00185-1; Yu Q, 2000, GENE DEV, V14, P163; Zirlik A, 2004, THROMB HAEMOSTASIS, V91, P674, DOI 10.1160/TH03-06-0384	45	93	94	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e448	10.1371/journal.pone.0000448	http://dx.doi.org/10.1371/journal.pone.0000448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505534	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445900008
J	Maye, A; Hsieh, CH; Sugihara, G; Brembs, B				Maye, Alexander; Hsieh, Chih-Hao; Sugihara, George; Brembs, Bjoern			Order in Spontaneous Behavior	PLOS ONE			English	Article							VISUAL FLIGHT ORIENTATION; DROSOPHILA-MELANOGASTER; NONLINEAR DYNAMICS; DECISION-MAKING; TIME-SERIES; PRISONERS-DILEMMA; OPERANT-BEHAVIOR; SEARCH PATTERNS; YAW TORQUE; FRUIT-FLY	Brains are usually described as input/output systems: they transform sensory input into motor output. However, the motor output of brains (behavior) is notoriously variable, even under identical sensory conditions. The question of whether this behavioral variability merely reflects residual deviations due to extrinsic random noise in such otherwise deterministic systems or an intrinsic, adaptive indeterminacy trait is central for the basic understanding of brain function. Instead of random noise, we find a fractal order (resembling Levy flights) in the temporal structure of spontaneous flight maneuvers in tethered Drosophila fruit flies. Levy-like probabilistic behavior patterns are evolutionarily conserved, suggesting a general neural mechanism underlying spontaneous behavior. Drosophila can produce these patterns endogenously, without any external cues. The fly's behavior is controlled by brain circuits which operate as a nonlinear system with unstable dynamics far from equilibrium. These findings suggest that both general models of brain function and autonomous agents ought to include biologically relevant nonlinear, endogenous behavior-initiating mechanisms if they strive to realistically simulate biological brains or out-compete other agents.	[Brembs, Bjoern] Free Univ Berlin, Inst Biol Neurobiol, D-1000 Berlin, Germany; [Maye, Alexander] Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, Inst Neurophysiol & Pathophysiol, Hamburg, Germany; [Hsieh, Chih-Hao; Sugihara, George] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Free University of Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of California System; University of California San Diego; Scripps Institution of Oceanography	Brembs, B (corresponding author), Free Univ Berlin, Inst Biol Neurobiol, D-1000 Berlin, Germany.	bjoern@brembs.net	Hsieh, Chih-hao/B-3797-2008; Brembs, Björn/A-9970-2008	Hsieh, Chih-hao/0000-0001-5935-7272; Brembs, Björn/0000-0001-7824-7650	DFG [BR 1893/3-2]	DFG(German Research Foundation (DFG))	Supported by the DFG (BR 1893/3-2)	Abbott A, 2007, NATURE, V445, P250, DOI 10.1038/445250a; Ashwin P, 2005, NATURE, V436, P36, DOI 10.1038/436036b; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barinaga M, 1996, SCIENCE, V274, P344, DOI 10.1126/science.274.5286.344; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Belanger JH, 1996, ADAPT BEHAV, V4, P217, DOI 10.1177/105971239600400302; Boeddeker N, 2005, J EXP BIOL, V208, P1563, DOI 10.1242/jeb.01558; Boeddeker N, 2003, P ROY SOC B-BIOL SCI, V270, P1971, DOI 10.1098/rspb.2003.2463; Bongard J, 2006, SCIENCE, V314, P1118, DOI 10.1126/science.1133687; Brembs B, 1996, OIKOS, V76, P14, DOI 10.2307/3545744; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Brembs B, 2006, LEARN MEMORY, V13, P618, DOI 10.1101/lm.318606; Brembs B, 2006, LEARN MEMORY, V13, P629, DOI 10.1101/lm.319406; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; BULTHOFF H, 1979, NATURE, V278, P636, DOI 10.1038/278636a0; COLE BJ, 1995, ANIM BEHAV, V50, P1317, DOI 10.1016/0003-3472(95)80047-6; COX DR, 1955, J ROY STAT SOC B, V17, P129; Cox DR, 1980, MONOGRAPHS APPL PROB; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Darbin O, 2006, BRAIN RES, V1118, P84, DOI 10.1016/j.brainres.2006.08.027; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Faure P, 2001, CR ACAD SCI III-VIE, V324, P773, DOI 10.1016/S0764-4469(01)01377-4; Keller EF, 2007, NATURE, V445, P603, DOI 10.1038/445603a; Franceschini N, 2007, CURR BIOL, V17, P329, DOI 10.1016/j.cub.2006.12.032; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Frye MA, 2004, CURR OPIN NEUROBIOL, V14, P729, DOI 10.1016/j.conb.2004.10.004; Garland B., 2004, NEUROSCIENCE LAW BRA; Glimcher PW, 2005, ANNU REV PSYCHOL, V56, P25, DOI 10.1146/annurev.psych.55.090902.141429; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Greene J, 2004, PHILOS T R SOC B, V359, P1775, DOI 10.1098/rstb.2004.1546; Greenspan RJ, 2005, CURR BIOL, V15, pR671, DOI 10.1016/j.cub.2005.08.018; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; Heisenberg M, 2001, LEARN MEMORY, V8, P1, DOI 10.1101/lm.8.1.1; HEISENBERG M, 1988, J COMP PHYSIOL A, V163, P373, DOI 10.1007/BF00604013; Heisenberg M., 1993, Reviews of Oculomotor Research, V5, P265; Heisenberg M., 1994, Life Sciences Research Report, V55, P147; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; Heisenberg M., 1984, VISION DROSOPHILA GE, P1; Heisenberg W., 1930, PHYS PRINCIPLES QUAN; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Jablonski PG, 2001, BRAIN BEHAV EVOLUT, V58, P218, DOI 10.1159/000057565; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Krechevsky I, 1937, J COMP PSYCHOL, V23, P139, DOI 10.1037/h0056131; Krichmar JL, 2005, P NATL ACAD SCI USA, V102, P2111, DOI 10.1073/pnas.0409792102; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; Laplace P., 1825, ESSAI PHILOS PROBABI; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Li JS, 2002, REV NEUROSCIENCE, V13, P31; LOWEN SB, 1991, PHYS REV A, V43, P4192, DOI 10.1103/PhysRevA.43.4192; Lowen SB, 2001, METHODS, V24, P377, DOI 10.1006/meth.2001.1207; Lum CS, 2005, J NEUROPHYSIOL, V94, P2427, DOI 10.1152/jn.00280.2005; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Malescio G, 2005, NATURE, V434, P1073, DOI 10.1038/4341073a; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Martin JR, 2001, J NEUROGENET, V15, P205, DOI 10.3109/01677060109167377; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mauk MD, 2000, NAT NEUROSCI, V3, P649, DOI 10.1038/76606; MAYER M, 1988, J COMP PHYSIOL A, V163, P389, DOI 10.1007/BF00604014; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; Miller G. F., 1997, MACHIAVELLIAN INTELL, P312, DOI [10.1017/CBO9780511525636.013, DOI 10.1017/CBO9780511525636.013]; Mobbs D, 2007, PLOS BIOL, V5, P693, DOI 10.1371/journal.pbio.0050103; Nepomnyashchikh VA, 2003, ADAPT BEHAV, V11, P245, DOI 10.1177/1059712303114002; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Pavlov I.P., 1927, CONDITIONED REFLEXES; Platt ML, 2004, NAT NEUROSCI, V7, P319, DOI 10.1038/nn0404-319; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schrodinger E, 1944, WHAT IS LIFE; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Shannon C.E., 1963, MATH THEORY COMMUNIC; Shultz S, 2006, BIOL LETTERS, V2, P505, DOI 10.1098/rsbl.2006.0519; Skinner B. F, 1974, BEHAVIORISM, V1st; Smolen P, 2000, NEURON, V26, P567, DOI 10.1016/S0896-6273(00)81194-0; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Sugihara G, 1999, P NATL ACAD SCI USA, V96, P14210, DOI 10.1073/pnas.96.25.14210; SUGIHARA G, 1990, PHILOS T R SOC B, V330, P235, DOI 10.1098/rstb.1990.0195; Tammero LF, 2002, J EXP BIOL, V205, P327; Teich MC, 2000, IEEE J SEL TOP QUANT, V6, P1450, DOI 10.1109/2944.902200; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Tu SJ, 2005, INT J MOD PHYS C, V16, P281, DOI 10.1142/S0129183105007091; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2001, PHYSICA A, V295, P85, DOI 10.1016/S0378-4371(01)00057-7; Viswanathan GM, 2001, BRAZ J PHYS, V31, P102, DOI 10.1590/S0103-97332001000100018; WALES DJ, 1991, NATURE, V350, P485, DOI 10.1038/350485a0; Webb B, 2002, NATURE, V417, P359, DOI 10.1038/417359a; WOLF R, 1990, J COMP PHYSIOL A, V167, P269, DOI 10.1007/BF00188119; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; [No title captured]; [No title captured]; [No title captured]; [No title captured]	102	162	162	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e443	10.1371/journal.pone.0000443	http://dx.doi.org/10.1371/journal.pone.0000443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505542	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445900003
J	Yang, JM; Chen, YF; Tu, YY; Yen, KR; Yang, YL				Yang, Jinn-Moon; Chen, Yan-Fu; Tu, Yu-Yin; Yen, Kuei-Rong; Yang, Yun-Liang			Combinatorial Computational Approaches to Identify Tetracycline Derivatives as Flavivirus Inhibitors	PLOS ONE			English	Article							GENERIC EVOLUTIONARY METHOD; VIRUS ENVELOPE PROTEIN; WEST-NILE-VIRUS; ENCEPHALITIS-VIRUS; MOLECULAR-BIOLOGY; STRUCTURAL BASIS; NEUROVIRULENCE; EPIDEMIOLOGY; ANTIBIOTICS; INFECTIONS	Limited structural information of drug targets, cellular toxicity possessed by lead compounds, and large amounts of potential leads are the major issues facing the design-oriented approach of discovering new leads. In an attempt to tackle these issues, we have developed a process of virtual screening based on the observation that conformational rearrangements of the dengue virus envelope protein are essential for the mediation of viral entry into host cells via membrane fusion. Screening was based solely on the structural information of the Dengue virus envelope protein and was focused on a target site that is presumably important for the conformational rearrangements necessary for viral entry. To circumvent the issue of lead compound toxicity, we performed screening based on molecular docking using structural databases of medical compounds. To enhance the identification of hits, we further categorized and selected candidates according to their novel structural characteristics. Finally, the selected candidates were subjected to a biological validation assay to assess inhibition of Dengue virus propagation in mammalian host cells using a plaque formation assay. Among the 10 compounds examined, rolitetracycline and doxycycline significantly inhibited plaque formation, demonstrating their inhibitory effect on dengue virus propagation. Both compounds were tetracycline derivatives with IC(50)s estimated to be 67.1 mu M and 55.6 mu M, respectively. Their docked conformations displayed common hydrophobic interactions with critical residues that affected membrane fusion during viral entry. These interactions will therefore position the tetracyclic ring moieties of both inhibitors to bind firmly to the target and, subsequently, disrupt conformational rearrangement and block viral entry. This process can be applied to other drug targets in which conformational rearrangement is critical to function.	[Yang, Jinn-Moon; Chen, Yan-Fu; Tu, Yu-Yin; Yen, Kuei-Rong; Yang, Yun-Liang] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yang, Jinn-Moon] Natl Chiao Tung Univ, Inst Bioinformat, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Yang, YL (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	yyang@mail.nctu.edu.tw	Yang, Jinn-Moon/AAU-4400-2021; Yang, Jinn-Moon/E-8287-2011	Yang, Jinn-Moon/0000-0002-3205-4391	National Chiao Tung University [95W821]; Academia Sinica [AS91IMB7PP]; National Science Council; University System at Taiwan-Veteran General Hospital	National Chiao Tung University; Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); University System at Taiwan-Veteran General Hospital	Y.-L. Yang, Y.-Y. Tu, and K.-R. Yen, are supported by National Chiao Tung University under the MoE ATU plan, grant 95W821, and Academia Sinica under grant AS91IMB7PP. J.-M. Yang and Y.-F. Chen are both supported by the National Science Council and a grant from the University System at Taiwan-Veteran General Hospital.	[Anonymous], FIELDS VIROLOGY; Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721; Bissantz C, 2000, J MED CHEM, V43, P4759, DOI 10.1021/jm001044l; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Chiu MW, 2003, BIOCHEM BIOPH RES CO, V309, P672, DOI 10.1016/j.bbrc.2003.08.053; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Connell SR, 2003, ANTIMICROB AGENTS CH, V47, P3675, DOI 10.1128/AAC.47.12.3675-3681.2003; Ghosh S, 2006, CURR OPIN CHEM BIOL, V10, P194, DOI 10.1016/j.cbpa.2006.04.002; Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001; Guirakhoo F, 2004, J VIROL, V78, P9998, DOI 10.1128/JVI.78.18.9998-10008.2004; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Hurrelbrink RJ, 2001, J VIROL, V75, P7692, DOI 10.1128/JVI.75.16.7692-7702.2001; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570; Leyssen P, 2000, CLIN MICROBIOL REV, V13, P67, DOI 10.1128/CMR.13.1.67-82.2000; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Monath TP, 2002, J VIROL, V76, P1932, DOI 10.1128/JVI.76.4.1932-1943.2002; Orth P, 2000, NAT STRUCT BIOL, V7, P215; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Serafin IL, 2001, ARCH VIROL, V146, P2469, DOI 10.1007/s007050170017; Shen M, 2002, J MED CHEM, V45, P2811, DOI 10.1021/jm010488u; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Yang JM, 2005, J CHEM INF MODEL, V45, P1134, DOI 10.1021/ci050034w; Yang JM, 2005, PROTEINS, V59, P205, DOI 10.1002/prot.20387; Yang JM, 2004, LECT NOTES COMPUT SC, V3102, P481; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Yang JM, 2004, J COMPUT CHEM, V25, P843, DOI 10.1002/jcc.20013	34	75	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e428	10.1371/journal.pone.0000428	http://dx.doi.org/10.1371/journal.pone.0000428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17502914	Green Submitted, gold, Green Published			2022-12-27	WOS:000207445800010
J	Stockholm, D; Benchaouir, R; Picot, J; Rameau, P; Neildez, TMA; Landini, G; Laplace-Builhe, C; Paldi, A				Stockholm, Daniel; Benchaouir, Rachid; Picot, Julien; Rameau, Philippe; Neildez, Thi My Anh; Landini, Gabriel; Laplace-Builhe, Corinne; Paldi, Andras			The Origin of Phenotypic Heterogeneity in a Clonal Cell Population In Vitro	PLOS ONE			English	Article								Background. The spontaneous emergence of phenotypic heterogeneity in clonal populations of mammalian cells in vitro is a rule rather than an exception. We consider two simple, mutually non-exclusive models that explain the generation of diverse cell types in a homogeneous population. In the first model, the phenotypic switch is the consequence of extrinsic factors. Initially identical cells may become different because they encounter different local environments that induce adaptive responses. According to the second model, the phenotypic switch is intrinsic to the cells that may occur even in homogeneous environments. Principal Findings. We have investigated the "extrinsic" and the "intrinsic" mechanisms using computer simulations and experimentation. First, we simulated in silico the emergence of two cell types in a clonal cell population using a multiagent model. Both mechanisms produced stable phenotypic heterogeneity, but the distribution of the cell types was different. The "intrinsic" model predicted an even distribution of the rare phenotype cells, while in the "extrinsic" model these cells formed small clusters. The key predictions of the two models were confronted with the results obtained experimentally using a myogenic cell line. Conclusions. The observations emphasize the importance of the "ecological" context and suggest that, consistently with the "extrinsic" model, local stochastic interactions between phenotypically identical cells play a key role in the initiation of phenotypic switch. Nevertheless, the "intrinsic" model also shows some other aspects of reality: The phenotypic switch is not triggered exclusively by the local environmental variations, but also depends to some extent on the phenotypic intrinsic robustness of the cells.	[Stockholm, Daniel; Benchaouir, Rachid; Picot, Julien; Rameau, Philippe; Neildez, Thi My Anh; Laplace-Builhe, Corinne; Paldi, Andras] GENETHON, CNRS, UMR 8115, Evry, France; [Neildez, Thi My Anh; Paldi, Andras] Ecole Prat Hautes Etud, Paris, France; [Landini, Gabriel] Univ Birmingham, Sch Dent, Oral Pathol Unit, Birmingham, W Midlands, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Birmingham	Paldi, A (corresponding author), GENETHON, CNRS, UMR 8115, Evry, France.	paldi@genethon.fr	Paldi, Andras/J-5757-2013; Stockholm, Daniel/J-7912-2013; Neildez, Thi My Anh/J-6900-2013; LAPLACE-BUILHE, Corinne/ABD-4479-2020	Landini, Gabriel/0000-0002-9689-0989; LAPLACE-BUILHE, Corinne/0000-0003-2885-6073	Association Francaise contre les Myopathies, Genopole (Evry); Conseil Regional de l'Essonne; Fondation pour la Recherche Medicale	Association Francaise contre les Myopathies, Genopole (Evry)(Association Francaise contre les Myopathies); Conseil Regional de l'Essonne; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was funded by the Association Francaise contre les Myopathies, Genopole (Evry), Conseil Regional de l'Essonne and the Fondation pour la Recherche Medicale.	ACKLIN SE, 1993, DEVELOPMENT, V118, P175; Avery SV, 2005, TRENDS MICROBIOL, V13, P459, DOI 10.1016/j.tim.2005.08.006; Benchaouir R, 2004, EXP CELL RES, V294, P254, DOI 10.1016/j.yexcr.2003.11.005; BENCHAOUIR RP, 2006, CYTOMETRY A IN PRESS; Czirok A, 1998, PHYS REV LETT, V81, P3038, DOI 10.1103/PhysRevLett.81.3038; Decraene C, 2005, PHYSIOL GENOMICS, V23, P132, DOI 10.1152/physiolgenomics.00141.2004; Furusawa C, 2006, INT J DEV BIOL, V50, P223, DOI 10.1387/ijdb.052051cf; KO EP, 1994, PHYSICA D, V75, P81, DOI 10.1016/0167-2789(94)90276-3; KUPIEC JJ, 1983, SPECULAT SCI TECHNOL, V6, P471; Laforge B, 2005, PROG BIOPHYS MOL BIO, V89, P93, DOI 10.1016/j.pbiomolbio.2004.11.004; LAVROVSKY VA, 1992, EUR J CANCER, V28A, P17, DOI 10.1016/0959-8049(92)90375-C; LI H, 1994, J CELL BIOL, V124, P827, DOI 10.1083/jcb.124.5.827; Loeffler M, 2004, CURR OPIN HEMATOL, V11, P81, DOI 10.1097/01.moh.0000133648.83991.af; Mombach JCM, 1996, PHYS REV LETT, V76, P3032, DOI 10.1103/PhysRevLett.76.3032; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Paldi A, 2003, CELL MOL LIFE SCI, V60, P1775, DOI 10.1007/s00018-003-23147-z; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Rubin H, 2005, P NATL ACAD SCI USA, V102, P9276, DOI 10.1073/pnas.0503688102; RUBIN H, 1993, P NATL ACAD SCI USA, V90, P10715, DOI 10.1073/pnas.90.22.10715; Rubin H, 2001, CANCER RES, V61, P799; RUBIN H, 1993, DIFFERENTIATION, V53, P123, DOI 10.1111/j.1432-0436.1993.tb00652.x; Soto AM, 2004, BIOESSAYS, V26, P1097, DOI 10.1002/bies.20087; Sun C, 1996, EUR J CANCER, V32A, P322, DOI 10.1016/0959-8049(95)00581-1; WEBSTER C, 1988, EXP CELL RES, V174, P252, DOI 10.1016/0014-4827(88)90159-0	24	63	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e394	10.1371/journal.pone.0000394	http://dx.doi.org/10.1371/journal.pone.0000394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460761	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445600008
J	Kothapalli, KSD; Anthony, JC; Pan, BS; Hsieh, AT; Nathanielsz, PW; Brenna, JT				Kothapalli, Kumar S. D.; Anthony, Joshua C.; Pan, Bruce S.; Hsieh, Andrea T.; Nathanielsz, Peter W.; Brenna, J. Thomas			Differential Cerebral Cortex Transcriptomes of Baboon Neonates Consuming Moderate and High Docosahexaenoic Acid Formulas	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; KERATAN SULFATE PROTEOGLYCAN; GLYCINE N-ACYLTRANSFERASE; SORSBYS FUNDUS DYSTROPHY; ALPHA CONVERTING-ENZYME; BREAST-MILK COMPOSITION; CENTRAL-NERVOUS-SYSTEM; BRAIN GENE-EXPRESSION; ANION CHANNEL VDAC; PROTEIN-KINASE-C	Background. Docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (ARA, 20:4n-6) are the major long chain polyunsaturated fatty acids (LCPUFA) of the central nervous system (CNS). These nutrients are present in most infant formulas at modest levels, intended to support visual and neural development. There are no investigations in primates of the biological consequences of dietary DHA at levels above those present in formulas but within normal breastmilk levels. Methods and Findings. Twelve baboons were divided into three formula groups: Control, with no DHA-ARA; "L", LCPUFA, with 0.33% DHA-0.67% ARA; "L3", LCPUFA, with 1.00% DHA-0.67% ARA. All the samples are from the precentral gyrus of cerebral cortex brain regions. At 12 weeks of age, changes in gene expression were detected in 1,108 of 54,000 probe sets (2.05%), with most showing < 2-fold change. Gene ontology analysis assigns them to diverse biological functions, notably lipid metabolism and transport, G-protein and signal transduction, development, visual perception, cytoskeleton, peptidases, stress response, transcription regulation, and 400 transcripts having no defined function. PLA2G6, a phospholipase recently associated with infantile neuroaxonal dystrophy, was downregulated in both LCPUFA groups. ELOVL5, a PUFA elongase, was the only LCPUFA biosynthetic enzyme that was differentially expressed. Mitochondrial fatty acid carrier, CPT2, was among several genes associated with mitochondrial fatty acid oxidation to be downregulated by high DHA, while the mitochondrial proton carrier, UCP2, was upregulated. TIMM8A, also known as deafness/dystonia peptide 1, was among several differentially expressed neural development genes. LUM and TIMP3, associated with corneal structure and age-related macular degeneration, respectively, were among visual perception genes influenced by LCPUFA. TIA1, a silencer of COX2 gene translation, is upregulated by high DHA. Ingenuity pathway analysis identified a highly significant nervous system network, with epidermal growth factor receptor (EGFR) as the outstanding interaction partner. Conclusions. These data indicate that LCPUFA concentrations within the normal range of human breastmilk induce global changes in gene expression across a wide array of processes, in addition to changes in visual and neural function normally associated with formula LCPUFA.	[Kothapalli, Kumar S. D.; Pan, Bruce S.; Hsieh, Andrea T.; Brenna, J. Thomas] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Anthony, Joshua C.] Mead Johnson & Co, Evansville, IN USA; [Nathanielsz, Peter W.] Univ Texas Hlth Sci Ctr San Antonio, Ctr Pregnancy & Newborn Res, San Antonio, TX 78229 USA	Cornell University; University of Texas System; University of Texas Health San Antonio	Brenna, JT (corresponding author), Cornell Univ, Div Nutr Sci, Savage Hall, Ithaca, NY 14853 USA.	jtb4@cornell.edu		Brenna, James Thomas/0000-0001-9494-4245; Nathanielsz, Peter/0000-0001-8410-6280	Mead Johnson and Company, Evansville; NIH [NIH Training Grant DK07158]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007158] Funding Source: NIH RePORTER	Mead Johnson and Company, Evansville; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: Mead Johnson and Company, Evansville, IN. BSP acknowledges support from NIH Training Grant DK07158.	Alessandri JM, 2004, REPROD NUTR DEV, V44, P509, DOI 10.1051/rnd:2004063; Baillie RA, 1999, PROSTAG LEUKOTR ESS, V60, P351, DOI 10.1016/S0952-3278(99)80011-8; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Barker DJP, 2003, HORM RES, V59, P35, DOI 10.1159/000067843; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Baur LA, 1998, METABOLISM, V47, P106, DOI 10.1016/S0026-0495(98)90202-5; Beecher N, 2006, INVEST OPHTH VIS SCI, V47, P146, DOI 10.1167/iovs.05-0907; BENOLKEN RM, 1973, SCIENCE, V182, P1253, DOI 10.1126/science.182.4118.1253; Benvenuti S, 2005, J CLIN ENDOCR METAB, V90, P1775, DOI 10.1210/jc.2004-0066; Berger Alvin, 2002, Lipids Health Dis, V1, P2, DOI 10.1186/1476-511X-1-2; Berger A, 2002, GENOME BIOL, V3; Bernstein HG, 2006, BRAIN RES BULL, V69, P546, DOI 10.1016/j.brainresbull.2006.02.017; Birch EE, 2005, AM J CLIN NUTR, V81, P871, DOI 10.1093/ajcn/81.4.871; Birch EE, 2000, DEV MED CHILD NEUROL, V42, P174, DOI 10.1017/S0012162200000311; BLACHLYDYSON E, 1994, GENOMICS, V20, P62, DOI 10.1006/geno.1994.1127; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Brenna JT, 2002, CURR OPIN CLIN NUTR, V5, P127, DOI 10.1097/00075197-200203000-00002; BRENNA JT, 2006, PEDIATRICS UNPUB; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; CHAKRAVARTI S, 1995, MAMM GENOME, V6, P367, DOI 10.1007/BF00364803; CLANDININ MT, 1980, EARLY HUM DEV, V4, P131, DOI 10.1016/0378-3782(80)90016-X; Clandinin MT, 2005, J PEDIATR-US, V146, P461, DOI 10.1016/j.jpeds.2004.11.030; CLANDININ MT, 1980, EARLY HUM DEV, V4, P121, DOI 10.1016/0378-3782(80)90015-8; Clarke M, 2001, BRIT J OPHTHALMOL, V85, P1429, DOI 10.1136/bjo.85.12.1429; CLARKE SD, 1994, ANNU REV NUTR, V14, P83, DOI 10.1146/annurev.nu.14.070194.000503; Colville D, 1997, OPHTHALMIC GENET, V18, P119, DOI 10.3109/13816819709057125; Cox LA, 2006, J PHYSIOL-LONDON, V572, P59, DOI 10.1113/jphysiol.2006.105726; CRAWFORD MA, 1976, COMP BIOCHEM PHYS B, V54, P395, DOI 10.1016/0305-0491(76)90264-9; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; de Rooij SR, 2006, DIABETOLOGIA, V49, P637, DOI 10.1007/s00125-005-0136-9; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Ding B, 2005, CIRCULATION, V111, P2469, DOI 10.1161/01.CIR.0000165128.39715.87; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Dooley CM, 2003, J NEUROBIOL, V54, P313, DOI 10.1002/neu.10176; Dufner A, 2006, P NATL ACAD SCI USA, V103, P988, DOI 10.1073/pnas.0510380103; Dumstrei K, 1998, DEVELOPMENT, V125, P3417; Dunlevy JR, 2000, EXP EYE RES, V70, P349, DOI 10.1006/exer.1999.0789; DYCK JR, 2006, AMPK ALTERATIONS CAR; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; EVANS AM, 2006, J PHYSL; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Ferner RE, 2004, J MED GENET, V41, P837, DOI 10.1136/jmg.2004.021683; FINLEY DA, 1985, AM J CLIN NUTR, V41, P787; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Ge GX, 2004, J BIOL CHEM, V279, P41626, DOI 10.1074/jbc.M406630200; Gehlert DR, 1998, P SOC EXP BIOL MED, V218, P7; Gibson RA, 2001, LIPIDS, V36, P873, DOI 10.1007/s11745-001-0797-2; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Haitchi HM, 2005, AM J RESP CRIT CARE, V171, P958, DOI 10.1164/rccm.200409-1251OC; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Harzenetter MD, 2002, EXP HEMATOL, V30, P306, DOI 10.1016/S0301-472X(02)00772-5; Hofmann S, 2002, J BIOL CHEM, V277, P23287, DOI 10.1074/jbc.M201154200; Holgate ST, 2006, J ALLERGY CLIN IMMUN, V117, P496, DOI 10.1016/j.jaci.2006.01.039; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; HSIEH AT, 2007, PED RES IN PRESS; Hun CS, 1999, BIOCHEM BIOPH RES CO, V259, P85, DOI 10.1006/bbrc.1999.0733; INNIS SM, 1988, EARLY HUM DEV, V18, P185, DOI 10.1016/0378-3782(88)90055-2; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jensen CL, 1997, J PEDIATR-US, V131, P200, DOI 10.1016/S0022-3476(97)70154-9; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Kitajka K, 2002, P NATL ACAD SCI USA, V99, P2619, DOI 10.1073/pnas.042698699; Kitajka K, 2004, P NATL ACAD SCI USA, V101, P10931, DOI 10.1073/pnas.0402342101; Kornblum HI, 1998, J NEUROSCI RES, V53, P697, DOI 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.3.CO;2-M; Kuehn MH, 1999, MATRIX BIOL, V18, P509, DOI 10.1016/S0945-053X(99)00043-8; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuorilehto T, 2006, J HISTOCHEM CYTOCHEM, V54, P363, DOI 10.1369/jhc.5A6784.2005; Kuroda H, 2002, PLANT CELL PHYSIOL, V43, P1073, DOI 10.1093/pcp/pcf151; Kuthe A, 2000, EUR UROL, V38, P108, DOI 10.1159/000020262; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lapillonne A, 2004, CURR OPIN CLIN NUTR, V7, P151, DOI 10.1097/00075197-200403000-00008; Lauritzen L, 2005, REPROD NUTR DEV, V45, P535, DOI 10.1051/rnd:2005044; Lauritzen L, 2002, LIPIDS, V37, P237, DOI 10.1007/s11745-002-0886-2; Leifert WR, 2000, J NUTR BIOCHEM, V11, P38, DOI 10.1016/S0955-2863(99)00069-8; Leon C, 2005, PHARM RES-DORDR, V22, P1578, DOI 10.1007/s11095-005-6306-0; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Leonard AE, 2002, LIPIDS, V37, P733, DOI 10.1007/s11745-002-0955-6; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Li Zheng, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010045; Litman BJ, 2001, J MOL NEUROSCI, V16, P237, DOI 10.1385/JMN:16:2-3:237; Liu AMF, 2005, J BIOL CHEM, V280, P34617, DOI 10.1074/jbc.M504264200; Liu H, 1998, BRIT J PHARMACOL, V125, P1501, DOI 10.1038/sj.bjp.0702227; Liu Y, 2001, DEV BIOL, V236, P30, DOI 10.1006/dbio.2000.0146; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; Makrides M, 1996, EUR J CLIN NUTR, V50, P352; Makrides M, 2000, AM J CLIN NUTR, V71, P120; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Martinez M, 1998, J NEUROCHEM, V71, P2528; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; Massa R, 2000, J MUSCLE RES CELL M, V21, P433, DOI 10.1023/A:1005688901635; Mathers PH, 2000, CELL MOL LIFE SCI, V57, P186, DOI 10.1007/PL00000683; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Mawal Y, 1997, J PEDIATR-US, V130, P1003, DOI 10.1016/S0022-3476(97)70293-2; MAWAL YR, 1994, BIOCHEM BIOPH RES CO, V205, P1373, DOI 10.1006/bbrc.1994.2817; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Miyazaki Akira, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P463, DOI 10.2174/156800605774962040; Morale SE, 2005, EARLY HUM DEV, V81, P197, DOI 10.1016/j.earlhumdev.2004.09.008; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P3205, DOI 10.1073/pnas.93.8.3205; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Mothes H, 2002, NEPHROL DIAL TRANSPL, V17, P70, DOI 10.1093/ndt/17.1.70; Mullenbach R, 2005, GUT, V54, P829, DOI 10.1136/gut.2004.058115; Narayanan BA, 2001, INT J ONCOL, V19, P1255; Niu SL, 2001, J BIOL CHEM, V276, P42807, DOI 10.1074/jbc.M105778200; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Percy ME, 1998, ANALYST, V123, P41, DOI 10.1039/a706355e; Peri A, 2005, J ENDOCRINOL INVEST, V28, P285, DOI 10.1007/BF03345387; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Picot CR, 2005, FREE RADICAL BIO MED, V39, P1332, DOI 10.1016/j.freeradbiomed.2005.06.017; Puskas LG, 2003, P NATL ACAD SCI USA, V100, P1580, DOI 10.1073/pnas.0337683100; Quantock AJ, 2001, INVEST OPHTH VIS SCI, V42, P1750; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; ROZEN R, 1994, GENOMICS, V24, P280, DOI 10.1006/geno.1994.1617; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Sarkadi-Nagy E, 2004, J LIPID RES, V45, P71, DOI 10.1194/jlr.M300106-JLR200; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Senderek J, 2003, AM J HUM GENET, V73, P1106, DOI 10.1086/379525; Seth D, 2003, AM J PATHOL, V163, P2303, DOI 10.1016/S0002-9440(10)63587-0; Shafir I, 1998, J BIOENERG BIOMEMBR, V30, P499, DOI 10.1023/A:1020598315287; Sokac AM, 2000, INT REV CYTOL, V200, P197, DOI 10.1016/S0074-7696(00)00005-X; Stein O, 2005, ATHEROSCLEROSIS, V178, P217, DOI 10.1016/j.atherosclerosis.2004.10.008; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Suetsugu S, 2004, BIOCHEM J, V384, P1, DOI 10.1042/BJ20041103; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; TAGAWA K, 1991, BIOCHEM BIOPH RES CO, V177, P377, DOI 10.1016/0006-291X(91)91994-N; Tasheva ES, 2004, MOL VIS, V10, P403; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Tranebjaerg L, 2001, Ophthalmic Genet, V22, P207; Tranebjaerg L, 2000, EUR J HUM GENET, V8, P464, DOI 10.1038/sj.ejhg.5200483; TREEN M, 1992, ARCH BIOCHEM BIOPHYS, V294, P564, DOI 10.1016/0003-9861(92)90726-D; Usdin TB, 2000, FRONT NEUROENDOCRIN, V21, P349, DOI 10.1006/frne.2000.0203; USDIN TB, 1995, J BIOL CHEM, V270, P15455, DOI 10.1074/jbc.270.26.15455; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Vasiliauskas D, 1999, MECH DEVELOP, V82, P79, DOI 10.1016/S0925-4773(99)00014-3; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Wada W, 2005, J HEPATOL, V43, P823, DOI 10.1016/j.jhep.2005.04.013; Wada W, 2004, AM J PHYSIOL-ENDOC M, V287, pE247, DOI 10.1152/ajpendo.00390.2003; Wang LW, 2000, PEDIATR INT, V42, P14, DOI 10.1046/j.1442-200x.2000.01169.x; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Weisinger HS, 2001, NAT MED, V7, P258, DOI 10.1038/85354; WELSCH DJ, 1994, P NATL ACAD SCI USA, V91, P9745, DOI 10.1073/pnas.91.21.9745; Willatts P, 1998, LANCET, V352, P688, DOI 10.1016/S0140-6736(97)11374-5; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275; WOLFSBERG TG, 1995, DEV BIOL, V169, P378, DOI 10.1006/dbio.1995.1152; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Ye X, 2004, MOL BIOL REP, V31, P191, DOI 10.1023/B:MOLE.0000043622.57408.6b; Yu S, 2004, BIOCHEM BIOPH RES CO, V322, P320, DOI 10.1016/j.bbrc.2004.07.120; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao JS, 2001, DEV BIOL, V232, P204, DOI 10.1006/dbio.2001.0176	188	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2007	2	4							e370	10.1371/journal.pone.0000370	http://dx.doi.org/10.1371/journal.pone.0000370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DT	17426818	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445400010
J	Tester, AM; Cox, JH; Connor, AR; Starr, AE; Dean, RA; Puente, XS; Lopez-Otin, C; Overall, CM				Tester, Angus M.; Cox, Jennifer H.; Connor, Andrea R.; Starr, Amanda E.; Dean, Richard A.; Puente, Xose S.; Lopez-Otin, Carlos; Overall, Christopher M.			LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CXC CHEMOKINES; POTENTIAL ROLE; TUMOR-CELLS; GRO-ALPHA; INTERLEUKIN-8; BINDING; VITRO; INFLAMMATION; PROTEIN-2	We identify matrix metalloproteinase (MMP)-8, the polymorphonuclear (PMN) leukocyte collagenase, as a critical mediator initiating lipopolysaccharide (LPS)-responsiveness in vivo. PMN infiltration towards LPS is abrogated in Mmp8-null mice. MMP-8 cleaves LPS-induced CXC chemokine (LIX) at Ser(4)similar to Val(5) and Lys(79)similar to Arg(80). LIX bioactivity is increased upon N-terminal cleavage, enhancing intracellular calcium mobilization and chemotaxis upon binding its cognate receptor, CXCR2. As there is no difference in PMN chemotaxis in Mmp8-null mice compared with wild-type mice towards synthetic analogues of MMP-8-cleaved LIX, MMP-8 is not essential for extravasation or cell migration in collagenous matrices in vivo. However, with biochemical redundancy between MMPs 1, 2, 9, and 13, which also cleave LIX at position 4 similar to 5, it was surprising to observe such a markedly reduced PMN infiltration towards LPS and LIX in Mmp8-/- mice. This lack of physiological redundancy in vivo identifies MMP-8 as a key mediator in the regulation of innate immunity. Comparable results were found with CXCL8/IL-8 and CXCL5/ENA-78, the human orthologues of LIX. MMP-8 cleaves CXCL8 at Arg(5)-Ser(6) and at Val(7)-Leu(8) in CXCL5 to activate respective chemokines. Hence, rather than collagen, these PMN chemoattractants are important MMP-8 substrates in vivo; PMN-derived MMP-8 cleaves and activates LIX to execute an in cis PMN-controlled feed-forward mechanism to orchestrate the initial inflammatory response and promote LPS responsiveness in tissue.	[Tester, Angus M.; Cox, Jennifer H.; Connor, Andrea R.; Starr, Amanda E.; Dean, Richard A.; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada; [Tester, Angus M.; Cox, Jennifer H.; Connor, Andrea R.; Starr, Amanda E.; Dean, Richard A.; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Puente, Xose S.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, Oviedo, Spain	University of British Columbia; University of British Columbia; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Overall, CM (corresponding author), Univ British Columbia, Ctr Blood Res, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada.	chris.overall@ubc.ca	Puente, Xosé S./ADB-0672-2022; López-Otín, Carlos/AAB-2106-2020	Puente, Xosé S./0000-0001-9525-1483; López-Otín, Carlos/0000-0001-6964-1904	Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada; CIHR [STP-53877]; Canadian Institutes of Health Research; National Cancer Institute of Canada; Michael Smith Research Foundation	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Michael Smith Research Foundation(Michael Smith Foundation for Health Research)	This work was supported by the Michael Smith Foundation for Health Research (JHC), Natural Sciences and Engineering Research Council of Canada (JHC and AES), CIHR Strategic Training Program STP-53877 (JHC and AES). CMO is a Canada Research Chair in Metalloproteinase Proteomics and Systems Biology, and has research grants from the Canadian Institutes of Health Research, the National Cancer Institute of Canada, and a Centre Grant from the Michael Smith Research Foundation (UBC Centre for Blood Research).	Acuff HB, 2006, CANCER RES, V66, P259, DOI 10.1158/0008-5472.CAN-05-2502; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Arcaroli J, 2002, CHEST, V121, p76S, DOI 10.1378/chest.121.3_suppl.76S; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Betsuyaku T, 1999, AM J RESP CELL MOL, V20, P1303, DOI 10.1165/ajrcmb.20.6.3558; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; Butler GS, 2002, J BIOL CHEM, V277, P17511, DOI 10.1074/jbc.M201461200; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; DEAN RA, 2007, MOL CELL PROTEOMICS; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; HASTY KA, 1987, J BIOL CHEM, V262, P10048; Houghton AM, 2006, CANCER RES, V66, P6149, DOI 10.1158/0008-5472.CAN-04-0297; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; LEE J, 1995, J IMMUNOL, V155, P2158; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Madri J A, 2000, Dev Immunol, V7, P103, DOI 10.1155/2000/79045; Malcolm KC, 2003, AM J PHYSIOL-LUNG C, V284, pL663, DOI 10.1152/ajplung.00094.2002; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Olszyna DP, 2001, INFECT IMMUN, V69, P2736, DOI 10.1128/IAI.69.4.2736-2738.2001; Overall Christopher M, 2004, Biochem J, V383, pe5; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; ROT A, 1993, EUR J IMMUNOL, V23, P303, DOI 10.1002/eji.1830230150; Smith JB, 1997, J LEUKOCYTE BIOL, V62, P598, DOI 10.1002/jlb.62.5.598; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tateda K, 2001, INFECT IMMUN, V69, P2017, DOI 10.1128/IAI.69.4.2017-2024.2001; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; VANDAMME J, 1990, EUR J IMMUNOL, V20, P2113, DOI 10.1002/eji.1830200933; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; WEISS SJ, 1985, SCIENCE, V227, P747, DOI 10.1126/science.2982211; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wuyts A, 1998, EUR J BIOCHEM, V255, P67, DOI 10.1046/j.1432-1327.1998.2550067.x; Wuyts A, 1999, J IMMUNOL, V163, P6155; Wuyts A, 1999, EUR J BIOCHEM, V260, P421, DOI 10.1046/j.1432-1327.1999.00166.x; Wuyts A, 1996, J IMMUNOL, V157, P1736; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	61	171	176	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e312	10.1371/journal.pone.0000312	http://dx.doi.org/10.1371/journal.pone.0000312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375198	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445100014
J	Chien, CV				Chien, Colleen V.			HIV/AIDS Drugs for Sub-Saharan Africa: How Do Brand and Generic Supply Compare?	PLOS ONE			English	Article							ANTIRETROVIRAL DRUGS; ACCESS; TRADE	Background. Significant quantities of antiretroviral drugs (ARVs) to treat HIV/AIDS have been procured for Sub-Saharan Africa for the first time in their 20-year history. This presents a novel opportunity to empirically study the roles of brand and generic suppliers in providing access to ARVs. Methodology/Principal Findings. An observational study of brand and generic supply based on a dataset of 2,162 orders of AIDS drugs for Sub-Saharan Africa reported to the Global Price Reporting Mechanism at the World Health Organization from January 2004-March 2006 was performed. Generic companies supplied 63% of the drugs studied, at prices that were on average about a third of the prices charged by brand companies. 96% of the procurement was of first line drugs, which were provided mostly by generic firms, while the remaining 4%, of second line drugs, was sourced primarily from brand companies. 85% of the generic drugs in the sample were manufactured in India, where the majority of the drugs procured were ineligible for patent protection. The remaining 15% was manufactured in South Africa, mostly under voluntary licenses provided by brand companies to a single generic company. In Sub-Saharan African countries, four first line drugs in the dataset were widely patented, however no general deterrent to generic purchasing based on a patent was detected. Conclusions/Significance. Generic and brand companies have played distinct roles in increasing the availability of ARVs in Sub-Saharan Africa. Generic companies provided most of the drugs studied, at prices below those charged by brand companies, and until now, almost exclusively supplied several fixed-dose combination drugs. Brand companies have supplied almost all second line drugs, signed voluntary licenses with generic companies, and are not strictly enforcing patents in certain countries. Further investigation into how price reductions in second line drugs can be achieved and the cheapest drugs can actually be procured is warranted.	Fenwick & W LLP, Oakland, CA USA		Chien, CV (corresponding author), Fenwick & W LLP, Oakland, CA USA.	colleenchien@gmail.com			Stanford Center for Law and the Biosciences at Stanford Law School	Stanford Center for Law and the Biosciences at Stanford Law School	This paper was written with the generous support of the Stanford Center for Law and the Biosciences at Stanford Law School, at which the author was a Fellow during its writing. The Center played no role in any part of the conception, analysis, or approval of the manuscript.	Abbott FM, 2005, AM J INT LAW, V99, P317, DOI 10.2307/1562501; Attaran A, 2001, JAMA-J AM MED ASSOC, V286, P1886, DOI 10.1001/jama.286.15.1886; *AVERT, 2006, PRES EM PLAN AIDS RE; Bartram D, 2006, COMPUTER-BASED TESTING AND THE INTERNET: ISSUES AND ADVANCES, P13; BOULET P, 2006, PATENT STATUS HIV AI; Butler D, 2005, NATURE, V436, P156, DOI 10.1038/436156a; CAMP R, 2006, ANTIRETROVIRALS PIPE; Cohen JC, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-17; *FOOD DRUG ADM, 2005, FDA CONSUM, V39, P3; Ford N, 2006, LANCET, V367, P794, DOI 10.1016/S0140-6736(06)68313-X; *GLAXOSMITHKLINE, 2006, GSK PAT PAT APPL COM; *GLOB FUND FIGHT A, 2006, DISTR FUND 5 ROUNDS; Grace C, 2004, EFFECT CHANGING INTE; HAMILTON D, 2006, GOOD DEED AIDS DRUG; *HOFFMANLAROCHE, 2004, REM BARR INCR ACC RO; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; KULLINAN K, 2006, ASPENS GENERICS ENSU; *LAW COLL HIV AIDS, 2006, ACC MED POSTTRIPS RE; Lee K, 2004, JAMA-J AM MED ASSOC, V291, P2636, DOI 10.1001/jama.291.21.2636; Medecins Sans Frontieres, 2006, UNT WEB PRIC RED PRI; THOEN E, 2003, DRUG PATENTS SPOTLIG; UNAIDS, 2006, REP GLOB AIDS EP; Vasan A, 2006, B WORLD HEALTH ORGAN, V84, P393, DOI 10.2471/BLT.05.025684; Westerhaus M, 2006, PLOS MED, V3, P1230, DOI 10.1371/journal.pmed.0030332; *WHO, 2006, REP WHO UNA IN PRESS; *WHO, 2006, GLOB PRIC REP MECH; *WHO, 2006, WEIGHT AV PRIC ARVS; *WHO, 2006, AIDS MED DIAGN SERV; WHO, 2004, SCAL ANT THER RES LI; *WORLD COMM ADV BO, 2005, WORLD COMM ADV BOARD; World Health Organization, 2006, ANT THER HIV INF AD; 2006, EC TIMES        0905; 2006, MED NEWS TODAY  1206	33	46	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e278	10.1371/journal.pone.0000278	http://dx.doi.org/10.1371/journal.pone.0000278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17372625	gold, Green Submitted, Green Published			2022-12-27	WOS:000207444800001
J	Seebacher, F; Murray, SA				Seebacher, Frank; Murray, Shauna A.			Transient Receptor Potential Ion Channels Control Thermoregulatory Behaviour in Reptiles	PLOS ONE			English	Article							BODY-TEMPERATURE; MELATONIN; MECHANISMS; EVOLUTION; RESPONSES; SELECTION; FALLACY; MODEL	Biological functions are governed by thermodynamics, and animals regulate their body temperature to optimise cellular performance and to avoid harmful extremes. The capacity to sense environmental and internal temperatures is a prerequisite for the evolution of thermoregulation. However, the mechanisms that enable ectothermic vertebrates to sense heat remain unknown. The recently discovered thermal characteristics of transient receptor potential ion channels (TRP) render these proteins suitable to act as temperature sensors. Here we test the hypothesis that TRPs are present in reptiles and function to control thermoregulatory behaviour. We show that the hot-sensing TRPV1 is expressed in a crocodile (Crocodylus porosus), an agamid (Amphibolurus muricatus) and a scincid (Pseudemoia entrecasteauxii) lizard, as well as in the quail and zebrafinch (Coturnix chinensis and Poephila guttata). The TRPV1 genes from all reptiles form a unique clade that is delineated from the mammalian and the ancestral Xenopus sequences by an insertion of two amino acids. TRPV1 and the cool-sensing TRPM8 are expressed in liver, muscle (transversospinalis complex), and heart tissues of the crocodile, and have the potential to act as internal thermometer and as external temperatures sensors. Inhibition of TRPV1 and TRPM8 in C. porosus abolishes the typically reptilian shuttling behaviour between cooling and heating environments, and leads to significantly altered body temperature patterns. Our results provide the proximate mechanism of thermal selection in terrestrial ectotherms, which heralds a fundamental change in interpretation, because TRPs provide the mechanism for a tissue-specific input into the animals' thermoregulatory response.	[Seebacher, Frank; Murray, Shauna A.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Seebacher, F (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	fseebach@bio.usyd.edu.au	Murray, Shauna/K-5781-2015	Murray, Shauna/0000-0001-7096-1307; Seebacher, Frank/0000-0002-2281-9311	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council. The authors have no financial interest in this manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AXELROD J, 1974, SCIENCE, V184, P1341, DOI 10.1126/science.184.4144.1341; BOGERT CM, 1949, EVOLUTION, V3, P195, DOI 10.2307/2405558; Boulant JA, 2006, J APPL PHYSIOL, V100, P1347, DOI 10.1152/japplphysiol.01064.2005; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cooper KE, 2002, J APPL PHYSIOL, V92, P1717, DOI 10.1152/japplphysiol.01051.2001; DiMicco JA, 2007, AM J PHYSIOL-REG I, V292, pR47, DOI 10.1152/ajpregu.00498.2006; Egan GF, 2005, P NATL ACAD SCI USA, V102, P5262, DOI 10.1073/pnas.0409753102; GILCHRIST GW, 1995, AM NAT, V146, P252, DOI 10.1086/285797; Glanville EJ, 2006, J EXP BIOL, V209, P4869, DOI 10.1242/jeb.02585; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAMMEL HT, 1967, SCIENCE, V156, P1260, DOI 10.1126/science.156.3779.1260; HERTZ PE, 1993, AM NAT, V142, P796, DOI 10.1086/285573; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Incropera F.P., 1996, FUNDAMENTALS HEAT MA; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; Lutterschmidt DI, 2002, HORM BEHAV, V41, P41, DOI 10.1006/hbeh.2001.1721; Lutterschmidt DI, 2003, CAN J ZOOL, V81, P1, DOI 10.1139/Z02-189; Lutterschmidt DI, 1997, COMP BIOCHEM PHYS C, V118, P271, DOI 10.1016/S0742-8413(97)00106-0; MCKEMY DD, 2007, ARCH EUR J IN PRESS; Nealen ML, 2003, J NEUROPHYSIOL, V90, P515, DOI 10.1152/jn.00843.2002; NELSON DO, 1984, AM ZOOL, V24, P791; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; REHNMARK S, 1990, J BIOL CHEM, V265, P16464; RIVKEES SA, 1989, P NATL ACAD SCI USA, V86, P3882, DOI 10.1073/pnas.86.10.3882; SATINOFF E, 1978, SCIENCE, V201, P16, DOI 10.1126/science.351802; Seebacher F, 2006, P ROY SOC B-BIOL SCI, V273, P565, DOI 10.1098/rspb.2005.3333; Seebacher F, 2004, J COMP PHYSIOL B, V174, P577, DOI 10.1007/s00360-004-0446-0; Seebacher F, 2004, PHYSIOL BIOCHEM ZOOL, V77, P688, DOI 10.1086/422052; Seebacher F, 1999, PHYSIOL BIOCHEM ZOOL, V72, P57, DOI 10.1086/316638; Tosini G, 1997, ETHOL ECOL EVOL, V9, P313, DOI 10.1080/08927014.1997.9522875; Weil A, 2005, MOL PHARMACOL, V68, P518, DOI 10.1124/mol.105.012146	40	38	40	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e281	10.1371/journal.pone.0000281	http://dx.doi.org/10.1371/journal.pone.0000281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356692	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444800004
J	Martin, JR; Rogers, KL; Chagneau, C; Brulet, P				Martin, Jean-Rene; Rogers, Kelly L.; Chagneau, Carine; Brulet, Philippe			In vivo Bioluminescence Imaging of Ca2+ Signalling in the Brain of Drosophila	PLOS ONE			English	Article							MUSHROOM BODY; LOCOMOTOR-ACTIVITY; CENTRAL COMPLEX; NEURONS; BODIES; DUNCE; GENE; PHOSPHODIESTERASE; MELANOGASTER; ARCHITECTURE	Many different cells' signalling pathways are universally regulated by Ca2+ concentration [Ca2+] rises that have highly variable amplitudes and kinetic properties. Optical imaging can provide the means to characterise both the temporal and spatial aspects of Ca2+ signals involved in neurophysiological functions. New methods for in vivo imaging of Ca2+ signalling in the brain of Drosophila are required for probing the different dynamic aspects of this system. In studies here, whole brain Ca2+ imaging was performed on transgenic flies with targeted expression of the bioluminescent Ca2+ reporter GFP-aequorin (GA) in different neural structures. A photon counting based technique was used to undertake continuous recordings of cytosolic [Ca2+] over hours. Time integrals for reconstructing images and analysis of the data were selected offline according to the signal intensity. This approach allowed a unique Ca2+ response associated with cholinergic transmission to be identified by whole brain imaging of specific neural structures. Notably, [Ca2+] transients in the Mushroom Bodies (MBs) following nicotine stimulation were accompanied by a delayed secondary [Ca2+] rise (up to 15 min. later) in the MB lobes. The delayed response was sensitive to thapsigargin, suggesting a role for intra-cellular Ca2+ stores. Moreover, it was reduced in dunce mutant flies, which are impaired in learning and memory. Bioluminescence imaging is therefore useful for studying Ca2+ signalling pathways and for functional mapping of neurophysiological processes in the fly brain.	[Martin, Jean-Rene] CNRS, Unite UPR 9040, Equipe Bases Neurales Comportements Chez Drosophi, Neurobiol Cellulaire & Mol Lab, Gif Sur Yvette, France; [Rogers, Kelly L.; Brulet, Philippe] Inst Pasteur, CNRS, URA 2578, Unite Embryol Mol, Paris, France; [Chagneau, Carine] Univ Paris 11, CNRS, UMR 8620, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Martin, JR (corresponding author), CNRS, Unite UPR 9040, Equipe Bases Neurales Comportements Chez Drosophi, Neurobiol Cellulaire & Mol Lab, Gif Sur Yvette, France.	jean-rene.martin@inaf.cnrs-gif.fr; pbrulet@pasteur.fr		Rogers, Kelly L./0000-0002-6755-0221	CNRS; ANR; Pasteur Institute	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); Pasteur Institute	This work was supported by Grants from CNRS and ANR (Neuroscience) to J-R Martin, and from Pasteur Institute and CNRS to P. Brulet.	Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; BRAND AH, 1993, DEVELOPMENT, V118, P401; Crittenden JR, 1998, LEARN MEMORY, V5, P38; CURIE T, 2007, MOL IMAGING IN PRESS; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; FIALA A, 2003, SCI STKE, V174, pPL6; Gorokhovatsky AY, 2004, BIOCHEM BIOPH RES CO, V320, P703, DOI 10.1016/j.bbrc.2004.06.014; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hou JM, 2004, J NEUROBIOL, V60, P249, DOI 10.1002/neu.20021; Ito K, 1998, LEARN MEMORY, V5, P52; KAUVAR LM, 1982, J NEUROSCI, V2, P1347; Kim YJ, 2006, CURR BIOL, V16, P1395, DOI 10.1016/j.cub.2006.06.027; Lee T, 1999, DEVELOPMENT, V126, P4065; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; Martin JR, 1998, LEARN MEMORY, V5, P179; MARTIN JR, 2002, J NEUROGENET, V15, P1; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; QIU YH, 1993, GENE DEV, V7, P1447, DOI 10.1101/gad.7.7b.1447; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rogers KL, 2005, EUR J NEUROSCI, V21, P597, DOI 10.1111/j.1460-9568.2005.03871.x; Rosay P, 2001, NEURON, V30, P759, DOI 10.1016/S0896-6273(01)00323-3; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; YANG MY, 1995, NEURON, V15, P45; Yasuyama K, 1999, MICROSC RES TECHNIQ, V45, P65, DOI 10.1002/(SICI)1097-0029(19990415)45:2<65::AID-JEMT2>3.0.CO;2-0; Yu DH, 2003, J NEUROSCI, V23, P64	33	58	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e275	10.1371/journal.pone.0000275	http://dx.doi.org/10.1371/journal.pone.0000275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17342209	gold, Green Published			2022-12-27	WOS:000207444700010
J	D'Angiolella, V; Palazzo, L; Santarpia, C; Costanzo, V; Grieco, D				D'Angiolella, Vincenzo; Palazzo, Luca; Santarpia, Concetta; Costanzo, Vincenzo; Grieco, Domenico			Role for Non-Proteolytic Control of M-phase Promoting Factor Activity at M-phase Exit	PLOS ONE			English	Article								M-phase Promoting Factor (MPF; the cyclin B-cdk 1 complex) is activated at M-phase onset by removal of inhibitory phosphorylation of cdk1 at thr-14 and tyr-15. At M-phase exit, MPF is destroyed by ubiquitin-dependent cyclin proteolysis. Thus, control of MPF activity via inhibitory phosphorylation is believed to be particularly crucial in regulating transition into, rather than out of, M-phase. Using the in vitro cell cycle system derived form Xenopus eggs, here we show, however, that inhibitory phosphorylation of cdk1 contributes to control MPF activity during M-phase exit. By sampling extracts at very short intervals during both meiotic and mitotic exit, we found that cyclin B1-associated cdk1 underwent transient inhibitory phosphorylation at tyr-15 and that cyclin B1-cdk1 activity fell more rapidly than the cyclin B1 content. Inhibitory phosphorylation of MPF correlated with phosphorylation changes of cdc25C, the MPF phosphatase, and physical interaction of cdk1 with wee1, the MPF kinase, during M-phase exit. MPF down-regulation required Ca++/calmodulin-dependent kinase II (CaMKII) and cAMP-dependent protein kinase (PKA) activities at meiosis and mitosis exit, respectively. Treatment of M-phase extracts with a mutant cyclin B1-cdk1AF complex, refractory to inhibition by phosphorylation, impaired binding of the Anaphase Promoting Complex/Cyclosome (APC/C) to its co-activator Cdc20 and altered M-phase exit. Thus, timely M-phase exit requires a tight coupling of proteolysis-dependent and proteolysis-independent mechanisms of MPF inactivation.	[D'Angiolella, Vincenzo; Palazzo, Luca; Santarpia, Concetta; Grieco, Domenico] Univ Naples Federico 2, Fac Biotechnol Sci, Naples, Italy; [D'Angiolella, Vincenzo; Palazzo, Luca; Santarpia, Concetta; Grieco, Domenico] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol L Calif, Naples, Italy; [Palazzo, Luca; Santarpia, Concetta; Grieco, Domenico] CEINGE Biotecnol Avanzate, Naples, Italy; [D'Angiolella, Vincenzo] NYU, Dept Pathol, New York, NY 10016 USA; [Costanzo, Vincenzo] London Res Inst, Clare Hall Labs, London, England	University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate; New York University	Grieco, D (corresponding author), Univ Naples Federico 2, Fac Biotechnol Sci, Naples, Italy.	domenico.grieco@unina.it	Palazzo, Luca/Q-1084-2017	Palazzo, Luca/0000-0002-5556-5549; Costanzo, Vincenzo/0000-0002-2920-9508; GRIECO, Domenico/0000-0002-7131-5742	Associazione Italiana per la Ricerca sul Cancro (AIRC)	Associazione Italiana per la Ricerca sul Cancro (AIRC)	Associazione Italiana per la Ricerca sul Cancro (AIRC)	Arnaoutov A, 2003, DEV CELL, V5, P99, DOI 10.1016/S1534-5807(03)00194-1; Ciliberto A, 2005, CELL CYCLE, V4, P1107; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; D'Angiolella V, 2004, CELL CYCLE, V3, P132; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; D'Angiolella V, 2001, CURR BIOL, V11, P1221, DOI 10.1016/S0960-9822(01)00352-9; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Dunphy William G., 1994, Trends in Cell Biology, V4, P202; GRIECO D, 1994, P NATL ACAD SCI USA, V91, P9896, DOI 10.1073/pnas.91.21.9896; Grieco D, 1996, SCIENCE, V271, P1718, DOI 10.1126/science.271.5256.1718; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hutchins JRA, 2003, MOL BIOL CELL, V14, P4003, DOI 10.1091/mbc.E03-02-0061; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; LUCA FC, 1991, EMBO J, V10, P4311, DOI 10.1002/j.1460-2075.1991.tb05009.x; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Stanford JS, 2005, MOL BIOL CELL, V16, P5749, DOI 10.1091/mbc.E05-06-0541; Stumpff J, 2005, CURR BIOL, V15, P1525, DOI 10.1016/j.cub.2005.07.031; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Wolfe BA, 2004, CELL CYCLE, V3, P601; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622	26	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e247	10.1371/journal.pone.0000247	http://dx.doi.org/10.1371/journal.pone.0000247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327911	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444600007
J	Unneberg, P; Claverie, JM				Unneberg, Per; Claverie, Jean-Michel			Tentative Mapping of Transcription-Induced Interchromosomal Interaction using Chimeric EST and mRNA Data	PLOS ONE			English	Article								Recent studies on chromosome conformation show that chromosomes colocalize in the nucleus, bringing together active genes in transcription factories. This spatial proximity of actively transcribing genes could provide a means for RNA interaction at the transcript level. We have screened public databases for chimeric EST and mRNA sequences with the intent of mapping transcription-induced interchromosomal interactions. We suggest that chimeric transcripts may be the result of close encounters of active genes, either as functional products or "noise'' in the transcription process, and that they could be used as probes for chromosome interactions. We have found a total of 5,614 chimeric ESTs and 587 chimeric mRNAs that meet our selection criteria. Due to their higher quality, the mRNA findings are of particular interest and we hope that they may serve as food for thought for specialists in diverse areas of molecular biology.	[Unneberg, Per; Claverie, Jean-Michel] CNRS, UPR 2589, Inst Biol Struct & Microbiol, Struct & Genom Informat Lab, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Unneberg, P (corresponding author), CNRS, UPR 2589, Inst Biol Struct & Microbiol, Struct & Genom Informat Lab, Marseille, France.	per.unneberg@igs.cnrs-mrs.fr	Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019	Claverie, Jean-Michel/0000-0003-1424-0315; Unneberg, Per/0000-0001-5735-3315	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Per Unneberg was supported by the Swedish Research Council.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Caudevilla C, 1998, P NATL ACAD SCI USA, V95, P12185, DOI 10.1073/pnas.95.21.12185; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Chuang CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-237; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Dahary D, 2005, GENOME RES, V15, P364, DOI 10.1101/gr.3308405; Dixon RJ, 2005, NUCLEIC ACIDS RES, V33, P5904, DOI 10.1093/nar/gki893; Finta C, 2002, J BIOL CHEM, V277, P5882, DOI 10.1074/jbc.M109175200; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Hahn Y, 2004, P NATL ACAD SCI USA, V101, P13257, DOI 10.1073/pnas.0405490101; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim N, 2006, NUCLEIC ACIDS RES, V34, pD21, DOI 10.1093/nar/gkj019; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Romani A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng017; Smalheiser NR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-403; Sorek R, 2003, NUCLEIC ACIDS RES, V31, P1067, DOI 10.1093/nar/gkg170; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhang C, 2003, DNA CELL BIOL, V22, P303, DOI 10.1089/104454903322216653	28	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e254	10.1371/journal.pone.0000254	http://dx.doi.org/10.1371/journal.pone.0000254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17330142	Green Published, gold			2022-12-27	WOS:000207444600014
J	Tikkinen, KAO; Tammela, TLJ; Rissanen, AM; Valpas, A; Huhtala, H; Auvinen, A				Tikkinen, Kari A. O.; Tammela, Teuvo L. J.; Rissanen, Aila M.; Valpas, Antti; Huhtala, Heini; Auvinen, Anssi			Is the Prevalence of Overactive Bladder Overestimated? A Population-Based Study in Finland	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; INCONTINENCE; WOMEN; NOCTURIA; MEN	Background. In earlier studies, one in six adults had overactive bladder which may impair quality of life. However, earlier studies have either not been population-based or have suffered from methodological limitations. Our aim was to assess the prevalence of overactive bladder symptoms, based on a representative study population and using consistent definitions and exclusions. Methodology/Principal Findings. The aim of the study was to assess the age-standardized prevalence of overactive bladder defined as urinary urgency, with or without urgency incontinence, usually with urinary frequency and nocturia in the absence of urinary tract infection or other obvious pathology. In 2003-2004, a questionnaire was mailed to 6,000 randomly selected Finns aged 18-79 years who were identified from the Finnish Population Register Centre. Information on voiding symptoms was collected using the validated Danish Prostatic Symptom Score, with additional frequency and nocturia questions. Corrected prevalence was calculated with adjustment for selection bias due to non-response. The questionnaire also elicited co-morbidity and socio-demographic information. Of the 6,000 subjects, 62.4% participated. The prevalence of overactive bladder was 6.5% (95% CI, 5.5% to 7.6%) for men and 9.3% (CI, 7.9% to 10.6%) for women. Exclusion of men with benign prostatic hyperplasia reduced prevalence among men by approximately one percentage point (to 5.6% [CI, 4.5% to 6.6%]). Among subjects with overactive bladder, urgency incontinence, frequency, and nocturia were reported by 11%, 23%, and 56% of men and 27%, 38%, and 40% of women, respectively. However, only 31% of men and 35% of women with frequency, and 31% of subjects of both sexes with nocturia reported overactive bladder. Conclusions/Significance. Our results indicate a prevalence of overactive bladder as low as 8% suggesting that, in previous studies, occurrence has been overestimated due to vague criteria and selected study populations regarding age distribution and low participation.	[Tikkinen, Kari A. O.; Tammela, Teuvo L. J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Tikkinen, Kari A. O.; Tammela, Teuvo L. J.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Tikkinen, Kari A. O.; Huhtala, Heini; Auvinen, Anssi] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; [Rissanen, Aila M.] Univ Helsinki, Cent Hosp, Obes Res Unit, Helsinki, Finland; [Valpas, Antti] S Karelian Cent Hosp, Dept Obstet & Gynecol, Lappeenranta, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University; University of Helsinki; Helsinki University Central Hospital	Tikkinen, KAO (corresponding author), Tampere Univ Hosp, Dept Urol, Tampere, Finland.	kari.tikkinen@fimnet.fi	Auvinen, Anssi/AAL-2111-2020; Auvinen, Anssi/AAD-9311-2020; Tikkinen, Kari/L-3632-2018	Auvinen, Anssi/0000-0003-1125-4818; Tikkinen, Kari/0000-0002-1389-8214	Medical Research Fund of the Tampere University Hospital; Emil Aaltonen Foundation; Lilly Foundation; Research Foundation of Orion Corporation; Tampere University Foundation	Medical Research Fund of the Tampere University Hospital; Emil Aaltonen Foundation; Lilly Foundation; Research Foundation of Orion Corporation; Tampere University Foundation	The study was funded by a grant from the Medical Research Fund of the Tampere University Hospital, and an unrestricted grant was accepted from Pfizer to cover the mailing and printing costs of questionnaires. The work of the corresponding author was funded by unrestricted grants from the Emil Aaltonen Foundation, the Lilly Foundation, the Medical Research Fund of the Tampere University Hospital, the Research Foundation of Orion Corporation, and the Tampere University Foundation. The funding sources had no role in study design, in the collection, analysis, and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication. The authors' work was independent of the funders. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; ARMSTRONG BK, 1992, PRINCIPLES EXPOSURE, P190; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Chen GD, 2003, NEUROUROL URODYNAM, V22, P109, DOI 10.1002/nau.10010; Corcos Jacques, 2004, Can J Urol, V11, P2278; dos Santos Silva I, 1999, CANC EPIDEMIOLOGY PR; Homma Y, 2005, BJU INT, V96, P1314, DOI 10.1111/j.1464-410X.2005.05835.x; Hu TW, 2005, BJU INT, V96, P43, DOI 10.1111/j.1464-410X.2005.05654.x; *IMS, 2006, IMS WORLD REV; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Khan MS, 2004, BJOG-INT J OBSTET GY, V111, P468, DOI 10.1111/j.1471-0528.2004.00126.x; Lapitan MC, 2001, INT UROGYNECOL J PEL, V12, P226, DOI 10.1007/s001920170043; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Moller LA, 2000, BMJ-BRIT MED J, V320, P1429, DOI 10.1136/bmj.320.7247.1429; Moorthy P, 2004, BJU INT, V93, P528, DOI 10.1111/j.1464-410X.2003.04682.x; Moynihan R, 2006, PLOS MED, V3, P425, DOI 10.1371/journal.pmed.0030191; Nabi G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003781.pub2; Ouslander JG, 2004, NEW ENGL J MED, V350, P786, DOI 10.1056/NEJMra032662; Parazzini F, 2002, J FAM PRACTICE, V51, P1072; *POP REG CTR, 2004, TASK FICKF 2004; SCHOU J, 1993, SCAND J UROL NEPHROL, V27, P489, DOI 10.3109/00365599309182282; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Swithinbank LV, 1999, BRIT J GEN PRACT, V49, P897; Teloken C, 2006, EUR UROL, V49, P1087, DOI 10.1016/j.eururo.2006.01.026; Temml C, 2005, EUR UROL, V48, P622, DOI 10.1016/j.eururo.2005.04.026; Tikkinen KAO, 2006, J UROLOGY, V175, P596, DOI 10.1016/S0022-5347(05)00245-4; Tikkinen KAO, 2006, AM J EPIDEMIOL, V163, P1003, DOI 10.1093/aje/kwj139; Yu HJ, 2006, UROL INT, V77, P327, DOI 10.1159/000096337; Zhang WJ, 2006, NEUROUROL URODYNAM, V25, P717, DOI 10.1002/nau.20293	30	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e195	10.1371/journal.pone.0000195	http://dx.doi.org/10.1371/journal.pone.0000195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17332843	Green Published, gold			2022-12-27	WOS:000207444300008
J	Onwuegbusi, BA; Rees, JRE; Lao-Sirieix, P; Fitzgerald, RC				Onwuegbusi, Benjamin A.; Rees, Jonathan R. E.; Lao-Sirieix, Pierre; Fitzgerald, Rebecca C.			Selective Loss of TGF beta Smad-Dependent Signalling Prevents Cell Cycle Arrest and Promotes Invasion in Oesophageal Adenocarcinoma Cell Lines	PLOS ONE			English	Article								In cancer, Transforming Growth Factor beta (TGF beta) increases proliferation and promotes invasion via selective loss of signalling pathways. Oesophageal adenocarcinoma arises from Barrett's oesophagus, progresses rapidly and is usually fatal. The contribution of perturbed TGF beta signalling in the promotion of metastasis in this disease has not been elucidated. We therefore investigated the role of TGF beta in Barrett's associated oesophageal adenocarcinoma using a panel of cell lines (OE33, TE7, SEG, BIC, FLO). 4/5 adenocarcinoma cell lines failed to cell cycle arrest, down-regulate c-Myc or induce p21 in response to TGF beta, and modulation of a Smad3/4 specific promoter was inhibited. These hyperproliferative adenocarcinoma cell lines displayed a TGF beta induced increase in the expression of the extracellular matrix degrading proteinases, urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1), which correlated with an invasive cell phenotype as measured by in vitro migration, invasion and cell scattering assays. Inhibiting ERK and JNK pathways significantly reduced PAI and uPA induction and inhibited the invasive cell phenotype. These results suggest that TGF beta Smad-dependent signalling is perturbed in Barrett's carcinogenesis, resulting in failure of growth-arrest. However, TGF beta can promote PAI and uPA expression and invasion through MAPK pathways. These data would support a dual role for TGF beta in oesophageal adenocarcinoma.	[Onwuegbusi, Benjamin A.; Rees, Jonathan R. E.; Lao-Sirieix, Pierre; Fitzgerald, Rebecca C.] Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge, England		Fitzgerald, RC (corresponding author), Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge, England.	rcf@hutchison-mrc.cam.ac.uk		Fitzgerald, Rebecca/0000-0002-3434-3568	Medical Research Council; MRC [MC_U105365007] Funding Source: UKRI; Medical Research Council [MC_U105365007] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Medical Research Council funded this work.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Arts J, 1996, EUR J BIOCHEM, V241, P393, DOI 10.1111/j.1432-1033.1996.00393.x; Bailey T, 1998, AM J PATHOL, V152, P135; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; BOTEBORG T, 2000, CELL AGGREGATION ASS, P33; Chazaud B, 2002, AM J PATHOL, V160, P237, DOI 10.1016/S0002-9440(10)64367-2; Chen LQ, 2001, ANN SURG, V234, P172, DOI 10.1097/00000658-200108000-00006; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duffy MJ, 2002, BIOCHEM SOC T, V30, P207, DOI 10.1042/BST0300207; Edmiston JS, 2005, CANCER RES, V65, P4782, DOI 10.1158/0008-5472.CAN-04-4354; Farina AR, 1998, INT J CANCER, V75, P721; Festuccia C, 2000, INT J CANCER, V85, P407, DOI 10.1002/(SICI)1097-0215(20000201)85:3<407::AID-IJC18>3.0.CO;2-8; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Hewin DF, 1996, BRIT J SURG, V83, P1152, DOI 10.1002/bjs.1800830838; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Kutz SM, 2001, J CELL SCI, V114, P3905; LENGYEL E, 1995, J BIOL CHEM, V270, P23007, DOI 10.1074/jbc.270.39.23007; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; MASUI T, 1986, P NATL ACAD SCI USA, V83, P2438, DOI 10.1073/pnas.83.8.2438; Morrissey D, 1999, CLIN EXP METASTAS, V17, P77; MULDER KM, 1992, J BIOL CHEM, V267, P5029; NAKAMURA T, 1994, CANCER-AM CANCER SOC, V73, P1785, DOI 10.1002/1097-0142(19940401)73:7<1785::AID-CNCR2820730703>3.0.CO;2-0; NERLOV C, 1991, ONCOGENE, V6, P1583; O'Shaughnessy JA, 2002, CLIN CANCER RES, V8, P314; Onwuegbusi BA, 2006, GUT, V55, P764, DOI 10.1136/gut.2005.076430; Providence KM, 2000, J CELL PHYSIOL, V182, P269, DOI 10.1002/(SICI)1097-4652(200002)182:2<269::AID-JCP16>3.0.CO;2-E; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Torquati A, 2004, SURGERY, V136, P310, DOI 10.1016/j.surg.2004.05.005; Wang L, 2004, ONCOGENE, V23, P5978, DOI 10.1038/sj.onc.1207802; WESTERHAUSEN DR, 1991, J BIOL CHEM, V266, P1092; Witowsky J, 2003, J BIOL CHEM, V278, P5941, DOI 10.1074/jbc.M212363200; Yang YM, 2003, CLIN CANCER RES, V9, P391; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	36	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e177	10.1371/journal.pone.0000177	http://dx.doi.org/10.1371/journal.pone.0000177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17264880	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444200002
J	Sendi, P; Gunthard, HF; Simcock, M; Ledergerber, B; Schupbach, J; Battegay, M				Sendi, Pedram; Guenthard, Huldrych F.; Simcock, Mathew; Ledergerber, Bruno; Schuepbach, Joerg; Battegay, Manuel		Swiss HIV Cohort Study	Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure	PLOS ONE			English	Article								Background. Genotypic antiretroviral resistance testing (GRT) in HIV infection with drug resistant virus is recommended to optimize antiretroviral therapy, in particular in patients with virological failure. We estimated the clinical effect, cost and cost-effectiveness of using GRT as compared to expert opinion in patients with antiretroviral treatment failure. Methods. We developed a mathematical model of HIV disease to describe disease progression in HIV-infected patients with treatment failure and compared the incremental impact of GRT versus expert opinion to guide antiretroviral therapy. The analysis was conducted from the health care (discount rate 4%) and societal (discount rate 2%) perspective. Outcome measures included life-expectancy, quality-adjusted life-expectancy, health care costs, productivity costs and cost-effectiveness in US Dollars per quality-adjusted life-year (QALY) gained. Clinical and economic data were extracted from the large Swiss HIV Cohort Study and clinical trials. Results. Patients whose treatment was optimized with GRT versus expert opinion had an increase in discounted life-expectancy and quality-adjusted life-expectancy of three and two weeks, respectively. Health care costs with and without GRT were $US 421,000 and $US 419,000, leading to an incremental cost-effectiveness ratio of $US 35,000 per QALY gained. In the analysis from the societal perspective, GRT versus expert opinion led to an increase in discounted life-expectancy and quality-adjusted life-expectancy of three and four weeks, respectively. Health care costs with and without GRT were $US 551,000 and $US 549,000, respectively. When productivity changes were included in the analysis, GRT was cost-saving. Conclusions. GRT for treatment optimization in HIV-infected patients with treatment failure is a cost-effective use of scarce health care resources and beneficial to the society at large.	[Sendi, Pedram; Simcock, Mathew; Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Sendi, Pedram; Simcock, Mathew] Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; [Guenthard, Huldrych F.; Ledergerber, Bruno] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Schuepbach, Joerg] Univ Zurich, Swiss Natl Ctr Retroviruses, Zurich, Switzerland	University of Basel; University of Basel; University of Zurich; University Zurich Hospital; University of Zurich	Sendi, P (corresponding author), Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland.	pedram.sendi@unibas.ch; mbattegay@uhbs.ch	Pantaleo, Giuseppe/K-6163-2016; gunthard, huldrych f/F-1724-2011; Sendi, Pedram/AAC-2067-2019; Ledergerber, Bruno/B-5656-2009; Schüpbach, Jörg/G-4209-2016; VALLET, Yannick/F-9979-2011; SHCS, social sciences/G-4093-2011; Sendi, Parham/R-3286-2018	gunthard, huldrych f/0000-0002-1142-6723; Ledergerber, Bruno/0000-0002-6881-4401; Schüpbach, Jörg/0000-0002-8074-5891; Sendi, Parham/0000-0002-7347-6312	Swiss National Science Foundation [3345CO-103560/1]; Stiftung Forschung Infektionskrankheiten Basel; Swiss HIV Cohort Study (SHCS) [400]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung Forschung Infektionskrankheiten Basel; Swiss HIV Cohort Study (SHCS)	This cost-effectiveness analysis was financially supported by the Swiss National Science Foundation (SNF project # 3345CO-103560/1), the Stiftung Forschung Infektionskrankheiten Basel and the Swiss HIV Cohort Study (SHCS project # 400), supported by the Swiss National Science Foundation.	Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Briggs AH, 1999, HEALTH ECON, V8, P257, DOI 10.1002/(SICI)1099-1050(199905)8:3<257::AID-HEC427>3.0.CO;2-E; Briggs AH, 2003, MED DECIS MAKING, V23, P341, DOI 10.1177/0272989X03255922; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; Chaix C, 2000, J ACQ IMMUN DEF SYND, V24, P227; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Clevenbergh P, 2000, ANTIVIR THER, V5, P65; Corzillius M, 2004, ANTIVIR THER, V9, P27; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Drummond MF, 2015, METHODS EC EVALUATIO; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Ena J, 2006, ENFERM INFEC MICR CL, V24, P232, DOI 10.1016/S0213-005X(06)73768-5; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Haupts S, 2003, ANTIVIR THER, V8, P443; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; Hirsch HH, 2005, EUR J CLIN MICROBIOL, V24, P733, DOI 10.1007/s10096-005-0044-4; Hirsch Martin S, 2003, Top HIV Med, V11, P150; Hirsch MS, 2003, CLIN INFECT DIS, V37, P113, DOI 10.1086/375597; Hunink MGM, 1998, MED DECIS MAKING, V18, P337, DOI 10.1177/0272989X9801800312; Jiang HY, 2003, J INFECT DIS, V188, P1001, DOI 10.1086/378355; Johannesson M, 1998, HEALTH ECON, V7, P1, DOI 10.1002/(SICI)1099-1050(199802)7:1<1::AID-HEC327>3.0.CO;2-U; Johannesson M, 1997, MED DECIS MAKING, V17, P382, DOI 10.1177/0272989X9701700403; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; KRAHN M, 1993, MED CARE, V31, P403, DOI 10.1097/00005650-199305000-00003; Krol M, 2006, PHARMACOECONOMICS, V24, P401, DOI 10.2165/00019053-200624040-00009; LEDERGERBER B, 1994, SOZ PRAVENTIV MED, V39, P387, DOI 10.1007/BF01299670; MCCARTHY BD, 1993, ARCH INTERN MED, V153, P1107, DOI 10.1001/archinte.153.9.1107; Meltzer D, 1999, MED DECIS MAKING, V19, P371, DOI 10.1177/0272989X9901900401; Mrus JM, 2003, MED DECIS MAKING, V23, P414, DOI 10.1177/0272989X03256884; OCHOA DE, 2005, AIDS, V19, P1385; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Panidou ET, 2004, AIDS, V18, P2153, DOI 10.1097/00002030-200411050-00007; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Sax PE, 2005, CLIN INFECT DIS, V41, P1316, DOI 10.1086/496984; Sendi P, 2005, HEALTH ECON, V14, P643, DOI 10.1002/hec.971; Sendi P, 2004, CLIN THER, V26, P791, DOI 10.1016/S0149-2918(04)90080-X; Sendi PP, 1999, AIDS, V13, P1115, DOI 10.1097/00002030-199906180-00016; Sendi PP, 1999, J ACQ IMMUN DEF SYND, V20, P376, DOI 10.1097/00042560-199904010-00008; Sendi PP, 1999, J EVAL CLIN PRACT, V5, P283, DOI 10.1046/j.1365-2753.1999.00174.x; Sendi PP, 1999, J ANTIMICROB CHEMOTH, V44, P811, DOI 10.1093/jac/44.6.811; Simcock M, 2006, ANTIVIR THER, V11, P305; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Torre Donato, 2002, HIV Clin Trials, V3, P1, DOI 10.1310/FY66-NVWJ-3332-HW3C; Vandamme AM, 2004, ANTIVIR THER, V9, P829; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251; Zinkernagel C, 1999, AIDS, V13, P1587, DOI 10.1097/00002030-199908200-00024	53	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e173	10.1371/journal.pone.0000173	http://dx.doi.org/10.1371/journal.pone.0000173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17245449	Green Published, gold			2022-12-27	WOS:000207444100010
J	Breuker, CJ; Patterson, JS; Klingenberg, CP				Breuker, Casper J.; Patterson, James S.; Klingenberg, Christian Peter			A Single Basis for Developmental Buffering of Drosophila Wing Shape	PLOS ONE			English	Article								The nature of developmental buffering processes has been debated extensively, based on both theoretical reasoning and empirical studies. In particular, controversy has focused on the question of whether distinct processes are responsible for canalization, the buffering against environmental or genetic variation, and for developmental stability, the buffering against random variation intrinsic in developmental processes. Here, we address this question for the size and shape of Drosophila melanogaster wings in an experimental design with extensively replicated and fully controlled genotypes. The amounts of variation among individuals and of fluctuating asymmetry differ markedly among genotypes, demonstrating a clear genetic basis for size and shape variability. For wing shape, there is a high correlation between the amounts of variation among individuals and fluctuating asymmetry, which indicates a correspondence between the two types of buffering. Likewise, the multivariate patterns of shape variation among individuals and of fluctuating asymmetry show a close association. For wing size, however, the amounts of individual variation and fluctuating asymmetry are not correlated. There was a significant link between the amounts of variation between wing size and shape, more so for fluctuating asymmetry than for variation among individuals. Overall, these experiments indicate a considerable degree of shared control of individual variation and fluctuating asymmetry, although it appears to differ between traits.	[Breuker, Casper J.; Patterson, James S.; Klingenberg, Christian Peter] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Klingenberg, CP (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	cpk@manchester.ac.uk	Breuker, Casper/P-8270-2019; Klingenberg, Christian Peter/B-3470-2010; Breuker, Casper/N-6582-2013; Rohlf, F J/A-8710-2008	Breuker, Casper/0000-0001-7909-1950; Klingenberg, Christian Peter/0000-0002-8117-6141; Breuker, Casper/0000-0001-7909-1950; 	Marie Curie Intra-European Fellowship, 6th European Community; UK Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/B/12253] Funding Source: researchfish	Marie Curie Intra-European Fellowship, 6th European Community; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a Marie Curie Intra-European Fellowship within the 6th European Community Framework Programme and a research grant from the UK Biotechnology and Biological Sciences Research Council.	Badyaev AV, 2004, AM NAT, V163, P868, DOI 10.1086/386551; Baylac M, 1998, ACTA ZOOL ACAD SCI H, V44, P97; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Clarke GM, 1998, HEREDITY, V80, P562, DOI 10.1046/j.1365-2540.1998.00294.x; Debat V, 2000, P ROY SOC B-BIOL SCI, V267, P423, DOI 10.1098/rspb.2000.1017; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Dworkin I, 2005, EVOLUTION, V59, P1500; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Good P, 2000, PERMUTATION TESTS PR; Hallgrimmson B., 2005, VARIATION CENTRAL CO, P525; Hallgrimsson B, 2004, J EXP ZOOL PART B, V302B, P207, DOI 10.1002/jez.b.21002; Hallgrimsson B, 2003, J EXP ZOOL PART B, V296B, P40, DOI 10.1002/jez.b.00015; Hallgrimsson B, 2002, YEARB PHYS ANTHROPOL, V45, P131, DOI 10.1002/ajpa.10182; Hoffmann AA, 2001, ECOL LETT, V4, P97, DOI 10.1046/j.1461-0248.2001.00205.x; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Iriarte PF, 2003, J GENET, V82, P95, DOI 10.1007/BF02715812; Klingenberg Christian Peter, 2003, P14; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1999, EVOLUTION, V53, P358, DOI [10.2307/2640773, 10.1111/j.1558-5646.1999.tb03772.x]; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; LEAMY L, 1993, GENETICA, V89, P139, DOI 10.1007/BF02424510; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; Loy A, 1998, J MORPHOL, V237, P137, DOI 10.1002/(SICI)1097-4687(199808)237:2<137::AID-JMOR5>3.0.CO;2-Z; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; McKenzie John A., 2003, P135; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Milton CC, 2003, P NATL ACAD SCI USA, V100, P13396, DOI 10.1073/pnas.1835613100; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Reale D, 2003, EVOLUTION, V57, P597, DOI 10.1111/j.0014-3820.2003.tb01551.x; Rego C, 2006, EVOLUTION, V60, P746, DOI 10.1111/j.0014-3820.2006.tb01153.x; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Santos M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-7; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Trotta V, 2005, EVOL DEV, V7, P234, DOI 10.1111/j.1525-142X.2005.05026.x; Van Valen Leigh, 2005, P29, DOI 10.1016/B978-012088777-4/50005-3; Willmore KE, 2006, J ANAT, V208, P361, DOI 10.1111/j.1469-7580.2006.00527.x; Willmore KE, 2005, EVOLUTION, V59, P898; Windig JJ, 2000, J EVOLUTION BIOL, V13, P29, DOI 10.1046/j.1420-9101.2000.00143.x; Woods RE, 1999, EVOLUTION, V53, P493, DOI [10.2307/2640785, 10.1111/j.1558-5646.1999.tb03784.x]; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	49	113	113	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e7	10.1371/journal.pone.0000007	http://dx.doi.org/10.1371/journal.pone.0000007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183701	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600007
J	Collins, C; Azmi, P; Berru, M; Zhu, XF; Shulman, MJ				Collins, Cathy; Azmi, Peter; Berru, Maribel; Zhu, Xiaofu; Shulman, Marc J.			A Weakened Transcriptional Enhancer Yields Variegated Gene Expression	PLOS ONE			English	Article							HEAVY-CHAIN LOCUS; MATRIX ATTACHMENT REGIONS; BINDING PROTEIN; IGH LOCUS; IMMUNOGLOBULIN; METHYLATION; CELLS; ELEMENTS; ABSENCE; SITES	Identical genes in the same cellular environment are sometimes expressed differently. In some cases, including the immunoglobulin heavy chain (IgH) locus, this type of differential gene expression has been related to the absence of a transcriptional enhancer. To gain additional information on the role of the IgH enhancer, we examined expression driven by enhancers that were merely weakened, rather than fully deleted, using both mutations and insulators to impair enhancer activity. For this purpose we used a LoxP/Cre system to place a reporter gene at the same genomic site of a stable cell line. Whereas expression of the reporter gene was uniformly high in the presence of the normal, uninsulated enhancer and undetectable in its absence, weakened enhancers yielded variegated expression of the reporter gene; i.e., the average level of expression of the same gene differed in different clones, and expression varied significantly among cells within individual clones. These results indicate that the weakened enhancer allows the reporter gene to exist in at least two states. Subtle aspects of the variegation suggest that the IgH enhancer decreases the average duration (half-life) of the silent state. This analysis has also tested the conventional wisdom that enhancer activity is independent of distance and orientation. Thus, our analysis of mutant (truncated) forms of the IgH enhancer revealed that the 250 bp core enhancer was active in its normal position, similar to 1.4 kb 3' of the promoter, but inactive,6 kb 3', indicating that the activity of the core enhancer was distance-dependent. A longer segment - the core enhancer plus, 1 kb of 3' flanking material, including the 3' matrix attachment region - was active, and the activity of this longer segment was orientation-dependent. Our data suggest that this 3' flank includes binding sites for at least two activators.	[Collins, Cathy; Azmi, Peter; Berru, Maribel; Zhu, Xiaofu; Shulman, Marc J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto	Shulman, MJ (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	marc.shulman@utoronto.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding: This work was supported by grants from the Canadian Institutes of Health Research.	Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BERTRAND E, 1994, NUCLEIC ACIDS RES, V22, P293, DOI 10.1093/nar/22.3.293; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cheng EY, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-27; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113; Forrester WC, 1999, GENE DEV, V13, P3003, DOI 10.1101/gad.13.22.3003; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; GROSSCHEDL R, 1988, CELL, V55, P645, DOI 10.1016/0092-8674(88)90223-1; Guo LY, 2005, IMMUNITY, V23, P89, DOI 10.1016/j.immuni.2005.05.008; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; JENUWEIN T, 1993, GENE DEV, V7, P2016, DOI 10.1101/gad.7.10.2016; KADESCH T, 1986, NUCLEIC ACIDS RES, V14, P8209, DOI 10.1093/nar/14.20.8209; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kurakin A, 2005, DEV GENES EVOL, V215, P46, DOI 10.1007/s00427-004-0448-7; LEE JJ, 1987, METHOD ENZYMOL, V152, P633; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; Oancea AE, 1997, MOL CELL BIOL, V17, P2658, DOI 10.1128/MCB.17.5.2658; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; PORTON B, 1990, MOL CELL BIOL, V10, P1076, DOI 10.1128/MCB.10.3.1076; Ronai D, 1999, MOL CELL BIOL, V19, P7031; Ronai D, 2004, GENETICS, V167, P411, DOI 10.1534/genetics.167.1.411; Ronai D, 2002, J IMMUNOL, V169, P6919, DOI 10.4049/jimmunol.169.12.6919; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; SCHEUERMANN RH, 1989, GENE DEV, V3, P1255, DOI 10.1101/gad.3.8.1255; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; SKOG S, 1979, CELL TISSUE KINET, V12, P501, DOI 10.1111/j.1365-2184.1979.tb00172.x; Sutter NB, 2003, P NATL ACAD SCI USA, V100, P1105, DOI 10.1073/pnas.242732999; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; WASYLYK C, 1986, EMBO J, V5, P553, DOI 10.1002/j.1460-2075.1986.tb04246.x; Wiersma EJ, 1999, J BIOL CHEM, V274, P4858, DOI 10.1074/jbc.274.8.4858; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zhao H, 2004, NUCLEIC ACIDS RES, V32, P4903, DOI 10.1093/nar/gkh832	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e33	10.1371/journal.pone.0000033	http://dx.doi.org/10.1371/journal.pone.0000033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183661	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600033
J	Goren, A; Simchen, G; Fibach, E; Szabo, PE; Tanimoto, K; Chakalova, L; Pfeifer, GP; Fraser, PJ; Engel, JD; Cedar, H				Goren, Alon; Simchen, Giora; Fibach, Eitan; Szabo, Piroska E.; Tanimoto, Keiji; Chakalova, Lyubomira; Pfeifer, Gerd P.; Fraser, Peter J.; Engel, James D.; Cedar, Howard			Fine Tuning of Globin Gene Expression by DNA Methylation	PLOS ONE			English	Article								Expression patterns in the globin gene cluster are subject to developmental regulation in vivo. While the gamma(A) and gamma(G) genes are expressed in fetal liver, both are silenced in adult erythrocytes. In order to decipher the role of DNA methylation in this process, we generated a gamma AC transgenic mouse system that allowed us to control gamma(A) methylation during development. DNA methylation causes a 20-fold repression of gamma(A) both in non-erythroid and adult erythroid cells. In erythroid cells this modification works as a dominant mechanism to repress gamma gene expression, probably through changes in histone acetylation that prevent the binding of erythroid transcription factors to the promoter. These studies demonstrate that DNA methylation serves as an elegant in vivo fine-tuning device for selecting appropriate genes in the globin locus. In addition, our findings provide a mechanism for understanding the high levels of gamma-globin transcription seen in patients with Hereditary Persistence of Fetal Hemoglobin, and help explain why 5azaC and butyrate compounds stimulate gamma-globin expression in patients with beta-hemoglobinopathies.	[Goren, Alon; Cedar, Howard] Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Jerusalem, Israel; [Simchen, Giora] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Fibach, Eitan] Hebrew Univ Jerusalem, Dept Hematol, IL-91904 Jerusalem, Israel; [Szabo, Piroska E.; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA USA; [Tanimoto, Keiji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Chakalova, Lyubomira; Fraser, Peter J.] Babraham Inst, Lab Chromatin & Gene Express, Cambridge, England; [Engel, James D.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; City of Hope; Beckman Research Institute of City of Hope; University of Tsukuba; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Michigan System; University of Michigan	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Jerusalem, Israel.	cedar@md.huji.ac.il	Chakalova, Lyubomira/C-6810-2012; Fraser, Peter/B-7549-2009; Tanimoto, Keiji/B-2600-2014	Fraser, Peter/0000-0002-0041-1227; Szabo, Piroska/0000-0001-9314-7009; Goren, Alon/0000-0001-5669-9357; Tanimoto, Keiji/0000-0003-1971-6546	NIH; Belfer Foundation; Israel Cancer Research Fund; Israel Ministry of Health; MRC [G117/530] Funding Source: UKRI; Medical Research Council [G117/530] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belfer Foundation; Israel Cancer Research Fund; Israel Ministry of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This work was supported by NIH, Belfer Foundation, Israel Cancer Research Fund and Israel Ministry of Health.	BERRY M, 1992, NATURE, V358, P499, DOI 10.1038/358499a0; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BRANDEIS M, 1993, BIOESSAYS, V15, P1; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; BUSSLINGER M, 1983, CELL, V34, P197, DOI 10.1016/0092-8674(83)90150-2; COLLINS FS, 1987, BLOOD, V70, P1797; DHAR V, 1988, MOL CELL BIOL, V8, P4958, DOI 10.1128/MCB.8.11.4958; Duan ZJ, 2001, MOL CELL BIOL, V21, P3083, DOI 10.1128/MCB.21.9.3083-3095.2001; ELDER JT, 1990, MOL CELL BIOL, V10, P1382, DOI 10.1128/MCB.10.4.1382; EPNER E, 1988, P NATL ACAD SCI USA, V85, P8081, DOI 10.1073/pnas.85.21.8081; FEINGOLD EA, 1989, BLOOD, V74, P2178; FIBACH E, 1989, BLOOD, V73, P100; Forget BG, 1998, ANN NY ACAD SCI, V850, P38, DOI 10.1111/j.1749-6632.1998.tb10460.x; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; Fu XH, 2002, EXP CELL RES, V278, P1, DOI 10.1006/excr.2002.5555; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; Gilbert DM, 2002, NAT GENET, V32, P336, DOI 10.1038/ng1102-336; Goren A, 2003, NAT REV MOL CELL BIO, V4, P25, DOI 10.1038/nrm1008; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; HUISMAN THJ, 1997, SICKLE CELL ANEMIA; Huxley C, 1998, METHODS, V14, P199, DOI 10.1006/meth.1997.0578; IKUTA T, 1991, P NATL ACAD SCI USA, V88, P10188, DOI 10.1073/pnas.88.22.10188; Ikuta T, 1996, J BIOL CHEM, V271, P14082, DOI 10.1074/jbc.271.24.14082; Ji YH, 2003, P NATL ACAD SCI USA, V100, P7557, DOI 10.1073/pnas.0932635100; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; Li F, 2001, J CELL BIOL, V154, P283, DOI 10.1083/jcb.200104043; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; OPPENHEIM A, 1985, BLOOD, V66, P1202; PERRINE SP, 1993, NEW ENGL J MED, V328, P81, DOI 10.1056/NEJM199301143280202; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Peterson KR, 1998, HUM MOL GENET, V7, P2079, DOI 10.1093/hmg/7.13.2079; PONCZ M, 1987, NUCLEIC ACIDS RES, V15, P5169, DOI 10.1093/nar/15.13.5169; RONCHI AE, 1995, J BIOL CHEM, V270, P21934, DOI 10.1074/jbc.270.37.21934; Rupon JW, 2006, P NATL ACAD SCI USA, V103, P6617, DOI 10.1073/pnas.0509322103; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Simon I, 2001, EMBO J, V20, P6150, DOI 10.1093/emboj/20.21.6150; Szabo PE, 2000, ANAL BIOCHEM, V283, P112, DOI 10.1006/abio.2000.4631; Szabo PE, 2004, MOL CELL BIOL, V24, P4858, DOI 10.1128/MCB.24.11.4858-4868.2004; Tanimoto K, 1999, NUCLEIC ACIDS RES, V27, P3130, DOI 10.1093/nar/27.15.3130; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; VANDERPLOEG LHT, 1980, CELL, V19, P947, DOI 10.1016/0092-8674(80)90086-0; Yeivin A, 1993, EXS, V64, P523; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150	51	40	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e46	10.1371/journal.pone.0000046	http://dx.doi.org/10.1371/journal.pone.0000046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183675	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600046
J	Marani, M; Zillio, T; Belluco, E; Silvestri, S; Maritan, A				Marani, Marco; Zillio, Tommaso; Belluco, Enrica; Silvestri, Sonia; Maritan, Amos			Non-Neutral Vegetation Dynamics	PLOS ONE			English	Article							RELATIVE SPECIES ABUNDANCE; BETA-DIVERSITY; PATTERNS; MODEL	The neutral theory of biodiversity constitutes a reference null hypothesis for the interpretation of ecosystem dynamics and produces relatively simple analytical descriptions of basic system properties, which can be easily compared to observations. On the contrary, investigations in non-neutral dynamics have in the past been limited by the complexity arising from heterogeneous demographic behaviours and by the relative paucity of detailed observations of the spatial distribution of species diversity (beta-diversity): These circumstances prevented the development and testing of explicit non-neutral mathematical descriptions linking competitive strategies and observable ecosystem properties. Here we introduce an exact non-neutral model of vegetation dynamics, based on cloning and seed dispersal, which yields closed-form characterizations of beta-diversity. The predictions of the non-neutral model are validated using new high-resolution remote-sensing observations of salt-marsh vegetation in the Venice Lagoon (Italy). Model expressions of beta-diversity show a remarkable agreement with observed distributions within the wide observational range of scales explored (5.10(-1) m divided by 10(3) m). We also consider a neutral version of the model and find its predictions to be in agreement with the more limited characterization of beta-diversity typical of the neutral theory (based on the likelihood that two sites be conspecific or heterospecific, irrespective of the species). However, such an agreement proves to be misleading as the recruitment rates by propagules and by seed dispersal assumed by the neutral model do not reflect known species characteristics and correspond to averages of those obtained under the more general non-neutral hypothesis. We conclude that non-neutral beta-diversity characterizations are required to describe ecosystem dynamics in the presence of species-dependent properties and to successfully relate the observed patterns to the underlying processes.	[Marani, Marco; Belluco, Enrica] Univ Padua, Dipartimento Ingn Idraul Marittima Ambientale & G, Padua, Italy; [Marani, Marco; Belluco, Enrica] Univ Padua, Int Ctr Hydrol, Padua, Italy; [Zillio, Tommaso] Int Sch Adv Studies SISSA, Trieste, Italy; [Silvestri, Sonia] CVN, Serv Informat, Venice, Italy; [Maritan, Amos] CNIS, Unita Padova, Padua, Italy	University of Padua; University of Padua; International School for Advanced Studies (SISSA)	Marani, M (corresponding author), Univ Padua, Dipartimento Ingn Idraul Marittima Ambientale & G, Padua, Italy.	marani@idra.unipd.it; amos.maritan@pd.infn.it	Marani, Marco/F-9451-2016	Belluco, Enrica/0000-0001-8094-0219; Marani, Marco/0000-0002-1493-6913; SILVESTRI, SONIA/0000-0002-5114-8633; Maritan, Amos/0000-0002-3535-7873	TIDE EU RTD [EVK3-CT-2001-00064]; NSF [DEB-0346488]	TIDE EU RTD; NSF(National Science Foundation (NSF))	This work was supported by the TIDE EU RTD Project (EVK3-CT-2001-00064) and by NSF grant DEB-0346488.	Abramowitz M., 1970, HDB MATH FUNCTIONS; Adam P., 1990, SALT MARSH ECOLOGY; Belluco E, 2006, REMOTE SENS ENVIRON, V105, P54, DOI 10.1016/j.rse.2006.06.006; CASTELLANOS EM, 1994, J ECOL, V82, P239, DOI 10.2307/2261292; Caylor KK, 2006, DRYLAND ECOHYDROLOGY, P259, DOI 10.1007/1-4020-4260-4_15; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Cronk J, 2001, WETLAND PLANTS BIOL; DACEY JWH, 1984, SCIENCE, V224, P487, DOI 10.1126/science.224.4648.487; Gosselink J.G., 2000, WETLANDS; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Hubbell Stephen P., 2001, V32, pi; KRUSE FA, 1993, REMOTE SENS ENVIRON, V44, P145, DOI 10.1016/0034-4257(93)90013-N; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Marani M, 2004, J MARINE SYST, V51, P191, DOI 10.1016/j.jmarsys.2004.05.012; MARANI M, 2006, WATER RESOUR RES, V42, pD606, DOI DOI 10.1029/2005WR004582; Marani M, 2006, ESTUAR COAST SHELF S, V69, P414, DOI 10.1016/j.ecss.2006.05.021; Pandolfi JM, 2006, NATURE, V440, P35, DOI 10.1038/440035a; Rodriguez-Iturbe I., 2005, ECOHYDROLOGY WATER C; Silvestri S, 2005, ESTUAR COAST SHELF S, V62, P119, DOI 10.1016/j.ecss.2004.08.010; Ursino N, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002702; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Zillio T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098101	26	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e78	10.1371/journal.pone.0000078	http://dx.doi.org/10.1371/journal.pone.0000078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183710	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600078
J	Rzhetsky, A; Zheng, T; Weinreb, C				Rzhetsky, Andrey; Zheng, Tian; Weinreb, Chani			Self-Correcting Maps of Molecular Pathways	PLOS ONE			English	Article							BAYESIAN NETWORKS; EXPRESSION; APOPTOSIS; PRESENILIN-1; KNOWLEDGE; MODELS	Reliable and comprehensive maps of molecular pathways are indispensable for guiding complex biomedical experiments. Such maps are typically assembled from myriads of disparate research reports and are replete with inconsistencies due to variations in experimental conditions and/or errors. It is often an intractable task to manually verify internal consistency over a large collection of experimental statements. To automate large-scale reconciliation efforts, we propose a random-arcs-and-nodes model where both nodes (tissue-specific states of biological molecules) and arcs (interactions between them) are represented with random variables. We show how to obtain a non-contradictory model of a molecular network by computing the joint distribution for arc and node variables, and then apply our methodology to a realistic network, generating a set of experimentally testable hypotheses. This network, derived from an automated analysis of over 3,000 full-text research articles, includes genes that have been hypothetically linked to four neurological disorders: Alzheimer's disease, autism, bipolar disorder, and schizophrenia. We estimated that approximately 10% of the published molecular interactions are logically incompatible. Our approach can be directly applied to an array of diverse problems including those encountered in molecular biology, ecology, economics, politics, and sociology.	[Rzhetsky, Andrey; Weinreb, Chani] Columbia Univ, Dept Biomed Informat, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Rzhetsky, Andrey; Weinreb, Chani] Columbia Univ, Joint Ctr Syst Biol, New York, NY USA; [Rzhetsky, Andrey] Columbia Univ, Judith P Sulzberger MD Columbia Genome Ctr, New York, NY USA; [Rzhetsky, Andrey] Columbia Univ, Dept Biol, New York, NY USA; [Zheng, Tian] Columbia Univ, Dept Stat, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Rzhetsky, A (corresponding author), Columbia Univ, Dept Biomed Informat, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA.	andrey.rzhetsky@dbmi.columbia.edu	rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405; Zheng, Tian/0000-0003-4889-0391	National Institutes of Health [GM61372, GM070789]; National Science Foundation [0438291, 0121687, 0532231]; Cure Autism Now Foundation; Defense Advanced Research Projects Agency [FA8750-04-2-0123];  [5-T15-LM007079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061372, R01GM070789] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Cure Autism Now Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institutes of Health (GM61372 to A. R., GM070789 to T. Z., and training fellowship 5-T15-LM007079 to C. W.), the National Science Foundation ( 0438291 and 0121687 to A. R., and 0532231 to T. Z.), the Cure Autism Now Foundation to A. R., and the Defense Advanced Research Projects Agency (FA8750-04-2-0123 to A. R.).	Amson R, 2000, P NATL ACAD SCI USA, V97, P5346, DOI 10.1073/pnas.97.10.5346; Barabasi AL, 2005, SCIENCE, V308, P639, DOI 10.1126/science.1112554; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Cokol M, 2005, NAT BIOTECHNOL, V23, P1243, DOI 10.1038/nbt1005-1243; da Costa CA, 2003, J BIOL CHEM, V278, P12064, DOI 10.1074/jbc.M212379200; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; Frey BJ, 2005, NAT GENET, V37, P991, DOI 10.1038/ng1630; Friedman C, 2001, Bioinformatics, V17 Suppl 1, pS74; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gilks WR, 1996, MARKOV CHAIN MONTE C; Hartemink A J, 2001, Pac Symp Biocomput, P422; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; HECKERMAN D, 1995, COMMUN ACM, V38, P27, DOI 10.1145/203330.203336; Hoff PD, 2004, POLIT ANAL, V12, P160, DOI 10.1093/pan/mph012; Kahn CE, 1997, COMPUT BIOL MED, V27, P19, DOI 10.1016/S0010-4825(96)00039-X; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Ligon KL, 2003, DEVELOPMENT, V130, P2275, DOI 10.1242/dev.00421; Liu J. S., 2001, SPRINGER SERIES STAT; Markowetz F, 2005, BIOINFORMATICS, V21, P4026, DOI 10.1093/bioinformatics/bti662; McDonough PM, 1997, J BIOL CHEM, V272, P24046, DOI 10.1074/jbc.272.38.24046; PEARL J, 1988, M KAUFMANN SERIES RE; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; RZHETSKY A, 2006, P NATL ACAD SCI US; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; SZOLOVITS P, 1995, METHOD INFORM MED, V34, P111; Von Neumann J., 1956, AUTOM STUD, V34, P43, DOI DOI 10.1515/9781400882618-003; Yeang CH, 2004, J COMPUT BIOL, V11, P243, DOI 10.1089/1066527041410382	29	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e61	10.1371/journal.pone.0000061	http://dx.doi.org/10.1371/journal.pone.0000061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183692	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600061
J	Addo, MM; Draenert, R; Rathod, A; Verrill, CL; Davis, BT; Gandhi, RT; Robbins, GK; Basgoz, NO; Stone, DR; Cohen, DE; Johnston, MN; Flynn, T; Wurcel, AG; Rosenberg, ES; Altfeld, M; Walker, BD				Addo, Marylyn M.; Draenert, Rika; Rathod, Almas; Verrill, Cori L.; Davis, Benjamin T.; Gandhi, Rajesh T.; Robbins, Gregory K.; Basgoz, Nesli O.; Stone, David R.; Cohen, Daniel E.; Johnston, Mary N.; Flynn, Theresa; Wurcel, Alysse G.; Rosenberg, Eric S.; Altfeld, Marcus; Walker, Bruce D.			Fully Differentiated HIV-1 Specific CD8+T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection	PLOS ONE			English	Article								Background. CD8+ T cells impact control of viral infections by direct elimination of infected cells and secretion of a number of soluble factors. In HIV-1 infection, persistent HIV-1 specific IFN-gamma+ CD8+ T cell responses are detected in the setting of disease progression, consistent with functional impairment in vivo. Recent data suggest that impaired maturation, as defined by the lineage markers CD45RA and CCR7, may contribute to a lack of immune control by these responses. Methodology/Principal Findings. We investigated the maturation phenotype of epitope-specific CD8+ T cell responses directed against HIV-1 in 42 chronically infected, untreated individuals, 22 of whom were "Controllers'' (median 1140 RNA copies/ml plasma, range, 50 to 2520), and 20 "progressors'' of whom had advanced disease and high viral loads (median 135,500 RNA copies/ml plasma, range 12100 to >750000). Evaluation of a mean of 5 epitopes per person revealed that terminally differentiated CD8+ T cells directed against HIV-1 are more often seen in HIV-1 Controllers (16/22; 73%) compared to HIV-1 progressors (7/20; 35%)(p = 0.015), but the maturation state of epitope-specific responses within a given individual was quite variable. Maturation phenotype was independent of the HLA restriction or the specificity of a given CD8+ T cell response and individual epitopes associated with slow disease progression were not more likely to be terminally differentiated. Conclusions/Significance. These data indicate that although full maturation of epitope-specific CD8+ T cell responses is associated with viral control, the maturation status of HIV-1 specific CD8+ T cell responses within a given individual are quite heterogeneous, suggesting epitope-specific influences on CD8+ T cell function.	[Draenert, Rika; Verrill, Cori L.; Walker, Bruce D.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Partners AIDS Res Ctr, Boston, MA 02114 USA; [Addo, Marylyn M.; Draenert, Rika; Rathod, Almas; Verrill, Cori L.; Davis, Benjamin T.; Gandhi, Rajesh T.; Robbins, Gregory K.; Basgoz, Nesli O.; Johnston, Mary N.; Flynn, Theresa; Wurcel, Alysse G.; Rosenberg, Eric S.; Altfeld, Marcus; Walker, Bruce D.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Addo, Marylyn M.; Draenert, Rika; Rathod, Almas; Verrill, Cori L.; Davis, Benjamin T.; Gandhi, Rajesh T.; Robbins, Gregory K.; Basgoz, Nesli O.; Johnston, Mary N.; Flynn, Theresa; Wurcel, Alysse G.; Rosenberg, Eric S.; Altfeld, Marcus; Walker, Bruce D.] Harvard Univ, Sch Med, Div Aids, Boston, MA 02115 USA; [Stone, David R.; Wurcel, Alysse G.] Lemuel Shattuck Hosp, Boston, MA USA; [Cohen, Daniel E.] Fenway Community Hlth Ctr, Boston, MA USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Walker, BD (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Partners AIDS Res Ctr, Boston, MA 02114 USA.	Bwalker@partners.org	Addo, Marylyn M./GNP-2548-2022; Robbins, Gregory/F-7988-2011; Wurcel, Alysse/AAZ-6132-2020; Wurcel, Alysse/AAC-5372-2019; Altfeld, Marcus/AAE-7306-2019	Wurcel, Alysse/0000-0002-8255-8387; Altfeld, Marcus/0000-0001-5972-2997; Robbins, Gregory/0000-0001-7545-5817; Addo, Marylyn/0000-0003-2836-9224	National Institutes of Health [RO1 AI28568, AI054178-01, NO1-A1-15442]; Deutsche Forschungsgemeinschaft [DR424/1-1]; Howard Hughes Medical Institute; Doris Duke Charitable Foundation (BDW); Partners/Fenway/Shattuck CFAR; Claflin Distinguished Scholar Award (MMA); Concerned Parents for AIDS Research (CPFA); AmfAR [70577-31-RFT]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028568, R01AI054178, R56AI054178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation (BDW)(Doris Duke Charitable Foundation (DDCF)); Partners/Fenway/Shattuck CFAR; Claflin Distinguished Scholar Award (MMA); Concerned Parents for AIDS Research (CPFA); AmfAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (RO1 AI28568 and AI054178-01, contract # NO1-A1-15442), the Deutsche Forschungsgemeinschaft DR424/1-1 (RD), the Howard Hughes Medical Institute (RD and BDW), the Doris Duke Charitable Foundation (BDW), the Partners/Fenway/Shattuck CFAR, the Claflin Distinguished Scholar Award (MMA), Concerned Parents for AIDS Research (CPFA) (MMA) and AmfAR (70577-31-RFT) (MMA).	Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chen G, 2001, BLOOD, V98, P156, DOI 10.1182/blood.V98.1.156; Draenert R, 2004, INFECTION, V32, P250, DOI 10.1007/s15010-004-6404-7; Draenert R, 2004, J VIROL, V78, P630, DOI 10.1128/JVI.78.2.630-641.2004; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; FRAHM N, 2002, HIV MOL IMMUNOLOGY; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, J VIROL, V75, P1339, DOI 10.1128/JVI.75.3.1339-1347.2001; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; KIEPIELA P, 2004, NATURE IN PRESS; Kostense S, 2001, EUR J IMMUNOL, V31, P677, DOI 10.1002/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO;2-M; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Lichterfeld M, 2004, BLOOD, V104, P487, DOI 10.1182/blood-2003-12-4341; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; van Baarle D, 2002, TRENDS IMMUNOL, V23, P586, DOI 10.1016/S1471-4906(02)02326-8	34	83	92	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e321	10.1371/journal.pone.0000321	http://dx.doi.org/10.1371/journal.pone.0000321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389912	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445200004
J	Goldreich, D				Goldreich, Daniel			A Bayesian Perceptual Model Replicates the Cutaneous Rabbit and Other Tactile Spatiotemporal Illusions	PLOS ONE			English	Article							SOMATOSENSORY CORTEX; TEMPORAL-ORDER; ELECTROCUTANEOUS STIMULATION; BODY SITE; SPACE; TIME; SALTATION; DISTANCE; TAU; DISCRIMINATION	Background. When brief stimuli contact the skin in rapid succession at two or more locations, perception strikingly shrinks the intervening distance, and expands the elapsed time, between consecutive events. The origins of these perceptual space-time distortions are unknown. Methodology/Principal Findings. Here I show that these illusory effects, which I term perceptual length contraction and time dilation, are emergent properties of a Bayesian observer model that incorporates prior expectation for speed. Rapidly moving stimuli violate expectation, provoking perceptual length contraction and time dilation. The Bayesian observer replicates the cutaneous rabbit illusion, the tau effect, the kappa effect, and other spatiotemporal illusions. Additionally, it shows realistic tactile temporal order judgment and spatial attention effects. Conclusions/Significance. The remarkable explanatory power of this simple model supports the hypothesis, first proposed by Helmholtz, that the brain biases perception in favor of expectation. Specifically, the results suggest that the brain automatically incorporates prior expectation for speed in order to overcome spatial and temporal imprecision inherent in the sensorineural signal.	McMaster Univ, Dept Psychol Neurosci & Behaviour, Hamilton, ON, Canada	McMaster University	Goldreich, D (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behaviour, Hamilton, ON, Canada.	goldrd@mcmaster.ca		Goldreich, Daniel/0000-0002-5104-2185	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by an individual Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC).	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Braun C, 2002, NEUROIMAGE, V17, P1451, DOI 10.1006/nimg.2002.1277; BRIGNER WL, 1984, PERCEPT MOTOR SKILL, V59, P359, DOI 10.2466/pms.1984.59.2.359; BRIGNER WL, 1988, PERCEPT MOTOR SKILL, V66, P637, DOI 10.2466/pms.1988.66.2.637; Burton H, 2000, SOMATOSENS MOT RES, V17, P213; Cholewiak RW, 1999, PERCEPTION, V28, P851, DOI 10.1068/p2873; Cholewiak RW, 2000, PERCEPT PSYCHOPHYS, V62, P1220, DOI 10.3758/BF03212124; COHEN J, 1953, NATURE, V172, P901, DOI 10.1038/172901a0; COLLYER CE, 1976, PERCEPT PSYCHOPHYS, V19, P47, DOI 10.3758/BF03199384; COLLYER CE, 1977, PERCEPT PSYCHOPHYS, V21, P357, DOI 10.3758/BF03199487; Craig JC, 2003, PERCEPT PSYCHOPHYS, V65, P81, DOI 10.3758/BF03194785; DARIANSMITH I, 1980, J PHYSIOL-LONDON, V309, P147, DOI 10.1113/jphysiol.1980.sp013500; Eimer M, 2005, PERCEPT PSYCHOPHYS, V67, P458, DOI 10.3758/BF03193324; Essick GK, 1998, ADV PSYCHOL, V127, P1; Flach R, 2006, J EXP PSYCHOL HUMAN, V32, P717, DOI 10.1037/0096-1523.32.3.717; Foffani G, 2004, J NEUROSCI, V24, P7266, DOI 10.1523/JNEUROSCI.2523-04.2004; GELDARD FA, 1972, SCIENCE, V178, P178, DOI 10.1126/science.178.4057.178; GELDARD FA, 1982, PSYCHOL BULL, V92, P136, DOI 10.1037/0033-2909.92.1.136; GREEN BG, 1982, PERCEPT PSYCHOPHYS, V31, P315, DOI 10.3758/BF03202654; Helmholtz H., 1925, TREATISE PHYSL OPTIC, V3; Helson H, 1930, Science, V71, P536, DOI 10.1126/science.71.1847.536; Helson H, 1931, J EXP PSYCHOL, V14, P202, DOI 10.1037/h0071164; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Iguchi Y, 2005, CLIN NEUROPHYSIOL, V116, P1077, DOI 10.1016/j.clinph.2004.12.005; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177, DOI 10.1152/jn.1981.46.6.1177; JONES B, 1982, PSYCHOL BULL, V91, P128, DOI 10.1037/0033-2909.91.1.128; JONES FN, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484; KILGARD MP, 1995, NATURE, V373, P663, DOI 10.1038/373663a0; KLEFFNER DA, 1992, PERCEPT PSYCHOPHYS, V52, P18, DOI 10.3758/BF03206757; Knill DC, 1996, PERCEPTION BAYESIAN; Lawson R.W, 1952, RELATIVITY SPECIAL G; LECHELT EC, 1977, B PSYCHONOMIC SOC, V10, P191; MARKS LE, 1982, PERCEPT PSYCHOPHYS, V32, P537, DOI 10.3758/BF03204207; MARKS LE, 1982, PERCEPT PSYCHOPHYS, V32, P529, DOI 10.3758/BF03204206; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; SHERRICK CE, 1970, IEEE T MAN MACHINE, VMM11, P25, DOI 10.1109/TMMS.1970.299957; Shore DI, 2005, PERCEPTION, V34, P1251, DOI 10.1068/p3313; Shore DI, 1998, J ACOUST SOC AM, V103, P3730, DOI 10.1121/1.423093; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Suto Y., 1952, JAPANESE J PSYCHOL, V22, P45; WASSLE H, 1990, VISION RES, V30, P1897, DOI 10.1016/0042-6989(90)90166-I; Weber EH., 1978, EH WEBER SENSE TOUCH; WEINSTEIN SIDNEY, 1968, P195; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WHITSEL BL, 1986, SOMATOSENS MOT RES, V3, P185, DOI 10.3109/07367228609144583; WIELAND BA, 1960, AM J PSYCHOL, V73, P248, DOI 10.2307/1419901; Wiemer J, 2000, BIOL CYBERN, V82, P173, DOI 10.1007/s004220050017	49	71	71	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e333	10.1371/journal.pone.0000333	http://dx.doi.org/10.1371/journal.pone.0000333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389923	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445200016
J	Hein, G; Alink, A; Kleinschmidt, A; Muller, NG				Hein, Grit; Alink, Arjen; Kleinschmidt, Andreas; Mueller, Notger G.			Competing Neural Responses for Auditory and Visual Decisions	PLOS ONE			English	Article								Why is it hard to divide attention between dissimilar activities, such as reading and listening to a conversation? We used functional magnetic resonance imaging (fMRI) to study interference between simple auditory and visual decisions, independently of motor competition. Overlapping activity for auditory and visual tasks performed in isolation was found in lateral prefrontal regions, middle temporal cortex and parietal cortex. When the visual stimulus occurred during the processing of the tone, its activation in prefrontal and middle temporal cortex was suppressed. Additionally, reduced activity was seen in modality-specific visual cortex. These results paralleled impaired awareness of the visual event. Even without competing motor responses, a simple auditory decision interferes with visual processing on different neural levels, including prefrontal cortex, middle temporal cortex and visual regions.	[Hein, Grit; Mueller, Notger G.] Goethe Univ Frankfurt, Cognit Neurol Unit, Frankfurt, Germany; [Hein, Grit; Alink, Arjen; Mueller, Notger G.] Brain Imaging Ctr, Frankfurt, Germany; [Hein, Grit] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Alink, Arjen] Max Planck Inst Brain Res, Dept Neurophysiol, D-60496 Frankfurt, Germany; [Kleinschmidt, Andreas] INSERM, U562, Gif Sur Yvette, France; [Kleinschmidt, Andreas] CEA, Life Sci Div DSV, Gif Sur Yvette, France	Goethe University Frankfurt; University of California System; University of California Berkeley; Max Planck Society; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Hein, G (corresponding author), Goethe Univ Frankfurt, Cognit Neurol Unit, Frankfurt, Germany.	ghein@berkeley.edu	Houghton, Peter/E-3265-2011; Hein, Grit/AAF-7964-2019	Mueller, Notger/0000-0002-5483-6423; Alink, Arjen/0000-0001-6468-5449	Volkswagen foundation; German Research Foundation [HE 4566/1-1]	Volkswagen foundation(Volkswagen); German Research Foundation(German Research Foundation (DFG))	Funding was obtained from the Volkswagen foundation (A. K., G. H.) and the German Research Foundation (HE 4566/1-1, G. H.).	ALLPORT DA, 1980, COGNITIVE PSYCHOL NE, P112; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Baier B, 2006, J NEUROSCI, V26, P12260, DOI 10.1523/JNEUROSCI.1457-06.2006; Barbas H, 2005, CEREB CORTEX, V15, P1356, DOI 10.1093/cercor/bhi018; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Bourke PA, 1996, Q J EXP PSYCHOL-A, V49, P525, DOI 10.1080/027249896392487; Brass M, 2005, J COGNITIVE NEUROSCI, V17, P1367, DOI 10.1162/0898929054985400; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Coull JT, 1998, J NEUROSCI, V18, P7426; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Erickson KI, 2005, NEUROIMAGE, V28, P967, DOI 10.1016/j.neuroimage.2005.06.047; Feinstein JS, 2004, CONSCIOUS COGN, V13, P323, DOI 10.1016/j.concog.2003.10.004; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Jiang YH, 2004, PSYCHOL SCI, V15, P390, DOI 10.1111/j.0956-7976.2004.00690.x; Johnson JA, 2005, CEREB CORTEX, V15, P1609, DOI 10.1093/cercor/bhi039; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; Jolicoeur P, 1999, PSYCHON B REV, V6, P87, DOI 10.3758/BF03210813; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; KRANCZIOCH C, 2004, NEUROIMAGE, V24, P707; Marcantoni WS, 2003, BRAIN COGNITION, V53, P318, DOI 10.1016/S0278-2626(03)00134-9; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MULLER NG, 2006, J COGN NEUR IN PRESS; PETRIDES M, 1988, J COMP NEUROL, V273, P52, DOI 10.1002/cne.902730106; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; Stelzel C, 2006, PSYCHOL RES-PSYCH FO, V70, P514, DOI 10.1007/s00426-005-0013-7; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Szameitat AJ, 2006, PSYCHOL RES-PSYCH FO, V70, P541, DOI 10.1007/s00426-005-0015-5; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261	45	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e320	10.1371/journal.pone.0000320	http://dx.doi.org/10.1371/journal.pone.0000320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389911	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445200003
J	Han, X; Boyden, ES				Han, Xue; Boyden, Edward S.			Multiple-Color Optical Activation, Silencing, and Desynchronization of Neural Activity, with Single-Spike Temporal Resolution	PLOS ONE			English	Article								The quest to determine how precise neural activity patterns mediate computation, behavior, and pathology would be greatly aided by a set of tools for reliably activating and inactivating genetically targeted neurons, in a temporally precise and rapidly reversible fashion. Having earlier adapted a light-activated cation channel, channelrhodopsin-2 (ChR2), for allowing neurons to be stimulated by blue light, we searched for a complementary tool that would enable optical neuronal inhibition, driven by light of a second color. Here we report that targeting the codon-optimized form of the light-driven chloride pump halorhodopsin from the archaebacterium Natronomas pharaonis (hereafter abbreviated Halo) to genetically-specified neurons enables them to be silenced reliably, and reversibly, by millisecond-timescale pulses of yellow light. We show that trains of yellow and blue light pulses can drive high-fidelity sequences of hyperpolarizations and depolarizations in neurons simultaneously expressing yellow light-driven Halo and blue light-driven ChR2, allowing for the first time manipulations of neural synchrony without perturbation of other parameters such as spiking rates. The Halo/ChR2 system thus constitutes a powerful toolbox for multichannel photoinhibition and photostimulation of virally or transgenically targeted neural circuits without need for exogenous chemicals, enabling systematic analysis and engineering of the brain, and quantitative bioengineering of excitable cells.	[Han, Xue; Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Han, Xue] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Stanford University	Boyden, ES (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	esb@media.mit.edu			MIT Media Lab; Helen Hay Whitney Foundation	MIT Media Lab; Helen Hay Whitney Foundation	This work was funded by an anonymous donor and the MIT Media Lab (E. S. B.), and the Helen Hay Whitney Foundation (X. H.).	Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Cerbai E, 2001, J MOL CELL CARDIOL, V33, P441, DOI 10.1006/jmcc.2000.1316; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chung Jin Mo, 2002, Pain Pract, V2, P87, DOI 10.1046/j.1533-2500.2002.02011.x; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; DUSCHL A, 1990, J BIOL CHEM, V265, P1261; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Gershon AA, 2003, AM J PSYCHIAT, V160, P835, DOI 10.1176/appi.ajp.160.5.835; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Huang CJ, 2006, NAT BIOTECHNOL, V24, P439, DOI 10.1038/nbt1194; IACONO RP, 1995, ACTA NEUROCHIR, V137, P106, DOI 10.1007/BF02188792; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Johns DC, 1999, J NEUROSCI, V19, P1691; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Kandel E., 2000, PRINCIPLES NEURAL SC; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Koch Christof, 2004, QUEST CONSCIOUSNESS; Koller WC, 1999, J NEUROL SCI, V167, P1, DOI 10.1016/S0022-510X(99)00139-2; Kumar R, 1998, NEUROLOGY, V51, P850, DOI 10.1212/WNL.51.3.850; LANYI JK, 1990, J BIOL CHEM, V265, P1253; LANYI JK, 1986, ANNU REV BIOPHYS BIO, V15, P11, DOI 10.1146/annurev.bb.15.060186.000303; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Leone M, 2003, NEUROL SCI, V24, pS143; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nuss HB, 1999, J CLIN INVEST, V103, P889, DOI 10.1172/JCI5073; OESTERHELT D, 1985, EMBO J, V4, P2351, DOI 10.1002/j.1460-2075.1985.tb03938.x; Poolos Nicholas P, 2006, Epilepsy Curr, V6, P88, DOI 10.1111/j.1535-7511.2006.00107.x; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; SCHRODERLANG S, 2006, NAT METHODS; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw BK, 1999, J NEUROPHYSIOL, V82, P1114, DOI 10.1152/jn.1999.82.3.1114; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Slimko EM, 2002, J NEUROSCI, V22, P7373; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Tse HF, 2006, CIRCULATION, V114, P1000, DOI 10.1161/CIRCULATIONAHA.106.615385; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang MS, 2002, GLIA, V38, P273, DOI 10.1002/glia.10057; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7	70	430	490	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e299	10.1371/journal.pone.0000299	http://dx.doi.org/10.1371/journal.pone.0000299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375185	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445100001
J	Fahlgren, N; Howell, MD; Kasschau, KD; Chapman, EJ; Sullivan, CM; Cumbie, JS; Givan, SA; Law, TF; Grant, SR; Dangl, JL; Carrington, JC				Fahlgren, Noah; Howell, Miya D.; Kasschau, Kristin D.; Chapman, Elisabeth J.; Sullivan, Christopher M.; Cumbie, Jason S.; Givan, Scott A.; Law, Theresa F.; Grant, Sarah R.; Dangl, Jeffery L.; Carrington, James C.			High-Throughput Sequencing of Arabidopsis microRNAs: Evidence for Frequent Birth and Death of MIRNA Genes	PLOS ONE			English	Article								In plants, microRNAs (miRNAs) comprise one of two classes of small RNAs that function primarily as negative regulators at the posttranscriptional level. Several MIRNA genes in the plant kingdom are ancient, with conservation extending between angiosperms and the mosses, whereas many others are more recently evolved. Here, we use deep sequencing and computational methods to identify, profile and analyze non-conserved MIRNA genes in Arabidopsis thaliana. 48 non-conserved MIRNA families, nearly all of which were represented by single genes, were identified. Sequence similarity analyses of miRNA precursor foldback arms revealed evidence for recent evolutionary origin of 16 MIRNA loci through inverted duplication events from protein-coding gene sequences. Interestingly, these recently evolved MIRNA genes have taken distinct paths. Whereas some non-conserved miRNAs interact with and regulate target transcripts from gene families that donated parental sequences, others have drifted to the point of non-interaction with parental gene family transcripts. Some young MIRNA loci clearly originated from one gene family but form miRNAs that target transcripts in another family. We suggest that MIRNA genes are undergoing relatively frequent birth and death, with only a subset being stabilized by integration into regulatory networks.	[Fahlgren, Noah; Howell, Miya D.; Kasschau, Kristin D.; Chapman, Elisabeth J.; Sullivan, Christopher M.; Cumbie, Jason S.; Givan, Scott A.; Carrington, James C.] Oregon State Univ, Dept Bot & Plant Pathol, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Fahlgren, Noah; Chapman, Elisabeth J.] Oregon State Univ, Mol & Cellular Biol Grad Program, Corvallis, OR 97331 USA; [Law, Theresa F.; Grant, Sarah R.; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Oregon State University; Oregon State University; University of North Carolina; University of North Carolina Chapel Hill	Carrington, JC (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA.	carrington@cgrb.oregonstate.edu	Carrington, James C/A-4656-2012; Fahlgren, Noah/D-4404-2011	Carrington, James C/0000-0003-3572-129X; Fahlgren, Noah/0000-0002-5597-4537; Givan, Scott/0000-0002-0630-8589	National Science Foundation [MCB-0618433]; National Institutes of Health [AI43288]; U. S. Department of Agriculture [2005-35319-15280]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043288, R21AI043288, R37AI043288] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Science Foundation 2010 Project (MCB-0618433), the National Institutes of Health (AI43288), and the U. S. Department of Agriculture (2005-35319-15280).	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jiang DH, 2006, CELL RES, V16, P507, DOI 10.1038/sj.cr.7310062; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lindow M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-119; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wang Y, 2006, BIOINFORMATICS, V22, P2585, DOI 10.1093/bioinformatics/btl437; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605	57	897	1005	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e219	10.1371/journal.pone.0000219	http://dx.doi.org/10.1371/journal.pone.0000219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299599	Green Submitted, gold, Green Published			2022-12-27	WOS:000207444400020
J	Gemmell, NJ; Slate, J				Gemmell, Neil J.; Slate, Jon			Heterozygote Advantage for Fecundity	PLOS ONE			English	Article								Heterozygote advantage, or overdominance, remains a popular and persuasive explanation for the maintenance of genetic variation in natural populations in the face of selection. However, despite being first proposed more than 80 years ago, there remain few examples that fit the criteria for heterozygote advantage, all of which are associated with disease resistance and are maintained only in the presence of disease or other gene-by-environment interaction. Here we report five new examples of heterozygote advantage, based around polymorphisms in the BMP15 and GDF9 genes that affect female fecundity in domesticated sheep and are not reliant on disease for their maintenance. Five separate mutations in these members of the transforming growth factor beta (TGF beta) superfamily give phenotypes with fitness differentials characteristic of heterozygous advantage. In each case, one copy of the mutant allele increases ovulation rate, and ultimately litter size per ewe lambing, relative to the wildtype. However, homozygous ewes inheriting mutant alleles from both parents have impaired oocyte development and maturation, which results in small undeveloped ovaries and infertility. Using data collected over many years on ovulation rates, litter size, and lambing rates, we have calculated the equilibrium solution for each of these polymorphisms using standard population genetic theory. The predicted equilibrium frequencies obtained for these mutant alleles range from 0.11 to 0.23, which are amongst the highest yet reported for a polymorphism maintained by heterozygote advantage. These are amongst the most frequent and compelling examples of heterozygote advantage yet described and the first documented examples of heterozygote advantage that are not reliant on a disease interaction for their maintenance.	[Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Slate, Jon] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Canterbury; University of Sheffield	Gemmell, NJ (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	neil.gemmell@canterbury.ac.nz	Gemmell, Neil J/C-6774-2009; Slate, Jon/D-2925-2012	Gemmell, Neil J/0000-0003-0671-3637; Slate, Jon/0000-0003-3356-5123	University of Canterbury Erskine	University of Canterbury Erskine	This collaboration was facilitated by a University of Canterbury Erskine Grant to J.S.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Amer PR, 1999, LIVEST PROD SCI, V58, P75, DOI 10.1016/S0301-6226(98)00192-4; Clutton-Brock T.H., 2004, SOAY SHEEP DYNAMICS; Davis GH, 2005, GENET SEL EVOL, V37, pS11, DOI 10.1051/gse:2004026; DAVIS GH, 1992, LIVESTOCK PRODUCTION, V34, P83; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Fisher R. A., 1922, P ROY SOC EDINB B, V42, P321, DOI DOI 10.1007/BF02459576; Fisher RA, 1930, GENETICAL THEORY NAT; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Galloway SM, 2002, MOL CELL ENDOCRINOL, V191, P15, DOI 10.1016/S0303-7207(02)00047-3; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hanrahan J. P., 1982, 2nd World Congress on Genetics applied to Livestock Production, 4th-8th October 1982. 5. Plenary sessions, P294; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Hedrick P.W., 2011, GENETICS POPULATIONS; Kreitman M, 2004, TRENDS GENET, V20, P300, DOI 10.1016/j.tig.2004.05.002; Lassoued N, 2004, SMALL RUMINANT RES, V52, P117, DOI 10.1016/S0921-4488(03)00250-5; O'Callaghan D, 1999, ANIM SCI, V68, P299, DOI 10.1017/S1357729800050311; ROBERTSON A, 1962, GENETICS, V47, P1291; Robinson JJ, 1996, ANIM REPROD SCI, V42, P25, DOI 10.1016/0378-4320(96)01526-6; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660	22	60	63	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e125	10.1371/journal.pone.0000125	http://dx.doi.org/10.1371/journal.pone.0000125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205129	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000207443700019
J	Breuert, S; Allers, T; Spohn, G; Soppa, J				Breuert, Sebastian; Allers, Thorsten; Spohn, Gabi; Soppa, Joerg			Regulated Polyploidy in Halophilic Archaea	PLOS ONE			English	Article								Polyploidy is common in higher eukaryotes, especially in plants, but it is generally assumed that most prokaryotes contain a single copy of a circular chromosome and are therefore monoploid. We have used two independent methods to determine the genome copy number in halophilic archaea, 1) cell lysis in agarose blocks and Southern blot analysis, and 2) Real-Time quantitative PCR. Fast growing H. salinarum cells contain on average about 25 copies of the chromosome in exponential phase, and their ploidy is downregulated to 15 copies in early stationary phase. The chromosome copy number is identical in cultures with a twofold lower growth rate, in contrast to the results reported for several other prokaryotic species. Of three additional replicons of H. salinarum, two have a low copy number that is not growth-phase regulated, while one replicon even shows a higher degree of growth phase-dependent regulation than the main replicon. The genome copy number of H. volcanii is similarly high during exponential phase (on average 18 copies/cell), and it is also downregulated (to 10 copies) as the cells enter stationary phase. The variation of genome copy numbers in the population was addressed by fluorescence microscopy and by FACS analysis. These methods allowed us to verify the growth phase-dependent regulation of ploidy in H. salinarum, and they revealed that there is a wide variation in genome copy numbers in individual cells that is much larger in exponential than in stationary phase. Our results indicate that polyploidy might be more widespread in archaea (or even prokaryotes in general) than previously assumed. Moreover, the presence of so many genome copies in a prokaryote raises questions about the evolutionary significance of this strategy.	[Breuert, Sebastian; Spohn, Gabi; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany; [Allers, Thorsten] Univ Nottingham, Inst Genet, Queens Med Ctr, Nottingham NG7 2RD, England	Goethe University Frankfurt; University of Nottingham	Soppa, J (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany.	soppa@em.uni-frankfurt.de	Allers, Thorsten/G-5503-2010	Allers, Thorsten/0000-0002-7308-3332; Soppa, Jorg/0000-0002-6132-5840	Deutsche Forschungsgemeinschaft (German Research Council) [So264/7-2]; Royal Society University	Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG)); Royal Society University(Royal Society of London)	This work was supported by the Deutsche Forschungsgemeinschaft (German Research Council) through grant No. So264/7-2 (to JS), and by a Royal Society University Research Fellowship (to TA).	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Bernander R, 1997, J BACTERIOL, V179, P4963, DOI 10.1128/jb.179.16.4963-4969.1997; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bremer H, 1996, ESCHERICHIA COLI SAL; CHANT J, 1986, SYST APPL MICROBIOL, V7, P106, DOI 10.1016/S0723-2020(86)80132-1; CLAVERO MRS, 1994, APPL ENVIRON MICROB, V60, P2069, DOI 10.1128/AEM.60.6.2069-2075.1994; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; DALY MJ, 1994, J BACTERIOL, V176, P3508, DOI 10.1128/JB.176.12.3508-3517.1994; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Herrmann U, 2002, MOL MICROBIOL, V46, P395, DOI 10.1046/j.1365-2958.2002.03181.x; Hiraoka Y, 2002, APPL ENVIRON MICROB, V68, P5104, DOI 10.1128/AEM.68.10.5104-5112.2002; Hjort K, 1999, J BACTERIOL, V181, P5669, DOI 10.1128/JB.181.18.5669-5675.1999; Khakhlova O, 2006, PLANT J, V46, P85, DOI 10.1111/j.1365-313X.2006.02673.x; KITAYAMA HS, 1981, J BIOCHEM-TOKYO, V90, P877; KITTEN T, 1992, GENETICS, V132, P311; Kottemann M, 2005, EXTREMOPHILES, V9, P219, DOI 10.1007/s00792-005-0437-4; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Maisnier-Patin S, 2002, MOL MICROBIOL, V45, P1443, DOI 10.1046/j.1365-2958.2002.03111.x; Majernik AI, 2005, J BACTERIOL, V187, P1856, DOI 10.1128/JB.187.5.1856-1858.2005; Malandrin L, 1999, GENETICS, V152, P1315; MALDONADO R, 1994, J BACTERIOL, V176, P3911, DOI 10.1128/JB.176.13.3911-3919.1994; MALDONADO R, 1992, GENETICS, V132, P869; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x; POSTGATE JR, 1984, J GEN MICROBIOL, V130, P1597; PUNITA SJ, 1989, J BACTERIOL, V171, P3133, DOI 10.1128/jb.171.6.3133-3138.1989; ROSENSHINE I, 1991, NATO ADV SCI I A-LIF, V201, P265; RUEPP A, 1995, J BACTERIOL, V177, P1129, DOI 10.1128/jb.177.5.1129-1136.1995; Ruepp A, 1996, J BACTERIOL, V178, P4942, DOI 10.1128/jb.178.16.4942-4947.1996; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; SOPPA J, 1989, J BIOL CHEM, V264, P13049; Soppa J, 2006, MICROBIOL-SGM, V152, P585, DOI 10.1099/mic.0.28504-0; Soppa J, 1998, J MICROBIOL METH, V34, P41, DOI 10.1016/S0167-7012(98)00067-0; Tobiason DM, 2006, PLOS BIOL, V4, P1069, DOI 10.1371/journal.pbio.0040185; van Gerwen SJC, 1999, J FOOD PROTECT, V62, P1024, DOI 10.4315/0362-028X-62.9.1024; Wang GJ, 2004, J BACTERIOL, V186, P3187, DOI 10.1128/JB.186.10.3187-3194.2004; Webb CD, 1998, MOL MICROBIOL, V28, P883, DOI 10.1046/j.1365-2958.1998.00808.x; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009	45	127	131	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e92	10.1371/journal.pone.0000092	http://dx.doi.org/10.1371/journal.pone.0000092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183724	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600091
J	Nagaoka, M; Koshimizu, U; Yuasa, S; Hattori, F; Chen, H; Tanaka, T; Okabe, M; Fukuda, K; Akaike, T				Nagaoka, Masato; Koshimizu, Uichi; Yuasa, Shinsuke; Hattori, Fumiyuki; Chen, Hao; Tanaka, Tomofumi; Okabe, Masaru; Fukuda, Keiichi; Akaike, Toshihiro			E-Cadherin-Coated Plates Maintain Pluripotent ES Cells without Colony Formation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; EXPRESSION; DIFFERENTIATION; ADHESION; MAINTENANCE; ACTIVATION; INDUCTION; CULTURE; OCT-3/4	Embryonic stem (ES) cells cultured on gelatin-coated plates or feeder layers form tight aggregated colonies by the E-cadherin-mediated cell-cell adhesions. Here we show that murine ES cells do not make cell-cell contacts or form colonies when cultured on the plate coated with a fusion protein of E-cadherin and IgG Fc domain. The cells in culture retain all ES cell features including pluripotency to differentiate into cells of all three germ layers and germ-line transmission after extended culture. Furthermore, they show a higher proliferative ability, lower dependency on LIF, and higher transfection efficiency than colony-forming conditions. Our results suggest that aggregated colony formation might inhibit diffusion of soluble factors and increase cell-cell communication, which may result in a heterogeneous environment within and between surrounding cells of the colony. This method should enable more efficient and scalable culture of ES cells, an important step towards the clinical application of these cells.	[Nagaoka, Masato; Akaike, Toshihiro] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa, Japan; [Koshimizu, Uichi; Hattori, Fumiyuki; Tanaka, Tomofumi] Daiichi Asubio Pharma Co Ltd, Biomed Res Labs, Osaka, Japan; [Yuasa, Shinsuke; Hattori, Fumiyuki; Chen, Hao; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Tokyo, Japan; [Okabe, Masaru] Osaka Univ, Genome Informat Res Ctr, Osaka, Japan	Tokyo Institute of Technology; Asubio Pharma Co., Ltd.; Keio University; Osaka University	Akaike, T (corresponding author), Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa, Japan.	takaike@bio.titech.ac.jp	Yuasa, Shinsuke/L-8310-2013; Fukuda, Keiichi/L-3777-2013; Nagaoka, Masato/GRF-5030-2022; Nagaoka, Masato/J-1551-2014; Okabe, Masaru/B-6917-2015	Yuasa, Shinsuke/0000-0001-5593-7552; Okabe, Masaru/0000-0002-0803-9044	21st Century COE Program; Ministry of Education, Culture, Sports, Science and Technology of Japan	21st Century COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant of the 21st Century COE Program and a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (T. A.).	Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cui L, 2004, J HISTOCHEM CYTOCHEM, V52, P1447, DOI 10.1369/jhc.3A6241.2004; Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Larue L, 1996, DEVELOPMENT, V122, P3185; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagaoka M, 2003, PROTEIN ENG, V16, P243, DOI 10.1093/proeng/gzg037; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Ojima T, 2006, AM J PATHOL, V168, P331, DOI 10.2353/ajpath.2006.050435; Orsulic S, 2000, J CELL SCI, V113, P1793; Prudhomme W, 2004, P NATL ACAD SCI USA, V101, P2900, DOI 10.1073/pnas.0308768101; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; SHIRAYOSHI Y, 1983, CELL, V35, P631, DOI 10.1016/0092-8674(83)90095-8; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	34	96	103	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e15	10.1371/journal.pone.0000015	http://dx.doi.org/10.1371/journal.pone.0000015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183641	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600015
J	Baysal, BE				Baysal, Bora E.			A Recurrent Stop-Codon Mutation in Succinate Dehydrogenase Subunit B Gene in Normal Peripheral Blood and Childhood T-Cell Acute Leukemia	PLOS ONE			English	Article								Background. Somatic cytidine mutations in normal mammalian nuclear genes occur during antibody diversification in B lymphocytes and generate an isoform of apolipoprotein B in intestinal cells by RNA editing. Here, I describe that succinate dehydrogenase (SDH; mitochondrial complex II) subunit B gene (SDHB) is somatically mutated at a cytidine residue in normal peripheral blood mononuclear cells (PBMCs) and T-cell acute leukemia. Germ line mutations in the SDHB, SDHC or SDHD genes cause hereditary paraganglioma (PGL) tumors which show constitutive activation of homeostatic mechanisms induced by oxygen deprivation (hypoxia). Principal Findings. To determine the prevalence of a mutation identified in the SDHB mRNA, 180 samples are tested. An SDHB stop-codon mutation c.136C>T (R46X) is present in a significant fraction (average = 5.8%, range = less than 1 to 30%, n = 52) of the mRNAs obtained from PBMCs. In contrast, the R46X mutation is present in the genomic DNA of PBMCs at very low levels. Examination of the PBMC cell-type subsets identifies monocytes and natural killer (NK) cells as primary sources of the mutant transcript, although lesser contributions also come from B and T lymphocytes. Transcript sequence analyses in leukemic cell lines derived from monocyte, NK, T and B cells indicate that the mutational mechanism targeting SDHB is operational in T-cell acute leukemia. Accordingly, substantial levels (more than 3%) of the mutant SDHB transcripts are detected in five of 20 primary childhood T-cell acute lymphoblastic leukemia (T-ALL) bone marrow samples, but in none of 20 B-ALL samples. In addition, distinct heterozygous SDHB missense DNA mutations are identified in Jurkat and TALL-104 cell lines which are derived from T-ALLs. Conclusions. The identification of a recurrent, inactivating stop-codon mutation in the SDHB gene in normal blood cells suggests that SDHB is targeted by a cytidine deaminase enzyme. The SDHB mutations in normal PBMCs and leukemic T cells might play a role in cellular pre-adaptation to hypoxia.	[Baysal, Bora E.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15261 USA; [Baysal, Bora E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Baysal, BE (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15261 USA.	baysalb@mwri.magee.edu			NIH [CA11236, CA98543, CA114766]; NATIONAL CANCER INSTITUTE [U24CA114766, U10CA098543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants (CA11236 to B. E. B, CA98543 and CA114766 to Children's Oncology Group). The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ALBERTINI RJ, 1990, ANNU REV GENET, V24, P305; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Arezi B, 2007, ANAL BIOCHEM, V360, P84, DOI 10.1016/j.ab.2006.10.009; Astrom K, 2003, HUM GENET, V113, P228, DOI 10.1007/s00439-003-0969-6; Bayley JP, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-39; Baysal B.E., 2005, DIS MECH, V2, P247; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Baysal BE, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-12; CHADWICK DJ, 2006, NOV FDN S; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Gabay C, 1999, EUR J HAEMATOL, V63, P180; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; LING PD, 2005, CURRENT PROTOCOLS MO; Mukhopadhyay D, 2002, AM J HUM GENET, V70, P38, DOI 10.1086/337952; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Neuberger MS, 2007, J EXP MED, V204, P7, DOI 10.1084/jem.20062409; Piruat JI, 2004, MOL CELL BIOL, V24, P10933, DOI 10.1128/MCB.24.24.10933-10940.2004; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; Stenmark KR, 2005, J APPL PHYSIOL, V98, P715, DOI 10.1152/japplphysiol.00840.2004; Ueijma H, 2000, NAT GENET, V25, P375, DOI 10.1038/78040; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4	23	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e436	10.1371/journal.pone.0000436	http://dx.doi.org/10.1371/journal.pone.0000436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487275	Green Accepted, Green Published, gold			2022-12-27	WOS:000207445800018
J	Powilleit, F; Breinig, T; Schmitt, MJ				Powilleit, Frank; Breinig, Tanja; Schmitt, Manfred J.			Exploiting the Yeast L-A Viral Capsid for the In Vivo Assembly of Chimeric VLPs as Platform in Vaccine Development and Foreign Protein Expression	PLOS ONE			English	Article								A novel expression system based on engineered variants of the yeast (Saccharomyces cerevisiae) dsRNA virus L-A was developed allowing the in vivo assembly of chimeric virus-like particles (VLPs) as a unique platform for a wide range of applications. We show that polypeptides fused to the viral capsid protein Gag self-assemble into isometric VLP chimeras carrying their cargo inside the capsid, thereby not only effectively preventing proteolytic degradation in the host cell cytosol, but also allowing the expression of a per se cytotoxic protein. Carboxyterminal extension of Gag by T cell epitopes from human cytomegalovirus pp65 resulted in the formation of hybrid VLPs that strongly activated antigen-specific CD8(+) memory T cells ex vivo. Besides being a carrier for polypeptides inducing antigen-specific immune responses in vivo, VLP chimeras were also shown to be effective in the expression and purification of (i) a heterologous model protein (GFP), (ii) a per se toxic protein (K28 alpha-subunit), and (iii) a particle-associated and fully recyclable biotechnologically relevant enzyme (esterase A). Thus, yeast viral Gag represents a unique platform for the in vivo assembly of chimeric VLPs, equally attractive and useful in vaccine development and recombinant protein production.	[Powilleit, Frank; Schmitt, Manfred J.] Univ Saarland, Saarbrucken, Germany; [Breinig, Tanja] Univ Saarland, Inst Virol, Homburg, Germany	Saarland University; Saarland University	Schmitt, MJ (corresponding author), Univ Saarland, Saarbrucken, Germany.	mjs@microbiol.uni-sb.de	Schmitt, Manfred J/AAA-5070-2022		Aventis Research & Technologies (Frankfurt Hoechst) [DE-102004032888]	Aventis Research & Technologies (Frankfurt Hoechst)	This research was supported by a grant from Aventis Research & Technologies (Frankfurt Hoechst) to MJS and is part of German patent number DE-102004032888.	Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; Breinig F, 2003, FEMS IMMUNOL MED MIC, V38, P231, DOI 10.1016/S0928-8244(03)00148-2; Breinig F, 2006, APPL ENVIRON MICROB, V72, P7140, DOI 10.1128/AEM.00503-06; Breinig T, 2006, METHODS, V38, P77, DOI 10.1016/j.ymeth.2005.09.016; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Burns Nigel R., 1994, Molecular Biotechnology, V1, P137, DOI 10.1007/BF02921554; Chang HC, 2005, J MOL BIOL, V353, P397, DOI 10.1016/j.jmb.2005.08.052; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; COOPER A, 1989, MOL CELL BIOL, V9, P2706, DOI 10.1128/MCB.9.6.2706; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; FUJIMURA T, 1992, NATURE, V359, P746, DOI 10.1038/359746a0; GILMOUR JEM, 1989, AIDS, V3, P717, DOI 10.1097/00002030-198911000-00005; Gyulai Z, 2000, J INFECT DIS, V181, P1537, DOI 10.1086/315445; Hansson M, 2000, BIOTECHNOL APPL BIOC, V32, P95, DOI 10.1042/BA20000034; Heiligenstein S, 2006, EMBO J, V25, P4717, DOI 10.1038/sj.emboj.7601350; HENSING MCM, 1995, ANTON LEEUW INT J G, V67, P261, DOI 10.1007/BF00873690; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Huang DG, 2006, APPL ENVIRON MICROB, V72, P7748, DOI 10.1128/AEM.01403-06; ICHO T, 1989, J BIOL CHEM, V264, P6716; KANG YS, 1990, MOL CELL BIOL, V10, P2582, DOI 10.1128/MCB.10.6.2582; Kern F, 2002, J INFECT DIS, V185, P1709, DOI 10.1086/340637; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kost TA, 1999, CURR OPIN BIOTECH, V10, P428, DOI 10.1016/S0958-1669(99)00005-1; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kruger DH, 1999, BIOL CHEM, V380, P275, DOI 10.1515/BC.1999.037; MCLAUGHLINTAYLOR E, 1994, J MED VIROL, V43, P103, DOI 10.1002/jmv.1890430119; Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; RABINOVICH NR, 1994, SCIENCE, V265, P1401, DOI 10.1126/science.7521064; Rai M, 2001, CURR SCI INDIA, V80, P1121; Reinisch KM, 2002, NAT STRUCT BIOL, V9, P714, DOI 10.1038/nsb1002-714; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHIRMBECK R, 1995, EUR J IMMUNOL, V25, P1063, DOI 10.1002/eji.1830250431; Schlacher A, 1998, J BIOTECHNOL, V62, P47, DOI 10.1016/S0168-1656(98)00042-X; Schleiss Mark, 2005, Herpes, V12, P66; Schultheiss E, 2002, J MOL CATAL B-ENZYM, V18, P89, DOI 10.1016/S1381-1177(02)00063-2; Solache A, 1999, J IMMUNOL, V163, P5512; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; Tsunetsugu-Yokota Y, 2003, J VIROL, V77, P10250, DOI 10.1128/JVI.77.19.10250-10259.2003; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996; WIDNER WR, 1993, MOL CELL BIOL, V13, P4331, DOI 10.1128/MCB.13.7.4331; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996	48	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e415	10.1371/journal.pone.0000415	http://dx.doi.org/10.1371/journal.pone.0000415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476337	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445700017
J	Zhong, JM; Jasinskas, A; Barbour, AG				Zhong, Jianmin; Jasinskas, Algimantas; Barbour, Alan G.			Antibiotic Treatment of the Tick Vector Amblyomma americanum Reduced Reproductive Fitness	PLOS ONE			English	Article								Background. The lone star tick Amblyomma americanum is a common pest and vector of infectious diseases for humans and other mammals in the southern and eastern United States. A Coxiella sp. bacterial endosymbiont was highly prevalent in both laboratory-reared and field-collected A. americanum. The Coxiella sp. was demonstrated in all stages of tick and in greatest densities in nymphs and adult females, while a Rickettsia sp. was less prevalent and in lower densities when present. Methodology/Principal Findings. We manipulated the numbers of both bacterial species in laboratory-reared A. americanum by injecting engorged nymphs or engorged, mated females with single doses of an antibiotic (rifampin or tetracycline) or buffer alone. Burdens of the bacteria after molting or after oviposition were estimated by quantitative polymerase chain reaction with primers and probes specific for each bacterial species or, as an internal standard, the host tick. Post-molt adult ticks that had been treated with rifampin or tetracycline had lower numbers of the Coxiella sp. and Rickettsia sp. and generally weighed less than ticks that received buffer alone. Similarly, after oviposition, females treated previously with either antibiotic had lower burdens of both bacterial species in comparison to controls. Treatment of engorged females with either antibiotic was associated with prolonged time to oviposition, lower proportions of ticks that hatched, lower proportions of viable larvae among total larvae, and lower numbers of viable larvae per tick. These fitness estimators were associated with reduced numbers of the Coxiella sp. but not the Rickettsia sp. Conclusion/Significance. The findings indicate that the Coxiella sp. is a primary endosymbiont, perhaps provisioning the obligately hematophagous parasites with essential nutrients. The results also suggest that antibiotics could be incorporated into an integrated pest management plan for control of these and other tick vectors of disease.	[Zhong, Jianmin; Jasinskas, Algimantas; Barbour, Alan G.] Univ Calif Irvine, Dept Med, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Zhong, Jianmin; Jasinskas, Algimantas; Barbour, Alan G.] Univ Calif Irvine, Pacific SW Ctr Biodefense & Emerging Infect, Irvine, CA USA; [Zhong, Jianmin] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; California State University System; California State Polytechnic University, Humboldt	Barbour, AG (corresponding author), Univ Calif Irvine, Dept Med, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	abarbour@uci.edu	Zhong, Jianmin/AAO-9401-2020	Zhong, Jianmin/0000-0002-4746-8458	Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	Senior Scholar in Global Infectious Diseases Program of the Ellison Medical Foundation (A. G. B.) and unrestricted patent royalties (A. G. B.). The study sponsor had no role in study design, the collection, analysis, and interpretation of data, the writing of the paper, or the decision to submit the manuscript for publication.	Bandi C, 1999, INT J PARASITOL, V29, P357, DOI 10.1016/S0020-7519(98)00200-8; BARBOUR A G, 1988, Clinical Microbiology Reviews, V1, P399; Barbour AG, 1996, J INFECT DIS, V173, P403, DOI 10.1093/infdis/173.2.403; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Boulos A, 2004, INT J ANTIMICROB AG, V23, P169, DOI 10.1016/j.ijantimicag.2003.07.007; Brennan RE, 2003, J CLIN MICROBIOL, V41, P1869, DOI 10.1128/JCM.41.5.1869-1874.2003; BRESSAC C, 1993, J INVERTEBR PATHOL, V61, P226, DOI 10.1006/jipa.1993.1044; Bunikis J, 2004, EMERG INFECT DIS, V10, P1661, DOI 10.3201/eid1009.040236; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Dale C, 2001, INT J PARASITOL, V31, P628, DOI 10.1016/S0020-7519(01)00151-5; Fenollar F, 2003, ANTIMICROB AGENTS CH, V47, P1665, DOI 10.1128/AAC.47.5.1665-1671.2003; Ginsberg HS, 2005, TICK-BORNE DISEASES OF HUMANS, P65; Goethert HK, 2005, J MED ENTOMOL, V42, P502, DOI 10.1603/0022-2585(2005)042[0502:ANFBFI]2.0.CO;2; HARINGTON JS, 1960, PARASITOLOGY, V50, P279, DOI 10.1017/S0031182000025373; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Jasinskas A, 2005, J MED ENTOMOL, V42, P359, DOI 10.1603/0022-2585(2005)042[0359:TFFMTU]2.0.CO;2; Jasinskas A, 2007, APPL ENVIRON MICROB, V73, P334, DOI 10.1128/AEM.02009-06; Jaworski DC, 2001, INSECT MOL BIOL, V10, P323, DOI 10.1046/j.0962-1075.2001.00271.x; KASHLYAEVA TK, 1983, ANTIBIOT MED BIOTEK, V28, P285; Kazragis RJ, 1996, ANTIMICROB AGENTS CH, V40, P2632, DOI 10.1128/AAC.40.11.2632; Labruna MB, 2004, J MED ENTOMOL, V41, P1073, DOI 10.1603/0022-2585-41.6.1073; Long SW, 2003, J MED ENTOMOL, V40, P1000, DOI 10.1603/0022-2585-40.6.1000; Mixson TR, 2006, J MED ENTOMOL, V43, P1261, DOI 10.1603/0022-2585(2006)43[1261:POEBAR]2.0.CO;2; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 2003, P NATL ACAD SCI USA, V100, P14543, DOI 10.1073/pnas.2135345100; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Munderloh UG, 2005, TICK-BORNE DISEASES OF HUMANS, P37; NDIAYE M, 1995, J SUBMICR CYTOL PATH, V27, P557; Niebylski ML, 1997, APPL ENVIRON MICROB, V63, P3933, DOI 10.1128/AEM.63.10.3933-3940.1997; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; PORTARO JK, 1975, J MED ENTOMOL, V12, P265, DOI 10.1093/jmedent/12.2.265; RAOULT D, 1989, EUR J EPIDEMIOL, V5, P432, DOI 10.1007/BF00140135; RAOULT D, 1987, J INFECT DIS, V155, P1059, DOI 10.1093/infdis/155.5.1059; Reeves WK, 2006, EXP APPL ACAROL, V39, P321, DOI 10.1007/s10493-006-9012-7; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Schulze TL, 2005, J MED ENTOMOL, V42, P450, DOI 10.1603/0022-2585(2005)042[0450:REFAPO]2.0.CO;2; Scoles GA, 2004, J MED ENTOMOL, V41, P277, DOI 10.1603/0022-2585-41.3.277; SILVA PMFE, 1994, J EUKARYOT MICROBIOL, V41, P55, DOI 10.1111/j.1550-7408.1994.tb05934.x; Simser JA, 2001, APPL ENVIRON MICROB, V67, P546, DOI 10.1128/AEM.67.2.546-552.2001; Thompson HA, 2005, TICK-BORNE DISEASES OF HUMANS, P328; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Weeks AR, 2004, P ROY SOC B-BIOL SCI, V271, pS193, DOI 10.1098/rsbl.2003.0137; ZCHORIFEIN E, 1995, INSECT MOL BIOL, V4, P173, DOI 10.1111/j.1365-2583.1995.tb00023.x; Zientz E, 2006, APPL ENVIRON MICROB, V72, P6027, DOI 10.1128/AEM.00933-06	45	152	156	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e405	10.1371/journal.pone.0000405	http://dx.doi.org/10.1371/journal.pone.0000405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476327	Green Published, gold			2022-12-27	WOS:000207445700007
J	Ribeiro, I; Kawakami, Y; Buscher, D; Raya, A; Rodriguez-Leon, J; Morita, M; Esteban, CR; Belmonte, JCI				Ribeiro, Ines; Kawakami, Yasuhiko; Buescher, Dirk; Raya, Angel; Rodriguez-Leon, Joaquin; Morita, Masanobu; Esteban, Concepcion Rodriguez; Izpisua Belmonte, Juan Carlos			Tbx2 and Tbx3 Regulate the Dynamics of Cell Proliferation during Heart Remodeling	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE RELATIONSHIP; HOLT-ORAM-SYNDROME; T-BOX GENES; MOUSE HEART; MORPHOGENESIS; MUTATIONS; DEFECTS; DIFFERENTIATION; LIMB; GROWTH	Background. The heart forms from a linear tube that is subject to complex remodeling during embryonic development. Hallmarks of this remodeling are the looping of the heart tube and the regionalization into chamber and non-chamber myocardium. Cardiomyocytes in the future chamber myocardium acquire different cellular and physiological characteristics through activation of a chamber-specific genetic program, which is in part mediated by T-box genes. Methodology/Principal Finding. We characterize two new zebrafish T-box transcription factors, tbx3b and tbx2a, and analyze their role during the development of the atrioventricular canal. Loss-and gain-of-function analyses demonstrate that tbx3b and tbx2a are necessary to repress the chamber-genetic program in the non-chamber myocardium. We also show that tbx3b and tbx2a are required to control cell proliferation in the atrioventricular canal and that misregulation of cell proliferation in the heart tube influences looping. Furthermore, we characterize the heart phenotype of a novel Tbx3 mutation in mice and show that both the control of cell proliferation and the repression of chamber-specific genetic program in the non-chamber myocardium are conserved roles of Tbx3 in this species. Conclusions/Significance. Taken together, our results uncover an evolutionarily conserved role of Tbx2/3 transcription factors during remodeling of the heart myocardium and highlight the importance of controlling cell proliferation as a driving force of morphogenesis.	[Ribeiro, Ines; Kawakami, Yasuhiko; Buescher, Dirk; Raya, Angel; Morita, Masanobu; Esteban, Concepcion Rodriguez; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Rodriguez-Leon, Joaquin] Inst Gulbenkian Ciencias, Unidade Desenvolvimento, Oeiras, Portugal	Salk Institute; Instituto Gulbenkian de Ciencia	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Leon, Joaquin Maria Rodriguez/C-6957-2013; Raya, Angel/E-6205-2010; Leon, Joaquin Maria Rodriguez/S-9814-2019; Ribeiro, Ines MA/AAK-4091-2020	Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Raya, Angel/0000-0003-2189-9775; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Ribeiro, Ines MA/0000-0002-7480-6918; Kawakami, Yasuhiko/0000-0002-0043-9705	Fundacao para a Ciencia e Tecnologia and dissertation; Instituto Gulbenkian Ciencia; Fundacao para a Ciencia e a Tecnologia; Foundation Inbiomed; G. Harold and Leila Y. Mathers Charitable Foundation; National Institutes of Health	Fundacao para a Ciencia e Tecnologia and dissertation; Instituto Gulbenkian Ciencia; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Foundation Inbiomed; G. Harold and Leila Y. Mathers Charitable Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I. R. was supported by a predoctoral fellowship from the Fundacao para a Ciencia e Tecnologia and dissertation fellowship from Instituto Gulbenkian Ciencia; J. R. L. was partially supported by a fellowship from Fundacao para a Ciencia e a Tecnologia, and A. R. and C. R. E. were partially supported by Foundation Inbiomed. This work was supported by grants from the G. Harold and Leila Y. Mathers Charitable Foundation, and the National Institutes of Health to J. C. I. B.	Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Bartram U, 2001, CIRCULATION, V103, P2745; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Charng MJ, 1998, DEV BIOL, V199, P72, DOI 10.1006/dbio.1998.8905; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Christoffels VM, 2004, TRENDS CARDIOVAS MED, V14, P301, DOI 10.1016/j.tcm.2004.09.002; Christoffels VM, 2004, DEV DYNAM, V229, P763, DOI 10.1002/dvdy.10487; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kang JS, 2004, MECH DEVELOP, V121, P301, DOI 10.1016/j.mod.2004.01.007; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; Li QY, 1997, NAT GENET, V15, P21; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Meneghini V, 2006, EUR J MED GENET, V49, P151, DOI 10.1016/j.ejmg.2005.04.021; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; MOENS CB, 1993, DEVELOPMENT, V119, P485; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Ng JK, 2002, DEVELOPMENT, V129, P5161; Palmer S, 2001, J CELL BIOL, V153, P985, DOI 10.1083/jcb.153.5.985; Paxton C, 2002, GENE, V283, P117, DOI 10.1016/S0378-1119(01)00878-2; Rasskin-Gutman D, 2004, BIOESSAYS, V26, P405, DOI 10.1002/bies.10410; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SAWAI S, 1993, DEVELOPMENT, V117, P1445; Sedmera D, 2003, ANAT REC PART A, V274A, P773, DOI 10.1002/ar.a.10085; Simon AM, 1998, CURR BIOL, V8, P295, DOI 10.1016/S0960-9822(98)70113-7; Singh MK, 2005, MECH DEVELOP, V122, P131, DOI 10.1016/j.mod.2004.10.011; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Szeto DP, 2002, DEVELOPMENT, V129, P5093; Taber LA, 2006, INT J DEV BIOL, V50, P323, DOI 10.1387/ijdb.052045lt; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; THOMPSON RP, 1990, DEVELOPMENTAL CARDIOLOGY, P219; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Walton RZ, 2006, DEV BIOL, V289, P482, DOI 10.1016/j.ydbio.2005.10.040; Yamamoto A, 1998, DEVELOPMENT, V125, P3389	51	73	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e398	10.1371/journal.pone.0000398	http://dx.doi.org/10.1371/journal.pone.0000398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460765	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445600012
J	Capone, C; Frigerio, S; Fumagalli, S; Gelati, M; Principato, MC; Storini, C; Montinaro, M; Kraftsik, R; De Curtis, M; Parati, E; De Simoni, MG				Capone, Carmen; Frigerio, Simona; Fumagalli, Stefano; Gelati, Maurizio; Principato, Maria-Cristina; Storini, Claudio; Montinaro, Mery; Kraftsik, Rudolf; De Curtis, Marco; Parati, Eugenio; De Simoni, Maria-Grazia			Neurosphere-Derived Cells Exert a Neuroprotective Action by Changing the Ischemic Microenvironment	PLOS ONE			English	Article								Background. Neurosphere-derived cells (NC), containing neural stem cells, various progenitors and more differentiated cells, were obtained from newborn C57/BL6 mice and infused in a murine model of focal ischemia with reperfusion to investigate if: 1) they decreased ischemic injury and restored brain function; 2) they induced changes in the environment in which they are infused; 3) changes in brain environment consequent to transient ischemia were relevant for NC action. Methodology/Principal Findings. NC were infused intracerebroventricularly 4 h or 7 d after 30 min middle cerebral artery occlusion. In ischemic mice receiving cells at 4 h, impairment of open field performance was significantly improved and neuronal loss significantly reduced 7-14 d after ischemia compared to controls and to ischemic mice receiving cells at 7 d. Infusion of murine foetal fibroblast in the same experimental conditions was not effective. Assessment of infused cell distribution revealed that they migrated from the ventricle to the parenchyma, progressively decreased in number but they were observable up to 14 d. In mice receiving NC at 7 d and in sham-operated mice, few cells could be observed only at 24 h, indicating that the survival of these cells in brain tissue relates to the ischemic environment. The mRNA expression of trophic factors such as Insulin Growth Factor-1, Vascular Endothelial Growth Factor-A, Transforming Growth Factor-beta 1, Brain Derived Neurotrophic Factor and Stromal Derived Factor-1 alpha, as well as microglia/macrophage activation, increased 24 h after NC infusion in ischemic mice treated at 4 h compared to sham-operated and to mice receiving cells at 7 d. Conclusions/Significance. NC reduce functional impairment and neuronal damage after ischemia/reperfusion injury. Several lines of evidence indicate that the reciprocal interaction between NC and the ischemic environment is crucial for NC protective actions. Based on these results we propose that a bystander control of the ischemic environment may be the mechanism used by NC to rapidly restore acutely injured brain function.	[Capone, Carmen; Fumagalli, Stefano; Principato, Maria-Cristina; Storini, Claudio; Montinaro, Mery; De Simoni, Maria-Grazia] Mario Negri Inst Pharmacol Res, Lab Inflammat & Nervous Syst Dis, Milan, Italy; [Frigerio, Simona; Gelati, Maurizio; Parati, Eugenio] Ist Nazl Neurol Carlo Besta, Lab Neurobiol & Neuroregenerat Therapies, Milan, Italy; [Kraftsik, Rudolf] Univ Lausanne, Dept Cell Biol & Morphol, Lausanne, Switzerland; [De Curtis, Marco] Ist Nazl Neurol Carlo Besta, Clin Epileptol & Expt Neurophysiol Unit, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Neurologico Besta; University of Lausanne; IRCCS Istituto Neurologico Besta	De Simoni, MG (corresponding author), Mario Negri Inst Pharmacol Res, Lab Inflammat & Nervous Syst Dis, Milan, Italy.	desimoni@marionegri.it	De Simoni, Maria Grazia/I-6021-2012; Gelati, Maurizio/T-4538-2019; Parati, Eugenio A/G-8765-2011; de Curtis, Marco M/J-8704-2016; Frigerio, Simona/AAI-3264-2021; Fumagalli, Stefano/I-3097-2019; Parati, Eugenio Agostino/AAN-5893-2021	De Simoni, Maria Grazia/0000-0001-6695-5297; Gelati, Maurizio/0000-0002-4828-9849; de Curtis, Marco M/0000-0001-7443-6737; Frigerio, Simona/0000-0001-7078-075X; Parati, Eugenio Agostino/0000-0001-5020-6523; de Curtis, Marco/0000-0002-5608-929X; Fumagalli, Stefano/0000-0003-3598-6263	Fondazione Cariplo [2005.1208/10.4963]; Istituto Superiore di Sanita [Conv.N.530/F-A11]	Fondazione Cariplo(Fondazione Cariplo); Istituto Superiore di Sanita	The work was partially supported by Fondazione Cariplo, grant 2005.1208/10.4963 and by Istituto Superiore di Sanita Conv.N.530/F-A11.	Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Boche D, 2003, J CEREBR BLOOD F MET, V23, P1174, DOI 10.1097/01.WCB.0000090080.64176.44; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Clawson TF, 1999, BIOL SIGNAL RECEPT, V8, P281; Conti L, 2003, PHARMACOL RES, V47, P289, DOI 10.1016/S1043-6618(03)00038-0; De Simoni MG, 2004, AM J PATHOL, V164, P1857, DOI 10.1016/S0002-9440(10)63744-3; De Simoni MG, 2003, J CEREBR BLOOD F MET, V23, P232, DOI 10.1097/01.WCB.0000046146.31247.A1; DESIMONI MG, 1990, J EXP MED, V171, P1773, DOI 10.1084/jem.171.5.1773; Francia N, 2006, EUR J NEUROSCI, V23, P711, DOI 10.1111/j.1460-9568.2006.04585.x; Gorski JA, 2003, J NEUROSCI, V23, P6856; Gritti A, 1999, J NEUROSCI, V19, P3287; Gritti A, 1996, J NEUROSCI, V16, P1091; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Krupinski J, 1996, STROKE, V27, P852, DOI 10.1161/01.STR.27.5.852; Lai AY, 2006, CAN J PHYSIOL PHARM, V84, P49, DOI 10.1139/y05-143; Lepore AC, 2004, NEURON GLIA BIOL, V1, P113, DOI 10.1017/S1740925X04000213; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Pallini R, 2005, NEUROSURGERY, V57, P1014, DOI 10.1227/01.NEU.0000180058.58372.4c; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Savitz Sean I, 2004, NeuroRx, V1, P406; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Storini C, 2005, NEUROBIOL DIS, V19, P10, DOI 10.1016/j.nbd.2004.11.001; Storini C, 2006, J PHARMACOL EXP THER, V318, P849, DOI 10.1124/jpet.106.105064; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Troglio F, 2004, P NATL ACAD SCI USA, V101, P15476, DOI 10.1073/pnas.0403283101; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; Wada T, 2006, J NEUROSCI, V26, P6803, DOI 10.1523/JNEUROSCI.0526-06.2006; WANG XK, 1995, BRAIN RES BULL, V36, P607, DOI 10.1016/0361-9230(94)00243-T; Wirenfeldt M, 2005, J NEUROSCI RES, V82, P507, DOI 10.1002/jnr.20659; Yan YP, 2006, EUR J NEUROSCI, V24, P45, DOI 10.1111/j.1460-9568.2006.04872.x	44	96	102	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e373	10.1371/journal.pone.0000373	http://dx.doi.org/10.1371/journal.pone.0000373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440609	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445500004
J	Lindqvist, C; Janczak, AM; Natt, D; Baranowska, I; Lindqvist, N; Wichman, A; Lundeberg, J; Lindberg, J; Torjesen, PA; Jensen, P				Lindqvist, Christina; Janczak, Andrew M.; Natt, Daniel; Baranowska, Izabella; Lindqvist, Niclas; Wichman, Anette; Lundeberg, Joakim; Lindberg, Johan; Torjesen, Peter A.; Jensen, Per			Transmission of Stress-Induced Learning Impairment and Associated Brain Gene Expression from Parents to Offspring in Chickens	PLOS ONE			English	Article							RED JUNGLEFOWL; WHITE LEGHORN; BEHAVIOR; TRAITS; GROWTH	Background. Stress influences many aspects of animal behaviour and is a major factor driving populations to adapt to changing living conditions, such as during domestication. Stress can affect offspring through non-genetic mechanisms, but recent research indicates that inherited epigenetic modifications of the genome could possibly also be involved. Methodology/Principal Findings. Red junglefowl (RJF, ancestors of modern chickens) and domesticated White Leghorn (WL) chickens were raised in a stressful environment (unpredictable light-dark rhythm) and control animals in similar pens, but on a 12/12 h light-dark rhythm. WL in both treatments had poorer spatial learning ability than RJF, and in both populations, stress caused a reduced ability to solve a spatial learning task. Offspring of stressed WL, but not RJF, raised without parental contact, had a reduced spatial learning ability compared to offspring of non-stressed animals in a similar test as that used for their parents. Offspring of stressed WL were also more competitive and grew faster than offspring of non-stressed parents. Using a whole-genome cDNA microarray, we found that in WL, the same changes in hypothalamic gene expression profile caused by stress in the parents were also found in the offspring. In offspring of stressed WL, at least 31 genes were up- or down-regulated in the hypothalamus and pituitary compared to offspring of non-stressed parents. Conclusions/Significance. Our results suggest that, in WL the gene expression response to stress, as well as some behavioural stress responses, were transmitted across generations. The ability to transmit epigenetic information and behaviour modifications between generations may therefore have been favoured by domestication. The mechanisms involved remain to be investigated; epigenetic modifications could either have been inherited or acquired de novo in the specific egg environment. In both cases, this would offer a novel explanation to rapid evolutionary adaptation of a population.	[Lindqvist, Christina; Natt, Daniel; Baranowska, Izabella; Lindqvist, Niclas; Jensen, Per] Linkoping Univ, IFM Biol, Linkoping, Sweden; [Janczak, Andrew M.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Wichman, Anette] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Skara, Sweden; [Lundeberg, Joakim; Lindberg, Johan] Royal Inst Technol, Sch Biotechnol, Dept Gene Technol, Stockholm, Sweden; [Torjesen, Peter A.] Aker Univ Hosp, Hormone Lab, Oslo, Norway	Linkoping University; Norwegian University of Life Sciences; Swedish University of Agricultural Sciences; Royal Institute of Technology; University of Oslo	Jensen, P (corresponding author), Linkoping Univ, IFM Biol, Linkoping, Sweden.	perje@ifm.liu.se	Lindberg, Johan/F-4104-2011; Janczak, Andrew M/B-4113-2013; Nätt, Daniel/E-9693-2011; Natt, Daniel/AAR-3928-2021	Janczak, Andrew M/0000-0002-1141-8272; Nätt, Daniel/0000-0002-3801-5705; Natt, Daniel/0000-0001-9182-9401; Lindberg, Johan/0000-0003-3610-6774	Wallenberg Consortium North; Swedish Reseach Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Research Council; Norwegian Research Council; Norwegian Centre of Poultry Science	Wallenberg Consortium North; Swedish Reseach Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Centre of Poultry Science	Funding: This project was supported by grants from Wallenberg Consortium North, the Swedish Reseach Council for Environment, Agricultural Sciences and Spatial Planning, the Swedish Research Council, the Norwegian Research Council and the Norwegian Centre of Poultry Science.	BELYAEV DK, 1985, APPL ANIM BEHAV SCI, V13, P359, DOI 10.1016/0168-1591(85)90015-2; BELYAEV DK, 1969, SCI J, V5, P47; Braastad BO, 1998, APPL ANIM BEHAV SCI, V61, P159, DOI 10.1016/S0168-1591(98)00188-9; de Kloet ER, 2005, NEUROSCI BIOBEHAV R, V29, P271, DOI 10.1016/j.neubiorev.2004.10.008; FITZIMMONS C, 2006, EXPLORING REALM GENE; FUMIHITO A, 1994, P NATL ACAD SCI USA, V91, P12505, DOI 10.1073/pnas.91.26.12505; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hansen SW, 1996, APPL ANIM BEHAV SCI, V49, P137, DOI 10.1016/0168-1591(96)01045-3; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Jablonka E., 1995, EPIGENETIC INHERITAN; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; LOFTHUS R, 1986, J STEROID BIOCHEM, V25, P541, DOI 10.1016/0022-4731(86)90400-0; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price E.O., 2002, ANIMAL DOMESTICATION; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rozen S, 2000, Methods Mol Biol, V132, P365; Savolainen P, 2005, CYTOGENET GENOME RES, V111, P79, DOI 10.1159/000085674; Schutz KE, 2004, BEHAV GENET, V34, P121, DOI 10.1023/B:BEGE.0000009481.98336.fc; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	20	72	74	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2007	2	4							e364	10.1371/journal.pone.0000364	http://dx.doi.org/10.1371/journal.pone.0000364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DT	17426812	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445400004
J	Nishida, M; Walker, MP				Nishida, Masaki; Walker, Matthew P.			Daytime Naps, Motor Memory Consolidation and Regionally Specific Sleep Spindles	PLOS ONE			English	Article							STAGE-2 SLEEP; TIME-COURSE; STIMULATION; EEG; SEQUENCE	Background. Increasing evidence demonstrates that motor-skill memories improve across a night of sleep, and that non-rapid eye movement (NREM) sleep commonly plays a role in orchestrating these consolidation enhancements. Here we show the benefit of a daytime nap on motor memory consolidation and its relationship not simply with global sleep-stage measures, but unique characteristics of sleep spindles at regionally specific locations; mapping to the corresponding memory representation. Methodology/Principal Findings. Two groups of subjects trained on a motor-skill task using their left hand-a paradigm known to result in overnight plastic changes in the contralateral, right motor cortex. Both groups trained in the morning and were tested 8 hr later, with one group obtaining a 60-90 minute intervening midday nap, while the other group remained awake. At testing, subjects that did not nap showed no significant performance improvement, yet those that did nap expressed a highly significant consolidation enhancement. Within the nap group, the amount of offline improvement showed a significant correlation with the global measure of stage-2 NREM sleep. However, topographical sleep spindle analysis revealed more precise correlations. Specifically, when spindle activity at the central electrode of the non-learning hemisphere (left) was subtracted from that in the learning hemisphere (right), representing the homeostatic difference following learning, strong positive relationships with offline memory improvement emerged-correlations that were not evident for either hemisphere alone. Conclusions/Significance. These results demonstrate that motor memories are dynamically facilitated across daytime naps, enhancements that are uniquely associated with electrophysiological events expressed at local, anatomically discrete locations of the brain.	[Nishida, Masaki; Walker, Matthew P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Sleep & Neuroimaging Lab,Dept Psychiat, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Walker, MP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Sleep & Neuroimaging Lab,Dept Psychiat, Boston, MA 02215 USA.	mwalker@hms.harvard.edu	Nishida, Masaki/O-7439-2018	Nishida, Masaki/0000-0003-2661-4425	National Institutes of Health [MH069935, MH48832, MH65292, MH67754]; American Academy of Sleep Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH067754, R03MH069935, R01MH065292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Sleep Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by grants from the National Institutes of Health (MH069935, MH48832, MH65292 and MH67754), and the American Academy of Sleep Medicine.	Cantero JL, 2002, J NEUROSCI, V22, P4702, DOI 10.1523/JNEUROSCI.22-11-04702.2002; De Gennaro L, 2000, J SLEEP RES, V9, P155, DOI 10.1046/j.1365-2869.2000.00193.x; FERRARELLI F, AM J PSYCHI IN PRESS; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fogel SM, 2006, J SLEEP RES, V15, P250, DOI 10.1111/j.1365-2869.2006.00522.x; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; IYAMA A, 1992, CLIN ELECTROENCEPHAL, V23, P137, DOI 10.1177/155005949202300308; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; MEDNICK SC, 2002, NAT NEUROSCI, V28, P28; PETERS K, J COGN NEUR IN PRESS; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; SMITH C, 1994, J SLEEP RES, V3, P206, DOI 10.1111/j.1365-2869.1994.tb00133.x; Smith CT, 2004, PSYCHOL BELG, V44, P81; Steriade M., 2001, INTACT SLICED BRAIN; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; TUCKER MA, 2006, NEUROBIOL LEARN MEM; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Zeitlhofer J, 1997, J SLEEP RES, V6, P149, DOI 10.1046/j.1365-2869.1997.00046.x	32	342	343	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e341	10.1371/journal.pone.0000341	http://dx.doi.org/10.1371/journal.pone.0000341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406665	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445300003
J	Reynolds, AM; Frye, MA				Reynolds, Andy M.; Frye, Mark A.			Free-Flight Odor Tracking in Drosophila Is Consistent with an Optimal Intermittent Scale-Free Search	PLOS ONE			English	Article								During their trajectories in still air, fruit flies (Drosophila melanogaster) explore their landscape using a series of straight flight paths punctuated by rapid 90 degrees body-saccades [1]. Some saccades are triggered by visual expansion associated with collision avoidance. Yet many saccades are not triggered by visual cues, but rather appear spontaneously. Our analysis reveals that the control of these visually independent saccades and the flight intervals between them constitute an optimal scale-free active searching strategy. Two characteristics of mathematical optimality that are apparent during free-flight in Drosophila are inter-saccade interval lengths distributed according to an inverse square law, which does not vary across landscape scale, and 90 degrees saccade angles, which increase the likelihood that territory will be revisited and thereby reduce the likelihood that near-by targets will be missed. We also show that searching is intermittent, such that active searching phases randomly alternate with relocation phases. Behaviorally, this intermittency is reflected in frequently occurring short, slow speed inter-saccade intervals randomly alternating with rarer, longer, faster inter-saccade intervals. Searching patterns that scale similarly across orders of magnitude of length (i.e., scale-free) have been revealed in animals as diverse as microzooplankton, bumblebees, albatrosses, and spider monkeys, but these do not appear to be optimised with respect to turning angle, whereas Drosophila free-flight search does. Also, intermittent searching patterns, such as those reported here for Drosophila, have been observed in foragers such as planktivorous fish and ground foraging birds. Our results with freely flying Drosophila may constitute the first reported example of searching behaviour that is both scale-free and intermittent.	[Reynolds, Andy M.] Rothamsted Res, Harpenden, Herts, England; [Frye, Mark A.] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of California System; University of California Los Angeles	Reynolds, AM (corresponding author), Rothamsted Res, Harpenden, Herts, England.	andy.reynolds@bbsrc.ac.uk		Frye, Mark/0000-0003-3277-3094	Biotechnology and Biological Sciences Research Council [BB/D007453/1]; Sloan Research Fellowship; UCLA; BBSRC [BB/D007453/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sloan Research Fellowship(Alfred P. Sloan Foundation); UCLA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (Grant BB/D007453/1) (A. M. R.) and by a Sloan Research Fellowship and UCLA Faculty Career award (M. A. F.). Rothamsted Research receives grant aided assistance from the Biotechnological and Biological Sciences Research Council.	Atkinson RPD, 2002, OIKOS, V98, P134, DOI 10.1034/j.1600-0706.2002.980114.x; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; Chapman SC, 2005, NONLINEAR PROC GEOPH, V12, P767, DOI 10.5194/npg-12-767-2005; Chechkin AV, 2000, CHAOS SOLITON FRACT, V11, P2379, DOI 10.1016/S0960-0779(99)00168-X; COLE BJ, 1995, ANIM BEHAV, V50, P1317, DOI 10.1016/0003-3472(95)80047-6; DICKE M, 1988, PHYSIOL ENTOMOL, V13, P393, DOI 10.1111/j.1365-3032.1988.tb01122.x; FOURCASSIE V, 1992, NATURWISSENSCHAFTEN, V79, P87, DOI 10.1007/BF01131811; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Frye MA, 2003, J EXP BIOL, V206, P843, DOI 10.1242/jeb.00175; HOFFMANN G, 1983, BEHAV ECOL SOCIOBIOL, V13, P81, DOI 10.1007/BF00293798; Kramer DL, 2001, AM ZOOL, V41, P137, DOI 10.1668/0003-1569(2001)041[0137:TBEOIL]2.0.CO;2; LAND MF, 1992, J INSECT PHYSIOL, V38, P939, DOI 10.1016/0022-1910(92)90002-U; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Martin JR, 2001, J NEUROGENET, V15, P205, DOI 10.3109/01677060109167377; Murdie G., 1973, MATH THEORY DYNAMICS, P87; Nakao H, 2000, PHYS LETT A, V266, P282, DOI 10.1016/S0375-9601(00)00059-1; OBRIEN WJ, 1990, AM SCI, V78, P152; Peng C-K., 1995, LEVY FLIGHTS RELATED, P313; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2006, EUROPHYS LETT, V75, P517, DOI 10.1209/epl/i2006-10157-x; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; SHIMADA I, 1993, BIOL CYBERN, V68, P477, DOI 10.1007/BF00200806; Shlesinger M. F., 1986, On Growth and Form - Fractal and Non-Fractal Patterns in Physics. Proceedings of the NATO Advanced Study Institute, P279; Tammero LF, 2002, J EXP BIOL, V205, P327; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; WIENS JA, 1995, ECOLOGY, V76, P663, DOI 10.2307/1941226	31	275	284	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e354	10.1371/journal.pone.0000354	http://dx.doi.org/10.1371/journal.pone.0000354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406678	Green Published, gold			2022-12-27	WOS:000207445300016
J	Suzan-Monti, M; La Scola, B; Barrassi, L; Espinosa, L; Raoult, D				Suzan-Monti, Marie; La Scola, Bernard; Barrassi, Lina; Espinosa, Leon; Raoult, Didier			Ultrastructural Characterization of the Giant Volcano-like Virus Factory of Acanthamoeba polyphaga Mimivirus	PLOS ONE			English	Article								Acanthamoeba polyphaga Mimivirus is a giant double-stranded DNA virus defining a new genus, the Mimiviridae, among the Nucleo-Cytoplasmic Large DNA Viruses (NCLDV). We used utrastructural studies to shed light on the different steps of the Mimivirus replication cycle: entry via phagocytosis, release of viral DNA into the cell cytoplasm through fusion of viral and vacuolar membranes, and finally viral morphogenesis in an extraordinary giant cytoplasmic virus factory (VF). Fluorescent staining of the AT-rich Mimivirus DNA showed that it enters the host nucleus prior to the generation of a cytoplasmic independent replication centre that forms the core of the VF. Assembly and filling of viral capsids were observed within the replication centre, before release into the cell cytoplasm where progeny virions accumulated. 3D reconstruction from fluorescent and differential contrast interference images revealed the VF emerging from the cell surface as a volcano-like structure. Its size dramatically grew during the 24 h infectious lytic cycle. Our results showed that Mimivirus replication is an extremely efficient process that results from a rapid takeover of cellular machinery, and takes place in a unique and autonomous giant assembly centre, leading to the release of a large number of complex virions through amoebal lysis.	[Suzan-Monti, Marie; La Scola, Bernard; Barrassi, Lina; Espinosa, Leon; Raoult, Didier] Univ Aix Marseille 2, Fac Med, CNRS, Unite Rickettsies,UMR 6020,IFR 48, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Suzan-Monti, M (corresponding author), Univ Aix Marseille 2, Fac Med, CNRS, Unite Rickettsies,UMR 6020,IFR 48, Marseille, France.	marie.suzan@medecine.univ-mrs.fr; Didier.Raoult@medecine.univ-mrs.fr	RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016; Espinosa, Leon/V-8410-2017	RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704; 	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	Centre National de la Recherche Scientifique (CNRS)	Andres G, 1997, J VIROL, V71, P2331; Berger P, 2006, EMERG INFECT DIS, V12, P248; Brookes SM, 1998, VIROLOGY, V249, P175, DOI 10.1006/viro.1998.9308; Brookes SM, 1996, VIROLOGY, V224, P84, DOI 10.1006/viro.1996.0509; GARCIABEATO R, 1992, VIROLOGY, V188, P637, DOI 10.1016/0042-6822(92)90518-T; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; KUBISTA M, 1987, BIOCHEMISTRY-US, V26, P4545, DOI 10.1021/bi00388a057; La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538; La Scola B, 2003, SCIENCE, V299, P2033; MOSS B, 2001, FIELDS VIROLOGY, P2637; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2006, ANN INTERN MED, V144, P702, DOI 10.7326/0003-4819-144-9-200605020-00025; Renesto P, 2006, J VIROL, V80, P11678, DOI 10.1128/JVI.00940-06; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Suzan-Monti M, 2006, VIRUS RES, V117, P145, DOI 10.1016/j.virusres.2005.07.011; Valdecasas AG, 2001, MICRON, V32, P559, DOI 10.1016/S0968-4328(00)00061-5; Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915; Van Etten JL, 1999, ANNU REV MICROBIOL, V53, P447, DOI 10.1146/annurev.micro.53.1.447; Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6; Williams T, 2005, ADV VIRUS RES, V65, P173, DOI 10.1016/S0065-3527(05)65006-3; Williams T, 1996, ADV VIRUS RES, V46, P345, DOI 10.1016/S0065-3527(08)60076-7; Xiao CA, 2005, J MOL BIOL, V353, P493, DOI 10.1016/j.jmb.2005.08.060	26	112	114	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e328	10.1371/journal.pone.0000328	http://dx.doi.org/10.1371/journal.pone.0000328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389919	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445200011
J	Wuchty, S				Wuchty, Stefan			Rich-Club Phenomenon in the Interactome of P. falciparum-Artifact or Signature of a Parasitic Life Style?	PLOS ONE			English	Article							PROTEINS; TOPOLOGY; VIRULENCE; DATABASE; BIOLOGY	Recent advances have provided a first experimental protein interaction map of the human malaria parasite P. falciparum, which appears to be remotely related to interactomes of other eukaryotes. Here, we present a comparative topological analysis of this experimentally determined web with a network of conserved interactions between proteins in S. cerevisiae, C. elegans and D. melanogaster that have an ortholog in Plasmodium. Focusing on experimental interactions, we find a significant presence of a "rich-club,'' a topological characteristic that features an "oligarchy'' of highly connected proteins being intertwined with one another. In complete contrast, the network of interologs and particularly the web of evolutionary-conserved interactions in P. falciparum lack this feature. This observation prompts the question of whether this result points to a topological signature of the parasite's biology, since experimentally obtained interactions widely cover parasite-specific functions. Significantly, hub proteins that appear in such an oligarchy revolve around invasion functions, shaping an island of parasite-specific activities in a sea of evolutionary inherited interactions. This presence of a biologically unprecedented network feature in the human malaria parasite might be an artifact of the quality and the methods to obtain interaction data in this organism. Yet, the observation that rich-club proteins have distinctive and statistically significant functions that revolve around parasite-specific activities point to a topological signature of a parasitic life style.	Northwestern Univ, NW Inst Complex, Evanston, IL 60208 USA	Northwestern University	Wuchty, S (corresponding author), Northwestern Univ, NW Inst Complex, Evanston, IL 60208 USA.	s-wuchty@northwest-ern.edu	li, lingxuan/F-7033-2010		Northwestern Institute of Complexity	Northwestern Institute of Complexity	The Northwestern Institute of Complexity supported this study.	Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Winzeler EA, 2006, NAT REV MICROBIOL, V4, P145, DOI 10.1038/nrmicro1327; Wuchty S, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-8; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Wuchty S, 2004, GENOME RES, V14, P1310, DOI 10.1101/gr.2300204; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	26	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e335	10.1371/journal.pone.0000335	http://dx.doi.org/10.1371/journal.pone.0000335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389924	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445200018
J	Daksis, JI; Erikson, GH				Daksis, Jasmine I.; Erikson, Glen H.			Heteropolymeric Triplex-Based Genomic Assay (R) to Detect Pathogens or Single-Nucleotide Polymorphisms in Human Genomic Samples	PLOS ONE			English	Article							HELIX FORMATION; MAJOR GROOVE; DNA; SEQUENCE; RECOGNITION; ELONGATION; RESISTANCE; MUTATION; BINDING	Human genomic samples are complex and are considered difficult to assay directly without denaturation or PCR amplification. We report the use of a base-specific heteropolymeric triplex, formed by native duplex genomic target and an oligonucleotide third strand probe, to assay for low copy pathogen genomes present in a sample also containing human genomic duplex DNA, or to assay human genomic duplex DNA for Single Nucleotide Polymorphisms (SNP), without PCR amplification. Wild-type and mutant probes are used to identify triplexes containing FVL G1691A, MTHFR C677T and CFTR mutations. The specific triplex structure forms rapidly at room temperature in solution and may be detected without a separation step. YOYO-1, a fluorescent bis-intercalator, promotes and signals the formation of the specific triplex. Genomic duplexes may be assayed homogeneously with single base pair resolution. The specific triple-stranded structures of the assay may approximate homologous recombination intermediates, which various models suggest may form in either the major or minor groove of the duplex. The bases of the stable duplex target are rendered specifically reactive to the bases of the probe because of the activity of intercalated YOYO-1, which is known to decondense duplex locally 1.3 fold. This may approximate the local decondensation effected by recombination proteins such as RecA in vivo. Our assay, while involving triplex formation, is sui generis, as it is not homopurine sequence-dependent, as are "canonical triplexes''. Rather, the base pair-specific heteropolymeric triplex of the assay is conformation-dependent. The highly sensitive diagnostic assay we present allows for the direct detection of base sequence in genomic duplex samples, including those containing human genomic duplex DNA, thereby bypassing the inherent problems and cost associated with conventional PCR based diagnostic assays.	[Daksis, Jasmine I.; Erikson, Glen H.] Ingeneus Res, Mississauga, ON, Canada		Daksis, JI (corresponding author), Ingeneus Res, Mississauga, ON, Canada.	jasmine@ingeneus.net			Ingeneus Inc.	Ingeneus Inc.	Ingeneus Inc.	BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bertucat G, 2000, J BIOMOL STRUCT DYN, P147, DOI 10.1080/07391102.2000.10506615; Birch L, 2004, CLIN CHEM, V50, P1553, DOI 10.1373/clinchem.2003.029454; Chan PP, 1997, J MOL MED, V75, P267, DOI 10.1007/s001090050112; CHENG AJ, 1994, NUCLEIC ACIDS RES, V22, P4742, DOI 10.1093/nar/22.22.4742; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Daksis JI, 2005, GENET TEST, V9, P111, DOI 10.1089/gte.2005.9.111; EGELMAN EH, 1993, CURR OPIN STRUC BIOL, V3, P189, DOI 10.1016/S0959-440X(05)80151-4; FRANKKAMENETSKI.MD, 1990, DNA TOPOLOGY ITS BIO, P185; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; GRIGORIEV M, 1992, J BIOL CHEM, V267, P3389; Grody Wayne W., 2001, Genetics in Medicine, V3, P149, DOI 10.1097/00125817-200103000-00010; HELENE C, 1992, ANN NY ACAD SCI, V660, P27, DOI 10.1111/j.1749-6632.1992.tb21054.x; Johansen F, 1998, J BIOMOL STRUCT DYN, V16, P205, DOI 10.1080/07391102.1998.10508240; KIM MG, 1995, J MOL BIOL, V247, P874, DOI 10.1006/jmbi.1994.0187; Kosikov KM, 1999, J MOL BIOL, V289, P1301, DOI 10.1006/jmbi.1999.2798; Leitner D, 2000, J BIOMOL STRUCT DYN, V17, P993, DOI 10.1080/07391102.2000.10506587; MAHER LJ, 1992, BIOCHEMISTRY-US, V31, P70, DOI 10.1021/bi00116a012; Malkov VA, 2000, J MOL BIOL, V299, P629, DOI 10.1006/jmbi.2000.3770; MERGNY JL, 1991, BIOCHEMISTRY-US, V30, P9791, DOI 10.1021/bi00104a031; Newman M, 1998, EMBO J, V17, P5466, DOI 10.1093/emboj/17.18.5466; Raggi CC, 2003, CLIN CHEM, V49, P782, DOI 10.1373/49.5.782; Seidman MM, 2003, J CLIN INVEST, V112, P487, DOI 10.1172/JCI200319552; SINGLETON SF, 1992, BIOCHEMISTRY-US, V31, P10995, DOI 10.1021/bi00160a008; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; SVENSSON PJ, 1994, NEW ENGL J MED, V330, P517, DOI 10.1056/NEJM199402243300801; Titus SA, 1997, J NEUROSCI, V17, P875; Vasquez KM, 1998, TRENDS BIOCHEM SCI, V23, P4, DOI 10.1016/S0968-0004(97)01158-4; YOUNG SL, 1991, P NATL ACAD SCI USA, V88, P10023, DOI 10.1073/pnas.88.22.10023; Zhang Y, 2005, BIOPHYS J, V89, P2950, DOI 10.1529/biophysj.104.058552; ZHURKIN VB, 1994, J MOL BIOL, V239, P181, DOI 10.1006/jmbi.1994.1362; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	33	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e305	10.1371/journal.pone.0000305	http://dx.doi.org/10.1371/journal.pone.0000305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375191	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445100007
J	Frak, V; Croteau, I; Bourbonnais, D; Duval, C; Duclos, C; Cohen, H				Frak, Victor; Croteau, Isabelle; Bourbonnais, Daniel; Duval, Christian; Duclos, Cyril; Cohen, Henri			Simulation Modifies Prehension: Evidence for a Conjoined Representation of the Graspable Features of an Object and the Action of Grasping It	PLOS ONE			English	Article							MAGNETIC STIMULATION; MOTOR IMAGERY; HAND; MOVEMENTS; BRAIN; MECHANISMS; ARM; ORIENTATION; INHIBITION; DORSAL	Movement formulas, engrams, kinesthetic images and internal models of the body in action are notions derived mostly from clinical observations of brain-damaged subjects. They also suggest that the prehensile geometry of an object is integrated in the neural circuits and includes the object's graspable characteristics as well as its semantic properties. In order to determine whether there is a conjoined representation of the graspable characteristics of an object in relation to the actual grasping, it is necessary to separate the graspable (low-level) from the semantic (high-level) properties of the object. Right-handed subjects were asked to grasp and lift a smooth 300-g cylinder with one hand, before and after judging the level of difficulty of a "grasping for pouring'' action, involving a smaller cylinder and using the opposite hand. The results showed that simulated grasps with the right hand exert a direct influence on actual motor acts with the left hand. These observations add to the evidence that there is a conjoined representation of the graspable characteristics of the object and the biomechanical constraints of the arm.	[Frak, Victor; Duval, Christian] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada; [Frak, Victor; Croteau, Isabelle; Bourbonnais, Daniel; Duclos, Cyril] Univ Quebec, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Inst Readaptat Montreal, Montreal, PQ H3C 3P8, Canada; [Cohen, Henri] Clin St Anne, Quebec Memory & Motor Skill Disorders Res Ctr, CNRS Paris Descartes, Psychol & Cognit Neurosci Lab, Quebec City, PQ, Canada	University of Quebec; University of Quebec Montreal; Universite de Montreal; University of Quebec; University of Quebec Montreal	Frak, V (corresponding author), Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada.	frak.victor@uqam.ca	Duclos, Cyril/C-4060-2014	Duclos, Cyril/0000-0002-5788-2396; Frak, Victor/0000-0002-3311-777X	PAFARC-Universite du Quebec a Montreal	PAFARC-Universite du Quebec a Montreal	PAFARC-Universite du Quebec a Montreal: publication fee.	AIZAWA H, 1990, EXP BRAIN RES, V82, P219; ANQUETIL T, 2007, BRAIN RES IN PRESS; Bastian H.C., 1887, BRAIN, V10, P1, DOI [10.1093/brain/10.1.1, DOI 10.1093/BRAIN/10.1.1]; Bernstein N, 1967, COORDINATION REGULAT; BRINKMAN J, 1973, BRAIN, V96, P653, DOI 10.1093/brain/96.4.653; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; CERNACEK J, 1961, ARCH NEUROL-CHICAGO, V4, P165, DOI 10.1001/archneur.1961.00450080047005; Daprati E, 2006, TRENDS COGN SCI, V10, P265, DOI 10.1016/j.tics.2006.04.005; Daskalakis ZJ, 2002, J PHYSIOL-LONDON, V543, P317, DOI 10.1113/jphysiol.2002.017673; Dettmers C, 1996, J APPL PHYSIOL, V81, P596, DOI 10.1152/jappl.1996.81.2.596; Donchin O, 2002, J NEUROPHYSIOL, V88, P3498, DOI 10.1152/jn.00335.2001; Farne A, 2003, NEUROPSYCHOLOGIA, V41, P739, DOI 10.1016/S0028-3932(02)00177-X; Frak V, 2006, THESCIENTIFICWORLDJO, V6, P1805, DOI 10.1100/tsw.2006.291; Frak V, 2004, NEUROREPORT, V15, P1489, DOI 10.1097/01.wnr.0000132429.68206.48; Frak V, 2001, EXP BRAIN RES, V136, P120, DOI 10.1007/s002210000583; Gallagher S, 2002, J CONSCIOUSNESS STUD, V9, P3; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Glover S, 2004, EXP BRAIN RES, V154, P103, DOI 10.1007/s00221-003-1659-2; HESS CW, 1986, NEUROSCI LETT, V71, P235, DOI 10.1016/0304-3940(86)90565-3; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jeannerod M, 2006, MOTOR COGNITION WHAT, DOI 10.1093/acprof:oso/9780198569657.001.0001/acprof-9780198569657; Johnson SH, 2000, COGNITION, V74, P33, DOI 10.1016/S0010-0277(99)00063-3; Kleist K., 1934, GEHIRNPATHOLOGIE; Liepmann H, 1900, MON PSYCHIATR NEUROL, V8, P15; Morton SM, 2001, EXP BRAIN RES, V141, P438, DOI 10.1007/s002210100889; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; Parsons LM, 1998, J NEUROSCI, V18, P6539; Paulignan Y, 1997, EXP BRAIN RES, V114, P226, DOI 10.1007/PL00005631; Rossetti Y, 2002, ATTENTION PERFORM, V19, P62; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Schnitzler A, 1996, EXP BRAIN RES, V112, P381; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e311	10.1371/journal.pone.0000311	http://dx.doi.org/10.1371/journal.pone.0000311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375197	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000207445100013
J	Lafay, B; Burdon, JJ				Lafay, Benedicte; Burdon, Jeremy J.			Molecular Diversity of Legume Root-Nodule Bacteria in Kakadu National Park, Northern Territory, Australia	PLOS ONE			English	Article								Background. Symbiotic relationships between leguminous plants (family Fabaceae) and nodule-forming bacteria in Australia native ecosystems remain poorly characterized despite their importance. Most studies have focused on temperate parts of the country, where the use of molecular approaches have already revealed the presence of Bradyrhizobium, Ensifer (formerly Sinorhizobium), Mesorhizobium and Rhizobium genera of legume root-nodule bacteria. We here provide the first molecular characterization of nodulating bacteria from tropical Australia. Methodology/Principal Findings. 45 nodule-forming bacterial strains, isolated from eight native legume hosts at eight locations in Kakadu National Park, Northern Territory, Australia, were examined for their genetic diversity and phylogenetic position. Using SSU rDNA PCR-RFLPs and phylogenetic analyses, our survey identified nine genospecies, two of which, Bradyrhizobium genospp. B and P, had been previously identified in south-eastern Australia and one, Mesorhizobium genospecies AA, in southern France. Three of the five newly characterized Bradyrhizobium genospecies were more closely related to B. japonicum USDA110, whereas the other two belonged to the B. elkanii group. All five were each more closely related to strains sampled in various tropical areas outside Australia than to strains known to occur in Australia. We also characterized an entirely novel nodule-forming lineage, phylogenetically distant from any previously described rhizobial and non-rhizobial legume-nodulating lineage within the Rhizobiales. Conclusions/Significance. Overall, the present results support the hypothesis of tropical areas being centres of biodiversity and diversification for legume root-nodule bacteria and confirm the widespread occurrence of Bradyrhizobium genosp. B in continental Australia.	[Lafay, Benedicte; Burdon, Jeremy J.] Commonwealth Sci & Ind Res Org Plant Ind, Ctr Plant Biodivers Res, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lafay, B (corresponding author), Ctr IRD, CNRS, UMR IRD 2724, Montpellier, France.	blafay@mpl.ird.fr	Lafay, Bénédicte/D-8359-2011; Burdon, Jeremy J/B-9913-2009	Lafay, Bénédicte/0000-0001-5783-5269; 				BARNET YM, 1991, PLANT SOIL, V135, P109, DOI 10.1007/BF00014783; BARNET YM, 1985, AUST J BOT, V33, P595, DOI 10.1071/BT9850595; Benhizia Y, 2004, SYST APPL MICROBIOL, V27, P462, DOI 10.1078/0723202041438527; Bowen G. D., 1956, Od. J. agric. Sci., V13, P47; BOWEN G. D., 1959, Queensland Journal of Agricultural Science, V16, P253; BOWEN GD, 1959, QLD J AGR SCI, V16, P267; Chen WM, 2001, INT J SYST EVOL MICR, V51, P1729, DOI 10.1099/00207713-51-5-1729; DAVIDSON BR, 1993, LEGUMES AUSTR EXPERI, P47; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Felsenstein J., 2004, PHYLIP PHYLOGENETIC; Jaftha JB, 2002, SYST APPL MICROBIOL, V25, P440, DOI 10.1078/0723-2020-00124; Lafay B, 2006, J APPL MICROBIOL, V100, P1228, DOI 10.1111/j.1365-2672.2006.02902.x; Lafay B, 1998, APPL ENVIRON MICROB, V64, P3989; Lafay B, 2001, APPL ENVIRON MICROB, V67, P396, DOI 10.1128/AEM.67.1.396-402.2001; LAGUERRE G, 1994, APPL ENVIRON MICROB, V60, P56, DOI 10.1128/AEM.60.1.56-63.1994; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P351; LANGE RT, 1961, J GEN MICROBIOL, V61, P351; LANGKAMP PJ, 1982, AUST J BOT, V30, P87, DOI 10.1071/BT9820087; LANGKAMP PJ, 1981, AUST J BOT, V29, P1, DOI 10.1071/BT9810001; LAWRIE AC, 1983, APPL ENVIRON MICROB, V45, P1822, DOI 10.1128/AEM.45.6.1822-1828.1983; Marsudi NDS, 1999, SOIL BIOL BIOCHEM, V31, P1229, DOI 10.1016/S0038-0717(99)00032-2; MCINNES A, 1996, COLLECTION ISOLATION; McKNIGHT T., 1949, QUEENSLAND JOUR AGRIC SCI, V6, P61; MOREIRA FMS, 1993, SYST APPL MICROBIOL, V16, P135, DOI 10.1016/S0723-2020(11)80258-4; Moreira FMS, 1998, MOL ECOL, V7, P889, DOI 10.1046/j.1365-294x.1998.00411.x; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Murray B. R., 2001, Ecological Management & Restoration, V2, P213, DOI 10.1046/j.1442-8903.2001.00086.x; Ngom A, 2004, J GEN APPL MICROBIOL, V50, P17, DOI 10.2323/jgam.50.17; Nick G, 1999, INT J SYST BACTERIOL, V49, P1359, DOI 10.1099/00207713-49-4-1359; NORRIS DO, 1956, EMPIRE J EXPER AGR, V24, P245; POHILL RM, 1981, ADV LEGUME SYSTEMA 1; PRIN Y, 1993, BOIS FOR TROP, V238, P5; REDDELL P, 1992, AUST J BOT, V40, P223, DOI 10.1071/BT9920223; Rivas R, 2002, APPL ENVIRON MICROB, V68, P5217, DOI 10.1128/AEM.68.11.5217-5222.2002; Sawada H, 2003, J GEN APPL MICROBIOL, V49, P155, DOI 10.2323/jgam.49.155; SPRENT JI, 1994, PLANT SOIL, V161, P1, DOI 10.1007/BF02183080; SRITHARAN V, 1991, MOL CELL PROBE, V5, P385, DOI 10.1016/S0890-8508(06)80011-3; Sy A, 2001, J BACTERIOL, V183, P214, DOI 10.1128/JB.183.1.214-220.2001; THOMPSON SC, 1984, AUSTR I AGR SCI OCCA, V12, P27; Thrall PH, 2005, J APPL ECOL, V42, P740, DOI 10.1111/j.1365-2664.2005.01058.x; van Berkum P, 2003, J BACTERIOL, V185, P2988, DOI 10.1128/JB.185.10.2988-2998.2003; van Berkum P, 2002, APPL ENVIRON MICROB, V68, P1132, DOI 10.1128/AEM.68.3.1132-1136.2002; Vandamme P, 2002, SYST APPL MICROBIOL, V25, P507, DOI 10.1078/07232020260517634; Vincent J., 1970, INT BIOL PROGRAMME H, V15; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	45	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e277	10.1371/journal.pone.0000277	http://dx.doi.org/10.1371/journal.pone.0000277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17356689	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444700012
J	Angilletta, MJ; Wilson, RS; Niehaus, AC; Sears, MW; Navas, CA; Ribeiro, PL				Angilletta, Michael J., Jr.; Wilson, Robbie S.; Niehaus, Amanda C.; Sears, Michael W.; Navas, Carlos A.; Ribeiro, Pedro L.			Urban Physiology: City Ants Possess High Heat Tolerance	PLOS ONE			English	Article							THERMAL PHYSIOLOGY; STRESS RESISTANCE; REACTION NORMS; TEMPERATURE; DROSOPHILA; EVOLUTION; ADAPTATION; ECTOTHERMS; LATITUDE; SIZE	Urbanization has caused regional increases in temperature that exceed those measured on a global scale, leading to urban heat islands as much as 12 degrees C hotter than their surroundings. Optimality models predict ectotherms in urban areas should tolerate heat better and cold worse than ectotherms in rural areas. We tested these predications by measuring heat and cold tolerances of leaf-cutter ants from South America's largest city (Sao Paulo, Brazil). Specifically, we compared thermal tolerances of ants from inside and outside of the city. Knock-down resistance and chill-coma recovery were used as indicators of heat and cold tolerances, respectively. Ants from within the city took 20% longer to lose mobility at 42 degrees C than ants from outside the city. Interestingly, greater heat tolerance came at no obvious expense of cold tolerance; hence, our observations only partially support current theory. Our results indicate that thermal tolerances of some organisms can respond to rapid changes in climate. Predictive models should account for acclimatory and evolutionary responses during climate change.	[Angilletta, Michael J., Jr.] Indiana State Univ, Dept Ecol & Organismal Biol, Terre Haute, IN 47809 USA; [Wilson, Robbie S.; Niehaus, Amanda C.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia; [Navas, Carlos A.; Ribeiro, Pedro L.] Univ Sao Paulo, Inst Biosci, Dept Physiol, Sao Paulo, Brazil; [Sears, Michael W.] So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA; [Sears, Michael W.] So Illinois Univ, Ctr Ecol, Carbondale, IL 62901 USA	Indiana State University; University of Queensland; Universidade de Sao Paulo; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Angilletta, MJ (corresponding author), Indiana State Univ, Dept Ecol & Organismal Biol, Terre Haute, IN 47809 USA.	mangilletta@indstate.edu	Wilson, Robbie S/F-1463-2011; Navas, Carlos/B-2138-2013	Navas, Carlos/0000-0002-9859-0568; Wilson, Robbie/0000-0002-0116-5427	University of Queensland's Graduate School; University of Queensland	University of Queensland's Graduate School(University of Queensland); University of Queensland(University of Queensland)	Amanda Niehaus was supported by a Student Travel Grant from the University of Queensland's Graduate School. Robbie Wilson was supported by a Faculty Travel Grant from the University of Queensland.	Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Berrigan D, 2000, OIKOS, V89, P301, DOI 10.1034/j.1600-0706.2000.890211.x; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Gabriel W, 2005, AM NAT, V166, P339, DOI 10.1086/432558; GABRIEL W, 1992, J EVOLUTION BIOL, V5, P41, DOI 10.1046/j.1420-9101.1992.5010041.x; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; HUEY RB, 1979, AM ZOOL, V19, P357; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; LYNCH M, 1987, AM NAT, V129, P283, DOI 10.1086/284635; McLean MA, 2005, J THERM BIOL, V30, P384, DOI 10.1016/j.jtherbio.2005.03.002; Monteiro C. A. F., 1986, URBAN CLIMATOLOGY IT, P166; Oke T.R., 1997, APPL CLIMATOLOGY PRI, p273; OKE TR, 1973, ATMOS ENVIRON, V7, P769, DOI 10.1016/0004-6981(73)90140-6; Roth M., 2002, EFFECTS CITIES LOCAL, P1; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Shih Hsi-Te, 2000, Acta Zoologica Taiwanica, V11, P47; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Therneau T.M., 2000, MODELING SURVIVAL DA; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882	27	112	118	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e258	10.1371/journal.pone.0000258	http://dx.doi.org/10.1371/journal.pone.0000258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327918	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444600018
J	Cudilo, E; Al Naemi, H; Marmorstein, L; Baldwin, AL				Cudilo, Elizabeth; Al Naemi, Hamda; Marmorstein, Lihua; Baldwin, Ann L.			Knockout Mice: Is It Just Genetics? Effect of Enriched Housing on Fibulin-4(+/-) Mice	PLOS ONE			English	Article								Background. Fibulin-4 is an extracellular matrix protein expressed by vascular smooth muscle cells that is essential for maintaining arterial integrity. Fibulin-4(-/-) mice die just before birth due to arterial hemorrhage, but fibulin-4(+/-) mice appear to be outwardly normal. Experiments were therefore performed to determine whether fibulin-4(+/-) mice display arterial pathologies on a microscopic scale. After preliminary experiments were performed, a second purpose developed, which was to test the hypothesis that any observed pathologies would be ameliorated by housing the animals in enriched cages. Methodology. Fibulin-4(+/-) and wild-type mice were housed either four/cage in standard cages or two per cage in larger cages, each cage containing a tunnel and a wheel. After three weeks the mice were sacrificed, and the aortas perfusion-fixed and excised for light and electron microscopy. Principle Findings. When the mice were in standard cages, localized regions of disorganized extracellular matrix and collagen fibers consistently appeared between some of the medial smooth muscle cells in the fibulin-4(+/-) mice. In the wild-type mice, the smooth muscle cells were closely connected to each other and the media was more compact. The number of disorganized regions per square mm was significantly greater for fibulin-4(+/-) mice (172 +/- 43 (SEM)) than for wild-type mice (15 +/- 8) (p<0.01, n = 8). When the mice were in enriched cages, the fibulin-4(+/-) mice showed significantly fewer disorganized regions than those in standard cages (35 +/- 12) (p<0.05, n = 8). The wild type mice also showed fewer disorganized regions (3 +/- 2), but this difference was not significant. Conclusions. These results indicate that arterial pathologies manifested in fibulin-4(+/-) mice can be reduced by enriching the housing conditions, and imply that appropriate environments may counteract the effects of some genetic deficiencies.	[Cudilo, Elizabeth; Baldwin, Ann L.] Univ Arizona, Coll Med, Dept Physiol, Tucson, AZ 85724 USA; [Al Naemi, Hamda] Univ Qatar, Doha, Qatar; [Marmorstein, Lihua] Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ USA	University of Arizona; Qatar University; University of Arizona	Baldwin, AL (corresponding author), Univ Arizona, Coll Med, Dept Physiol, Tucson, AZ 85724 USA.	abaldwin@u.arizona.edu			National Center for Research Resources (NCRR) [RR017358]; National Center for Complementary and Alternative Medicine (NCCAM) [P20AT00774]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P20AT000774] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR017358] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the National Center for Research Resources (NCRR) grant RR017358 and the National Center for Complementary and Alternative Medicine (NCCAM) P20AT00774. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NCCAM.	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003; Collod G, 1996, EUR J HUM GENET, V4, P292; Collod-Beroud G, 2002, EUR J HUM GENET, V10, P673, DOI 10.1038/sj.ejhg.5200876; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; DAVIS EC, 1993, CELL TISSUE RES, V272, P211, DOI 10.1007/BF00302726; Gilbert SF, 2005, J BIOSCIENCES, V30, P65, DOI 10.1007/BF02705151; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; HUMASON GL, 1979, ANIMAL TISSUE TECHNI, P147; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lin CH, 2005, P NATL ACAD SCI USA, V102, P14877, DOI 10.1073/pnas.0506785102; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; ROARK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401, DOI 10.1177/43.4.7534784; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; SOSAMELGAREJO JA, 1989, J PATHOL, V157, P213, DOI 10.1002/path.1711570307; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Tsuda T, 2001, DEV DYNAM, V222, P89, DOI 10.1002/dvdy.1172; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e229	10.1371/journal.pone.0000229	http://dx.doi.org/10.1371/journal.pone.0000229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311093	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444500010
J	Tabatabaei-Zavareh, N; Vlasova, A; Greenwood, CP; Takei, F				Tabatabaei-Zavareh, Nooshin; Vlasova, Anastasia; Greenwood, Chelsea Pamela; Takei, Fumio			Characterization of Developmental Pathway of Natural Killer Cells from Embryonic Stem Cells In Vitro	PLOS ONE			English	Article								In vitro differentiation of embryonic stem (ES) cells is often used to study hematopoiesis. However, the differentiation pathway of lymphocytes, in particular natural killer (NK) cells, from ES cells is still unclear. Here, we used a multi-step in vitro ES cell differentiation system to study lymphocyte development from ES cells, and to characterize NK developmental intermediates. We generated embryoid bodies (EBs) from ES cells, isolated CD34(+) EB cells and cultured them on OP9 stroma with a cocktail of cytokines to generate cells we termed ES-derived hematopoietic progenitors (ES-HPs). EB cell subsets, as well as ES-HPs derived from EBs, were tested for NK, T, B and myeloid lineage potentials using lineage specific cultures. ES-HPs derived from CD34(+) EBs differentiated into NK cells when cultured on OP9 stroma with IL-2 and IL-15, and into T cells on Delta-like 1-transduced OP9 (OP9-DL1) with IL-7 and Flt3-L. Among CD34(+) EB cells, NK and T cell potentials were detected in a CD45(-) subset, whereas CD45(+) EB cells had myeloid but not lymphoid potentials. Limiting dilution analysis of ES-HPs generated from CD34(+) CD45(-) EB cells showed that CD45(+) Mac-1(-) Ter119(-) ES-HPs are highly enriched for NK progenitors, but they also have T, B and myeloid potentials. We concluded that CD45(-) CD34(+) EB cells have lymphoid potential, and they differentiate into more mature CD45+ Lin(-) hematopoietic progenitors that have lymphoid and myeloid potential. NK progenitors among ES-HPs are CD122(-) and they rapidly acquire CD122 as they differentiate along the NK lineage.	[Takei, Fumio] Univ British Columbia, Terry Fox Lab, British Columbia Canc Res Ctr, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Takei, F (corresponding author), Univ British Columbia, Terry Fox Lab, British Columbia Canc Res Ctr, Vancouver, BC V5Z 1M9, Canada.	ftakei@bccrc.ca		Takei, Fumio/0000-0002-3620-5046	National Cancer Institute of Canada; Canadian Institute of Health Research	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the National Cancer Institute of Canada and the Canadian Institute of Health Research.	Balciunaite G, 2005, EUR J IMMUNOL, V35, P1292, DOI 10.1002/eji.200425822; Baumann CI, 2004, BLOOD, V104, P1010, DOI 10.1182/blood-2004-03-0989; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; de Pooter RF, 2003, BLOOD, V102, P1649, DOI 10.1182/blood-2003-01-0224; Douagi I, 2002, BLOOD, V99, P463, DOI 10.1182/blood.V99.2.463; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Huang JX, 2005, J IMMUNOL, V175, P4858, DOI 10.4049/jimmunol.175.8.4858; Ikawa T, 1999, J EXP MED, V190, P1617, DOI 10.1084/jem.190.11.1617; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lian RH, 2002, J IMMUNOL, V168, P4980, DOI 10.4049/jimmunol.168.10.4980; Maeda M, 2005, J IMMUNOL, V175, P4426, DOI 10.4049/jimmunol.175.7.4426; Masuda K, 2005, J IMMUNOL, V174, P2525, DOI 10.4049/jimmunol.174.5.2525; Miller CL, 1997, BLOOD, V89, P1214, DOI 10.1182/blood.V89.4.1214; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakayama N, 1998, BLOOD, V91, P2283, DOI 10.1182/blood.V91.7.2283.2283_2283_2295; NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x; POTOCNIK AJ, 1994, EMBO J, V13, P5274, DOI 10.1002/j.1460-2075.1994.tb06861.x; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Veinotte LL, 2006, BLOOD, V107, P2673, DOI 10.1182/blood-2005-07-2797; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	30	17	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e232	10.1371/journal.pone.0000232	http://dx.doi.org/10.1371/journal.pone.0000232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311098	gold, Green Published			2022-12-27	WOS:000207444500013
J	Fayos, J; Fayos, C				Fayos, Jose; Fayos, Carolina			Wind Data Mining by Kohonen Neural Networks	PLOS ONE			English	Article								Time series of Circulation Weather Type (CWT), including daily averaged wind direction and vorticity, are self-classified by similarity using Kohonen Neural Networks (KNN). It is shown that KNN is able to map by similarity all 7300 five-day CWT sequences during the period of 1975-94, in London, United Kingdom. It gives, as a first result, the most probable wind sequences preceding each one of the 27 CWT Lamb classes in that period. Inversely, as a second result, the observed diffuse correlation between both five-day CWT sequences and the CWT of the 6(th) day, in the long 20-year period, can be generalized to predict the last from the previous CWT sequence in a different test period, like 1995, as both time series are similar. Although the average prediction error is comparable to that obtained by forecasting standard methods, the KNN approach gives complementary results, as they depend only on an objective classification of observed CWT data, without any model assumption. The 27 CWT of the Lamb Catalogue were coded with binary three-dimensional vectors, pointing to faces, edges and vertex of a "wind-cube,'' so that similar CWT vectors were close.	[Fayos, Jose] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog, Madrid, Spain; [Fayos, Carolina] Raytheon Informat Solut, Silver Spring, MD USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Fayos, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Cristalog, Madrid, Spain.	xpepe@iqfr.csic.es		Fayos, Jose/0000-0002-9303-2268	Spanish MEC [CTQ2005-02058/BQU]	Spanish MEC(Spanish Government)	J. Fayos thanks the Spanish MEC for support under project CTQ2005-02058/BQU.	BRIFFA KR, 1995, ANAL CLIMATE VARIABI, P122; CAWLEY GC, 1996, P INT C ART NEUR NET, V96, P281; Chen DL, 2000, INT J CLIMATOL, V20, P1067, DOI 10.1002/1097-0088(200008)20:10&lt;1067::AID-JOC528&gt;3.0.CO;2-Q; DAVIES TD, 1991, INT J CLIMATOL, V11, P795; HULME M, 1993, CLIM DYNAM, V9, P95, DOI 10.1007/BF00210012; Jenkinson A.F., 1977, SYNOPTIC CLIMATOLOGY; JONES PD, 1993, INT J CLIMATOL, V13, P655, DOI 10.1002/joc.3370130606; Kohonen T., 1995, SERIES INFORM SCI, V30; Kretzschmar R, 2004, J APPL METEOROL, V43, P727, DOI 10.1175/2057.1; Lamb H., 1972, GEOPHYS MEMOIRS, V116; LAMB HH, 1950, Q J ROY METEOR SOC, V76, P393, DOI 10.1002/qj.49707633005; Marzban C, 1998, WEATHER FORECAST, V13, P151, DOI 10.1175/1520-0434(1998)013<0151:ANNFDW>2.0.CO;2; Ultsch A, 2002, INFORM SCIENCES, V144, P91, DOI 10.1016/S0020-0255(02)00203-7	13	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e210	10.1371/journal.pone.0000210	http://dx.doi.org/10.1371/journal.pone.0000210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299590	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444400011
J	Nikolaidis, N; Chalkia, D; Watkins, DN; Barrow, RK; Snyder, SH; van Rossum, DB; Patterson, RL				Nikolaidis, Nikolas; Chalkia, Dimitra; Watkins, D. Neil; Barrow, Roxanne K.; Snyder, Solomon H.; van Rossum, Damian B.; Patterson, Randen L.			Ancient Origin of the New Developmental Superfamily DANGER	PLOS ONE			English	Article								Developmental proteins play a pivotal role in the origin of animal complexity and diversity. We report here the identification of a highly divergent developmental protein superfamily (DANGER), which originated before the emergence of animals (similar to 850 million years ago) and experienced major expansion-contraction events during metazoan evolution. Sequence analysis demonstrates that DANGER proteins diverged via multiple mechanisms, including amino acid substitution, intron gain and/or loss, and recombination. Divergence for DANGER proteins is substantially greater than for the prototypic member of the superfamily (Mab-21 family) and other developmental protein families (e. g., WNT proteins). DANGER proteins are widely expressed and display species-dependent tissue expression patterns, with many members having roles in development. DANGER1A, which regulates the inositol trisphosphate receptor, promotes the differentiation and outgrowth of neuronal processes. Regulation of development may be a universal function of DANGER family members. This family provides a model system to investigate how rapid protein divergence contributes to morphological complexity.	[Nikolaidis, Nikolas; Chalkia, Dimitra; van Rossum, Damian B.; Patterson, Randen L.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Watkins, D. Neil] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Inst, Baltimore, MD USA; [Barrow, Roxanne K.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD USA; [Snyder, Solomon H.] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD USA; [Snyder, Solomon H.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Nikolaidis, N (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	nxn7@psu.edu; rlp25@psu.edu	Chalkia, Dimitra/J-3793-2016; Watkins, David N/I-6113-2013	Chalkia, Dimitra/0000-0003-4780-544X; van Rossum, Damian/0000-0003-1011-2586	SEARLE; PSU; Eberly College of Sciences; Huck Institute; USPHS [MH 68830, MH 18501]; Research Scientist Award [DA 00074]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830, R01MH018501, R37MH018501] Funding Source: NIH RePORTER	SEARLE; PSU; Eberly College of Sciences; Huck Institute; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the SEARLE award and start-up monies from PSU (RLP), a Fellowship from the Eberly College of Sciences and the Huck Institute (DVR), USPHS grant Conte Center grant MH 68830 and MH 18501 (SHS) and Research Scientist Award DA 00074 (SHS).	Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Bird M, 1998, J ANAT, V193, P503, DOI 10.1046/j.1469-7580.1998.19340503.x; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Carroll S. B., 2004, DNA DIVERSITY MOL GE; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Carson-Walter EB, 1998, ONCOGENE, V17, P367, DOI 10.1038/sj.onc.1201938; CHOW KL, 1995, DEVELOPMENT, V121, P3615; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Ko MSH, 2000, DEVELOPMENT, V127, P1737; Kopczynski CC, 1998, P NATL ACAD SCI USA, V95, P9973, DOI 10.1073/pnas.95.17.9973; Korf I., 2003, BLAST; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lau GTC, 2001, BIOCHEM BIOPH RES CO, V280, P1378, DOI 10.1006/bbrc.2001.4290; LI WH, 1991, FUNDAMENTALS MOL EVO; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Mariani M, 1999, HUM MOL GENET, V8, P2397, DOI 10.1093/hmg/8.13.2397; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Prado FL, 2003, CURR GENET, V42, P185, DOI 10.1007/s00294-002-0346-3; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; Qian XZ, 2001, MOL CELL BIOL, V21, P1613, DOI 10.1128/MCB.21.5.1613-1620.2001; Ranwez V, 2001, MOL BIOL EVOL, V18, P1103, DOI 10.1093/oxfordjournals.molbev.a003881; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shaw CJ, 2005, HUM GENET, V116, P1, DOI 10.1007/s00439-004-1204-9; Stevens-Kroef MJPL, 2000, CANCER GENET CYTOGEN, V116, P119, DOI 10.1016/S0165-4608(99)00119-3; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Rossum DB, 2006, J BIOL CHEM, V281, P37111, DOI 10.1074/jbc.M608760200; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Wong RLY, 2002, TERATOLOGY, V65, P70, DOI 10.1002/tera.10018; Wong YM, 2002, MECH DEVELOP, V113, P149, DOI 10.1016/S0925-4773(02)00012-6; Yamada R, 2004, DEV BIOL, V274, P295, DOI 10.1016/j.ydbio.2004.07.016; Yamada R, 2003, DEVELOPMENT, V130, P1759, DOI 10.1242/dev.00399; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Zika R, 2004, NUCLEIC ACIDS RES, V32, pW48, DOI 10.1093/nar/gkh358	59	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e204	10.1371/journal.pone.0000204	http://dx.doi.org/10.1371/journal.pone.0000204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17301879	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444400005
J	van Gils, JA; Munster, VJ; Radersma, R; Liefhebber, D; Fouchier, RAM; Klaassen, M				van Gils, Jan A.; Munster, Vincent J.; Radersma, Reinder; Liefhebber, Daan; Fouchier, Ron A. M.; Klaassen, Marcel			Hampered Foraging and Migratory Performance in Swans Infected with Low-Pathogenic Avian Influenza A Virus	PLOS ONE			English	Article							BODY CONDITION; BIRDS; SURVEILLANCE; CALIFORNIA; EVOLUTION; H6N2; SIZE	It is increasingly acknowledged that migratory birds, notably waterfowl, play a critical role in the maintenance and spread of influenza A viruses. In order to elucidate the epidemiology of influenza A viruses in their natural hosts, a better understanding of the pathological effects in these hosts is required. Here we report on the feeding and migratory performance of wild migratory Bewick's swans (Cygnus columbianus bewickii Yarrell) naturally infected with low-pathogenic avian influenza (LPAI) A viruses of subtypes H6N2 and H6N8. Using information on geolocation data collected from Global Positioning Systems fitted to neck-collars, we show that infected swans experienced delayed migration, leaving their wintering site more than a month after uninfected animals. This was correlated with infected birds travelling shorter distances and fuelling and feeding at reduced rates. The data suggest that LPAI virus infections in wild migratory birds may have higher clinical and ecological impacts than previously recognised.	[van Gils, Jan A.; Radersma, Reinder; Liefhebber, Daan; Klaassen, Marcel] Netherlands Inst Ecol NIOO KNAW, Ctr Limnol, Dept Plant Anim Interact, Nieuwersluis, Netherlands; [Munster, Vincent J.; Fouchier, Ron A. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Erasmus University Rotterdam; Erasmus MC	van Gils, JA (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol, Avon, England.	j.vangils@nioo.knaw.nl	Munster, Vincent/I-7607-2018; van Gils, Jan/B-5544-2008; Klaassen, Marcel/B-4325-2008; Fouchier, Ron A/A-1911-2014	Munster, Vincent/0000-0002-2288-3196; van Gils, Jan/0000-0002-4132-8243; Klaassen, Marcel/0000-0003-3907-9599; Fouchier, Ron A/0000-0001-8095-2869	Royal Netherlands Academy of Arts and Sciences	Royal Netherlands Academy of Arts and Sciences	Royal Netherlands Academy of Arts and Sciences	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; BOWLER JM, 1994, ARDEA, V82, P241; Choudhury S, 1996, IBIS, V138, P700, DOI 10.1111/j.1474-919X.1996.tb04772.x; Coleman JT, 2002, WATERBIRDS, V25, P346; Evans M.E., 1978, Wildfowl, V29, P118; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; KIDA H, 1980, INFECT IMMUN, V30, P547; Kinde H, 2003, AVIAN DIS, V47, P1214, DOI 10.1637/0005-2086-47.s3.1214; Klaassen M, 2006, J APPL ECOL, V43, P92, DOI 10.1111/j.1365-2664.2005.01109.x; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Madsen J, 2006, J AVIAN BIOL, V37, P283, DOI 10.1111/j.2006.0908-8857.03555.x; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Munster VJ, 2006, VACCINE, V24, P6729, DOI 10.1016/j.vaccine.2006.05.060; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Nolet BA, 1998, J AVIAN BIOL, V29, P574, DOI 10.2307/3677178; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Rees E. C., 1996, PARTNERSHIPS BIRDS S, P118; Rees EC, 2006, BEWICKS SWAN; RISING JD, 1989, AUK, V106, P666; Sedinger JS, 1997, CONDOR, V99, P314, DOI 10.2307/1369937; Spackman E, 2005, VIRUS RES, V114, P89, DOI 10.1016/j.virusres.2005.05.013; *SYST SOFTW, 2000, SYSTAT VERS 10; VANGILS JA, BASED DISSECTI UNPUB; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Wallensten A, 2006, ANTARCT SCI, V18, P353, DOI 10.1017/S095410200600040X; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Woolcock PR, 2003, AVIAN DIS, V47, P872, DOI 10.1637/0005-2086-47.s3.872	35	170	181	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e184	10.1371/journal.pone.0000184	http://dx.doi.org/10.1371/journal.pone.0000184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17264886	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444200008
J	Kim, W; Yoo, TK; Kim, SJ; Shin, DJ; Tyler-Smith, C; Jin, HJ; Kwak, KD; Kim, ET; Bae, YS				Kim, Wook; Yoo, Tag-Keun; Kim, Sung-Joo; Shin, Dong-Jik; Tyler-Smith, Chris; Jin, Han-Jun; Kwak, Kyoung-Don; Kim, Eun-Tak; Bae, Yoon-Sun			Lack of Association between Y-Chromosomal Haplogroups and Prostate Cancer in the Korean Population	PLOS ONE			English	Article								The Y chromosome has recently been suggested to have an association with prostate cancer risk in human populations. Since this chromosome is haploid and lacks recombination over most of its length, haplotypes constructed from binary markers throughout the chromosome can be used for association studies. To assess the possible Y-chromosomal contribution to prostate cancer risk, we have therefore analyzed 14 Y-chromosomal binary markers in 106 prostate cancer cases and 110 controls from the Korean population. In contrast to previous findings in the Japanese population, no statistically significant difference in the distribution of Y-chromosomal haplogroup frequencies was observed between the case and control groups of Koreans. Thus, our data imply that the previously reported associations between Y-chromosomal lineages and a predisposition to, or protection against, prostate cancer might be explained by statistical fluctuations, or by genetic effects that are seen only in some environments.	[Kim, Wook; Jin, Han-Jun; Kwak, Kyoung-Don] Dankook Univ, Dept Biol Sci, Cheonan, South Korea; [Yoo, Tag-Keun] Eulji Univ, Sch Med, Eulji Med Ctr, Dept Urol, Seoul, South Korea; [Kim, Sung-Joo] Catholic Res Inst Med Sci, Res Inst Mol Genet, Seoul, South Korea; [Shin, Dong-Jik; Bae, Yoon-Sun] Yonsei Univ, Coll Med, Cardiovasc Genome Ctr, Seoul, South Korea; [Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge, England; [Kim, Eun-Tak] Eulji Univ, Sch Med, Dept Urol, Taejon, South Korea	Dankook University; Eulji University; Catholic University of Korea; Yonsei University; Yonsei University Health System; Wellcome Trust Sanger Institute; Eulji University	Kim, W (corresponding author), Dankook Univ, Dept Biol Sci, Cheonan, South Korea.	wookkim@dankook.ac.kr	Yoo, Tag/M-8852-2019		Korean Science and Engineering Foundation (KOSEF), Republic of Korea [R01-2005-000-10534-0]; The Wellcome Trust	Korean Science and Engineering Foundation (KOSEF), Republic of Korea(Korea Science and Engineering Foundation); The Wellcome Trust(Wellcome TrustEuropean Commission)	WK is supported by a grant from the Korean Science and Engineering Foundation (KOSEF R01-2005-000-10534-0), Republic of Korea. CTS is supported by The Wellcome Trust.	[Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Brothman AR, 1999, PROSTATE, V38, P303; Dagnelie PC, 2004, BJU INT, V93, P1139, DOI 10.1111/j.1464-410X.2004.04795.x; Dasari VK, 2001, J UROLOGY, V165, P1335, DOI 10.1016/S0022-5347(01)69895-1; Ellis N, 2002, GENOME RES, V12, P339; Ewis AA, 2006, PROSTATE CANCER P D, V9, P303, DOI 10.1038/sj.pcan.4500876; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1997, GENETICS, V145, P787; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Horai S, 1996, AM J HUM GENET, V59, P579; Hsing AW, 2000, CANCER EPIDEM BIOMAR, V9, P1335; Jin HJ, 2003, HUM GENET, V114, P27, DOI 10.1007/s00439-003-1019-0; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Jordan JJ, 2001, CANCER GENET CYTOGEN, V124, P122, DOI 10.1016/S0165-4608(00)00340-X; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kutach LS, 1999, ELECTROPHORESIS, V20, P1204, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1204::AID-ELPS1204>3.3.CO;2-J; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lau YFC, 2000, MOL CARCINOGEN, V27, P308, DOI 10.1002/(SICI)1098-2744(200004)27:4<308::AID-MC9>3.0.CO;2-R; McElreavey K, 2000, Results Probl Cell Differ, V28, P211; Paracchini S, 2003, J MED GENET, V40, P815, DOI 10.1136/jmg.40.11.815; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; RABILLOUD T, 1988, ELECTROPHORESIS, V9, P288, DOI 10.1002/elps.1150090608; Sambrook J., 2002, MOL CLONING LAB MANU; Santos FR, 2000, HUM MOL GENET, V9, P421, DOI 10.1093/hmg/9.3.421; Shinka T, 1999, J HUM GENET, V44, P240, DOI 10.1007/s100380050151; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Tajima A, 2002, HUM GENET, V110, P80, DOI 10.1007/s00439-001-0651-9; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Whittemore AS, 1999, AM J HUM GENET, V65, P254, DOI 10.1086/302457; Yuan X, 2001, J BIOL CHEM, V276, P46647, DOI 10.1074/jbc.M108404200	38	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e172	10.1371/journal.pone.0000172	http://dx.doi.org/10.1371/journal.pone.0000172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17245448	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444100009
J	Lehrmann, E; Colantuoni, C; Deep-Soboslay, A; Becker, KG; Lowe, R; Huestis, MA; Hyde, TM; Kleinman, JE; Freed, WJ				Lehrmann, Elin; Colantuoni, Carlo; Deep-Soboslay, Amy; Becker, Kevin G.; Lowe, Ross; Huestis, Marilyn A.; Hyde, Thomas M.; Kleinman, Joel E.; Freed, William J.			Transcriptional Changes Common to Human Cocaine, Cannabis and Phencyclidine Abuse	PLOS ONE			English	Article								A major goal of drug abuse research is to identify and understand drug-induced changes in brain function that are common to many or all drugs of abuse. As these may underlie drug dependence and addiction, the purpose of the present study was to examine if different drugs of abuse effect changes in gene expression that converge in common molecular pathways. Microarray analysis was employed to assay brain gene expression in postmortem anterior prefrontal cortex ( aPFC) from 42 human cocaine, cannabis and/or phencyclidine abuse cases and 30 control cases, which were characterized by toxicology and drug abuse history. Common transcriptional changes were demonstrated for a majority of drug abuse cases (N = 34), representing a number of consistently changed functional classes: Calmodulin-related transcripts (CALM1, CALM2, CAMK2B) were decreased, while transcripts related to cholesterol biosynthesis and trafficking (FDFT1, APOL2, SCARB1), and Golgi/endoplasmic reticulum (ER) functions (SEMA3B, GCC1) were all increased. Quantitative PCR validated decreases in calmodulin 2 (CALM2) mRNA and increases in apolipoprotein L, 2 (APOL2) and semaphorin 3B (SEMA3B) mRNA for individual cases. A comparison between control cases with and without cardiovascular disease and elevated body mass index indicated that these changes were not due to general cellular and metabolic stress, but appeared specific to the use of drugs. Therefore, humans who abused cocaine, cannabis and/or phencyclidine share a decrease in transcription of calmodulin-related genes and increased transcription related to lipid/cholesterol and Golgi/ER function. These changes represent common molecular features of drug abuse, which may underlie changes in synaptic function and plasticity that could have important ramifications for decision-making capabilities in drug abusers.	[Lehrmann, Elin; Freed, William J.] NIDA, Cellular Neurobiol Res Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA; [Colantuoni, Carlo; Deep-Soboslay, Amy; Hyde, Thomas M.; Kleinman, Joel E.] NIMH, Clin Brain Disorders Branch, GCAP, Intramural Res Program,NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Becker, Kevin G.] NIA, Res Resources Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Lehrmann, Elin; Lowe, Ross; Huestis, Marilyn A.] NIDA, Chem & Drug Metab Sect, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Lehrmann, E (corresponding author), NIDA, Cellular Neurobiol Res Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA.	elehrman@intra.nida.nih.gov		Colantuoni, Carlo/0000-0001-6818-6380; Lehrmann, Elin/0000-0002-9869-9475; Becker, Kevin/0000-0002-6794-6656	Intramural Research Programs at the NIDA, NIMH; NIA, NIH, DHHS; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002399, Z01MH002399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000411, Z01DA000411] Funding Source: NIH RePORTER	Intramural Research Programs at the NIDA, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute on Drug Abuse (NIDA)); NIA, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the Intramural Research Programs at the NIDA, NIMH and NIA, NIH, DHHS.	Albertson DN, 2004, J NEUROCHEM, V88, P1211, DOI 10.1046/j.1471-4159.2003.02247.x; Bahi A, 2005, MOL CELL NEUROSCI, V28, P275, DOI 10.1016/j.mcn.2004.09.011; Bartzokis G, 2002, BIOL PSYCHIAT, V51, P605, DOI 10.1016/S0006-3223(02)01315-X; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Crombag HS, 2005, CEREB CORTEX, V15, P341, DOI 10.1093/cercor/bhh136; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Ferrer-Alcon M, 2004, J NEUROCHEM, V90, P220, DOI 10.1111/j.1471-4159.2004.02473.x; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hashimoto E, 1998, ALCOHOL CLIN EXP RES, V22, p88S, DOI 10.1111/acer.1998.22.s3_part1.88s; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, J NEUROSCI, V23, P6188; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; Kolb B, 2003, P NATL ACAD SCI USA, V100, P10523, DOI 10.1073/pnas.1834271100; Kufahl PR, 2005, NEUROIMAGE, V28, P904, DOI 10.1016/j.neuroimage.2005.06.039; Lehrmann E, 2003, PHARMACOGENOMICS J, V3, P27, DOI 10.1038/sj.tpj.6500146; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Lowe RH, 2006, J MASS SPECTROM, V41, P175, DOI 10.1002/jms.975; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Mimmack ML, 2002, P NATL ACAD SCI USA, V99, P4680, DOI 10.1073/pnas.032069099; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Robinson TE, 2001, SYNAPSE, V39, P257; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; Rounsaville BJ, 2003, DRUG ALCOHOL DEPEN, V70, P117, DOI 10.1016/S0376-8716(03)00033-4; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; SCHLAEPFER TE, 2005, INT J NEUROPSYCHOPH, V8, P1; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shichinohe S, 2001, J NEURAL TRANSM, V108, P335, DOI 10.1007/s007020170079; Sohma H, 1999, BBA-MOL BASIS DIS, V1454, P11, DOI 10.1016/S0925-4439(99)00018-6; Sokolov BP, 2003, J NEUROSCI RES, V72, P756, DOI 10.1002/jnr.10631; Spinella M, 2003, ADDICT BIOL, V8, P67, DOI 10.1080/1355621031000069909; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suemaru J, 2000, SYNAPSE, V36, P155, DOI 10.1002/(SICI)1098-2396(20000601)36:3<155::AID-SYN1>3.0.CO;2-N; Tang WX, 2003, J NEUROCHEM, V85, P911, DOI 10.1046/j.1471-4159.2003.01740.x; Vawter MP, 2002, SCHIZOPHR RES, V58, P11, DOI 10.1016/S0920-9964(01)00377-2; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647	46	39	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e114	10.1371/journal.pone.0000114	http://dx.doi.org/10.1371/journal.pone.0000114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205118	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700008
J	Perchepied, L; Kroj, T; Tronchet, M; Loudet, O; Roby, D				Perchepied, Laure; Kroj, Thomas; Tronchet, Maurice; Loudet, Olivier; Roby, Dominique			Natural Variation in Partial Resistance to Pseudomonas syringae Is Controlled by Two Major QTLs in Arabidopsis thaliana	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; MEDIATED DISEASE RESISTANCE; INBRED LINE POPULATION; RECEPTOR-LIKE KINASE; TRAIT LOCI ANALYSIS; ORYZA-SATIVA L.; GENETIC ARCHITECTURE; INNATE IMMUNITY; NONHOST RESISTANCE; DEFENSE RESPONSES	Background. Low-level, partial resistance is pre-eminent in natural populations, however, the mechanisms underlying this form of resistance are still poorly understood. Methodology/Principal Findings. In the present study, we used the model pathosystem Pseudomonas syringae pv. tomato DC3000 (Pst) - Arabidopsis thaliana to study the genetic basis of this form of resistance. Phenotypic analysis of a set of Arabidopsis accessions, based on evaluation of in planta pathogen growth revealed extensive quantitative variation for partial resistance to Pst. It allowed choosing a recombinant inbred line (RIL) population derived from a cross between the accessions Bayreuth and Shahdara for quantitative genetic analysis. Experiments performed under two different environmental conditions led to the detection of two major and two minor quantitative trait loci (QTLs) governing partial resistance to Pst and called PRP-Ps1 to PRP-Ps4. The two major QTLs, PRP-Ps1 and PRP-Ps2, were confirmed in near isogenic lines (NILs), following the heterogeneous inbred families (HIFs) strategy. Analysis of marker gene expression using these HIFs indicated a negative correlation between the induced amount of transcripts of SA-dependent genes PR1, ICS and PR5, and the in planta bacterial growth in the HIF segregating at PRP-Ps2 locus, suggesting an implication of PRP-Ps2 in the activation of SA dependent responses. Conclusions/Significance. These results show that variation in partial resistance to Pst in Arabidopsis is governed by relatively few loci, and the validation of two major loci opens the way for their fine mapping and their cloning, which will improve our understanding of the molecular mechanisms underlying partial resistance.	[Perchepied, Laure; Kroj, Thomas; Tronchet, Maurice; Roby, Dominique] Natl Inst Agron Res, CNRS, UMR 2594, LIPM, Castanet Tolosan, France; [Loudet, Olivier] INRA, F-78026 Versailles, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Roby, D (corresponding author), Natl Inst Agron Res, CNRS, UMR 2594, LIPM, Castanet Tolosan, France.	Dominique.roby@toulouse.inra.fr	Loudet, Olivier/K-8266-2012; Loudet, Olivier/CAF-7559-2022; Kroj, Thomas/ABG-3249-2020	Loudet, Olivier/0000-0003-3717-0137; kroj, thomas/0000-0002-3752-1788	GABI-Genoplante-MCyt contract on Plant Genome Research	GABI-Genoplante-MCyt contract on Plant Genome Research	This work has been financially supported by a GABI-Genoplante-MCyt contract on Plant Genome Research.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Al-Chaarani G, 2002, THEOR APPL GENET, V104, P490, DOI 10.1007/s001220100742; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Alonso-Blanco C, 1998, METH MOL B, V82, P137; Alonso-Blanco C, 1998, GENETICS, V149, P749; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Arahana VS, 2001, CROP SCI, V41, P180, DOI 10.2135/cropsci2001.411180x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bai YL, 2003, MOL PLANT MICROBE IN, V16, P169, DOI 10.1094/MPMI.2003.16.2.169; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Buell CR, 1997, PLANT J, V12, P21, DOI 10.1046/j.1365-313X.1997.12010021.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; Denby KJ, 2004, PLANT J, V38, P473, DOI 10.1111/j.0960-7412.2004.02059.x; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Foulongne M, 2003, MOL BREEDING, V12, P33, DOI 10.1023/A:1025417507358; Gallais A, 1990, THEORIE SELECTION AM; Gebhardt C, 2001, ANNU REV PHYTOPATHOL, V39, P79, DOI 10.1146/annurev.phyto.39.1.79; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Glazebrook J, 1997, ANNU REV GENET, V31, P547, DOI 10.1146/annurev.genet.31.1.547; Godiard L, 2003, PLANT J, V36, P353, DOI 10.1046/j.1365-313X.2003.01877.x; Gu YQ, 2002, PLANT CELL, V14, P817, DOI 10.1105/tpc.000794; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Inukai T, 2006, MOL PLANT MICROBE IN, V19, P1034, DOI 10.1094/MPMI-19-1034; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Jones JDG, 2001, CURR OPIN PLANT BIOL, V4, P281, DOI 10.1016/S1369-5266(00)00174-6; Kamoun S, 1999, TRENDS PLANT SCI, V4, P196, DOI 10.1016/S1360-1385(99)01404-1; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; KEEN NT, 1990, ANNU REV GENET, V24, P447, DOI 10.1146/annurev.ge.24.120190.002311; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kover PX, 2005, HEREDITY, V94, P507, DOI 10.1038/sj.hdy.6800651; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; LAMB CJ, 1992, BIO-TECHNOL, V10, P1436, DOI 10.1038/nbt1192-1436; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Li ZK, 2006, P NATL ACAD SCI USA, V103, P7994, DOI 10.1073/pnas.0507492103; Liao CY, 2001, THEOR APPL GENET, V103, P104, DOI 10.1007/s001220000528; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; Lorrain S, 2004, PLANT CELL, V16, P2217, DOI 10.1105/tpc.104.022038; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mauricio R, 2005, GENETICA, V123, P75, DOI 10.1007/s10709-002-2714-9; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Mouille G, 2006, PLANT PHYSIOL, V141, P1035, DOI 10.1104/pp.106.079384; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nguyen HQ, 2006, RARE METAL MAT ENG, V35, P188; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; PARLEVLIET JE, 1979, ANNU REV PHYTOPATHOL, V17, P203, DOI 10.1146/annurev.py.17.090179.001223; Perchepied L, 2005, THEOR APPL GENET, V111, P65, DOI 10.1007/s00122-005-1991-y; Quirino BF, 2003, MOL PLANT PATHOL, V4, P517, DOI 10.1046/J.1364-3703.2003.00198.X; ROBERTSON A, 1989, DEV APPL MOL MARKERS, P81; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Williams KJ, 2003, AUST J AGR RES, V54, P1065, DOI 10.1071/AR02219; Wilson IW, 2001, GENETICS, V158, P1301; Young ND, 1996, ANNU REV PHYTOPATHOL, V34, P479, DOI 10.1146/annurev.phyto.34.1.479; ZENG ZB, 1994, GENETICS, V136, P1457; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	75	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e123	10.1371/journal.pone.0000123	http://dx.doi.org/10.1371/journal.pone.0000123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205127	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443700017
J	Bensch, S; Andren, H; Hansson, B; Pedersen, HC; Sand, H; Sejberg, D; Wabakken, P; Akesson, M; Liberg, O				Bensch, Staffan; Andren, Henrik; Hansson, Bengt; Pedersen, Hans Chr.; Sand, Hakan; Sejberg, Douglas; Wabakken, Petter; Akesson, Mikael; Liberg, Olof			Selection for Heterozygosity Gives Hope to a Wild Population of Inbred Wolves	PLOS ONE			English	Article								Recent analyses have questioned the usefulness of heterozygosity estimates as measures of the inbreeding coefficient (f), a finding that may have dramatic consequences for the management of endangered populations. We confirm that f and heterozygosity is poorly correlated in a wild and highly inbred wolf population. Yet, our data show that for each level of f, it was the most heterozygous wolves that established themselves as breeders, a selection process that seems to have decelerated the loss of heterozygosity in the population despite a steady increase of f. The markers contributing to the positive relationship between heterozygosity and breeding success were found to be located on different chromosomes, but there was a substantial amount of linkage disequilibrium in the population, indicating that the markers are reflecting heterozygosity over relatively wide genomic regions. Following our results we recommend that management programs of endangered populations include estimates of both f and heterozygosity, as they may contribute with complementary information about population viability.	[Bensch, Staffan; Hansson, Bengt; Sejberg, Douglas; Akesson, Mikael] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Andren, Henrik; Sand, Hakan; Liberg, Olof] Swedish Univ Agr Sci, Dept Conservat Biol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Pedersen, Hans Chr.] Norwegian Inst Nat Res, Div Terr Ecol, N-7004 Trondheim, Norway; [Wabakken, Petter] Hedmark Univ Coll, Fac Forestry & Wildlife Management, Koppang, Norway	Lund University; Swedish University of Agricultural Sciences; Norwegian Institute Nature Research; Inland Norway University of Applied Sciences	Bensch, S (corresponding author), Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden.	staffan.bensch@zooekol.lu.se	Hansson, Bengt/L-8874-2013; Åkesson, Mikael/K-5370-2014; Andrén, Henrik/C-8995-2015	Hansson, Bengt/0000-0001-6694-8169; Andren, Henrik/0000-0002-5616-2426	Swedish Research Council; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Environmental Protection Agency; World Wide Fund for Nature ( Sweden); Swedish Association for Hunting and Wildlife Management; Olle och Signhild Engkvists Stiftelser; Norwegian Research Council; Norwegian Directorate for Nature Management; Norwegian Institute for Nature Research; Norwegian Ministry of Environment; Hedmark University College	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Environmental Protection Agency; World Wide Fund for Nature ( Sweden); Swedish Association for Hunting and Wildlife Management; Olle och Signhild Engkvists Stiftelser; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Directorate for Nature Management; Norwegian Institute for Nature Research(Bioforsk); Norwegian Ministry of Environment; Hedmark University College	Funding was provided to SB and BH from the Swedish Research Council, to OL and SB from the the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, to OL, HA and HS by the Swedish Environmental Protection Agency, the World Wide Fund for Nature ( Sweden), the Swedish Association for Hunting and Wildlife Management, the private foundation "Olle och Signhild Engkvists Stiftelser'' to HCP and PW by the Norwegian Research Council, the Norwegian Directorate for Nature Management, the Norwegian Institute for Nature Research, Norwegian Ministry of Environment, and the Hedmark University College.	ANDREN H, 2006, GENETIC ASPECTS VIAB, P59; Aspi J, 2006, MOL ECOL, V15, P1561, DOI 10.1111/j.1365-294X.2006.02877.x; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Bierne N, 1998, GENETICS, V148, P1893; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Ellegren H, 1999, HEREDITAS, V130, P239, DOI 10.1111/j.1601-5223.1999.00239.x; Falconer D. S., 1996, INTRO QUANTITATIVE G; Flagstad O, 2003, MOL ECOL, V12, P869, DOI 10.1046/j.1365-294X.2003.01784.x; Garner A, 2005, CONSERV BIOL, V19, P1215, DOI 10.1111/j.1523-1739.2005.00105.x; Gilpin M.E., 1986, P19; Hansson B, 2004, EVOLUTION, V58, P870; Hard D. L, 1997, PRINCIPLES POPULATIO; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Kalinowski ST, 1998, ZOO BIOL, V17, P481, DOI 10.1002/(SICI)1098-2361(1998)17:6<481::AID-ZOO2>3.0.CO;2-G; Kalinowski ST, 1999, CONSERV BIOL, V13, P1371, DOI 10.1046/j.1523-1739.1999.98346.x; KELLER LF, 1994, NATURE, V372, P356, DOI 10.1038/372356a0; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kimura M., 1983, NEUTRAL THEORY MOL E; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; LACY RC, 1995, VORTEX STOCHASTIC SI; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LEARY RF, 1987, EVOLUTION, V41, P1413, DOI 10.1111/j.1558-5646.1987.tb02480.x; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; Liberg O, 2005, BIOL LETT-UK, V1, P17, DOI 10.1098/rsbl.2004.0266; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; Markert JA, 2004, HEREDITY, V92, P306, DOI 10.1038/sj.hdy.6800409; McKusick VA, 2000, NAT GENET, V24, P203, DOI 10.1038/73389; McRae AF, 2002, GENETICS, V160, P1113; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; Otto SP, 1997, GENETICS, V146, P723; Peel D., 2004, NEESTIMATOR SOFTWARE; Pemberton J, 2004, TRENDS ECOL EVOL, V19, P613, DOI 10.1016/j.tree.2004.09.010; Raikkonen J, 2006, MAMM BIOL, V71, P65, DOI 10.1016/j.mambio.2005.12.002; RALLS K, 1988, Conservation Biology, V2, P185, DOI 10.1111/j.1523-1739.1988.tb00169.x; SCHLUTER D, 1986, EVOLUTION, V40, P221, DOI 10.1111/j.1558-5646.1986.tb00465.x; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; WABAKKEN P, 2005, 62005 HOGSK HEDM	43	91	93	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e72	10.1371/journal.pone.0000072	http://dx.doi.org/10.1371/journal.pone.0000072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183704	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600072
J	Demuth, JP; De Bie, T; Stajich, JE; Cristianini, N; Hahn, MW				Demuth, Jeffery P.; De Bie, Tijl; Stajich, Jason E.; Cristianini, Nello; Hahn, Matthew W.			The Evolution of Mammalian Gene Families	PLOS ONE			English	Article							POSITIVE SELECTION; GENOME SEQUENCE; CHIMPANZEE; DUPLICATION; HUMANS; NUMBER; MOUSE; REPERTOIRE; DIVERGENCE; ALGORITHM	Gene families are groups of homologous genes that are likely to have highly similar functions. Differences in family size due to lineage-specific gene duplication and gene loss may provide clues to the evolutionary forces that have shaped mammalian genomes. Here we analyze the gene families contained within the whole genomes of human, chimpanzee, mouse, rat, and dog. In total we find that more than half of the 9,990 families present in the mammalian common ancestor have either expanded or contracted along at least one lineage. Additionally, we find that a large number of families are completely lost from one or more mammalian genomes, and a similar number of gene families have arisen subsequent to the mammalian common ancestor. Along the lineage leading to modern humans we infer the gain of 689 genes and the loss of 86 genes since the split from chimpanzees, including changes likely driven by adaptive natural selection. Our results imply that humans and chimpanzees differ by at least 6% (1,418 of 22,000 genes) in their complement of genes, which stands in stark contrast to the oft-cited 1.5% difference between orthologous nucleotide sequences. This genomic "revolving door'' of gene gain and loss represents a large number of genetic differences separating humans from our closest relatives.	[Demuth, Jeffery P.; Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Demuth, Jeffery P.; Hahn, Matthew W.] Indiana Univ, Sch Informat, Bloomington, IN USA; [De Bie, Tijl] Univ Southampton, Sch Elect & Comp Sci, ISIS Grp, Southampton, Hants, England; [Stajich, Jason E.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Cristianini, Nello] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Southampton; Duke University; University of California System; University of California Davis	Hahn, MW (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	mwh@indiana.edu	Stajich, Jason Eric/C-7297-2008; De Bie, Tijl/B-2920-2013	Stajich, Jason Eric/0000-0002-7591-0020; Hahn, Matthew/0000-0002-5731-8808; De Bie, Tijl/0000-0002-2692-7504	National Science Foundation [MCB-0528465, DBI-0543586]; National Institutes of Health [R33HG003070-01]; CoE [EF/05/007]; Research Council K. U. Leuven; Indiana University; Lilly Endowment, Inc.;  [GOA/2005/04]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R33HG003070] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CoE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Council K. U. Leuven(KU Leuven); Indiana University; Lilly Endowment, Inc.; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from the National Science Foundation (MCB-0528465 and DBI-0543586) to MWH and the National Institutes of Health (R33HG003070-01) to NC. TDB acknowledges support from the CoE EF/05/007 SymBioSys, and from GOA/2005/04, both from the Research Council K. U. Leuven. MWH and JPD are also supported by the METACyt Initiative of Indiana University, funded in part through a major grant from the Lilly Endowment, Inc. None of the sponsors played any role in any part of the study.	Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Copley RR, 2003, CURR OPIN GENET DEV, V13, P623, DOI 10.1016/j.gde.2003.10.004; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Eystathioy T, 2000, J AUTOIMMUN, V14, P179, DOI 10.1006/jaut.1999.0359; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Garczarek L, 2000, P NATL ACAD SCI USA, V97, P4098, DOI 10.1073/pnas.070040897; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Grus WE, 2005, P NATL ACAD SCI USA, V102, P5767, DOI 10.1073/pnas.0501589102; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Hahn MW, 2004, GENETICS, V167, P867, DOI 10.1534/genetics.103.025726; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; Hughes AL, 2004, J MOL EVOL, V59, P827, DOI 10.1007/s00239-004-0115-7; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Li W. H, 1997, MOL EVOLUTION; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Niimura Y, 2005, GENE, V346, P23, DOI 10.1016/j.gene.2004.09.027; Noonan JP, 2003, AM J HUM GENET, V72, P621, DOI 10.1086/368060; Ohno S., 1970, EVOLUTION GENE DUPLI; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shiu SH, 2006, P NATL ACAD SCI USA, V103, P2232, DOI 10.1073/pnas.0510388103; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Vallender EJ, 2006, HUM MOL GENET, V15, P3034, DOI 10.1093/hmg/ddl245; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Wassink TH, 2005, AM J MED GENET B, V136B, P36, DOI 10.1002/ajmg.b.30180; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620; Wooding S, 2006, BIOESSAYS, V28, P335, DOI 10.1002/bies.20385; Zhang JZ, 2002, GENETICS, V162, P1825; Zmasek CM, 2001, BIOINFORMATICS, V17, P821, DOI 10.1093/bioinformatics/17.9.821	59	225	231	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e85	10.1371/journal.pone.0000085	http://dx.doi.org/10.1371/journal.pone.0000085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183716	Green Published, gold			2022-12-27	WOS:000207443600084
J	Smeesters, PR; Vergison, A; Campos, D; de Aguiar, E; Deyi, VYM; Van Melderen, L				Smeesters, Pierre Robert; Vergison, Anne; Campos, Dioclecio; de Aguiar, Eurico; Deyi, Veronique Yvette Miendje; Van Melderen, Laurence			Differences between Belgian and Brazilian Group A Streptococcus Epidemiologic Landscape	PLOS ONE			English	Article							EMM TYPES; RHEUMATIC-FEVER; HIGH DIVERSITY; NORTH-AMERICA; INFECTIONS; PHARYNGITIS; GUIDELINES; DIAGNOSIS; COMMUNITY; ETHIOPIA	Background. Group A Streptococcus (GAS) clinical and molecular epidemiology varies with location and time. These differences are not or are poorly understood. Methods and Findings. We prospectively studied the epidemiology of GAS infections among children in outpatient hospital clinics in Brussels (Belgium) and Brasilia (Brazil). Clinical questionnaires were filled out and microbiological sampling was performed. GAS isolates were emm-typed according to the Center for Disease Control protocol. emm pattern was predicted for each isolate. 334 GAS isolates were recovered from 706 children. Skin infections were frequent in Brasilia (48% of the GAS infections), whereas pharyngitis were predominant (88%) in Brussels. The mean age of children with GAS pharyngitis in Brussels was lower than in Brasilia (65/92 months, p < 0.001). emm-typing revealed striking differences between Brazilian and Belgian GAS isolates. While 20 distinct emm-types were identified among 200 Belgian isolates, 48 were found among 128 Brazilian isolates. Belgian isolates belong mainly to emm pattern A-C (55%) and E (42.5%) while emm pattern E (51.5%) and D (36%) were predominant in Brasilia. In Brasilia, emm pattern D isolates were recovered from 18.5% of the pharyngitis, although this emm pattern is supposed to have a skin tropism. By contrast, A-C pattern isolates were unfrequently recovered in a region where rheumatic fever is still highly prevalent. Conclusions. Epidemiologic features of GAS from a pediatric population were very different in an industrialised country and a low incomes region, not only in term of clinical presentation, but also in terms of genetic diversity and distribution of emm patterns. These differences should be taken into account for designing treatment guidelines and vaccine strategies.	[Smeesters, Pierre Robert; Vergison, Anne] Univ Libre Brussels, Hop Univ Enfants Reine Fabiola, Dept Infect Dis, Brussels, Belgium; [Smeesters, Pierre Robert; Van Melderen, Laurence] Univ Libre Brussels, Inst Biol & Med Mol, Lab Genet Procaryotes, Brussels, Belgium; [Deyi, Veronique Yvette Miendje] Univ Libre Brussels, Ctr Hosp Univ Brugmann, Dept Microbiol, Brussels, Belgium; [Vergison, Anne] Univ Libre Brussels, Hop Univ Enfants Reine Fabiola, Epidemiol & Infect Control Unit, Brussels, Belgium; [de Aguiar, Eurico] Hosp Reg Asa Sul, Dept Microbiol, Brasilia, DF, Brazil; [Smeesters, Pierre Robert; Campos, Dioclecio] Univ Brasilia, Hosp Univ Brasilia, Dept Pediat, Brasilia, DF, Brazil	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universidade de Brasilia	Smeesters, PR (corresponding author), Univ Libre Brussels, Hop Univ Enfants Reine Fabiola, Dept Infect Dis, Brussels, Belgium.	psmeeste@ulb.ac.be	Smeesters, Pierre/I-7723-2012	Smeesters, Pierre/0000-0002-2642-9919; Van Melderen, Laurence/0000-0002-7778-1736	Belgian Kid's Foundation; Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium	Belgian Kid's Foundation; Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium	PRS is supported by a grant of the Belgian Kid's Foundation. LVM is chercheur qualifie du FNRS. This project was funded by the Service de Pediatrie of the Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium.	Abdissa A, 2006, CLIN INFECT DIS, V42, P1362, DOI 10.1086/503422; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 1999, CLIN INFECT DIS, V28, P205, DOI 10.1086/515114; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; Dey N, 2005, CLIN INFECT DIS, V40, P46, DOI 10.1086/426443; Espinosa LE, 2003, J CLIN MICROBIOL, V41, P373, DOI 10.1128/JCM.41.1.373-378.2003; Kaplan EL, 1996, PEDIATRICS, V97, P945; Kim Seon-Ju, 1996, Journal of Korean Medical Science, V11, P133; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; McGregor KF, 2004, J INFECT DIS, V189, P717, DOI 10.1086/381452; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Sakota V, 2006, J CLIN MICROBIOL, V44, P2160, DOI 10.1128/JCM.02456-05; Shulman ST, 2004, CLIN INFECT DIS, V39, P325, DOI 10.1086/421949; Smeesters PR, 2006, PEDIATRICS, V118, pE1607, DOI 10.1542/peds.2006-1025; Stollerman GH, 2001, CLIN INFECT DIS, V33, P806, DOI 10.1086/322665; Tewodros W, 2005, J CLIN MICROBIOL, V43, P4369, DOI 10.1128/JCM.43.9.4369-4376.2005	21	57	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e10	10.1371/journal.pone.0000010	http://dx.doi.org/10.1371/journal.pone.0000010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183632	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600010
J	Spierings, E; Drabbels, J; Hendriks, M; Pool, J; Spruyt-Gerritse, M; Claas, F; Goulmy, E				Spierings, Eric; Drabbels, Jos; Hendriks, Matthijs; Pool, Jos; Spruyt-Gerritse, Marijke; Claas, Frans; Goulmy, Els			A Uniform Genomic Minor Histocompatibility Antigen Typing Methodology and Database Designed to Facilitate Clinical Applications	PLOS ONE			English	Article								Background. Minor Histocompatibility (H) antigen mismatches significantly influence the outcome of HLA-matched allogeneic stem cell transplantation. The molecular identification of human H antigens is increasing rapidly. In parallel, clinical application of minor H antigen typing has gained interest. So far, relevant and simple tools to analyze the minor H antigens in a quick and reliable way are lacking. Methodology and Findings. We developed a uniform PCR with sequence-specific primers (PCR-SSP) for 10 different autosomal minor H antigens and H-Y. This genomic minor H antigen typing methodology allows easy incorporation in the routine HLA typing procedures. DNA from previously typed EBV-LCL was used to validate the methodology. To facilitate easy interpretation for clinical purposes, a minor H database named dbMinor (http://www.lumc.nl/dbminor) was developed. Input of the minor H antigen typing results subsequently provides all relevant information for a given patient/donor pair and additional information on the putative graft-versus-host, graft-versus-tumor and host-versus-graft reactivities. Significance. A simple, uniform and rapid methodology was developed enabling determination of minor H antigen genotypes of all currently identified minor H antigens. A dbMinor database was developed to interpret the genomic typing for its potential clinical relevance. The combination of the minor H antigen genomic typing methodology with the online dbMinor database and applications facilitates the clinical application of minor H antigens anti-tumor targets after stem cell transplantation.	[Spierings, Eric; Drabbels, Jos; Hendriks, Matthijs; Pool, Jos; Spruyt-Gerritse, Marijke; Claas, Frans; Goulmy, Els] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Spierings, E (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	eric.spierings@lumc.nl	Spierings, Eric/AAU-5138-2021	Spierings, Eric/0000-0001-9441-1019; Hendriks, Matthijs/0000-0003-2334-9013	European Commission; Leiden University Medical Center, the Netherlands Organization for Scientific Research (NWO); Macropa Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Leiden University Medical Center, the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Macropa Foundation	Funding: This study was supported in part by grants of the Leukemia and Lymphoma Society of America, the 6th Framework Programme "Allostem" of the European Commission, the Leiden University Medical Center, the Netherlands Organization for Scientific Research (NWO) and the Macropa Foundation.	Akatsuka Y, 2003, J EXP MED, V197, P1489, DOI 10.1084/jem.20021925; Brickner AG, 2006, BLOOD, V107, P3779, DOI 10.1182/blood-2005-08-3501; Brickner AG, 2001, J EXP MED, V193, P195, DOI 10.1084/jem.193.2.195; Cai JC, 2004, J EXP MED, V199, P1017, DOI 10.1084/jem.20031012; DEBUEGER M, 1992, J IMMUNOL, V149, P1788; den Haan JMM, 1998, SCIENCE, V279, P1054, DOI 10.1126/science.279.5353.1054; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; Dolstra H, 2002, EUR J IMMUNOL, V32, P2748, DOI 10.1002/1521-4141(2002010)32:10<2748::AID-IMMU2748>3.0.CO;2-T; Dolstra H, 1999, J EXP MED, V189, P301, DOI 10.1084/jem.189.2.301; Fujii N, 2002, TRANSPLANTATION, V73, P1137, DOI 10.1097/00007890-200204150-00022; GOULMY E, 1976, LANCET, V2, P1206; GOULMY E, 1983, NATURE, V302, P159, DOI 10.1038/302159a0; Goulmy E, 1996, CURR OPIN IMMUNOL, V8, P75, DOI 10.1016/S0952-7915(96)80108-7; Goulmy E, 1997, IMMUNOL REV, V157, P125, DOI 10.1111/j.1600-065X.1997.tb00978.x; Goulmy E, 2006, HUM IMMUNOL, V67, P433, DOI 10.1016/j.humimm.2006.03.012; Hambach L, 2005, CURR OPIN IMMUNOL, V17, P202, DOI 10.1016/j.coi.2005.01.010; Ivanov R, 2005, CLIN CANCER RES, V11, P1694, DOI 10.1158/1078-0432.CCR-04-1772; Klein CA, 2002, J EXP MED, V196, P359, DOI 10.1084/jem.20011838; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Mommaas B, 2002, J IMMUNOL, V169, P3131, DOI 10.4049/jimmunol.169.6.3131; Murata M, 2003, J EXP MED, V197, P1279, DOI 10.1084/jem.20030044; Nishida T, 2004, BRIT J HAEMATOL, V124, P629, DOI 10.1111/j.1365-2141.2004.04823.x; OLERUP O, 1991, TISSUE ANTIGENS, V37, P197, DOI 10.1111/j.1399-0039.1991.tb01872.x; Pierce RA, 1999, J IMMUNOL, V163, P6360; Rijke BC, 2005, J CLIN INVEST, V115, P3506, DOI 10.1172/JCI24832; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Spierings E, 2005, J CLIN INVEST, V115, P3397, DOI 10.1172/JCI27094; Spierings E, 2003, LANCET, V362, P610, DOI 10.1016/S0140-6736(03)14191-8; Spierings E, 2003, BLOOD, V102, P621, DOI 10.1182/blood-2003-01-0260; Torikai H, 2004, J IMMUNOL, V173, P7046, DOI 10.4049/jimmunol.173.11.7046; Tseng LH, 1998, TISSUE ANTIGENS, V52, P305, DOI 10.1111/j.1399-0039.1998.tb03052.x; Vogt MHJ, 2000, BLOOD, V96, P3126, DOI 10.1182/blood.V96.9.3126.h8003126_3126_3132; Vogt MHJ, 2000, BLOOD, V95, P1100, DOI 10.1182/blood.V95.3.1100.003k42_1100_1105; Vogt MHJ, 2002, BLOOD, V99, P3027, DOI 10.1182/blood.V99.8.3027; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660; Warren EH, 2000, J IMMUNOL, V164, P2807, DOI 10.4049/jimmunol.164.5.2807; Warren EH, 1998, BLOOD, V91, P2197, DOI 10.1182/blood.V91.6.2197; Wilke M, 2002, TISSUE ANTIGENS, V59, P304, DOI 10.1034/j.1399-0039.2002.590408.x; Wilke M, 1998, TISSUE ANTIGENS, V52, P312, DOI 10.1111/j.1399-0039.1998.tb03053.x; Wilke Martina, 2003, Hematol J, V4, P315, DOI 10.1038/sj.thj.6200318; Zorn E, 2004, J EXP MED, V199, P1133, DOI 10.1084/jem.20031560	43	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e42	10.1371/journal.pone.0000042	http://dx.doi.org/10.1371/journal.pone.0000042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183671	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600042
J	Uechi, T; Nakajima, Y; Nakao, A; Torihara, H; Chakraborty, A; Inoue, K; Kenmochi, N				Uechi, Tamayo; Nakajima, Yukari; Nakao, Akihiro; Torihara, Hidetsugu; Chakraborty, Anirban; Inoue, Kunio; Kenmochi, Naoya			Ribosomal Protein Gene Knockdown Causes Developmental Defects in Zebrafish	PLOS ONE			English	Article								The ribosomal proteins (RPs) form the majority of cellular proteins and are mandatory for cellular growth. RP genes have been linked, either directly or indirectly, to various diseases in humans. Mutations in RP genes are also associated with tissue-specific phenotypes, suggesting a possible role in organ development during early embryogenesis. However, it is not yet known how mutations in a particular RP gene result in specific cellular changes, or how RP genes might contribute to human diseases. The development of animal models with defects in RP genes will be essential for studying these questions. In this study, we knocked down 21 RP genes in zebrafish by using morpholino antisense oligos to inhibit their translation. Of these 21, knockdown of 19 RPs resulted in the development of morphants with obvious deformities. Although mutations in RP genes, like other housekeeping genes, would be expected to result in nonspecific developmental defects with widespread phenotypes, we found that knockdown of some RP genes resulted in phenotypes specific to each gene, with varying degrees of abnormality in the brain, body trunk, eyes, and ears at about 25 hours post fertilization. We focused further on the organogenesis of the brain. Each knocked-down gene that affected the morphogenesis of the brain produced a different pattern of abnormality. Among the 7 RP genes whose knockdown produced severe brain phenotypes, 3 human orthologs are located within chromosomal regions that have been linked to brain-associated diseases, suggesting a possible involvement of RP genes in brain or neurological diseases. The RP gene knockdown system developed in this study could be a powerful tool for studying the roles of ribosomes in human diseases.	[Uechi, Tamayo; Nakajima, Yukari; Nakao, Akihiro; Torihara, Hidetsugu; Chakraborty, Anirban; Kenmochi, Naoya] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan; [Inoue, Kunio] Kobe Univ, Grad Sch Sci & Technol, Dept Biol, Kobe, Hyogo 657, Japan	University of Miyazaki; Kobe University	Kenmochi, N (corresponding author), Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan.	kenmochi@med.miyazaki-u.ac.jp	Kenmochi, Naoya/ABF-3564-2021; Chakraborty, Anirban/AAP-5348-2020	/0000-0003-3476-6576	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [14035103, 17790653, 188093]; Japan Society for the Promotion of Science (JSPS) [P06457]; Sasagawa Grants for Science Fellows (SGSF)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sasagawa Grants for Science Fellows (SGSF)	Funding: This study was supported by Grants-in-Aid for Scientific Research (14035103, 17790653, and 188093) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS), and Sasagawa Grants for Science Fellows (SGSF). AC is a research fellow of JSPS (P06457).	Abidi F, 1999, AM J MED GENET, V85, P223, DOI 10.1002/(SICI)1096-8628(19990730)85:3<223::AID-AJMG8>3.0.CO;2-R; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; AMSTERDAM A, 2004, P NATL ACAD SCI USA, V170, P245; CAVASLAR GN, 2002, AM J HUM GENET, V66, P1705; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Driever W, 1996, DEVELOPMENT, V123, P37; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Haffter P, 1996, DEVELOPMENT, V123, P1; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Ishijima J, 1998, GENOMICS, V49, P341, DOI 10.1006/geno.1998.5277; Kenmochi N, 1998, GENOME RES, V8, P509, DOI 10.1101/gr.8.5.509; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; Nakao A, 2004, NUCLEIC ACIDS RES, V32, pD168, DOI 10.1093/nar/gkh004; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Uechi T, 2001, GENOMICS, V72, P223, DOI 10.1006/geno.2000.6470; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; Willig TN, 1999, BLOOD, V94, P4294; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202	29	73	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e37	10.1371/journal.pone.0000037	http://dx.doi.org/10.1371/journal.pone.0000037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183665	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600037
J	Kulkarni, AV; Busse, JW; Shams, I				Kulkarni, Abhaya V.; Busse, Jason W.; Shams, Iffat			Characteristics Associated with Citation Rate of the Medical Literature	PLOS ONE			English	Article								Background. The citation rate for articles is viewed as a measure of their importance and impact; however, little is known about what features of articles are associated with higher citation rate. Methodology/Principal Findings. We conducted a cohort study of all original articles, regardless of study methodology, published in the Lancet, JAMA, and New England Journal of Medicine, from October 1, 1999 to March 31, 2000. We identified 328 articles. Two blinded, independent reviewers extracted, in duplicate, nine variables from each article, which were analyzed in both univariable and multivariable linear least-squares regression models for their association with the annual rate of citations received by the article since publication. A two-way interaction between industry funding and an industry-favoring result was tested and found to be significant (p = 0.02). In our adjusted analysis, the presence of industry funding and an industry-favoring result was associated with an increase in annual citation rate of 25.7 (95% confidence interval, 8.5 to 42.8) compared to the absence of both industry funding and industry-favoring results. Higher annual rates of citation were also associated with articles dealing with cardiovascular medicine (13.3 more; 95% confidence interval, 3.9 to 22.3) and oncology (12.6 more; 95% confidence interval, 1.2 to 24.0), articles with group authorship (11.1 more; 95% confidence interval, 2.7 to 19.5), larger sample size and journal of publication. Conclusions/Significance. Large trials, with group authorship, industry-funded, with industry-favoring results, in oncology or cardiology were associated with greater subsequent citations.	[Kulkarni, Abhaya V.; Shams, Iffat] Hosp Sick Children, Div Populat Hlth Sci, Toronto, ON M5G 1X8, Canada; [Busse, Jason W.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University	Kulkarni, AV (corresponding author), Hosp Sick Children, Div Populat Hlth Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	abhaya.kulkarni@sickkids.ca	Busse, Jason/CAH-3696-2022	Busse, Jason/0000-0002-0178-8712	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	No funds were received for this analysis. Dr. Jason Busse is funded by a Canadian Institutes of Health Research Fellowship Award.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Dickersin K, 2002, JAMA-J AM MED ASSOC, V287, P2772, DOI 10.1001/jama.287.21.2772; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Fassoulaki A, 2000, BRIT J ANAESTH, V84, P266, DOI 10.1093/oxfordjournals.bja.a013418; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Gami AS, 2004, CAN MED ASSOC J, V170, P1925, DOI 10.1503/cmaj.1031879; GARFIELD E, 1992, THEOR MED, V13, P117, DOI 10.1007/BF02163625; Garfield E, 1996, BRIT MED J, V313, P411, DOI 10.1136/bmj.313.7054.411; GOTZSCHE PC, 1987, BRIT MED J, V295, P654, DOI 10.1136/bmj.295.6599.654; Healy D, 2003, BRIT J PSYCHIAT, V183, P22, DOI 10.1192/bjp.183.1.22; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; MacKinnon L, 2002, LANCET, V360, P1513, DOI 10.1016/S0140-6736(02)11452-8; Olson C M, 1994, Acad Emerg Med, V1, P207; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; RAVNSKOV U, 1992, BMJ-BRIT MED J, V305, P15, DOI 10.1136/bmj.305.6844.15; RAVNSKOV U, 1995, J CLIN EPIDEMIOL, V48, P713, DOI 10.1016/0895-4356(94)00222-C; Schmidt LM, 2005, J FAM PRACTICE, V54, P334; Weeks WB, 2004, SOC SCI MED, V59, P1949, DOI 10.1016/j.socscimed.2004.02.029; Welsch R, 1980, REGRESSION DIAGNOSTI	25	121	121	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e403	10.1371/journal.pone.0000403	http://dx.doi.org/10.1371/journal.pone.0000403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476325	Green Submitted, gold, Green Published			2022-12-27	WOS:000207445700005
J	Babu, H; Cheung, G; Kettenmann, H; Palmer, TD; Kempermann, G				Babu, Harish; Cheung, Giselle; Kettenmann, Helmut; Palmer, Theo D.; Kempermann, Gerd			Enriched Monolayer Precursor Cell Cultures from Micro-Dissected Adult Mouse Dentate Gyrus Yield Functional Granule Cell-Like Neurons	PLOS ONE			English	Article								Background. Stem cell cultures are key tools of basic and applied research in Regenerative Medicine. In the adult mammalian brain, lifelong neurogenesis originating from local precursor cells occurs in the neurogenic regions of the hippocampal dentate gyrus. Despite widespread interest in adult hippocampal neurogenesis and the use of mouse models to study it, no protocol existed for adult murine long-term precursor cell cultures with hippocampus-specific differentiation potential. Methodology/Principal Findings. We describe a new strategy to obtain serum-free monolayer cultures of neural precursor cells from microdissected dentate gyrus of adult mice. Neurons generated from these adherent hippocampal precursor cell cultures expressed the characteristic markers like transcription factor Prox1 and showed the TTX-sensitive sodium currents of mature granule cells in vivo. Similar to granule cells in vivo, treatment with kainic acid or brain derived neurotrophic factor (BDNF) elicited the expression of GABAergic markers, further supporting the correspondence between the in vitro and in vivo phenotype. When plated as single cells (in individual wells) or at lowest density for two to three consecutive generations, a subset of the cells showed self-renewal and gave rise to cells with properties of neurons, astrocytes and oligodendrocytes. The precursor cell fate was sensitive to culture conditions with their phenotype highly influenced by factors within the media (sonic hedgehog, BMP, LIF) and externally applied growth factors (EGF, FGF2, BDNF, and NT3). Conclusions/Significance. We report the conditions required to generate adult murine dentate gyrus precursor cell cultures and to analyze functional properties of precursor cells and their differentiated granule cell-like progeny in vitro.	[Babu, Harish; Cheung, Giselle; Kettenmann, Helmut; Kempermann, Gerd] Max Delbruck Ctr Mol Med MDC Berlin Buch, Berlin, Germany; [Babu, Harish; Kempermann, Gerd] Charite, Dept Expt Neurol, VolkswagenStiftung Res Grp, D-13353 Berlin, Germany; [Palmer, Theo D.] Stanford Univ, Dept Neurosurg, Palo Alto, CA 94304 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Volkswagen; Volkswagen Germany; Stanford University	Kempermann, G (corresponding author), Max Delbruck Ctr Mol Med MDC Berlin Buch, Berlin, Germany.	gerd.kempermann@mdc-berlin.de	Palmer, Theo/GSI-6635-2022; Kettenmann, Helmut/AAJ-5142-2021; Kempermann, Gerd/F-5416-2010	Kempermann, Gerd/0000-0002-5304-4061; Palmer, Theo/0000-0002-6266-1862; Kettenmann, Helmut/0000-0001-8208-0291; Cheung, Giselle/0000-0001-8457-2572	Volkswagenstiftung, Thyssen Stiftung; Deutsche Forschungsgemeinschaft (DFG)	Volkswagenstiftung, Thyssen Stiftung(Volkswagen); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by grants from Volkswagenstiftung, Thyssen Stiftung, and Deutsche Forschungsgemeinschaft (DFG).	Adachi T, 2005, J NEUROSCI RES, V79, P608, DOI 10.1002/jnr.20373; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Arsenijevic Y, 1998, J NEUROSCI, V18, P2118; Barami K, 2001, NEUROL RES, V23, P321, DOI 10.1179/016164101101198686; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Ernst C, 2005, EUR J NEUROSCI, V22, P3059, DOI 10.1111/j.1460-9568.2005.04499.x; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Friedman WJ, 1998, NEUROSCIENCE, V84, P101, DOI 10.1016/S0306-4522(97)00526-5; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gutierrez R, 2005, TRENDS NEUROSCI, V28, P297, DOI 10.1016/j.tins.2005.04.005; JESSBERGER S, 2006, STEM CELLS; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; SANDLER R, 1991, J COMP NEUROL, V303, P177, DOI 10.1002/cne.903030202; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Seki T, 1999, J COMP NEUROL, V410, P503, DOI 10.1002/(SICI)1096-9861(19990802)410:3<503::AID-CNE11>3.0.CO;2-H; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Singec I, 2002, J COMP NEUROL, V452, P139, DOI 10.1002/cne.10371; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; THALLMAIR M, 2006, EXP NEUROL; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037	63	119	121	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e388	10.1371/journal.pone.0000388	http://dx.doi.org/10.1371/journal.pone.0000388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460755	gold, Green Published, Green Accepted			2022-12-27	WOS:000207445600002
J	Kouprina, N; Noskov, VN; Pavlicek, A; Collins, NK; Bortz, PDS; Ottolenghi, C; Loukinov, D; Goldsmith, P; Risinger, JI; Kim, JH; Westbrook, VA; Solomon, G; Sounders, H; Herr, JC; Jurka, J; Lobanenkov, V; Schlessinger, D; Larionov, V				Kouprina, Natalay; Noskov, Vladimir N.; Pavlicek, Adam; Collins, N. Keith; Bortz, Pamela D. Schoppee; Ottolenghi, Chris; Loukinov, Dmitri; Goldsmith, Paul; Risinger, John I.; Kim, Jung-Hyun; Westbrook, V. Anne; Solomon, Gregory; Sounders, Hanna; Herr, John C.; Jurka, Jerzy; Lobanenkov, Victor; Schlessinger, David; Larionov, Vladimir			Evolutionary Diversification of SPANX-N Sperm Protein Gene Structure and Expression	PLOS ONE			English	Article								The sperm protein associated with nucleus in the X chromosome (SPANX) genes cluster at Xq27 in two subfamilies, SPANX-A/D and SPANX-N. SPANX-A/D is specific for hominoids and is fairly well characterized. The SPANX-N gave rise to SPANX-A/D in the hominoid lineage similar to 7 MYA. Given the proposed role of SPANX genes in spermatogenesis, we have extended studies to SPANX-N gene evolution, variation, regulation of expression, and intra-sperm localization. By immunofluorescence analysis, SPANX-N proteins are localized in post-meiotic spermatids exclusively, like SPANX-A/D. But in contrast to SPANX-A/D, SPANX-N are found in all ejaculated spermatozoa rather than only in a subpopulation, are localized in the acrosome rather than in the nuclear envelope, and are expressed at a low level in several nongametogenic adult tissues as well as many cancers. Presence of a binding site for CTCF and its testis-specific paralogue BORIS in the SPANX promoters suggests, by analogy to MAGE-A1 and NY-ESO-1, that their activation in spermatogenesis is mediated by the programmed replacement of CTCF by BORIS. Based on the relative density of CpG, the more extended expression of SPANX-N compared to SPANX-A/D in nongametogenic tissues is likely attributed to differences in promoter methylation. Our findings suggest that the recent duplication of SPANX genes in hominoids was accompanied by different localization of SPANX-N proteins in post-meiotic sperm and additional expression in several nongonadal tissues. This suggests a corresponding functional diversification of SPANX gene families in hominoids. SPANX proteins thus provide unique targets to investigate their roles in the function of spermatozoa, selected malignancies, and for SPANX-N, in other tissues as well.	[Kouprina, Natalay; Noskov, Vladimir N.; Collins, N. Keith; Goldsmith, Paul; Risinger, John I.; Kim, Jung-Hyun; Larionov, Vladimir] NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; [Pavlicek, Adam; Jurka, Jerzy] Genet Informat Res Inst, Mountain View, CA USA; [Bortz, Pamela D. Schoppee; Herr, John C.] Univ Virginia Hlth Syst, Dept Cell Biol, Charlottesville, VA USA; [Ottolenghi, Chris; Schlessinger, David] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; [Loukinov, Dmitri; Lobanenkov, Victor] NIAID, Immunol Lab, Bethesda, MD 20892 USA; [Westbrook, V. Anne] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Solomon, Gregory; Sounders, Hanna] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Virginia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Virginia; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kouprina, N (corresponding author), NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA.	kouprinn@mail.nih.gov	Lobanenkov, Victor V./AGQ-8903-2022; Lobanenkov, Victor/ABD-5710-2021; Ottolenghi, Chris/H-3745-2017	Ottolenghi, Chris/0000-0002-0734-344X; Lobanenkov, Victor/0000-0001-6665-3635; Westbrook, Anne/0000-0003-4570-0126	NIH; National Cancer Institute; Center for Cancer Research; National Institute on Aging, NIA; NATIONAL CANCER INSTITUTE [ZIABC010413, Z01BC010413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000860, ZIAAI000860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000647, Z01AG000647] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the intramural research program of the NIH, National Cancer Institute, Center for Cancer Research and National Institute on Aging, NIA.	Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; Baffoe-Bonnie AB, 2005, HUM GENET, V117, P307, DOI 10.1007/s00439-005-1306-z; Ball MA, 2003, J THEOR BIOL, V224, P27, DOI 10.1016/S0022-5193(03)00118-8; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; GOLDSMITH P, 1988, BIOCHEMISTRY-US, V27, P7085, DOI 10.1021/bi00418a062; Goydos JS, 2001, J SURG RES, V98, P76, DOI 10.1006/jsre.2001.6148; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Hao ZL, 2002, BIOL REPROD, V66, P735, DOI 10.1095/biolreprod66.3.735; HERR JC, 1990, BIOL REPROD, V42, P181, DOI 10.1095/biolreprod42.1.181; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Jagadish N, 2005, BIOCHEM J, V389, P73, DOI 10.1042/BJ20041577; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; KANG Y, 2007, ONCOGENE IN PRESS; Kim M, 2006, J BIOL CHEM, V281, P34288, DOI 10.1074/jbc.M607168200; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Kouprina N, 2005, GENOME RES, V15, P1477, DOI 10.1101/gr.4212705; Kouprina N, 2004, P NATL ACAD SCI USA, V101, P3077, DOI 10.1073/pnas.0308532100; Kouprina Natalay, 2006, V349, P85; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; Lim JH, 2005, INT J CANCER, V116, P200, DOI 10.1002/ijc.21007; LIN Y, 1994, J CELL BIOL, V125, P1157, DOI 10.1083/jcb.125.5.1157; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Nayernia K, 1996, INT J DEV BIOL, V40, P379; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ohno S., 1970, EVOLUTION GENE DUPLI; Rapley EA, 2000, NAT GENET, V24, P197, DOI 10.1038/72877; Salemi Michele, 2006, Hum Cell, V19, P87, DOI 10.1111/j.1749-0774.2006.00014.x; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Shetty J, 2003, J BIOL CHEM, V278, P30506, DOI 10.1074/jbc.M301713200; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Suri A, 2005, EXPERT OPIN BIOL TH, V5, P381, DOI 10.1517/14712598.5.3.381; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Toshimori K, 2003, ARCH HISTOL CYTOL, V66, P383, DOI 10.1679/aohc.66.383; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Wang XX, 2004, GENETICS, V167, P879, DOI 10.1534/genetics.103.025072; Wang ZQ, 2006, INT J CANCER, V118, P1436, DOI 10.1002/ijc.21499; Wang ZQ, 2003, BLOOD, V101, P955, DOI 10.1182/blood-2002-06-1930; Westbrook VA, 2006, MOL HUM REPROD, V12, P703, DOI 10.1093/molehr/gal079; Westbrook VA, 2000, BIOL REPROD, V63, P469, DOI 10.1093/biolreprod/63.2.469; Westbrook VA, 2004, CLIN CANCER RES, V10, P101, DOI 10.1158/1078-0432.CCR-0647-3; Westbrook VA, 2001, BIOL REPROD, V64, P345; Wolkowicz MJ, 2003, BIOL REPROD, V69, P735, DOI 10.1095/biolreprod.103.016675; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yamshchikov GV, 2001, INT J CANCER, V92, P703, DOI 10.1002/1097-0215(20010601)92:5<703::AID-IJC1250>3.0.CO;2-5; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zendman AJW, 2003, GENE, V309, P125, DOI 10.1016/S0378-1119(03)00497-9; Zendman AJW, 1999, CANCER RES, V59, P6223; Zhao L, 2004, WORLD J GASTROENTERO, V10, P2034, DOI 10.3748/wjg.v10.i14.2034	57	28	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e359	10.1371/journal.pone.0000359	http://dx.doi.org/10.1371/journal.pone.0000359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406683	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445300021
J	Nicholson, KE; Harmon, LJ; Losos, JB				Nicholson, Kirsten E.; Harmon, Luke J.; Losos, Jonathan B.			Evolution of Anolis Lizard Dewlap Diversity	PLOS ONE			English	Article							VISUAL SIGNAL-DESIGN; MALE MATING SUCCESS; SPECIES-RECOGNITION; MORPHOLOGY; PATTERNS; DISPLAY; SIZE; CONSTRAINTS; ADAPTATION; DIMORPHISM	Background. The dewlaps of Anolis lizards provide a classic example of a complex signaling system whose function and evolution is poorly understood. Dewlaps are flaps of skin beneath the chin that are extended and combined with head and body movements for visual signals and displays. They exhibit extensive morphological variation and are one of two cladistic features uniting anoles, yet little is known regarding their function and evolution. We quantified the diversity of anole dewlaps, investigated whether dewlap morphology was informative regarding phylogenetic relationships, and tested two separate hypotheses: (A) similar Anolis habitat specialists possess similar dewlap configurations (Ecomorph Convergence hypothesis), and (B) sympatric species differ in their dewlap morphologies to a greater extent than expected by chance (Species Recognition hypothesis). Methodology/Principal Findings. We found that dewlap configurations (sizes, patterns and colors) exhibit substantial diversity, but that most are easily categorized into six patterns that incorporate one to three of 13 recognizable colors. Dewlap morphology is not phylogenetically informative and, like other features of anoles, exhibits convergence in configurations. We found no support for the Ecomorph Convergence hypothesis; species using the same structural habitat were no more similar in dewlap configuration than expected by chance. With one exception, all sympatric species in four communities differ in dewlap configuration. However, this provides only weak support for the Species Recognition hypothesis because, due to the great diversity in dewlap configurations observed across each island, few cases of sympatric species with identical dewlaps would be expected to co-occur by chance alone. Conclusions/Significance. Despite previous thought, most dewlaps exhibit easily characterizable patterns and colorations. Nevertheless, dewlap variation is extensive and explanations for the origin and evolution of this diversity are lacking. Our data do not support two hypothesized explanations for this diversity, but others such as sexual selection remain to be tested.	[Nicholson, Kirsten E.] Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA; [Harmon, Luke J.] Univ British Columbia, Biodivers Ctr, Vancouver, BC V5Z 1M9, Canada; [Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Losos, Jonathan B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Central Michigan University; University of British Columbia; Harvard University; Harvard University	Nicholson, KE (corresponding author), Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA.	kirsten.nicholson@cmich.edu	Harmon, Luke/A-8225-2012	Harmon, Luke/0000-0002-4985-5750	NSF [DEB-9982736]	NSF(National Science Foundation (NSF))	This project was supported by NSF grant DEB-9982736.	Ashton R. E., 1991, HDB REPTILES AMPHI 2; BELS VL, 1990, J MORPHOL, V206, P225, DOI 10.1002/jmor.1052060209; Beuttell K, 1999, HERPETOL MONOGR, V13, P1, DOI 10.2307/1467059; Bohning-Gaese K, 2003, J EVOLUTION BIOL, V16, P956, DOI 10.1046/j.1420-9101.2003.00605.x; Butler MA, 2000, EVOLUTION, V54, P259, DOI 10.1111/j.0014-3820.2000.tb00026.x; Butler MA, 2002, ECOL MONOGR, V72, P541, DOI 10.1890/0012-9615(2002)072[0541:MSDSSA]2.0.CO;2; CASGRAIN P, 2001, PERMUTEL VERS 3 4 AL; COOPER WE, 1992, BIOL REPTILIA HORMON, P578; DAWKINS MS, 1993, PHILOS T ROY SOC B, V340, P251, DOI 10.1098/rstb.1993.0065; ECHELLE A A, 1971, Herpetologica, V27, P271; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; ERHARDT HC, 2002, ACOUSTIC COMMUNICATI; Espmark Y., 2000, ANIMAL SIGNALS SIGNA; FITCH H S, 1987, Amphibia-Reptilia, V8, P69, DOI 10.1163/156853887X00063; FITCH HS, 1984, COPEIA, P315, DOI 10.2307/1445187; Fleishman Leo J., 2000, P209; FLEISHMAN LJ, 1993, NATURE, V365, P397, DOI 10.1038/365397a0; FLEISHMAN LJ, 1992, AM NAT, V139, pS36, DOI 10.1086/285304; Fleishman LK, 2001, J EXP BIOL, V204, P1559; FONT E, 1990, J MORPHOL, V206, P245, DOI 10.1002/jmor.1052060210; Greenfield MD, 2002, SIGNALERS RECEIVERS; Harmon LJ, 2005, EVOLUTION, V59, P409; Jackman TR, 1999, SYST BIOL, V48, P254, DOI 10.1080/106351599260283; JENSSEN TA, 1977, AM ZOOL, V17, P203; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Leal M, 2004, AM NAT, V163, P26, DOI 10.1086/379794; Leal M, 2002, P ROY SOC B-BIOL SCI, V269, P351, DOI 10.1098/rspb.2001.1904; Leal M, 1997, BIOTROPICA, V29, P372, DOI 10.1111/j.1744-7429.1997.tb00440.x; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 1998, COPEIA, P430, DOI 10.2307/1447437; LOSOS JB, 1985, COPEIA, P905, DOI 10.2307/1445240; LOSOS JB, 2004, ADAPTIVE SPECIATION, P335; MACEDONIA JM, 1994, ETHOLOGY, V98, P246; MACEDONIA JM, 1994, ANIM BEHAV, V47, P1220, DOI 10.1006/anbe.1994.1163; Martins EP, 2004, ANIM BEHAV, V68, P453, DOI 10.1016/j.anbehav.2003.08.026; MOERMOND TC, 1979, ECOLOGY, V60, P152, DOI 10.2307/1936477; Nicholson JC, 2002, BRIT J NEUROSURG, V16, P93, DOI 10.1080/02688690220131688; Nicholson KE, 2005, J BIOGEOGR, V32, P929, DOI 10.1111/j.1365-2699.2004.01222.x; Ord TJ, 2002, BIOL J LINN SOC, V76, P145, DOI 10.1046/j.1095-8312.2002.00058.x; Ord TJ, 2002, BIOL J LINN SOC, V77, P127, DOI 10.1046/j.1095-8312.2002.00100.x; Persons MH, 1999, J COMP PHYSIOL A, V184, P585, DOI 10.1007/s003590050358; Poe S, 2004, HERPETOL MONOGR, V18, P37, DOI 10.1655/0733-1347(2004)018[0037:POA]2.0.CO;2; RAMBAUT A, 2001, TREEEDIT V 1 08; RAND A S, 1970, American Naturalist, V104, P99, DOI 10.1086/282643; Rivero J.A., 1978, AMPHIBIANS REPTILES; Rodrigues Miguel Trefaut, 2002, Pap. Avulsos Zool. (São Paulo), V42, P363, DOI 10.1590/S0031-10492002001600001; Rodriguez-Schettino L., 1999, IGUANID LIZARDS CUBA; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SCHWARTZ A., 1991, AMPHIBIANS REPTILES; SMITHE F.B., 1981, NATURALISTS COLOR GU; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Tokarz RR, 2005, J HERPETOL, V39, P174, DOI 10.1670/0022-1511(2005)039[0174:IODDIM]2.0.CO;2; Tokarz RR, 2003, COPEIA, P502, DOI 10.1643/00-170; Tokarz RR, 2002, HERPETOLOGICA, V58, P87, DOI 10.1655/0018-0831(2002)058[0087:AETOTI]2.0.CO;2; Williams E.E., 1983, LIZARD ECOLOGY STUDI, P326, DOI DOI 10.4159/HARVARD.9780674183384.C18; WILLIAMS EE, 1977, AM ZOOL, V17, P261; Williams EE., 1972, EVOL BIOL, V6, P47, DOI [DOI 10.1007/978-1-4684-9063-3_3, 10. 1007/978-1-4684-9063-3]; [No title captured]	58	101	111	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e274	10.1371/journal.pone.0000274	http://dx.doi.org/10.1371/journal.pone.0000274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17342208	Green Published, gold			2022-12-27	WOS:000207444700009
J	Howe, PDL; Livingstone, MS				Howe, Piers D. L.; Livingstone, Margaret S.			The Use of the Cancellation Technique to Quantify the Hermann Grid Illusion	PLOS ONE			English	Article								When observers view a grid of mid-gray lines superimposed on a black background, they report seeing illusory dark gray smudges at the grid intersections, an effect known as the Hermann grid illusion. The strength of the illusion is often measured using the cancellation technique: A white disk is placed over one of these intersections and the luminance of the disk is reduced until the disk disappears. Its luminance at this point, i.e., the disk's detection threshold, is taken to be a measure of the strength of the illusion. Our experiments showed that some distortions of the Hermann grid, which were sufficient to completely disrupt the illusion, did not reduce the disk's detection threshold. This showed that the cancellation technique is not a valid method for measuring the strength of the Hermann grid illusion. Those studies that attempted to use this technique inadvertently studied a different effect known as the blanking phenomenon. We conclude by presenting an explanation for the latter effect.	[Howe, Piers D. L.; Livingstone, Margaret S.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Howe, PDL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	phowe@hms.harvard.edu		Livingstone, Margaret/0000-0002-1950-0123; Howe, Piers/0000-0001-6171-1381	Helen Hay Whitney Foundation; NIH [EY 13135]; ARO [46961]; NATIONAL EYE INSTITUTE [R01EY013135] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARO; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a Helen Hay Whitney Foundation grant to P. H., and an NIH grant EY 13135 and an ARO grant 46961 to M. L. None of these sponsors played any role in the any part of the experiment or the manuscript preparation.	de Lafuente V, 2004, EXP BRAIN RES, V154, P255, DOI 10.1007/s00221-003-1700-5; Dresp B, 1999, SPATIAL VISION, V12, P129, DOI 10.1163/156856899X00085; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; Hermann L., 1870, ARCHIV FR GESAMTE PH, V3, P13, DOI DOI 10.1007/BF01855743; McAnany JJ, 2005, VISION RES, V45, P193, DOI 10.1016/j.visres.2004.08.003; McAnany JJ, 2004, VISION RES, V44, P993, DOI 10.1016/j.visres.2003.11.010; Schrauf M, 1997, VISION RES, V37, P1033, DOI 10.1016/S0042-6989(96)00255-6; Solomon JA, 2000, VISION RES, V40, P279, DOI 10.1016/S0275-5408(99)00059-9; TROSCIANKO T, 1982, VISION RES, V22, P485, DOI 10.1016/0042-6989(82)90197-3; TROSCIANKO T, 1982, VISION RES, V22, P1363, DOI 10.1016/0042-6989(82)90226-7	10	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e265	10.1371/journal.pone.0000265	http://dx.doi.org/10.1371/journal.pone.0000265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327924	Green Published, gold			2022-12-27	WOS:000207444600025
J	Blanvillain, S; Meyer, D; Boulanger, A; Lautier, M; Guynet, C; Denance, N; Vasse, J; Lauber, E; Arlat, M				Blanvillain, Servane; Meyer, Damien; Boulanger, Alice; Lautier, Martine; Guynet, Catherine; Denance, Nicolas; Vasse, Jacques; Lauber, Emmanuelle; Arlat, Matthieu			Plant Carbohydrate Scavenging through TonB-Dependent Receptors: A Feature Shared by Phytopathogenic and Aquatic Bacteria	PLOS ONE			English	Article							CAMPESTRIS PV. CAMPESTRIS; MULTIPLE SEQUENCE ALIGNMENT; MEMBRANE TRANSPORTER FECA; COMPLETE GENOME SEQUENCE; GRAM-NEGATIVE BACTERIA; SOLANACEARUM-HRP GENES; III SECRETION SYSTEM; GYP DOMAIN PROTEIN; XANTHOMONAS-CAMPESTRIS; OUTER-MEMBRANE	TonB-dependent receptors (TBDRs) are outer membrane proteins mainly known for the active transport of iron siderophore complexes in Gram-negative bacteria. Analysis of the genome of the phytopathogenic bacterium Xanthomonas campestris pv. campestris (Xcc), predicts 72 TBDRs. Such an overrepresentation is common in Xanthomonas species but is limited to only a small number of bacteria. Here, we show that one Xcc TBDR transports sucrose with a very high affinity, suggesting that it might be a sucrose scavenger. This TBDR acts with an inner membrane transporter, an amylosucrase and a regulator to utilize sucrose, thus defining a new type of carbohydrate utilization locus, named CUT locus, involving a TBDR for the transport of substrate across the outer membrane. This sucrose CUT locus is required for full pathogenicity on Arabidopsis, showing its importance for the adaptation to host plants. A systematic analysis of Xcc TBDR genes and a genome context survey suggested that several Xcc TBDRs belong to other CUT loci involved in the utilization of various plant carbohydrates. Interestingly, several Xcc TBDRs and CUT loci are conserved in aquatic bacteria such as Caulobacter crescentus, Colwellia psychrerythraea, Saccharophagus degradans, Shewanella spp., Sphingomonas spp. or Pseudoalteromonas spp., which share the ability to degrade a wide variety of complex carbohydrates and display TBDR overrepresentation. We therefore propose that TBDR overrepresentation and the presence of CUT loci designate the ability to scavenge carbohydrates. Thus CUT loci, which seem to participate to the adaptation of phytopathogenic bacteria to their host plants, might also play a very important role in the biogeochemical cycling of plant-derived nutrients in marine environments. Moreover, the TBDRs and CUT loci identified in this study are clearly different from those characterized in the human gut symbiont Bacteroides thetaiotaomicron, which allow glycan foraging, suggesting a convergent evolution of TBDRs in Proteobacteria and Bacteroidetes.	[Blanvillain, Servane; Meyer, Damien; Boulanger, Alice; Lautier, Martine; Guynet, Catherine; Denance, Nicolas; Vasse, Jacques; Lauber, Emmanuelle; Arlat, Matthieu] INRA, CNRS, Lab Interact Plantes Microorganismes, UMR2594 441, F-31326 Castanet Tolosan, France; [Lautier, Martine; Arlat, Matthieu] Univ Toulouse 3, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lauber, E (corresponding author), INRA, CNRS, Lab Interact Plantes Microorganismes, UMR2594 441, F-31326 Castanet Tolosan, France.	elauber@toulouse.inra.fr; arlat@toulouse.inra.fr	Guynet, Catherine/A-4815-2011; Denancé, Nicolas/I-1554-2019; Boulanger, Alice/E-6279-2019; Lauber, Emmanuelle/ABB-3077-2021; Arlat, Matthieu/CAH-3310-2022; MEYER, Damien F/G-2607-2013; Guynet, Catherine/GPX-0917-2022; Denancé, Nicolas/C-7008-2015	Denancé, Nicolas/0000-0003-0173-3970; Boulanger, Alice/0000-0001-5918-9547; Lauber, Emmanuelle/0000-0001-5933-4476; MEYER, Damien F/0000-0003-2735-176X; Denancé, Nicolas/0000-0003-0173-3970; Arlat, Matthieu/0000-0001-6196-4856	Ministere de la Recherche et de l'Enseignement Superieur; Departement Sante des Plantes et Environnement de L'Institut National de la Recherche Agronomique	Ministere de la Recherche et de l'Enseignement Superieur; Departement Sante des Plantes et Environnement de L'Institut National de la Recherche Agronomique	S. Blanvillain, D. Meyer and A. Boulanger were supported by grants from the Ministere de la Recherche et de l'Enseignement Superieur. We gratefully acknowledge financial support from the Departement Sante des Plantes et Environnement de L'Institut National de la Recherche Agronomique.	AHMER BMM, 1995, J BACTERIOL, V177, P4742, DOI 10.1128/jb.177.16.4742-4747.1995; Aldon D, 2000, EMBO J, V19, P2304, DOI 10.1093/emboj/19.10.2304; Alvarez A. M., 2000, MECH RESISTANCE PLAN, P21, DOI [10.1007/978-94-011-3937-3_2, DOI 10.1007/978-94-011-3937-3_2]; Angot A, 2006, P NATL ACAD SCI USA, V103, P14620, DOI 10.1073/pnas.0509393103; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; ARLAT M, 1991, MOL PLANT MICROBE IN, V4, P593, DOI 10.1094/MPMI-4-593; Aso Y, 2006, NAT BIOTECHNOL, V24, P188, DOI 10.1038/nbt1181; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bogs J, 2000, J BACTERIOL, V182, P5351, DOI 10.1128/JB.182.19.5351-5358.2000; BRADBEER C, 1976, J BACTERIOL, V128, P99, DOI 10.1128/JB.128.1.99-104.1976; Braun V, 1997, ARCH MICROBIOL, V167, P325, DOI 10.1007/s002030050451; Braun V, 2005, FEMS MICROBIOL REV, V29, P673, DOI 10.1016/j.femsre.2004.10.001; Brito B, 2002, MOL PLANT MICROBE IN, V15, P109, DOI 10.1094/MPMI.2002.15.2.109; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Cases I, 2005, INT MICROBIOL, V8, P213; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cubero J, 2004, INT J SYST EVOL MICR, V54, P429, DOI 10.1099/ijs.0.02784-0; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; Cunnac S, 2004, J BACTERIOL, V186, P2309, DOI 10.1128/JB.186.8.2309-2318.2004; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; DELORENZO V, 1988, J MOL BIOL, V203, P875, DOI 10.1016/0022-2836(88)90113-1; DIGROLAM.PM, 1971, J BACTERIOL, V106, P745, DOI 10.1128/JB.106.3.745-750.1971; Dombrecht B, 2001, MOL PLANT MICROBE IN, V14, P426, DOI 10.1094/MPMI.2001.14.3.426; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; DOW JM, 1990, APPL ENVIRON MICROB, V56, P2994, DOI 10.1128/AEM.56.10.2994-2998.1990; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Faure D, 2001, J MOL MICROB BIOTECH, V3, P467; Fenselau S, 1995, MOL PLANT MICROBE IN, V8, P845, DOI 10.1094/MPMI-8-0845; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; GOUGH CL, 1990, GENE, V89, P53, DOI 10.1016/0378-1119(90)90205-6; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; Hashidoko Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1427, DOI 10.1271/bbb.69.1427; Hashimoto W, 2005, BIOCHEMISTRY-US, V44, P13783, DOI 10.1021/bi050873b; Hashimoto W, 2005, BIOSCI BIOTECH BIOCH, V69, P673, DOI 10.1271/bbb.69.673; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Huang BX, 2004, J BACTERIOL, V186, P4387, DOI 10.1128/JB.186.13.4387-4389.2004; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Ireland MME, 2002, MOL MICROBIOL, V45, P1029, DOI 10.1046/j.1365-2958.2002.03071.x; JAHREIS K, 1993, MOL MICROBIOL, V9, P195, DOI 10.1111/j.1365-2958.1993.tb01681.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KADNER RJ, 1990, MOL MICROBIOL, V4, P2027, DOI 10.1111/j.1365-2958.1990.tb00562.x; Kim HS, 2004, J BACTERIOL, V186, P411, DOI 10.1128/JB.186.2.411-418.2004; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Koebnik R, 1993, Trends Microbiol, V1, P201, DOI 10.1016/0966-842X(93)90092-6; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Leveau JHJ, 2001, P NATL ACAD SCI USA, V98, P3446, DOI 10.1073/pnas.061629598; Lima WC, 2005, OMICS, V9, P160, DOI 10.1089/omi.2005.9.160; Llamas MA, 2006, J BACTERIOL, V188, P1882, DOI 10.1128/JB.188.5.1882-1891.2006; Loprasert S, 1999, GENE, V239, P251, DOI 10.1016/S0378-1119(99)00412-6; LUNDRIGAN MD, 1986, J BIOL CHEM, V261, P797; Marenda M, 1998, MOL MICROBIOL, V27, P437, DOI 10.1046/j.1365-2958.1998.00692.x; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mercier J, 2000, APPL ENVIRON MICROB, V66, P369, DOI 10.1128/AEM.66.1.369-374.2000; Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005; Meyer D, 2005, MOL PLANT PATHOL, V6, P327, DOI 10.1111/j.1364-3703.2005.00287.x; Meyer D, 2006, J BACTERIOL, V188, P4903, DOI 10.1128/JB.00180-06; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Molloy MP, 2002, PROTEOMICS, V2, P899, DOI 10.1002/1615-9861(200207)2:7<899::AID-PROT899>3.0.CO;2-Y; Morales CQ, 2005, MOL PLANT MICROBE IN, V18, P477, DOI 10.1094/MPMI-18-0477; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; Oke V, 1999, MOL MICROBIOL, V32, P837, DOI 10.1046/j.1365-2958.1999.01402.x; Papa R, 2006, EXTREMOPHILES, V10, P483, DOI 10.1007/s00792-006-0525-0; Paquelin A, 2001, MOL MICROBIOL, V42, P995, DOI 10.1046/j.1365-2958.2001.02628.x; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Phadke ND, 2001, PROTEOMICS, V1, P705, DOI 10.1002/1615-9861(200104)1:5<705::AID-PROT705>3.3.CO;2-E; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Puhler A, 2004, CURR OPIN PLANT BIOL, V7, P137, DOI 10.1016/j.pbi.2004.01.009; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Reid SJ, 2005, APPL MICROBIOL BIOT, V67, P312, DOI 10.1007/s00253-004-1885-y; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; SCHMID K, 1982, J BACTERIOL, V151, P68, DOI 10.1128/JB.151.1.68-76.1982; SCHULEIN K, 1991, MOL MICROBIOL, V5, P2233, DOI 10.1111/j.1365-2958.1991.tb02153.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Seliger SS, 2001, MOL MICROBIOL, V39, P801, DOI 10.1046/j.1365-2958.2001.02273.x; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Somers E, 2000, MOL GEN GENET, V263, P1038, DOI 10.1007/PL00008692; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; SPRENGER GA, 1988, J GEN MICROBIOL, V134, P1635; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; Subramoni S, 2005, MOL PLANT MICROBE IN, V18, P644, DOI 10.1094/MPMI-18-0644; Tanabe T, 2003, J BACTERIOL, V185, P6938, DOI 10.1128/JB.185.23.6938-6949.2003; TANG JL, 1990, MOL GEN GENET, V222, P157, DOI 10.1007/BF00283038; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuge S, 2006, J BACTERIOL, V188, P4158, DOI 10.1128/JB.00006-06; Van Gelder P, 2001, PROTEIN ENG, V14, P943, DOI 10.1093/protein/14.11.943; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Wiggerich HG, 2000, MICROBIOL-UK, V146, P1053, DOI 10.1099/00221287-146-5-1053; Wiggerich HG, 1997, J BACTERIOL, V179, P7103, DOI 10.1128/jb.179.22.7103-7110.1997; Williams P. H., 1980, Plant Disease, V64, P736, DOI 10.1094/PD-64-736; WILSON M, 1994, APPL ENVIRON MICROB, V60, P4468, DOI 10.1128/AEM.60.12.4468-4477.1994; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yue WW, 2003, J MOL BIOL, V332, P353, DOI 10.1016/S0022-2836(03)00855-6; Zhao QX, 2002, J BACTERIOL, V184, P1503, DOI 10.1128/JB.184.6.1503-1513.2002; Zou LF, 2006, APPL ENVIRON MICROB, V72, P6212, DOI 10.1128/AEM.00511-06	123	237	246	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e224	10.1371/journal.pone.0000224	http://dx.doi.org/10.1371/journal.pone.0000224			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311090	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444500005
J	Sengupta, K; Upender, MB; Barenboim-Stapleton, L; Nguyen, QT; Wincovitch, SM; Garfield, SH; Difilippantonio, MJ; Ried, T				Sengupta, Kundan; Upender, Madhvi B.; Barenboim-Stapleton, Linda; Nguyen, Quang Tri; Wincovitch, Stephen M., Sr.; Garfield, Susan H.; Difilippantonio, Michael J.; Ried, Thomas			Artificially Introduced Aneuploid Chromosomes Assume a Conserved Position in Colon Cancer Cells	PLOS ONE			English	Article								Background. Chromosomal aneuploidy is a defining feature of carcinomas. For instance, in colon cancer, an additional copy of Chromosome 7 is not only observed in early pre-malignant polyps, but is faithfully maintained throughout progression to metastasis. These copy number changes show a positive correlation with average transcript levels of resident genes. An independent line of research has also established that specific chromosomes occupy a well conserved 3D position within the interphase nucleus. Methodology/Principal Findings. We investigated whether cancer-specific aneuploid chromosomes assume a 3D-position similar to that of its endogenous homologues, which would suggest a possible correlation with transcriptional activity. Using 3D-FISH and confocal laser scanning microscopy, we show that Chromosomes 7, 18, or 19 introduced via microcell-mediated chromosome transfer into the parental diploid colon cancer cell line DLD-1 maintain their conserved position in the interphase nucleus. Conclusions. Our data is therefore consistent with the model that each chromosome has an associated zip code (possibly gene density) that determines its nuclear localization. Whether the nuclear localization determines or is determined by the transcriptional activity of resident genes has yet to be ascertained.	[Sengupta, Kundan; Upender, Madhvi B.; Barenboim-Stapleton, Linda; Nguyen, Quang Tri; Difilippantonio, Michael J.; Ried, Thomas] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Wincovitch, Stephen M., Sr.; Garfield, Susan H.] NCI, Expt Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ried, T (corresponding author), NCI, Genet Branch, NIH, Bethesda, MD 20892 USA.	riedt@mail.nih.gov	Difilippantonio, Michael/AAF-2839-2021	Difilippantonio, Michael/0000-0002-4676-7034	NIH; National Cancer Institute; NATIONAL CANCER INSTITUTE [Z01BC010835] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200348] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the intramural research program of the NIH, National Cancer Institute.	Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Goldberg M, 1999, P NATL ACAD SCI USA, V96, P2852, DOI 10.1073/pnas.96.6.2852; GRADE M, 2006, CANC RES IN PRESS; Grade M, 2006, CELL ONCOL, V28, P71; Habermann JK, 2007, GENE CHROMOSOME CANC, V46, P10, DOI 10.1002/gcc.20382; Hyman E, 2002, CANCER RES, V62, P6240; Macville M, 1997, HISTOCHEM CELL BIOL, V108, P299, DOI 10.1007/s004180050169; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; SCHLEGEL J, 1995, CANCER RES, V55, P6002; Schrock E, 1996, GENE CHROMOSOME CANC, V15, P199, DOI 10.1002/(SICI)1098-2264(199604)15:4<199::AID-GCC1>3.0.CO;2-X; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Upender MB, 2004, CANCER RES, V64, P6941, DOI 10.1158/0008-5472.CAN-04-0474; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Williams RRE, 2002, EXP CELL RES, V272, P163, DOI 10.1006/excr.2001.5400; Zinner R, 2006, HISTOCHEM CELL BIOL, V125, P3, DOI 10.1007/s00418-005-0049-1	25	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e199	10.1371/journal.pone.0000199	http://dx.doi.org/10.1371/journal.pone.0000199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17332847	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444300011
J	Wu, LJ; Ko, SW; Toyoda, H; Zhao, MG; Xu, H; Vadakkan, KI; Ren, M; Knifed, E; Shum, F; Quan, J; Zhang, XH; Zhuo, M				Wu, Long-Jun; Ko, Shanelle W.; Toyoda, Hiroki; Zhao, Ming-Gao; Xu, Hui; Vadakkan, Kunjumon I.; Ren, Ming; Knifed, Eva; Shum, Fanny; Quan, Jessica; Zhang, Xue-Han; Zhuo, Min			Increased Anxiety-Like Behavior and Enhanced Synaptic Efficacy in the Amygdala of GluR5 Knockout Mice	PLOS ONE			English	Article								GABAergic transmission in the amygdala modulates the expression of anxiety. Understanding the interplay between GABAergic transmission and excitatory circuits in the amygdala is, therefore, critical for understanding the neurobiological basis of anxiety. Here, we used a multi-disciplinary approach to demonstrate that GluR5-containing kainate receptors regulate local inhibitory circuits, modulate the excitatory transmission from the basolateral amygdala to the central amygdala, and control behavioral anxiety. Genetic deletion of GluR5 or local injection of a GluR5 antagonist into the basolateral amygdala increases anxiety-like behavior. Activation of GluR5 selectively depolarized inhibitory neurons, thereby increasing GABA release and contributing to tonic GABA current in the basolateral amygdala. The enhanced GABAergic transmission leads to reduced excitatory inputs in the central amygdala. Our results suggest that GluR5 is a key regulator of inhibitory circuits in the amygdala and highlight the potential use of GluR5-specific drugs in the treatment of pathological anxiety.	[Wu, Long-Jun; Ko, Shanelle W.; Toyoda, Hiroki; Zhao, Ming-Gao; Xu, Hui; Vadakkan, Kunjumon I.; Ren, Ming; Knifed, Eva; Shum, Fanny; Quan, Jessica; Zhang, Xue-Han; Zhuo, Min] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Zhuo, M (corresponding author), Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada.	min.zhuo@utoronto.ca	Wu, Long-Jun/AAK-7113-2020; Zhuo, Min/A-2072-2008; Wu, Long-Jun/E-2684-2012; Vadakkan, Kunjumon/A-3254-2008	Wu, Long-Jun/0000-0001-8019-3380; Zhuo, Min/0000-0001-9062-3241; Vadakkan, Kunjumon/0000-0002-2721-6931; Zhao, Ming-gao/0000-0002-7539-3887; Toyoda, Hiroki/0000-0002-9907-7176	NINDS [NS42722]; Canadian Institutes of Health Research; EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health; Canada Research Chair; Fragile X Research Foundation of Canada; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042722] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Fragile X Research Foundation of Canada; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from NINDS NS42722, the Canadian Institutes of Health Research, the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, and the Canada Research Chair to M.Z. L.-J.W. is supported by postdoctoral fellowships from the Canadian Institutes of Health Research and Fragile X Research Foundation of Canada.	BAHN S, 1994, J NEUROSCI, V14, P5525; Braga MFM, 2003, J NEUROSCI, V23, P442, DOI 10.1523/JNEUROSCI.23-02-00442.2003; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; De Armentia ML, 2004, J NEUROPHYSIOL, V92, P1285, DOI 10.1152/jn.00211.2004; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Fu Y, 2005, J NEUROPHYSIOL, V93, P3012, DOI 10.1152/jn.00871.2004; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P556, DOI 10.1001/archpsyc.58.6.556; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Kent JM, 2002, BIOL PSYCHIAT, V52, P1008, DOI 10.1016/S0006-3223(02)01672-4; Kerchner GA, 2002, J NEUROSCI, V22, P8010; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Khalilov I, 2002, J NEUROPHYSIOL, V88, P523, DOI 10.1152/jn.2002.88.1.523; Ko S, 2005, J NEUROSCI, V25, P977, DOI 10.1523/JNEUROSCI.4059-04.2005; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Rogawski MA, 2001, NEUROPHARMACOLOGY, V40, P28, DOI 10.1016/S0028-3908(00)00112-X; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Royer S, 1999, J NEUROSCI, V19, P10575; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Sandford JJ, 2000, PHARMACOL THERAPEUT, V88, P197, DOI 10.1016/S0163-7258(00)00082-6; Savander V, 1996, J COMP NEUROL, V374, P291, DOI 10.1002/(SICI)1096-9861(19961014)374:2<291::AID-CNE10>3.0.CO;2-Y; Semyanov A, 2001, NAT NEUROSCI, V4, P718, DOI 10.1038/89506; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Simmons RMA, 1998, NEUROPHARMACOLOGY, V37, P25, DOI 10.1016/S0028-3908(97)00188-3; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Smolders I, 2002, NAT NEUROSCI, V5, P796, DOI 10.1038/nn880; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Wieronska JM, 2005, PHARMACOL REP, V57, P734; WISDEN W, 1993, J NEUROSCI, V13, P3582; Wu LJ, 2005, J NEUROSCI, V25, P11107, DOI 10.1523/JNEUROSCI.1678-05.2005; Wu LJ, 2005, J NEUROPHYSIOL, V94, P1805, DOI 10.1152/jn.00091.2005; WU LJ, J NEUROBIOL IN PRESS; Xu H, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-29; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	56	62	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e167	10.1371/journal.pone.0000167	http://dx.doi.org/10.1371/journal.pone.0000167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17245443	gold, Green Published			2022-12-27	WOS:000207444100004
J	Zajitschek, F; Hunt, J; Zajitschek, SRK; Jennions, MD; Brooks, R				Zajitschek, Felix; Hunt, John; Zajitschek, Susanne R. K.; Jennions, Michael D.; Brooks, Robert			No Intra-Locus Sexual Conflict over Reproductive Fitness or Ageing in Field Crickets	PLOS ONE			English	Article							LIFE-HISTORY; DROSOPHILA-MELANOGASTER; ANTAGONISTIC PLEIOTROPY; GENETIC CORRELATION; MATE CHOICE; SELECTION; EVOLUTION; AGE; PERSPECTIVE; ADAPTATION	Differences in the ways in which males and females maximize evolutionary fitness can lead to intra-locus sexual conflict in which genes delivering fitness benefits to one sex are costly when expressed in the other. Trade-offs between current reproductive effort and future reproduction and survival are fundamental to the evolutionary biology of ageing. This leads to the prediction that sex differences in the optimization of age-dependent reproductive effort may generate intra-locus sexual conflict over ageing rates. Here we test for intra-locus sexual conflict over age-dependent reproductive effort and longevity in the black field cricket, Teleogryllus commodus. Using a half-sib breeding design, we show that the most important components of male and female reproductive effort (male calling effort and the number of eggs laid by females) were positively genetically correlated, especially in early adulthood. However, the genetic relationships between longevity and reproductive effort were different for males and females, leading to low genetic covariation between male and female longevity. The apparent absence of intra-locus sexual conflict over ageing suggests that male and female longevity can evolve largely independently of one another.	[Zajitschek, Felix; Hunt, John; Zajitschek, Susanne R. K.; Brooks, Robert] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Hunt, John] Univ Exeter, Ctr Ecol & Conservat, Cornwall, Penryn, England; [Jennions, Michael D.] Australian Natl Univ, Sch Bot & Zool, Canberra, ACT, Australia	University of New South Wales Sydney; University of Exeter; Australian National University	Zajitschek, F (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	felix.zajitschek@student.unsw.edu.au	Zajitschek, Felix/B-2596-2010; Brooks, Robert/A-1251-2008; Jennions, Michael D/C-7560-2009; Hunt, John/F-1279-2014; Zajitschek, Susanne/E-2958-2012	Zajitschek, Felix/0000-0001-6010-6112; Brooks, Robert/0000-0001-6926-0781; Jennions, Michael D/0000-0001-9221-2788; Zajitschek, Susanne/0000-0003-4676-9950; Hunt, John/0000-0002-4962-8750	Australian Research Council	Australian Research Council(Australian Research Council)	J.H., R. B. and M.D.J. were funded by the Australian Research Council.	Arnqvist Goran, 2005, pUnpaginated; Bentsen CL, 2006, AM NAT, V167, pE102, DOI 10.1086/501376; Bonduriansky R, 2005, EVOLUTION, V59, P1965; Bussiere LF, 2006, EVOLUTION, V60, P792, DOI 10.1554/05-378.1; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Day T, 2004, GENETICS, V167, P1537, DOI 10.1534/genetics.103.026211; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; Fisher RA, 1930, GENETICAL THEORY NAT; FRY JD, 1993, EVOLUTION, V47, P327, DOI 10.1111/j.1558-5646.1993.tb01224.x; FRY JD, 1990, AM NAT, V136, P569, DOI 10.1086/285116; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; HOULE D, 1991, EVOLUTION, V45, P630, DOI 10.1111/j.1558-5646.1991.tb04334.x; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; Hunt J, 2006, AM NAT, V168, pE72, DOI 10.1086/506918; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Lynch M., 1998, GENETICS ANAL QUANTI; Maklakov AA, 2005, P ROY SOC B-BIOL SCI, V272, P2485, DOI 10.1098/rspb.2005.3240; Matos M, 2001, AM NAT, V158, P655, DOI 10.1086/323591; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; PARTRIDGE L, 1992, EVOLUTION, V46, P76, DOI [10.2307/2409806, 10.1111/j.1558-5646.1992.tb01986.x]; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; PEASE CM, 1988, J EVOLUTION BIOL, V1, P293, DOI 10.1046/j.1420-9101.1988.1040293.x; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Pizzari T, 2003, EVOLUTION, V57, P1223, DOI 10.1111/j.0014-3820.2003.tb00331.x; Promislow D, 2003, BEHAV GENET, V33, P191, DOI 10.1023/A:1022562103669; Promislow DEL, 2002, MECH AGEING DEV, V123, P841, DOI 10.1016/S0047-6374(02)00021-0; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Roff Derek A., 1992; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; ROSE MR, 1982, HEREDITY, V48, P63, DOI 10.1038/hdy.1982.7; ROSE MR, 1981, GENETICS, V97, P172; ROSE MR, 1981, GENETICS, V97, P187; SERVICE PM, 1985, EVOLUTION, V39, P943, DOI [10.2307/2408694, 10.1111/j.1558-5646.1985.tb00436.x]; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Simons AM, 1996, EVOLUTION, V50, P267, DOI 10.1111/j.1558-5646.1996.tb04490.x; Stearns S.C., 1992, pi; Tregenza T, 2006, PHILOS T R SOC B, V361, P229, DOI 10.1098/rstb.2005.1796; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; ZWAAN B, 1995, EVOLUTION, V49, P649, DOI 10.2307/2410318	51	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e155	10.1371/journal.pone.0000155	http://dx.doi.org/10.1371/journal.pone.0000155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225859	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444000006
J	Reina, JH; Azzouz, TN; Hernandez, N				Reina, Jaime H.; Azzouz, Teldja N.; Hernandez, Nouria			Maf1, a New Player in the Regulation of Human RNA Polymerase III Transcription	PLOS ONE			English	Article								Background. Human RNA polymerase III (pol III) transcription is regulated by several factors, including the tumor suppressors P53 and Rb, and the proto-oncogene c-Myc. In yeast, which lacks these proteins, a central regulator of pol III transcription, called Maf1, has been described. Maf1 is required for repression of pol III transcription in response to several signal transduction pathways and is broadly conserved in eukaryotes. Methodology/Principal Findings. We show that human endogenous Maf1 can be co-immunoprecipitated with pol III and associates in vitro with two pol III subunits, the largest subunit RPC1 and the alpha-like subunit RPAC2. Maf1 represses pol III transcription in vitro and in vivo and is required for maximal pol III repression after exposure to MMS or rapamycin, treatments that both lead to Maf1 dephosphorylation. Conclusions/Significance. These data suggest that Maf1 is a major regulator of pol III transcription in human cells.	[Reina, Jaime H.; Azzouz, Teldja N.; Hernandez, Nouria] Univ Lausanne, CIG, Lausanne, Switzerland	University of Lausanne	Hernandez, N (corresponding author), Univ Lausanne, CIG, Lausanne, Switzerland.	Nouria.Hernandez@unil.ch		Hernandez, Nouria/0000-0003-1465-4585	University of Lausanne, SNSF [3100A0-109941/1]; NIH [GM38810]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038810] Funding Source: NIH RePORTER	University of Lausanne, SNSF(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	University of Lausanne, SNSF grant 3100A0-109941/1, NIH grant GM38810	Cairns CA, 1998, EMBO J, V17, P3112, DOI 10.1093/emboj/17.11.3112; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; Geiduschek EP, 2006, CURR BIOL, V16, pR849, DOI 10.1016/j.cub.2006.08.071; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; GREEN CJ, 1990, J BIOL CHEM, V265, P12139; Gridasova AA, 2005, MOL CELL BIOL, V25, P3247, DOI 10.1128/MCB.25.8.3247-3260.2005; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hirsch HA, 2004, MOL CELL BIOL, V24, P5989, DOI 10.1128/MCB.24.13.5989-5999.2004; Hirsch HA, 2000, MOL CELL BIOL, V20, P9182, DOI 10.1128/MCB.20.24.9182-9191.2000; Hu P, 2002, MOL CELL BIOL, V22, P8044, DOI 10.1128/MCB.22.22.8044-8055.2002; Kuhlman TC, 1999, MOL CELL BIOL, V19, P2130; Larminie CGC, 1997, EMBO J, V16, P2061, DOI 10.1093/emboj/16.8.2061; LITTLE RD, 1989, GENOMICS, V4, P376, DOI 10.1016/0888-7543(89)90345-5; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; LOBO SM, 1990, NUCLEIC ACIDS RES, V18, P2891, DOI 10.1093/nar/18.10.2891; MACPHERSON JM, 1986, GENE, V42, P101, DOI 10.1016/0378-1119(86)90155-1; MARONEY PA, 1990, P NATL ACAD SCI USA, V87, P709, DOI 10.1073/pnas.87.2.709; MOIR RD, 2006, P NATL ACAD SCI US; Murawski Marcin, 1994, Acta Biochimica Polonica, V41, P441; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pillai RS, 2001, EMBO J, V20, P5470, DOI 10.1093/emboj/20.19.5470; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Saxena A, 2005, MOL CELL BIOL, V25, P9406, DOI 10.1128/MCB.25.21.9406-9418.2005; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Stein T, 2002, ONCOGENE, V21, P5540, DOI 10.1038/sj.onc.1205739; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sutcliffe JE, 2000, MOL CELL BIOL, V20, P9192, DOI 10.1128/MCB.20.24.9192-9202.2000; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; Willis IM, 2004, PROG NUCLEIC ACID RE, V77, P323, DOI 10.1016/S0079-6603(04)77009-9; YUO CY, 1985, CELL, V42, P193, DOI 10.1016/S0092-8674(85)80115-X	41	80	83	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e134	10.1371/journal.pone.0000134	http://dx.doi.org/10.1371/journal.pone.0000134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205138	Green Published, gold			2022-12-27	WOS:000207443700028
J	Carey, CC; Gorman, KF; Rutherford, S				Carey, Charles C.; Gorman, Kristen F.; Rutherford, Suzannah			Modularity and Intrinsic Evolvability of Hsp90-Buffered Change	PLOS ONE			English	Article								Hsp90 controls dramatic phenotypic transitions in a wide array of morphological features of many organisms. The genetic-background dependence of specific abnormalities and their response to laboratory selection suggested Hsp90 could be an 'evolutionary capacitor', allowing developmental variation to accumulate as neutral alleles under normal conditions and manifest selectable morphological differences during environmental stress. The relevance of Hsp90-buffered variation for evolution has been most often challenged by the idea that large morphological changes controlled by Hsp90 are unconditionally deleterious. To address this issue, we tested an Hsp90-buffered abnormality in Drosophila for unselected pleiotropic effects and correlated fitness costs. Up to 120-fold differences in penetrance among six highly related selection lines, started from an initially small number of flies and rapidly selected for and against a deformed eye trait (dfe), did not translate into measurable differences in any of several tests of viability, lifespan or competitive fitness. Nor were 17 dfe Quantitative Trait Loci (QTL) associated with fitness effects in over 1,400 recombinant lines. Our ability to detect measurable effects of inbreeding, media environment and the white mutation in the selection line backgrounds independent of dfe penetrance suggests that, within the limitations of laboratory tests of fitness, this large morphological change controlled by Hsp90 was selectable independent of strong, correlated and unconditionally deleterious effects-abundant, polygenic variation hidden by Hsp90 allows potentially deleterious alleles to be readily replaced during selection by less deleterious alleles with similar phenotypic effects. Hsp90 links environmental stress with the expression of developmental variation controlling unprecedented morphological plasticity. As outlined here and in the companion paper of this issue, the complex genetic architecture of Hsp90-buffered variation supports a remarkable modularity of Hsp90 effects on quantitative and qualitative phenotypes, consistent with the 'Hsp90 capacitor hypothesis' and standard quantitative genetic models of threshold traits.	[Carey, Charles C.; Gorman, Kristen F.; Rutherford, Suzannah] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Rutherford, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	srutherf@fhcrc.org	Rutherford, Suzannah/L-7355-2019	Rutherford, Suzannah/0000-0002-7809-3337	Damon Runyon Walter Winchel Foundation Scholar Award NIH [R01 GM068873]; NIH [F32 GM07542, T32 CA80416]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068873] Funding Source: NIH RePORTER	Damon Runyon Walter Winchel Foundation Scholar Award NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Damon Runyon Walter Winchel Foundation Scholar Award NIH R01 GM068873. Chuck Carey was funded by NIH F32 GM07542 and NIH T32 CA80416.	Ashburner M., 1989, DROSOPHILA; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Bishop CD, 2002, DEV GENES EVOL, V212, P70, DOI 10.1007/s00427-002-0212-9; CLARK AG, 1995, GENETICA, V96, P225, DOI 10.1007/BF01439576; DEBAT V, 2006, EVOLUTION IN PRESS; Dickinson WJ, 1999, NATURE, V399, P30, DOI 10.1038/19894; Dietrich MR, 2003, NAT REV GENET, V4, P68, DOI 10.1038/nrg979; Fisher R. A., 1932, GENETICAL THEORY NAT; Frankel J, 2001, J EUKARYOT MICROBIOL, V48, P147, DOI 10.1111/j.1550-7408.2001.tb00297.x; Frankel J, 2001, J EUKARYOT MICROBIOL, V48, P135, DOI 10.1111/j.1550-7408.2001.tb00296.x; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Kimura M, 1983, NEUTRAL THEORY MOL E, pXV; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Loubradou G, 1997, GENETICS, V147, P581; Loubradou G, 1999, GENETICS, V152, P519; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Milton CC, 2003, P NATL ACAD SCI USA, V100, P13396, DOI 10.1073/pnas.1835613100; Milton CC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000075; Nollen EAA, 2002, J CELL SCI, V115, P2809; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Roberts SP, 1999, OECOLOGIA, V121, P323, DOI 10.1007/s004420050935; RUTHERFORD S, 2007, MOL ASPECTS STRESS R; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Wagner GP, 1999, J EXP ZOOL, V285, P116, DOI 10.1002/(SICI)1097-010X(19990815)285:2<116::AID-JEZ3>3.0.CO;2-P; Wiesgigl M, 2001, MOL BIOL CELL, V12, P3307, DOI 10.1091/mbc.12.11.3307; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	29	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e76	10.1371/journal.pone.0000076	http://dx.doi.org/10.1371/journal.pone.0000076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183708	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600076
J	Graefe, SEB; Streichert, T; Budde, BS; Nurnberg, P; Steeg, C; Muller-Myhsok, B; Fleischer, B				Graefe, Sebastian E. B.; Streichert, Thomas; Budde, Birgit S.; Nuernberg, Peter; Steeg, Christiane; Mueller-Myhsok, Bertram; Fleischer, Bernhard			Genes from Chagas Susceptibility Loci That Are Differentially Expressed in T-cruzi-Resistant Mice Are Candidates Accounting for Impaired Immunity	PLOS ONE			English	Article								Variation between inbred mice of susceptibility to experimental Trypanosoma cruzi infection has frequently been described, but the immunogenetic background is poorly understood. The outcross of the susceptible parental mouse strains C57BL/6 (B6) and DBA/2 (D2), B6D2F1 (F1) mice, is highly resistant to this parasite. In the present study we show by quantitative PCR that the increase of tissue parasitism during the early phase of infection is comparable up to day 11 between susceptible B6 and resistant F1 mice. A reduction of splenic parasite burdens occurs thereafter in both strains but is comparatively retarded in susceptible mice. Splenic microarchitecture is progressively disrupted with loss of follicles and B lymphocytes in B6 mice, but not in F1 mice. By genotyping of additional backcross offspring we corroborate our earlier findings that susceptibility maps to three loci on Chromosomes 5, 13 and 17. Analysis of gene expression of spleen cells from infected B6 and F1 mice with microarrays identifies about 0.3% of transcripts that are differentially expressed. Assuming that differential susceptibility is mediated by altered gene expression, we propose that the following differentially expressed transcripts from these loci are strong candidates for the observed phenotypic variation: H2-E alpha, H2-D1, Ng23, Msh5 and Tubb5 from Chromosome 17; and Cxcl11, Bmp2k and Spp1 from Chromosome 5. Our results indicate that innate mechanisms are not of primary relevance to resistance of F1 mice to T. cruzi infection, and that differential susceptibility to experimental infection with this protozoan pathogen is not paralleled by extensive variation of the transcriptome.	[Graefe, Sebastian E. B.; Fleischer, Bernhard] Univ Hosp Eppendorf, Inst Immunol, Hamburg, Germany; [Graefe, Sebastian E. B.; Steeg, Christiane; Fleischer, Bernhard] Bernhard Nocht Inst Trop Med, Dept Med Microbiol & Immunol, Hamburg, Germany; [Streichert, Thomas] Univ Hosp, Inst Clin Chem, Hamburg, Germany; [Budde, Birgit S.] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Budde, Birgit S.; Nuernberg, Peter] Univ Cologne, Inst Genet, D-5000 Cologne, Germany; [Mueller-Myhsok, Bertram] Max Planck Inst Expt Psychiat, Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Bernhard Nocht Institut fur Tropenmedizin; University of Cologne; University of Cologne; Max Planck Society	Graefe, SEB (corresponding author), Univ Hosp Eppendorf, Inst Immunol, Hamburg, Germany.	graefe@bni-hamburg.de	Müller-Myhsok, Bertram/A-3289-2013	Budde, Birgit/0000-0001-9385-4168	German Federal Ministry of Science and Education through the National Genome Research Network	German Federal Ministry of Science and Education through the National Genome Research Network	This work was supported by the German Federal Ministry of Science and Education through the National Genome Research Network.	Abel B, 2005, J IMMUNOL, V175, P6006, DOI 10.4049/jimmunol.175.9.6006; Allcock RJN, 2000, IMMUNOL TODAY, V21, P328, DOI 10.1016/S0167-5699(00)01654-6; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; ANDRADE V, 1985, BRAZ J MED BIOL RES, V18, P499; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bonner AE, 2003, J MED GENET, V40, P408, DOI 10.1136/jmg.40.6.408; Buckner FS, 1999, INFECT IMMUN, V67, P403, DOI 10.1128/IAI.67.1.403-409.1999; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Campbell DA, 2004, CURR MOL MED, V4, P549, DOI 10.2174/1566524043360249; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Colorado IA, 2000, HUM IMMUNOL, V61, P320, DOI 10.1016/S0198-8859(99)00177-9; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Deghaide NHS, 1998, DIGEST DIS SCI, V43, P246, DOI 10.1023/A:1018829600200; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Fae KC, 2000, MICROBES INFECT, V2, P745, DOI 10.1016/S1286-4579(00)00501-3; Fernandez-Mestre MT, 1998, PARASITE IMMUNOL, V20, P197; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Graefe SEB, 2003, MICROBES INFECT, V5, P833, DOI 10.1016/S1286-4579(03)00176-X; Graefe SEB, 2003, GENES IMMUN, V4, P321, DOI 10.1038/sj.gene.6363972; Guarner J, 2001, AM J TROP MED HYG, V65, P152, DOI 10.4269/ajtmh.2001.65.152; Hardison JL, 2006, INFECT IMMUN, V74, P135, DOI 10.1128/IAI.74.1.135-143.2006; Hardison JL, 2006, INFECT IMMUN, V74, P125, DOI 10.1128/IAI.74.1.125-134.2006; HOFF R, 1974, J PARASITOL, V60, P527, DOI 10.2307/3278377; Holscher C, 1998, INFECT IMMUN, V66, P1208; JONES PP, 1981, IMMUNOGENETICS, V12, P321, DOI 10.1007/BF01561674; Kearns AE, 2001, J BIOL CHEM, V276, P42213, DOI 10.1074/jbc.M106163200; Kellam P, 2006, CELL, V124, P695, DOI 10.1016/j.cell.2006.02.003; KNUDSEN S, GUIDE ANAL DNA MICRO, P184; Koguchi Y, 2003, AM J RESP CRIT CARE, V167, P1355, DOI 10.1164/rccm.200209-1113OC; Kumar S, 1998, PARASITE IMMUNOL, V20, P207, DOI 10.1046/j.1365-3024.1998.00154.x; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; Liaw L, 1998, J CLIN INVEST, V101, P1468; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Luduena RF, 1998, INT REV CYTOL, V178, P207; Machado FS, 2005, J INFECT DIS, V191, P627, DOI 10.1086/427515; Maeno Y, 2006, ACTA TROP, V98, P305, DOI 10.1016/j.actatropica.2006.05.001; Marinho CRF, 1999, INFECT IMMUN, V67, P308, DOI 10.1128/IAI.67.1.308-318.1999; Marinho CRF, 2004, INFECT IMMUN, V72, P2350, DOI 10.1128/IAI.72.4.2350-2357.2004; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; *MGD, 2006, MOUS GEN INF WEB SIT; Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2; MILES MA, 2005, TOPLEY WILSONS MICRO, P376; MORGADO MG, 1989, EMBO J, V8, P3245, DOI 10.1002/j.1460-2075.1989.tb08484.x; Nau GJ, 1999, INFECT IMMUN, V67, P4223, DOI 10.1128/IAI.67.8.4223-4230.1999; Nieto A, 2000, TISSUE ANTIGENS, V55, P195, DOI 10.1034/j.1399-0039.2000.550301.x; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; Petkovic V, 2004, J LEUKOCYTE BIOL, V76, P701, DOI 10.1189/jlb.1103570; POTTS WK, 1995, IMMUNOL REV, V143, P181, DOI 10.1111/j.1600-065X.1995.tb00675.x; POWELL MR, 1993, PARASITE IMMUNOL, V15, P215, DOI 10.1111/j.1365-3024.1993.tb00603.x; Rajagopalan D, 2003, BIOINFORMATICS, V19, P1469, DOI 10.1093/bioinformatics/btg202; ROTTENBERG ME, 1993, INFECT IMMUN, V61, P5129, DOI 10.1128/IAI.61.12.5129-5133.1993; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; SILVA JS, 1992, J EXP MED, V175, P169, DOI 10.1084/jem.175.1.169; SINGH RP, 1990, J EXP MED, V171, P1931, DOI 10.1084/jem.171.6.1931; Soares MBP, 2001, AM J PATHOL, V159, P703, DOI 10.1016/S0002-9440(10)61741-5; Soto CDA, 2003, INFECT IMMUN, V71, P1194, DOI 10.1128/IAI.71.3.1194-1199.2003; Talvani A, 2000, MICROBES INFECT, V2, P851, DOI 10.1016/S1286-4579(00)00388-9; Tarleton RL, 1997, P NATL ACAD SCI USA, V94, P3932, DOI 10.1073/pnas.94.8.3932; TARLETON RL, 1992, NATURE, V356, P338, DOI 10.1038/356338a0; TRISCHMANN TM, 1982, INFECT IMMUN, V35, P546, DOI 10.1128/IAI.35.2.546-551.1982; TRISCHMANN TM, 1984, PARASITE IMMUNOL, V6, P561, DOI 10.1111/j.1365-3024.1984.tb00825.x; TRISCHMANN TM, 1983, J IMMUNOL, V130, P1953; Vago AR, 1996, LANCET, V348, P891, DOI 10.1016/S0140-6736(05)64761-7; WilliamsBlangero S, 1997, AM J TROP MED HYG, V57, P538, DOI 10.4269/ajtmh.1997.57.538; WRIGHTSMAN R, 1982, INFECT IMMUN, V36, P637, DOI 10.1128/IAI.36.2.637-644.1982; WRIGHTSMAN RA, 1984, INFECT IMMUN, V44, P351, DOI 10.1128/IAI.44.2.351-354.1984; Xanthou G, 2003, EUR J IMMUNOL, V33, P2241, DOI 10.1002/eji.200323787; Zhang L, 1996, EUR J IMMUNOL, V26, P102, DOI 10.1002/eji.1830260116; Zhang L, 1999, J INFECT DIS, V180, P480, DOI 10.1086/314889; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	76	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e57	10.1371/journal.pone.0000057	http://dx.doi.org/10.1371/journal.pone.0000057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183687	Green Published, gold, Green Accepted			2022-12-27	WOS:000207443600057
J	Hill, PC; Brookes, RH; Fox, A; Jackson-Sillah, D; Lugos, MD; Jeffries, DJ; Donkor, SA; Adegbola, RA; McAdam, KPWJ				Hill, Philip C.; Brookes, Roger H.; Fox, Annette; Jackson-Sillah, Dolly; Lugos, Moses D.; Jeffries, David J.; Donkor, Simon A.; Adegbola, Richard A.; McAdam, Keith P. W. J.			Surprisingly High Specificity of the PPD Skin Test for M-tuberculosis Infection from Recent Exposure in The Gambia	PLOS ONE			English	Article								Background. Options for intervention against Mycobacterium tuberculosis infection are limited by the diagnostic tools available. The Purified Protein Derivative (PPD) skin test is thought to be non-specific, especially in tropical settings. We compared the PPD skin test with an ELISPOT test in The Gambia. Methodology/Principal Findings. Household contacts over six months of age of sputum smear positive TB cases and community controls were recruited. They underwent a PPD skin test and an ELISPOT test for the T cell response to PPD and ESAT-6/CFP10 antigens. Responsiveness to M. tuberculosis exposure was analysed according to sleeping proximity to an index case using logistic regression. 615 household contacts and 105 community controls were recruited. All three tests assessed increased significantly in positivity with increasing M. tuberculosis exposure, the PPD skin test most dramatically (OR 15.7; 95% CI 6.6-35.3). While the PPD skin test positivity continued to trend downwards in the community with increasing distance from a known case (61.9% to 14.3%), the PPD and ESAT-6/CFP-10 ELISPOT positivity did not. The PPD skin test was more in agreement with ESAT-6/CFP-10 ELISPOT (75%, p = 0.01) than the PPD ELISPOT (53%, p < 0.0001). With increasing M. tuberculosis exposure, the proportion of ESAT-6/CFP-10 positive contacts who were PPD skin test positive increased (p < 0.0001), and the proportion of ESAT-6/CFP-10 negative contacts that were PPD skin test negative decreased (p < 0.0001); the converse did not occur. Conclusions/Significance. The PPD skin test has surprisingly high specificity for M. tuberculosis infection from recent exposure in The Gambia. In this setting, anti-tuberculous prophylaxis in PPD skin test positive individuals should be revisited.	[Hill, Philip C.; Brookes, Roger H.; Fox, Annette; Jackson-Sillah, Dolly; Lugos, Moses D.; Jeffries, David J.; Donkor, Simon A.; Adegbola, Richard A.; McAdam, Keith P. W. J.] MRC Unit, Bacterial Dis Programme, Banjul, Gambia	University of London; London School of Hygiene & Tropical Medicine	Hill, PC (corresponding author), MRC Unit, Bacterial Dis Programme, Banjul, Gambia.	phill@mrc.gm	Lugos, Moses D/AAZ-5179-2020	Lugos, Moses D/0000-0002-4921-2691; Brookes, Roger/0000-0002-5361-0617; Fox, Annette/0000-0002-0565-7146	The Medical Research Council (UK); European Commission; MRC [MC_U190071468] Funding Source: UKRI; Medical Research Council [MC_U190071468] Funding Source: researchfish	The Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Medical Research Council (UK) and the European Commission. Neither had any role in the design or conduct or collection analysis and interpretation of the data, or in the preparation, review or approval of the manuscript.	Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; [Anonymous], 1956, Br Med J, V1, P413; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Black GF, 2001, INT J TUBERC LUNG D, V5, P664; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMSTOCK GW, 1969, AM REV RESPIR DIS, V100, P839; Crampin AC, 2001, T ROY SOC TROP MED H, V95, P481, DOI 10.1016/S0035-9203(01)90009-4; DEJONG BC, 2006, J INFECT DI IN PRESS; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Floyd S, 2002, J INFECT DIS, V186, P807, DOI 10.1086/342416; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hill PC, 2005, J CLIN MICROBIOL, V43, P2070, DOI 10.1128/JCM.43.5.2070-2074.2005; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Hoft DF, 2000, CLIN INFECT DIS, V30, pS217, DOI 10.1086/313864; Jeffries DJ, 2004, INT J TUBERC LUNG D, V8, P1095; Koch R., 1891, DEUT MED WOCHENSCHR, V17, P101, DOI [10.1055/s-0029-1206198, DOI 10.1055/S-0029-1206198]; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lienhardt C, 2003, PEDIATRICS, V111, pE608, DOI 10.1542/peds.111.5.e608; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; Marshall RJ, 2001, STAT MED, V20, P1077, DOI 10.1002/sim.747; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pitman R, 2002, INT J TUBERC LUNG D, V6, P485; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Sester M, 2004, KIDNEY INT, V65, P1826, DOI 10.1111/j.1523-1755.2004.00586.x	32	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e68	10.1371/journal.pone.0000068	http://dx.doi.org/10.1371/journal.pone.0000068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183699	Green Published, gold			2022-12-27	WOS:000207443600068
J	Ioannidis, JPA				Ioannidis, John P. A.			Concentration of the Most-Cited Papers in the Scientific Literature: Analysis of Journal Ecosystems	PLOS ONE			English	Article							CITATION; IMPACT; SCIENCE; PUBLICATION	Background. A minority of scientific journals publishes the majority of scientific papers and receives the majority of citations. The extent of concentration of the most influential articles is less well known. Methods/Principal Findings. The 100 most-cited papers in the last decade in each of 21 scientific fields were analyzed; fields were considered as ecosystems and their "species'' (journal) diversity was evaluated. Only 9% of journals in Journal Citation Reports had published at least one such paper. Among this 9%, half of them had published only one such paper. The number of journals that had published a larger number of most-cited papers decreased exponentially according to a Lotka law. Except for three scientific fields, six journals accounted for 53 to 94 of the 100 most-cited papers in their field. With increasing average number of citations per paper (citation density) in a scientific field, concentration of the most-cited papers in a few journals became even more prominent (p < 0.001). Concentration was unrelated to the number of papers published or number of journals available in a scientific field. Multidisciplinary journals accounted for 24% of all most-cited papers, with large variability across fields. The concentration of most-cited papers in multidisciplinary journals was most prominent in fields with high citation density (correlation coefficient 0.70, p < 0.001). Multidisciplinary journals had published fewer than eight of the 100 most-cited papers in eight scientific fields (none in two fields). Journals concentrating most-cited original articles often differed from those concentrating most-cited reviews. The concentration of the most-influential papers was stronger than the already prominent concentration of papers published and citations received. Conclusions. Despite a plethora of available journals, the most influential papers are extremely concentrated in few journals, especially in fields with high citation density. Existing multidisciplinary journals publish selectively most-cited papers from fields with high citation density.	[Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece	University of Ioannina; Tufts University; Foundation for Research & Technology - Hellas (FORTH)	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011					[Anonymous], 2006, PLOS MED, V3, pe291, DOI 10.1371/journal.pmed.0030291; Bhandari M, 2004, J BONE JOINT SURG AM, V86A, P1012, DOI 10.2106/00004623-200405000-00019; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Case DO, 2000, J AM SOC INFORM SCI, V51, P635, DOI 10.1002/(SICI)1097-4571(2000)51:7<635::AID-ASI6>3.0.CO;2-H; Garcia-Berthou Emili, 2004, BMC Med Res Methodol, V4, P13, DOI 10.1186/1471-2288-4-13; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Garfield E, 1996, SCIENTIST, V10, P13; GARFIELD E, 1979, CITATION INDEXING; GILBERT GN, 1977, SOC STUD SCI, V7, P113; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2004, FASEB J, V18, P936, DOI 10.1096/fj.03-1394lfe; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Mervis J, 2006, SCIENCE, V312, P829; Montori VM, 2003, BMC MED, V1, DOI 10.1186/1741-7015-1-2; Ojima DS, 2006, SCIENCE, V312, P1470; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Patterson M, 2005, PLOS BIOL, V3, P545, DOI 10.1371/journal.pbio.0030129; SARAMAGO J, 2003, HOMEM DUPLICADO; *THOMS SCI I SCI I, ESS SCI IND MOD; Wong BBM, 2005, TRENDS ECOL EVOL, V20, P475, DOI 10.1016/j.tree.2005.07.003	25	73	74	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e5	10.1371/journal.pone.0000005	http://dx.doi.org/10.1371/journal.pone.0000005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183679	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600005
J	Jensen, ML; Dave, S; van der Loeff, MS; da Costa, C; Vincent, T; Leligdowicz, A; Benn, CS; Roth, A; Ravn, H; Lisse, IM; Whittle, H; Aaby, P				Jensen, Mette Lundsby; Dave, Sangeeta; van der Loeff, Maarten Schim; da Costa, Carlos; Vincent, Tim; Leligdowicz, Aleksandra; Benn, Christine Stabell; Roth, Adam; Ravn, Henrik; Lisse, Ida Maria; Whittle, Hilton; Aaby, Peter			Vaccinia Scars Associated with Improved Survival among Adults in Rural Guinea-Bissau	PLOS ONE			English	Article							MEASLES IMMUNIZATION; MALIGNANT-MELANOMA; CHILD-MORTALITY; HIV-2 INFECTION; PROVIRUS LOAD; COMMUNITY; SMALLPOX; BCG; VACCINATIONS; COHORT	Background. In urban Guinea-Bissau, adults with a vaccinia scar had better survival but also a higher prevalence of HIV-2 infection. We therefore investigated the association between vaccinia scar and survival and HIV infection in a rural area of Guinea-Bissau. Methodology/Principal Findings. In connection with a study of HIV in rural Guinea-Bissau, we assessed vaccinia and BCG scars in 193 HIV-1 or HIV-2 infected and 174 uninfected participants. Mortality was assessed after 2 1/2-3 years of follow-up. The analyses were adjusted for age, sex, village, and HIV status. The prevalence of vaccinia scar was associated with age, village, and HIV-2 status but not with sex and schooling. Compared with individuals without any scar, individuals with a vaccinia scar had better survival (mortality rate ratio (MR) = 0.22 (95% CI 0.08-0.61)), the MR being 0.19 (95% CI 0.06-0.57) for women and 0.40 (95% CI 0.04-3.74) for men. Estimates were similar for HIV-2 infected and HIV-1 and HIV-2 uninfected individuals. The HIV-2 prevalence was higher among individuals with a vaccinia scar compared to individuals without a vaccinia scar (RR = 1.57 (95% CI 1.02-2.36)). Conclusion. The present study supports the hypothesis that vaccinia vaccination may have a non-specific beneficial effect on adult survival.	[Jensen, Mette Lundsby; da Costa, Carlos; Benn, Christine Stabell; Roth, Adam; Ravn, Henrik; Aaby, Peter] Statens Serum Inst, Projecto Saude Bandim, Bissau, Guinea Bissau; [Dave, Sangeeta; van der Loeff, Maarten Schim; Vincent, Tim; Leligdowicz, Aleksandra; Whittle, Hilton] MRC Labs, Fajara, Gambia; [Lisse, Ida Maria] Herlev Univ Hosp, Dept Pathol, Copenhagen, Denmark	Statens Serum Institut; MRC Laboratory Molecular Biology; University of Copenhagen; Herlev & Gentofte Hospital	Aaby, P (corresponding author), Statens Serum Inst, Projecto Saude Bandim, Bissau, Guinea Bissau.	p.aaby@bandim.org	Leligdowicz, Aleksandra/Q-2494-2016; Leligdowicz, Aleksandra/GLS-9028-2022	Leligdowicz, Aleksandra/0000-0001-6055-4644; Leligdowicz, Aleksandra/0000-0001-6055-4644; Aaby, Peter/0000-0001-8331-1389	British Medical Research Council; Danish Medical Research Council; DANIDA; Novo Nordisk Foundation; Danish National Research Foundation	British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DANIDA; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation(Danmarks Grundforskningsfond)	The study received financial support from the British Medical Research Council and the Danish Medical Research Council, DANIDA, Novo Nordisk Foundation and Danish National Research Foundation. PA holds a research professorship grant from the Novo Nordisk Foundation. These institutions played no role in the conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	AABY P, 1993, AM J EPIDEMIOL, V138, P746, DOI 10.1093/oxfordjournals.aje.a116912; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 1996, AIDS, V10, P1585, DOI 10.1097/00002030-199611000-00019; Aaby P, 2006, VACCINE, V24, P5718, DOI 10.1016/j.vaccine.2006.04.045; Ariyoshi K, 2003, J INFECT DIS, V188, P1648, DOI 10.1086/379780; Ariyoshi K, 1996, J INFECT DIS, V173, P245, DOI 10.1093/infdis/173.1.245; Ashorn P, 2002, ARCH DIS CHILD, V87, P386, DOI 10.1136/adc.87.5.386; Bager P, 2003, J ALLERGY CLIN IMMUN, V111, P1227, DOI 10.1067/mai.2003.1483; Berry N, 2002, AIDS RES HUM RETROV, V18, P1167, DOI 10.1089/08892220260387904; Cox D. R., 1984, ANAL SURVIVAL DATA; Demkowicz WE, 1996, J VIROL, V70, P2627, DOI 10.1128/JVI.70.4.2627-2631.1996; DEMKOWICZ WE, 1993, J VIROL, V67, P1538, DOI 10.1128/JVI.67.3.1538-1544.1993; FINE PEM, 1989, B WORLD HEALTH ORGAN, V67, P35; Frey SE, 2002, NEW ENGL J MED, V346, P1275, DOI 10.1056/NEJMoa013431; Garly ML, 2003, VACCINE, V21, P2782, DOI 10.1016/S0264-410X(03)00181-6; GILAT T, 1987, SCAND J GASTROENTERO, V22, P1009, DOI 10.3109/00365528708991950; GRUFFERMAN S, 1982, JNCI-J NATL CANCER I, V68, P107; HENDERSON DA, 1999, VACCINES, P74; Jaffar S, 2005, AIDS RES HUM RETROV, V21, P560, DOI 10.1089/aid.2005.21.560; Knudsen KM, 1996, INT J EPIDEMIOL, V25, P665, DOI 10.1093/ije/25.3.665; Kolmel KF, 2005, EUR J CANCER, V41, P118, DOI 10.1016/j.ejca.2004.09.023; KOLMEL KF, 1992, MELANOMA RES, V2, P207; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Kurtzke JF, 1997, ACTA NEUROL SCAND, V96, P149; Mercer A, 1990, DIS MORTALITY POPULA; Moore ZS, 2006, LANCET, V367, P425, DOI 10.1016/S0140-6736(06)68143-9; Pfahlberg A, 2002, J INVEST DERMATOL, V119, P570, DOI 10.1046/j.1523-1747.2002.00643.x; Poulsen AG, 2000, SCAND J INFECT DIS, V32, P169, DOI 10.1080/003655400750045286; RICARD D, 1994, AIDS, V8, P977, DOI 10.1097/00002030-199407000-00016; Shann F, 2004, PEDIATR INFECT DIS J, V23, P555, DOI 10.1097/01.inf.0000130155.42392.04; van der Loeff MFS, 2001, AIDS, V15, P2303, DOI 10.1097/00002030-200111230-00012; VELEMA JP, 1991, INT J EPIDEMIOL, V20, P474, DOI 10.1093/ije/20.2.474; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; WILKINS A, 1993, AIDS, V7, P1119, DOI 10.1097/00002030-199308000-00015	34	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e101	10.1371/journal.pone.0000101	http://dx.doi.org/10.1371/journal.pone.0000101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183634	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600100
J	Russell, CA; Real, LA; Smith, DL				Russell, Colin A.; Real, Leslie A.; Smith, David L.			Spatial Control of Rabies on Heterogeneous Landscapes	PLOS ONE			English	Article							RACCOON RABIES; METAPOPULATION DYNAMICS; TRAVELING-WAVES; SPREAD; HIERARCHIES; EPIDEMIC; MODEL	Rabies control in terrestrial wildlife reservoirs relies heavily on an oral rabies vaccine (ORV). In addition to direct ORV delivery to protect wildlife in natural habitats, vaccine corridors have been constructed to control the spread; these corridors are often developed around natural barriers, such as rivers, to enhance the effectiveness of vaccine deployment. However, the question of how to optimally deploy ORV around a river (or other natural barrier) to best exploit the barrier for rabies control has not been addressed using mathematical models. Given an advancing epidemic wave, should the vaccine be distributed on both sides of barrier, behind the barrier, or in front of it? Here, we introduce a new mathematical model for the dynamics of raccoon rabies on a spatially heterogeneous landscape that is both simple and realistic. We demonstrate that the vaccine should always be deployed behind a barrier to minimize the recurrence of subsequent epidemics. Although the oral rabies vaccine is sufficient to induce herd immunity inside the vaccinated area, it simultaneously creates a demographic refuge. When that refuge is in front of a natural barrier, seasonal dispersal from the vaccine corridor into an endemic region sustains epidemic oscillations of raccoon rabies. When the vaccine barrier creates a refuge behind the river, the low permeability of the barrier to host movement limits dispersal of the host population from the protected populations into the rabies endemic area and limits subsequent rabies epidemics.	[Russell, Colin A.] Univ Cambridge, Dept Zool, Cambridge, England; [Real, Leslie A.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Smith, David L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Cambridge; Emory University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Russell, CA (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	car44@cam.ac.uk	Smith, David L/L-8850-2013; Russell, Colin/ABE-7106-2020	Smith, David L/0000-0003-4367-3849; Russell, Colin/0000-0002-2113-162X	Gates Cambridge Trust	Gates Cambridge Trust	Funding: This work was supported by a Gates Cambridge Trust Fellowship to CAR.	ANDERSON RM, 1986, NATURE, V322, P304, DOI 10.1038/322304a0; Bourhy H, 1999, J GEN VIROL, V80, P2545, DOI 10.1099/0022-1317-80-10-2545; BROADFOOT J, 2000, ECOLOGICAL APPL, V11, P295; Childs JE, 2000, P NATL ACAD SCI USA, V97, P13666, DOI 10.1073/pnas.240326697; COYNE MJ, 1989, AM J VET RES, V50, P2148; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; KAUFMANN J, 1982, WILD MAMMALS N AM BI; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Krebs J W, 1998, J Public Health Manag Pract, V4, P56; Lucey BT, 2002, VECTOR-BORNE ZOONOT, V2, P77, DOI 10.1089/153036602321131878; MURRAY JD, 1986, PROC R SOC SER B-BIO, V229, P111, DOI 10.1098/rspb.1986.0078; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Roscoe DE, 1998, J WILDLIFE DIS, V34, P752, DOI 10.7589/0090-3558-34.4.752; Russell CA, 2005, PLOS BIOL, V3, P382, DOI 10.1371/journal.pbio.0030088; Selhorst T, 1999, ECOL MODEL, V124, P221, DOI 10.1016/S0304-3800(99)00170-2; Smith DL, 2005, PREV VET MED, V71, P225, DOI 10.1016/j.prevetmed.2005.07.009; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; SMITH G, 1995, J AM VET MED ASSOC, V208, P1666; SMITH GC, 2002, ECOLOGICAL MODELLING, V150, P129; Thulke HH, 1999, ECOL MODEL, V117, P179, DOI 10.1016/S0304-3800(98)00198-7; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	25	51	53	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e27	10.1371/journal.pone.0000027	http://dx.doi.org/10.1371/journal.pone.0000027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183654	gold, Green Published			2022-12-27	WOS:000207443600027
J	Strathdee, D; Ibbotson, H; Grant, SGN				Strathdee, Douglas; Ibbotson, Helen; Grant, Seth G. N.			Expression of Transgenes Targeted to the Gt(ROSA)26Sor Locus Is Orientation Dependent	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; HPRT LOCUS; TRANSCRIPTIONAL INTERFERENCE; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; MOUSE; MICE; ACTIVATION; PROMOTERS	Background. Targeting transgenes to a chosen location in the genome has a number of advantages. A single copy of the DNA construct can be inserted by targeting into regions of chromatin that allow the desired developmental and tissue-specific expression of the transgene. Methodology. In order to develop a reliable system for reproducibly expressing trangenes it was decided to insert constructs at the Gt(ROSA)26Sor locus. A cytomegalovirus (CMV) promoter was used to drive expression of the Tetracycline (tet) transcriptional activator, rtTA2(s)-M2, and test the effectiveness of using the ROSA26 locus to allow transgene expression. The tet operator construct was inserted into one allele of ROSA26 and a tet responder construct controlling expression of EGFP was inserted into the other allele. Conclusions. Expression of the targeted transgenes was shown to be affected by both the presence of selectable marker cassettes and by the orientation of the transgenes with respect to the endogenous ROSA26 promoter. These results suggest that transcriptional interference from the endogenous gene promoter or from promoters in the selectable marker cassettes may be affecting transgene expression at the locus. Additionally we have been able to determine the optimal orientation for transgene expression at the ROSA26 locus.	[Strathdee, Douglas; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Cambridge, England; [Strathdee, Douglas; Ibbotson, Helen; Grant, Seth G. N.] Univ Edinburgh, Neurosci Res Ctr, Edinburgh, Midlothian, Scotland	Wellcome Trust Sanger Institute; University of Edinburgh	Strathdee, D (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	ds10@sanger.ac.uk		Grant, Seth/0000-0001-8732-8735	Gatsby Charitable Foundation; Wellcome Trust	Gatsby Charitable Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Gatsby Charitable Foundation and the Wellcome Trust.	Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Bagchi B, 2006, CELL BIOL INT, V30, P505, DOI 10.1016/j.cellbi.2006.01.008; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Bryja V, 2003, REPROD NUTR DEV, V43, P477, DOI 10.1051/rnd:2004001; Chiaromonte F, 2003, GENOME RES, V13, P2602, DOI 10.1101/gr.1169203; Chung SM, 2002, STEM CELLS, V20, P139, DOI 10.1634/stemcells.20-2-139; CLARK AJ, 1994, REPROD FERT DEVELOP, V6, P589, DOI 10.1071/RD9940589; Cvetkovic B, 2000, J BIOL CHEM, V275, P1073, DOI 10.1074/jbc.275.2.1073; Dorer DR, 1997, TRANSGENIC RES, V6, P3, DOI 10.1023/A:1018460413680; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Evans V, 2000, PHYSIOL GENOMICS, V2, P67, DOI 10.1152/physiolgenomics.2000.2.2.67; Feng YQ, 2005, MOL CELL BIOL, V25, P3864, DOI 10.1128/MCB.25.10.3864-3874.2005; Fiering S, 1999, METHOD ENZYMOL, V306, P42; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Greger IH, 1998, NUCLEIC ACIDS RES, V26, P1294, DOI 10.1093/nar/26.5.1294; Guillot PV, 2000, PHYSIOL GENOMICS, V2, P77, DOI 10.1152/physiolgenomics.2000.2.2.77; Hasegawa K, 2002, FEBS LETT, V520, P47, DOI 10.1016/S0014-5793(02)02761-8; Heaney JD, 2004, GENOMICS, V83, P1072, DOI 10.1016/j.ygeno.2003.12.015; Herrera FJ, 2004, J VIROL, V78, P9689, DOI 10.1128/JVI.78.18.9689-9696.2004; Kisseberth WC, 1999, DEV BIOL, V214, P128, DOI 10.1006/dbio.1999.9417; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Liu WM, 2006, J MOL MED, V84, P57, DOI 10.1007/s00109-005-0711-z; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Misra RP, 2002, ENDOCRINE, V19, P229, DOI 10.1385/ENDO:19:3:229; Miyazaki S, 2005, BIOCHEM BIOPH RES CO, V338, P1083, DOI 10.1016/j.bbrc.2005.10.054; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Yata Y, 2003, HEPATOLOGY, V37, P267, DOI 10.1053/jhep.2003.50067; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	43	43	50	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e4	10.1371/journal.pone.0000004	http://dx.doi.org/10.1371/journal.pone.0000004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183668	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600004
J	Malhi, RS; Sickler, B; Lin, DW; Satkoski, J; Tito, RY; George, D; Kanthaswamy, S; Smith, DG				Malhi, Ripan S.; Sickler, Brad; Lin, Dawei; Satkoski, Jessica; Tito, Raul Y.; George, Debbie; Kanthaswamy, Sreetharan; Smith, David Glenn			MamuSNP: A Resource for Rhesus Macaque (Macaca mulatta) Genomics	PLOS ONE			English	Article								We developed a novel method for identifying SNPs widely distributed throughout the coding and non-coding regions of a genome. The method uses large-scale parallel pyrosequencing technology in combination with bioinformatics tools. We used this method to generate approximately 23,000 candidate SNPs throughout the Macaca mulatta genome. We estimate that over 60% of the SNPs will be of high frequency and useful for mapping QTLs, genetic management, and studies of individual relatedness, whereas other less frequent SNPs may be useful as population specific markers for ancestry identification. We have created a web resource called MamuSNP to view the SNPs and associated information online. This resource will also be useful for researchers using a wide variety of Macaca species in their research.	[Malhi, Ripan S.; Tito, Raul Y.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Malhi, Ripan S.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Kanthaswamy, Sreetharan; Smith, David Glenn] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Satkoski, Jessica; George, Debbie; Smith, David Glenn] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Sickler, Brad; Lin, Dawei] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Malhi, RS (corresponding author), Univ Illinois, Dept Anthropol, 109 Davenport Hall, Urbana, IL 61801 USA.	malhi@uiuc.edu	Tito, Raul/CAG-3546-2022	Tito Tadeo, Raul Yhossef/0000-0001-9660-7621; Malhi, Ripan/0000-0002-1484-0292; Trask, Jessica/0000-0002-9902-8753	NIH [RR05090]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR005090] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	NIH grant RR05090 to DGS	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Doxiadis GGM, 2006, IMMUNOGENETICS, V58, P259, DOI 10.1007/s00251-006-0083-8; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462; Kanthaswamy S, 2006, AM J PRIMATOL, V68, P73, DOI 10.1002/ajp.20207; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SATKOSKI JA, J MED PRIMA IN PRESS; Smith DG, 2007, AM J PRIMATOL, V69, P182, DOI 10.1002/ajp.20337	12	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e438	10.1371/journal.pone.0000438	http://dx.doi.org/10.1371/journal.pone.0000438			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487284	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445800020
J	Bressler, D; Spotswood, N; Whitney, D				Bressler, David; Spotswood, Nicole; Whitney, David			Negative BOLD fMRI Response in the Visual Cortex Carries Precise Stimulus-Specific Information	PLOS ONE			English	Article							FUNCTIONAL MRI; ATTENTIONAL MODULATION; SELECTIVE ATTENTION; NEURAL MECHANISMS; BLOOD-FLOW; AREAS; SUPPRESSION; SEPARATION; STRIATE; FIELD	Sustained positive BOLD (blood oxygen level-dependent) activity is employed extensively in functional magnetic resonance imaging (fMRI) studies as evidence for task or stimulus-specific neural responses. However, the presence of sustained negative BOLD activity (i.e., sustained responses that are lower than the fixation baseline) has remained more difficult to interpret. Some studies suggest that it results from local "blood stealing'' wherein blood is diverted to neurally active regions without a concomitant change of neural activity in the negative BOLD regions. However, other evidence suggests that negative BOLD is a result of local neural suppression. In both cases, regions of negative BOLD response are usually interpreted as carrying relatively little, if any, stimulus-specific information (hence the predominant reliance on positive BOLD activity in fMRI). Here we show that the negative BOLD response resulting from visual stimulation can carry high information content that is stimulus-specific. Using a general linear model (GLM), we contrasted standard flickering stimuli to a fixation baseline and found regions of the visual cortex that displayed a sustained negative BOLD response, consistent with several previous studies. Within these negative BOLD regions, we compared patterns of fMRI activity generated by flickering Gabors that were systematically shifted in position. As the Gabors were shifted further from each other, the correlation in the spatial pattern of activity across a population of voxels (such as the population of V1 voxels that displayed a negative BOLD response) decreased significantly. Despite the fact that the BOLD signal was significantly negative (lower than fixation baseline), these regions were able to discriminate objects separated by less than 0.5 deg (at similar to 10 deg eccentricity). The results suggest that meaningful, stimulus-specific processing occurs even in regions that display a strong negative BOLD response.	[Whitney, David] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Whitney, D (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	dwhitney@ucdavis.edu			National Eye Institute (NEI), NIH; NATIONAL EYE INSTITUTE [R01EY018216] Funding Source: NIH RePORTER	National Eye Institute (NEI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Eye Institute (NEI), NIH.	BECK J, 1985, VISION RES, V25, P1105, DOI 10.1016/0042-6989(85)90099-9; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Chen CC, 2005, NEUROIMAGE, V24, P802, DOI 10.1016/j.neuroimage.2004.09.021; Cohen J.E., 1988, STAT POWER ANAL BEHA; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Devor A, 2005, P NATL ACAD SCI USA, V102, P3822, DOI 10.1073/pnas.0407789102; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; LEVI DM, 1988, VISION RES, V28, P597, DOI 10.1016/0042-6989(88)90109-5; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Macmillan N.A., 2004, DETECTION THEORY USE, DOI DOI 10.4324/9781410611147; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; MCKEE SP, 1984, VISION RES, V24, P25, DOI 10.1016/0042-6989(84)90140-8; MCKEE SP, 1986, VISION RES, V26, P609, DOI 10.1016/0042-6989(86)90009-X; MCKEE SP, 1981, VISION RES, V21, P491, DOI 10.1016/0042-6989(81)90095-X; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muller NG, 2005, VISION RES, V45, P1129, DOI 10.1016/j.visres.2004.11.003; Muller NG, 2004, NEUROREPORT, V15, P977, DOI 10.1097/01.wnr.000012504766941.17; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P11026, DOI 10.1073/pnas.97.20.11026; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Regan David, 2000, HUMAN PERCEPTION OBJ; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Slotnick SD, 2003, NEUROIMAGE, V19, P1602, DOI 10.1016/S1053-8119(03)00187-3; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tootell RBH, 1997, J NEUROSCI, V17, P7060; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; WATT RJ, 1985, VISION RES, V25, P1661, DOI 10.1016/0042-6989(85)90138-5; WESTHEIMER G, 1977, VISION RES, V17, P89, DOI 10.1016/0042-6989(77)90206-1; Whitaker D, 1996, VISION RES, V36, P2957, DOI 10.1016/0042-6989(96)00031-4; Whitaker D, 1998, VISION RES, V38, P3591, DOI 10.1016/S0042-6989(98)00032-7; Whitaker D, 1997, VISION RES, V37, P2207, DOI 10.1016/S0042-6989(97)00030-8; WHITE JM, 1992, VISION RES, V32, P513, DOI 10.1016/0042-6989(92)90243-C; Woolsey TA, 1996, CEREB CORTEX, V6, P647, DOI 10.1093/cercor/6.5.647; YAP YL, 1989, VISION RES, V29, P789, DOI 10.1016/0042-6989(89)90091-6; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	52	58	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e410	10.1371/journal.pone.0000410	http://dx.doi.org/10.1371/journal.pone.0000410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476332	gold, Green Published			2022-12-27	WOS:000207445700012
J	Taubert, D; Grimberg, G; Stenzel, W; Schomig, E				Taubert, Dirk; Grimberg, Gundula; Stenzel, Werner; Schoemig, Edgar			Identification of the Endogenous Key Substrates of the Human Organic Cation Transporter OCT2 and Their Implication in Function of Dopaminergic Neurons	PLOS ONE			English	Article								Background. The etiology of neurodegenerative disorders, such as the accelerated loss of dopaminergic neurons in Parkinson's disease, is unclear. Current hypotheses suggest an abnormal function of the neuronal sodium-dependent dopamine transporter DAT to contribute to cell death in the dopaminergic system, but it has not been investigated whether sodium-independent amine transporters are implicated in the pathogenesis of Parkinson's disease. Methodology/Principal Findings. By the use of a novel tandem-mass spectrometry-based substrate search technique, we have shown that the dopaminergic neuromodulators histidyl-proline diketopiperazine (cyclo(his-pro)) and salsolinol were the endogenous key substrates of the sodium-independent organic cation transporter OCT2. Quantitative real-time mRNA expression analysis revealed that OCT2 in contrast to its related transporters was preferentially expressed in the dopaminergic regions of the substantia nigra where it colocalized with DAT and tyrosine hydroxylase. By assessing cell viability with the MTT reduction assay, we found that salsolinol exhibited a selective toxicity toward OCT2-expressing cells that was prevented by cyclo(hispro). A frequent genetic variant of OCT2 with the amino acid substitution R400C reduced the transport efficiency for the cytoprotective cyclo(his-pro) and thereby increased the susceptibility to salsolinol-induced cell death. Conclusions/Significance. Our findings indicate that the OCT2-regulated interplay between cyclo(his-pro) and salsolinol is crucial for nigral cell integrity and that a shift in transport efficiency may impact the risk of Parkinson's disease.	[Taubert, Dirk; Grimberg, Gundula; Schoemig, Edgar] Univ Cologne, Hosp Med, Dept Pharmacol, Cologne, Germany; [Stenzel, Werner] Univ Cologne, Hosp Med, Div Neuropathol, Cologne, Germany	University of Cologne; University of Cologne	Taubert, D (corresponding author), Univ Cologne, Hosp Med, Dept Pharmacol, Cologne, Germany.	dirk.taubert@medizin.uni-koeln.de		Stenzel, Werner/0000-0002-1143-2103				AntkiewiczMichaluk L, 1997, BIOL PSYCHIAT, V42, P514, DOI 10.1016/S0006-3223(96)00408-8; AUGUSTIN M, 1966, J PRAKT CHEM, V32, P158, DOI 10.1002/prac.19660320307; Busch AE, 1998, MOL PHARMACOL, V54, P342, DOI 10.1124/mol.54.2.342; Caccamo D, 2004, AMINO ACIDS, V27, P373, DOI 10.1007/s00726-004-0117-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Grundemann D, 1998, J BIOL CHEM, V273, P30915, DOI 10.1074/jbc.273.47.30915; Grundemann D, 1997, J BIOL CHEM, V272, P10408; HATZOPOULOS AK, 1990, DEVELOPMENT, V109, P349; Hayer-Zillgen M, 2002, BRIT J PHARMACOL, V136, P829, DOI 10.1038/sj.bjp.0704785; IKEGAMI H, 1990, PEPTIDES, V11, P145, DOI 10.1016/0196-9781(90)90123-M; Jonker JW, 2004, J PHARMACOL EXP THER, V308, P2, DOI 10.1124/jpet.103.053298; Koepsell H, 2004, TRENDS PHARMACOL SCI, V25, P375, DOI 10.1016/j.tips.2004.05.005; Leabman MK, 2002, PHARMACOGENETICS, V12, P395, DOI 10.1097/00008571-200207000-00007; Lesch K. P., 2004, MEMBRANE TRANSPORTER, P349; Mravec B, 2006, PHYSIOL RES, V55, P353, DOI 10.33549/physiolres.930810; Naoi M, 2002, NEUROTOXICOL TERATOL, V24, P579, DOI 10.1016/S0892-0362(02)00211-8; Naoi M, 1997, J NEURAL TRANSM-SUPP, P89; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasad C, 1998, THYROID, V8, P969, DOI 10.1089/thy.1998.8.969; Schomig E, 2006, HANDB EXP PHARM, V175, P151; Storch A, 1999, NEUROCHEM INT, V35, P393, DOI 10.1016/S0197-0186(99)00083-2; Storch A, 2002, BIOCHEM PHARMACOL, V63, P909, DOI 10.1016/S0006-2952(01)00922-4; Taubert D, 2006, CLIN PHARMACOL THER, V80, P486, DOI 10.1016/j.clpt.2006.07.007; Toth BE, 2002, NEUROTOXICOL TERATOL, V24, P655, DOI 10.1016/S0892-0362(02)00216-7	26	46	47	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e385	10.1371/journal.pone.0000385	http://dx.doi.org/10.1371/journal.pone.0000385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460754	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445600001
J	Nato, F; Phalipon, A; Lan, PTN; Diep, TT; Sansonetti, P; Germani, Y				Nato, Faridabano; Phalipon, Armelle; Lan Phuong Thi Nguyen; Diep, Tai The; Sansonetti, Philippe; Germani, Yves			Dipstick for Rapid Diagnosis of Shigella flexneri 2a in Stool	PLOS ONE			English	Article							ENTEROINVASIVE ESCHERICHIA-COLI; VIBRIO-CHOLERAE O1; B-CELL EPITOPES; DYSENTERY PATIENTS; PCR ASSAY; INVASION; IDENTIFICATION; ANTIGEN; AMPLIFICATION; SURVEILLANCE	Background. Shigellosis or bacillary dysentery, an acute bloody diarrhoea, is a major public health burden in developing countries. In the absence of prompt and appropriate treatment, the infection is often fatal, particularly in young malnourished children. Here, we describe a new diagnostic test for rapid detection, in stool, at the bedside of patients, of Shigella flexneri 2a, the most predominant agent of the endemic form of the disease. Methodology/Principal Findings. The test is based on the detection of S. flexneri 2a lipopolysaccharide (LPS) using serotype 2a-specific monoclonal antibodies coupled to gold particles and displayed on one-step immunochromatographic dipstick. A concentration as low as 20 ng/ml of LPS is detected in distilled water and in reconstituted stools in under 15 minutes. The threshold of detection corresponds to a concentration of 5 x 10(7) CFU/ml of S. flexneri 2a, which provides an unequivocal positive reaction in three minutes in distilled water and reconstituted stools. The specificity is 100% when tested with a battery of Shigella and unrelated strains, in culture. When tested in Vietnam, on clinical samples, the specificity and sensitivity were 99.2 and 91.5%, respectively. A decrease of the sensitivity during the evaluation on stool samples was observed after five weeks at room temperature and was due to moistening of the dipsticks caused by the humidity of the air during the fifth week of the evaluation. This drawback is now overcome by improving the packaging and providing dipsticks individually wrapped in waterproof bags. Conclusion. This simple dipstick-bases test represents a powerful tool for case management and epidemiological surveys.	[Phalipon, Armelle; Sansonetti, Philippe; Germani, Yves] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Phalipon, Armelle; Sansonetti, Philippe; Germani, Yves] INSERM, U786, Paris, France; [Lan Phuong Thi Nguyen; Diep, Tai The] Inst Pasteur, Ho Chi Minh City, Vietnam	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Germani, Y (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.	ygermani@pasteur.fr	Diep, Tai/ABG-9477-2021	Diep, Tai/0000-0001-7166-6369; Nguyen Thi Phuong, Lan/0000-0003-4027-6872	Institut Pasteur, Paris [ACIP, PTR 179]; TOTAL SA	Institut Pasteur, Paris; TOTAL SA(Total SA)	This work was supported by the Institut Pasteur, Paris (grant ACIP and PTR 179). Part of the work was funded by a grant from TOTAL SA.	BARZU S, 1993, INFECT IMMUN, V61, P3825, DOI 10.1128/IAI.61.9.3825-3831.1993; Bhuiyan NA, 2003, J CLIN MICROBIOL, V41, P3939, DOI 10.1128/JCM.41.8.3939-3941.2003; BRENNER DJ, 1984, INT J SYST BACTERIOL, V34, P87, DOI 10.1099/00207713-34-1-87; Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2; Chanteau S, 2006, PLOS MED, V3, P1579, DOI 10.1371/journal.pmed.0030337; Chompook P, 2005, B WORLD HEALTH ORGAN, V83, P739; Diniz-Santos Daniel R., 2005, Braz J Infect Dis, V9, P77, DOI 10.1590/S1413-86702005000100013; FRANKEL G, 1990, J INFECT DIS, V161, P1252, DOI 10.1093/infdis/161.6.1252; Gaudio PA, 1997, J INFECT DIS, V176, P1013, DOI 10.1086/516531; Germani Y, 1998, AM J TROP MED HYG, V59, P1008, DOI 10.4269/ajtmh.1998.59.1008; Houng HSH, 1997, DIAGN MICR INFEC DIS, V28, P19, DOI 10.1016/S0732-8893(97)89154-7; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lee LA, 1995, B WORLD HEALTH ORGAN, V73, P779; Legros D, 1999, TROP MED INT HEALTH, V4, P428, DOI 10.1046/j.1365-3156.1999.00413.x; LINDBERG AA, REV INFECT DIS S4, V13, pS279; Nato F, 2003, CLIN DIAGN LAB IMMUN, V10, P476, DOI 10.1128/CDLI.10.3.476-478.2003; Nguyen TV, 2006, INT J INFECT DIS, V10, P298, DOI 10.1016/j.ijid.2005.05.009; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; Phalipon A, 2006, J IMMUNOL, V176, P1686, DOI 10.4049/jimmunol.176.3.1686; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; Sansonetti PJ, 1999, CLIN INFECT DIS, V28, P466, DOI 10.1086/515150; SETHABUTR O, 1994, J DIARRHOEAL DIS RES, V12, P265; SETHABUTR O, 1993, J INFECT DIS, V167, P458, DOI 10.1093/infdis/167.2.458; Shears P, 1996, ANN TROP MED PARASIT, V90, P105, DOI 10.1080/00034983.1996.11813034; TAYLOR WI, 1975, J CLIN MICROBIOL, V2, P281; Thiem VD, 2004, J CLIN MICROBIOL, V42, P2031, DOI 10.1128/JCM.42.5.2031-2035.2004; Toma C, 2003, J CLIN MICROBIOL, V41, P2669, DOI 10.1128/JCM.41.6.2669-2671.2003; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; *WHO, 2005, WEEKLY EPIDEMIOLOGIC, V80, P93; Wierzba TF, 2006, AM J TROP MED HYG, V74, P148, DOI 10.4269/ajtmh.2006.74.148	32	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e361	10.1371/journal.pone.0000361	http://dx.doi.org/10.1371/journal.pone.0000361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440606	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445500001
J	Pfister, P; Randall, J; Montoya-Burgos, JI; Rodriguez, I				Pfister, Patrick; Randall, Jerome; Montoya-Burgos, Juan I.; Rodriguez, Ivan			Divergent Evolution among Teleost V1r Receptor Genes	PLOS ONE			English	Article								The survival of vertebrate species is dependent on the ability of individuals to adequately interact with each other, a function often mediated by the olfactory system. Diverse olfactory receptor repertoires are used by this system to recognize chemicals. Among these receptors, the V1rs, encoded by a very large gene family in most mammals, are able to detect pheromones. Teleosts, which also express V1r receptors, possess a very limited V1r repertoire. Here, taking advantage of the possibility to unequivocally identify V1r orthologs in teleosts, we analyzed the olfactory expression and evolutionary constraints of a pair of clustered fish V1r receptor genes, V1r1 and V1r2. Orthologs of the two genes were found in zebrafish, medaka, and threespine stickleback, but a single representative was observed in tetraodontidae species. Analysis of V1r1 and V1r2 sequences from 12 different euteleost species indicate different evolutionary rates between the two paralogous genes, leading to a highly conserved V1r2 gene and a V1r1 gene under more relaxed selective constraint. Moreover, positively-selected sites were detected in specific branches of the V1r1 clade. Our results suggest a conserved agonist specificity of the V1R2 receptor between euteleost species, its loss in the tetraodontidae lineage, and the acquisition of different chemosensory characteristics for the V1R1 receptor.	[Pfister, Patrick; Randall, Jerome; Montoya-Burgos, Juan I.; Rodriguez, Ivan] Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland; [Pfister, Patrick; Randall, Jerome; Rodriguez, Ivan] Univ Geneva, Natl Ctr Competence Res Frontiers Genet, Geneva, Switzerland	University of Geneva; University of Geneva	Rodriguez, I (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Geneva, Switzerland.	ivan.rodriguez@zoo.unige.ch		Pfister, Patrick/0000-0002-1192-8600; Montoya-Burgos, Juan I./0000-0001-9080-9820; rodriguez, ivan/0000-0002-6468-0565	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation.	Alioto TS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-173; Alioto TS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-309; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bjarndottir TK, 2005, GENE, V362, P70, DOI 10.1016/j.gene.2005.07.029; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; Chen WJ, 2004, TRENDS GENET, V20, P424, DOI 10.1016/j.tig.2004.07.005; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; CrnogoracJurcevic T, 1997, GENOMICS, V41, P177, DOI 10.1006/geno.1997.4646; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Gloriam DEI, 2005, MOL PHYLOGENET EVOL, V35, P470, DOI 10.1016/j.ympev.2004.12.003; Grus WE, 2005, P NATL ACAD SCI USA, V102, P5767, DOI 10.1073/pnas.0501589102; Grus WE, 2004, GENE, V340, P303, DOI 10.1016/j.gene.2004.07.037; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hashiguchi Y, 2005, GENE, V362, P19, DOI 10.1016/j.gene.2005.07.044; Lane RP, 2004, GENOME RES, V14, P603, DOI 10.1101/gr.2117004; Lane RP, 2002, P NATL ACAD SCI USA, V99, P291, DOI 10.1073/pnas.012608399; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Mundy NI, 2003, MOL BIOL EVOL, V20, P1805, DOI 10.1093/molbev/msg192; Pfister P, 2005, P NATL ACAD SCI USA, V102, P5489, DOI 10.1073/pnas.0402581102; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shi P, 2005, J MOL EVOL, V60, P566, DOI 10.1007/s00239-004-0172-y; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Suga H, 1999, J MOL EVOL, V48, P646, DOI 10.1007/PL00006508; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Young JM, 2005, GENOME RES, V15, P231, DOI 10.1101/gr.3339905; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang XM, 2004, GENOMICS, V83, P802, DOI 10.1016/j.ygeno.2003.10.009	39	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e379	10.1371/journal.pone.0000379	http://dx.doi.org/10.1371/journal.pone.0000379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440615	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445500010
J	Gomez-Zurita, J; Hunt, T; Kopliku, F; Vogler, AP				Gomez-Zurita, Jesus; Hunt, Toby; Kopliku, Fatos; Vogler, Alfried P.			Recalibrated Tree of Leaf Beetles (Chrysomelidae) Indicates Independent Diversification of Angiosperms and Their Insect Herbivores	PLOS ONE			English	Article							MOLECULAR SYSTEMATICS; INORDINATE FONDNESS; SEQUENCE ALIGNMENT; DIVERGENCE TIMES; PLANTS; PHYLOGENIES; COLEOPTERA; BIOGEOGRAPHY; COEVOLUTION; LIKELIHOOD	Background. The great diversity of the "Phytophaga" (weevils, longhorn beetles and leaf beetles) has been attributed to their co-radiation with the angiosperms based on matching age estimates for both groups, but phylogenetic information and molecular clock calibrations remain insufficient for this conclusion. Methodology. A phylogenetic analysis of the leaf beetles (Chrysomelidae) was conducted based on three partial ribosomal gene markers (mitochondrial rrnL, nuclear small and large subunit rRNA) including over 3000 bp for 167 taxa representing most major chrysomelid lineages and outgroups. Molecular clock calibrations and confidence intervals were based on paleontological data from the oldest (K-T boundary) leaf beetle fossil, ancient feeding traces ascribed to hispoid Cassidinae, and the vicariant split of Nearctic and Palearctic members of the Timarchini. Principal Findings. The origin of the Chrysomelidae was dated to 73-79 Mya (confidence interval 63-86 Mya), and most subfamilies were post-Cretaceous, consistent with the ages of all confirmed body fossils. Two major monocot feeding chrysomelid lineages formed widely separated clades, demonstrating independent colonization of this ancient (early Cretaceous) angiosperm lineage. Conclusions. Previous calibrations proposing a much older origin of Chrysomelidae were not supported. Therefore, chrysomelid beetles likely radiated long after the origin of their host lineages and their diversification was driven by repeated radiaton on a pre-existing diverse resource, rather than ancient host associations.	[Gomez-Zurita, Jesus; Hunt, Toby; Kopliku, Fatos; Vogler, Alfried P.] Nat Hist Museum, Dept Entomol, London SW7 5BD, England; [Gomez-Zurita, Jesus; Hunt, Toby; Kopliku, Fatos; Vogler, Alfried P.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England; [Gomez-Zurita, Jesus] Zool Staatssammlung Munchen, Munich, Germany	Natural History Museum London; Imperial College London	Gomez-Zurita, J (corresponding author), Nat Hist Museum, Dept Entomol, Cromwell Rd, London SW7 5BD, England.	jgzurita@um.es	Gomez-Zurita, Jesus/C-4248-2008	Gomez-Zurita, Jesus/0000-0001-7337-6541; Hunt, Toby/0000-0001-8377-0841	Marie Curie Action [HPMF-CT-2000-00744]; Humboldt Research Fellowship; NERC CASE studentship; Leverhulme Trust [F/969/H]	Marie Curie Action(European Commission); Humboldt Research Fellowship(Alexander von Humboldt Foundation); NERC CASE studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust)	Funding: This study benefited from Marie Curie Action HPMF-CT-2000-00744 and a Humboldt Research Fellowship to JGZ, a NERC CASE studentship to TH, and Leverhulme Trust grant F/969/H to APV and P. Hammond.	[Anonymous], 2005, PHYLIP PHYLOGENY INF; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; Barraclough TG, 1998, CURR BIOL, V8, pR843, DOI 10.1016/S0960-9822(07)00527-1; Barrett PM, 2000, TRENDS ECOL EVOL, V15, P99, DOI 10.1016/S0169-5347(99)01782-6; Becerra JX, 2003, P NATL ACAD SCI USA, V100, P12804, DOI 10.1073/pnas.2133013100; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; BLAY JAS, 1994, NOVEL ASPECTS BIOL C, P1; Bremer K, 2000, P NATL ACAD SCI USA, V97, P4707, DOI 10.1073/pnas.080421597; Carpenter F. M., 1992, TREATISE INVERTEBR R; Chase MW, 2004, AM J BOT, V91, P1645, DOI 10.3732/ajb.91.10.1645; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Crowson R.A., 1981, BIOL COLEOPTERA, P802; Duckett Catherine N., 2004, P3; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Erber D., 1988, BIOL CHRYSOMELIDAE, P513, DOI DOI 10.1007/978-94-009-3105-3_; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Farrell BD, 2004, EVOLUTION, V58, P1984; Friis EM, 2004, P NATL ACAD SCI USA, V101, P16565, DOI 10.1073/pnas.0407174101; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Giannini NP, 2003, CLADISTICS, V19, P496, DOI 10.1111/j.1096-0031.2003.tb00385.x; Gomez-Zurita J, 2005, MOL PHYLOGENET EVOL, V34, P584, DOI 10.1016/j.ympev.2004.11.022; Gomez-Zurita J, 2004, MOL PHYLOGENET EVOL, V32, P647, DOI 10.1016/j.ympev.2004.02.009; Grimaldi David, 2005, pi; Grove SJ, 2000, INVERTEBR TAXON, V14, P733, DOI 10.1071/IT00023; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAMMOND PM, 1992, GLOBAL BIODIVERSITY, V17; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Jolivet P, 2002, BIOL LEAF BEETLES; Labandeira Conrad C., 2002, P26; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; Magallon SA, 2004, INT J PLANT SCI, V165, pS7, DOI 10.1086/383336; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Mantovani A., 2005, P153; Marvaldi AE, 2002, SYST BIOL, V51, P761, DOI 10.1080/10635150290102465; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; MEDVEDEV LN, 1968, S JURASSIC INSECTS K, P155; MITTER C, 1991, INSECT PLANT INTERAC, V3, P35; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Napp Dilma Solange, 1994, Revista Brasileira de Entomologia, V38, P265; Ogden TH, 2005, CLADISTICS, V21, P295, DOI 10.1111/j.1096-0031.2005.00061.x; Poinar Jr. G.O., 1999, AMBER FOREST; Ponomarenko A.G., 1995, P155; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reid C.A.M., 1995, P559; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Shull VL, 2001, SYST BIOL, V50, P945, DOI 10.1080/106351501753462894; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Svacha P, 1997, ANN SOC ENTOMOL FR, V33, P323; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; WHEELER WC, 2002, POY VERSION 3 0; Wilf P, 2000, SCIENCE, V289, P291, DOI 10.1126/science.289.5477.291	55	125	148	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2007	2	4							e360	10.1371/journal.pone.0000360	http://dx.doi.org/10.1371/journal.pone.0000360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DT	17426809	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445400001
J	Rodriguez-Molina, VM; Aertsen, A; Heck, DH				Rodriguez-Molina, Victor M.; Aertsen, Ad; Heck, Detlef H.			Spike Timing and Reliability in Cortical Pyramidal Neurons: Effects of EPSC Kinetics, Input Synchronization and Background Noise on Spike Timing	PLOS ONE			English	Article								In vivo studies have shown that neurons in the neocortex can generate action potentials at high temporal precision. The mechanisms controlling timing and reliability of action potential generation in neocortical neurons, however, are still poorly understood. Here we investigated the temporal precision and reliability of spike firing in cortical layer V pyramidal cells at near-threshold membrane potentials. Timing and reliability of spike responses were a function of EPSC kinetics, temporal jitter of population excitatory inputs, and of background synaptic noise. We used somatic current injection to mimic population synaptic input events and measured spike probability and spike time precision (STP), the latter defined as the time window (Delta t) holding 80% of response spikes. EPSC rise and decay times were varied over the known physiological spectrum. At spike threshold level, EPSC decay time had a stronger influence on STP than rise time. Generally, STP was highest (<= 2.45 ms) in response to synchronous compounds of EPSCs with fast rise and decay kinetics. Compounds with slow EPSC kinetics (decay time constants>6 ms) triggered spikes at lower temporal precision (>= 6.58 ms). We found an overall linear relationship between STP and spike delay. The difference in STP between fast and slow compound EPSCs could be reduced by incrementing the amplitude of slow compound EPSCs. The introduction of a temporal jitter to compound EPSCs had a comparatively small effect on STP, with a tenfold increase in jitter resulting in only a five fold decrease in STP. In the presence of simulated synaptic background activity, precisely timed spikes could still be induced by fast EPSCs, but not by slow EPSCs.	[Heck, Detlef H.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Rodriguez-Molina, Victor M.; Aertsen, Ad] Univ Freiburg, Inst Biol 3, Dept Neurobiol & Biophys, D-7800 Freiburg, Germany; [Rodriguez-Molina, Victor M.] Univ Autonoma Estado Morelos, Fac Med, Cuernavaca, Morelos, Mexico; [Aertsen, Ad] Univ Freiburg, Bernstein Ctr Computat Neurosci, Freiburg, Germany	University of Tennessee System; University of Tennessee Health Science Center; University of Freiburg; Universidad Autonoma del Estado de Morelos; University of Freiburg	Heck, DH (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	dheck@utmem.edu	Heck, Detlef/GPS-4854-2022	Heck, Detlef/0000-0003-2438-4064	German Research Foundation [DFG-SFB505]; German Academic Exchange Service (DAAD)	German Research Foundation(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Funding for this study was provided by the German Research Foundation (DFG-SFB505); V. M. R. was supported by the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1982, ISRAEL J MED SCI, V18, P83; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azouz R, 1999, J NEUROSCI, V19, P2209; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Boucsein C, 2005, J NEUROPHYSIOL, V94, P2948, DOI 10.1152/jn.00245.2005; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; COPE TC, 1987, J PHYSIOL-LONDON, V390, P161, DOI 10.1113/jphysiol.1987.sp016692; DAYHOFF JE, 1983, J NEUROPHYSIOL, V49, P1334, DOI 10.1152/jn.1983.49.6.1334; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2000, NEUROCOMPUTING, V32, P113, DOI 10.1016/S0925-2312(00)00151-X; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Grande LA, 2004, J NEUROSCI, V24, P1839, DOI 10.1523/JNEUROSCI.3500-03.2004; GUSTAFSSON B, 1984, J PHYSIOL-LONDON, V347, P431, DOI 10.1113/jphysiol.1984.sp015074; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; JACK JJB, 1971, J PHYSIOL-LONDON, V215, P283, DOI 10.1113/jphysiol.1971.sp009472; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; Marom S, 1998, J MEMBRANE BIOL, V161, P105, DOI 10.1007/s002329900318; NICOLL A, 1993, J PHYSIOL-LONDON, V468, P693, DOI 10.1113/jphysiol.1993.sp019795; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Poliakov AV, 1997, J PHYSIOL-LONDON, V504, P401, DOI 10.1111/j.1469-7793.1997.401be.x; Powers RK, 2000, J NEUROPHYSIOL, V83, P483, DOI 10.1152/jn.2000.83.1.483; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Shadlen M N, 1995, Curr Opin Neurobiol, V5, P248, DOI 10.1016/0959-4388(95)80033-6; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Stricker C, 1996, J PHYSIOL-LONDON, V490, P419, DOI 10.1113/jphysiol.1996.sp021155; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1998, J NEUROSCI, V18, P3501; Toib A, 1998, J NEUROSCI, V18, P1893; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450; van Rossum MCW, 2003, J NEUROPHYSIOL, V89, P2406, DOI 10.1152/jn.01106.2002; VILLA AEP, 1990, BRAIN RES, V509, P325, DOI 10.1016/0006-8993(90)90558-S; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Zsiros V, 2005, J NEUROPHYSIOL, V93, P3248, DOI 10.1152/jn.01027.2004	59	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e319	10.1371/journal.pone.0000319	http://dx.doi.org/10.1371/journal.pone.0000319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389910	Green Published, gold			2022-12-27	WOS:000207445200002
J	Noble, CG; Song, HW				Noble, Christian G.; Song, Haiwei			MLN51 Stimulates the RNA-Helicase Activity of eIF4AIII	PLOS ONE			English	Article								The core of the exon-junction complex consists of Y14, Magoh, MLN51 and eIF4AIII, a DEAD-box RNA helicase. MLN51 stimulates the ATPase activity of eIF4AIII, whilst the Y14-Magoh complex inhibits it. We show that the MLN51-dependent stimulation increases both the affinity of eIF4AIII for ATP and the rate of enzyme turnover; the KM is decreased by an order of magnitude and k(cat) increases 30 fold. Y14-Magoh do inhibit the MLN51-stimulated ATPase activity, but not back to background levels. The ATP-bound form of the eIF4AIII-MLN51 complex has a 100-fold higher affinity for RNA than the unbound form and ATP hydrolysis reduces this affinity. MLN51 stimulates the RNA-helicase activity of eIF4AIII, suggesting that this activity may be functionally important.	[Noble, Christian G.; Song, Haiwei] Natl Univ Singapore, Inst Mol & Cell Biol, Lab Macromol Struct, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Song, HW (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, Lab Macromol Struct, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	haiwei@imcb.a-star.edu.sg	song, haiwei/H-6082-2011		Agency for Science Technology and Research (A*-Star), Singapore	Agency for Science Technology and Research (A*-Star), Singapore(Agency for Science Technology & Research (A*STAR))	This research was funded by the Agency for Science Technology and Research (A*-Star), Singapore.	Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Degot S, 2002, ONCOGENE, V21, P4422, DOI 10.1038/sj.onc.1205611; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Li QY, 1999, MOL CELL BIOL, V19, P7336; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Noble CG, 2004, NUCLEIC ACIDS RES, V32, P3364, DOI 10.1093/nar/gkh664; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Shi H, 2003, GENE DEV, V17, P971, DOI 10.1101/gad.260403; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012	21	40	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e303	10.1371/journal.pone.0000303	http://dx.doi.org/10.1371/journal.pone.0000303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375189	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445100005
J	Prinz, S; Aldridge, C; Ramsey, SA; Taylor, RJ; Galitski, T				Prinz, Susanne; Aldridge, Christine; Ramsey, Stephen A.; Taylor, R. James; Galitski, Timothy			Control of Signaling in a MAP-kinase Pathway by an RNA-Binding Protein	PLOS ONE			English	Article							PHEROMONE RESPONSE PATHWAY; SACCHAROMYCES-CEREVISIAE; FEEDBACK-REGULATION; MESSENGER-RNAS; PUF FAMILY; YEAST; GROWTH; GENE; RECOVERY; PUMILIO	Signaling-protein mRNAs tend to have long untranslated regions (UTRs) containing binding sites for RNA-binding proteins regulating gene expression. Here we show that a PUF-family RNA-binding protein, Mpt5, represses the yeast MAP-kinase pathway controlling differentiation to the filamentous form. Mpt5 represses the protein levels of two pathway components, the Ste7 MAP-kinase kinase and the Tec1 transcriptional activator, and negatively regulates the kinase activity of the Kss1 MAP kinase. Moreover, Mpt5 specifically inhibits the output of the pathway in the absence of stimuli, and thereby prevents inappropriate cell differentiation. The results provide an example of what may be a genome-scale level of regulation at the interface of signaling networks and protein-RNA binding networks.	[Prinz, Susanne; Aldridge, Christine; Ramsey, Stephen A.; Taylor, R. James; Galitski, Timothy] Inst Syst Biol, Seattle, WA USA; [Taylor, R. James; Galitski, Timothy] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Institute for Systems Biology (ISB); University of British Columbia	Galitski, T (corresponding author), Inst Syst Biol, Seattle, WA USA.	tgalitski@system-sbiology.org			NIH [P50 GM076547, U54 AI054523R]; Michael Smith Foundation; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI054523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Smith Foundation(Michael Smith Foundation for Health Research); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grant P50 GM076547 from NIH. S. A. Ramsey was supported by grant U54 AI054523R from NIH. R.J. Taylor was supported by a junior graduate studentship from the Michael Smith Foundation for Health Research. T. Galitski is a recipient of a Burroughs Wellcome Fund Career Award in the Biomedical Sciences.	Bardwell L, 1998, GENE DEV, V12, P2887, DOI 10.1101/gad.12.18.2887; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Chen TS, 1997, MOL CELL BIOL, V17, P3429, DOI 10.1128/MCB.17.6.3429; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Errede B, 1996, PHILOS T ROY SOC B, V351, P143, DOI 10.1098/rstb.1996.0010; ERREDE B, 1993, NATURE, V362, P261, DOI 10.1038/362261a0; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Guthrie C, 1991, GUIDE YEAST GENETICS; Heikkinen HL, 2003, NUCLEIC ACIDS RES, V31, P4006, DOI 10.1093/nar/gkg474; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hurowitz EH, 2004, GENOME BIOL, V5; Kaeberlein M, 2002, GENETICS, V160, P83; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; KIKUCHI Y, 1994, MOL GEN GENET, V245, P107, DOI 10.1007/BF00279756; LASKO P, 2003, SCI STKE, pRE6; Lin HF, 1997, DEVELOPMENT, V124, P2463; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Ohkuni K, 2006, MOL GENET GENOMICS, V275, P81, DOI 10.1007/s00438-005-0064-x; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Prinz S, 2004, GENOME RES, V14, P380, DOI 10.1101/gr.2020604; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; STEWART MS, 2006, MPT5P STRESS TOLERAN; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Sugiura R, 2003, NATURE, V424, P961, DOI 10.1038/nature01907; Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552; Xu BE, 2001, GENETICS, V159, P1559	43	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e249	10.1371/journal.pone.0000249	http://dx.doi.org/10.1371/journal.pone.0000249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327913	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444600009
J	Dey, S; Joshi, A				Dey, Sutirth; Joshi, Amitabh			Local Perturbations Do Not Affect Stability of Laboratory Fruitfly Metapopulations	PLOS ONE			English	Article							POPULATION STABILITY; SPATIOTEMPORAL CHAOS; DYNAMICS; IMMIGRATION; TRANSIENTS; MIGRATION; MODELS	Background. A large number of theoretical studies predict that the dynamics of spatially structured populations (metapopulations) can be altered by constant perturbations to local population size. However, these studies presume large metapopulations inhabiting noise-free, zero-extinction environments, and their predictions have never been empirically verified. Methodology/Principal Findings. Here we report an empirical study on the effects of localized perturbations on global dynamics and stability, using fruitfly metapopulations in the laboratory. We find that constant addition of individuals to a particular subpopulation in every generation stabilizes that subpopulation locally, but does not have any detectable effect on the dynamics and stability of the metapopulation. Simulations of our experimental system using a simple but widely applicable model of population dynamics were able to recover the empirical findings, indicating the generality of our results. We then simulated the possible consequences of perturbing more subpopulations, increasing the strength of perturbations, and varying the rate of migration, but found that none of these conditions were expected to alter the outcomes of our experiments. Finally, we show that our main results are robust to the presence of local extinctions in the metapopulation. Conclusions/Significance. Our study shows that localized perturbations are unlikely to affect the dynamics of real metapopulations, a finding that has cautionary implications for ecologists and conservation biologists faced with the problem of stabilizing unstable metapopulations in nature.	[Dey, Sutirth; Joshi, Amitabh] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary Biol Lab, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Joshi, A (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary Biol Lab, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India.	ajoshi@jncasr.ac.in			Department of Science and Technology, Government of India; Council for Scientific and Industrial Research, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by funds from the Department of Science and Technology, Government of India, to A. Joshi. S. Dey was supported by a Senior Research Fellowship from the Council for Scientific and Industrial Research, Government of India.	ARANSON I, 1994, PHYS REV LETT, V72, P2561, DOI 10.1103/PhysRevLett.72.2561; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; BRAIMAN Y, 1995, NATURE, V378, P465, DOI 10.1038/378465a0; Brannstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2065, DOI 10.1098/rspb.2005.3185; CHEKE RA, 1993, ECOL ENTOMOL, V18, P109, DOI 10.1111/j.1365-2311.1993.tb01191.x; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Dey S, 2006, J THEOR BIOL, V238, P78, DOI 10.1016/j.jtbi.2005.05.013; Doebeli M, 1997, B MATH BIOL, V59, P497, DOI 10.1016/S0092-8240(96)00097-3; Drake JM, 2005, PLOS BIOL, V3, P1300, DOI 10.1371/journal.pbio.0030222; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Grigoriev RO, 1997, PHYS REV LETT, V79, P2795, DOI 10.1103/PhysRevLett.79.2795; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; GUEMEZ J, 1993, PHYS LETT A, V181, P29, DOI 10.1016/0375-9601(93)91119-P; Gueron S, 1998, PHYS REV E, V57, P3645, DOI 10.1103/PhysRevE.57.3645; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; HASTINGS A, 1994, SCIENCE, V263, P1133, DOI 10.1126/science.263.5150.1133; Henson SM, 2001, SCIENCE, V294, P602, DOI 10.1126/science.1063358; HUNT ER, 1991, PHYS REV LETT, V67, P1953, DOI 10.1103/PhysRevLett.67.1953; Ives AR, 2004, AM NAT, V163, P375, DOI 10.1086/381942; Kaneko K, 1998, ENVIRONM INTELL UNIT, P27; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MCCALLUM HI, 1992, J THEOR BIOL, V154, P277, DOI 10.1016/S0022-5193(05)80170-5; MUELLER LD, 1994, ECOLOGY, V75, P430, DOI 10.2307/1939546; Mueller LD, 2000, ECOLOGY, V81, P1273, DOI 10.1890/0012-9658(2000)081[1273:DPSE]2.0.CO;2; Parekh N, 1998, PHYS REV LETT, V81, P1401, DOI 10.1103/PhysRevLett.81.1401; Parekh N, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036227; PAREKH N, 1999, NONLINEAR DYNAMICS B; PARTHASARATHY S, 1995, PHYS REV E, V51, P6239, DOI 10.1103/PhysRevE.51.6239; Prasad NG, 2003, P ROY SOC B-BIOL SCI, V270, pS84, DOI 10.1098/rsbl.2003.0020; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; RICKER W E, 1975, P382; ROY R, 1992, PHYS REV LETT, V68, P1259, DOI 10.1103/PhysRevLett.68.1259; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; SEPULCHRE JA, 1993, PHYS REV E, V48, P945, DOI 10.1103/PhysRevE.48.945; Sheeba V, 1998, CURR SCI INDIA, V75, P1406; Sheeba V, 1998, J BIOSCIENCE, V23, P93, DOI 10.1007/BF02703000; Sole RV, 1999, B MATH BIOL, V61, P1187, DOI 10.1006/bulm.1999.0141; STONE L, 1993, NATURE, V365, P617, DOI 10.1038/365617a0; Stone L, 1999, THEOR POPUL BIOL, V55, P227, DOI 10.1006/tpbi.1998.1393; von Bremen HF, 2002, APPL MATH COMPUT, V129, P55, DOI 10.1016/S0096-3003(01)00028-5	42	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e233	10.1371/journal.pone.0000233	http://dx.doi.org/10.1371/journal.pone.0000233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311100	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444500014
J	Jiu, M; Zhou, XP; Tong, L; Xu, J; Yang, X; Wan, FH; Liu, SS				Jiu, Min; Zhou, Xue-Ping; Tong, Lin; Xu, Jing; Yang, Xiao; Wan, Fang-Hao; Liu, Shu-Sheng			Vector-Virus Mutualism Accelerates Population Increase of an Invasive Whitefly	PLOS ONE			English	Article							BEMISIA-TABACI HOMOPTERA; GRAIN APHID HOMOPTERA; SPOTTED WILT VIRUS; NON-B-BIOTYPE; GENETIC DIVERSITY; FRANKLINIELLA-OCCIDENTALIS; LIFE-HISTORY; TOMATO; TRANSMISSION; ALEYRODIDAE	The relationships between plant viruses, their herbivore vectors and host plants can be beneficial, neutral, or antagonistic, depending on the species involved. This variation in relationships may affect the process of biological invasion and the displacement of indigenous species by invaders when the invasive and indigenous organisms occur with niche overlap but differ in the interactions. The notorious invasive B biotype of the whitefly complex Bemisia tabaci entered China in the late 1990s and is now the predominant or only biotype in many regions of the country. Tobacco curly shoot virus (TbCSV) and Tomato yellow leaf curl China virus (TYLCCNV) are two whitefly-transmitted begomoviruses that have become widespread recently in south China. We compared the performance of the invasive B and indigenous ZHJ1 whitefly biotypes on healthy, TbCSV-infected and TYLCCNV-infected tobacco plants. Compared to its performance on healthy plants, the invasive B biotype increased its fecundity and longevity by 12 and 6 fold when feeding on TbCSV-infected plants, and by 18 and 7 fold when feeding on TYLCCNV-infected plants. Population density of the B biotype on TbCSV- and TYLCCNV-infected plants reached 2 and 13 times that on healthy plants respectively in 56 days. In contrast, the indigenous ZHJ1 performed similarly on healthy and virus-infected plants. Virus-infection status of the whiteflies per se of both biotypes showed limited effects on performance of vectors on cotton, a nonhost plant of the viruses. The indirect mutualism between the B biotype whitefly and these viruses via their host plants, and the apparent lack of such mutualism for the indigenous whitefly, may contribute to the ability of the B whitefly biotype to invade, the displacement of indigenous whiteflies, and the disease pandemics of the viruses associated with this vector.	[Jiu, Min; Tong, Lin; Xu, Jing; Yang, Xiao; Liu, Shu-Sheng] Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Xue-Ping] Zhejiang Univ, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Liu, SS (corresponding author), Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	shshliu@zju.edu.cn	yang, xiao/K-8509-2013; Liu, Shu-Sheng/D-2300-2013; xu, jing/GRR-8698-2022	Yang, Xiao/0000-0002-2351-4827	National Basic Research and Development Program of China [2002CB111403]; Zhejiang Agricultural Science and Technology Key Research Project [2005C12008-02]	National Basic Research and Development Program of China(National Basic Research Program of China); Zhejiang Agricultural Science and Technology Key Research Project	This study was funded by the National Basic Research and Development Program of China (2002CB111403) and Zhejiang Agricultural Science and Technology Key Research Project (2005C12008-02).	*APPL BIOST INC, 2002, BIOMSTAT STAT SOFTW; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; CASTLE SJ, 1993, ENTOMOL EXP APPL, V69, P51, DOI 10.1007/BF02380673; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; COHEN S, 1966, PHYTOPATHOLOGY, V56, P1127; Colvin J, 2006, ADV VIRUS RES, V67, P419, DOI 10.1016/S0065-3527(06)67011-5; Colvin J, 2004, PLANT PATHOL, V53, P577, DOI 10.1111/j.0032-0862.2004.01062.x; COSTA HS, 1991, ENVIRON ENTOMOL, V20, P1102, DOI 10.1093/ee/20.4.1102; COSTA HS, 1993, INSECT SCI APPL, V14, P255, DOI 10.1017/S1742758400014703; Cui XF, 2004, J VIROL, V78, P13966, DOI 10.1128/JVI.78.24.13966-13974.2004; De Barro PJ, 2000, MOL PHYLOGENET EVOL, V16, P29, DOI 10.1006/mpev.1999.0768; De Barro PJ, 2005, MOL ECOL, V14, P3695, DOI 10.1111/j.1365-294X.2005.02700.x; De Barro PJ, 2005, B ENTOMOL RES, V95, P193, DOI 10.1079/BER2004351; DEANGELIS JD, 1993, ENVIRON ENTOMOL, V22, P1308, DOI 10.1093/ee/22.6.1308; Fauquet CM, 2005, ARCH VIROL, V150, P2151, DOI 10.1007/s00705-005-0583-0; FERERES A, 1989, ENVIRON ENTOMOL, V18, P388, DOI 10.1093/ee/18.3.388; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Jimenez-Martinez ES, 2004, J ECON ENTOMOL, V97, P203, DOI 10.1603/0022-0493-97.2.203; Jiu M, 2006, J PHYTOPATHOL, V154, P587, DOI 10.1111/j.1439-0434.2006.01151.x; Johnson SN, 2003, OECOLOGIA, V134, P388, DOI 10.1007/s00442-002-1139-6; KENNEDY JS, 1951, NATURE, V168, P825, DOI 10.1038/168825a0; Kluth S, 2002, OECOLOGIA, V133, P193, DOI 10.1007/s00442-002-1016-3; Li ZH, 2005, PHYTOPATHOLOGY, V95, P902, DOI 10.1094/PHYTO-95-0902; Li Zheng-Xi, 2005, Insect Science, V12, P421, DOI 10.1111/j.1744-7917.2005.00053.x; Lima LHC, 2002, GENET MOL BIOL, V25, P217, DOI 10.1590/S1415-47572002000200016; Lin Ke-Jian, 2003, Acta Ecologica Sinica, V23, P870; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; McKenzie CL, 2004, FLA ENTOMOL, V87, P403, DOI 10.1653/0015-4040(2004)087[0403:AESOBT]2.0.CO;2; McKenzie CL, 2002, FLA ENTOMOL, V85, P367, DOI 10.1653/0015-4040(2002)085[0367:EOTMVT]2.0.CO;2; McKenzie CL, 2002, ARCH INSECT BIOCHEM, V49, P203, DOI 10.1002/arch.10020; MEHTA P, 1994, J ECON ENTOMOL, V87, P1291, DOI 10.1093/jee/87.5.1291; Morales FJ, 2001, CROP PROT, V20, P825, DOI 10.1016/S0261-2194(01)00114-4; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Perring Thomas M., 1996, P3; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Polston JE, 1997, PLANT DIS, V81, P1358, DOI 10.1094/PDIS.1997.81.12.1358; Qiu Bao-Li, 2003, Acta Entomologica Sinica, V46, P605; QUIROZ C, 1991, J ECON ENTOMOL, V84, P1920, DOI 10.1093/jee/84.6.1920; Rekha AR, 2005, ENTOMOL EXP APPL, V117, P221, DOI 10.1111/j.1570-7458.2005.00352.x; Ribeiro SG, 2003, ARCH VIROL, V148, P281, DOI 10.1007/s00705-002-0917-0; Roca E, 1997, PLANT PATHOL, V46, P407, DOI 10.1046/j.1365-3059.1997.d01-29.x; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Wijkamp I, 1996, ENTOMOL EXP APPL, V81, P285, DOI 10.1007/BF00187037; Wu XX, 2003, PROG NAT SCI-MATER, V13, P276, DOI 10.1360/03jz9049; Xie Y, 2002, CHINESE SCI BULL, V47, P197, DOI 10.1360/02tb9047; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x; Zang Lian-Sheng, 2005, Acta Entomologica Sinica, V48, P742; Zang Lian-Sheng, 2005, Chinese Bulletin of Entomology, V42, P329; Zang LianSheng, 2005, Biodiversity Science, V13, P181, DOI 10.1360/biodiv.040202; Zhang LP, 2005, J APPL ENTOMOL, V129, P121, DOI 10.1111/j.1439-0418.2005.00950.x; Zhou XP, 2003, J GEN VIROL, V84, P237, DOI 10.1099/vir.0.18608-0	56	233	284	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e182	10.1371/journal.pone.0000182	http://dx.doi.org/10.1371/journal.pone.0000182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17264884	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444200006
J	Luxenburg, C; Geblinger, D; Klein, E; Anderson, K; Hanein, D; Geiger, B; Addadi, L				Luxenburg, Chen; Geblinger, Dafna; Klein, Eugenia; Anderson, Karen; Hanein, Dorit; Geiger, Benny; Addadi, Lia			The Architecture of the Adhesive Apparatus of Cultured Osteoclasts: From Podosome Formation to Sealing Zone Assembly	PLOS ONE			English	Article							CELL-SUBSTRATUM ADHESIONS; VITRONECTIN RECEPTOR; ACTIN-CYTOSKELETON; BONE-RESORPTION; ORGANIZATION; DEFICIENCY; INTEGRIN; GELSOLIN	Background. Osteoclasts are bone-degrading cells, which play a central role in physiological bone remodeling. Unbalanced osteoclast activity is largely responsible for pathological conditions such as osteoporosis. Osteoclasts develop specialized adhesion structures, the so-called podosomes, which subsequently undergo dramatic reorganization into sealing zones. These ring-like adhesion structures, which delimit the resorption site, effectively seal the cell to the substrate forming a diffusion barrier. The structural integrity of the sealing zone is essential for the cell ability to degrade bone, yet its structural organization is poorly understood. Principal Findings. Combining high-resolution scanning electron microscopy with fluorescence microscopy performed on the same sample, we mapped the molecular architecture of the osteoclast resorptive apparatus from individual podosomes to the sealing zone, at an unprecedented resolution. Podosomes are composed of an actin-bundle core, flanked by a ring containing adhesion proteins connected to the core via dome-like radial actin fibers. The sealing zone, hallmark of bone-resorbing osteoclasts, consists of a dense array of podosomes communicating through a network of actin filaments, parallel to the substrate and anchored to the adhesive plaque domain via radial actin fibers. Significance. The sealing zone of osteoclasts cultured on bone is made of structural units clearly related to individual podosomes. It differs from individual or clustered podosomes in the higher density and degree of inter-connectivity of its building blocks, thus forming a unique continuous functional structure connecting the cell to its extracellular milieu. Through this continuous structure, signals reporting on the substrate condition may be transmitted to the whole cell, modulating the cell response under physiological and pathological conditions.	[Luxenburg, Chen; Geblinger, Dafna; Addadi, Lia] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Luxenburg, Chen; Geiger, Benny] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Klein, Eugenia] Weizmann Inst Sci, Chem Res Support Unit, IL-76100 Rehovot, Israel; [Anderson, Karen; Hanein, Dorit] Burnham Inst Med Res, Infect Dis & Cell Adhes Programs, La Jolla, CA USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Sanford Burnham Prebys Medical Discovery Institute	Addadi, L (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	lia.addadi@weizmann.ac.il			National Institute of General Medical Sciences (NIGMS), National Institutes of Health Cell Migration Consortium [U54 GM64346]; Women's Health Research Center, WIS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS), National Institutes of Health Cell Migration Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Women's Health Research Center, WIS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Institute of General Medical Sciences (NIGMS), National Institutes of Health Cell Migration Consortium, Grant U54 GM64346 (BG and DH). CL was funded in part by the Women's Health Research Center, WIS.	Akisaka T, 2001, J BONE MINER RES, V16, P1248, DOI 10.1359/jbmr.2001.16.7.1248; Akisaka T, 2006, J ELECTRON MICROSC, V55, P53, DOI 10.1093/jmicro/dfl012; AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chiusaroli R, 2004, MOL BIOL CELL, V15, P234, DOI 10.1091/mbc.e03-04-0207; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; GAVAZZI I, 1989, J CELL SCI, V94, P85; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; LAKKAKORPI PT, 1993, J CELL SCI, V104, P663; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; LUXENBURG C, 2006, J CELL SCI; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; NERMUT MV, 1991, EXP CELL RES, V193, P382, DOI 10.1016/0014-4827(91)90111-7; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Pfaff M, 2001, J CELL SCI, V114, P2775; Rodan GA, 2003, CANCER, V97, P726, DOI 10.1002/cncr.11147; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teti A, 1999, J BONE MINER RES, V14, P2107, DOI 10.1359/jbmr.1999.14.12.2107; TROTTER JA, 1981, EXP CELL RES, V132, P235, DOI 10.1016/0014-4827(81)90099-9; Vaananen HK, 2000, J CELL SCI, V113, P377; VAANANEN HK, 1995, J CELL SCI, V108, P2729; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; ZALLONE AZ, 1989, CONNECT TISSUE RES, V20, P143, DOI 10.3109/03008208909023882; ZAMBONINZALLONE A, 1989, EXP CELL RES, V182, P645, DOI 10.1016/0014-4827(89)90266-8; ZAMBONINZALLONE A, 1988, J BONE MINER RES, V3, P517; Zamir E, 1999, J CELL SCI, V112, P1655	36	218	221	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e179	10.1371/journal.pone.0000179	http://dx.doi.org/10.1371/journal.pone.0000179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17264882	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444200004
J	Waters, PD; Dobigny, G; Waddell, PJ; Robinson, TJ				Waters, Paul D.; Dobigny, Gauthier; Waddell, Peter J.; Robinson, Terence J.			Evolutionary History of LINE-1 in the Major Clades of Placental Mammals	PLOS ONE			English	Article								Background. LINE-1 constitutes an important component of mammalian genomes. It has a dynamic evolutionary history characterized by the rise, fall and replacement of subfamilies. Most data concerning LINE-1 biology and evolution are derived from the human and mouse genomes and are often assumed to hold for all placentals. Methodology. To examine LINE-1 relationships, sequences from the 39 region of the reverse transcriptase from 21 species (representing 13 orders across Afrotheria, Xenarthra, Supraprimates and Laurasiatheria) were obtained from whole genome sequence assemblies, or by PCR with degenerate primers. These sequences were aligned and analysed. Principal Findings. Our analysis reflects accepted placental relationships suggesting mostly lineage-specific LINE-1 families. The data provide clear support for several clades including Glires, Supraprimates, Laurasiatheria, Boreoeutheria, Xenarthra and Afrotheria. Within the afrotherian LINE-1 (AfroLINE) clade, our tree supports Paenungulata, Afroinsectivora and Afroinsectiphillia. Xenarthran LINE-1 (XenaLINE) falls sister to AfroLINE, providing some support for the Atlantogenata (Xenarthra+Afrotheria) hypothesis. Significance. LINEs and SINEs make up approximately half of all placental genomes, so understanding their dynamics is an essential aspect of comparative genomics. Importantly, a tree of LINE-1 offers a different view of the root, as long edges (branches) such as that to marsupials are shortened and/or broken up. Additionally, a robust phylogeny of diverse LINE-1 is essential in testing that site-specific LINE-1 insertions, often regarded as homoplasy-free phylogenetic markers, are indeed unique and not convergent.	[Waters, Paul D.; Dobigny, Gauthier; Robinson, Terence J.] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, Matieland, South Africa; [Waters, Paul D.] Australian Natl Univ, Res Sch Biol Sci, Comparat Genom Grp, Canberra, ACT 2601, Australia; [Dobigny, Gauthier] Ctr Biol Gest Populat, Inst Rech Dev, Montferrier Sur Lez, France; [Waddell, Peter J.] Univ Tokyo, Lab Biometry & Bioinformat, Tokyo, Japan; [Waddell, Peter J.] Univ S Carolina, S Carolina Canc Ctr, Columbia, SC 29208 USA	Stellenbosch University; Australian National University; Institut de Recherche pour le Developpement (IRD); University of Tokyo; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Robinson, TJ (corresponding author), Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, Matieland, South Africa.	tjr@sun.ac.za	Waters, Paul/D-1044-2009; Waters, Paul D/B-7871-2015; Robinson, Terence J./K-7342-2017	Waters, Paul D/0000-0002-4689-8747; Robinson, Terence J./0000-0002-4298-4891	Wellcome Trust; University of Stellenbosch; National Research Foundation [GUN 2053812]; NIH [5R01LM8626]; NATIONAL LIBRARY OF MEDICINE [R01LM008626] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); University of Stellenbosch; National Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Financial support from the Wellcome Trust, the University of Stellenbosch and the National Research Foundation (GUN 2053812) to TJR is gratefully acknowledged. PJW thanks JSPS for support via their fellowship program, NIH grant 5R01LM8626.	Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P225, DOI 10.1016/S1055-7903(03)00118-0; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Cabot EL, 1997, J MOL EVOL, V45, P412, DOI 10.1007/PL00006246; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Delsuc F, 2002, MOL BIOL EVOL, V19, P1656, DOI 10.1093/oxfordjournals.molbev.a003989; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hansen RS, 2003, HUM MOL GENET, V12, P2559, DOI 10.1093/hmg/ddg268; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; MACPHEE RDE, 1993, MAMMAL PHYLOGENY : PLACENTALS, P13; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nikaido M, 2003, MOL BIOL EVOL, V20, P522, DOI 10.1093/molbev/msg052; Nishihara H, 2005, MOL BIOL EVOL, V22, P1823, DOI 10.1093/molbev/msi179; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohshima K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r74; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Robinson TJ, 2004, P ROY SOC B-BIOL SCI, V271, P1477, DOI 10.1098/rspb.2004.2754; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCULLY M, 2001, J MAMM EVOL, V8, P239; Shoshani J, 1998, MOL PHYLOGENET EVOL, V9, P572, DOI 10.1006/mpev.1998.0520; SMIT AF, 1995, J MOL BIOL, V264, P401; Springer MS, 2004, MOL PHYLOGENET EVOL, V30, P883, DOI 10.1016/j.ympev.2003.09.019; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407; SWOFFORD DL, PAUP PHYLOGENETIC AN; Thomsen PD, 1996, MAMM GENOME, V7, P42, DOI 10.1007/s003359900010; Waddell P J, 2001, Genome Inform, V12, P141; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Waddell PJ, 1997, MOL PHYLOGENET EVOL, V8, P398, DOI 10.1006/mpev.1997.0452; Waddell PJ, 1999, SYST BIOL, V48, P31, DOI 10.1080/106351599260427; Waddell PJ, 2003, MOL PHYLOGENET EVOL, V28, P197, DOI 10.1016/S1055-7903(03)00115-5; WADDELL PJ, 1996, HDB SYMBOLIC EVOLUTI, P53; Waters PD, 2004, CHROMOSOMA, V113, P137, DOI 10.1007/s00412-004-0301-9; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891	43	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e158	10.1371/journal.pone.0000158	http://dx.doi.org/10.1371/journal.pone.0000158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225861	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444000009
J	Clarke, E; Reichard, UH; Zuberbuhler, K				Clarke, Esther; Reichard, Ulrich H.; Zuberbuehler, Klaus			The Syntax and Meaning of Wild Gibbon Songs	PLOS ONE			English	Article								Spoken language is a result of the human capacity to assemble simple vocal units into more complex utterances, the basic carriers of semantic information. Not much is known about the evolutionary origins of this behaviour. The vocal abilities of non-human primates are relatively unimpressive in comparison, with gibbon songs being a rare exception. These apes assemble a repertoire of call notes into elaborate songs, which function to repel conspecific intruders, advertise pair bonds, and attract mates. We conducted a series of field experiments with white-handed gibbons at Khao Yai National Park, Thailand, which showed that this ape species uses songs also to protect themselves against predation. We compared the acoustic structure of predatory-induced songs with regular songs that were given as part of their daily routine. Predator-induced songs were identical to normal songs in the call note repertoire, but we found consistent differences in how the notes were assembled into songs. The responses of out-of-sight receivers demonstrated that these syntactic differences were meaningful to conspecifics. Our study provides the first evidence of referential signalling in a free-ranging ape species, based on a communication system that utilises combinatorial rules.	[Clarke, Esther; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol, St Andrews, Scotland; [Reichard, Ulrich H.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Reichard, Ulrich H.] So Illinois Univ, Dept Anthropol, Carbondale, IL 62901 USA	University of St Andrews; Max Planck Society; Southern Illinois University System; Southern Illinois University	Zuberbuhler, K (corresponding author), Univ St Andrews, Sch Psychol, St Andrews, Scotland.	kz3@st-and.ac.uk	Clarke, Esther/AAH-3822-2019; Zuberbühler, Klaus/A-9053-2011	Clarke, Esther/0000-0002-9002-9223; Zuberbühler, Klaus/0000-0001-8378-088X; Reichard, Ulrich H./0000-0002-5564-3922	Khao Yai white-handed gibbon project; University of St Andrews; BBSRC studentship	Khao Yai white-handed gibbon project; University of St Andrews; BBSRC studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Max-Planck-Institute for Evolutionary Anthropology, Leipzig, has provided generous long-term support of the Khao Yai white-handed gibbon project. This research was funded by the University of St Andrews and by a BBSRC studentship to Esther Clarke.	Arnold K, 2006, NATURE, V441, P303, DOI 10.1038/441303a; ARNOLD K, MONKEYS APE IN PRESS; BARELLI C, HORMONES BE IN PRESS; Bartlett Thad Q., 2007, P274; Brockelman WY, 1998, BEHAV ECOL SOCIOBIOL, V42, P329, DOI 10.1007/s002650050445; Catchpole CK, 1995, BIRD SONG BIOL THEME; Cowlishaw G, 1996, ETHOLOGY, V102, P272; Fichtel C, 2005, ANIM BEHAV, V70, P165, DOI 10.1016/j.anbehav.2004.09.020; Geissmann T, 2000, ANIM BEHAV, V60, P805, DOI 10.1006/anbe.2000.1540; Geissmann T, 1999, BEHAVIOUR, V136, P1005, DOI 10.1163/156853999501694; GRICE HP, 1969, PHILOS REV, V78, P147, DOI 10.2307/2184179; Haraway MM, 1998, PRIMATES, V39, P1, DOI 10.1007/BF02557739; Leighton D. R., 1986, PRIMATE SOC, P135; Marler P., 1977, RECOGNITION COMPLEX, P17; MARSHALL JT, 1976, SCIENCE, V193, P235, DOI 10.1126/science.193.4249.235; MAYNARDSMITH J, 1965, AM NAT, V99, P59; MITANI JC, 1985, BEHAVIOUR, V92, P59, DOI 10.1163/156853985X00389; PALOMBIT RA, 1994, ANIM BEHAV, V47, P721, DOI 10.1006/anbe.1994.1097; RAEMAEKERS JJ, 1985, ANIM BEHAV, V33, P481, DOI 10.1016/S0003-3472(85)80071-3; RAEMAEKERS JJ, 1984, BEHAVIOUR, V91, P146, DOI 10.1163/156853984X00263; REICHARD U, 1995, ETHOLOGY, V100, P99; Reichard U, 1998, AM J PRIMATOL, V46, P35, DOI 10.1002/(SICI)1098-2345(1998)46:1<35::AID-AJP4>3.0.CO;2-W; Reichard U. H., 2003, MONOGAMY MATING STRA; Reichard Ulrich H., 2003, P190; SAVINI T, AM J PHYS A IN PRESS; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Slocombe KE, 2006, ANIM BEHAV, V72, P989, DOI 10.1016/j.anbehav.2006.01.030; Slocombe KE, 2005, CURR BIOL, V15, P1779, DOI 10.1016/j.cub.2005.08.068; Snowdon Charles T., 2004, P57, DOI 10.1017/CBO9780511542459.006; Sommer V, 2000, PRIMATE MALES, P159; Sunquist ME, 2002, WILD CATS WORLD; TENAZA RR, 1977, NATURE, V268, P233, DOI 10.1038/268233a0; Todd NPM, 2004, J ACOUST SOC AM, V115, P3077, DOI 10.1121/1.1736273; Uhde NL, 2002, EAT OR BE EATEN, P268, DOI 10.1017/CBO9780511610233.017; VANSCHAIK CP, 1983, BEHAVIOUR, V85, P91, DOI 10.1163/156853983X00057; *WILDL CONS SOC, 2001, STAT EC CONS TIG THE; Zuberbuhler K, 1999, ETHOLOGY, V105, P477, DOI 10.1046/j.1439-0310.1999.00396.x; Zuberbuhler K, 2001, BEHAV ECOL SOCIOBIOL, V50, P414, DOI 10.1007/s002650100383; Zuberbuhler K, 1997, ANIM BEHAV, V53, P589, DOI 10.1006/anbe.1996.0334; Zuberbuhler K., 2006, ENCY LANGUAGE LINGUI, P143	40	153	157	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e73	10.1371/journal.pone.0000073	http://dx.doi.org/10.1371/journal.pone.0000073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183705	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000207443600073
J	Franscini, N; El Gedaily, A; Matthey, U; Franitza, S; Sy, MS; Burkle, A; Groschup, M; Braun, U; Zahn, R				Franscini, Nicola; El Gedaily, Ahmed; Matthey, Ulrich; Franitza, Susanne; Sy, Man-Sun; Buerkle, Alexander; Groschup, Martin; Braun, Ueli; Zahn, Ralph			Prion Protein in Milk	PLOS ONE			English	Article								Background. Prions are known to cause transmissible spongiform encephalopathies (TSE) after accumulation in the central nervous system. There is increasing evidence that prions are also present in body fluids and that prion infection by blood transmission is possible. The low concentration of the proteinaceous agent in body fluids and its long incubation time complicate epidemiologic analysis and estimation of spreading and thus the risk of human infection. This situation is particularly unsatisfactory for food and pharmaceutical industries, given the lack of sensitive tools for monitoring the infectious agent. Methodology/Principal Findings. We have developed an adsorption matrix, Alicon PrioTrap (R), which binds with high affinity and specificity to prion proteins. Thus we were able to identify prion protein (PrPC)-the precursor of prions (PrPSc)-in milk from humans, cows, sheep, and goats. The absolute amount of PrPC differs between the species (from mu g/l range in sheep to ng/l range in human milk). PrPC is also found in homogenised and pasteurised off-the-shelf milk, and even ultrahigh temperature treatment only partially diminishes endogenous PrPC concentration. Conclusions/Significance. In view of a recent study showing evidence of prion replication occurring in the mammary gland of scrapie infected sheep suffering from mastitis, the appearance of PrPC in milk implies the possibility that milk of TSE-infected animals serves as source for PrPSc.	[Franscini, Nicola; El Gedaily, Ahmed; Matthey, Ulrich; Franitza, Susanne; Zahn, Ralph] Alicon AG, Schlieren, Switzerland; [Sy, Man-Sun] Case Western Univ, Sch Med, Inst Pathol, Cleveland, OH USA; [Buerkle, Alexander] Univ Konstanz, Lehrstuhl Mol Toxikol, Constance, Germany; [Groschup, Martin] Bundesforschungsinst Tiergesundheit, Friedrich Loeffler Inst, Greifswald, Germany; [Braun, Ueli] Univ Zurich, Dept Nutztiere, Zurich, Switzerland	Case Western Reserve University; University of Konstanz; Friedrich Loeffler Institute; University of Zurich	Zahn, R (corresponding author), Alicon AG, Schlieren, Switzerland.	info@alicon.ch						Barclay GR, 2002, TRANSFUSION, V42, P517, DOI 10.1046/j.1537-2995.2002.00095.x; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BRADLEY R, 1993, BRIT MED BULL, V49, P932, DOI 10.1093/oxfordjournals.bmb.a072654; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; *EC, 1997, VI819796 EC; *EC MULT SCI COMM, 1997, OP POSS RISKS REL US; HADLOW WJ, 1980, VET PATHOL, V17, P187, DOI 10.1177/030098588001700207; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; Ironside JW, 2004, HAEMOPHILIA, V10, P64, DOI 10.1111/j.1365-2516.2004.00982.x; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Laffont-Proust I, 2005, FEBS LETT, V579, P6333, DOI 10.1016/j.febslet.2005.10.013; Li RL, 2000, J MOL BIOL, V301, P567, DOI 10.1006/jmbi.2000.3986; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; MacGregor I, 1999, VOX SANG, V77, P88; MANSON J, 1992, DEVELOPMENT, V115, P117; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; *STAT EUR FOOD SAF, 2004, BSE TSE SCI PAN BIOL; TAYLOR DM, 1995, VET REC, V136, P592, DOI 10.1136/vr.136.23.592; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	29	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e71	10.1371/journal.pone.0000071	http://dx.doi.org/10.1371/journal.pone.0000071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183703	Green Published, Green Accepted, gold			2022-12-27	WOS:000207443600071
J	Leppanen, P; Kholova, I; Mahonen, AJ; Airenne, K; Koota, S; Mansukoski, H; Narvainen, J; Wirzenius, M; Alhonen, L; Janne, J; Alitalo, K; Yla-Herttuala, S				Leppanen, Pia; Kholova, Ivana; Mahonen, Anssi J.; Airenne, Kari; Koota, Suvi; Mansukoski, Hannu; Narvainen, Johanna; Wirzenius, Maria; Alhonen, Leena; Janne, Juhani; Alitalo, Kari; Yla-Herttuala, Seppo			Short and Long-Term Effects of hVEGF-A(165) in Cre-Activated Transgenic Mice	PLOS ONE			English	Article								We have generated a transgenic mouse where hVEGF-A(165) expression has been silenced with loxP-STOP fragment, and we used this model to study the effects of hVEGF-A(165) over-expression in mice after systemic adenovirus mediated Cre-gene transfer. Unlike previous conventional transgenic models, this model leads to the expression of hVEGF-A(165) in only a low number of cells in the target tissues in adult mice. Levels of hVEGF-A(165) expression were moderate and morphological changes were found mainly in the liver, showing typical signs of active angiogenesis. Most mice were healthy without any major consequences up to 18 months after the activation of hVEGF-A(165) expression. However, one mouse with a high plasma hVEGF-A(165) level died spontaneously because of bleeding into abdominal cavity and having liver hemangioma, haemorrhagic paratubarian cystic lesions and spleen peliosis. Also, two mice developed malignant tumors (hepatocellular carcinoma and lung adenocarcinoma), which were not seen in control mice. We conclude that long-term uncontrolled hVEGF-A(165) expression in only a limited number of target cells in adult mice can be associated with pathological changes, including possible formation of malignant tumors and uncontrolled bleeding in target tissues. These findings have implications for the design of long-term clinical trials using hVEGF-A(165) gene and protein.	[Leppanen, Pia; Kholova, Ivana; Mahonen, Anssi J.; Airenne, Kari; Koota, Suvi; Alhonen, Leena; Janne, Juhani; Yla-Herttuala, Seppo] Univ Kuopio, AI Virtanen Inst, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland; [Wirzenius, Maria; Alitalo, Kari] Univ Helsinki, Biomedicum, Lab Mol Canc Biol, Helsinki, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Gene Therapy Unit, SF-70210 Kuopio, Finland; [Mansukoski, Hannu] Tech Univ Dresden, Dresden, Germany; [Narvainen, Johanna] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Eastern Finland; University of Helsinki; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Technische Universitat Dresden; University of Manchester	Yla-Herttuala, S (corresponding author), Univ Kuopio, AI Virtanen Inst, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland.	Seppo.Ylaherttuala@uku.fi	Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902; Yla-Herttuala, Seppo/0000-0001-7593-2708	Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research, Finnish Academy and European Union (Lymphangiogenenomics) [LSHG-CT-2004-503573]; European Vascular Genomics Network (EVGN) [LSHM-CT-2003-503254]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research, Finnish Academy and European Union (Lymphangiogenenomics); European Vascular Genomics Network (EVGN)	This work was supported by grants from Sigrid Juselius Foundation, Finnish Foundation for Cardiovascular Research, Finnish Academy and European Union (Lymphangiogenenomics LSHG-CT-2004-503573) and European Vascular Genomics Network (EVGN, LSHM-CT-2003-503254).	Baldwin ME, 2005, MOL CELL BIOL, V25, P2441, DOI 10.1128/MCB.25.6.2441-2449.2005; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Bhardwaj S, 2003, HUM GENE THER, V14, P1451, DOI 10.1089/104303403769211664; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Cursiefen C, 2002, INVEST OPHTH VIS SCI, V43, P2127; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FRITH CH, 1982, LAB ANIM SCI, V32, P157; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Hiltunen MO, 2000, FASEB J, V14, P2230, DOI 10.1096/fj.00-0145com; Hiltunen MO, 2003, FASEB J, V17, P1147, DOI 10.1096/fj.02-0514fje; Jalkanen J, 2003, ATHEROSCLEROSIS, V169, P95, DOI 10.1016/S0021-9150(03)00155-2; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1996, EMBO J, V15, P290; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; Laitinen M, 1998, HUM GENE THER, V9, P1481, DOI 10.1089/hum.1998.9.10-1481; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Leppanen P, 2005, CIRCULATION, V112, P1347, DOI 10.1161/CIRCULATIONAHA.105.534107; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Odorisio T, 2002, J CELL SCI, V115, P2559; Okamoto N, 1997, AM J PATHOL, V151, P281; Puumalainen AM, 1998, HUM GENE THER, V9, P1769, DOI 10.1089/hum.1998.9.12-1769; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Vogel J, 2004, J CEREBR BLOOD F MET, V24, P849, DOI 10.1097/01.WCB.0000126564.89011.11; Yla-Herttuala S, 2000, LANCET, V355, P213, DOI 10.1016/S0140-6736(99)04180-X; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694; Zeng X, 1998, DEV DYNAM, V211, P215, DOI 10.1002/(SICI)1097-0177(199803)211:3<215::AID-AJA3>3.0.CO;2-K	36	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e13	10.1371/journal.pone.0000013	http://dx.doi.org/10.1371/journal.pone.0000013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183639	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600013
J	Neyrolles, O; Hernandez-Pando, R; Pietri-Rouxel, F; Fornes, P; Tailleux, L; Payan, JAB; Pivert, E; Bordat, Y; Aguilar, D; Prevost, MC; Petit, C; Gicquel, B				Neyrolles, Olivier; Hernandez-Pando, Rogelio; Pietri-Rouxel, France; Fornes, Paul; Tailleux, Ludovic; Barrios Payan, Jorge Alberto; Pivert, Elisabeth; Bordat, Yann; Aguilar, Diane; Prevost, Marie-Christine; Petit, Caroline; Gicquel, Brigitte			Is Adipose Tissue a Place for Mycobacterium tuberculosis Persistence?	PLOS ONE			English	Article								Background. Mycobacterium tuberculosis, the etiological agent of tuberculosis (TB), has the ability to persist in its human host for exceptionally long periods of time. However, little is known about the location of the bacilli in latently infected individuals. Long-term mycobacterial persistence in the lungs has been reported, but this may not sufficiently account for strictly extra-pulmonary TB, which represents 10-15% of the reactivation cases. Methodology/Principal Findings. We applied in situ and conventional PCR to sections of adipose tissue samples of various anatomical origins from 19 individuals from Mexico and 20 from France who had died from causes other than TB. M. tuberculosis DNA could be detected by either or both techniques in fat tissue surrounding the kidneys, the stomach, the lymph nodes, the heart and the skin in 9/57 Mexican samples (6/19 individuals), and in 8/26 French samples (6/20 individuals). In addition, mycobacteria could be immuno-detected in perinodal adipose tissue of 1 out of 3 biopsy samples from individuals with active TB. In vitro, using a combination of adipose cell models, including the widely used murine adipose cell line 3T3-L1, as well as primary human adipocytes, we show that after binding to scavenger receptors, M. tuberculosis can enter within adipocytes, where it accumulates intracytoplasmic lipid inclusions and survives in a non-replicating state that is insensitive to the major anti-mycobacterial drug isoniazid. Conclusions/Significance. Given the abundance and the wide distribution of the adipose tissue throughout the body, our results suggest that this tissue, among others, might constitute a vast reservoir where the tubercle bacillus could persist for long periods of time, and avoid both killing by antimicrobials and recognition by the host immune system. In addition, M. tuberculosis-infected adipocytes might provide a new model to investigate dormancy and to evaluate new drugs for the treatment of persistent infection.	[Neyrolles, Olivier] CNRS, Paris, France; [Neyrolles, Olivier; Tailleux, Ludovic; Pivert, Elisabeth; Bordat, Yann; Gicquel, Brigitte] Inst Pasteur, Unit Mycobacterial Genet, Paris, France; [Hernandez-Pando, Rogelio; Barrios Payan, Jorge Alberto; Aguilar, Diane] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Pathol, Tlalpan, Mexico; [Pietri-Rouxel, France; Petit, Caroline] Inst Cochin, Dept Infect Dis, Paris, France; [Fornes, Paul] Hop Europeen Georges Pompidou, AP HP, Dept Anatomopathol, Paris, France; [Prevost, Marie-Christine] Inst Pasteur, Electron Microscopy Lab, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Neyrolles, O (corresponding author), CNRS, Paris, France.	neyrolle@pasteur.fr	Neyrolles, Olivier/AAG-3692-2019; Neyrolles, Olivier B/A-3184-2011	Neyrolles, Olivier/0000-0003-0047-5885; BORDAT, Yann/0000-0001-8616-6498; Hernandez-Pando, Rogelio/0000-0003-1292-3833; Pietri-Rouxel, France/0000-0002-6258-7594; Tailleux, Ludovic/0000-0003-3931-1052	Institut Pasteur	Institut Pasteur(European Commission)	Funding: This work was funded by Institut Pasteur.	Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Byrd TF, 1998, INFECT IMMUN, V66, P5132, DOI 10.1128/IAI.66.11.5132-5139.1998; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; DEWIT D, 1992, TUBERCLE LUNG DIS, V73, P262, DOI 10.1016/0962-8479(92)90130-C; FARER LS, 1979, AM J EPIDEMIOL, V109, P205, DOI 10.1093/oxfordjournals.aje.a112675; Fine PEM, 1999, NEW ENGL J MED, V341, P1226, DOI 10.1056/NEJM199910143411609; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Godard C M, 1993, Acta Leprol, V8, P133; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hart PD, 1996, INFECT IMMUN, V64, P1491, DOI 10.1128/IAI.64.4.1491-1493.1996; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Hopewell Philip C., 1994, P25; Hu Y, 2006, INT J TUBERC LUNG D, V10, P317; ITABE H, 1988, BIOCHIM BIOPHYS ACTA, V963, P192, DOI 10.1016/0005-2760(88)90280-9; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kuniyasu A, 2003, FEBS LETT, V537, P85, DOI 10.1016/S0014-5793(03)00096-6; Kuniyasu A, 2002, BIOCHEM BIOPH RES CO, V295, P319, DOI 10.1016/S0006-291X(02)00666-6; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; RASTOGI N, 1992, CURR MICROBIOL, V25, P203, DOI 10.1007/BF01570720; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Stute N, 2004, EXP HEMATOL, V32, P1212, DOI 10.1016/j.exphem.2004.09.003; Tailleux L, 2003, TRENDS MICROBIOL, V11, P259, DOI 10.1016/S0966-842X(03)00102-1; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; TYRRELL DAJ, 1975, BRIT J EXP PATHOL, V56, P99; Ulrichs T, 2005, J PATHOL, V205, P633, DOI 10.1002/path.1728; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271	38	231	239	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e43	10.1371/journal.pone.0000043	http://dx.doi.org/10.1371/journal.pone.0000043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183672	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600043
J	Jack, AI; Patel, GH; Astafiev, SV; Snyder, AZ; Akbudak, E; Shulman, GL; Corbetta, M				Jack, Anthony I.; Patel, Gaurav H.; Astafiev, Serguei V.; Snyder, Abraham Z.; Akbudak, Erbil; Shulman, Gordon L.; Corbetta, Maurizio			Changing Human Visual Field Organization from Early Visual to Extra-Occipital Cortex	PLOS ONE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; FRONTAL EYE FIELDS; SPATIAL ATTENTION; RETINOTOPIC ORGANIZATION; TOPOGRAPHIC ORGANIZATION; MACAQUE MONKEYS; CORTICAL AREA; MAPS; REPRESENTATION	Background. The early visual areas have a clear topographic organization, such that adjacent parts of the cortical surface represent distinct yet adjacent parts of the contralateral visual field. We examined whether cortical regions outside occipital cortex show a similar organization. Methodology/Principal Findings. The BOLD responses to discrete visual field locations that varied in both polar angle and eccentricity were measured using two different tasks. As described previously, numerous occipital regions are both selective for the contralateral visual field and show topographic organization within that field. Extra-occipital regions are also selective for the contralateral visual field, but possess little ( or no) topographic organization. A regional analysis demonstrates that this weak topography is not due to increased receptive field size in extra-occipital areas. Conclusions/Significance. A number of extra-occipital areas are identified that are sensitive to visual field location. Neurons in these areas corresponding to different locations in the contralateral visual field do not demonstrate any regular or robust topographic organization, but appear instead to be intermixed on the cortical surface. This suggests a shift from processing that is predominately local in visual space, in occipital areas, to global, in extra-occipital areas. Global processing fits with a role for these extra-occipital areas in selecting a spatial locus for attention and/or eye-movements.	[Jack, Anthony I.; Patel, Gaurav H.; Astafiev, Serguei V.; Snyder, Abraham Z.; Akbudak, Erbil; Shulman, Gordon L.; Corbetta, Maurizio] Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	mau@npg.wustl.edu	Patel, Gaurav/AAW-3195-2021; Astafiev, Serguei/A-9734-2014; Jack, Anthony Ian/AAJ-7153-2021; Corbetta, Maurizio/AAZ-5219-2020; Jack, Anthony/A-8929-2008	Patel, Gaurav/0000-0003-0028-2098; Jack, Anthony Ian/0000-0001-9613-3964; Jack, Anthony/0000-0001-9613-3964; CORBETTA, MAURIZIO/0000-0001-8295-3304; Astafiev, Serguei/0000-0003-3736-7095	National Institutes of Health; National Eye Institute Institutional National Research Service Award [5-T32EY13360-04]; National Institute of Mental Health [R01 MH71920-06]; National Institute of Neurological Disorders and Stroke [R01 NS48013]; NATIONAL EYE INSTITUTE [T32EY013360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was supported by National Institutes of Health, National Eye Institute Institutional National Research Service Award 5-T32EY13360-04, National Institute of Mental Health R01 MH71920-06, National Institute of Neurological Disorders and Stroke R01 NS48013. The authors declare no conflicts of interest.	Arguin M, 2000, NEUROPSYCHOLOGIA, V38, P283, DOI 10.1016/S0028-3932(99)00077-9; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Claeys KG, 2003, NEURON, V40, P631, DOI 10.1016/S0896-6273(03)00590-7; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fize D, 2003, J NEUROSCI, V23, P7395; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hagler DJ, 2006, NEUROIMAGE, V29, P567, DOI 10.1016/j.neuroimage.2005.08.058; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hines RJ, 2002, NEUROPSYCHOLOGIA, V40, P1804, DOI 10.1016/S0028-3932(02)00032-5; Huk AC, 2002, J NEUROSCI, V22, P7195; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; Kraft A, 2005, NEUROIMAGE, V28, P453, DOI 10.1016/j.neuroimage.2005.05.050; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Macaluso E, 2003, CURR BIOL, V13, P990, DOI 10.1016/S0960-9822(03)00377-4; Macaluso E, 2002, CEREB CORTEX, V12, P357, DOI 10.1093/cercor/12.4.357; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Medendorp WP, 2006, J NEUROPHYSIOL, V95, P1645, DOI 10.1152/jn.00905.2005; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Petit L, 1997, J NEUROPHYSIOL, V77, P3386, DOI 10.1152/jn.1997.77.6.3386; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Platt ML, 1998, EXP BRAIN RES, V121, P65, DOI 10.1007/s002210050438; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Sawaguchi T, 2001, J NEUROPHYSIOL, V86, P2041, DOI 10.1152/jn.2001.86.4.2041; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Schluppeck D, 2006, J NEUROSCI, V26, P5098, DOI 10.1523/JNEUROSCI.5330-05.2006; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; SUZUKI H, 1983, EXP BRAIN RES, V53, P47; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	52	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e452	10.1371/journal.pone.0000452	http://dx.doi.org/10.1371/journal.pone.0000452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505546	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445900011
J	Cusack, MP; Thibert, B; Bredesen, DE; del Rio, G				Cusack, Michael P.; Thibert, Boris; Bredesen, Dale E.; del Rio, Gabriel			Efficient Identification of Critical Residues Based Only on Protein Structure by Network Analysis	PLOS ONE			English	Article							PREDICTION; SITES	Despite the increasing number of published protein structures, and the fact that each protein's function relies on its three-dimensional structure, there is limited access to automatic programs used for the identification of critical residues from the protein structure, compared with those based on protein sequence. Here we present a new algorithm based on network analysis applied exclusively on protein structures to identify critical residues. Our results show that this method identifies critical residues for protein function with high reliability and improves automatic sequence-based approaches and previous network-based approaches. The reliability of the method depends on the conformational diversity screened for the protein of interest. We have designed a web site to give access to this software at http://bis.ifc.unam.mx/jamming/. In summary, a new method is presented that relates critical residues for protein function with the most traversed residues in networks derived from protein structures. A unique feature of the method is the inclusion of the conformational diversity of proteins in the prediction, thus reproducing a basic feature of the structure/function relationship of proteins.	[del Rio, Gabriel] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim, Mexico City 04510, DF, Mexico; [Bredesen, Dale E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cusack, Michael P.; Bredesen, Dale E.] Buck Inst Age Res, Novato, CA USA; [Thibert, Boris] Lab Modelisat & Calcul LMC IMAG, Grenoble, France	Universidad Nacional Autonoma de Mexico; University of California System; University of California San Francisco; Buck Institute for Research on Aging	del Rio, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim, Mexico City 04510, DF, Mexico.	gdelrio@ifc.unam.mx			Glenn Foundation; CoNaCyT [SEP-2004-C01-47399/A-1, PAPIIT IN210705-3]; Macroproyecto UNAM Tecnologias para la Universidad de la Informacion y la Computacion	Glenn Foundation; CoNaCyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Macroproyecto UNAM Tecnologias para la Universidad de la Informacion y la Computacion	The first author, Michael P. Cusack, was supported by a grant from the Glenn Foundation that supports students during summer research. This work was supported in part by three grants to the corresponding author, Gabriel del Rio, CoNaCyT SEP-2004-C01-47399/A-1, PAPIIT IN210705-3 and Macroproyecto UNAM Tecnologias para la Universidad de la Informacion y la Computacion.	Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Christendat D, 2000, NAT STRUCT BIOL, V7, P903; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; George RA, 2005, P NATL ACAD SCI USA, V102, P12299, DOI 10.1073/pnas.0504833102; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; HOLM L, 1992, PROTEIN SCI, V1, P1691, DOI 10.1002/pro.5560011217; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Mattos C, 1996, NAT BIOTECHNOL, V14, P595, DOI 10.1038/nbt0596-595; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Pal D, 2005, STRUCTURE, V13, P121, DOI 10.1016/j.str.2004.10.015; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; PHILIPPSEN M, 1997, PRACTICE EXPERIENCE, V9, P1225; POTEETE AR, 1992, PROTEINS, V13, P38, DOI 10.1002/prot.340130104; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; Sadreyev RI, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-6; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Thibert B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-213; Thornton JM, 2000, NAT STRUCT BIOL, V7, P991, DOI 10.1038/80784; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; WEISS M, 1999, DATA STRUCTURES ALGO, P291	28	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e421	10.1371/journal.pone.0000421	http://dx.doi.org/10.1371/journal.pone.0000421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17502913	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445800003
J	Cox, SE; Doherty, C; Atkinson, SH; Nweneka, CV; Fulford, AJC; Ghattas, H; Rockett, KA; Kwiatkowski, DP; Prentice, AM				Cox, Sharon E.; Doherty, Conor; Atkinson, Sarah H.; Nweneka, Chidi V.; Fulford, Anthony J. C.; Ghattas, Hala; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Prentice, Andrew M.			Haplotype Association between Haptoglobin (Hp2) and Hp Promoter SNP (A-61C) May Explain Previous Controversy of Haptoglobin and Malaria Protection	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SICKLE-CELL TRAIT; GENE DELETION; 2-2 PHENOTYPE; IRON STATUS; IN-VITRO; POLYMORPHISM; HEMOGLOBIN; GENOTYPE; AHAPTOGLOBINEMIA	Background. Malaria is one of the strongest recent selective pressures on the human genome, as evidenced by the high levels of varying haemoglobinopathies in human populations-despite the increased risk of mortality in the homozygous states. Previously, functional polymorphisms of Hp, coded by the co-dominant alleles Hp1 and Hp2, have been variously associated with several infectious diseases, including malaria susceptibility. Methodology/Principal Findings. Risk of a clinical malarial episode over the course of a malarial transmission season was assessed using active surveillance in a cohort of Gambian children aged 10-72 months. We report for the first time that the major haplotype for the A-61C mutant allele in the promoter of haptoglobin (Hp)-an acute phase protein that clears haemoglobin released from haemolysis of red cells-is associated with protection from malarial infection in older children, (children aged >= 36 months, > 500 parasites/ul and temperature > 37.5 degrees C; OR = 0.42; [95% CI 0.24-0.73] p = 0.002) (Ir test for interaction, < 36 vs >= 36 months, p = 0.014). Protection was also observed using two other definitions, including temperature > 37.5 degrees C, dipstick positive, plus clinical judgement of malaria blinded to dipstick result (all ages, OR = 0.48, [95% CI 0.30-0.78] p = 0.003; >= 36 months, OR = 0.31, [95% CI 0.15-0.62] p = 0.001). A similar level of protection was observed for the known protective genetic variant, sickle cell trait (HbAS). Conclusions/Significance. We propose that previous conflicting results between Hp phenotypes/ genotypes and malaria susceptibility may be explained by differing prevalence of the A-61C SNP in the populations studied, which we found to be highly associated with the Hp2 allele. We report the -61C allele to be associated with decreased Hp protein levels (independent of Hp phenotype), confirming in vitro studies. Decreased Hp expression may lead to increased oxidant stress and increased red cell turnover, and facilitate the development of acquired immunity, similar to a mechanism suggested for sickle cell trait.	[Cox, Sharon E.; Atkinson, Sarah H.; Fulford, Anthony J. C.; Ghattas, Hala; Prentice, Andrew M.] London Sch Hyg & Trop Med, Int Nutr Grp, MRC, London WC1, England; [Rockett, Kirk A.; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Oxford, England; [Doherty, Conor; Atkinson, Sarah H.; Nweneka, Chidi V.] MRC Labs, MRC Keneba, Keneba, Gambia	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology	Cox, SE (corresponding author), London Sch Hyg & Trop Med, Int Nutr Grp, MRC, London WC1, England.	Sharon.cox@lshtm.ac.uk	Prentice, Andrew/AAG-1961-2019; Cox, Sharon E/ABA-7986-2020; Ghattas, Hala/K-5661-2016; Nweneka, Chidi/AAH-9947-2021	Cox, Sharon E/0000-0002-9908-2936; Nweneka, Chidi/0000-0002-7278-2035; Kwiatkowski, Dominic/0000-0002-5023-0176	UK Medical Research Council; Medical Research Council [G19/9, G9505090] Funding Source: researchfish; MRC [G9505090, G19/9] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This study was funded by UK Medical Research Council who had no part in the design or analysis of the study.	Arredouani M, 2003, IMMUNOLOGY, V108, P144, DOI 10.1046/j.1365-2567.2003.01569.x; Asleh R, 2005, CIRC RES, V96, P435, DOI 10.1161/01.RES.0000156653.05853.b9; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; Atkinson SH, 2007, CLIN INFECT DIS, V44, P802, DOI 10.1086/511868; Aucan C, 2002, T ROY SOC TROP MED H, V96, P327, DOI 10.1016/S0035-9203(02)90114-8; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Bienzle U, 2005, TROP MED INT HEALTH, V10, P668, DOI 10.1111/j.1365-3156.2005.01444.x; BOREHAM PFL, 1981, T ROY SOC TROP MED H, V75, P193, DOI 10.1016/0035-9203(81)90316-3; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; Calderoni DR, 2006, ANN TROP MED PARASIT, V100, P213, DOI 10.1179/136485906X86356; CLAYTON D, SNPHAP PROGRAM ESTIM; Delanghe JR, 1998, AIDS, V12, P1027, DOI 10.1097/00002030-199809000-00009; Elagib AA, 1998, T ROY SOC TROP MED H, V92, P309, DOI 10.1016/S0035-9203(98)91025-2; ElGhmati SM, 1996, J IMMUNOL, V156, P2542; Fowkes FJI, 2006, AM J TROP MED HYG, V74, P26, DOI 10.4269/ajtmh.2006.74.26; Friis T, 2003, JAIDS-J ACQ IMM DEF, V33, P74, DOI 10.1097/00126334-200305010-00011; GRANT DJ, 1993, AM J HUM GENET, V52, P974; GUETTA J, 2006, ATHEROSCLEROSIS; Hunt NH, 2001, REDOX REP, V6, P389, DOI 10.1179/135100001101536508; Imrie H, 2006, AM J TROP MED HYG, V74, P965, DOI 10.4269/ajtmh.2006.74.965; Imrie H, 2004, MOL BIOCHEM PARASIT, V133, P93, DOI 10.1016/j.molbiopara.2003.07.007; Koch W, 2003, CLIN CHEM, V49, P1937, DOI 10.1373/clinchem.2003.022442; Koch W, 2002, CLIN CHEM, V48, P1377; Koda Y, 1998, AM J HUM GENET, V62, P245, DOI 10.1086/301701; Koda Y, 2000, BLOOD, V95, P1138, DOI 10.1182/blood.V95.4.1138.004k27_1138_1143; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Langlois M, 1997, EUR J CLIN CHEM CLIN, V35, P199; Langlois MR, 2000, CLIN CHEM, V46, P1619; Langlois MR, 1997, AM J CLIN NUTR, V66, P606, DOI 10.1093/ajcn/66.3.606; Langlois MR, 1996, CLIN CHEM, V42, P1589; MAEDA N, 1991, AM J HUM GENET, V49, P158; MARSH K, 1988, T ROY SOC TROP MED H, V82, P532, DOI 10.1016/0035-9203(88)90495-6; McDermid JM, 2006, CLIN SCI, V110, P503, DOI 10.1042/CS20050273; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Minang JT, 2004, ACTA TROP, V90, P107, DOI 10.1016/j.actatropica.2003.10.016; Mustafa S, 2004, DIABETES CARE, V27, P2103, DOI 10.2337/diacare.27.9.2103; Okazaki T, 1997, CLIN CHEM, V43, P2012; Okazaki T, 1997, CLIN CHIM ACTA, V258, P137, DOI 10.1016/S0009-8981(96)06468-6; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Quaye IK, 2006, J ATHEROSCLER THROMB, V13, P90, DOI 10.5551/jat.13.90; Quaye IKE, 2000, HUM HERED, V50, P382, DOI 10.1159/000022944; Quaye IKE, 2000, T ROY SOC TROP MED H, V94, P216, DOI 10.1016/S0035-9203(00)90281-5; ROUGEMONT A, 1988, LANCET, V2, P709; SINGH IP, 1986, HUM HERED, V36, P31, DOI 10.1159/000153596; TAKIZAWA T, 1987, Genomics, V1, P228, DOI 10.1016/0888-7543(87)90048-6; Teye K, 2003, CLIN GENET, V64, P439, DOI 10.1034/j.1399-0004.2003.00149.x; Teye K, 2006, HUM BIOL, V78, P121, DOI 10.1353/hub.2006.0029; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P430, DOI 10.1016/0035-9203(85)90053-7; TRAPE JF, 1988, AM J EPIDEMIOL, V127, P1282, DOI 10.1093/oxfordjournals.aje.a114920; Williams TN, 2006, MOL BIOCHEM PARASIT, V149, P121, DOI 10.1016/j.molbiopara.2006.05.007; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Yano A, 1998, ACTA MED OKAYAMA, V52, P173	53	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2007	2	4							e362	10.1371/journal.pone.0000362	http://dx.doi.org/10.1371/journal.pone.0000362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DT	17426810	Green Published, Green Accepted, gold			2022-12-27	WOS:000207445400002
J	Bhat, R; Watzl, C				Bhat, Rauf; Watzl, Carsten			Serial Killing of Tumor Cells by Human Natural Killer Cells - Enhancement by Therapeutic Antibodies	PLOS ONE			English	Article								Background. Natural killer cells are an important component of the innate immune system. Anti-cancer therapies utilizing monoclonal antibodies also rely on the cytotoxicity of NK cells for their effectiveness. Here, we study the dynamics of NK cell cytotoxicity. Methodology/Principal Findings. We observe that IL-2 activated human NK cells can serially hit multiple targets. Using functional assays, we demonstrate that on an average, a single IL-2 activated NK cell can kill four target cells. Data using live video microscopy suggest that an individual NK cell can make serial contacts with multiple targets and majority of contacts lead to lysis of target cells. Serial killing is associated with a loss of Perforin and Granzyme B content. A large majority of NK cells survive serial killing, and IL-2 can replenish their granular stock and restore the diminished cytotoxicity of 'exhausted' NK cells. IL-2 and IL-15 are equally effective in enhancing the killing frequency of resting NK cells. Significantly, Rituximab, a therapeutic monoclonal antibody increases the killing frequency of both resting and IL-2 activated NK cells. Conclusion/Significance. Our data suggest that NK cell-based therapies for overcoming tumors rely on their serial killing ability. Therefore, strategies augmenting the killing ability of NK cells can boost the immune system and enhance the effectiveness of monoclonal antibody-based therapies.	[Bhat, Rauf; Watzl, Carsten] Heidelberg Univ, Inst Immunol, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Watzl, C (corresponding author), Heidelberg Univ, Inst Immunol, Neuenheimer Feld 305, D-6900 Heidelberg, Germany.	Carsten.watzl@urz.uni-heidelberg.de	Watzl, Carsten/B-4911-2013; Bhat, Rauf/AGI-1900-2022	Watzl, Carsten/0000-0001-5195-0995; Bhat, Rauf/0000-0001-8503-2447	Deutsche Forschungsgemeinschaft (DFG) [SFB405, A9, A13]; Deutsche Krebshilfe; BioFuture Program of the BMBF	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); BioFuture Program of the BMBF	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, SFB405, A9, A13), the Deutsche Krebshilfe and the BioFuture Program of the BMBF. Other than financial support, these funders had no impact in this study.	Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Eisenbeis CF, 2004, CLIN CANCER RES, V10, P6101, DOI 10.1158/1078-0432.CCR-04-0525; Gluck WL, 2004, CLIN CANCER RES, V10, P2253, DOI 10.1158/1078-0432.CCR-1087-3; Harris M, 2004, LANCET ONCOL, V5, P292, DOI 10.1016/S1470-2045(04)01467-6; Jewett A, 1996, J IMMUNOL, V156, P907; JEWETT A, 1995, CELL IMMUNOL, V160, P91, DOI 10.1016/0008-8749(95)80013-9; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; MARTZ E, 1976, TRANSPLANTATION, V21, P5, DOI 10.1097/00007890-197601000-00002; PERELSON AS, 1982, J IMMUNOL, V129, P2796; PERELSON AS, 1984, J IMMUNOL, V132, P2190; Sandusky MM, 2006, EUR J IMMUNOL, V36, P3268, DOI 10.1002/eji.200636146; THORN RM, 1976, J IMMUNOL, V117, P2213; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(01)00093-0; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103; Wulfing C, 2003, P NATL ACAD SCI USA, V100, P7767, DOI 10.1073/pnas.1336920100	22	176	182	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e326	10.1371/journal.pone.0000326	http://dx.doi.org/10.1371/journal.pone.0000326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389917	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445200009
J	Lu, XY; Shaw, CA; Patel, A; Li, JZ; Cooper, ML; Wells, WR; Sullivan, CM; Sahoo, T; Yatsenko, SA; Bacino, CA; Stankiewicz, P; Ou, ZS; Chinault, AC; Beaudet, AL; Lupski, JR; Cheung, SW; Ward, PA				Lu, Xinyan; Shaw, Chad A.; Patel, Ankita; Li, Jiangzhen; Cooper, M. Lance; Wells, William R.; Sullivan, Cathy M.; Sahoo, Trilochan; Yatsenko, Svetlana A.; Bacino, Carlos A.; Stankiewicz, Pawel; Ou, Zhishu; Chinault, A. Craig; Beaudet, Arthur L.; Lupski, James R.; Cheung, Sau W.; Ward, Patricia A.			Clinical Implementation of Chromosomal Microarray Analysis: Summary of 2513 Postnatal Cases	PLOS ONE			English	Article								Background. Array Comparative Genomic Hybridization (a-CGH) is a powerful molecular cytogenetic tool to detect genomic imbalances and study disease mechanism and pathogenesis. We report our experience with the clinical implementation of this high resolution human genome analysis, referred to as Chromosomal Microarray Analysis (CMA). Methods and Findings. CMA was performed clinically on 2513 postnatal samples from patients referred with a variety of clinical phenotypes. The initial 775 samples were studied using CMA array version 4 and the remaining 1738 samples were analyzed with CMA version 5 containing expanded genomic coverage. Overall, CMA identified clinically relevant genomic imbalances in 8.5% of patients: 7.6% using V4 and 8.9% using V5. Among 117 cases referred for additional investigation of a known cytogenetically detectable rearrangement, CMA identified the majority (92.5%) of the genomic imbalances. Importantly, abnormal CMA findings were observed in 5.2% of patients (98/1872) with normal karyotypes/FISH results, and V5, with expanded genomic coverage, enabled a higher detection rate in this category than V4. For cases without cytogenetic results available, 8.0% (42/524) abnormal CMA results were detected; again, V5 demonstrated an increased ability to detect abnormality. Improved diagnostic potential of CMA is illustrated by 90 cases identified with 51 cryptic microdeletions and 39 predicted apparent reciprocal microduplications in 13 specific chromosomal regions associated with 11 known genomic disorders. In addition, CMA identified copy number variations (CNVs) of uncertain significance in 262 probands; however, parental studies usually facilitated clinical interpretation. Of these, 217 were interpreted as familial variants and 11 were determined to be de novo; the remaining 34 await parental studies to resolve the clinical significance. Conclusions. This large set of clinical results demonstrates the significantly improved sensitivity of CMA for the detection of clinically relevant genomic imbalances and highlights the need for comprehensive genetic counseling to facilitate accurate clinical correlation and interpretation.	[Lu, Xinyan; Shaw, Chad A.; Patel, Ankita; Li, Jiangzhen; Cooper, M. Lance; Wells, William R.; Sullivan, Cathy M.; Sahoo, Trilochan; Yatsenko, Svetlana A.; Bacino, Carlos A.; Stankiewicz, Pawel; Ou, Zhishu; Chinault, A. Craig; Beaudet, Arthur L.; Lupski, James R.; Cheung, Sau W.; Ward, Patricia A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Cheung, SW (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	scheung@bcm.tmc.edu	Stankiewicz, Paweł/AAP-7906-2021; Patel, Ankita/D-3247-2013	Stankiewicz, Paweł/0000-0002-6456-7490; Shaw, Chad/0000-0001-7267-5398				Baldocchi RA, 2005, CYTOM PART A, V67A, P129, DOI 10.1002/cyto.a.20161; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; Biesecker LG, 2002, AM J MED GENET, V107, P263, DOI 10.1002/ajmg.10160.abs; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; CHEUNG SW, 2007, AM J MED GE IN PRESS; Ciccone R, 2005, HUM GENET, V117, P571, DOI 10.1007/s00439-005-1324-x; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; Fauth C, 2006, HUM GENET, V119, P145, DOI 10.1007/s00439-005-0103-z; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Goidts V, 2006, HUM GENET, V119, P185, DOI 10.1007/s00439-005-0130-9; Gribble SM, 2005, J MED GENET, V42, P8, DOI 10.1136/jmg.2004.024141; Gribble SM, 2004, CHROMOSOME RES, V12, P35, DOI 10.1023/B:CHRO.0000009325.69828.83; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Hwang KS, 2005, AM J MED GENET A, V137A, P88, DOI 10.1002/ajmg.a.30858; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Koolen DA, 2005, EUR J HUM GENET, V13, P1019, DOI 10.1038/sj.ejhg.5201456; Lau CC, 2004, GENE CHROMOSOME CANC, V39, P11, DOI 10.1002/gcc.10291; Lavoie BD, 2002, J CELL BIOL, V156, P805, DOI 10.1083/jcb.200109056; LE CC, 2005, AM J MED GENET A, V132, P175; Lee JA, 2005, PRENATAL DIAG, V25, P1188, DOI 10.1002/pd.1308; LENNON PA, 2007, AM J MED GE IN PRESS; Lu XY, 2002, LEUKEMIA, V16, P2222, DOI 10.1038/sj.leu.2402662; Lupski J.R., 2006, GENOMIC DISORDERS TH; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, MOL MED, V4, P3, DOI 10.1007/BF03401724; LUPSKI JR, 2007, N ENGL J MED UNPUB; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Misawa A, 2005, CANCER RES, V65, P10233, DOI 10.1158/0008-5472.CAN-05-1073; Miura S, 2006, J HUM GENET, V51, P412, DOI 10.1007/s10038-006-0376-7; Peng HH, 2006, J REPROD MED, V51, P438; Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140; POTOCKI L, 2007, AM J HUM GE IN PRESS; Rao PH, 1998, BLOOD, V92, P234, DOI 10.1182/blood.V92.1.234.413k22_234_240; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rickman L, 2005, EUR J MED GENET, V48, P232, DOI 10.1016/j.ejmg.2005.03.003; Rickman L, 2006, J MED GENET, V43, P353, DOI 10.1136/jmg.2005.037648; Rosenberg C, 2005, HUM GENET, V116, P390, DOI 10.1007/s00439-004-1248-x; Sahoo T, 2006, GENET MED, V8, P719, DOI 10.1097/01.gim.0000245576.47154.63; Schulz R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl461; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Shaw CJ, 2004, J MED GENET, V41, P113, DOI 10.1136/jmg.2003.012831; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Speicher MR, 2005, NAT REV GENET, V6, P782, DOI 10.1038/nrg1692; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; TRASK BJ, 1991, TRENDS GENET, V7, P149, DOI 10.1016/0168-9525(91)90378-4; Tyson C, 2005, AM J MED GENET A, V139A, P173, DOI 10.1002/ajmg.a.31015; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Vermeesch JR, 2005, J HISTOCHEM CYTOCHEM, V53, P413, DOI 10.1369/jhc.4A6436.2005; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Vissers LELM, 2005, HUM MOL GENET, V14, pR215, DOI 10.1093/hmg/ddi268; Wilson GM, 2006, GENOME RES, V16, P173, DOI 10.1101/gr.4456006; Yu W, 2003, HUM MOL GENET, V12, P2145, DOI 10.1093/hmg/ddg230	66	173	176	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e327	10.1371/journal.pone.0000327	http://dx.doi.org/10.1371/journal.pone.0000327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389918	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445200010
J	Gu, XXJ; Yue, FY; Kovacs, CM; Ostrowski, MA				Gu, Xiao Xiao Jenny; Yue, Feng Yun; Kovacs, Colin M.; Ostrowski, Mario A.			The Role of Cytokines which Signal through the Common gamma Chain Cytokine Receptor in the Reversal of HIV Specific CD4(+) and CD8(+) T Cell Anergy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRIMARY IMMUNE-RESPONSE; LYMPHOCYTE RESPONSE; CROSS-LINKING; INTERLEUKIN-2; INFECTION; MEMORY; IL-2; PROLIFERATION; PROGRESSION	Background. HIV specific T cells are putatively anergic in vivo. IL-2, a member of a class of cytokines that binds to receptors containing the common gamma chain (gamma c) has been shown to reverse anergy. We examined the role of gamma c cytokines in reversing HIV specific T cell anergy. Methods. PBMC from untreated HIV-infected individuals were briefly exposed to a panel of gamma c cytokines, and frequencies of gag specific T cells were enumerated by intracellular IFN-gamma flow cytometry. Results. Of the gamma c cytokines, brief exposure to IL-2, IL-15, or combined IL-15/IL-7 significantly enhanced (range 2-7 fold) the CD4(+) and CD8(+) T cell IFN-gamma responses to HIV gag, with IL-15 giving the greatest enhancement. The effects of cytokines were not due to enhanced proliferation of pre-existing antigen specific cells, but were due to a combination of enhanced cytokine production from antigen specific T cells plus activation of non-epitope specific T cells. Conclusions. These observations support the notion that a significant number of HIV specific T cells are circulating in an anergic state. IL-2, IL-7 and particularly IL-15 as an immune modulator to reverse HIV-1 specific T cell anergy should be investigated, with the caveat that non-specific activation of T cells may also be induced.	[Gu, Xiao Xiao Jenny; Yue, Feng Yun; Kovacs, Colin M.; Ostrowski, Mario A.] Univ Toronto, Div Clin Sci, Toronto, ON, Canada; [Ostrowski, Mario A.] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Kovacs, Colin M.] CIRC, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Ostrowski, MA (corresponding author), Univ Toronto, Div Clin Sci, Toronto, ON, Canada.	m.ostrowski@utoronto.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Ontario HIV Treatment Network, Canadian Institutes of Health Research	Arno A, 1999, J INFECT DIS, V180, P56, DOI 10.1086/314831; BANDA NK, 1992, J EXP MED, V176, P1099, DOI 10.1084/jem.176.4.1099; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Biglino A, 1996, CLIN IMMUNOL IMMUNOP, V78, P61, DOI 10.1006/clin.1996.0009; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Calarota SA, 2003, J IMMUNOL METHODS, V279, P55, DOI 10.1016/S0022-1759(03)00246-1; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Chitnis V, 2003, CLIN IMMUNOL, V107, P36, DOI 10.1016/S1521-6616(02)00051-7; Clark S J, 1993, Semin Immunol, V5, P149, DOI 10.1006/smim.1993.1018; Collins KL, 2003, CURR HIV RES, V1, P31, DOI 10.2174/1570162033352138; Dybul M, 2002, J INFECT DIS, V185, P61, DOI 10.1086/338123; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Goepfert PA, 2000, J VIROL, V74, P10249, DOI 10.1128/JVI.74.21.10249-10255.2000; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Jennes W, 2002, J IMMUNOL METHODS, V270, P99, DOI 10.1016/S0022-1759(02)00275-2; KLENERMAN P, 1995, EUR J IMMUNOL, V25, P1927, DOI 10.1002/eji.1830250720; Kostense S, 2002, BLOOD, V99, P2505, DOI 10.1182/blood.V99.7.2505; Lane C, 1997, AIDS Treat News, P1; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; McNeil AC, 2001, P NATL ACAD SCI USA, V98, P13878, DOI 10.1073/pnas.251539598; MIGUELES SA, 2002, NAT IMMUNOL, V7, P7; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; NIU MT, 1993, J INFECT DIS, V168, P1490, DOI 10.1093/infdis/168.6.1490; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Reusser P, 1999, J INFECT DIS, V180, P247, DOI 10.1086/314879; ROOS MTL, 1994, AIDS, V8, P1533, DOI 10.1097/00002030-199411000-00003; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rosenberg ES, 1999, IMMUNOL LETT, V66, P89, DOI 10.1016/S0165-2478(98)00165-5; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Scriba TJ, 2005, J CLIN INVEST, V115, P443, DOI 10.1172/JCI200523084; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; Vogel TU, 2001, J VIROL, V75, P2458, DOI 10.1128/JVI.75.5.2458-2461.2001; Whitmire JK, 1996, J VIROL, V70, P8375, DOI 10.1128/JVI.70.12.8375-8381.1996; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Yue FY, 2004, J IMMUNOL, V172, P2476, DOI 10.4049/jimmunol.172.4.2476	39	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e300	10.1371/journal.pone.0000300	http://dx.doi.org/10.1371/journal.pone.0000300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375186	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445100002
J	Coll, BA; Garcia, RA; Marmer, WN				Coll, Brian A.; Garcia, Rafael A.; Marmer, William N.			Diffusion of Protease into Meat & Bone Meal for Solubility Improvement and Potential Inactivation of the BSE Prion	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; ENZYME INFUSION; HYDROLYSIS; RELEVANT; NITRITE; NITRATE	Background. Government-imposed feed bans have created a need for new applications for meat & bone meal (MBM). Many potential new applications require MBM protein to be both soluble and free of infectious prion. Treatment with protease is generally effective in reducing insoluble, thermally-denatured proteins to soluble peptides. It has been reported in the literature that certain proteases, including Versazyme (TM), are able to degrade infectious prions in a system where the prions are readily accessible to proteolytic attack. Prions distributed within MBM, however, may conceivably be protected from proteases. Methodology/Principal Findings. The overall rate of proteolytic MBM digestion depends greatly on whether the protease can penetrate deep within individual particles, or if the protease can only act near the surface of the particle. This research examined the barriers to the diffusion of Versazyme (TM) into particles of MBM. Confocal microscopy demonstrated differences in the density distributions between the bone and the soft tissue particles of MBM. By tracking the diffusion of fluorescently labeled Versazyme (TM) through individual particles, it was found that bone particles show full Versazyme (TM) penetration within 30 minutes, while penetration of soft tissue particles can take up to four hours, depending on the particle's diameter. From the variety of normal proteins comprising MBM, a specific protein was chosen to serve as a prion surrogate based on characteristics including size, solubility, distribution and abundance. This surrogate was used to measure the effect of several factors on Versazyme (TM) diffusion. Conclusions/Significance. Results showed that surrogate distributed in bone particles was more susceptible to degradation than that in soft tissue particles. Three factors controllable by unit operations in an industrial-scale process were also tested. It was found that removing the lipid content and hydrating MBM prior to incubation both significantly increased the rate of surrogate degradation. In a test of particle size, the smallest collected diameter range demonstrated the largest degradation of the prion surrogate, suggesting milling would be beneficial.	[Coll, Brian A.; Garcia, Rafael A.; Marmer, William N.] ARS, USDA, Eastern Reg Res Ctr, Fats Oils & Anim Coprod Res Unit, Wyndmoor, PA USA; [Coll, Brian A.] Widener Univ, Dept Chem Engn, Chester, PA 19013 USA	United States Department of Agriculture (USDA); Widener University	Garcia, RA (corresponding author), ARS, USDA, Eastern Reg Res Ctr, Fats Oils & Anim Coprod Res Unit, Wyndmoor, PA USA.	Rafael.Garcia@ars.usda.gov	Garcia, Rafael A./D-2796-2009	Garcia, Rafael A./0000-0002-5452-3929	Fats and Proteins Research Foundation, Alexandria, VA	Fats and Proteins Research Foundation, Alexandria, VA	This research was supported in part by a grant from the Fats and Proteins Research Foundation, Alexandria, VA.	Baker RA, 1996, TRENDS FOOD SCI TECH, V7, P279, DOI 10.1016/0924-2244(96)10030-3; CAPARELLA T, 2006, RENDER, P32; CAPARELLA T, 2006, RENDER, P39; Caughey B, 1997, J VIROL, V71, P4107, DOI 10.1128/JVI.71.5.4107-4110.1997; CHO HJ, 1983, CAN J COMP MED, V47, P494; Culver CA, 2000, J AGR FOOD CHEM, V48, P5933, DOI 10.1021/jf000094w; FOX JB, 1980, J FOOD SCI, V45, P1740, DOI 10.1111/j.1365-2621.1980.tb07601.x; Garcia RA, 2006, APPL ENG AGRIC, V22, P729; Heilemann M, 2002, DEUT TIERARZTL WOCH, V109, P354; Hui Z, 2004, BIOCHEM BIOPH RES CO, V321, P45, DOI 10.1016/j.bbrc.2004.06.100; Jung S, 2004, J AM OIL CHEM SOC, V81, P953, DOI 10.1007/s11746-004-1007-3; Kalambura S., 2005, Krmiva, V47, P97; Kasermann F, 2003, J GEN VIROL, V84, P3173, DOI 10.1099/vir.0.19355-0; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; Matthews D, 2003, REV SCI TECH OIE, V22, P283, DOI 10.20506/rst.22.1.1393; NASH A, 1971, J FOOD SCI, V36, P930, DOI 10.1111/j.1365-2621.1971.tb15562.x; Novakofski J, 2005, J ANIM SCI, V83, P1455; Oidtmann B, 2003, ARCH LEBENSMITTELHYG, V54, P141; Park SK, 2000, J AM OIL CHEM SOC, V77, P1223, DOI 10.1007/s11746-000-0191-5; Pinotti A, 2002, J FOOD SCI, V67, P2165, DOI 10.1111/j.1365-2621.2002.tb09521.x; QUAGLIA GB, 1987, J SCI FOOD AGR, V38, P271, DOI 10.1002/jsfa.2740380311; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Struckmann P., 2004, VGB Powertech, V85, P72; Taylor DM, 2003, REV SCI TECH OIE, V22, P297, DOI 10.20506/rst.22.1.1400; Taylor MM, 2006, J AM LEATHER CHEM AS, V101, P169; Tsiroulnikov K, 2004, J AGR FOOD CHEM, V52, P6353, DOI 10.1021/jf0493324; Varzakas TH, 2005, LWT-FOOD SCI TECHNOL, V38, P239, DOI 10.1016/j.lwt.2004.05.009; WEBSTER JD, 1982, MEAT SCI, V7, P147, DOI 10.1016/0309-1740(82)90080-8; Whiteman MD, 2003, BIOPHARM INT, V16, P20; Yokoyama T, 2006, SOIL SCI PLANT NUTR, V52, P71, DOI 10.1111/j.1747-0765.2006.00011.x	30	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e245	10.1371/journal.pone.0000245	http://dx.doi.org/10.1371/journal.pone.0000245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327909	gold, Green Published			2022-12-27	WOS:000207444600005
J	Le Foll, B; Wertheim, C; Goldberg, SR				Le Foll, Bernard; Wertheim, Carrie; Goldberg, Steven R.			High Reinforcing Efficacy of Nicotine in Non-Human Primates	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCES; PROGRESSIVE RATIO SCHEDULE; ADMINISTER PURE NICOTINE; DOPAMINE D-3 RECEPTOR; MONOAMINE-OXIDASE; INTRAVENOUS NICOTINE; DRAMATICALLY INCREASES; FIXED-RATIO; BEHAVIOR; DRUG	Although tobacco appears highly addictive in humans, there has been persistent controversy about the ability of its psychoactive ingredient nicotine to induce self-administration behavior in laboratory animals, bringing into question nicotine's role in reinforcing tobacco smoking. Because of ethical difficulties in inducing nicotine dependence in naive human subjects, we explored reinforcing effects of nicotine in experimentally-naive non-human primates given access to nicotine for periods of time up to two years. Five squirrel monkeys with no experimental history were allowed to intravenously self-administer nicotine by pressing one of two levers. The number of presses on the active lever needed to obtain each injection was fixed (fixed-ratio schedule) or increased progressively with successive injections during the session (progressive-ratio schedule), allowing evaluation of both reinforcing and motivational effects of nicotine under conditions of increasing response cost. Over time, a progressive shift toward high rates of responding on the active lever, but not the inactive lever, developed. The monkeys' behavior was clearly directed toward nicotine self-administration, rather than presentation of environmental stimuli associated with nicotine injection. Both schedules of reinforcement revealed a high motivation to self-administer nicotine, with monkeys continuing to press the lever when up to 600 lever-presses were needed for each injection of nicotine. Thus, nicotine, by itself, in the absence of behavioral or drug-exposure history, is a robust and highly effective reinforcer of drug-taking behavior in a non-human primate model predictive of human behavior. This supports the use of nicotinic ligands for the treatment of smokers, and this novel preclinical model offers opportunities to test future medications for the treatment of nicotine dependence.	[Le Foll, Bernard; Wertheim, Carrie; Goldberg, Steven R.] NIDA, Preclin Pharmacol Sect, NIH, Dept Hlth & Human Serv, Baltimore, MD 20892 USA; [Le Foll, Bernard] Ctr Addict & Mental Hlth, Translat Addict Res Lab, Toronto, ON, Canada; [Le Foll, Bernard] Univ Toronto, Toronto, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Le Foll, B (corresponding author), NIDA, Preclin Pharmacol Sect, NIH, Dept Hlth & Human Serv, Baltimore, MD 20892 USA.	bernard_lefoll@camh.net	Le Foll, Bernard/K-2952-2014	Le Foll, Bernard/0000-0002-6406-4973	Intramural Research Program of the National Institute on Drug Abuse; National Institutes of Health; Department of Health and Human Services; NATIONAL INSTITUTE ON DRUG ABUSE [ZIFDA000001, Z02DA000001, Z01DA000001, ZIADA000001] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services.	Agatsuma S, 2006, HUM MOL GENET, V15, P2721, DOI 10.1093/hmg/ddl206; ATOR NA, 1983, PHARMACOL BIOCHEM BE, V19, P993, DOI 10.1016/0091-3057(83)90406-9; BELLUZZI JD, 2004, NEUROPSYCHOPHARMACOL; Bruijnzeel AW, 2003, SYNAPSE, V50, P20, DOI 10.1002/syn.10242; Caggiula AR, 2001, PHARMACOL BIOCHEM BE, V70, P515, DOI 10.1016/S0091-3057(01)00676-1; Caggiula AR, 2002, PHYSIOL BEHAV, V77, P683, DOI 10.1016/S0031-9384(02)00918-6; Cohen C, 2005, NEUROPSYCHOPHARMACOL, V30, P145, DOI 10.1038/sj.npp.1300541; Corrigall W A, 1999, Nicotine Tob Res, V1, P11, DOI 10.1080/14622299050011121; Dar R, 2004, PSYCHOPHARMACOLOGY, V173, P18, DOI 10.1007/s00213-004-1781-2; Dar R, 2002, ADDICT RES THEORY, V10, P545, DOI 10.1080/1606635021000041753; DELAGARZA R, 1987, DRUG ALCOHOL DEPEN, V19, P17, DOI 10.1016/0376-8716(87)90083-4; DENEAU GA, 1967, ANN NY ACAD SCI, V142, P277, DOI 10.1111/j.1749-6632.1967.tb13730.x; Donny EC, 1999, PSYCHOPHARMACOLOGY, V147, P135, DOI 10.1007/s002130051153; Donny EC, 2003, PSYCHOPHARMACOLOGY, V169, P68, DOI 10.1007/s00213-003-1473-3; Donny EC, 2000, PSYCHOPHARMACOLOGY, V151, P392, DOI 10.1007/s002130000497; Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0; Fowler JS, 1996, P NATL ACAD SCI USA, V93, P14065, DOI 10.1073/pnas.93.24.14065; Garrett BE, 2001, J PHARMACOL EXP THER, V296, P486; GLOWA JR, 1983, SCIENCE, V220, P333; GOLDBERG SR, 1973, J PHARMACOL EXP THER, V186, P18; GOLDBERG SR, 1981, SCIENCE, V214, P573; GOLDBERG SR, 1983, PHARMACOL BIOCHEM BE, V19, P1011, DOI 10.1016/0091-3057(83)90408-2; GOLDBERG SR, 2005, PSYCHOPHARMACOLOGY B; Goldstein MG, 2000, CLIN PRACTICE GUIDEL; Griffiths R, 1979, ADV BEHAV PHARMACOL, V2, P163; Grigson PS, 1997, BEHAV NEUROSCI, V111, P129, DOI 10.1037/0735-7044.111.1.129; Guillem K, 2005, J NEUROSCI, V25, P8593, DOI 10.1523/JNEUROSCI.2139-05.2005; Harvey DM, 2004, PSYCHOPHARMACOLOGY, V175, P134, DOI 10.1007/s00213-004-1818-6; HENNINGFIELD JE, 1985, J PHARMACOL EXP THER, V234, P1; HENNINGFIELD JE, 1983, PHARMACOL BIOCHEM BE, V19, P1021, DOI 10.1016/0091-3057(83)90409-4; Hill R. T., 1970, AMPHETAMINE RELATED, P781; Justinova Z, 2003, PSYCHOPHARMACOLOGY, V169, P135, DOI 10.1007/s00213-003-1484-0; Laviolette SR, 2003, MOL PSYCHIATR, V8, P50, DOI 10.1038/sj.mp.4001197; Le Foll B, 2006, BEHAV PHARMACOL, V17, P195; Le Foll B, 2005, TRENDS PHARMACOL SCI, V26, P287, DOI 10.1016/j.tips.2005.04.005; Le Foll B, 2005, J PHARMACOL EXP THER, V312, P875, DOI 10.1124/jpet.104.077974; Le Foll B, 2005, NEUROPSYCHOPHARMACOL, V30, P720, DOI 10.1038/sj.npp.1300622; Le Foll B, 2005, PSYCHOPHARMACOLOGY, V178, P481, DOI 10.1007/s00213-004-2021-5; Le Foll B, 2006, PSYCHOPHARMACOLOGY, V184, P367, DOI 10.1007/s00213-005-0155-8; Le Foll B, 2005, NEUROPHARMACOLOGY, V49, P525, DOI 10.1016/j.neuropharm.2005.04.022; Le Foll B, 2004, NEUROREPORT, V15, P2139, DOI 10.1097/00001756-200409150-00028; Manzardo AM, 2002, BRAIN RES, V924, P10, DOI 10.1016/S0006-8993(01)03215-2; Markou A, 2004, ANN NY ACAD SCI, V1025, P491, DOI 10.1196/annals.1316.061; Olausson P, 2004, PSYCHOPHARMACOLOGY, V171, P173, DOI 10.1007/s00213-003-1575-y; Olausson P, 2003, NEUROPSYCHOPHARMACOL, V28, P1264, DOI 10.1038/sj.npp.1300173; Paterson NE, 2004, PSYCHOPHARMACOLOGY, V172, P179, DOI 10.1007/s00213-003-1637-1; Perkins KA, 2004, PSYCHOPHARMACOLOGY, V175, P256, DOI 10.1007/s00213-004-1930-7; ROBERTS DCS, 1993, PSYCHOPHARMACOLOGY, V111, P215, DOI 10.1007/BF02245526; ROBINSON JH, 1992, PSYCHOPHARMACOLOGY, V108, P397, DOI 10.1007/BF02247412; Samaha AN, 2005, TRENDS PHARMACOL SCI, V26, P82, DOI 10.1016/j.tips.2004.12.007; SANNERUD CA, 1994, EUR J PHARMACOL, V271, P461, DOI 10.1016/0014-2999(94)90807-9; SLIFER BL, 1985, PHARMACOL BIOCHEM BE, V22, P61, DOI 10.1016/0091-3057(85)90487-3; Soria R, 1996, PSYCHOPHARMACOLOGY, V128, P221, DOI 10.1007/s002130050129; SPEALMAN RD, 1982, J PHARMACOL EXP THER, V223, P402; SPEAR DJ, 1991, PHARMACOL BIOCHEM BE, V38, P411, DOI 10.1016/0091-3057(91)90300-Q; STOLERMAN IP, 1991, TRENDS PHARMACOL SCI, V12, P467, DOI 10.1016/0165-6147(91)90638-9; Tanda G, 2000, NAT NEUROSCI, V3, P1073, DOI 10.1038/80577; Villegier AS, 2006, NEUROPSYCHOPHARMACOL, V31, P1704, DOI 10.1038/sj.npp.1300987; Wakasa Yoshio, 1995, Japanese Journal of Psychopharmacology, V15, P53; WEST R, 1992, PSYCHOPHARMACOLOGY, V108, P408, DOI 10.1007/BF02247413; YANAGITA T, 1977, PREDICTING DEPENDENC, P231	61	55	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e230	10.1371/journal.pone.0000230	http://dx.doi.org/10.1371/journal.pone.0000230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311094	gold, Green Submitted, Green Published			2022-12-27	WOS:000207444500011
J	Andersen, GL; Krzywinski, K				Andersen, Gidske L.; Krzywinski, Knut			Mortality, Recruitment and Change of Desert Tree Populations in a Hyper-Arid Environment	PLOS ONE			English	Article							ACACIA-TORTILIS; NEGEV DESERT; PLANTS; ECOLOGY; DESERTIFICATION; RADDIANA; SAVANNA; REGION; CORONA	Background. Long-term vegetation changes in hyper-arid areas have long been neglected. Mortality, recruitment and change in populations of the ecologically and culturally important and drought persistent Acacia tortilis and Balanites aegyptiaca are therefore estimated in the Eastern Desert of Egypt, and are related to the primary agents of change, water conditions and human intervention. Methodology. A change analysis using high-resolution CORONA images (1965) in combination with field data (2003) is the basis for recruitment, mortality and change estimates. For assessing the influence of water conditions on patterns in recruitment and survival, different types of generalized linear models are tested. Conclusions. The overall trend in population size in that part of the Eastern Desert studied here is negative. At some sites this negative trend is alarming, because the reduction in mature trees is substantial (>50%) at the same time as recruitment is nearly absent. At a few sites there is a positive trend and better recruitment. Frequent observations of sprouting in saplings indicate that this is an important mechanism to increase their persistence. It is the establishment itself that seems to be the main challenge in the recruitment process. There are indications that hydrological variables and surface water in particular can explain some of the observed pattern in mortality, but our results indicate that direct human intervention, i.e., charcoal production, is the main cause of tree mortality in the Eastern Desert.	[Andersen, Gidske L.; Krzywinski, Knut] Univ Bergen, Dept Biol, Bergen, Norway	University of Bergen	Andersen, GL (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	Gidske.Andersen@bio.uib.no	Andersen, Gidske L./AAA-5332-2020; Andersen, Gary/G-2792-2015	Andersen, Gidske L./0000-0002-7941-4155; Andersen, Gary/0000-0002-1618-9827	Norwegian Research Council [149181/730]; Faculty of Mathematics and Natural Sciences, University of Bergen; Olaf Grolle Olsens Legat; L. Meltzers Hoyskolefond	Norwegian Research Council(Research Council of NorwayEuropean Commission); Faculty of Mathematics and Natural Sciences, University of Bergen; Olaf Grolle Olsens Legat; L. Meltzers Hoyskolefond	The Norwegian Research Council ( project no. 149181/730), the Faculty of Mathematics and Natural Sciences, University of Bergen, Olaf Grolle Olsens Legat and L. Meltzers Hoyskolefond funded this research.	Andersen GL, 2006, J ARID ENVIRON, V65, P491, DOI 10.1016/j.jaridenv.2005.07.010; ANDERSEN GL, 1999, CHANGE VARIATION HYP; Anyamba A, 2005, J ARID ENVIRON, V63, P596, DOI 10.1016/j.jaridenv.2005.03.007; Archibald S, 2003, OIKOS, V102, P3, DOI 10.1034/j.1600-0706.2003.12181.x; Ashkenazi S., 1995, ACACIA TREES NEGEV A, pXVII; Ayyad M. A., 1985, HOT DESERT ARID SHRU, V149-202; Bassett TJ, 2000, ANN ASSOC AM GEOGR, V90, P67, DOI 10.1111/0004-5608.00184; BATANOUNY KH, 1973, OECOLOGIA, V11, P151, DOI 10.1007/BF00345129; BenDavidNovak H, 1997, CATENA, V29, P341, DOI 10.1016/S0341-8162(96)00066-5; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Bond WJ, 2003, INT J PLANT SCI, V164, pS103, DOI 10.1086/374191; Boulos L, 1999, FLORA EGYPT; BRIGGS J, 1993, APPL GEOGR, V13, P259, DOI 10.1016/0143-6228(93)90004-K; COLE R, 1989, MEASURING DROUGHT DR, P266; Crawley M. J, 2002, STAT COMPUTING INTRO; Del Tredici P, 2001, BOT REV, V67, P121, DOI 10.1007/BF02858075; Floyer E.A., GEOGR J, V1, P408, DOI [10.2307/1774067, DOI 10.2307/1774067]; Foody GM, 2004, J HYDROL, V292, P48, DOI 10.1016/j.jhydrol.2003.12.045; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gheith H, 2002, J HYDROL, V263, P36, DOI 10.1016/S0022-1694(02)00027-6; HALEVY G, 1973, ISRAEL J BOT, V22, P120; HELLDEN U, 1991, AMBIO, V20, P372; Hobbs JJ., 1989, BEDOUIN LIFE EGYPTIA; Hutchinson CF, 2005, J ARID ENVIRON, V63, P535, DOI 10.1016/j.jaridenv.2005.03.002; KASSAS M, 1954, J ECOL, V42, P424, DOI 10.2307/2256869; KENNENNI L, 1990, J VEG SCI, V1, P419, DOI 10.2307/3235719; Klunzinger C. B, 1878, UPPER EGYPT ITS PEOP; Krzywinski K., 2001, DESERTING DESERT THR; Lambin EF, 1997, REMOTE SENS ENVIRON, V61, P181, DOI 10.1016/S0034-4257(97)00001-1; Martin DM, 1997, AFR J ECOL, V35, P266, DOI 10.1111/j.1365-2028.1997.067-89067.x; MCDONALD RA, 1995, PHOTOGRAMM ENG REM S, V61, P689; Midgley JJ, 2001, J TROP ECOL, V17, P871, DOI 10.1017/S026646740100164X; *MILL EC ASS, EC HUM WELL BEING DE; Murray G. W., 1935, SONS ISHMAEL; Rasmussen K, 2001, GLOBAL ENVIRON CHANG, V11, P271, DOI 10.1016/S0959-3780(01)00005-X; Rohner C, 1999, CONSERV BIOL, V13, P1162, DOI 10.1046/j.1523-1739.1999.97300.x; Shrestha MK, 2003, PLANT ECOL, V168, P297, DOI 10.1023/A:1024431124954; SPRINGUEL I, 1994, ENVIRON CONSERV, V21, P41, DOI 10.1017/S0376892900024061; Thomas D., 1994, DESERTIFICATION EXPL; TUCKER CJ, 1991, SCIENCE, V253, P299, DOI 10.1126/science.253.5017.299; Venables WN., 2002, MODERN APPL STAT S 4; Ward D, 1997, BIODIVERS CONSERV, V6, P877, DOI 10.1023/B:BIOC.0000010408.90955.48; Wiegand K, 2004, OECOLOGIA, V141, P363, DOI 10.1007/s00442-003-1439-5; Wiegand K, 2000, J VEG SCI, V11, P473, DOI 10.2307/3246577; Wilson TB, 1998, J ARID ENVIRON, V38, P541, DOI 10.1006/jare.1998.0362	45	36	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e208	10.1371/journal.pone.0000208	http://dx.doi.org/10.1371/journal.pone.0000208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299588	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444400009
J	Lemjabbar-Alaoui, H; Dasari, V; Sidhu, SS; Mengistab, A; Finkbeiner, W; Gallup, M; Basbaum, C				Lemjabbar-Alaoui, Hassan; Dasari, Vijay; Sidhu, Sukhvinder S.; Mengistab, Aklilu; Finkbeiner, Walter; Gallup, Marianne; Basbaum, Carol			Wnt and Hedgehog Are Critical Mediators of Cigarette Smoke-Induced Lung Cancer	PLOS ONE			English	Article								Background. Lung cancer is the leading cause of cancer death in the world, and greater than 90% of lung cancers are cigarette smoke-related. Current treatment options are inadequate, because the molecular basis of cigarette-induced lung cancer is poorly understood. Methodology/Principal Findings. Here, we show that human primary or immortalized bronchial epithelial cells exposed to cigarette smoke for eight days in culture rapidly proliferate, show anchorage-independent growth, and form tumors in nude mice. Using this model of the early stages of smoke-induced tumorigenesis, we examined the molecular changes leading to lung cancer. We observed that the embryonic signaling pathways mediated by Hedgehog and Wnt are activated by smoke. Pharmacological inhibition of these pathways blocked the transformed phenotype. Conclusions/Significance. These experiments provide a model in which the early stages of smoke-induced tumorigenesis can be elicited, and should permit us to identify molecular changes driving this process. Results obtained so far indicate that smoke-induced lung tumors are driven by activation of two embryonic regulatory pathways, Hedgehog (Hh) and Wnt. Based on the current and emerging availability of drugs to inhibit Hh and Wnt signaling, it is possible that an understanding of the role of Hh and Wnt in lung cancer pathogenesis will lead to the development of new therapies.	[Lemjabbar-Alaoui, Hassan; Dasari, Vijay; Sidhu, Sukhvinder S.; Mengistab, Aklilu; Gallup, Marianne; Basbaum, Carol] Univ Calif San Francisco, Cardiovasc Res Inst, Program Biomed Sci, San Francisco, CA 94143 USA; [Lemjabbar-Alaoui, Hassan; Dasari, Vijay; Sidhu, Sukhvinder S.; Mengistab, Aklilu; Gallup, Marianne; Basbaum, Carol] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Sidhu, Sukhvinder S.] Univ Calif San Francisco, Div Pulm & Crit Care, Dept Med, San Francisco, CA 94143 USA; [Sidhu, Sukhvinder S.] Univ Calif San Francisco, Div Allergy Immunol, Dept Med, San Francisco, CA 94143 USA; [Finkbeiner, Walter] San Francisco Gen Hosp, Dept Anat Pathol, San Francisco, CA 94110 USA; [Finkbeiner, Walter] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California Davis	Lemjabbar-Alaoui, H (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Program Biomed Sci, San Francisco, CA 94143 USA.	Hassan.alaoui@yahoo.com		Sidhu, Sukhvinder/0000-0002-2999-4358	National Institutes of Health [R01 HL075602, P01 HL024136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136, R01HL075602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants R01 HL075602 and P01 HL024136 from the National Institutes of Health.	Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Boon EMJ, 2002, CANCER RES, V62, P5126; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Fujita E, 1997, BIOCHEM BIOPH RES CO, V238, P658, DOI 10.1006/bbrc.1997.7262; HAN W, 2005, MOL CARCINOG; Hecht SS, 2005, CARCINOGENESIS, V26, P1488, DOI 10.1093/carcin/bgi148; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kim Y, 2006, CANCER LETT, V234, P209, DOI 10.1016/j.canlet.2005.03.052; Lechner J F, 1985, J TISSUE CULT METHOD, V9, P43; Lemjabbar H, 2003, J BIOL CHEM, V278, P26202, DOI 10.1074/jbc.M207018200; Polakis P, 2000, GENE DEV, V14, P1837; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Schuller HM, 2005, LUNG CANCER, V49, P35, DOI 10.1016/j.lungcan.2004.12.012; Shapiro SD, 2004, AM J RESP CELL MOL, V31, P481, DOI 10.1165/rcmb.F285; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Uren A, 2005, CANCER RES, V65, P6199, DOI 10.1158/0008-5472.CAN-05-0455; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vassallo R, 2005, J IMMUNOL, V175, P2684, DOI 10.4049/jimmunol.175.4.2684; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wetmore C, 2003, CURR OPIN GENET DEV, V13, P34, DOI 10.1016/S0959-437X(03)00002-9; *WHO, 2000, 11 C TOB OR HLTH; Witschi H, 1997, CARCINOGENESIS, V18, P2035, DOI 10.1093/carcin/18.11.2035; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219	31	90	93	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e93	10.1371/journal.pone.0000093	http://dx.doi.org/10.1371/journal.pone.0000093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183725	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600092
J	Nahrendorf, M; Weissleder, R; Ertl, G				Nahrendorf, Matthias; Weissleder, Ralph; Ertl, Georg			Does FXIII Deficiency Impair Wound Healing after Myocardial Infarction?	PLOS ONE			English	Article								Inadequate healing of myocardial infarction may contribute to local expansion of the infarct, frequently leading to chamber dilation, heart failure, or myocardial rupture. Experimental evidence in mouse models suggests that Factor XIII might play a key role in wound healing, and low persistent values lead to increased incidence of cardiac rupture following myocardial infarction. Here we would like to share our initial clinical experiences with strikingly similar observations in patients with this grave disease, and compare these observations to experimental findings.	[Nahrendorf, Matthias; Ertl, Georg] Univ Wurzburg, Med Klin & Poliklin 1, Wurzburg, Germany; [Nahrendorf, Matthias; Weissleder, Ralph] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA	University of Wurzburg; Harvard University; Massachusetts General Hospital	Ertl, G (corresponding author), Univ Wurzburg, Med Klin & Poliklin 1, Wurzburg, Germany.	Ertl_G@medizin.uni-wuerzburg.de		/0000-0003-0828-4143				GAUDRON P, 1993, CIRCULATION, V87, P755, DOI 10.1161/01.CIR.87.3.755; Inbal A, 2005, THROMB HAEMOSTASIS, V94, P432, DOI 10.1160/TH05-04-0291; Nahrendorf M, 2006, CIRCULATION, V113, P1196, DOI 10.1161/CIRCULATIONAHA.105.602094	3	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e48	10.1371/journal.pone.0000048	http://dx.doi.org/10.1371/journal.pone.0000048			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183677	Green Published, gold			2022-12-27	WOS:000207443600048
J	Pickart, MA; Klee, EW; Nielsen, AL; Sivasubbu, S; Mendenhall, EM; Bill, BR; Chen, E; Eckfeldt, CE; Knowlton, M; Robu, ME; Larson, JD; Deng, Y; Schimmenti, LA; Ellis, LBM; Verfaillie, CM; Hammerschmidt, M; Farber, SA; Ekker, SC				Pickart, Michael A.; Klee, Eric W.; Nielsen, Aubrey L.; Sivasubbu, Sridhar; Mendenhall, Eric M.; Bill, Brent R.; Chen, Eleanor; Eckfeldt, Craig E.; Knowlton, Michelle; Robu, Mara E.; Larson, Jon D.; Deng, Yun; Schimmenti, Lisa A.; Ellis, Lynda B. M.; Verfaillie, Catherine M.; Hammerschmidt, Matthias; Farber, Steven A.; Ekker, Stephen C.			Genome-Wide Reverse Genetics Framework to Identify Novel Functions of the Vertebrate Secretome	PLOS ONE			English	Article								Background. Understanding the functional role(s) of the more than 20,000 proteins of the vertebrate genome is a major next step in the post-genome era. The approximately 4,000 co-translationally translocated (CTT) proteins - representing the vertebrate secretome - are important for such vertebrate-critical processes as organogenesis. However, the role(s) for most of these genes is currently unknown. Results. We identified 585 putative full-length zebrafish CTT proteins using cross-species genomic and EST-based comparative sequence analyses. We further investigated 150 of these genes (Figure 1) for unique function using morpholino-based analysis in zebrafish embryos. 12% of the CTT protein-deficient embryos resulted in specific developmental defects, a notably higher rate of gene function annotation than the 2%-3% estimate from random gene mutagenesis studies. Conclusion(s). This initial collection includes novel genes required for the development of vascular, hematopoietic, pigmentation, and craniofacial tissues, as well as lipid metabolism, and organogenesis. This study provides a framework utilizing zebrafish for the systematic assignment of biological function in a vertebrate genome.	[Nielsen, Aubrey L.; Sivasubbu, Sridhar; Mendenhall, Eric M.; Bill, Brent R.; Chen, Eleanor; Knowlton, Michelle; Robu, Mara E.; Larson, Jon D.; Schimmenti, Lisa A.; Ekker, Stephen C.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Nielsen, Aubrey L.; Sivasubbu, Sridhar; Mendenhall, Eric M.; Bill, Brent R.; Chen, Eleanor; Knowlton, Michelle; Robu, Mara E.; Larson, Jon D.; Ekker, Stephen C.] Univ Minnesota, Arnold & Mabel Beckman Ctr Transposon Res, Minneapolis, MN USA; [Pickart, Michael A.; Robu, Mara E.] Univ Minnesota, Dept Oral Sci, Minneapolis, MN USA; [Pickart, Michael A.; Robu, Mara E.] Univ Minnesota, MinnCResT, Minneapolis, MN USA; [Bill, Brent R.; Schimmenti, Lisa A.] Univ Minnesota, Dept Pediat Genet & Metab, Minneapolis, MN USA; [Bill, Brent R.; Schimmenti, Lisa A.] Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA; [Klee, Eric W.; Ellis, Lynda B. M.] Univ Minnesota, Lab Med & Pathol & Comp Sci & Engn, Minneapolis, MN 55455 USA; [Mendenhall, Eric M.; Eckfeldt, Craig E.; Verfaillie, Catherine M.] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; [Mendenhall, Eric M.; Eckfeldt, Craig E.; Verfaillie, Catherine M.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Hammerschmidt, Matthias] Max Planck Inst Immunobiol, D-7800 Freiburg, Germany; [Deng, Yun; Farber, Steven A.] Carnegie Inst Washington, Baltimore, MD USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Max Planck Society; Carnegie Institution for Science	Ekker, SC (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	ekker001@umn.edu	Farber, Steven A/G-5851-2012; Verfaillie, Catherine/H-5148-2013	Farber, Steven A/0000-0002-8037-7312; Verfaillie, Catherine/0000-0001-7564-4079; Eckfeldt, Craig/0000-0003-2834-0421; Schimmenti, Lisa/0000-0003-3154-4249; Ekker, Stephen/0000-0003-0726-4212; Mendenhall, Eric/0000-0002-7395-6295; Bill, Brent/0000-0002-3436-1969	NIH [T32-DE07288-07 (NIDCR), NLM TG-0704l, RO1 to SCE GM63904]; Arnold and Mabel Beckman Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM063904, R01GM063904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants: Postdoctoral traineeship to MAP NIH T32-DE07288-07 (NIDCR), a predoctoral traineeship to EWK (NLM TG-0704l), NIH RO1 to SCE GM63904 (NIH) and the Arnold and Mabel Beckman Foundation.	Amsterdam A, 2006, TRENDS GENET, V22, P473, DOI 10.1016/j.tig.2006.06.011; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783; Chen E, 2005, DEV BIOL, V284, P364, DOI 10.1016/j.ydbio.2005.05.032; Chen E, 2006, BLOOD, V107, P4364, DOI 10.1182/blood-2005-02-0789; CHEN PS, 1956, ANAL CHEM, V28, P1758; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Driever W, 1996, DEVELOPMENT, V123, P37; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; Ekker SC, 2004, METHOD CELL BIOL, V77, P121; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Hermanson S, 2004, METHOD CELL BIOL, V77, P349; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Kenwrick S, 2004, DEV DYNAM, V229, P289, DOI 10.1002/dvdy.10440; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klee EW, 2005, NUCLEIC ACIDS RES, V33, pW506, DOI 10.1093/nar/gki453; Klee EW, 2004, NUCLEIC ACIDS RES, V32, P1414, DOI 10.1093/nar/gkh286; Klee EW, 2001, GENESIS, V30, P123, DOI 10.1002/gene.1045; Liang F, 2000, NUCLEIC ACIDS RES, V28, P3657, DOI 10.1093/nar/28.18.3657; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pelegri F, 1999, METHOD CELL BIOL, V60, P1; Pickart MA, 2004, PIGM CELL RES, V17, P461, DOI 10.1111/j.1600-0749.2004.00189.x; Shen Y, 2002, J BIOL CHEM, V277, P4334, DOI 10.1074/jbc.M105421200; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wagner DS, 2004, DEV CELL, V6, P781, DOI 10.1016/j.devcel.2004.04.001; Yamada L, 2003, DEVELOPMENT, V130, P6485, DOI 10.1242/dev.00847	32	61	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e104	10.1371/journal.pone.0000104	http://dx.doi.org/10.1371/journal.pone.0000104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17218990	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600103
J	Slater, M; Antley, A; Davison, A; Swapp, D; Guger, C; Barker, C; Pistrang, N; Sanchez-Vives, MV				Slater, Mel; Antley, Angus; Davison, Adam; Swapp, David; Guger, Christoph; Barker, Chris; Pistrang, Nancy; Sanchez-Vives, Maria V.			A Virtual Reprise of the Stanley Milgram Obedience Experiments	PLOS ONE			English	Article							REALITY; PSYCHOLOGY	Background. Stanley Milgram's 1960s experimental findings that people would administer apparently lethal electric shocks to a stranger at the behest of an authority figure remain critical for understanding obedience. Yet, due to the ethical controversy that his experiments ignited, it is nowadays impossible to carry out direct experimental studies in this area. In the study reported in this paper, we have used a similar paradigm to the one used by Milgram within an immersive virtual environment. Our objective has not been the study of obedience in itself, but of the extent to which participants would respond to such an extreme social situation as if it were real in spite of their knowledge that no real events were taking place. Methodology. Following the style of the original experiments, the participants were invited to administer a series of word association memory tests to the (female) virtual human representing the stranger. When she gave an incorrect answer, the participants were instructed to administer an 'electric shock' to her, increasing the voltage each time. She responded with increasing discomfort and protests, eventually demanding termination of the experiment. Of the 34 participants, 23 saw and heard the virtual human, and 11 communicated with her only through a text interface. Conclusions. Our results show that in spite of the fact that all participants knew for sure that neither the stranger nor the shocks were real, the participants who saw and heard her tended to respond to the situation at the subjective, behavioural and physiological levels as if it were real. This result reopens the door to direct empirical studies of obedience and related extreme social situations, an area of research that is otherwise not open to experimental study for ethical reasons, through the employment of virtual environments.	[Slater, Mel; Antley, Angus; Davison, Adam; Swapp, David] UCL, Dept Comp Sci, London, England; [Guger, Christoph] Guger Technol OEG, Schiedlberg, Austria; [Barker, Chris; Pistrang, Nancy] UCL, Subdept Clin Hlth Psychol, London, England; [Sanchez-Vives, Maria V.] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain; [Slater, Mel] Univ Politecn Cataluna, Inst Catalana Recerca & Estudis Avancats, Virtual Real Ctr Barcelona, Barcelona, Spain	University of London; University College London; University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); ICREA; Universitat Politecnica de Catalunya	Slater, M (corresponding author), UCL, Dept Comp Sci, London, England.	melslater@gmail.com	Sanchez-Vives, Maria/J-8526-2014; Slater, Mel/M-5210-2014; Pistrang, Nancy/C-3021-2008; Barker, Chris/C-2193-2008	Sanchez-Vives, Maria/0000-0002-8437-9083; Slater, Mel/0000-0002-6223-0050; Barker, Chris/0000-0002-9268-9356; Swapp, David/0000-0002-9335-8663	European Union [PRESENCIA IST-2001-37927]; ICREA Funding Source: Custom	European Union(European Commission); ICREA(ICREA)	Funding: The work described in this paper was funded under the European Union IST FET research grant PRESENCIA IST-2001-37927. The funding agency was not involved at all in the study, nor in any aspect of analysis or writing up of the results, nor in the preparation of the paper.	Atran S, 2003, SCIENCE, V299, P1534, DOI 10.1126/science.1078854; Bailenson JN, 2005, PSYCHOL SCI, V16, P814, DOI 10.1111/j.1467-9280.2005.01619.x; BAUMRIND D, 1964, AM PSYCHOL, V19, P421, DOI 10.1037/h0040128; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Blass T, 2001, CURR PSYCHOL, V20, P115, DOI 10.1007/s12144-001-1019-y; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Camm AJ, 1996, EUR HEART J, V17, P354; Costa PT, 2007, REVISED NEO PERSONAL; Critchley HD, 2000, J NEUROSCI, V20, P3033; Cruz-Neira C., 1993, SIGGRAPH 93 P 20 ANN, P135, DOI [10.1145/166117.166134, DOI 10.1145/166117.166134]; Dienes Z, 1999, BEHAV BRAIN SCI, V22, P735, DOI 10.1017/S0140525X99002186; Draper JV, 1998, HUM FACTORS, V40, P354, DOI 10.1518/001872098779591386; Ellis S. R., 1991, Computing Systems in Engineering, V2, P321, DOI 10.1016/0956-0521(91)90001-L; Fiske ST, 2004, SCIENCE, V306, P1482, DOI 10.1126/science.1103788; Freeman D, 2005, J NERV MENT DIS, V193, P302, DOI 10.1097/01.nmd.0000161687.12931.67; Freeman D, 2005, J NERV MENT DIS, V193, P309, DOI 10.1097/01.nmd.0000161686.53245.70; Freeman D, 2003, J NERV MENT DIS, V191, P509, DOI 10.1097/01.nmd.0000082212.83842.fe; Held R.M., 1992, PRESENCE TELEOPERATO, V1, P109, DOI [10.1121/1.404500, 10.1162/pres.1992.1.1.109, DOI 10.1162/PRES.1992.1.1.109]; Levine M, 2002, J APPL SOC PSYCHOL, V32, P1452, DOI 10.1111/j.1559-1816.2002.tb01446.x; MANDLER G, 1958, J ABNORM SOC PSYCH, V56, P367, DOI 10.1037/h0048083; MCCULLAGH P, 1989, GEN LINEAR MODELS, pR19; MILGRAM S, 1964, AM PSYCHOL, V19, P848, DOI 10.1037/h0044954; MILGRAM S., 1974, OBEDIENCE AUTHORITY; Mixon D., 1972, J THEOR SOC BEHAV, V2, P145, DOI DOI 10.1111/J.1468-5914.1972.TB00309.X; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Pertaub DP, 2002, PRESENCE-TELEOP VIRT, V11, P68, DOI 10.1162/105474602317343668; Rizzo AA, 2004, BIOL PSYCHIAT, V55, p50S; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Sheridan T.B., 1992, PRESENCE TELEOPERATO, V1, P120, DOI [10.1162/pres.1992.1.1.120, DOI 10.1162/PRES.1992.1.1.120]; VENABLES P, 1978, PSYCHOPHYSIOLOGY, V15, P302, DOI 10.1111/j.1469-8986.1978.tb01383.x	32	281	282	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e39	10.1371/journal.pone.0000039	http://dx.doi.org/10.1371/journal.pone.0000039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183667	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600039
J	Zhu, JC; Jambhekar, A; Sarver, A; DeRisi, J				Zhu, Jingchun; Jambhekar, Ashwini; Sarver, Aaron; DeRisi, Joseph			A Bayesian Network Driven Approach to Model the Transcriptional Response to Nitric Oxide in Saccharomyces cerevisiae	PLOS ONE			English	Article							GENE-EXPRESSION; NITROSATIVE STRESS; REACTIVE OXYGEN	The transcriptional response to exogenously supplied nitric oxide in Saccharomyces cerevisiae was modeled using an integrated framework of Bayesian network learning and experimental feedback. A Bayesian network learning algorithm was used to generate network models of transcriptional output, followed by model verification and revision through experimentation. Using this framework, we generated a network model of the yeast transcriptional response to nitric oxide and a panel of other environmental signals. We discovered two environmental triggers, the diauxic shift and glucose repression, that affected the observed transcriptional profile. The computational method predicted the transcriptional control of yeast flavohemoglobin YHB1 by glucose repression, which was subsequently experimentally verified. A freely available software application, ExpressionNet, was developed to derive Bayesian network models from a combination of gene expression profile clusters, genetic information and experimental conditions.	[Zhu, Jingchun; Jambhekar, Ashwini; Sarver, Aaron; DeRisi, Joseph] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [DeRisi, Joseph] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	DeRisi, J (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	joe@derisilab.ucsf.edu		Jambhekar, Ashwini/0000-0003-1078-6601	Burroughs Wellcome Fund; National Science Foundation; David and Lucile Packard Foundation; Howard Hughes Medical Institute	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Burroughs Wellcome Fund (JZ, JDR), the National Science Foundation (AJ), the David and Lucile Packard Foundation (AS, JDR), and the Howard Hughes Medical Institute (JDR).	Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; BROACH JR, 1991, MOL CELLULAR BIOL YE, pR5; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; FANG FC, 1999, NITRIC OXIDE INFECT, pR25; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hartemink A J, 2001, Pac Symp Biocomput, P422; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Heckerman D., 1999, LEARNING GRAPHICAL M, P301; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; HROMATKA BS, 2005, MOL BIOL CELL; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JORDAN MI, 1999, LEARNING GRAPHICAL M, pR7; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Missall TA, 2004, EUKARYOT CELL, V3, P835, DOI 10.1128/EC.3.4.835-846.2004; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; NITTLER MP, 2005, MOL BIOL CELL; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; PEARL J, 1988, PROBABILISTIC REASON, pR19; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; SARVER A, 2005, MOL BIOL CELL; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; SEGAL E, 2003, BIOINFORMATICS, V1, P1; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; Zhao XJ, 1996, J BIOL CHEM, V271, P25131, DOI 10.1074/jbc.271.41.25131	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e94	10.1371/journal.pone.0000094	http://dx.doi.org/10.1371/journal.pone.0000094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183726	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600093
J	Smolen, P				Smolen, Paul			A Model of Late Long-Term Potentiation Simulates Aspects of Memory Maintenance	PLOS ONE			English	Article								Late long-term potentiation (L-LTP) denotes long-lasting strengthening of synapses between neurons. L-LTP appears essential for the formation of long-term memory, with memories at least partly encoded by patterns of strengthened synapses. How memories are preserved for months or years, despite molecular turnover, is not well understood. Ongoing recurrent neuronal activity, during memory recall or during sleep, has been hypothesized to preferentially potentiate strong synapses, preserving memories. This hypothesis has not been evaluated in the context of a mathematical model representing ongoing activity and biochemical pathways important for L-LTP. In this study, ongoing activity was incorporated into two such models - a reduced model that represents some of the essential biochemical processes, and a more detailed published model. The reduced model represents synaptic tagging and gene induction simply and intuitively, and the detailed model adds activation of essential kinases by Ca(2+). Ongoing activity was modeled as continual brief elevations of Ca(2+). In each model, two stable states of synaptic strength/weight resulted. Positive feedback between synaptic weight and the amplitude of ongoing Ca(2+) transients underlies this bistability. A tetanic or theta-burst stimulus switches a model synapse from a low basal weight to a high weight that is stabilized by ongoing activity. Bistability was robust to parameter variations in both models. Simulations illustrated that prolonged periods of decreased activity reset synaptic strengths to low values, suggesting a plausible forgetting mechanism. However, episodic activity with shorter inactive intervals maintained strong synapses. Both models support experimental predictions. Tests of these predictions are expected to further understanding of how neuronal activity is coupled to maintenance of synaptic strength. Further investigations that examine the dynamics of activity and synaptic maintenance can be expected to help in understanding how memories are preserved for up to a lifetime in animals including humans.	Univ Texas Med Sch Houston, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Smolen, P (corresponding author), Univ Texas Med Sch Houston, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX USA.	Paul.D.Smolen@uth.tmc.edu			National Institutes of Health [P01 NS038310]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grant P01 NS038310	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ABELES M, 1993, J NEUROPHYSIOL, V70, P1624; Abraham WC, 2002, J NEUROSCI, V22, P9626; Bhalla US, 2004, BIOPHYS J, V87, P745, DOI 10.1529/biophysj.104.040501; Bhalla US, 2002, BIOPHYS J, V83, P740, DOI 10.1016/S0006-3495(02)75205-3; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Blitzer RD, 2005, BIOL PSYCHIAT, V57, P113, DOI 10.1016/j.biopsych.2004.02.031; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Buckby LE, 2006, MOL CELL NEUROSCI, V31, P805, DOI 10.1016/j.mcn.2006.01.009; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; Cui ZZ, 2005, EUR J NEUROSCI, V22, P755, DOI 10.1111/j.1460-9568.2005.04257.x; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fusi S, 2000, NEURAL COMPUT, V12, P2227, DOI 10.1162/089976600300014917; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Hayer A, 2005, PLOS COMPUT BIOL, V1, P137, DOI 10.1371/journal.pcbi.0010020; Hayon G, 2005, J COMPUT NEUROSCI, V18, P41, DOI 10.1007/s10827-005-5479-1; Horn D, 1998, NETWORK-COMP NEURAL, V9, P577, DOI 10.1088/0954-898X/9/4/011; Horn D, 1998, NEURAL COMPUT, V10, P1, DOI 10.1162/089976698300017863; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Kalitzin S, 2000, BIOL CYBERN, V83, P139, DOI 10.1007/s004220000157; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Karpova A, 2006, NEUROSCIENCE, V137, P833, DOI 10.1016/j.neuroscience.2005.10.012; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; KAVANAU JL, 1994, BEHAV BRAIN RES, V63, P111; Kavanau JL, 1997, NEUROSCIENCE, V79, P7, DOI 10.1016/S0306-4522(96)00610-0; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kikuchi S, 2003, NEURAL NETWORKS, V16, P1389, DOI 10.1016/j.neunet.2003.09.002; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lestienne R, 2001, PROG NEUROBIOL, V65, P545, DOI 10.1016/S0301-0082(01)00019-3; Levy WB, 2005, NEURAL NETWORKS, V18, P1242, DOI 10.1016/j.neunet.2005.08.005; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Molter C, 2007, HIPPOCAMPUS, V17, P201, DOI 10.1002/hipo.20258; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Park CS, 2006, J BIOL CHEM, V281, P30195, DOI 10.1074/jbc.M605876200; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Press W., 1992, NUMERICAL RECIPES FO; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Sakagami H, 2005, EUR J NEUROSCI, V22, P2697, DOI 10.1111/j.1460-9568.2005.04463.x; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Seliger P, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.011905; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Simpson RE, 2006, J BIOL CHEM, V281, P17379, DOI 10.1074/jbc.M510992200; Smolen P, 2006, BIOPHYS J, V90, P2760, DOI 10.1529/biophysj.105.072470; SORRA KE, 1993, J NEUROSCI, V13, P3736; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Vickers CA, 2005, J PHYSIOL-LONDON, V568, P803, DOI 10.1113/jphysiol.2005.092924; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wittenberg GM, 2002, HIPPOCAMPUS, V12, P637, DOI 10.1002/hipo.10102; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Woo NH, 2000, J NEUROPHYSIOL, V84, P2739, DOI 10.1152/jn.2000.84.6.2739; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yeung LC, 2004, P NATL ACAD SCI USA, V101, P14943, DOI 10.1073/pnas.0405555101; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Young JZ, 2006, EUR J NEUROSCI, V23, P1784, DOI 10.1111/j.1460-9568.2006.04707.x	81	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e445	10.1371/journal.pone.0000445	http://dx.doi.org/10.1371/journal.pone.0000445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505541	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445900005
J	Lin, B; Malanoski, AP; Wang, Z; Blaney, KM; Ligler, AG; Rowley, RK; Hanson, EH; von Rosenvinge, E; Ligler, FS; Kusterbeck, AW; Metzgar, D; Barrozo, CP; Russell, KL; Tibbetts, C; Schnur, JM; Stenger, DA				Lin, Baochuan; Malanoski, Anthony P.; Wang, Zheng; Blaney, Kate M.; Ligler, Adam G.; Rowley, Robb K.; Hanson, Eric H.; von Rosenvinge, Erik; Ligler, Frances S.; Kusterbeck, Anne W.; Metzgar, David; Barrozo, Christopher P.; Russell, Kevin L.; Tibbetts, Clark; Schnur, Joel M.; Stenger, David A.			Application of Broad-Spectrum, Sequence-Based Pathogen Identification in an Urban Population	PLOS ONE			English	Article								A broad spectrum detection platform that provides sequence level resolution of target regions would have a significant impact in public health, case management, and means of expanding our understanding of the etiology of diseases. A previously developed respiratory pathogen microarray (RPM v.1) demonstrated the capability of this platform for this purpose. This newly developed RPM v.1 was used to analyze 424 well-characterized nasal wash specimens from patients presenting with febrile respiratory illness in the Washington, D. C. metropolitan region. For each specimen, the RPM v.1 results were compared against composite reference assay (viral and bacterial culture and, where appropriate, RT-PCR/PCR) results. Across this panel, the RPM assay showed >= 98% overall agreement for all the organisms detected compared with reference methods. Additionally, the RPM v.1 results provide sequence information which allowed phylogenetic classification of circulating influenza A viruses in similar to 250 clinical specimens, and allowed monitoring the genetic variation as well as antigenic variability prediction. Multiple pathogens (2-4) were detected in 58 specimens (13.7%) with notably increased abundances of respiratory colonizers (esp. S. pneumoniae) during viral infection. This first-ever comparison of a broad-spectrum viral and bacterial identification technology of this type against a large battery of conventional "gold standard'' assays confirms the utility of the approach for both medical surveillance and investigations of complex etiologies of illness caused by respiratory co-infections.	[Lin, Baochuan; Malanoski, Anthony P.; Ligler, Frances S.; Kusterbeck, Anne W.; Schnur, Joel M.; Stenger, David A.] USN, Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Wang, Zheng; Blaney, Kate M.; Ligler, Adam G.] NOVA Res Inc, Alexandria, VA USA; [Rowley, Robb K.; Hanson, Eric H.; Tibbetts, Clark] Headquarters USAF Surg Gen, Falls Church, VA USA; [von Rosenvinge, Erik] Malcolm Grow USAF Med Ctr, Andrews AFB, MD USA; [Metzgar, David; Barrozo, Christopher P.; Russell, Kevin L.] Naval Hlth Res Ctr, Ctr Deployment Hlth Res, Dept Def, San Diego, CA USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Nova Research, Inc.; United States Department of Defense; United States Air Force; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Lin, B (corresponding author), USN, Res Lab, Ctr Bio Mol Sci & Engn, Code 6900, Washington, DC 20375 USA.	baochuan.lin@nrl.navy.mil	Lin, Baochuan/A-8390-2009; Malanoski, Anthony/P-6975-2019; Hanson, Eric H/B-7367-2009; Malanoski, Anthony P/C-7814-2011	Lin, Baochuan/0000-0002-9484-0785; Malanoski, Anthony/0000-0001-6192-888X; Malanoski, Anthony P/0000-0001-6192-888X; von Rosenvinge, Erik C./0000-0002-1862-7288	NRL; Office of Naval Research	NRL; Office of Naval Research(Office of Naval Research)	The funding for this research is provided by the NRL base program and the Office of Naval Research. This project would not be possible without the support from the Air Force Surgeon General Office, the Joint Program Executive Office and Defense Threat Reduction Agency during the Silent Guardian Demonstration Project.	Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Davignon L, 2005, J CLIN MICROBIOL, V43, P5690, DOI 10.1128/JCM.43.11.5690-5695.2005; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Lewis MD, 2002, AM J PREV MED, V23, P180, DOI 10.1016/S0749-3797(02)00490-7; LIN B, 2006, J CLIN MICROBIO; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lin BC, 2004, J CLIN MICROBIOL, V42, P3232, DOI 10.1128/JCM.42.7.3232-3239.2004; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Malanoski AP, 2006, NUCLEIC ACIDS RES, V34, P5300, DOI 10.1093/nar/gkl565; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Vora GJ, 2006, EMERG INFECT DIS, V12, P921, DOI 10.3201/eid1206.050245; Vora GJ, 2005, P NATL ACAD SCI USA, V102, P19109, DOI 10.1073/pnas.0505033102; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; Wilson KH, 2002, APPL ENVIRON MICROB, V68, P2535, DOI 10.1128/AEM.68.5.2535-2541.2002; Wilson WJ, 2002, MOL CELL PROBE, V16, P119, DOI 10.1006/mcpr.2001.0397	23	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e419	10.1371/journal.pone.0000419	http://dx.doi.org/10.1371/journal.pone.0000419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17502915	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445800001
J	Pai, NP; Joshi, R; Dogra, S; Taksande, B; Kalantri, SP; Pai, M; Narang, P; Tulsky, JP; Reingold, AL				Pai, Nitika Pant; Joshi, Rajnish; Dogra, Sandeep; Taksande, Bharati; Kalantri, S. P.; Pai, Madhukar; Narang, Pratibha; Tulsky, Jacqueline P.; Reingold, Arthur L.			Evaluation of Diagnostic Accuracy, Feasibility and Client Preference for Rapid Oral Fluid-Based Diagnosis of HIV Infection in Rural India	PLOS ONE			English	Article								Background. Oral fluid-based rapid tests are promising for improving HIV diagnosis and screening. However, recent reports from the United States of false-positive results with the oral OraQuick (R) ADVANCE HIV1/2 test have raised concerns about their performance in routine practice. We report a field evaluation of the diagnostic accuracy, client preference, and feasibility for the oral fluid-based OraQuick (R) Rapid HIV1/2 test in a rural hospital in India. Methodology/Principal Findings.. A cross-sectional, hospital-based study was conducted in 450 consenting participants with suspected HIV infection in rural India. The objectives were to evaluate performance, client preference and feasibility of the OraQuick (R) Rapid HIV-1/2 tests. Two Oraquick (R) Rapid HIV1/2 tests (oral fluid and finger stick) were administered in parallel with confirmatory ELISA/Western Blot (reference standard). Pre- and post-test counseling and face to face interviews were conducted to determine client preference. Of the 450 participants, 146 were deemed to be HIV sero-positive using the reference standard (seropositivity rate of 32% (95% confidence interval [CI] 28%, 37%)). The OraQuick test on oral fluid specimens had better performance with a sensitivity of 100% (95% CI 98, 100) and a specificity of 100% (95% CI 99, 100), as compared to the OraQuick test on finger stick specimens with a sensitivity of 100% (95% CI 98, 100), and a specificity of 99.7% (95% CI 98.4, 99.9). The OraQuick oral fluid-based test was preferred by 87% of the participants for first time testing and 60% of the participants for repeat testing. Conclusion/Significance. In a rural Indian hospital setting, the OraQuick (R) Rapid-HIV1/2 test was found to be highly accurate. The oral fluid-based test performed marginally better than the finger stick test. The oral OraQuick test was highly preferred by participants. In the context of global efforts to scale-up HIV testing, our data suggest that oral fluid-based rapid HIV testing may work well in rural, resource-limited settings.	[Pai, Nitika Pant] McGill Univ, Immunodeficiency Serv, Montreal Chest Inst, Ctr Hlth, Montreal, PQ, Canada; [Joshi, Rajnish; Taksande, Bharati; Kalantri, S. P.; Narang, Pratibha] Mahatma Gandhi Inst Med Sci, Sevagram, Maharashtra, India; [Dogra, Sandeep] Acharya Shri Chander Coll Med Sci, Jammu, India; [Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Tulsky, Jacqueline P.] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Reingold, Arthur L.] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA	McGill University; Mahatma Gandhi Institute of Medical Sciences, Sevagram; McGill University; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Pai, NP (corresponding author), McGill Univ, Immunodeficiency Serv, Montreal Chest Inst, Ctr Hlth, Montreal, PQ, Canada.	Nitika.Pai@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021; Dogra, Sandeep/AAS-6079-2021; Kalantri, Shriprakash/ABG-9318-2021; Taksande, Amar/ABA-4130-2020	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Kalantri, Shriprakash/0000-0002-1633-1029; Taksande, Amar/0000-0003-3097-7405; Narang, Pratibha/0000-0001-6135-1857; Joshi, Rajnish/0000-0002-4702-0522; Pant Pai, Nitika/0000-0002-4672-0500	UCB/UCSF Fogarty AIDS International Research and Training Grant [AITRP] [I-D43-TW00008-16]; Orasure Technologies PA USA	UCB/UCSF Fogarty AIDS International Research and Training Grant [AITRP](UCB Pharma SA); Orasure Technologies PA USA	Funding: We acknowledge the support of UCB/UCSF Fogarty AIDS International Research and Training Grant [AITRP] (I-D43-TW00008-16). We acknowledge the support of Orasure Technologies, PA USA for their generous donation of kits. Orasure Technologies, Philadelphia, USA, did not provide funding for this study. Neither Fogarty AITRP (I-D43-TW00008-16) nor Orasure Technologies, PA, USA had any role in the design and conduct of the study nor preparation of the manuscript.	Aaron Erika, 2006, AIDS Read, V16, P22; Bhore AV, 2003, INT J STD AIDS, V14, P37, DOI 10.1258/095646203321043246; Brahme RG, 2005, AIDS CARE, V17, P377, DOI 10.1080/09540120412331299771; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bulterys M, 2004, JAMA-J AM MED ASSOC, V292, P219, DOI 10.1001/jama.292.2.219; CHASSANY O, 1994, AIDS, V8, P713, DOI 10.1097/00002030-199405000-00026; De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Granade TC, 2004, J CLIN VIROL, V30, P229, DOI 10.1016/j.jcv.2003.12.006; Greensides DR, 2003, PUBLIC HEALTH REP, V118, P531, DOI 10.1016/S0033-3549(04)50289-3; Greenwald JL, 2006, AIDS PATIENT CARE ST, V20, P311, DOI 10.1089/apc.2006.20.311; Jafa K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000185; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; Liang TS, 2005, AIDS PATIENT CARE ST, V19, P253, DOI 10.1089/apc.2005.19.253; *NAT AIDS CONTR OR, 2006, NACO GUID HIV TEST; *UNAIDS, 2006, REP GLOB AIDS EPID M; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed	17	50	53	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2007	2	4							e367	10.1371/journal.pone.0000367	http://dx.doi.org/10.1371/journal.pone.0000367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DT	17426815	Green Published, gold			2022-12-27	WOS:000207445400007
J	Min, XJ; Hickey, DA				Min, Xiang Jia; Hickey, Donal A.			DNA Barcodes Provide a Quick Preview of Mitochondrial Genome Composition	PLOS ONE			English	Article								DNA barcodes have achieved prominence as a tool for species-level identifications. Consequently, there is a rapidly growing database of these short sequences from a wide variety of taxa. In this study, we have analyzed the correlation between the nucleotide content of the short DNA barcode sequences and the genomes from which they are derived. Our results show that such short sequences can yield important, and surprisingly accurate, information about the composition of the entire genome. In other words, for unsequenced genomes, the DNA barcodes can provide a quick preview of the whole genome composition.	[Min, Xiang Jia; Hickey, Donal A.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada	Hickey, DA (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	dhickey@alcor.concordia.ca	Min, Xiangjia Jack/O-9509-2014	Min, Xiangjia Jack/0000-0001-7978-0596	Natural Sciences and Engineering Research Council (Canada); Genome Canada to the Canadian Barcode of Life Network	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada to the Canadian Barcode of Life Network(Genome Canada)	This study was supported by grants from the Natural Sciences and Engineering Research Council (Canada) and Genome Canada to the Canadian Barcode of Life Network, and by a Discovery Grant to DAH from the Natural Sciences and Engineering Research Council (Canada).	Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; NAYLOR GJP, 1995, NATURE, V373, P565, DOI 10.1038/373565b0; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182	7	41	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e325	10.1371/journal.pone.0000325	http://dx.doi.org/10.1371/journal.pone.0000325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389916	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000207445200008
J	Laponogov, I; Veselkov, DA; Sohi, MK; Pan, XS; Achari, A; Yang, C; Ferrara, JD; Fisher, LM; Sanderson, MR				Laponogov, Ivan; Veselkov, Dennis A.; Sohi, Maninder K.; Pan, Xiao-Su; Achari, Aniruddha; Yang, Cheng; Ferrara, Joseph D.; Fisher, L. Mark; Sanderson, Mark R.			Breakage-Reunion Domain of Streptococcus pneumoniae Topoisomerase IV: Crystal Structure of a Gram-Positive Quinolone Target	PLOS ONE			English	Article								The 2.7 angstrom crystal structure of the 55-kDa N-terminal breakage-reunion domain of topoisomerase (topo) IV subunit A (ParC) from Streptococcus pneumoniae, the first for the quinolone targets from a gram-positive bacterium, has been solved and reveals a 'closed' dimer similar in fold to Escherichia coli DNA gyrase subunit A (GyrA), but distinct from the 'open' gate structure of Escherichia coli ParC. Unlike GyrA whose DNA binding groove is largely positively charged, the DNA binding site of ParC exhibits a distinct pattern of alternating positively and negatively charged regions coincident with the predicted positions of the grooves and phosphate backbone of DNA. Based on the ParC structure, a new induced-fit model for sequence-specific recognition of the gate (G) segment by ParC has been proposed. These features may account for the unique DNA recognition and quinolone targeting properties of pneumococcal type II topoisomerases compared to their gram-negative counterparts.	[Pan, Xiao-Su; Fisher, L. Mark] Univ London, Div Basic Med Sci, Mol & Metab Signalling Ctr, Mol Genet Grp, London, England; [Laponogov, Ivan; Veselkov, Dennis A.; Sohi, Maninder K.; Achari, Aniruddha; Sanderson, Mark R.] Kings Coll London, Sch Biomed & Hlth Sci, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Yang, Cheng; Ferrara, Joseph D.] Rigaku Amer Corp, The Woodlands, TX USA	University of London; University of London; King's College London; Rigaku Corporation	Fisher, LM (corresponding author), Univ London, Div Basic Med Sci, Mol & Metab Signalling Ctr, Mol Genet Grp, London, England.	lfisher@sgul.ac.uk; mark.sanderson@kcl.ac.uk		Fisher, Larry Mark/0000-0002-2172-3369	Biotechnology and Biological Sciences Research Council of the United Kingdom [C16747]; School of Biomedical and Health Sciences; ORS Award; Biotechnology and Biological Sciences Research Council [BB/D01882X/1] Funding Source: researchfish; BBSRC [BB/D01882X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); School of Biomedical and Health Sciences; ORS Award; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Project Grant C16747 from the Biotechnology and Biological Sciences Research Council of the United Kingdom (to L. M. Fisher and M. R. Sanderson). I. Laponogov was supported by a scholarship from the School of Biomedical and Health Sciences and ORS Award. Xiao- Su Pan, Dennis A. Veselkov and this work were funded by Project Grant C16747 from the Biotechnology and Biological Sciences Research Council of the United Kingdom (to L. M. Fisher and M. R. Sanderson).	[Anonymous], ACTA CRYSTALLOGR D, V50, P760; Bates PA, 2001, PROTEINS, P39; Bates PA, 1999, PROTEINS, P47; Bellon S, 2004, ANTIMICROB AGENTS CH, V48, P1856, DOI 10.1128/AAC.48.5.1856-1864.2004; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, BBA-GENE STRUCT EXPR, V1400, P3, DOI 10.1016/S0167-4781(98)00124-9; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISHER LM, 1981, P NATL ACAD SCI-BIOL, V78, P4165, DOI 10.1073/pnas.78.7.4165; Gadelle D, 2003, BIOESSAYS, V25, P232, DOI 10.1002/bies.10245; Huang W M, 1994, Adv Pharmacol, V29A, P201; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; KIRKEGAARD K, 1981, CELL, V23, P721, DOI 10.1016/0092-8674(81)90435-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leo E, 2005, J BIOL CHEM, V280, P14252, DOI 10.1074/jbc.M500156200; Maxwell A, 1996, NAT STRUCT BIOL, V3, P109, DOI 10.1038/nsb0296-109; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; MORRISON A, 1981, P NATL ACAD SCI-BIOL, V78, P1416, DOI 10.1073/pnas.78.3.1416; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan XS, 1999, ANTIMICROB AGENTS CH, V43, P1129, DOI 10.1128/AAC.43.5.1129; Pan XS, 1998, ANTIMICROB AGENTS CH, V42, P2810, DOI 10.1128/AAC.42.11.2810; Pan XS, 1997, ANTIMICROB AGENTS CH, V41, P471, DOI 10.1128/AAC.41.2.471; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; PENG H, 1995, J BIOL CHEM, V270, P25286, DOI 10.1074/jbc.270.42.25286; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; Richter SN, 2006, NUCLEIC ACIDS RES, V34, P1982, DOI 10.1093/nar/gkl127; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SHEN LL, 1989, BIOCHEMISTRY-US, V28, P3886, DOI 10.1021/bi00435a039; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; WILLMOTT CJR, 1993, ANTIMICROB AGENTS CH, V37, P126, DOI 10.1128/AAC.37.1.126; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	52	31	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e301	10.1371/journal.pone.0000301	http://dx.doi.org/10.1371/journal.pone.0000301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375187	Green Submitted, gold, Green Published			2022-12-27	WOS:000207445100003
J	Seshasayee, ASN				Seshasayee, Aswin Sai Narain			An Assessment of the Role of DNA Adenine Methyltransferase on Gene Expression Regulation in E coli	PLOS ONE			English	Article								N6-Adenine methylation is an important epigenetic signal, which regulates various processes, such as DNA replication and repair and transcription. In gamma-proteobacteria, Dam is a stand-alone enzyme that methylates GATC sites, which are non-randomly distributed in the genome. Some of these overlap with transcription factor binding sites. This work describes a global computational analysis of a published Dam knockout microarray alongside other publicly available data to throw insights into the extent to which Dam regulates transcription by interfering with protein binding. The results indicate that DNA methylation by DAM may not globally affect gene transcription by physically blocking access of transcription factors to binding sites. Down-regulation of Dam during stationary phase correlates with the activity of TFs whose binding sites are enriched for GATC sites.	EMBL European Bioinformat Inst, Genom & Regulatory Syst Grp, Cambridge, England	European Molecular Biology Laboratory (EMBL)	Seshasayee, ASN (corresponding author), EMBL European Bioinformat Inst, Genom & Regulatory Syst Grp, Wellcome Trust Genome Campus, Cambridge, England.	aswin@ebi.ac.uk	Hide, Winston/R-3815-2019; Hide, Winston Hide/C-7217-2009; Hide, Winston A/V-2727-2017	Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271	Cambridge Commonwealth Trust	Cambridge Commonwealth Trust	This is an entirely independent project carried out by me without the aid of any funding agency. My studentship at the EMBL-EBI is partly covered by the Cambridge Commonwealth Trust.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glasner JD, 2003, NUCLEIC ACIDS RES, V31, P147, DOI 10.1093/nar/gkg125; Henaut A, 1996, J MOL BIOL, V257, P574, DOI 10.1006/jmbi.1996.0186; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kouzminova EA, 2004, P NATL ACAD SCI USA, V101, P16262, DOI 10.1073/pnas.0405943101; Lobner-Olesen A, 2003, P NATL ACAD SCI USA, V100, P4672, DOI 10.1073/pnas.0538053100; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; RASMUSSEN LJ, 1994, MOL MICROBIOL, V12, P631, DOI 10.1111/j.1365-2958.1994.tb01050.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robbins-Manke JL, 2005, J BACTERIOL, V187, P7027, DOI 10.1128/JB.187.20.7027-7037.2005; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Sivaraman K, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-20; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; VONHEYDEBRECK A, 2004, BIOCONDUCTOR PROJECT, V7; VONHEYDEBRECK A, 2004, BIOCONDUCTOR WORKING; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; YAMANAKA K, 1995, FEMS MICROBIOL LETT, V133, P59, DOI 10.1111/j.1574-6968.1995.tb07861.x; ZHANG H, 1994, J MOL BIOL, V238, P592, DOI 10.1006/jmbi.1994.1317	26	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e273	10.1371/journal.pone.0000273	http://dx.doi.org/10.1371/journal.pone.0000273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17342207	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444700008
J	Mamane, Y; Petroulakis, E; Martineau, Y; Sato, TA; Larsson, O; Rajasekhar, VK; Sonenberg, N				Mamane, Yael; Petroulakis, Emmanuel; Martineau, Yvan; Sato, Taka-Aki; Larsson, Ola; Rajasekhar, Vinagolu K.; Sonenberg, Nahum			Epigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN GENES; CAP-BINDING PROTEIN; TRANSLATIONAL CONTROL; ORNITHINE-DECARBOXYLASE; INITIATION FACTOR-4E; SECONDARY STRUCTURE; NONCODING REGION; EXPRESSION; CANCER; GROWTH	Background. Translation deregulation is an important mechanism that causes aberrant cell growth, proliferation and survival. eIF4E, the mRNA 5' capbinding protein, plays a major role in translational control. To understand how eIF4E affects cell proliferation and survival, we studied mRNA targets that are translationally responsive to eIF4E. Methodology/ Principal Findings. Microarray analysis of polysomal mRNA from an eIF4E-inducible NIH 3T3 cell line was performed. Inducible expression of eIF4E resulted in increased translation of defined sets of mRNAs. Many of the mRNAs are novel targets, including those that encode large- and small-subunit ribosomal proteins and cell growth-related factors. In addition, there was augmented translation of mRNAs encoding antiapoptotic proteins, which conferred resistance to endoplasmic reticulum-mediated apoptosis. Conclusions/Significance. Our results shed new light on the mechanisms by which eIF4E prevents apoptosis and transforms cells. Downregulation of eIF4E and its downstream targets is a potential therapeutic option for the development of novel anticancer drugs.	[Mamane, Yael; Petroulakis, Emmanuel; Martineau, Yvan; Sonenberg, Nahum] McGill Univ, Dept Biochem, McGill Canc Ctr, Montreal, PQ, Canada; [Sato, Taka-Aki] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA; [Larsson, Ola] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Rajasekhar, Vinagolu K.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	McGill University; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; Memorial Sloan Kettering Cancer Center	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, McGill Canc Ctr, Montreal, PQ, Canada.	nahum.sonenberg@mcgill.ca	Larsson, Ola/F-8151-2013; Martineau, Yvan/G-2387-2017	Martineau, Yvan/0000-0002-0575-4085; Vinagolu, Rajasekhar/0000-0002-7364-2675; Larsson, Ola/0000-0003-1412-1308	National Cancer Institute of Canada (NCIC); McGill University; Association pour la Recherche sur le Cancer (France); Swedish Research Council; CIHR; Howard Hughes Medical Institute (HHMI) International Scholar	National Cancer Institute of Canada (NCIC)(Canadian Cancer Society (CCS)); McGill University; Association pour la Recherche sur le Cancer (France)(Fondation ARC pour la Recherche sur le Cancer); Swedish Research Council(Swedish Research CouncilEuropean Commission); CIHR(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute (HHMI) International Scholar(Howard Hughes Medical Institute)	This research was supported by a grant from the National Cancer Institute of Canada (NCIC). Y. Mamane is a recipient of a fellowship from the NCIC. E. P. was supported by a Fellowship from the Cancer Research Society and a Chemical Biology Fellowship from McGill University. Y. Martineau is a recipient of a postdoctoral fellowship from Association pour la Recherche sur le Cancer (France) and a Canadian Institute of Health Research (CIHR) Cancer Consortium Training Award from McGill University. O. Larsson is supported by a postdoctoral fellowship from the Swedish Research Council. N.S. is a CIHR distinguished scientist and a Howard Hughes Medical Institute (HHMI) International Scholar.	Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bassoe CF, 1998, LEUKEMIA RES, V22, P329, DOI 10.1016/S0145-2126(97)00178-1; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; De Benedetti A, 1999, INT J BIOCHEM CELL B, V31, P59, DOI 10.1016/S1357-2725(98)00132-0; DEBENEDETTI A, 1991, MOL CELL BIOL, V11, P5435, DOI 10.1128/MCB.11.11.5435; Decker T, 2003, BLOOD, V101, P278, DOI 10.1182/blood-2002-01-0189; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Dua K, 2001, PROTEOMICS, V1, P1191, DOI 10.1002/1615-9861(200110)1:10<1191::AID-PROT1191>3.0.CO;2-8; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; FERRARI S, 1990, CANCER RES, V50, P5825; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; GRAFF JR, 1995, INT J CANCER, V60, P255; Graff JR, 2003, CLIN EXP METASTAS, V20, P265, DOI 10.1023/A:1022943419011; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; HAMMOND ML, 1991, GENE DEV, V5, P1723, DOI 10.1101/gad.5.9.1723; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HIREMATH LS, 1985, J BIOL CHEM, V260, P7843; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Hong NA, 2000, DEV BIOL, V220, P76, DOI 10.1006/dbio.2000.9615; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Karan D, 2002, CARCINOGENESIS, V23, P967, DOI 10.1093/carcin/23.6.967; KASPAR RL, 1990, J BIOL CHEM, V265, P3619; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Kinzy TG, 2000, COLD SPRING HARBOR M, V39, P973; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Larsson O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-129; LARSSON O, 2006, NUCL ACIDS RES; Larsson O, 2006, NAT BIOTECHNOL, V24, P1322, DOI 10.1038/nbt1106-1322; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li SN, 2004, J BIOL CHEM, V279, P21312, DOI 10.1074/jbc.M312467200; Loging WT, 1999, CANCER EPIDEM BIOMAR, V8, P1011; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; MAO XH, 1992, J BIOL CHEM, V267, P20444; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Morand EF, 2005, INTERN MED J, V35, P419, DOI 10.1111/j.1445-5994.2005.00853.x; Nadano D, 2000, JPN J CANCER RES, V91, P802, DOI 10.1111/j.1349-7006.2000.tb01017.x; Oridate N, 2005, CANCER BIOL THER, V4, P318, DOI 10.4161/cbt.4.3.1504; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Proud CG, 2003, CURR TOP MICROBIOL, V279, P215; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; RINKERSCHAEFFER CW, 1993, INT J CANCER, V55, P841, DOI 10.1002/ijc.2910550525; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; RUVINSKY I, 2006, TRENDS BIOCH SCI; SantaCruz DJ, 1997, J CUTAN PATHOL, V24, P533, DOI 10.1111/j.1600-0560.1997.tb01457.x; SCHNEIDER R, 2007, TRANSLATIONAL CONTRO; SHANTZ LM, 1994, CANCER RES, V54, P2313; Shantz LM, 1996, CANCER RES, V56, P3265; Shi YQ, 2004, EXP CELL RES, V296, P337, DOI 10.1016/j.yexcr.2004.02.009; Shimizu T, 2005, J DERMATOL SCI, V37, P65, DOI 10.1016/j.jdermsci.2004.08.007; Stromberg T, 2004, BLOOD, V103, P3138, DOI 10.1182/blood-2003-05-1543; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Thompson B., 2007, TRANSLATIONAL CONTRO; Tomonaga T, 2003, CANCER RES, V63, P3511; Trempat P, 2004, LEUKEMIA LYMPHOMA, V45, P2001, DOI 10.1080/10428190410001713189; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uechi T, 2001, GENOMICS, V72, P223, DOI 10.1006/geno.2000.6470; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; NUCL ACIDS RES, V34, pD322	86	171	177	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e242	10.1371/journal.pone.0000242	http://dx.doi.org/10.1371/journal.pone.0000242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311107	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444500021
J	Zhou, TS; Zhang, JJ; Yuan, ZJ; Xu, AL				Zhou, Tianshou; Zhang, Jiajun; Yuan, Zhanjiang; Xu, Anlong			External Stimuli Mediate Collective Rhythms: Artificial Control Strategies	PLOS ONE			English	Article								The artificial intervention of biological rhythms remains an exciting challenge. Here, we proposed artificial control strategies that were developed to mediate the collective rhythms emerging in multicellular structures. Based on noisy repressilators and by injecting a periodic control amount to the extracellular medium, we introduced two typical kinds of control models. In one, there are information exchanges among cells, where signaling molecules receive the injected stimulus that freely diffuses toward/from the intercellular medium. In the other, there is no information exchange among cells, but signaling molecules also receive the stimulus that directionally diffuses into each cell from the common environment. We uncovered physical mechanisms for how the stimulus induces, enhances or ruins collective rhythms. We found that only when the extrinsic period is close to an integer multiplicity of the averaged intrinsic period can the collective behaviors be induced/enhanced; otherwise, the stimulus possibly ruins the achieved collective behaviors. Such entrainment properties of these oscillators to external signals would be exploited by realistic living cells to sense external signals. Our results not only provide a new perspective to the understanding of the interplays between extrinsic stimuli and intrinsic physiological rhythms, but also would lead to the development of medical therapies or devices.	[Zhou, Tianshou; Zhang, Jiajun; Yuan, Zhanjiang] Sun Yat Sen Univ, Sch Math & Computat Sci, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Tianshou; Xu, Anlong] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Tianshou; Xu, Anlong] Sun Yat Sen Univ, Guangzhou Ctr Bioinformat, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhou, TS (corresponding author), Sun Yat Sen Univ, Sch Math & Computat Sci, Guangzhou 510275, Guangdong, Peoples R China.	mcszhtsh@mail.sysu.edu.cn		Zhang, Jiajun/0000-0001-7107-4814	Natural Science Foundation of Guangdong Province [50033047]; National Distinguished Ph.D. Theses Grant [200521]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Distinguished Ph.D. Theses Grant	Natural Science Foundation of Guangdong Province (No. 50033047); National Distinguished Ph.D. Theses Grant (200521)	Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; CHEN W, 1993, GENE, V130, P15, DOI 10.1016/0378-1119(93)90341-Y; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; GLASS L, 1994, PHYS REV E, V50, P5077, DOI 10.1103/PhysRevE.50.5077; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2001, CHAOS, V11, P207, DOI 10.1063/1.1345702; Kaplan DT, 1996, PHYS REV LETT, V76, P4074, DOI 10.1103/PhysRevLett.76.4074; Kuramoto Y., 2003, CHEM OSCILLATION WAV; KURAMOTO Y, 1984, CHEM OSCILLATION WAV, P62; Lai YC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.214101; Lebiedz D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108303; Liu B, 2005, INT J BIFURCAT CHAOS, V15, P517, DOI 10.1142/S0218127405012338; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Osipov GV, 1997, PHYS REV E, V55, P2353, DOI 10.1103/PhysRevE.55.2353; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Pikovsky AS, 1996, EUROPHYS LETT, V34, P165, DOI 10.1209/epl/i1996-00433-3; Schultz TF, 2003, SCIENCE, V301, P326, DOI 10.1126/science.1085935; Simon PM, 2000, J APPL PHYSIOL, V89, P760, DOI 10.1152/jappl.2000.89.2.760; Tang SY, 2003, INT J BIFURCAT CHAOS, V13, P973, DOI 10.1142/S0218127403007011; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Wagemakers A, 2006, CHAOS, V16, DOI 10.1063/1.2173048; Zhou TS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178103	28	19	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e231	10.1371/journal.pone.0000231	http://dx.doi.org/10.1371/journal.pone.0000231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311095	gold, Green Submitted, Green Published			2022-12-27	WOS:000207444500012
J	Hamon, Y; Trompier, D; Ma, Z; Venegas, V; Pophillat, M; Mignotte, V; Zhou, Z; Chimini, G				Hamon, Yannick; Trompier, Doriane; Ma, Zhong; Venegas, Victor; Pophillat, Matthieu; Mignotte, Vincent; Zhou, Zheng; Chimini, Giovanna			Cooperation between Engulfment Receptors: The Case of ABCA1 and MEGF10	PLOS ONE			English	Article								The engulfment of dying cells is a specialized form of phagocytosis that is extremely conserved across evolution. In the worm, it is genetically controlled by two parallel pathways, which are only partially reconstituted in mammals. We focused on the recapitulation of the CED-1 defined pathway in mammalian systems. We first explored and validated MEGF10, a novel receptor bearing striking structural similarities to CED-1, as a bona fide functional ortholog in mammals and hence progressed toward the analysis of molecular interactions along the corresponding pathway. We ascertained that, in a system of forced expression by transfection, MEGF10 function can be modulated by the ATP binding cassette transporter ABCA1, ortholog to CED-7. Indeed, the coexpression of either a functional or a mutant ABCA1 exerted a transdominant positive or negative modulation on the MEGF10-dependent engulfment. The combined use of biochemical and biophysical approaches indicated that this functional cooperation relies on the alternate association of these receptors with a common partner, endogenously expressed in our cell system. We provide the first working model structuring in mammals the CED-1 dependent pathway.	[Hamon, Yannick; Trompier, Doriane; Pophillat, Matthieu; Chimini, Giovanna] Univ Aix Marseille 2, CNRS, INSERM, Ctr Immunol Marseille Luminy, Marseille, France; [Ma, Zhong] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA USA; [Ma, Zhong] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Venegas, Victor; Zhou, Zheng] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Mignotte, Vincent] Univ Paris 05, CNRS, INSERM, Inst Cochin,U567,UMR 8104, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Virginia; University of Virginia; Baylor College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chimini, G (corresponding author), Univ Aix Marseille 2, CNRS, INSERM, Ctr Immunol Marseille Luminy, Marseille, France.	chimini@ciml.univ-mrs.fr	TROMPIER, Doriane/D-5862-2017; HAMON, Yannick/S-3118-2019; HAMON, Yannick YH/N-5372-2016	HAMON, Yannick/0000-0002-7636-2310; HAMON, Yannick YH/0000-0002-7636-2310; Trompier, Doriane/0000-0002-0746-1753	INSERM; CNRS; European Community-APOCLEAR; FLIPPASE; Nouvelle Societe Francaise d'Atherosclerose	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Community-APOCLEAR; FLIPPASE; Nouvelle Societe Francaise d'Atherosclerose	This work has been funded by institutional grants from INSERM and CNRS and specific grants from the European Community-APOCLEAR and FLIPPASE. DT was funded in part by a fellowship, allocated by the Nouvelle Societe Francaise d'Atherosclerose.	Abe-Dohmae S, 2006, FEBS LETT, V580, P1178, DOI 10.1016/j.febslet.2005.12.029; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; Broccardo C, 2001, CYTOGENET CELL GENET, V92, P264, DOI 10.1159/000056914; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Castellano F, 2000, J CELL SCI, V113, P2955; ELLIS RE, 1991, GENETICS, V129, P79; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kiss RS, 2006, J BIOL CHEM, V281, P12081, DOI 10.1074/jbc.M600621200; Liu QA, 1999, CURR BIOL, V9, P1347, DOI 10.1016/S0960-9822(00)80061-5; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; PETER GF, 1991, J BIOL CHEM, V266, P16745; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; Rigot W, 2002, J LIPID RES, V43, P2077, DOI 10.1194/jlr.M200279-JLR200; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Smits E, 1999, CURR BIOL, V9, P1351, DOI 10.1016/S0960-9822(00)80062-7; Su HP, 2000, J BIOL CHEM, V275, P9542, DOI 10.1074/jbc.275.13.9542; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; TROMPIER D, 2005, ABCA1 AFCS NATURE MO, DOI DOI 10.1038/MP.A002593.01; TROMPIER D, 2005, ABCA7 AFCS NATURE MO, DOI DOI 10.1038/MP.A002599.01; Trompier D, 2006, J BIOL CHEM, V281, P20283, DOI 10.1074/jbc.M601072200; Valentin G, 2005, NAT METHODS, V2, P801, DOI 10.1038/nmeth1105-801; Vallejo Abbe N., 1995, P603; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	40	78	84	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e120	10.1371/journal.pone.0000120	http://dx.doi.org/10.1371/journal.pone.0000120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205124	Green Submitted, gold, Green Published			2022-12-27	WOS:000207443700014
J	Lindholm, E; Melander, O; Almgren, P; Berglund, G; Agardh, CD; Groop, L; Orho-Melander, M				Lindholm, Eero; Melander, Olle; Almgren, Peter; Berglund, Goran; Agardh, Carl-David; Groop, Leif; Orho-Melander, Marju			Polymorphism in the MHC2TA Gene Is Associated with Features of the Metabolic Syndrome and Cardiovascular Mortality	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; DIABETIC-NEPHROPATHY; RISK-FACTORS; MICROALBUMINURIA; SUSCEPTIBILITY; INFLAMMATION; MULTIPLE; HISTORY; DESIGN	Background. Recently, a -168A -> G polymorphism in the MHC class II transactivator gene (MHC2TA) was shown to be associated with increased susceptibility to myocardial infarction (MI). Aim. To confirm the association between the MHC2TA -168A -> G polymorphism and MI and to study its putative role for microalbuminuria, the metabolic syndrome (MetS) and cardiovascular mortality. Materials and Methods. Using an allelic discrimination method we genotyped 11,064 individuals from three study populations: 1) 4,432 individuals from the Botnia type 2 diabetes (T2D) study, 2) 1,222 patients with MI and 2,345 control subjects participating in the Malmo "Diet and Cancer study and comprising an MI case-control sample, and 3) 3,065 T2D patients from the Local Swedish Diabetes registry. Results. No association between the -168A -> G polymorphism in MHC2TA and MI was observed. However, in the Botnia cohort the AG/GG genotypes were associated with cardiovascular mortality after MI (1.78 [1.09-2.92], p = 0.02). In addition, the AG/GG genotypes were more common in subjects with MetS (40.1% vs. 36.9%, p = 0.03) and in non-diabetic subjects with microalbuminuria (45.4% vs. 36.5%, p = 0.003) compared to control subjects. Conclusions. A polymorphism in MHC2TA was associated with cardiovascular mortality and predictors of cardiovascular mortality, microalbuminuria and MetS.	[Lindholm, Eero; Melander, Olle; Almgren, Peter; Berglund, Goran; Agardh, Carl-David; Groop, Leif; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Clin Res Ctr, Univ Hosp Malmo MAS, Malmo, Sweden	Lund University	Lindholm, E (corresponding author), Lund Univ, Dept Clin Sci, Clin Res Ctr, Univ Hosp Malmo MAS, Malmo, Sweden.	Eero.Lindholm@lu.se		Lindholm, Eero/0000-0002-8869-681X; Melander, Olle/0000-0002-2581-484X	Diabetes Program at Lund University (DPLU); Foundation for Strategic Research through the National Network for Cardiovascular Research; Swedish Medical Research Council; Albert Pa hlssons Foundation; Malmo University Hospital Foundations; Crafoord Foundation; Novo Nordisk Foundation; Swedish Heart and Lung Foundation; Medical Faculty of Lund University; Skane County Council Research and Development Foundation; Sigrid Juselius Foundation; Academy of Finland; Finnish Diabetes Research Foundation; Folkhalsan Research Foundation; Viktor Ollqvist Foundation	Diabetes Program at Lund University (DPLU); Foundation for Strategic Research through the National Network for Cardiovascular Research; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Albert Pa hlssons Foundation; Malmo University Hospital Foundations; Crafoord Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; Skane County Council Research and Development Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Folkhalsan Research Foundation; Viktor Ollqvist Foundation	This work was supported by grants from the Diabetes Program at Lund University (DPLU), the Foundation for Strategic Research through the National Network for Cardiovascular Research, the Swedish Medical Research Council, the Albert Pa hlssons Foundation, the Malmo University Hospital Foundations, the Crafoord Foundation, the Novo Nordisk Foundation, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University and the Skane County Council Research and Development Foundation. The Botnia Study is principally supported by the Sigrid Juselius Foundation, the Academy of Finland, the Finnish Diabetes Research Foundation, the Folkhalsan Research Foundation, and the Viktor Ollqvist Foundation.	Aso Y, 2004, CLIN CHIM ACTA, V348, P139, DOI 10.1016/j.cccn.2004.05.006; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P48, DOI 10.1093/oxfordjournals.aje.a114223; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Lee SH, 2005, NEPHROLOGY, V10, pS32, DOI 10.1111/j.1440-1797.2005.00454.x; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lindholm E, 2001, EUR J EPIDEMIOL, V17, P983, DOI 10.1023/A:1020036805655; MOGENSEN CE, 1995, DIABETES CARE, V18, P572, DOI 10.2337/diacare.18.4.572; MOGENSEN CE, 1985, UREMIA INVEST, V9, P85, DOI 10.3109/08860228509088195; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pasternak Richard C., 2003, Cardiology Clinics, V21, P393, DOI 10.1016/S0733-8651(03)00080-8; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; von Wowern F, 2005, KIDNEY INT, V68, P2164, DOI 10.1111/j.1523-1755.2005.00672.x; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; YUDKIN JS, 1988, LANCET, V2, P530	23	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e64	10.1371/journal.pone.0000064	http://dx.doi.org/10.1371/journal.pone.0000064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183695	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600064
J	Roord, STA; Zonneveld-Huijssoon, E; Le, T; Yung, GP; Koffeman, E; Ronaghy, A; Ghahramani, N; Lanza, P; Billetta, R; Prakken, BJ; Albani, S				Roord, Sarah T. A.; Zonneveld-Huijssoon, Evelien; Le, Tho; Yung, Gisella Puga; Koffeman, Eva; Ronaghy, Arash; Ghahramani, Negar; Lanza, Paola; Billetta, Rosario; Prakken, Berent J.; Albani, Salvatore			Modulation of T Cell Function by Combination of Epitope Specific and Low Dose Anticytokine Therapy Controls Autoimmune Arthritis	PLOS ONE			English	Article								Innate and adaptive immunity contribute to the pathogenesis of autoimmune arthritis by generating and maintaining inflammation, which leads to tissue damage. Current biological therapies target innate immunity, eminently by interfering with single pro-inflammatory cytokine pathways. This approach has shown excellent efficacy in a good proportion of patients with Rheumatoid Arthritis (RA), but is limited by cost and side effects. Adaptive immunity, particularly T cells with a regulatory function, plays a fundamental role in controlling inflammation in physiologic conditions. A growing body of evidence suggests that modulation of T cell function is impaired in autoimmunity. Restoration of such function could be of significant therapeutic value. We have recently demonstrated that epitope-specific therapy can restore modulation of T cell function in RA patients. Here, we tested the hypothesis that a combination of anti-cytokine and epitope-specific immunotherapy may facilitate the control of autoimmune inflammation by generating active T cell regulation. This novel combination of mucosal tolerization to a pathogenic T cell epitope and single low dose anti-TNF alpha was as therapeutically effective as full dose anti-TNFa treatment. Analysis of the underlying immunological mechanisms showed induction of T cell immune deviation.	[Roord, Sarah T. A.; Le, Tho; Yung, Gisella Puga; Koffeman, Eva; Ronaghy, Arash; Albani, Salvatore] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Roord, Sarah T. A.; Le, Tho; Yung, Gisella Puga; Koffeman, Eva; Albani, Salvatore] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Roord, Sarah T. A.; Zonneveld-Huijssoon, Evelien; Prakken, Berent J.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Immunol, Utrecht, Netherlands; [Ghahramani, Negar; Lanza, Paola; Billetta, Rosario; Albani, Salvatore] Androclus Therapeut, San Diego, CA USA; [Roord, Sarah T. A.; Zonneveld-Huijssoon, Evelien; Le, Tho; Yung, Gisella Puga; Koffeman, Eva; Prakken, Berent J.; Albani, Salvatore] EUREKA Inst Translat Med, Immunol Adv Ctr, Preclin Immunogenom Project, Siracusa, Italy	University of California System; University of California San Diego; University of California System; University of California San Diego; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Albani, S (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	salbani@ucsd.edu		, Gisella/0000-0002-2283-7798	Royal Netherlands Academy of Arts and Sciences; Dutch Society of Scientific Research (NWO); NIAMS and NIAD, NIH	Royal Netherlands Academy of Arts and Sciences; Dutch Society of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NIAMS and NIAD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Roord was supported by a grant from the Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences and the Dutch Society of Scientific Research (NWO). The work was in part supported by grants from the NIAMS and NIAD branches of the NIH, and by a gift from Associazione Italiana per la Ricerca contro l'Artrite. Prakken and Zonneveld-Huijssoon are supported by an Innovation Grant from the Dutch Society for Scientific Research (NWO). Koffeman is supported by a Grant from the Ter Meulen Fund from the Royal Netherlands Academy for Arts and Sciences.	ALBANI S, 1994, J PEDIATR-US, V124, P561, DOI 10.1016/S0022-3476(05)83134-8; Albani S, 1996, IMMUNOL TODAY, V17, P466, DOI 10.1016/0167-5699(96)20029-G; ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; ALBANI S, 1994, CLIN EXP RHEUMATOL, V12, pS35; Anderson PO, 2006, EUR J IMMUNOL, V36, P1374, DOI 10.1002/eji.200635883; ANDERTON SM, 1995, J EXP MED, V181, P943, DOI 10.1084/jem.181.3.943; Bach JF, 2003, NAT REV IMMUNOL, V3, P189, DOI 10.1038/nri1026; Baecher-Allan C, 2004, SEMIN IMMUNOL, V16, P89, DOI 10.1016/j.smim.2003.12.005; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Bendele AM, 1999, CLIN EXP RHEUMATOL, V17, P553; Bloom BJ, 2000, ARTHRITIS RHEUM, V43, P2606, DOI 10.1002/1529-0131(200011)43:11<2606::AID-ANR31>3.0.CO;2-X; Bluestone JA, 2006, SEMIN IMMUNOL, V18, P77, DOI 10.1016/j.smim.2006.01.003; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Cope AP, 2004, CURR OPIN IMMUNOL, V16, P780, DOI 10.1016/j.coi.2004.09.005; de Kleer I, 2006, BLOOD, V107, P1696, DOI 10.1182/blood-2005-07-2800; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; Dekker L, 2004, CLIN EXP RHEUMATOL, V22, P252; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Garrood T, 2006, ARTHRITIS RHEUM-US, V54, P1055, DOI 10.1002/art.21720; Johnson MR, 2000, ANAL BIOCHEM, V278, P175, DOI 10.1006/abio.1999.4461; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kamphuis S, 2005, LANCET, V366, P50, DOI 10.1016/S0140-6736(05)66827-4; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; LaCava A, 1997, J CLIN INVEST, V100, P658, DOI 10.1172/JCI119577; Larche M, 2006, IMMUNOL ALLERGY CLIN, V26, P321, DOI 10.1016/j.iac.2006.02.005; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Masteller EL, 2006, SEMIN IMMUNOL, V18, P103, DOI 10.1016/j.smim.2006.01.004; Nolte-'t Hoen ENM, 2004, EUR J IMMUNOL, V34, P3016, DOI 10.1002/eji.200324725; Olsen NJ, 2004, NEW ENGL J MED, V350, P2167, DOI 10.1056/NEJMra032906; Prakken ABJ, 1996, ARTHRITIS RHEUM-US, V39, P1826, DOI 10.1002/art.1780391108; Prakken BJ, 2001, CURR DIRECT AUTOIMMU, V3, P51; Prakken BJ, 2004, P NATL ACAD SCI USA, V101, P4228, DOI 10.1073/pnas.0400061101; Prakken BJ, 2003, SPRINGER SEMIN IMMUN, V25, P47, DOI 10.1007/s00281-003-0128-7; Prakken BJ, 1997, P NATL ACAD SCI USA, V94, P3284, DOI 10.1073/pnas.94.7.3284; Prakken BJ, 2002, ARTHRITIS RHEUM, V46, P1937, DOI 10.1002/art.10366; Sakaguchi S, 2003, J CLIN INVEST, V112, P1310, DOI 10.1172/JCI200320274; Schotte H, 2004, RHEUMATOLOGY, V43, P960, DOI 10.1093/rheumatology/keh178; Tarzi M, 2006, CLIN EXP ALLERGY, V36, P465, DOI 10.1111/j.1365-2222.2006.02469.x; Taylor PC, 2001, CURR OPIN RHEUMATOL, V13, P164, DOI 10.1097/00002281-200105000-00003; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; van Eden W, 1998, IMMUNOL TODAY, V19, P303, DOI 10.1016/S0167-5699(98)01283-3; VANEDEN W, 1985, P NATL ACAD SCI USA, V82, P5117; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zou J, 2003, ANN RHEUM DIS, V62, P561, DOI 10.1136/ard.62.6.561	49	29	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e87	10.1371/journal.pone.0000087	http://dx.doi.org/10.1371/journal.pone.0000087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183718	gold, Green Submitted, Green Published			2022-12-27	WOS:000207443600086
J	Kentsis, A; Gindin, T; Mezei, M; Osman, R				Kentsis, Alex; Gindin, Tatyana; Mezei, Mihaly; Osman, Roman			Calculation of the Free Energy and Cooperativity of Protein Folding	PLOS ONE			English	Article								Calculation of the free energy of protein folding and delineation of its pre-organization are of foremost importance for understanding, predicting and designing biological macromolecules. Here, we introduce an energy smoothing variant of parallel tempering replica exchange Monte Carlo (REMS) that allows for efficient configurational sampling of flexible solutes under the conditions of molecular hydration. Its usage to calculate the thermal stability of a model globular protein, Trp cage TC5b, achieves excellent agreement with experimental measurements. We find that the stability of TC5b is attained through the coupled formation of local and non-local interactions. Remarkably, many of these structures persist at high temperature, concomitant with the origin of native-like configurations and mesostates in an otherwise macroscopically disordered unfolded state. Graph manifold learning reveals that the conversion of these mesostates to the native state is structurally heterogeneous, and that the cooperativity of their formation is encoded largely by the unfolded state ensemble. In all, these studies establish the extent of thermodynamic and structural pre-organization of folding of this model globular protein, and achieve the calculation of macromolecular stability ab initio, as required for ab initio structure prediction, genome annotation, and drug design.	[Kentsis, Alex; Gindin, Tatyana; Mezei, Mihaly; Osman, Roman] NYU, Mt Sinai Sch Med, Dept Mol Physiol & Biophys, New York, NY USA	Icahn School of Medicine at Mount Sinai; New York University	Kentsis, A (corresponding author), Harvard Univ, Sch Med, Dept Med, Childrens Hosp Boston, Boston, MA 02115 USA.	alex.kentsis@childrens.harvard.edu			National Institutes of Health Medical Scientist Training Program [DK 43046]	National Institutes of Health Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health Medical Scientist Training Program, Grant DK 43046.	ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; Ahmed Z, 2005, J AM CHEM SOC, V127, P10943, DOI 10.1021/ja050664e; Andrec M, 2005, P NATL ACAD SCI USA, V102, P6801, DOI 10.1073/pnas.0408970102; Bai YW, 2001, PROTEIN SCI, V10, P1056, DOI 10.1110/ps.00601; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Biswas P, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2062047; Brown S, 2003, J COMPUT CHEM, V24, P68, DOI 10.1002/jcc.10181; Bunagan MR, 2006, J PHYS CHEM B, V110, P3759, DOI 10.1021/jp055288z; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Cheng XL, 2005, J PHYS CHEM B, V109, P8220, DOI 10.1021/jp045437y; Cheung MS, 2003, J PHYS CHEM B, V107, P11193, DOI 10.1021/jp034441r; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Dyson HJ, 2005, METHOD ENZYMOL, V394, P299, DOI 10.1016/S0076-6879(05)94011-1; Faisca PFN, 2005, PROTEINS, V60, P712, DOI 10.1002/prot.20521; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Geney R, 2006, J CHEM THEORY COMPUT, V2, P115, DOI 10.1021/ct050183l; GEYER CJ, 1995, J AM STAT ASSOC, V90, P909, DOI 10.1080/01621459.1995.10476590; GO N, 1978, P NATL ACAD SCI USA, V75, P559, DOI 10.1073/pnas.75.2.559; Hansmann UHE, 1997, CHEM PHYS LETT, V281, P140, DOI 10.1016/S0009-2614(97)01198-6; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KARPEN ME, 1993, BIOCHEMISTRY-US, V32, P412, DOI 10.1021/bi00053a005; Kentsis A, 2005, PROTEINS, V61, P769, DOI 10.1002/prot.20655; Kentsis A, 2004, PROTEINS, V55, P493, DOI 10.1002/prot.20051; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618; Krantz BA, 2004, J MOL BIOL, V337, P463, DOI 10.1016/j.jmb.2004.01.018; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Liu P, 2005, P NATL ACAD SCI USA, V102, P13749, DOI 10.1073/pnas.0506346102; LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173; Lwin TZ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2161202; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mezei M, 2004, PROTEINS, V55, P502, DOI 10.1002/prot.20050; Mezei M, 2003, J CHEM PHYS, V118, P3874, DOI 10.1063/1.1539839; Mitsutake A, 2004, J CHEM PHYS, V121, P2491, DOI 10.1063/1.1766015; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Neirotti JP, 2000, J CHEM PHYS, V112, P10340, DOI 10.1063/1.481671; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Neuweiler H, 2005, P NATL ACAD SCI USA, V102, P16650, DOI 10.1073/pnas.0507351102; Nikiforovich GV, 2003, PROTEINS, V52, P292, DOI 10.1002/prot.10409; Nymeyer H, 2004, METHOD ENZYMOL, V383, P119; Opps SB, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.056701; Pitera JW, 2003, P NATL ACAD SCI USA, V100, P7587, DOI 10.1073/pnas.1330954100; Prompers JJ, 2002, PROTEINS, V46, P177, DOI 10.1002/prot.10025; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; Rao F, 2004, J MOL BIOL, V342, P299, DOI 10.1016/j.jmb.2004.06.063; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; SAUL LK, 2005, SEMISUPERVISED LEARN; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Schug A, 2004, EUROPHYS LETT, V67, P307, DOI 10.1209/epl/i2004-10056-2; Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q; Shi ZS, 2002, P NATL ACAD SCI USA, V99, P9190, DOI 10.1073/pnas.112193999; Shoemaker BA, 1997, P NATL ACAD SCI USA, V94, P777, DOI 10.1073/pnas.94.3.777; Singhal N, 2004, J CHEM PHYS, V121, P415, DOI 10.1063/1.1738647; Sosnick TR, 1996, PROTEINS, V24, P413; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Ulmschneider JP, 2004, J AM CHEM SOC, V126, P1849, DOI 10.1021/ja0378862; Zhou RH, 2002, P NATL ACAD SCI USA, V99, P12777, DOI 10.1073/pnas.142430099; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100	63	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e446	10.1371/journal.pone.0000446	http://dx.doi.org/10.1371/journal.pone.0000446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505540	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445900006
J	Cushion, MT; Smulian, AG; Slaven, BE; Sesterhenn, T; Arnold, J; Staben, C; Porollo, A; Adamczak, R; Meller, J				Cushion, Melanie T.; Smulian, A. George; Slaven, Bradley E.; Sesterhenn, Tom; Arnold, Jonathan; Staben, Chuck; Porollo, Aleksey; Adamczak, Rafal; Meller, Jarek			Transcriptome of Pneumocystis carinii during Fulminate Infection: Carbohydrate Metabolism and the Concept of a Compatible Parasite	PLOS ONE			English	Article								Members of the genus Pneumocystis are fungal pathogens that cause pneumonia in a wide variety of mammals with debilitated immune systems. Little is known about their basic biological functions, including life cycle, since no species can be cultured continuously outside the mammalian lung. To better understand the pathological process, about 4500 ESTS derived from sequencing of the poly(A) tail ends of P. carinii mRNAs during fulminate infection were annotated and functionally characterized as unassembled reads, and then clustered and reduced to a unigene set with 1042 members. Because of the presence of sequences from other microbial genomes and the rat host, the analysis and compression to a unigene set was necessarily an iterative process. BLASTx analysis of the unassembled reads (UR) vs. the Uni-Prot and TREMBL databases revealed 56% had similarities to existing polypeptides at E values of <= 10(-6), with the remainder lacking any significant homology. The most abundant transcripts in the UR were associated with stress responses, energy production, transcription and translation. Most (70%) of the UR had similarities to proteins from filamentous fungi (e. g., Aspergillus, Neurospora) and existing P. carinii gene products. In contrast, similarities to proteins of the yeast-like fungi, Schizosaccharomyces pombe and Saccharomyces cerevisiae, predominated in the unigene set. Gene Ontology analysis using BLAST2GO revealed P. carinii dedicated most of its transcripts to cellular and physiological processes (similar to 80%), molecular binding and catalytic activities (similar to 70%), and were primarily derived from cell and organellar compartments (similar to 80%). KEGG Pathway mapping showed the putative P. carinii genes represented most standard metabolic pathways and cellular processes, including the tricarboxylic acid cycle, glycolysis, amino acid biosynthesis, cell cycle and mitochondrial function. Several gene homologs associated with mating, meiosis, and sterol biosynthesis in fungi were identified. Genes encoding the major surface glycoprotein family (MSG), heat shock (HSP70), and proteases (PROT/KEX) were the most abundantly expressed of known P. carinii genes. The apparent presence of many metabolic pathways in P. carinii, sexual reproduction within the host, and lack of an invasive infection process in the immunologically intact host suggest members of the genus Pneumocystis may be adapted parasites and have a compatible relationship with their mammalian hosts. This study represents the first characterization of the expressed genes of a non-culturable fungal pathogen of mammals during the infective process.	[Cushion, Melanie T.; Smulian, A. George; Slaven, Bradley E.; Sesterhenn, Tom] Univ Cincinnati, Coll Med, Dept Internal Med, Div Infect Dis, Cincinnati, OH 45221 USA; [Arnold, Jonathan] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Staben, Chuck] Univ Kentucky, Lexington, KY USA; [Cushion, Melanie T.] Cincinnati Vet Adm Med Ctr, Cincinnati, OH USA; [Porollo, Aleksey; Adamczak, Rafal; Meller, Jarek] Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Georgia; University of Georgia; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Cushion, MT (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Infect Dis, Cincinnati, OH 45221 USA.	melanie.cushion@uc.edu	Meller, Jaroslaw/A-1971-2011; Adamczak, Rafal/F-2965-2014; Staben, Charles/C-1562-2013	Meller, Jaroslaw/0000-0002-1162-8253; Adamczak, Rafal/0000-0002-0261-8184; Cushion, Melanie T./0000-0001-6621-2784; Porollo, Alexey/0000-0002-3202-5099; arnold, jonathan/0000-0001-5845-1048	NIH [R01 AI44651, R21]; Veterans Administration; UGA College of Agricultural and Environmental Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044651] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); UGA College of Agricultural and Environmental Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH: R01 AI44651 (M. T. C., A. G. S., J.A., C. S.) and R21 (J.M., A. G. S.); the Veterans Administration (Medical Research Equipment Grant) (A. G. S., M. T. C.). The NIH or the VA had no role in the design or conduct etc. of the study. They provided funds to execute the studies after award of grants (NIH) or equipment (VA). We also thank the UGA College of Agricultural and Environmental Sciences for their support.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; BECK JM, 1991, AM J RESP CELL MOL, V5, P186, DOI 10.1165/ajrcmb/5.2.186; Bozdech Z, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-17; Calderon E, 2004, EUR J CLIN MICROBIOL, V23, P545, DOI 10.1007/s10096-004-1151-3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crothers K, 2005, AIDS, V19, P801, DOI 10.1097/01.aids.0000168974.67090.70; Cushion M.T., 2006, TOPLEY WILSONS MED M, P763; Cushion MT, 2005, MYCOLOGIA, V97, P268, DOI 10.3852/mycologia.97.1.268; Cushion MT, 2004, MYCOLOGIA, V96, P429, DOI 10.2307/3762163; Cushion MT, 2004, TRENDS MICROBIOL, V12, P243, DOI 10.1016/j.tim.2004.03.005; Cushion MT, 2004, J EUKARYOT MICROBIOL, V51, P30, DOI 10.1111/j.1550-7408.2004.tb00158.x; CUSHION MT, 1993, INFECT IMMUN, V61, P4801, DOI 10.1128/IAI.61.11.4801-4813.1993; Cushion MT, 1997, J EUKARYOT MICROBIOL, V44, p7S, DOI 10.1111/j.1550-7408.1997.tb05737.x; CUSHION MT, 1984, INFECT IMMUN, V44, P245, DOI 10.1128/IAI.44.2.245-251.1984; Cushion MT, 1997, INFECT IMMUN, V65, P4365, DOI 10.1128/IAI.65.10.4365-4365.1997; Dei-Cas E, 2006, FEMS MICROBIOL REV, V30, P853, DOI 10.1111/j.1574-6976.2006.00037.x; EDMAN JC, 1988, NATURE, V334, P519, DOI 10.1038/334519a0; Enyenihi AH, 2003, GENETICS, V163, P47; Eschrich D, 2002, FEMS YEAST RES, V2, P315, DOI 10.1016/S1567-1356(02)00087-9; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELDMANN H, 2005, SHORT COMPENDIUM BAS; Fisk DT, 2003, CLIN INFECT DIS, V36, P70, DOI 10.1086/344951; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; Frenkel J K, 1976, Natl Cancer Inst Monogr, V43, P13; Frenkel JK, 1999, J EUKARYOT MICROBIOL, V46, p89S; FURLONG ST, 1994, ANTIMICROB AGENTS CH, V38, P2534, DOI 10.1128/AAC.38.11.2534; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Huang L, 2004, EMERG INFECT DIS, V10, P1721, DOI 10.3201/eid1010.030994; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Icenhour CR, 2002, EUKARYOT CELL, V1, P414, DOI 10.1128/EC.1.3.414-419.2002; Icenhour CR, 2001, J CLIN MICROBIOL, V39, P3437, DOI 10.1128/JCM.39.10.3437-3441.2001; JOFFRION T, 2006, J EUKARYOTI IN PRESS; Kaneshiro ES, 2000, ANTIMICROB AGENTS CH, V44, P1630, DOI 10.1128/AAC.44.6.1630-1638.2000; KANESHIRO ES, 1994, J EUKARYOT MICROBIOL, V41, P78, DOI 10.1111/j.1550-7408.1994.tb05938.x; Kaneshiro ES, 2002, MOL MICROBIOL, V44, P989, DOI 10.1046/j.1365-2958.2002.02932.x; Kazanjian P, 2001, J INFECT DIS, V183, P819, DOI 10.1086/318835; Kazanjian PH, 2004, J INFECT DIS, V189, P1684, DOI 10.1086/382957; Keely SP, 2004, MICROBIOL-SGM, V150, P1153, DOI 10.1099/mic.0.26921-0; Keely SP, 2003, INFECT IMMUN, V71, P47, DOI 10.1128/IAI.71.1.47-60.2003; Kovacs JA, 2001, JAMA-J AM MED ASSOC, V286, P2450, DOI 10.1001/jama.286.19.2450; LANGRETH SG, 1994, J EUKARYOT MICROBIOL, V41, pS95; Larochelle M, 2006, MOL CELL BIOL, V26, P6690, DOI 10.1128/MCB.02450-05; Lee JG, 2000, J BIOCHEM-TOKYO, V128, P1059, DOI 10.1093/oxfordjournals.jbchem.a022834; LI J, 1994, J EUKARYOT MICROBIOL, V41, pS97; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; LIMPER AH, 1993, INFECT IMMUN, V61, P4302, DOI 10.1128/IAI.61.10.4302-4309.1993; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; MATSUMOTO Y, 1984, J PROTOZOOL, V31, P420, DOI 10.1111/j.1550-7408.1984.tb02989.x; Milla P, 2002, LIPIDS, V37, P1171, DOI 10.1007/s11745-002-1017-9; Morales IJ, 2003, AM J RESP CELL MOL, V29, P232, DOI 10.1165/rcmb.2003-0012OC; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Morris A, 2004, AM J RESP CRIT CARE, V170, P408, DOI 10.1164/rccm.200401-094OC; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; PARK YU, 2006, EUKARYOT CELL; PIFER LL, 1978, PEDIATRICS, V61, P35; PIXLEY FJ, 1991, MOL MICROBIOL, V5, P1347, DOI 10.1111/j.1365-2958.1991.tb00781.x; POTTRATZ ST, 1994, J LAB CLIN MED, V123, P273; POTTRATZ ST, 1995, EXP CELL RES, V221, P357, DOI 10.1006/excr.1995.1385; REDHEAD S, 2005, J EUKARYOT IN PRESS; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakurai M, 2004, FEMS YEAST RES, V4, P649, DOI 10.1016/j.femsyr.2003.12.009; Sharma SK, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-52; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Smulian AG, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P347; Smulian AG, 2001, GENETICS, V157, P991; Solomon PS, 2004, MOL MICROBIOL, V53, P1065, DOI 10.1111/j.1365-2958.2004.04178.x; STRINGER SL, 1989, EXP PARASITOL, V68, P450, DOI 10.1016/0014-4894(89)90130-6; Tatebe H, 2003, MOL CELL BIOL, V23, P5132, DOI 10.1128/MCB.23.15.5132-5142.2003; Teixeira MC, 2006, FEMS YEAST RES, V6, P230, DOI 10.1111/j.1567-1364.2006.00041.x; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Vidal S, 2006, CLIN MICROBIOL INFEC, V12, P231, DOI 10.1111/j.1469-0691.2005.01337.x; Vohra PK, 2004, BIOCHEM BIOPH RES CO, V319, P193, DOI 10.1016/j.bbrc.2004.04.154; WISNIOWSKI P, 1995, J LAB CLIN MED, V125, P38; Zar HJ, 2004, CLIN INFECT DIS, V39, P1047, DOI 10.1086/424010	80	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e423	10.1371/journal.pone.0000423	http://dx.doi.org/10.1371/journal.pone.0000423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487271	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445800005
J	Ricaud, L; Proux, C; Renou, JP; Pichon, O; Fochesato, S; Ortet, P; Montane, MH				Ricaud, Lilian; Proux, Caroline; Renou, Jean-Pierre; Pichon, Olivier; Fochesato, Sylvain; Ortet, Philippe; Montane, Marie-Helene			ATM-Mediated Transcriptional and Developmental Responses to gamma-rays in Arabidopsis	PLOS ONE			English	Article							STRAND BREAK REPAIR; CELL-CYCLE CHECKPOINT; DNA-DAMAGE RESPONSE; DEPENDENT PROTEIN-KINASE; HOMOLOGOUS RECOMBINATION; IONIZING-RADIATION; GENE-EXPRESSION; ATAXIA-TELANGIECTASIA; S-PHASE; HISTONE ACETYLATION	ATM (Ataxia Telangiectasia Mutated) is an essential checkpoint kinase that signals DNA double-strand breaks in eukaryotes. Its depletion causes meiotic and somatic defects in Arabidopsis and progressive motor impairment accompanied by several cell deficiencies in patients with ataxia telangiectasia (AT). To obtain a comprehensive view of the ATM pathway in plants, we performed a time-course analysis of seedling responses by combining confocal laser scanning microscopy studies of root development and genome-wide expression profiling of wild-type (WT) and homozygous ATM-deficient mutants challenged with a dose of gamma-rays (IR) that is sublethal for WT plants. Early morphologic defects in meristematic stem cells indicated that AtATM, an Arabidopsis homolog of the human ATM gene, is essential for maintaining the quiescent center and controlling the differentiation of initial cells after exposure to IR. Results of several microarray experiments performed with whole seedlings and roots up to 5 h post-IR were compiled in a single table, which was used to import gene information and extract gene sets. Sequence and function homology searches; import of spatio-temporal, cell cycling, and mutant-constitutive expression characteristics; and a simplified functional classification system were used to identify novel genes in all functional classes. The hundreds of radiomodulated genes identified were not a random collection, but belonged to functional pathways such as those of the cell cycle; cell death and repair; DNA replication, repair, and recombination; and transcription; translation; and signaling, indicating the strong cell reprogramming and double-strand break abrogation functions of ATM checkpoints. Accordingly, genes in all functional classes were either down or up-regulated concomitantly with downregulation of chromatin deacetylases or upregulation of acetylases and methylases, respectively. Determining the early transcriptional indicators of prolonged S-G2 phases that coincided with cell proliferation delay, or an anticipated subsequent auxin increase, accelerated cell differentiation or death, was used to link IR-regulated hallmark functions and tissue phenotypes after IR. The transcription burst was almost exclusively AtATM-dependent or weakly AtATR-dependent, and followed two major trends of expression in atm: (i)-loss or severe attenuation and delay, and (ii)-inverse and/or stochastic, as well as specific, enabling one to distinguish IR/ATM pathway constituents. Our data provide a large resource for studies on the interaction between plant checkpoints of the cell cycle, development, hormone response, and DNA repair functions, because IR-induced transcriptional changes partially overlap with the response to environmental stress. Putative connections of ATM to stem cell maintenance pathways after IR are also discussed.	[Ricaud, Lilian; Fochesato, Sylvain; Ortet, Philippe; Montane, Marie-Helene] CEA, DSV, Inst Biol Environm & Biotechnol, SBVME, Cadarache, St Paul Lez Dur, France; [Proux, Caroline; Renou, Jean-Pierre; Pichon, Olivier] UEVE, Unite Rech Genom Vegetale, CNRS 8114, UMR INRA 1165, Evry, France	CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Montane, MH (corresponding author), CEA, DSV, Inst Biol Environm & Biotechnol, SBVME, Cadarache, St Paul Lez Dur, France.	marie-helene.montane@cea.fr	ORTET, Philippe/T-8172-2018	ORTET, Philippe/0000-0002-2648-8978	GENOPLANTE [AF2001051]	GENOPLANTE	This work was supported by a GENOPLANTE contract (AF2001051).	Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Aplan PD, 2006, TRENDS GENET, V22, P46, DOI 10.1016/j.tig.2005.10.002; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barber LJ, 2005, MOL CELL BIOL, V25, P2297, DOI 10.1128/MCB.25.6.2297-2309.2005; Barroco RM, 2005, PLANT PHYSIOL, V137, P127, DOI 10.1104/pp.104.049361; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bleuyard JY, 2006, DNA REPAIR, V5, P1, DOI 10.1016/j.dnarep.2005.08.017; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Bonatto D, 2005, BRAZ J MED BIOL RES, V38, P321, DOI 10.1590/S0100-879X2005000300002; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Boyko A, 2006, PLANT CELL PHYSIOL, V47, P736, DOI 10.1093/pcp/pcj045; Brown EJ, 2000, GENE DEV, V14, P397; Buscemi G, 2004, ONCOGENE, V23, P7691, DOI 10.1038/sj.onc.1207986; Carballo JA, 2006, BIOL RES, V39, P331, DOI 10.4067/S0716-97602006000200015; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476; Chang MS, 2000, BIOCHEM BIOPH RES CO, V279, P732, DOI 10.1006/bbrc.2000.3992; Chen IP, 2003, PLANT J, V35, P771, DOI 10.1046/j.1365-313X.2003.01847.x; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Criqui MC, 2000, PLANT J, V24, P763, DOI 10.1111/j.1365-313X.2000.t01-1-.x; Crowe ML, 2003, NUCLEIC ACIDS RES, V31, P156, DOI 10.1093/nar/gkg071; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Da Costa M, 2006, PLANT CELL, V18, P1426, DOI 10.1105/tpc.105.040485; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; Deveaux Y, 2000, RADIAT RES, V154, P355, DOI 10.1667/0033-7587(2000)154[0355:MCADEO]2.0.CO;2; Ding YH, 2006, PLANT CELL, V18, P815, DOI 10.1105/tpc.105.039495; Doerner P, 1996, NATURE, V380, P520, DOI 10.1038/380520a0; Doerner P, 2006, CURR BIOL, V16, pR199, DOI 10.1016/j.cub.2006.02.027; Doutriaux MP, 1998, MOL GEN GENET, V257, P283, DOI 10.1007/s004380050649; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Duque P, 2003, PLANT J, V35, P787, DOI 10.1046/j.1365-313X.2003.01848.x; Elkon R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r43; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Endo M, 2006, EMBO J, V25, P5579, DOI 10.1038/sj.emboj.7601434; Esmon CA, 2006, P NATL ACAD SCI USA, V103, P236, DOI 10.1073/pnas.0507127103; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; Fleming AJ, 2006, J PLANT RES, V119, P31, DOI 10.1007/s10265-005-0240-4; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Frame FM, 2006, ONCOGENE, V25, P3258, DOI 10.1038/sj.onc.1209352; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fritsch O, 2004, MOL CELL, V16, P479, DOI 10.1016/j.molcel.2004.09.034; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fulop K, 2005, CELL CYCLE, V4, P1084; Garber PM, 2005, TRENDS BIOCHEM SCI, V30, P63, DOI 10.1016/j.tibs.2004.12.004; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; Garcia V, 2000, NUCLEIC ACIDS RES, V28, P1692, DOI 10.1093/nar/28.8.1692; Garcia-Ortiz MV, 2004, PLANT J, V39, P84, DOI 10.1111/j.1365-313X.2004.02112.x; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; GUO C, 2007, CELLULAR SIGNALLING, V3, P504; Hamant O, 2006, ANNU REV PLANT BIOL, V57, P267, DOI 10.1146/annurev.arplant.57.032905.105255; He SS, 2004, PLANT MOL BIOL, V56, P171, DOI 10.1007/s11103-004-2748-8; Hefner E, 2006, DNA REPAIR, V5, P102, DOI 10.1016/j.dnarep.2005.08.013; Hefner E, 2003, J EXP BOT, V54, P669, DOI 10.1093/jxb/erg069; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Hirayama T, 1996, P NATL ACAD SCI USA, V93, P13371, DOI 10.1073/pnas.93.23.13371; Hu QH, 2006, NUCLEIC ACIDS RES, V34, P6272, DOI 10.1093/nar/gkl801; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Inagaki S, 2006, PLANT CELL, V18, P879, DOI 10.1105/tpc.105.036798; Innes CL, 2006, MOL CANCER RES, V4, P197, DOI 10.1158/1541-7786.MCR-05-0154; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Ishimi Y, 2004, J STRUCT BIOL, V146, P234, DOI 10.1016/j.jsb.2003.11.027; Ismail IH, 2005, J BIOL CHEM, V280, P4649, DOI 10.1074/jbc.M411588200; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Iwakawa H, 2006, PLANT J, V45, P819, DOI 10.1111/j.1365-313X.2005.02643.x; Iwanaga R, 2006, ONCOGENE, V25, P1786, DOI 10.1038/sj.onc.1209210; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jeggo PA, 1998, TRENDS GENET, V14, P312, DOI 10.1016/S0168-9525(98)01511-X; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; Kandasamy MK, 2005, PLANT J, V41, P845, DOI 10.1111/j.1365-313X.2005.02345.x; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kats ES, 2006, P NATL ACAD SCI USA, V103, P3710, DOI 10.1073/pnas.0511102103; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kimura S, 2006, CHEM REV, V106, P753, DOI 10.1021/cr040482n; Kirik A, 2006, PLANT CELL, V18, P2431, DOI 10.1105/tpc.106.045088; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Krizek BA, 2006, PLANTA, V224, P612, DOI 10.1007/s00425-006-0253-9; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lafarge S, 2003, NUCLEIC ACIDS RES, V31, P1148, DOI 10.1093/nar/gkg202; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Le Roy F, 2005, NAT STRUCT MOL BIOL, V12, P505, DOI 10.1038/nsmb944; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li CX, 2005, P NATL ACAD SCI USA, V102, P12978, DOI 10.1073/pnas.0504039102; Lin WC, 2001, GENE DEV, V15, P1833; Lobrich M, 2005, RADIOTHER ONCOL, V76, P112, DOI 10.1016/j.radonc.2005.06.027; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Lydall D, 2005, DNA REPAIR, V4, P1195, DOI 10.1016/j.dnarep.2005.06.007; Matei IR, 2006, IMMUNOL REV, V209, P142, DOI 10.1111/j.0105-2896.2006.00361.x; McGarry RC, 2003, PLANT CELL, V15, P1605, DOI 10.1105/tpc.012120; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Menges M, 2006, PLANT CELL, V18, P893, DOI 10.1105/tpc.105.039636; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Menges M, 2002, J BIOL CHEM, V277, P41987, DOI 10.1074/jbc.M207570200; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Mercier G, 2001, MUTAT RES-DNA REPAIR, V487, P157, DOI 10.1016/S0921-8777(01)00116-1; Mischo HE, 2005, J BIOL CHEM, V280, P9586, DOI 10.1074/jbc.M411444200; Mizukami Y, 2001, CURR OPIN PLANT BIOL, V4, P533, DOI 10.1016/S1369-5266(00)00212-0; Molinier J, 2005, MUTAT RES-FUND MOL M, V571, P235, DOI 10.1016/j.mrfmmm.2004.09.016; Molinier J, 2004, PLANT CELL, V16, P1633, DOI 10.1105/tpc.021378; Morikawa H, 2004, MOL CELL BIOL, V24, P9401, DOI 10.1128/MCB.24.21.9401-9413.2004; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nakai T, 2006, FEBS LETT, V580, P336, DOI 10.1016/j.febslet.2005.12.018; Ng DWK, 2006, PLANT CELL, V18, P119, DOI 10.1105/tpc.105.037010; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nicolai M, 2006, PLANT PHYSIOL, V141, P663, DOI 10.1104/pp.106.079418; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Nole-Wilson S, 2006, PLANT PHYSIOL, V141, P977, DOI 10.1104/pp.106.076604; O'Brien PJ, 2006, CHEM REV, V106, P720, DOI 10.1021/cr040481v; Ohno T, 2004, BIOCHEM BIOPH RES CO, V317, P925, DOI 10.1016/j.bbrc.2004.03.131; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Patel JH, 2006, J BIOL CHEM, V281, P3283, DOI 10.1074/jbc.M513038200; PICCOLI GD, 2006, NAT CELL BIOL, V8, P1032; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Post SM, 2003, NUCLEIC ACIDS RES, V31, P5568, DOI 10.1093/nar/gkg765; Preuss SB, 2003, GENETICS, V164, P323; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saintigny Y, 2007, ONCOGENE, V26, P2769, DOI 10.1038/sj.onc.1210075; Sanchez-Moran E, 2005, CYTOGENET GENOME RES, V109, P181, DOI 10.1159/000082398; Sano T, 2006, FEBS LETT, V580, P597, DOI 10.1016/j.febslet.2005.12.074; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schindler K, 2003, MOL CELL BIOL, V23, P8718, DOI 10.1128/MCB.23.23.8718-8728.2003; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Schwaiger M, 2006, CURR OPIN GENET DEV, V16, P177, DOI 10.1016/j.gde.2006.02.007; Sedgwick C, 2006, BIOCHEM J, V399, P151, DOI 10.1042/BJ20060363; Shechter D, 2005, CELL CYCLE, V4, P235; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Shiloh Y, 2004, NAT CELL BIOL, V6, P923, DOI 10.1038/ncb1004-923; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Shimotohno A, 2006, PLANT J, V47, P701, DOI 10.1111/j.1365-313X.2006.02820.x; Shukla A, 2005, BIOCHEM BIOPH RES CO, V329, P1240, DOI 10.1016/j.bbrc.2005.02.106; Siaud N, 2004, EMBO J, V23, P1392, DOI 10.1038/sj.emboj.7600146; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stankovic T, 2004, BLOOD, V103, P291, DOI 10.1182/blood-2003-04-1161; Stoynova-Bakalova E, 2004, NEW PHYTOL, V162, P471, DOI 10.1111/j.1469-8137.2004.01031.x; Summers MK, 2005, ONCOGENE, V24, P2589, DOI 10.1038/sj.onc.1208428; Sutherland BM, 2000, BIOCHEMISTRY-US, V39, P8026, DOI 10.1021/bi9927989; Takeda S, 2004, GENE DEV, V18, P782, DOI 10.1101/gad.295404; Takemura M, 2002, BIOSYSTEMS, V65, P139, DOI 10.1016/S0303-2647(02)00007-2; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Thareau V, 2003, BIOINFORMATICS, V19, P2191, DOI 10.1093/bioinformatics/btg286; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Tremousaygue D, 2003, PLANT J, V33, P957, DOI 10.1046/j.1365-313X.2003.01682.x; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Umeda M, 2000, P NATL ACAD SCI USA, V97, P13396, DOI 10.1073/pnas.240458997; Utley RT, 2005, MOL CELL BIOL, V25, P8179, DOI 10.1128/MCB.25.18.8179-8190.2005; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; Weingartner M, 2004, PLANT CELL, V16, P643, DOI 10.1105/tpc.020057; West CE, 2000, PLANT J, V24, P67, DOI 10.1046/j.1365-313x.2000.00856.x; West CE, 2004, BIOCHEM SOC T, V32, P964, DOI 10.1042/BST0320964; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Wu KQ, 2003, PLANT J, V34, P241, DOI 10.1046/j.1365-313X.2003.01714.x; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yamanaka T, 2002, J VIROL, V76, P2491, DOI 10.1128/JVI.76.5.2491-2497.2002; Yang ZB, 1998, CURR OPIN PLANT BIOL, V1, P525, DOI 10.1016/S1369-5266(98)80046-0; Yao JL, 2001, J BIOL CHEM, V276, P13517, DOI 10.1074/jbc.M007006200; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zhang CQ, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-7; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	196	82	83	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e430	10.1371/journal.pone.0000430	http://dx.doi.org/10.1371/journal.pone.0000430			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487278	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445800012
J	Fujita, M; Takeshita, H; Sawa, H				Fujita, Masaki; Takeshita, Hisako; Sawa, Hitoshi			Cyclin E and CDK2 Repress the Terminal Differentiation of Quiescent Cells after Asymmetric Division in C. elegans	PLOS ONE			English	Article								Coordination between cell proliferation and differentiation is important in normal development and oncogenesis. These processes usually have an antagonistic relationship, in that differentiation is blocked in proliferative cells, and terminally differentiated cells do not divide. In some instances, cyclins, cyclin-dependent kinases (CDKs) and their inhibitors (CKIs) play important roles in this antagonistic regulation. However, it is unknown whether CKIs and cyclin/CDKs regulate the uncommitted state in quiescent cells where CDK activities are likely to be low. Here, we show in C. elegans that cye-1/cyclin E and cdk-2/CDK2 repress terminal differentiation in quiescent cells. In cye-1 mutants and cdk-2(RNAi) animals, after asymmetric division, certain quiescent cells adopted their sister cells' phenotype and differentiated at some frequency. In contrast, in cki-1(RNAi) animals, these cells underwent extra divisions, while, in cki-1(RNAi); cdk-2( RNAi) or cki-1(RNAi); cye-1 animals, they remained quiescent or differentiated. Therefore, in wild-type animals, CKI-1/CKI in these cells maintained quiescence by inhibiting CYE-1/CDK-2, while sufficient CYE-1/CDK-2 remained to repress the terminal differentiation. The difference between sister cells is regulated by the Wnt/MAP kinase pathway, which causes asymmetric expression of CYE-1 and CKI-1. Our results suggest that the balance between the levels of CKI and cyclin E determines three distinct cell states: terminally differentiated, quiescent and uncommitted, and proliferating.	[Fujita, Masaki; Takeshita, Hisako; Sawa, Hitoshi] Ctr Dev Biol, RIKEN, Lab Cell Fate Decis, Kobe, Hyogo, Japan; [Sawa, Hitoshi] Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo 657, Japan	RIKEN; Kobe University	Sawa, H (corresponding author), Ctr Dev Biol, RIKEN, Lab Cell Fate Decis, Kobe, Hyogo, Japan.	sawa@cdb.riken.jp		Sawa, Hitoshi/0000-0001-9774-7976	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Berger C, 2005, NAT CELL BIOL, V7, P56, DOI 10.1038/ncb1203; Blelloch R, 1999, DEV BIOL, V216, P382, DOI 10.1006/dbio.1999.9491; Boxem M, 1999, DEVELOPMENT, V126, P2227; Boxem M, 2001, DEVELOPMENT, V128, P4349; BRENNER S, 1974, GENETICS, V77, P71; Brodigan TM, 2003, DEV BIOL, V254, P102, DOI 10.1016/S0012-1606(02)00032-5; Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Chen S.-C., 2000, KLUW INT S ADV DATA, V21; Chen Z, 2001, DEVELOPMENT, V128, P4911; Cheng T, 2004, ONCOGENE, V23, P7256, DOI 10.1038/sj.onc.1207945; Fay DS, 2000, DEVELOPMENT, V127, P4049; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Fukuyama M, 2003, DEV BIOL, V260, P273, DOI 10.1016/S0012-1606(03)00239-2; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hong Y, 1998, DEVELOPMENT, V125, P3585; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kostic I, 2003, DEV BIOL, V263, P242, DOI 10.1016/S0012-1606(03)00452-4; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Nakamura K, 2005, GENE DEV, V19, P1749, DOI 10.1101/gad.1323705; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Reynaud EG, 1999, MOL CELL BIOL, V19, P7621; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Saito RM, 2004, NAT CELL BIOL, V6, P777, DOI 10.1038/ncb1154; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Siegfried KR, 2002, DEVELOPMENT, V129, P443; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; Terns RM, 1997, GENETICS, V146, P185; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Tilmann C, 2005, DEV CELL, V9, P489, DOI 10.1016/j.devcel.2005.09.004; Wang MQ, 2000, DEVELOPMENT, V127, P5047; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	38	17	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e407	10.1371/journal.pone.0000407	http://dx.doi.org/10.1371/journal.pone.0000407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476329	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445700009
J	Hsu, CY; Ko, FY; Li, CW; Fann, K; Lue, JT				Hsu, Chin-Yuan; Ko, Fu-Yao; Li, Chia-Wei; Fann, Kuni; Lue, Juh-Tzeng			Magnetoreception System in Honeybees (Apis mellifera)	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; IRON-CONTAINING CELLS; ELF MAGNETIC-FIELD; PULSED ELECTROMAGNETIC-FIELDS; BEES; GRANULES; ORIENTATION; CA2+; NANOPARTICLES; MAGNETOSOMES	Honeybees (Apis mellifera) undergo iron biomineralization, providing the basis for magnetoreception. We showed earlier the presence of superparamagnetic magnetite in iron granules formed in honeybees, and subscribed to the notion that external magnetic fields may cause expansion or contraction of the superparamagnetic particles in an orientation-specific manner, relaying the signal via cytoskeleton (Hsu and Li 1994). In this study, we established a size-density purification procedure, with which quantitative amount of iron granules was obtained from honey bee trophocytes and characterized; the density of iron granules was determined to be 1.25 g/cm(3). While we confirmed the presence of superparamagnetic magnetite in the iron granules, we observed changes in the size of the magnetic granules in the trophycytes upon applying additional magnetic field to the cells. A concomitant release of calcium ion was observed by confocal microscope. This size fluctuation triggered the increase of intracellular Ca+2, which was inhibited by colchicines and latrunculin B, known to be blockers for microtubule and microfilament syntheses, respectively. The associated cytoskeleton may thus relay the magnetosignal, initiating a neural response. A model for the mechanism of magnetoreception in honeybees is proposed, which may be applicable to most, if not all, magnetotactic organisms.	[Hsu, Chin-Yuan] Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan; [Ko, Fu-Yao; Li, Chia-Wei] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Fann, Kuni] York Univ, Atkinson Coll, Dept Philosophy, Toronto, ON M3J 2R7, Canada; [Lue, Juh-Tzeng] Natl Tsing Hua Univ, Dept Phys, Hsinchu, Taiwan	Chang Gung University; National Tsing Hua University; York University - Canada; National Tsing Hua University	Hsu, CY (corresponding author), Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan.	hsu@mail.cgu.edu.tw			National Science Council [NSC 94-2311-B-182-008]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (NSC 94-2311-B-182-008) from the National Science Council, R. O. C.	Abracado LG, 2005, J MAGN RESON, V175, P309, DOI 10.1016/j.jmr.2005.05.006; Acosta-Avalos D, 1999, J EXP BIOL, V202, P2687; Aldinucci C, 2000, BBA-MOL CELL RES, V1499, P101, DOI 10.1016/S0167-4889(00)00111-7; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Alves OC, 2004, J MAGN RESON, V168, P246, DOI 10.1016/j.jmr.2004.03.010; Balcavage WX, 1996, BIOCHEM BIOPH RES CO, V222, P374, DOI 10.1006/bbrc.1996.0751; BECKER L, 1958, Z VERGL PHYSIOL, V41, P1; Bersani F, 1997, BIOELECTROMAGNETICS, V18, P463, DOI 10.1002/(SICI)1521-186X(1997)18:7<463::AID-BEM1>3.0.CO;2-0; Bianchi MG, 2006, NEUROCHEM INT, V48, P341, DOI 10.1016/j.neuint.2005.11.013; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Boyain-Goitia AR, 2003, APPL OPTICS, V42, P6119, DOI 10.1364/AO.42.006119; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; COLLETT TS, 1994, NATURE, V368, P137, DOI 10.1038/368137a0; Desoil M, 2005, J PHYS CONF SER, V17, P45, DOI 10.1088/1742-6596/17/1/007; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Dowell ML, 2005, J APPL PHYSIOL, V98, P489, DOI 10.1152/japplphysiol.01378.2003; DYER FC, 1981, SCIENCE, V214, P1041, DOI 10.1126/science.214.4524.1041; El-Jaick LJ, 2001, EUR BIOPHYS J BIOPHY, V29, P579, DOI 10.1007/s002490000115; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Esquivel DMS, 1999, NATURWISSENSCHAFTEN, V86, P30, DOI 10.1007/s001140050564; Ferreira J, 2005, J MAGN MAGN MATER, V289, P442, DOI 10.1016/j.jmmm.2004.11.124; Flipo D, 1998, J TOXICOL ENV HEAL A, V54, P63; Frier HJ, 1996, J EXP BIOL, V199, P1353; GOULD JL, 1980, J EXP BIOL, V86, P1; GOULD JL, 1986, SCIENCE, V232, P861, DOI 10.1126/science.232.4752.861; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; Haskew-Layton RE, 2005, J BIOL CHEM, V280, P3548, DOI 10.1074/jbc.M409803200; HSU CY, 1994, SCIENCE, V265, P95, DOI 10.1126/science.265.5168.95; HSU CY, 1993, J EXP BIOL, V180, P1; Ikehara T, 2005, BBA-GEN SUBJECTS, V1724, P8, DOI 10.1016/j.bbagen.2005.03.008; Ikehara T, 2003, BIOELECTROMAGNETICS, V24, P457, DOI 10.1002/bem.10120; Kalmijn AJ., 1978, ANIMAL MIGRATION NAV, P354; Keim CN, 2002, MICRON, V33, P53, DOI 10.1016/S0968-4328(00)00071-8; Kirschvink JL, 1997, J EXP BIOL, V200, P1363; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; KIRSCHVINK JL, 1991, AM ZOOL, V31, P169; KIRSCHVINK JL, 1995, SCIENCE, V269, P1889, DOI 10.1126/science.269.5232.1889; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Koronkiewicz S, 2001, BBA-BIOMEMBRANES, V1510, P300, DOI 10.1016/S0005-2736(00)00362-X; KREBS AT, 1965, NATURE, V207, P1412, DOI 10.1038/2071412a0; KUTERBACH DA, 1986, J EXP BIOL, V126, P375; KUTERBACH DA, 1986, J EXP BIOL, V126, P389; KUTERBACH DA, 1982, SCIENCE, V218, P695, DOI 10.1126/science.218.4573.695; Lechaire JP, 2002, BIOL CELL, V94, P243, DOI 10.1016/S0248-4900(02)01199-1; Lins U, 1999, FEMS MICROBIOL LETT, V172, P23, DOI 10.1016/S0378-1097(99)00011-7; Lucano MJ, 2006, BIOMETALS, V19, P295, DOI 10.1007/s10534-005-0520-4; Manni V, 2004, BIOELECTROMAGNETICS, V25, P118, DOI 10.1002/bem.10158; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Morgado-Valle C, 1998, CELL TISSUE RES, V291, P217, DOI 10.1007/s004410050992; Pessina GP, 2001, BIOELECTROMAGNETICS, V22, P503, DOI 10.1002/bem.79; Petersen OH, 1996, NEWS PHYSIOL SCI, V11, P13; Rasa M, 2002, J COLLOID INTERF SCI, V250, P303, DOI 10.1006/jcis.2002.8345; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; ROSSEL S, 1986, NATURE, V323, P128, DOI 10.1038/323128a0; ROSSEL S, 1984, J COMP PHYSIOL, V154, P607, DOI 10.1007/BF01350213; ROSSEL S, 1984, J COMP PHYSIOL, V155, P605, DOI 10.1007/BF00610846; Santoro N, 1997, BBA-MOL CELL RES, V1357, P281, DOI 10.1016/S0167-4889(97)00032-3; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; SMITH OM, 1991, BIOELECTROMAGNETICS, V12, P197, DOI 10.1002/bem.2250120307; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Tautz J, 2004, PLOS BIOL, V2, P915, DOI 10.1371/journal.pbio.0020211; TOWNE WF, 1985, MAGNETITE BIOMINERAL, P385; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wajnberg E, 2000, BIOPHYS J, V78, P1018, DOI 10.1016/S0006-3495(00)76660-4; Wajnberg E, 2001, J MAGN RESON, V153, P69, DOI 10.1006/jmre.2001.2430; Wakatsuki T, 2001, J CELL SCI, V114, P1025; WALKER MM, 1989, J COMP PSYCHOL, V103, P62; WALKER MM, 1989, J EXP BIOL, V145, P489; WALKER MM, 1985, J COMP PHYSIOL A, V157, P67, DOI 10.1007/BF00611096; WALKER MM, 1989, J EXP BIOL, V141, P447; Winston M.L., 1991, BIOL HONEY BEE	73	72	77	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e395	10.1371/journal.pone.0000395	http://dx.doi.org/10.1371/journal.pone.0000395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460762	Green Published, gold			2022-12-27	WOS:000207445600009
J	Dingli, D; Traulsen, A; Pacheco, JM				Dingli, David; Traulsen, Arne; Pacheco, Jorge M.			Compartmental Architecture and Dynamics of Hematopoiesis	PLOS ONE			English	Article								Background. Blood cell formation is maintained by the replication of hematopoietic stem cells (HSC) that continuously feed downstream "compartments" where amplification and differentiation of cells occurs, giving rise to all blood lineages. Whereas HSC replicate slowly, committed cells replicate faster as they become more differentiated. Methodology/Significant Finding. We propose a multi-compartment model of hematopoiesis, designed on the principle of cell flow conservation under stationary conditions. Cells lost from one compartment due to differentiation are replaced by cells from the upstream compartment. We assume that there is a constant relationship between cell input and output in each compartment and fix the single parameter of the model using data available for granulocyte maturation. We predict that similar to 31 mitotic events separate the HSC from the mature cells observed in the circulation. Besides estimating the number of compartments, our model allows us to estimate the size of each compartment, the rate of cell replication within each compartment, the mean time a given cell type contributes to hematopoiesis, the amplification rate in each compartment, as well as the mean time separating stem-cell replication and mature blood-cell formation. Conclusions. Despite its simplicity, the model agrees with the limited in vivo data available and can make testable predictions. In particular, our prediction of the average lifetime of a PIG-A mutated clone agrees closely with the experimental results available for the PIG-A gene mutation in healthy adults. The present elucidation of the compartment structure and dynamics of hematopoiesis may prove insightful in further understanding a variety of hematopoietic disorders.	[Dingli, David] Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA; [Dingli, David; Traulsen, Arne; Pacheco, Jorge M.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Pacheco, Jorge M.] Univ Lisbon, Fac Ciencias, Dept Fis, Lisbon, Portugal; [Pacheco, Jorge M.] Ctr Fis Teor & Computac, Lisbon, Portugal	Mayo Clinic; Harvard University; Universidade de Lisboa; Universidade de Lisboa	Dingli, D (corresponding author), Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA.	dingli.david@mayo.edu	Pacheco, Jorge M/B-6116-2008; Traulsen, Arne/A-4955-2009; Pacheco, Jorge M./O-8184-2019	Pacheco, Jorge M/0000-0002-2579-8499; Traulsen, Arne/0000-0002-0669-5267; Pacheco, Jorge M./0000-0002-2579-8499				Araten DJ, 2006, BLOOD, V108, P734, DOI 10.1182/blood-2006-01-0256; Araten DJ, 1999, P NATL ACAD SCI USA, V96, P5209, DOI 10.1073/pnas.96.9.5209; Colijn C, 2005, J THEOR BIOL, V237, P133, DOI 10.1016/j.jtbi.2005.03.034; Colijn C, 2005, J THEOR BIOL, V237, P117, DOI 10.1016/j.jtbi.2005.03.033; CRONKITE EP, 1964, NEW ENGL J MED, V270, P1347, DOI 10.1056/NEJM196406182702506; DINGLI D, 2007, PLOS COMPUT IN PRESS; Dingli D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000002; DONOHUE DM, 1958, J CLIN INVEST, V37, P1571, DOI 10.1172/JCI103750; FINCH CA, 1977, BLOOD, V50, P699; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Mackey MC, 2001, CELL PROLIFERAT, V34, P71, DOI 10.1046/j.1365-2184.2001.00195.x; Marley SB, 2003, BRIT J HAEMATOL, V121, P643, DOI 10.1046/j.1365-2141.2003.04338.x; Marley SB, 2001, BONE MARROW TRANSPL, V27, P241, DOI 10.1038/sj.bmt.1702777; McCulloch EA, 2005, NAT MED, V11, P1026, DOI 10.1038/nm1005-1026; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Obeyesekere MN, 2004, CELL PROLIFERAT, V37, P279, DOI 10.1111/j.1365-2184.2004.00312.x; Panetta JC, 2003, MATH BIOSCI, V186, P29, DOI 10.1016/j.mbs.2003.07.002; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Shochat E, 2002, B MATH BIOL, V64, P861, DOI 10.1006/bulm.2002.0305; Vainstein V, 2005, J THEOR BIOL, V234, P311, DOI 10.1016/j.jtbi.2004.11.026; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; WALKER RI, 1964, BLOOD, V23, P795, DOI 10.1182/blood.V23.6.795.795	23	64	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e345	10.1371/journal.pone.0000345	http://dx.doi.org/10.1371/journal.pone.0000345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406669	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445300007
J	Shrager, J; Waldinger, R; Stickel, M; Massar, JP				Shrager, Jeff; Waldinger, Richard; Stickel, Mark; Massar, J. P.			Deductive Biocomputing	PLOS ONE			English	Article								Background. As biologists increasingly rely upon computational tools, it is imperative that they be able to appropriately apply these tools and clearly understand the methods the tools employ. Such tools must have access to all the relevant data and knowledge and, in some sense, "understand" biology so that they can serve biologists' goals appropriately and "explain" in biological terms how results are computed. Methodology/Principal Findings. We describe a deduction-based approach to biocomputation that semiautomatically combines knowledge, software, and data to satisfy goals expressed in a high-level biological language. The approach is implemented in an open source web-based biocomputing platform called BioDeducta, which combines SRI's SNARK theorem prover with the BioBike interactive integrated knowledge base. The biologist/user expresses a high-level conjecture, representing a biocomputational goal query, without indicating how this goal is to be achieved. A subject domain theory, represented in SNARK's logical language, transforms the terms in the conjecture into capabilities of the available resources and the background knowledge necessary to link them together. If the subject domain theory enables SNARK to prove the conjecture-that is, to find paths between the goal and BioBike resources-then the resulting proofs represent solutions to the conjecture/query. Such proofs provide provenance for each result, indicating in detail how they were computed. We demonstrate BioDeducta by showing how it can approximately replicate a previously published analysis of genes involved in the adaptation of cyanobacteria to different light niches. Conclusions/Significance. Through the use of automated deduction guided by a biological subject domain theory, this work is a step towards enabling biologists to conveniently and efficiently marshal integrated knowledge, data, and computational tools toward resolving complex biological queries.	[Shrager, Jeff] Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; [Waldinger, Richard; Stickel, Mark] SRI Int, Ctr Artificial Intelligence, Menlo Pk, CA 94025 USA	Carnegie Institution for Science; SRI International	Shrager, J (corresponding author), Carnegie Inst Washington, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	jshrager@stanford.edu			National Science Foundation [NSF IIS-0513857]; NASA; Inst. for the Study of Learning and Expertise	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Inst. for the Study of Learning and Expertise	This research was supported in part by the National Science Foundation, under the Science and Engineering Information Integration and Informatics (SEIII) Program (NSF IIS-0513857), and by a grant from the NASA Advanced Information Systems Research Program through cooperative agreement NO6-4803 between NASA-Ames (Andrew Pohorille P. I.) and The Inst. for the Study of Learning and Expertise.	ALLEN JF, 1983, COMMUN ACM, V26, P11; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BACLAWSKI K, 2005, ONT BIOINFORMATICS; Barr M., 1999, CATEGORY THEORY COMP; BHAYA D, 2002, FEMS MICROBIOLOGY LE, V215; Burstall R.M., 1977, P 5 INT JOINT C ARTI, P1045; Cycorp, 2002, ONT ENG HDB; EKER S, 2002, P PAC S BIOC; Fedoroff N, 2005, SCIENTIST, V19, P20; GREEN C, 1969, P INT JOINT C ART IN; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; LOWRY MR, 1994, AMPHION ANTOMATIC PR, P326; Manna Z., 1980, ACM Transactions on Programming Languages and Systems, V2, P90, DOI 10.1145/357084.357090; Massar JP, 2005, BIOINFORMATICS, V21, P199, DOI 10.1093/bioinformatics/bth465; Niles I., 2001, P 2 INT C FORM ONT I; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Racunas SA, 2004, BIOINFORMATICS, V20, P257, DOI 10.1093/bioinformatics/bth905; Russell S.J., 2010, ARTIFICIAL INTELLIGE; Shrager J, 2003, BIOINFORMATICS, V19, P1934, DOI 10.1093/bioinformatics/btg277; SHRAGER J, 2002, P PAC S BIOC; SMITH DR, 2006, COMPOSITION COLIMIT; STICKEL ME, 2000, GUIDE SNARK; STICKEL ME, 1995, SPRINGER VERLAG LECT, V814; TALCOTT C, 2004, P PAC S BIOC; *TEKN, 2004, SUMO ONT; TRAVERS M, 2005, P INT LISP C STANF C; WALDINGER R, 2003, NEW DIRECTIONS QUEST	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e339	10.1371/journal.pone.0000339	http://dx.doi.org/10.1371/journal.pone.0000339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17415407	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445300001
J	Agaugue, S; Perrin-Cocon, L; Andre, P; Lotteau, V				Agaugue, Sophie; Perrin-Cocon, Laure; Andre, Patrice; Lotteau, Vincent			Hepatitis C Lipo-Viro-Particle from Chronically Infected Patients Interferes with TLR4 Signaling in Dendritic Cell	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TOLL-LIKE RECEPTOR-4; ACTIVATED PROTEIN-KINASE; REAL-TIME PCR; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; FATTY-ACIDS; MATURATION; EXPRESSION; ALPHA	Background. Hepatitis C virus (HCV) can be purified from serum of chronically-infected patients in the form of Lipo-Viro-Particles (LVP), which are triglycerid-rich lipoprotein-like particles containing viral RNA and proteins. Since LVP is a constant feature of chronically infected patients, we asked whether purified LVP could interfere with the immune response by acting directly on dendritic cell (DC) function. Methods and Findings. We have analyzed the impact of LVP on the maturation monocyte-derived DC induced by TLR3 or TLR4 ligands. Following incubation with LVP, immature DC supported weak transient HCV-RNA replication and type I IFN synthesis. This, however, did not lead to viral particle production nor to maturation of DC. LVP-treatment prior to TLR3 stimulation by polyI:C only enhanced the secretion of IL-12, IL-6 and TNF alpha yielding typical mature DC. In contrast, LVP-treated DC activated by the TLR4 ligand LPS yielded phenotypically mature DC with reduced capacity to secrete both pro-and anti-inflammatory cytokines. Their ability to stimulate allogeneic T lymphocytes was strongly affected since activated T cells produced IL-5 and IL-13 instead of IFN gamma. Addition of IFN alpha prevented the effect of LVP on DC function. Restoration of IFN gamma secretion by T cells was obtained by blocking ERK activation in DC, while induction of IL-5 and IL-13 secretion was inhibited by blocking the p38-MAPK pathway in DC. Conclusions. LVP can interfere with TLR4-triggered maturation of DC, inducing a shift in DC function that stimulates Th2 cells instead of Th1, by a mechanism that is ERK- and p38-MAPK-dependent. The effect of LVP on DC polarization was reversed by IFN alpha, providing an additional rationale for the interferon therapy of chronically-infected patients. By acting on TLR4 pathway with LVP, HCV may thus exploit a natural protective mechanism of the liver and the intestine normally used to control inflammation and immunity to commensal microorganisms.	[Agaugue, Sophie; Perrin-Cocon, Laure; Andre, Patrice; Lotteau, Vincent] INSERM, U851, F-69008 Lyon, France; [Agaugue, Sophie; Perrin-Cocon, Laure; Andre, Patrice; Lotteau, Vincent] Univ Lyon, Lyon, France; [Andre, Patrice; Lotteau, Vincent] Hop Croix Rousse, Hosp Civils Lyon, Virol Lab, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Lotteau, V (corresponding author), INSERM, U851, F-69008 Lyon, France.	lotteau@cervi-lyon.inserm.fr	Perrin-Cocon, Laure A/M-8099-2014; André, Patrice/M-8139-2014; lotteau, vincent/M-8143-2014	Perrin-Cocon, Laure A/0000-0003-0501-6733; André, Patrice/0000-0002-5834-7395; Lotteau, Vincent/0000-0003-0997-3282	Agence Nationale de Recherche sur le Sida [HC EP 05]; Institut National de la Sante et de la Recherche Medicale; Hospices Civils de Lyon	Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Hospices Civils de Lyon	This work was supported by the Agence Nationale de Recherche sur le Sida (grant HC EP 05), Institut National de la Sante et de la Recherche Medicale, and the Hospices Civils de Lyon. S. A. was first recipient of a Ligue Nationale Francaise contre le Cancer doctoral scholarship and then of a Association pour la Recherche sur le Cancer doctoral scholarship.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Auffermann-Gratzinger S, 2001, BLOOD, V97, P3171, DOI 10.1182/blood.V97.10.3171; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; Bluml S, 2005, J IMMUNOL, V175, P501, DOI 10.4049/jimmunol.175.1.501; Bochkov VN, 2003, J MOL MED, V81, P613, DOI 10.1007/s00109-003-0467-2; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Coutant F, 2002, J IMMUNOL, V169, P1688, DOI 10.4049/jimmunol.169.4.1688; Coutant F, 2004, J IMMUNOL, V172, P54, DOI 10.4049/jimmunol.172.1.54; Deforges S, 2004, J GEN VIROL, V85, P2515, DOI 10.1099/vir.0.80071-0; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; DUSSAIX E, 1985, ACTA NEUROL SCAND, V71, P504; Fang SH, 2001, J CLIN MICROBIOL, V39, P3895, DOI 10.1128/JCM.39.11.3895-3901.2001; Furnkranz A, 2004, CURR PHARM DESIGN, V10, P915, DOI 10.2174/1381612043452929; Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284; Goodridge HS, 2004, IMMUNOLOGY, V113, P491, DOI 10.1111/j.1365-2567.2004.01993.x; Goutagny N, 2004, J INFECT DIS, V189, P1646, DOI 10.1086/383248; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; He XS, 1999, P NATL ACAD SCI USA, V96, P5692, DOI 10.1073/pnas.96.10.5692; Hoofnagle JH, 1997, HEPATOLOGY, V26, pS15, DOI 10.1002/hep.510260703; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Kanto T, 2005, INTERVIROLOGY, V49, P58, DOI 10.1159/000087264; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kanto T, 1999, J IMMUNOL, V162, P5584; Komurian-Pradel F, 2004, J VIROL METHODS, V116, P103, DOI 10.1016/j.jviromet.2003.10.004; Komurian-Pradel F, 2001, J VIROL METHODS, V95, P111, DOI 10.1016/S0166-0934(01)00300-7; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Larsson M, 2004, SEMIN IMMUNOL, V16, P147, DOI 10.1016/j.smim.2004.02.002; Lauer GM, 2004, GASTROENTEROLOGY, V127, P924, DOI 10.1053/j.gastro.2004.06.015; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Longman RS, 2005, J INFECT DIS, V192, P497, DOI 10.1086/431523; Longman RS, 2004, BLOOD, V103, P1026, DOI 10.1182/blood-2003-04-1339; Luo YK, 2004, J CARDIOVASC PHARM, V44, P381, DOI 10.1097/01.fjc.0000138164.88740.f8; Murakami H, 2004, CLIN EXP IMMUNOL, V137, P559, DOI 10.1111/j.1365-2249.2004.02550.x; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Nielsen SU, 2004, J GEN VIROL, V85, P1497, DOI 10.1099/vir.0.79967-0; Panther E, 2002, J IMMUNOL, V169, P4129, DOI 10.4049/jimmunol.169.8.4129; Perrin-Cocon L, 2006, VACCINE, V24, P1254, DOI 10.1016/j.vaccine.2005.09.036; Perrin-Cocon L, 2001, J IMMUNOL, V167, P3785, DOI 10.4049/jimmunol.167.7.3785; Piccioli D, 2005, J HEPATOL, V42, P61, DOI 10.1016/j.jhep.2004.09.014; Price DA, 2006, GUT, V55, P715, DOI 10.1136/gut.2005.079905; Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175; Randall G, 2001, CURR OPIN INFECT DIS, V14, P743, DOI 10.1097/00001432-200112000-00013; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; Shaw PX, 2004, ARCH IMMUNOL THER EX, V52, P225; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Zeisel MB, 2006, J HEPATOL, V44, P436, DOI 10.1016/j.jhep.2005.11.031; Zeyda M, 2005, J BIOL CHEM, V280, P14293, DOI 10.1074/jbc.M410000200	60	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e330	10.1371/journal.pone.0000330	http://dx.doi.org/10.1371/journal.pone.0000330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389921	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445200013
J	Kaipainen, A; Kieran, MW; Huang, S; Butterfield, C; Bielenberg, D; Mostoslavsky, G; Mulligan, R; Folkman, J; Panigrahy, D				Kaipainen, Arja; Kieran, Mark W.; Huang, Sui; Butterfield, Catherine; Bielenberg, Diane; Mostoslavsky, Gustavo; Mulligan, Richard; Folkman, Judah; Panigrahy, Dipak			PPAR alpha Deficiency in Inflammatory Cells Suppresses Tumor Growth	PLOS ONE			English	Article								Inflammation in the tumor bed can either promote or inhibit tumor growth. Peroxisome proliferator-activated receptor (PPAR)alpha is a central transcriptional suppressor of inflammation, and may therefore modulate tumor growth. Here we show that PPAR alpha deficiency in the host leads to overt inflammation that suppresses angiogenesis via excess production of the endogenous angiogenesis inhibitor thrombospondin-1 and prevents tumor growth. Bone marrow transplantation and granulocyte depletion show that PPAR alpha expressing granulocytes are necessary for tumor growth. Neutralization of thrombospondin-1 restores tumor growth in PPAR alpha-deficient mice. These findings suggest that the absence of PPAR alpha activity renders inflammatory infiltrates tumor suppressive and, thus, may provide a target for inhibiting tumor growth by modulating stromal processes, such as angiogenesis.	[Kaipainen, Arja; Kieran, Mark W.; Huang, Sui; Butterfield, Catherine; Bielenberg, Diane; Folkman, Judah; Panigrahy, Dipak] Harvard Univ, Childrens Hosp, Sch Med, Dept Surg,Vasc Biol Program, Boston, MA 02115 USA; [Kieran, Mark W.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Mostoslavsky, Gustavo; Mulligan, Richard] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Panigrahy, D (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Surg,Vasc Biol Program, Boston, MA 02115 USA.	dipak.panigrahy@childrens.harvard.edu		Kieran, Mark/0000-0003-2184-7692; Mostoslavsky, Gustavo/0000-0002-0784-2169	Stop & Shop Pediatric Brain Tumor Fund; C.J. Buckley Pediatric Brain Tumor Research Fund; Department of Defense Innovator Award [W81XWH-04-1-0316]; private philanthropic funds	Stop & Shop Pediatric Brain Tumor Fund; C.J. Buckley Pediatric Brain Tumor Research Fund; Department of Defense Innovator Award(United States Department of Defense); private philanthropic funds	This study was supported by the Stop & Shop Pediatric Brain Tumor Fund and the C.J. Buckley Pediatric Brain Tumor Research Fund ( M. K.) and Department of Defense Innovator Award #W81XWH-04-1-0316 and private philanthropic funds (J.F.).	Achilles EG, 2001, J NATL CANCER I, V93, P1075, DOI 10.1093/jnci/93.14.1075; Albo D, 1998, J SURG RES, V76, P86, DOI 10.1006/jsre.1998.5299; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Cattley RC, 1998, REGUL TOXICOL PHARM, V27, P47, DOI 10.1006/rtph.1997.1163; Celik I, 2005, CANCER RES, V65, P11044, DOI 10.1158/0008-5472.CAN-05-2617; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; Collett GP, 2000, CLIN CANCER RES, V6, P3241; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crawford SE, 1998, HUM PATHOL, V29, P1039, DOI 10.1016/S0046-8177(98)90410-5; CROMMELIN DJA, 2002, PHARM BIOTECHNOLOGY, P125; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; de Fraipont F, 2001, TRENDS MOL MED, V7, P401, DOI 10.1016/S1471-4914(01)02102-5; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Gonzalez FJ, 2002, MOL CELL ENDOCRINOL, V193, P71, DOI 10.1016/S0303-7207(02)00098-9; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grossfeld GD, 1997, J NATL CANCER I, V89, P219, DOI 10.1093/jnci/89.3.219; Hadley C, 2003, EMBO REP, V4, P924, DOI 10.1038/sj.embor.embor953; Hamano Y, 2004, CANCER RES, V64, P1570, DOI 10.1158/0008-5472.CAN-03-3126; Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285; Joussen AM, 2002, AM J PATHOL, V160, P501, DOI 10.1016/S0002-9440(10)64869-9; Kammertoens T, 2005, TRENDS MOL MED, V11, P225, DOI 10.1016/j.molmed.2005.03.002; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Komuves LG, 2000, J INVEST DERMATOL, V115, P353, DOI 10.1046/j.1523-1747.2000.00073.x; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; MANSFIELD PJ, 1990, J CELL BIOL, V111, P3077, DOI 10.1083/jcb.111.6.3077; Mehta R, 2001, CLIN CANCER RES, V7, P81; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Motegi K, 2002, HISTOCHEM J, V34, P411, DOI 10.1023/A:1023687505139; NATHAN FE, 1994, CANCER, V73, P2853, DOI 10.1002/1097-0142(19940601)73:11<2853::AID-CNCR2820731131>3.0.CO;2-9; Neve BP, 2000, BIOCHEM PHARMACOL, V60, P1245, DOI 10.1016/S0006-2952(00)00430-5; Ohta Y, 1999, CANCER, V85, P2570, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2570::AID-CNCR12>3.3.CO;2-6; Oshiba G, 1999, ANTICANCER RES, V19, P4375; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; SJIN RMT, 2006, CANC GENE THER; Slaton JW, 1999, CLIN CANCER RES, V5, P2726; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Streit M, 1999, AM J PATHOL, V155, P441, DOI 10.1016/S0002-9440(10)65140-1; Tanaka T, 2001, CANCER RES, V61, P2424; Thuillier P, 2000, MOL CARCINOGEN, V29, P134, DOI 10.1002/1098-2744(200011)29:3<134::AID-MC2>3.0.CO;2-F; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; TUSZYNSKI GP, 1992, THROMB HAEMOSTASIS, V67, P607; Udagawa T, 2002, FASEB J, V16, P1361, DOI 10.1096/fj.01-0813com; Wang TN, 1996, SURGERY, V120, P449, DOI 10.1016/S0039-6060(96)80322-9; Wang TN, 1996, J SURG RES, V63, P39, DOI 10.1006/jsre.1996.0219; WEINSTATSASLOW DL, 1994, CANCER RES, V54, P6504; Yamashita Y, 1998, CANCER, V82, P632, DOI 10.1002/(SICI)1097-0142(19980215)82:4<632::AID-CNCR3>3.0.CO;2-N; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	67	72	73	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e260	10.1371/journal.pone.0000260	http://dx.doi.org/10.1371/journal.pone.0000260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327920	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444600020
J	Raffi, M; Siegel, RM				Raffi, Milena; Siegel, Ralph M.			A Functional Architecture of Optic Flow in the Inferior Parietal Lobule of the Behaving Monkey	PLOS ONE			English	Article							MULTIPLE-STIMULUS DISPLAYS; VISUAL ASSOCIATION CORTEX; NEURONAL RESPONSES; MACAQUE MONKEY; AREA 7A; HEADING PERCEPTION; POLYSENSORY AREA; PRELUNATE GYRUS; RHESUS-MONKEY; CORTICAL MAPS	The representation of navigational optic flow across the inferior parietal lobule was assessed using optical imaging of intrinsic signals in behaving monkeys. The exposed cortex, corresponding to the dorsal-most portion of areas 7a and dorsal prelunate (DP), was imaged in two hemispheres of two rhesus monkeys. The monkeys actively attended to changes in motion stimuli while fixating. Radial expansion and contraction, and rotation clockwise and counter-clockwise optic flow stimuli were presented concentric to the fixation point at two angles of gaze to assess the interrelationship between the eye position and optic flow signal. The cortical response depended upon the type of flow and was modulated by eye position. The optic flow selectivity was embedded in a patchy architecture within the gain field architecture. All four optic flow stimuli tested were represented in areas 7a and DP. The location of the patches varied across days. However the spatial periodicity of the patches remained constant across days at,950 and 1100 mm for the two animals examined. These optical recordings agree with previous electrophysiological studies of area 7a, and provide new evidence for flow selectivity in DP and a fine scale description of its cortical topography. That the functional architectures for optic flow can change over time was unexpected. These and earlier results also from inferior parietal lobule support the inclusion of both static and dynamic functional architectures that define association cortical areas and ultimately support complex cognitive function.	[Raffi, Milena; Siegel, Ralph M.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Siegel, RM (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	axon@cortex.rutgers.edu	Raffi, Milena/AAU-9845-2020	RAFFI, MILENA/0000-0002-7467-5591	Whitehall Foundation; NIH/NEI [EY09223, EY014657]; NEI/NCRR [RR12873]; Programma Marco Polo; VIII Tornata of University of Bologna; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012873] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009223, R03EY014657] Funding Source: NIH RePORTER	Whitehall Foundation; NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)NIH National Center for Research Resources (NCRR)); Programma Marco Polo; VIII Tornata of University of Bologna; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by the Whitehall Foundation, NIH/NEI EY09223, NIH/NEI EY014657, and NEI/NCRR RR12873 to RMS. A travel grant to Milena Raffi was funded by Programma Marco Polo, VIII Tornata of University of Bologna.	ANDERSEN RA, 1985, J COMP NEUROL, V232, P443, DOI 10.1002/cne.902320403; ANDERSEN RA, 1989, ANNU REV NEUROSCI, V12, P377, DOI 10.1146/annurev.neuro.12.1.377; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Anderson KC, 1999, J NEUROSCI, V19, P2681; Arieli A, 2002, J NEUROSCI METH, V116, P15, DOI 10.1016/S0165-0270(02)00022-5; ARNSTEN AFT, 1984, BRAIN RES, V306, P9, DOI 10.1016/0006-8993(84)90351-2; Batschelet E, 1981, CIRCULAR STAT BIOL; Birbaumer N, 1997, J NEUROSCI, V17, P5503; Britten KH, 2002, CEREB CORTEX, V12, P692, DOI 10.1093/cercor/12.7.692; Britten KH, 1998, VISUAL NEUROSCI, V15, P553; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buchner H, 1999, NEUROSCI LETT, V260, P57, DOI 10.1016/S0304-3940(98)00948-3; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; CAVADA C, 1991, NEUROSCIENCE, V42, P683, DOI 10.1016/0306-4522(91)90037-O; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Constantinidis C, 2001, CEREB CORTEX, V11, P592, DOI 10.1093/cercor/11.7.592; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; Critchley M., 1953, PARIETAL LOBES; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; Duann JR, 2002, NEUROIMAGE, V15, P823, DOI 10.1006/nimg.2001.1049; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Geesaman BJ, 1997, CEREB CORTEX, V7, P749, DOI 10.1093/cercor/7.8.749; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Heider B, 2005, CEREB CORTEX, V15, P460, DOI 10.1093/cercor/bhh148; HOF PR, 1995, J COMP NEUROL, V352, P161, DOI 10.1002/cne.903520202; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; KARNI A, 1995, NATURE, V377, P155; Kleinfeld D, 2005, PLOS BIOL, V3, P1685, DOI 10.1371/journal.pbio.0030355; Kondo H, 1999, EUR J NEUROSCI, V11, P4197, DOI 10.1046/j.1460-9568.1999.00844.x; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; LI CY, 1989, BRAIN RES, V496, P307, DOI 10.1016/0006-8993(89)91078-0; LONGUETHIGGINS HC, 1980, PROC R SOC SER B-BIO, V208, P385, DOI 10.1098/rspb.1980.0057; MAGUIRE WM, 1984, J NEUROSCI, V4, P1690; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Marr D., 1982, VISION; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Merchant H, 2003, J NEUROPHYSIOL, V90, P675, DOI 10.1152/jn.00331.2003; Merchant H, 2001, J NEUROPHYSIOL, V86, P1937, DOI 10.1152/jn.2001.86.4.1937; MOTTER BC, 1987, J NEUROSCI, V7, P154; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; PHINNEY RE, 1996, ABSTRSOCNEUROSCI, V22, P1693; Pigarev IN, 2001, EXP BRAIN RES, V136, P108, DOI 10.1007/s002210000566; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Raffi M, 2004, SYNTH LIBR, V324, P3; Raffi M, 2005, J NEUROSCI, V25, P5171, DOI 10.1523/JNEUROSCI.5201-04.2005; Read HL, 1997, CEREB CORTEX, V7, P647, DOI 10.1093/cercor/7.7.647; Rossini PM, 2000, BRAIN RES REV, V33, P131, DOI 10.1016/S0169-328X(00)00090-5; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Siegel R M, 1990, J Cogn Neurosci, V2, P306, DOI 10.1162/jocn.1990.2.4.306; SIEGEL RM, 1988, NATURE, V331, P259, DOI 10.1038/331259a0; Siegel RM, 2003, J NEUROPHYSIOL, V90, P1279, DOI 10.1152/jn.01179.2002; Siegel RM, 1997, CEREBR CORT, V12, P499; Siegel RM, 1997, CEREB CORTEX, V7, P327, DOI 10.1093/cercor/7.4.327; SIEGEL RM, 2006, CEREB CORTEX; Spengler F, 1997, NEUROSCI LETT, V232, P151, DOI 10.1016/S0304-3940(97)00602-2; SPORNS O, 1989, P NATL ACAD SCI USA, V86, P7265, DOI 10.1073/pnas.86.18.7265; STEINMETZ MA, 1987, J NEUROSCI, V7, P177; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; TANAKA K, 1986, J NEUROSCI, V6, P134; ULLMAN S, 1979, PROC R SOC SER B-BIO, V203, P405, DOI 10.1098/rspb.1979.0006; VAINA LM, 1994, INVEST OPHTH VIS SCI, V35, P1438; VAINA LM, 2000, INT REV NEUROBIOL, P293; van Essen D.C., 1985, P259	74	24	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e200	10.1371/journal.pone.0000200	http://dx.doi.org/10.1371/journal.pone.0000200			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17285147	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444300012
J	Belgacem, YH; Martin, JR				Belgacem, Yesser Hadj; Martin, Jean-Rene			Hmgcr in the Corpus Allatum Controls Sexual Dimorphism of Locomotor Activity and Body Size via the Insulin Pathway in Drosophila	PLOS ONE			English	Article								The insulin signaling pathway has been implicated in several physiological and developmental processes. In mammals, it controls expression of 3-Hydroxy-3-Methylglutaryl CoA Reductase (HMGCR), a key enzyme in cholesterol biosynthesis. In insects, which can not synthesize cholesterol de novo, the HMGCR is implicated in the biosynthesis of juvenile hormone (JH). However, the link between the insulin pathway and JH has not been established. In Drosophila, mutations in the insulin receptor (InR) decrease the rate of JH synthesis. It is also known that both the insulin pathway and JH play a role in the control of sexual dimorphism in locomotor activity. In studies here, to demonstrate that the insulin pathway and HMGCR are functionally linked in Drosophila, we first show that hmgcr mutation also disrupts the sexual dimorphism. Similarly to the InR, HMGCR is expressed in the corpus allatum(ca), which is the gland where JH biosynthesis occurs. Two p[hmgcr-GAL4] lines were therefore generated where RNAi was targeted specifically against the HMGCR or the InR in the ca. We found that RNAi-HMGCR blocked HMGCR expression, while the RNAi-InR blocked both InR and HMGCR expression. Each RNAi caused disruption of sexual dimorphism and produced dwarf flies at specific rearing temperatures. These results provide evidence: (i) that HMGCR expression is controlled by the InR and (ii) that InR and HMGCR specifically in the ca, are involved in the control of body size and sexual dimorphism of locomotor activity.	[Belgacem, Yesser Hadj; Martin, Jean-Rene] CNRS, Neurobiol Cellulaire & Mol Lab, Unite UPR 9040, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Martin, JR (corresponding author), CNRS, Neurobiol Cellulaire & Mol Lab, Unite UPR 9040, Gif Sur Yvette, France.	jean-rene.martin@inaf.cnrs-gif.fr			French Ministry of Research and Education; CNRS	French Ministry of Research and Education; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work (J.R. Martin) was supported by the French Ministry of Research and Education (ACI: Action Concertee Incitative: Biologie du Developpement et Physiologie Integrative) and by the CNRS (ATIPE-Neurobiologie), France.	ADAMSON ED, 1993, J CELL BIOCHEM, V53, P280, DOI 10.1002/jcb.240530403; Araki E, 1994, Nihon Rinsho, V52, P2659; AZROLAN NI, 1989, BIOCHEM J, V258, P421, DOI 10.1042/bj2580421; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; CLAYTON RB, 1964, J LIPID RES, V5, P3; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Deshpande G, 2005, DEV CELL, V9, P629, DOI 10.1016/j.devcel.2005.09.014; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Duncan RE, 2005, CANCER EPIDEM BIOMAR, V14, P1897, DOI 10.1158/1055-9965.EPI-05-0027; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Foufelle Fabienne, 2001, Journal de la Societe de Biologie, V195, P243; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; GRUNDY SM, 1986, JAMA-J AM MED ASSOC, V256, P2849, DOI 10.1001/jama.256.20.2849; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; IRONS M, 1994, AM J MED GENET, V50, P347, DOI 10.1002/ajmg.1320500409; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Ito K, 1998, LEARN MEMORY, V5, P52; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; LAKSHMANAN M R, 1973, Biochemical and Biophysical Research Communications, V50, P704, DOI 10.1016/0006-291X(73)91301-6; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; LI AC, 1988, J LIPID RES, V29, P781; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Ness GC, 2000, P SOC EXP BIOL MED, V224, P8, DOI 10.1046/j.1525-1373.2000.22359.x; Osborne AR, 2004, BIOCHEM BIOPH RES CO, V318, P814, DOI 10.1016/j.bbrc.2004.04.105; PENHOS JC, 1968, METABOLISM, V17, P246, DOI 10.1016/0026-0495(68)90127-3; Plosker GL, 1996, DRUGS, V51, P433, DOI 10.2165/00003495-199651030-00011; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; SINGER II, 1984, P NATL ACAD SCI-BIOL, V81, P5556, DOI 10.1073/pnas.81.17.5556; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Takahashi Y, 1997, ENDOCRINOLOGY, V138, P741, DOI 10.1210/en.138.2.741; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Theopold U, 1996, P NATL ACAD SCI USA, V93, P1195, DOI 10.1073/pnas.93.3.1195; Thorpe JL, 2004, DEV CELL, V6, P295, DOI 10.1016/S1534-5807(04)00032-2; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Tu MP, 2005, GEN COMP ENDOCR, V142, P347, DOI 10.1016/j.ygcen.2005.02.009; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; YAO KM, 1993, J NEUROBIOL, V24, P723, DOI 10.1002/neu.480240604	64	80	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e187	10.1371/journal.pone.0000187	http://dx.doi.org/10.1371/journal.pone.0000187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17264888	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444200011
J	Baxter-Roshek, JL; Petrov, AN; Dinman, JD				Baxter-Roshek, Jennifer L.; Petrov, Alexey N.; Dinman, Jonathan D.			Optimization of Ribosome Structure and Function by rRNA Base Modification	PLOS ONE			English	Article								Background. Translating mRNA sequences into functional proteins is a fundamental process necessary for the viability of organisms throughout all kingdoms of life. The ribosome carries out this process with a delicate balance between speed and accuracy. This work investigates how ribosome structure and function are affected by rRNA base modification. The prevailing view is that rRNA base modifications serve to fine tune ribosome structure and function. Methodology/Principal Findings. To test this hypothesis, yeast strains deficient in rRNA modifications in the ribosomal peptidyltransferase center were monitored for changes in and translational fidelity. These studies revealed allele-specific sensitivity to translational inhibitors, changes in reading frame maintenance, nonsense suppression and aa-tRNA selection. Ribosomes isolated from two mutants with the most pronounced phenotypic changes had increased affinities for aa-tRNA, and surprisingly, increased rates of peptidyltransfer as monitored by the puromycin assay. rRNA chemical analyses of one of these mutants identified structural changes in five specific bases associated with the ribosomal A-site. Conclusions/Significance. Together, the data suggest that modification of these bases fine tune the structure of the A-site region of the large subunit so as to assure correct positioning of critical rRNA bases involved in aa-tRNA accommodation into the PTC, of the eEF-1A.aa-tRNANGTP ternary complex with the GTPase associated center, and of the aa-tRNA in the A-site. These findings represent a direct demonstration in support of the prevailing hypothesis that rRNA modifications serve to optimize rRNA structure for production of accurate and efficient ribosomes.	[Baxter-Roshek, Jennifer L.; Petrov, Alexey N.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Dinman, JD (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu		Dinman, Jonathan/0000-0002-2402-9698	National Institutes of Health [R01 GM58859, T32 AI051967]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI051967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant to JDD from the National Institutes of Health (R01 GM58859). JLB-R was supported in part by a Virology Training Grant from the National Institutes of Health (T32 AI051967).	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BELCOURT MF, 1990, CELL, V62, P339, DOI 10.1016/0092-8674(90)90371-K; Bonnerot C, 2003, MOL CELL, V12, P1309, DOI 10.1016/S1097-2765(03)00435-0; Bugl H, 2000, MOL CELL, V6, P349, DOI 10.1016/S1097-2765(00)00035-6; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; CARRASCO L, 1973, BIOCHIM BIOPHYS ACTA, V312, P368, DOI 10.1016/0005-2787(73)90381-X; Charette M, 2000, IUBMB LIFE, V49, P341; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; DINMAN JD, 1994, GENETICS, V136, P75; Green R, 1996, RNA, V2, P1011; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; Gustafsson C, 1998, J BACTERIOL, V180, P359, DOI 10.1128/JB.180.2.359-365.1998; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hansen TM, 2003, EMBO REP, V4, P499, DOI 10.1038/sj.embor.embor825; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; HERNER AE, 1969, BIOCHEMISTRY-US, V8, P1335, DOI 10.1021/bi00832a006; Hirabayashi N, 2006, J BIOL CHEM, V281, P17203, DOI 10.1074/jbc.M511728200; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; JAYARAMA.J, 1968, BIOCHEMISTRY-US, V7, P418, DOI 10.1021/bi00841a053; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; King TH, 2003, MOL CELL, V11, P425, DOI 10.1016/S1097-2765(03)00040-6; Kiparisov S, 2005, MOL GENET GENOMICS, V274, P235, DOI 10.1007/s00438-005-0020-9; Lapeyre B, 2004, MOL CELL, V16, P663, DOI 10.1016/j.molcel.2004.10.022; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Meroueh M, 2000, NUCLEIC ACIDS RES, V28, P2075, DOI 10.1093/nar/28.10.2075; Meskauskas A, 2005, MOL CELL BIOL, V25, P10863, DOI 10.1128/MCB.25.24.10863-10874.2005; Meskauskas A, 2001, RNA, V7, P1084, DOI 10.1017/S1355838201001480; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Ofengand J, 1995, BIOCHEM CELL BIOL, V73, P915, DOI 10.1139/o95-099; OHTAKE Y, 1995, MOL CELL BIOL, V15, P2772; Rakauskaite R, 2006, MOL CELL BIOL, V26, P8992, DOI 10.1128/MCB.01311-06; Raychaudhuri S, 1999, J BIOL CHEM, V274, P18880, DOI 10.1074/jbc.274.27.18880; Raychaudhuri S, 1998, RNA, V4, P1407, DOI 10.1017/S1355838298981146; Samarsky DA, 1999, NUCLEIC ACIDS RES, V27, P161, DOI 10.1093/nar/27.1.161; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; SCHINDLER D, 1974, NATURE, V249, P38, DOI 10.1038/249038a0; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sumita M, 2005, RNA, V11, P1420, DOI 10.1261/rna.2320605; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996; Williams DJ, 2001, RNA, V7, P44, DOI 10.1017/S1355838201001558; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	49	96	97	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e174	10.1371/journal.pone.0000174	http://dx.doi.org/10.1371/journal.pone.0000174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17245450	gold, Green Submitted, Green Published			2022-12-27	WOS:000207444100011
J	Yamagishi, T; Ozawa, M; Ohtsuka, C; Ohyama-Goto, R; Kondo, T				Yamagishi, Takumi; Ozawa, Michiru; Ohtsuka, Chiho; Ohyama-Goto, Ritsuko; Kondo, Takashi			Evx2-Hoxd13 Intergenic Region Restricts Enhancer Association to Hoxd13 Promoter	PLOS ONE			English	Article								Expression of Hox genes is tightly regulated in spatial and temporal domains. Evx2 is located next to Hoxd13 within 8 kb on the opposite DNA strand. Early in development, the pattern of Hoxd13 expression resembles that of Evx2 in limb and genital buds. After 10 dpc, however, Evx2 begins to be expressed in CNS as well. We analyzed the region responsible for these differences using ES cell techniques, and found that the intergenic region between Evx2 and Hoxd13 behaves as a boundary element that functions differentially in space and time, specifically in the development of limbs, genital bud, and brain. This boundary element comprises a large sequence spanning several kilobases that can be divided into at least two units: a constitutive boundary element, which blocks transcription regulatory influences from the chromosomal environment, and a regulatory element, which controls the function of the constitutive boundary element in time and space.	[Yamagishi, Takumi; Ozawa, Michiru; Ohtsuka, Chiho; Ohyama-Goto, Ritsuko; Kondo, Takashi] RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Kondo Res Unit,Brain Dev Res Grp, Wako, Saitama 35101, Japan	RIKEN	Kondo, T (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Kondo Res Unit,Brain Dev Res Grp, Wako, Saitama 35101, Japan.	TKondo@brain.riken.jp		jin teng, long/0000-0002-1948-9331	Human Frontier Scientific Program Organization (HFSPO); The Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan	Human Frontier Scientific Program Organization (HFSPO)(Human Frontier Science Program); The Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Human Frontier Scientific Program Organization (HFSPO) and Grant-in-Aid for Scientific Research on Priority Areas from The Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan.	Akasaka T, 1996, DEVELOPMENT, V122, P1513; Archey WB, 1999, CANCER RES, V59, P2292; Barges S, 2000, DEVELOPMENT, V127, P779; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Core N, 1997, DEVELOPMENT, V124, P721; DOLLE P, 1994, DEVELOPMENT, P143; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; GEORGIEV PG, 1995, P NATL ACAD SCI USA, V92, P5184, DOI 10.1073/pnas.92.11.5184; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; GYURKOVICS H, 1990, EMBO J, V9, P2579, DOI 10.1002/j.1460-2075.1990.tb07439.x; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; KARCH F, 1994, NUCLEIC ACIDS RES, V22, P3138, DOI 10.1093/nar/22.15.3138; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2000, GENE DEV, V14, P198; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; Kondo T, 1998, MOL CELL, V1, P289, DOI 10.1016/S1097-2765(00)80029-5; KONDO T, 1992, NUCLEIC ACIDS RES, V20, P5729, DOI 10.1093/nar/20.21.5729; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Monge I, 2003, DEV BIOL, V256, P212, DOI 10.1016/S0012-1606(02)00136-7; PEIFER M, 1986, EMBO J, V5, P2293, DOI 10.1002/j.1460-2075.1986.tb04497.x; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Schweinsberg S, 2004, GENETICS, V168, P1371, DOI 10.1534/genetics.104.029561; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	35	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e175	10.1371/journal.pone.0000175	http://dx.doi.org/10.1371/journal.pone.0000175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17245451	gold, Green Submitted, Green Published			2022-12-27	WOS:000207444100012
J	Aguayo-Mazzucato, C; Sanchez-Soto, C; Godinez-Puig, V; Gutierrez-Ospina, G; Hiriart, M				Aguayo-Mazzucato, Cristina; Sanchez-Soto, Carmen; Godinez-Puig, Victoria; Gutierrez-Ospina, Gabriel; Hiriart, Marcia			Restructuring of Pancreatic Islets and Insulin Secretion in a Postnatal Critical Window	PLOS ONE			English	Article							ENDOCRINE PANCREAS; BETA-CELLS; GLUCOSE-METABOLISM; HIGH-CARBOHYDRATE; GENE-EXPRESSION; NEONATAL-RAT; B-CELLS; GLUCOKINASE; FETAL; INTERVENTION	Function and structure of adult pancreatic islets are determined by early postnatal development, which in rats corresponds to the first month of life. We analyzed changes in blood glucose and hormones during this stage and their association with morphological and functional changes of alpha and beta cell populations during this period. At day 20 (d20), insulin and glucose plasma levels were two- and six-fold higher, respectively, as compared to d6. Interestingly, this period is characterized by physiological hyperglycemia and hyperinsulinemia, where peripheral insulin resistance and a high plasmatic concentration of glucagon are also observed. These functional changes were paralleled by reorganization of islet structure, cell mass and aggregate size of alpha and beta cells. Cultured beta cells from d20 secreted the same amount of insulin in 15.6 mM than in 5.6 mM glucose (basal conditions), and were characterized by a high basal insulin secretion. However, beta cells from d28 were already glucose sensitive. Understanding and establishing morphophysiological relationships in the developing endocrine pancreas may explain how events in early life are important in determining adult islet physiology and metabolism.	[Aguayo-Mazzucato, Cristina; Sanchez-Soto, Carmen; Hiriart, Marcia] Univ Nacl Autonoma Mexico, Inst Cellular Physiol, Dept Biophys, Mexico City 04510, DF, Mexico; [Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Biomed Res Inst, Dept Cell Biol & Physiol, Mexico City 04510, DF, Mexico; [Godinez-Puig, Victoria] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Hiriart, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Cellular Physiol, Dept Biophys, Mexico City 04510, DF, Mexico.	mhiriart@ifc.unam.mx	Hiriart, Marcia/A-3988-2008	Hiriart, Marcia/0000-0001-5711-8868; Gutierrez Ospina, Gabriel/0000-0002-6286-8281	CONACYT [D39822]; DGAPA [211800]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA	Funding: This work was supported by CONACYT D39822 and DGAPA 211800. CAM is a fellow of CONACyT and DGEP.	Aalinkeel R, 2001, AM J PHYSIOL-ENDOC M, V281, pE640, DOI 10.1152/ajpendo.2001.281.3.E640; Aalinkeel R, 1999, AM J PHYSIOL-ENDOC M, V277, pE1061, DOI 10.1152/ajpendo.1999.277.6.E1061; ASPLUND K, 1972, DIABETOLOGIA, V8, P153, DOI 10.1007/BF01212254; ASPLUND K, 1969, DIABETOLOGIA, V5, P260, DOI 10.1007/BF01212095; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Bains RK, 2004, ENDOCRINOLOGY, V145, P2666, DOI 10.1210/en.2003-1608; Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20; Cerf ME, 2005, AM J PHYSIOL-REG I, V288, pR1122, DOI 10.1152/ajpregu.00335.2004; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; HEINZE E, 1971, ENDOCRINOLOGY, V88, P1259, DOI 10.1210/endo-88-5-1259; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; HIRIART M, 1991, ENDOCRINOLOGY, V128, P3193, DOI 10.1210/endo-128-6-3193; HOLE RL, 1988, AM J PHYSIOL, V254, pE167, DOI 10.1152/ajpendo.1988.254.2.E167; HUGHES SJ, 1994, DIABETOLOGIA, V37, P134, DOI 10.1007/s001250050083; LEAHY JL, 1986, J CLIN INVEST, V77, P908, DOI 10.1172/JCI112389; Lucas A, 1998, J NUTR, V128, p401S, DOI 10.1093/jn/128.2.401S; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; MORLEY MG, 1982, AM J PHYSIOL, V242, pG354, DOI 10.1152/ajpgi.1982.242.4.G354; Navarro-Tableros V, 2004, DIABETES, V53, P2018, DOI 10.2337/diabetes.53.8.2018; Ong KK, 2004, DIABETOLOGIA, V47, P1064, DOI 10.1007/s00125-004-1405-8; Ozanne SE, 2002, TRENDS ENDOCRIN MET, V13, P368, DOI 10.1016/S1043-2760(02)00666-5; Petrik J, 2001, PEDIATR RES, V49, P84, DOI 10.1203/00006450-200101000-00019; Rosenbaum T, 2001, DIABETES, V50, P1755, DOI 10.2337/diabetes.50.8.1755; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; SMITH PF, 1989, SELECTED METHODS ENZ, P205; Srinivasan M, 2003, EXP BIOL MED, V228, P15, DOI 10.1177/153537020322800102; Straub SG, 2004, AM J PHYSIOL-CELL PH, V287, pC565, DOI 10.1152/ajpcell.00079.2004; THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858; TIEDGE M, 1993, BIOCHEM MOL BIOL INT, V29, P161; TRIMBLE ER, 1982, J CLIN INVEST, V69, P405, DOI 10.1172/JCI110464; Vidaltamayo R, 1996, ENDOCRINE, V4, P19, DOI 10.1007/BF02738870; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205	36	64	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e35	10.1371/journal.pone.0000035	http://dx.doi.org/10.1371/journal.pone.0000035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183663	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600035
J	Colosimo, PF; Tolwinski, NS				Colosimo, Pamela F.; Tolwinski, Nicholas S.			Wnt, Hedgehog and Junctional Armadillo/beta-Catenin Establish Planar Polarity in the Drosophila Embryo	PLOS ONE			English	Article								To generate specialized structures, cells must obtain positional and directional information. In multi-cellular organisms, cells use the non-canonical Wnt or planar cell polarity (PCP) signaling pathway to establish directionality within a cell. In vertebrates, several Wnt molecules have been proposed as permissible polarity signals, but none has been shown to provide a directional cue. While PCP signaling components are conserved from human to fly, no PCP ligands have been reported in Drosophila. Here we report that in the epidermis of the Drosophila embryo two signaling molecules, Hedgehog (Hh) and Wingless (Wg or Wnt1), provide directional cues that induce the proper orientation of Actin-rich structures in the larval cuticle. We further find that proper polarity in the late embryo also involves the asymmetric distribution and phosphorylation of Armadillo (Arm or beta-catenin) at the membrane and that interference with this Arm phosphorylation leads to polarity defects. Our results suggest new roles for Hh and Wg as instructive polarizing cues that help establish directionality within a cell sheet, and a new polarity-signaling role for the membrane fraction of the oncoprotein Arm.	[Colosimo, Pamela F.; Tolwinski, Nicholas S.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Tolwinski, NS (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, 1275 York Ave, New York, NY 10021 USA.	tolwinsn@mskcc.org	Tolwinski, Nicholas/Q-5782-2019; Tolwinski, Nicholas/D-1481-2014	Tolwinski, Nicholas/0000-0002-8507-2737; 	Howard Fellows program at Sloan-Kettering Institute	Howard Fellows program at Sloan-Kettering Institute	The funding for this project comes from the Howard Fellows program at Sloan-Kettering Institute. The funding is entirely institutional, and the Institute does not interfere in the running of individual laboratories.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Axelrod Jeffrey D, 2002, ScientificWorldJournal, V2, P434; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; CHOU TB, 1992, GENETICS, V131, P643; Collier S, 2005, GENETICS, V169, P2035, DOI 10.1534/genetics.104.033381; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dumstrei K, 2002, DEVELOPMENT, V129, P3983; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Gritzan U, 1999, DEVELOPMENT, V126, P4107; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Hatini V, 2001, TRENDS GENET, V17, P574, DOI 10.1016/S0168-9525(01)02448-9; Hays R, 1997, DEVELOPMENT, V124, P3727; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; HEEMSKERK J, 1991, NATURE, V352, P404, DOI 10.1038/352404a0; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Kalderon D, 2002, TRENDS CELL BIOL, V12, P523, DOI 10.1016/S0962-8924(02)02388-7; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Larsen CW, 2003, DEVELOPMENT, V130, P5625, DOI 10.1242/dev.00867; Lawrence PA, 2004, DEVELOPMENT, V131, P4651, DOI 10.1242/dev.01351; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Lawrence PA, 1996, DEVELOPMENT, V122, P4095; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Morel V, 2004, DEVELOPMENT, V131, P3273, DOI 10.1242/dev.01217; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; SAMPEDRO J, 1993, DEVELOPMENT, V117, P677; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Szuts D, 1997, DEVELOPMENT, V124, P3209; Tada M, 2000, DEVELOPMENT, V127, P2227; Tolwinski NS, 2004, PLOS BIOL, V2, P486, DOI 10.1371/journal.pbio.0020095; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Walters JW, 2005, DEV BIOL, V286, P415, DOI 10.1016/j.ydbio.2005.06.031; WALTERS JW, 2006, DEV BIOL; Wehrli M, 1998, DEVELOPMENT, V125, P1421; WEHRLI M, 1995, DEVELOPMENT, V121, P2451; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; WODRAZ A, 2006, J CELL SCI; WU M, 2006, DEV BIOL; XU T, 1993, DEVELOPMENT, V117, P1223; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	70	34	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e9	10.1371/journal.pone.0000009	http://dx.doi.org/10.1371/journal.pone.0000009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183721	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600009
J	Kashiwagi, A; Urabe, I; Kaneko, K; Yomo, T				Kashiwagi, Akiko; Urabe, Itaru; Kaneko, Kunihiko; Yomo, Tetsuya			Adaptive Response of a Gene Network to Environmental Changes by Fitness-Induced Attractor Selection	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-DIFFERENTIATION; SINGLE-CELL; NOISE; EXPRESSION; DIVERSIFICATION; MULTISTABILITY; CONSTRUCTION; DEGRADATION; PLASTICITY	Cells switch between various stable genetic programs (attractors) to accommodate environmental conditions. Signal transduction machineries efficiently convey environmental changes to the gene regulation apparatus in order to express the appropriate genetic program. However, since the number of environmental conditions is much larger than that of available genetic programs so that the cell may utilize the same genetic program for a large set of conditions, it may not have evolved a signaling pathway for every environmental condition, notably those that are rarely encountered. Here we show that in the absence of signal transduction, switching to the appropriate attractor state expressing the genes that afford adaptation to the external condition can occur. In a synthetic bistable gene switch in Escherichia coli in which mutually inhibitory operons govern the expression of two genes required in two alternative nutritional environments, cells reliably selected the "adaptive attractor" driven by gene expression noise. A mathematical model suggests that the "non-adaptive attractor" is avoided because in unfavorable conditions, cellular activity is lower, which suppresses mRNA metabolism, leading to larger fluctuations in gene expression. This, in turn, renders the non-adaptive state less stable. Although attractor selection is not as efficient as signal transduction via a dedicated cascade, it is simple and robust, and may represent a primordial mechanism for adaptive responses that preceded the evolution of signaling cascades for the frequently encountered environmental changes.	[Kashiwagi, Akiko; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka, Japan; [Urabe, Itaru] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Osaka, Japan; [Kaneko, Kunihiko; Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Yomo, Tetsuya] Osaka Univ, Japan Sci & Technol Agcy, Complex Syst Biol Project, Osaka, Japan; [Kaneko, Kunihiko] Univ Tokyo, Dept Pure & Appl Sci, Tokyo, Japan; [Kaneko, Kunihiko] Univ Tokyo, Japan Sci & Technol Agcy, Complex Syst Biol Project, Tokyo, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Yomo, T (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka, Japan.	yomo@ist.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [11CE2006, 15207020, 15013235]; Takeda Science Foundation; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [U17CE002006] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding: This work was supported in part by Grants-in-Aid (Nos. 11CE2006, 15207020, and 15013235), "The 21st Century Center of Excellence Program" and "Special Coordination Funds for Promoting Science and Technology: Yuragi Project" of the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a grant from Takeda Science Foundation.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Albert B., 2002, MOL BIOL CELL, V4th ed.; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; APPLEMAN JR, 1988, J BIOL CHEM, V263, P10304; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; BROSIUS J, 1981, PLASMID, V6, P112, DOI 10.1016/0147-619X(81)90058-5; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerhardt P., 1994, METHODS GEN MOL BACT; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaneko K, 1997, B MATH BIOL, V59, P139, DOI 10.1016/S0092-8240(96)00044-4; Kaneko K, 1997, PHYS REV LETT, V78, P2736, DOI 10.1103/PhysRevLett.78.2736; Kaneko K, 2000, P ROY SOC B-BIOL SCI, V267, P2367, DOI 10.1098/rspb.2000.1293; Kaneko K, 2006, LIFE INTRO COMPLEX S; Kashiwagi A, 2001, J MOL EVOL, V52, P502, DOI 10.1007/s002390010180; KAUFFMAN SA, 1993, ORIGIN ORDER; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; PLATT T, 1970, NATURE, V228, P1154, DOI 10.1038/2281154a0; Press W., 1986, NUMERICAL RECIPES; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLOTMANN M, 1979, EUR J BIOCHEM, V95, P39, DOI 10.1111/j.1432-1033.1979.tb12937.x; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Willeboordse FH, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026207; XU WZ, 1994, J FERMENT BIOENG, V77, P252, DOI 10.1016/0922-338X(94)90229-1	42	183	189	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e49	10.1371/journal.pone.0000049	http://dx.doi.org/10.1371/journal.pone.0000049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183678	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600049
J	Drosopoulos, S; Windau, E; Wagner, U; Born, J				Drosopoulos, Spyridon; Windau, Eike; Wagner, Ullrich; Born, Jan			Sleep Enforces the Temporal Order in Memory	PLOS ONE			English	Article							DECLARATIVE MEMORY; BACKWARD RECALL; SEQUENCES; HIPPOCAMPUS; CONSOLIDATION; RETRIEVAL; REPLAY; OSCILLATIONS; EXPERIENCE; NEOCORTEX	Background. Temporal sequence represents the main principle underlying episodic memory. The storage of temporal sequence information is thought to involve hippocampus-dependent memory systems, preserving temporal structure possibly via chaining of sequence elements in heteroassociative networks. Converging evidence indicates that sleep enhances the consolidation of recently acquired representations in the hippocampus-dependent declarative memory system. Yet, it is unknown if this consolidation process comprises strengthening of the temporal sequence structure of the representation as well, or is restricted to sequence elements independent of their temporal order. To address this issue we tested the influence of sleep on the strength of forward and backward associations in word-triplets. Methodology/Principal Findings. Subjects learned a list of 32 triplets of unrelated words, presented successively (A-B-C) in the center of a screen, and either slept normally or stayed awake in the subsequent night. After two days, retrieval was assessed for the triplets sequentially either in a forward direction (cueing with A and B and asking for B and C, respectively) or in a backward direction (cueing with C and B and asking for B and A, respectively). Memory was better for forward than backward associations (p<0.01). Sleep did not affect backward associations, but enhanced forward associations, specifically for the first (AB) transitions (p<0.01), which were generally more difficult to retrieve than the second transitions. Conclusions/Significance. Our data demonstrate that consolidation during sleep strengthens the original temporal sequence structure in memory, presumably as a result of a replay of new representations during sleep in forward direction. Our finding suggests that the temporally directed replay of memory during sleep, apart from strengthening those traces, could be the key mechanism that explains how temporal order is integrated and maintained in the trace of an episodic memory.	[Drosopoulos, Spyridon; Windau, Eike; Wagner, Ullrich; Born, Jan] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany	University of Lubeck	Born, J (corresponding author), Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany.	born@kfg.uni-luebeck.de	Born, Jan/K-2596-2016	Born, Jan/0000-0002-1847-6248	German Research Foundation [SFB654]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (SFB654 "Plasticity and Sleep''). The authors have no financial interest in the manuscript.	ASCHBRENNER S, 2000, REGENSBURGER WORTFLU; Born J, 2004, ANN NY ACAD SCI, V1032, P198, DOI 10.1196/annals.1314.020; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Caplan JB, 2003, J NEUROSCI, V23, P4726; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Drosopoulos S, 2005, LEARN MEMORY, V12, P44, DOI 10.1101/lm.83805; DROSOPOULOS S, 2007, J EXP PSYCH IN PRESS; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P1877, DOI 10.1016/j.neuropsychologia.2004.05.008; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Johnson A, 2005, NEURAL NETWORKS, V18, P1163, DOI 10.1016/j.neunet.2005.08.009; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Kahana MJ, 2002, MEM COGNITION, V30, P841, DOI 10.3758/BF03195770; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Leibold C, 2006, NEURAL COMPUT, V18, P904, DOI 10.1162/089976606775774714; LI SC, 1995, J EXP PSYCHOL LEARN, V21, P837, DOI 10.1037/0278-7393.21.4.837; Lisman JE, 2005, NEURAL NETWORKS, V18, P1191, DOI 10.1016/j.neunet.2005.08.008; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshuetz C, 2006, NEUROSCIENCE, V139, P195, DOI 10.1016/j.neuroscience.2005.08.024; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Morita M, 1996, COGNITIVE BRAIN RES, V5, P137, DOI 10.1016/S0926-6410(96)00050-X; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Orban P, 2006, P NATL ACAD SCI USA, V103, P7124, DOI 10.1073/pnas.0510198103; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rauchs G, 2004, SLEEP, V27, P395, DOI 10.1093/sleep/27.3.395; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Thomas JG, 2003, PSYCHOL SCI, V14, P169, DOI 10.1111/1467-9280.01437; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tsukiura T, 2002, HUM BRAIN MAPP, V17, P203, DOI 10.1002/hbm.10068; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Wagner U, 2005, BIOL PSYCHIAT, V58, P885, DOI 10.1016/j.biopsych.2005.05.008; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; WAUGH NC, 1970, ACTA PSYCHOL, V33, P326, DOI 10.1016/0001-6918(70)90144-7; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	49	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e376	10.1371/journal.pone.0000376	http://dx.doi.org/10.1371/journal.pone.0000376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440612	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445500007
J	Fox, JH; Kama, JA; Lieberman, G; Chopra, R; Dorsey, K; Chopra, V; Volitakis, I; Cherny, RA; Bush, AI; Hersch, S				Fox, Jonathan H.; Kama, Jibrin A.; Lieberman, Gregory; Chopra, Raman; Dorsey, Kate; Chopra, Vanita; Volitakis, Irene; Cherny, Robert A.; Bush, Ashley I.; Hersch, Steven			Mechanisms of Copper Ion Mediated Huntington's Disease Progression	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; MOUSE MODEL; OXIDATIVE DAMAGE; IN-VITRO; BRAIN; 3-HYDROXYKYNURENINE; DYSFUNCTION; TOXICITY; FERRITIN; ALPHA	Huntington's disease (HD) is caused by a dominant polyglutamine expansion within the N-terminus of huntingtin protein and results in oxidative stress, energetic insufficiency and striatal degeneration. Copper and iron are increased in the striata of HD patients, but the role of these metals in HD pathogenesis is unknown. We found, using inductively-coupled-plasma mass spectroscopy, that elevations of copper and iron found in human HD brain are reiterated in the brains of affected HD transgenic mice. Increased brain copper correlated with decreased levels of the copper export protein, amyloid precursor protein. We hypothesized that increased amounts of copper bound to low affinity sites could contribute to pro-oxidant activities and neurodegeneration. We focused on two proteins:huntingtin, because of its centrality to HD, and lactate dehydrogenase (LDH), because of its documented sensitivity to copper, necessity for normoxic brain energy metabolism and evidence for altered lactate metabolism in HD brain. The first 171 amino acids of wild-type huntingtin, and its glutamine expanded mutant form, interacted with copper, but not iron. N171 reduced Cu2+ in vitro in a 1:1 copper:protein stoichiometry indicating that this fragment is very redox active. Further, copper promoted and metal chelation inhibited aggregation of cell-free huntingtin. We found decreased LDH activity, but not protein, and increased lactate levels in HD transgenic mouse brain. The LDH inhibitor oxamate resulted in neurodegeneration when delivered intra-striatially to healthy mice, indicating that LDH inhibition is relevant to neurodegeneration in HD. Our findings support a role of pro-oxidant copper-protein interactions in HD progression and offer a novel target for pharmacotherapeutics.	[Fox, Jonathan H.; Kama, Jibrin A.; Lieberman, Gregory; Chopra, Raman; Dorsey, Kate; Chopra, Vanita; Hersch, Steven] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Bush, Ashley I.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; [Bush, Ashley I.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA; [Volitakis, Irene; Cherny, Robert A.; Bush, Ashley I.] Univ Melbourne, Oxidat Disorders Lab, Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia; [Volitakis, Irene; Cherny, Robert A.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Melbourne; University of Melbourne	Hersch, S (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA.	HERSCH@HELIX.MGH.HARVARD.EDU	Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007	Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Volitakis, Irene/0000-0003-0766-817X	Huntington's Disease Society of America (HDSA); HighQ Foundation; NIH/NINDS [NS35255, NS045242]; NIH/NCCAM [AT00613]; Australian Research Council; National Health and Research Council of Australia; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000613] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [U01AT000613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035255, P01NS045242] Funding Source: NIH RePORTER	Huntington's Disease Society of America (HDSA); HighQ Foundation; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Australian Research Council(Australian Research Council); National Health and Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by the Huntington's Disease Society of America (HDSA), The HighQ Foundation, NIH/NINDS (NS35255 and NS045242) and NIH/NCCAM (AT00613). The Australian Research Council and the National Health and Research Council of Australia supported RAC, IV and AIB.	ARUOMA OI, 1991, BIOCHEM J, V273, P601, DOI 10.1042/bj2730601; Bartzokis G, 2000, CELL MOL BIOL, V46, P821; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Brewer GJ, 1999, SEMIN NEUROL, V19, P261, DOI 10.1055/s-2008-1040842; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Chen Chun-Wei David, 2006, Current Alzheimer Research, V3, P63, DOI 10.2174/156720506775697205; CHENG RZ, 1994, EUR J BIOCHEM, V223, P759, DOI 10.1111/j.1432-1033.1994.tb19050.x; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Firdaus WJJ, 2006, FEBS J, V273, P5428, DOI 10.1111/j.1742-4658.2006.05537.x; Fox JH, 2004, J NEUROCHEM, V91, P413, DOI 10.1111/j.1471-4159.2004.02726.x; Ghosh KS, 2006, FEBS LETT, V580, P4703, DOI 10.1016/j.febslet.2006.07.054; Goldstein LE, 2000, BIOCHEMISTRY-US, V39, P7266, DOI 10.1021/bi992997s; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Guidetti P, 2003, ADV EXP MED BIOL, V527, P137; Guidetti P, 2006, NEUROBIOL DIS, V23, P190, DOI 10.1016/j.nbd.2006.02.011; Harms L, 1997, J NEUROL NEUROSUR PS, V62, P27, DOI 10.1136/jnnp.62.1.27; Heron P, 2001, LIFE SCI, V68, P1575, DOI 10.1016/S0024-3205(01)00948-1; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kitzberger R, 2005, METAB BRAIN DIS, V20, P295, DOI 10.1007/s11011-005-7910-8; Kogel D, 2003, J NEUROCHEM, V87, P248, DOI 10.1046/j.1471-4159.2003.02000.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mancuso M, 2005, J NEUROPATH EXP NEUR, V64, P280, DOI 10.1093/jnen/64.4.280; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Pamp K, 2005, FREE RADICAL RES, V39, P31, DOI 10.1080/10715760400023671; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Shanmuganathan A, 2004, FEBS LETT, V556, P253, DOI 10.1016/S0014-5793(03)01428-5; Sheline CT, 2004, ANN NEUROL, V55, P645, DOI 10.1002/ana.20047; Stockel J, 1998, BIOCHEMISTRY-US, V37, P7185, DOI 10.1021/bi972827k; TACHON P, 1989, FREE RADICAL RES COM, V7, P1, DOI 10.3109/10715768909088155; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	51	136	138	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e334	10.1371/journal.pone.0000334	http://dx.doi.org/10.1371/journal.pone.0000334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17396163	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445200017
J	Xia, XH				Xia, Xuhua			The+4G Site in Kozak Consensus Is Not Related to the Efficiency of Translation Initiation	PLOS ONE			English	Article								The optimal context for translation initiation in mammalian species is GCCRCCaugG (where R = purine and "aug'' is the initiation codon), with the -3R and +4G being particularly important. The presence of +4G has been interpreted as necessary for efficient translation initiation. Accumulated experimental and bioinformatic evidence has suggested an alternative explanation based on amino acid constraint on the second codon, i.e., amino acid Ala or Gly are needed as the second amino acid in the nascent peptide for the cleavage of the initiator Met, and the consequent overuse of Ala and Gly codons (GCN and GGN) leads to the +4G consensus. I performed a critical test of these alternative hypotheses on +4G based on 34169 human protein-coding genes and published gene expression data. The result shows that the prevalence of +4G is not related to translation initiation. Among the five G-starting codons, only alanine codons (GCN), and glycine codons (GGN) to a much smaller extent, are overrepresented at the second codon, whereas the other three codons are not overrepresented. While highly expressed genes have more +4G than lowly expressed genes, the difference is caused by GCN and GGN codons at the second codon. These results are inconsistent with +4G being needed for efficient translation initiation, but consistent with the proposal of amino acid constraint hypothesis.	Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of Ottawa	Xia, XH (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	xxia@uottawa.ca	Xia, Xuhua/E-5264-2010	Xia, Xuhua/0000-0002-3092-7566	Discovery, Strategic Research, and Research Tools; Natural Science and Engineering Research Council of Canada	Discovery, Strategic Research, and Research Tools; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project is supported by the Discovery, Strategic Research, and Research Tools and Instruments Grants from the Natural Science and Engineering Research Council of Canada.	Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; CIGAN AM, 1987, GENE, V59, P1; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; de Vries JS, 2006, PLANT J, V45, P31, DOI 10.1111/j.1365-313X.2005.02590.x; Dinel S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni025; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Futcher B, 1999, MOL CELL BIOL, V19, P7357; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; GRUNERT S, 1994, EMBO J, V13, P3618, DOI 10.1002/j.1460-2075.1994.tb06669.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harkins S, 2005, J VIROL, V79, P987, DOI 10.1128/JVI.79.2.987-996.2005; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Kozak M, 2003, BLOOD, V101, P1202, DOI 10.1182/blood-2002-10-3194; KOZAK M, 1991, GENE EXPRESSION, V1, P117; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 2001, SCI STKE, pPE1; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MOERSCHELL RP, 1990, J BIOL CHEM, V265, P19638; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Provitera P, 2006, BIOPHYS CHEM, V119, P23, DOI 10.1016/j.bpc.2005.08.008; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robert-Seilaniantz A, 2006, MOL PLANT MICROBE IN, V19, P130, DOI 10.1094/MPMI-19-0130; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; Semon M, 2006, MOL BIOL EVOL, V23, P523, DOI 10.1093/molbev/msj053; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; SHINE J, 1975, EUR J BIOCHEM, V57, P221, DOI 10.1111/j.1432-1033.1975.tb02294.x; Tats A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-28; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, DATA ANAL MOL BIOL E; Xia XH, 2005, GENE, V345, P13, DOI 10.1016/j.gene.2004.11.019; Xia XH, 1998, GENETICS, V149, P37; ZAR JH, BIOSTATISTICAL AANAL	47	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e188	10.1371/journal.pone.0000188	http://dx.doi.org/10.1371/journal.pone.0000188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17285142	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444300001
J	Hatherill, M; Hawkridge, T; Whitelaw, A; Tameris, M; Mahomed, H; Moyo, S; Hanekom, W; Hussey, G				Hatherill, Mark; Hawkridge, Tony; Whitelaw, Andrew; Tameris, Michele; Mahomed, Hassan; Moyo, Sizulu; Hanekom, Willem; Hussey, Gregory			Isolation of Non-Tuberculous Mycobacteria in Children Investigated for Pulmonary Tuberculosis	PLOS ONE			English	Article							RAPID IDENTIFICATION; INFECTION; VACCINATION; PREVENTION; SPECIMENS; EFFICACY; INFANTS; DISEASE; SPUTUM	Objective. To evaluate the frequency and clinical significance of non-tuberculous mycobacteria (NTM) isolates among children investigated for pulmonary tuberculosis in a rural South African community. Methods. Children were investigated for pulmonary tuberculosis as part of a tuberculosis vaccine surveillance program (2001-2005). The clinical features of children in whom NTM were isolated, from induced sputum or gastric lavage, were compared to those with culture-proven M. tuberculosis. Results. Mycobacterial culture demonstrated 114 NTM isolates from 109 of the 1,732 children investigated, a crude yield of 6% (95% CI 5-7). The comparative yield of positive NTM cultures from gastric lavage was 40% (95% CI 31-50), compared to 67% (95% CI 58-76) from induced sputum. 95% of children with NTM isolates were symptomatic. Two children were HIV-infected. By contrast, M. tuberculosis was isolated in 187 children, a crude yield of 11% (95% CI 9-12). Compared to those with culture-proven M. tuberculosis, children with NTM isolates were less likely to demonstrate acid-fast bacilli on direct smear microscopy (OR 0.19; 95% 0.0-0.76). Children with NTM were older (p < 0.0001), and more likely to demonstrate constitutional symptoms (p = 0.001), including fever (p = 0.003) and loss of weight or failure to gain weight (p = 0.04), but less likely to demonstrate a strongly positive tuberculin skin test (p, 0.0001) or radiological features consistent with pulmonary tuberculosis (p = 0.04). Discussion. NTM were isolated in 6% of all children investigated for pulmonary tuberculosis and in more than one third of those with a positive mycobacterial culture. NTM may complicate the diagnosis of PTB in regions that lack capacity for mycobacterial species identification. The association of NTM isolates with constitutional symptoms suggestive of host recognition requires further investigation.	[Hatherill, Mark; Hawkridge, Tony; Tameris, Michele; Mahomed, Hassan; Moyo, Sizulu; Hanekom, Willem; Hussey, Gregory] Univ Cape Town, Inst Infect Dis & Mol Med, S African TB Vaccine Initiat SATVI, ZA-7925 Cape Town, South Africa; [Hatherill, Mark; Hawkridge, Tony; Tameris, Michele; Mahomed, Hassan; Moyo, Sizulu; Hanekom, Willem; Hussey, Gregory] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Whitelaw, Andrew] Univ Cape Town, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Whitelaw, Andrew] Natl Hlth Lab Serv, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Hatherill, M (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, S African TB Vaccine Initiat SATVI, ZA-7925 Cape Town, South Africa.	mark@rmh.uct.ac.za	Tameris, Michele/AAR-6663-2021	Tameris, Michele/0000-0002-7983-7203; Hanekom, Willem/0000-0003-3070-6154; Whitelaw, Andrew/0000-0001-9070-5247	Aeras Global Tuberculosis Vaccine Foundation; NIH [Al-065653]; EDCTP; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065653] Funding Source: NIH RePORTER	Aeras Global Tuberculosis Vaccine Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EDCTP; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Aeras Global Tuberculosis Vaccine Foundation. WH is funded by the NIH (Al-065653), EDCTP, and Dana Foundation.	Arend SM, 2002, J INFECT DIS, V186, P1797, DOI 10.1086/345760; Brunello F, 2001, J CLIN MICROBIOL, V39, P2799, DOI 10.1128/JCM.39.8.2799-2806.2001; Buddle BM, 2002, VACCINE, V20, P1126, DOI 10.1016/S0264-410X(01)00436-4; COLDITZ GA, 1995, PEDIATRICS, V96, P29; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; DEWIT D, 1990, J CLIN MICROBIOL, V28, P2437, DOI 10.1128/JCM.28.11.2437-2441.1990; Erasmus JJ, 1999, RADIOGRAPHICS, V19, P1487, DOI 10.1148/radiographics.19.6.g99no101487; GROENEWALD P, 2003, BOLAND OVERBERG REGI; Haverkamp MH, 2004, CLIN INFECT DIS, V39, P450, DOI 10.1086/422319; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Jeon K, 2005, INT J TUBERC LUNG D, V9, P1046; Nolt D, 2003, PEDIATRICS, V112, pE434, DOI 10.1542/peds.112.5.e434; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Rice G, 2005, J TOXICOL ENV HEAL A, V68, P1033, DOI 10.1080/15287390590912630; Steingrube VA, 1997, J CLIN MICROBIOL, V35, P817, DOI 10.1128/JCM.35.4.817-822.1997; Talbot EA, 1997, J CLIN MICROBIOL, V35, P566, DOI 10.1128/JCM.35.3.566-569.1997; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Wallace RJ, 1997, AM J RESP CRIT CARE, V156, pS1, DOI 10.1164/ajrccm.156.2.atsstatement; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2; Zumla A, 2002, CURR OPIN PULM MED, V8, P166, DOI 10.1097/00063198-200205000-00003	21	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e21	10.1371/journal.pone.0000021	http://dx.doi.org/10.1371/journal.pone.0000021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183648	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600021
J	Kalisch, T; Wilimzig, C; Kleibel, N; Tegenthoff, M; Dinse, HR				Kalisch, Tobias; Wilimzig, Claudia; Kleibel, Nadine; Tegenthoff, Martin; Dinse, Hubert R.			Age-Related Attenuation of Dominant Hand Superiority	PLOS ONE			English	Article								Background. The decline of motor performance of the human hand-arm system with age is well-documented. While dominant hand performance is superior to that of the non-dominant hand in young individuals, little is known of possible age-related changes in hand dominance. We investigated age-related alterations of hand dominance in 20 to 90 year old subjects. All subjects were unambiguously right-handed according to the Edinburgh Handedness Inventory. In Experiment 1, motor performance for aiming, postural tremor, precision of arm-hand movement, speed of arm-hand movement, and wrist-finger speed tasks were tested. In Experiment 2, accelerometer-sensors were used to obtain objective records of hand use in everyday activities. Principal Findings. Our data confirm previous findings of a general task-dependent decline in motor performance with age. Analysis of the relationship between right/left-hand performances using a laterality index showed a loss of right hand dominance with advancing age. The clear right-hand advantage present at younger ages changed to a more balanced performance in advanced age. This shift was due to a more pronounced age-related decline of right hand performance. Accelerometer-sensor measurements supported these findings by demonstrating that the frequency of hand use also shifted from a clear right hand preference in young adults to a more balanced usage of both hands in old age. Despite these age-related changes in the relative level of performance in defined motor tasks and in the frequency of hand use, elderly subjects continued to rate themselves as unambiguous right-handers. Conclusion. The discrepancy between hand-specific practical performance in controlled motor tests as well as under everyday conditions and the results of questionnaires concerning hand use and hand dominance suggests that most elderly subjects are unaware of the changes in hand dominance that occur over their lifespan, i.e., a shift to ambidexterity.	[Kalisch, Tobias; Wilimzig, Claudia; Kleibel, Nadine; Dinse, Hubert R.] Ruhr Univ Bochum, Dept Theoret Biol, Neural Plast Lab, Inst Neuroinformat, Bochum, Germany; [Wilimzig, Claudia] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Tegenthoff, Martin] Ruhr Univ Bochum, Dept Neurol, BG Kliniken Bergmannsheil, Bochum, Germany	Ruhr University Bochum; California Institute of Technology; Ruhr University Bochum	Dinse, HR (corresponding author), Ruhr Univ Bochum, Dept Theoret Biol, Neural Plast Lab, Inst Neuroinformat, Bochum, Germany.	hubert.dinse@neuroinformatik.rub.de	Kalisch, Tobias/AAY-4182-2021	Kalisch, Tobias/0000-0003-4206-4283; dinse, hubert/0000-0001-9024-0451	DFG [Di 334/10-4, Te 315/2-1]; Schering Stiftung; Studienstiftung des Deutschen Volkes	DFG(German Research Foundation (DFG)); Schering Stiftung; Studienstiftung des Deutschen Volkes	This research was supported by grants from the DFG awarded to HRD (Di 334/10-4) and MT (Te 315/2-1), a grant from the Schering Stiftung awarded to TK, and a grant from the Studienstiftung des Deutschen Volkes awarded to CW.	Albert M. S., 1988, GERIATRIC NEUROPSYCH; Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Bishop DVM, 1996, BRIT J PSYCHOL, V87, P269, DOI 10.1111/j.2044-8295.1996.tb02590.x; BOLTZ MG, 1994, J EXP PSYCHOL LEARN, V20, P1154, DOI 10.1037/0278-7393.20.5.1154; BROWN JW, 1975, NEUROPSYCHOLOGIA, V13, P107, DOI 10.1016/0028-3932(75)90054-8; Cabeza R, 1997, J NEUROSCI, V17, P391; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; CARELLA J, 1990, HDB PSYCHOL AGING, P201; Carmeli E, 2003, J GERONTOL A-BIOL, V58, P146, DOI 10.1093/gerona/58.2.M146; Carmelli D, 2000, J APPL PHYSIOL, V89, P1879, DOI 10.1152/jappl.2000.89.5.1879; Cavill S, 2003, BRAIN COGNITION, V53, P149, DOI 10.1016/S0278-2626(03)00098-8; Chan KM, 2000, CAN J NEUROL SCI, V27, P220, DOI 10.1017/S0317167100000858; CHODZKOZAJKO WJ, 1991, MED SCI SPORT EXER, V23, P868; Civardi C, 2000, CLIN NEUROPHYSIOL, V111, P624, DOI 10.1016/S1388-2457(99)00301-6; COLE KJ, 1991, J MOTOR BEHAV, V23, P251, DOI 10.1080/00222895.1991.9942036; Corey DM, 2001, NEUROPSY NEUROPSY BE, V14, P144; DENNER B, 1964, PERCEPT MOTOR SKILL, V19, P723, DOI 10.2466/pms.1964.19.3.723; Dik MG, 2003, J CLIN EXP NEUROPSYC, V25, P643, DOI 10.1076/jcen.25.5.643.14583; DIXIT NK, 2000, NEUROIMAGE, V5, P94; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Elias LJ, 1998, NEUROPSYCHOLOGIA, V36, P37, DOI 10.1016/S0028-3932(97)00107-3; Fleishman E.A., 1972, PSYCHOMOTOR DOMAIN, P78; FLEMINGER JJ, 1977, NEUROPSYCHOLOGIA, V15, P471, DOI 10.1016/0028-3932(77)90101-4; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Francis KL, 2000, EXP AGING RES, V26, P169, DOI 10.1080/036107300243632; FROLKIS VV, 1976, GERONTOLOGY, V22, P244, DOI 10.1159/000212143; GALGANSKI ME, 1993, J NEUROPHYSIOL, V69, P2108, DOI 10.1152/jn.1993.69.6.2108; GOLDSTEIN G, 1981, Journal of Clinical Neuropsychology, V3, P65, DOI 10.1080/01688638108403114; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; Grady CL, 1998, NEUROIMAGE, V8, P409, DOI 10.1006/nimg.1998.0376; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; GRIMBY G, 1982, ACTA PHYSIOL SCAND, V115, P125, DOI 10.1111/j.1748-1716.1982.tb07054.x; Hausmann M, 2003, LATERALITY, V8, P277, DOI 10.1080/13576500244000201; Henkel V, 2001, NEUROPSYCHOLOGIA, V39, P1158, DOI 10.1016/S0028-3932(01)00043-4; HORN JL, 1977, AM PSYCHOL, V31, P269; Hughes S, 1997, J AM GERIATR SOC, V45, P905, DOI 10.1111/j.1532-5415.1997.tb02957.x; Hutchinson S, 2002, NEUROIMAGE, V17, P1720, DOI 10.1006/nimg.2002.1309; JAGACINSKI RJ, 1995, PSYCHOL AGING, V10, P8, DOI 10.1037/0882-7974.10.1.8; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; KEEN DA, 1994, J APPL PHYSIOL, V77, P2648, DOI 10.1152/jappl.1994.77.6.2648; Kinoshita H, 1996, EUR J APPL PHYSIOL, V74, P450; KOCEL KM, 1980, NEUROPSYCHOLOGY LEFT, P293; Krampe RT, 2002, NEUROSCI BIOBEHAV R, V26, P769, DOI 10.1016/S0149-7634(02)00064-7; Kraus PH, 2000, J NEURAL TRANSM, V107, P73, DOI 10.1007/s007020050006; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Liao MJ, 1997, J EXP PSYCHOL HUMAN, V23, P1644, DOI 10.1037/0096-1523.23.6.1644; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; MCFIE J, 1975, ASSESSMENT ORGANIC I; MEUDELL PR, 1987, CORTEX, V23, P431; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; MURRAY MP, 1980, PHYS THER, V60, P412, DOI 10.1093/ptj/60.4.412; Nielson KA, 2002, PSYCHOL AGING, V17, P56, DOI 10.1037//0882-7974.17.1.56; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peters A, 2002, NEUROSCI BIOBEHAV R, V26, P733, DOI 10.1016/S0149-7634(02)00060-X; Peters M, 1998, Laterality, V3, P77, DOI 10.1080/713754291; PORAC C, 1993, CAN J EXP PSYCHOL, V47, P697, DOI 10.1037/h0078873; Ranganathan VK, 2001, J AM GERIATR SOC, V49, P1478, DOI 10.1046/j.1532-5415.2001.4911240.x; Sailer A, 2000, NEUROLOGY, V55, P979, DOI 10.1212/WNL.55.7.979; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SAND PL, 1973, PERCEPT MOTOR SKILL, V36, P1343, DOI 10.2466/pms.1973.36.3c.1343; Schut LJ, 1998, GERIATRICS, V53, pS16; Smith CD, 1999, NEUROLOGY, V53, P1458, DOI 10.1212/WNL.53.7.1458; SPERLING L, 1980, SCAND J REHABIL MED, V12, P139; Triggs WJ, 2000, CORTEX, V36, P679, DOI 10.1016/S0010-9452(08)70545-8; WARABI T, 1986, EXP NEUROL, V92, P686, DOI 10.1016/0014-4886(86)90309-2; Wechsler D, 1958, MEASUREMENT APPRAISA; WELLER MPI, 1985, PSYCHOL MED, V15, P867, DOI 10.1017/S0033291700005109; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454	69	72	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e90	10.1371/journal.pone.0000090	http://dx.doi.org/10.1371/journal.pone.0000090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183722	Green Published, gold, Green Accepted			2022-12-27	WOS:000207443600089
J	Kaneko, K				Kaneko, Kunihiko			Evolution of Robustness to Noise and Mutation in Gene Expression Dynamics	PLOS ONE			English	Article								Phenotype of biological systems needs to be robust against mutation in order to sustain themselves between generations. On the other hand, phenotype of an individual also needs to be robust against fluctuations of both internal and external origins that are encountered during growth and development. Is there a relationship between these two types of robustness, one during a single generation and the other during evolution? Could stochasticity in gene expression have any relevance to the evolution of these types of robustness? Robustness can be defined by the sharpness of the distribution of phenotype; the variance of phenotype distribution due to genetic variation gives a measure of 'genetic robustness', while that of isogenic individuals gives a measure of 'developmental robustness'. Through simulations of a simple stochastic gene expression network that undergoes mutation and selection, we show that in order for the network to acquire both types of robustness, the phenotypic variance induced by mutations must be smaller than that observed in an isogenic population. As the latter originates from noise in gene expression, this signifies that the genetic robustness evolves only when the noise strength in gene expression is larger than some threshold. In such a case, the two variances decrease throughout the evolutionary time course, indicating increase in robustness. The results reveal how noise that cells encounter during growth and development shapes networks' robustness to stochasticity in gene expression, which in turn shapes networks' robustness to mutation. The necessary condition for evolution of robustness, as well as the relationship between genetic and developmental robustness, is derived quantitatively through the variance of phenotypic fluctuations, which are directly measurable experimentally.	[Kaneko, Kunihiko] Univ Tokyo, Dept Pure & Appl Sci, Tokyo, Japan; [Kaneko, Kunihiko] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Complex Syst Biol Project, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Kaneko, K (corresponding author), Univ Tokyo, Dept Pure & Appl Sci, Tokyo, Japan.	kaneko@complex.c.u-tokyo.ac.jp						ABE H, 1980, I FORMULATION BIOPOL, P1013; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Ancel LW, 2000, THEOR POPUL BIOL, V58, P307, DOI 10.1006/tpbi.2000.1484; ANCEL LW, 2002, J EXPT ZOOLOGY, P242; Ao P, 2005, PHYS LIFE REV, V2, P117, DOI 10.1016/j.plrev.2005.03.002; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Callahan HS, 1997, BIOESSAYS, V19, P519, DOI 10.1002/bies.950190611; CILIBERTI S, 2007, PLOS COMPUTATIONAL B, pE15; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; EDWARDS AWF, 2000, FDN MATH GENETICS; Eigen M, 1979, HYPERCYCLE; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fisher RA, 1930, GENETICAL THEORY NAT; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; Futuyma DJ, 1986, EVOL BIOL; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; GOMPERTS BD, 2002, SIGNAL TRANSDUCTION; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hertz JA, 2018, INTRO THEORY NEURAL; ISHIHARA S, 2004, PHYS REV LETT; JNONUCHIC JN, 1995, P NATL ACAD SCI USA, P3626; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaneko K, 1999, J THEOR BIOL, V199, P243, DOI 10.1006/jtbi.1999.0952; Kaneko K, 2006, LIFE INTRO COMPLEX S; Kaneko K, 2006, J THEOR BIOL, V240, P78, DOI 10.1016/j.jtbi.2005.08.029; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; KIRSCHNER MW, 2005, PLAUSBILITY LIFE; Kubo R., 1985, STAT PHYS, V2; LI F, 2004, P NATL ACAD SCI USA, P10040; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Mezard M., 1987, WORLD SCI LECT NOT P, V9; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Nishimori H., 2001, STAT PHYS SPIN GLASS; Saito S, 1997, P NATL ACAD SCI USA, V94, P11324, DOI 10.1073/pnas.94.21.11324; Salazar-Ciudad I, 2000, J THEOR BIOL, V205, P587, DOI 10.1006/jtbi.2000.2092; Salazar-Ciudad I, 2001, EVOL DEV, V3, P84, DOI 10.1046/j.1525-142x.2001.003002084.x; Sato K, 2003, P NATL ACAD SCI USA, V100, P14086, DOI 10.1073/pnas.2334996100; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Schmalhausen II, 1949, FACTORS EVOLUTION TH; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Waddington C., 1957, STRATEGY GENES; WAGNER A, 2000, NAT GENET, P355; WAGNER GP, 1997, POPULATION GENETIC T, P329; West-Eberhard Mary Jane, 2003, pi	47	103	103	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e434	10.1371/journal.pone.0000434	http://dx.doi.org/10.1371/journal.pone.0000434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17502916	Green Submitted, gold, Green Published			2022-12-27	WOS:000207445800016
J	Leucht, P; Kim, JB; Currey, JA; Brunski, J; Helms, JA				Leucht, Philipp; Kim, Jae-Beom; Currey, Jennifer A.; Brunski, John; Helms, Jill A.			FAK-Mediated Mechanotransduction in Skeletal Regeneration	PLOS ONE			English	Article							IN-VITRO; MECHANICAL STRAIN; STEM-CELLS; ARTICULAR-CARTILAGE; FOCAL ADHESIONS; POISSONS RATIO; BONE; DIFFERENTIATION; OSTEOBLAST; COLLAGEN	The majority of cells are equipped to detect and decipher physical stimuli, and then react to these stimuli in a cell type-specific manner. Ultimately, these cellular behaviors are synchronized to produce a tissue response, but how this is achieved remains enigmatic. Here, we investigated the genetic basis for mechanotransduction using the bone marrow as a model system. We found that physical stimuli produced a pattern of principal strain that precisely corresponded to the site-specific expression of sox9 and runx2, two transcription factors required for the commitment of stem cells to a skeletogenic lineage, and the arrangement and orientation of newly deposited type I collagen fibrils. To gain insights into the genetic basis for skeletal mechanotransduction we conditionally inactivated focal adhesion kinase (FAK), an intracellular component of the integrin signaling pathway. By doing so we abolished the mechanically induced osteogenic response and thus identified a critical genetic component of the molecular machinery required for mechanotransduction. Our data provide a new framework in which to consider how physical forces and molecular signals are synchronized during the program of skeletal regeneration.	[Leucht, Philipp; Kim, Jae-Beom; Helms, Jill A.] Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Leucht, Philipp] Univ Frankfurt Main, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany; [Currey, Jennifer A.; Brunski, John] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA	Stanford University; Goethe University Frankfurt; Rensselaer Polytechnic Institute	Helms, JA (corresponding author), Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.	jhelms@stanford.edu	Leucht, Philipp/H-7238-2019	Leucht, Philipp/0000-0002-8409-8513; Helms, Jill/0000-0002-0463-396X	NIH [RO1-EB00504]; CA Arthritis Foundation;  [FA9550-04-1-0075]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CA Arthritis Foundation; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by NIH RO1-EB00504 (JBB), N. CA Arthritis Foundation (JBK), and FA9550-04-1-0075 (JAH).	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Albrecht U, 1997, MOL CELLULAR METHODS, P23; Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Carter DR, 2001, SKELETAL FUNCTION FO; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Claes LE, 1998, CLIN ORTHOP RELAT R, pS132; CLIFFORD DH, 1984, PREANESTHESIA ANESTH, P527; Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101; HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037; Jin H, 2004, J BIOMECH ENG-T ASME, V126, P138, DOI 10.1115/1.1688772; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kim DG, 2005, P I MECH ENG H, V219, P119, DOI 10.1243/095441105X9291; KIM J, 2007, BONE IN PRESS; Kiviranta P, 2006, J ORTHOP RES, V24, P690, DOI 10.1002/jor.20107; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Kurata K, 2001, J BONE MINER RES, V16, P722, DOI 10.1359/jbmr.2001.16.4.722; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Nelson CM, 2004, MOL BIOL CELL, V15, P2943, DOI 10.1091/mbc.E03-10-0745; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Rabbany SY, 2003, TRENDS MOL MED, V9, P109, DOI 10.1016/S1471-4914(03)00021-2; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rubin J, 1999, J ORTHOPAED RES, V17, P639, DOI 10.1002/jor.1100170504; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; SHEEHAN DC, 1980, THEORY PRACTICE HIST, P103; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; SOBALLE K, 1992, ACTA ORTHOP SCAND, V63, P128, DOI 10.3109/17453679209154808; Thomas GP, 1996, CALCIFIED TISSUE INT, V58, P101, DOI 10.1007/s002239900018; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; WASEEM NH, 1990, J CELL SCI, V96, P121; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; You LD, 2001, J BIOMECH, V34, P1375, DOI 10.1016/S0021-9290(01)00107-5	48	62	66	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e390	10.1371/journal.pone.0000390	http://dx.doi.org/10.1371/journal.pone.0000390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460757	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445600004
J	Opel, M; Lando, D; Bonilla, C; Trewick, SC; Boukaba, A; Walfridsson, J; Cauwood, J; Werler, PJH; Carr, AM; Kouzarides, T; Murzina, NV; Allshire, RC; Ekwall, K; Laue, ED				Opel, Michael; Lando, David; Bonilla, Carolina; Trewick, Sarah C.; Boukaba, Abdelhalim; Walfridsson, Julian; Cauwood, James; Werler, Petra J. H.; Carr, Antony M.; Kouzarides, Tony; Murzina, Natalia V.; Allshire, Robin C.; Ekwall, Karl; Laue, Ernest D.			Genome-Wide Studies of Histone Demethylation Catalysed by the Fission Yeast Homologues of Mammalian LSD1	PLOS ONE			English	Article								In order to gain a more global view of the activity of histone demethylases, we report here genome-wide studies of the fission yeast SWIRM and polyamine oxidase (PAO) domain homologues of mammalian LSD1. Consistent with previous work we find that the two S. pombe proteins, which we name Swm1 and Swm2 (after SWIRM1 and SWIRM2), associate together in a complex. However, we find that this complex specifically demethylates lysine 9 in histone H3 (H3K9) and both up-and down-regulates expression of different groups of genes. Using chromatin-immunoprecipitation, to isolate fragments of chromatin containing either H3K4me2 or H3K9me2, and DNA microarray analysis (ChIP-chip), we have studied genome-wide changes in patterns of histone methylation, and their correlation with gene expression, upon deletion of the swm1(+) gene. Using hyper-geometric probability comparisons we uncover genetic links between lysine-specific demethylases, the histone deacetylase Clr6, and the chromatin remodeller Hrp1. The data presented here demonstrate that in fission yeast the SWIRM/PAO domain proteins Swm1 and Swm2 are associated in complexes that can remove methyl groups from lysine 9 methylated histone H3. In vitro, we show that bacterially expressed Swm1 also possesses lysine 9 demethylase activity. In vivo, loss of Swm1 increases the global levels of both H3K9me2 and H3K4me2. A significant accumulation of H3K4me2 is observed at genes that are up-regulated in a swm1 deletion strain. In addition, H3K9me2 accumulates at some genes known to be direct Swm1/2 targets that are down-regulated in the swm1 Delta strain. The in vivo data indicate that Swm1 acts in concert with the HDAC Clr6 and the chromatin remodeller Hrp1 to repress gene expression. In addition, our in vitro analyses suggest that the H3K9 demethylase activity requires an unidentified post-translational modification to allow it to act. Thus, our results highlight complex interactions between histone demethylase, deacetylase and chromatin remodelling activities in the regulation of gene expression.	[Trewick, Sarah C.; Boukaba, Abdelhalim; Allshire, Robin C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Opel, Michael; Cauwood, James; Murzina, Natalia V.; Laue, Ernest D.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Lando, David; Kouzarides, Tony] Gurdon Inst, Cambridge, England; [Lando, David; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Bonilla, Carolina; Walfridsson, Julian; Ekwall, Karl] Univ Coll Sodertorn, Karolinska Inst, Sch Life Sci, Dept Biosci, Huddinge, Sweden; [Werler, Petra J. H.; Carr, Antony M.] Univ Sussex, Sch Biol Sci, Genome Damage & Stabil Ctr, Falmer, Sussex, England	University of Edinburgh; University of Cambridge; University of Cambridge; Karolinska Institutet; Sodertorn University; University of Sussex	Allshire, RC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	robin.allshire@ed.ac.uk; karl.ekwall@sh.se; e.d.laue@bioc.cam.ac.uk	Lando, David/AAH-3052-2019; Lando, David/A-2546-2010	Lando, David/0000-0001-5783-8769; Ekwall, Karl/0000-0002-3029-4041; Carr, Antony Michael/0000-0002-2028-2389; Laue, Ernest/0000-0002-7476-4148; Allshire, Robin/0000-0002-8005-3625; Kouzarides, Tony/0000-0002-8918-4162	Wellcome Trust; Knut and Alice Wallenberg Foundation; Swedish Cancer Society; Swedish Research Council; Royal Society; National Health and Medical Research Council of Australia; Medical Research Council [G0001129] Funding Source: researchfish; MRC [G0001129] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Society(Royal Society of London); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	R. C. A. and E. D. L. thank the Wellcome Trust for financial support. K. E. is a Royal Swedish Academy of Sciences Research Fellow supported by grants from the Knut and Alice Wallenberg Foundation, Swedish Cancer Society, Swedish Research Council (VR) M. Bergvalls stiftelse and the EU The Epigenome NoE network. R. C. A is a Wellcome Trust Principal Research Fellow; S. C. T is a Dorothy Hodgkin Fellow of the Royal Society; D. L. is a CJ Martin Fellow of the National Health and Medical Research Council of Australia.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Grewal SIS, 1998, GENETICS, V150, P563; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; KLEEBERG U, 1982, J PHARMACOL METHOD, V8, P19, DOI 10.1016/0160-5402(82)90004-3; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nakayama J, 2003, EMBO J, V22, P2776, DOI 10.1093/emboj/cdg248; Nicolas E, 2006, J BIOL CHEM, V281, P35983, DOI 10.1074/jbc.M606349200; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robyr D, 2003, METHODS, V31, P83, DOI 10.1016/S1046-2023(03)00091-4; Schneider R, 2002, METHODS, V26, P226, DOI 10.1016/S1046-2023(02)00026-9; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sinha I, 2006, CHROMOSOME RES, V14, P95, DOI 10.1007/s10577-005-1023-4; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Werler PJH, 2003, GENE, V304, P133, DOI 10.1016/S0378-1119(03)00402-5; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Xue YT, 2004, YEAST, V21, P25, DOI 10.1002/yea.1053; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	34	30	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e386	10.1371/journal.pone.0000386	http://dx.doi.org/10.1371/journal.pone.0000386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440621	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000207445500016
J	Chaudhuri, RR; Ren, CP; Desmond, L; Vincent, GA; Silman, NJ; Brehm, JK; Elmore, MJ; Hudson, MJ; Forsman, M; Isherwood, KE; Gurycova, D; Minton, NP; Titball, RW; Pallen, MJ; Vipond, R				Chaudhuri, Roy R.; Ren, Chuan-Peng; Desmond, Leah; Vincent, Gemma A.; Silman, Nigel J.; Brehm, John K.; Elmore, Michael J.; Hudson, Michael J.; Forsman, Mats; Isherwood, Karen E.; Gurycova, Darina; Minton, Nigel P.; Titball, Richard W.; Pallen, Mark J.; Vipond, Richard			Genome Sequencing Shows that European Isolates of Francisella tularensis Subspecies tularensis Are Almost Identical to US Laboratory Strain Schu S4	PLOS ONE			English	Article								Background. Francisella tularensis causes tularaemia, a life-threatening zoonosis, and has potential as a biowarfare agent. F. tularensis subsp. tularensis, which causes the most severe form of tularaemia, is usually confined to North America. However, a handful of isolates from this subspecies was obtained in the 1980s from ticks and mites from Slovakia and Austria. Our aim was to uncover the origins of these enigmatic European isolates. Methodology/Principal Findings. We determined the complete genome sequence of FSC198, a European isolate of F. tularensis subsp. tularensis, by whole-genome shotgun sequencing and compared it to that of the North American laboratory strain Schu S4. Apparent differences between the two genomes were resolved by re-sequencing discrepant loci in both strains. We found that the genome of FSC198 is almost identical to that of Schu S4, with only eight SNPs and three VNTR differences between the two sequences. Sequencing of these loci in two other European isolates of F. tularensis subsp. tularensis confirmed that all three European isolates are also closely related to, but distinct from Schu S4. Conclusions/Significance. The data presented here suggest that the Schu S4 laboratory strain is the most likely source of the European isolates of F. tularensis subsp. tularensis and indicate that anthropogenic activities, such as movement of strains or animal vectors, account for the presence of these isolates in Europe. Given the highly pathogenic nature of this subspecies, the possibility that it has become established wild in the heartland of Europe carries significant public health implications.	[Chaudhuri, Roy R.; Ren, Chuan-Peng; Pallen, Mark J.] Univ Birmingham, Div Immun & Infect, Edgbaston, England; [Desmond, Leah; Vincent, Gemma A.; Silman, Nigel J.; Brehm, John K.; Elmore, Michael J.; Hudson, Michael J.; Minton, Nigel P.; Vipond, Richard] Ctr Emergency Preparedness & Response, Hlth Protect Agcy, Salisbury, Wilts, England; [Forsman, Mats] FOI Swedish Def Res Agcy, Div NBC Def, Dept NBC Anal, Umea, Sweden; [Isherwood, Karen E.] Def Sci & Technol Lab, Salisbury, Wilts, England; [Gurycova, Darina] Comenius Univ, Med Facil, Dept Epidemiol, Bratislava, Slovakia; [Minton, Nigel P.] Univ Nottingham, Ctr Biomol Sci, Inst Infect Immun & Inflammat, Nottingham NG7 2RD, England	University of Birmingham; Health Protection Agency; FOI - Swedish Defence Research Agency; Defence Science & Technology Laboratory; Comenius University Bratislava; University of Nottingham	Pallen, MJ (corresponding author), Univ Birmingham, Div Immun & Infect, Edgbaston, England.	m.pallen@bham.ac.uk	Chaudhuri, Roy/E-3774-2014; Forsman, Mats/A-1426-2016; Pallen, Mark J./E-7619-2011	Chaudhuri, Roy/0000-0001-5037-2695; Forsman, Mats/0000-0002-4466-5325; Pallen, Mark/0000-0003-1807-3657; Minton, Nigel/0000-0002-9277-1261; Vincent, Gemma/0000-0003-1479-0114	U.K. Department of Health	U.K. Department of Health	This research was funded by the U.K. Department of Health. The funding sources had no influence upon the study design, collection, analysis and interpretation of the data, or on the preparation of the manuscript.	Ben Zakour N, 2004, NUCLEIC ACIDS RES, V32, P17, DOI 10.1093/nar/gkg928; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chaudhuri RR, 2006, NUCLEIC ACIDS RES, V34, pD335, DOI 10.1093/nar/gkj140; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; DIENST F T Jr, 1963, J La State Med Soc, V115, P114; *DIR CULT CULT NAT, 2001, BERN CONV ACT INV AL; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; EIGELSBACH HT, 1951, J BACTERIOL, V61, P557, DOI 10.1128/JB.61.5.557-569.1951; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Feldman KA, 2003, EMERG INFECT DIS, V9, P350, DOI 10.3201/eid0903.020462; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gurycova D, 1998, EUR J EPIDEMIOL, V14, P797, DOI 10.1023/A:1007537405242; HESSELBROCK W, 1945, J BACTERIOL, V49, P209, DOI 10.1128/JB.49.3.209-231.1945; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Ohnishi M, 2002, P NATL ACAD SCI USA, V99, P17043, DOI 10.1073/pnas.262441699; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Ren CP, 2004, J BACTERIOL, V186, P3547, DOI 10.1128/JB.186.11.3547-3560.2004; RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069; Rozen S, 2000, Methods Mol Biol, V132, P365; SANDSTORM G, 1994, J CHEM TECHNOL BIOT, V59, P315, DOI 10.1002/jctb.280590402; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; SYRJALA H, 1985, SCAND J INFECT DIS, V17, P371; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Tropp BE, 1997, BBA-LIPID LIPID MET, V1348, P192, DOI 10.1016/S0005-2760(97)00100-8; Whipp MJ, 2003, J MED MICROBIOL, V52, P839, DOI 10.1099/jmm.0.05245-0	33	41	312	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e352	10.1371/journal.pone.0000352	http://dx.doi.org/10.1371/journal.pone.0000352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406676	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445300014
J	Gillet, L; Adler, H; Stevenson, PG				Gillet, Laurent; Adler, Heiko; Stevenson, Philip G.			Glycosaminoglycan Interactions in Murine Gammaherpesvirus-68 Infection	PLOS ONE			English	Article								Glycosaminoglycans (GAGs) commonly participate in herpesvirus entry. They are thought to provide a reversible attachment to cells that promotes subsequent receptor binding. Murine gamma-herpesvirus-68 (MHV-68) infection of fibroblasts and epithelial cells is highly GAG-dependent. This is a function of the viral gp150, in that gp150-deficient mutants are much less GAG-dependent than wild-type. Here we show that the major MHV-68 GAG-binding protein is not gp150 but gp70, a product of ORF4. Surprisingly, ORF4-deficient MHV-68 showed normal cell binding and was more sensitive than wild-type to inhibition by soluble heparin rather than less. Thus, the most obvious viral GAG interaction made little direct contribution to infection. Indeed, a large fraction of the virion gp70 had its GAG-binding domain removed by post-translational cleavage. ORF4 may therefore act mainly to absorb soluble GAGs and prevent them from engaging gp150 prematurely. In contrast to gp70, gp150 bound poorly to GAGs, implying that it provides little in the way of adhesion. We hypothesize that it acts instead as a GAG-sensitive switch that selectively activates MHV-68 entry at cell surfaces.	[Gillet, Laurent; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Adler, Heiko] GSF, Res Ctr Environm & Hlth, Inst Mol Immunol, Clin Cooperat Grp Hematopoiet Cell Transplantat, Munichmm, Germany	University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Stevenson, PG (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip g/F-9688-2014; Adler, Heiko/M-7355-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; Adler, Heiko/0000-0002-6481-6709; Gillet, Laurent/0000-0002-1047-2525	Fonds National Belge de la Recherche Scientifique (FNRS); Wellcome Trust [GR076956MA]; Medical Research Council [G0400427, G9800903]; CRUK; MRC [G0400427, G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Fonds National Belge de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Laurent Gillet is a Postdoctoral Researcher of the Fonds National Belge de la Recherche Scientifique (FNRS). Philip Stevenson is a Wellcome Trust Senior Clinical Fellow (GR076956MA). This work was also supported by Medical Research Council grants G0400427 and G9800903 and a CRUK project grant.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Akula SM, 2001, VIROLOGY, V284, P235, DOI 10.1006/viro.2001.0921; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Fusco D, 2005, P NATL ACAD SCI USA, V102, P9323, DOI 10.1073/pnas.0503907102; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Kapadia SB, 2002, IMMUNITY, V17, P143, DOI 10.1016/S1074-7613(02)00369-2; Kapadia SB, 1999, J VIROL, V73, P7658, DOI 10.1128/JVI.73.9.7658-7670.1999; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Lopes FB, 2004, J VIROL, V78, P13370, DOI 10.1128/JVI.78.23.13370-13375.2004; Mark L, 2006, MOL IMMUNOL, V43, P1665, DOI 10.1016/j.molimm.2005.09.016; May JS, 2005, J GEN VIROL, V86, P919, DOI 10.1099/vir.0.80661-0; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Means RE, 2004, VIROLOGY, V326, P67, DOI 10.1016/j.virol.2004.05.015; MISTRIKOVA J, 1985, ACTA VIROL, V29, P312; NASH AA, 1994, CURR OPIN IMMUNOL, V6, P560, DOI 10.1016/0952-7915(94)90141-4; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Spiller OB, 2003, J VIROL, V77, P592, DOI 10.1128/JVI.77.1.592-599.2003; Stevenson PG, 2005, VIRAL IMMUNOL, V18, P445, DOI 10.1089/vim.2005.18.445; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; TRYBALA E, 1993, J VIROL, V67, P1278, DOI 10.1128/JVI.67.3.1278-1285.1993; VANDERPLASSCHEN A, 1993, VIROLOGY, V196, P232, DOI 10.1006/viro.1993.1471; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Wang FZ, 2001, J VIROL, V75, P7517, DOI 10.1128/JVI.75.16.7517-7527.2001; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; Williams RK, 1997, J VIROL, V71, P1375, DOI 10.1128/JVI.71.2.1375-1380.1997	39	48	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e347	10.1371/journal.pone.0000347	http://dx.doi.org/10.1371/journal.pone.0000347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406671	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445300009
J	King, EMJ; van der Sar, SJA; Hardwick, KG				King, Emma M. J.; van der Sar, Sjaak J. A.; Hardwick, Kevin G.			Mad3 KEN Boxes Mediate both Cdc20 and Mad3 Turnover, and Are Critical for the Spindle Checkpoint	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; MITOTIC CHECKPOINT; PROTEIN BUBR1; ASSEMBLY CHECKPOINT; CRYSTAL-STRUCTURE; UBIQUITIN LIGASE; KINETOCHORES; INHIBITION; ACTIVATION; RECOGNITION	Mitotic progression is controlled by proteolytic destruction of securin and cyclin. The mitotic E3 ubiquitin ligase, known as the anaphase promoting complex or cyclosome (APC/C), in partnership with its activators Cdc20p and Cdh1p, targets these proteins for degradation. In the presence of defective kinetochore-microtubule interactions, APC/C-Cdc20 is inhibited by the spindle checkpoint, thereby delaying anaphase onset and providing more time for spindle assembly. Cdc20p interacts directly with Mad2p, and its levels are subject to careful regulation, but the precise mode(s) of APC/C-Cdc20 inhibition remain unclear. The mitotic checkpoint complex (MCC, consisting of Mad3p, Mad2p, Bub3p and Cdc20p in budding yeast) is a potent APC/C inhibitor. Here we focus on Mad3p and how it acts, in concert with Mad2p, to efficiently inhibit Cdc20p. We identify and analyse the function of two motifs in Mad3p, KEN30 and KEN296, which are conserved from yeast Mad3p to human BubR1. These KEN amino acid sequences resemble 'degron' signals that confer interaction with APC/C activators and target proteins for degradation. We show that both Mad3p KEN boxes are necessary for spindle checkpoint function. Mutation of KEN30 abolished MCC formation and stabilised Cdc20p in mitosis. In addition, mutation of Mad3-KEN30, APC/C subunits, or Cdh1p, stabilised Mad3p in G1, indicating that the N-terminal KEN box could be a Mad3p degron. To determine the significance of Mad3p turnover, we analysed the consequences of MAD3 overexpression and found that four-fold overproduction of Mad3p led to chromosome bi-orientation defects and significant chromosome loss during recovery from anti-microtubule drug induced checkpoint arrest. In conclusion, Mad3p KEN30 mediates interactions that regulate the proteolytic turnover of Cdc20p and Mad3p, and the levels of both of these proteins are critical for spindle checkpoint signaling and high fidelity chromosome segregation.	[King, Emma M. J.; van der Sar, Sjaak J. A.; Hardwick, Kevin G.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hardwick, KG (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	Kevin.Hardwick@ed.ac.uk		Hardwick, Kevin/0000-0002-6462-1047	Wellcome Trust; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	KGH and SJAvdS are funded by the Wellcome Trust, of which KGH is a Senior Research Fellow. EMJK was funded by a BBSRC Studentship.	Bolanos-Garcia VM, 2005, BIOPHYS J, V89, P2640, DOI 10.1529/biophysj.105.063511; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chung EN, 2003, NAT CELL BIOL, V5, P748, DOI 10.1038/ncb1022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Larsen NA, 2004, J MOL BIOL, V344, P885, DOI 10.1016/j.jmb.2004.09.094; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Logarinho E, 2004, J CELL SCI, V117, P1757, DOI 10.1242/jcs.01033; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Poddar A, 2005, EUKARYOT CELL, V4, P867, DOI 10.1128/EC.4.5.867-878.2005; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 2001, MOL CLONING LAB MANU; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang Q, 2004, BLOOD, V103, P1278, DOI 10.1182/blood-2003-06-2158; Wilson DK, 2005, J BIOL CHEM, V280, P13944, DOI 10.1074/jbc.M412919200; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	57	109	109	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e342	10.1371/journal.pone.0000342	http://dx.doi.org/10.1371/journal.pone.0000342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406666	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445300004
J	Nariai, N; Kolaczyk, ED; Kasif, S				Nariai, Naoki; Kolaczyk, Eric D.; Kasif, Simon			Probabilistic Protein Function Prediction from Heterogeneous Genome-Wide Data	PLOS ONE			English	Article								Dramatic improvements in high throughput sequencing technologies have led to a staggering growth in the number of predicted genes. However, a large fraction of these newly discovered genes do not have a functional assignment. Fortunately, a variety of novel high-throughput genome-wide functional screening technologies provide important clues that shed light on gene function. The integration of heterogeneous data to predict protein function has been shown to improve the accuracy of automated gene annotation systems. In this paper, we propose and evaluate a probabilistic approach for protein function prediction that integrates protein-protein interaction (PPI) data, gene expression data, protein motif information, mutant phenotype data, and protein localization data. First, functional linkage graphs are constructed from PPI data and gene expression data, in which an edge between nodes (proteins) represents evidence for functional similarity. The assumption here is that graph neighbors are more likely to share protein function, compared to proteins that are not neighbors. The functional linkage graph model is then used in concert with protein domain, mutant phenotype and protein localization data to produce a functional prediction. Our method is applied to the functional prediction of Saccharomyces cerevisiae genes, using Gene Ontology (GO) terms as the basis of our annotation. In a cross validation study we show that the integrated model increases recall by 18%, compared to using PPI data alone at the 50% precision. We also show that the integrated predictor is significantly better than each individual predictor. However, the observed improvement vs. PPI depends on both the new source of data and the functional category to be predicted. Surprisingly, in some contexts integration hurts overall prediction accuracy. Lastly, we provide a comprehensive assignment of putative GO terms to 463 proteins that currently have no assigned function.	[Nariai, Naoki; Kasif, Simon] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Kolaczyk, Eric D.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Kasif, Simon] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Nariai, N (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	nariai@bu.edu			NSF [ITR-048715]; NHGRI [R01 HG003367-01A1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003367] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NSF grant ITR-048715 and NHGRI grant R01 HG003367-01A1.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Butte A J, 2000, Pac Symp Biocomput, P418; Deng MH, 2004, J COMPUT BIOL, V11, P463, DOI 10.1089/1066527041410346; Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361; Dwight SS, 2004, BRIEF BIOINFORM, V5, P9, DOI 10.1093/bib/5.1.9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Escusa S, 2006, MOL MICROBIOL, V60, P1014, DOI 10.1111/j.1365-2958.2006.05153.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gaasterland T, 1998, Microb Comp Genomics, V3, P199; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Protchenko O, 2006, J BIOL CHEM, V281, P21445, DOI 10.1074/jbc.M512812200; RACHLIN J, 1994, INT C MACH LEARN, P242; Rempola B, 2006, BIOCHEM BIOPH RES CO, V346, P546, DOI 10.1016/j.bbrc.2006.05.140; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Wade CH, 2006, YEAST, V23, P293, DOI 10.1002/yea.1353; Wong SL, 2005, TRENDS GENET, V21, P424, DOI 10.1016/j.tig.2005.06.006; Yanai I., 2002, GENOME BIOL, V3, P0064; Zhou XH, 2002, P NATL ACAD SCI USA, V99, P12783, DOI 10.1073/pnas.192159399	35	70	73	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e337	10.1371/journal.pone.0000337	http://dx.doi.org/10.1371/journal.pone.0000337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17396164	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445200020
J	Byrnes, JE; Reynolds, PL; Stachowicz, JJ				Byrnes, Jarrett E.; Reynolds, Pamela L.; Stachowicz, John J.			Invasions and Extinctions Reshape Coastal Marine Food Webs	PLOS ONE			English	Article								The biodiversity of ecosystems worldwide is changing because of species loss due to human-caused extinctions and species gain through intentional and accidental introductions. Here we show that the combined effect of these two processes is altering the trophic structure of food webs in coastal marine systems. This is because most extinctions (similar to 70%) occur at high trophic levels (top predators and other carnivores), while most invasions are by species from lower trophic levels (70% macroplanktivores, deposit feeders, and detritivores). These opposing changes thus alter the shape of marine food webs from a trophic pyramid capped by a diverse array of predators and consumers to a shorter, squatter configuration dominated by filter feeders and scavengers. The consequences of the simultaneous loss of diversity at top trophic levels and gain at lower trophic levels is largely unknown. However, current research suggests that a better understanding of how such simultaneous changes in diversity can impact ecosystem function will be required to manage coastal ecosystems and forecast future changes.	[Byrnes, Jarrett E.; Stachowicz, John J.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Reynolds, Pamela L.] Bodega Bay Marine Lab, Bodega Bay, CA USA	University of California System; University of California Davis	Byrnes, JE (corresponding author), Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA.	jebyrnes@ucdavis.edu		Byrnes, Jarrett/0000-0002-9791-9472; Reynolds, Pamela/0000-0002-0177-3537	NSF-DGE [0114432]; National Science Foundation [OCE 03-17778]	NSF-DGE(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); National Science Foundation(National Science Foundation (NSF))	Funding and other support for this study was provided by the UC Davis IGERT on Biological Invasions (NSF-DGE No. 0114432) and the National Science Foundation Biological Oceanography program (OCE 03-17778 to JJS).	*A WEGN I POL MAR, 2006, FLOR FAUN NO WADD SE; ALPINE AE, 1992, LIMNOL OCEANOGR, V37, P946, DOI 10.4319/lo.1992.37.5.0946; Aquilino KM, 2005, OIKOS, V108, P275, DOI 10.1111/j.0030-1299.2005.13418.x; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; Cardinale BJ, 2003, ECOL LETT, V6, P857, DOI 10.1046/j.1461-0248.2003.00508.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Carlton J.T., 1995, NONINDIGENOUS AQUATI; CARPENTER SR, TROPHIC CASCADE LAKE; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Duffy JE, 2003, ECOL LETT, V6, P637; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Dyer LA, 2003, ECOL LETT, V6, P60, DOI 10.1046/j.1461-0248.2003.00398.x; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Finke DL, 2005, ECOL LETT, V8, P1299, DOI 10.1111/j.1461-0248.2005.00832.x; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; HEWITT CL, 2002, NATL INTRO MARINE PE; Levin PS, 2002, ECOLOGY, V83, P3182, DOI 10.2307/3071852; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2005, HELGOLAND MAR RES, V59, P84, DOI 10.1007/s10152-004-0209-z; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; NEHRING S, 2006, AQUATIC ALIEN SPECIE; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Steneck RS, 2004, ECOSYSTEMS, V7, P323, DOI 10.1007/s10021-004-0240-6; Thebault E, 2006, ECOL RES, V21, P17, DOI 10.1007/s11284-005-0127-9; Wasson K, 2005, BIOL INVASIONS, V7, P935, DOI 10.1007/s10530-004-2995-2; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	37	161	166	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e295	10.1371/journal.pone.0000295	http://dx.doi.org/10.1371/journal.pone.0000295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356703	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444800018
J	Paoletti, M; Saupe, SJ; Clave, C				Paoletti, Mathieu; Saupe, Sven J.; Clave, Corinne			Genesis of a Fungal Non-Self Recognition Repertoire	PLOS ONE			English	Article								Conspecific allorecognition, the ability for an organism to discriminate its own cells from those of another individual of the same species, has been developed by many organisms. Allorecognition specificities are determined by highly polymorphic genes. The processes by which this extreme polymorphism is generated remain largely unknown. Fungi are able to form heterokaryons by fusion of somatic cells, and somatic non self-recognition is controlled by heterokaryon incompatibility loci (het loci). Herein, we have analyzed the evolutionary features of the het-d and het-e fungal allorecognition genes. In these het genes, allorecognition specificity is determined by a polymorphic WD-repeat domain. We found that het-d and het-e belong to a large gene family with 10 members that all share the WD-repeat domain and show that repeats of all members of the family undergo concerted evolution. It follows that repeat units are constantly exchanged both within and between members of the gene family. As a consequence, high mutation supply in the repeat domain is ensured due to the high total copy number of repeats. We then show that in each repeat four residues located at the protein/protein interaction surface of the WD-repeat domain are under positive diversifying selection. Diversification of het-d and het-e is thus ensured by high mutation supply, followed by reshuffling of the repeats and positive selection for favourable variants. We also propose that RIP, a fungal specific hypermutation process acting specifically on repeated sequences might further enhance mutation supply. The combination of these evolutionary mechanisms constitutes an original process for generating extensive polymorphism at loci that require rapid diversification.	[Paoletti, Mathieu] CNRS, Lab Genet Mol Champignons, UMR 5095, Bordeaux, France; Univ Bordeaux 2, F-33076 Bordeaux, France; IBGC, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Paoletti, M (corresponding author), CNRS, Lab Genet Mol Champignons, UMR 5095, Bordeaux, France.	mathieu.paoletti@ibgc.u-bordeaux2.fr		saupe, sven/0000-0002-5589-721X	European commission [511983]	European commission(European CommissionEuropean Commission Joint Research Centre)	M. P. is funded by a European commission grant (Transdeath Contract 511983).	Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; BEGUERET J, 1973, THESIS U BORDEAUX 2; BERNET J, 1967, CR ACAD SCI D NAT, V265, P1330; Biella S, 2002, P ROY SOC B-BIOL SCI, V269, P2269, DOI 10.1098/rspb.2002.2148; BOUCHERIE H, 1981, BIOCHIM BIOPHYS ACTA, V653, P18, DOI 10.1016/0005-2787(81)90100-3; Bouhouche K, 2004, GENETICS, V167, P151, DOI 10.1534/genetics.167.1.151; Braun FN, 2004, J MOL EVOL, V59, P97, DOI 10.1007/s00239-004-2608-9; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Drake JW, 1998, GENETICS, V148, P1667; Espagne E, 1997, MOL GEN GENET, V256, P620, DOI 10.1007/s004380050610; Espagne E, 2002, GENETICS, V161, P71; ESPAGNE E, 2000, THESIS U BORDEAUX 2; Fedorova ND, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-177; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; GLASS NL, 2006, CURR OPIN MICROBIOL; Gout L, 2006, MOL MICROBIOL, V60, P67, DOI 10.1111/j.1365-2958.2006.05076.x; Hamann A, 2000, MOL GEN GENET, V263, P1061, DOI 10.1007/s004380050035; Kaneko I, 2006, GENETICS, V172, P1545, DOI 10.1534/genetics.105.051490; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LABARERE J, 1973, CR ACAD SCI D NAT, V276, P1301; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; Mondragon-Palomino M, 2005, MOL BIOL EVOL, V22, P2444, DOI 10.1093/molbev/msi241; Montiel MD, 2006, FUNGAL GENET BIOL, V43, P439, DOI 10.1016/j.fgb.2006.01.011; Nasrallah JB, 2005, TRENDS IMMUNOL, V26, P412, DOI 10.1016/j.it.2005.06.005; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M, 1996, ANNU REV GENET, V30, P371, DOI 10.1146/annurev.genet.30.1.371; NEI M, 2005, ANN REV GENET; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; Paoletti M, 2006, MOL ECOL, V15, P249, DOI 10.1111/j.1365-294X.2005.02728.x; Pinan-Lucarre B, 2005, EUKARYOT CELL, V4, P1765, DOI 10.1128/EC.4.11.1765-1774.2005; Pinan-Lucarre R, 2003, MOL MICROBIOL, V47, P321, DOI 10.1046/j.1365-2958.2003.03208.x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Queller DC, 2002, SCIENCE, V296, P311, DOI 10.1126/science.1070671; Richman A, 2000, MOL ECOL, V9, P1953, DOI 10.1046/j.1365-294X.2000.01125.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAUPE S, 1995, CURR GENET, V27, P466, DOI 10.1007/BF00311217; SAUPE S, 1995, GENE, V162, P135, DOI 10.1016/0378-1119(95)00272-8; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Shiu PKT, 1999, GENETICS, V151, P545; Smith ML, 2000, GENETICS, V155, P1095; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Vallender EJ, 2006, HUM MOL GENET, V15, P3034, DOI 10.1093/hmg/ddl245; Wu J, 1998, P NATL ACAD SCI USA, V95, P12398, DOI 10.1073/pnas.95.21.12398	65	62	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e283	10.1371/journal.pone.0000283	http://dx.doi.org/10.1371/journal.pone.0000283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356694	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444800006
J	Huber, R; Esser, SK; Ferrarelli, F; Massimini, M; Peterson, MJ; Tononi, G				Huber, Reto; Esser, Steve K.; Ferrarelli, Fabio; Massimini, Marcello; Peterson, Michael J.; Tononi, Giulio			TMS-Induced Cortical Potentiation during Wakefulness Locally Increases Slow Wave Activity during Sleep	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LONG-TERM POTENTIATION; REPETITIVE TMS; CORTICOSPINAL EXCITABILITY; MOTOR CORTEX; HOMEOSTASIS; ACTIVATION; RESPONSES	Background. Sleep slow wave activity (SWA) is thought to reflect sleep need, increasing in proportion to the length of prior wakefulness and decreasing during sleep. However, the process responsible for SWA regulation is not known. We showed recently that SWA increases locally after a learning task involving a circumscribed brain region, suggesting that SWA may reflect plastic changes triggered by learning. Methodology/Principal Findings. To test this hypothesis directly, we used transcranial magnetic stimulation (TMS) in conjunction with high-density EEG in humans. We show that 5-Hz TMS applied to motor cortex induces a localized potentiation of TMS-evoked cortical EEG responses. We then show that, in the sleep episode following 5-Hz TMS, SWA increases markedly (+39.1 +/- 17.4%, p<0.01, n = 10). Electrode coregistration with magnetic resonance images localized the increase in SWA to the same premotor site as the maximum TMS-induced potentiation during wakefulness. Moreover, the magnitude of potentiation during wakefulness predicts the local increase in SWA during sleep. Conclusions/Significance. These results provide direct evidence for a link between plastic changes and the local regulation of sleep need.	[Huber, Reto; Esser, Steve K.; Ferrarelli, Fabio; Massimini, Marcello; Peterson, Michael J.; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.	gtononi@wisc.edu	ferrarelli, fabio/C-2945-2011; Ferrarelli, Fabio/D-3219-2019; Peterson, Michael J./A-8834-2009; Massimini, Marcello/T-8115-2017	Ferrarelli, Fabio/0000-0003-0560-0227; Peterson, Michael J./0000-0001-9181-1009; Massimini, Marcello/0000-0003-2271-957X	Swiss Foundation [LSHM-CT-2005-518189]; NRSA [1F31NS055553-01]; National Institutes of Health [1RO1 NS 055 185-01]; McDonnell Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055185] Funding Source: NIH RePORTER	Swiss Foundation(Swiss National Science Foundation (SNSF)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Swiss Foundation for Fellowships in Biology and Medicine to R. H., from LSHM-CT-2005-518189 to R. H., from a NRSA (1F31NS055553-01) to S. K. E., from a NIH Pioneer Award to G. T., from the National Institutes of Health (1RO1 NS 055 185-01) to G. T and from a McDonnell Foundation grant to G. T.	Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely A. A., 2000, PRINCIPLES PRACTICE, P377; Borbely AA, 2001, ARCH ITAL BIOL, V139, P53; Clapp WC, 2005, NEUROREPORT, V16, P1977, DOI 10.1097/00001756-200512190-00001; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Di Lazzaro V, 2002, EXP BRAIN RES, V144, P549, DOI 10.1007/s00221-002-1106-9; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Esser SK, 2005, J NEUROPHYSIOL, V94, P622, DOI 10.1152/jn.01230.2004; Ferrarelli F, 2004, BRAIN RES BULL, V64, P103, DOI 10.1016/j.brainresbull.2004.04.020; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Huber R, 2000, NEUROREPORT, V11, P3321, DOI 10.1097/00001756-200010200-00012; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Kole MHP, 1999, BRAIN RES, V826, P309, DOI 10.1016/S0006-8993(99)01257-3; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Loo CK, 2005, J AFFECT DISORDERS, V88, P255, DOI 10.1016/j.jad.2005.08.001; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Matsunaga K, 2005, J PHYSIOL-LONDON, V562, P295, DOI 10.1113/jphysiol.2004.070755; MORECRAFT RJ, 1993, J COMP NEUROL, V337, P669, DOI 10.1002/cne.903370411; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Quartarone A, 2005, EXP BRAIN RES, V161, P114, DOI 10.1007/s00221-004-2052-5; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Siebner HR, 2000, NEUROLOGY, V54, P956, DOI 10.1212/WNL.54.4.956; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tegenthoff M, 2005, PLOS BIOL, V3, P2031, DOI 10.1371/journal.pbio.0030362; Teyler TJ, 2005, EUR J NEUROSCI, V21, P2045, DOI 10.1111/j.1460-9568.2005.04007.x; Tokuno H, 2000, CEREB CORTEX, V10, P58, DOI 10.1093/cercor/10.1.58; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Werth E, 1997, J SLEEP RES, V6, P102, DOI 10.1046/j.1365-2869.1997.d01-36.x; Ziemann U, 2004, REV NEUROSCIENCE, V15, P253	46	168	170	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e276	10.1371/journal.pone.0000276	http://dx.doi.org/10.1371/journal.pone.0000276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17342210	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444700011
J	Gutova, M; Najbauer, J; Gevorgyan, A; Metz, MZ; Weng, YH; Shih, CC; Aboody, KS				Gutova, Margarita; Najbauer, Joseph; Gevorgyan, Anna; Metz, Marianne Z.; Weng, Yehua; Shih, Chu-Chih; Aboody, Karen S.			Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer	PLOS ONE			English	Article								Background. The urokinase plasminogen activator (uPA) and its receptor (uPAR/CD87) are major regulators of extracellular matrix degradation and are involved in cell migration and invasion under physiological and pathological conditions. The uPA/uPAR system has been of great interest in cancer research because it is involved in the development of most invasive cancer phenotypes and is a strong predictor of poor patient survival. However, little is known about the role of uPA/uPAR in small cell lung cancer (SCLC), the most aggressive type of lung cancer. We therefore determined whether uPA and uPAR are involved in generation of drug resistant SCLC cell phenotype. Methods and Findings. We screened six human SCLC cell lines for surface markers for putative stem and cancer cells. We used fluorescence-activated cell sorting (FACS), fluorescence microscopy and clonogenic assays to demonstrate uPAR expression in a subpopulation of cells derived from primary and metastatic SCLC cell lines. Cytotoxic assays were used to determine the sensitivity of uPAR-positive and uPAR-negative cells to chemotherapeutic agents. The uPAR-positive cells in all SCLC lines demonstrated multi-drug resistance, high clonogenic activity and co-expression of CD44 and MDR1, putative cancer stem cell markers. Conclusions. These data suggest that uPAR-positive cells may define a functionally important population of cancer cells in SCLC, which are resistant to traditional chemotherapies, and could serve as critical targets for more effective therapeutic interventions in SCLC.	[Gutova, Margarita; Najbauer, Joseph; Gevorgyan, Anna; Metz, Marianne Z.; Weng, Yehua; Shih, Chu-Chih; Aboody, Karen S.] City Hope Natl Med Ctr, Div Hematol Hematopoiet Cell Transplantat, Duarte, CA 91010 USA; [Gutova, Margarita; Najbauer, Joseph; Gevorgyan, Anna; Metz, Marianne Z.; Weng, Yehua; Shih, Chu-Chih; Aboody, Karen S.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Aboody, Karen S.] City Hope Natl Med Ctr, Div Neurosci, Duarte, CA 91010 USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Gutova, M (corresponding author), City Hope Natl Med Ctr, Div Hematol Hematopoiet Cell Transplantat, 1500 E Duarte Rd, Duarte, CA 91010 USA.	mgutova@coh.org; kaboody@coh.org			Stop Cancer Foundation; Rosalinde and Arthur Gilbert Foundation; Marcus Foundation	Stop Cancer Foundation; Rosalinde and Arthur Gilbert Foundation; Marcus Foundation	This work was supported by Stop Cancer Foundation, The Rosalinde and Arthur Gilbert Foundation, and Marcus Foundation.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alfano D, 2005, THROMB HAEMOSTASIS, V93, P205, DOI 10.1160/TH04-09-0592; Alfano D, 2006, J BIOL CHEM, V281, P17758, DOI 10.1074/jbc.M601812200; Allgayer H, 2006, EUR J CANCER, V42, P811, DOI 10.1016/j.ejca.2006.01.018; Almasi CE, 2005, LUNG CANCER, V48, P349, DOI 10.1016/j.lungcan.2004.11.020; Aref S, 2003, Hematology, V8, P385, DOI 10.1080/10245330310001621323; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dick JE, 2003, P NATL ACAD SCI USA, V100, P3547, DOI 10.1073/pnas.0830967100; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Foekens JA, 2000, CANCER RES, V60, P636; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gelder MEV, 2004, CANCER RES, V64, P4563, DOI 10.1158/0008-5472.CAN-03-3848; Ghiso JAA, 1999, EUR J BIOCHEM, V263, P295, DOI 10.1046/j.1432-1327.1999.00507.x; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kamikura DM, 2000, MOL CELL BIOL, V20, P3482, DOI 10.1128/MCB.20.10.3482-3496.2000; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kobayashi H, 2002, INT J CANCER, V102, P379, DOI 10.1002/ijc.10710; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Lakka SS, 2001, INT J ONCOL, V18, P71; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Margheri F, 2005, GENE THER, V12, P702, DOI 10.1038/sj.gt.3302456; Miletti-Gonzalez KE, 2005, CANCER RES, V65, P6660, DOI 10.1158/0008-5472.CAN-04-3478; Montuori N, 2005, THROMB HAEMOSTASIS, V93, P192, DOI 10.1160/TH04-09-0580; MURALIKRISHNA PS, 2005, J BIOL CHEM; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pisick Evan, 2003, J Exp Ther Oncol, V3, P305, DOI 10.1111/j.1533-869X.2003.01103.x; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Rigolin GM, 2003, BRIT J HAEMATOL, V120, P953, DOI 10.1046/j.1365-2141.2003.04176.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Werle B, 2004, ANTICANCER RES, V24, P4147; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	36	114	118	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e243	10.1371/journal.pone.0000243	http://dx.doi.org/10.1371/journal.pone.0000243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327908	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444600003
J	Nielsen, JS; Graves, ML; Chelliah, S; Vogl, AW; Roskelley, CD; McNagny, KM				Nielsen, Julie S.; Graves, Marcia L.; Chelliah, Shierley; Vogl, A. Wayne; Roskelley, Calvin D.; McNagny, Kelly M.			The CD34-Related Molecule Podocalyxin Is a Potent Inducer of Microvillus Formation	PLOS ONE			English	Article								Background. Podocalyxin is a CD34-related transmembrane protein involved in hematopoietic cell homing, kidney morphogenesis, breast cancer progression, and epithelial cell polarization. Although this sialomucin has been shown to block cell adhesion, the mechanisms involved remain enigmatic. It has, however, been postulated that the adaptor proteins NHERF-1 and 2 could regulate apical targeting of Podocalyxin by linking it to the actin cytoskeleton. Principal Findings. Here, in contrast, we find that full-length Podocalyxin acts to recruit NHERF-1 to the apical domain. Moreover, we show that ectopic expression of Podocalyxin in epithelial cells leads to microvillus formation along an expanded apical domain that extends laterally to the junctional complexes. Removal of the C-terminal PDZ-binding domain of Podocalyxin abolishes NHERF-1 recruitment but, surprisingly, has no effect on the formation of microvilli. Instead, we find that the extracellular domain and transmembrane region of Podocalyxin are sufficient to direct recruitment of filamentous actin and ezrin to the plasma membrane and induce microvillus formation. Conclusions/Significance. Our data suggest that this single molecule can modulate NHERF localization and, independently, act as a key orchestrator of apical cell morphology, thereby lending mechanistic insights into its multiple roles as a polarity regulator, tumor progression marker, and anti-adhesin.	[Nielsen, Julie S.; Chelliah, Shierley; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Graves, Marcia L.; Vogl, A. Wayne; Roskelley, Calvin D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	McNagny, KM (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	Kelly@brc.ubc.ca	Roskelley, Calvin D/F-4630-2011; McNagny, Kelly/P-5239-2014	McNagny, Kelly/0000-0003-4737-3499	NSERC Canada Graduate Scholarship; UBC Graduate Fellowship; MSFHR; CIHR [MT-15477]; CBCRA [15322]	NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); UBC Graduate Fellowship; MSFHR(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); CBCRA	JSN is a recipient of an NSERC Canada Graduate Scholarship; MLG is a recipient of a UBC Graduate Fellowship; KMM is an MSFHR scholar. This work was funded by CIHR grant #MT-15477 and CBCRA grant #15322.	Alexander WS, 2006, P NATL ACAD SCI USA, V103, P16442, DOI 10.1073/pnas.0607872103; ANDREWS PM, 1979, KIDNEY INT, V15, P376, DOI 10.1038/ki.1979.49; Berndt C, 2004, CELL BIOL INT, V28, P829, DOI 10.1016/j.cellbi.2004.08.003; Cleton-Jansen AM, 2002, BREAST CANCER RES, V4, P5, DOI 10.1186/bcr416; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; D'Alterio C, 2005, J CELL BIOL, V171, P549, DOI 10.1083/jcb.200507072; DEKAN G, 1990, AM J PATHOL, V137, P913; DEKAN G, 1991, P NATL ACAD SCI USA, V88, P5398, DOI 10.1073/pnas.88.12.5398; Doyonnas R, 2005, BLOOD, V105, P4170, DOI 10.1182/blood-2004-10-4077; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; FRIEDERICH E, 1989, CELL, V59, P461, DOI 10.1016/0092-8674(89)90030-5; Gelberg H, 1996, LAB INVEST, V74, P907; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kershaw DB, 1997, J BIOL CHEM, V272, P15708, DOI 10.1074/jbc.272.25.15708; Li Y, 2002, AM J PHYSIOL-RENAL, V282, pF1129, DOI 10.1152/ajprenal.00131.2001; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; MCNAGNY KM, 1992, LEUKEMIA, V6, P975; McNagny KM, 1997, J CELL BIOL, V138, P1395, DOI 10.1083/jcb.138.6.1395; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Miettinen A, 1999, AM J PATHOL, V154, P813, DOI 10.1016/S0002-9440(10)65328-X; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; SAWADA H, 1986, AM J PATHOL, V125, P309; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; SCHNABEL E, 1989, EUR J CELL BIOL, V48, P313; Scholl FG, 1999, J CELL SCI, V112, P4601; SEILER MW, 1977, LAB INVEST, V36, P48; SEILER MW, 1975, SCIENCE, V189, P390, DOI 10.1126/science.1145209; Serrador JM, 2002, J BIOL CHEM, V277, P10400, DOI 10.1074/jbc.M110694200; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Tan PC, 2006, STEM CELLS, V24, P1150, DOI 10.1634/stemcells.2005-0426; Vitureira N, 2005, GENE EXPR PATTERNS, V5, P349, DOI 10.1016/j.modgep.2004.10.002; Weinman EJ, 2001, J CLIN INVEST, V108, P185, DOI 10.1172/JCI13518; WEINMAN EJ, 2005, ANN REV PHYSL; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856	44	62	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e237	10.1371/journal.pone.0000237	http://dx.doi.org/10.1371/journal.pone.0000237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311105	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444500018
J	Ugurel, S; Thirumaran, RK; Bloethner, S; Gast, A; Sucker, A; Mueller-Berghaus, J; Rittgen, W; Hemminki, K; Becker, JC; Kumar, R; Schadendorf, D				Ugurel, Selma; Thirumaran, Ranjit K.; Bloethner, Sandra; Gast, Andreas; Sucker, Antje; Mueller-Berghaus, Jan; Rittgen, Werner; Hemminki, Kari; Becker, Juergen C.; Kumar, Rajiv; Schadendorf, Dirk			B-RAF and N-RAS Mutations Are Preserved during Short Time In Vitro Propagation and Differentially Impact Prognosis	PLOS ONE			English	Article							MALIGNANT-MELANOMA; BRAF MUTATIONS; CANCER; ASSOCIATION; GENE	In melanoma, the RAS/RAF/MEK/ERK signalling pathway is an area of great interest, because it regulates tumor cell proliferation and survival. A varying mutation rate has been reported for B-RAF and N-RAS, which has been largely attributed to the differential source of tumor DNA analyzed, e. g., fixed tumor tissues or in vitro propagated melanoma cells. Notably, this variation also interfered with interpreting the impact of these mutations on the clinical course of the disease. Consequently, we investigated the mutational profile of B-RAF and N-RAS in biopsies and corresponding cell lines from metastatic tumor lesions of 109 melanoma patients (AJCC stage III/IV), and its respective impact on survival. 97 tissue biopsies and 105 biopsy-derived cell lines were screened for B-RAF and N-RAS mutations by PCR single strand conformation polymorphism and DNA sequencing. Mutations were correlated with patient survival data obtained within a median follow-up time of 31 months. B-RAF mutations were detected in 55% tissues and 51% cell lines, N-RAS mutations in 23% tissues and 25% cell lines, respectively. There was strong concordance between the mutational status of tissues and corresponding cell lines, showing a differing status for B-RAF in only 5% and N-RAS in only 6%, respectively. Patients with tumors carrying mutated B-RAF showed an impaired median survival (8.0 versus 11.8 months, p = 0.055, tissues; 7.1 versus 9.3 months, p = 0.068, cell lines), whereas patients with N-RAS-mutated tumors presented with a favorable prognosis (median survival 12.5 versus 7.9 months, p = 0.084, tissues; 15.4 versus 6.8 months, p = 0.0008, cell lines), each in comparison with wildtype gene status. Multivariate analysis qualified N-RAS (p = 0.006) but not B-RAF mutation status as an independent prognostic factor of overall survival. Our findings demonstrate that B-RAF and N-RAS mutations are well preserved during short term in vitro propagation and, most importantly, differentially impact the outcome of melanoma patients.	[Ugurel, Selma; Sucker, Antje; Mueller-Berghaus, Jan; Schadendorf, Dirk] Univ Med Ctr Mannheim, Skin Canc Unit, German Canc Res Ctr Heidelberg, Mannheim, Germany; [Ugurel, Selma; Sucker, Antje; Mueller-Berghaus, Jan; Schadendorf, Dirk] Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany; [Thirumaran, Ranjit K.; Bloethner, Sandra; Gast, Andreas; Hemminki, Kari; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Rittgen, Werner] German Canc Res Ctr, Cent Unit Biostat, D-6900 Heidelberg, Germany; [Hemminki, Kari; Kumar, Rajiv] Karolinska Inst, Dept Biosci, Huddinge, Sweden; [Becker, Juergen C.] Univ Wurzburg, Dept Dermatol, D-97070 Wurzburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet; University of Wurzburg	Ugurel, S (corresponding author), Univ Med Ctr Mannheim, Skin Canc Unit, German Canc Res Ctr Heidelberg, Mannheim, Germany.	s.ugurel@dkfz.de	Schadendorf, Dirk/AAE-8206-2019; Kumar, Rajiv/H-6431-2019; Thirumaran, Ranjit/F-6809-2012	Kumar, Rajiv/0000-0002-6093-0395; 				Akslen LA, 2005, J INVEST DERMATOL, V125, P312, DOI 10.1111/j.0022-202X.2005.23788.x; Andersen MH, 2004, CANCER RES, V64, P5456, DOI 10.1158/0008-5472.CAN-04-0937; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Becker JC, 2006, CANCER-AM CANCER SOC, V107, P2317, DOI 10.1002/cncr.22273; Beeram M, 2005, J CLIN ONCOL, V23, P6771, DOI 10.1200/JCO.2005.08.036; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Brose MS, 2002, CANCER RES, V62, P6997; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deichmann M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-58; Demunter A, 2001, CANCER RES, V61, P4916; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; Kumar R, 2003, ONCOGENE, V22, P9217, DOI 10.1038/sj.onc.1206909; Kumar R, 2003, CLIN CANCER RES, V9, P3362; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Omholt K, 2002, CLIN CANCER RES, V8, P3468; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Satyamoorthy K, 2003, CANCER RES, V63, P756; Smalley KSM, 2003, INT J CANCER, V105, P165, DOI 10.1002/ijc.11064; Smeds J, 2002, CARCINOGENESIS, V23, P645, DOI 10.1093/carcin/23.4.645; van Rhijn BWG, 2001, CANCER RES, V61, P1265	23	106	106	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e236	10.1371/journal.pone.0000236	http://dx.doi.org/10.1371/journal.pone.0000236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311103	Green Published, gold			2022-12-27	WOS:000207444500017
J	Tenaillon, O; Silander, OK; Uzan, JP; Chao, L				Tenaillon, Olivier; Silander, Olin K.; Uzan, Jean-Philippe; Chao, Lin			Quantifying Organismal Complexity using a Population Genetic Approach	PLOS ONE			English	Article							EVOLUTION; FITNESS; ADAPTATION; EPISTASIS; SIZE; REPLICATION; MUTATIONS; MELTDOWN; CHANCE; TESTS	Background. Various definitions of biological complexity have been proposed: the number of genes, cell types, or metabolic processes within an organism. As knowledge of biological systems has increased, it has become apparent that these metrics are often incongruent. Methodology. Here we propose an alternative complexity metric based on the number of genetically uncorrelated phenotypic traits contributing to an organism's fitness. This metric, phenotypic complexity, is more objective than previous suggestions, as complexity is measured from a fundamental biological perspective, that of natural selection. We utilize a model linking the equilibrium fitness (drift load) of a population to phenotypic complexity. We then use results from viral evolution experiments to compare the phenotypic complexities of two viruses, the bacteriophage X174 and vesicular stomatitis virus, and to illustrate the consistency of our approach and its applicability. Conclusions/Significance. Because Darwinian evolution through natural selection is the fundamental element unifying all biological organisms, we propose that our metric of complexity is potentially a more relevant metric than others, based on the count of artificially defined set of objects.	[Tenaillon, Olivier] Univ Denis Diderot Paris VII, Fac Med Xavier Bichat, INSERM, U722, Paris, France; [Tenaillon, Olivier; Silander, Olin K.; Chao, Lin] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Silander, Olin K.] ETH, ETH Zentrum NW, Zurich, Switzerland; [Uzan, Jean-Philippe] Univ Paris 06, CNRS, Inst Astrophys Paris, UMR 7095, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Tenaillon, O (corresponding author), Univ Denis Diderot Paris VII, Fac Med Xavier Bichat, INSERM, U722, Paris, France.	Olivier.Tenaillon@bichat.inserm.fr	Tenaillon, Olivier/L-9857-2017	Silander, Olin/0000-0003-4105-8316; Tenaillon, Olivier/0000-0002-3796-1601	Agence Nationale de la Recherche [ANR-05-JCJC0136-01]; NIH	Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	OT was funded by the Agence Nationale de la Recherche (ANR-05-JCJC0136-01). OS was partially funded by an NIH training grant. LC was funded by an NIH grant.	Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Bose S, 2003, J GEN VIROL, V84, P1687, DOI 10.1099/vir.0.19074-0; Bull JJ, 1997, GENETICS, V147, P1497; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; Burch CL, 1999, GENETICS, V151, P921; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Estes S, 2004, GENETICS, V166, P1269, DOI 10.1534/genetics.166.3.1269; Fisher RA, 1930, GENETICAL THEORY NAT; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Hartl DL, 1998, GENETICA, V102-3, P525, DOI 10.1023/A:1017071901530; Martin G, 2006, EVOLUTION, V60, P893; McShea DW, 1996, EVOLUTION, V50, P477, DOI 10.1111/j.1558-5646.1996.tb03861.x; NOVELLA IS, 1995, J VIROL, V69, P2869, DOI 10.1128/JVI.69.5.2869-2872.1995; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Pearson H, 2006, NATURE, V441, P398, DOI 10.1038/441398a; Poon A, 2000, EVOLUTION, V54, P1467, DOI 10.1111/j.0014-3820.2000.tb00693.x; Reynolds MG, 2000, GENETICS, V156, P1471; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Sella G, 2005, P NATL ACAD SCI USA, V102, P9541, DOI 10.1073/pnas.0501865102; SHLOMAI J, 1981, J BIOL CHEM, V256, P5233; SILANDER OK, 2007, PLOS BIOL IN PRESS; Szathmary E, 2001, SCIENCE, V292, P1315, DOI 10.1126/science.1060852; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; WAGNER GP, 1990, EVOLUTION, V44, P715, DOI 10.1111/j.1558-5646.1990.tb05950.x; Welch JJ, 2003, EVOLUTION, V57, P1723, DOI 10.1554/02-673; Whitlock MC, 2003, ANN ZOOL FENN, V40, P169; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103	33	49	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e217	10.1371/journal.pone.0000217	http://dx.doi.org/10.1371/journal.pone.0000217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299597	Green Published, gold			2022-12-27	WOS:000207444400018
J	Meary, D; Kitromilides, E; Mazens, K; Graff, C; Gentaz, E				Meary, David; Kitromilides, Elenitsa; Mazens, Karine; Graff, Christian; Gentaz, Edouard			Four-Day-Old Human Neonates Look Longer at Non-Biological Motions of a Single Point-of-Light	PLOS ONE			English	Article							INFANT SENSITIVITY; BIOLOGICAL MOTION; PERCEPTION; VELOCITY; REPRESENTATION; SPEED; MODEL	Background. Biological motions, that is, the movements of humans and other vertebrates, are characterized by dynamic regularities that reflect the structure and the control schemes of the musculo-skeletal system. Early studies on the development of the visual perception of biological motion showed that infants after three months of age distinguished between biological and non-biological locomotion. Methodology/Principal Findings. Using single point-light motions that varied with respect to the "two-third-power law" of motion generation and perception, we observed that four-day-old human neonates looked longer at non-biological motions than at biological motions when these were simultaneously presented in a standard preferential looking paradigm. Conclusion/Significance. This result can be interpreted within the "violation of expectation" framework and can indicate that neonates' motion perception-like adults'-is attuned to biological kinematics.	[Meary, David; Kitromilides, Elenitsa; Mazens, Karine; Graff, Christian; Gentaz, Edouard] Univ Pierre Mendes France, CNRS, UMR 5105, Psychol & NeuroCognit Lab, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Gentaz, E (corresponding author), Univ Pierre Mendes France, CNRS, UMR 5105, Psychol & NeuroCognit Lab, Grenoble, France.	edouard.gentaz@upmf-grenoble.fr			Fyssen Foundation; Region Rhone-Alpes; CNRS	Fyssen Foundation; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); CNRS(Centre National de la Recherche Scientifique (CNRS))	The research was supported by Fyssen Foundation, Region Rhone-Alpes and CNRS grants.	BERTENTHAL BI, 1987, J EXP PSYCHOL HUMAN, V13, P577, DOI 10.1037/0096-1523.13.4.577; BERTENTHAL BI, 1984, J EXP CHILD PSYCHOL, V37, P213, DOI 10.1016/0022-0965(84)90001-8; Cashon CH, 2000, INFANCY, V1, P429, DOI 10.1207/S15327078IN0104_4; Dannemiller JL, 2000, J EXP CHILD PSYCHOL, V76, P253, DOI 10.1006/jecp.1999.2551; deSperati C, 1997, J NEUROSCI, V17, P3932; Fadiga L, 2000, INT J PSYCHOPHYSIOL, V35, P165, DOI 10.1016/S0167-8760(99)00051-3; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; HAITH MM, 1966, J EXP CHILD PSYCHOL, V3, P235, DOI 10.1016/0022-0965(66)90067-1; Hespos SJ, 2001, COGNITION, V78, P207, DOI 10.1016/S0010-0277(00)00118-9; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; JOHANSSON G, 1976, PSYCHOL RES-PSYCH FO, V38, P379, DOI 10.1007/BF00309043; Kim IK, 1999, DEVELOPMENTAL SCI, V2, P339, DOI 10.1111/1467-7687.00080; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Perrone JA, 2002, VISION RES, V42, P1035, DOI 10.1016/S0042-6989(02)00029-9; Pollick FE, 1997, VISION RES, V37, P347, DOI 10.1016/S0042-6989(96)00116-2; Priebe NJ, 2003, J NEUROSCI, V23, P5650; Reisbeck TE, 1999, VISION RES, V39, P3267, DOI 10.1016/S0042-6989(99)00017-6; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037/0033-295X.99.4.605; Streri A, 2003, SOMATOSENS MOT RES, V20, P13, DOI 10.1080/0899022031000083799; VIVIANI P, 1989, PERCEPT PSYCHOPHYS, V46, P266, DOI 10.3758/BF03208089; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; Viviani P, 2002, ATTENTION PERFORM, V19, P406; VIVIANI P, 1991, J EXP PSYCHOL HUMAN, V17, P198, DOI 10.1037/0096-1523.17.1.198; VIVIANI P, 1992, TUTORIALS MOTOR BEHA, V2, P229; Wang SH, 2004, COGNITION, V93, P167, DOI 10.1016/j.cognition.2003.09.012; Wickelgren EA, 2001, J EXP PSYCHOL HUMAN, V27, P942, DOI 10.1037//-1523.27.4.942	29	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e186	10.1371/journal.pone.0000186	http://dx.doi.org/10.1371/journal.pone.0000186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17264887	Green Published, gold			2022-12-27	WOS:000207444200010
J	Ryan, JF; Mazza, ME; Pang, K; Matus, DQ; Baxevanis, AD; Martindale, MQ; Finnerty, JR				Ryan, Joseph F.; Mazza, Maureen E.; Pang, Kevin; Matus, David Q.; Baxevanis, Andreas D.; Martindale, Mark Q.; Finnerty, John R.			Pre-Bilaterian Origins of the Hox Cluster and the Hox Code: Evidence from the Sea Anemone, Nematostella vectensis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BAYESIAN PHYLOGENETIC INFERENCE; HOMEOBOX GENES; EXPRESSION PATTERNS; PARAHOX GENES; EVOLUTIONARY IMPLICATIONS; SCHISTOCERCA-GREGARIA; ANTENNAPEDIA COMPLEX; ACROPORA-MILLEPORA; MOLECULAR EVIDENCE	Background. Hox genes were critical to many morphological innovations of bilaterian animals. However, early Hox evolution remains obscure. Phylogenetic, developmental, and genomic analyses on the cnidarian sea anemone Nematostella vectensis challenge recent claims that the Hox code is a bilaterian invention and that no "true'' Hox genes exist in the phylum Cnidaria. Methodology/Principal Findings. Phylogenetic analyses of 18 Hox-related genes from Nematostella identify putative Hox1, Hox2, and Hox9+ genes. Statistical comparisons among competing hypotheses bolster these findings, including an explicit consideration of the gene losses implied by alternate topologies. In situ hybridization studies of 20 Hox-related genes reveal that multiple Hox genes are expressed in distinct regions along the primary body axis, supporting the existence of a pre-bilaterian Hox code. Additionally, several Hox genes are expressed in nested domains along the secondary body axis, suggesting a role in "dorsoventral'' patterning. Conclusions/Significance. A cluster of anterior and posterior Hox genes, as well as ParaHox cluster of genes evolved prior to the cnidarian-bilaterian split. There is evidence to suggest that these clusters were formed from a series of tandem gene duplication events and played a role in patterning both the primary and secondary body axes in a bilaterally symmetrical common ancestor. Cnidarians and bilaterians shared a common ancestor some 570 to 700 million years ago, and as such, are derived from a common body plan. Our work reveals several conserved genetic components that are found in both of these diverse lineages. This finding is consistent with the hypothesis that a set of developmental rules established in the common ancestor of cnidarians and bilaterians is still at work today.	[Ryan, Joseph F.; Finnerty, John R.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Mazza, Maureen E.; Finnerty, John R.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Pang, Kevin; Matus, David Q.; Martindale, Mark Q.] Univ Hawaii, Pacific Biosci Res Ctr, Kewalo Marine Lab, Honolulu, HI 96822 USA; [Ryan, Joseph F.; Baxevanis, Andreas D.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	Boston University; Boston University; University of Hawaii System; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Finnerty, JR (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	jrf3@bu.edu	Matus, David/E-9972-2010	Matus, David/0000-0002-1570-5025; Baxevanis, Andy/0000-0002-5370-0014; Ryan, Joseph/0000-0001-5478-0522	National Science Foundation [DEB51 9727244, IBN-0212773]; National Atmospheric and Space Administration [NAG2-1374, NAG2-1519]; National Human Genome Research Institute; National Institutes of Health; Boston University Women's Guild; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG021374] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Atmospheric and Space Administration; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Women's Guild; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Science Foundation and the National Atmospheric and Space Administration (NSF grant number DEB51 9727244 to M. Q. M. and J.R.F.; NSF grant number IBN-0212773 to J.R.F.; NASA grant number NAG2-1374 and NAG2-1519s to M. Q. M.) and by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. M. E. M. received financial support from the Boston University Women's Guild.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AERNE BL, 1995, DEV BIOL, V169, P547, DOI 10.1006/dbio.1995.1168; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Arenas-Mena C, 2000, DEVELOPMENT, V127, P4631; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; BONCINELLI E, 1993, ANN GENET-PARIS, V36, P30; Bonneton F, 2003, M S-MED SCI, V19, P1265, DOI 10.1051/medsci/200319121265; Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; Brown SJ, 2002, GENETICS, V160, P1067; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Burglin TR, 2005, ENCY MOL CELL BIOL M; BURKE AC, 1995, DEVELOPMENT, V121, P333; Cameron RA, 2006, J EXP ZOOL PART B, V306B, P45, DOI 10.1002/jez.b.21070; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Damen WGM, 1998, DEV GENES EVOL, V208, P586, DOI 10.1007/s004270050218; Dayhoff M, 1978, ATLAS PROTEIN SEQ ST, P345; Dearden P, 2000, EVOL DEV, V2, P261, DOI 10.1046/j.1525-142x.2000.00065.x; Devenport MP, 2000, EVOL DEV, V2, P326, DOI 10.1046/j.1525-142x.2000.00074.x; DUBOULE D, 1992, BIOESSAYS, V14, P375, DOI 10.1002/bies.950140606; Edvardsen RB, 2005, CURR BIOL, V15, pR12, DOI 10.1016/j.cub.2004.12.010; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferrier DEK, 1996, P NATL ACAD SCI USA, V93, P13024, DOI 10.1073/pnas.93.23.13024; Ferrier DEK, 2002, MOL PHYLOGENET EVOL, V24, P412, DOI 10.1016/S1055-7903(02)00204-X; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Finnerty JR, 1998, CURR TOP DEV BIOL, V40, P211, DOI 10.1016/S0070-2153(08)60368-3; Finnerty JR, 1997, BIOL BULL-US, V193, P62, DOI 10.2307/1542736; Finnerty JR, 1999, EVOL DEV, V1, P16, DOI 10.1046/j.1525-142x.1999.99010.x; Finnerty JR, 2003, EVOL DEV, V5, P331, DOI 10.1046/j.1525-142X.2003.03041.x; Finnerty JR, 2001, AM ZOOL, V41, P608, DOI 10.1668/0003-1569(2001)041[0608:CRISIT]2.0.CO;2; Frobius AC, 2006, DEV GENES EVOL, V216, P81, DOI 10.1007/s00427-005-0049-0; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Galliot B, 2000, CURR OPIN GENET DEV, V10, P629, DOI 10.1016/S0959-437X(00)00141-6; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gauchat D, 2000, P NATL ACAD SCI USA, V97, P4493, DOI 10.1073/pnas.97.9.4493; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; GRAHAM A, 1991, DEVELOPMENT, V112, P255; Grienenberger A, 2003, DEVELOPMENT, V130, P5445, DOI 10.1242/dev.00760; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499; Hayward DC, 2001, DEV GENES EVOL, V211, P10; Hughes CL, 2004, EVOL DEV, V6, P393, DOI 10.1111/j.1525-142X.2004.04048.x; Hughes CL, 2002, DEVELOPMENT, V129, P1225; HUNT P, 1991, DEVELOPMENT, P63; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; *JOINT GEN I, NEM VECT GEN PORT V1; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KAMM K, 2006, J EXP ZOOLOG B; Kamm K, 2006, CURR BIOL, V16, P920, DOI 10.1016/j.cub.2006.03.036; Kappen C, 1996, COMPUT CHEM, V20, P49, DOI 10.1016/S0097-8485(96)80007-6; Kawazoe Y, 2002, DEV GROWTH DIFFER, V44, P77; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kmita-Cunisse M, 1998, P NATL ACAD SCI USA, V95, P3030, DOI 10.1073/pnas.95.6.3030; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kourakis MJ, 1997, DEV BIOL, V190, P284, DOI 10.1006/dbio.1997.8689; Kourakis MJ, 2000, J EXP ZOOL, V288, P175, DOI 10.1002/1097-010X(20000815)288:2<175::AID-JEZ8>3.0.CO;2-N; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Kuhn K, 1999, J EXP ZOOL, V285, P63, DOI 10.1002/(SICI)1097-010X(19990415)285:1<63::AID-JEZ8>3.0.CO;2-X; Kuhn K, 1996, MOL PHYLOGENET EVOL, V6, P30, DOI 10.1006/mpev.1996.0055; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lee PN, 2003, NATURE, V424, P1061, DOI 10.1038/nature01872; Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664; MADDISON DR, 2000, MCCLADE 4 ANAL PHYLO; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Martinez DE, 1998, NATURE, V393, P748, DOI 10.1038/31616; Masuda-Nakagawa LM, 2000, DEV GENES EVOL, V210, P151, DOI 10.1007/s004270050022; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Matus DQ, 2006, CURR BIOL, V16, P499, DOI 10.1016/j.cub.2006.01.052; MAZZA ME, NEMATOSTELLA UNPUB; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Minguillon C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r12; Minguillon C, 2005, INT J BIOL SCI, V1, P19; Monteiro AS, 2006, INT J BIOL SCI, V2, P95; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; NAITO M, 1993, FEBS LETT, V333, P271, DOI 10.1016/0014-5793(93)80668-K; Negre B, 2005, GENOME RES, V15, P692, DOI 10.1101/gr.3468605; Negre B, 2003, MOL BIOL EVOL, V20, P2042, DOI 10.1093/molbev/msg238; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Pierce RJ, 2005, MOL BIOL EVOL, V22, P2491, DOI 10.1093/molbev/msi239; Popovici C, 2001, FEBS LETT, V491, P237, DOI 10.1016/S0014-5793(01)02187-1; Powers TP, 2000, EVOL DEV, V2, P311, DOI 10.1046/j.1525-142x.2000.00072.x; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; RANDAZZO FM, 1993, GENETICS, V134, P319; RENTZSCH F, 2006, DEV BIOL; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruvinsky I, 2000, DEVELOPMENT, V127, P5233; RYAN JF, 2006, GENOME BIOL IN PRESS; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakiyama J, 2001, MECH DEVELOP, V101, P233, DOI 10.1016/S0925-4773(00)00564-5; SCHIERWATER B, 1991, J EXP ZOOL, V260, P413, DOI 10.1002/jez.1402600316; SCHUBERT FR, 1993, P NATL ACAD SCI USA, V90, P143, DOI 10.1073/pnas.90.1.143; SCHUMMER M, 1992, EMBO J, V11, P1815, DOI 10.1002/j.1460-2075.1992.tb05233.x; Sekimoto T, 1998, GENES CELLS, V3, P51, DOI 10.1046/j.1365-2443.1998.00167.x; SHENK MA, 1993, DEV BIOL, V160, P108, DOI 10.1006/dbio.1993.1290; SHENK MA, 1993, DEVELOPMENT, V117, P657; Sinsheimer JS, 1996, BIOMETRICS, V52, P193, DOI 10.2307/2533156; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; Stauber M, 2002, P NATL ACAD SCI USA, V99, P274, DOI 10.1073/pnas.012292899; *STELLABASE, NEM VECT GEN DAT; Stephenson T.A, 1928, BRIT SEA ANEMONES; Stephenson TA, 1935, BRIT SEA ANEMONES, VII; STRUHL G, 1984, NATURE, V308, P454, DOI 10.1038/308454a0; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Taylor HS, 1997, BIOL REPROD, V57, P1338, DOI 10.1095/biolreprod57.6.1338; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; TIONG SYK, 1987, DEVELOPMENT, V101, P135; Valentine JW, 2003, INT J DEV BIOL, V47, P517; Van Auken K, 2000, P NATL ACAD SCI USA, V97, P4499, DOI 10.1073/pnas.97.9.4499; van den Akker E, 2002, DEVELOPMENT, V129, P2181; VonAllmen G, 1996, NATURE, V380, P116, DOI 10.1038/380116a0; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Zhang JZ, 1996, GENETICS, V142, P295	129	178	180	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e153	10.1371/journal.pone.0000153	http://dx.doi.org/10.1371/journal.pone.0000153			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17252055	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444100001
J	Wu, JF; Xue, LX; Weng, M; Sun, Y; Zhang, ZY; Wang, WG; Tong, TJ				Wu, Junfeng; Xue, Lixiang; Weng, Mo; Sun, Ying; Zhang, Zongyu; Wang, Wengong; Tong, Tanjun			Sp1 Is Essential for p16(INK4a) Expression in Human Diploid Fibroblasts during Senescence	PLOS ONE			English	Article							REPLICATIVE SENESCENCE; TRANSCRIPTION FACTOR; O-GLYCOSYLATION; GROWTH-FACTOR; CELLULAR SENESCENCE; PROTEIN; ACTIVATION; P16; PHOSPHORYLATION; BINDING	Background. p16(INK4a) tumor suppressor protein has been widely proposed to mediate entrance of the cells into the senescent stage. Promoter of p16(INK4a) gene contains at least five putative GC boxes, named GC-I to V, respectively. Our previous data showed that a potential Sp1 binding site, within the promoter region from 2466 to 2451, acts as a positive transcription regulatory element. These results led us to examine how Sp1 and/or Sp3 act on these GC boxes during aging in cultured human diploid fibroblasts. Methodology/Principal Findings. Mutagenesis studies revealed that GC-I, II and IV, especially GC-II, are essential for p16(INK4a) gene expression in senescent cells. Electrophoretic mobility shift assays (EMSA) and ChIP assays demonstrated that both Sp1 and Sp3 bind to these elements and the binding activity is enhanced in senescent cells. Ectopic overexpression of Sp1, but not Sp3, induced the transcription of p16(INK4a). Both Sp1 RNAi and Mithramycin, a DNA intercalating agent that interferes with Sp1 and Sp3 binding activities, reduced p16(INK4a) gene expression. In addition, the enhanced binding of Sp1 to p16(INK4a) promoter during cellular senescence appeared to be the result of increased Sp1 binding affinity, not an alteration in Sp1 protein level. Conclusions/Significance. All these results suggest that GC-II is the key site for Sp1 binding and increase of Sp1 binding activity rather than protein levels contributes to the induction of p16(INK4a) expression during cell aging.	[Wu, Junfeng; Xue, Lixiang; Weng, Mo; Sun, Ying; Zhang, Zongyu; Wang, Wengong; Tong, Tanjun] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Peking Univ Res Ctr Aging, Beijing 100871, Peoples R China	Peking University	Wang, WG (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Peking Univ Res Ctr Aging, Beijing 100871, Peoples R China.	wwg@bjmu.edu.cn; ttj@bjmu.edu.cn			National Basic Research Programs of China [2007CB507400]; National Natural Science Foundation of China [30500082, 30671064]	National Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Basic Research Programs of China (No. 2007CB507400) and the National Natural Science Foundation of China (No. 30500082 and No. 30671064)	Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Ding H, 1999, J BIOL CHEM, V274, P19573, DOI 10.1074/jbc.274.28.19573; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Duan JM, 2001, J BIOL CHEM, V276, P48325, DOI 10.1074/jbc.M104814200; Fang L, 1999, ONCOGENE, V18, P2789, DOI 10.1038/sj.onc.1202615; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Guo SZ, 2004, EXP CELL RES, V298, P465, DOI 10.1016/j.yexcr.2004.04.044; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jarrard DF, 1999, CANCER RES, V59, P2957; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; LI JH, 1995, MECH AGEING DEV, V80, P25, DOI 10.1016/0047-6374(94)01557-3; Ma H, 2004, EXP GERONTOL, V39, P415, DOI 10.1016/j.exger.2003.11.012; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Pagliuca A, 2000, J CELL BIOCHEM, V76, P360, DOI 10.1002/(SICI)1097-4644(20000301)76:3<360::AID-JCB3>3.0.CO;2-1; Parkinson EK, 2000, BIOCHEM SOC T, V28, P226, DOI 10.1042/bst0280226; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Rafty LA, 2001, NUCLEIC ACIDS RES, V29, P1027, DOI 10.1093/nar/29.5.1027; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sandhu C, 2000, CANCER RES, V60, P2616; TANG ZQ, 1994, MECH AGEING DEV, V73, P57, DOI 10.1016/0047-6374(94)90038-8; Wagner M, 2001, FEBS LETT, V499, P101, DOI 10.1016/S0014-5793(01)02524-8; Wang W, 2001, J BIOL CHEM, V276, P48655, DOI 10.1074/jbc.M108278200; Xue LX, 2004, FEBS LETT, V564, P199, DOI 10.1016/S0014-5793(04)00352-7; Zheng WJ, 2004, J BIOL CHEM, V279, P31524, DOI 10.1074/jbc.M400365200	39	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e164	10.1371/journal.pone.0000164	http://dx.doi.org/10.1371/journal.pone.0000164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225865	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444000014
J	Nelson, XJ; Jackson, RR				Nelson, Ximena J.; Jackson, Robert R.			A Predator from East Africa that Chooses Malaria Vectors as Preferred Prey	PLOS ONE			English	Article								Background. All vectors of human malaria, a disease responsible for more than one million deaths per year, are female mosquitoes from the genus Anopheles. Evarcha culicivora is an East African jumping spider (Salticidae) that feeds indirectly on vertebrate blood by selecting blood-carrying female mosquitoes as preferred prey. Methodology/Principal Findings. By testing with motionless lures made from mounting dead insects in lifelike posture on cork discs, we show that E. culicivora selects Anopheles mosquitoes in preference to other mosquitoes and that this predator can identify Anopheles by static appearance alone. Tests using active (grooming) virtual mosquitoes rendered in 3-D animation show that Anopheles' characteristic resting posture is an important prey-choice cue for E. culicivora. Expression of the spider's preference for Anopheles varies with the spider's size, varies with its prior feeding condition and is independent of the spider gaining a blood meal. Conclusions/Significance. This is the first experimental study to show that a predator of any type actively chooses Anopheles as preferred prey, suggesting that specialized predators having a role in the biological control of disease vectors is a realistic possibility.	[Nelson, Ximena J.; Jackson, Robert R.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Jackson, Robert R.] Int Ctr Insect Physiol & Ecol, Mbita Point, Kenya	University of Canterbury; International Centre of Insect Physiology & Ecology (ICIPE)	Nelson, XJ (corresponding author), Macquarie Univ, Ctr Integrat Study Anim Behav, Sydney, NSW 2109, Australia.	ximena@galliform.bhs.mq.edu.au		Nelson, Ximena/0000-0003-4301-2928	Marsden Grant of New Zealand; University of Canterbury Doctoral Scholarship	Marsden Grant of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); University of Canterbury Doctoral Scholarship	This research was supported by the Marsden Grant of New Zealand (to RRJ) and a University of Canterbury Doctoral Scholarship (to XJN). No funding agency was involved in the design or interpretation of this study.	Alibu VP, 2003, PLOS BIOL, V1, P142, DOI 10.1371/journal.pbio.0000039; Beadle LC, 1981, INLAND WATERS TROPIC; BLEST AD, 1981, J COMP PHYSIOL, V145, P227, DOI 10.1007/BF00605035; BLEST AD, 1990, CELL TISSUE RES, V262, P445, DOI 10.1007/BF00305241; Clements AN., 1999, SENSORY RECEPTION BE; COLLINS FH, 1995, ANNU REV ENTOMOL, V40, P195, DOI 10.1146/annurev.en.40.010195.001211; DEVOE RD, 1975, J GEN PHYSIOL, V66, P193, DOI 10.1085/jgp.66.2.193; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Jackson RR, 2005, P NATL ACAD SCI USA, V102, P15155, DOI 10.1073/pnas.0507398102; KRYWINSKI J, 2003, ANNU REV ENTOMOL, V48, P111; Land M.F., 1985, P53; LAND MF, 1969, J EXP BIOL, V51, P443; Land MF, 2002, ANIMAL EYES; Lehmann T, 1998, MOL BIOL EVOL, V15, P264, DOI 10.1093/oxfordjournals.molbev.a025923; Li DQ, 2003, BEHAV ECOL SOCIOBIOL, V55, P129, DOI 10.1007/s00265-003-0689-x; Lim MLM, 2006, J COMP PHYSIOL A, V192, P871, DOI 10.1007/s00359-006-0126-5; Minakawa N, 2001, J MED ENTOMOL, V38, P388, DOI 10.1603/0022-2585-38.3.388; Morse DH., 1980, BEHAV MECH ECOLOGY; Nelson XJ, 2005, J ARACHNOL, V33, P541, DOI 10.1636/05-3.1; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Wesolowska W, 2003, ANN ZOOL, V53, P335; WHO UNICEF, 2005, WORLD MALARIA REPORT; WILLIAMS DS, 1980, NATURE, V288, P578, DOI 10.1038/288578a0; YAMASHITA S, 1976, J COMP PHYSIOL, V105, P29, DOI 10.1007/BF01380051; [No title captured]	26	48	49	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e132	10.1371/journal.pone.0000132	http://dx.doi.org/10.1371/journal.pone.0000132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205136	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700026
J	Arunkumar, KP; Nagaraju, J				Arunkumar, K. P.; Nagaraju, Javaregowda			Unusually Long Palindromes Are Abundant in Mitochondrial Control Regions of Insects and Nematodes	PLOS ONE			English	Article								Background. Palindromes are known to be involved in a variety of biological processes. In the present investigation we carried out a comprehensive analysis of palindromes in the mitochondrial control regions (CRs) of several animal groups to study their frequency, distribution and architecture to gain insights into the origin of replication of mtDNA. Methodology/Principal Findings. Many species of Arthropoda, Nematoda, Mollusca and Annelida harbor palindromes and inverted repeats (IRs) in their CRs. Lower animals like cnidarians and higher animal groups like chordates are almost devoid of palindromes and IRs. The study revealed that palindrome occurrence is positively correlated with the AT content of CRs, and that IRs are likely to give rise to longer palindromes. Conclusions/Significance. The present study attempts to explain possible reasons and gives in silico evidence for absence of palindromes and IRs from CR of vertebrate mtDNA and acquisition and retention of the same in insects. Study of CRs of different animal phyla uncovered unique architecture of this locus, be it high abundance of long palindromes and IRs in CRs of Insecta and Nematoda, or short IRs of 10-20 nucleotides with a spacer region of 12-14 bases in subphylum Chelicerata, or nearly complete of absence of any long palindromes and IRs in Vertebrata, Cnidaria and Echinodermata.	[Arunkumar, K. P.; Nagaraju, Javaregowda] Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Nacharam, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Nagaraju, J (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Nacharam, India.	jnagaraju@cdfd.org.in			Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Financial support for this project was from Department of Biotechnology, Government of India. KPA is recipient of the fellowship from Council of Scientific and Industrial Research (CSIR), India.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; Albrecht EB, 2000, MOL BIOL CELL, V11, P873, DOI 10.1091/mbc.11.3.873; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; BERG DE, 1980, COLD SPRING HARB SYM, V45, P115; Brown W. M., 1985, MOL EVOLUTIONARY GEN; Butler DK, 1996, CELL, V87, P1115, DOI 10.1016/S0092-8674(00)81805-X; Butler DK, 2002, GENETICS, V161, P1065; BUTLER DK, 1995, MOL CELL BIOL, V15, P7117; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; Cheung AK, 2004, J VIROL, V78, P9016, DOI 10.1128/JVI.78.17.9016-9029.2004; CLARY DO, 1987, J MOL EVOL, V25, P116, DOI 10.1007/BF02101753; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; COLLINS J, 1980, COLD SPRING HARB SYM, V45, P409, DOI 10.1101/SQB.1981.045.01.055; COLLINS J, 1982, GENE, V19, P139, DOI 10.1016/0378-1119(82)90198-6; Creighton T.E., 1993, PROTEINS; CROZIER RH, 1993, GENETICS, V133, P97; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; EGNER C, 1981, P NATL ACAD SCI-BIOL, V78, P459, DOI 10.1073/pnas.78.1.459; FAURON CMR, 1976, P NATL ACAD SCI USA, V73, P3623, DOI 10.1073/pnas.73.10.3623; FOSTER TJ, 1981, CELL, V23, P215, DOI 10.1016/0092-8674(81)90286-5; FRAPPIER L, 1989, J BIOL CHEM, V264, P334; GARESSE R, 1988, GENETICS, V118, P649; GLICKMAN BW, 1984, P NATL ACAD SCI-BIOL, V81, P512, DOI 10.1073/pnas.81.2.512; GODDARD JM, 1980, NUCLEIC ACIDS RES, V8, P741; GODDARD JM, 1978, P NATL ACAD SCI USA, V75, P3886, DOI 10.1073/pnas.75.8.3886; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gray MW, 1996, EVOLUTION MICROBIAL; HIXSON JE, 1986, J BIOL CHEM, V261, P2384; Kornberg A., 1992, DNA REPLICATION; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; LILLEY DMJ, 1980, P NATL ACAD SCI-BIOL, V77, P6468, DOI 10.1073/pnas.77.11.6468; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; MASSE MJO, 1992, P NATL ACAD SCI USA, V89, P5246, DOI 10.1073/pnas.89.12.5246; NALBANTOGLU J, 1986, EMBO J, V5, P1199, DOI 10.1002/j.1460-2075.1986.tb04347.x; PANAYOTATOS N, 1981, NATURE, V289, P466, DOI 10.1038/289466a0; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; Qin ZJ, 2000, GENE DEV, V14, P1789; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200; SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; SHAFFERMAN A, 1987, MOL GEN GENET, V208, P294, DOI 10.1007/BF00330456; SHEFLIN LG, 1985, NUCLEIC ACIDS RES, V13, P6137, DOI 10.1093/nar/13.17.6137; SINDEN RR, 1991, GENETICS, V129, P991; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TAPPER DP, 1981, J BIOL CHEM, V256, P5109; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; WAGNER E, 1991, HERPESVIRUS TRANSCRI; Waterman M.S., 1995, INTRO COMPUTATIONAL; WELLER SK, 1985, MOL CELL BIOL, V5, P930, DOI 10.1128/MCB.5.5.930; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; YASUDA LF, 1991, CELL, V67, P505, DOI 10.1016/0092-8674(91)90525-4	59	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e110	10.1371/journal.pone.0000110	http://dx.doi.org/10.1371/journal.pone.0000110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17205114	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600105
J	de la Fuente-Fernandez, R				de la Fuente-Fernandez, Raul			Impact of Neuroprotection on Incidence of Alzheimer's Disease	PLOS ONE			English	Article							VASCULAR DEMENTIA; COMMUNITY POPULATION; COGNITIVE FUNCTION; AFRICAN-AMERICANS; ENTORHINAL CORTEX; RURAL-COMMUNITY; NEURONAL LOSS; RISK-FACTORS; AGE; MILD	Converging evidence suggests that high levels of education and intellectual activity increase the cognitive reserve and reduce the risk of dementia. However, little is known about the impact that different neuroprotective strategies may have on the incidence of Alzheimer's disease. Using a simple mathematical regression model, it is shown here that age-specific counts of basic cognitive units (surrogate of neurons or synapses) in the normal population can be estimated from Alzheimer's incidence rates. Hence, the model can be used to test the effect of neuroprotection on Alzheimer's incidence. It was found that the number of basic cognitive units decreases with age, but levels off in older people. There were no gender differences after correcting for survival. The model shows that even modest neuroprotective effects on basic cognitive units can lead to dramatic reductions in the number of Alzheimer's cases. Most remarkably, a 5% increase in the cognitive reserve would prevent one third of Alzheimer's cases. These results suggest that public health policies aimed at increasing the cognitive reserve in the general population (e.g., implementing higher levels of education) are likely the most effective strategy for preventing Alzheimer's disease.	Hosp A Marcide, Neurol Sect, Ferrol, Spain	Complejo Hospitalario Universitario de Ferrol	de la Fuente-Fernandez, R (corresponding author), Hosp A Marcide, Neurol Sect, Ferrol, Spain.	rfuente@medynet.com						Aevarsson O, 1996, J AM GERIATR SOC, V44, P1455, DOI 10.1111/j.1532-5415.1996.tb04070.x; Andersen K, 1999, NEUROLOGY, V52, P85, DOI 10.1212/WNL.52.1.85; Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Bowman AW, 1997, APPL SMOOTHING TECHN; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAYNE C, 1995, BRIT J PSYCHIAT, V167, P255, DOI 10.1192/bjp.167.2.255; CALNE DB, 1991, ANN NEUROL, V30, P206, DOI 10.1002/ana.410300213; Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Cleveland W.S., 1996, P STAT THEORY COMPUT, P10; Copeland JRM, 1999, BRIT J PSYCHIAT, V175, P433, DOI 10.1192/bjp.175.5.433; Di Carlo A, 2002, J AM GERIATR SOC, V50, P41, DOI 10.1046/j.1532-5415.2002.50006.x; Esiri MM, 2001, LANCET, V357, P169; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Falke E, 2003, AM J PATHOL, V163, P1615, DOI 10.1016/S0002-9440(10)63518-3; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Fukunishi I, 1991, Int J Soc Psychiatry, V37, P51, DOI 10.1177/002076409103700107; Ganguli M, 2000, NEUROLOGY, V54, P1109, DOI 10.1212/WNL.54.5.1109; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; HAGNELL O, 1992, NEUROEPIDEMIOLOGY, V11, P61, DOI 10.1159/000110981; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Hills, 1993, STAT MODELS EPIDEMIO; Irizarry MC, 2001, PRINCIPLES OF NEUROEPIDEMIOLOGY, P69; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Kubis N, 2000, BRAIN, V123, P366, DOI 10.1093/brain/123.2.366; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; LETENNEUR L, 1994, INT J EPIDEMIOL, V23, P1256, DOI 10.1093/ije/23.6.1256; Liu CK, 1998, NEUROLOGY, V50, P1572, DOI 10.1212/WNL.50.6.1572; Lopez-Pousa S, 2004, NEUROEPIDEMIOLOGY, V23, P170, DOI 10.1159/000078502; McDowell I, 2000, NEUROLOGY, V55, P66; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; Morris JC, 1999, J CLIN INVEST, V104, P1171, DOI 10.1172/JCI8560; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Nitrini R, 2004, ALZ DIS ASSOC DIS, V18, P241; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Ravaglia G, 2005, NEUROLOGY, V64, P1525, DOI 10.1212/01.WNL.0000160107.02316.BF; Riley KP, 2005, NEUROBIOL AGING, V26, P341, DOI 10.1016/j.neurobiolaging.2004.06.019; RITCHIE K, 1995, LANCET, V346, P931, DOI 10.1016/S0140-6736(95)91556-7; Rocca WA, 2000, NEUROLOGY, V54, pS38; Scarmeas Nikolaos, 2004, Curr Neurol Neurosci Rep, V4, P374, DOI 10.1007/s11910-004-0084-7; Scrucca L., 2001, J STAT SOFTW, V6, P1; Shoulson I, 1998, SCIENCE, V282, P1072, DOI 10.1126/science.282.5391.1072; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Small SA, 2001, ARCH NEUROL-CHICAGO, V58, P360, DOI 10.1001/archneur.58.3.360; Spector A, 2003, BRIT J PSYCHIAT, V183, P248, DOI 10.1192/bjp.183.3.248; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; Terry RD, 2001, NEUROBIOL AGING, V22, P347, DOI 10.1016/S0197-4580(00)00250-5; *US BUR CENS, 2006, IDB POP PYR; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Waite LM, 2001, INT J GERIATR PSYCH, V16, P680, DOI 10.1002/gps.404; Wang JYJ, 2006, NEUROLOGY, V66, P911, DOI 10.1212/01.wnl.0000192165.99963.2a; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161	63	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e52	10.1371/journal.pone.0000052	http://dx.doi.org/10.1371/journal.pone.0000052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183682	Green Published, gold			2022-12-27	WOS:000207443600052
J	Mahenthiralingam, E; Baldwin, A; Drevinek, P; Vanlaere, E; Vandamme, P; LiPuma, JJ; Dowson, CG				Mahenthiralingam, Eshwar; Baldwin, Adam; Drevinek, Pavel; Vanlaere, Elke; Vandamme, Peter; LiPuma, John J.; Dowson, Chris G.			Multilocus Sequence Typing Breathes Life into a Microbial Metagenome	PLOS ONE			English	Article								Shot-gun sequencing of DNA isolated from the environment and the assembly of metagenomes from the resulting data has considerably advanced the study of microbial diversity. However, the subsequent matching of these hypothetical metagenomes to cultivable microorganisms is a limitation of such cultivation-independent methods of population analysis. Using a nucleotide sequence-based genetic typing method, multilocus sequence typing, we were able for the first time to match clonal cultivable isolates to a published and controversial bacterial metagenome, Burkholderia SAR-1, which derived from analysis of the Sargasso Sea. The matching cultivable isolates were all associated with infection and geographically widely distributed; taxonomic analysis demonstrated they were members of Burkholderia cepacia complex Group K. Comparison of the Burkholderia SAR-1 metagenome to closely related B. cepacia complex genomes indicated that it was greater than 98% intact in terms of conserved genes, and it also shared complete sequence identity with the cultivable isolates at random loci beyond the genes sampled by the multilocus sequence typing. Two features of the extant cultivable clones support the argument that the Burkholderia SAR-1 sequence may have been a contaminant in the original metagenomic survey: (i) their growth in conditions reflective of sea water was poor, suggesting the ocean was not their preferred habitat, and (ii) several of the matching isolates were epidemiologically linked to outbreaks of infection that resulted from contaminated medical devices or products, indicating an adaptive fitness of this bacterial strain towards contamination-associated environments. The ability to match identical cultivable strains of bacteria to a hypothetical metagenome is a unique feature of nucleotide sequence-based microbial typing methods; such matching would not have been possible with more traditional methods of genetic typing, such as those based on pattern matching of genomic restriction fragments or amplified DNA fragments. Overall, we have taken the first steps in moving the status of the Burkholderia SAR-1 metagenome from a hypothetical entity towards the basis for life of cultivable strains that may now be analysed in conjunction with the assembled metagenomic sequence data by the wider scientific community.	[Baldwin, Adam; Dowson, Chris G.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Mahenthiralingam, Eshwar; Drevinek, Pavel] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Vanlaere, Elke; Vandamme, Peter] Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium; [LiPuma, John J.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA	University of Warwick; Cardiff University; Ghent University; University of Michigan System; University of Michigan	Mahenthiralingam, E (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.	MahenthiralingamE@cardiff.ac.uk	Vandamme, Peter AR/B-7967-2009; Dowson, Chris/N-6195-2014; Dowson, Christopher/ABG-5083-2021; Mahenthiralingam, Eshwar/D-3333-2009; Vandamme, Peter/ABG-3431-2021	Vandamme, Peter AR/0000-0002-5581-7937; Dowson, Chris/0000-0002-8294-8836; Dowson, Christopher/0000-0002-8294-8836; Mahenthiralingam, Eshwar/0000-0001-9014-3790; Vandamme, Peter/0000-0002-5581-7937	Wellcome Trust [072853]; Natural Environment Research Council [NER/T/S/2001/0299]; Nederlandse Cystic Fibrosis Stichting; Cystic Fibrosis Foundation (US);  [075586]	Wellcome Trust(Wellcome TrustEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Nederlandse Cystic Fibrosis Stichting; Cystic Fibrosis Foundation (US); 	C. G. D., A. B., and E. M. thank the Wellcome Trust (grant 072853) for funding the MLST analysis; E. M. and P. D. also acknowledge additional funding from this charity (grant 075586). E. M. is also grateful for financial support from the Natural Environment Research Council (grant NER/T/S/2001/0299). P. V. is indebted to the Stichting Kapteinfonds and the Nederlandse Cystic Fibrosis Stichting for financial support for the European B. 21 cepacia complex Referral Laboratory and Repository. J.J.L. is indebted to the Cystic Fibrosis Foundation (US) for financial support.	ANDERSON RL, 1991, INFECT CONT HOSP EP, V12, P297; Baldwin A, 2005, J CLIN MICROBIOL, V43, P4665, DOI 10.1128/JCM.43.9.4665-4673.2005; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Berriatua E, 2001, J CLIN MICROBIOL, V39, P990, DOI 10.1128/JCM.39.3.990-994.2001; Campana S, 2005, J CLIN MICROBIOL, V43, P5136, DOI 10.1128/JCM.43.10.5136-5142.2005; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Coenye T, 2001, J CLIN MICROBIOL, V39, P3427, DOI 10.1128/JCM.39.10.3427-3436.2001; De Boeck K, 2004, EUR RESPIR J, V23, P851, DOI 10.1183/09031936.04.00118804; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HARELAND WA, 1975, J BACTERIOL, V121, P272, DOI 10.1128/JB.121.1.272-285.1975; Hicks CL, 2000, AUST VET J, V78, P193, DOI 10.1111/j.1751-0813.2000.tb10593.x; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Kimata N, 2004, MICROBIAL ECOL, V47, P41, DOI 10.1007/s00248-003-1032-9; LEFF LG, 1995, APPL ENVIRON MICROB, V61, P1634, DOI 10.1128/AEM.61.4.1634-1636.1995; Lewis DA, 2005, AM J RESP CELL MOL, V33, P56, DOI 10.1165/rcmb.2004-0352OC; LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P3165, DOI 10.1128/JCM.38.9.3165-3173.2000; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Mahenthiralingam E, 1996, J CLIN MICROBIOL, V34, P2914, DOI 10.1128/JCM.34.12.2914-2920.1996; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; O'Sullivan LA, 2005, LETT APPL MICROBIOL, V41, P8, DOI 10.1111/j.1472-765X.2005.01758.x; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; PERRY B, 2001, MICROBIOL TODAY, V28, P185; Sambrook J., 2002, MOL CLONING LAB MANU; SHIRAKI M, 1995, J ENVIRON POLYM DEGR, V3, P13, DOI 10.1007/BF02067789; Souza AV, 2004, J MED MICROBIOL, V53, P999, DOI 10.1099/jmm.0.45702-0; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Vandamme P, 2000, J CLIN MICROBIOL, V38, P1042, DOI 10.1128/JCM.38.3.1042-1047.2000; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vermis K, 2002, J MED MICROBIOL, V51, P937, DOI 10.1099/0022-1317-51-11-937; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; 2004, MORBID MORTALITY WEE	36	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e17	10.1371/journal.pone.0000017	http://dx.doi.org/10.1371/journal.pone.0000017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183643	gold, Green Submitted, Green Published			2022-12-27	WOS:000207443600017
J	Pang, YP				Pang, Yuan-Ping			Novel Acetylcholinesterase Target Site for Malaria Mosquito Control	PLOS ONE			English	Article								Current anticholinesterase pesticides were developed during World War II and are toxic to mammals because they target a catalytic serine residue of acetylcholinesterases (AChEs) in insects and in mammals. A sequence analysis of AChEs from 73 species and a three-dimensional model of a malaria-carrying mosquito (Anopheles gambiae) AChE (AgAChE) reported here show that C286 and R339 of AgAChE are conserved at the opening of the active site of AChEs in 17 invertebrate and four insect species, respectively. Both residues are absent in the active site of AChEs of human, monkey, dog, cat, cattle, rabbit, rat, and mouse. The 17 invertebrates include house mosquito, Japanese encephalitis mosquito, African malaria mosquito, German cockroach, Florida lancelet, rice leaf beetle, African bollworm, beet armyworm, codling moth, diamondback moth, domestic silkworm, honey bee, oat or wheat aphid, the greenbug, melon or cotton aphid, green peach aphid, and English grain aphid. The four insects are house mosquito, Japanese encephalitis mosquito, African malaria mosquito, and German cockroach. The discovery of the two invertebrate-specific residues enables the development of effective and safer pesticides that target the residues present only in mosquito AChEs rather than the ubiquitous serine residue, thus potentially offering an effective control of mosquito-borne malaria. Anti-AgAChE pesticides can be designed to interact with R339 and subsequently covalently bond to C286. Such pesticides would be toxic to mosquitoes but not to mammals.	Mayo Clin, Coll Med, Comp Aided Mol Design Lab, Rochester, MN 55905 USA	Mayo Clinic	Pang, YP (corresponding author), Mayo Clin, Coll Med, Comp Aided Mol Design Lab, Rochester, MN 55905 USA.	pang@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560	Mayo Foundation for Medical Education and Research	Mayo Foundation for Medical Education and Research	This work was supported by the Mayo Foundation for Medical Education and Research.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bourne Y, 1999, J BIOL CHEM, V274, P30370, DOI 10.1074/jbc.274.43.30370; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Boyd AE, 2000, J BIOL CHEM, V275, P22401, DOI 10.1074/jbc.M000606200; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dooley AJ, 2006, BIOORG MED CHEM LETT, V16, P830, DOI 10.1016/j.bmcl.2005.11.018; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Fialka J. J., 2006, WALL STREET J, pA4; Filler Scott J., 2006, Morbidity and Mortality Weekly Report, V55, P1; Frisch M J, 1999, GAUSSIAN 98 REVISION; Johnson JL, 2003, J BIOL CHEM, V278, P38948, DOI 10.1074/jbc.M304797200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Oelschlaeger P, 2003, BIOCHEMISTRY-US, V42, P8945, DOI 10.1021/bi0300332; Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249; Pang YP, 2001, FEBS LETT, V502, P93, DOI 10.1016/S0014-5793(01)02672-2; Pang YP, 1996, J BIOL CHEM, V271, P23646, DOI 10.1074/jbc.271.39.23646; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Perola E, 2000, J MED CHEM, V43, P401, DOI 10.1021/jm990408a; Raves ML, 1997, NAT STRUCT BIOL, V4, P57, DOI 10.1038/nsb0197-57; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Smith LJ, 2002, PROTEINS, V48, P487, DOI 10.1002/prot.10144; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Zagrovic B, 2002, J MOL BIOL, V323, P927, DOI 10.1016/S0022-2836(02)00997-X; Zauhar RJ, 2000, BIOPOLYMERS, V53, P233, DOI 10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.3.CO;2-W	30	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e58	10.1371/journal.pone.0000058	http://dx.doi.org/10.1371/journal.pone.0000058			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183688	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600058
J	Sonoyama, W; Liu, Y; Fang, DAJ; Yamaza, T; Seo, BM; Zhang, CM; Liu, H; Gronthos, S; Wang, CY; Shi, ST; Wang, SL				Sonoyama, Wataru; Liu, Yi; Fang, Dianji; Yamaza, Takayoshi; Seo, Byoung-Moo; Zhang, Chunmei; Liu, He; Gronthos, Stan; Wang, Cun-Yu; Shi, Songtao; Wang, Songlin			Mesenchymal Stem Cell-Mediated Functional Tooth Regeneration in Swine	PLOS ONE			English	Article								Mesenchymal stem cell-mediated tissue regeneration is a promising approach for regenerative medicine for a wide range of applications. Here we report a new population of stem cells isolated from the root apical papilla of human teeth (SCAP, stem cells from apical papilla). Using a minipig model, we transplanted both human SCAP and periodontal ligament stem cells (PDLSCs) to generate a root/periodontal complex capable of supporting a porcelain crown, resulting in normal tooth function. This work integrates a stem cell-mediated tissue regeneration strategy, engineered materials for structure, and current dental crown technologies. This hybridized tissue engineering approach led to recovery of tooth strength and appearance.	[Liu, Yi; Fang, Dianji; Zhang, Chunmei; Shi, Songtao] Capital Med Univ, Sch Stomatol, Salivary Gland Dis Ctr, Beijing, Peoples R China; [Liu, Yi; Fang, Dianji; Zhang, Chunmei; Shi, Songtao] Capital Med Univ, Sch Stomatol, Mol Lab Gene Therapy, Beijing, Peoples R China; [Sonoyama, Wataru; Yamaza, Takayoshi; Wang, Songlin] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Sonoyama, Wataru] Okayama Univ, Dept Oral & Maxillofacial Rehabil, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Seo, Byoung-Moo] Seoul Natl Univ, Dept Oral & Maxillofacial Rehabil, Sch Dent, Dent Res Inst, Seoul, South Korea; [Liu, He] Peking Univ, Sch Stomatol, Beijing 100871, Peoples R China; [Gronthos, Stan] Inst Med & Vet Sci, Div Haematol, Mesenchymal Stem Cell Grp, Adelaide, SA 5000, Australia; [Wang, Cun-Yu] Univ Michigan, Lab Mol Signaling & Apoptosis, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Wang, Cun-Yu] Univ Michigan, Program Mol & Cellular Biol, Ann Arbor, MI 48109 USA	Capital Medical University; Capital Medical University; University of Southern California; Okayama University; Seoul National University (SNU); Peking University; Institute Medical & Veterinary Science Australia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shi, ST (corresponding author), Capital Med Univ, Sch Stomatol, Salivary Gland Dis Ctr, Beijing, Peoples R China.	songtaos@usc.edu; songlinwang@dentist.org.cn	Gronthos, Stan/Y-4419-2019; Sonoyama, Wataru/B-2160-2011	Gronthos, Stan/0000-0002-6225-3084; Yamaza, Takayoshi/0000-0001-7055-3370	University of Southern California School of Dentistry; National Natural Science Foundation of China [30428009]; Beijing Major Scientific program [D0906007000091]; Division of Intramural Research; National Institute of Dental and Craniofacial Research, National Institutes of Health; Department of Health and Human Service	University of Southern California School of Dentistry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Major Scientific program; Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Department of Health and Human Service	This study was sponsored by the University of Southern California School of Dentistry, grants from the National Natural Science Foundation of China (30428009), the Beijing Major Scientific program grant (D0906007000091), and the Division of Intramural Research, the National Institute of Dental and Craniofacial Research, the National Institutes of Health, Department of Health and Human Service.	Blazer S, 2002, BIOCHEM BIOPH RES CO, V296, P93, DOI 10.1016/S0006-291X(02)00818-5; Chai Y, 2003, MICROSC RES TECHNIQ, V60, P469, DOI 10.1002/jemt.10287; Duailibi MT, 2004, J DENT RES, V83, P523, DOI 10.1177/154405910408300703; Eckert SE, 2005, INT J ORAL MAX IMPL, V20, P406; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Heitz-Mayfield LJA, 2004, INT J ORAL MAX IMPL, V19, P128; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Larsen MO, 2004, ILAR J, V45, P303, DOI 10.1093/ilar.45.3.303; MILLIKAN LE, 1974, J INVEST DERMATOL, V62, P20, DOI 10.1111/1523-1747.ep12676714; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Ohazama A, 2004, J DENT RES, V83, P518, DOI 10.1177/154405910408300702; Park Sang-Hoon, 2005, Implant Dent, V14, P211, DOI 10.1097/01.id.0000173334.60107.1a; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x; Shi S, 2001, BONE, V29, P532, DOI 10.1016/S8756-3282(01)00612-3; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Thesleff I, 2003, QUINTESSENCE INT, V34, P613; Tummers M, 2003, DEVELOPMENT, V130, P1049, DOI 10.1242/dev.00332; Yen AHH, 2006, EXPERT OPIN BIOL TH, V6, P9, DOI 10.1517/14712598.6.1.9; Young CS, 2005, TISSUE ENG, V11, P1599, DOI 10.1089/ten.2005.11.1599	21	819	891	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e79	10.1371/journal.pone.0000079	http://dx.doi.org/10.1371/journal.pone.0000079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183711	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600079
J	Xing, Y; Kapur, K; Wong, WH				Xing, Yi; Kapur, Karen; Wong, Wing Hung			Probe Selection and Expression Index Computation of Affymetrix Exon Arrays	PLOS ONE			English	Article							MICROARRAY DATA; PREDICTION; CANCER	Background. There is great current interest in developing microarray platforms for measuring mRNA abundance at both gene level and exon level. The Affymetrix Exon Array is a new high-density gene expression microarray platform, with over six million probes targeting all annotated and predicted exons in a genome. An important question for the analysis of exon array data is how to compute overall gene expression indexes. Because of the complexity of the design of exon array probes, this problem is different in nature from summarizing gene-level expression from traditional 39 expression arrays. Methodology/Principal Findings. In this manuscript, we use exon array data from 11 human tissues to study methods for computing gene-level expression. We showed that for most genes there is a subset of exon array probes having highly correlated intensities across multiple samples. We suggest that these probes could be used as reliable indicators of overall gene expression levels. We developed a probe selection algorithm to select such a subset of highly correlated probes for each gene, and computed gene expression indexes using the selected probes. Conclusions/Significance. Our results demonstrate that probe selection improves gene expression estimates from exon arrays. The selected probes can be used in future analyses of other exon array datasets to compute gene expression indexes.	[Xing, Yi; Kapur, Karen; Wong, Wing Hung] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Xing, Yi] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Stanford University; University of Iowa	Wong, WH (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.	whwong@stanford.edu	Xing, yi/E-2884-2010		NIH [HG02341]; NSF [DMS0505732]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002341] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	NIH HG02341, NSF DMS0505732	*AFF, GEN SIGN EST EX ARR; *AFF, EX ARR DES DAT; *AFF, GUID PROB LOG INT ER; *AFF, EX ARR PROB ANN; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Gupta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-72; Hardiman G, 2004, PHARMACOGENOMICS, V5, P487, DOI 10.1517/14622416.5.5.487; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Le K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh173; Lee C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-231; Lee C, 2003, NUCLEIC ACIDS RES, V31, P101, DOI 10.1093/nar/gkg029; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li HR, 2006, CANCER RES, V66, P4079, DOI 10.1158/0008-5472.CAN-05-4264; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Nagase T, 2000, DNA RES, V7, P273; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Sorek R, 2003, CANCER RES, V63, P6996; Stoughton RB, 2005, ANNU REV BIOCHEM, V74, P53, DOI 10.1146/annurev.biochem.74.082803.133212; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Zhu J, 2003, SCIENCE, V301, P836, DOI 10.1126/science.1085792	28	53	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e88	10.1371/journal.pone.0000088	http://dx.doi.org/10.1371/journal.pone.0000088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183719	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600087
J	Karagiannis, J; Balasubramanian, MK				Karagiannis, Jim; Balasubramanian, Mohan K.			A Cyclin-Dependent Kinase that Promotes Cytokinesis through Modulating Phosphorylation of the Carboxy Terminal Domain of the RNA Pol II Rpb1p Sub-Unit	PLOS ONE			English	Article								In Schizosaccharomyces pombe, the nuclear-localized kinase, Lsk1p, promotes cytokinesis by positively regulating the Septation Initiation Network (SIN). Although a member of the cyclin-dependent kinase (CDK) family, neither a cyclin partner nor a physiological target has been identified. In this report we identify a cyclin, Lsc1p, that physically interacts and co-localizes with Lsk1p. Furthermore, lsk1 Delta, lsc1 Delta, as well as kinase-dead lsk1-K306R mutants, display highly similar cytokinesis defects. Lsk1p is related to CDKs that phosphorylate the carboxy-terminal domain (CTD) of the largest sub-unit of RNA polymerase II (Rpb1p). Interestingly, we find that Lsk1p and Lsc1p are required for phosphorylation of Ser-2 residues found in the heptad repeats of the CTD. To determine if Rpb1p could be a physiological target, we replaced the native rpb1 gene with a synthetic gene encoding a Rpb1p protein in which Ser-2 was substituted with the non-phosphorylatable amino-acid alanine in all heptads. Cells carrying this allele were similar to lsk1 Delta mutants: They were viable, displayed genetic interactions with the SIN, and were unable to complete cytokinesis upon perturbation of the cell division machinery. We conclude that Ser-2 phosphorylation of the CTD heptads plays a novel physiological role in the regulation of cytokinesis.	[Balasubramanian, Mohan K.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Karagiannis, Jim; Balasubramanian, Mohan K.] Temasek Life Sci Lab, Lab Cell Div, Singapore, Singapore	National University of Singapore	Karagiannis, J (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	jkaragia@uwo.ca		Karagiannis, Jim/0000-0002-7901-1815; Balasubramanian, Mohan/0000-0002-1292-8602	Temasek Life Sciences Laboratory; Singapore Millennium Foundation	Temasek Life Sciences Laboratory(National University of Singapore); Singapore Millennium Foundation(Singapore Millennium Foundation)	This work was supported by research funds from Temasek Life Sciences Laboratory. JK is a recipient of a Singapore Millennium Foundation post-doctoral fellowship.	Alfa C, 1993, EXPT FISSION YEAST L; Balasubramanian MK, 1997, METHOD ENZYMOL, V283, P494; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; BOOHER RN, 1989, CELL, V58, P485, DOI 10.1016/0092-8674(89)90429-7; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; Chang YW, 2004, MOL CELL, V15, P107, DOI 10.1016/j.molcel.2004.05.021; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Cueille N, 2001, J CELL SCI, V114, P2649; FANKHAUSER C, 1993, EMBO J, V12, P2697, DOI 10.1002/j.1460-2075.1993.tb05931.x; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Hausmann S, 2002, J BIOL CHEM, V277, P21213, DOI 10.1074/jbc.M202056200; Howe KJ, 2002, BBA-GENE STRUCT EXPR, V1577, P308, DOI 10.1016/S0167-4781(02)00460-8; Jeong SJ, 2005, J MICROBIOL, V43, P516; Karagiannis J, 2005, MOL BIOL CELL, V16, P358, DOI 10.1091/mbc.E04-06-0502; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kimura M, 2002, MOL CELL BIOL, V22, P1577, DOI 10.1128/MCB.22.5.1577-1588.2002; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Larschan E, 2005, MOL CELL BIOL, V25, P114, DOI 10.1128/MCB.25.1.114-123.2005; Le Goff X, 1999, MOL GEN GENET, V262, P163; Lee KM, 2005, MOL BIOL CELL, V16, P2734, DOI 10.1091/mbc.E04-11-0982; Liu JH, 2000, J CELL SCI, V113, P1223; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; MINET M, 1979, J BACTERIOL, V137, P440, DOI 10.1128/JB.137.1.440-446.1979; Mishra M, 2005, CURR BIOL, V15, P1376, DOI 10.1016/j.cub.2005.06.070; Mishra M, 2004, J CELL SCI, V117, P3897, DOI 10.1242/jcs.01244; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Ostapenko D, 2003, EUKARYOT CELL, V2, P274, DOI 10.1128/EC.2.2.274-283.2003; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; WEST ML, 1995, GENETICS, V140, P1223; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Yuryev A, 1996, GENETICS, V143, P661	43	30	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e433	10.1371/journal.pone.0000433	http://dx.doi.org/10.1371/journal.pone.0000433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17502918	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445800015
J	Seidel, B; Thomzig, A; Buschmann, A; Groschup, MH; Peters, R; Beekes, M; Terytze, K				Seidel, Bjoern; Thomzig, Achim; Buschmann, Anne; Groschup, Martin H.; Peters, Rainer; Beekes, Michael; Terytze, Konstantin			Scrapie Agent (Strain 263K) Can Transmit Disease via the Oral Route after Persistence in Soil over Years	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; PATHOLOGICAL PRION PROTEIN; CENTRAL-NERVOUS-SYSTEM; CYCLIC AMPLIFICATION; INFECTIOUS PRIONS; SODIUM-HYDROXIDE; E-CADHERIN; MULE DEER; HAMSTERS	The persistence of infectious biomolecules in soil constitutes a substantial challenge. This holds particularly true with respect to prions, the causative agents of transmissible spongiform encephalopathies (TSEs) such as scrapie, bovine spongiform encephalopathy (BSE), or chronic wasting disease (CWD). Various studies have indicated that prions are able to persist in soil for years without losing their pathogenic activity. Dissemination of prions into the environment can occur from several sources, e. g., infectious placenta or amniotic fluid of sheep. Furthermore, environmental contamination by saliva, excrements or non-sterilized agricultural organic fertilizer is conceivable. Natural transmission of scrapie in the field seems to occur via the alimentary tract in the majority of cases, and scrapie-free sheep flocks can become infected on pastures where outbreaks of scrapie had been observed before. These findings point to a sustained contagion in the environment, and notably the soil. By using outdoor lysimeters, we simulated a contamination of standard soil with hamster-adapted 263K scrapie prions, and analyzed the presence and biological activity of the soil-associated PrPSc and infectivity by Western blotting and hamster bioassay, respectively. Our results showed that 263K scrapie agent can persist in soil at least over 29 months. Strikingly, not only the contaminated soil itself retained high levels of infectivity, as evidenced by oral administration to Syrian hamsters, but also feeding of aqueous soil extracts was able to induce disease in the reporter animals. We could also demonstrate that PrPSc in soil, extracted after 21 months, provides a catalytically active seed in the protein misfolding cyclic amplification (PMCA) reaction. PMCA opens therefore a perspective for considerably improving the detectability of prions in soil samples from the field.	[Seidel, Bjoern; Peters, Rainer] Fraunhofer Inst Mol Biol & Appl Ecol IME, Schmallenberg, Germany; [Thomzig, Achim; Beekes, Michael] Robert Koch Inst, Transmissible Spongiform Encephalopathies P24, D-1000 Berlin, Germany; [Terytze, Konstantin] UBA, German Fed Environm Agcy, Dessau, Germany; [Buschmann, Anne; Groschup, Martin H.] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Insel Riems, Germany	Fraunhofer Gesellschaft; Robert Koch Institute; Friedrich Loeffler Institute	Seidel, B (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Schmallenberg, Germany.	bjoern.seidel@ime.fraunhofer.de	Beekes, Michael/S-1975-2018	Beekes, Michael/0000-0002-6454-6657	German Federal Environmental Agency (UBA); EU [QLK-CT 2001-309]	German Federal Environmental Agency (UBA)(University of Buenos Aires); EU(European Commission)	This research project was funded by the German Federal Environmental Agency (UBA). This work was supported by the EU grant QLK-CT 2001-309 and the EU funded Network of Excellence 'NeuroPrion'.	ALPER T, 1966, BIOCHEM BIOPH RES CO, V22, P278, DOI 10.1016/0006-291X(66)90478-5; Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Beekes M, 1996, J GEN VIROL, V77, P1925, DOI 10.1099/0022-1317-77-8-1925; Beekes M, 1998, J GEN VIROL, V79, P601, DOI 10.1099/0022-1317-79-3-601; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BRADLEY R, 1993, BRIT MED BULL, V49, P932, DOI 10.1093/oxfordjournals.bmb.a072654; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; CINDY M, 2007, SCI TECHNOL, V41, P811; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; FOSTER JD, 1992, VET REC, V130, P341, DOI 10.1136/vr.130.16.341; GIBBONS RA, 1967, NATURE, V215, P1041, DOI 10.1038/2151041a0; Giehl K, 2000, ONCOGENE, V19, P4531, DOI 10.1038/sj.onc.1203806; GREIG J. R., 1940, VET JOUR, V96, P203; Gudmundsdottir KB, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-16; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; HATZINGER PB, 1995, ENVIRON SCI TECHNOL, V29, P537, DOI 10.1021/es00002a033; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Kim TY, 2005, J VET MED SCI, V67, P753, DOI 10.1292/jvms.67.753; Lupi O, 2005, MED HYPOTHESES, V65, P47, DOI 10.1016/j.mehy.2005.01.039; Lupi O, 2003, INT J DERMATOL, V42, P425, DOI 10.1046/j.1365-4362.2003.00345.x; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; McBride PA, 2001, J VIROL, V75, P9320, DOI 10.1128/JVI.75.19.9320-9327.2001; McBride PA, 1999, NEUROSCI LETT, V265, P135, DOI 10.1016/S0304-3940(99)00223-2; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Menke A, 2001, CANCER RES, V61, P3508; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; PALLSON P, 1979, SLOW TRANSMISSIBLE D, V1, P357; Post K, 1999, LANCET, V354, P1969, DOI 10.1016/S0140-6736(99)00469-9; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purdey M, 2000, MED HYPOTHESES, V54, P278, DOI 10.1054/mehy.1999.0836; Purdey M, 1998, MED HYPOTHESES, V50, P91, DOI 10.1016/S0306-9877(98)90194-3; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Schreuder BEC, 2003, REV SCI TECH OIE, V22, P103, DOI 10.20506/rst.22.1.1387; Scow KM, 1995, ENVIRON HEALTH PERSP, V103, P93, DOI 10.2307/3432488; Scudamore JM, 2002, REV SCI TECH OIE, V21, P699, DOI 10.20506/rst.21.3.1351; Seidel B, 2004, ONCOGENE, V23, P5532, DOI 10.1038/sj.onc.1207718; Shaked GM, 2001, J BIOL CHEM, V276, P31479, DOI 10.1074/jbc.C100278200; SIGURDSSON BJORN, 1954, BRIT VET JOUR, V110, P341; Sohn HJ, 2002, J VET MED SCI, V64, P855, DOI 10.1292/jvms.64.855; TAYLOR DM, 1991, J HOSP INFECT, V18, P141, DOI 10.1016/0195-6701(91)90016-2; TAYLOR DM, 1993, BRIT MED BULL, V49, P810, DOI 10.1093/oxfordjournals.bmb.a072648; Taylor DM, 1996, J GEN VIROL, V77, P811, DOI 10.1099/0022-1317-77-4-811; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Taylor DM, 1999, VET MICROBIOL, V67, P13, DOI 10.1016/S0378-1135(99)00026-7; Taylor DM, 1997, VET MICROBIOL, V58, P87, DOI 10.1016/S0378-1135(97)00103-X; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827; Tomzig A, 2004, J BIOL CHEM, V279, P33847, DOI 10.1074/jbc.M403730200; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; Wisniewski HM, 1996, LANCET, V347, P1114, DOI 10.1016/S0140-6736(96)90310-4	58	107	108	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e435	10.1371/journal.pone.0000435	http://dx.doi.org/10.1371/journal.pone.0000435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17502917	Green Published, gold			2022-12-27	WOS:000207445800017
J	Besson, C; Roetynck, S; Williams, F; Orsi, L; Amiel, C; Lependeven, C; Antoni, G; Hermine, O; Brice, P; Ferme, C; Carde, P; Canioni, D; Briere, J; Raphael, M; Nicolas, JC; Clavel, J; Middleton, D; Vivier, E; Abel, L				Besson, Caroline; Roetynck, Sophie; Williams, Fionnuala; Orsi, Laurent; Amiel, Corinne; Lependeven, Catherine; Antoni, Guillemette; Hermine, Olivier; Brice, Pauline; Ferme, Christophe; Carde, Patrice; Canioni, Danielle; Briere, Josette; Raphael, Martine; Nicolas, Jean-Claude; Clavel, Jacqueline; Middleton, Derek; Vivier, Eric; Abel, Laurent			Association of Killer Cell Immunoglobulin-Like Receptor Genes with Hodgkin's Lymphoma in a Familial Study	PLOS ONE			English	Article								Background. Epstein-Barr virus (EBV) is the major environmental factor associated with Hodgkin's lymphoma (HL), a common lymphoma in young adults. Natural killer (NK) cells are key actors of the innate immune response against viruses. The regulation of NK cell function involves activating and inhibitory Killer cell Immunoglobulin-like receptors (KIRs), which are expressed in variable numbers on NK cells. Various viral and virus-related malignant disorders have been associated with the presence/absence of certain KIR genes in case/control studies. We investigated the role of the KIR cluster in HL in a family-based association study. Methodology. We included 90 families with 90 HL index cases (age 16-35 years) and 255 first-degree relatives (parents and siblings). We developed a procedure for reconstructing full genotypic information (number of gene copies) at each KIR locus from the standard KIR gene content. Out of the 90 collected families, 84 were informative and suitable for further analysis. An association study was then carried out with specific family-based analysis methods on these 84 families. Principal Findings. Five KIR genes in strong linkage disequilibrium were found significantly associated with HL. Refined haplotype analysis showed that the association was supported by a dominant protective effect of KIR3DS1 and/or KIR2DS1, both of which are activating receptors. The odds ratios for developing HL in subjects with at least one copy of KIR3DS1 or KIR2DS1 with respect to subjects with neither of these genes were 0.44[95% confidence interval 0.23-0.85] and 0.42[0.21-0.85], respectively. No significant association was found in a tentative replication case/control study of 68 HL cases (age 1871 years). In the familial study, the protective effect of KIR3DS1/KIR2DS1 tended to be stronger in HL patients with detectable EBV in blood or tumour cells. Conclusions. This work defines a template for family-based association studies based on full genotypic information for the KIR cluster, and provides the first evidence that activating KIRs can have a protective role in HL.	[Besson, Caroline; Antoni, Guillemette; Abel, Laurent] INSERM, U550, Lab Genet Humaine Malad Infect, Paris, France; [Besson, Caroline; Antoni, Guillemette; Abel, Laurent] Univ Paris 05, Fac Med Rene Descartes, Paris, France; [Besson, Caroline; Raphael, Martine] CHU Bicetre, AP HP, Serv Hematol & Immunol Biol, Le Kremlin Bicetre, France; [Besson, Caroline; Raphael, Martine; Clavel, Jacqueline] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France; [Roetynck, Sophie; Vivier, Eric] Univ Mediterranee, Ctr Immunol Marseille Luminy, Marseille, France; [Roetynck, Sophie; Vivier, Eric] INSERM, U631, F-13258 Marseille, France; [Roetynck, Sophie; Vivier, Eric] CNRS, UMR6102, Marseille, France; [Williams, Fionnuala; Middleton, Derek] Belfast City Hosp, No Ireland Reg Histocompatibil & Immunogenet Lab, Belfast BT9 7AD, Antrim, North Ireland; [Orsi, Laurent; Clavel, Jacqueline] Univ Paris 11, INSERM, U754, Villejuif, France; [Amiel, Corinne; Lependeven, Catherine; Nicolas, Jean-Claude] Hop Tenon, Virol Lab, F-75970 Paris, France; [Hermine, Olivier] Hop Necker Enfants Malad, Serv Hematol Adultes, Paris, France; [Brice, Pauline] Hop St Louis, Serv Oncohematol, Paris, France; [Ferme, Christophe; Carde, Patrice] Inst Gustave Roussy, Dept Hematol, Villejuif, France; [Canioni, Danielle] Hop Necker Enfants Malad, Serv Anatomopathol, Paris, France; [Briere, Josette] Hop St Louis, Serv Anatomopathol, Paris, France; [Middleton, Derek] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Vivier, Eric] Hop Conception, Assistance Publ Hop Marseille, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Belfast City Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Ulster University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Abel, L (corresponding author), INSERM, U550, Lab Genet Humaine Malad Infect, Paris, France.	abel@necker.fr	Vivier, Eric/F-8939-2010; Besson, Caroline/H-4648-2018; AMIEL, Corinne/B-7854-2012; Clavel, Jacqueline/Q-2750-2016; Abel, Laurent/H-8888-2017; Hermine, Olivier/Q-7072-2018; Orsi, Laurent/H-7863-2018	Vivier, Eric/0000-0001-7022-8287; Besson, Caroline/0000-0003-4364-7173; AMIEL, Corinne/0000-0002-1144-4868; Clavel, Jacqueline/0000-0002-3616-7676; Abel, Laurent/0000-0001-7016-6493; Orsi, Laurent/0000-0002-9332-3620; Hermine, Olivier/0000-0003-2574-3874	Association pour la Recherche contre le Cancer; Ligue Nationale contre le cancer; Fondation de France European Union FP6 [LSHB-CT-2004-503319-Allostem]; Agence Nationale de la Recherche (Reseau Innovation Biotechnologiesand Microbiologie Immunologie Maladies Emergentes); INSERM; CNRS; Ministeere de l'Enseignement Superieur et de la Recherche; Fondation Schlumberger; Fondation BNP Paribas; Fondation de France; Northern Ireland Histocompatibility and Immunogenetics Laboratory Research Trust Fund	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Fondation de France European Union FP6; Agence Nationale de la Recherche (Reseau Innovation Biotechnologiesand Microbiologie Immunologie Maladies Emergentes)(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministeere de l'Enseignement Superieur et de la Recherche; Fondation Schlumberger(Schlumberger); Fondation BNP Paribas; Fondation de France(Fondation de France); Northern Ireland Histocompatibility and Immunogenetics Laboratory Research Trust Fund	This work was supported by Association pour la Recherche contre le Cancer, Ligue Nationale contre le cancer (EV : 'Equipe labellisee La Ligue'), Fondation de France European Union FP6, LSHB-CT-2004-503319-Allostem, Agence Nationale de la Recherche (Reseau Innovation Biotechnologiesand Microbiologie Immunologie Maladies Emergentes), INSERM, CNRS and Ministeere de l'Enseignement Superieur et de la Recherche and by donations from the Fondation Schlumberger and Fondation BNP Paribas. CB was supported by Fondation de France. SR was supported in part by Northern Ireland Histocompatibility and Immunogenetics Laboratory Research Trust Fund. The sponsors and funders did not participate with the design, conduct of the study, analysis, interpretation of the data, preparation, review or approval of the manuscript.	Andre P, 2001, NAT IMMUNOL, V2, P661, DOI 10.1038/90589; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; BASHIROVA AA, 2006, ANN REV GENOMICS HUM; Besson C, 2006, J CLIN MICROBIOL, V44, P47, DOI 10.1128/JCM.44.1.47-50.2006; Callan MFC, 2004, MICROBES INFECT, V6, P937, DOI 10.1016/j.micinf.2004.04.014; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Cartwright RA, 2004, HEMATOL ONCOL, V22, P11, DOI 10.1002/hon.723; Crum KA, 2000, TISSUE ANTIGENS, V56, P313, DOI 10.1034/j.1399-0039.2000.560403.x; Denis L, 2005, TISSUE ANTIGENS, V66, P267, DOI 10.1111/j.1399-0039.2005.00473.x; Desrosiers MP, 2005, NAT GENET, V37, P593, DOI 10.1038/ng1564; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Eidenschenk C, 2006, AM J HUM GENET, V78, P721, DOI 10.1086/503269; Ferraris AM, 1997, ANN HEMATOL, V74, P131, DOI 10.1007/s002770050270; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Gandhi MK, 2004, BRIT J HAEMATOL, V125, P267, DOI 10.1111/j.1365-2141.2004.04902.x; Goldin LR, 2005, J MED GENET, V42, P595, DOI 10.1136/jmg.2004.027433; GRUFFERMAN S, 1977, NEW ENGL J MED, V296, P248, DOI 10.1056/NEJM197702032960504; Halfpenny IA, 2004, HUM IMMUNOL, V65, P602, DOI 10.1016/j.humimm.2004.03.003; Harty LC, 2002, BLOOD, V99, P690, DOI 10.1182/blood.V99.2.690; Hjalgrim H, 2003, NEW ENGL J MED, V349, P1324, DOI 10.1056/NEJMoa023141; Hjalgrim H, 2001, LANCET, V358, P297, DOI 10.1016/S0140-6736(01)05498-8; HORS J, 1983, IMMUNOL REV, V70, P167, DOI 10.1111/j.1600-065X.1983.tb00714.x; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Kovacic MB, 2005, CANCER EPIDEM BIOMAR, V14, P2673, DOI 10.1158/1055-9965.EPI-05-0229; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Loh J, 2005, J VIROL, V79, P661, DOI 10.1128/JVI.79.1.661-667.2005; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; MACK TM, 1995, NEW ENGL J MED, V332, P413, DOI 10.1056/NEJM199502163320701; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Maxwell LD, 2004, HUM IMMUNOL, V65, P613, DOI 10.1016/j.humimm.2004.02.028; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; MENDEZ AGH, 2006, TISSUE ANTI IN PRESS; MIDDLETON D, 1995, TISSUE ANTIGENS, V45, P232, DOI 10.1111/j.1399-0039.1995.tb02445.x; Middleton D, 2005, TRANSPL IMMUNOL, V14, P135, DOI 10.1016/j.trim.2005.03.002; MUELLER N, 1989, NEW ENGL J MED, V320, P689, DOI 10.1056/NEJM198903163201103; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; Pappworth IY, 2007, J VIROL, V81, P474, DOI 10.1128/JVI.01777-06; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Re D, 2005, J CLIN ONCOL, V23, P6379, DOI 10.1200/JCO.2005.55.013; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Shugart YY, 2000, HUM GENET, V106, P553, DOI 10.1007/s004390050024; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102; Thomas RK, 2004, LANCET ONCOL, V5, P11, DOI 10.1016/S1470-2045(03)01319-6; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Williams F, 2004, HUM IMMUNOL, V65, P31, DOI 10.1016/j.humimm.2003.10.009; Williams F, 2002, HUM IMMUNOL, V63, P602, DOI 10.1016/S0198-8859(02)00408-1; Williams H, 2005, BRIT J HAEMATOL, V129, P266, DOI 10.1111/j.1365-2141.2005.05452.x	59	53	57	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e406	10.1371/journal.pone.0000406	http://dx.doi.org/10.1371/journal.pone.0000406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476328	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445700008
J	Knox, S; Ge, H; Dimitroff, BD; Ren, Y; Howe, KA; Arsham, AM; Easterday, MC; Neufeld, TP; O'Connor, MB; Selleck, SB				Knox, Sarah; Ge, Hong; Dimitroff, Brian D.; Ren, Yi; Howe, Katie A.; Arsham, Andrew M.; Easterday, Mathew C.; Neufeld, Thomas P.; O'Connor, Michael B.; Selleck, Scott B.			Mechanisms of TSC-mediated Control of Synapse Assembly and Axon Guidance	PLOS ONE			English	Article							CELL-GROWTH; DROSOPHILA TARGET; II RECEPTOR; SIZE; PROLIFERATION; PATHWAY; NUMBER; GIGAS; RHEB; MORPHOLOGY	Tuberous sclerosis complex is a dominant genetic disorder produced by mutations in either of two tumor suppressor genes, TSC1 and TSC2; it is characterized by hamartomatous tumors, and is associated with severe neurological and behavioral disturbances. Mutations in TSC1 or TSC2 deregulate a conserved growth control pathway that includes Ras homolog enriched in brain (Rheb) and Target of Rapamycin (TOR). To understand the function of this pathway in neural development, we have examined the contributions of multiple components of this pathway in both neuromuscular junction assembly and photoreceptor axon guidance in Drosophila. Expression of Rheb in the motoneuron, but not the muscle of the larval neuromuscular junction produced synaptic overgrowth and enhanced synaptic function, while reductions in Rheb function compromised synapse development. Synapse growth produced by Rheb is insensitive to rapamycin, an inhibitor of Tor complex 1, and requires wishful thinking, a bone morphogenetic protein receptor critical for functional synapse expansion. In the visual system, loss of Tsc1 in the developing retina disrupted axon guidance independently of cellular growth. Inhibiting Tor complex 1 with rapamycin or eliminating the Tor complex 1 effector, S6 kinase (S6k), did not rescue axon guidance abnormalities of Tsc1 mosaics, while reductions in Tor function suppressed those phenotypes. These findings show that Tsc-mediated control of axon guidance and synapse assembly occurs via growth-independent signaling mechanisms, and suggest that Tor complex 2, a regulator of actin organization, is critical in these aspects of neuronal development.	[Knox, Sarah; Ge, Hong; Dimitroff, Brian D.; Ren, Yi; Howe, Katie A.; Easterday, Mathew C.; Selleck, Scott B.] Univ Minnesota, Dept Pediat, Ctr Dev Biol, Minneapolis, MN 55455 USA; [Dimitroff, Brian D.; Ren, Yi; Howe, Katie A.; Arsham, Andrew M.; Easterday, Mathew C.; Neufeld, Thomas P.; O'Connor, Michael B.; Selleck, Scott B.] Univ Minnesota, Ctr Dev Biol, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Selleck, SB (corresponding author), Univ Minnesota, Dept Pediat, Ctr Dev Biol, Minneapolis, MN 55455 USA.	selle011@umn.edu	O'Connor, Michael B/C-9977-2014	O'Connor, Michael B/0000-0002-3067-5506; Arsham, Andrew/0000-0002-5274-8710; Neufeld, Thomas/0000-0001-5659-4811	NIH [GM54832-09, RO1 GMO62509]; Martin Lenz Harrison Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054832, R01GM062509] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martin Lenz Harrison Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH contract grant number GM54832-09 to SBS, the Martin Lenz Harrison Endowment to SBS, and NIH grant RO1 GMO62509 to TN. MBO is an investigator with the Howard Hughes Medical Institute.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Acebes A, 2001, J NEUROSCI, V21, P6264, DOI 10.1523/JNEUROSCI.21-16-06264.2001; ANG LH, 2006, DEV BIOL; Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028; Blair SS, 2000, DROSOPHILA PROTOCOLS, P159; Canal I, 1998, J NEUROSCI, V18, P999; Chalhoub N, 2006, BRAIN RES, V1100, P32, DOI 10.1016/j.brainres.2006.05.013; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Ess Kevin C, 2006, Semin Pediatr Neurol, V13, P37, DOI 10.1016/j.spen.2006.01.009; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Huang H, 1999, DEVELOPMENT, V126, P5365; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; Mast JD, 2006, SEMIN CELL DEV BIOL, V17, P42, DOI 10.1016/j.semcdb.2005.11.004; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; MEINERTZHAGEN IA, 1994, J NEUROGENET, V9, P157, DOI 10.3109/01677069409167277; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Neufeld TP, 2003, CURR TOP MICROBIOL, V279, P139; Newsome TP, 2000, DEVELOPMENT, V127, P851; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Rao Y, 2005, INT J BIOL SCI, V1, P80; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; von der Brelie C, 2006, EUR J NEUROSCI, V23, P686, DOI 10.1111/j.1460-9568.2006.04594.x; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979	47	41	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e375	10.1371/journal.pone.0000375	http://dx.doi.org/10.1371/journal.pone.0000375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440611	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445500006
J	Zhang, KL; Mangeat, B; Ortiz, M; Zoete, V; Trono, D; Telenti, A; Michielin, O				Zhang, Kun-Lin; Mangeat, Bastien; Ortiz, Millan; Zoete, Vincent; Trono, Didier; Telenti, Amalio; Michielin, Olivier			Model Structure of Human APOBEC3G	PLOS ONE			English	Article								Background. APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G) has antiretroviral activity associated with the hypermutation of viral DNA through cytosine deamination. APOBEC3G has two cytosine deaminase (CDA) domains; the catalytically inactive amino-terminal domain of APOBEC3G (N-CDA) carries the Vif interaction domain. There is no 3-D structure of APOBEC3G solved by X-ray or nuclear magnetic resonance. Methodology/Principal Findings. We predicted the structure of human APOBEC3G based on the crystal structure of APOBEC2. To assess the model structure, we evaluated 48 mutants of APOBEC3G N-CDA that identify novel variants altering Delta Vif HIV-1 infectivity and packaging of APOBEC3G. Results indicated that the key residue D128 is exposed at the surface of the model, with a negative local electrostatic potential. Mutation D128K changes the sign of that local potential. In addition, two novel functionally relevant residues that result in defective APOBEC3G encapsidation, R122 and W127, cluster at the surface. Conclusions/Significance. The structure model identifies a cluster of residues important for packaging of APOBEC3G into virions, and may serve to guide functional analysis of APOBEC3G.	[Zhang, Kun-Lin; Ortiz, Millan; Telenti, Amalio] Univ Lausanne, Inst Microbiol, Univ Hosp Ctr, Lausanne, Switzerland; [Mangeat, Bastien; Trono, Didier] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Telenti, A (corresponding author), Univ Lausanne, Inst Microbiol, Univ Hosp Ctr, Lausanne, Switzerland.	amalio.telenti@chuv.ch; olivier.michielin@unil.ch	Michielin, Olivier/ABE-7924-2020; Telenti, Amalio/AAY-1674-2021	Mangeat, Bastien/0000-0003-2592-0236	Swiss National Science Foundation [310000-110012/1]; SCORE funds [3232B0-103172, 3200B0-103173]; Faculty of Biology and Medicine of the University of Lausanne; Foundation for advancement in Microbiology and Infectious Diseases	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SCORE funds; Faculty of Biology and Medicine of the University of Lausanne; Foundation for advancement in Microbiology and Infectious Diseases	Supported by Swiss National Science Foundation grant no. 310000-110012/1 (to A. T.), SCORE funds 3232B0-103172 and 3200B0-103173 (to O.M.) and a grant for interdisciplinary research from the Faculty of Biology and Medicine of the University of Lausanne (to A. T. and O.M.). KZ received a postdoctoral award from the Foundation for advancement in Microbiology and Infectious Diseases. The funding agencies had no role in the design or interpretation of the study.	Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; DAVIS ME, 1991, COMPUT PHYS COMMUN, V62, P187, DOI 10.1016/0010-4655(91)90094-2; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Harris RS, 2006, NAT STRUCT MOL BIOL, V13, P380, DOI 10.1038/nsmb0506-380; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; HUTHOFF H, 2007, J VIROL; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; NAVARATNAM N, 1995, CELL, V81, P187, DOI 10.1016/0092-8674(95)90328-3; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Ortiz M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-11; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROCHNOW C, 2006, NATURE; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Scott J, 1998, ATHEROSCLEROSIS, V141, pS17, DOI 10.1016/S0021-9150(98)00213-5; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Yu XF, 2006, CURR OPIN HIV AIDS, V1, P187, DOI 10.1097/01.COH.0000221590.03670.32; Zaim J, 2003, NAT IMMUNOL, V4, P1153, DOI 10.1038/ni1203-1153; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004	45	45	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e378	10.1371/journal.pone.0000378	http://dx.doi.org/10.1371/journal.pone.0000378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440614	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445500009
J	Glezer, I; Chernomoretz, A; David, S; Plante, MM; Rivest, S				Glezer, Isaias; Chernomoretz, Ariel; David, Samuel; Plante, Marie-Michele; Rivest, Serge			Genes Involved in the Balance between Neuronal Survival and Death during Inflammation	PLOS ONE			English	Article								Glucocorticoids are potent regulators of the innate immune response, and alteration in this inhibitory feedback has detrimental consequences for the neural tissue. This study profiled and investigated functionally candidate genes mediating this switch between cell survival and death during an acute inflammatory reaction subsequent to the absence of glucocorticoid signaling. Oligonucleotide microarray analysis revealed that following lipopolysaccharide (LPS) intracerebral administration at striatum level, more modulated genes presented transcription impairment than exacerbation upon glucocorticoid receptor blockage. Among impaired genes we identified ceruloplasmin (Cp), which plays a key role in iron metabolism and is implicated in a neurodegenative disease. Microglial and endothelial induction of Cp is a natural neuroprotective mechanism during inflammation, because Cp-deficient mice exhibited increased iron accumulation and demyelination when exposed to LPS and neurovascular reactivity to pneumococcal meningitis. This study has identified genes that can play a critical role in programming the innate immune response, helping to clarify the mechanisms leading to protection or damage during inflammatory conditions in the CNS.	[Glezer, Isaias; Chernomoretz, Ariel; Plante, Marie-Michele; Rivest, Serge] CHU Laval, Res Ctr, Mol Endocrinol Lab, Laurier, PQ, Canada; [Glezer, Isaias; Chernomoretz, Ariel; Plante, Marie-Michele; Rivest, Serge] Univ Laval, Dept Anat & Physiol, Laurier, PQ, Canada; [Chernomoretz, Ariel] Univ Buenos Aires, FCE&N, Dept Phys, Buenos Aires, DF, Argentina; [David, Samuel] McGill Univ, Montreal Gen Hosp, Ctr Res Neurosci, Res Inst,Hlth Ctr, Montreal, PQ H3G 1A4, Canada	Laval University; Laval University; University of Buenos Aires; McGill University	Rivest, S (corresponding author), CHU Laval, Res Ctr, Mol Endocrinol Lab, Laurier, PQ, Canada.	Serge.Rivest@crchul.ulaval.ca	Glezer, Isaias/D-2867-2013	Glezer, Isaias/0000-0002-9799-1933; Rivest, Serge/0000-0002-6082-770X	Canadian Institutes in Health Research (CIHR); Multiple Sclerosis Society of Canada	Canadian Institutes in Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada	The Canadian Institutes in Health Research (CIHR) supported this research. I. G. is the recipient of a Postdoctoral Fellowship from the Multiple Sclerosis Society of Canada. A. C. is a member of the "Carrera del Investigador'' CONICET Argentina. S. R. holds a Canadian Research Chair in Neuroimmunology.	Aisen PS, 2002, LANCET NEUROL, V1, P279, DOI 10.1016/S1474-4422(02)00133-3; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Dinkel K, 2003, J NEUROCHEM, V84, P705, DOI 10.1046/j.1471-4159.2003.01604.x; Doraiswamy PM, 2004, LANCET NEUROL, V3, P431, DOI 10.1016/S1474-4422(04)00809-9; Fischer M, 2005, NEW ENGL J MED, V353, P2352, DOI 10.1056/NEJMoa051620; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Glezer I, 2004, NEUROSCIENTIST, V10, P538, DOI 10.1177/1073858404263494; Glezer I, 2003, J NEUROSCI, V23, P11094; Glezer I, 2006, FASEB J, V20, P750, DOI 10.1096/fj.05-5234fje; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kwon B, 2003, EXP MOL MED, V35, P8, DOI 10.1038/emm.2003.2; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; LeVine SM, 2004, ANN NY ACAD SCI, V1012, P252, DOI 10.1196/annals.1306.021; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Maier J, 2002, AM J PATHOL, V160, P271, DOI 10.1016/S0002-9440(10)64371-4; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; MIYAJIMA H, 1987, NEUROLOGY, V37, P761, DOI 10.1212/WNL.37.5.761; Mukhopadhyay CK, 1998, SCIENCE, V279, P714, DOI 10.1126/science.279.5351.714; Nadeau S, 2003, J NEUROSCI, V23, P5536, DOI 10.1523/jneurosci.23-13-05536.2003; Nadeau S, 2002, J IMMUNOL, V169, P3370, DOI 10.4049/jimmunol.169.6.3370; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Papassotiropoulos A, 2005, NEURODEGENER DIS, V2, P233, DOI 10.1159/000090362; Patel BN, 2002, J NEUROSCI, V22, P6578; Paxino G, 2001, MOUSE BRAIN STEREOTA; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Simmons CP, 2005, J IMMUNOL, V175, P579, DOI 10.4049/jimmunol.175.1.579; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Soulet D, 2003, J CELL BIOL, V162, P257, DOI 10.1083/jcb.200301097; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Vasseur Sophie, 2003, Mol Cancer, V2, P19, DOI 10.1186/1476-4598-2-19; Vizzardelli C, 2006, EUR J IMMUNOL, V36, P1504, DOI 10.1002/eji.200535488; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zinser E, 2004, J EXP MED, V200, P345, DOI 10.1084/jem.20030973	49	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e310	10.1371/journal.pone.0000310	http://dx.doi.org/10.1371/journal.pone.0000310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375196	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445100012
J	Song, HL; Ramus, SJ; Kjaer, SK; Hogdall, E; DiCioccio, RA; Whittemore, AS; McGuire, V; Hogdall, C; Jacobs, IJ; Easton, DF; Ponder, BAJ; Dunning, AM; Gayther, SA; Pharoah, PDP				Song, Honglin; Ramus, Susan J.; Kjaer, Susanne Kruger; Hogdall, Estrid; DiCioccio, Richard A.; Whittemore, Alice S.; McGuire, Valerie; Hogdall, Claus; Jacobs, Ian J.; Easton, Douglas F.; Ponder, Bruce A. J.; Dunning, Alison M.; Gayther, Simon A.; Pharoah, Paul D. P.			Tagging Single Nucleotide Polymorphisms in the BRIP1 Gene and Susceptibility to Breast and Ovarian Cancer	PLOS ONE			English	Article								Background. BRIP1 interacts with BRCA1 and functions in regulating DNA double strand break repair pathways. Germline BRIP1 mutations are associated with breast cancer and Fanconi anemia. Thus, common variants in the BRIP1 are candidates for breast and ovarian cancer susceptibility. Methods. We used a SNP tagging approach to evaluate the association between common variants (minor allele frequency >= 0.05) in BRIP1 and the risks of breast cancer and invasive ovarian cancer. 12 tagging SNPs (tSNPs) in the gene were identified and genotyped in up to 2,270 breast cancer cases and 2,280 controls from the UK and up to 1,513 invasive ovarian cancer cases and 2,515 controls from the UK, Denmark and USA. Genotype frequencies in cases and controls were compared using logistic regression. Results. Two tSNPs showed a marginal significant association with ovarian cancer: Carriers of the minor allele of rs2191249 were at reduced risk compared with the common homozygotes (Odds Ratio (OR) = 0.90 (95% CI, 0.82-1.0), P-trend = 0.045) and the minor allele of rs4988344 was associated with increased risk (OR = 1.15 (95% CI, 1.02-1.30), P-trend = 0.02). When the analyses were restricted to serous ovarian cancers, these effects became slightly stronger. These results were not significant at the 5% level after adjusting for multiple testing. None of the tSNPs was associated with breast cancer. Conclusions. It is unlikely that common variants in BRIP1 contribute significantly to breast cancer susceptibility. The possible association of rs2191249 and rs4988344 with ovarian cancer risks warrant confirmation in independent case-control studies.	[Song, Honglin; Ponder, Bruce A. J.; Dunning, Alison M.; Pharoah, Paul D. P.] Univ Cambridge, Strangeways Res Lab, Dept Oncol, Canc Res UK, Cambridge, England; [Ramus, Susan J.; Jacobs, Ian J.; Gayther, Simon A.] UCL, Inst Womens Hlth, Translat Res Labs, London WC1E 6BT, England; [Kjaer, Susanne Kruger; Hogdall, Estrid] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [DiCioccio, Richard A.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Whittemore, Alice S.; McGuire, Valerie] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Kjaer, Susanne Kruger; Hogdall, Claus] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; [Easton, Douglas F.] Univ Cambridge, Strangeways Res Lab, Genet Epidemiol Unit, Canc Res UK, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London; Danish Cancer Society; Roswell Park Cancer Institute; Stanford University; Rigshospitalet; University of Copenhagen; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Song, HL (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Oncol, Canc Res UK, Cambridge, England.	honglin@srl.cam.ac.uk	Susan, Ramus/C-1607-2008; Pharoah, Paul/V-6658-2019; Jacobs, Ian J/F-1743-2013; Ramus, Susan/AAG-8352-2019	Pharoah, Paul/0000-0001-8494-732X; Jacobs, Ian J/0000-0002-8112-4624; Ramus, Susan/0000-0003-0005-7798; Hogdall, Claus/0000-0002-5959-8874; Kjaer, Susanne/0000-0002-8347-1398; Dunning, Alison Margaret/0000-0001-6651-7166; Jacobs, Ian/0000-0002-5005-2672; Hogdall, Estrid/0000-0003-4689-5658	Cancer Research UK; Roswell Park Alliance; Danish Cancer Society; National Cancer Institute [CA71766, CA16056, RO1 CA61107]; WellBeing; Eve Appeal; NATIONAL CANCER INSTITUTE [R01CA061107, P30CA016056] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Roswell Park Alliance; Danish Cancer Society(Danish Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); WellBeing; Eve Appeal; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from Cancer Research UK, the Roswell Park Alliance, the Danish Cancer Society and the National Cancer Institute (CA71766 and Core Grant CA16056 and RO1 CA61107). HS was funded by a grant from WellBeing; BAJP is a Gibb Fellow, DFE is a Principal Research Fellow and PDPP is a Senior Clinical Research Fellow of Cancer Research UK; SAG is a HEFCE Funded Senior lecturer; SJR is funded by the Mermaid component of the Eve Appeal.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Callahan R, 1998, BIOCHEM SOC SYMP, P211; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen K C, 1995, J Obstet Gynaecol (Tokyo 1995), V21, P619; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; GARCIACLOSAS M, 2006, HUM GENET; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Lei HX, 2003, INT J CANCER, V104, P389, DOI 10.1002/ijc.10947; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Lewis AG, 2005, BREAST CANCER RES, V7, pR1005, DOI 10.1186/bcr1336; Luo LP, 2002, INT J CANCER, V98, P638, DOI 10.1002/ijc.10214; Lynch HT, 1998, SEMIN ONCOL, V25, P265; Pharoah PDP, 2002, BEST PRACT RES CL OB, V16, P449, DOI 10.1053/beog.2002.0296; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rutter JL, 2003, HUM MUTAT, V22, P121, DOI 10.1002/humu.10238; SEAL S, 2006, NAT GENET; Sigurdson AJ, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-9; Smith P, 2006, GENE CHROMOSOME CANC, V45, P646, DOI 10.1002/gcc.20330; Song HL, 2006, CARCINOGENESIS, V27, P2235, DOI 10.1093/carcin/bgl089; Vahteristo P, 2005, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-19; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	26	51	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2007	2	3							e268	10.1371/journal.pone.0000268	http://dx.doi.org/10.1371/journal.pone.0000268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DM	17342202	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444700003
J	Macleod, ET; Darby, AC; Maudlin, I; Welburn, SC				Macleod, Ewan Thomas; Darby, Alistair Charles; Maudlin, Ian; Welburn, Sue Christina			Factors Affecting Trypanosome Maturation in Tsetse Flies	PLOS ONE			English	Article								Trypanosoma brucei brucei infections which establish successfully in the tsetse fly midgut may subsequently mature into mammalian infective trypanosomes in the salivary glands. This maturation is not automatic and the control of these events is complex. Utilising direct in vivo feeding experiments, we report maturation of T. b. brucei infections in tsetse is regulated by antioxidants as well as environmental stimuli. Dissection of the maturation process provides opportunities to develop transmission blocking vaccines for trypanosomiasis. The present work suggests L-cysteine and/or nitric oxide are necessary for the differentiation of trypanosome midgut infections in tsetse.	[Macleod, Ewan Thomas; Darby, Alistair Charles; Maudlin, Ian; Welburn, Sue Christina] Univ Edinburgh, Ctr Infect Dis, Coll Med & Vet Med, Easter Bush Vet Ctr, Roslin, Midlothian, Scotland	University of Edinburgh	Welburn, SC (corresponding author), Univ Edinburgh, Ctr Infect Dis, Coll Med & Vet Med, Easter Bush Vet Ctr, Roslin, Midlothian, Scotland.	sue.welburn@ed.ac.uk	Darby, Alistair/I-6485-2012; macleod, ewan/AAG-1005-2019	Darby, Alistair/0000-0002-3786-6209; macleod, ewan/0000-0002-5517-0619; Welburn, Susan/0000-0002-9903-7086	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The financial support of the Wellcome Trust is gratefully acknowledged. The funders played no part in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	BASS KE, 1991, MOL BIOCHEM PARASIT, V44, P261, DOI 10.1016/0166-6851(91)90012-U; BURTON V, 1988, MOL CELL BIOL, V8, P3550, DOI 10.1128/MCB.8.8.3550; DALE C, 1995, PARASITOLOGY, V111, P187, DOI 10.1017/S0031182000064933; DENLINGER DL, 1984, COMP BIOCHEM PHYS C, V77, P233, DOI 10.1016/0742-8413(84)90006-9; Dipeolu O O, 1974, Acta Trop, V32, P185; DUSZENKO M, 1992, MOL BIOCHEM PARASIT, V50, P269, DOI 10.1016/0166-6851(92)90224-8; Fairbairn H., 1948, Tropical Diseases Bulletin London, V45, P1; GLAZENBURG EJ, 1984, BIOCHEM PHARMACOL, V33, P625, DOI 10.1016/0006-2952(84)90318-6; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; MACLEOD ET, 2007, PARASITOLOG IN PRESS; MACLEOD ET, 2005, THESIS U EDINBURGH; MAUDLIN I, 1987, TROP MED PARASITOL, V38, P167; MAUDLIN I, 1984, Z PARASITENKD, V70, P11, DOI 10.1007/BF00929570; MAUDLIN I, 1988, TROP MED PARASITOL, V39, P56; MAUDLIN I, 1989, ANN TROP MED PARASIT, V83, P431, DOI 10.1080/00034983.1989.11812368; Milligan PJM, 1995, EXP PARASITOL, V81, P409, DOI 10.1006/expr.1995.1132; MOLOO SK, 1985, ANN TROP MED PARASIT, V79, P223, DOI 10.1080/00034983.1985.11811911; OKOTH JO, 1986, ANN TROP MED PARASIT, V80, P459, DOI 10.1080/00034983.1986.11812048; OTIENO LH, 1983, ACTA TROP, V40, P113; PHELPS RJ, 1969, J APPL ECOL, V6, P323, DOI 10.2307/2401546; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; WELBURN SC, 1987, ANN TROP MED PARASIT, V81, P453, DOI 10.1080/00034983.1987.11812144; Welburn SC, 1997, MED VET ENTOMOL, V11, P286, DOI 10.1111/j.1365-2915.1997.tb00408.x; WELBURN SC, 1989, MED VET ENTOMOL, V3, P141, DOI 10.1111/j.1365-2915.1989.tb00489.x; Welburn SC, 1995, EXP PARASITOL, V81, P404, DOI 10.1006/expr.1995.1131; Whitten MMA, 2001, EXP PARASITOL, V98, P44, DOI 10.1006/expr.2001.4615; Xing RE, 2006, BIOORGAN MED CHEM, V14, P1706, DOI 10.1016/j.bmc.2005.10.018	29	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e239	10.1371/journal.pone.0000239	http://dx.doi.org/10.1371/journal.pone.0000239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17318257	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444500019
J	Janhunen, P; Kaartokallio, H; Oksanen, I; Lehto, K; Lehto, H				Janhunen, Pekka; Kaartokallio, Hermanni; Oksanen, Ilona; Lehto, Kirsi; Lehto, Harry			Biological Feedbacks as Cause and Demise of Neoproterozoic Icehouse: Astrobiological Prospects for Faster Evolution and Importance of Cold Conditions	PLOS ONE			English	Article							SNOWBALL EARTH; ICE SHELF; CARBON; ECOLOGY; CLIMATE; CYANOBACTERIA; ECOSYSTEMS; INITIATION; METHANE; ORIGIN	Several severe glaciations occurred during the Neoproterozoic eon, and especially near its end in the Cryogenian period (630-850 Ma). While the glacial periods themselves were probably related to the continental positions being appropriate for glaciation, the general coldness of the Neoproterozoic and Cryogenian as a whole lacks specific explanation. The Cryogenian was immediately followed by the Ediacaran biota and Cambrian Metazoan, thus understanding the climate-biosphere interactions around the Cryogenian period is central to understanding the development of complex multicellular life in general. Here we present a feedback mechanism between growth of eukaryotic algal phytoplankton and climate which explains how the Earth system gradually entered the Cryogenian icehouse from the warm Mesoproterozoic greenhouse. The more abrupt termination of the Cryogenian is explained by the increase in gaseous carbon release caused by the more complex planktonic and benthic foodwebs and enhanced by a diversification of metazoan zooplankton and benthic animals. The increased ecosystem complexity caused a decrease in organic carbon burial rate, breaking the algal-climatic feedback loop of the earlier Neoproterozoic eon. Prior to the Neoproterozoic eon, eukaryotic evolution took place in a slow timescale regulated by interior cooling of the Earth and solar brightening. Evolution could have proceeded faster had these geophysical processes been faster. Thus, complex life could theoretically also be found around stars that are more massive than the Sun and have main sequence life shorter than 10 Ga. We also suggest that snow and glaciers are, in a statistical sense, important markers for conditions that may possibly promote the development of complex life on extrasolar planets.	[Janhunen, Pekka] Univ Helsinki, Dept Phys Sci, Helsinki, Finland; [Janhunen, Pekka] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; [Kaartokallio, Hermanni] Finnish Inst Marine Res, Helsinki, Finland; [Oksanen, Ilona] Univ Helsinki, Dept Appl Chem & Microbiol, Helsinki, Finland; [Oksanen, Ilona] Univ Stockholm, Dept Bot, S-10691 Stockholm, Sweden; [Lehto, Kirsi; Lehto, Harry] Nord Inst Theoret Phys NORDITA, Copenhagen, Denmark; [Lehto, Kirsi] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Lehto, Harry] Univ Turku, Tuorla Observ, Turku, Finland	University of Helsinki; Finnish Meteorological Institute; University of Helsinki; Stockholm University; Nordic Institute for Theoretical Physics; University of Turku; University of Turku	Janhunen, P (corresponding author), Univ Helsinki, Dept Phys Sci, Helsinki, Finland.	pekka.janhunen@fmi.fi	Kaartokallio, Hermanni/D-1143-2010	Janhunen, Pekka/0000-0001-5650-8039				Bartley JK, 2004, GEOLOGY, V32, P129, DOI 10.1130/G19939.1; Bodiselitsch B, 2005, SCIENCE, V308, P239, DOI 10.1126/science.1104657; Butterfield NJ, 1997, PALEOBIOLOGY, V23, P247, DOI 10.1017/S009483730001681X; Chandler MA, 2000, J GEOPHYS RES-ATMOS, V105, P20737, DOI 10.1029/2000JD900221; Deynoux M., 2004, EARTHS GLACIAL RECOR; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fedonkin Mikhail A., 2003, Paleontological Research, V7, P9, DOI 10.2517/prpsj.7.9; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hyde WT, 2000, NATURE, V405, P425, DOI 10.1038/35013005; Kasting JF, 2005, PRECAMBRIAN RES, V137, P119, DOI 10.1016/j.precamres.2005.03.002; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; KNOLL AH, 1994, P NATL ACAD SCI USA, V91, P6743, DOI 10.1073/pnas.91.15.6743; Knoll AH, 1996, NATURE, V382, P111, DOI 10.1038/382111a0; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Lenton TM, 2002, PHILOS T R SOC B, V357, P683, DOI 10.1098/rstb.2001.1014; Olcott AN, 2005, SCIENCE, V310, P471, DOI 10.1126/science.1115769; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Schrag DP, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000219; Shaviv NirJ., 2003, GSA TODAY, V137, P4, DOI DOI 10.1130/1052-5173(2003)013; STAL LJ, 1995, NEW PHYTOL, V131, P1, DOI 10.1111/j.1469-8137.1995.tb03051.x; STANLEY SM, 1973, P NATL ACAD SCI USA, V70, P1486, DOI 10.1073/pnas.70.5.1486; Tajika E, 2003, EARTH PLANET SC LETT, V214, P443, DOI 10.1016/S0012-821X(03)00396-0; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Vincent WF, 2000, NATURWISSENSCHAFTEN, V87, P137, DOI 10.1007/s001140050692; Vincent WF, 2004, CRYOBIOLOGY, V48, P103, DOI 10.1016/j.cryobiol.2004.01.006; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	30	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e214	10.1371/journal.pone.0000214	http://dx.doi.org/10.1371/journal.pone.0000214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299594	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444400015
J	Immler, S; Moore, HDM; Breed, WG; Birkhead, TR				Immler, Simone; Moore, Harry D. M.; Breed, William G.; Birkhead, Tim R.			By Hook or by Crook? Morphometry, Competition and Cooperation in Rodent Sperm	PLOS ONE			English	Article							PLAINS MOUSE; EVOLUTION; SPERMATOZOA; SIZE; MIDPIECE; MOTILITY; HEAD	Background. Sperm design varies enormously across species and sperm competition is thought to be a major factor influencing this variation. However, the functional significance of many sperm traits is still poorly understood. The sperm of most murid rodents are characterised by an apical hook of the sperm head that varies markedly in extent across species. In the European woodmouse Apodemus sylvaticus(Muridae), the highly reflected apical hook of sperm is used to form sperm groups, or "trains,'' which exhibited increased swimming velocity and thrusting force compared to individual sperm. Methodology/Principal Findings. Here we use a comparative study of murine rodent sperm and demonstrate that the apical hook and sperm cooperation are likely to be general adaptations to sperm competition in rodents. We found that species with relatively larger testes, and therefore more intense sperm competition, have a longer, more reflected apical sperm hook. In addition, we show that sperm groups also occur in rodents other than the European woodmouse. Conclusions. Our results suggest that in rodents sperm cooperation is more widespread than assumed so far and highlight the importance of diploid versus haploid selection in the evolution of sperm design and function.	[Immler, Simone; Birkhead, Tim R.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Breed, William G.] Univ Adelaide, Fac Hlth Sci, Sch Med Sci, Discipline Anat Sci, Adelaide, SA 5005, Australia	University of Sheffield; University of Adelaide	Immler, S (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	s.immler@sheffield.ac.uk	Immler, Simone/F-8708-2014; Immler, Simone/A-1707-2014	Breed, William/0000-0003-1739-6593	Roche Research Foundation	Roche Research Foundation	This study was funded by a grant from the Roche Research Foundation to SI and TRB.	Anderson MJ, 2005, J ZOOL, V267, P135, DOI 10.1017/S0952836905007284; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Breed WG, 2004, J MORPHOL, V261, P52, DOI 10.1002/jmor.10228; Breed WG, 2000, J MAMMAL, V81, P758, DOI 10.1644/1545-1542(2000)081&lt;0758:BMTMAS&gt;2.3.CO;2; COHEN J, 1977, REPRODUCTION; Cohen J.E., 1988, STAT POWER ANAL BEHA; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; FLAHERTY SP, 1983, J EXP ZOOL, V225, P497, DOI 10.1002/jez.1402250318; FLAHERTY SP, 1987, ANAT REC, V217, P240, DOI 10.1002/ar.1092170304; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; HAIG D, 1995, J EVOLUTION BIOL, V8, P265, DOI 10.1046/j.1420-9101.1995.8030265.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Hayashi F, 1998, FUNCT ECOL, V12, P347, DOI 10.1046/j.1365-2435.1998.00205.x; HOLLOWAY AJ, 1990, FUND APPL TOXICOL, V14, P113, DOI 10.1016/0272-0590(90)90237-E; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; Jamieson B.G., 1987, ULTRASTRUCTURE PHYLO; JAMIESON BGM, 1987, NEW HORIZONS SPERM C, P311; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; MCGREGOR L, 1989, GAMETE RES, V23, P279, DOI 10.1002/mrd.1120230305; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; MOORE HDM, 1995, BIOL REPROD, V52, P947, DOI 10.1095/biolreprod52.4.947; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P255, DOI 10.1098/rspb.1993.0111; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pitnick S, 2001, P ROY SOC B-BIOL SCI, V268, P1071, DOI 10.1098/rspb.2001.1621; Pizzari T, 2002, BIOL REV, V77, P183, DOI 10.1017/S1464793101005863; Ramm SA, 2005, P ROY SOC B-BIOL SCI, V272, P949, DOI 10.1098/rspb.2004.3048; ROHLF FJ, 1992, EFA VERSION 1 33; Rohlf FJ, 2004, TPSUTIL FILE UTILITY; ROLDAN ERS, 1992, BIOL REV, V67, P551, DOI 10.1111/j.1469-185X.1992.tb01193.x; Sivinsky J., 1984, SPERM COMPETITION EV, P86; SMITH TT, 1990, BIOL REPROD, V42, P450, DOI 10.1095/biolreprod42.3.450; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; VOSS R, 1979, Occasional Papers of the Museum of Zoology University of Michigan, P1; Woolley DM, 2003, REPRODUCTION, V126, P259, DOI 10.1530/rep.0.1260259	36	103	108	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e170	10.1371/journal.pone.0000170	http://dx.doi.org/10.1371/journal.pone.0000170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17245446	Green Published, Green Accepted, gold			2022-12-27	WOS:000207444100007
J	Farjo, R; Skaggs, J; Quiambao, AB; Cooper, MJ; Naash, MI				Farjo, Rafal; Skaggs, Jeff; Quiambao, Alexander B.; Cooper, Mark J.; Naash, Muna I.			Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles	PLOS ONE			English	Article								Background. The eye is an excellent candidate for gene therapy as it is immune privileged and much of the disease-causing genetics are well understood. Towards this goal, we evaluated the efficiency of compacted DNA nanoparticles as a system for non-viral gene transfer to ocular tissues. The compacted DNA nanoparticles examined here have been shown to be safe and effective in a human clinical trial, have no theoretical limitation on plasmid size, do not provoke immune responses, and can be highly concentrated. Methods and Findings. Here we show that these nanoparticles can be targeted to different tissues within the eye by varying the site of injection. Almost all cell types of the eye were capable of transfection by the nanoparticle and produced robust levels of gene expression that were dose-dependent. Most impressively, subretinal delivery of these nanoparticles transfected nearly all of the photoreceptor population and produced expression levels almost equal to that of rod opsin, the highest expressed gene in the retina. Conclusions. As no deleterious effects on retinal function were observed, this treatment strategy appears to be clinically viable and provides a highly efficient non-viral technology to safely deliver and express nucleic acids in the retina and other ocular tissues.	[Farjo, Rafal; Skaggs, Jeff; Quiambao, Alexander B.; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73190 USA; [Cooper, Mark J.] Copernicus Therapeut Inc, Cleveland, OH USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73190 USA.	muna-naash@ouhsc.edu			National Institutes of Health [EY016201, EY10609, EY12190]; Foundation Fighting Blindness; Oklahoma Center for the Advancement of Science and Technology; Research to Prevent Blindness James S. Adams Scholar; NATIONAL EYE INSTITUTE [R01EY010609, R56EY010609, P30EY012190, R55EY010609, R03EY016201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Oklahoma Center for the Advancement of Science and Technology; Research to Prevent Blindness James S. Adams Scholar; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This study was supported by grants from the National Institutes of Health (EY016201 and EY10609, and Core Grant for Vision Research EY12190), the Foundation Fighting Blindness, and the Oklahoma Center for the Advancement of Science and Technology. M. I. Naash is a recipient of the Research to Prevent Blindness James S. Adams Scholar Award.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre G D, 1998, Mol Vis, V4, P23; Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Atencio IA, 2004, CURR OPIN MOL THER, V6, P624; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Bauer S, 2005, DNA CELL BIOL, V24, P381, DOI 10.1089/dna.2005.24.381; Baum C, 2006, HUM GENE THER, V17, P253, DOI 10.1089/hum.2006.17.253; Bennett J, 2006, HUM GENE THER, V17, P177, DOI 10.1089/hum.2006.17.177; Bennett J, 1999, P NATL ACAD SCI USA, V96, P9920, DOI 10.1073/pnas.96.17.9920; Bennett J, 1996, NAT MED, V2, P649, DOI 10.1038/nm0696-649; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Cashman SM, 2005, GENE THER, V12, P1223, DOI 10.1038/sj.gt.3302512; Chen Y, 2006, INVEST OPHTH VIS SCI, V47, P1177, DOI 10.1167/iovs.05-0965; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Dinculescu A, 2005, HUM GENE THER, V16, P649, DOI 10.1089/hum.2005.16.649; Drenser KA, 1998, INVEST OPHTH VIS SCI, V39, P681; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; Ferreira PA, 2005, HUM MOL GENET, V14, pR259, DOI 10.1093/hmg/ddi272; FINK TL, 2006, GENE THER EPUB; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; Hong DH, 2005, INVEST OPHTH VIS SCI, V46, P435, DOI 10.1167/iovs.04-1065; Jun AS, 2003, EYE, V17, P906, DOI 10.1038/sj.eye.6700565; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Konstan MW, 2004, HUM GENE THER, V15, P1255, DOI 10.1089/hum.2004.15.1255; Kowalczyk T, 2001, MOL THER, V3, pS359; Kube D, 2003, MOL THER, V7, pS371; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200; Liu G, 2001, J BIOL CHEM, V276, P34379, DOI 10.1074/jbc.M105250200; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Martin AC, 2004, INVEST OPHTH VIS SCI, V45, P3387, DOI 10.1167/iovs.04-0349; Martin KRG, 2004, EYE, V18, P1049, DOI 10.1038/sj.eye.6701579; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; NAASH MI, 2006, MOL THER, pS882; Narfstrom K, 2005, DOC OPHTHALMOL, V111, P39, DOI [10.1007/s10633-005-3159-0, 10.1007/S10633-005-3159-0]; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P15, DOI 10.1167/iovs.03-0663; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Pan QW, 2006, MOL THER, V13, pS398, DOI 10.1016/j.ymthe.2006.08.1133; Peeters L, 2005, INVEST OPHTH VIS SCI, V46, P3553, DOI 10.1167/iovs.05-0165; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Rolling F, 2004, GENE THER, V11, pS26, DOI 10.1038/sj.gt.3302366; Rosenfeld PJ, 2006, OPHTHALMOLOGY, V113, P623, DOI 10.1016/j.ophtha.2006.01.027; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154; Ziady AG, 2003, MOL THER, V8, P936, DOI 10.1016/j.ymthe.2003.07.007; Ziady AG, 2003, MOL THER, V8, P948, DOI 10.1016/j.ymthe.2003.09.002	61	164	173	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e38	10.1371/journal.pone.0000038	http://dx.doi.org/10.1371/journal.pone.0000038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183666	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600038
J	Yan, JZ; Chen, YX; Desmond, A; Silva, A; Yang, YQ; Wang, HR; Hua, XX				Yan, Jizhou; Chen, Ya-Xiong; Desmond, Angela; Silva, Albert; Yang, Yuqing; Wang, Haoren; Hua, Xianxin			Cdx4 and Menin Co-Regulate Hoxa9 Expression in Hematopoietic Cells	PLOS ONE			English	Article								Background. Transcription factor Cdx4 and transcriptional coregulator menin are essential for Hoxa9 expression and normal hematopoiesis. However, the precise mechanism underlying Hoxa9 regulation is not clear. Methods and Findings. Here, we show that the expression level of Hoxa9 is correlated with the location of increased trimethylated histone 3 lysine 4 (H3K4M3). The active and repressive histone modifications co-exist along the Hoxa9 regulatory region. We further demonstrate that both Cdx4 and menin bind to the same regulatory region at the Hoxa9 locus in vivo, and co-activate the reporter gene driven by the Hoxa9 cis-elements that contain Cdx4 binding sites. Ablation of menin abrogates Cdx4 access to the chromatin target and significantly reduces both active and repressive histone H3 modifications in the Hoxa9 locus. Conclusion. These results suggest a functional link among Cdx4, menin and histone modifications in Hoxa9 regulation in hematopoietic cells.	[Yan, Jizhou; Chen, Ya-Xiong; Desmond, Angela; Silva, Albert; Yang, Yuqing; Wang, Haoren; Hua, Xianxin] Univ Penn, Abramson Canc Ctr, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Hua, XX (corresponding author), Univ Penn, Abramson Canc Ctr, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	huax@mail.med.upenn.edu		Yan, Jizhou/0000-0001-7482-7842	NIH [CA100912]; Burroughs Wellcome Career Award; NATIONAL CANCER INSTITUTE [R01CA100912] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was in part supported by NIH grant (CA100912 to XH) and the Burroughs Wellcome Career Award (XH).	Araten DJ, 2005, CANCER RES, V65, P8111, DOI 10.1158/0008-5472.CAN-04-1198; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Dobson CL, 1999, EMBO J, V18, P3564, DOI 10.1093/emboj/18.13.3564; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gaunt SJ, 2005, INT J DEV BIOL, V49, P901, DOI 10.1387/ijdb.052021sg; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gregory PA, 2006, PHARMACOGENET GENOM, V16, P527, DOI 10.1097/01.fpc.0000215068.06471.35; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jin SH, 2003, CANCER RES, V63, P4204; Johnson JJ, 2003, BLOOD, V101, P3229, DOI 10.1182/blood-2002-05-1515; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lavau C, 2000, P NATL ACAD SCI USA, V97, P10984, DOI 10.1073/pnas.190167297; Lavau C, 2000, EMBO J, V19, P4655, DOI 10.1093/emboj/19.17.4655; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Lawrence HJ, 1999, LEUKEMIA, V13, P1993, DOI 10.1038/sj.leu.2401578; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Lemmens IH, 2001, BIOCHEM BIOPH RES CO, V286, P426, DOI 10.1006/bbrc.2001.5405; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Luzzatto L, 2001, EUR J CANCER, V37, pS114; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; Martin ME, 2003, CANCER CELL, V4, P197, DOI 10.1016/S1535-6108(03)00214-9; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Moore MAS, 2005, EXP HEMATOL, V33, P719, DOI 10.1016/j.exphem.2005.04.011; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Owens BM, 2002, STEM CELLS, V20, P364, DOI 10.1634/stemcells.20-5-364; Pollard SL, 2000, CURR BIOL, V10, P1059, DOI 10.1016/S0960-9822(00)00676-X; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schnepp RW, 2004, CANCER RES, V64, P6791, DOI 10.1158/0008-5472.CAN-04-0724; Schnepp RW, 2004, J BIOL CHEM, V279, P10685, DOI 10.1074/jbc.M308073200; SORENSEN PHB, 1994, J CLIN INVEST, V93, P429, DOI 10.1172/JCI116978; Tabaries S, 2005, MOL CELL BIOL, V25, P1389, DOI 10.1128/MCB.25.4.1389-1401.2005; van Dijk K, 2005, PLANT CELL, V17, P2439, DOI 10.1105/tpc.105.034165; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015	59	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e47	10.1371/journal.pone.0000047	http://dx.doi.org/10.1371/journal.pone.0000047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183676	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600047
J	Zaleskas, VM; Krause, DS; Lazarides, K; Patel, N; Hu, YG; Li, SG; Van Etten, RA				Zaleskas, Virginia M.; Krause, Daniela S.; Lazarides, Katherine; Patel, Nihal; Hu, Yiguo; Li, Shaoguang; Van Etten, Richard A.			Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617F	PLOS ONE			English	Article								Background. A somatic activating mutation (V617F) in the JAK2 tyrosine kinase was recently discovered in the majority of patients with polycythemia vera (PV), and some with essential thrombocythemia (ET) and chronic idiopathic myelofibrosis. However, the role of mutant JAK2 in disease pathogenesis is unclear. Methods and Findings. We expressed murine JAK2 WT or V617F via retroviral bone marrow transduction/transplantation in the hematopoietic system of two different inbred mouse strains, Balb/c and C57Bl/6 (B6). In both strains, JAK2 V617F, but not JAK2 WT, induced non-fatal polycythemia characterized by increased hematocrit and hemoglobin, reticulocytosis, splenomegaly, low plasma erythropoietin (Epo), and Epo-independent erythroid colonies. JAK2 V617F also induced leukocytosis and neutrophilia that was much more prominent in Balb/c mice than in B6. Platelet counts were not affected in either strain despite expression of JAK2 V617F in megakaryocytes and markedly prolonged tail bleeding times. The polycythemia tended to resolve after several months, coincident with increased spleen and marrow fibrosis, but was resurrected by transplantation to secondary recipients. Using donor mice with mutations in Lyn, Hck, and Fgr, we demonstrated that the polycythemia was independent of Src kinases. Polycythemia and reticulocytosis responded to treatment with imatinib or a JAK2 inhibitor, but were unresponsive to the Src inhibitor dasatinib. Conclusions. These findings demonstrate that JAK2 V617F induces Epo-independent expansion of the erythroid lineage in vivo. The fact that the central erythroid features of PV are recapitulated by expression of JAK2 V617F argues that it is the primary and direct cause of human PV. The lack of thrombocytosis suggests that additional events may be required for JAK2 V617F to cause ET, but qualitative platelet abnormalities induced by JAK2 V617F may contribute to the hemostatic complications of PV. Despite the role of Src kinases in Epo signaling, our studies predict that Src inhibitors will be ineffective for therapy of PV. However, we provide proof-of-principle that a JAK2 inhibitor should have therapeutic effects on the polycythemia, and perhaps myelofibrosis and hemostatic abnormalities, suffered by MPD patients carrying the JAK2 V617F mutation.	[Zaleskas, Virginia M.; Krause, Daniela S.; Lazarides, Katherine; Patel, Nihal; Van Etten, Richard A.] Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Hu, Yiguo; Li, Shaoguang] Jackson Lab, Bar Harbor, ME 04609 USA	Tufts Medical Center; Jackson Laboratory	Van Etten, RA (corresponding author), Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA.	rvanetten@tufts-nemc.org			NIH [CA90576, HL56949, T32CA009429, CA11419]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA090576, T32CA009429] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH grants CA90576 and HL56949 (to R. A. V.), T32CA009429 (to V.Z.) and CA11419 (to S. L.), and by a SCOR grant from the Leukemia and Lymphoma Society (to R. A. V.).	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellanne-Chantelot C, 2006, BLOOD, V108, P346, DOI 10.1182/blood-2005-12-4852; Campbell PJ, 2006, METH MOLEC MED, V125, P253; Campbell PJ, 2006, BLOOD, V107, P2098, DOI 10.1182/blood-2005-08-3395; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; Cario H, 2005, BRIT J HAEMATOL, V130, P800, DOI 10.1111/j.1365-2141.2005.05683.x; CORREA PN, 1994, BLOOD, V83, P99; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; Drachman JG, 1997, BLOOD, V89, P483, DOI 10.1182/blood.V89.2.483; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Ingley E, 2005, ONCOGENE, V24, P336, DOI 10.1038/sj.onc.1208199; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2006, BLOOD, V107, P3339, DOI 10.1182/blood-2005-09-3917; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Ramakrishnan V, 1999, P NATL ACAD SCI USA, V96, P13336, DOI 10.1073/pnas.96.23.13336; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Roumiantsev S, 2004, CANCER CELL, V5, P287, DOI 10.1016/S1535-6108(04)00053-4; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Tefferi A, 2006, CANCER-AM CANCER SOC, V106, P631, DOI 10.1002/cncr.21645; Temerinac S, 2000, BLOOD, V95, P2569; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Westervelt P, 1999, BLOOD, V93, P2143, DOI 10.1182/blood.V93.7.2143.407a32_2143_2148; Wolff NC, 2005, BLOOD, V105, P3995, DOI 10.1182/blood-2004-09-3534; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Xu MJ, 2003, BLOOD, V102, P4354, DOI 10.1182/blood-2003-04-1308; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	48	186	195	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e18	10.1371/journal.pone.0000018	http://dx.doi.org/10.1371/journal.pone.0000018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183644	gold, Green Published			2022-12-27	WOS:000207443600018
J	Nawroth, R; van Zante, A; Cervantes, S; McManus, M; Hebrok, M; Rosen, SD				Nawroth, Roman; van Zante, Annemieke; Cervantes, Sara; McManus, Michael; Hebrok, Matthias; Rosen, Steven D.			Extracellular Sulfatases, Elements of the Wnt Signaling Pathway, Positively Regulate Growth and Tumorigenicity of Human Pancreatic Cancer Cells	PLOS ONE			English	Article								Background. Heparan sulfate proteoglycans (HSPGs) are control elements in Wnt signaling, which bind extracellularly to Wnt ligands and regulate their ability to interact with signal transduction receptors on the cell surface. Sulf-1 and Sulf-2 are novel extracellular sulfatases that act on internal glucosamine-6-sulfate (6S) modifications within HSPGs and thereby modulate HSPG interactions with various signaling molecules, including Wnt ligands. Emerging evidence indicates the importance of reactivated Wnt signaling in a number of cancers, including pancreatic adenocarcinoma. Principle Findings. Both Sulf proteins were upregulated in human pancreatic adenocarcinoma tumors and were broadly expressed in human pancreatic adenocarcinoma cell lines. Expression of human extracellular sulfatases Sulf-1 and Sulf-2 enhanced Wnt signaling in a reconstituted system. Three of four pancreatic adenocarcinoma cell lines tested exhibited autocrine Wnt signaling, in that extracellular Wnt ligands were required to initiate downstream Wnt signaling. Exposure of these pancreatic adenocarcinoma cells to a catalytically inactive form of Sulf-2 or siRNA-mediated silencing of endogenous Sulf-2 inhibited both Wnt signaling and cell growth. Sulf-2 silencing in two of these lines resulted in markedly reduced tumorigenesis in immunocompromised mice. Conclusions/Significance. We have identified the Sulfs as potentiators of autocrine Wnt signaling in pancreatic cancer cells and have demonstrated their contribution to the growth and tumorigenicity of these cells. Since the Sulfs are extracellular enzymes, they would be attractive targets for therapy of pancreatic cancer. Our results run counter to the prevailing view in the literature that the Sulfs are negative regulators of tumorigenesis.	[Nawroth, Roman; Rosen, Steven D.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [van Zante, Annemieke] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Cervantes, Sara; McManus, Michael; Hebrok, Matthias] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Hebrok, Matthias; Rosen, Steven D.] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Rosen, SD (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	steven.rosen@ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Rosen, Steven/0000-0002-6245-701X	Susan Komen Breast Cancer Foundation [PDF0402844]; German Research Foundation [NA439/1-1]; Ministerio de Educacion, Cultura y Deporte of the Spanish Government (SC); National Institute of Health [GM57411, CA122025, HL075602, CA112537]; NATIONAL CANCER INSTITUTE [R21CA122025, R01CA112537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057411] Funding Source: NIH RePORTER	Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); German Research Foundation(German Research Foundation (DFG)); Ministerio de Educacion, Cultura y Deporte of the Spanish Government (SC); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by a Susan Komen Breast Cancer Foundation Grant PDF0402844 (RN and SDR), the German Research Foundation Grant NA439/1-1 (RN), Ministerio de Educacion, Cultura y Deporte of the Spanish Government (SC) and National Institute of Health Grants GM57411 (SDR), CA122025 (SDR), HL075602 (SDR) and CA112537 (MH). The preparation of the lentiviruses was subsidized by the Sandler Lentivirus Core Facility at UCSF. The sponsors had no role in design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Chada S, 2005, MOL THER, V11, P724, DOI 10.1016/j.ymthe.2004.12.021; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Galli LM, 2006, DEV DYNAM, V235, P681, DOI 10.1002/dvdy.20681; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; He B, 2005, CANCER RES, V65, P743; Heller RS, 2003, GENE EXPRESSION, V11, P141, DOI 10.3727/000000003108749035; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Kakinuma Y, 2004, J NEUROSCI RES, V77, P653, DOI 10.1002/jnr.20197; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Laheru D, 2005, NAT REV CANCER, V5, P459, DOI 10.1038/nrc1630; Lai JP, 2006, GASTROENTEROLOGY, V130, P2130, DOI 10.1053/j.gastro.2006.02.056; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lowy AM, 2003, ANN SURG ONCOL, V10, P284, DOI 10.1245/ASO.2003.05.003; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; Marcao A, 2003, BIOCHEM BIOPH RES CO, V306, P293, DOI 10.1016/S0006-291X(03)00969-0; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2003, TRENDS GLYCOSCI GLYC, V15, P159, DOI 10.4052/tigg.15.159; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Ohto T, 2002, GENES CELLS, V7, P173, DOI 10.1046/j.1356-9597.2001.00502.x; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Su AI, 2001, CANCER RES, V61, P7388; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	50	141	143	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e392	10.1371/journal.pone.0000392	http://dx.doi.org/10.1371/journal.pone.0000392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460759	Green Published, gold			2022-12-27	WOS:000207445600006
J	Kiya, T; Kunieda, T; Kubo, T				Kiya, Taketoshi; Kunieda, Takekazu; Kubo, Takeo			Increased Neural Activity of a Mushroom Body Neuron Subtype in the Brains of Forager Honeybees	PLOS ONE			English	Article								Honeybees organize a sophisticated society, and the workers transmit information about the location of food sources using a symbolic dance, known as 'dance communication'. Recent studies indicate that workers integrate sensory information during foraging flight for dance communication. The neural mechanisms that account for this remarkable ability are, however, unknown. In the present study, we established a novel method to visualize neural activity in the honeybee brain using a novel immediate early gene, kakusei, as a marker of neural activity. The kakusei transcript was localized in the nuclei of brain neurons and did not encode an open reading frame, suggesting that it functions as a non-coding nuclear RNA. Using this method, we show that neural activity of a mushroom body neuron subtype, the small-type Kenyon cells, is prominently increased in the brains of dancer and forager honeybees. In contrast, the neural activity of the two mushroom body neuron subtypes, the small-and large-type Kenyon cells, is increased in the brains of re-orienting workers, which memorize their hive location during re-orienting flights. These findings demonstrate that the small-type Kenyon cell-preferential activity is associated with foraging behavior, suggesting its involvement in information integration during foraging flight, which is an essential basis for dance communication.	[Kiya, Taketoshi; Kunieda, Takekazu; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan	University of Tokyo	Kiya, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	kiya@biol.s.u-tokyo.ac.jp; stkubo@biol.s.u-tokyo.ac.jp	Kiya, Taketoshi/J-9032-2015; Kiya, Taketoshi/ABE-6519-2020; Kunieda, Takekazu/G-4946-2014; KUBO, TAKEO/G-4951-2014; Kiya, Taketoshi/GVT-7846-2022	Kiya, Taketoshi/0000-0002-5709-8016; Kiya, Taketoshi/0000-0002-5709-8016; Kubo, Takeo/0000-0002-5914-5269; Kunieda, Takekazu/0000-0002-6256-1335	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Japan Society for the Promotion of Science (JSPS)	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN). T. Kiya is the recipient of a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows.	Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Grunewald B, 1999, J COMP NEUROL, V404, P114; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Ismail N, 2006, P NATL ACAD SCI USA, V103, P207, DOI 10.1073/pnas.0508318102; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Klein ME, 2005, CURR OPIN NEUROBIOL, V15, P507, DOI 10.1016/j.conb.2005.08.011; Komischke B, 2005, EUR J NEUROSCI, V21, P477, DOI 10.1111/j.1460-9568.2005.03879.x; Malun D, 2002, J NEUROBIOL, V53, P343, DOI 10.1002/neu.10119; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Nieh JC, 2000, J EXP BIOL, V203, P1573; Paul RK, 2005, INSECT MOL BIOL, V14, P9, DOI 10.1111/j.1365-2583.2004.00524.x; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Sakata S, 2002, EUR J NEUROSCI, V15, P735, DOI 10.1046/j.1460-9568.2002.01905.x; Sandeman DC, 1996, J EXP BIOL, V199, P2585; Sawata M, 2002, RNA, V8, P772, DOI 10.1017/S1355838202028790; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schroter U, 2003, J COMP NEUROL, V465, P168, DOI 10.1002/cne.10843; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1988, BEHAV ECOL SOCIOBIOL, V22, P229, DOI 10.1007/BF00299837; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Takeuchi H, 2003, INSECT MOL BIOL, V12, P291, DOI 10.1046/j.1365-2583.2003.00414.x; Takeuchi H, 2002, FEBS LETT, V513, P230, DOI 10.1016/S0014-5793(02)02319-0; Takeuchi H, 2001, INSECT MOL BIOL, V10, P487, DOI 10.1046/j.0962-1075.2001.00288.x; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; von Frisch K, 1969, DANCE LANGUAGE ORIEN; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; WILSON EO, 1975, SCIOBIOLOGY NEW SYNT; Winston M.L., 1991, BIOL HONEY BEE; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402	48	48	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e371	10.1371/journal.pone.0000371	http://dx.doi.org/10.1371/journal.pone.0000371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440607	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445500002
J	Friedlaender, JS; Friedlaender, FR; Hodgson, JA; Stoltz, M; Koki, G; Horvat, G; Zhadanov, S; Schurr, TG; Merriwether, DA				Friedlaender, Jonathan S.; Friedlaender, Francoise R.; Hodgson, Jason A.; Stoltz, Matthew; Koki, George; Horvat, Gisele; Zhadanov, Sergey; Schurr, Theodore G.; Merriwether, D. Andrew			Melanesian mtDNA Complexity	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; EVOLUTIONARY HISTORY; Y-CHROMOSOME; ANCIENT; POLYNESIANS; ORIGIN; MUTATIONS; SEQUENCES; SELECTION; LANGUAGE	Melanesian populations are known for their diversity, but it has been hard to grasp the pattern of the variation or its underlying dynamic. Using 1,223 mitochondrial DNA (mtDNA) sequences from hypervariable regions 1 and 2 (HVR1 and HVR2) from 32 populations, we found the among-group variation is structured by island, island size, and also by language affiliation. The more isolated inland Papuan-speaking groups on the largest islands have the greatest distinctions, while shore dwelling populations are considerably less diverse (at the same time, within-group haplotype diversity is less in the most isolated groups). Persistent differences between shore and inland groups in effective population sizes and marital migration rates probably cause these differences. We also add 16 whole sequences to the Melanesian mtDNA phylogenies. We identify the likely origins of a number of the haplogroups and ancient branches in specific islands, point to some ancient mtDNA connections between Near Oceania and Australia, and show additional Holocene connections between Island Southeast Asia/Taiwan and Island Melanesia with branches of haplogroup E. Coalescence estimates based on synonymous transitions in the coding region suggest an initial settlement and expansion in the region at similar to 30-50,000 years before present (YBP), and a second important expansion from Island Southeast Asia/Taiwan during the interval similar to 3,500-8,000 YBP. However, there are some important variance components in molecular dating that have been overlooked, and the specific nature of ancestral (maternal) Austronesian influence in this region remains unresolved.	[Friedlaender, Jonathan S.] Temple Univ, Dept Anthropol, Philadelphia, PA 19122 USA; [Hodgson, Jason A.; Stoltz, Matthew; Merriwether, D. Andrew] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Koki, George] Inst Med Res, Goroka, Papua N Guinea; [Zhadanov, Sergey; Schurr, Theodore G.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; PNG Institute Of Medical Research; University of Pennsylvania	Friedlaender, JS (corresponding author), Temple Univ, Dept Anthropol, Philadelphia, PA 19122 USA.	jfriedla@temple.edu	Hodgson, Jason A/F-8849-2013; Hodgson, Jason/O-7395-2019	Hodgson, Jason A/0000-0003-0767-7703; Hodgson, Jason A/0000-0002-3849-2245	National Science Foundation; Wenner-Gren Foundation; National Geographic Society Exploration Fund; Penn Faculty Research Funds	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; National Geographic Society Exploration Fund(National Geographic Society); Penn Faculty Research Funds	Financial support was provided by grants from the National Science Foundation, the Wenner-Gren Foundation for Anthropological Research, the National Geographic Society Exploration Fund, and the Penn Faculty Research Funds.	ALLEN J, 2003, CAHIERS ARCHEOLOGIE, P33; Anderson A, 2000, MOD QUAT RE, V16, P13; BALLINGER SW, 1992, GENETICS, V130, P139; Bellwood P., 1996, ORIGINS SPREAD AGR P, P465; BELLWOOD P, 1995, AUSTRONESIANS HIST C, P1; Cox MP, 2005, HUM BIOL, V77, P179, DOI 10.1353/hub.2005.0037; COX MP, 2003, THESIS U OTAGO DUNED; Dunn M, 2002, OCEAN LINGUIST, V41, P28, DOI 10.1353/ol.2002.0019; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; Friedlaender Jonathan, 2005, PAPUAN PASTS CULTURA, P693; Friedlaender JS, 2002, HUM BIOL, V74, P453, DOI 10.1353/hub.2002.0029; FRIEDLAENDER JS, 2007, GENES LANGUAGE CULTU, P61; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Green R.C., 1991, MAN HALF ESSAYS PACI, P491; Hagelberg E, 1997, ELECTROPHORESIS, V18, P1529, DOI 10.1002/elps.1150180907; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HILL AVS, 1985, AM J HUM GENET, V37, P571; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huoponen K, 2001, HUM IMMUNOL, V62, P954, DOI 10.1016/S0198-8859(01)00294-4; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; KAYSER M, 2006, MOL BIOL EVOL; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; LEAVESLEY M, 2004, BUANG MERABAK ADDITI; Lewis CM, 2005, AM J PHYS ANTHROPOL, V127, P351, DOI 10.1002/ajpa.20102; Lindstrom E, 2007, GENES LANGUAGE CULTU, P118; Lum JK, 1998, AM J PHYS ANTHROPOL, V105, P109, DOI 10.1002/(SICI)1096-8644(199802)105:2<109::AID-AJPA1>3.0.CO;2-Q; LUM JK, 1994, HUM BIOL, V66, P567; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Melton T, 1998, AM J HUM GENET, V63, P1807, DOI 10.1086/302131; Merriwether DA, 1999, AM J PHYS ANTHROPOL, V110, P243, DOI 10.1002/(SICI)1096-8644(199911)110:3<243::AID-AJPA1>3.0.CO;2-M; Merriwether DA, 2005, P NATL ACAD SCI USA, V102, P13034, DOI 10.1073/pnas.0506195102; Merriwether DA, 1999, GENOMIC DIVERSITY, P153; Metspalu M, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-41; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Ohashi J, 2006, AM J PHYS ANTHROPOL, V130, P551, DOI 10.1002/ajpa.20383; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; PAVLIDES C, 1994, ANTIQUITY, V68, P604, DOI 10.1017/S0003598X00047104; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; PIERSON MJ, 2006, MOL BIOL EVOL; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Ross Malcolm, 1988, PROTOOCEANIC AUSTRON; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; SOODYALL H, 1995, NAT GENET, V10, P377, DOI 10.1038/ng0895-377; Spriggs M., 1997, ISLAND MELANESIANS; STONEKING M, 1990, J MOL EVOL, V31, P343, DOI 10.1007/BF02101128; SUMMERHAYES GR, 2007, GENES LANGUAGE CULTU, P10; SUMMERHAYES GR, 2007, SE ASIA PACIFIC ARCH; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; TREJAUT JA, 2006, ANTHR TRANSFUS UNPUB; Tryon, 1994, LANGUAGE CONTACT CHA, P573, DOI [DOI 10.1515/9783110883091, 10.1515/9783110883091]; Pellekaan SMV, 2006, AM J PHYS ANTHROPOL, V131, P282, DOI 10.1002/ajpa.20426; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408	68	92	94	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e248	10.1371/journal.pone.0000248	http://dx.doi.org/10.1371/journal.pone.0000248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327912	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444600008
J	Lamanda, A; Cheaib, Z; Turgut, MD; Lussi, A				Lamanda, Andreas; Cheaib, Zeinab; Turgut, Melek Dilek; Lussi, Adrian			Protein Buffering in Model Systems and in Whole Human Saliva	PLOS ONE			English	Article								The aim of this study was to quantify the buffer attributes (value, power, range and optimum) of two model systems for whole human resting saliva, the purified proteins from whole human resting saliva and single proteins. Two model systems, the first containing amyloglucosidase and lysozyme, and the second containing amyloglucosidase and alpha-amylase, were shown to provide, in combination with hydrogencarbonate and di-hydrogenphosphate, almost identical buffer attributes as whole human resting saliva. It was further demonstrated that changes in the protein concentration as small as 0.1% may change the buffer value of a buffer solution up to 15 times. Additionally, it was shown that there was a protein concentration change in the same range (0.16%) between saliva samples collected at the time periods of 13: 00 and others collected at 9: 00 am and 17:00. The mode of the protein expression changed between these samples corresponded to the change in basic buffer power and the change of the buffer value at pH 6.7. Finally, SDS Page and Ruthenium II tris (bathophenantroline disulfonate) staining unveiled a constant protein expression in all samples except for one 50 kDa protein band. As the change in the expression pattern of that 50 kDa protein band corresponded to the change in basic buffer power and the buffer value at pH 6.7, it was reasonable to conclude that this 50 kDa protein band may contain the protein(s) belonging to the protein buffer system of human saliva.	[Lamanda, Andreas; Cheaib, Zeinab; Lussi, Adrian] Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland; [Turgut, Melek Dilek] Hacettepe Univ, Fac Dent, Dept Pediat Dent, Ankara, Turkey	University of Bern; Hacettepe University	Lamanda, A (corresponding author), Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland.	lamanda3@hotmail.com			University of Bern, Switzerland	University of Bern, Switzerland	This study was supported by the University of Bern, Switzerland. None of the authors have any financial arrangements with any commercial organisation that could benefit from this study.	ALFONSKY D, 1961, SALIVA ITS RELATION; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amerongen AV, 2004, CARIES RES, V38, P247, DOI 10.1159/000077762; Bardow A, 2000, ARCH ORAL BIOL, V45, P1, DOI 10.1016/S0003-9969(99)00119-3; BARGEN JA, 1937, J AM DENT ASSOC, V24, P1271; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAWES C, 1981, J PHYSIOL-LONDON, V320, P139, DOI 10.1113/jphysiol.1981.sp013940; Daws C, 2001, CARIES RES, V35, P344, DOI 10.1159/000047473; Dugmore C R, 2003, Int J Paediatr Dent, V13, P295, DOI 10.1046/j.1365-263X.2003.00487.x; ECCLES JD, 1979, J PROSTHET DENT, V42, P649, DOI 10.1016/0022-3913(79)90196-3; Freidin L I, 1985, Stomatologiia (Mosk), V64, P16; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghafouri B, 2003, PROTEOMICS, V3, P1003, DOI 10.1002/pmic.200300426; Good N E, 1972, Methods Enzymol, V24, P53; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Hasselbalch KA, 1917, BIOCHEM Z, V78, P112; Hirtz C, 2005, PROTEOMICS, V5, P4597, DOI 10.1002/pmic.200401316; Hu S, 2005, PROTEOMICS, V5, P1714, DOI 10.1002/pmic.200401037; Huang CM, 2004, ARCH ORAL BIOL, V49, P951, DOI 10.1016/j.archoralbio.2004.06.003; HUANG XQ, 1990, COMPUT APPL BIOSCI, V6, P373; IZUTSU KT, 1981, J THEOR BIOL, V90, P397, DOI 10.1016/0022-5193(81)90320-9; Jensdottir T, 2004, Clin Oral Investig, V8, P91; Kojima T, 2000, J DENT RES, V79, P740, DOI 10.1177/00220345000790020701; Kreusser W, 1972, Verh Dtsch Ges Inn Med, V78, P1518; KURAMITSU S, 1980, J BIOCHEM-TOKYO, V87, P1215; Lamanda A, 2004, PROTEOMICS, V4, P599, DOI 10.1002/pmic.200300587; Larsen MJ, 1999, ARCH ORAL BIOL, V44, P111, DOI 10.1016/S0003-9969(98)00108-3; Lenander-Lumikari M, 2000, Adv Dent Res, V14, P40; LILIENTHAL B., 1955, JOUR DENTAL RES, V34, P516, DOI 10.1177/00220345550340040701; Lussi A, 2006, MG ORAL SCI, V20, P1, DOI 10.1159/000093343; Lussi A., 2004, Caries Research, V38, P34, DOI 10.1159/000074360; MEURMAN JH, 1994, ORAL SURG ORAL MED O, V78, P583, DOI 10.1016/0030-4220(94)90168-6; Nagler RM, 2005, ARCH ORAL BIOL, V50, P7, DOI 10.1016/j.archoralbio.2004.07.012; Nunn J H, 2003, Int J Paediatr Dent, V13, P98, DOI 10.1046/j.1365-263X.2003.00433.x; Pedersen AML, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-4; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; SELLMAN S, 1949, Acta Odontol Scand, V8, P244, DOI 10.3109/00016354909014465; SIGAARDANDERSON O, 1963, ACID BASE STATUS BLO; STOELTING KR, 1999, PHARM PHYSL ANESTHET; Van Slyke DD, 1922, J BIOL CHEM, V52, P525; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; Wilmarth PA, 2004, J PROTEOME RES, V3, P1017, DOI 10.1021/pr049911o; Xie HW, 2005, MOL CELL PROTEOMICS, V4, P1826, DOI 10.1074/mcp.D500008-MCP200; Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200; Zero DT, 2000, TOOTH WEAR SENSITIVI, P121; ZIPKIN I, 1949, J DENT RES, V28, P613, DOI 10.1177/00220345490280061301	46	26	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e263	10.1371/journal.pone.0000263	http://dx.doi.org/10.1371/journal.pone.0000263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327922	Green Published, gold			2022-12-27	WOS:000207444600023
J	Zhao, GY; Chang, KY; Varley, K; Stormo, GD				Zhao, Guoyan; Chang, Kuan Y.; Varley, Katherine; Stormo, Gary D.			Evidence for Active Maintenance of Inverted Repeat Structures Identified by a Comparative Genomic Approach	PLOS ONE			English	Article								Inverted repeats have been found to occur in both prokaryotic and eukaryotic genomes. Usually they are short and some have important functions in various biological processes. However, long inverted repeats are rare and can cause genome instability. Analyses of C. elegans genome identified long, nearly-perfect inverted repeat sequences involving both divergently and convergently oriented homologous gene pairs and complete intergenic sequences. Comparisons with the orthologous regions from the genomes of C. briggsae and C. remanei show that the inverted repeat structures are often far more conserved than the sequences. This observation implies that there is an active mechanism for maintaining the inverted repeat nature of the sequences.	[Zhao, Guoyan; Varley, Katherine; Stormo, Gary D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Chang, Kuan Y.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Stormo, GD (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	stormo@genetics.wustl.edu	Chang, Kuan Y./AAB-3639-2020; Stormo, Gary D/C-5367-2013	Chang, Kuan Y./0000-0002-2262-5218; Stormo, Gary D/0000-0001-6896-1850; Varley, Katherine/0000-0003-1622-5290; Zhao, Guoyan/0000-0001-5615-6774	National Institute of Health [HG00249]; National Institute of Health Institutional [5 T32 HG000045-08]; National Institute of General Medical Sciences NRSA [1 F32 GM73444-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000045, R01HG000249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM073444] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health Institutional; National Institute of General Medical Sciences NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health grants HG00249, and G.Z. was supported by National Institute of Health Institutional training grant 5 T32 HG000045-08 and National Institute of General Medical Sciences NRSA service award 1 F32 GM73444-01. The funding agencies did not play any role in the preparation, review, or approval of the manuscript.	Achaz G, 2001, MOL BIOL EVOL, V18, P2280, DOI 10.1093/oxfordjournals.molbev.a003774; Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bissler John J., 1998, Frontiers in Bioscience, V3, pD408; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; Dai X, 1997, P NATL ACAD SCI USA, V94, P2174, DOI 10.1073/pnas.94.6.2174; GLUCKSMANN MA, 1992, CELL, V70, P491, DOI 10.1016/0092-8674(92)90173-A; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Higgs PG, 1998, GENETICA, V102-3, P91, DOI 10.1023/A:1017059530664; Jin RZ, 1997, EMBO J, V16, P4456, DOI 10.1093/emboj/16.14.4456; Kim EL, 1998, NUCLEIC ACIDS RES, V26, P1793, DOI 10.1093/nar/26.7.1793; KIONTKE K, 2005, WORMBOOK; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; LeBlanc MD, 2000, GENOME RES, V10, P1381, DOI 10.1101/gr.122700; Lobachev KS, 1998, GENETICS, V148, P1507; MARKIEWICZ P, 1992, GENE DEV, V6, P2010, DOI 10.1101/gad.6.10.2010; Nag DK, 1997, GENETICS, V146, P835; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; RUSSNAK RH, 1985, MOL CELL BIOL, V5, P1268, DOI 10.1128/MCB.5.6.1268; Semple C, 1999, J MOL EVOL, V48, P555, DOI 10.1007/PL00006498; Spiro C, 1997, J BIOL CHEM, V272, P33145, DOI 10.1074/jbc.272.52.33145; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; Wang Y, 2006, FEBS LETT, V580, P1277, DOI 10.1016/j.febslet.2006.01.045; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; ZHENG GX, 1991, J MOL BIOL, V221, P122	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e262	10.1371/journal.pone.0000262	http://dx.doi.org/10.1371/journal.pone.0000262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327921	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444600022
J	Gelain, F; Bottai, D; Vescovi, A; Zhang, SG				Gelain, Fabrizio; Bottai, Daniele; Vescovi, Angleo; Zhang, Shuguang			Designer Self-Assembling Peptide Nanofiber Scaffolds for Adult Mouse Neural Stem Cell 3-Dimensional Cultures	PLOS ONE			English	Article								Biomedical researchers have become increasingly aware of the limitations of conventional 2-dimensional tissue cell culture systems, including coated Petri dishes, multi-well plates and slides, to fully address many critical issues in cell biology, cancer biology and neurobiology, such as the 3-D microenvironment, 3-D gradient diffusion, 3-D cell migration and 3-D cell-cell contact interactions. In order to fully understand how cells behave in the 3-D body, it is important to develop a well-controlled 3-D cell culture system where every single ingredient is known. Here we report the development of a 3-D cell culture system using a designer peptide nanofiber scaffold with mouse adult neural stem cells. We attached several functional motifs, including cell adhesion, differentiation and bone marrow homing motifs, to a self-assembling peptide RADA16 (Ac-RADARADARADARADA-COHN2). These functionalized peptides undergo self-assembly into a nanofiber structure similar to Matrigel. During cell culture, the cells were fully embedded in the 3-D environment of the scaffold. Two of the peptide scaffolds containing bone marrow homing motifs significantly enhanced the neural cell survival without extra soluble growth and neurotrophic factors to the routine cell culture media. In these designer scaffolds, the cell populations with beta-Tubulin(+), GFAP(+) and Nestin(+) markers are similar to those found in cell populations cultured on Matrigel. The gene expression profiling array experiments showed selective gene expression, possibly involved in neural stem cell adhesion and differentiation. Because the synthetic peptides are intrinsically pure and a number of desired function cellular motifs are easy to incorporate, these designer peptide nanofiber scaffolds provide a promising controlled 3-D culture system for diverse tissue cells, and are useful as well for general molecular and cell biology.	[Gelain, Fabrizio; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Gelain, Fabrizio; Bottai, Daniele; Vescovi, Angleo] Fdn Ctr San Raffaele Monte Tabor, Dept Biol & Technol Res, Stem Cell Res Inst, Milan, Italy; [Gelain, Fabrizio; Vescovi, Angleo] Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy; [Bottai, Daniele] Univ Milan, Dept Med Surg & Dent, Fac Med, Milan, Italy	Massachusetts Institute of Technology (MIT); University of Milano-Bicocca; University of Milan	Zhang, SG (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shuguang@mit.edu	Bottai, Daniele/O-2586-2017; Gelain, Fabrizio G/K-5069-2012	Bottai, Daniele/0000-0002-7951-9512; Gelain, Fabrizio G/0000-0002-2624-5853; Zhang, Shuguang/0000-0002-3856-3752	Cross fellowship from CARIPLO and Hospital S. Raffaele, Milano, Italy; Olympus Corp; NIH BRP [EB003805]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003805] Funding Source: NIH RePORTER	Cross fellowship from CARIPLO and Hospital S. Raffaele, Milano, Italy; Olympus Corp; NIH BRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	F. G. was supported by the Cross fellowship from CARIPLO and Hospital S. Raffaele, Milano, Italy. This work was supported in part by grants from Olympus Corp and by NIH BRP Grant EB003805. We also received free RADA16 (Puramatrix) samples from 3DM, an MIT startup, instead of purchasing the RADA16 (Puramatrix) from BD Biosciences.	Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Durselen L, 2001, J BIOMED MATER RES, V58, P666, DOI 10.1002/jbm.1067; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Galli R, 2000, DEV NEUROSCI-BASEL, V22, P86, DOI 10.1159/000017430; Greenberg Z, 1997, J CELL BIOCHEM, V65, P359, DOI 10.1002/(SICI)1097-4644(19970601)65:3<359::AID-JCB6>3.0.CO;2-R; Hayashido Y, 1998, INT J CANCER, V75, P654, DOI 10.1002/(SICI)1097-0215(19980209)75:4<654::AID-IJC26>3.0.CO;2-7; Helfrich MH, 1996, BONE, V19, P317, DOI 10.1016/S8756-3282(96)00223-2; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Kreis T, 1999, GUIDE BOOK EXTRACELL; Lanza R.P., 2000, PRINCIPLES TISSUE EN; LEBEAU JM, 1994, EXP NEUROL, V127, P1, DOI 10.1006/exnr.1994.1074; Lelievre SA, 1998, P NATL ACAD SCI USA, V95, P14711, DOI 10.1073/pnas.95.25.14711; Mikhailova A, 2003, REGUL PEPTIDES, V114, P183, DOI 10.1016/S0167-0115(03)00123-X; Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005; Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030; Palou E, 2000, TISSUE ANTIGENS, V55, P118, DOI 10.1034/j.1399-0039.2000.550203.x; Palsson B, 2003, TISSUE ENG PRINCIPLE; Petrov RV, 1997, BIOPOLYMERS, V43, P139; Qing J, 1997, ONCOGENE, V15, P2159, DOI 10.1038/sj.onc.1201385; RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038; Schense JC, 2000, NAT BIOTECHNOL, V18, P415, DOI 10.1038/74473; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Spancake KM, 1999, CANCER RES, V59, P6042; Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100; Twal WO, 2001, J CELL SCI, V114, P4587; Wallquist W, 2002, J COMP NEUROL, V454, P284, DOI 10.1002/cne.10434; WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021; Zhang S., 2005, SCAFFOLDING TISSUE E, P217, DOI 10.1201/9781420027563; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhau HE, 1997, IN VITRO CELL DEV-AN, V33, P375	42	484	519	5	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e119	10.1371/journal.pone.0000119	http://dx.doi.org/10.1371/journal.pone.0000119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205123	Green Published, gold			2022-12-27	WOS:000207443700013
J	Valmas, N; Ebert, PR				Valmas, Nicholas; Ebert, Paul R.			Comparative Toxicity of Fumigants and a Phosphine Synergist Using a Novel Containment Chamber for the Safe Generation of Concentrated Phosphine Gas	PLOS ONE			English	Article							INDUCED OXIDATIVE DAMAGE; DEVELOPMENTAL STAGES; CYTOCHROME-C; COLEOPTERA; RESISTANCE; TEMPERATURES; EXPOSURE; OXIDASE; RATS	Background. With the phasing out of ozone-depleting substances in accordance with the United Nations Montreal Protocol, phosphine remains as the only economically viable fumigant for widespread use. However the development of high-level resistance in several pest insects threatens the future usage of phosphine; yet research into phosphine resistance mechanisms has been limited due to the potential for human poisoning in enclosed laboratory environments. Principal Findings. Here we describe a custom-designed chamber for safely containing phosphine gas generated from aluminium phosphide tablets. In an improvement on previous generation systems, this chamber can be completely sealed to control the escape of phosphine. The device has been utilised in a screening program with C. elegans that has identified a phosphine synergist, and quantified the efficacy of a new fumigant against that of phosphine. The phosphine-induced mortality at 20 degrees C has been determined with an LC50 of 732 ppm. This result was contrasted with the efficacy of a potential new botanical pesticide dimethyl disulphide, which for a 24 hour exposure at 20 degrees C is 600 times more potent than phosphine (LC50 1.24 ppm). We also found that co-administration of the glutathione depletor diethyl maleate (DEM) with a sublethal dose of phosphine (70 ppm, <LC5), results in a doubling of mortality in C. elegans relative to DEM alone. Conclusions. The prohibitive danger associated with the generation, containment, and use of phosphine in a laboratory environment has now been substantially reduced by the implementation of our novel gas generation chamber. We have also identified a novel phosphine synergist, the glutathione depletor DEM, suggesting an effective pathway to be targeted in future synergist research; as well as quantifying the efficacy of a potential alternative to phosphine, dimethyl disulphide.	[Valmas, Nicholas; Ebert, Paul R.] Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld, Australia; [Ebert, Paul R.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Ebert, PR (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld, Australia.	p.ebert@uq.edu.au		Ebert, Paul/0000-0002-4435-0737; Valmas, Nicholas/0000-0002-6925-9673	Grains Research and Development Corporation [UQ10]; Australian Research Council [DP0558507]; Australian Postgraduate Award	Grains Research and Development Corporation(Grains R&D Corp); Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	This work was supported in part by a research grant from the Grains Research and Development Corporation (UQ10) as well as research funding from the Australian Research Council (DP0558507). Nicholas Valmas was supported by an Australian Postgraduate Award.	BELL CH, 1977, J STORED PROD RES, V13, P149, DOI 10.1016/0022-474X(77)90024-8; BELL CH, 1976, J STORED PROD RES, V12, P77, DOI 10.1016/0022-474X(76)90027-8; Bengston M, 1999, J ECON ENTOMOL, V92, P17, DOI 10.1093/jee/92.1.17; BOND E. J., 1967, Journal of Stored Products Research, V3, P295, DOI 10.1016/0022-474X(67)90033-1; BOND EJ, 1984, 54 FAO; CHAUDHRY MQ, 1992, PESTIC BIOCHEM PHYS, V42, P167, DOI 10.1016/0048-3575(92)90063-6; Chaudhry MQ, 2004, J STORED PROD RES, V40, P125, DOI 10.1016/S0022-474X(02)00093-0; CHEFURKA W, 1976, PESTIC BIOCHEM PHYS, V6, P65, DOI 10.1016/0048-3575(76)90010-9; Cheng Q, 2003, TOXICOL SCI, V73, P60, DOI 10.1093/toxsci/kfg049; Chugh SN, 1997, MAGNESIUM RES, V10, P225; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Coosemans J, 2005, ACTA HORTIC, P57, DOI 10.17660/ActaHortic.2005.698.6; Dua R, 2004, BBA-GEN SUBJECTS, V1674, P4, DOI 10.1016/j.bbagen.2004.05.003; Dugravot E, 2003, J NEUROPHYSIOL, V90, P259, DOI 10.1152/jn.01096.2002; Dugravot S, 2004, ENTOMOL EXP APPL, V113, P173, DOI 10.1111/j.0013-8703.2004.00216.x; Dugravot S, 2002, ENVIRON ENTOMOL, V31, P550, DOI 10.1603/0046-225X-31.3.550; Fritsch J, 2005, ACTA HORTIC, P71, DOI 10.17660/ActaHortic.2005.698.8; Hartsell PL, 2005, SOUTHWEST ENTOMOL, V30, P47; HASAN M, 2003, P 8 INT WORK C STOR, P656; HOLE BD, 1976, J STORED PROD RES, V12, P235, DOI 10.1016/0022-474X(76)90039-4; Hsu CH, 2000, FREE RADICAL BIO MED, V28, P636, DOI 10.1016/S0891-5849(99)00277-4; Hsu CH, 1998, TOXICOL SCI, V46, P204, DOI 10.1093/toxsci/46.1.204; Hsu CH, 2002, J PINEAL RES, V32, P53, DOI 10.1034/j.1600-079x.2002.10809.x; Hsu CH, 2002, TOXICOLOGY, V179, P1, DOI 10.1016/S0300-483X(02)00246-9; Jian F, 2000, PHYTOPROTECTION, V81, P23, DOI 10.7202/706197ar; KASHI KP, 1976, PESTIC BIOCHEM PHYS, V6, P350, DOI 10.1016/0048-3575(76)90045-6; KASHI KP, 1981, PESTIC SCI, V12, P111, DOI 10.1002/ps.2780120202; MUTHU M, 1980, B ENVIRON CONTAM TOX, V24, P404, DOI 10.1007/BF01608130; Sato K., 1973, Botyu-Kagaku, V38, P22; Schlipalius DI, 2002, GENETICS, V161, P773; Singh S, 2006, CLIN TOXICOL, V44, P155, DOI 10.1080/15563650500514467; Sohail Ahmed, 2002, International Journal of Agriculture and Biology, V4, P329; VINCENT LE, 1977, J ECON ENTOMOL, V70, P497, DOI 10.1093/jee/70.4.497	33	28	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e130	10.1371/journal.pone.0000130	http://dx.doi.org/10.1371/journal.pone.0000130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205134	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443700024
J	Haskell, DG; Evans, JP; Pelkey, NW				Haskell, David G.; Evans, Jonathan P.; Pelkey, Neil W.			Depauperate Avifauna in Plantations Compared to Forests and Exurban Areas	PLOS ONE			English	Article							BIRD COMMUNITIES; UNITED-STATES; BIODIVERSITY; CONSERVATION; OVENBIRD; FRAGMENTATION; URBANIZATION; POPULATIONS; MANAGEMENT; HABITAT	Native forests are shrinking worldwide, causing a loss of biological diversity. Our ability to prioritize forest conservation actions is hampered by a lack of information about the relative impacts of different types of forest loss on biodiversity. In particular, we lack rigorous comparisons of the effects of clearing forests for tree plantations and for human settlements, two leading causes of deforestation worldwide. We compared avian diversity in forests, plantations and exurban areas on the Cumberland Plateau, USA, an area of global importance for biodiversity. By combining field surveys with digital habitat databases, and then analyzing diversity at multiple scales, we found that plantations had lower diversity and fewer conservation priority species than did other habitats. Exurban areas had higher diversity than did native forests, but native forests outscored exurban areas for some measures of conservation priority. Overall therefore, pine plantations had impoverished avian communities relative to both native forests and to exurban areas. Thus, reports on the status of forests give misleading signals about biological diversity when they include plantations in their estimates of forest cover but exclude forested areas in which humans live. Likewise, forest conservation programs should downgrade incentives for plantations and should include settled areas within their purview.	[Haskell, David G.; Evans, Jonathan P.] Univ South, Dept Biol, Sewanee, TN 37375 USA; [Pelkey, Neil W.] Juniata Coll, Huntingdon, PA 16652 USA	Sewanee: University of the South	Haskell, DG (corresponding author), Univ South, Dept Biol, Sewanee, TN 37375 USA.	dhaskell@sewanee.edu		Haskell, David G./0000-0003-1580-9438; Evans, Jonathan P./0000-0002-2550-0031	United States Environmental Protection Agency; United States Fish and Wildlife Service; Rockefeller Brothers Foundation; Associated Colleges of the South; University of the South	United States Environmental Protection Agency(United States Environmental Protection Agency); United States Fish and Wildlife Service(US Fish & Wildlife Service); Rockefeller Brothers Foundation; Associated Colleges of the South; University of the South	We thank the United States Environmental Protection Agency, the United States Fish and Wildlife Service, the Rockefeller Brothers Foundation, the Associated Colleges of the South, and the University of the South for funding this study and the larger land-use project in which this study is embedded.	Bawa KS, 2004, SCIENCE, V306, P227; Bayne EM, 1997, CONSERV BIOL, V11, P1418, DOI 10.1046/j.1523-1739.1997.96135.x; BELLEFONTAINE R, 2002, FAO UN CONSERVATION, V35; Betts MG, 2006, ECOL MODEL, V191, P197, DOI 10.1016/j.ecolmodel.2005.04.027; Bowles IA, 1998, SCIENCE, V280, P1899, DOI 10.1126/science.280.5371.1899; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Burel F, 1998, ACTA OECOL, V19, P47, DOI 10.1016/S1146-609X(98)80007-6; Burke DM, 1998, AUK, V115, P96, DOI 10.2307/4089115; CADE BS, 2001, BLOSSOM VERSION W200; Carter MF, 2000, AUK, V117, P541, DOI 10.1642/0004-8038(2000)117[0541:SCPFLI]2.0.CO;2; CORVALAN C, 2005, ECOSYSTEMS HUMAN WE; DICKSON JG, 1979, J WILDLIFE MANAGE, V43, P549, DOI 10.2307/3800371; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Drapeau P, 2000, ECOL MONOGR, V70, P423, DOI 10.1890/0012-9615(2000)070[0423:LSDACI]2.0.CO;2; ERDELEN M, 1984, OECOLOGIA, V61, P277, DOI 10.1007/BF00396773; EVANS JP, 2002, ASSESSMENT FOREST CH; *FAO UN, 2000, GLOB FOR RES ASS 200; Flaspohler DJ, 2001, CONSERV BIOL, V15, P173, DOI 10.1046/j.1523-1739.2001.99397.x; *FOR SURV IND, 2006, INV FOR TREE RES; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; GIBBS JP, 1990, CONSERV BIOL, V4, P193, DOI 10.1111/j.1523-1739.1990.tb00108.x; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GOTELLI NJ, 2001, ECOSIM NULL MODELS E; *GREAT BRIT FOR CO, 2003, NAT INV WOODL TREES; Hagan JM, 2002, FOREST SCI, V48, P231; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Hartley MJ, 2002, FOREST ECOL MANAG, V155, P81, DOI 10.1016/S0378-1127(01)00549-7; Haskell David G., 2001, P243; HIDALGO D. M., 2002, FAO UN CONSERVATION, V35, P141; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; JONES AG, 1997, CAMBRIDGE STUDIES AP; King DI, 1996, CONSERV BIOL, V10, P1380, DOI 10.1046/j.1523-1739.1996.10051380.x; Kovach W. L., 2005, MVSP MULTIVARIATE ST; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; Lim HC, 2004, LANDSCAPE URBAN PLAN, V66, P199, DOI 10.1016/S0169-2046(03)00111-7; Lomberg B, 2001, SKEPTICAL ENV MEASUR; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marzluff J. M., 2001, AVIAN CONSERV ECOL, P1, DOI DOI 10.1007/978-1-4615-1531-9; McGrath DA, 2004, EARTH INTERACT, V8; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McLaughlin A, 1995, AGR ECOSYST ENVIRON, V55, P201, DOI 10.1016/0167-8809(95)00609-V; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; PANDEY D, 2002, FAO UN CONSERVATION, V35, P157; Pearce D, 2003, FOREST ECOL MANAG, V172, P229, DOI 10.1016/S0378-1127(01)00798-8; POOLE A, 1992, BIRDS N AM; Putz FE, 2001, CONSERV BIOL, V15, P7, DOI 10.1046/j.1523-1739.2001.00018.x; REMPEL R, 2000, PATCH ANAL VERSION 2; REPENNING RW, 1985, J WILDLIFE MANAGE, V49, P1088, DOI 10.2307/3801400; RICH TD, 2004, PARTNERS FLIGHT N AM; ROTH RR, 1976, ECOLOGY, V57, P773, DOI 10.2307/1936190; Savard Jean-Pierre L., 2001, P543; SEELYE KQ, 2001, NY TIMES        1127, P10; Thomas L, 1998, DISTANCE 3 5 RELEASE; Trani M.K., 2002, SO FOREST RESOURCE A, P3; *UN ENV PROGR, 2002, GLOB ENV OUTL, V3	57	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e63	10.1371/journal.pone.0000063	http://dx.doi.org/10.1371/journal.pone.0000063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183694	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600063
J	Hayashi, Y; Aita, T; Toyota, H; Husimi, Y; Urabe, I; Yomo, T				Hayashi, Yuuki; Aita, Takuyo; Toyota, Hitoshi; Husimi, Yuzuru; Urabe, Itaru; Yomo, Tetsuya			Experimental Rugged Fitness Landscape in Protein Sequence Space	PLOS ONE			English	Article							THERMODYNAMICAL INTERPRETATION; EVOLUTIONARY DYNAMICS; ARBITRARY SEQUENCE; ESCHERICHIA-COLI; STRUCTURAL UNITS; INFECTION; SELECTION; REACTOR	The fitness landscape in sequence space determines the process of biomolecular evolution. To plot the fitness landscape of protein function, we carried out in vitro molecular evolution beginning with a defective fd phage carrying a random polypeptide of 139 amino acids in place of the g3p minor coat protein D2 domain, which is essential for phage infection. After 20 cycles of random substitution at sites 12-130 of the initial random polypeptide and selection for infectivity, the selected phage showed a 1.7x10(4)-fold increase in infectivity, defined as the number of infected cells per ml of phage suspension. Fitness was defined as the logarithm of infectivity, and we analyzed (1) the dependence of stationary fitness on library size, which increased gradually, and (2) the time course of changes in fitness in transitional phases, based on an original theory regarding the evolutionary dynamics in Kauffman's n-k fitness landscape model. In the landscape model, single mutations at single sites among n sites affect the contribution of k other sites to fitness. Based on the results of these analyses, k was estimated to be 18-24. According to the estimated parameters, the landscape was plotted as a smooth surface up to a relative fitness of 0.4 of the global peak, whereas the landscape had a highly rugged surface with many local peaks above this relative fitness value. Based on the landscapes of these two different surfaces, it appears possible for adaptive walks with only random substitutions to climb with relative ease up to the middle region of the fitness landscape from any primordial or random sequence, whereas an enormous range of sequence diversity is required to climb further up the rugged surface above the middle region.	[Hayashi, Yuuki; Yomo, Tetsuya] Osaka Univ, Dept Bioinformat Engn, Osaka, Japan; [Aita, Takuyo] Saitama Small Enterprise Promot Corp SKIP City, Rat Evolutionary Design Adv Biomol REDS Grp JST, Kawaguchi, Saitama, Japan; [Aita, Takuyo; Husimi, Yuzuru] Saitama Univ, Dept Funct Mat Sci, Saitama 3388570, Japan; [Toyota, Hitoshi; Urabe, Itaru] Osaka Univ, Dept Biotechnol, Osaka, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Yomo, Tetsuya] Japan Sci & Technol Agcy JST, Expoloratory Res Adv Technol ERATO, Osaka, Japan	Osaka University; Saitama University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yomo, T (corresponding author), Osaka Univ, Dept Bioinformat Engn, Osaka, Japan.	yomo@ist.osaka-u.ac.jp	Husimi, Yuzuru/L-5536-2019; Hayashi, Yuuki/Q-7515-2019	Hayashi, Yuuki/0000-0002-7073-0151	21st Century Center of Excellence Program; Ministry of Education, Culture, Sports, Science and Technology, Japan	21st Century Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by "The 21st Century Center of Excellence Program" and "Special Coordination Funds for Promoting Science and Technology: Yuragi Project" of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Aita T, 2005, B MATH BIOL, V67, P613, DOI 10.1016/j.bulm.2004.09.004; Aita T, 2004, B MATH BIOL, V66, P1371, DOI 10.1016/j.bulm.2004.01.004; Aita T, 2003, J THEOR BIOL, V225, P215, DOI 10.1016/S0022-5193(03)00240-6; Aita T, 2002, BIOPOLYMERS, V64, P95, DOI 10.1002/bip.10126; Arakawa T, 1996, DNA Res, V3, P87, DOI 10.1093/dnares/3.2.87; Bogarad LD, 1999, P NATL ACAD SCI USA, V96, P2591, DOI 10.1073/pnas.96.6.2591; Chaput JC, 2004, CHEM BIOL, V11, P865, DOI 10.1016/j.chembiol.2004.04.006; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; EIGEN M, 1985, BER BUNSEN PHYS CHEM, V89, P658, DOI 10.1002/bbpc.19850890619; GO M, 1983, P NATL ACAD SCI-BIOL, V80, P1964, DOI 10.1073/pnas.80.7.1964; GO M, 1981, NATURE, V291, P90, DOI 10.1038/291090a0; Hayashi Y, 2003, J MOL EVOL, V56, P162, DOI 10.1007/s00239-002-2389-y; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Ito Y, 2004, J MOL EVOL, V58, P196, DOI 10.1007/s00239-003-2542-2; KAUFFMAN SA, 1989, J THEOR BIOL, V141, P211, DOI 10.1016/S0022-5193(89)80019-0; Kauffman Stuart A., 1993; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; Matsuura T, 1998, PROTEIN ENG, V11, P789, DOI 10.1093/protein/11.9.789; Novella IS, 1999, J VIROL, V73, P1668, DOI 10.1128/JVI.73.2.1668-1671.1999; NOVELLA IS, 1995, P NATL ACAD SCI USA, V92, P5841, DOI 10.1073/pnas.92.13.5841; Prijambada ID, 1996, FEBS LETT, V382, P21, DOI 10.1016/0014-5793(96)00123-8; PrugelBennett A, 1997, J THEOR BIOL, V185, P81, DOI 10.1006/jtbi.1996.0295; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; Roberts RW, 1999, CURR OPIN CHEM BIOL, V3, P268, DOI 10.1016/S1367-5931(99)80042-8; Sambrook J., 2001, MOL CLONING LAB MANU; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; SCHUSTER P, 1995, J BIOTECHNOL, V41, P239, DOI 10.1016/0168-1656(94)00085-Q; TRAKULNALEAMSAI S, 1995, J FERMENT BIOENG, V79, P107, DOI 10.1016/0922-338X(95)94076-4; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; WAGNER CR, 1995, BIOCHEMISTRY-US, V34, P15671, DOI 10.1021/bi00048a011; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Woodcock G, 1996, J THEOR BIOL, V179, P61, DOI 10.1006/jtbi.1996.0049; Wright S, 1931, GENETICS, V16, P0097; Yamauchi A, 2002, PROTEIN ENG, V15, P619, DOI 10.1093/protein/15.7.619; ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7	37	37	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e96	10.1371/journal.pone.0000096	http://dx.doi.org/10.1371/journal.pone.0000096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183728	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600095
J	Klinkenberg, D; Fraser, C; Heesterbeek, H				Klinkenberg, Don; Fraser, Christophe; Heesterbeek, Hans			The Effectiveness of Contact Tracing in Emerging Epidemics	PLOS ONE			English	Article								Background. Contact tracing plays an important role in the control of emerging infectious diseases, but little is known yet about its effectiveness. Here we deduce from a generic mathematical model how effectiveness of tracing relates to various aspects of time, such as the course of individual infectivity, the (variability in) time between infection and symptom-based detection, and delays in the tracing process. In addition, the possibility of iteratively tracing of yet asymptomatic infecteds is considered. With these insights we explain why contact tracing was and will be effective for control of smallpox and SARS, only partially effective for foot-and-mouth disease, and likely not effective for influenza. Methods and Findings. We investigate contact tracing in a model of an emerging epidemic that is flexible enough to use for most infections. We consider isolation of symptomatic infecteds as the basic scenario, and express effectiveness as the proportion of contacts that need to be traced for a reproduction ratio smaller than 1. We obtain general results for special cases, which are interpreted with respect to the likely success of tracing for influenza, smallpox, SARS, and foot-and-mouth disease epidemics. Conclusions. We conclude that (1) there is no general predictive formula for the proportion to be traced as there is for the proportion to be vaccinated; (2) variability in time to detection is favourable for effective tracing; (3) tracing effectiveness need not be sensitive to the duration of the latent period and tracing delays; (4) iterative tracing primarily improves effectiveness when single-step tracing is on the brink of being effective.	[Klinkenberg, Don; Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Fraser, Christophe] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	Utrecht University; Imperial College London	Klinkenberg, D (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands.	d.klinkenberg@vet.uu.nl	Fraser, Christophe/A-8109-2008	Fraser, Christophe/0000-0003-2399-9657; Heesterbeek, Hans/0000-0001-8537-6418; Klinkenberg, Don/0000-0002-9449-6873	EU Sixth Framework Programme [SP22-CT-2004-511066]; Netherlands Organisation for Scientific Research (NWO) [918.56.620]	EU Sixth Framework Programme(European Commission); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The research of D. K. is supported by the EU Sixth Framework Programme for research for policy support (contract SP22-CT-2004-511066). The research of H. H. is supported by the Netherlands Organisation for Scientific Research (NWO grant 918.56.620).	Aldis GK, 2005, MATH BIOSCI, V195, P1, DOI 10.1016/j.mbs.2005.01.006; Becker NG, 2005, MATH BIOSCI, V193, P205, DOI 10.1016/j.mbs.2004.07.006; Bell D, 2006, EMERG INFECT DIS, V12, P81; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Eichner M, 2003, AM J EPIDEMIOL, V158, P118, DOI 10.1093/aje/kwg104; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Jezek Z, 1988, HUMAN MONKEYPOX; Kiss IZ, 2005, P ROY SOC B-BIOL SCI, V272, P1407, DOI 10.1098/rspb.2005.3092; Lloyd-Smith JO, 2003, P ROY SOC B-BIOL SCI, V270, P1979, DOI 10.1098/rspb.2003.2481; Muller J, 2000, MATH BIOSCI, V164, P39, DOI 10.1016/S0025-5564(99)00061-9; Porco TC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-34	15	128	129	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e12	10.1371/journal.pone.0000012	http://dx.doi.org/10.1371/journal.pone.0000012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183638	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600012
J	Liu, YT; Carson, DA				Liu, Yu-Tsueng; Carson, Dennis A.			A Novel Approach for Determining Cancer Genomic Breakpoints in the Presence of Normal DNA	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; METHYLTHIOADENOSINE PHOSPHORYLASE GENE; CHROMOSOME 9P21 DELETIONS; TIME QUANTITATIVE PCR; BARR-VIRUS DNA; TUMOR-SUPPRESSOR; HOMOZYGOUS DELETIONS; B-CELL; HYBRIDIZATION	CDKN2A (encodes p16(INK4A) and p14(ARF)) deletion, which results in both Rb and p53 inactivation, is the most common chromosomal anomaly in human cancers. To precisely map the deletion breakpoints is important to understanding the molecular mechanism of genomic rearrangement and may also be useful for clinical applications. However, current methods for determining the breakpoint are either of low resolution or require the isolation of relatively pure cancer cells, which can be difficult for clinical samples that are typically contaminated with various amounts of normal host cells. To overcome this hurdle, we have developed a novel approach, designated Primer Approximation Multiplex PCR (PAMP), for enriching breakpoint sequences followed by genomic tiling array hybridization to locate the breakpoints. In a series of proof-of-concept experiments, we were able to identify cancer-derived CDKN2A genomic breakpoints when more than 99.9% of wild type genome was present in a model system. This design can be scaled up with bioinformatics support and can be applied to validate other candidate cancer-associated loci that are revealed by other more systemic but lower throughput assays.	[Liu, Yu-Tsueng; Carson, Dennis A.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Liu, YT (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	ytliu@ucsd.edu			National Institutes of Health [CA119335, CA23100, AI36214-12S1]; NATIONAL CANCER INSTITUTE [U54CA119335, P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported in part by grants for the UCSD NanoTumor Center of Excellence for Cancer Nanotechnology (CA119335), CA23100 (D. A. C.) and AI36214-12S1 (Y-T L.) from the National Institutes of Health.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Armour JAL, 2002, HUM MUTAT, V20, P325, DOI 10.1002/humu.10133; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Batova A, 1996, BLOOD, V88, P3083, DOI 10.1182/blood.V88.8.3083.bloodjournal8883083; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Carter TL, 2001, BLOOD, V97, P572, DOI 10.1182/blood.V97.2.572; Cayuela JM, 1997, BLOOD, V90, P3720, DOI 10.1182/blood.V90.9.3720; Cazzaniga G, 2006, ANN MED, V38, P512, DOI 10.1080/07853890600978123; Dijkman R, 2006, J CLIN ONCOL, V24, P296, DOI 10.1200/JCO.2005.02.0842; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Goulden N, 2006, BRIT J HAEMATOL, V134, P273, DOI 10.1111/j.1365-2141.2006.06182.x; Heisterkamp N, 2002, ONCOGENE, V21, P8536, DOI 10.1038/sj.onc.1206080; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; JOOS S, 1992, HUM MOL GENET, V1, P625, DOI 10.1093/hmg/1.8.625; JOOS S, 1992, CANCER RES, V52, P6547; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kees UR, 2005, LEUKEMIA RES, V29, P165, DOI 10.1016/j.leukres.2004.05.021; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kitagawa Y, 2002, J BIOL CHEM, V277, P46289, DOI 10.1074/jbc.M208353200; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; M'soka TJ, 2000, LEUKEMIA, V14, P935, DOI 10.1038/sj.leu.2401771; Maley CC, 2005, SEMIN CANCER BIOL, V15, P474, DOI 10.1016/j.semcancer.2005.06.004; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nobori T, 1996, P NATL ACAD SCI USA, V93, P6203, DOI 10.1073/pnas.93.12.6203; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; OLOPADE OI, 1995, P NATL ACAD SCI USA, V92, P6489, DOI 10.1073/pnas.92.14.6489; Perry A, 1997, J NEUROPATH EXP NEUR, V56, P999, DOI 10.1097/00005072-199709000-00005; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; QUELLE DE, 1995, CELL, V83, P993; Raschke S, 2005, GENE CHROMOSOME CANC, V42, P58, DOI 10.1002/gcc.20119; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sasaki S, 2003, ONCOGENE, V22, P3792, DOI 10.1038/sj.onc.1206589; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Szczepanski T, 2007, LEUKEMIA, V21, P622, DOI 10.1038/sj.leu.2404603; To EWH, 2003, CLIN CANCER RES, V9, P3254; van der Velden VHJ, 2003, LEUKEMIA, V17, P1013, DOI 10.1038/sj.leu.2402922; Vastag B, 2006, J NATL CANCER I, V98, P162, DOI 10.1093/jnci/djj062; Vogelstein B., 2002, GENETIC BASIS HUMAN; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wang HY, 2005, GENOME RES, V15, P276, DOI 10.1101/gr.2885205; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	59	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e380	10.1371/journal.pone.0000380	http://dx.doi.org/10.1371/journal.pone.0000380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440616	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445500011
J	Dramard, X; Heidmann, T; Jensen, S				Dramard, Xavier; Heidmann, Thierry; Jensen, Silke			Natural Epigenetic Protection against the I-factor, a Drosophila LINE Retrotransposon, by Remnants of Ancestral Invasions	PLOS ONE			English	Article								Transposable elements are major components of most eukaryotic genomes. Such sequences are generally defective for transposition and have little or no coding capacity. Because transposition can be highly mutagenic, mobile elements that remain functional are tightly repressed in all living species. Drosophila pericentromeric heterochromatin naturally contains transposition-defective, non-coding derivatives of a LINE retrotransposon related to the I-factor. The I-factor is a good model to study the regulation of transposition in vivo because, under specific conditions, current functional copies of this mobile element can transpose at high frequency, specifically in female germ cells, with deleterious effects including female sterility. However, this high transpositional activity becomes spontaneously repressed upon ageing or heat treatment, by a maternally transmitted, transgenerational epigenetic mechanism of unknown nature. We have analyzed, by quantitative real time RT-PCR, the RNA profile of the transposition-defective I-related sequences, in the Drosophila ovary during ageing and upon heat treatment, and also in female somatic tissues and in males, which are not permissive for I-factor transposition. We found evidence for a role of transcripts from these ancestral remnants in the natural epigenetic protection of the Drosophila melanogaster genome against the deleterious effects of new invasions by functional I-factors. These results provide a molecular basis for a probably widespread natural protection against transposable elements by persisting vestiges of ancient invasions.	[Dramard, Xavier; Heidmann, Thierry; Jensen, Silke] Inst Gustave Roussy, CNRS, UMR 8122, Unite Retrovirus Endogenes & Elements Retroides E, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Jensen, S (corresponding author), Inst Gustave Roussy, CNRS, UMR 8122, Unite Retrovirus Endogenes & Elements Retroides E, Villejuif, France.	sjensen@igr.fr		Jensen, Silke/0000-0002-1858-8792	Ligue Nationale Contre le Cancer	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	X. D. is supported by a grant from the Ligue Nationale Contre le Cancer for PhD students.	Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Bazin C, 1999, MOL GEN GENET, V261, P480, DOI 10.1007/s004380050991; Birchler JA, 2000, CURR OPIN GENET DEV, V10, P211, DOI 10.1016/S0959-437X(00)00065-4; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; BUCHETON A, 1978, HEREDITY, V41, P357, DOI 10.1038/hdy.1978.106; BUCHETON A, 1979, GENETICS, V93, P131; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; BUCHETON A, 2002, MOBILE DNA, V2, P796; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; CHABOISSIER MC, 1990, EMBO J, V9, P3557, DOI 10.1002/j.1460-2075.1990.tb07566.x; Dimitri P, 2005, CYTOGENET GENOME RES, V110, P160, DOI 10.1159/000084948; FAWCETT DH, 1986, CELL, V47, P1007, DOI 10.1016/0092-8674(86)90815-9; Gauthier E, 2000, GENETICS, V156, P1867; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; JENSEN S, 1991, EMBO J, V10, P1927, DOI 10.1002/j.1460-2075.1991.tb07719.x; JENSEN S, 1995, MOL GEN GENET, V248, P381, DOI 10.1007/BF02191637; Jensen S, 1999, GENETICS, V153, P1767; Jensen S, 2002, GENETICS, V162, P1197; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Kavi HH, 2005, FEBS LETT, V579, P5940, DOI 10.1016/j.febslet.2005.08.069; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUNING KG, 1981, HEREDITAS, V95, P181; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Malinsky S, 2000, GENETICS, V156, P1147; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Meyer P, 1996, ANNU REV PLANT PHYS, V47, P23, DOI 10.1146/annurev.arplant.47.1.23; PELISSON A, 1991, P NATL ACAD SCI USA, V88, P4907, DOI 10.1073/pnas.88.11.4907; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Picard G, 1971, DIS, V46, P54; Ronsseray S, 1996, GENETICS, V143, P1663; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vagin Vasily V, 2004, RNA Biol, V1, P54; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; VAURY C, 1990, J MOL EVOL, V31, P424, DOI 10.1007/BF02106056; VAURY C, 1989, CHROMOSOMA, V98, P215, DOI 10.1007/BF00329686; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	46	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e304	10.1371/journal.pone.0000304	http://dx.doi.org/10.1371/journal.pone.0000304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375190	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445100006
J	Hashmi, SK; Afridi, MB; Abbas, K; Sajwani, RA; Saleheen, D; Frossard, PM; Ishaq, M; Ambreen, A; Ahmad, U				Hashmi, Saman K.; Afridi, Maria B.; Abbas, Kanza; Sajwani, Rubina A.; Saleheen, Danish; Frossard, Philippe M.; Ishaq, Mohammad; Ambreen, Aisha; Ahmad, Usman			Factors Associated with Adherence to Anti-Hypertensive Treatment in Pakistan	PLOS ONE			English	Article							JOINT-NATIONAL-COMMITTEE; BLOOD-PRESSURE; MEDICATION ADHERENCE; THERAPEUTIC REGIMEN; HYPERTENSIVE MEN; RISK-FACTORS; NONCOMPLIANCE; PREVENTION; IMPACT; WOMEN	Objectives. Poor adherence is one of the biggest obstacles in therapeutic control of high blood pressure. The objectives of this study were (i) to measure adherence to antihypertensive therapy in a representative sample of the hypertensive Pakistani population and (ii) to investigate the factors associated with adherence in the studied population. Methods and Results. A cross-sectional study was conducted on a simple random sample of 460 patients at the Aga Khan University Hospital (AKUH) and National Institute of Cardiovascular Diseases, Karachi, from September 2005-May 2006. Adherence was assessed using the Morisky Medication Adherence Scale (MMAS), with scores ranging from 0 (non-adherent) to 4 (adherent). In addition to MMAS, patient self-reports about the number of pills taken over a prescribed period were used to estimate adherence as a percentage. AKU Anxiety and Depression Scale (AKU-ADS) was incorporated to find any association between depression and adherence. At a cut-off value of 80%, 77% of the cases were adherent. Upon univariate analyses, increasing age, better awareness and increasing number of pills prescribed significantly improved adherence, while depression showed no association. Significant associations, upon multivariate analyses, included number of drugs that a patient was taking (P<0.02) and whether he/she was taking medication regularly or only for symptomatic relief (P<0.00001). Conclusions. Similar to what has been reported worldwide, younger age, poor awareness, and symptomatic treatment adversely affected adherence to antihypertensive medication in our population. In contrast, monotherapy reduced adherence, whereas psychosocial factors such as depression showed no association. These findings may be used to identify the subset of population at risk of low adherence who should be targeted for interventions to achieve better blood pressure control and hence prevent complications.	[Saleheen, Danish; Frossard, Philippe M.; Ahmad, Usman] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Hashmi, Saman K.; Afridi, Maria B.; Abbas, Kanza; Sajwani, Rubina A.] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Ishaq, Mohammad] Natl Inst Cardiovasc Dis, Karachi, Pakistan; [Ambreen, Aisha] Aga Khan Univ, Dept Family Med, Karachi, Pakistan	Aga Khan University; Aga Khan University; Aga Khan University	Frossard, PM (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.	philippe.frossard@aku.edu	Hashmi, Saman/GOK-2190-2022	Hashmi, Saman/0000-0002-0470-1846; Parekh, Maria/0000-0003-0465-8400	Department of Biological and Biomedical Sciences, Aga Khan University	Department of Biological and Biomedical Sciences, Aga Khan University	This research was partially supported by research funds from the Department of Biological and Biomedical Sciences, Aga Khan University.	Ali B S, 1998, J Pak Med Assoc, V48, P261; Almas Aysha, 2006, J Coll Physicians Surg Pak, V16, P23; Baune B T, 2006, Ann Gen Psychiatry, V5, P6, DOI 10.1186/1744-859X-5-6; Baune BT, 2005, EUR J EPIDEMIOL, V20, P411, DOI 10.1007/s10654-005-0675-x; Baune BT, 2004, SAUDI MED J, V25, P1683; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bloom BS, 2001, BMJ-BRIT MED J, V323, P647, DOI 10.1136/bmj.323.7314.647; Caro JJ, 1999, CAN MED ASSOC J, V160, P31; Cheng JWM, 2001, PHARMACOTHERAPY, V21, P828, DOI 10.1592/phco.21.9.828.34557; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Dunbar-Jacob J, 1995, MANAGING CHRONIC ILL, P313; Egan BM, 2003, ARCH INTERN MED, V163, P681, DOI 10.1001/archinte.163.6.681; FALASCHETTI E, 2004, HLTH SURVEY ENGLAND, P181; Garfield F B, 1999, Curr Hypertens Rep, V1, P502, DOI 10.1007/s11906-996-0022-y; Gryglewska B, 2005, BLOOD PRESSURE, V14, P46, DOI 10.1080/08038020500428740; Hassan NB, 2006, J HUM HYPERTENS, V20, P23, DOI 10.1038/sj.jhh.1001930; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Krousel-Wood M, 2005, CURR OPIN CARDIOL, V20, P296, DOI 10.1097/01.hco.0000166597.52335.23; Krousel-Wood M, 2004, CURR OPIN CARDIOL, V19, P357, DOI 10.1097/01.hco.0000126978.03828.9e; LENNON C, 2001, INT J PHARM PRACT, V9, pR8; Mant J, 2006, J HUM HYPERTENS, V20, P551, DOI 10.1038/sj.jhh.1002046; MEINKSTER, 2006, J HUM HYPERTENS, V20, P295; Monane M, 1996, AM J PUBLIC HEALTH, V86, P1805, DOI 10.2105/AJPH.86.12.1805; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pakistan Medical Research Council, 1998, NAT HLTH SURV PAK HL, P50; Payne K A, 2000, Curr Hypertens Rep, V2, P515, DOI 10.1007/s11906-996-0035-6; Pratt R J, 2001, HIV Clin Trials, V2, P146; RUDD P, 1991, PATIENT COMPLIANCE M, P283; Thompson DW, 1996, NEUROL CLIN, V14, P309, DOI 10.1016/S0733-8619(05)70258-9; Wang PS, 2002, J GEN INTERN MED, V17, P504, DOI 10.1046/j.1525-1497.2002.00406.x; *WHO, 2003, HYP ADH LONG TERM TH, P27; *WHO, 2003, HYP ADH LONG TERM TH, P129; Yiannakopoulou EC, 2005, EUR J CARDIOV PREV R, V12, P243, DOI 10.1097/01.hjr.0000160601.41762.44; YOUSSEF RM, 2002, E MEDITERR HEALTH J, V8, P4	38	109	112	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e280	10.1371/journal.pone.0000280	http://dx.doi.org/10.1371/journal.pone.0000280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356691	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444800003
J	Karlsson, AC; Iversen, AKN; Chapman, JM; de Oliveira, T; Spotts, G; McMichael, AJ; Davenport, MP; Hecht, FM; Nixon, DF				Karlsson, Annika C.; Iversen, Astrid K. N.; Chapman, Joan M.; de Oliveira, Tulio; Spotts, Gerald; McMichael, Andrew J.; Davenport, Miles P.; Hecht, Frederick M.; Nixon, Douglas F.			Sequential Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape	PLOS ONE			English	Article								Background. Antigen-specific CTL responses are thought to play a central role in containment of HIV-1 infection, but no consistent correlation has been found between the magnitude and/or breadth of response and viral load changes during disease progression. Methods and Findings. We undertook a detailed investigation of longitudinal CTL responses and HIV-1 evolution beginning with primary infection in 11 untreated HLA-A2 positive individuals. A subset of patients developed broad responses, which selected for consensus B epitope variants in Gag, Pol, and Nef, suggesting CTL-induced adaptation of HIV-1 at the population level. The patients who developed viral escape mutations and broad autologous CTL responses over time had a significantly higher increase in viral load during the first year of infection compared to those who did not develop viral escape mutations. Conclusions. A continuous dynamic development of CTL responses was associated with viral escape from temporarily effective immune responses. Our results suggest that broad CTL responses often represent footprints left by viral CTL escape rather than effective immune control, and help explain earlier findings that fail to show an association between breadth of CTL responses and viral load. Our results also demonstrate that CTL pressures help to maintain certain elements of consensus viral sequence, which likely represent viral escape from common HLA-restricted CTL responses. The ability of HIV to evolve to escape CTL responses restricted by a common HLA type highlights the challenges posed to development of an effective CTL-based vaccine.	[Karlsson, Annika C.; Chapman, Joan M.; Nixon, Douglas F.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Karlsson, Annika C.] Karolinska Inst, Swedish Inst Infect Dis Control, Solna, Sweden; [Karlsson, Annika C.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden; [Iversen, Astrid K. N.; McMichael, Andrew J.] Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [de Oliveira, Tulio] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Spotts, Gerald; Hecht, Frederick M.; Nixon, Douglas F.] Univ Calif San Francisco, Div Expt Med, Dept Med, San Francisco, CA USA; [Davenport, Miles P.] Univ New S Wales, Sydney, NSW, Australia	University of California System; University of California San Francisco; The J David Gladstone Institutes; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; University of Oxford; University of Oxford; University of California System; University of California San Francisco; University of New South Wales Sydney	Karlsson, AC (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA.	annika.karlsson@smi.ki.se	Nixon, Douglas/AAU-5734-2020; Karlsson, Annika/R-2255-2016	Nixon, Douglas/0000-0002-2801-1786; Karlsson, Annika/0000-0002-2028-8393; Davenport, Miles/0000-0002-4751-1831; Hecht, Frederick/0000-0002-5782-1171	NIH [U01 AI41531, R01 AI44595]; UCSF/Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 AI27763]; MRC UK; The Swedish Agency for International Development Cooperation, Sida [2005-001756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041531, R01AI044595, P30AI027763] Funding Source: NIH RePORTER; MRC [MC_U137884177] Funding Source: UKRI; Medical Research Council [MC_U137884177] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF/Gladstone Institute of Virology & Immunology Center for AIDS Research; MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Swedish Agency for International Development Cooperation, Sida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the NIH (U01 AI41531 and R01 AI44595), UCSF/Gladstone Institute of Virology & Immunology Center for AIDS Research (P30 AI27763), MRC UK, and The Swedish Agency for International Development Cooperation, Sida (2005-001756).	Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altfeld M, 2005, J VIROL, V79, P5000, DOI 10.1128/JVI.79.8.5000-5005.2005; Barouch DH, 2005, NAT IMMUNOL, V6, P247, DOI 10.1038/ni1167; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Cao JH, 2003, J IMMUNOL, V171, P3837, DOI 10.4049/jimmunol.171.7.3837; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Dalod M, 1999, J CLIN INVEST, V104, P1431, DOI 10.1172/JCI7162; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Draenert R, 2004, J VIROL, V78, P630, DOI 10.1128/JVI.78.2.630-641.2004; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; Ferrari G, 2004, J IMMUNOL, V173, P2126, DOI 10.4049/jimmunol.173.3.2126; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hay CM, 1999, J VIROL, V73, P5509, DOI 10.1128/JVI.73.7.5509-5519.1999; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Karlsson AC, 2003, J VIROL, V77, P6743, DOI 10.1128/JVI.77.12.6743-6752.2003; Karlsson AC, 1999, J VIROL, V73, P6191, DOI 10.1128/JVI.73.7.6191-6196.1999; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Karlsson AC, 1998, AIDS, V12, P839, DOI 10.1097/00002030-199808000-00005; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Keoshkerian E, 2003, J MED VIROL, V71, P483, DOI 10.1002/jmv.10525; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; KORBER B, 2002, HIV MOL IMMUNOLOGY 2; KORBER BTM, 2005, HIV MOL IMMUNOLOGY 2; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KUIKEN CL, 2002, HIV SEQUENCE COMPEND; LEITNER T, 2005, HIV SEQUENCE COMPEND; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Lindback S, 2000, AIDS, V14, P2283, DOI 10.1097/00002030-200010200-00009; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; McMichael A, 2002, SCIENCE, V296, P1410, DOI 10.1126/science.1072492; Meyer-Olson D, 2006, BLOOD, V107, P2373, DOI 10.1182/blood-2005-04-1636; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Milicic A, 2005, J VIROL, V79, P13953, DOI 10.1128/JVI.79.22.13953-13962.2005; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nielsen R, 1998, GENETICS, V148, P929; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Oxenius A, 2004, J INFECT DIS, V190, P713, DOI 10.1086/422760; Sandberg JK, 2000, VIROLOGY, V273, P112, DOI 10.1006/viro.2000.0360; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; SWOFFORD DL, 1999, 4 0B2A; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Wagner R, 1999, J IMMUNOL, V162, P3727; Yang ZH, 2000, J MOL EVOL, V51, P423, DOI 10.1007/s002390010105; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002	72	61	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e225	10.1371/journal.pone.0000225	http://dx.doi.org/10.1371/journal.pone.0000225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311088	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444500006
J	Xia, XH; Huang, H; Carullo, M; Betran, E; Moriyama, EN				Xia, Xuhua; Huang, Huang; Carullo, Malisa; Betran, Esther; Moriyama, Etsuko N.			Conflict between Translation Initiation and Elongation in Vertebrate Mitochondrial Genomes	PLOS ONE			English	Article								The strand-biased mutation spectrum in vertebrate mitochondrial genomes results in an AC-rich L-strand and a GT-rich H-strand. Because the L-strand is the sense strand of 12 protein-coding genes out of the 13, the third codon position is overall strongly AC-biased. The wobble site of the anticodon of the 22 mitochondrial tRNAs is either U or G to pair with the most abundant synonymous codon, with only one exception. The wobble site of Met-tRNA is C instead of U, forming the Watson-Crick match with AUG instead of AUA, the latter being much more frequent than the former. This has been attributed to a compromise between translation initiation and elongation; i.e., AUG is not only a methionine codon, but also an initiation codon, and an anticodon matching AUG will increase the initiation rate. However, such an anticodon would impose selection against the use of AUA codons because AUA needs to be wobble-translated. According to this translation conflict hypothesis, AUA should be used relatively less frequently compared to UUA in the UUR codon family. A comprehensive analysis of mitochondrial genomes from a variety of vertebrate species revealed a general deficiency of AUA codons relative to UUA codons. In contrast, urochordate mitochondrial genomes with two tRNA Met genes with CAU and UAU anticodons exhibit increased AUA codon usage. Furthermore, six bivalve mitochondrial genomes with both of their tRNA-Met genes with a CAU anticodon have reduced AUA usage relative to three other bivalve mitochondrial genomes with one of their two tRNA-Met genes having a CAU anticodon and the other having a UAU anticodon. We conclude that the translation conflict hypothesis is empirically supported, and our results highlight the fine details of selection in shaping molecular evolution.	[Xia, Xuhua; Huang, Huang; Carullo, Malisa] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Betran, Esther] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Moriyama, Etsuko N.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Moriyama, Etsuko N.] Univ Nebraska, Inst Plant Sci, Lincoln, NE USA	University of Ottawa; University of Ottawa; University of Ottawa; University of Texas System; University of Texas Arlington; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Xia, XH (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	xxia@uottawa.ca	Xia, Xuhua/E-5264-2010	Xia, Xuhua/0000-0002-3092-7566; Betran, Esther/0000-0002-4742-7963	Discovery Grant; Research Tools and Instrument Grant; NSERC-Canada	Discovery Grant; Research Tools and Instrument Grant; NSERC-Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Discovery Grant, Research Tools and Instrument Grant, and Strategic Research Grant from NSERC-Canada. Funders are not involved in the study other than providing funds.	Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; BULMER M, 1991, GENETICS, V129, P897; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Faith JJ, 2003, GENETICS, V165, P735; FOLLEY LS, 1991, GENETICS, V129, P659; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Gissi C, 2004, J MOL EVOL, V58, P376, DOI 10.1007/s00239-003-2559-6; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; HECKMAN JE, 1980, P NATL ACAD SCI-BIOL, V77, P3159, DOI 10.1073/pnas.77.6.3159; HOFFMANN RJ, 1992, GENETICS, V131, P397; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ikemura T., 1992, TRANSFER RNA PROTEIN, P87; JERMIIN LS, 1995, MOL BIOL EVOL, V12, P558; Kondow A, 1998, NUCLEOS NUCLEOT NUCL, V17, P531, DOI 10.1080/07328319808005196; LILJENSTROM H, 1987, J THEOR BIOL, V124, P43, DOI 10.1016/S0022-5193(87)80251-5; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lobry JR, 2002, GENOME BIOL, V3; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; MARTIN RP, 1990, BIOCHEMISTRY-US, V29, P956, DOI 10.1021/bi00456a016; Matsuyama S, 1998, J BIOL CHEM, V273, P3363, DOI 10.1074/jbc.273.6.3363; McInerney JO, 1998, P NATL ACAD SCI USA, V95, P10698, DOI 10.1073/pnas.95.18.10698; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; MULERO JJ, 1994, MOL GEN GENET, V242, P383, DOI 10.1007/BF00281787; Nett JH, 2001, EUR J BIOCHEM, V268, P5209, DOI 10.1046/j.0014-2956.2001.02454.x; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Raina SZ, 2005, GENOME RES, V15, P665, DOI 10.1101/gr.3128605; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; ROMERO A, 1991, FEMS MICROBIOL LETT, V84, P325, DOI 10.1016/0378-1097(91)90377-M; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; Serb JM, 2003, MOL BIOL EVOL, V20, P1854, DOI 10.1093/molbev/msg218; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Tong KL, 2004, GENE, V333, P169, DOI 10.1016/j.gene.2004.02.028; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2001, DATA ANAL MOL BIOL E; Xia XH, 2005, GENE, V345, P13, DOI 10.1016/j.gene.2004.11.019; Xia XH, 1998, GENETICS, V149, P37; Yokobori S, 2005, MOL PHYLOGENET EVOL, V34, P273, DOI 10.1016/j.ympev.2004.10.002; Yokobori S, 2003, J MOL EVOL, V57, P574, DOI 10.1007/s00239-003-2511-9; Yokobori S, 1999, GENETICS, V153, P1851	44	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e227	10.1371/journal.pone.0000227	http://dx.doi.org/10.1371/journal.pone.0000227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311091	Green Published, gold			2022-12-27	WOS:000207444500008
J	Piriyapongsa, J; Jordan, IK				Piriyapongsa, Jittima; Jordan, I. King			A Family of Human MicroRNA Genes from Miniature Inverted-Repeat Transposable Elements	PLOS ONE			English	Article							SMALL RNAS; EVOLUTION; IDENTIFICATION; SEQUENCES; GENOME; DNA; DUPLICATION; MICROARRAYS; EXPRESSION; ALIGNMENT	While hundreds of novel microRNA (miRNA) genes have been discovered in the last few years alone, the origin and evolution of these non-coding regulatory sequences remain largely obscure. In this report, we demonstrate that members of a recently discovered family of human miRNA genes, hsa-mir-548, are derived from Made1 transposable elements. Made1 elements are short miniature inverted-repeat transposable elements (MITEs), which consist of two 37 base pair (bp) terminal inverted repeats that flank 6 bp of internal sequence. Thus, Made1 elements are nearly perfect palindromes, and when expressed as RNA they form highly stable hairpin loops. Apparently, these Made1-related structures are recognized by the RNA interference enzymatic machinery and processed to form 22 bp mature miRNA sequences. Consistent with their origin from MITEs, hsa-mir-548 genes are primate-specific and have many potential paralogs in the human genome. There are more than 3,500 putative hsa-mir-548 target genes; analysis of their expression profiles and functional affinities suggests cancer-related regulatory roles for hsa-mir-548. Taken together, the characteristics of Made1 elements, and MITEs in general, point to a specific mechanism for the generation of numerous small regulatory RNAs and target sites throughout the genome. The evolutionary lineage-specific nature of MITEs could also provide for the generation of novel regulatory phenotypes related to species diversification. Finally, we propose that MITEs may represent an evolutionary link between siRNAs and miRNAs.	[Piriyapongsa, Jittima; Jordan, I. King] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Jordan, IK (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	king.jordan@biology.gatech.edu	Piriyapongsa, Jittima/F-7581-2012		Ministry of Science and Technology of Thailand; School of Biology at the Georgia Institute of Technology	Ministry of Science and Technology of Thailand; School of Biology at the Georgia Institute of Technology	Jittima Piriyapongsa is supported by the Ministry of Science and Technology of Thailand. I. King Jordan is supported by the School of Biology at the Georgia Institute of Technology. Neither funding agency played any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; FESCHOTTE C, 2002, MOBILE DNA, V2; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang N, 2004, CURR OPIN PLANT BIOL, V7, P115, DOI 10.1016/j.pbi.2004.01.004; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Matzke MA, 2004, PLOS BIOL, V2, P582, DOI 10.1371/journal.pbio.0020133; McDonald JF, 2005, CYTOGENET GENOME RES, V110, P242, DOI 10.1159/000084958; MORGAN GT, 1995, J MOL BIOL, V254, P1, DOI 10.1006/jmbi.1995.0593; OOSUMI T, 1995, NATURE, V378, P672, DOI 10.1038/378672a0; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; Shih W, 2005, ONCOL REP, V13, P517; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Smit A, 1996, REPEATMASKER OPEN 30; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	222	238	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e203	10.1371/journal.pone.0000203	http://dx.doi.org/10.1371/journal.pone.0000203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17301878	Green Submitted, gold, Green Published			2022-12-27	WOS:000207444400004
J	El-Shemy, HA; Aboul-Enein, AM; Aboul-Enein, KM; Fujita, K				El-Shemy, Hany A.; Aboul-Enein, Ahmed M.; Aboul-Enein, Khalid Mostafa; Fujita, Kounosuke			Willow Leaves' Extracts Contain Anti-Tumor Agents Effective against Three Cell Types	PLOS ONE			English	Article								Many higher plants contain novel metabolites with antimicrobial, antifungal and antiviral properties. However, in the developed world almost all clinically used chemotherapeutics have been produced by in vitro chemical synthesis. Exceptions, like taxol and vincristine, were structurally complex metabolites that were difficult to synthesize in vitro. Many non-natural, synthetic drugs cause severe side effects that were not acceptable except as treatments of last resort for terminal diseases such as cancer. The metabolites discovered in medicinal plants may avoid the side effect of synthetic drugs, because they must accumulate within living cells. The aim here was to test an aqueous extract from the young developing leaves of willow (Salix safsaf, Salicaceae) trees for activity against human carcinoma cells in vivo and in vitro. In vivo Ehrlich Ascites Carcinoma Cells (EACC) were injected into the intraperitoneal cavity of mice. The willow extract was fed via stomach tube. The (EACC) derived tumor growth was reduced by the willow extract and death was delayed (for 35 days). In vitro the willow extract could kill the majority (75%-80%) of abnormal cells among primary cells harvested from seven patients with acute lymphoblastic leukemia (ALL) and 13 with AML (acute myeloid leukemia). DNA fragmentation patterns within treated cells inferred targeted cell death by apoptosis had occurred. The metabolites within the willow extract may act as tumor inhibitors that promote apoptosis, cause DNA damage, and affect cell membranes and/or denature proteins.	[El-Shemy, Hany A.; Aboul-Enein, Ahmed M.] Cairo Univ, Fac Agr, Dept Biochem, Giza, Egypt; [Aboul-Enein, Khalid Mostafa] Cairo Univ, Natl Canc Inst, Dept Clin Pathol, Cairo, Egypt; [El-Shemy, Hany A.; Fujita, Kounosuke] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; Hiroshima University	El-Shemy, HA (corresponding author), Cairo Univ, Fac Agr, Dept Biochem, Giza, Egypt.	helshemy@hotmail.com	El-Shemy, Hany A./A-6367-2008	Aboul-Enein, Ahmed/0000-0002-3350-3451				ADAMKIEWICZ V, 1961, CAN J BIOCHEM PHYS, V39, P1097, DOI 10.1139/o61-111; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; BHATT KKS, 1995, MEDICINAL PLANT INFO; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Cheng JT, 2000, J CLIN PHARMACOL, V40, P445, DOI 10.1177/00912700022009198; CLAUDIA O, 2003, LANCET ONCOL, V4, P200; Clement MV, 1998, BLOOD, V92, P996; El-Shemy HA, 2003, J BIOCHEM MOL BIOL, V36, P387; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; Gao XH, 2002, J NUTR, V132, P2076, DOI 10.1093/jn/132.7.2076; GRONBECK M, 1995, BRIT MED J, V310, P1169; Han SS, 2002, J BIOCHEM MOL BIOL, V35, P337; Hsieh TC, 1999, EXP CELL RES, V249, P109, DOI 10.1006/excr.1999.4471; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; KUPCHAN SM, 1976, SCIENCE, V191, P571, DOI 10.1126/science.1251193; Leven MD, 1979, PLANTA MED, V36, P311; MATSUMOTO Y, 1993, J PHARM SCI, V82, P399, DOI 10.1002/jps.2600820413; METZNER J, 1989, PHARMAZIE, V44, P555; Mungur R, 2005, J BIOMED BIOTECHNOL, V2, P198, DOI DOI 10.1016/J.CHEMOLAB.2010.04.010; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; STEINEGGER E, 1972, PHARM ACTA HELV, V47, P222; WILLETT WC, 1994, SCIENCE, V264, P532, DOI 10.1126/science.8160011; Wood M, 1997, BOOK HERBAL WISDOM U	25	47	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2007	2	1							e178	10.1371/journal.pone.0000178	http://dx.doi.org/10.1371/journal.pone.0000178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DH	17264881	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444200003
J	Vardavas, R; Blower, S				Vardavas, Raffaele; Blower, Sally			The Emergence of HIV Transmitted Resistance in Botswana: "When Will the WHO Detection Threshold Be Exceeded?''	PLOS ONE			English	Article								Background. The Botswana antiretroviral program began in 2002 and currently treats 42,000 patients, with a goal of treating 85,000 by 2009. The World Health Organization (WHO) has begun to implement a surveillance system for detecting transmitted resistance that exceeds a threshold of 5%. However, the WHO has not determined when this threshold will be reached. Here we model the Botswana government's treatment plan and predict, to 2009, the likely stochastic evolution of transmitted resistance. Methods. We developed a model of the stochastic evolution of drug-resistant strains and formulated a birth-death Master equation. We analyzed this equation to obtain an analytical solution of the probabilistic evolutionary trajectory for transmitted resistance, and used treatment and demographic data from Botswana. We determined the temporal dynamics of transmitted resistance as a function of: (i) the transmissibility (i.e., fitness) of the drug-resistant strains that may evolve and (ii) the rate of acquired resistance. Results. Transmitted resistance in Botswana will be unlikely to exceed the WHO's threshold by 2009 even if the rate of acquired resistance is high and the strains that evolve are half as fit as the wild-type strains. However, we also found that transmission of drug-resistant strains in Botswana could increase to similar to 15% by 2009 if the drug-resistant strains that evolve are as fit as the wild-type strains. Conclusions. Transmitted resistance will only be detected by the WHO (by 2009) if the strains that evolve are extremely fit and acquired resistance is high. Initially after a treatment program is begun a threshold lower than 5% should be used; and we advise that predictions should be made before setting a threshold. Our results indicate that it may be several years before the WHO's surveillance system is likely to detect transmitted resistance in other resource-poor countries that have significantly less ambitious treatment programs than Botswana.	[Vardavas, Raffaele; Blower, Sally] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Blower, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.	sblower@mednet.ucla.edu	Vardavas, Constantine I/G-7598-2011		NIH/NIAID [RO1 AI041935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041935] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH/NIAID (RO1 AI041935)	[Anonymous], 2004, MED NEWS TODAY; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bailey N. T. J., 1964, ELEMENTS STOCHASTIC; Barbour JD, 2004, J INFECT DIS, V190, P251, DOI 10.1086/422036; Bertagnolio S, 2005, AIDS, V19, P1329, DOI 10.1097/01.aids.0000180107.19006.02; Blackham J, 2005, AIDS, V19, P487; Blower S, 2005, AIDS, V19, P1, DOI 10.1097/00002030-200501030-00001; Blower S., 2003, AIDS Reviews, V5, P113; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Blower SM, 2001, NAT MED, V7, P1016, DOI 10.1038/nm0901-1016; Bouchonnet F, 2005, J VIROL, V79, P812, DOI 10.1128/JVI.79.2.812-822.2005; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; French Martyn, 2002, HIV Clin Trials, V3, P177; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; KHAN AB, 2003, NATL HIV AIDS STRATE; Lloyd AL, 2004, THEOR POPUL BIOL, V65, P49, DOI 10.1016/j.tpb.2003.07.002; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; Mode CJ., 2000, STOCHASTIC PROCESSES; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; Porter K, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406002-00002; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Susman E, 2004, AIDS, V18, pN1, DOI 10.1097/00002030-200401230-00001; Tang JW, 2004, J CLIN VIROL, V30, P1, DOI 10.1016/j.jcv.2003.12.002; Vergne L, 2003, AIDS, V17, pS31, DOI 10.1097/00002030-200317003-00005; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Wensing Annemarie M. J., 2003, AIDS Reviews, V5, P140; WHO, 2003, GUIDELINES SURVEILLA; *WHO, 2005, HIVRESNET PLEN M	35	47	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e152	10.1371/journal.pone.0000152	http://dx.doi.org/10.1371/journal.pone.0000152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225857	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444000004
J	Hua, Z; Lv, Q; Ye, WB; Wong, CKA; Cai, GP; Gu, DY; Ji, YH; Zhao, C; Wang, JF; Yang, BB; Zhang, Y				Hua, Zhong; Lv, Qing; Ye, Wenbin; Wong, Chung-Kwun Amy; Cai, Guoping; Gu, Dayong; Ji, Yanhong; Zhao, Chen; Wang, Jifeng; Yang, Burton B.; Zhang, Yaou			MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia	PLOS ONE			English	Article							MICRORNA EXPRESSION; P53; MICROARRAYS; PREDICTION; BIOLOGY; RNAS	MicroRNAs (miRNAs) are a class of 20-24 nt non-coding RNAs that regulate gene expression primarily through post-transcriptional repression or mRNA degradation in a sequence-specific manner. The roles of miRNAs are just beginning to be understood, but the study of miRNA function has been limited by poor understanding of the general principles of gene regulation by miRNAs. Here we used CNE cells from a human nasopharyngeal carcinoma cell line as a cellular system to investigate miRNA-directed regulation of VEGF and other angiogenic factors under hypoxia, and to explore the principles of gene regulation by miRNAs. Through computational analysis, 96 miRNAs were predicted as putative regulators of VEGF. But when we analyzed the miRNA expression profile of CNE and four other VEGF-expressing cell lines, we found that only some of these miRNAs could be involved in VEGF regulation, and that VEGF may be regulated by different miRNAs that were differentially chosen from 96 putative regulatory miRNAs of VEGF in different cells. Some of these miRNAs also co-regulate other angiogenic factors ( differential regulation and co-regulation principle). We also found that VEGF was regulated by multiple miRNAs using different combinations, including both coordinate and competitive interactions. The coordinate principle states that miRNAs with independent binding sites in a gene can produce coordinate action to increase the repressive effect of miRNAs on this gene. By contrast, the competitive principle states when multiple miRNAs compete with each other for a common binding site, or when a functional miRNA competes with a false positive miRNA for the same binding site, the repressive effects of miRNAs may be decreased. Through the competitive principle, false positive miRNAs, which cannot directly repress gene expression, can sometimes play a role in miRNA-mediated gene regulation. The competitive principle, differential regulation, multi-miRNA binding sites, and false positive miRNAs might be useful strategies in the avoidance of unwanted cross-action among genes targeted by miRNAs with multiple targets.	[Wong, Chung-Kwun Amy; Yang, Burton B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hua, Zhong; Lv, Qing; Ye, Wenbin; Cai, Guoping; Gu, Dayong; Ji, Yanhong; Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Peoples R China; [Zhao, Chen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Peoples R China; [Wang, Jifeng] Beijing Univ Chinese Med, Cell & Biochem Lab, Beijing, Peoples R China	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Xi'an Jiaotong University; Beijing University of Chinese Medicine	Yang, BB (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	byang@sri.utoronto.ca; zhangyo@sz.tsinghua.edu.cn	Lyu, Qing/AAF-5181-2021; Lyu, Qing/AAP-8387-2020; Hua, Zhong/J-8149-2014	Lyu, Qing/0000-0002-1325-6828; gu, dayong/0000-0002-9547-8474	National Natural Science Foundation of China [30611120519]; Canadian Institutes of Health Research [MOP-62729]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a China-Canada Joint Health Research Initiative grant from the National Natural Science Foundation of China (Grant No. 30611120519) and Canadian Institutes of Health Research to Yaou Zhang and Burton B. Yang, and Grant MOP-62729 from Canadian Institutes of Health Research to Burton B. Yang.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Enright AJ, 2004, GENOME BIOL, V5; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nakahara K, 2004, CURR OPIN CELL BIOL, V16, P127, DOI 10.1016/j.ceb.2004.02.006; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Takei Y, 2004, CANCER RES, V64, P3365, DOI 10.1158/0008-5472.CAN-03-2682; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang MB, 2005, CURR OPIN PLANT BIOL, V8, P216, DOI 10.1016/j.pbi.2005.01.006; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu YJ, 2005, MATRIX BIOL, V24, P3, DOI 10.1016/j.matbio.2004.11.007; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010	40	520	559	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e116	10.1371/journal.pone.0000116	http://dx.doi.org/10.1371/journal.pone.0000116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205120	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700010
J	Roato, I; Brunetti, G; Gorassini, E; Grano, M; Colucci, S; Bonello, L; Buffoni, L; Manfredi, R; Ruffini, E; Ottaviani, D; Ciuffreda, L; Mussa, A; Ferracini, R				Roato, Ilaria; Brunetti, Giacomina; Gorassini, Eva; Grano, Maria; Colucci, Silvia; Bonello, Lisa; Buffoni, Lucio; Manfredi, Roberto; Ruffini, Enrico; Ottaviani, Davide; Ciuffreda, Libero; Mussa, Antonio; Ferracini, Riccardo			IL-7 Up-Regulates TNF-alpha-Dependent Osteoclastogenesis in Patients Affected by Solid Tumor	PLOS ONE			English	Article								Background. Interleukin-7 (IL-7) is a potent regulator of lymphocyte development, which has also significant effects on bone; in fact it is a potent osteoclastogenic factor. Some human solid tumors produce high IL-7 levels, suggesting a potential IL-7 role on tumor development and progression. Methodology. We studied 50 male patients affected by solid tumors, and their blood samples were collected at tumor diagnosis. PBMCs were isolated and cultured with/without IL-7 to study its influence on osteoclastogenesis. Serum and cell culture supernatant IL-7 levels were measured by ELISA. The quantitative analysis of IL-7 expression on T and B cells was performed by Real-Time PCR. Principal Findings. Serum IL-7 levels were highest in osteolytic cancer patients, followed by cancer patients without bone lesions, and then healthy controls. We showed the IL-7 production in PBMC cultures and particularly in monocyte and B cell co-cultures. A quantitative analysis of IL-7 expression in T and B cells confirmed that B cells had a high IL-7 expression. In all cell culture conditions, IL-7 significantly increased osteoclastogenesis and an anti-IL-7 antibody inhibited it. We demonstrated that IL-7 supports OC formation by inducing the TNF-alpha production and low RANKL levels, which synergize in promoting osteoclastogenesis. Conclusions. We demonstrated the presence of high serum IL-7 levels in patients with bone metastasis, suggesting the use of serum IL-7 level as a clinical marker of disease progression and of bone involvement. Moreover, we showed the capability of IL-7 to stimulate spontaneous osteoclastogenesis of bone metastatic patients and to induce osteoclastogenesis in cancer patients without bone involvement. These findings add further details to the disclosure of the mechanisms controlling bone metastasis in solid tumors.	[Roato, Ilaria; Gorassini, Eva; Bonello, Lisa] Univ Turin, CeRMS, Turin, Italy; [Brunetti, Giacomina; Grano, Maria; Colucci, Silvia] Univ Bari, Dept Human Anat & Histol, Bari, Italy; [Roato, Ilaria; Buffoni, Lucio; Ottaviani, Davide; Ciuffreda, Libero; Mussa, Antonio] Univ Turin, Dept Med Oncol, Turin, Italy; [Manfredi, Roberto] Osped Civile, Dept Med Oncol, Asti, Italy; [Ruffini, Enrico] AZO San Giovanni Battista, Dept Torac Surg, Turin, Italy; [Ferracini, Riccardo] AZO San Giovanni Battista, Dept Orthopaed, Turin, Italy; [Roato, Ilaria; Gorassini, Eva; Bonello, Lisa] AZO San Giovanni Battista, CeRMS, Turin, Italy; [Roato, Ilaria; Buffoni, Lucio; Ottaviani, Davide; Ciuffreda, Libero; Mussa, Antonio] AZO San Giovanni Battista, Dept Med Oncol, Turin, Italy	University of Turin; Universita degli Studi di Bari Aldo Moro; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Roato, I (corresponding author), Univ Turin, CeRMS, Turin, Italy.	roato78@libero.it	Giacomina, Brunetti/J-7692-2016; Ferracini, Riccardo/AAL-4622-2020	Giacomina, Brunetti/0000-0002-0681-1432; Grano, Maria/0000-0002-7121-5899; Colucci, Silvia/0000-0001-9970-3539; Roato, Ilaria/0000-0003-3029-4743; Ruffini, Enrico/0000-0002-7225-2456	Fondazione Internazionale di Ricerca in Medicina Sperimentale (FIRMS); Compagnia di San Paolo, "Special Project Oncology"	Fondazione Internazionale di Ricerca in Medicina Sperimentale (FIRMS); Compagnia di San Paolo, "Special Project Oncology"(Compagnia di San Paolo)	This work was mainly supported by a grant from Fondazione Internazionale di Ricerca in Medicina Sperimentale (FIRMS) and from Compagnia di San Paolo, "Special Project Oncology".	Al-Rawi MAA, 2004, EUR J CANCER, V40, P494, DOI 10.1016/j.ejca.2003.10.016; Al-Rawi MAA, 2003, HISTOL HISTOPATHOL, V18, P911, DOI 10.14670/HH-18.911; Appasamy PM, 1999, CYTOKINES CELL MOL T, V5, P25; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Chopra V, 1998, CANCER INVEST, V16, P152, DOI 10.3109/07357909809050029; Chopra V, 1997, J CANCER RES CLIN, V123, P167, DOI 10.1007/BF01214669; Chopra V, 1996, Cancer J Sci Am, V2, P279; Cosenza L, 2002, CELL SIGNAL, V14, P317, DOI 10.1016/S0898-6568(01)00245-5; DAMELIO P, 2006, BONE; DEBENEDETTI F, 1995, J RHEUMATOL, V22, P1581; EDER M, 1992, BLOOD, V79, P3274; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; FOSS HD, 1995, AM J PATHOL, V146, P33; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Giuliani N, 2002, BLOOD, V100, P4615, DOI 10.1182/blood-2002-04-1121; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee SK, 2003, ENDOCRINOLOGY, V144, P3524, DOI 10.1210/en.2002-221057; Li LQ, 2000, SCAND J IMMUNOL, V51, P361; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONG BW, 1995, P NATL ACAD SCI USA, V92, P1416, DOI 10.1073/pnas.92.5.1416; Maeurer MJ, 1997, SCAND J IMMUNOL, V45, P182, DOI 10.1046/j.1365-3083.1997.d01-384.x; Miyaura C, 1997, P NATL ACAD SCI USA, V94, P9360, DOI 10.1073/pnas.94.17.9360; Okopien B, 2005, J CARDIOVASC PHARM, V46, P377, DOI 10.1097/01.fjc.0000175455.46245.c8; Roato I, 2004, FASEB J, V18, P228, DOI 10.1096/fj.04-1823fje; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Sharma S, 1996, CANCER GENE THER, V3, P302; Szepietowski JC, 2000, CLIN EXP DERMATOL, V25, P643, DOI 10.1046/j.1365-2230.2000.00727.x; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Toraldo G, 2003, P NATL ACAD SCI USA, V100, P125, DOI 10.1073/pnas.0136772100; Trinder P, 1999, INT J ONCOL, V14, P23; van Roon JAG, 2003, ANN RHEUM DIS, V62, P113, DOI 10.1136/ard.62.2.113; Varas A, 1998, BLOOD, V92, P93, DOI 10.1182/blood.V92.1.93.413a03_93_100; Wasilewska A, 2005, PEDIATR INT, V47, P424, DOI 10.1111/j.1442-200x.2005.02078.x; Weitzmann MN, 2000, BLOOD, V96, P1873, DOI 10.1182/blood.V96.5.1873.h8001873_1873_1878; Weitzmann MN, 2001, J BONE MINER RES, V16, P328, DOI 10.1359/jbmr.2001.16.2.328; Weitzmann MN, 2002, J CLIN INVEST, V110, P1643, DOI 10.1172/JCI200215687	39	53	56	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e124	10.1371/journal.pone.0000124	http://dx.doi.org/10.1371/journal.pone.0000124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205128	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700018
J	Brennan, IM; Peters, U; Kapoor, TM; Straight, AF				Brennan, Ian M.; Peters, Ulf; Kapoor, Tarun M.; Straight, Aaron F.			Polo-Like Kinase Controls Vertebrate Spindle Elongation and Cytokinesis	PLOS ONE			English	Article								During cell division, chromosome segregation must be coordinated with cell cleavage so that cytokinesis occurs after chromosomes have been safely distributed to each spindle pole. Polo-like kinase 1 (Plk1) is an essential kinase that regulates spindle assembly, mitotic entry and chromosome segregation, but because of its many mitotic roles it has been difficult to specifically study its post-anaphase functions. Here we use small molecule inhibitors to block Plk1 activity at anaphase onset, and demonstrate that Plk1 controls both spindle elongation and cytokinesis. Plk1 inhibition did not affect anaphase A chromosome to pole movement, but blocked anaphase B spindle elongation. Plk1-inhibited cells failed to assemble a contractile ring and contract the cleavage furrow due to a defect in Rho and Rho-GEF localization to the division site. Our results demonstrate that Plk1 coordinates chromosome segregation with cytokinesis through its dual control of anaphase B and contractile ring assembly.	[Brennan, Ian M.; Straight, Aaron F.] Stanford Med Sch, Dept Biochem, Stanford, CA USA; [Peters, Ulf; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	Stanford University; Rockefeller University	Straight, AF (corresponding author), Stanford Med Sch, Dept Biochem, Stanford, CA USA.	astraigh@stanford.edu		Straight, Aaron/0000-0001-5885-7881; Peters, Ulf/0000-0003-4664-8198	National Science Foundation; NIH; Damon Runyon Cancer Research Foundation	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation	IMB is supported by the National Science Foundation. TMK receives support from the NIH. AFS is the Gordon Family Damon Runyon Scholar supported by the Damon Runyon Cancer Research Foundation and is supported by the NIH.	Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Fink G, 2006, EMBO J, V25, P4897, DOI 10.1038/sj.emboj.7601354; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; HECK MMS, 1993, J CELL BIOL, V123, P665, DOI 10.1083/jcb.123.3.665; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; Khodjakov A, 1997, J CELL BIOL, V136, P229, DOI 10.1083/jcb.136.2.229; KIEHART DP, 1982, J CELL BIOL, V94, P165, DOI 10.1083/jcb.94.1.165; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Mabuchi I, 1993, ZYGOTE, V1, P325, DOI 10.1017/S0967199400001659; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; MARTINEAU SN, 1995, J CELL BIOL, V131, P191, DOI 10.1083/jcb.131.1.191; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; PETERS U, 2006, NAT CHEM BIOL; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; SCHROEDER TE, 1972, J CELL BIOL, V53, P419, DOI 10.1083/jcb.53.2.419; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; Steegmaier M, 2005, CLIN CANCER RES, V11, p9147S; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; TAKAISHI K, 1995, ONCOGENE, V11, P39; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zhang DH, 1996, NATURE, V382, P466, DOI 10.1038/382466a0; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102	51	98	102	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e409	10.1371/journal.pone.0000409	http://dx.doi.org/10.1371/journal.pone.0000409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476331	Green Submitted, gold, Green Published			2022-12-27	WOS:000207445700011
J	Wasser, M; Chia, W				Wasser, Martin; Chia, William			The Extrachromosomal EAST Protein of Drosophila Can Associate with Polytene Chromosomes and Regulate Gene Expression	PLOS ONE			English	Article								The EAST protein of Drosophila is a component of an expandable extrachromosomal domain of the nucleus. To better understand its function, we studied the dynamics and localization of GFP-tagged EAST. In live larval salivary glands, EAST-GFP is highly mobile and localizes to the extrachromosomal nucleoplasm. When these cells are permeabilized, EAST-GFP rapidly associated with polytene chromosomes. The affinity to chromatin increases and mobility decreases with decreasing salt concentration. Deleting the C-terminal residues 1535 to 2301 of EAST strongly reduces the affinity to polytene chromosomes. The bulk of EAST-GFP co-localizes with heterochromatin and is absent from transcriptionally active chromosomal regions. The predominantly chromosomal localization of EAST-GFP can be detected in non-detergent treated salivary glands of pupae as they undergo apoptosis, however not in earlier stages of development. Consistent with this chromosomal pattern of localization, genetic evidence indicates a role for EAST in the repression of gene expression, since a lethal east mutation is allelic to the viable mutation suppressor of white-spotted. We propose that EAST acts as an ion sensor that modulates gene expression in response to changing intracellular ion concentrations.	[Wasser, Martin] Bioinformat Inst, Dept Imaging Informat, Singapore, Singapore; [Wasser, Martin; Chia, William] Natl Univ Singapore, Temasek LifeSci Lab, Singapore 117548, Singapore; [Chia, William] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; National University of Singapore	Wasser, M (corresponding author), Bioinformat Inst, Dept Imaging Informat, Singapore, Singapore.	martinw@bii.a-star.edu.sg		Wasser, Martin/0000-0002-8753-2346	Temasek LifeSciences Laboratories, Singapore	Temasek LifeSciences Laboratories, Singapore	The study was funded by the Temasek LifeSciences Laboratories, Singapore.	Alberts B, 2002, MOL BIOL CELL, P615; BRAND AH, 1993, DEVELOPMENT, V118, P401; DAVISON D, 1985, GENETICS, V110, P479; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Jiang CG, 1997, DEVELOPMENT, V124, P4673; Lee CY, 2001, DEVELOPMENT, V128, P1443; LEVIS R, 1984, CELL, V38, P471, DOI 10.1016/0092-8674(84)90502-6; Long AR, 1998, GENE, V208, P191, DOI 10.1016/S0378-1119(97)00652-5; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Paro R., 2000, DROSOPHILA PROTOCOLS, P131; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; PIRROTTA V, 1984, EMBO J, V3, P563, DOI 10.1002/j.1460-2075.1984.tb01847.x; Qi HY, 2005, J CELL BIOCHEM, V95, P1284, DOI 10.1002/jcb.20495; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Rath U, 2006, J CELL SCI, V119, P2332, DOI 10.1242/jcs.02960; VIJAYRAGHAVAN K, 1992, DEV BIOL, V154, P23, DOI 10.1016/0012-1606(92)90044-H; Walker DL, 2000, J CELL BIOL, V151, P1401, DOI 10.1083/jcb.151.7.1401; Wasser M, 2000, NAT CELL BIOL, V2, P268, DOI 10.1038/35010535; Wasser M, 2003, J CELL SCI, V116, P1733, DOI 10.1242/jcs.00379; Wells WA, 2001, J CELL BIOL, V154, P1102, DOI 10.1083/jcb.200108139	26	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e412	10.1371/journal.pone.0000412	http://dx.doi.org/10.1371/journal.pone.0000412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476334	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445700014
J	Coolen, M; Sauka-Spengler, T; Nicolle, D; Le-Mentec, C; Lallemand, Y; Da Silva, C; Plouhinec, JL; Robert, B; Wincker, P; Shi, DL; Mazan, S				Coolen, Marion; Sauka-Spengler, Tatjana; Nicolle, Delphine; Le-Mentec, Chantal; Lallemand, Yvan; Da Silva, Corinne; Plouhinec, Jean-Louis; Robert, Benoit; Wincker, Patrick; Shi, De-Li; Mazan, Sylvie			Evolution of Axis Specification Mechanisms in Jawed Vertebrates: Insights from a Chondrichthyan	PLOS ONE			English	Article							ANTERIOR VISCERAL ENDODERM; NODAL-RELATED SIGNALS; GERM-LAYER FORMATION; PRIMITIVE STREAK FORMATION; EARLY CHICK BLASTODERM; EARLY MOUSE EMBRYO; HOMEOBOX GENE; NEURAL INDUCTION; SPEMANNS ORGANIZER; FOREBRAIN DEVELOPMENT	The genetic mechanisms that control the establishment of early polarities and their link with embryonic axis specification and patterning seem to substantially diverge across vertebrates. In amphibians and teleosts, the establishment of an early dorsoventral polarity determines both the site of axis formation and its rostro-caudal orientation. In contrast, amniotes retain a considerable plasticity for their site of axis formation until blastula stages and rely on signals secreted by extraembryonic tissues, which have no clear equivalents in the former, for the establishment of their rostro-caudal pattern. The rationale for these differences remains unknown. Through detailed expression analyses of key development genes in a chondrichthyan, the dogfish Scyliorhinus canicula, we have reconstructed the ancestral pattern of axis specification in jawed vertebrates. We show that the dogfish displays compelling similarities with amniotes at blastula and early gastrula stages, including the presence of clear homologs of the hypoblast and extraembryonic ectoderm. In the ancestral state, these territories are specified at opposite poles of an early axis of bilateral symmetry, homologous to the dorso-ventral axis of amphibians or teleosts, and aligned with the later forming embryonic axis, from head to tail. Comparisons with amniotes suggest that a dorsal expansion of extraembryonic ectoderm, resulting in an apparently radial symmetry at late blastula stages, has taken place in their lineage. The synthesis of these results with those of functional analyses in model organisms supports an evolutionary link between the dorso-ventral polarity of amphibians and teleosts and the embryonic-extraembryonic organisation of amniotes. It leads to a general model of axis specification in gnathostomes, which provides a comparative framework for a reassessment of conservations both among vertebrates and with more distant metazoans.	[Coolen, Marion; Nicolle, Delphine; Plouhinec, Jean-Louis; Mazan, Sylvie] Univ Orleans, UMR 6218, Equipe Dev & Evolut Vertebres, Orleans, France; [Sauka-Spengler, Tatjana; Le-Mentec, Chantal] Univ Paris 11, UPRES A 8080, Equipe Dev & Evolut Vertebres, Orsay, France; [Da Silva, Corinne; Wincker, Patrick] CNRS, UMR 8030, Evry, France; [Shi, De-Li] Univ Paris 06, UMR7622, Paris, France; [Lallemand, Yvan; Robert, Benoit] Inst Pasteur, CNRS, URA 2578, Unite Genet Mol Morphogenese, Paris, France	Universite de Orleans; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mazan, S (corresponding author), Univ Orleans, UMR 6218, Equipe Dev & Evolut Vertebres, Orleans, France.	mazan@cnrs-orleans.fr	Shi, De-Li/AAG-1807-2021	DA SILVA, Corinne/0000-0002-7618-7831; Coolen, Marion/0000-0001-5658-5296; Sauka-Spengler, Tatjana/0000-0001-9289-0263	CNRG; Groupement d'Interet Scientifique "Genomique marine''; Centre National de la Recherche Scientifique, Universite Paris-Sud; Universite d'Orleans; MRT; AMX; BDI-CNRS	CNRG; Groupement d'Interet Scientifique "Genomique marine''; Centre National de la Recherche Scientifique, Universite Paris-Sud(Centre National de la Recherche Scientifique (CNRS)); Universite d'Orleans; MRT; AMX; BDI-CNRS	EST sequencing was funded by CNRG. This work was supported by a Groupement d'Interet Scientifique "Genomique marine'', the Centre National de la Recherche Scientifique, Universite Paris-Sud and Universite d'Orleans. T. S. S., J.L.P. and M. C. were recipients of MRT, AMX and BDI-CNRS fellowships respectively.	Agius E, 2000, DEVELOPMENT, V127, P1173; ALBAZERCHI A, 2006, DEV BIOL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreazzoli M, 1997, DEVELOPMENT, V124, P1733; ANG SL, 1993, DEVELOPMENT, V118, P139; ANG SL, 1994, DEVELOPMENT, V120, P2979; Arendt D, 1999, MECH DEVELOP, V81, P3, DOI 10.1016/S0925-4773(98)00226-3; Arendt D, 2003, INT J DEV BIOL, V47, P563; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; BALLYCUIF L, 1995, MECH DEVELOP, V49, P49, DOI 10.1016/0925-4773(94)00301-3; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Bouillet P, 1996, MECH DEVELOP, V58, P141, DOI 10.1016/S0925-4773(96)00569-2; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; BURIAN RM, 1993, J HIST BIOL, V26, P351, DOI 10.1007/BF01061974; CALLEBAUT M, 1995, EUR J MORPHOL, V33, P221; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman SC, 2003, DEVELOPMENT, V130, P5091, DOI 10.1242/dev.00712; Chazaud C, 2006, DEVELOPMENT, V133, P3379, DOI 10.1242/dev.02523; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; COOPER MS, 2007, J EXP ZOOLOG B; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; Erter CE, 2001, DEVELOPMENT, V128, P3571; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Fekany K, 1999, DEVELOPMENT, V126, P1427; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Feldman B, 2000, CURR BIOL, V10, P531, DOI 10.1016/S0960-9822(00)00469-3; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Foley AC, 2000, DEVELOPMENT, V127, P3839; Foley AC, 2001, J ANAT, V199, P35; Force A, 1999, GENETICS, V151, P1531; Fredieu JR, 1997, DEV BIOL, V186, P100, DOI 10.1006/dbio.1997.8566; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; Gardner RL, 1997, DEVELOPMENT, V124, P289; Georgiades P, 2006, DEVELOPMENT, V133, P1059, DOI 10.1242/dev.02277; GERHARDT J, 1997, CELLS EMBRYOS EVOLUT; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; GODSAVE S, 1994, DEV BIOL, V166, P465, DOI 10.1006/dbio.1994.1330; Gore AV, 2005, NATURE, V438, P1030, DOI 10.1038/nature04184; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; Ho CY, 1999, CURR BIOL, V9, P1131, DOI 10.1016/S0960-9822(99)80485-0; HUME CR, 1993, DEVELOPMENT, V119, P1147; IZPISUABELMONTE JC, 1993, CELL, V74, P645, DOI 10.1016/0092-8674(93)90512-O; Jiang YM, 1996, DEV BIOL, V174, P258, DOI 10.1006/dbio.1996.0071; Jiang YM, 1998, DEV GENET, V22, P263, DOI 10.1002/(SICI)1520-6408(1998)22:3<263::AID-DVG8>3.0.CO;2-4; Jones CM, 1999, CURR BIOL, V9, P946, DOI 10.1016/S0960-9822(99)80421-7; Joubin K, 2001, INT J DEV BIOL, V45, P165; Kablar B, 1996, MECH DEVELOP, V55, P145, DOI 10.1016/0925-4773(96)00497-2; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Kimura-Yoshida C, 2005, DEV CELL, V9, P639, DOI 10.1016/j.devcel.2005.09.011; Klingensmith J, 1999, DEV BIOL, V216, P535, DOI 10.1006/dbio.1999.9525; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAWSON KA, 1987, DEVELOPMENT, V101, P627; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Locascio A, 2002, P NATL ACAD SCI USA, V99, P16841, DOI 10.1073/pnas.262525399; Martyn U, 2003, DEV BIOL, V260, P58, DOI 10.1016/S0012-1606(03)00221-5; MERCIER P, 1995, INT J DEV BIOL, V39, P559; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Niehrs C, 2001, INT J DEV BIOL, V45, P237; Nieuwkoop PD, 1967, NORMAL TABLES XENOPU; PANNESE M, 1995, DEVELOPMENT, V121, P707; PARAMESWARAN M, 1995, DEV GENET, V17, P16, DOI 10.1002/dvg.1020170104; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Perea-Gomez A, 2001, INT J DEV BIOL, V45, P311; Plouhinec JL, 2005, DEV BIOL, V278, P560, DOI 10.1016/j.ydbio.2004.11.019; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Reece-Hoyes JS, 2002, DEV DYNAM, V223, P134, DOI 10.1002/dvdy.1234; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Rhinn M, 1998, DEVELOPMENT, V125, P845; Richardson L, 2006, MECH DEVELOP, V123, P288, DOI 10.1016/j.mod.2006.01.004; Robinson-Rechavi M, 2004, MOL BIOL EVOL, V21, P580, DOI 10.1093/molbev/msh046; Rodriguez TA, 2005, DEVELOPMENT, V132, P2513, DOI 10.1242/dev.01847; Sauka-Spengler T, 2003, DEV BIOL, V263, P296, DOI 10.1016/j.ydbio.2003.07.009; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 1998, CURR OPIN GENET DEV, V8, P464, DOI 10.1016/S0959-437X(98)80119-6; Schneider VA, 1999, CURR BIOL, V9, P800, DOI 10.1016/S0960-9822(99)80363-7; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Skromne I, 2002, MECH DEVELOP, V114, P115, DOI 10.1016/S0925-4773(02)00034-5; Skromne I, 2001, DEVELOPMENT, V128, P2915; Smith JL, 1998, CURR TOP DEV BIOL, V40, P79, DOI 10.1016/S0070-2153(08)60365-8; SPRATT NT, 1960, J EXP ZOOL, V145, P97, DOI 10.1002/jez.1401450202; STEINBEISSER H, 1993, CR ACAD SCI III-VIE, V316, P966; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; STERN CD, 2004, GASTRULATION CELLS E, pR9; STERN CD, 2004, GASTRULATION CELLS E, P219; Stern CD, 2006, CURR OPIN GENET DEV, V16, P413, DOI 10.1016/j.gde.2006.06.005; Streit A, 1998, DEVELOPMENT, V125, P507; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takaoka K, 2006, DEV CELL, V10, P451, DOI 10.1016/j.devcel.2006.02.017; Takemoto T, 2006, DEVELOPMENT, V133, P297, DOI 10.1242/dev.02196; Tam PPL, 1999, DEVELOPMENT, V126, P5171; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Thomas PQ, 1998, DEVELOPMENT, V125, P85; TOYAMA R, 1995, DEVELOPMENT, V121, P383; Vandebroek G., 1936, Archives de Biologie Liege, V47, P499; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yao J, 2001, DEVELOPMENT, V128, P2975; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472	121	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e374	10.1371/journal.pone.0000374	http://dx.doi.org/10.1371/journal.pone.0000374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440610	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000207445500005
J	Piwowar, HA; Day, RS; Fridsma, DB				Piwowar, Heather A.; Day, Roger S.; Fridsma, Douglas B.			Sharing Detailed Research Data Is Associated with Increased Citation Rate	PLOS ONE			English	Article							MICROARRAY DATABASE; GENE-EXPRESSION; CANCER; INFORMATION; ARTICLES; IMPACT	Background. Sharing research data provides benefit to the general scientific community, but the benefit is less obvious for the investigator who makes his or her data available. Principal Findings. We examined the citation history of 85 cancer microarray clinical trial publications with respect to the availability of their data. The 48% of trials with publicly available microarray data received 85% of the aggregate citations. Publicly available data was significantly (p = 0.006) associated with a 69% increase in citations, independently of journal impact factor, date of publication, and author country of origin using linear regression. Significance. This correlation between publicly available data and increased literature impact may further motivate investigators to share their detailed research data.	[Piwowar, Heather A.; Day, Roger S.; Fridsma, Douglas B.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Piwowar, HA (corresponding author), Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15260 USA.	hpiwowar@cbmi.pitt.edu	El-Halwagi, Mahmoud M/F-7464-2011; Piwowar, Heather A/A-4680-2009	El-Halwagi, Mahmoud M/0000-0002-0020-2281; Piwowar, Heather/0000-0003-1613-5981	NLM [5T15-LM007059-19]; NATIONAL LIBRARY OF MEDICINE [T15LM007059] Funding Source: NIH RePORTER	NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	HAP was supported by NLM Training Grant Number 5T15-LM007059-19. The NIH had no role in study design, data collection or analysis, writing the paper, or the decision to submit it for publication. The publication contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Antelman K, 2004, COLL RES LIBR, V65, P372, DOI 10.5860/crl.65.5.372; Ball CA, 2005, NUCLEIC ACIDS RES, V33, pD580; Ball CA, 2004, NAT BIOTECHNOL, V22, P1179, DOI 10.1038/nbt0904-1179; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brazma A, 2000, NATURE, V403, P699, DOI 10.1038/35001676; Buetow KH, 2005, SCIENCE, V308, P821, DOI 10.1126/science.1112120; Case DO, 2000, J AM SOC INFORM SCI, V51, P635, DOI 10.1002/(SICI)1097-4571(2000)51:7<635::AID-ASI6>3.0.CO;2-H; Cech T. R., 2003, SHARING PUBLICATION; Check E, 2004, NATURE, V429, P496, DOI 10.1038/429496a; DIAMOND AM, 1986, J HUM RESOUR, V21, P200; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evangelou E, 2005, FASEB J, V19, P1943, DOI 10.1096/fj.05-4784lsf; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; FIENBERG SE, 1985, SHARING RES DATA, pR8; Gupta D, 2004, AM J CLIN PATHOL, V121, P176, DOI 10.1309/E6K33GBPE5C27FYU; Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Liotta LA, 2005, JNCI-J NATL CANCER I, V97, P310, DOI 10.1093/jnci/dji053; MCCAIN KW, 1995, SCI COMMUN, V16, P403, DOI 10.1177/1075547095016004003; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Popat S, 2005, J NATL CANCER I, V97, P1855, DOI 10.1093/jnci/dji445; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riley RD, 2003, BRIT J CANCER, V88, P1191, DOI 10.1038/sj.bjc.6600886; Santos C, 2005, NATURE, V438, P738, DOI 10.1038/438738a; Seglen PO, 1997, BRIT MED J, V314, P498; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Spellman PT, 2002, GENOME BIOL, V3; Swan A, 2004, LEARN PUBL, V17, P219, DOI 10.1087/095315104323159649; Theologis A, 2004, PLANT PHYSIOL, V135, P4, DOI 10.1104/pp.104.043083; Ventura B, 2005, PHYSIOL GENOMICS, V20, P153, DOI 10.1152/physiolgenomics.00264.2004; Weale Andy R, 2004, BMC Med Res Methodol, V4, P14, DOI 10.1186/1471-2288-4-14; 1997, NUCL ACIDS RES, V15; 2003, NAT IMMUNOL, V4, P93	37	421	431	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e308	10.1371/journal.pone.0000308	http://dx.doi.org/10.1371/journal.pone.0000308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375194	gold, Green Accepted, Green Published			2022-12-27	WOS:000207445100010
J	Koizumi, A; Zeck, G; Ben, YX; Masland, RH; Jakobs, TC				Koizumi, Amane; Zeck, Guenther; Ben, Yixin; Masland, Richard H.; Jakobs, Tatjana C.			Organotypic Culture of Physiologically Functional Adult Mammalian Retinas	PLOS ONE			English	Article								Background. The adult mammalian retina is an important model in research on the central nervous system. Many experiments require the combined use of genetic manipulation, imaging, and electrophysiological recording, which make it desirable to use an in vitro preparation. Unfortunately, the tissue culture of the adult mammalian retina is difficult, mainly because of the high energy consumption of photoreceptors. Methods and Findings. We describe an interphase culture system for adult mammalian retina that allows for the expression of genes delivered to retinal neurons by particle-mediated transfer. The retinas retain their morphology and function for up to six days-long enough for the expression of many genes of interest-so that effects upon responses to light and receptive fields could be measured by patch recording or multielectrode array recording. We show that a variety of genes encoding pre- and post-synaptic marker proteins are localized correctly in ganglion and amacrine cells. Conclusions. In this system the effects on neuronal function of one or several introduced exogenous genes can be studied within intact neural circuitry of adult mammalian retina. This system is flexible enough to be compatible with genetic manipulation, imaging, cell transfection, pharmacological assay, and electrophysiological recordings.	[Koizumi, Amane; Masland, Richard H.; Jakobs, Tatjana C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; [Zeck, Guenther] Max Planck Inst Neurobiol, Martinsried, Germany; [Ben, Yixin] Burke Inst, White Plains, NY USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Max Planck Society	Jakobs, TC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA.	Jakobs@helix.mgh.harvard.edu	Koizumi, Amane/E-7771-2011; Zeck, Günther/H-7419-2013	Zeck, Günther/0000-0003-3998-9883; Jakobs, Tatjana/0000-0002-8104-9206; Koizumi, Amane/0000-0003-1177-0185	NIH [RO1-017169]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grant RO1-017169. RHM is a Senior Investigator of Research to Prevent Blindness. The funding institution had no part in the design of the study, data collection, or the preparation of the manuscript.	Adler R, 2001, DEV BIOL, V236, P454, DOI 10.1006/dbio.2001.0331; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; AMES A, 1990, PREPARATIONS VERTEBR, P183; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Famiglietti EV, 2002, VISUAL NEUROSCI, V19, P145, DOI 10.1017/S0952523802191139; FAMIGLIETTI EV, 1985, J NEUROSCI, V5, P562; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; HUANG L, 2003, J COMP NEUROL, V455; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Koch K, 2006, CURR BIOL, V16, P1428, DOI 10.1016/j.cub.2006.05.056; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Kuzmanovic M, 2003, INVEST OPHTH VIS SCI, V44, P3606, DOI 10.1167/iovs.02-1265; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; Meier J, 2004, J NEUROSCI, V24, P1398, DOI 10.1523/JNEUROSCI.4260-03.2004; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Reid CA, 1997, J NEUROSCI, V17, P2738; Reidel B, 2006, VISION RES, V46, P4464, DOI 10.1016/j.visres.2006.07.019; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; Rockhill RL, 2002, J NEUROSCI, V22, P3831; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Sinclair JR, 2004, J NEUROSCI, V24, P1459, DOI 10.1523/JNEUROSCI.3959-03.2004; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Streichert LC, 1999, J NEUROBIOL, V39, P475, DOI 10.1002/(SICI)1097-4695(19990615)39:4<475::AID-NEU2>3.0.CO;2-#; Xin H, 2007, J NEUROSCI METH, V159, P35, DOI 10.1016/j.jneumeth.2006.06.013; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zeck GM, 2005, EUR J NEUROSCI, V22, P2016, DOI 10.1111/j.1460-9568.2005.04390.x; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571	40	47	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e221	10.1371/journal.pone.0000221	http://dx.doi.org/10.1371/journal.pone.0000221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311097	Green Published, gold			2022-12-27	WOS:000207444500002
J	Gadit, AAM; Mugford, G				Gadit, Amin A. Muhammad; Mugford, Gerry			Prevalence of Depression among Households in Three Capital Cities of Pakistan: Need to Revise the Mental Health Policy	PLOS ONE			English	Article								Background. Pakistan, among the other developing countries, has a higher prevalence rate of depression because of the current social adversities. There is, thus, a great need for systematic studies on prevalence of depression. The current study aims at exploring the prevalence of depression among households in three capital cities of Pakistan. Methodology and Principal Findings. A sample of N=820 was randomly selected, and a cross sectional telephone-based study was conducted for a duration of six months. It was found that there was a regional variation in prevalence rates for depression among the three cities. Lahore had the highest number of depressives (53.4%), as compared to Quetta (43.9%) and Karachi (35.7%). Middle age, female gender and secondary school level of education were significantly associated with depression among the study group. Conclusions/Significance. The different rates of prevalence among the three cities could be attributed to local cultural influence, geographical locations and social adversities. There is a need for revision of existing health policy by the government.	[Gadit, Amin A. Muhammad] Mem Univ Newfoundland, Discipline Psychiat, St John, NF, Canada; [Mugford, Gerry] Mem Univ Newfoundland, Fac Psychiat Pharm & Med, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Gadit, AAM (corresponding author), Mem Univ Newfoundland, Discipline Psychiat, St John, NF, Canada.	amin.muhammad@med.mun.ca			Merck Marker Ltd. Pakistan	Merck Marker Ltd. Pakistan	The Merck Marker Ltd. Pakistan provided a small amount of funding for compensating the interviewers in three cities; for traveling and stationary an additional small amount was provided. There was no further role of sponsor in data collection, analysis, interpretation of data, writing of paper and decision for submission for publication. There were no additional sources for funding.	AHMAD I, 2001, MED FORUM MONTHLY, V12, P5; Desjarlais R., 2001, WORLD HLTH REPORT; Gadit A, 2002, STATE MENTAL HLTH PA, P36; GADIT A, 1998, J COLL PHYS SURG PK, V8, P262; Gadit A., 2002, STATE MENTAL HLTH PA, P38; Husain N, 2000, PSYCHOL MED, V30, P395, DOI 10.1017/S0033291700001707; Lerer B, 1996, Int Psychogeriatr, V8, P83, DOI 10.1017/S1041610296002499; MIROWSKY J, 1992, J HEALTH SOC BEHAV, V33, P187, DOI 10.2307/2137349; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Mumford DB, 1997, BRIT J PSYCHIAT, V170, P473, DOI 10.1192/bjp.170.5.473; Nisar N, 2004, J Pak Med Assoc, V54, P519; SARTORIUS N, 2004, BRIT J PSYCHIAT, V184, P8; Stordal E, 2003, ACTA PSYCHIAT SCAND, V107, P132, DOI 10.1034/j.1600-0447.2003.02056.x; *UNICEF, 2006, STAT WORLDS CHILDR, P98; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; *WHO, 2006, MENT HLTH; World Health Organization, 2001, WORLD HLTH REP; World Health Organization (WHO), 2005, MENT HLTH ATL	18	54	55	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e209	10.1371/journal.pone.0000209	http://dx.doi.org/10.1371/journal.pone.0000209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299589	Green Accepted, Green Published, gold			2022-12-27	WOS:000207444400010
J	Okabe, H; Lee, SH; Phuchareon, J; Albertson, DG; McCormick, F; Tetsu, O				Okabe, Hiroshi; Lee, Sang-Hyun; Phuchareon, Janyaporn; Albertson, Donna G.; McCormick, Frank; Tetsu, Osamu			A Critical Role for FBXW8 and MAPK in Cyclin D1 Degradation and Cancer Cell Proliferation	PLOS ONE			English	Article								Cyclin D1 regulates G1 progression. Its transcriptional regulation is well understood. However, the mechanism underlying cyclin D1 ubiquitination and its subsequent degradation is not yet clear. We report that cyclin D1 undergoes increased degradation in the cytoplasm during S phase in a variety of cancer cells. This is mediated by phosphorylation at Thr286 through the activity of the Ras/Raf/MEK/ERK cascade and the F-box protein FBXW8, which is an E3 ligase. The majority of FBXW8 is expressed in the cytoplasm during G1 and S phase. In contrast, cyclin D1 accumulates in the nucleus during G1 phase and exits into the cytoplasm in S phase. Increased cyclin D1 degradation is linked to association with FBXW8 in the cytoplasm, and enhanced phosphorylation of cyclin D1 through sustained ERK1/2 signaling. Depletion of FBXW8 caused a significant accumulation of cyclin D1, as well as sequestration of CDK1 in the cytoplasm. This resulted in a severe reduction of cell proliferation. These effects could be rescued by constitutive nuclear expression of cyclin D1-T286A. Thus, FBXW8 plays an essential role in cancer cell proliferation through proteolysis of cyclin D1. It may present new opportunities to develop therapies targeting destruction of cyclin D1 or its regulator E3 ligase selectively.	[Okabe, Hiroshi; Phuchareon, Janyaporn; Tetsu, Osamu] Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA; [Lee, Sang-Hyun; Albertson, Donna G.; McCormick, Frank] Univ Calif San Francisco, Sch Med, Canc Res Inst, San Francisco, CA 94143 USA; [Okabe, Hiroshi; Lee, Sang-Hyun; Phuchareon, Janyaporn; Albertson, Donna G.; McCormick, Frank; Tetsu, Osamu] Univ Calif San Francisco, Sch Med, UCSF Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Tetsu, O (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA.	tetsu@cc.ucsf.edu	高, 雨莉/HGU-8187-2022	Tetsu, Osamu/0000-0003-1820-7539	American Cancer Society; Concern Foundation; Daiichi Pharmaceuticals; UCSF Research-Evaluation Allocation Committee; V Foundation; National Institutes of Health [R01 CA101359]; Wood Foundation; NATIONAL CANCER INSTITUTE [R01CA101359] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Concern Foundation; Daiichi Pharmaceuticals(Daiichi Sankyo Company Limited); UCSF Research-Evaluation Allocation Committee; V Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wood Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the American Cancer Society, the Concern Foundation, the Daiichi Pharmaceuticals, the UCSF Research-Evaluation Allocation Committee, and the V Foundation to O.T., the National Institutes of Health (R01 CA101359) to D. G. A., and the Wood Foundation to F. M.	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ganiatsas S, 2001, ONCOGENE, V20, P3641, DOI 10.1038/sj.onc.1204501; Guo Y, 2005, ONCOGENE, V24, P2599, DOI 10.1038/sj.onc.1208326; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; MACDONALD SG, 1997, RAS RAF ERK SIGNALIN, P121; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Russell A, 1999, ONCOGENE, V18, P1983, DOI 10.1038/sj.onc.1202511; Shao JY, 2000, J BIOL CHEM, V275, P22916, DOI 10.1074/jbc.M002235200; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	33	155	157	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e128	10.1371/journal.pone.0000128	http://dx.doi.org/10.1371/journal.pone.0000128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205132	gold, Green Submitted, Green Published			2022-12-27	WOS:000207443700022
J	Bonarius, HPJ; Baas, F; Remmerswaal, EBM; van Lier, RAW; ten Berge, IJM; Tak, PP; de Vries, N				Bonarius, Hendrik P. J.; Baas, Frank; Remmerswaal, Ester B. M.; van Lier, Rene A. W.; ten Berge, Ineke J. M.; Tak, Paul P.; de Vries, Niek			Monitoring the T-Cell Receptor Repertoire at Single-Clone Resolution	PLOS ONE			English	Article								The adaptive immune system recognizes billions of unique antigens using highly variable T-cell receptors. The alpha beta T-cell receptor repertoire includes an estimated 10(6) different rearranged beta chains per individual. This paper describes a novel microarray based method that monitors the beta chain repertoire with a resolution of a single T-cell clone. These T-arrays are quantitative and detect T-cell clones at a frequency of less than one T cell in a million, which is 2 logs more sensitive than spectratyping (immunoscope), the current standard in repertoire analysis. Using T-arrays we detected CMV-specific CD4+ and CD8+ T-cell clones that expanded early after viral antigen stimulation in vitro and in vivo. This approach will be useful in monitoring individual T-cell clones in diverse experimental settings, and in identification of T-cell clones associated with infectious disease, autoimmune disease and cancer.	[Bonarius, Hendrik P. J.; Baas, Frank; Tak, Paul P.; de Vries, Niek] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands; [Remmerswaal, Ester B. M.; van Lier, Rene A. W.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [ten Berge, Ineke J. M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Nephrol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Vries, N (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	Niek.deVries@amc.uva.nl	Baas, Frank/F-9574-2010; de Vries, Niek/J-9348-2013; Remmerswaal, Ester/ABF-3596-2020	Baas, Frank/0000-0003-3912-5428; de Vries, Niek/0000-0002-6257-8604; Remmerswaal, Ester/0000-0003-4694-6048; van Lier, Rene/0000-0002-3201-7144	The Netherlands Genomics Initiative	The Netherlands Genomics Initiative	The Netherlands Genomics Initiative (NGI: www.genomics.nl) funded the position of H. P.J.B. in a Horizon Breakthrough Grant to N.V. The NGI did not play a role in the conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript. There are no other financial or other relations that might be relevant to the submission of this manuscript.	Arden Bernhard, 1995, Immunogenetics, V42, P455; Arstila T P, 2000, Science, V288, P1135; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Douek DC, 2002, J IMMUNOL, V168, P3099, DOI 10.4049/jimmunol.168.6.3099; Doumaid K, 2000, TRANSPL IMMUNOL, V8, P83, DOI 10.1016/S0966-3274(00)00008-3; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hohlfeld R, 2003, BRAIN, V126, P2, DOI 10.1093/brain/awg001; James KD, 1998, NUCLEIC ACIDS RES, V26, P5203, DOI 10.1093/nar/26.22.5203; Janeway C., 2004, IMMUNOBIOLOGY; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Muraro PA, 2003, BRAIN, V126, P20, DOI 10.1093/brain/awg021; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Rohrlich PS, 2005, P NATL ACAD SCI USA, V102, P12855, DOI 10.1073/pnas.0502309102; Roth ME, 2004, NAT BIOTECHNOL, V22, P418, DOI 10.1038/nbt948; Ruiz M, 2000, NUCLEIC ACIDS RES, V28, P219, DOI 10.1093/nar/28.1.219; VANLEEUWEN EM, 2006, BLOOD       IN PRESS, DOI DOI 10.1182/BLOOD-2006-03-006809; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; ZANDERS ED, 1983, NATURE, V303, P625, DOI 10.1038/303625a0; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	26	14	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e55	10.1371/journal.pone.0000055	http://dx.doi.org/10.1371/journal.pone.0000055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183685	gold, Green Submitted, Green Published			2022-12-27	WOS:000207443600055
J	Buvoli, M; Buvoli, A; Leinwand, LA				Buvoli, Massimo; Buvoli, Ada; Leinwand, Leslie A.			Interplay between Exonic Splicing Enhancers, mRNA Processing, and mRNA Surveillance in the Dystrophic Mdx Mouse	PLOS ONE			English	Article								Background. Pre-mRNA splicing, the removal of introns from RNA, takes place within the spliceosome, a macromolecular complex composed of five small nuclear RNAs and a large number of associated proteins. Spliceosome assembly is modulated by the 5' and 3' splice site consensus sequences situated at the ends of each intron, as well as by exonic and intronic splicing enhancers/silencers recognized by SR and hnRNP proteins. Nonsense mutations introducing a premature termination codon (PTC) often result in the activation of cellular quality control systems that reduce mRNA levels or alter the mRNA splicing pattern. The mdx mouse, a commonly used genetic model for Duchenne muscular dystrophy (DMD), lacks dystrophin by virtue of a premature termination codon (PTC) in exon 23 that also severely reduces the level of dystrophin mRNA. However, the effect of the mutation on dystrophin RNA processing has not yet been described. Methodology/Principal Finding. Using combinations of different biochemical and cellular assays, we found that the mdx mutation partially disrupts a multisite exonic splicing enhancer (ESE) that is recognized by a 40 kDa SR protein. In spite of the presence of an inefficient intron 22 3' splice site containing the rare GAG triplet, the mdx mutation does not activate nonsense-associated altered splicing (NAS), but induces exclusively nonsense-mediated mRNA decay (NMD). Functional binding sites for SR proteins were also identified in exon 22 and 24, and in vitro experiments show that SR proteins can mediate direct association between exon 22, 23, and 24. Conclusions/Significance. Our findings highlight the complex crosstalk between trans-acting factors, cis-elements and the RNA surveillance machinery occurring during dystrophin mRNA processing. Moreover, they suggest that dystrophin exon-exon interactions could play an important role in preventing mdx exon 23 skipping, as well as in facilitating the pairing of committed splice sites.	[Buvoli, Massimo; Buvoli, Ada; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	Leslie.Leinwand@Colorado.edu		LEINWAND, LESLIE/0000-0003-1470-4810	NIH [GM29090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by a grant from the NIH (GM29090) to L. A. L.	Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Behm-Ansmant I, 2006, GENE DEV, V20, P391, DOI 10.1101/gad.1407606; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BIENVENU T, 1994, HUM GENET, V94, P65, DOI 10.1007/BF02272843; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Buvoli M, 2000, MOL CELL BIOL, V20, P3116, DOI 10.1128/MCB.20.9.3116-3124.2000; Buvoli M, 1997, EMBO J, V16, P7174, DOI 10.1093/emboj/16.23.7174; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Caudevilla C, 2001, NUCLEIC ACIDS RES, V29, P3108, DOI 10.1093/nar/29.14.3108; CHAMBERLAIN JS, 1988, SCIENCE, V239, P1416, DOI 10.1126/science.3347839; COFFEY AJ, 1992, GENOMICS, V12, P474, DOI 10.1016/0888-7543(92)90437-W; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Disset A, 2006, HUM MOL GENET, V15, P999, DOI 10.1093/hmg/ddl015; Dye DT, 1998, RNA, V4, P1523, DOI 10.1017/S1355838298980360; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gersappe A, 1999, J BIOL CHEM, V274, P22452, DOI 10.1074/jbc.274.32.22452; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; Graveley BR, 1999, CURR BIOL, V9, pR6, DOI 10.1016/S0960-9822(99)80032-3; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; Hertel KJ, 1998, MOL CELL, V1, P449, DOI 10.1016/S1097-2765(00)80045-3; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Ito Toshiyuki, 2001, Kobe Journal of Medical Sciences, V47, P193; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; Kessler O, 1996, MOL CELL BIOL, V16, P4426; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Konarska MM, 2005, GENE DEV, V19, P2255, DOI 10.1101/gad.1363105; Lam BJ, 2002, RNA, V8, P1233, DOI 10.1017/S1355838202028030; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Maquat LE, 2002, GENE DEV, V16, P1743, DOI 10.1101/gad.1014502; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Mayeda A, 1999, MOL CELL BIOL, V19, P1853; MONACO AP, 1992, GENOMICS, V12, P465, DOI 10.1016/0888-7543(92)90436-V; Nasim FUH, 2002, RNA, V8, P1078, DOI 10.1017/S1355838202024056; Pollard AJ, 2002, J BIOL CHEM, V277, P15241, DOI 10.1074/jbc.M109046200; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; Schaal TD, 1999, MOL CELL BIOL, V19, P261; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Stark JM, 1998, P NATL ACAD SCI USA, V95, P2163, DOI 10.1073/pnas.95.5.2163; Stark JM, 1999, J BIOL CHEM, V274, P29838, DOI 10.1074/jbc.274.42.29838; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; TAKESHIMA Y, 1995, J CLIN INVEST, V95, P515, DOI 10.1172/JCI117693; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; TIAN HC, 1995, MOL CELL BIOL, V15, P6291; Tian HH, 2001, J BIOL CHEM, V276, P33833, DOI 10.1074/jbc.M102957200; Tran Q, 2003, BBA-GENE STRUCT EXPR, V1625, P141, DOI 10.1016/S0167-4781(02)00600-0; Tran VK, 2006, J MED GENET, V43, P924, DOI 10.1136/jmg.2006.042317; TSUKAHARA T, 1994, NUCLEIC ACIDS RES, V22, P2318, DOI 10.1093/nar/22.12.2318; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang J, 2002, SCIENCE, V297, P108, DOI 10.1126/science.1069757; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; Wilton SD, 2006, CURR OPIN MOL THER, V8, P130; WONG C, 1989, BLOOD, V73, P914; Wu YC, 2005, GENOMICS, V86, P329, DOI 10.1016/j.ygeno.2005.05.011; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660; Yu J, 2001, MOL CELL BIOL, V21, P5879, DOI 10.1128/MCB.21.17.5879-5888.2001; ZAHLER AM, 1993, MOL CELL BIOL, V13, P4023, DOI 10.1128/MCB.13.7.4023; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	84	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e427	10.1371/journal.pone.0000427	http://dx.doi.org/10.1371/journal.pone.0000427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487273	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445800009
J	Peretti-Watel, P; Spire, B; Obadia, Y; Moatti, JP				Peretti-Watel, Patrick; Spire, Bruno; Obadia, Yolande; Moatti, Jean-Paul		VESPA Grp	Discrimination against HIV-Infected People and the Spread of HIV: Some Evidence from France	PLOS ONE			English	Article							SEXUAL RISK BEHAVIOR; UNPROTECTED SEX; AIDS; TRANSMISSION; PREVENTION; HIV/AIDS; EPIDEMIC; STIGMA; HAART; MEN	Background. Many people living with HIV/AIDS (PLWHA) suffer from stigma and discrimination. There is an ongoing debate, however, about whether stigma, fear and discrimination actually fuel the persisting spread of HIV, or slow it down by reducing contacts between the whole population and high-risk minorities. To contribute to this debate, we analysed the relationship between perceived discrimination and unsafe sex in a large sample of French PLWHAs. Methodology/Principal Findings. In 2003, we conducted a national cross-sectional survey among a random sample of HIV-infected patients. The analysis was restricted to sexually active respondents (N = 2,136). Unsafe sex was defined as sexual intercourse without a condom with a seronegative/unknown serostatus partner during the prior 12 months. Separate analyses were performed for each transmission group (injecting drug use (IDU), homosexual contact, heterosexual contact). Overall, 24% of respondents reported experiences of discrimination in their close social environment (relatives, friends and colleagues) and 18% reported unsafe sex during the previous 12 months. Both prevalences were higher in the IDU group (32% for perceived discrimination, 23% for unsafe sex). In multivariate analyses, experience of discrimination in the close social environment was associated with an increase in unsafe sex for both PLWHAs infected through IDU and heterosexual contact (OR = 1.65 and 1.80 respectively). Conclusions. Our study clearly confirms a relationship between discrimination and unsafe sex among PLWHAs infected through either IDU or heterosexual contact. This relationship was especially strong in the heterosexual group that has become the main vector of HIV transmission in France, and who is the more likely of sexual mixing with the general population. These results seriously question the hypothesis that HIV-stigma has no effect or could even reduce the infection spread of HIV.	[Peretti-Watel, Patrick; Spire, Bruno; Obadia, Yolande; Moatti, Jean-Paul] INSERM, U379, F-13258 Marseille, France; [Peretti-Watel, Patrick; Spire, Bruno; Obadia, Yolande; Moatti, Jean-Paul] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Peretti-Watel, Patrick; Spire, Bruno; Obadia, Yolande] SE Hlth Reg Observ ORS PACA, Marseille, France; [Moatti, Jean-Paul] Univ Aix Marseille 2, Dept Econ, F-13284 Marseille 07, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite	Peretti-Watel, P (corresponding author), INSERM, U379, F-13258 Marseille, France.	peretti@marseille.inserm.fr	Peretti-Watel, Patrick/P-4535-2017; Spire, Bruno/F-5546-2013	Spire, Bruno/0000-0002-3546-8020	French National Agency of AIDS Research (ANRS, France) [ANRS-EN12-VESPA]	French National Agency of AIDS Research (ANRS, France)(ANRS)	This study was supported by the French National Agency of AIDS Research (ANRS, France, grant ANRS-EN12-VESPA).	ANDERSON VN, 1992, J APPL SOC PSYCHOL, V22, P248, DOI 10.1111/j.1559-1816.1992.tb01538.x; Bonnet F, 2005, SCAND J INFECT DIS, V37, P482, DOI 10.1080/00365540510035328; Botnick MR, 2000, J HOMOSEXUAL, V38, P77, DOI 10.1300/J082v38n04_04; Bouhnik AD, 2007, AIDS, V21, pS43, DOI 10.1097/01.aids.0000255084.69846.97; Bryant K J, 1999, Focus, V14, P1; Burkholder G. J., 1999, J APPL BIOBEHAVIORAL, V4, P27, DOI [DOI 10.1111/J.1751-9861.1999.TB00053.X, 10.1111/j.1751-9861.1999.tb00053.x]; Carrieri MP, 2006, CLIN INFECT DIS, V43, pS197, DOI 10.1086/508184; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; DAB W, 1989, AIDS, V3, P433, DOI 10.1097/00002030-198907000-00005; Delor F, 2000, SOC AS AIDS, P77; Delpierre C, 2006, AIDS PATIENT CARE ST, V20, P838, DOI 10.1089/apc.2006.20.838; Doherty T, 2006, B WORLD HEALTH ORGAN, V84, P90, DOI 10.2471/BLT.04.019448; Douglas M., 1992, RISK BLAME; Dray-Spira R, 2003, AIDS CARE, V15, P739, DOI 10.1080/09540120310001618595; Ehiri John E, 2005, AIDS Public Policy J, V20, P25; EHRHARDT AA, 1992, J PSYCHOL HUMAN SEXU, V5, P37; Gayet-Ageron A, 2004, HIV MED, V5, P163, DOI 10.1111/j.1468-1293.2004.00205.x; Gremy I, 2004, AIDS, V18, P805, DOI [10.1097/01.aids.0000111390.02002.f4, 10.1097/00002030-200403260-00013]; GREMY I, 2005, MED MOL INFECT, V5; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Herek GM, 1999, AM BEHAV SCI, V42, P1130, DOI 10.1177/0002764299042007006; Herida M, 2005, MED MALADIES INFECT, V35, P281, DOI 10.1016/j.medmal.2005.03.011; *INVS, 2005, 3 INVS; KELLY JA, 1992, ARCH INTERN MED, V152, P2293, DOI 10.1001/archinte.152.11.2293; Kelly JA, 1998, HEALTH PSYCHOL, V17, P310, DOI 10.1037/0278-6133.17.4.310; Kippax SC, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000255078.01234.71; Kurzban R, 2001, PSYCHOL BULL, V127, P187, DOI 10.1037//0033-2909.127.2.187; Lievre L, 2006, AIDS, V20, P2392, DOI 10.1097/QAD.0b013e32801104b0; Liu H, 2005, SEX TRANSM INFECT, V81, P511, DOI 10.1136/sti.2005.014977; Luo RF, 2006, AIDS, V20, P935, DOI 10.1097/01.aids.0000218561.74779.77; Lupton D., 1994, QUALITATIVE HLTH RES, V4, P304, DOI DOI 10.1177/104973239400400304; Magee EM, 2006, J URBAN HEALTH, V83, P625, DOI 10.1007/s11524-006-9063-4; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; McLean J., 1994, AIDS Care, V6, P331, DOI 10.1080/09540129408258645; MILES L, 1993, WOMEN STUD INT FORUM, V16, P497, DOI 10.1016/0277-5395(93)90099-U; Peretti-Watel P, 2006, AIDS CARE, V18, P254, DOI 10.1080/09540120500456193; Peretti-Watel P, 2006, SOC SCI MED, V62, P2420, DOI 10.1016/j.socscimed.2005.10.020; Peretti-Watel P, 2005, POPULATION, V60, P525, DOI 10.2307/4150781; PERETTIWATEL P, 2005, PSYCHOL HEALTH MED, V10, P215, DOI DOI 10.1080/13548500412331334118; Reidpath DD, 2006, PLOS MED, V3, P1708, DOI 10.1371/journal.pmed.0030435; Reidpath DD, 2005, AIDS CARE, V17, pS117, DOI 10.1080/09540120500120195; Rhodes T, 1997, SOCIOL HEALTH ILL, V19, P208, DOI 10.1111/1467-9566.ep10934410; Rhodes T, 2002, SOC SCI MED, V55, P211, DOI 10.1016/S0277-9536(01)00162-9; ROSENBERG CE, 1988, SOC RES, V55, P327; Rosenbrock R, 2000, SOC SCI MED, V50, P1607, DOI 10.1016/S0277-9536(99)00469-4; Stall R, 1996, J ACQ IMMUN DEF SYND, V11, P151, DOI 10.1097/00042560-199602010-00006; Stein M, 2005, ALCOHOL CLIN EXP RES, V29, P837, DOI 10.1097/01.ALC.0000164363.40533.E0; *UNAIDS, 2004, REP GLOB AIDS EP; UNAIDS, 2000, PROT ID DISCR PEOPL; *UNAIDS, 2006, STIGM DISCR; *WHO, 2005, EMRO WORLD AIDS CAMP; WILTON T, 1991, SOC AS AIDS, P149	54	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e411	10.1371/journal.pone.0000411	http://dx.doi.org/10.1371/journal.pone.0000411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476333	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445700013
J	Catic, A; Misaghi, S; Korbel, GA; Ploegh, HL				Catic, Andre; Misaghi, Shahram; Korbel, Gregory A.; Ploegh, Hidde L.			ElaD, a Deubiquitinating Protease Expressed by E. coli	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; FUNCTIONAL PROTEOMICS; STRUCTURAL BASIS; UBIQUITIN; ACTIVATION; MECHANISM; PROTEINS; EFFECTOR; NEDD8; EXPLOITATION	Background. Ubiquitin and ubiquitin-like proteins (Ubl) are designed to modify polypeptides in eukaryotes. Covalent binding of ubiquitin or Ubls to substrate proteins can be reversed by specific hydrolases. One particular set of cysteine proteases, the CE clan, which targets ubiquitin and Ubls, has homologs in eukaryotes, prokaryotes, and viruses. Findings. We have cloned and analyzed the E. coli protein elaD, which is distantly related to eukaryotic CE clan members of the ULP/SENP protease family that are specific for SUMO and Nedd8. Previously misannotated as a putative sulfatase/phosphatase, elaD is an efficient and specific deubiquitinating enzyme in vitro. Interestingly, elaD is present in all intestinal pathogenic E. coli strains, but conspicuously absent from extraintestinal pathogenic strains (ExPECs). Further homologs of this protease can be found in Acanthamoeba Polyphaga Mimivirus, and in Alpha-, Beta-and Gammaproteobacteria. Conclusion. The expression of ULP/SENP-related hydrolases in bacteria therefore extends to plant pathogens and medically relevant strains of Escherichia coli, Legionella pneumophila, Rickettsiae, Chlamydiae, and Salmonellae, in which the elaD ortholog sseL has recently been identified as a virulence factor with deubiquitinating activity. As a counterpoint, our phylogenetic and functional examination reveals that ancient eukaryotic ULP/SENP proteases also have the potential of ubiquitin-specific hydrolysis, suggesting an early common origin of this peptidase clan.	[Catic, Andre; Misaghi, Shahram; Korbel, Gregory A.; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Catic, Andre; Misaghi, Shahram; Korbel, Gregory A.; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA USA; [Catic, Andre] Harvard Univ, Sch Med, Program Immunol, Boston, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.	ploegh@wi.mit.edu		Catic, Andre/0000-0002-3572-7598	NIH; AstraZeneca	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca)	This work was supported by grants from the NIH and from AstraZeneca. The sponsors were neither involved in the conduct of the study, nor in collection, analysis, or interpretation of the data.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Andres G, 2001, J BIOL CHEM, V276, P780, DOI 10.1074/jbc.M006844200; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Baba Tomoya, 2006, Mol Syst Biol, V2; Balakirev MY, 2002, J VIROL, V76, P6323, DOI 10.1128/JVI.76.12.6323-6331.2002; Barrett AJ, 2001, J STRUCT BIOL, V134, P95, DOI 10.1006/jsbi.2000.4332; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Golubtsov A, 2006, FEBS LETT, V580, P1502, DOI 10.1016/j.febslet.2006.01.071; Gurlebeck D, 2006, J PLANT PHYSIOL, V163, P233, DOI 10.1016/j.jplph.2005.11.011; Hemelaar J, 2004, J PROTEOME RES, V3, P268, DOI 10.1021/pr0341080; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; HINGAMP PM, 1992, EMBO J, V11, P361, DOI 10.1002/j.1460-2075.1992.tb05058.x; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; LOPEZOTIN C, 1989, J BIOL CHEM, V264, P9107; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Misaghi S, 2006, MOL MICROBIOL, V61, P142, DOI 10.1111/j.1365-2958.2006.05199.x; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; RODRIGUEZ JM, 1992, VIROLOGY, V186, P40, DOI 10.1016/0042-6822(92)90059-X; Ruzindana-Umunyana A, 2002, VIRUS RES, V89, P41, DOI 10.1016/S0168-1702(02)00111-9; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Schlieker C, 2005, J VIROL, V79, P15582, DOI 10.1128/JVI.79.24.15582-15585.2005; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Strunnikov AV, 2001, GENETICS, V158, P95; Sulea T, 2006, BIOL CHEM, V387, P853, DOI 10.1515/BC.2006.106; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Wenzl P, 2005, MOL BIOL EVOL, V22, P308, DOI 10.1093/molbev/msi018; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wolf YI, 1999, TRENDS GENET, V15, P173, DOI 10.1016/S0168-9525(99)01704-7; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	56	51	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e381	10.1371/journal.pone.0000381	http://dx.doi.org/10.1371/journal.pone.0000381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440617	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445500012
J	Henderson, SO; Haiman, CA; Wilkens, LR; Kolonel, LN; Wan, P; Pike, MC				Henderson, Sean O.; Haiman, Christopher A.; Wilkens, Lynne R.; Kolonel, Laurence N.; Wan, Peggy; Pike, Malcolm C.			Established Risk Factors Account for Most of the Racial Differences in Cardiovascular Disease Mortality	PLOS ONE			English	Article								Background. Cardiovascular disease (CVD) mortality varies across racial and ethnic groups in the U. S., and the extent that known risk factors can explain the differences has not been extensively explored. Methods. We examined the risk of dying from acute myocardial infarction (AMI) and other heart disease (OHD) among 139,406 African-American (AA), Native Hawaiian (NH), Japanese-American (JA), Latino and White men and women initially free from cardiovascular disease followed prospectively between 1993-1996 and 2003 in the Multiethnic Cohort Study (MEC). During this period, 946 deaths from AMI and 2,323 deaths from OHD were observed. Relative risks of AMI and OHD mortality were calculated accounting for established CVD risk factors: body mass index (BMI), hypertension, diabetes, smoking, alcohol consumption, amount of vigorous physical activity, educational level, diet and, for women, type and age at menopause and hormone replacement therapy (HRT) use. Results. Established CVD risk factors explained much of the observed racial and ethnic differences in risk of AMI and OHD mortality. After adjustment, NH men and women had greater risks of OHD than Whites (69% excess, P<0.001 and 62% excess, P = 0.003, respectively), and AA women had greater risks of AMI (48% excess, P = 0.01) and OHD (35% excess, P = 0.007). JA men had lower risks of AMI (51% deficit, P<0.001) and OHD (27% deficit, P = 0.001), as did JA women (AMI, 37% deficit, P = 0.03; OHD, 40% deficit, P = 0.001). Latinos had underlying lower risk of AMI death (26% deficit in men and 35% in women, P = 0.03). Conclusion. Known risk factors explain the majority of racial and ethnic differences in mortality due to AMI and OHD. The unexplained excess in NH and AA and the deficits in JA suggest the presence of unmeasured determinants for cardiovascular mortality that are distributed unequally across these populations.	[Henderson, Sean O.; Haiman, Christopher A.; Wan, Peggy; Pike, Malcolm C.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Henderson, Sean O.] Univ So Calif, Keck Sch Med, Dept Emergency Med, Los Angeles, CA 90033 USA; [Wilkens, Lynne R.; Kolonel, Laurence N.] Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96813 USA	University of Southern California; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System	Henderson, SO (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	sohender@hsc.usc.edu			US National Cancer Institute [R37 CA54281]; NATIONAL CANCER INSTITUTE [R37CA054281] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Public Health Service Grant R37 CA54281 from the US National Cancer Institute.	Altieri A, 2004, ANN EPIDEMIOL, V14, P461, DOI 10.1016/j.annepidem.2003.11.005; ALULI NE, 1991, AM J CLIN NUTR, V53, pS1556, DOI 10.1093/ajcn/53.6.1556S; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; Bauman WA, 1998, ARCH PHYS MED REHAB, V79, P176, DOI 10.1016/S0003-9993(98)90296-9; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; Braun KL, 1996, AM J PUBLIC HEALTH, V86, P888, DOI 10.2105/AJPH.86.6.888; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; BROWN SA, 1993, ARTERIOSCLER THROMB, V13, P1139, DOI 10.1161/01.ATV.13.8.1139; Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79; CURB JD, 1991, AM J PUBLIC HEALTH, V81, P164, DOI 10.2105/AJPH.81.2.164; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Dorn JP, 1999, ANN EPIDEMIOL, V9, P366, DOI 10.1016/S1047-2797(99)00025-3; Fang J, 1996, NEW ENGL J MED, V335, P1545, DOI 10.1056/NEJM199611213352101; Finkelstein EA, 2004, J WOMENS HEALTH, V13, P503, DOI 10.1089/1540999041280963; Fukiyama K, 2000, HYPERTENS RES, V23, P127, DOI 10.1291/hypres.23.127; Geronimus AT, 1996, NEW ENGL J MED, V335, P1552, DOI 10.1056/NEJM199611213352102; Haapanen N, 1997, INT J EPIDEMIOL, V26, P739, DOI 10.1093/ije/26.4.739; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Henderson SO, 2001, ACAD EMERG MED, V8, P1163, DOI 10.1111/j.1553-2712.2001.tb01134.x; Henderson SO, 2000, AM J MED SCI, V320, P18, DOI 10.1097/00000441-200007000-00004; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Mau MK, 1997, DIABETES CARE, V20, P1376, DOI 10.2337/diacare.20.9.1376; Mitchell B D, 1991, Ann Epidemiol, V1, P415; MOKUAU N, 1995, HEALTH SOC WORK, V20, P46, DOI 10.1093/hsw/20.1.46; Mukamal KJ, 2001, JAMA-J AM MED ASSOC, V285, P1965, DOI 10.1001/jama.285.15.1965; Pike MC, 1997, J NATL CANCER I, V89, P1110, DOI 10.1093/jnci/89.15.1110; Pike MC, 2000, STEROIDS, V65, P659, DOI 10.1016/S0039-128X(00)00122-7; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Shimamoto T, 1996, J Epidemiol, V6, pS43; Smith GD, 1998, LANCET, V351, P934, DOI 10.1016/S0140-6736(05)60603-4; Suka M, 2001, HYPERTENS RES, V24, P685, DOI 10.1291/hypres.24.685; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; Thomas AJ, 2005, AM J PUBLIC HEALTH, V95, P1417, DOI 10.2105/AJPH.2004.048165; Ueshima H, 2000, J HUM HYPERTENS, V14, P765, DOI 10.1038/sj.jhh.1001054; Ueshima H, 2003, J HUM HYPERTENS, V17, P631, DOI 10.1038/sj.jhh.1001606; *US BUR CENS, 2004, STAT ABSTR US 2004 2, P81; Wannamethee SG, 2001, SPORTS MED, V31, P101, DOI 10.2165/00007256-200131020-00003; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	41	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e377	10.1371/journal.pone.0000377	http://dx.doi.org/10.1371/journal.pone.0000377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440613	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445500008
J	Viveiros, M; Dupont, M; Rodrigues, L; Couto, I; Davin-Regli, A; Martins, M; Pages, JM; Amaral, L				Viveiros, Miguel; Dupont, Myrielle; Rodrigues, Liliana; Couto, Isabel; Davin-Regli, Anne; Martins, Marta; Pages, Jean-Marie; Amaral, Leonard			Antibiotic Stress, Genetic Response and Altered Permeability of E. coli	PLOS ONE			English	Article								Background. Membrane permeability is the first step involved in resistance of bacteria to an antibiotic. The number and activity of efflux pumps and outer membrane proteins that constitute porins play major roles in the definition of intrinsic resistance in Gram-negative bacteria that is altered under antibiotic exposure. Methodology/Principal Findings. Here we describe the genetic regulation of porins and efflux pumps of Escherichia coli during prolonged exposure to increasing concentrations of tetracycline and demonstrate, with the aid of quantitative real-time reverse transcriptase-polymerase chain reaction methodology and western blot detection, the sequence order of genetic expression of regulatory genes, their relationship to each other, and the ensuing increased activity of genes that code for transporter proteins of efflux pumps and down-regulation of porin expression. Conclusions/Significance. This study demonstrates that, in addition to the transcriptional regulation of genes coding for membrane proteins, the post-translational regulation of proteins involved in the permeability of Gram-negative bacteria also plays a major role in the physiological adaptation to antibiotic exposure. A model is presented that summarizes events during the physiological adaptation of E. coli to tetracycline exposure.	[Viveiros, Miguel; Rodrigues, Liliana; Couto, Isabel; Martins, Marta; Amaral, Leonard] Univ Nova Lisboa, Unit Mycobacteriol, UPMM, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Dupont, Myrielle; Davin-Regli, Anne; Pages, Jean-Marie] Univ Mediterranee, UMR MD 1, IFR48, Fac Med & Pharm, Marseille, France; [Couto, Isabel] Univ Nova Lisboa, Ctr Recursos Microbiol CREM, Fac Ciencias & Tecnol, P-1200 Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; UDICE-French Research Universities; Aix-Marseille Universite; Universidade Nova de Lisboa	Amaral, L (corresponding author), Univ Nova Lisboa, Unit Mycobacteriol, UPMM, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.	lamaral@ihmt.unl.pt	Amaral, Leonard/I-2112-2012; MARTINS, MARTA/I-3015-2012; Rodrigues, Liliana/N-2463-2014; Couto, Isabel/I-2640-2012; Viveiros, Miguel/A-7326-2008; PAGES, jean-marie/F-2555-2013	Amaral, Leonard/0000-0003-3127-1295; Rodrigues, Liliana/0000-0002-2094-2666; Couto, Isabel/0000-0003-3536-2733; Viveiros, Miguel/0000-0001-9676-6251; PAGES, jean-marie/0000-0001-7092-7977; Martins, Marta/0000-0002-0323-2857	Luso-French Integrated Actions [CRUP/2006-F-33/06]; EU [FSE/FEDER-POCI/SAU-MMO/59370/2004]; Universite de la Mediterranee; Service de Sante des Armees; Eloi Collery Prix Academie Nationale de Medecine; Fundacao para a Ciencia e Tecnologia (FCT) of Portugal [SFRH/BD/24931/2005, SFRH/BD/14319/2003]	Luso-French Integrated Actions; EU(European Commission); Universite de la Mediterranee; Service de Sante des Armees; Eloi Collery Prix Academie Nationale de Medecine; Fundacao para a Ciencia e Tecnologia (FCT) of Portugal(Portuguese Foundation for Science and Technology)	Funding: This work was supported by grants (i) Luso-French Integrated Actions (CRUP/2006-F-33/06) (ii) EU-FSE/FEDER-POCI/SAU-MMO/59370/2004 and (iii) the Universite de la Mediterranee, the Service de Sante des Armees and from Eloi Collery Prix Academie Nationale de Medecine (J.-M.P.). L. Rodrigues and M. Martins were supported by grants SFRH/BD/24931/2005 and SFRH/BD/14319/2003, respectively, from Fundacao para a Ciencia e Tecnologia (FCT) of Portugal.	ARIZA RR, 1995, J BACTERIOL, V177, P1655, DOI 10.1128/jb.177.7.1655-1661.1995; Baquero F, 2001, DRUG RESIST UPDATE, V4, P93, DOI 10.1054/drup.2001.0196; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BOHNERT JA, 2007, J ANTIMICRO IN PRESS; BOLLA JM, 1988, EMBO J, V7, P3595, DOI 10.1002/j.1460-2075.1988.tb03237.x; BRANLANT G, 1985, EUR J BIOCHEM, V150, P61, DOI 10.1111/j.1432-1033.1985.tb08988.x; Castillo-Keller M, 2006, J BACTERIOL, V188, P576, DOI 10.1128/JB.188.2.576-586.2006; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Chen S, 2004, J BACTERIOL, V186, P6689, DOI 10.1128/JB.186.20.6689-6697.2004; COHEN SP, 1993, J BACTERIOL, V175, P1484, DOI 10.1128/JB.175.5.1484-1492.1993; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Davin-Regli A., 2006, ANTIMICROBIAL RESIST, P55; De E, 2001, MOL MICROBIOL, V41, P189, DOI 10.1046/j.1365-2958.2001.02501.x; Delihas N, 2001, J MOL BIOL, V313, P1, DOI 10.1006/jmbi.2001.5029; Douchin V, 2006, J BIOL CHEM, V281, P12253, DOI 10.1074/jbc.M600819200; Dupont M, 2004, FEBS LETT, V569, P27, DOI 10.1016/j.febslet.2004.05.047; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Eliopoulos G.M., 1991, ANTIBIOTICS LAB MED, V3rd Edn, P432; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; GAMBINO L, 1993, J BACTERIOL, V175, P2888, DOI 10.1128/JB.175.10.2888-2894.1993; Gootz TD, 2006, BIOCHEM PHARMACOL, V71, P1073, DOI 10.1016/j.bcp.2005.11.006; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; Kawamura-Sato K, 1999, FEMS MICROBIOL LETT, V179, P345, DOI 10.1016/S0378-1097(99)00433-4; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Liu XQ, 2001, MICROBIOL-SGM, V147, P2981, DOI 10.1099/00221287-147-11-2981; LOMOVSKAYA O, 1992, P NATL ACAD SCI USA, V89, P8938, DOI 10.1073/pnas.89.19.8938; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Ma Dzwokai, 1994, Trends in Microbiology, V2, P489, DOI 10.1016/0966-842X(94)90654-8; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Martins M, 2006, IN VIVO, V20, P657; Michan C, 2002, J BACTERIOL, V184, P4733, DOI 10.1128/JB.184.17.4733-4738.2002; NAKAJIMA H, 1995, APPL ENVIRON MICROB, V61, P2302, DOI 10.1128/AEM.61.6.2302-2307.1995; NARODITSKAYA V, 1993, BIOCHEM BIOPH RES CO, V196, P803, DOI 10.1006/bbrc.1993.2320; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 2001, SEMIN CELL DEV BIOL, V12, P215, DOI 10.1006/scdb.2000.0247; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Pratt LA, 1996, P NATL ACAD SCI USA, V93, P2488, DOI 10.1073/pnas.93.6.2488; PUREWAL AS, 1991, FEMS MICROBIOL LETT, V82, P229, DOI 10.1111/j.1574-6968.1991.tb04870.x; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; Rosenberg EY, 2000, J BACTERIOL, V182, P1754, DOI 10.1128/JB.182.6.1754-1756.2000; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Turner RJ, 1997, ANTIMICROB AGENTS CH, V41, P440, DOI 10.1128/AAC.41.2.440; Viveiros M, 2005, ANTIMICROB AGENTS CH, V49, P3578, DOI 10.1128/AAC.49.8.3578-3582.2005; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	52	159	167	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2007	2	4							e365	10.1371/journal.pone.0000365	http://dx.doi.org/10.1371/journal.pone.0000365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DT	17426813	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445400005
J	Bendle, GM; Xue, SA; Holler, A; Stauss, HJ				Bendle, Gavin M.; Xue, Shao-An; Holler, Angelika; Stauss, Hans J.			A Study of T Cell Tolerance to the Tumor-Associated Antigen MDM2: Cytokines Can Restore Antigen Responsiveness, but Not High Avidity T Cell Function	PLOS ONE			English	Article							CLASS-I MOLECULES; TRANSGENIC MICE; P53 PROTEIN; GRANZYME-B; GENE; LYMPHOCYTES; INDUCTION; AMPLIFICATION; EXPRESSION; RECEPTOR	Background. Most tumor-associated antigens (TAA) currently used for immunotherapy of cancer are also expressed in normal tissues, which may induce tolerance and impair T cell-mediated immunity. However, there is limited information about how physiological expression in normal tissues alters the function of TAA-specific T cells. Methodology/Principal Findings. We used a T cell receptor transgenic model to study how MDM2 expression in normal tissues affects the function of T cells specific for this TAA that is found at high levels in many different types of tumors. We found that some MDM2-specific T cells escaped thymic deletion and persisted in the peripheral T cell pool. When stimulated with antigen, these T cells readily initiated cell division but failed to proliferate and expand, which was associated with a high rate of apoptosis. Both IL-2 and IL-15 efficiently rescued T cell survival and antigen-specific T cell proliferation, while IL-7 and IL-21 were ineffective. Antigen-stimulated T cells showed impaired expression of the effector molecules CD43, granzyme-B and IFN-gamma, a defect that was completely restored when T cells were stimulated in the presence of IL-2. In contrast, IL-15 and IL-21 only restored the expression of CD43 and granzyme-B, but not IFN-gamma production. Finally, peptide titration experiments with IL-2 rescued T cells indicated that they were of lower avidity than non-tolerant control T cells expressing the same TCR. Conclusions/Significance. These data indicate that cytokines can rescue the antigen-specific proliferation and effector function of MDM2-specific T cells, although this does not lead to the recovery of high avidity T cell function. This study sheds light on possible limitations of immunotherapy approaches that target widely expressed TAA, such as MDM2.				h.stauss@medsch.ucl.ac.uk	Stauss, Hans J/A-6569-2011; Xue, Shao-An/A-2735-2011		Leukaemia Research Fund (LRF), UK	Leukaemia Research Fund (LRF), UK	This work was funded by a research grant of the Leukaemia Research Fund (LRF), UK. The LRF was not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Alves NL, 2005, J IMMUNOL, V175, P755, DOI 10.4049/jimmunol.175.2.755; Barouch-Bentov R, 2005, J IMMUNOL, V175, P5126, DOI 10.4049/jimmunol.175.8.5126; Bendle GM, 2004, CANCER RES, V64, P8052, DOI 10.1158/0008-5472.CAN-04-0630; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Bream JH, 2004, J BIOL CHEM, V279, P41249, DOI 10.1074/jbc.M401168200; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; BUESORAMOS CE, 1993, BLOOD, V82, P2617; Dahl AM, 1996, J IMMUNOL, V157, P239; Freedman DA, 1999, CANCER RES, V59, P1; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; LADANYI M, 1993, CANCER RES, V53, P16; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; MCCOY JL, 1967, CANCER RES, V27, P1743; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MORAHAN G, 1989, NATURE, V339, P622, DOI 10.1038/339622a0; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Ohlen C, 2002, J EXP MED, V195, P1407, DOI 10.1084/jem.20011063; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; OTTEN GR, 1991, SCIENCE, V251, P1228, DOI 10.1126/science.1900952; Overwijk WW, 1999, P NATL ACAD SCI USA, V96, P2982, DOI 10.1073/pnas.96.6.2982; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; REIFENBERGER G, 1993, CANCER RES, V53, P2736; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Rosenberg SA, 2004, P NATL ACAD SCI USA, V101, P14639, DOI 10.1073/pnas.0405730101; SADOVNIKOVA E, 1994, INT IMMUNOL, V6, P289, DOI 10.1093/intimm/6.2.289; Sadovnikova E, 1996, P NATL ACAD SCI USA, V93, P13114, DOI 10.1073/pnas.93.23.13114; SCHONRICH G, 1992, INT IMMUNOL, V4, P581, DOI 10.1093/intimm/4.5.581; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Weber LW, 1998, J CLIN INVEST, V102, P1258, DOI 10.1172/JCI4004; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	44	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e353	10.1371/journal.pone.0000353	http://dx.doi.org/10.1371/journal.pone.0000353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406677	Green Published, gold			2022-12-27	WOS:000207445300015
J	Scobie, HM; Marlett, JM; Rainey, GJA; Lacy, DB; Collier, RJ; Young, JAT				Scobie, Heather M.; Marlett, John M.; Rainey, G. Jonah A.; Lacy, D. Borden; Collier, R. John; Young, John A. T.			Anthrax Toxin Receptor 2 Determinants that Dictate the pH Threshold of Toxin Pore Formation	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; PROTECTIVE ANTIGEN; CRYSTAL-STRUCTURE; KINASE-KINASE; TRANSLOCATION; ACTIVATION; DELIVERY; COMPLEX; CYCLASE; DOMAIN	The anthrax toxin receptors, ANTXR1 and ANTXR2, act as molecular clamps to prevent the protective antigen ( PA) toxin subunit from forming pores until exposure to low pH. PA forms pores at pH similar to 6.0 or below when it is bound to ANTXR1, but only at pH similar to 5.0 or below when it is bound to ANTXR2. Here, structure-based mutagenesis was used to identify non-conserved ANTXR2 residues responsible for this striking 1.0 pH unit difference in pH threshold. Residues conserved between ANTXR2 and ANTXR1 that influence the ANTXR2-associated pH threshold of pore formation were also identified. All of these residues contact either PA domain 2 or the neighboring edge of PA domain 4. These results provide genetic evidence for receptor release of these regions of PA as being necessary for the protein rearrangements that accompany anthrax toxin pore formation.	[Scobie, Heather M.; Marlett, John M.; Rainey, G. Jonah A.] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA; [Scobie, Heather M.] Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI USA; [Lacy, D. Borden] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN USA; [Collier, R. John] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Salk Institute; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; Harvard University; Harvard Medical School		jyoung@salk.edu	Lacy, D. Borden/AFQ-2203-2022	Young, John/0000-0003-1824-2561; Collier, R John/0000-0002-2427-4239; Lacy, Borden/0000-0003-2273-8121	NIH [AI48489, AI56013]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048489, P01AI056013] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI48489 and AI56013 (JATY and RJC).	Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; CHEN KH, 2007, J BIOL CHEM     0124; CHOPRA AP, 2003, J BIOL CHEM; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; EZZELL JW, 1992, J GEN MICROBIOL, V138, P543, DOI 10.1099/00221287-138-3-543; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Panchal RG, 2005, J BIOL CHEM, V280, P10834, DOI 10.1074/jbc.M412210200; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wolfe JT, 2005, J BIOL CHEM, V280, P39417, DOI 10.1074/jbc.M509049200	28	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e329	10.1371/journal.pone.0000329	http://dx.doi.org/10.1371/journal.pone.0000329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389920	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445200012
J	Wilson, GA; Feil, EJ; Lilley, AK; Field, D				Wilson, Gareth A.; Feil, Edward J.; Lilley, Andrew K.; Field, Dawn			Large-Scale Comparative Genomic Ranking of Taxonomically Restricted Genes (TRGs) in Bacterial and Archaeal Genomes	PLOS ONE			English	Article							SHEWANELLA-ONEIDENSIS MR-1; ESCHERICHIA-COLI; ORPHAN GENES; HYPOTHETICAL GENES; EXPRESSION; PROTEIN; IDENTIFICATION; NUMBER; VALIDATION; SEQUENCE	Background. Lineage-specific, or taxonomically restricted genes (TRGs), especially those that are species and strain-specific, are of special interest because they are expected to play a role in defining exclusive ecological adaptations to particular niches. Despite this, they are relatively poorly studied and little understood, in large part because many are still orphans or only have homologues in very closely related isolates. This lack of homology confounds attempts to establish the likelihood that a hypothetical gene is expressed and, if so, to determine the putative function of the protein. Methodology/Principal Findings. We have developed "QIPP'' ("Quality Index for Predicted Proteins''), an index that scores the "quality'' of a protein based on non-homology-based criteria. QIPP can be used to assign a value between zero and one to any protein based on comparing its features to other proteins in a given genome. We have used QIPP to rank the predicted proteins in the proteomes of Bacteria and Archaea. This ranking reveals that there is a large amount of variation in QIPP scores, and identifies many high-scoring orphans as potentially "authentic'' (expressed) orphans. There are significant differences in the distributions of QIPP scores between orphan and non-orphan genes for many genomes and a trend for less well-conserved genes to have lower QIPP scores. Conclusions. The implication of this work is that QIPP scores can be used to further annotate predicted proteins with information that is independent of homology. Such information can be used to prioritize candidates for further analysis. Data generated for this study can be found in the OrphanMine at http://www.genomics.ceh.ac.uk/orphan_mine.	[Wilson, Gareth A.; Lilley, Andrew K.; Field, Dawn] CEH, Oxford, England; [Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	UK Centre for Ecology & Hydrology (UKCEH); University of Bath	Wilson, GA (corresponding author), CEH, Oxford, England.	gawi@ceh.ac.uk	Field, Dawn/C-1653-2010		Natural Environment Research Council [NER/S/A/2003/11341]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded through a Natural Environment Research Council Ph. D studentship awarded to GW (NER/S/A/2003/11341).	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Alimi JP, 2000, GENOME RES, V10, P959, DOI 10.1101/gr.10.7.959; Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amiri H, 2003, MOL BIOL EVOL, V20, P1575, DOI 10.1093/molbev/msg175; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; Courcelle J, 2001, GENETICS, V158, P41; Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; FIELD D, 2007, NATURE BIOT IN PRESS; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; Fukuchi S, 2004, DNA RES, V11, P219; Galperin MY, 2006, CURR OPIN BIOTECH, V17, P440, DOI 10.1016/j.copbio.2006.08.007; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gevaert K, 2002, MOL CELL PROTEOMICS, V1, P896, DOI 10.1074/mcp.M200061-MCP200; Gutierrez-Rios RM, 2003, GENOME RES, V13, P2435, DOI 10.1101/gr.1387003; Heizer EM, 2006, MOL BIOL EVOL, V23, P1670, DOI 10.1093/molbev/msl029; Hurst LD, 2006, NATURE, V442, pE11, DOI 10.1038/nature05137; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kawarabayasi Y, 1999, DNA Res, V6, P83, DOI 10.1093/dnares/6.2.83; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P12170, DOI 10.1073/pnas.220414297; Kolker E, 2005, P NATL ACAD SCI USA, V102, P2099, DOI 10.1073/pnas.0409111102; Kolker E, 2004, NUCLEIC ACIDS RES, V32, P2353, DOI 10.1093/nar/gkh555; Kosuge T, 2006, DNA RES, V13, P245, DOI 10.1093/dnares/dsl014; Manning PA, 1997, GENE, V192, P63, DOI 10.1016/S0378-1119(97)00036-X; Martiny JBH, 2005, ECOL LETT, V8, P1334, DOI 10.1111/j.1461-0248.2005.00837.x; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Misra RV, 2005, NUCLEIC ACIDS RES, V33, pD329, DOI 10.1093/nar/gki028; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229; Petrov DA, 1999, P NATL ACAD SCI USA, V96, P1475, DOI 10.1073/pnas.96.4.1475; Roberts RJ, 2004, PLOS BIOL, V2, P293, DOI 10.1371/journal.pbio.0020042; ROBERTS RJ, 2005, EXPT APPROACH GENOME; Romine MF, 2004, OMICS, V8, P239, DOI 10.1089/omi.2004.8.239; Ruby EG, 2005, P NATL ACAD SCI USA, V102, P3004, DOI 10.1073/pnas.0409900102; Shmuely H, 2004, BIOINFORMATICS, V20, P1248, DOI 10.1093/bioinformatics/bth075; Siew N, 2003, STRUCTURE, V11, P7, DOI 10.1016/S0969-2126(02)00938-3; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Taoka M, 2004, MOL CELL PROTEOMICS, V3, P780, DOI 10.1074/mcp.M400030-MCP200; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Ussery DW, 2004, MICROBIOL-SGM, V150, P2015, DOI 10.1099/mic.0.27338-0; VONMERING C, 2006, NUCLEIC ACIDS RES, V10, P10; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Yin YB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-63; Zheng Y, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-243	52	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e324	10.1371/journal.pone.0000324	http://dx.doi.org/10.1371/journal.pone.0000324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389915	Green Submitted, gold, Green Published			2022-12-27	WOS:000207445200007
J	Vergoz, V; Roussel, E; Sandoz, JC; Giurfa, M				Vergoz, Vanina; Roussel, Edith; Sandoz, Jean-Christophe; Giurfa, Martin			Aversive Learning in Honeybees Revealed by the Olfactory Conditioning of the Sting Extension Reflex	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; PROBOSCIS EXTENSION; APIS-MELLIFERA; MINI-BRAIN; DROSOPHILA; RECEPTOR; MEMORY; OCTOPAMINE; BEES; PHARMACOLOGY	Invertebrates have contributed greatly to our understanding of associative learning because they allow learning protocols to be combined with experimental access to the nervous system. The honeybee Apis mellifera constitutes a standard model for the study of appetitive learning and memory since it was shown, almost a century ago, that bees learn to associate different sensory cues with a reward of sugar solution. However, up to now, no study has explored aversive learning in bees in such a way that simultaneous access to its neural bases is granted. Using odorants paired with electric shocks, we conditioned the sting extension reflex, which is exhibited by harnessed bees when subjected to a noxious stimulation. We show that this response can be conditioned so that bees learn to extend their sting in response to the odorant previously punished. Bees also learn to extend the proboscis to one odorant paired with sugar solution and the sting to a different odorant paired with electric shock, thus showing that they can master both appetitive and aversive associations simultaneously. Responding to the appropriate odorant with the appropriate response is possible because two different biogenic amines, octopamine and dopamine subserve appetitive and aversive reinforcement, respectively. While octopamine has been previously shown to substitute for appetitive reinforcement, we demonstrate that blocking of dopaminergic, but not octopaminergic, receptors suppresses aversive learning. Therefore, aversive learning in honeybees can now be accessed both at the behavioral and neural levels, thus opening new research avenues for understanding basic mechanisms of learning and memory.	[Vergoz, Vanina; Roussel, Edith; Sandoz, Jean-Christophe; Giurfa, Martin] Univ Toulouse 3, CNRS, Res Ctr Anim Cognit, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Giurfa, M (corresponding author), Univ Toulouse 3, CNRS, Res Ctr Anim Cognit, F-31062 Toulouse, France.	giurfa@cict.fr	Giurfa, Martin/H-5140-2016; Giurfa, Martin MG/A-7322-2008; Giurfa, Martin/AAS-4945-2020; Sandoz, Jean-Christophe/A-6085-2012; Vergoz, Vanina/L-9638-2015	Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X; Sandoz, Jean-Christophe/0000-0002-5423-9645; 	BEESHOP; French Research Council (CNRS); University Paul-Sabatier; Institute Universitaire de France; ACI Neurosciences Integratives (French Research Ministry)	BEESHOP; French Research Council (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul-Sabatier; Institute Universitaire de France; ACI Neurosciences Integratives (French Research Ministry)(Ministry of Research, France)	This work was supported by BEESHOP (European research grant 'Bees in Europe and Sustainable Honey Production'), the French Research Council (CNRS), the University Paul-Sabatier, the Institute Universitaire de France and the ACI Neurosciences Integratives (French Research Ministry).	ABRAMSON CI, 1986, J COMP PSYCHOL, V100, P108, DOI 10.1037/0735-7036.100.2.108; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Blenau W, 1998, J NEUROCHEM, V70, P15; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BURRELL BD, 1994, J COMP PHYSIOL A, V174, P581, DOI 10.1007/BF00217379; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Farooqui T, 2003, J NEUROSCI, V23, P5370; Frisch K.v, 1914, ZOOLOGISCHE JB, V37, P1, DOI DOI 10.5962/BHL.TITLE.11736; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Giurfa M, 2006, CURR BIOL, V16, pR892, DOI 10.1016/j.cub.2006.09.021; GOULD JL, 1987, ANIM BEHAV, V35, P1579, DOI 10.1016/S0003-3472(87)80038-6; GOULD JL, 1986, ANIM BEHAV, V34, P990, DOI 10.1016/S0003-3472(86)80157-9; Hammer M, 1998, LEARN MEMORY, V5, P146; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Humphries MA, 2003, J NEUROBIOL, V55, P315, DOI 10.1002/neu.10209; Jaber M, 1996, NEUROPHARMACOLOGY, V35, P1503, DOI 10.1016/S0028-3908(96)00100-1; Lenoir JC, 2006, INSECT SOC, V53, P80, DOI 10.1007/s00040-005-0838-5; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; NUNEZ J, 1983, PHARMACOL BIOCHEM BE, V19, P921, DOI 10.1016/0091-3057(83)90391-X; Nunez J, 1997, PHYSIOL BEHAV, V63, P75, DOI 10.1016/S0031-9384(97)00391-0; NUNEZ JA, 1970, ACTA PHYSIOL LAT AM, V20, P140; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SMITH BH, 1991, J COMP PSYCHOL, V105, P345, DOI 10.1037/0735-7036.105.4.345; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4	43	214	219	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e288	10.1371/journal.pone.0000288	http://dx.doi.org/10.1371/journal.pone.0000288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17372627	gold, Green Published			2022-12-27	WOS:000207444800011
J	Binladen, J; Gilbert, MTP; Bollback, JP; Panitz, F; Bendixen, C; Nielsen, R; Willerslev, E				Binladen, Jonas; Gilbert, M. Thomas P.; Bollback, Jonathan P.; Panitz, Frank; Bendixen, Christian; Nielsen, Rasmus; Willerslev, Eske			The Use of Coded PCR Primers Enables High-Throughput Sequencing of Multiple Homolog Amplification Products by 454 Parallel Sequencing	PLOS ONE			English	Article								Background. The invention of the Genome Sequence 20 (TM) DNA Sequencing System (454 parallel sequencing platform) has enabled the rapid and high-volume production of sequence data. Until now, however, individual emulsion PCR (emPCR) reactions and subsequent sequencing runs have been unable to combine template DNA from multiple individuals, as homologous sequences cannot be subsequently assigned to their original sources. Methodology. We use conventional PCR with 5'-nucleotide tagged primers to generate homologous DNA amplification products from multiple specimens, followed by sequencing through the high-throughput Genome Sequence 20 (TM) DNA Sequencing System (GS20, Roche/454 Life Sciences). Each DNA sequence is subsequently traced back to its individual source through 5'tag-analysis. Conclusions. We demonstrate that this new approach enables the assignment of virtually all the generated DNA sequences to the correct source once sequencing anomalies are accounted for (miss-assignment rate <0.4%). Therefore, the method enables accurate sequencing and assignment of homologous DNA sequences from multiple sources in single high-throughput GS20 run. We observe a bias in the distribution of the differently tagged primers that is dependent on the 5' nucleotide of the tag. In particular, primers 5' labelled with a cytosine are heavily overrepresented among the final sequences, while those 5' labelled with a thymine are strongly underrepresented. A weaker bias also exists with regards to the distribution of the sequences as sorted by the second nucleotide of the dinucleotide tags. As the results are based on a single GS20 run, the general applicability of the approach requires confirmation. However, our experiments demonstrate that 5' primer tagging is a useful method in which the sequencing power of the GS20 can be applied to PCR-based assays of multiple homologous PCR products. The new approach will be of value to a broad range of research areas, such as those of comparative genomics, complete mitochondrial analyses, population genetics, and phylogenetics.	[Binladen, Jonas; Gilbert, M. Thomas P.; Willerslev, Eske] Univ Copenhagen, Inst Biol, Ctr Ancient Genet, Copenhagen, Denmark; [Bollback, Jonathan P.; Nielsen, Rasmus] Univ Copenhagen, Ctr Bioinformat, Copenhagen, Denmark; [Panitz, Frank; Bendixen, Christian] Res Ctr Foulum, Danish Inst Agr Sci, Dept Genet & Biotechnol, Tjele, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University	Willerslev, E (corresponding author), Univ Copenhagen, Inst Biol, Ctr Ancient Genet, Copenhagen, Denmark.	ewillerslev@bi.ku.dk	Panitz, Frank/A-3281-2017; Gilbert, Marcus TP/A-8936-2013; Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Nielsen, Rasmus/D-4405-2009	Panitz, Frank/0000-0002-6909-5162; Gilbert, Marcus TP/0000-0002-5805-7195; Willerslev, Eske/0000-0002-7081-6748; Nielsen, Rasmus/0000-0003-0513-6591	Wellcome Trust, UK; Carlsberg Foundation, DK; National Science Foundation, DK; Marie Curie Actions [FP6-MEIF-CT-2005-025002]; Danish FSS	Wellcome Trust, UK(Wellcome Trust); Carlsberg Foundation, DK(Carlsberg Foundation); National Science Foundation, DK(National Science Foundation (NSF)); Marie Curie Actions(European Commission); Danish FSS	JB and EW were supported by the Wellcome Trust, UK, the Carlsberg Foundation, DK, and the National Science Foundation, DK. MTPG acknowledges the Marie Curie Actions FP6-MEIF-CT-2005-025002 'FORMAPLEX' grant for funding his research. JPB and RN were funded by the Danish FSS and the National Science Foundation, DK. None of the sponsors or funders have had any influence on the data or manuscript presented here.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; GILBERT MTP, NUCL ACIDS IN PRESS; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Taylor PG, 1996, MOL BIOL EVOL, V13, P283, DOI 10.1093/oxfordjournals.molbev.a025566; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	7	376	456	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e197	10.1371/journal.pone.0000197	http://dx.doi.org/10.1371/journal.pone.0000197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299583	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444400002
J	Lamaziere, A; Burlina, F; Wolf, C; Chassaing, G; Trugnan, G; Ayala-Sanmartin, J				Lamaziere, Antonin; Burlina, Fabienne; Wolf, Claude; Chassaing, Gerard; Trugnan, Germain; Ayala-Sanmartin, Jesus			Non-Metabolic Membrane Tubulation and Permeability Induced by Bioactive Peptides	PLOS ONE			English	Article								Background. Basic cell-penetrating peptides are potential vectors for therapeutic molecules and display antimicrobial activity. The peptide-membrane contact is the first step of the sequential processes leading to peptide internalization and cell activity. However, the molecular mechanisms involved in peptide-membrane interaction are not well understood and are frequently controversial. Herein, we compared the membrane activities of six basic peptides with different size, charge density and amphipaticity: Two cell-penetrating peptides (penetratin and R9), three amphipathic peptides and the neuromodulator substance P. Methodology/Principal Findings. Experiments of X ray diffraction, video-microscopy of giant vesicles, fluorescence spectroscopy, turbidimetry and calcein leakage from large vesicles are reported. Permeability and toxicity experiments were performed on cultured cells. The peptides showed differences in bilayer thickness perturbations, vesicles aggregation and local bending properties which form lipidic tubular structures. These structures invade the vesicle lumen in the absence of exogenous energy. Conclusions/Significance. We showed that the degree of membrane permeabilization with amphipathic peptides is dependent on both peptide size and hydrophobic nature of the residues. We propose a model for peptide-induced membrane perturbations that explains the differences in peptide membrane activities and suggests the existence of a facilitated "physical endocytosis,'' which represents a new pathway for peptide cellular internalization.	[Lamaziere, Antonin; Wolf, Claude; Trugnan, Germain; Ayala-Sanmartin, Jesus] CHU St Antoine, INSERM, UMR 538, Paris, France; [Lamaziere, Antonin; Wolf, Claude; Trugnan, Germain; Ayala-Sanmartin, Jesus] Univ Paris 06, CHU St Antoine, Paris, France; [Burlina, Fabienne; Chassaing, Gerard] Univ Paris 06, CNRS, UMR 7613, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Ayala-Sanmartin, J (corresponding author), CHU St Antoine, INSERM, UMR 538, Paris, France.	jayala@chusa.jussieu.fr	Lamaziere, Antonin/AFM-0000-2022; Lamaziere, Antonin/AAH-2285-2022	Burlina, Fabienne/0000-0002-6042-680X	INSERM; ANR-PCV; ACI	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR-PCV(French National Research Agency (ANR)); ACI	This work was supported by INSERM, ANR-PCV and ACI grants.	Ambroggio EE, 2005, BIOPHYS J, V89, P1874, DOI 10.1529/biophysj.105.066589; AYALASANMARTIN J, 2004, ANNEXINS, V1, P19; Balayssac S, 2006, BIOCHEMISTRY-US, V45, P1408, DOI 10.1021/bi0518390; Bellet-Amalric E, 2000, BBA-BIOMEMBRANES, V1467, P131, DOI 10.1016/S0005-2736(00)00218-2; Berlose JP, 1996, EUR J BIOCHEM, V242, P372, DOI 10.1111/j.1432-1033.1996.0372r.x; Binder H, 2004, BIOPHYS J, V87, P332, DOI 10.1529/biophysj.103.034025; Brattwall CEB, 2003, J AM CHEM SOC, V125, P14214, DOI 10.1021/ja0366989; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cedric T, 2004, EUR BIOPHYS J BIOPHY, V33, P513, DOI 10.1007/s00249-004-0392-5; Chachaty C, 2005, BIOPHYS J, V88, P4032, DOI 10.1529/biophysj.104.054155; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Drin G, 2001, BIOCHEMISTRY-US, V40, P1824, DOI 10.1021/bi002019k; DUPLAA H, 1992, BIOCHIM BIOPHYS ACTA, V1107, P12, DOI 10.1016/0005-2736(92)90323-E; FARGE E, 1992, BIOPHYS J, V61, P347, DOI 10.1016/S0006-3495(92)81841-6; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i; Hallbrink M, 2001, BBA-BIOMEMBRANES, V1515, P101, DOI 10.1016/S0005-2736(01)00398-4; Hitz T, 2006, BIOCHEMISTRY-US, V45, P5817, DOI 10.1021/bi060285d; Huang HW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198304; HUANG HW, 2006, BIOCH BIOPHYS ACTA; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lambert O, 2004, J BIOL CHEM, V279, P10872, DOI 10.1074/jbc.M313657200; Lee MT, 2005, BIOPHYS J, V89, P4006, DOI 10.1529/biophysj.105.068080; LI C, 2006, BIOPHYS J; Magzoub M, 2002, BBA-BIOMEMBRANES, V1563, P53, DOI 10.1016/S0005-2736(02)00373-5; Magzoub M, 2001, BBA-BIOMEMBRANES, V1512, P77, DOI 10.1016/S0005-2736(01)00304-2; Magzoub M, 2003, BIOPHYS CHEM, V103, P271, DOI 10.1016/S0301-4622(02)00321-6; Mangavel C, 1998, BBA-BIOMEMBRANES, V1371, P265, DOI 10.1016/S0005-2736(98)00026-1; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; McIntosh TJ, 1999, BIOPHYS J, V76, P2090, DOI 10.1016/S0006-3495(99)77365-0; Menger FM, 2003, J AM CHEM SOC, V125, P2846, DOI 10.1021/ja021337z; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nekhotiaeva N, 2003, FASEB J, V17, P394, DOI 10.1096/fj.03-0449fje; Oehlke J, 2005, J MOL RECOGNIT, V18, P50, DOI 10.1002/jmr.691; Palm C, 2006, PEPTIDES, V27, P1710, DOI 10.1016/j.peptides.2006.01.006; PEREZ F, 1994, MOL ENDOCRINOL, V8, P1278, DOI 10.1210/me.8.9.1278; Persson D, 2004, BIOCHEMISTRY-US, V43, P11045, DOI 10.1021/bi036054d; Persson D, 2001, FEBS LETT, V505, P307, DOI 10.1016/S0014-5793(01)02843-5; Puff N, 2005, CHEM PHYS LIPIDS, V133, P195, DOI 10.1016/j.chemphyslip.2004.10.003; Rauch C, 2000, BIOPHYS J, V78, P3036, DOI 10.1016/S0006-3495(00)76842-1; Siegel DP, 2006, BIOPHYS J, V90, P200, DOI 10.1529/biophysj.105.070466; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Thoren PEG, 2004, BIOCHEMISTRY-US, V43, P3471, DOI 10.1021/bi0360049; Vives E, 2005, J CONTROL RELEASE, V109, P77, DOI 10.1016/j.jconrel.2005.09.032; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	54	71	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e201	10.1371/journal.pone.0000201	http://dx.doi.org/10.1371/journal.pone.0000201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299584	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444400003
J	Babel, AR; Bruce, J; Young, JAT				Babel, Angeline Rose; Bruce, James; Young, John A. T.			The hr1 and Fusion Peptide Regions of the Subgroup B Avian Sarcoma and Leukosis Virus Envelope Glycoprotein Influence Low pH-Dependent Membrane Fusion	PLOS ONE			English	Article								The avian sarcoma and leukosis virus (ASLV) envelope glycoprotein (Env) is activated to trigger fusion by a two-step mechanism involving receptor-priming and low pH fusion activation. In order to identify regions of ASLV Env that can regulate this process, a genetic selection method was used to identify subgroup B (ASLV-B) virus-infected cells resistant to low pH-triggered fusion when incubated with cells expressing the cognate TVB receptor. The subgroup B viral Env (envB) genes were then isolated from these cells and characterized by DNA sequencing. This led to identification of two frequent EnvB alterations which allowed TVB receptor-binding but altered the pH-threshold of membrane fusion activation: a 13 amino acid deletion in the host range 1 (hr1) region of the surface (SU) EnvB subunit, and the A32V amino acid change within the fusion peptide of the transmembrane (TM) EnvB subunit. These data indicate that these two regions of EnvB can influence the pH threshold of fusion activation.	[Young, John A. T.] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA; [Babel, Angeline Rose] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Madison, WI 53706 USA; [Bruce, James] Univ Wisconsin, Bock Labs, Inst Mol Virol, Madison, WI 53706 USA	Salk Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Young, JAT (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jyoung@salk.edu		Young, John/0000-0003-1824-2561	NIH [CA70810, AI053668]; NSRA [T32 CA009135, P01-CA22443]; NATIONAL CANCER INSTITUTE [R01CA070810, P01CA022443, T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants CA70810 and AI053668 to J.A.T.Y and NSRA T32 CA009135 and P01-CA22443 to A. R. B.	Adkins HB, 1997, P NATL ACAD SCI USA, V94, P11617, DOI 10.1073/pnas.94.21.11617; Adkins HB, 2000, J VIROL, V74, P3572, DOI 10.1128/JVI.74.8.3572-3578.2000; Adkins HB, 2001, J VIROL, V75, P3520, DOI 10.1128/JVI.75.8.3520-3526.2001; Balliet JW, 2000, J VIROL, V74, P3731, DOI 10.1128/JVI.74.8.3731-3739.2000; Barnard RJO, 2006, VIROLOGY, V344, P25, DOI 10.1016/j.virol.2005.09.021; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Boerger AL, 1999, P NATL ACAD SCI USA, V96, P9867, DOI 10.1073/pnas.96.17.9867; BOVA CA, 1988, J VIROL, V62, P75, DOI 10.1128/JVI.62.1.75-83.1988; BOVA CA, 1986, VIROLOGY, V152, P343, DOI 10.1016/0042-6822(86)90137-6; Brojatsch J, 2000, J VIROL, V74, P11490, DOI 10.1128/JVI.74.24.11490-11494.2000; Bruce JW, 2005, J VIROL, V79, P12969, DOI 10.1128/JVI.79.20.12969-12978.2005; Chai N, 2006, P NATL ACAD SCI USA, V103, P5531, DOI 10.1073/pnas.0509785103; Damico R, 1999, J VIROL, V73, P3087, DOI 10.1128/JVI.73.4.3087-3094.1999; Damico RL, 1998, P NATL ACAD SCI USA, V95, P2580, DOI 10.1073/pnas.95.5.2580; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Delos SE, 2000, J VIROL, V74, P9738, DOI 10.1128/JVI.74.20.9738-9741.2000; Delos SE, 2005, J VIROL, V79, P3488, DOI 10.1128/JVI.79.6.3488-3499.2005; Delos SE, 2000, J VIROL, V74, P1686, DOI 10.1128/JVI.74.4.1686-1693.2000; DORNER AJ, 1986, CELL, V45, P365, DOI 10.1016/0092-8674(86)90322-3; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Earp LJ, 2003, J VIROL, V77, P3058, DOI 10.1128/JVI.77.5.3058-3066.2003; Elleder D, 2005, J VIROL, V79, P10408, DOI 10.1128/JVI.79.16.10408-10419.2005; Hernandez LD, 1998, J VIROL, V72, P3259, DOI 10.1128/JVI.72.4.3259-3267.1998; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Holmen SL, 2000, VIROLOGY, V273, P364, DOI 10.1006/viro.2000.0424; Holmen SL, 2001, J VIROL, V75, P726, DOI 10.1128/JVI.75.2.726-737.2001; Jonah G, 2003, J VIROL, V77, P6709, DOI 10.1128/JVI.77.12.6709-6719.2003; KATZ RA, 1990, ANNU REV GENET, V24, P409, DOI 10.1146/annurev.ge.24.120190.002205; Markosyan RM, 2004, BIOPHYS J, V87, P3291, DOI 10.1529/biophysj.104.047696; Matsuyama S, 2004, J VIROL, V78, P8201, DOI 10.1128/JVI.78.15.8201-8209.2004; Melder DC, 2003, J VIROL, V77, P10504, DOI 10.1128/JVI.77.19.10504-10514.2003; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Melikyan GB, 2004, J VIROL, V78, P3753, DOI 10.1128/JVI.78.7.3753-3762.2004; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Netter RC, 2004, J VIROL, V78, P13430, DOI 10.1128/JVI.78.24.13430-13439.2004; Rong LJ, 1997, J VIROL, V71, P3458, DOI 10.1128/JVI.71.5.3458-3465.1997; STEINHAUER DA, 1995, J VIROL, V69, P6643, DOI 10.1128/JVI.69.11.6643-6651.1995; Taplitz RA, 1997, J VIROL, V71, P7814, DOI 10.1128/JVI.71.10.7814-7819.1997; YOUNG JAT, 1993, J VIROL, V67, P1811, DOI 10.1128/JVI.67.4.1811-1816.1993	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2007	2	1							e171	10.1371/journal.pone.0000171	http://dx.doi.org/10.1371/journal.pone.0000171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DG	17245447	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444100008
J	Carling, MD; Brumfield, RT				Carling, Matthew D.; Brumfield, Robb T.			Gene Sampling Strategies for Multi-Locus Population Estimates of Genetic Diversity (theta)	PLOS ONE			English	Article								Background. Theoretical work suggests that data from multiple nuclear loci provide better estimates of population genetic parameters than do single loci, but just how many loci are needed and how much sequence is required from each has been little explored. Methodology/Principle Findings. To investigate how much data is required to estimate the population genetic parameter theta (4N(e)mu) accurately under ideal circumstances, we simulated datasets of DNA sequences under three values of theta per site (0.1, 0.01, 0.001), varying in both the total number of base pairs sequenced per individual and the number of equal-length loci. From these datasets we estimated theta using the maximum likelihood coalescent framework implemented in the computer program MIGRATE. Our results corroborated the theoretical expectation that increasing the number of loci impacted the accuracy of the estimate more than increasing the sequence length at single loci. However, when the value of theta was low (0.001), the per-locus sequence length was also important for estimating theta accurately, something that has not been emphasized in previous work. Conclusions/Significance. Accurate estimation of theta required data from at least 25 independently evolving loci. Beyond this, there was little added benefit in terms of decreasing the squared coefficient of variation of the coalescent estimates relative to the extra effort required to sample more loci.	[Carling, Matthew D.; Brumfield, Robb T.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Carling, Matthew D.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Carling, MD (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	mcarli1@lsu.edu	Brumfield, Robb T/K-6108-2015	Brumfield, Robb T/0000-0003-2307-0688	NSF [DEB-0332093]	NSF(National Science Foundation (NSF))	This work was funded by NSF grant DEB-0332093 to RTB.	Beerli P, 1999, GENETICS, V152, P763; BEGUN DJ, 1991, GENETICS, V129, P1147; BERRY AJ, 1991, GENETICS, V129, P1111; Congdon BC, 2000, EVOLUTION, V54, P974; Crawford AJ, 2003, MOL ECOL, V12, P2525, DOI 10.1046/j.1365-294X.2003.01910.x; DRUMMOND AJ, 2003, BEAST V1 0; Edwards SV, 2000, EVOLUTION, V54, P1839; Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Ford MJ, 1998, EVOLUTION, V52, P539, DOI 10.1111/j.1558-5646.1998.tb01653.x; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1999, THEOR POPUL BIOL, V56, P1, DOI 10.1006/tpbi.1999.1421; FU YX, 1993, GENETICS, V134, P1261; Grassly NC, 1999, GENETICS, V151, P427; Hare MP, 2002, EVOLUTION, V56, P804; Hare MP, 2001, TRENDS ECOL EVOL, V16, P700, DOI 10.1016/S0169-5347(01)02326-6; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Kliman RM, 2000, GENETICS, V156, P1913; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kuhner MK, 2000, GENETICS, V156, P439; KUHNER MK, 1995, GENETICS, V140, P1421; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Llopart A, 2005, GENETICS, V171, P197, DOI 10.1534/genetics.104.033597; Moore WS, 1997, EVOLUTION, V51, P627, DOI 10.1111/j.1558-5646.1997.tb02452.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Nachman MW, 1997, GENETICS, V147, P1303; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Nachman MW, 1998, GENETICS, V150, P1133; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Nielsen R, 2000, GENETICS, V154, P931; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pluzhnikov A, 1996, GENETICS, V144, P1247; Pogson GH, 2003, MOL ECOL, V12, P63, DOI 10.1046/j.1365-294X.2003.01713.x; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Saillant E, 2004, MOL ECOL, V13, P2947, DOI 10.1111/j.1365-294X.2004.02303.x; Sokal RR, 1995, BIOMETRY; Strasburg JL, 2005, MOL ECOL, V14, P2755, DOI 10.1111/j.1365-294X.2005.02627.X; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; Wakeley J, 2004, J HERED, V95, P397, DOI 10.1093/jhered/esh062; Wakeley J, 1997, GENETICS, V145, P847; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yang ZH, 1997, GENET RES, V69, P111, DOI 10.1017/S001667239700270X; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x	49	52	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e160	10.1371/journal.pone.0000160	http://dx.doi.org/10.1371/journal.pone.0000160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225863	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444000011
J	Khonsari, RH; Calvez, V				Khonsari, Roman H.; Calvez, Vincent			The Origins of Concentric Demyelination: Self-Organization in the Human Brain	PLOS ONE			English	Article								Balo's concentric sclerosis is a rare atypical form of multiple sclerosis characterized by striking concentric demyelination patterns. We propose a robust mathematical model for Balo's sclerosis, sharing common molecular and cellular mechanisms with multiple sclerosis. A reconsideration of the analogies between Balo's sclerosis and the Liesegang periodic precipitation phenomenon led us to propose a chemotactic cellular model for this disease. Rings of demyelination appear as a result of self-organization processes, and closely mimic Balo lesions. According to our results, homogeneous and concentric demyelinations may be two different macroscopic outcomes of a single fundamental immune disorder. Furthermore, in chemotactic models, cellular aggressivity appears to play a central role in pattern formation.	[Khonsari, Roman H.] CHU Nantes, Serv Chirurg Maxillofaciale, F-44035 Nantes 01, France; [Khonsari, Roman H.] Hop La Pitie Salpetriere, Lab Neuropathol R Escourolle, F-75651 Paris, France; [Calvez, Vincent] Ecole Normale Super, Dept Math & Applicat, F-75231 Paris, France	Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Khonsari, RH (corresponding author), CHU Nantes, Serv Chirurg Maxillofaciale, F-44035 Nantes 01, France.	hossein.khonsari@ens.fr	Calvez, Vincent/D-1119-2014; Khonsari, Roman Hossein/H-7460-2017	Calvez, Vincent/0000-0002-3674-1965; Khonsari, Roman Hossein/0000-0002-0649-1432	Department de Mathematiques of the Ecole normale superieure in Paris; Agence Nationale de la Recherche	Department de Mathematiques of the Ecole normale superieure in Paris; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Department de Mathematiques of the Ecole normale superieure in Paris and has been partially financed by the MACBAC project of the Agence Nationale de la Recherche.	Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8; Anschel DJ, 2006, EUR NEUROL, V55, P111, DOI 10.1159/000092788; Balo J, 1927, MAGY ORVOSI ARCH, V28, P108; Barnett FH, 2004, NEUROSURGERY, V55, P468, DOI 10.1227/00006123-200408000-00083; Brosnan CF, 1996, BRAIN PATHOL, V6, P243, DOI 10.1111/j.1750-3639.1996.tb00853.x; CALVEZ V, 2006, J MATH PURE APPL, V86, P2; Chen CJ, 1999, ANN NEUROL, V46, P651, DOI 10.1002/1531-8249(199910)46:4<651::AID-ANA15>3.0.CO;2-Y; Chen CJ, 2001, J COMPUT ASSIST TOMO, V25, P713, DOI 10.1097/00004728-200109000-00008; COURVILLE CB, 1970, MULTIPLE SCLEROSIS O, P437; Dolbeault J, 2004, CR MATH, V339, P611, DOI 10.1016/j.crma.2004.08.011; Droz M, 2000, J STAT PHYS, V101, P509, DOI 10.1023/A:1026489416640; Ferraro A, 1933, PSYCHIAT QUART, V7, P267, DOI 10.1007/BF01572459; Gajewski H, 1998, MATH NACHR, V195, P77, DOI 10.1002/mana.19981950106; Genain CP, 1997, J MOL MED, V75, P187, DOI 10.1007/s001090050103; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; Hallervorden J, 1933, ARCH PSYCHIAT NERVEN, V98, P641, DOI 10.1007/BF01814664; Hatschek E, 1925, KOLLOID Z, V37, P297, DOI 10.1007/BF01424995; HENISCH HK, 1986, CRYSTALS GELS LIESEG, P137; ITOYAMA Y, 1984, ANN NEUROL, V17, P481; JAGER W, 1992, T AM MATH SOC, V329, P819, DOI 10.2307/2153966; Kastrup O, 2002, J NEUROL, V249, P811, DOI 10.1007/s00415-002-0718-0; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Krug HJ, 1996, GEOL RUNDSCH, V85, P19, DOI 10.1007/s005310050047; Krug HJ, 1999, J PHYS CHEM A, V103, P7811, DOI 10.1021/jp991092l; Lassmann H, 2005, BRAIN PATHOL, V15, P217; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lumsden CE, 1970, HDB CLINICAL NEUROLO, P217; Markiewicz D, 1977, Neuropatol Pol, V15, P491; MICHALAK S, 2004, STUDIA PHILOS TARTU, V4, P139; Moore GRW, 2001, MULT SCLER J, V7, P375, DOI 10.1177/135245850100700606; MOORE GRW, 1985, ANN NEUROL, V17, P604, DOI 10.1002/ana.410170614; Nagai T., 1995, ADV MATH SCI APPL, V5, P581; NANJUNDIAH V, 1973, J THEOR BIOL, V42, P63, DOI 10.1016/0022-5193(73)90149-5; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ostwald W., 1897, Z PHYS CHEM, V22, P289; Painter K. J., 2002, CANADIAN APPL MATH Q, V10, P501; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; Pohl D, 2005, J NEUROL NEUROSUR PS, V76, P1723, DOI 10.1136/jnnp.2004.062331; Stadelmann C, 2005, BRAIN, V128, P979, DOI 10.1093/brain/awh457; Stadelmann C, 2004, NEUROL SCI, V25, pS319, DOI 10.1007/s10072-004-0333-1; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; VENZL G, 1982, J CHEM PHYS, V77, P1302, DOI 10.1063/1.443952; Wiendl H, 2005, EUR NEUROL, V53, P42, DOI 10.1159/000084264; YAO DL, 1994, ANN NEUROL, V35, P18, DOI 10.1002/ana.410350105; ZEMAN W, 1949, ARCH PSYCHIAT NERVEN, V181, P187	47	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e150	10.1371/journal.pone.0000150	http://dx.doi.org/10.1371/journal.pone.0000150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225855	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444000002
J	Dean, SO; Spudich, JA				Dean, Sara O.; Spudich, James A.			Rho Kinase's Role in Myosin Recruitment to the Equatorial Cortex of Mitotic Drosophila S2 Cells Is for Myosin Regulatory Light Chain Phosphorylation	PLOS ONE			English	Article								Background. Myosin II recruitment to the equatorial cortex is one of the earliest events in establishment of the cytokinetic contractile ring. In Drosophila S2 cells, we previously showed that myosin II is recruited to the furrow independently of F-actin, and that Rho1 and Rok are essential for this recruitment [1]. Rok phosphorylates several cellular proteins, including the myosin regulatory light chain (RLC). Methodology/Principal Findings. Here we express phosphorylation state mimic constructs of the RLC in S2 cells to examine the role of RLC phosphorylation involving Rok in the localization of myosin. Phosphorylation of the RLC is required for myosin localization to the equatorial cortex during mitosis, and the essential role of Rok in this localization and for cytokinesis is to maintain phosphorylation of the RLC. The ability to regulate the RLC phosphorylation state spatio-temporally is not essential for the myosin localization. Furthermore, the essential role of Citron in cytokinesis is not phosphorylation of the RLC. Conclusions/Significance. We conclude that the Rho1 pathway leading to myosin localization to the future cytokinetic furrow is relatively straightforward, where only Rok is needed, and it is only needed to maintain phosphorylation of the myosin RLC.	[Dean, Sara O.; Spudich, James A.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Spudich, JA (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	jspudich@stanford.edu			National Institutes of Health [GM07276, HG00044, GM46551]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG000044, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, R01GM033289, R37GM046551, R01GM046551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Cell and Molecular Biology Training Grant GM07276 and Genome Training Grant HG00044 (to S.O.D.) and National Institutes of Health Grant GM46551 (to J.A.S.).	Afshar K, 2000, DEVELOPMENT, V127, P1887; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Chodagam S, 2005, CURR BIOL, V15, P1308, DOI 10.1016/j.cub.2005.06.024; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; D'Avino PP, 2004, J CELL BIOL, V166, P61, DOI 10.1083/jcb.200402157; Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102; DeBiasio RL, 1996, MOL BIOL CELL, V7, P1259, DOI 10.1091/mbc.7.8.1259; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hickson GRX, 2006, CURR BIOL, V16, P359, DOI 10.1016/j.cub.2005.12.043; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; KENDRICKJONES J, 1987, J MOL BIOL, V198, P241, DOI 10.1016/0022-2836(87)90310-X; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Mizuno T, 1999, GENE, V238, P437, DOI 10.1016/S0378-1119(99)00351-0; Naim V, 2004, MOL BIOL CELL, V15, P5053, DOI 10.1091/mbc.E04-06-0536; Piekny AJ, 2002, J CELL SCI, V115, P2271; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sabry JH, 1997, MOL BIOL CELL, V8, P2605, DOI 10.1091/mbc.8.12.2605; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Ueda K, 2002, ONCOGENE, V21, P5852, DOI 10.1038/sj.onc.1205747; Vereshchagina N, 2004, MOL BIOL CELL, V15, P4395, DOI 10.1091/mbc.E04-02-0139; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427	40	56	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e131	10.1371/journal.pone.0000131	http://dx.doi.org/10.1371/journal.pone.0000131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205135	Green Submitted, gold, Green Published			2022-12-27	WOS:000207443700025
J	Happonen, P; Voutilainen, S; Tuomainen, TP; Salonen, JT				Happonen, Pertti; Voutilainen, Sari; Tuomainen, Tomi-Pekka; Salonen, Jukka T.			Catechol-O-Methyltransferase Gene Polymorphism Modifies the Effect of Coffee Intake on Incidence of Acute Coronary Events	PLOS ONE			English	Article								Background. The role of coffee intake as a risk factor for coronary heart disease (CHD) has been debated for decades. We examined whether the relationship between coffee intake and incidence of CHD events is dependent on the metabolism of circulating catecholamines, as determined by functional polymorphism of the catechol-O-methyltransferase (COMT) gene. Methodology/Principal Findings. In a cohort of 773 men who were 42 to 60 years old and free of symptomatic CHD at baseline in 1984-89, 78 participants experienced an acute coronary event during an average follow-up of 13 years. In logistic regression adjusting for age, smoking, family history of CHD, vitamin C deficiency, blood pressure, plasma cholesterol concentration, and diabetes, the odds ratio (90% confidence interval) comparing heavy coffee drinkers with the low activity COMT genotype with those with the high activity or heterozygotic genotypes was 3.2 (1.2-8.4). Urinary adrenaline excretion increased with increasing coffee intake, being over two-fold in heavy drinkers compared with nondrinkers (p = 0.008 for trend). Conclusions/Significance. Heavy coffee consumption increases the incidence of acute coronary events in men with low but not high COMT activity. Further studies are required to determine to which extent circulating catecholamines mediate the relationship between coffee intake and CHD.	[Happonen, Pertti; Salonen, Jukka T.] Univ Kuopio, Dept Publ Hlth, Sch Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland; [Voutilainen, Sari; Tuomainen, Tomi-Pekka; Salonen, Jukka T.] Univ Kuopio, Publ Hlth Res Inst, FIN-70211 Kuopio, Finland; [Tuomainen, Tomi-Pekka] Univ Kuopio, Clin Res Ctr, Atherosclerosis Unit, FIN-70211 Kuopio, Finland; [Salonen, Jukka T.] Oy Jurilab Ltd, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland	Happonen, P (corresponding author), Univ Kuopio, Dept Publ Hlth, Sch Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland.	pertti.happonen@uku.fi			Academy of Finland [201688, 80185]; Ministry of Education of Finland; city of Kuopio; National Heart, Lung, and Blood Institute of the United States; Juho Vainio Foundation; Finnish Cultural Fund/North Savo Fund; Yrjo Jahnsson Foundation; Finnish Foundation for Medical Science	Academy of Finland(Academy of Finland); Ministry of Education of Finland; city of Kuopio; National Heart, Lung, and Blood Institute of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Juho Vainio Foundation; Finnish Cultural Fund/North Savo Fund; Yrjo Jahnsson Foundation; Finnish Foundation for Medical Science	This study was supported in part by grants from the Academy of Finland (201688 and 80185 for S. V.), the Ministry of Education of Finland, the city of Kuopio, and the National Heart, Lung, and Blood Institute of the United States. Additional support was provided to P. H. by the Juho Vainio Foundation, the Finnish Cultural Fund/North Savo Fund, the Yrjo Jahnsson Foundation, and the Finnish Foundation for Medical Science.	Boekschoten MV, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-8; Brandin L, 2003, J HYPERTENS, V21, P1695, DOI 10.1097/00004872-200309000-00019; Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135; Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A; Eisenhofer G, 2001, Rev Endocr Metab Disord, V2, P297, DOI 10.1023/A:1011572617314; Gidron Y, 2002, CARDIOVASC RES, V56, P15, DOI 10.1016/S0008-6363(02)00537-0; GREENLAND S, 1993, EPIDEMIOLOGY, V4, P366, DOI 10.1097/00001648-199307000-00013; GROBBEE DE, 1990, NEW ENGL J MED, V323, P1026, DOI 10.1056/NEJM199010113231504; GYNTELBERG F, 1995, J INTERN MED, V237, P55, DOI 10.1111/j.1365-2796.1995.tb01140.x; Hammar N, 2003, J INTERN MED, V253, P653, DOI 10.1046/j.1365-2796.2003.01142.x; Happonen P, 2004, J NUTR, V134, P2381, DOI 10.1093/jn/134.9.2381; IHANAINEN M, 1989, NUTR RES, V9, P597, DOI 10.1016/S0271-5317(89)80126-5; Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393; KUMADA Y, 1976, J ANTIBIOT, V29, P882, DOI 10.7164/antibiotics.29.882; LACROIX AZ, 1986, NEW ENGL J MED, V315, P977, DOI 10.1056/NEJM198610163151601; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; LANE JD, 1990, PSYCHOSOM MED, V52, P320, DOI 10.1097/00006842-199005000-00006; Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840; NISTRUPMADSEN S, 1978, BRIT J SURG, V65, P191, DOI 10.1002/bjs.1800650315; Nyyssonen K, 1997, BRIT MED J, V314, P634, DOI 10.1136/bmj.314.7081.634; Panagiotakos DB, 2003, J NUTR, V133, P3228, DOI 10.1093/jn/133.10.3228; PINCOMB GA, 1988, AM J CARDIOL, V61, P798, DOI 10.1016/0002-9149(88)91069-7; ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403; ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124; ROSENBERG L, 1988, AM J EPIDEMIOL, V128, P570, DOI 10.1093/oxfordjournals.aje.a115004; Saboury AA, 2003, ACTA BIOCHIM POL, V50, P849; SALONEN JT, 1988, AM J CLIN NUTR, V48, P1226, DOI 10.1093/ajcn/48.5.1226; SALONEN JT, 1988, ANN CLIN RES, V20, P46; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; SMITS P, 1986, CLIN PHARMACOL THER, V40, P431, DOI 10.1038/clpt.1986.203; Stevens RD, 2003, ANESTH ANALG, V97, P623, DOI 10.1213/01.ANE.0000074795.68061.16; Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562; Syvanen AC, 1997, PHARMACOGENETICS, V7, P65; Tavani A, 2001, EUR J EPIDEMIOL, V17, P1131, DOI 10.1023/A:1021276932160; Thelle Dag S., 1995, Current Opinion in Lipidology, V6, P25, DOI 10.1097/00041433-199502000-00006; TUOMILEHTO J, 1992, EUR HEART J, V13, P577, DOI 10.1093/oxfordjournals.eurheartj.a060219; WHITSETT TL, 1984, AM J CARDIOL, V53, P918, DOI 10.1016/0002-9149(84)90525-3; Willett WC, 1996, JAMA-J AM MED ASSOC, V275, P458, DOI 10.1001/jama.275.6.458; WILSON PWF, 1989, ARCH INTERN MED, V149, P1169, DOI 10.1001/archinte.149.5.1169; Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481; Zhu BT, 2002, HISTOL HISTOPATHOL, V17, P1283, DOI 10.14670/HH-17.1283	42	32	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e117	10.1371/journal.pone.0000117	http://dx.doi.org/10.1371/journal.pone.0000117			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205121	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700011
J	Li, Y; Roycewicz, P; Smith, E; Borevitz, JO				Li, Yan; Roycewicz, Peter; Smith, Evadne; Borevitz, Justin O.			Genetics of Local Adaptation in the Laboratory: Flowering Time Quantitative Trait Loci under Geographic and Seasonal Conditions in Arabidopsis	PLOS ONE			English	Article								Flowering time in Arabidopsis thaliana is controlled by a large number of genes and various environmental factors, such as light and temperature. The objective of this study was to identify flowering time quantitative trait loci (QTL) under growth conditions simulating seasonal conditions from native geographic locations. Our growth chambers were set to simulate the spring conditions in Spain and Sweden, with appropriate changes in light color, intensity and day length, as well as temperature and relative humidity. Thus the Sweden-like spring conditions changed more dramatically compared to Spain-like spring conditions across the duration of our experiment. We have used these conditions to map QTL responsible for flowering time in the Kas-1/Col-gl1 recombinant inbred lines (RILs) across two replicate blocks. A linkage map from 96 RILs was established using 119 markers including 64 new SNPs markers. One major QTL, mapping to the FRIGIDA (FRI) locus, was detected on the top of chromosome 4 that showed significant gene x seasonal environment interactions. Three other minor QTL also were detected. One QTL mapping near FLOWERING LOCUS M(FLM) showed an epistatic interaction with the QTL at FRI. These QTL x environment and QTL x QTL interactions suggest that subtle ecologically relevant changes in light, temperature, and relative humidity are differentially felt by alleles controlling flowering time and may be responsible for adaptation to regional environments.	[Li, Yan; Smith, Evadne; Borevitz, Justin O.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Roycewicz, Peter; Borevitz, Justin O.] Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Borevitz, JO (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	borevitz@uchicago.edu	Borevitz, Justin/B-5423-2012; Li, Yan/AAF-5886-2019	Borevitz, Justin/0000-0001-8408-3699; Li, Yan/0000-0002-1627-7763	NIH [R01 GM073822]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Startup fund to Justin Borevitz supported this work; Yan Li was supported by NIH R01 GM073822 to Justin Borevitz.	Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Amasino RM, 2005, CURR OPIN BIOTECH, V16, P154, DOI 10.1016/j.copbio.2005.02.004; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Blazquez M, 2001, EMBO REP, V2, P1078, DOI 10.1093/embo-reports/kve254; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Borevitz JO, 2002, GENETICS, V160, P683; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; CHURCHILL GA, 1994, GENETICS, V138, P963; Grini PE, 1999, GENETICS, V151, P849; Harushima Y, 1996, THEOR APPL GENET, V92, P145, DOI 10.1007/BF00223368; HOLLOWAY JL, 1994, GMENDEL 3 0 USERS GU; Howden R, 1998, GENETICS, V149, P621; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Searle I, 2004, EMBO J, V23, P1217, DOI 10.1038/sj.emboj.7600117; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Stinchcombe JR, 2005, AM J BOT, V92, P1701, DOI 10.3732/ajb.92.10.1701; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Weinig C, 2003, GENETICS, V165, P321; Weinig C, 2002, GENETICS, V162, P1875; Werner JD, 2005, GENETICS, V170, P1197, DOI 10.1534/genetics.104.036533; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Wilson IW, 2001, GENETICS, V158, P1301; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355	30	40	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e105	10.1371/journal.pone.0000105	http://dx.doi.org/10.1371/journal.pone.0000105			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205109	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443700001
J	Oikonomou, N; Harokopos, V; Zalevsky, J; Valavanis, C; Kotanidou, A; Szymkowski, DE; Kollias, G; Aidinis, V				Oikonomou, Nikos; Harokopos, Vaggelis; Zalevsky, Jonathan; Valavanis, Christos; Kotanidou, Anastasia; Szymkowski, David E.; Kollias, George; Aidinis, Vassilis			Soluble TNF Mediates the Transition from Pulmonary Inflammation to Fibrosis	PLOS ONE			English	Article								Background. Fibrosis, the replacement of functional tissue with excessive fibrous tissue, can occur in all the main tissues and organ systems, resulting in various pathological disorders. Idiopathic Pulmonary Fibrosis is a prototype fibrotic disease involving abnormal wound healing in response to multiple sites of ongoing alveolar epithelial injury. Methodology/Principal Findings. To decipher the role of TNF and TNF-mediated inflammation in the development of fibrosis, we have utilized the bleomycin-induced animal model of Pulmonary Fibrosis and a series of genetically modified mice lacking components of TNF signaling. Transmembrane TNF expression is shown to be sufficient to elicit an inflammatory response, but inadequate for the transition to the fibrotic phase of the disease. Soluble TNF expression is shown to be crucial for lymphocyte recruitment, a prerequisite for TGF-b1 expression and the development of fibrotic lesions. Moreover, through a series of bone marrow transfers, the necessary TNF expression is shown to originate from the non-hematopoietic compartment further localized in apoptosing epithelial cells. Conclusions. These results suggest a primary detrimental role of soluble TNF in the pathologic cascade, separating it from the beneficial role of transmembrane TNF, and indicate the importance of assessing the efficacy of soluble TNF antagonists in the treatment of Idiopathic Pulmonary Fibrosis.	[Oikonomou, Nikos; Harokopos, Vaggelis; Kollias, George; Aidinis, Vassilis] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Athens, Greece; [Zalevsky, Jonathan; Szymkowski, David E.] Xencor Inc, Monrovia, CA USA; [Valavanis, Christos] Metaxa Canc Hosp, Dept Pathol, Mol Pathol Unit, Piraeus, Greece; [Kotanidou, Anastasia] Univ Athens, Sch Med, Dept Crit Care 1, GR-11527 Athens, Greece	Alexander Fleming Biomedical Sciences Research Center; Athens Medical School; National & Kapodistrian University of Athens	Aidinis, V (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Athens, Greece.	V.Aidinis@Fleming.gr	Kotanidou, Anastasia/AAB-4731-2020; Aidinis, Vassilis/AAF-5380-2021; Kollias, George/A-7079-2012	Kollias, George/0000-0003-1867-3150; Aidinis, Vassilis/0000-0001-9531-7729; Szymkowski, David/0000-0002-8934-7902	EC [QLRT-CT-2001-01407, LSHG-CT-2005-005203]	EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by the EC grants QLRT-CT-2001-01407 and LSHG-CT-2005-005203.	Alexopoulou L, 2006, EUR J IMMUNOL, V36, P2768, DOI 10.1002/eji.200635921; Allen JT, 2001, RESP RES, V3, DOI 10.1186/rr162; ANTONIOU KM, 2006, EUR RESP J; Artis D, 1999, J EXP MED, V190, P953, DOI 10.1084/jem.190.7.953; BARGAGLI E, 2005, RESPIRATION; Boylen, 2002, AM J RESP CRIT CARE, V165, pA728; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fremond C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-136; Fujita M, 2001, AM J PHYSIOL-LUNG C, V280, pL39, DOI 10.1152/ajplung.2001.280.1.L39; Fujita M, 2003, AM J RESP CELL MOL, V29, P669, DOI 10.1165/rcmb.2002-0046OC; Gauldie J, 2001, RESP RES, V3; Gauldie J, 2002, AM J RESP CRIT CARE, V165, P1205, DOI 10.1164/rccm.2202054; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Hardie WD, 2004, AM J PHYSIOL-LUNG C, V286, pL741, DOI 10.1152/ajplung.00208.2003; Hasegawa M, 1997, J RHEUMATOL, V24, P663; HOYT DG, 1992, AM J RESP CELL MOL, V7, P645, DOI 10.1165/ajrcmb/7.6.645; Huaux F, 2003, J IMMUNOL, V171, P5470, DOI 10.4049/jimmunol.171.10.5470; Huaux F, 2003, J IMMUNOL, V170, P2083, DOI 10.4049/jimmunol.170.4.2083; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; KAPANCI Y, 1995, AM J RESP CRIT CARE, V152, P2163, DOI 10.1164/ajrccm.152.6.8520791; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kollias G, 2004, Autoimmun Rev, V3 Suppl 1, pS24; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Kuroki M, 2003, J IMMUNOL, V170, P567, DOI 10.4049/jimmunol.170.1.567; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; Kuwano K, 1996, AM J RESP CRIT CARE, V154, P477, DOI 10.1164/ajrccm.154.2.8756825; Kuwano K, 2001, AM J PHYSIOL-LUNG C, V280, pL316, DOI 10.1152/ajplung.2001.280.2.L316; Lake-Bullock MHV, 1999, J LEUKOCYTE BIOL, V65, P187, DOI 10.1002/jlb.65.2.187; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Liu JY, 1998, AM J PATHOL, V153, P1839, DOI 10.1016/S0002-9440(10)65698-2; Liu JY, 2001, AM J RESP CELL MOL, V25, P3, DOI 10.1165/ajrcmb.25.1.4481; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LUNDBLAD LK, 2005, AM J RESP CRIT CARE; Maeyama T, 2001, EUR RESPIR J, V17, P180, DOI 10.1183/09031936.01.17201800; Mauviel A, 2005, METH MOLEC MED, V117, P69; MIYAZAKI Y, 1995, J CLIN INVEST, V96, P250, DOI 10.1172/JCI118029; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; NASH JRG, 1993, HISTOPATHOLOGY, V22, P343, DOI 10.1111/j.1365-2559.1993.tb00133.x; Nathan SD, 2004, RESPIRATION, V71, P77, DOI 10.1159/000075653; OHMORI Y, 1993, AM J PATHOL, V142, P861; Okudela K, 1999, AM J PATHOL, V155, P1341, DOI 10.1016/S0002-9440(10)65236-4; Ortiz LA, 1998, EXP LUNG RES, V24, P721, DOI 10.3109/01902149809099592; Ortiz LA, 1999, AM J RESP CELL MOL, V20, P825, DOI 10.1165/ajrcmb.20.4.3193; Ortiz LA, 1999, AM J PHYSIOL-LUNG C, V277, pL1239, DOI 10.1152/ajplung.1999.277.6.L1239; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PHAN SH, 1992, EXP LUNG RES, V18, P29, DOI 10.3109/01902149209020649; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; PIGUET PF, 1994, EUR RESPIR J, V7, P515, DOI 10.1183/09031936.94.07030515; PIGUET PF, 1989, J EXP MED, V170, P655, DOI 10.1084/jem.170.3.655; PIGUET PF, 1990, NATURE, V344, P245, DOI 10.1038/344245a0; PIGUET PF, 1994, INT J EXP PATHOL, V75, P321; PIGUET PF, 1993, AM J PATHOL, V143, P651; Plataki M, 2005, CHEST, V127, P266, DOI 10.1378/chest.127.1.266; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sheppard D, 2001, J CLIN INVEST, V107, P1501, DOI 10.1172/JCI13318; Sime PJ, 1998, AM J PATHOL, V153, P825, DOI 10.1016/S0002-9440(10)65624-6; Steed PM, 2003, SCIENCE, V301, P1895, DOI 10.1126/science.1081297; Strieter RM, 2002, AM J RESP CRIT CARE, V165, P1206, DOI 10.1164/rccm.2202055; Strieter Robert M., 2001, Chest, V120, p77S, DOI 10.1378/chest.120.1_suppl.S77-a; Thrall RS, 1997, AM J PATHOL, V151, P1303; Torres D, 2005, AM J PATHOL, V167, P1677, DOI 10.1016/S0002-9440(10)61250-3; Uhal BD, 1998, AM J PHYSIOL-LUNG C, V275, pL1192, DOI 10.1152/ajplung.1998.275.6.L1192; Uhal BD, 1995, AM J PHYSIOL-LUNG C, V269, pL819, DOI 10.1152/ajplung.1995.269.6.L819; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; Vassallo Robert, 2002, Chest, V122, P1093, DOI 10.1378/chest.122.3.1093; VLADUTIU AO, 1993, CLIN EXP IMMUNOL, V93, P1; Vuillemenot BR, 2004, AM J RESP CELL MOL, V30, P438, DOI 10.1165/rcmb.2003-0062OC; Wang RG, 1999, AM J PHYSIOL-LUNG C, V277, pL1158, DOI 10.1152/ajplung.1999.277.6.L1158; Wang RQ, 2000, AM J PHYSIOL-LUNG C, V279, pL143, DOI 10.1152/ajplung.2000.279.1.L143; Whyte M, 2000, AM J RESP CRIT CARE, V162, P755, DOI 10.1164/ajrccm.162.2.9909053; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zhang K, 1997, J IMMUNOL, V158, P954; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zhu J, 1996, ANN NY ACAD SCI, V796, P194, DOI 10.1111/j.1749-6632.1996.tb32581.x; Ziegenhagen MW, 1998, J INVEST MED, V46, P223	84	95	99	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e108	10.1371/journal.pone.0000108	http://dx.doi.org/10.1371/journal.pone.0000108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205112	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443700003
J	Canamero, RC; Boccalandro, H; Casal, J; Serna, L				Canamero, Roberto C.; Boccalandro, Hernan; Casal, Jorge; Serna, Laura			Use of Confocal Laser as Light Source Reveals Stomata-Autonomous Function	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTEIN; BLUE-LIGHT; INDUCED PHOSPHORYLATION; ACTION SPECTRUM; PHOTOTROPIN-2; MEDIATE; NPH1; NPL1	In most terrestrial plants, stomata open during the day to maximize the update of CO2 for photosynthesis, but they close at night to minimize water loss. Blue light, among several environmental factors, controls this process. Stomata response to diverse stimuli seems to be dictated by the behaviour of neighbour stomata creating leaf areas of coordinated response. Here individual stomata of Arabidopsis leaves were illuminated with a short blue-light pulse by focusing a confocal argon laser. Beautifully, the illuminated stomata open their pores, whereas their dark-adapted neighbours unexpectedly experience no change. This induction of individual stomata opening by low fluence rates of blue light was disrupted in the phototropin1 phototropin2 (phot1 phot2) double mutant, which exhibits insensitivity of stomatal movements in blue-illuminated epidermal strips. The irradiation of all epidermal cells making direct contact with a given stoma in both wild type and phot1 phot2 plants does not trigger its movement. These results unravel the stoma autonomous function in the blue light response and illuminate the implication of PHOT1 and/or PHOT2 in such response. The micro spatial heterogeneity that solar blue light suffers in partially shaded leaves under natural conditions highlights the physiological significance of the autonomous stomatal behaviour.	[Canamero, Roberto C.; Boccalandro, Hernan; Serna, Laura] Univ Castilla La Mancha, Environm Sci Fac, Toledo, Spain; [Boccalandro, Hernan; Casal, Jorge] Univ Buenos Aires, Fac Agron, Inst Invest Fisiol & Ecol Vinculadas Agr IFEVA, Buenos Aires, DF, Argentina; [Boccalandro, Hernan; Casal, Jorge] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	Universidad de Castilla-La Mancha; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Serna, L (corresponding author), Univ Castilla La Mancha, Environm Sci Fac, Toledo, Spain.	laura.serna@uclm.es		Casal, Jorge/0000-0001-6525-8414; Serna, Laura/0000-0002-4705-3519	Castilla-La Mancha University [PAI-05-058]; Ministry of Education and Culture of Spain [BIO2005-04493]	Castilla-La Mancha University; Ministry of Education and Culture of Spain(Spanish Government)	Funding: This work was supported by grants from the Castilla-La Mancha University (to LS, JC and HB), and both the Communities Council of Castilla-La Mancha (PAI-05-058) and the Ministry of Education and Culture of Spain (BIO2005-04493) (to LS). RCC was supported by a Communities Council of Castilla-La Mancha fellowship. HB was supported by a grant from the Castilla-La Mancha University.	Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Eisinger W, 2000, PLANT PHYSIOL, V122, P99, DOI 10.1104/pp.122.1.99; Fan LM, 2004, CURR OPIN PLANT BIOL, V7, P537, DOI 10.1016/j.pbi.2004.07.009; GALLAGHER S, 1988, P NATL ACAD SCI USA, V85, P8003, DOI 10.1073/pnas.85.21.8003; HAGER A, 1993, PLANTA, V189, P567, DOI 10.1007/BF00198221; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; KARLSSON PE, 1986, PHYSIOL PLANTARUM, V66, P207, DOI 10.1111/j.1399-3054.1986.tb02410.x; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kong SG, 2006, PLANT J, V45, P994, DOI 10.1111/j.1365-313X.2006.02667.x; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Mott KA, 2000, TRENDS PLANT SCI, V5, P258, DOI 10.1016/S1360-1385(00)01648-4; Mott KA, 1997, PLANT CELL ENVIRON, V20, P1098, DOI 10.1046/j.1365-3040.1997.d01-138.x; Mott KA, 2001, PLANT CELL ENVIRON, V24, P657, DOI 10.1046/j.0016-8025.2001.00705.x; PALMER JM, 1993, PLANT PHYSIOL, V102, P1211, DOI 10.1104/pp.102.4.1211; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Salomon M, 1996, PLANTA, V199, P336, DOI 10.1007/BF00195724; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Serna L, 2000, PHYSIOL PLANTARUM, V109, P351, DOI 10.1034/j.1399-3054.2000.100317.x; Sharma VK, 1997, PHYTOCHEMISTRY, V44, P775, DOI 10.1016/S0031-9422(96)00624-3; SHORT TW, 1993, PLANT PHYSIOL, V101, P647, DOI 10.1104/pp.101.2.647; Talbott LD, 2003, PLANT PHYSIOL, V133, P1522, DOI 10.1104/pp.103.029587; Talbott LD, 2002, AM J BOT, V89, P366, DOI 10.3732/ajb.89.2.366; ZEIGER E, 1977, SCIENCE, V196, P887, DOI 10.1126/science.196.4292.887; ZEIGER E, 1983, ANNU REV PLANT PHYS, V34, P441, DOI 10.1146/annurev.pp.34.060183.002301	31	4	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e36	10.1371/journal.pone.0000036	http://dx.doi.org/10.1371/journal.pone.0000036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183664	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600036
J	Carmena, A; Speicher, S; Baylies, M				Carmena, Ana; Speicher, Stephan; Baylies, Mary			The PDZ Protein Canoe/AF-6 Links Ras-MAPK, Notch and Wingless/Wnt Signaling Pathways by Directly Interacting with Ras, Notch and Dishevelled	PLOS ONE			English	Article								Over the past few years, it has become increasingly apparent that signal transduction pathways are not merely linear cascades; they are organized into complex signaling networks that require high levels of regulation to generate precise and unique cell responses. However, the underlying regulatory mechanisms by which signaling pathways cross-communicate remain poorly understood. Here we show that the Ras-binding protein Canoe (Cno)/AF-6, a PDZ protein normally associated with cellular junctions, is a key modulator of Wingless (Wg)/Wnt, Ras-Mitogen Activated Protein Kinase (MAPK) and Notch (N) signaling pathways cross-communication. Our data show a repressive effect of Cno/AF-6 on these three signaling pathways through physical interactions with Ras, N and the cytoplasmic protein Dishevelled (Dsh), a key Wg effector. We propose a model in which Cno, through those interactions, actively coordinates, at the membrane level, Ras-MAPK, N and Wg signaling pathways during progenitor specification.	[Carmena, Ana; Baylies, Mary] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, New York, NY 10021 USA; [Carmena, Ana; Speicher, Stephan] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Unidad Neurobiol Desarrollo, Alicante, Spain	Memorial Sloan Kettering Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Carmena, A (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, 1275 York Ave, New York, NY 10021 USA.	acarmena@umh.es	Carmena, Ana/H-3506-2015	Carmena, Ana/0000-0003-1855-7934	National Institutes of Health [GM56989]; Human Frontiers Postdoctoral Fellowship; Generalitat Valenciana [GV05/075]; Marie Curie Program [MIRG-CT-2005016536]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Postdoctoral Fellowship; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Marie Curie Program(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M. B. and A. C. were supported by National Institutes of Health Grant GM56989, a Human Frontiers Postdoctoral Fellowship and Grants from the Generalitat Valenciana GV05/075 and Marie Curie Program (MIRG-CT-2005016536).	Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bate Michael, 1993, P1013; Baylies MK, 2001, CURR OPIN GENET DEV, V11, P431, DOI 10.1016/S0959-437X(00)00214-8; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Bellotto M, 2002, INT J DEV BIOL, V46, P149; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Boettner B, 2003, GENETICS, V165, P159; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Buff E, 1998, DEVELOPMENT, V125, P2075; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; Carmena A, 2002, DEV BIOL, V244, P226, DOI 10.1006/dbio.2002.0606; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; Cooper MTD, 2000, CURR BIOL, V10, P1507, DOI 10.1016/S0960-9822(00)00826-5; Culi J, 2001, DEVELOPMENT, V128, P299; DUNINBORKOWSKI OM, 1995, DEV BIOL, V168, P689, DOI 10.1006/dbio.1995.1115; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Fitzgerald K, 2000, ONCOGENE, V19, P4191, DOI 10.1038/sj.onc.1203766; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gaengel K, 2003, DEVELOPMENT, V130, P5413, DOI 10.1242/dev.00759; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Gomez MR, 1997, DEVELOPMENT, V124, P4857; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Ikeya T, 1999, DEVELOPMENT, V126, P4455; James P, 1996, GENETICS, V144, P1425; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Knirr S, 2001, DEV BIOL, V238, P13, DOI 10.1006/dbio.2001.0397; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Lawrence PA, 1995, DEVELOPMENT, V121, P4303; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; MARTINBERMUDO MD, 1991, DEVELOPMENT, V113, P445; Matsuo T, 1997, DEVELOPMENT, V124, P2671; Michelson AM, 1998, DEV GENET, V22, P212, DOI 10.1002/(SICI)1520-6408(1998)22:3<212::AID-DVG4>3.0.CO;2-9; MIYAMOTO H, 1995, GENE DEV, V9, P612, DOI 10.1101/gad.9.5.612; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P265, DOI 10.1016/S0968-0004(00)89040-4; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; PRASAD R, 1993, CANCER RES, V53, P5624; Radziwill G, 2003, MOL CELL BIOL, V23, P4663, DOI 10.1128/MCB.23.13.4663-4672.2003; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Rohrbaugh M, 2002, CURR BIOL, V12, P576, DOI 10.1016/S0960-9822(02)00743-1; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shimada Y, 2001, CURR BIOL, V11, P859, DOI 10.1016/S0960-9822(01)00233-0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Su MT, 1999, DEVELOPMENT, V126, P3241; Sundaram MV, 2005, GENE DEV, V19, P1825, DOI 10.1101/gad.1330605; Takahashi K, 1998, MECH DEVELOP, V78, P97, DOI 10.1016/S0925-4773(98)00151-8; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; YAMAMOTO D, 1996, MOL DYNAMICS DEV DRO; Yamamoto T, 1999, BIOCHEM BIOPH RES CO, V259, P103, DOI 10.1006/bbrc.1999.0731; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; zur Lage P, 1999, DEVELOPMENT, V126, P3149	74	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e66	10.1371/journal.pone.0000066	http://dx.doi.org/10.1371/journal.pone.0000066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183697	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600066
J	Kallikourdis, M; Betz, AG				Kallikourdis, Marinos; Betz, Alexander G.			Periodic Accumulation of Regulatory T Cells in the Uterus: Preparation for the Implantation of a Semi-Allogeneic Fetus?	PLOS ONE			English	Article							HUMAN ENDOMETRIUM; ADOPTIVE TRANSFER; EXPRESSION; CHEMOKINE; CD4(+)CD25(+); RECRUITMENT; FRACTALKINE; RECEPTORS	Background. Naturally occurring Foxp3+ regulatory T cells play an important role in the inhibition of an immunological attack of the fetus. As implantation of the fetus poses an immediate antigenic challenge, the immune system has to prepare itself for this event prior to implantation. Methodology and Principal Findings. Here, we show using quantitative RT-PCR and flow cytometry that regulatory T cells accumulate in the uterus not only during pregnancy, but also every time the female becomes fertile. Their periodic accumulation is accompanied by matching fluctuations in uterine expression of several chemokines, which have been shown to play a role in the recruitment and retention of regulatory T cells. Conclusions/Significance. The data lead us to propose that every time a female approaches estrus, regulatory T cells start to accumulate in the uterus in preparation for a possible implantation event. Once pregnancy is established, those regulatory T cells that have seen alloantigen need to be retained at their site of action. Whilst several chemokines appear to be involved in the recruitment and/or retention of regulatory T cells during estrus, in pregnancy this role appears to be taken over by CCL4.	[Kallikourdis, Marinos; Betz, Alexander G.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Betz, AG (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	betz@mrc-lmb.cam.ac.uk	Kallikourdis, Marinos/AAA-5593-2019; Betz, Alexander/GQQ-2221-2022	Kallikourdis, Marinos/0000-0001-9318-3368; 	Medical Research Council UK; Arthritis Research Campaign [B0750]; Medical Research Council [MC_U105184296] Funding Source: researchfish; MRC [MC_U105184296] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research Campaign(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK and a grant from the Arthritis Research Campaign (grant no: B0750).	Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010; Akiyama M, 1999, BRIT J OBSTET GYNAEC, V106, P725, DOI 10.1111/j.1471-0528.1999.tb08374.x; Aluvihare VR, 2006, IMMUNOL REV, V212, P330, DOI 10.1111/j.0105-2896.2006.00408.x; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572; Caballero-Campo P, 2002, MOL HUM REPROD, V8, P375, DOI 10.1093/molehr/8.4.375; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Itoh M, 1999, J IMMUNOL, V162, P5317; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; Kitaya K, 2003, J CLIN ENDOCR METAB, V88, P1809, DOI 10.1210/jc.2002-020980; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Papadopoulos EJ, 1999, EUR J IMMUNOL, V29, P2551, DOI 10.1002/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T; Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4; Rushbrook SM, 2005, J VIROL, V79, P7852, DOI 10.1128/JVI.79.12.7852-7859.2005; Salamonsen LA, 2002, J REPROD IMMUNOL, V57, P95, DOI 10.1016/S0165-0378(02)00011-6; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; SHORT DJ, 1969, IAT MANUAL LAB ANIMA, P342; Szanya V, 2002, J IMMUNOL, V169, P2461, DOI 10.4049/jimmunol.169.5.2461; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Watanabe M, 2006, INT J GYNECOL OBSTET, V92, P242, DOI 10.1016/j.ijgo.2005.12.012; Wysocki CA, 2005, BLOOD, V106, P3300, DOI 10.1182/blood-2005-04-1632; Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956; Zenclussen AC, 2004, EUR J IMMUNOL, V34, P377, DOI 10.1002/eji.200324469	28	80	85	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e382	10.1371/journal.pone.0000382	http://dx.doi.org/10.1371/journal.pone.0000382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440618	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445500013
J	Plamondon, M; Labbe, AC; Frost, E; Deslandes, S; Alves, AC; Bastien, N; Pepin, J				Plamondon, Mireille; Labbe, Annie-Claude; Frost, Eric; Deslandes, Sylvie; Alves, Alfredo Claudino; Bastien, Nathalie; Pepin, Jacques			Hepatitis C Virus Infection in Guinea-Bissau: A Sexually Transmitted Genotype 2 with Parenteral Amplification?	PLOS ONE			English	Article							GENETIC DIVERSITY; HCV INFECTION; RISK-FACTORS; TRANSMISSION; ANTIBODIES; PREVALENCE; HETEROGENEITY; EPIDEMIOLOGY; HISTORY; WORKERS	Background. Sub-Saharan Africa is the continent with the highest prevalence of Hepatitis C virus (HCV) infection. Genotype 2 HCV is thought to have originated from West Africa several hundred years ago. Mechanisms of transmission remain poorly understood. Methodology/Principal Findings. To delineate mechanisms for HCV transmission in West Africa, we conducted a cross-sectional survey of individuals aged >= 50 years in Bissau, Guinea-Bissau. Dried blood spots were obtained for HCV serology and PCR amplification. Prevalence of HCV was 4.4% (47/1066) among women and 5.0% (27/544) among men. In multivariate analysis, the independent risk factors for HCV infection were age (baseline: 50-59 y; 60-69 y, adjusted odds ratio [AOR]: 1.67, 95% CI: 0.91-3.06; >= 70 y, AOR: 3.47, 95% CI: 1.89-6.39), belonging to the Papel, Mancanha, Balanta or Mandjako ethnic groups (AOR: 2.45, 95% CI: 1.32-4.53), originating from the Biombo, Cacheu or Oio regions north of Bissau (AOR: 4.16, 95% CI: 1.18-14.73) and having bought or sold sexual services (AOR: 3.60, 95% CI: 1.88-6.89). Of 57 isolates that could be genotyped, 56 were genotype 2. Conclusions. Our results suggest that transmission of HCV genotype 2 in West Africa occurs through sexual intercourse. In specific locations and subpopulations, medical interventions may have amplified transmission parenterally.	[Plamondon, Mireille; Frost, Eric; Deslandes, Sylvie; Pepin, Jacques] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada; [Plamondon, Mireille; Frost, Eric; Deslandes, Sylvie; Pepin, Jacques] Univ Sherbrooke, Ctr Int Hlth, Sherbrooke, PQ J1K 2R1, Canada; [Labbe, Annie-Claude; Bastien, Nathalie] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; [Alves, Alfredo Claudino] Hop Simao Mendes, Bissau, Guinea Bissau	University of Sherbrooke; University of Sherbrooke; Universite de Montreal	Pepin, J (corresponding author), Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada.	jacques.pepin@usherbrooke.ca		Frost, Eric/0000-0001-8958-4388				Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Ayele W, 2002, J MED VIROL, V68, P12, DOI 10.1002/jmv.10164; Braga ACD, 2006, ACTA TROP, V97, P88, DOI 10.1016/j.actatropica.2005.09.003; Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; DACOSTA FMC, 1960, B CULTURAL GUINE POR, V15, P521; DENIS F, 1994, J MED VIROL, V43, P1, DOI 10.1002/jmv.1890430102; DEVELOUX M, 1994, T ROY SOC TROP MED H, V88, P536, DOI 10.1016/0035-9203(94)90151-1; Egawa K, 1996, J HEPATOL, V24, P397, DOI 10.1016/S0168-8278(96)80159-0; ELTIS D, 1999, TRANSATLANTIC SLAVE; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; FRETZ C, 1995, J MED VIROL, V47, P435, DOI 10.1002/jmv.1890470423; FROMMEL D, 1993, AM J TROP MED HYG, V49, P435, DOI 10.4269/ajtmh.1993.49.435; Jagger J, 2002, JAMA-J AM MED ASSOC, V288, P1469, DOI 10.1001/jama.288.12.1469; Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;92::AID-JMV2&gt;3.0.CO;2-I; Laurent C, 2001, INT J EPIDEMIOL, V30, P872, DOI 10.1093/ije/30.4.872; LECUONA MD, 1966, B CULTURAL GUINE POR, V21, P45; Madhava V, 2002, LANCET INFECT DIS, V2, P293, DOI 10.1016/S1473-3099(02)00264-5; Martial J, 2004, J CLIN MICROBIOL, V42, P784, DOI 10.1128/JCM.42.2.784-791.2004; Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701; Memon MI, 2002, J VIRAL HEPATITIS, V9, P84, DOI 10.1046/j.1365-2893.2002.00329.x; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Ndjomou J, 2003, J GEN VIROL, V84, P2333, DOI 10.1099/vir.0.19240-0; Pasquier C, 2005, J MED VIROL, V77, P390, DOI 10.1002/jmv.20468; Pepin J, 2006, AIDS, V20, P1303, DOI 10.1097/01.aids.0000232239.05545.33; Piazza M, 1997, ARCH INTERN MED, V157, P1537, DOI 10.1001/archinte.157.14.1537; PINTO A R, 1960, An Inst Med Trop (Lisb), V17, P817; PINTO AR, 1959, B CULTURAL GUINE POR, V14, P603; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Ruggieri A, 1996, J GEN VIROL, V77, P2073, DOI 10.1099/0022-1317-77-9-2073; SHEV S, 1995, SEX TRANSM DIS, V22, P210, DOI 10.1097/00007435-199507000-00002; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Stark K, 2000, J MED VIROL, V62, P524, DOI 10.1002/1096-9071(200012)62:4&lt;524::AID-JMV19&gt;3.0.CO;2-N; Tovo PA, 2005, J INFECT DIS, V192, P1872, DOI 10.1086/497695; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; Yazdanpanah Y, 2005, CLIN INFECT DIS, V41, P1423, DOI 10.1086/497131	37	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e372	10.1371/journal.pone.0000372	http://dx.doi.org/10.1371/journal.pone.0000372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440608	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445500003
J	Mainguy, G; Koster, J; Woltering, J; Jansen, H; Durston, A				Mainguy, Gaell; Koster, Jan; Woltering, Joost; Jansen, Hans; Durston, Antony			Extensive Polycistronism and Antisense Transcription in the Mammalian Hox Clusters	PLOS ONE			English	Article								The Hox clusters play a crucial role in body patterning during animal development. They encode both Hox transcription factor and micro-RNA genes that are activated in a precise temporal and spatial sequence that follows their chromosomal order. These remarkable collinear properties confer functional unit status for Hox clusters. We developed the TranscriptView platform to establish high resolution transcriptional profiling and report here that transcription in the Hox clusters is far more complex than previously described in both human and mouse. Unannotated transcripts can represent up to 60% of the total transcriptional output of a cluster. In particular, we identified 14 non-coding Transcriptional Units antisense to Hox genes, 10 of which (70%) have a detectable mouse homolog. Most of these Transcriptional Units in both human and mouse present conserved sizeable sequences (. 40 bp) overlapping Hox transcripts, suggesting that these Hox antisense transcripts are functional. Hox clusters also display at least seven polycistronic clusters, i.e., different genes being co-transcribed on long isoforms (up to 30 kb). This work provides a reevaluated framework for understanding Hox gene function and dys-function. Such extensive transcriptions may provide a structural explanation for Hox clustering.	[Mainguy, Gaell; Woltering, Joost; Jansen, Hans; Durston, Antony] Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; [Koster, Jan] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of Amsterdam; Academic Medical Center Amsterdam	Mainguy, G (corresponding author), Inst Veolia Environm, Paris, France.	gaell.mainguy@institut.veolia.org; A.J.Durston@biology.leidenuniv.nl	Koster, Jan/C-5934-2008	Koster, Jan/0000-0002-0890-7585; Woltering, Joost/0000-0002-2630-6572; Jansen, Hans/0000-0002-8563-4146	European Union; EMBO	European Union(European Commission); EMBO(European Molecular Biology Organization (EMBO))	This work was supported by the European Union FP5 Marie Curie and Biotech programmes, and also by an EMBO long term fellowship to GM and a Marie Curie individual fellowship to G. M. These sponsors supported all phases of this work up until the final writing phase.	Blumenthal T, 1998, BIOESSAYS, V20, P480, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;480::AID-BIES6&gt;3.0.CO;2-Q; Cook PR, 2003, J CELL SCI, V116, P4483, DOI 10.1242/jcs.00819; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; Huang XQ, 1996, GENOMICS, V33, P21, DOI 10.1006/geno.1996.0155; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Nelson CE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r25; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Shiga Y, 2006, EVOL DEV, V8, P407, DOI 10.1111/j.1525-142X.2006.00114.x; SIMEONE A, 1988, NUCLEIC ACIDS RES, V16, P5379, DOI 10.1093/nar/16.12.5379; Thanaraj TA, 2003, NUCLEIC ACIDS RES, V31, P2544, DOI 10.1093/nar/gkg355; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yousef GM, 2003, CLIN BIOCHEM, V36, P443, DOI 10.1016/S0009-9120(03)00055-9	26	69	72	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e356	10.1371/journal.pone.0000356	http://dx.doi.org/10.1371/journal.pone.0000356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406680	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445300018
J	Cobo, E; Selva-O'Callagham, A; Ribera, JM; Cardellach, F; Dominguez, R; Vilardell, M				Cobo, Erik; Selva-O'Callagham, Albert; Ribera, Josep-Maria; Cardellach, Francesc; Dominguez, Ruth; Vilardell, Miquel			Statistical Reviewers Improve Reporting in Biomedical Articles: A Randomized Trial	PLOS ONE			English	Article								Background. Although peer review is widely considered to be the most credible way of selecting manuscripts and improving the quality of accepted papers in scientific journals, there is little evidence to support its use. Our aim was to estimate the effects on manuscript quality of either adding a statistical peer reviewer or suggesting the use of checklists such as CONSORT or STARD to clinical reviewers or both. Methodology and Principal Findings. Interventions were defined as 1) the addition of a statistical reviewer to the clinical peer review process, and 2) suggesting reporting guidelines to reviewers; with "no statistical expert'' and "no checklist'' as controls. The two interventions were crossed in a 262 balanced factorial design including original research articles consecutively selected, between May 2004 and March 2005, by the Medicina Clinica (Barc) editorial committee. We randomized manuscripts to minimize differences in terms of baseline quality and type of study (intervention, longitudinal, cross-sectional, others). Sample-size calculations indicated that 100 papers provide an 80% power to test a 55% standardized difference. We specified the main outcome as the increment in quality of papers as measured on the Goodman Scale. Two blinded evaluators rated the quality of manuscripts at initial submission and final post peer review version. Of the 327 manuscripts submitted to the journal, 131 were accepted for further review, and 129 were randomized. Of those, 14 that were lost to follow-up showed no differences in initial quality to the followed-up papers. Hence, 115 were included in the main analysis, with 16 rejected for publication after peer review. 21 (18.3%) of the 115 included papers were interventions, 46 (40.0%) were longitudinal designs, 28 (24.3%) cross-sectional and 20 (17.4%) others. The 16 (13.9%) rejected papers had a significantly lower initial score on the overall Goodman scale than accepted papers (difference 15.0, 95% CI: 4.6-24.4). The effect of suggesting a guideline to the reviewers had no effect on change in overall quality as measured by the Goodman scale (0.9, 95% CI: -0.3-+2.1). The estimated effect of adding a statistical reviewer was 5.5 (95% CI: 4.3-6.7), showing a significant improvement in quality. Conclusions and Significance. This prospective randomized study shows the positive effect of adding a statistical reviewer to the field-expert peers in improving manuscript quality. We did not find a statistically significant positive effect by suggesting reviewers use reporting guidelines.	[Cobo, Erik; Dominguez, Ruth] Technol Univ Catalonia, Dept Stat & Operat Res, Barcelona, Spain; [Selva-O'Callagham, Albert; Vilardell, Miquel] Hosp Gen Valle Hebron, Dept Internal Med, Barcelona, Spain; [Ribera, Josep-Maria] Univ Hosp, Dept Hematol, Barcelona, Spain; [Cardellach, Francesc] Hosp Clin Barcelona, Dept Med, Barcelona, Spain; [Cardellach, Francesc] Univ Barcelona, Barcelona, Spain; [Cobo, Erik; Selva-O'Callagham, Albert; Ribera, Josep-Maria; Cardellach, Francesc; Vilardell, Miquel] Med Clin, Barcelona, Spain	Universitat Politecnica de Catalunya; Hospital Universitari Vall d'Hebron; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Cobo, E (corresponding author), Technol Univ Catalonia, Dept Stat & Operat Res, Barcelona, Spain.	erik.cobo@upc.edu	Ribera, JM/B-8181-2009; Cobo, Erik/H-6230-2011	Ribera, JM/0000-0003-1042-6024; Cobo, Erik/0000-0002-3534-5602; Selva-O'Callaghan, Albert/0000-0003-2823-9761	Carlos III Institute of Health [PI041945]	Carlos III Institute of Health(Instituto de Salud Carlos III)	This study was funded by grant PI041945 from the Carlos III Institute of Health (to E. C. and A. S.).	ALCMAN D, 1999, PEER REV HLTH SCI, P157; Altman DG, 2002, JAMA-J AM MED ASSOC, V287, P2765, DOI 10.1001/jama.287.21.2765; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Arnau C, 2003, MED CLIN-BARCELONA, V121, P690, DOI 10.1157/13054597; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bosch F, 2003, MED CLIN-BARCELONA, V121, P228, DOI 10.1157/13050000; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; CALLAHAM ML, 2001, JAMA-J AM MED ASSOC, V287, P2781; Campanelli M, 1998, MULTIBODY SYST DYN, V2, P277, DOI 10.1023/A:1009758701296; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Enserink M, 2001, SCIENCE, V293, P2187; GARDNER MJ, 1990, JAMA-J AM MED ASSOC, V263, P1355, DOI 10.1001/jama.263.10.1355; Godlee F, 1998, JAMA-J AM MED ASSOC, V280, P237, DOI 10.1001/jama.280.3.237; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; GORE SM, 1992, LANCET, V340, P100, DOI 10.1016/0140-6736(92)90409-V; Hanks G, 2005, PALLIATIVE MED, V19, P359, DOI 10.1191/0269216305pm1039ed; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2784, DOI 10.1001/jama.287.21.2784; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; LOCK S, 1994, ANN INTERN MED, V121, P60, DOI 10.7326/0003-4819-121-1-199407010-00012; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MORARIPOLL M, 1999, MED CLIN-BARCELONA, V113, P138; NYLENNA M, 1994, JAMA-J AM MED ASSOC, V272, P149, DOI 10.1001/jama.272.2.149; Pierie JPEN, 1996, LANCET, V348, P1480, DOI 10.1016/S0140-6736(96)05016-7; Porta M, 2006, INT J EPIDEMIOL, V35, P1130, DOI 10.1093/ije/dyl196; RENNIE D, 1992, CONTROL CLIN TRIALS, V13, P443, DOI 10.1016/0197-2456(92)90201-A; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; ROSS J, 2006, JAMA-J AM MED ASSOC, V295, P167; Scarpa T, 2006, SCIENCE, V311, P41, DOI 10.1126/science.1122796; Schriger DL, 2006, ANN EMERG MED, V48, P750, DOI 10.1016/j.annemergmed.2006.06.017; Schroter S, 2004, BRIT MED J, V328, P658, DOI 10.1136/bmj.328.7441.658; Smith JA, 2002, J UROLOGY, V168, P2123, DOI 10.1016/S0022-5347(05)64315-7; *STROBE GROUP, STROBE STAT; van Rooyen S, 1998, JAMA-J AM MED ASSOC, V280, P234, DOI 10.1001/jama.280.3.234; van Rooyen S, 1999, BRIT MED J, V318, P23; 2002, JAMA, V287, P2749; 2000, NAT STRUCT BIOL, V7, P1075; 2001, NATURE, V413, P93	39	57	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e332	10.1371/journal.pone.0000332	http://dx.doi.org/10.1371/journal.pone.0000332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389922	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445200015
J	Leonard, KC; Petrin, D; Coupland, SG; Baker, AN; Leonard, BC; LaCasse, EC; Hauswirth, WW; Korneluk, RG; Tsilfidis, C				Leonard, Kevin C.; Petrin, Dino; Coupland, Stuart G.; Baker, Adam N.; Leonard, Brian C.; LaCasse, Eric C.; Hauswirth, William W.; Korneluk, Robert G.; Tsilfidis, Catherine			XIAP Protection of Photoreceptors in Animal Models of Retinitis Pigmentosa	PLOS ONE			English	Article								Background. Retinitis pigmentosa (RP) is a blinding genetic disorder that is caused by the death of photoreceptors in the outer nuclear layer of the retina. To date, 39 different genetic loci have been associated with the disease, and 28 mutated genes have been identified. Despite the complexity of the underlying genetic basis for RP, the final common pathway is photoreceptor cell death via apoptosis. Methodology/Principal Findings. In this study, P23H and S334ter rhodopsin transgenic rat models of RP were used to test the neuroprotective effects of anti-apoptotic gene therapy. Adeno-associated viruses (AAV) carrying the X-linked inhibitor of apoptosis (XIAP) or green fluorescent protein (GFP) were delivered subretinally into the eye of transgenic rat pups. Histological and functional measures were used to assess neuroprotection. XIAP is known to block apoptosis by inhibiting the action of caspases-3, -7 and -9. The results show that XIAP gene therapy provides long-term neuroprotection of photoreceptors at both structural and functional levels. Conclusions/Significance. Our gene therapy strategy targets the apoptotic cascade, which is the final common pathway in all forms of retinitis pigmentosa. This strategy holds great promise for the treatment of RP, as it allows for the broad protection of photoreceptors, regardless of the initial disease causing mutation.	[Leonard, Kevin C.; Petrin, Dino; Coupland, Stuart G.; Baker, Adam N.; Leonard, Brian C.; Tsilfidis, Catherine] Univ Ottawa, Inst Eye, Ottawa, ON, Canada; [Leonard, Kevin C.; Petrin, Dino; Baker, Adam N.; Tsilfidis, Catherine] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Hauswirth, William W.] Univ Florida, Gainesville, FL USA; [LaCasse, Eric C.; Korneluk, Robert G.] Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; State University System of Florida; University of Florida; University of Ottawa; Children's Hospital of Eastern Ontario	Tsilfidis, C (corresponding author), Univ Ottawa, Inst Eye, Ottawa, ON, Canada.	ctsilfidis@ohri.ca			Canadian Institutes of Health Research (CIHR); Canadian Genetic Diseases Network (CGDN); Natural Sciences and Engineering Council of Canada (NSERC); Canadian Foundation Fighting Blindness Competing	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Genetic Diseases Network (CGDN); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation Fighting Blindness Competing	Canadian Institutes of Health Research (CIHR), and the Canadian Genetic Diseases Network (CGDN). KCL was supported by an Ontario Graduate Scholarship and a scholarship from the Natural Sciences and Engineering Council of Canada (NSERC) and DP was supported by the Canadian Foundation Fighting Blindness Competing	Adler R, 1996, ARCH OPHTHALMOL-CHIC, V114, P79, DOI 10.1001/archopht.1996.01100130075012; Bennett J, 1998, GENE THER, V5, P1156, DOI 10.1038/sj.gt.3300733; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Chen J, 1996, P NATL ACAD SCI USA, V93, P7042, DOI 10.1073/pnas.93.14.7042; Clem RJ, 2001, CELL DEATH DIFFER, V8, P137, DOI 10.1038/sj.cdd.4400821; Cooper LB, 2006, OTOL NEUROTOL, V27, P484, DOI 10.1097/00129492-200606000-00009; Crocker SJ, 2003, NEUROBIOL DIS, V12, P150, DOI 10.1016/S0969-9961(02)00020-7; DAIGER S, 2006, RETNET RETINAL INFOR; Doonan F, 2003, J NEUROSCI, V23, P5723; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Eberhardt O, 2000, J NEUROSCI, V20, P9126; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Hicks D, 1999, INVEST OPHTH VIS SCI, V40, P3071; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Hurley JB, 1998, VISION RES, V38, P1341, DOI 10.1016/S0042-6989(97)00459-8; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; John SK, 2000, MOL VIS, V6, P204; Jomary C, 2001, MOL CELL NEUROSCI, V18, P335, DOI 10.1006/mcne.2001.1036; Katai N, 1999, INVEST OPHTH VIS SCI, V40, P1802; Kennan A, 2005, TRENDS GENET, V21, P103, DOI 10.1016/j.tig.2004.12.001; Kugler S, 2000, CELL DEATH DIFFER, V7, P815, DOI 10.1038/sj.cdd.4400712; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu CD, 1999, J NEUROSCI, V19, P4778; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Marc RE, 2003, MOL NEUROBIOL, V28, P139, DOI 10.1385/MN:28:2:139; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; McKinnon SJ, 2002, MOL THER, V5, P780, DOI 10.1006/mthe.2002.0608; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mohand-Said S, 2000, ARCH OPHTHALMOL-CHIC, V118, P807, DOI 10.1001/archopht.118.6.807; PAGON RA, 1988, SURV OPHTHALMOL, V33, P137, DOI 10.1016/0039-6257(88)90085-9; Petrin D, 2003, ADV EXP MED BIOL, V533, P385; Petrin D, 2003, INVEST OPHTH VIS SCI, V44, P2757, DOI 10.1167/iovs.02-0729; Phelan JK, 2000, MOL VIS, V6, P116; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Renwick J, 2006, GENE THER, V13, P339, DOI 10.1038/sj.gt.3302683; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Saliba RS, 2002, J CELL SCI, V115, P2907; Salvesen GS, 1999, APMIS, V107, P73, DOI 10.1111/j.1699-0463.1999.tb01528.x; Straten G, 2002, NEUROBIOL DIS, V11, P123, DOI 10.1006/nbdi.2002.0543; SUNG CH, 1994, J NEUROSCI, V14, P5818; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Timmers A, 2001, MOL VIS, V7, P131; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; Tsang SH, 1997, INVEST OPHTH VIS SCI, V38, P943; Wasowicz M, 2002, INVEST OPHTH VIS SCI, V43, P813; Xu DG, 1999, J NEUROSCI, V19, P5026; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	55	70	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e314	10.1371/journal.pone.0000314	http://dx.doi.org/10.1371/journal.pone.0000314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375200	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445100016
J	Welch, TJ; Fricke, WF; McDermott, PF; White, DG; Rosso, ML; Rasko, DA; Mammel, MK; Eppinger, M; Rosovitz, MJ; Wagner, D; Rahalison, L; LeClerc, JE; Hinshaw, JM; Lindler, LE; Cebula, TA; Carniel, E; Ravel, J				Welch, Timothy J.; Fricke, W. Florian; McDermott, Patrick F.; White, David G.; Rosso, Marie-Laure; Rasko, David A.; Mammel, Mark K.; Eppinger, Mark; Rosovitz, M. J.; Wagner, David; Rahalison, Lila; LeClerc, J. Eugene; Hinshaw, Jeffrey M.; Lindler, Luther E.; Cebula, Thomas A.; Carniel, Elisabeth; Ravel, Jacques			Multiple Antimicrobial Resistance in Plague: An Emerging Public Health Risk	PLOS ONE			English	Article								Antimicrobial resistance in Yersinia pestis is rare, yet constitutes a significant international public health and biodefense threat. In 1995, the first multidrug resistant (MDR) isolate of Y. pestis (strain IP275) was identified, and was shown to contain a self-transmissible plasmid (pIP1202) that conferred resistance to many of the antimicrobials recommended for plague treatment and prophylaxis. Comparative analysis of the DNA sequence of Y. pestis plasmid pIP1202 revealed a near identical IncA/C plasmid backbone that is shared by MDR plasmids isolated from Salmonella enterica serotype Newport SL254 and the fish pathogen Yersinia ruckeri YR71. The high degree of sequence identity and gene synteny between the plasmid backbones suggests recent acquisition of these plasmids from a common ancestor. In addition, the Y. pestis pIP1202-like plasmid backbone was detected in numerous MDR enterobacterial pathogens isolated from retail meat samples collected between 2002 and 2005 in the United States. Plasmid-positive strains were isolated from beef, chicken, turkey and pork, and were found in samples from the following states: California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York and Oregon. Our studies reveal that this common plasmid backbone is broadly disseminated among MDR zoonotic pathogens associated with agriculture. This reservoir of mobile resistance determinants has the potential to disseminate to Y. pestis and other human and zoonotic bacterial pathogens and therefore represents a significant public health concern.	[Fricke, W. Florian; Rasko, David A.; Eppinger, Mark; Rosovitz, M. J.; Ravel, Jacques] Inst Genom Res, Rockville, MD USA; [Welch, Timothy J.] ARS, Natl Ctr Cool & Cold Water Aquaculture, USDA, Kearneysville, WV USA; [McDermott, Patrick F.; White, David G.] US FDA, Res Off, Ctr Vet Med, Laurel, MD USA; [Rosso, Marie-Laure; Carniel, Elisabeth] Inst Pasteur, Yersinia Res Unit, Paris, France; [Rasko, David A.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Mammel, Mark K.; LeClerc, J. Eugene; Cebula, Thomas A.] US FDA, Off Appl Res & Safety Assessment, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Wagner, David] No Arizona Univ, Flagstaff, AZ 86011 USA; [Rahalison, Lila] Inst Pasteur, Antananarivo, Madagascar; [Hinshaw, Jeffrey M.] N Carolina State Univ, Dept Zool, Fletcher, NC USA; [Lindler, Luther E.] DoD GEIS, Publ Hlth Lab Serv, Silver Spring, MD USA	J. Craig Venter Institute; United States Department of Agriculture (USDA); US Food & Drug Administration (FDA); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Food & Drug Administration (FDA); Northern Arizona University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University of North Carolina; North Carolina State University	Ravel, J (corresponding author), Inst Genom Res, Rockville, MD USA.	jravel@tigr.org	Ravel, Jacques/D-2530-2009; Wagner, David M/A-5125-2010; McDermott, Patrick F./ABE-4374-2021	McDermott, Patrick F./0000-0003-1868-8096; David, Rasko/0000-0002-7337-7154; Wagner, David/0000-0003-2684-6007; Fricke, W. Florian/0000-0003-1586-0962; Ravel, Jacques/0000-0002-0851-2233; Welch, Tim/0000-0003-1096-3006	National Institute of Allergy and Infectious Diseases, NIH, DHHS [N01-AI-30071]; ARS [1930-31000-002]	National Institute of Allergy and Infectious Diseases, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by Federal funds from the National Institute of Allergy and Infectious Diseases, NIH, DHHS, under Contract No. N01-AI-30071 and by ARS CRIS project 1930-31000-002.	Anisimov AP, 2006, J MED MICROBIOL, V55, P1461, DOI 10.1099/jmm.0.46697-0; Butaye P, 2006, MICROBES INFECT, V8, P1891, DOI 10.1016/j.micinf.2005.12.020; Carattoli A, 2006, EMERG INFECT DIS, V12, P1145, DOI 10.3201/eid1207.051555; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Galimand M, 2006, ANTIMICROB AGENTS CH, V50, P3233, DOI 10.1128/AAC.00306-06; Guiyoule A, 2001, EMERG INFECT DIS, V7, P43, DOI 10.3201/eid0701.010106; Gupta A, 2003, J INFECT DIS, V188, P1707, DOI 10.1086/379668; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; *US DEP HHS, 2006, NAT ANT RES MON SYST; Varma JK, 2006, J INFECT DIS, V194, P222, DOI 10.1086/505084; Wang YD, 1998, J BACTERIOL, V180, P4102, DOI 10.1128/JB.180.16.4102-4110.1998; Zhao S, 2003, J CLIN MICROBIOL, V41, P5366, DOI 10.1128/JCM.41.12.5366-5371.2003	18	301	317	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e309	10.1371/journal.pone.0000309	http://dx.doi.org/10.1371/journal.pone.0000309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375195	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445100011
J	Peterson, AT; Benz, BW; Papes, M				Peterson, A. Townsend; Benz, Brett W.; Papes, Monica			Highly Pathogenic H5N1 Avian Influenza: Entry Pathways into North America via Bird Migration	PLOS ONE			English	Article								Given the possibility of highly pathogenic H5N1 avian influenza arriving in North America and monitoring programs that have been established to detect and track it, we review intercontinental movements of birds. We divided 157 bird species showing regular intercontinental movements into four groups based on patterns of movement-one of these groups ( breed Holarctic, winter Eurasia) fits well with the design of the monitoring programs (i.e., western Alaska), but the other groups have quite different movement patterns, which would suggest the importance of H5N1 monitoring along the Pacific, Atlantic, and Gulf coasts of North America.	[Peterson, A. Townsend] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Peterson, AT (corresponding author), Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA.	town@ku.edu	Peterson, A. Townsend/I-5697-2013	Peterson, A. Townsend/0000-0003-0243-2379	U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	Funding for this research was provided in part by a grant from the National Biological Information Infrastructure of the U.S. Geological Survey.	ABC, 2005, AV INFL SPREADS ROL; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; AOU, 1998, CHECK LIST N AM BIRD; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; BirdLife International, 2006, BIRDLIFE STAT AV INF; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; *CCWHC, 2006, CAN INT WILD BIRD IN; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Cramp S, 1977, HDB BIRDS EUROPE MID, P1; del Hoyo J, 2013, HDB BIRDS WORLD; *FAO, 2005, UPD AV INFL SIT 01 0; Guo YJ, 2002, VACCINE, V20, pS28, DOI 10.1016/S0264-410X(02)00126-3; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hsieh YC, 2006, J FORMOS MED ASSOC, V105, P1, DOI 10.1016/S0929-6646(09)60102-9; JNCC, 2006, POS STAT AV INFL; Kwon YK, 2005, J VET MED SCI, V67, P1193, DOI 10.1292/jvms.67.1193; Lavanchy D, 1998, Euro Surveill, V3, P23; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Mermel LA, 2005, LANCET INFECT DIS, V5, P666, DOI 10.1016/S1473-3099(05)70246-2; *NAS, 2005, AV INFL INF; *NBII, 2006, NAT AV INFL SURV INF; Normile D, 2005, SCIENCE, V310, P417, DOI 10.1126/science.310.5747.417; *OIE, 2005, RAPP MISS MISS RUSS; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parry J, 2006, BRIT MED J, V332, P67, DOI 10.1136/bmj.332.7533.67-a; *PROMED, 2006, AV INFL EUR 36 HONG; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P1; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; World Health Organization, 2005, H5N1 AV INFL TIM	31	47	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e261	10.1371/journal.pone.0000261	http://dx.doi.org/10.1371/journal.pone.0000261			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17330144	Green Published, gold			2022-12-27	WOS:000207444600021
J	Esnault, S; Braun, RK; Shen, ZJ; Xiang, ZZ; Heninger, E; Love, RB; Sandor, M; Malter, JS				Esnault, Stephane; Braun, Ruedi K.; Shen, Zhong-Jian; Xiang, Zhuzai; Heninger, Erika; Love, Robert B.; Sandor, Matyas; Malter, James S.			Pin1 Modulates the Type 1 Immune Response	PLOS ONE			English	Article								Background/Abstract. Immune responses initiated by T cell receptor (TCR) and costimulatory molecule mediated signaling culminate in maximal cytokine mRNA production and stability. The transcriptional responses to co-stimulatory T cell signalling involve calcineurin and NF-AT, which can be antagonized by interference with the cis-trans peptidyl-prolyl isomerases (PPIase), cyclophilin A and FKBP. Signalling molecules downstream of CD28 which are essential for the stabilization of cytokine mRNAs are largely unknown. Methodology/Principal Findings. We now show that Pin1, a third member of the PPIase family mediates the post-transcriptional regulation of Th1 cytokines by activated T cells. Blockade of Pin1 by pharmacologic or genetic means greatly attenuated IFN-gamma, IL-2 and CXCL-10 mRNA stability, accumulation and protein expression after cell activation. In vivo, Pin1 blockade prevented both the acute and chronic rejection of MHC mismatched, orthotopic rat lung transplants by reducing the expression of IFN-gamma and CXCL-10. Combined transcriptional and post-transcriptional blockade with cyclosporine A and the Pin1 inhibitor, juglone, was synergistic. Conclusions/Significance. These data suggest Pin1 inhibitors should be explored for use as immunosuppressants and employed with available calcineurin inhibitors to reduce toxicity and enhance effectiveness.	[Esnault, Stephane; Shen, Zhong-Jian; Heninger, Erika; Sandor, Matyas; Malter, James S.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Esnault, Stephane; Shen, Zhong-Jian; Malter, James S.] Waisman Ctr Dev Disabil, Madison, WI USA; [Braun, Ruedi K.; Xiang, Zhuzai; Love, Robert B.] Univ Wisconsin, Dept Surg, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Malter, JS (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	jsmalter@wisc.edu	Esnault, Stephane/AAJ-4511-2020; Heninger, Erika/AAJ-8408-2021; Esnault, Stephane/AAO-4712-2020	Esnault, Stephane/0000-0001-7238-8671; Braun, Rudolf/0000-0002-1778-9613; Heninger, Erika/0000-0003-0166-9972	NIH P50HL56396; Department of Surgery; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056396] Funding Source: NIH RePORTER	NIH P50HL56396; Department of Surgery; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH (P50HL56396 to J.S.M.) and the Department of Surgery (to R. K. B.).	Agostini C, 2001, AM J PATHOL, V158, P1703, DOI 10.1016/S0002-9440(10)64126-0; Ayala G, 2003, CANCER RES, V63, P6244; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Chao SH, 2001, NUCLEIC ACIDS RES, V29, P767, DOI 10.1093/nar/29.3.767; Duncan Michael D, 2005, Proc Am Thorac Soc, V2, P449, DOI 10.1513/pats.200507-073JS; Esnault S, 2006, J IMMUNOL, V177, P6999, DOI 10.4049/jimmunol.177.10.6999; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Haque MA, 2002, J IMMUNOL, V169, P1542, DOI 10.4049/jimmunol.169.3.1542; Haring JS, 2005, J IMMUNOL, V174, P6791, DOI 10.4049/jimmunol.174.11.6791; Hauser IA, 2005, J AM SOC NEPHROL, V16, P1849, DOI 10.1681/ASN.2004100836; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hodge G, 2005, CLIN EXP IMMUNOL, V139, P159, DOI 10.1111/j.1365-2249.2005.02671.x; Kitade H, 2004, TRANSPLANTATION, V78, P1747, DOI 10.1097/01.TP.0000147788.23922.5B; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 1996, NATURE, V380, P544; Mavropoulos A, 2005, BLOOD, V105, P282, DOI 10.1182/blood-2004-07-2782; Mizobucbi T, 2003, J IMMUNOL, V171, P1140, DOI 10.4049/jimmunol.171.3.1140; Nickel P, 2004, TRANSPLANTATION, V78, P1640, DOI 10.1097/01.TP.0000144057.31799.6A; Pierog J, 2005, EUR J CARDIO-THORAC, V27, P1030, DOI 10.1016/j.ejcts.2005.03.008; Reinders MEJ, 2003, J CLIN INVEST, V112, P1655, DOI 10.1172/JCI200317712; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sekine Y, 1997, J IMMUNOL, V159, P4084; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; van Besouw NM, 2005, CLIN EXP IMMUNOL, V141, P534, DOI 10.1111/j.1365-2249.2005.02871.x; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yi T, 2006, TRANSPLANTATION, V81, P559, DOI 10.1097/01.tp.0000198737.12507.19; Zhao DXM, 2002, J IMMUNOL, V169, P1556, DOI 10.4049/jimmunol.169.3.1556; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	34	30	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e226	10.1371/journal.pone.0000226	http://dx.doi.org/10.1371/journal.pone.0000226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311089	Green Submitted, gold, Green Published			2022-12-27	WOS:000207444500007
J	Ramis, JM; Collart, C; Smith, JC				Ramis, Joana M.; Collart, Clara; Smith, James C.			Xnrs and Activin Regulate Distinct Genes during Xenopus Development: Activin Regulates Cell Division	PLOS ONE			English	Article								Background. The mesoderm of the amphibian embryo is formed through an inductive interaction in which vegetal cells of the blastula-staged embryo act on overlying equatorial cells. Candidate mesoderm-inducing factors include members of the transforming growth factor type beta family such as Vg1, activin B, the nodal-related proteins and derriere. Methodology and Principle Findings. Microarray analysis reveals different functions for activin B and the nodal-related proteins during early Xenopus development. Inhibition of nodal-related protein function causes the down-regulation of regionally expressed genes such as chordin, dickkopf and XSox17 alpha/beta, while genes that are mis-regulated in the absence of activin B tend to be more widely expressed and, interestingly, include several that are involved in cell cycle regulation. Consistent with the latter observation, cells of the involuting dorsal axial mesoderm, which normally undergo cell cycle arrest, continue to proliferate when the function of activin B is inhibited. Conclusions/Significance. These observations reveal distinct functions for these two classes of the TGF-beta family during early Xenopus development, and in doing so identify a new role for activin B during gastrulation.	[Smith, James C.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England; Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge; University of Cambridge	Smith, JC (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England.	jim@gurdon.cam.ac.uk	Ramis, Joana Maria/AAF-4892-2020	Ramis, Joana Maria/0000-0001-9109-8362; Smith, Jim/0000-0003-2413-9392	Wellcome Trust; EC; Medical Research Council [G0300723B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EC(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the Wellcome Trust, an EC Marie Curie Individual Fellowship to JMR, and the EC Network of Excellence 'Cells into Organs'.	Agius E, 2000, DEVELOPMENT, V127, P1173; ASASHIMA M, 1990, ROUX ARCH DEV BIOL, V198, P330, DOI 10.1007/BF00383771; Bellefroid EJ, 1998, EMBO J, V17, P191, DOI 10.1093/emboj/17.1.191; Birsoy B, 2006, DEVELOPMENT, V133, P15, DOI 10.1242/dev.02144; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Chalmers AD, 2005, MECH DEVELOP, V122, P355, DOI 10.1016/j.mod.2004.09.004; Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; DOHRMANN CE, 1993, DEV BIOL, V157, P474, DOI 10.1006/dbio.1993.1150; Dorey K, 2006, DEV BIOL, V292, P303, DOI 10.1016/j.ydbio.2006.01.006; Dyson S, 1997, CURR BIOL, V7, P81, DOI 10.1016/S0960-9822(06)00030-3; Fletcher G, 2006, MECH DEVELOP, V123, P730, DOI 10.1016/j.mod.2006.07.007; Gilchrist MJ, 2004, DEV BIOL, V271, P498, DOI 10.1016/j.ydbio.2004.04.023; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heasman J, 1997, DEVELOPMENT, V124, P4179; Ho J, 2004, CELL SIGNAL, V16, P693, DOI 10.1016/j.cellsig.2003.11.002; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Jones CM, 1996, CURR BIOL, V6, P1468, DOI 10.1016/S0960-9822(96)00751-8; Jones CM, 1999, CURR BIOL, V9, P946, DOI 10.1016/S0960-9822(99)80421-7; JONES CM, 1995, DEVELOPMENT, V121, P3651; JONES SD, 1993, DEV GENET, V14, P185, DOI 10.1002/dvg.1020140305; Joseph EM, 1997, DEV BIOL, V184, P367, DOI 10.1006/dbio.1997.8510; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Kurth T, 2005, MECH DEVELOP, V122, P1251, DOI 10.1016/j.mod.2005.09.002; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee MA, 2001, DEVELOPMENT, V128, P2939; Leise WF, 2004, DEVELOPMENT, V131, P1703, DOI 10.1242/dev.01054; Marchant L, 1998, DEV GENES EVOL, V208, P157, DOI 10.1007/s004270050167; Murakami MS, 2004, DEVELOPMENT, V131, P571, DOI 10.1242/dev.00971; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; Onuma Y, 2006, DEVELOPMENT, V133, P237, DOI 10.1242/dev.02188; Pera EM, 2003, GENE EXPR PATTERNS, V3, P147, DOI 10.1016/S1567-133X(03)00011-5; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Piepenburg O, 2004, DEVELOPMENT, V131, P4977, DOI 10.1242/dev.01323; Pollet N, 2005, MECH DEVELOP, V122, P365, DOI 10.1016/j.mod.2004.11.009; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Saka Y, 2001, DEV BIOL, V229, P307, DOI 10.1006/dbio.2000.0101; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Sinner D, 2006, DEVELOPMENT, V133, P1955, DOI 10.1242/dev.02358; SLACK JMW, 1984, J EMBRYOL EXP MORPH, V80, P289; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; Sun BI, 1999, DEVELOPMENT, V126, P1467; Takahashi S, 2000, DEVELOPMENT, V127, P5319; Toyoizumi R, 2005, INT J DEV BIOL, V49, P923, DOI 10.1387/ijdb.052008rt; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; Wessely O, 2004, DEV BIOL, V269, P552, DOI 10.1016/j.ydbio.2004.01.018; Williams PH, 2004, CURR BIOL, V14, P1916, DOI 10.1016/j.cub.2004.10.020	52	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2007	2	2							e213	10.1371/journal.pone.0000213	http://dx.doi.org/10.1371/journal.pone.0000213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DJ	17299593	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444400014
J	Butchart, SHM; Akcakaya, HR; Chanson, J; Baillie, JEM; Collen, B; Quader, S; Turner, WR; Amin, R; Stuart, SN; Hilton-Taylor, C				Butchart, Stuart H. M.; Akcakaya, H. Resit; Chanson, Janice; Baillie, Jonathan E. M.; Collen, Ben; Quader, Suhel; Turner, Will R.; Amin, Rajan; Stuart, Simon N.; Hilton-Taylor, Craig			Improvements to the Red List Index	PLOS ONE			English	Article								The Red List Index uses information from the IUCN Red List to track trends in the projected overall extinction risk of sets of species. It has been widely recognised as an important component of the suite of indicators needed to measure progress towards the international target of significantly reducing the rate of biodiversity loss by 2010. However, further application of the RLI (to non-avian taxa in particular) has revealed some shortcomings in the original formula and approach: It performs inappropriately when a value of zero is reached; RLI values are affected by the frequency of assessments; and newly evaluated species may introduce bias. Here we propose a revision to the formula, and recommend how it should be applied in order to overcome these shortcomings. Two additional advantages of the revisions are that assessment errors are not propagated through time, and the overall level extinction risk can be determined as well as trends in this over time.	[Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Akcakaya, H. Resit] Setauket, Appl Biomath, New York, NY USA; [Chanson, Janice; Stuart, Simon N.] Conservat Int, Ctr Appl Biodivers Sci, IUCN Species Programme, World Conservat Union IUCN,Species Survival Commi, Washington, DC USA; [Baillie, Jonathan E. M.; Collen, Ben; Amin, Rajan] Zool Soc London, Inst Zool, London NW1 4RY, England; [Quader, Suhel] Univ Cambridge, Dept Zool, Cambridge, England; [Hilton-Taylor, Craig] World Conservat Union IUCN Species Programme, Cambridge, England; [Quader, Suhel] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England	BirdLife International; Conservation International; Zoological Society of London; University of Cambridge; Royal Society for Protection of Birds	Butchart, SHM (corresponding author), BirdLife Int, Cambridge, England.	stuart.butchart@birdlife.org	Collen, Ben/D-5055-2011; Akcakaya, H. Resit/A-7830-2008; Mace, Georgina M/I-3072-2016; Quader, Suhel/D-4454-2011; Butchart, Stuart/AAJ-1852-2021; Collen, Ben/F-2543-2016; Butchart, Stuart HM/Y-2711-2018	Akcakaya, H. Resit/0000-0002-8679-5929; Mace, Georgina M/0000-0001-8965-5211; Butchart, Stuart/0000-0002-1140-4049; Collen, Ben/0000-0003-2564-4243; 				Akcakaya HR, 2000, CONSERV BIOL, V14, P1001, DOI 10.1046/j.1523-1739.2000.99125.x; [Anonymous], 2005, EC HUM WELL BEING WE; *BIRDLIFE INT, 2006, SPEC FACTSH TRICH RU; Brooks T, 2004, NATURE, V431, P1046, DOI 10.1038/4311046a; Butchart SHM, 2006, CONSERV BIOL, V20, P579, DOI 10.1111/j.1523-1739.2006.00410.x; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; de Grammont PC, 2006, CONSERV BIOL, V20, P14, DOI 10.1111/j.1523-1739.2006.00352.x; *EUR COUNC, 2001, PRES CONCL GOT EUR C; Ferson S., 2001, RAMAS RED LIST THREA; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Hambler C., 2004, CONSERVATION; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; *IUCN, 2006, 2006 IUCN RED LIST T; IUCN, 2006, IUCN RED LIST THREAT; IUCN Red List Standards and Petitions Subcommittee, 2006, GUID US IUCN RED LIS; Keith DA, 2004, ECOL LETT, V7, P1101, DOI 10.1111/j.1461-0248.2004.00663.x; Lamoreux J, 2003, TRENDS ECOL EVOL, V18, P214, DOI 10.1016/S0169-5347(03)00090-9; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Mace GM, 2005, NATURE, V434, P32, DOI 10.1038/434032a; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Regan TJ, 2005, CONSERV BIOL, V19, P1969, DOI 10.1111/j.1523-1739.2005.00235.x; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Secretariat of the Convention on Biological Diversity, 2006, GLOB BIOD OUTL 2; Secretariat of the Convention on Biological Diversity, 2003, HDB CONV BIOL DIV; UNEP, 2006, GLOB ENV OUTL YB 200	26	178	196	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2007	2	1							e140	10.1371/journal.pone.0000140	http://dx.doi.org/10.1371/journal.pone.0000140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DD	17206275	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443800002
J	Noranate, N; Durand, R; Tall, A; Marrama, L; Spiegel, A; Sokhna, C; Pradines, B; Cojean, S; Guillotte, M; Bischoff, E; Ekala, MT; Bouchier, C; Fandeur, T; Ariey, F; Patarapotikul, J; Le Bras, J; Trape, JF; Rogier, C; Mercereau-Puijalon, O				Noranate, Nitchakarn; Durand, Remy; Tall, Adama; Marrama, Laurence; Spiegel, Andre; Sokhna, Cheikh; Pradines, Bruno; Cojean, Sandrine; Guillotte, Micheline; Bischoff, Emmanuel; Ekala, Marie-Therese; Bouchier, Christiane; Fandeur, Thierry; Ariey, Frederic; Patarapotikul, Jintana; Le Bras, Jacques; Trape, Jean Francois; Rogier, Christophe; Mercereau-Puijalon, Odile			Rapid Dissemination of Plasmodium falciparum Drug Resistance Despite Strictly Controlled Antimalarial Use	PLOS ONE			English	Article								Background. Inadequate treatment practices with antimalarials are considered major contributors to Plasmodium falciparum resistance to chloroquine, pyrimethamine and sulfadoxine. The longitudinal survey conducted in Dielmo, a rural Senegalese community, offers a unique frame to explore the impact of strictly controlled and quantified antimalarial use for diagnosed malaria on drug resistance. Methodology/Principal Findings. We conducted on a yearly basis a retrospective survey over a ten-year period that included two successive treatment policies, namely quinine during 1990-1994, and chloroquine (CQ) and sulfadoxine/pyrimethamine (SP) as first and second line treatments, respectively, during 1995-1999. Molecular beacon-based genotyping, gene sequencing and microsatellite analysis showed a low prevalence of Pfcrt and Pfdhfr-ts resistance alleles of Southeast Asian origin by the end of 1994 and their effective dissemination within one year of CQ and SP implementation. The Pfcrt resistant allele rose from 9% to 46% prevalence during the first year of CQ reintroduction, i.e., after a mean of 1.66 CQ treatment courses/person/year. The Pfdhfr-ts triple mutant rose from 0% to 20% by end 1996, after a mean of 0.35 SP treatment courses/person in a 16-month period. Both resistance alleles were observed at a younger age than all other alleles. Their spreading was associated with enhanced in vitro resistance and rapidly translated in an increased incidence of clinical malaria episodes during the early post-treatment period. Conclusion/Significance. In such a highly endemic setting, selection of drug-resistant parasites took a single year after drug implementation, resulting in a rapid progression of the incidence of clinical malaria during the early post-treatment period. Controlled antimalarial use at the community level did not prevent dissemination of resistance haplotypes. This data pleads against reintroduction of CQ in places where resistant allele frequency has dropped to a very low level after CQ use has been discontinued, unless drastic measures are put in place to prevent selection and spreading of mutants during the post-treatment period.	[Noranate, Nitchakarn; Guillotte, Micheline; Bischoff, Emmanuel; Ekala, Marie-Therese; Mercereau-Puijalon, Odile] Inst Pasteur, CNRS, URA 2581, Unite Immunol Mol Parasites, Paris, France; [Durand, Remy] Hop Avicenne, AP HP, F-93009 Bobigny, France; [Tall, Adama; Marrama, Laurence; Spiegel, Andre; Rogier, Christophe] Inst Pasteur, Unite Epidemiol, Dakar, Senegal; [Sokhna, Cheikh; Trape, Jean Francois] IRD, Lab Paludol Zool Med, Dakar, Senegal; [Pradines, Bruno; Rogier, Christophe] Inst Trop Med, Serv Sante Armees, Marseille, France; [Cojean, Sandrine; Le Bras, Jacques] Univ R Descartes, Paris, France; [Cojean, Sandrine; Le Bras, Jacques] Hop Bichat Claude Bernard, AP HP, F-75877 Paris 18, France; [Fandeur, Thierry; Ariey, Frederic] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Noranate, Nitchakarn; Patarapotikul, Jintana] Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Mahidol University	Mercereau-Puijalon, O (corresponding author), Inst Pasteur, CNRS, URA 2581, Unite Immunol Mol Parasites, Paris, France.	omp@pasteur.fr	ariey, frederic/P-1185-2017; Bischoff, Emmanuel/F-1197-2011; ROGIER, Christophe/C-2550-2008; Mercereau-Puijalon, Odile/AAA-2242-2020	ariey, frederic/0000-0002-0680-1090; Bischoff, Emmanuel/0000-0003-4655-4247; Cojean, Sandrine/0000-0001-6914-7957; Pradines, Bruno/0000-0002-2360-3803	Royal Golden Jubilee, Thailand Research Fund; EU [QLK2-CT-2002-01503]	Royal Golden Jubilee, Thailand Research Fund; EU(European Commission)	NN was supported by a fellowship from the Royal Golden Jubilee, Thailand Research Fund and from the EU-funded grant QLK2-CT-2002-01503 (RESMALCHIP). This work was funded by the Prix Louis D of the French Academy of Sciences and the EU-funded grant QLK2-CT-2002-01503 (RESMALCHIP).	Anderson TJC, 2003, TROP MED INT HEALTH, V8, P1068, DOI 10.1046/j.1360-2276.2003.01144.x; Ariey F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-34; Basco LK, 1997, B SOC PATHOL EXOT, V90, P90; Chusacultanachai S, 2002, MOL BIOCHEM PARASIT, V120, P61, DOI 10.1016/S0166-6851(01)00440-6; Contamin H, 1996, AM J TROP MED HYG, V54, P632, DOI 10.4269/ajtmh.1996.54.632; CONTAMIN H, 1995, J CLIN MICROBIOL, V33, P944, DOI 10.1128/JCM.33.4.944-951.1995; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; Depoortere E, 2005, TROP MED INT HEALTH, V10, P139, DOI 10.1111/j.1365-3156.2004.01363.x; Depoortere E, 2004, TROP MED INT HEALTH, V9, P62, DOI 10.1046/j.1365-3156.2003.01157.x; Dieye A, 1997, PARASITOL TODAY, V13, P48, DOI 10.1016/S0169-4758(96)20062-6; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Durand R, 2002, ANTIMICROB AGENTS CH, V46, P2684, DOI 10.1128/AAC.46.8.2684-2686.2002; Durand R, 2000, ANTIMICROB AGENTS CH, V44, P3461, DOI 10.1128/AAC.44.12.3461-3464.2000; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1996, GENETICS, V144, P1933; GREENBERG AE, 1989, B WORLD HEALTH ORGAN, V67, P189; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; Khim N, 2005, ANTIMICROB AGENTS CH, V49, P3147, DOI 10.1128/AAC.49.8.3147-3152.2005; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Mabuza A, 2005, SAMJ S AFR MED J, V95, P346; Mita T, 2003, AM J TROP MED HYG, V68, P413, DOI 10.4269/ajtmh.2003.68.413; Mita T, 2004, MOL BIOCHEM PARASIT, V135, P159, DOI 10.1016/j.molbiopara.2004.01.011; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; Ndiaye D, 2006, ACTA TROP, V99, P106, DOI 10.1016/j.actatropica.2006.07.002; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; NEI M, 1978, GENETICS, V89, P583; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Plowe CV, 1996, AM J TROP MED HYG, V55, P467, DOI 10.4269/ajtmh.1996.55.467; Pradines B, 1999, ANTIMICROB AGENTS CH, V43, P418, DOI 10.1128/AAC.43.2.418; Pradines B, 1998, J ANTIMICROB CHEMOTH, V42, P333, DOI 10.1093/jac/42.3.333; Pradines B, 1996, Med Trop (Mars), V56, P141; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 2003, T ROY SOC TROP MED H, V97, P193, DOI 10.1016/S0035-9203(03)90116-7; Rogier C, 1996, T ROY SOC TROP MED H, V90, P175, DOI 10.1016/S0035-9203(96)90128-5; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sokhna CS, 2000, AM J TROP MED HYG, V62, P266, DOI 10.4269/ajtmh.2000.62.266; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Thera MA, 2005, J INFECT DIS, V192, P1823, DOI 10.1086/498249; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Wellems TE, 2004, NAT MED, V10, P1169, DOI 10.1038/nm1104-1169; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	54	46	46	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2007	2	1							e139	10.1371/journal.pone.0000139	http://dx.doi.org/10.1371/journal.pone.0000139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DD	17206274	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443800001
J	Bulone, D; Masino, L; Thomas, DJ; Biagio, PLS; Pastore, A				Bulone, Donatella; Masino, Laura; Thomas, David J.; Biagio, Pier Luigi San; Pastore, Annalisa			The Interplay between PolyQ and Protein Context Delays Aggregation by Forming a Reservoir of Protofibrils	PLOS ONE			English	Article								Polyglutamine (polyQ) diseases are inherited neurodegenerative disorders caused by the expansion of CAG codon repeats, which code for polyQ in the corresponding gene products. These diseases are associated with the presence of amyloid-like protein aggregates, induced by polyQ expansion. It has been suggested that the soluble aggregates rather than the mature fibrillar aggregates are the toxic species, and that the aggregation properties of polyQ can be strongly modulated by the surrounding protein context. To assess the importance of the protein carrier in polyQ aggregation, we have studied the misfolding pathway and the kinetics of aggregation of polyQ of lengths above (Q41) and below (Q22) the pathological threshold fused to the well-characterized protein carrier glutathione S-transferase (GST). This protein, chosen as a model system, is per se able to misfold and aggregate irreversibly, thus mimicking the behaviour of domains of naturally occurring polyQ proteins. We prove that, while it is generally accepted that the aggregation kinetics of polyQ depend on its length and are faster for longer polyQ tracts, the presence of GST alters the polyQ aggregation pathway and reverses this trend. Aggregation occurs through formation of a reservoir of soluble intermediates whose populations and kinetic stabilities increase with polyQ length. Our results provide a new model that explains the toxicity of expanded polyQ proteins, in which the interplay between polyQ regions and other aggregation-prone domains plays a key role in determining the aggregation pathway.	[Masino, Laura; Pastore, Annalisa] Natl Inst Med Res, London NW7 1AA, England; [Bulone, Donatella; Biagio, Pier Luigi San] Ist Biofis, CNR, Palermo, Italy; [Thomas, David J.] Sci Software Solut, Paisley, Renfrew, Scotland	MRC National Institute for Medical Research; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Pastore, A (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk	bulone, donatella/AAB-6116-2022	bulone, donatella/0000-0002-5841-9133; Masino, Laura/0000-0002-5326-7003; SAN BIAGIO, PIER LUIGI/0000-0002-4622-7361	EUROSCA European network of excellence; Medical Research Council [MC_U117584256] Funding Source: researchfish; MRC [MC_U117584256] Funding Source: UKRI	EUROSCA European network of excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the EUROSCA European network of excellence.	Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carrotta R, 2006, FASEB J, V20, P1916, DOI 10.1096/fj.06-5716fje; Carrotta R, 2005, J BIOL CHEM, V280, P30001, DOI 10.1074/jbc.M500052200; Caughey B, 2003, ANNU REV NEUROSCI, V9, P9; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chen YW, 1999, P NATL ACAD SCI USA, V96, P1257, DOI 10.1073/pnas.96.4.1257; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Kaplan W, 1997, PROTEIN SCI, V6, P399; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KLEIN F, 2006, J BIOL CHEM UNPUB; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2002, FEBS LETT, V513, P267, DOI 10.1016/S0014-5793(02)02335-9; MENON RP, 2006, CELL MOL LI IN PRESS; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tanaka M, 2003, J BIOL CHEM, V278, P34717, DOI 10.1074/jbc.M209852200; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Weydt P, 2006, EXPERT OPIN THER TAR, V10, P505, DOI 10.1517/14728222.10.4.505; Zhu YJ, 2000, FASEB J, V14, P1244, DOI 10.1096/fasebj.14.9.1244; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	39	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e111	10.1371/journal.pone.0000111	http://dx.doi.org/10.1371/journal.pone.0000111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205115	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443700005
J	Beste, C; Saft, C; Andrich, J; Gold, R; Falkenstein, M				Beste, Christian; Saft, Carsten; Andrich, Juergen; Gold, Ralf; Falkenstein, Michael			Error Processing in Huntington's Disease	PLOS ONE			English	Article								Background. Huntington's disease (HD) is a genetic disorder expressed by a degeneration of the basal ganglia inter alia accompanied with dopaminergic alterations. These dopaminergic alterations are related to genetic factors i.e., CAG-repeat expansion. The error (related) negativity (Ne/ERN), a cognitive event-related potential related to performance monitoring, is generated in the anterior cingulate cortex (ACC) and supposed to depend on the dopaminergic system. The Ne is reduced in Parkinson's Disease (PD). Due to a dopaminergic deficit in HD, a reduction of the Ne is also likely. Furthermore it is assumed that movement dysfunction emerges as a consequence of dysfunctional error-feedback processing. Since dopaminergic alterations are related to the CAG-repeat, a Ne reduction may furthermore also be related to the genetic disease load. Methodology/Principle Findings. We assessed the error negativity (Ne) in a speeded reaction task under consideration of the underlying genetic abnormalities. HD patients showed a specific reduction in the Ne, which suggests impaired error processing in these patients. Furthermore, the Ne was closely related to CAG-repeat expansion. Conclusions/Significance. The reduction of the Ne is likely to be an effect of the dopaminergic pathology. The result resembles findings in Parkinson's Disease. As such the Ne might be a measure for the integrity of striatal dopaminergic output function. The relation to the CAG-repeat expansion indicates that the Ne could serve as a gene-associated "cognitive'' biomarker in HD.	[Beste, Christian; Falkenstein, Michael] WHO Collaborating Ctr Occupat Hlth & Human Factor, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Beste, Christian; Saft, Carsten; Andrich, Juergen; Gold, Ralf] Ruhr Univ Bochum, Dept Neurol, Huntington Ctr NRW, St Josef Hosp, Bochum, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Ruhr University Bochum	Beste, C (corresponding author), WHO Collaborating Ctr Occupat Hlth & Human Factor, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	beste@ifado.de	Falkenstein, Michael/ABA-7497-2020	Saft, Carsten/0000-0002-3983-7292	Univerisity of Bochum (FoRUM) [AZ-F479-2005]	Univerisity of Bochum (FoRUM)	The study was funded by a grant from the Univerisity of Bochum (FoRUM AZ-F479-2005). The funders played no role in design and conduction of the study, as well as in the collection, analysis or interpretation of the data. The same is the case for preparation, review and approval of the manuscript.	Antonini A, 1998, ANN NEUROL, V43, P253, DOI 10.1002/ana.410430216; Bartenstein P, 1997, BRAIN, V120, P1553, DOI 10.1093/brain/120.9.1553; Capuron L, 2005, BIOL PSYCHIAT, V58, P190, DOI 10.1016/j.biopsych.2005.03.033; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Craufurd D., 2002, HUNTINGTONS DIS, P62; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Falkenstein M, 2005, J PSYCHOPHYSIOL, V19, P305, DOI 10.1027/0269-8803.19.4.305; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Frodl-Bauch T, 1999, NEUROPSYCHOBIOLOGY, V40, P86, DOI 10.1159/000026603; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Ginovart N, 1997, BRAIN, V120, P503, DOI 10.1093/brain/120.3.503; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gutekunst CA, 2002, HUNTINGTONS DIS, P251; Holroyd CB, 2003, TRENDS NEUROSCI, V26, P402, DOI 10.1016/S0166-2236(03)00175-9; Holroyd CB, 2002, SCIENCE, V296, P1610, DOI 10.1126/science.296.5573.1610; Holroyd CB, 2002, NEUROPSYCHOLOGIA, V40, P2116, DOI 10.1016/S0028-3932(02)00052-0; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jazbec S, 2005, BIOL PSYCHIAT, V58, P632, DOI 10.1016/j.biopsych.2005.04.010; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Liotti M, 2005, CORTEX, V41, P377, DOI 10.1016/S0010-9452(08)70274-0; MELAMED E, 1982, NEUROLOGY, V32, P640, DOI 10.1212/WNL.32.6.640; Paulsen JS, 2001, NEUROLOGY, V57, P658, DOI 10.1212/WNL.57.4.658; Pavese N, 2003, BRAIN, V126, P1127, DOI 10.1093/brain/awg119; Petersen A, 2001, HUM MOL GENET, V10, P1243, DOI 10.1093/hmg/10.12.1243; Rachakonda V, 2004, CELL RES, V14, P347, DOI 10.1038/sj.cr.7290235; RANEN NG, 1995, AM J HUM GENET, V57, P593; Reading SAJ, 2004, ANN NEUROL, V55, P879, DOI 10.1002/ana.20121; REYNOLDS GP, 1986, J NEURAL TRANSM, V65, P151, DOI 10.1007/BF01256491; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Sanchez-Pernaute R, 2000, NEUROLOGY, V54, P119, DOI 10.1212/WNL.54.1.119; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; Ullsperger M, 2006, INT J PSYCHOPHYSIOL, V59, P59, DOI 10.1016/j.ijpsycho.2005.06.010; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; van Oostrom JCH, 2005, NEUROLOGY, V65, P941, DOI 10.1212/01.wnl.0000176071.08694.cc; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; YOHRLING GJ, 2002, HUNTINGTONS DIS, P276; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779; 1993, CELL, V72, P971	44	55	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e86	10.1371/journal.pone.0000086	http://dx.doi.org/10.1371/journal.pone.0000086			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183717	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600085
J	Brewer, DD; Potterat, JJ; Muth, SQ; Roberts, JM				Brewer, Devon D.; Potterat, John J.; Muth, Stephen Q.; Roberts, John M., Jr.			A Large Specific Deterrent Effect of Arrest for Patronizing a Prostitute	PLOS ONE			English	Article								Background. Prior research suggests that arrest, compared with no police detection, of some types of offenders does not decrease the chances they will reoffend. Methodology/Principal Findings. We assessed the specific deterrent effect of arrest for patronizing a street prostitute in Colorado Springs by comparing the incidence of arrest for clients of prostitutes first detected through public health surveillance with the incidence of rearrest for clients first detected by police arrest. Although these sets of clients were demographically and behaviorally similar, arrest reduced the likelihood of a subsequent arrest by approximately 70%. In other areas of the United States, arrest did not appear to displace a client's patronizing. Conclusions/Significance. Our results suggest that apprehending clients decreases their patronizing behavior substantially.	[Brewer, Devon D.] Interdisciplinary Sci Res, Seattle, WA USA; [Muth, Stephen Q.] Quintus Ential Solut, Colorado Springs, CO USA; [Roberts, John M., Jr.] Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Brewer, DD (corresponding author), Interdisciplinary Sci Res, Seattle, WA USA.	interscientific@yahoo.com	Potterat, John J/B-4680-2009		National Institute of Justice [2003-IJ-CX-1036]; Veterans Affairs [IK2CX001036] Funding Source: NIH RePORTER	National Institute of Justice(US National Institute of Justice); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by National Institute of Justice grant 2003-IJ-CX-1036. Opinions or points of view expressed are those of the authors and do not necessarily reflect the official position or polices of the U.S. Department of Justice. The funding agency had no role in the conduct of this research, writing of the manuscript, or the decision to publish.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; [Anonymous], 1986, STAT METHODS SOCIAL; BARTELL T, 1977, CRIMINOLOGY, V15, P387, DOI 10.1111/j.1745-9125.1977.tb00074.x; Bazemore G, 2004, JUSTICE Q, V21, P269, DOI 10.1080/07418820400095811; Becker H. S., 1997, OUTSIDERS STUDIES SO; Bernburg JG, 2003, CRIMINOLOGY, V41, P1287, DOI 10.1111/j.1745-9125.2003.tb01020.x; BOIK RJ, 2005, COMPUTATION CONFIDEN; BRENNAN PA, 1994, J ABNORM PSYCHOL, V103, P430, DOI 10.1037/0021-843X.103.3.430; Brewer DD, 2000, P NATL ACAD SCI USA, V97, P12385, DOI 10.1073/pnas.210392097; CHRISTENSEN LW, 2001, HOOKERS TRICKS COPS; Dejong C, 1997, CRIMINOLOGY, V35, P561, DOI 10.1111/j.1745-9125.1997.tb01230.x; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; Deyoung DJ, 1999, ACCIDENT ANAL PREV, V31, P45, DOI 10.1016/S0001-4575(98)00043-8; DIOTTE K, 1998, EDMONTON SUN    1108, pSE12; Ekberg G, 2004, VIOLENCE AGAINST WOM, V10, P1187, DOI 10.1177/1077801204268647; Fergusson DM, 2003, DRUG ALCOHOL DEPEN, V70, P53, DOI 10.1016/S0376-8716(02)00336-8; Gold, 1970, DELINQUENT BEHAV AM; GOLD M, 1969, PROSPECTUS, V3, P3; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Graham PL, 2003, STAT MED, V22, P2071, DOI 10.1002/sim.1405; HUIZINGA D, 2004, EFFECT JUVENILE JUST; KLOVDAHL AS, 1994, SOC SCI MED, V38, P78; Lau JTF, 2000, AIDS, V14, P1277, DOI 10.1097/00002030-200006160-00028; Lau JTF, 2003, SEX TRANSM INFECT, V79, P325, DOI 10.1136/sti.79.4.325; Manly BFJ, 1997, RANDOMIZATION BOOTST; MATTHEWS R, 1993, POLICE RES GROUP CRI, V43; McArthur DL, 1999, AM J PREV MED, V16, P68, DOI 10.1016/S0749-3797(98)00119-6; MONTO MA, 2002, W CRIMINOL REV, V3; MYERS MH, 1973, BIOMETRICS, V29, P257, DOI 10.2307/2529390; POTTERAT JJ, 1990, J SEX RES, V27, P233, DOI 10.1080/00224499009551554; Roberts JM, 2006, J R STAT SOC A STAT, V169, P745, DOI 10.1111/j.1467-985X.2006.00416.x; Rogers SM, 2005, SEX TRANSM INFECT, V81, P501, DOI 10.1136/sti.2004.014266; SCHNEIDER AL, 1986, CRIMINOLOGY, V24, P533, DOI 10.1111/j.1745-9125.1986.tb00389.x; Sherman L. W., 1992, POLICING DOMESTIC VI; SMITH DA, 1989, AM SOCIOL REV, V54, P94, DOI 10.2307/2095664; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; van Griensven F, 2006, AM J EPIDEMIOL, V163, P271, DOI 10.1093/aje/kwj038; WEISBURD D, 1995, CRIMINOLOGY, V33, P587, DOI 10.1111/j.1745-9125.1995.tb01191.x; Wortley S, 2002, CAN J CRIMINOL, V44, P369	40	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e60	10.1371/journal.pone.0000060	http://dx.doi.org/10.1371/journal.pone.0000060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183691	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600060
J	Davids, BJ; Reiner, DS; Birkeland, SR; Preheim, SP; Cipriano, MJ; McArthur, AG; Gillin, FD				Davids, Barbara J.; Reiner, David S.; Birkeland, Shanda R.; Preheim, Sarah P.; Cipriano, Michael J.; McArthur, Andrew G.; Gillin, Frances D.			A New Family of Giardial Cysteine-Rich Non-VSP Protein Genes and a Novel Cyst Protein	PLOS ONE			English	Article							EARLY DIVERGING EUKARYOTE; ANTIGENIC VARIATION; SURFACE PROTEIN; PRIMITIVE EUKARYOTE; ENTAMOEBA-HISTOLYTICA; SECRETORY APPARATUS; ANCIENT EUKARYOTE; LAMBLIA; WALL; ENCYSTATION	Since the Giardia lamblia cyst wall is necessary for survival in the environment and host infection, we tested the hypothesis that it contains proteins other than the three known cyst wall proteins. Serial analysis of gene expression during growth and encystation revealed a gene, "HCNCp" (High Cysteine Non-variant Cyst protein), that was upregulated late in encystation, and that resembled the classic Giardia variable surface proteins (VSPs) that cover the trophozoite plasmalemma. HCNCp is 13.9% cysteine, with many "CxxC" tetrapeptide motifs and a transmembrane sequence near the C-terminus. However, HCNCp has multiple "CxC" motifs rarely found in VSPs, and does not localize to the trophozoite plasmalemma. Moreover, the HCNCp C-terminus differed from the canonical VSP signature. Full-length epitope-tagged HCNCp expressed under its own promoter was upregulated during encystation with highest expression in cysts, including 42 and 21 kDa C-terminal fragments. Tagged HCNCp targeted to the nuclear envelope in trophozoites, and co-localized with cyst proteins to encystation-specific secretory vesicles during encystation. HCNCp defined a novel trafficking pathway as it localized to the wall and body of cysts, while the cyst proteins were exclusively in the wall. Unlike VSPs, HCNCp is expressed in at least five giardial strains and four WB subclones expressing different VSPs. Bioinformatics identified 60 additional large high cysteine membrane proteins (HCMp) containing >= 20 CxxC/CxC's lacking the VSP-specific C-terminal CRGKA. HCMp were absent or rare in other model or parasite genomes, except for Tetrahymena thermophila with 30. MEME analysis classified the 61 gHCMp genes into nine groups with similar internal motifs. Our data suggest that HCNCp is a novel invariant cyst protein belonging to a new HCMp family that is abundant in the Giardia genome. HCNCp and the other HCMp provide a rich source for developing parasite-specific diagnostic reagents, vaccine candidates, and subjects for further research into Giardia biology.	[Davids, Barbara J.; Reiner, David S.; Gillin, Frances D.] Univ Calif San Diego, Dept Pathol, Div Infect Dis, San Diego, CA 92103 USA; [Birkeland, Shanda R.; Cipriano, Michael J.; McArthur, Andrew G.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Preheim, Sarah P.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	University of California System; University of California San Diego; Marine Biological Laboratory - Woods Hole; Woods Hole Oceanographic Institution	Davids, BJ (corresponding author), Univ Calif San Diego, Dept Pathol, Div Infect Dis, San Diego, CA 92103 USA.	Bdavids@ucsd.edu	Preheim, Sarah P/B-3432-2010; Reiner, David S./F-6106-2012	Preheim, Sarah P/0000-0001-7365-2382; Reiner, David S./0000-0002-8289-7311; McArthur, Andrew/0000-0002-1142-3063; Cipriano, Michael/0000-0001-8163-8812	NIH [GM61896, AI51687, AI42488, DK35108, AI51089]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042488, R01AI051687, R01AI051089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061896] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: BJD, DSR, and FDG were supported by NIH grants GM61896, AI51687, AI42488, and DK35108. AGM, SPP, SRB, and MJC were supported by NIH grant AI51089 and the Marine Biological Laboratory's Program in Global Infectious Diseases, funded by the Ellison Medical Foundation. Computational resources were provided by the Josephine Bay Paul Center for Comparative Molecular Biology and Evolution (Marine Biological Laboratory) through funds provided by the W. M. Keck Foundation and the G. Unger Vetlesen Foundation.	Abel ES, 2001, J BIOL CHEM, V276, P10320, DOI 10.1074/jbc.M006589200; ADAM RD, 1988, J EXP MED, V167, P109, DOI 10.1084/jem.167.1.109; Adam RD, 2000, INT J PARASITOL, V30, P475, DOI 10.1016/S0020-7519(99)00191-5; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; AGGARWAL A, 1989, MOL BIOCHEM PARASIT, V32, P39, DOI 10.1016/0166-6851(89)90127-8; AGGARWAL A, 1988, INFECT IMMUN, V56, P1420, DOI 10.1128/IAI.56.6.1420-1423.1988; ALEY SB, 1995, INFECT AGENT DIS, V4, P161; ALEY SB, 1993, EXP PARASITOL, V77, P295, DOI 10.1006/expr.1993.1087; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beck DL, 2005, EUKARYOT CELL, V4, P722, DOI 10.1128/EC.4.4.722-732.2005; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernander R, 2001, CELL MICROBIOL, V3, P55, DOI 10.1046/j.1462-5822.2001.00094.x; Bienz M, 2001, INFECT IMMUN, V69, P5278, DOI 10.1128/IAI.69.9.5278-5285.2001; CAPON AG, 1989, INT J PARASITOL, V19, P91, DOI 10.1016/0020-7519(89)90026-X; DAS S, 1991, J BIOL CHEM, V266, P21318; Davids BJ, 2004, MOL BIOCHEM PARASIT, V136, P173, DOI 10.1016/j.molbiopara.2004.03.011; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; GILLIN FD, 1987, SCIENCE, V235, P1040, DOI 10.1126/science.3547646; GILLIN FD, 1990, P NATL ACAD SCI USA, V87, P4463, DOI 10.1073/pnas.87.12.4463; GILLIN FD, 1981, EXP PARASITOL, V51, P382, DOI 10.1016/0014-4894(81)90125-9; GILLIN FD, 1981, EXP PARASITOL, V52, P9, DOI 10.1016/0014-4894(81)90055-2; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gottig N, 2006, J BIOL CHEM, V281, P18156, DOI 10.1074/jbc.M602081200; Hehl AB, 2000, MOL BIOL CELL, V11, P1789, DOI 10.1091/mbc.11.5.1789; Hehl AB, 2004, MOL MICROBIOL, V53, P19, DOI 10.1111/j.1365-2958.2004.04115.x; Hiltpold A, 2000, MOL BIOCHEM PARASIT, V109, P61, DOI 10.1016/S0166-6851(00)00229-2; HOWARDTILL RA, 2006, MOL CELL BI IN PRESS; JARROLL EL, 1989, MOL BIOCHEM PARASIT, V32, P121, DOI 10.1016/0166-6851(89)90063-7; Karr CD, 2004, MICROBIOL-SGM, V150, P1237, DOI 10.1099/mic.0.26922-0; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Knodler LA, 1999, J BIOL CHEM, V274, P29805, DOI 10.1074/jbc.274.42.29805; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larocque R, 2003, INFECT IMMUN, V71, P5662, DOI 10.1128/IAI.71.10.5662-5669.2003; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; LUJAN HD, 1994, J EUKARYOT MICROBIOL, V41, P169, DOI 10.1111/j.1550-7408.1994.tb01491.x; Marshall MM, 1997, CLIN MICROBIOL REV, V10, P67, DOI 10.1128/CMR.10.1.67; Marti M, 2003, TRENDS PARASITOL, V19, P440, DOI 10.1016/S1471-4922(03)00201-0; Marti M, 2003, J BIOL CHEM, V278, P24837, DOI 10.1074/jbc.M302082200; Marti M, 2003, MOL BIOL CELL, V14, P1433, DOI 10.1091/mbc.E02-08-0467; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; MCCAFFERY JM, 1994, EXP PARASITOL, V79, P236, DOI 10.1006/expr.1994.1087; MENG TC, 1993, INFECT IMMUN, V61, P5394, DOI 10.1128/IAI.61.12.5394-5397.1993; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; MOWATT MR, 1994, INFECT IMMUN, V62, P1213, DOI 10.1128/IAI.62.4.1213-1218.1994; NAKAGAWA T, 1993, FEBS LETT, V327, P165, DOI 10.1016/0014-5793(93)80163-O; NASH T, 1992, PARASITOL TODAY, V8, P229, DOI 10.1016/0169-4758(92)90119-M; NASH TE, 1989, EXP PARASITOL, V68, P238, DOI 10.1016/0014-4894(89)90104-5; NASH TE, 1990, EXP PARASITOL, V71, P415, DOI 10.1016/0014-4894(90)90067-M; Nash TE, 2002, MOL MICROBIOL, V45, P585, DOI 10.1046/j.1365-2958.2002.03029.x; NASH TE, 1991, INFECT IMMUN, V59, P1334, DOI 10.1128/IAI.59.4.1334-1340.1991; NASH TE, 1988, J IMMUNOL, V141, P636; Nash TE, 2001, INFECT IMMUN, V69, P1922, DOI 10.1128/IAI.69.3.1922-1923.2001; NASH TE, 1985, J INFECT DIS, V152, P1166, DOI 10.1093/infdis/152.6.1166; ORTEGABARRIA E, 1990, MOL BIOCHEM PARASIT, V43, P151, DOI 10.1016/0166-6851(90)90141-8; REINER DS, 1990, EUR J CELL BIOL, V53, P142; Reiner DS, 2003, J BIOL CHEM, V278, P2533, DOI 10.1074/jbc.M208033200; RODNEY YM, 1995, J EUKARYOT MICROBIOL, V42, P439, DOI 10.1111/j.1550-7408.1995.tb05888.x; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Singer SM, 2001, J INFECT DIS, V183, P119, DOI 10.1086/317659; SMITH PD, 1982, GASTROENTEROLOGY, V83, P797; SMITH PD, 1982, INFECT IMMUN, V36, P714, DOI 10.1128/IAI.36.2.714-719.1982; Stefanic S, 2006, J BIOL CHEM, V281, P7595, DOI 10.1074/jbc.M510940200; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Svard SG, 1998, MOL MICROBIOL, V30, P979, DOI 10.1046/j.1365-2958.1998.01125.x; Svard SG, 2003, FEMS MICROBIOL LETT, V218, P3, DOI 10.1016/S0378-1097(02)01107-2; Thompson RCA, 2000, PARASITOL TODAY, V16, P210, DOI 10.1016/S0169-4758(99)01624-5; Touz MC, 2005, MOL MICROBIOL, V58, P999, DOI 10.1111/j.1365-2958.2005.04891.x; Touz MC, 2002, J BIOL CHEM, V277, P8474, DOI 10.1074/jbc.M110250200; WARD HD, 1990, BIOESSAYS, V12, P211, DOI 10.1002/bies.950120504; Weiland MEL, 2003, INT J PARASITOL, V33, P1341, DOI 10.1016/S0020-7519(03)00201-7; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992; Woycechowsky KJ, 2003, BIOCHEMISTRY-US, V42, P5387, DOI 10.1021/bi026993q	81	68	79	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e44	10.1371/journal.pone.0000044	http://dx.doi.org/10.1371/journal.pone.0000044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183673	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600044
J	Falagas, ME; Fragoulis, KN; Karydis, I				Falagas, Matthew E.; Fragoulis, Konstantinos N.; Karydis, Ioannis			A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories	PLOS ONE			English	Article								Background. Drug treatment is becoming more expensive due to the increased cost for the introduction of new drugs, and there seems to be an uneven distribution of medication cost for different therapeutic categories. We hypothesized that the cost of new antimicrobial agents may differ from that of other therapeutic categories and this may play a role in the stagnation of development of new antibiotics. Methodology/Principal Findings. We performed a pharmaco-economical comparative analysis of the drug cost of treatment for new agents introduced in the United States drug market in various therapeutic categories. We calculated the drug cost (in US dollars) of a ten-day treatment of all new drugs approved by the FDA during the period between January 1997 and July 2003, according to the 2004 Red Book Pharmacy's Fundamental Reference. New antineoplastic agents were found to be the most expensive drugs in comparison to all other therapeutic categories, with a median ten-day drug-treatment cost of US$848 compared to the median ten-day drug-treatment costs of all other categories ranging from US$29 to US$301. On the other hand, new antimicrobial drugs were found to be much less expensive, with a median ten-day drug-treatment cost of US$137 and $US85 for all anti-microbial agents and for anti-microbial agents excluding anti-HIV medications, respectively. Conclusions/Significance. The drug-treatment cost of new medications varies considerably by different therapeutic categories. This fact may influence industry decisions regarding the development of new drugs and may play a role in the shortage of new antimicrobial agents in the fight against the serious problem of antimicrobial resistance.	[Falagas, Matthew E.; Fragoulis, Konstantinos N.; Karydis, Ioannis] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.; Fragoulis, Konstantinos N.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Henry Dunant Hospital; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	matthew.falagas@tufts.edu						DIMASI JA, 1995, PHARMACOECONOMICS, V7, P152, DOI 10.2165/00019053-199507020-00007; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2001, PHARMACOECONOMICS, V19, P753, DOI 10.2165/00019053-200119070-00004; Emanuel EJ, 2003, J CLIN ONCOL, V21, P4145, DOI 10.1200/JCO.2003.08.156; Falagas ME, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-99; Falagas ME, 2006, CLIN INFECT DIS, V43, P630, DOI 10.1086/506443; Kelloff GJ, 2005, EUR J CANCER, V41, P491, DOI 10.1016/j.ejca.2004.12.006; Letizia C, 1995, Qual Assur, V4, P68; Levy C, 2003, B CANCER, V90, P976; Mehl B, 2001, AM J HEALTH-SYST PH, V58, P125, DOI 10.1093/ajhp/58.2.125; Shah PM, 2005, CLIN MICROBIOL INFEC, V11, P36, DOI 10.1111/j.1469-0691.2005.01141.x; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; TABLOT GH, 2006, CLIN INFECT DIS, V42, P657; 2004, RED BOOK PHARM FUNDA	14	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e11	10.1371/journal.pone.0000011	http://dx.doi.org/10.1371/journal.pone.0000011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183637	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600011
J	Forgber, M; Basu, R; Roychoudhury, K; Theinert, S; Roy, S; Sundar, S; Walden, P				Forgber, Michael; Basu, Rajatava; Roychoudhury, Kaushik; Theinert, Stephan; Roy, Syamal; Sundar, Shyam; Walden, Peter			Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome Serology	PLOS ONE			English	Article							GLUCOSE-REGULATED PROTEIN-78; CONFERS PROTECTIVE IMMUNITY; VISCERAL LEISHMANIASIS; DRUG-RESISTANCE; KALA-AZAR; DNA; VACCINATION; HOST; IDENTIFICATION; EXPRESSION	Background. Leishmaniasis defines a cluster of protozoal diseases with diverse clinical manifestations. The visceral form caused by Leishmania donovani is the most severe. So far, no vaccines exist for visceral leishmaniasis despite indications of naturally developing immunity, and sensitive immunodiagnostics are still at early stages of development. Methodology/Principle Findings. Establishing a proteome-serological methodology, we mapped the antigenicity of the parasites and the specificities of the immune responses in human leishmaniasis. Using 2-dimensional Western blot analyses with sera and parasites isolated from patients in India, we detected immune responses with widely divergent specificities for up to 330 different leishmanial antigens. 68 antigens were assigned to proteins in silver- and fluorochrome-stained gels. The antigenicity of these proteins did not correlate with the expression levels of the proteins. Although some antigens are shared among different parasite isolates, there are extensive differences and no immunodominant antigens, but indications of antigenic drift in the parasites. Six antigens were identified by mass spectrometry. Conclusions/Significance. Proteomics-based dissection of the serospecificities of leishmaniasis patients provides a comprehensive inventory of the complexity and interindividual heterogeneity of the host-responses to and variations in the antigenicity of the Leishmania parasites. This information can be instrumental in the development of vaccines and new immune monitoring and diagnostic devices.	[Forgber, Michael; Theinert, Stephan; Walden, Peter] Humboldt Univ, Charite Univ Med, Dept Dermatol Venerol & Allergy, Berlin, Germany; [Basu, Rajatava; Roychoudhury, Kaushik; Roy, Syamal] Indian Inst Chem Biol, Dept Immunol, Kolkata 700032, W Bengal, India; [Sundar, Shyam] Banaras Hindu Univ, Kala Azar Med Res Ctr, Varanasi 221005, Uttar Pradesh, India	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Banaras Hindu University (BHU)	Walden, P (corresponding author), Humboldt Univ, Charite Univ Med, Dept Dermatol Venerol & Allergy, Berlin, Germany.	peter.walden@charite.de	BASU, RAJATAVA/F-2756-2014	Roychoudhury, Kaushik/0000-0002-9585-7722; BASU, RAJATAVA/0000-0003-4029-8043	Volkswagen Foundation, Hannover, Germany [I/77 908]; Deutsche Forschungsgemeinschaft (DFG), Germany [446 IND 121/3/03]	Volkswagen Foundation, Hannover, Germany(Volkswagen); Deutsche Forschungsgemeinschaft (DFG), Germany(German Research Foundation (DFG))	Funding: The work was supported by a grant from the Volkswagen Foundation, Hannover, Germany, grant I/77 908, and the Deutsche Forschungsgemeinschaft (DFG), Germany, grant 446 IND 121/3/03.	Berman J, 2006, INDIAN J MED RES, V123, P289; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bull PC, 2005, J INFECT DIS, V192, P1119, DOI 10.1086/432761; Campos-Neto A, 2002, INFECT IMMUN, V70, P2828, DOI 10.1128/IAI.70.6.2828-2836.2002; Chan C, 1999, ELECTROPHORESIS, V20, P3467, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3467::AID-ELPS3467>3.3.CO;2-0; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cunningham DA, 2005, MOL MICROBIOL, V58, P636, DOI 10.1111/j.1365-2958.2005.04840.x; Davidson RN, 1999, J INFECTION, V39, P112, DOI 10.1016/S0163-4453(99)90001-4; Demine R, 2004, RAPID COMMUN MASS SP, V18, P907, DOI 10.1002/rcm.1420; Dubois ME, 2005, INFECT IMMUN, V73, P2690, DOI 10.1128/IAI.73.5.2690-2697.2005; Frank SA, 2006, INFECT GENET EVOL, V6, P141, DOI 10.1016/j.meegid.2004.10.005; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Ghedin E, 1998, J BIOL CHEM, V273, P22997, DOI 10.1074/jbc.273.36.22997; Ghosh A, 2001, VACCINE, V19, P3169, DOI 10.1016/S0264-410X(01)00023-8; Gopal S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r95; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Gupta S, 2005, CURR OPIN MICROBIOL, V8, P428, DOI 10.1016/j.mib.2005.06.011; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; JARDIM A, 1991, J IMMUNOL, V147, P3538; Jensen ATR, 2002, TROP MED INT HEALTH, V7, P471, DOI 10.1046/j.1365-3156.2002.00880.x; Jensen ATR, 2001, BBA-PROTEIN STRUCT M, V1549, P73, DOI 10.1016/S0167-4838(01)00240-0; Khalil EAG, 2000, LANCET, V356, P1565, DOI 10.1016/S0140-6736(00)03128-7; KILLICKKENDRICK R, 1990, ANN PARASIT HUM COMP, V65, P37, DOI 10.1051/parasite/1990651037; Krah Alexander, 2004, Methods Mol Med, V94, P19; Kumar R, 2006, TROP MED INT HEALTH, V11, P41, DOI 10.1111/j.1365-3156.2005.01538.x; Lopez-Fuertes L, 2002, VACCINE, V21, P247, DOI 10.1016/S0264-410X(02)00450-4; MACFARLANE J, 1990, EUR J BIOCHEM, V190, P377, DOI 10.1111/j.1432-1033.1990.tb15586.x; Mansfield JM, 2005, PARASITE IMMUNOL, V27, P361, DOI 10.1111/j.1365-3024.2005.00791.x; MCMAHONPRATT D, 1993, INFECT IMMUN, V61, P3351, DOI 10.1128/IAI.61.8.3351-3359.1993; Morrison LJ, 2005, INT J PARASITOL, V35, P961, DOI 10.1016/j.ijpara.2005.05.004; PEARSON RD, 1983, REV INFECT DIS, V5, P907; Rafati S, 2001, VACCINE, V19, P3369, DOI 10.1016/S0264-410X(01)00081-0; Requena JM, 2000, PARASITOL TODAY, V16, P246, DOI 10.1016/S0169-4758(00)01651-3; Requena JM, 2001, TRENDS PARASITOL, V17, P64, DOI 10.1016/S1471-4922(00)01769-4; RUSSO DM, 1991, J IMMUNOL, V147, P3575; Schallig HDFH, 2002, MEM I OSWALDO CRUZ, V97, P1015, DOI 10.1590/S0074-02762002000700015; Sjolander A, 1998, J IMMUNOL, V160, P3949; SKEIKY YAW, 1995, INFECT IMMUN, V63, P4105, DOI 10.1128/IAI.63.10.4105-4114.1995; SKEIKY YAW, 1994, INFECT IMMUN, V62, P1643, DOI 10.1128/IAI.62.5.1643-1651.1994; Sukumaran B, 2003, VACCINE, V21, P1292, DOI 10.1016/S0264-410X(02)00352-3; Sundar S, 2006, J CLIN MICROBIOL, V44, P251, DOI 10.1128/JCM.44.1.251-253.2006; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Theinert SM, 2005, INFECT IMMUN, V73, P7018, DOI 10.1128/IAI.73.10.7018-7021.2005; TITUS RG, 1995, P NATL ACAD SCI USA, V92, P10267, DOI 10.1073/pnas.92.22.10267; YANG DM, 1990, J IMMUNOL, V145, P2281; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1	51	45	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e40	10.1371/journal.pone.0000040	http://dx.doi.org/10.1371/journal.pone.0000040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183669	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600040
J	Girelli, D; Martinelli, N; Olivieri, O; Pizzolo, F; Friso, S; Faccini, G; Bozzini, C; Tenuti, I; Lotto, V; Villa, G; Guarini, P; Trabetti, E; Pignatti, PF; Mazzucco, A; Corrocher, R				Girelli, Domenico; Martinelli, Nicola; Olivieri, Oliviero; Pizzolo, Francesca; Friso, Simonetta; Faccini, Giovanni; Bozzini, Claudia; Tenuti, Ilaria; Lotto, Valentina; Villa, Giuliano; Guarini, Patrizia; Trabetti, Elisabetta; Pignatti, Pier Franco; Mazzucco, Alessandro; Corrocher, Roberto			Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting	PLOS ONE			English	Article								Background. The independent prognostic impact, as well as the possible causal role, of hyperhomocysteinemia (HHcy) in coronary artery disease (CAD) is controversial. No previous study specifically has addressed the relationship between HHcy and mortality after coronary artery bypass grafting (CABG) surgery. The aim of this study is to evaluate the prognostic impact of HHcy after CABG surgery. Methodology and Principal Findings. We prospectively followed 350 patients who underwent elective CABG between May 1996 and May 1999. At baseline, fasting total homocysteine (tHcy) levels were measured in all participants, and a post-methionine loading (PML) test was performed in 77.7% of them (n = 272). After a median follow-up of 58 months, 33 patients (9.4%) had died, 25 because of cardiovascular events. HHcy, defined by levels higher than the 90(th) percentile (25.2 mmol/L) of the population's distribution, was significantly associated to total and cardiovascular mortality (P = 0.018 [log-rank test 5.57]; P = 0.002 [log-rank test 9.76], respectively). The PML test had no prognostic value. After multiple adjustment for other univariate predictors by Cox regression, including statin therapy (the most powerful predictor in uni-/multivariate analyses), high-sensitivity C Reactive Protein (hs-CRP) levels, and all known major genetic (MTHFR 677C -> T polymorphism) and non-genetic (B-group vitamin status and renal function) tHcy determinants, HHcy remained an independent prognostic factor for mortality (HRs: 5.02, 95% CIs 1.88 to 13.42, P = 0.001). Conclusions. HHcy is an important prognostic marker after CABG, independent of modern drug therapy and biomarkers.	[Girelli, Domenico; Martinelli, Nicola; Olivieri, Oliviero; Pizzolo, Francesca; Friso, Simonetta; Bozzini, Claudia; Tenuti, Ilaria; Lotto, Valentina; Villa, Giuliano; Guarini, Patrizia; Corrocher, Roberto] Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy; [Faccini, Giovanni] Univ Verona, Inst Clin Chem, I-37100 Verona, Italy; [Trabetti, Elisabetta; Pignatti, Pier Franco] Univ Verona, Sect Biol & Genet, I-37100 Verona, Italy	University of Verona; University of Verona; University of Verona	Girelli, D (corresponding author), Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy.	domenico.girelli@univr.it	Pizzolo, Francesca/AAF-6581-2020; Martinelli, Nicola/J-5622-2016; Olivieri, Oliviero/A-9126-2008; Girelli, Domenico/B-1183-2008; Friso, Simonetta/K-4715-2016	Pizzolo, Francesca/0000-0003-4419-3994; Martinelli, Nicola/0000-0001-6465-5119; Olivieri, Oliviero/0000-0001-8209-9056; Girelli, Domenico/0000-0001-9684-1899; 	Veneto Region; MIUR; Cariverona Foundation, Verona, Italy	Veneto Region(Regione Veneto); MIUR(Ministry of Education, Universities and Research (MIUR)); Cariverona Foundation, Verona, Italy(Fondazione Cariverona)	Supported by grants from the Veneto Region, MIUR, and the Cariverona Foundation, Verona, Italy.	Anderson JL, 2000, CIRCULATION, V102, P1227, DOI 10.1161/01.CIR.102.11.1227; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Brattstrom L, 1998, CIRCULATION, V98, P2520, DOI 10.1161/01.CIR.98.23.2520; Campeau L, 1997, NEW ENGL J MED, V336, P153; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Eagle KA, 1999, CIRCULATION, V100, P1464, DOI 10.1161/01.CIR.100.13.1464; Ford ES, 2002, INT J EPIDEMIOL, V31, P59, DOI 10.1093/ije/31.1.59; Frederiksen J, 2004, BLOOD, V104, P3046, DOI 10.1182/blood-2004-03-0897; Friso S, 2004, AM J CLIN NUTR, V79, P992; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gersh BJ, 2005, NEW ENGL J MED, V352, P2235, DOI 10.1056/NEJMe058053; Girelli D, 1998, BLOOD, V91, P4158, DOI 10.1182/blood.V91.11.4158.411k23_4158_4163; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Lewis SJ, 2005, BMJ-BRIT MED J, V331, P1053, DOI 10.1136/bmj.38611.658947.55; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Loscalzo J, 2006, NEW ENGL J MED, V354, P1629, DOI 10.1056/NEJMe068060; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smulders Yvo M, 2005, Semin Vasc Med, V5, P87, DOI 10.1055/s-2005-872395; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Van Der Griend R, 1998, J LAB CLIN MED, V132, P67, DOI 10.1016/S0022-2143(98)90027-0; WELCH CN, 1998, NEW ENGL J MED, V388, P1042	30	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e83	10.1371/journal.pone.0000083	http://dx.doi.org/10.1371/journal.pone.0000083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183715	gold, Green Submitted, Green Published			2022-12-27	WOS:000207443600083
J	Legrand, FA; Nixon, DF; Loo, CP; Ono, E; Chapman, JM; Miyamoto, M; Diaz, RS; Santos, AMN; Succi, RCM; Abadi, J; Rosenberg, MG; de Moraes-Pinto, MI; Kallas, EG				Legrand, Fatema A.; Nixon, Douglas F.; Loo, Christopher P.; Ono, Erika; Chapman, Joan M.; Miyamoto, Maristela; Diaz, Ricardo S.; Santos, Amelia M. N.; Succi, Regina C. M.; Abadi, Jacob; Rosenberg, Michael G.; de Moraes-Pinto, Maria Isabel; Kallas, Esper G.			Strong HIV-1-Specific T Cell Responses in HIV-1-Exposed Uninfected Infants and Neonates Revealed after Regulatory T Cell Removal	PLOS ONE			English	Article								Background. In utero transmission of HIV-1 occurs on average in only 3%-15% of HIV-1-exposed neonates born to mothers not on antiretroviral drug therapy. Thus, despite potential exposure, the majority of infants remain uninfected. Weak HIV-1specific T-cell responses have been detected in children exposed to HIV-1, and potentially contribute to protection against infection. We, and others, have recently shown that the removal of CD4(+)CD25(+) T-regulatory (Treg) cells can reveal strong HIV-1 specific T-cell responses in some HIV-1 infected adults. Here, we hypothesized that Treg cells could suppress HIV-1-specific immune responses in young children. Methodology/Principal Findings. We studied two cohorts of children. The first group included HIV-1-exposed-uninfected (EU) as well as unexposed (UNEX) neonates. The second group comprised HIV-1-infected and HIV-1-EU children. We quantified the frequency of Treg cells, T-cell activation, and cell-mediated immune responses. We detected high levels of CD4(+)CD25(+)CD127(-) Treg cells and low levels of CD4(+) and CD8(+) T cell activation in the cord blood of the EU neonates. We observed HIV-1-specific T cell immune responses in all of the children exposed to the virus. These T-cell responses were not seen in the cord blood of control HIV-1 unexposed neonates. Moreover, the depletion of CD4(+)CD25(+) Treg cells from the cord blood of EU newborns strikingly augmented both CD4(+) and CD8(+) HIV-1-specific immune responses. Conclusions/Significance. This study provides new evidence that EU infants can mount strong HIV-1-specific T cell responses, and that in utero CD4(+)CD25(+) T-regulatory cells may be contributing to the lack of vertical transmission by reducing T cell activation.	[Nixon, Douglas F.; Loo, Christopher P.; Chapman, Joan M.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Legrand, Fatema A.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Ono, Erika; Miyamoto, Maristela; Diaz, Ricardo S.; Santos, Amelia M. N.; Succi, Regina C. M.; de Moraes-Pinto, Maria Isabel; Kallas, Esper G.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Abadi, Jacob; Rosenberg, Michael G.] Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Universidade Federal de Sao Paulo (UNIFESP); Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine	Nixon, DF (corresponding author), Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA.	douglas.nixon@ucsf.edu	Diaz, Ricardo/K-3978-2012; Miyamoto, Maristela/B-3834-2013; Nixon, Douglas/AAU-5734-2020; Kallas, Esper G/C-9539-2012; dos Santos, Amelia MN/H-5986-2013	Nixon, Douglas/0000-0002-2801-1786; dos Santos, Amelia MN/0000-0002-8407-1556; Loo, Christopher/0000-0002-5302-8774; Kallas, Esper/0000-0003-2026-6925	Elizabeth Glaser Pediatric AIDS Foundation; National Institutes of Health [AI060379, AI060407]; John E. Fogarty International Center [D43 TW00003]; FAPESP [01/11011-6, 04/15317-0]; UC President's Postdoctoral; CAPES; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060379, R21AI060379, R21AI060407] Funding Source: NIH RePORTER	Elizabeth Glaser Pediatric AIDS Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John E. Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); UC President's Postdoctoral; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Elizabeth Glaser Pediatric AIDS Foundation, the National Institutes of Health (AI060379 and AI060407), the John E. Fogarty International Center (D43 TW00003), and FAPESP, a Brazilian funding agency (01/11011-6). D. F. N. is an Elizabeth Glaser Scientist of the Elizabeth Glaser Pediatric AIDS Foundation. F. A. L. is supported by the UC President's Postdoctoral Fellowship. E. O. is supported by a CAPES (a Brazilian funding agency) MSc fellowship. M. M. is supported by a FAPESP PhD fellowship (04/15317-0).	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BURCHETT SK, 1992, J INFECT DIS, V165, P813, DOI 10.1093/infdis/165.5.813; BUSEYNE F, 1993, J IMMUNOL, V150, P3569; Chakraborty R, 2005, J IMMUNOL, V174, P8191, DOI 10.4049/jimmunol.174.12.8191; CHEYNIER R, 1992, EUR J IMMUNOL, V22, P2211, DOI 10.1002/eji.1830220905; CLERICI M, 1993, AIDS, V7, P1427, DOI 10.1097/00002030-199311000-00004; CONNOR EM, 1994, PEDIATR INFECT DIS J, V13, P440, DOI 10.1097/00006454-199405000-00036; DEMARIA A, 1994, J INFECT DIS, V170, P1296, DOI 10.1093/infdis/170.5.1296; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Frenkel LM, 1998, SCIENCE, V280, P1073, DOI 10.1126/science.280.5366.1073; Gibson L, 2004, J IMMUNOL, V172, P2256, DOI 10.4049/jimmunol.172.4.2256; Hermann E, 2002, BLOOD, V100, P2153, DOI 10.1182/blood.V100.6.2153.h81802002153_2153_2158; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lichterfeld M, 2004, BLOOD, V104, P487, DOI 10.1182/blood-2003-12-4341; LIU W, 2006, J EXP MED; Lohman BL, 2005, J VIROL, V79, P8121, DOI 10.1128/JVI.79.13.8121-8130.2005; Luzuriaga K, 2005, CLIN INFECT DIS, V40, P466; LUZURIAGA K, 1991, J PEDIATR-US, V119, P230, DOI 10.1016/S0022-3476(05)80732-2; Luzuriaga Katherine, 2002, AIDS Reviews, V4, P21; Magder LS, 2005, JAIDS-J ACQ IMM DEF, V38, P87, DOI 10.1097/00126334-200501010-00016; Malhotra I, 1999, J IMMUNOL, V162, P6843; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI17470; Mascart F, 2003, J IMMUNOL, V170, P1504, DOI 10.4049/jimmunol.170.3.1504; MCFARLAND EJ, 1994, J INFECT DIS, V170, P766, DOI 10.1093/infdis/170.4.766; McGowan JP, 2000, J ANTIMICROB CHEMOTH, V46, P657, DOI 10.1093/jac/46.5.657; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; RINALDO C, 1995, J VIROL, V69, P5838, DOI 10.1128/JVI.69.9.5838-5842.1995; ROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Scott-Algara D, 2001, J INFECT DIS, V183, P1565, DOI 10.1086/320708; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Spiegel HML, 2000, J INFECT DIS, V182, P88, DOI 10.1086/315639; Tsaknaridis L, 2003, J NEUROSCI RES, V74, P296, DOI 10.1002/jnr.10766; Zhang QB, 2002, PEDIATR INFECT DIS J, V21, P209, DOI 10.1097/00006454-200203000-00010; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102; CLIN INFECT DIS, V40, P458	53	114	115	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e102	10.1371/journal.pone.0000102	http://dx.doi.org/10.1371/journal.pone.0000102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183635	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600101
J	Ruf, T; Valencak, T; Tataruch, F; Arnold, W				Ruf, Thomas; Valencak, Teresa; Tataruch, Frieda; Arnold, Walter			Running Speed in Mammals Increases with Muscle n-6 Polyunsaturated Fatty Acid Content	PLOS ONE			English	Article								Polyunsaturated fatty acids (PUFAs) are important dietary components that mammals cannot synthesize de novo. Beneficial effects of PUFAs, in particular of the n-3 class, for certain aspects of animal and human health (e.g., cardiovascular function) are well known. Several observations suggest, however, that PUFAs may also affect the performance of skeletal muscles in vertebrates. For instance, it has been shown that experimentally n-6 PUFA-enriched diets increase the maximum swimming speed in salmon. Also, we recently found that the proportion of PUFAs in the muscle phospholipids of an extremely fast runner, the brown hare (Lepus europaeus), are very high compared to other mammals. Therefore, we predicted that locomotor performance, namely running speed, should be associated with differences in muscle fatty acid profiles. To test this hypothesis, we determined phospholipid fatty acid profiles in skeletal muscles of 36 mammalian species ranging from shrews to elephants. We found that there is indeed a general positive, surprisingly strong relation between the n-6 PUFAs content in muscle phospholipids and maximum running speed of mammals. This finding suggests that muscle fatty acid composition directly affects a highly fitness-relevant trait, which may be decisive for the ability of animals to escape from predators or catch prey.	[Ruf, Thomas; Valencak, Teresa; Tataruch, Frieda; Arnold, Walter] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria	University of Veterinary Medicine Vienna	Ruf, T (corresponding author), Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria.	thomas.ruf@vu-wien.ac.at	Valencak, Teresa G./ABG-7985-2020; Arnold, Walter/C-3394-2013	Valencak, Teresa G./0000-0002-7222-2265; Arnold, Walter/0000-0001-6785-5685; Ruf, Thomas/0000-0002-9235-7079	City of Vienna; Province of Lower Austria	City of Vienna; Province of Lower Austria	This study was supported by the City of Vienna and the Province of Lower Austria.	Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Ayre KJ, 1997, LIPIDS, V32, P1265, DOI 10.1007/s11745-006-0162-5; BENNETT AF, 1991, J EXP BIOL, V160, P1; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Blackard WG, 1997, LIPIDS, V32, P193, DOI 10.1007/s11745-997-0024-1; COUTURE P, 1995, J MEMBRANE BIOL, V148, P27; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; GARLAND T, 1983, J ZOOL, V199, P157, DOI 10.1111/j.1469-7998.1983.tb02087.x; Helge JW, 2001, J APPL PHYSIOL, V90, P670, DOI 10.1063/1.1380406; Hulbert AJ, 1999, J THEOR BIOL, V199, P257, DOI 10.1006/jtbi.1999.0955; Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399; Hulbert AJ, 2002, COMP BIOCHEM PHYS B, V132, P515, DOI 10.1016/S1096-4959(02)00066-0; Infante JP, 2001, COMP BIOCHEM PHYS B, V130, P291, DOI 10.1016/S1096-4959(01)00443-2; Iriarte-Diaz J, 2002, J EXP BIOL, V205, P2897; KRIKETOS AD, 1995, AM J PHYSIOL-REG I, V269, pR1154, DOI 10.1152/ajpregu.1995.269.5.R1154; McKenzie DJ, 1998, FISH PHYSIOL BIOCHEM, V19, P111, DOI 10.1023/A:1007779619087; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nikolaidis MG, 2006, PHYSIOL RES, V55, P259, DOI 10.33549/physiolres.930792; R Development Core Team, 2006, R LANG ENV STAT COMP; Rome LC, 1998, NEWS PHYSIOL SCI, V13, P261, DOI 10.1152/physiologyonline.1998.13.6.261; SWANSON JE, 1989, J NUTR, V119, P364, DOI 10.1093/jn/119.3.364; Turner N, 2004, J APPL PHYSIOL, V96, P974, DOI 10.1152/japplphysiol.01003.2003; Ushio H, 1997, COMP BIOCHEM PHYS B, V118, P681, DOI 10.1016/S0305-0491(97)00229-0; Valencak TG, 2003, J COMP PHYSIOL B, V173, P695, DOI 10.1007/s00360-003-0382-4; Weyand PG, 2005, AM J PHYSIOL-REG I, V288, pR956, DOI 10.1152/ajpregu.00628.2004; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wu BJ, 2001, J EXP BIOL, V204, P4271	27	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e65	10.1371/journal.pone.0000065	http://dx.doi.org/10.1371/journal.pone.0000065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183696	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600065
J	Brennan, PLR; Prum, RO; McCracken, KG; Sorenson, MD; Wilson, RE; Birkhead, TR				Brennan, Patricia L. R.; Prum, Richard O.; McCracken, Kevin G.; Sorenson, Michael D.; Wilson, Robert E.; Birkhead, Tim R.			Coevolution of Male and Female Genital Morphology in Waterfowl	PLOS ONE			English	Article							FORCED COPULATION; SEXUAL SELECTION; INTROMITTENT ORGAN; EVOLUTION; SPERM; PATERNITY	Most birds have simple genitalia; males lack external genitalia and females have simple vaginas. However, male waterfowl have a phallus whose length (1.5->40 cm) and morphological elaborations vary among species and are positively correlated with the frequency of forced extra-pair copulations among waterfowl species. Here we report morphological complexity in female genital morphology in waterfowl and describe variation vaginal morphology that is unprecedented in birds. This variation comprises two anatomical novelties: (i) dead end sacs, and (ii) clockwise coils. These vaginal structures appear to function to exclude the intromission of the counter-clockwise spiralling male phallus without female cooperation. A phylogenetically controlled comparative analysis of 16 waterfowl species shows that the degree of vaginal elaboration is positively correlated with phallus length, demonstrating that female morphological complexity has co-evolved with male phallus length. Intersexual selection is most likely responsible for the observed coevolution, although identifying the specific mechanism is difficult. Our results suggest that females have evolved a cryptic anatomical mechanism of choice in response to forced extra-pair copulations.	[Brennan, Patricia L. R.; Prum, Richard O.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Brennan, Patricia L. R.; Prum, Richard O.] Yale Univ, Peabody Nat Hist Museum, New Haven, CT USA; [Brennan, Patricia L. R.; Birkhead, Tim R.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [McCracken, Kevin G.; Wilson, Robert E.] Univ Alaska Fairbanks, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK USA; [McCracken, Kevin G.; Wilson, Robert E.] Univ Alaska Fairbanks, Univ Alaska Museum, Fairbanks, AK USA; [Sorenson, Michael D.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Yale University; Yale University; University of Sheffield; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; Boston University	Brennan, PLR (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	patricia.brennan@yale.edu	Sorenson, Michael/D-8065-2011	Sorenson, Michael/0000-0001-5375-2917; Prum, Richard/0000-0002-4741-7132; Brennan, Patricia/0000-0002-1905-3327	NSF	NSF(National Science Foundation (NSF))	Funding was provided by an NSF post-doctoral research fellowship to P. Brennan.	Alexander Richard D., 1997, P4, DOI 10.1017/CBO9780511721946.002; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist G, 2002, EVOLUTION, V56, P936; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Arnqvist Goran, 2005, pUnpaginated; BOBR LW, 1964, J REPROD FERTIL, V8, P39, DOI 10.1530/jrf.0.0080039; Breazile J.E.H.E., 1993, HDB AVIAN ANATOMY NO, P329; Briskie JV, 1997, J AVIAN BIOL, V28, P73, DOI 10.2307/3677097; BURNS JT, 1980, AUK, V97, P875; Carayon J., 1966, MONOGRAPH CIMICIDAE, P81, DOI DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Coker CR, 2002, AUK, V119, P403, DOI 10.1642/0004-8038(2002)119[0403:IOMATS]2.0.CO;2; Dixson AF, 2004, INT J PRIMATOL, V25, P1159, DOI 10.1023/B:IJOP.0000043356.60404.be; DIXSON AF, 1994, ARCH SEX BEHAV, V23, P267, DOI 10.1007/BF01541563; Dunn PO, 1999, ANIM BEHAV, V57, P1071, DOI 10.1006/anbe.1998.1066; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard WG, 2003, TRENDS ECOL EVOL, V18, P438, DOI 10.1016/S0169-5347(03)00180-0; EVARTS S, 1987, AUK, V104, P597, DOI 10.1093/auk/104.4.597; Fox H., 1977, BIOL REPTILIA, P1; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gilbert A.B., 1979, P237; GOMENDIO M, 1993, P ROY SOC B-BIOL SCI, V252, P7, DOI 10.1098/rspb.1993.0039; Gowaty PA, 1998, AM ZOOL, V38, P207; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Ilango K, 2000, J MED ENTOMOL, V37, P653, DOI 10.1603/0022-2585-37.5.653; Jacob M., 2007, REPROD BIOL PHYLOGEN, V6A, P149; Johnsgard PA, 1965, HDB WATERFOWL BEHAV; King A.S., 1981, P107; Koene JM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-25; LOWRY R, 2007, CONCEPTS APPL INFERE; MADDISON WP, 2000, MACCLADE 4 0 ANAL PH; McCracken KG, 2000, AUK, V117, P820, DOI 10.1642/0004-8038(2000)117[0820:TCSPOT]2.0.CO;2; McCracken KG, 2001, NATURE, V413, P128, DOI 10.1038/35093160; MCKINNEY F, 1983, BEHAVIOUR, V86, P250, DOI 10.1163/156853983X00390; MCKINNEY F, 1998, AVIAN REPROD TACTICS, P163; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; MILLER PL, 1991, ZOOL J LINN SOC-LOND, V102, P43, DOI 10.1111/j.1096-3642.1991.tb01536.x; Montgomerie R, 2007, REPROD BIOL PHYLOGEN, V1, P115; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Peters JL, 2003, AUK, V120, P883, DOI 10.1642/0004-8038(2003)120[0883:EPABSI]2.0.CO;2; PETERS JL, 2002, EXTRAPAIR PATERNITY; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Presgraves DC, 1999, P ROY SOC B-BIOL SCI, V266, P1041, DOI 10.1098/rspb.1999.0741; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Simmons L. W., 2001, MG BEH ECOL; SMITH JM, 1978, EVOLUTION SEX; THORBJARNARSON JB, 1993, J HERPETOL, V27, P371, DOI 10.2307/1564822	51	131	131	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e418	10.1371/journal.pone.0000418	http://dx.doi.org/10.1371/journal.pone.0000418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476339	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000207445700020
J	Hung, SC; Pochampally, RR; Hsu, SC; Sanchez, C; Chen, SC; Spees, J; Prockop, DJ				Hung, Shih-Chieh; Pochampally, Radhika R.; Hsu, Shu-Ching; Sanchez, Cecelia; Chen, Sy-Chi; Spees, Jeffrey; Prockop, Darwin J.			Short-Term Exposure of Multipotent Stromal Cells to Low Oxygen Increases Their Expression of CX3CR1 and CXCR4 and Their Engraftment In Vivo	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CHEMOKINE RECEPTOR CXCR4; BONE-MARROW; UTERO TRANSPLANTATION; PROMOTING MIGRATION; DIFFERENTIATION; RECRUITMENT; DELIVERY; TENSION; SITE	The ability of stem/progenitor cells to migrate and engraft into host tissues is key to their potential use in gene and cell therapy. Among the cells of interest are the adherent cells from bone marrow, referred to as mesenchymal stem cells or multipotent stromal cells (MSC). Since the bone marrow environment is hypoxic, with oxygen tensions ranging from 1% to 7%, we decided to test whether hypoxia can upregulate chemokine receptors and enhance the ability of human MSCs to engraft in vivo. Short-term exposure of MSCs to 1% oxygen increased expression of the chemokine receptors CX3CR1 and CXCR4, both as mRNA and as protein. After 1-day exposure to low oxygen, MSCs increased in vitro migration in response to the fractalkine and SDF-1 alpha in a dose dependent manner. Blocking antibodies for the chemokine receptors significantly decreased the migration. Xenotypic grafting into early chick embryos demonstrated cells from hypoxic cultures engrafted more efficiently than cells from normoxic cultures and generated a variety of cell types in host tissues. The results suggest that short-term culture of MSCs under hypoxic conditions may provide a general method of enhancing their engraftment in vivo into a variety of tissues.	[Hung, Shih-Chieh; Pochampally, Radhika R.; Hsu, Shu-Ching; Sanchez, Cecelia; Spees, Jeffrey; Prockop, Darwin J.] Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70118 USA; [Hung, Shih-Chieh; Chen, Sy-Chi] Vet Gen Hosp, Dept Med Res & Educ, Stem Cell Lab, Taipei, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan	Tulane University; National Yang Ming Chiao Tung University	Hung, SC (corresponding author), Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70118 USA.	hungsc@vghtpe.gov.tw; dprocko@tulane.edu	Hsu, Shu-Ching/E-3869-2010	Pochampally, Radhika/0000-0002-4263-0364	NIH [HL73755, AR48323, HL73252]; NSC of Taiwan [NSC95-2314-B-075-047-MY3]; HCA the Healthcare Company; Louisiana Gene Therapy Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073252, R01HL073755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048323] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSC of Taiwan(Ministry of Science and Technology, Taiwan); HCA the Healthcare Company; Louisiana Gene Therapy Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	NIH grants HL73755, AR48323 and HL73252; the NSC of Taiwan (NSC95-2314-B-075-047-MY3), HCA the Healthcare Company; and the Louisiana Gene Therapy Research Consortium.	Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Becker M, 2002, BRIT J CANCER, V87, P1328, DOI 10.1038/sj.bjc.6600573; Brenner S, 2004, STEM CELLS, V22, P1128, DOI 10.1634/stemcells.2003-0196; Chou SH, 2006, J ORTHOP RES, V24, P301, DOI 10.1002/jor.20047; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Fink T, 2004, STEM CELLS, V22, P1346, DOI 10.1634/stemcells.2004-0038; Goldstein RS, 2002, DEV DYNAM, V225, P80, DOI 10.1002/dvdy.10108; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; Kucia M, 2004, CIRC RES, V95, P1191, DOI 10.1161/01.RES.0000150856.47324.5b; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; OWEN M, 1988, CIBA F SYMP, V136, P42; Pochampally RR, 2004, P NATL ACAD SCI USA, V101, P9282, DOI 10.1073/pnas.0401558101; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Salim A, 2004, J BIOL CHEM, V279, P40007, DOI 10.1074/jbc.M403715200; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Sigurjonsson OE, 2005, P NATL ACAD SCI USA, V102, P5227, DOI 10.1073/pnas.0501029102; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	31	246	259	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e416	10.1371/journal.pone.0000416	http://dx.doi.org/10.1371/journal.pone.0000416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476338	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445700018
J	Osan, R; Zhu, LP; Shoham, S; Tsien, JZ				Osan, Remus; Zhu, Liping; Shoham, Shy; Tsien, Joe Z.			Subspace Projection Approaches to Classification and Visualization of Neural Network-Level Encoding Patterns	PLOS ONE			English	Article							ENSEMBLE ACTIVITY; CORTICAL-NEURONS; TEMPORAL CORTEX; L-CURVE; INFORMATION; REPRESENTATIONS; REGULARIZATION; PERFORMANCE; ASSEMBLIES; PRINCIPLES	Recent advances in large-scale ensemble recordings allow monitoring of activity patterns of several hundreds of neurons in freely behaving animals. The emergence of such high-dimensional datasets poses challenges for the identification and analysis of dynamical network patterns. While several types of multivariate statistical methods have been used for integrating responses from multiple neurons, their effectiveness in pattern classification and predictive power has not been compared in a direct and systematic manner. Here we systematically employed a series of projection methods, such as Multiple Discriminant Analysis (MDA), Principal Components Analysis (PCA) and Artificial Neural Networks (ANN), and compared them with non-projection multivariate statistical methods such as Multivariate Gaussian Distributions (MGD). Our analyses of hippocampal data recorded during episodic memory events and cortical data simulated during face perception or arm movements illustrate how low-dimensional encoding subspaces can reveal the existence of network-level ensemble representations. We show how the use of regularization methods can prevent these statistical methods from over-fitting of training data sets when the trial numbers are much smaller than the number of recorded units. Moreover, we investigated the extent to which the computations implemented by the projection methods reflect the underlying hierarchical properties of the neural populations. Based on their ability to extract the essential features for pattern classification, we conclude that the typical performance ranking of these methods on under-sampled neural data of large dimension is MDA>PCA>ANN>MGD.	[Osan, Remus; Zhu, Liping; Tsien, Joe Z.] Boston Univ, Ctr Syst Neurobiol, Dept Pharmacol, Boston, MA 02215 USA; [Osan, Remus; Zhu, Liping; Tsien, Joe Z.] Boston Univ, Dept Biomed Engn, Ctr Syst Neurobiol, Boston, MA 02215 USA; [Zhu, Liping; Tsien, Joe Z.] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Labs, Minist Educ MOE, Shanghai 200062, Peoples R China; [Zhu, Liping; Tsien, Joe Z.] E China Normal Univ, SSTC, Shanghai 200062, Peoples R China; [Zhu, Liping; Tsien, Joe Z.] E China Normal Univ, Dept Math Stat, Shanghai 200062, Peoples R China; [Shoham, Shy] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel	Boston University; Boston University; East China Normal University; East China Normal University; East China Normal University; Technion Israel Institute of Technology	Osan, R (corresponding author), Boston Univ, Ctr Syst Neurobiol, Dept Pharmacol, Boston, MA 02215 USA.	osan@bu.edu; jtsien@bu.edu	Zhu, Li/GXH-9801-2022	Shoham, Shy/0000-0003-0376-3495	NIH [MH60236, MH61925, MH62632, AG02022]; Burroughs Welcome Fund; W. M. Keck Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236, R01MH062632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Welcome Fund(Burroughs Wellcome Fund); W. M. Keck Foundations(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funds from NIH (MH60236, MH61925, MH62632, AG02022), Burroughs Welcome Fund, and W. M. Keck Foundations (JZT).	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bishop C.M., 1995, NEURAL NETWORKS PATT; Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Brown GD, 2001, TRENDS NEUROSCI, V24, P54, DOI 10.1016/S0166-2236(00)01683-0; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Calvetti D, 2000, J COMPUT APPL MATH, V123, P423, DOI 10.1016/S0377-0427(00)00414-3; Carmena JM, 2005, J NEUROSCI, V25, P10712, DOI 10.1523/JNEUROSCI.2772-05.2005; Chapin JK, 2004, NAT NEUROSCI, V7, P452, DOI 10.1038/nn1234; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Duda R.O., 2006, PATTERN CLASSIFICATI; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Furukawa S, 2002, J NEUROPHYSIOL, V87, P1749, DOI 10.1152/jn.00491.2001; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; Gross CG, 2005, AM PSYCHOL, V60, P755, DOI 10.1037/0003-066X.60.8.755; GUO Y, 2007, BIOSTATISTI IN PRESS; Hansen P. C., 1997, RANK DEFICIENT DISCR; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kim SJ, 2006, ANN BIOMED ENG, V34, P300, DOI 10.1007/s10439-005-9037-9; Laubach M, 2004, J NEUROSCI METH, V134, P159, DOI 10.1016/j.jneumeth.2003.11.007; Lin LN, 2006, TRENDS NEUROSCI, V29, P48, DOI 10.1016/j.tins.2005.11.004; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; Nicolelis MAL, 1997, J NEUROPHYSIOL, V78, P1691, DOI 10.1152/jn.1997.78.3.1691; NICOLELIS MAL, 1999, CRC METH NEUROSCI S, P121; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P147, DOI 10.1152/jn.1987.57.1.147; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P751, DOI 10.1152/jn.1995.74.2.751; Shoham S, 2005, IEEE T BIO-MED ENG, V52, P1312, DOI 10.1109/TBME.2005.847542; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Weber DJ, 2004, PROG BRAIN RES, V143, P477, DOI 10.1016/S0079-6123(03)43045-8; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2007	2	5							e404	10.1371/journal.pone.0000404	http://dx.doi.org/10.1371/journal.pone.0000404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DW	17476326	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445700006
J	Fujii, N; Hihara, S; Iriki, A				Fujii, Naotaka; Hihara, Sayaka; Iriki, Atsushi			Dynamic Social Adaptation of Motion-Related Neurons in Primate Parietal Cortex	PLOS ONE			English	Article								Social brain function, which allows us to adapt our behavior to social context, is poorly understood at the single-cell level due largely to technical limitations. But the questions involved are vital: How do neurons recognize and modulate their activity in response to social context? To probe the mechanisms involved, we developed a novel recording technique, called multi-dimensional recording, and applied it simultaneously in the left parietal cortices of two monkeys while they shared a common social space. When the monkeys sat near each other but did not interact, each monkey's parietal activity showed robust response preference to action by his own right arm and almost no response to action by the other's arm. But the preference was broken if social conflict emerged between the monkeys-specifically, if both were able to reach for the same food item placed on the table between them. Under these circumstances, parietal neurons started to show complex combinatorial responses to motion of self and other. Parietal cortex adapted its response properties in the social context by discarding and recruiting different neural populations. Our results suggest that parietal neurons can recognize social events in the environment linked with current social context and form part of a larger social brain network.	[Fujii, Naotaka; Hihara, Sayaka; Iriki, Atsushi] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan	RIKEN	Fujii, N (corresponding author), RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan.	na@brain.riken.jp			MEXT of Japan [17021048, 18047029]; President's Discretionary Fund	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); President's Discretionary Fund	This research was supported by Grant-in-Aid for Scientific Research on Priority Areas Integrative Brain Research from the MEXT of Japan (17021048), Grant-in-Aid for Scientific Research on Priority Areas Mobiligence from the MEXT of Japan (18047029) and 2006 Riken Strategic Programs for R&D (President's Discretionary Fund).	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Beer JS, 2006, BRAIN RES, V1079, P1, DOI 10.1016/j.brainres.2006.02.001; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; FUJII N, 2006, 2006 ABSTRACT VIEWER; FUJII N, 2005, 2005 ABSTRACT VIEWER; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Goel V, 2004, BRAIN, V127, P783, DOI 10.1093/brain/awh086; Hietanen JK, 1999, NEUROREPORT, V10, P3443, DOI 10.1097/00001756-199911080-00033; HIHARA S, 2006, NEUROPSYCHOLOGIA; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iriki A, 1996, NEUROREPORT, V7, P2325; Iriki A, 2001, NEUROSCI RES, V40, P163, DOI 10.1016/S0168-0102(01)00225-5; Iriki A, 2006, CURR OPIN NEUROBIOL, V16, P660, DOI 10.1016/j.conb.2006.10.008; Iwamura Y, 1998, CURR OPIN NEUROBIOL, V8, P522, DOI 10.1016/S0959-4388(98)80041-X; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Jellema T, 2006, NEUROPSYCHOLOGIA, V44, P1535, DOI 10.1016/j.neuropsychologia.2006.01.020; Lotze M, 2006, NEUROPSYCHOLOGIA, V44, P1787, DOI 10.1016/j.neuropsychologia.2006.03.016; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Matsumoto K, 2004, CURR OPIN NEUROBIOL, V14, P178, DOI 10.1016/j.conb.2004.03.005; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Muhammad R, 2006, J COGNITIVE NEUROSCI, V18, P974, DOI 10.1162/jocn.2006.18.6.974; Obayashi S, 2000, NEUROREPORT, V11, P3499, DOI 10.1097/00001756-200011090-00020; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048; Shomstein S, 2006, J NEUROSCI, V26, P435, DOI 10.1523/JNEUROSCI.4408-05.2006	35	55	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2007	2	4							e397	10.1371/journal.pone.0000397	http://dx.doi.org/10.1371/journal.pone.0000397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DV	17460764	Green Submitted, gold, Green Published			2022-12-27	WOS:000207445600011
J	Chen, F; Mackey, AJ; Vermunt, JK; Roos, DS				Chen, Feng; Mackey, Aaron J.; Vermunt, Jeroen K.; Roos, David S.			Assessing Performance of Orthology Detection Strategies Applied to Eukaryotic Genomes	PLOS ONE			English	Article							COG DATABASE; CLASSIFICATION; IDENTIFICATION; ALGORITHM; PARALOGS; INFERENCE; PROTEINS; ORTHOMCL; DOMAINS; BLAST	Orthology detection is critically important for accurate functional annotation, and has been widely used to facilitate studies on comparative and evolutionary genomics. Although various methods are now available, there has been no comprehensive analysis of performance, due to the lack of a genomic-scale 'gold standard' orthology dataset. Even in the absence of such datasets, the comparison of results from alternative methodologies contains useful information, as agreement enhances confidence and disagreement indicates possible errors. Latent Class Analysis (LCA) is a statistical technique that can exploit this information to reasonably infer sensitivities and specificities, and is applied here to evaluate the performance of various orthology detection methods on a eukaryotic dataset. Overall, we observe a trade-off between sensitivity and specificity in orthology detection, with BLAST-based methods characterized by high sensitivity, and tree-based methods by high specificity. Two algorithms exhibit the best overall balance, with both sensitivity and specificity>80%: INPARANOID identifies orthologs across two species while OrthoMCL clusters orthologs from multiple species. Among methods that permit clustering of ortholog groups spanning multiple genomes, the (automated) OrthoMCL algorithm exhibits better within-group consistency with respect to protein function and domain architecture than the (manually curated) KOG database, and the homolog clustering algorithm TribeMCL as well. By way of using LCA, we are also able to comprehensively assess similarities and statistical dependence between various strategies, and evaluate the effects of parameter settings on performance. In summary, we present a comprehensive evaluation of orthology detection on a divergent set of eukaryotic genomes, thus providing insights and guides for method selection, tuning and development for different applications. Many biological questions have been addressed by multiple tests yielding binary (yes/no) outcomes but no clear definition of truth, making LCA an attractive approach for computational biology.	[Mackey, Aaron J.; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Chen, Feng] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Chen, Feng; Mackey, Aaron J.; Roos, David S.] Univ Penn, Genom Inst, Philadelphia, PA 19104 USA; [Vermunt, Jeroen K.] Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Tilburg University	Roos, DS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	droos@sas.upenn.edu	Chen, Feng/A-4497-2011; vermunt, jeroen k/K-3680-2012	vermunt, jeroen k/0000-0001-9053-9330; Roos, David Siker/0000-0001-6725-4089	NIH; NIAID	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the NIH, and implementation by a Bioinformatics Resource Center contract from NIAID; DSR is a Senior Scholar in Global Infectious Diseases of the Ellison Medical Foundation.	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bandyopadhyay S, 2006, GENOME RES, V16, P428, DOI 10.1101/gr.4526006; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; DeLuca TF, 2006, BIOINFORMATICS, V22, P2044, DOI 10.1093/bioinformatics/btl286; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enright AJ, 2001, BIOINFORMATICS, V17, P853, DOI 10.1093/bioinformatics/17.9.853; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Gouzy J, 1999, COMPUT CHEM, V23, P333, DOI 10.1016/S0097-8485(99)00011-X; Hadgu A, 1998, J R STAT SOC C-APPL, V47, P603, DOI 10.1111/1467-9876.00131; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; Henikoff S, 1997, SCIENCE, V278, P609, DOI 10.1126/science.278.5338.609; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Lee Y, 2002, GENOME RES, V12, P493, DOI 10.1101/gr.212002; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Magidson J., 2004, SAGE HDB QUANTITATIV, P175; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Storm CEV, 2003, GENOME RES, V13, P2353, DOI 10.1101/gr1305203; Storm CEV, 2002, BIOINFORMATICS, V18, P92, DOI 10.1093/bioinformatics/18.1.92; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Dongen SM, 2000, THESIS U UTRECHT NET; Vermunt J., 2016, TECHNICAL GUIDE LATE; Vermunt J.K., 2005, LATENT GOLD 40 USERS; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Zmasek CM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-14; Zmasek CM, 2001, BIOINFORMATICS, V17, P821, DOI 10.1093/bioinformatics/17.9.821	40	289	302	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e383	10.1371/journal.pone.0000383	http://dx.doi.org/10.1371/journal.pone.0000383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440619	gold, Green Published, Green Submitted			2022-12-27	WOS:000207445500014
J	Kitazoe, Y; Kishino, H; Waddell, PJ; Nakajima, N; Okabayashi, T; Watabe, T; Okuhara, Y				Kitazoe, Yasuhiro; Kishino, Hirohisa; Waddell, Peter J.; Nakajima, Noriaki; Okabayashi, Takahisa; Watabe, Teruaki; Okuhara, Yoshiyasu			Robust Time Estimation Reconciles Views of the Antiquity of Placental Mammals	PLOS ONE			English	Article								Background. Molecular studies have reported divergence times of modern placental orders long before the Cretaceous-Tertiary boundary and far older than paleontological data. However, this discrepancy may not be real, but rather appear because of the violation of implicit assumptions in the estimation procedures, such as non-gradual change of evolutionary rate and failure to correct for convergent evolution. Methodology/Principal Findings. New procedures for divergence-time estimation robust to abrupt changes in the rate of molecular evolution are described. We used a variant of the multidimensional vector space (MVS) procedure to take account of possible convergent evolution. Numerical simulations of abrupt rate change and convergent evolution showed good performance of the new procedures in contrast to current methods. Application to complete mitochondrial genomes identified marked rate accelerations and decelerations, which are not obtained with current methods. The root of placental mammals is estimated to be similar to 18 million years more recent than when assuming a log Brownian motion model. Correcting the pairwise distances for convergent evolution using MVS lowers the age of the root about another 20 million years compared to using standard maximum likelihood tree branch lengths. These two procedures combined revise the root time of placental mammals from around 122 million years ago to close to 84 million years ago. As a result, the estimated distribution of molecular divergence times is broadly consistent with quantitative analysis of the North American fossil record and traditional morphological views. Conclusions/Significance. By including the dual effects of abrupt rate change and directly accounting for convergent evolution at the molecular level, these estimates provide congruence between the molecular results, paleontological analyses and morphological expectations. The programs developed here are provided along with sample data that reproduce the results of this study and are especially applicable studies using genome-scale sequence lengths.	[Kitazoe, Yasuhiro; Nakajima, Noriaki; Okabayashi, Takahisa; Watabe, Teruaki; Okuhara, Yoshiyasu] Kochi Med Sch, Ctr Med Informat, Nanko Ku, Kochi, Japan; [Kishino, Hirohisa; Waddell, Peter J.] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Waddell, Peter J.] Univ S Carolina, S Carolina Canc Ctr, Columbia, SC 29208 USA	Kochi University; University of Tokyo; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Kitazoe, Y (corresponding author), Kochi Med Sch, Ctr Med Informat, Nanko Ku, Kochi, Japan.	kitazoey@kochi-u.ac.jp	Kishino, Hirohisa/U-9311-2019		Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [SR B-16300086]; NIH [5R01LM8626]; NATIONAL LIBRARY OF MEDICINE [R01LM008626] Funding Source: NIH RePORTER	Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Technology Agency (JST) and the Japan Society for the Promotion of Science (JSPS grant SR B-16300086 to YK and HK). PJW acknowledges the JSPS Senior Fellowship Program and NIH grant 5R01LM8626 for support.	Alroy J, 1999, SYST BIOL, V48, P107, DOI 10.1080/106351599260472; Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Bromham L, 1998, P NATL ACAD SCI USA, V95, P12386, DOI 10.1073/pnas.95.21.12386; Cao Y, 2000, GENE, V259, P149, DOI 10.1016/S0378-1119(00)00427-3; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Easteal S, 1999, BIOESSAYS, V21, P1052, DOI 10.1002/(SICI)1521-1878(199912)22:1<1052::AID-BIES9>3.0.CO;2-6; Hedges SB, 2004, TRENDS GENET, V20, P242, DOI 10.1016/j.tig.2004.03.004; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kitazoe Y, 2005, MOL BIOL EVOL, V22, P704, DOI 10.1093/molbev/msi051; Kitazoe Y, 2001, MOL BIOL EVOL, V18, P812, DOI 10.1093/oxfordjournals.molbev.a003863; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Misawa K, 2003, J MOL EVOL, V57, pS290, DOI 10.1007/s00239-003-0039-7; Mouchaty SK, 2000, MOL BIOL EVOL, V17, P60, DOI 10.1093/oxfordjournals.molbev.a026238; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Near TJ, 2004, PHILOS T R SOC B, V359, P1477, DOI 10.1098/rstb.2004.1523; Nikaido M, 2003, MOL PHYLOGENET EVOL, V28, P276, DOI 10.1016/S1055-7903(03)00120-9; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Okabayashi T, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-41; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Stein C., 1956, INADMISSIBILITY USUA, DOI DOI 10.1525/9780520313880-018; Swofford D. L., 1996, MOL SYSTEMATICS, P450; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Waddell P J, 2001, Genome Inform, V12, P141; Waddell PJ, 1999, SYST BIOL, V48, P119; Waddell PJ, 1999, SYST BIOL, V48, P31, DOI 10.1080/106351599260427; Waters PD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000158; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; Zhang JZ, 1997, MOL BIOL EVOL, V14, P527, DOI 10.1093/oxfordjournals.molbev.a025789; Zuckerkandl E., 1965, EVOLVING GENES PROTE; [No title captured]	42	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2007	2	4							e384	10.1371/journal.pone.0000384	http://dx.doi.org/10.1371/journal.pone.0000384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DU	17440620	Green Published, gold, Green Submitted			2022-12-27	WOS:000207445500015
J	Diretto, G; Al-Babili, S; Tavazza, R; Papacchioli, V; Beyer, P; Giuliano, G				Diretto, Gianfranco; Al-Babili, Salim; Tavazza, Raffaela; Papacchioli, Velia; Beyer, Peter; Giuliano, Giovanni			Metabolic Engineering of Potato Carotenoid Content through Tuber-Specific Overexpression of a Bacterial Mini-Pathway	PLOS ONE			English	Article								Background. Since the creation of "Golden Rice", biofortification of plant-derived foods is a promising strategy for the alleviation of nutritional deficiencies. Potato is the most important staple food for mankind after the cereals rice, wheat and maize, and is extremely poor in provitamin A carotenoids. Methodology. We transformed potato with a mini-pathway of bacterial origin, driving the synthesis of beta-carotene (Provitamin A) from geranylgeranyl diphosphate. Three genes, encoding phytoene synthase (CrtB), phytoene desaturase (CrtI) and lycopene beta-cyclase (CrtY) from Erwinia, under tuber-specific or constitutive promoter control, were used. 86 independent transgenic lines, containing six different promoter/gene combinations, were produced and analyzed. Extensive regulatory effects on the expression of endogenous genes for carotenoid biosynthesis are observed in transgenic lines. Constitutive expression of the CrtY and/or CrtI genes interferes with the establishment of transgenosis and with the accumulation of leaf carotenoids. Expression of all three genes, under tuber-specific promoter control, results in tubers with a deep yellow ("golden") phenotype without any adverse leaf phenotypes. In these tubers, carotenoids increase approx. 20-fold, to 114 mcg/g dry weight and beta-carotene 3600-fold, to 47 mcg/g dry weight. Conclusions. This is the highest carotenoid and beta-carotene content reported for biofortified potato as well as for any of the four major staple foods (the next best event being "Golden Rice 2", with 31 mcg/g dry weight beta-carotene). Assuming a beta-carotene to retinol conversion of 6: 1, this is sufficient to provide 50% of the Recommended Daily Allowance of Vitamin A with 250 gms (fresh weight) of "golden" potatoes.	[Diretto, Gianfranco; Tavazza, Raffaela; Papacchioli, Velia; Giuliano, Giovanni] Ente Nuove Tecnol Energia & Ambiente ENEA, Casaccia Res Ctr, Rome, Italy; [Al-Babili, Salim; Beyer, Peter] Univ Freiburg, Fac Biol, Freiburg, Germany	Italian National Agency New Technical Energy & Sustainable Economics Development; University of Freiburg	Giuliano, G (corresponding author), Ente Nuove Tecnol Energia & Ambiente ENEA, Casaccia Res Ctr, Rome, Italy.	giuliano@casaccia.enea.it	Giuliano, Giovanni/A-2701-2012; Diretto, Gianfranco/L-9279-2017	Giuliano, Giovanni/0000-0002-2486-0510; Diretto, Gianfranco/0000-0002-1441-0233; Al-Babili, Salim/0000-0003-4823-2882	EC; HarvestPlus; Italian Ministry of Research	EC(European CommissionEuropean Commission Joint Research Centre); HarvestPlus; Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	The work was supported by the EC projects ProVitA, EU-SOL and DeveloNutri, by the HarvestPlus (www.harvestplus.org) research consortium, and by the Italian Ministry of Research (FIRB project). None of the funding bodies took part in experiment planning, data analysis or in the writing of the paper.	Al-Babili S, 2006, J EXP BOT, V57, P1007, DOI 10.1093/jxb/erj086; Al-Babili S, 2005, TRENDS PLANT SCI, V10, P565, DOI 10.1016/j.tplants.2005.10.006; Diretto G, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-11; Diretto G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-13; DUCKHAM SC, 1991, PLANT CELL ENVIRON, V14, P601, DOI 10.1111/j.1365-3040.1991.tb01531.x; Ducreux LJM, 2005, J EXP BOT, V56, P81, DOI 10.1093/jxb/eri016; Fiore A, 2006, FEBS LETT, V580, P4718, DOI 10.1016/j.febslet.2006.07.055; FRAY RG, 1995, PLANT J, V8, P693, DOI 10.1046/j.1365-313X.1995.08050693.x; Giuliano G, 2000, TRENDS PLANT SCI, V5, P406, DOI 10.1016/S1360-1385(00)01749-0; Griffiths DW, 2007, J AGR FOOD CHEM, V55, P379, DOI 10.1021/jf0620822; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hoa TTC, 2003, PLANT PHYSIOL, V133, P161, DOI 10.1104/pp.103.023457; Howe JA, 2006, J NUTR, V136, P2562, DOI 10.1093/jn/136.10.2562; Kim J, 2006, P NATL ACAD SCI USA, V103, P3474, DOI 10.1073/pnas.0511207103; Krinsky NI, 2002, J NUTR, V132, p540S, DOI 10.1093/jn/132.3.540S; Li L, 2006, PHYTOCHEMISTRY, V67, P1177, DOI 10.1016/j.phytochem.2006.05.013; LIU XY, 1991, PLANT MOL BIOL, V17, P1139, DOI 10.1007/BF00028731; Lu S, 2006, PLANT CELL, V18, P3594, DOI 10.1105/tpc.106.046417; MISAWA N, 1993, PLANT J, V4, P833, DOI 10.1046/j.1365-313X.1993.04050833.x; Morris WL, 2004, J EXP BOT, V55, P975, DOI 10.1093/jxb/erh121; Nesterenko S, 2003, HORTSCIENCE, V38, P1173, DOI 10.21273/HORTSCI.38.6.1173; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Ravanello MP, 2003, METAB ENG, V5, P255, DOI 10.1016/j.ymben.2003.08.001; ROCHASOSA M, 1989, EMBO J, V8, P23, DOI 10.1002/j.1460-2075.1989.tb03344.x; Romer S, 2002, METAB ENG, V4, P263, DOI 10.1006/mben.2002.0234; Romer S, 2000, NAT BIOTECHNOL, V18, P666, DOI 10.1038/76523; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schaub P, 2005, PLANT PHYSIOL, V138, P441, DOI 10.1104/pp.104.057927; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; TAVAZZA R, 1989, PLANT SCI, V59, P175, DOI 10.1016/0168-9452(89)90135-0; Tian L, 2004, P NATL ACAD SCI USA, V101, P402, DOI 10.1073/pnas.2237237100; Tian L, 2003, PLANT CELL, V15, P1320, DOI 10.1105/tpc.011403; TO KY, 1994, MICROBIOL-SGM, V140, P331, DOI 10.1099/13500872-140-2-331; van Jaarsveld PJ, 2005, AM J CLIN NUTR, V81, P1080; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303	37	213	225	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e350	10.1371/journal.pone.0000350	http://dx.doi.org/10.1371/journal.pone.0000350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406674	gold, Green Submitted, Green Published			2022-12-27	WOS:000207445300012
J	Landi, S; Cenni, MC; Maffei, L; Berardi, N				Landi, Silvia; Cenni, Maria Cristina; Maffei, Lamberto; Berardi, Nicoletta			Environmental Enrichment Effects on Development of Retinal Ganglion Cell Dendritic Stratification Require Retinal BDNF	PLOS ONE			English	Article								A well-known developmental event of retinal maturation is the progressive segregation of retinal ganglion cell (RGC) dendrites into a and b sublaminae of the inner plexiform layer (IPL), a morphological rearrangement crucial for the emergence of the ON and OFF pathways. The factors regulating this process are not known, although electrical activity has been demonstrated to play a role. Here we report that Environmental Enrichment (EE) accelerates the developmental segregation of RGC dendrites and prevents the effects exerted on it by dark rearing (DR). Development of RGC stratification was analyzed in a line of transgenic mice expressing plasma-membrane marker green fluorescent protein (GFP) under the control of Thy-1 promoter; we visualized the a and b sublaminae of the IPL by using an antibody selectively directed against a specific marker of cholinergic neurons. EE precociously increases Brain Derived Neurotrophic Factor (BDNF) in the retina, in parallel with the precocious segregation of RGC dendrites; in addition, EE counteracts retinal BDNF reduction in DR retinas and promotes a normal segregation of RGC dendrites. Blocking retinal BDNF by means of antisense oligos blocks EE effects on the maturation of RGC dendritic stratification. Thus, EE affects the development of RGC dendritic segregation and retinal BDNF is required for this effect to take place, suggesting that BDNF could play an important role in the emergence of the ON and OFF pathways.	[Landi, Silvia; Maffei, Lamberto] Scuola Normale Super Pisa, Pisa, Italy; [Cenni, Maria Cristina; Maffei, Lamberto; Berardi, Nicoletta] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Berardi, Nicoletta] Univ Florence, Dipartimento Psicol, Florence, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Florence	Landi, S (corresponding author), Scuola Normale Super Pisa, Pisa, Italy.	landi@in.cnr.it	Landi, Silvia/P-9418-2018	Landi, Silvia/0000-0001-7999-3452	MIUR COFIN	MIUR COFIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by MIUR COFIN to Lamberto Maffei.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bansal A, 2000, J NEUROSCI, V20, P7672; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; Bodnarenko SR, 1999, NEUROREPORT, V10, P2955, DOI 10.1097/00001756-199909290-00015; BODNARENKO SR, 1995, J NEUROSCI, V15, P7037; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Cellerino A, 1998, J NEUROSCI, V18, P3351; Cellerino A, 1997, J COMP NEUROL, V386, P149; Cohen-Cory S, 2004, INT J DEV BIOL, V48, P947, DOI 10.1387/ijdb.041883sc; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Deplano S, 2004, DEV NEUROSCI-BASEL, V26, P396, DOI 10.1159/000082282; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Galli-Resta L, 2000, EUR J NEUROSCI, V12, P3819, DOI 10.1046/j.1460-9568.2000.00280.x; Galli-Resta L, 2002, DEVELOPMENT, V129, P3803; Garrett KL, 2001, J GENE MED, V3, P373, DOI 10.1002/jgm.197; Gunhan-Agar E, 2000, J NEUROSCI, V20, P306, DOI 10.1523/JNEUROSCI.20-01-00306.2000; KIRBY MA, 1991, VISUAL NEUROSCI, V7, P513, DOI 10.1017/S0952523800010324; Ladewig T, 2004, NEUROREPORT, V15, P2495, DOI 10.1097/00001756-200411150-00013; Landi S, 2007, FASEB J, V21, P130, DOI 10.1096/fj.06-6083com; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lom B, 1999, J NEUROSCI, V19, P9928; Mandolesi G, 2005, CURR BIOL, V15, P2119, DOI 10.1016/j.cub.2005.10.045; MASLIM J, 1988, DEV BRAIN RES, V44, P87, DOI 10.1016/0165-3806(88)90120-4; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Menna E, 2003, MOL CELL NEUROSCI, V24, P972, DOI 10.1016/S1044-7431(03)00258-6; Miller ED, 1999, VISUAL NEUROSCI, V16, P1133, DOI 10.1017/S0952523899166136; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; PEREZ MTR, 1995, NEUROSCI LETT, V183, P96, DOI 10.1016/0304-3940(94)11123-Z; Pollock GS, 2001, J NEUROSCI, V21, P3923, DOI 10.1523/JNEUROSCI.21-11-03923.2001; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; Sale A, 2004, NEUROPHARMACOLOGY, V47, P649, DOI 10.1016/j.neuropharm.2004.07.008; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Sernagor E, 2001, J ANAT, V199, P375, DOI 10.1046/j.1469-7580.2001.19940375.x; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Thaler S, 2006, MOL VIS, V12, P100; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Vecino E, 2002, VISION RES, V42, P151, DOI 10.1016/S0042-6989(01)00251-6; Vorwerk CK, 2000, INVEST OPHTH VIS SCI, V41, P3615; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Zhang M, 2005, J COMP NEUROL, V484, P331, DOI 10.1002/cne.20470	47	59	61	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e346	10.1371/journal.pone.0000346	http://dx.doi.org/10.1371/journal.pone.0000346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406670	Green Published, gold			2022-12-27	WOS:000207445300008
J	Lee, HJ; Kim, KS; Park, IH; Kim, SU				Lee, Hong J.; Kim, Kwang S.; Park, In H.; Kim, Seung U.			Human Neural Stem Cells Over-Expressing VEGF Provide Neuroprotection, Angiogenesis and Functional Recovery in Mouse Stroke Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; BRAIN TRANSPLANTATION; HIPPOCAMPAL-NEURONS; RAT-BRAIN; PROLIFERATION; DIFFERENTIATE; PERMEABILITY; MIGRATE; CULTURE	Background. Intracerebral hemorrhage (ICH) is a lethal stroke type. As mortality approaches 50%, and current medical therapy against ICH shows only limited effectiveness, an alternative approach is required, such as stem cell-based cell therapy. Previously we have shown that intravenously transplanted human neural stem cells (NSCs) selectively migrate to the brain and induce behavioral recovery in rat ICH model, and that combined administration of NSCs and vascular endothelial growth factor (VEGF) results in improved structural and functional outcome from cerebral ischemia. Methods and Findings. We postulated that human NSCs overexpressing VEGF transplanted into cerebral cortex overlying ICH lesion could provide improved survival of grafted NSCs, increased angiogenesis and behavioral recovery in mouse ICH model. ICH was induced in adult mice by unilateral injection of bacterial collagenase into striatum. HB1.F3.VEGF human NSC line produced an amount of VEGF four times higher than parental F3 cell line in vitro, and induced behavioral improvement and 2-3 fold increase in cell survival at two weeks and eight weeks post-transplantation. Conclusions. Brain transplantation of F3 human NSCs over-expressing VEGF near ICH lesion sites provided differentiation and survival of grafted human NSCs and renewed angiogenesis of host brain and functional recovery of ICH animals. These results suggest a possible application of the human neural stem cell line, which is genetically modified to over-express VEGF, as a therapeutic agent for ICH-stroke.	[Lee, Hong J.; Kim, Kwang S.; Park, In H.; Kim, Seung U.] Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 441749, South Korea; [Lee, Hong J.] Korea Univ, Coll Biosci & Biotechnol, Seoul, South Korea; [Lee, Hong J.; Kim, Kwang S.; Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, Univ British Columbia Hosp, Vancouver, BC V6T 1W5, Canada	Ajou University; Korea University; University of British Columbia	Kim, SU (corresponding author), Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 441749, South Korea.	sukim@interchange.ubc.ca			Korean Science and Engineering Foundation/Brain Disease Research Center-Ajou University; Canadian Myelin Research Initiative	Korean Science and Engineering Foundation/Brain Disease Research Center-Ajou University(Korea Science and Engineering Foundation); Canadian Myelin Research Initiative	The study was supported by the Korean Science and Engineering Foundation/Brain Disease Research Center-Ajou University and the Canadian Myelin Research Initiative.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; Chu K, 2004, NEUROSCI RES, V50, P459, DOI 10.1016/j.neures.2004.08.015; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; DelBigio MR, 1996, STROKE, V27, P2312, DOI 10.1161/01.STR.27.12.2312; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Friguls B, 2001, NEUROREPORT, V12, P3381, DOI 10.1097/00001756-200110290-00046; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gebel JM, 2000, NEUROL CLIN, V18, P419, DOI 10.1016/S0733-8619(05)70200-0; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Harrigan MR, 2003, ACTA NEUROCHIR, V145, P49, DOI 10.1007/s00701-002-1035-1; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Inagawa T, 2002, NEUROSURG REV, V25, P237, DOI 10.1007/s10143-002-0222-0; Ishibashi S, 2004, J NEUROSCI RES, V78, P215, DOI 10.1002/jnr.20246; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim SU, 2006, NEUROPATHOLOGY, V26, P129, DOI 10.1111/j.1440-1789.2006.00688.x; KIM SU, 1986, J NEUROSCI RES, V15, P303, DOI 10.1002/jnr.490150303; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; KIM SU, 1983, BRAIN RES, V274, P79, DOI 10.1016/0006-8993(83)90522-X; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Marti HH, 2002, ADV EXP MED BIOL, V513, P375; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meng XL, 2003, J NEUROSCI RES, V74, P266, DOI 10.1002/jnr.10764; Morgenstern LB, 2005, STROKE, V36, pE23, DOI 10.1161/01.STR.0000155685.77775.4c; Paxinos G., 2003, RAT BRAIN STEREOTAXI; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; Puurunen K, 2001, NEUROPHARMACOLOGY, V40, P597, DOI 10.1016/S0028-3908(00)00182-9; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Ryu JK, 2003, J NEUROSCI RES, V72, P352, DOI 10.1002/jnr.10507; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2002, TRENDS CARDIOVAS MED, V12, P62, DOI 10.1016/S1050-1738(01)00149-9	50	158	180	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e156	10.1371/journal.pone.0000156	http://dx.doi.org/10.1371/journal.pone.0000156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225860	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444000007
J	Raymond, CS; Soriano, P				Raymond, Christopher S.; Soriano, Philippe			High-Efficiency FLP and Phi C31 Site-Specific Recombination in Mammalian Cells	PLOS ONE			English	Article							MOUSE ES CELLS; DNA RECOMBINATION; TRANSGENIC MICE; CRE; INTEGRASE; EXPRESSION	DNA site-specific recombinases (SSRs) such as Cre, FLPe, and Phi C31, are powerful tools for analyzing gene function in vertebrates. While the availability of multiple high-efficiency SSRs would facilitate a wide array of genomic engineering possibilities, efficient recombination in mammalian cells has only been observed with Cre recombinase. Here we report the de novo synthesis of mouse codon-optimized FLP (FLPo) and Phi C31 (Phi C31o) SSRs, which result in recombination efficiencies similar to Cre.	[Raymond, Christopher S.; Soriano, Philippe] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Program Dev Biol, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Soriano, P (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Program Dev Biol, 1124 Columbia St, Seattle, WA 98104 USA.	psoriano@fhcrc.org	Soriano, Philippe M/E-5797-2015	Soriano, Philippe M/0000-0002-0427-926X; Raymond, Christopher/0000-0003-1128-8524	Chromosome and Metabolism Training Grant [CA09657]; National Institute of Child Health and Human Development [HD24875]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024875] Funding Source: NIH RePORTER	Chromosome and Metabolism Training Grant; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	R. was supported by the Chromosome and Metabolism Training Grant (CA09657). This work was supported by grant HD24875 from the National Institute of Child Health and Human Development to P. S.	Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Liu J, 2006, GENE THER, V13, P1188, DOI 10.1038/sj.gt.3302789; MCLEOD M, 1986, MOL CELL BIOL, V6, P3357, DOI 10.1128/MCB.6.10.3357; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Schumacher A, 2000, J BIOL CHEM, V275, P37915, DOI 10.1074/jbc.M004839200; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007	16	259	307	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e162	10.1371/journal.pone.0000162	http://dx.doi.org/10.1371/journal.pone.0000162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225864	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444000012
J	Park, ES; Lee, JS; Woo, HG; Zhan, FH; Shih, JH; Shaughnessy, JD; Mushinski, JF				Park, Eun Sung; Lee, Ju-Seog; Woo, Hyun Goo; Zhan, Fenghuang; Shih, Joanna H.; Shaughnessy, John D., Jr.; Mushinski, J. Frederic			Heterologous Tissue Culture Expression Signature Predicts Human Breast Cancer Prognosis	PLOS ONE			English	Article								Background. Cancer patients have highly variable clinical outcomes owing to many factors, among which are genes that determine the likelihood of invasion and metastasis. This predisposition can be reflected in the gene expression pattern of the primary tumor, which may predict outcomes and guide the choice of treatment better than other clinical predictors. Methodology/Principal Findings. We developed an mRNA expression-based model that can predict prognosis/outcomes of human breast cancer patients regardless of microarray platform and patient group. Our model was developed using genes differentially expressed in mouse plasma cell tumors growing in vivo versus those growing in vitro. The prediction system was validated using published data from three cohorts of patients for whom microarray and clinical data had been compiled. The model stratified patients into four independent survival groups (BEST, GOOD, BAD, and WORST: log-rank test p = 1.7x10(-8)). Conclusions. Our model significantly improved the survival prediction over other expression-based models and permitted recognition of patients with different prognoses within the estrogen receptor-positive group and within a single pathological tumor class. Basing our predictor on a dataset that originated in a different species and a different cell type may have rendered it less sensitive to proliferation differences and endowed it with wide applicability. Significance. Prognosis prediction for patients with breast cancer is currently based on histopathological typing and estrogen receptor positivity. Yet both assays define groups that are heterogeneous in survival. Gene expression profiling allows subdivision of these groups and recognition of patients whose tumors are very unlikely to be lethal and those with much grimmer outlooks, which can augment the predictive power of conventional tumor analysis and aid the clinician in choosing relaxed vs. aggressive therapy.	[Park, Eun Sung; Mushinski, J. Frederic] NCI, Genet Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lee, Ju-Seog; Woo, Hyun Goo] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Shih, Joanna H.] NCI, Biometr Res Branch, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Zhan, Fenghuang; Shaughnessy, John D., Jr.] Univ Arkansas Med Sci, Donna & Donald Lambert Lab Myeloma Genet, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Arkansas System; University of Arkansas Medical Sciences	Park, ES (corresponding author), NCI, Genet Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	parkeu@mail.nih.gov; jm8p@nih.gov	Lee, Ju-Seog/X-1786-2018; Woo, Hyun Goo/AEJ-7372-2022; Woo, Hyun Goo | 우현구/I-8954-2019	Lee, Ju-Seog/0000-0002-5666-9753; Woo, Hyun Goo/0000-0002-0916-893X; Woo, Hyun Goo | 우현구/0000-0002-0916-893X	NIH; National Cancer Institute; National Institutes of Health [CA55819, CA97513]; NATIONAL CANCER INSTITUTE [Z01BC008727, R33CA097513, P01CA055819] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH and the National Cancer Institute. JDS and FZ were supported by National Institutes of Health grants CA55819 and CA97513, the Fund to Cure Myeloma and the Peninsula Community Foundation.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; DEGRASSI A, 1993, P NATL ACAD SCI USA, V90, P2060, DOI 10.1073/pnas.90.5.2060; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Gruvberger SK, 2003, BREAST CANCER RES, V5, P23, DOI 10.1186/bcr548; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Oue N, 2005, ONCOLOGY-BASEL, V69, P17, DOI 10.1159/000086627; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; POTTER M, 1973, SCIENCE, V182, P592, DOI 10.1126/science.182.4112.592; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	28	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2007	2	1							e145	10.1371/journal.pone.0000145	http://dx.doi.org/10.1371/journal.pone.0000145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DD	17206280	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443800007
J	Theisen, H; Syed, A; Nguyen, BT; Lukacsovich, T; Purcell, J; Srivastava, GP; Iron, D; Gaudenz, K; Nie, Q; Wan, FYM; Waterman, ML; Marsh, JL				Theisen, Heidi; Syed, Adeela; Nguyen, Baochi T.; Lukacsovich, Tamas; Purcell, Judith; Srivastava, Gyan Prakash; Iron, David; Gaudenz, Karin; Nie, Qing; Wan, Frederic Y. M.; Waterman, Marian L.; Marsh, J. Lawrence			Wingless Directly Represses DPP Morphogen Expression via an Armadillo/TCF/Brinker Complex	PLOS ONE			English	Article								Background. Spatially restricted morphogen expression drives many patterning and regeneration processes, but how is the pattern of morphogen expression established and maintained? Patterning of Drosophila leg imaginal discs requires expression of the DPP morphogen dorsally and the wingless (WG) morphogen ventrally. We have shown that these mutually exclusive patterns of expression are controlled by a self-organizing system of feedback loops that involve WG and DPP, but whether the feedback is direct or indirect is not known. Methods/Findings. By analyzing expression patterns of regulatory DNA driving reporter genes in different genetic backgrounds, we identify a key component of this system by showing that WG directly represses transcription of the dpp gene in the ventral leg disc. Repression of dpp requires a tri-partite complex of the WG mediators armadillo ( ARM) and dTCF, and the co-repressor Brinker, (BRK), wherein ARMNdTCF and BRK bind to independent sites within the dpp locus. Conclusions/Significance. Many examples of dTCF repression in the absence of WNT signaling have been described, but few examples of signal-driven repression requiring both ARM and dTCF binding have been reported. Thus, our findings represent a new mode of WG mediated repression and demonstrate that direct regulation between morphogen signaling pathways can contribute to a robust self-organizing system capable of dynamically maintaining territories of morphogen expression.	[Theisen, Heidi; Syed, Adeela; Lukacsovich, Tamas; Purcell, Judith; Gaudenz, Karin; Marsh, J. Lawrence] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Nguyen, Baochi T.; Iron, David; Nie, Qing; Wan, Frederic Y. M.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Waterman, Marian L.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Theisen, Heidi; Syed, Adeela; Lukacsovich, Tamas; Purcell, Judith; Srivastava, Gyan Prakash; Gaudenz, Karin; Marsh, J. Lawrence] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Marsh, JL (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	jlmarsh@uci.edu			NIH [RO1 HD36081, RO1 HD36049, CA83982, GM067247, GM75309]; NSF SCREMS [DMS0112416, P20GM066051]; Chao Family Comprehensive Cancer Center Functional Genomics Program; PHS [5T32 GM07311-17]; University of California, Irvine. [CA-62203]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036081, R01HD036049] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA083982, P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075309, P20GM066051, T32GM007311, R01GM067247] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF SCREMS(National Science Foundation (NSF)); Chao Family Comprehensive Cancer Center Functional Genomics Program; PHS(United States Department of Health & Human ServicesUnited States Public Health Service); University of California, Irvine.(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants RO1 HD36081 and RO1 HD36049 to JLM and NIH CA83982 to MLW, by NIH GM067247 and GM75309 to QN and FW through the Joint NSF/NIGMS Initiative to Support Research in the Area of Mathematical Biology, by NSF SCREMS Grant #DMS0112416, P20GM066051 JLM, QN, FW and by the Chao Family Comprehensive Cancer Center Functional Genomics Program. HT was supported in part by a PHS training grant 5T32 GM07311-17. This work was made possible, in part, through access to the confocal facility and Biacore facility of the Optical Biology Shared Resource of the Cancer Center Support Grant (CA-62203) at the University of California, Irvine.	Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BERGSTROM DE, 1995, GENETICS, V139, P1331; Bienz M, 1999, CURR OPIN GENET DEV, V9, P595, DOI 10.1016/S0959-437X(99)00016-7; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cadigan KM, 2002, DEVELOPMENT, V129, P3393; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Cavallo R, 1997, CURR OPIN GENET DEV, V7, P459, DOI 10.1016/S0959-437X(97)80071-8; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Fall CP., 2002, COMPUTATIONAL CELL B; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Heslip TR, 1997, DEVELOPMENT, V124, P1069; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; Johnston LA, 1996, DEVELOPMENT, V122, P3519; JONES KA, 1988, GENE DEV, V2, P1101, DOI 10.1101/gad.2.9.1101; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Knapp S, 2001, J MOL BIOL, V306, P1179, DOI 10.1006/jmbi.2001.4463; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Marsh JL, 1999, SEMIN CELL DEV BIOL, V10, P365, DOI 10.1006/scdb.1999.0323; MASUCCI JD, 1990, GENE DEV, V4, P2011, DOI 10.1101/gad.4.11.2011; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; RAFTERY LA, 1991, DEVELOPMENT, V113, P27; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Saller E, 2001, EMBO REP, V2, P298, DOI 10.1093/embo-reports/kve068; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; STJOHNSTON RD, 1990, GENE DEV, V4, P1114, DOI 10.1101/gad.4.7.1114; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Theisen H, 1996, DEVELOPMENT, V122, P3939; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Yang X, 2000, DEVELOPMENT, V127, P3695; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8	61	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2007	2	1							e142	10.1371/journal.pone.0000142	http://dx.doi.org/10.1371/journal.pone.0000142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DD	17206277	gold, Green Published			2022-12-27	WOS:000207443800004
J	Zachariah, R; Harries, AD; Manzi, M; Gomani, P; Teck, R; Phillips, M; Firmenich, P				Zachariah, Rony; Harries, Anthony David; Manzi, Marcel; Gomani, Patrick; Teck, Roger; Phillips, Mit; Firmenich, Peter			Acceptance of Anti-Retroviral Therapy among Patients Infected with HIV and Tuberculosis in Rural Malawi Is Low and Associated with Cost of Transport	PLOS ONE			English	Article								Background. A study was conducted among newly registered HIV-positive tuberculosis ( TB) patients systematically offered anti-retroviral treatment (ART) in a district hospital in rural Malawi in order to a) determine the acceptance of ART b) conduct a geographic mapping of those placed on ART and c) examine the association between "cost of transport'' and ART acceptance. Methodology/Principal Findings. A retrospective cross-sectional analysis was performed on routine program data for the period of February 2003 to July 2004. Standardized registers and patient cards were used to gather data. The place of residence was used to determine road distances to the Thyolo district hospital. Cost of transport from different parts of the district was based on the known cost for public transport to the road-stop closest to the patient's residence. Of 1,290 newly registered TB patients, 1,003(78%) underwent HIV-testing of whom 770 (77%) were HIV-positive. 742 of these individuals (pulmonary TB = 607; extra-pulmonary TB = 135) were considered eligible for ART of whom only 101(13.6%) accepted ART. Cost of transport to the hospital ART site was significantly associated with ART acceptance and there was a linear trend in association between cost and ART acceptance (X(2) for trend = 25.4, P<0.001). Individuals who had to pay 50 Malawi Kwacha (1 United States Dollar = 100 Malawi Kwacha, MW) or less for a one-way trip to the Thyolo hospital were four times more likely to accept ART than those who had to pay over 100 MW (Adjusted Odds ratio = 4.0, 95% confidence interval: 2.0-8.1, P<0.001). Conclusions/Significance. ART acceptance among TB patients in a rural district in Malawi is low and associated with cost of transport to the centralized hospital based ART site. Decentralizing the ART offer from the hospital to health centers that are closer to home communities would be an essential step towards reducing the overall cost and burden of travel.	[Zachariah, Rony; Manzi, Marcel] Brussels Operat Ctr, Med Dept Operat Res, Brussels, Belgium; [Harries, Anthony David] HIV Care & Support, Minist Hlth, Lilongwe, Malawi; [Gomani, Patrick] Thyolo Dist Hlth Serv, Minist Hlth & Populat, Thyolo, Malawi; [Teck, Roger] Medecins Sans Frontieres, Thyolo, Malawi; [Phillips, Mit] Medecins Sans Frontieres, Access Hlth, Brussels, Belgium; [Firmenich, Peter] Brussels Operat Ctr, Operat Dept, Luxembourg, Luxembourg	Doctors Without Borders	Zachariah, R (corresponding author), Brussels Operat Ctr, Med Dept Operat Res, Brussels, Belgium.	zachariah@internet.lu		zachariah, rony/0000-0002-2915-9328	Medecins sans Frontieres-Brussels; Family Health International, USA; Department for International Development (DFID); Norwegian Agency for Technical Cooperation (NORAD); Royal Dutch TB Association (KNCV); USAID; STOP-TB; WHO; CIFF	Medecins sans Frontieres-Brussels; Family Health International, USA; Department for International Development (DFID); Norwegian Agency for Technical Cooperation (NORAD); Royal Dutch TB Association (KNCV); USAID(United States Agency for International Development (USAID)); STOP-TB; WHO(World Health Organization); CIFF	The joint TB-HIV support program, including ART in Thyolo, is supported by Medecins sans Frontieres-Brussels. We are grateful to Family Health International, USA, the Department for International Development (DFID), the Norwegian Agency for Technical Cooperation (NORAD), the Royal Dutch TB Association (KNCV), USAID, STOP-TB, WHO, and CIFF for supporting TB and TB-HIV control country-wide in Malawi.	Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Floyd K, 2003, INT J TUBERC LUNG D, V7, pS29; Harries AD, 2004, T ROY SOC TROP MED H, V98, P695, DOI 10.1016/j.trstmh.2004.05.002; Harries AD, 2000, SCOT MED J, V45, P47, DOI 10.1177/00369330000450S122; KAPULULA PK, 2001, INT J TUBERC LUNG S1, V5, P167; Kwanjana JK, 2001, MALAWI MED J, V13, P7; MANN GH, 2005, 36 WORLD C LUNG HLTH; *MOHP, 2003, GUID US ANT THER MAL; *MOHP, 2003, MAL HLTH FAC SURV RE; *NAC, 2003, NAT EST HIV AIDS MAL; RAVIGLIONE MC, 1997, AIDS, V11, P115; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; SALANIPONI FM, 2003, INT J TUBERC LUNG S1, V7, P167; *UNAIDS WHO, 1997, WKLY EPIDEMIOL REC, V72, P81; Zachariah R, 2001, INT J TUBERC LUNG D, V5, P843; Zachariah R, 2006, T ROY SOC TROP MED H, V100, P167, DOI 10.1016/j.trstmh.2005.07.008; Zachariah R, 2005, INT J TUBERC LUNG D, V9, P238; Zachariah R, 2002, INT J TUBERC LUNG D, V6, P1046	18	88	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e121	10.1371/journal.pone.0000121	http://dx.doi.org/10.1371/journal.pone.0000121			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205125	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000207443700015
J	Aboody, KS; Bush, RA; Garcia, E; Metz, MZ; Najbauer, J; Justus, KA; Phelps, DA; Remack, JS; Yoon, KJ; Gillespie, S; Kim, SU; Glackin, CA; Potter, PM; Danks, MK				Aboody, Karen S.; Bush, Rebecca A.; Garcia, Elizabeth; Metz, Marianne Z.; Najbauer, Joseph; Justus, Kristine A.; Phelps, Doris A.; Remack, Joanna S.; Yoon, Karina Jin; Gillespie, Shanna; Kim, Seung U.; Glackin, Carlotta A.; Potter, Philip M.; Danks, Mary K.			Development of a Tumor-Selective Approach to Treat Metastatic Cancer	PLOS ONE			English	Article							NEURAL STEM-CELLS; RABBIT LIVER CARBOXYLESTERASE; BONE-MARROW-TRANSPLANTATION; GENE-THERAPY; NEUROBLASTOMA; BRAIN; DELIVERY; GROWTH; CPT-11; ACTIVATION	Background. Patients diagnosed with metastatic cancer have almost uniformly poor prognoses. The treatments available for patients with disseminated disease are usually not curative and have side effects that limit the therapy that can be given. A treatment that is selectively toxic to tumors would maximize the beneficial effects of therapy and minimize side effects, potentially enabling effective treatment to be administered. Methods and Findings. We postulated that the tumor-tropic property of stem cells or progenitor cells could be exploited to selectively deliver a therapeutic gene to metastatic solid tumors, and that expression of an appropriate transgene at tumor loci might mediate cures of metastatic disease. To test this hypothesis, we injected HB1.F3.C1 cells transduced to express an enzyme that efficiently activates the anti-cancer prodrug CPT-11 intravenously into mice bearing disseminated neuroblastoma tumors. The HB1.F3.C1 cells migrated selectively to tumor sites regardless of the size or anatomical location of the tumors. Mice were then treated systemically with CPT-11, and the efficacy of treatment was monitored. Mice treated with the combination of HB1.F3.C1 cells expressing the CPT-11-activating enzyme and this prodrug produced tumor-free survival of 100% of the mice for >6 months (P < 0.001 compared to control groups). Conclusions. The novel and significant finding of this study is that it may be possible to exploit the tumor-tropic property of stem or progenitor cells to mediate effective, tumor-selective therapy for metastatic tumors, for which no tolerated curative treatments are currently available.	[Aboody, Karen S.; Garcia, Elizabeth; Metz, Marianne Z.; Najbauer, Joseph; Justus, Kristine A.; Gillespie, Shanna; Glackin, Carlotta A.] City Hope Natl Med Ctr, Div Hematol Hematopoiet Cell Transplantat, Duarte, CA 91010 USA; [Aboody, Karen S.; Garcia, Elizabeth; Metz, Marianne Z.; Najbauer, Joseph; Justus, Kristine A.; Gillespie, Shanna; Glackin, Carlotta A.] City Hope Natl Med Ctr, Div Neurosci, Duarte, CA 91010 USA; [Aboody, Karen S.; Garcia, Elizabeth; Metz, Marianne Z.; Najbauer, Joseph; Justus, Kristine A.; Gillespie, Shanna; Glackin, Carlotta A.] City Hope Natl Med Ctr, Dept Profess Educ, Duarte, CA 91010 USA; [Bush, Rebecca A.; Phelps, Doris A.; Remack, Joanna S.; Yoon, Karina Jin; Potter, Philip M.; Danks, Mary K.] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; [Kim, Seung U.] Univ British Columbia Hosp, Dept Med, Vancouver, BC V6T 1W5, Canada; [Kim, Seung U.] Ajou Univ, Sch Med, Suwon 441749, South Korea	City of Hope; City of Hope; City of Hope; St Jude Children's Research Hospital; University of British Columbia; Ajou University	Aboody, KS (corresponding author), City Hope Natl Med Ctr, Div Hematol Hematopoiet Cell Transplantat, 1500 E Duarte Rd, Duarte, CA 91010 USA.	kaboody@coh.org; mary.danks@stjude.org	Justus, Kristine/GRF-1361-2022; Bush, Rebecca/D-3458-2018; Potter, Philip/J-4515-2013	Bush, Rebecca/0000-0003-0388-5134; Potter, Philip/0000-0001-8922-8535	National Institutes of Health/National Cancer Institute [CA113446, CA79763, CA76202, CA21765]; Stop Cancer Foundation; Phi Beta Psi Sorority; Rosalinde and Arthur Gilbert Foundation; Neidorf Family Foundation; Marcus Foundation; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765, R01CA113446, R01CA076202, R01CA079763] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stop Cancer Foundation; Phi Beta Psi Sorority; Rosalinde and Arthur Gilbert Foundation; Neidorf Family Foundation; Marcus Foundation; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health/National Cancer Institute (CA113446, CA79763, CA76202, and CA21765); Stop Cancer Foundation, Phi Beta Psi Sorority, The Rosalinde and Arthur Gilbert Foundation, Neidorf Family Foundation, Marcus Foundation, and American Lebanese Syrian Associated Charities (ALSAC).	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Aboody KS, 2006, NEURO-ONCOLOGY, V8, P119, DOI 10.1215/15228517-2005-012; Allers C, 2004, TRANSPLANTATION, V78, P503, DOI 10.1097/01.TP.0000128334.93343.B3; Beppu K, 2004, JNCI-J NATL CANCER I, V96, P46, DOI 10.1093/jnci/djh004; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Conti Luciano, 2002, Methods Mol Biol, V198, P233; Danks MK, 1998, CANCER RES, V58, P20; Danks MK, 1999, CLIN CANCER RES, V5, P917; Ehtesham M, 2004, NEOPLASIA, V6, P287, DOI 10.1593/neo.03427; Ehtesham M, 2002, CANCER RES, V62, P7170; Ehtesham M, 2002, CANCER RES, V62, P5657; EVANS AE, 1994, MED PEDIATR ONCOL, V23, P323, DOI 10.1002/mpo.2950230402; Fraser SE, 1996, METHOD CELL BIOL, V51, P147, DOI 10.1016/S0091-679X(08)60627-5; Furman WL, 1999, J CLIN ONCOL, V17, P1815, DOI 10.1200/JCO.1999.17.6.1815; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Guemei AA, 2001, CANCER CHEMOTH PHARM, V47, P283, DOI 10.1007/s002800000258; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Kabos P, 2003, EXPERT OPIN BIOL TH, V3, P759; Kim Seung U, 2002, Methods Mol Biol, V198, P55; Kim SK, 2005, CLIN CANCER RES, V11, P5965, DOI 10.1158/1078-0432.CCR-05-0371; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Martinez-Serrano Alberto, 2001, Current Gene Therapy, V1, P279, DOI 10.2174/1566523013348562; MATTHAY KK, 1994, J CLIN ONCOL, V12, P2382, DOI 10.1200/JCO.1994.12.11.2382; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; McKenzie PP, 2003, CANCER RES, V63, P3840; Meng XL, 2003, J NEUROSCI RES, V74, P266, DOI 10.1002/jnr.10764; Morton CL, 2005, CANCER CHEMOTH PHARM, V56, P629, DOI 10.1007/s00280-005-1027-y; Morton CL, 2000, CANCER RES, V60, P4206; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ourednik V, 2000, NOVART FDN SYMP, V231, P242, DOI 10.1002/0470870834.ch15; Potter PM, 1998, CANCER RES, V58, P3627; Potter PM, 1998, CANCER RES, V58, P2646; Ryu JK, 2003, J NEUROSCI RES, V72, P352, DOI 10.1002/jnr.10507; Schmidt NO, 2005, NEOPLASIA, V7, P623, DOI 10.1593/neo.04781; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Thompson J, 2001, CANCER CHEMOTH PHARM, V47, P211, DOI 10.1007/s002800000235; Wagner LM, 2002, CANCER RES, V62, P5001; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Zhou C, 2003, CELL BIOL INT, V27, P943, DOI 10.1016/j.cellbi.2003.08.001	46	110	111	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e23	10.1371/journal.pone.0000023	http://dx.doi.org/10.1371/journal.pone.0000023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183650	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600023
J	Calderon, IL; Arenas, FA; Perez, JM; Fuentes, DE; Araya, MA; Saavedra, CP; Tantalean, JC; Pichuantes, SE; Youderian, PA; Vasquez, CC				Calderon, Ivan L.; Arenas, Felipe A.; Perez, Jose Manuel; Fuentes, Derie E.; Araya, Manuel A.; Saavedra, Claudia P.; Tantalean, Juan C.; Pichuantes, Sergio E.; Youderian, Philip A.; Vasquez, Claudio C.			Catalases Are NAD(P)H-Dependent Tellurite Reductases	PLOS ONE			English	Article								Reactive oxygen species damage intracellular targets and are implicated in cancer, genetic disease, mutagenesis, and aging. Catalases are among the key enzymatic defenses against one of the most physiologically abundant reactive oxygen species, hydrogen peroxide. The well-studied, heme-dependent catalases accelerate the rate of the dismutation of peroxide to molecular oxygen and water with near kinetic perfection. Many catalases also bind the cofactors NADPH and NADH tenaciously, but, surprisingly, NAD(P)H is not required for their dismutase activity. Although NAD(P)H protects bovine catalase against oxidative damage by its peroxide substrate, the catalytic role of the nicotinamide cofactor in the function of this enzyme has remained a biochemical mystery to date. Anions formed by heavy metal oxides are among the most highly reactive, natural oxidizing agents. Here, we show that a natural isolate of Staphylococcus epidermidis resistant to tellurite detoxifies this anion thanks to a novel activity of its catalase, and that a subset of both bacterial and mammalian catalases carry out the NAD(P)H-dependent reduction of soluble tellurite ion (TeO32-) to the less toxic, insoluble metal, tellurium (Te degrees), in vitro. An Escherichia coli mutant defective in the KatG catalase/peroxidase is sensitive to tellurite, and expression of the S. epidermidis catalase gene in a heterologous E. coli host confers increased resistance to tellurite as well as to hydrogen peroxide in vivo, arguing that S. epidermidis catalase provides a physiological line of defense against both of these strong oxidizing agents. Kinetic studies reveal that bovine catalase reduces tellurite with a low Michaelis-Menten constant, a result suggesting that tellurite is among the natural substrates of this enzyme. The reduction of tellurite by bovine catalase occurs at the expense of producing the highly reactive superoxide radical.	[Calderon, Ivan L.; Arenas, Felipe A.; Perez, Jose Manuel; Fuentes, Derie E.; Araya, Manuel A.; Vasquez, Claudio C.] Univ Santiago Chile, Fac Quim & Biol, Mol Microbiol Lab, Santiago, Chile; [Saavedra, Claudia P.] Univ Andres Bello, Fac Ciencias Salud, Lab Microbiol Mol & Biotecnol, Santiago, Chile; [Tantalean, Juan C.] Univ San Luis Gonzaga Ica, Fac Ciencias, Lab Microbiol Ind & Biotecnol, Ica, Peru; [Pichuantes, Sergio E.] Chiron Corp, Blood Testing Div, Emeryville, CA 94608 USA; [Youderian, Philip A.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Universidad de Santiago de Chile; Universidad Andres Bello; Universidad Nacional San Luis Gonzaga; Novartis; Texas A&M University System; Texas A&M University College Station	Vasquez, CC (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Mol Microbiol Lab, Santiago, Chile.	cvasquez@usach.cl	Pérez-Donoso, José M./G-3668-2013; Fuentes, Derie/GLS-8773-2022	Pérez-Donoso, José M./0000-0002-9506-1716; TANTALEAN, JUAN/0000-0002-9541-7102; Fuentes, Derie/0000-0002-8189-8515	Fondo de Ciencia y Tecnologia Chile [1030234, 1060022]; Direccion de Investigacion, Universidad de Santiago de Chile; National Institutes of Health [GM59336]; Comision Nacional de Ciencia y Tecnologia; Mejoramiento de la Calidad y Equidad de la Educacion Superior project of the government of Chile; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059336] Funding Source: NIH RePORTER	Fondo de Ciencia y Tecnologia Chile; Direccion de Investigacion, Universidad de Santiago de Chile; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comision Nacional de Ciencia y Tecnologia; Mejoramiento de la Calidad y Equidad de la Educacion Superior project of the government of Chile; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Fondo de Ciencia y Tecnologia Chile (#1030234 and #1060022) and from the Direccion de Investigacion, Universidad de Santiago de Chile to C. C. V. and by National Institutes of Health grant GM59336 to P. Y. Doctoral fellowships have been awarded to I. L. C. from the Comision Nacional de Ciencia y Tecnologia, and to D. E. F. and J. M. P. from the Mejoramiento de la Calidad y Equidad de la Educacion Superior project of the government of Chile.	AEBI H, 1960, B SOC CHIM BIOL, V42, P187; Avazeri C, 1997, MICROBIOL-SGM, V143, P1181, DOI 10.1099/00221287-143-4-1181; CHIONG M, 1988, J BACTERIOL, V170, P3269, DOI 10.1128/jb.170.7.3269-3273.1988; CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245; DU SH, 1983, ENVIRON EXP BOT, V23, P347, DOI 10.1016/0098-8472(83)90009-6; FITA I, 1985, P NATL ACAD SCI USA, V82, P1604, DOI 10.1073/pnas.82.6.1604; Fuentes DE, 2005, RES MICROBIOL, V156, P472, DOI 10.1016/j.resmic.2005.01.002; Gaetani GF, 2005, BIOCHEM J, V385, P763, DOI 10.1042/BJ20041495; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; GREGORY EM, 1974, ANAL BIOCHEM, V58, P57, DOI 10.1016/0003-2697(74)90440-0; Grotti M, 2004, ANN CHIM-ROME, V94, P1, DOI 10.1002/adic.200490011; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HASSAN HM, 1978, J BIOL CHEM, V253, P6445; HEYM B, 1993, J BACTERIOL, V175, P4255, DOI 10.1128/JB.175.13.4255-4259.1993; KEILIN D, 1945, BIOCHEM J, V39, P293, DOI 10.1042/bj0390293; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kirkman HN, 1999, J BIOL CHEM, V274, P13908, DOI 10.1074/jbc.274.20.13908; KIRKMAN HN, 1984, P NATL ACAD SCI-BIOL, V81, P4343, DOI 10.1073/pnas.81.14.4343; KIRKMAN HN, 1987, J BIOL CHEM, V262, P660; Klotz MG, 2003, MOL BIOL EVOL, V20, P1098, DOI 10.1093/molbev/msg129; Klotz MG, 1997, MOL BIOL EVOL, V14, P951, DOI 10.1093/oxfordjournals.molbev.a025838; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARDINOIS OM, 1995, FREE RADICAL RES, V22, P251, DOI 10.3109/10715769509147544; LEOW O, 1900, REPT US DEP AGR DIV, V65, P5; Lithgow JK, 2004, J BACTERIOL, V186, P1579, DOI 10.1128/JB.186.6.1579-1590.2004; Lohmeier-Vogel EM, 2004, APPL ENVIRON MICROB, V70, P7342, DOI 10.1128/AEM.70.12.7342-7347.2004; MAGOS L, 1978, BIOCHEM PHARMACOL, V27, P1373, DOI 10.1016/0006-2952(78)90122-3; Mao SZ, 2005, J AM CHEM SOC, V127, P11588, DOI 10.1021/ja052451v; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; MOORE MD, 1992, J BACTERIOL, V174, P1505, DOI 10.1128/jb.174.5.1505-1514.1992; Moscoso H, 1998, RES MICROBIOL, V149, P389, DOI 10.1016/S0923-2508(98)80321-5; Nicholls P., 1963, ENZYMES, V8, P147; OGara JP, 1997, APPL ENVIRON MICROB, V63, P4713, DOI 10.1128/AEM.63.12.4713-4720.1997; OGATA M, 1983, PHYSIOL CHEM PHYS, V15, P89; OSHINO N, 1973, BIOCHEM J, V131, P555, DOI 10.1042/bj1310555; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; Smith T, 1998, APPL ENVIRON MICROB, V64, P1328; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUMMERS AO, 1977, J BACTERIOL, V129, P276, DOI 10.1128/JB.129.1.276-281.1977; Sumner JB, 1937, J BIOL CHEM, V121, P417; Tantalean JC, 2003, J BACTERIOL, V185, P5831, DOI 10.1128/JB.185.19.5831-5837.2003; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; TAYLOR DE, 1988, J ULTRA MOL STRUCT R, V99, P18, DOI 10.1016/0889-1605(88)90029-8; Trutko SM, 1998, DOKL AKAD NAUK+, V358, P836; TUCKER FL, 1966, J BACTERIOL, V92, P1311, DOI 10.1128/JB.92.5.1311-1314.1966; Turner RJ, 1999, MICROBIOL-UK, V145, P2549, DOI 10.1099/00221287-145-9-2549; Turner RJ, 1995, MICROBIOL-UK, V141, P3133, DOI 10.1099/13500872-141-12-3133; VANITERSON W, 1964, J CELL BIOL, V20, P377, DOI 10.1083/jcb.20.3.377; VANITERSON W, 1964, J CELL BIOL, V20, P361, DOI 10.1083/jcb.20.3.361; Vasquez CC, 2001, CURR MICROBIOL, V43, P418, DOI 10.1007/s002840010331; WALTER EG, 1992, PLASMID, V27, P52, DOI 10.1016/0147-619X(92)90006-V; WOODBURY W, 1971, ANAL BIOCHEM, V44, P301, DOI 10.1016/0003-2697(71)90375-7; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	55	69	69	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e70	10.1371/journal.pone.0000070	http://dx.doi.org/10.1371/journal.pone.0000070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183702	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600070
J	Jiang, ZH; Michal, JJ; Williams, GA; Daniels, TF; Kunej, T				Jiang, Zhihua; Michal, Jennifer J.; Williams, Galen A.; Daniels, Tyler F.; Kunej, Tanja			Cross Species Association Examination of UCN3 and CRHR2 as Potential Pharmacological Targets for Antiobesity Drugs	PLOS ONE			English	Article								Background. Obesity now constitutes a leading global public health problem. Studies have shown that insulin resistance affiliated with obesity is associated with intramyocellular lipid (IMCL) accumulation. Therefore, identification of genes associated with the phenotype would provide a clear target for pharmaceutical intervention and care for the condition. We hypothesized that urocortin 3 (UCN3) and corticotropin-releasing hormone receptor 2 (CRHR2) are associated with IMCL and subcutaneous fat depth (SFD), because the corticotropin-releasing hormone family of peptides are capable of strong anorectic and thermogenic effects. Methodology/Principal Findings. We annotated both bovine UCN3 and CRHR2 genes and identified 12 genetic mutations in the former gene and 5 genetic markers in the promoter region of the latter gene. Genotyping of these 17 markers on WagyuxLimousin F(2) progeny revealed significant associations between promoter polymorphisms and SFD (P = 0.0203-0.0685) and between missense mutations of exon 2 and IMCL (P = 0.0055-0.0369) in the bovine UCN3 gene. The SFD associated promoter SNPs caused a gain/loss of 12 potential transcription regulatory binding sites, while the IMCL associated coding SNPs affected the secondary structure of UCN3 mRNA. However, none of five polymorphisms in CRHR2 gene clearly co-segregated with either trait in the population (P > 0.6000). Conclusions/Significance. Because UCN3 is located on human chromosome 10p15.1 where quantitative trait loci for obesity have been reported, our cross species study provides further evidence that it could be proposed as a potential target for developing antiobesity drugs. None of the markers in CRHR2 was associated with obesity-type traits in cattle, which is consistent with findings in human. Therefore, CRHR2 does not lend itself to the development of antiobesity drugs.	[Jiang, Zhihua; Michal, Jennifer J.; Williams, Galen A.; Daniels, Tyler F.; Kunej, Tanja] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	Washington State University	Jiang, ZH (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	jiangz@wsu.edu	Jiang, Zhihua/A-3378-2008; Kunej, Tanja/G-5957-2017	Jiang, Zhihua/0000-0003-1986-088X; Kunej, Tanja/0000-0002-0465-1762	Agricultural Research Center; Washington State University; Merial Ltd.	Agricultural Research Center; Washington State University; Merial Ltd.	Agricultural Research Center, Washington State University, and Merial Ltd. supported this project.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bale TL, 2003, ENDOCRINOLOGY, V144, P2580, DOI 10.1210/en.2002-0091; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bertram L, 2005, J MED GENET, V42, P857, DOI 10.1136/jmg.2004.024596; Boorse GC, 2006, GEN COMP ENDOCR, V146, P9, DOI 10.1016/j.ygcen.2005.11.014; Chagnon YC, 2001, J APPL PHYSIOL, V90, P1777, DOI 10.1152/jappl.2001.90.5.1777; Challis BG, 2004, INT J OBESITY, V28, P442, DOI 10.1038/sj.ijo.0802564; Doyon C, 2004, DRUG NEWS PERSPECT, V17, P505, DOI 10.1358/dnp.2004.17.8.863694; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Gelmann EP, 2002, CANCER RES, V62, P2654; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Jiang ZH, 2005, BIOCHEM BIOPH RES CO, V334, P516, DOI 10.1016/j.bbrc.2005.06.120; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li C, 2003, ENDOCRINOLOGY, V144, P3216, DOI 10.1210/en.2002-0087; Li C, 2002, J NEUROSCI, V22, P991, DOI 10.1523/JNEUROSCI.22-03-00991.2002; Lindsay RS, 2001, DIABETES, V50, P2850, DOI 10.2337/diabetes.50.12.2850; Mir PS, 2002, J ANIM SCI, V80, P2996; Ohata H, 2004, PEPTIDES, V25, P1703, DOI 10.1016/j.peptides.2004.05.023; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Seres J, 2004, J CLIN ENDOCR METAB, V89, P965, DOI 10.1210/jc.2003-031299; Yang BM, 2006, DIABETES, V55, P1450, DOI 10.2337/db05-1260; Zorrilla EP, 2003, TRENDS PHARMACOL SCI, V24, P421, DOI 10.1016/S0165-6147(03)00177-9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e80	10.1371/journal.pone.0000080	http://dx.doi.org/10.1371/journal.pone.0000080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183713	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600080
J	Li, J; McClure, SM; King-Casas, B; Montague, PR				Li, Jian; McClure, Samuel M.; King-Casas, Brooks; Montague, P. Read			Policy Adjustment in a Dynamic Economic Game	PLOS ONE			English	Article							TEMPORAL DIFFERENCE MODELS; PREFRONTAL CORTEX; DECISION-MAKING; BRAIN-REGIONS; NEURAL BASIS; SYSTEMS; PREDICTION; RESPONSES; DOPAMINE; ACTIVATION	Making sequential decisions to harvest rewards is a notoriously difficult problem. One difficulty is that the real world is not stationary and the reward expected from a contemplated action may depend in complex ways on the history of an animal's choices. Previous functional neuroimaging work combined with principled models has detected brain responses that correlate with computations thought to guide simple learning and action choice. Those works generally employed instrumental conditioning tasks with fixed action-reward contingencies. For real-world learning problems, the history of reward-harvesting choices can change the likelihood of rewards collected by the same choices in the near-term future. We used functional MRI to probe brain and behavioral responses in a continuous decision-making task where reward contingency is a function of both a subject's immediate choice and his choice history. In these more complex tasks, we demonstrated that a simple actor-critic model can account for both the subjects' behavioral and brain responses, and identified a reward prediction error signal in ventral striatal structures active during these non-stationary decision tasks. However, a sudden introduction of new reward structures engages more complex control circuitry in the prefrontal cortex ( inferior frontal gyrus and anterior insula) and is not captured by a simple actor-critic model. Taken together, these results extend our knowledge of reward-learning signals into more complex, history-dependent choice tasks. They also highlight the important interplay between striatum and prefrontal cortex as decision-makers respond to the strategic demands imposed by non-stationary reward environments more reminiscent of real-world tasks.	[Li, Jian; McClure, Samuel M.; King-Casas, Brooks; Montague, P. Read] Baylor Coll Med, Dept Neurosci, Ctr Theoret Neurosci, Human Neuroimaging Lab, Houston, TX 77030 USA; [Montague, P. Read] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Montague, PR (corresponding author), Baylor Coll Med, Dept Neurosci, Ctr Theoret Neurosci, Human Neuroimaging Lab, Houston, TX 77030 USA.	read@bcm.tmc.edu			Kane Family Foundation [NS-045790]; NIDA [DA-11723]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER	Kane Family Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the Kane Family Foundation (P. R. M.), NINDS grant NS-045790 (P. R. M.) and NIDA grant DA-11723 (P. R. M.).	Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Clayton EC, 2004, J NEUROSCI, V24, P9914, DOI 10.1523/JNEUROSCI.2446-04.2004; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; EAGLEMAN DM, 1998, J COGNITIVE NEUROSCI, V10, P623; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005; Glascher J, 2005, NEURON, V47, P295, DOI 10.1016/j.neuron.2005.06.008; Gray JR, 2004, CURR DIR PSYCHOL SCI, V13, P46, DOI 10.1111/j.0963-7214.2004.00272.x; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Herrnstein R.J., 1982, QUANTITATIVE ANAL BE, VII, P433; HERRNSTEIN RJ, 1990, AM PSYCHOL, V45, P356; HERRNSTEIN RJ, 1991, J ECON PERSPECT, V5, P137, DOI 10.1257/jep.5.3.137; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schmitz C, 2005, J NEUROPHYSIOL, V93, P1498, DOI 10.1152/jn.00230.2004; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Stephens DW, 1987, FORAGING THEORY; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	50	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e103	10.1371/journal.pone.0000103	http://dx.doi.org/10.1371/journal.pone.0000103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183636	Green Published, gold			2022-12-27	WOS:000207443600102
J	Reddy, JV; Ganley, IG; Pfeffer, SR				Reddy, Jonathan V.; Ganley, Ian G.; Pfeffer, Suzanne R.			Clues to Neuro-Degeneration in Niemann-Pick Type C Disease from Global Gene Expression Profiling	PLOS ONE			English	Article								Background. Niemann-Pick Type C (NPC) disease is a neurodegenerative disease that is characterized by the accumulation of cholesterol and glycosphingolipids in the late endocytic pathway. The majority of NPC cases are due to mutations in the NPC1 gene. The precise function of this gene is not yet known. Methodology/Principal Findings. Using cDNA microarrays, we analyzed the genome-wide expression patterns of human fibroblasts homozygous for the I1061T NPC1 mutation that is characterized by a severe defect in the intracellular processing of low density lipoprotein-derived cholesterol. A distinct gene expression profile was identified in NPC fibroblasts from different individuals when compared with fibroblasts isolated from normal subjects. As expected, NPC1 mutant cells displayed an inappropriate homeostatic response to accumulated intracellular cholesterol. In addition, a number of striking parallels were observed between NPC disease and Alzheimer's disease. Conclusions/Significance. Many genes involved in the trafficking and processing of amyloid precursor protein and the microtubule binding protein, tau, were more highly expressed. Numerous genes important for membrane traffic and the cellular regulation of calcium, metals and other ions were upregulated. Finally, NPC fibroblasts exhibited a gene expression profile indicative of oxidative stress. These changes are likely contributors to the pathophysiology of Niemann-Pick Type C disease.	[Reddy, Jonathan V.; Ganley, Ian G.; Pfeffer, Suzanne R.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pfeffer@stanford.edu		Ganley, Ian/0000-0003-1481-9407	Ara Parseghian Medical Research Foundation; NIH [DK37332]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037332, R37DK037332] Funding Source: NIH RePORTER	Ara Parseghian Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Ara Parseghian Medical Research Foundation and the NIH (DK37332).	Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Appelt DM, 1997, BRAIN RES, V745, P21, DOI 10.1016/S0006-8993(96)01121-3; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; AUER IA, 1995, ACTA NEUROPATHOL, V90, P547; Blom TS, 2003, HUM MOL GENET, V12, P257, DOI 10.1093/hmg/ddg025; BRION JP, 1991, BRAIN RES, V539, P143, DOI 10.1016/0006-8993(91)90697-T; Burns M, 2003, J NEUROSCI, V23, P5645; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; CORREAS I, 1992, J BIOL CHEM, V267, P15721; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ekinci FJ, 1999, J BIOL CHEM, V274, P30322, DOI 10.1074/jbc.274.42.30322; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Klein William L, 2006, Alzheimers Dement, V2, P43, DOI 10.1016/j.jalz.2005.11.003; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; Muresan Z, 2005, J CELL BIOL, V171, P615, DOI 10.1083/jcb.200502043; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Olkkonen VM, 2004, BIOCHEM CELL BIOL, V82, P87, DOI 10.1139/o03-088; Park WD, 2003, HUM MUTAT, V22, P313, DOI 10.1002/humu.10255; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Tomizawa K, 2001, FEBS LETT, V492, P221, DOI 10.1016/S0014-5793(01)02256-6; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Twig G, 2005, AM J PHYSIOL-CELL PH, V288, pC169, DOI 10.1152/ajpcell.00308.2004; Ueda K, 1997, J NEUROCHEM, V68, P265; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Yang LS, 1999, J NEUROSCI RES, V55, P36, DOI 10.1002/(SICI)1097-4547(19990101)55:1<36::AID-JNR5>3.3.CO;2-5; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	60	88	92	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e19	10.1371/journal.pone.0000019	http://dx.doi.org/10.1371/journal.pone.0000019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183645	gold, Green Published, Green Submitted			2022-12-27	WOS:000207443600019
J	Rota, J; Wagner, DL				Rota, Jadranka; Wagner, David L.			Predator Mimicry: Metalmark Moths Mimic Their Jumping Spider Predators	PLOS ONE			English	Article							EVASIVE MIMICRY; ARANEAE; SALTICIDAE; HOMOPTERA	Cases of mimicry provide many of the nature's most convincing examples of natural selection. Here we report evidence for a case of predator mimicry in which metalmark moths in the genus Brenthia mimic jumping spiders, one of their predators. In controlled trials, Brenthia had higher survival rates than other similarly sized moths in the presence of jumping spiders and jumping spiders responded to Brenthia with territorial displays, indicating that Brenthia were sometimes mistaken for jumping spiders, and not recognized as prey. Our experimental results and a review of wing patterns of other insects indicate that jumping spider mimicry is more widespread than heretofore appreciated, and that jumping spiders are probably an important selective pressure shaping the evolution of diurnal insects that perch on vegetation.	[Rota, Jadranka; Wagner, David L.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Rota, J (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	jadranka.rota@uconn.edu	Rota, Jadranka/C-6702-2011	Rota, Jadranka/0000-0003-0220-3920	Organization for Tropical Studies/Thompson Fellowship; University of Connecticut's Center for Conservation and Biodiversity Award; University of Connecticut Department of Ecology and Evolutionary Biology's/Connecticut State Natural History Museum's DeCoursey, Penner	Organization for Tropical Studies/Thompson Fellowship; University of Connecticut's Center for Conservation and Biodiversity Award; University of Connecticut Department of Ecology and Evolutionary Biology's/Connecticut State Natural History Museum's DeCoursey, Penner	Funding: This work was supported with the following awards to J. R.: Organization for Tropical Studies/Thompson Fellowship, University of Connecticut's Center for Conservation and Biodiversity Award, and three separate stipends from the University of Connecticut Department of Ecology and Evolutionary Biology's/Connecticut State Natural History Museum's DeCoursey, Penner, and Slater endowments.	Aiello Annette, 2004, Journal of the Lepidopterists' Society, V58, P55; Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Balgooyen TG, 1997, AM MIDL NAT, V137, P183, DOI 10.2307/2426768; Bates H.W., 1862, T LINN SOC LOND, V23, P495; Clemens B., 1860, P ACAD NAT SCI PHILA, V12; Floren A, 2001, ECOTROPICA, V7, P33; GREENE E, 1987, SCIENCE, V236, P310, DOI 10.1126/science.236.4799.310; Harland DP, 1999, J ZOOL, V247, P357, DOI 10.1111/j.1469-7998.1999.tb00998.x; Jackson R.R., 1982, P213; Jackson RR, 1996, ANNU REV ENTOMOL, V41, P287, DOI 10.1146/annurev.en.41.010196.001443; LINDROTH C H, 1971, Entomologica Scandinavica, V2, P41; LLOYD JE, 1965, SCIENCE, V149, P653, DOI 10.1126/science.149.3684.653; MATHER MH, 1987, SCIENCE, V236, P308, DOI 10.1126/science.236.4799.308; MCIVER JD, 1993, ANNU REV ENTOMOL, V38, P351, DOI 10.1146/annurev.en.38.010193.002031; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; Nelson XJ, 2005, J ARACHNOL, V33, P813, DOI 10.1636/S04-12.1; OBRIEN LB, 1967, PAN-PAC ENTOMOL, V43, P130; Owen D., 1980, CAMOUFLAGE MIMICRY; PERRONE M, 1981, CONDOR, V83, P383, DOI 10.2307/1367512; RETTENMEYER CW, 1970, ANNU REV ENTOMOL, V15, P43, DOI 10.1146/annurev.en.15.010170.000355; Ruxton GD, 2004, P ROY SOC B-BIOL SCI, V271, P2135, DOI 10.1098/rspb.2004.2816; Sokal RR, BIOMETRY PRINCIPLES; Stevens M, 2005, BIOL REV, V80, P573, DOI 10.1017/S1464793105006810; WELLS MS, 1988, ANIM BEHAV, V36, P321, DOI 10.1016/S0003-3472(88)80001-0; WHITMAN DW, 1988, ANN ENTOMOL SOC AM, V81, P532, DOI 10.1093/aesa/81.3.532; ZARET TM, 1977, EVOLUTION, V31, P421, DOI 10.1111/j.1558-5646.1977.tb01022.x; ZOLNEROWICH G, 1992, J NEW YORK ENTOMOL S, V100, P498	27	32	36	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e45	10.1371/journal.pone.0000045	http://dx.doi.org/10.1371/journal.pone.0000045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183674	gold, Green Submitted, Green Published			2022-12-27	WOS:000207443600045
J	Marks, JL; McLellan, MD; Zakowski, MF; Lash, AE; Kasai, Y; Broderick, S; Sarkaria, IS; Pham, D; Singh, B; Miner, TL; Fewell, GA; Fulton, LL; Mardis, ER; Wilson, RK; Kris, MG; Rusch, VW; Varmus, H; Pao, W				Marks, Jenifer L.; McLellan, Michael D.; Zakowski, Maureen F.; Lash, Alex E.; Kasai, Yumi; Broderick, Stephen; Sarkaria, Inderpal S.; Pham, DuyKhanh; Singh, Bhuvanesh; Miner, Tracie L.; Fewell, Ginger A.; Fulton, Lucinda L.; Mardis, Elaine R.; Wilson, Richard K.; Kris, Mark G.; Rusch, Valerie W.; Varmus, Harold; Pao, William			Mutational Analysis of EGFR and Related Signaling Pathway Genes in Lung Adenocarcinomas Identifies a Novel Somatic Kinase Domain Mutation in FGFR4	PLOS ONE			English	Article								Background. Fifty percent of lung adenocarcinomas harbor somatic mutations in six genes that encode proteins in the EGFR signaling pathway, i.e., EGFR, HER2/ERBB2, HER4/ERBB4, PIK3CA, BRAF, and KRAS. We performed mutational profiling of a large cohort of lung adenocarcinomas to uncover other potential somatic mutations in genes of this signaling pathway that could contribute to lung tumorigenesis. Methodology/Principal Findings. We analyzed genomic DNA from a total of 261 resected, clinically annotated non-small cell lung cancer (NSCLC) specimens. The coding sequences of 39 genes were screened for somatic mutations via high-throughput dideoxynucleotide sequencing of PCR-amplified gene products. Mutations were considered to be somatic only if they were found in an independent tumor-derived PCR product but not in matched normal tissue. Sequencing of 9MB of tumor sequence identified 239 putative genetic variants. We further examined 22 variants found in RAS family genes and 135 variants localized to exons encoding the kinase domain of respective proteins. We identified a total of 37 non-synonymous somatic mutations; 36 were found collectively in EGFR, KRAS, BRAF, and PIK3CA. One somatic mutation was a previously unreported mutation in the kinase domain (exon 16) of FGFR4 (Glu681Lys), identified in 1 of 158 tumors. The FGFR4 mutation is analogous to a reported tumor-specific somatic mutation in ERBB2 and is located in the same exon as a previously reported kinase domain mutation in FGFR4 (Pro712Thr) in a lung adenocarcinoma cell line. Conclusions/Significance. This study is one of the first comprehensive mutational analyses of major genes in a specific signaling pathway in a sizeable cohort of lung adenocarcinomas. Our results suggest the majority of gain-of-function mutations within kinase genes in the EGFR signaling pathway have already been identified. Our findings also implicate FGFR4 in the pathogenesis of a subset of lung adenocarcinomas.	[Marks, Jenifer L.; Pao, William] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [McLellan, Michael D.; Kasai, Yumi; Miner, Tracie L.; Fewell, Ginger A.; Fulton, Lucinda L.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO USA; [Broderick, Stephen; Sarkaria, Inderpal S.; Pham, DuyKhanh; Singh, Bhuvanesh; Rusch, Valerie W.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Lash, Alex E.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Zakowski, Maureen F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Kris, Mark G.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, New York, NY 10021 USA; [Varmus, Harold] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; [Kris, Mark G.; Pao, William] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Pao, W (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	paow@mskcc.org	Wilson, Richard K./AAF-4139-2019; Sarkaria, Inderpal/ABA-7401-2021; Mardis, Elaine/W-2202-2019	Wilson, Richard K./0000-0002-1992-1358; MCLELLAN, MICHAEL/0000-0002-2703-8784; Rusch, Valerie/0000-0003-2345-6900; Kris, Mark/0000-0002-7317-5341; Lash, Alex/0000-0003-3787-1590	Doris Duke Charitable Foundation [NIH K08-CA097980]; Bristol-Myers Squibb Foundation; Jodi Spiegel Fisher Cancer Foundation; Carmel Hill Fund; NATIONAL CANCER INSTITUTE [K08CA097980] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Bristol-Myers Squibb Foundation(Bristol-Myers Squibb); Jodi Spiegel Fisher Cancer Foundation; Carmel Hill Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Doris Duke Charitable Foundation (WP), Joan's Legacy: The Joan Scarangello Foundation to Conquer Lung Cancer (WP), NIH K08-CA097980 (WP), the Bristol-Myers Squibb Foundation (AL), the Jodi Spiegel Fisher Cancer Foundation (WP), and The Carmel Hill Fund. WP is the incumbent of the Miner Family Chair for Intrathoracic Cancers. The funders of this study had no role in the design and conduct of the study, in the collection, analysis and interpretation of the data, or preparation and review of the manuscript.	Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Bredel M, 2005, J MOL DIAGN, V7, P171, DOI 10.1016/S1525-1578(10)60543-0; Brose MS, 2002, CANCER RES, V62, P6997; CHEN K, GENOME RES IN PRESS; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clark JC, 2001, AM J PHYSIOL-LUNG C, V280, pL705, DOI 10.1152/ajplung.2001.280.4.L705; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ebright MI, 2002, ANN THORAC SURG, V74, P1640, DOI 10.1016/S0003-4975(02)03897-3; Endoh H, 2006, J THORAC ONCOL, V1, P629; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Gabrielson E, 2006, RESPIROLOGY, V11, P533, DOI 10.1111/j.1440-1843.2006.00909.x; Giaccone G, 2006, CLIN CANCER RES, V12, P6049, DOI 10.1158/1078-0432.CCR-06-0260; HAN SW, 2005, J CLIN ONCOL, V23; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maglott D, 2006, NUCL ACIDS RES; MARCHLERBAUER A, 2006, NUCL ACIDS RES; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Naoki K, 2002, CANCER RES, V62, P7001; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; SHIGEMATSU H, 2005, P AACR LB, V39; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Zhao BH, 2001, P NATL ACAD SCI USA, V98, P5898, DOI 10.1073/pnas.101116598	39	73	82	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e426	10.1371/journal.pone.0000426	http://dx.doi.org/10.1371/journal.pone.0000426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487277	Green Submitted, Green Published, gold			2022-12-27	WOS:000207445800008
J	Sehat, B; Andersson, S; Vasilcanu, R; Girnita, L; Larsson, O				Sehat, Bita; Andersson, Sandra; Vasilcanu, Radu; Girnita, Leonard; Larsson, Olle			Role of Ubiquitination in IGF-1 Receptor Signaling and Degradation	PLOS ONE			English	Article							FACTOR-I RECEPTOR; GROWTH-FACTOR RECEPTOR; INSULIN-RECEPTOR; INSULIN-LIKE-GROWTH-FACTOR-1 RECEPTOR; BETA-ARRESTIN; CANCER; CELLS; PROTEASOME; PATHWAY; PROTEIN	Background. The insulin-like growth factor 1 receptor (IGF-1R) plays numerous crucial roles in cancer biology. The majority of knowledge on IGF-1R signaling is concerned with its role in the activation of the canonical phosphatidyl inositol-3 kinase (PI3K)/Akt and MAPK/ERK pathways. However, the role of IGF-1R ubiquitination in modulating IGF-1R function is an area of current research. In light of this we sought to determine the relationship between IGF-1R phosphorylation, ubiquitination, and modulation of growth signals. Methodology. Wild type and mutant constructs of IGF-1R were transfected into IGF-1R null fibroblasts. IGF-1R autophosphorylation and ubiquitination were determined by immunoprecipitation and western blotting. IGF-1R degradation and stability was determined by cyclohexamide-chase assay in combination with lysosome and proteasome inhibitors. Principal Findings. IGF-1R autophosphorylation was found to be an absolute requirement for receptor ubiquitination. Deletion of C-terminal domain had minimal effect on IGF-1 induced receptor autophosphorylation, however, ubiquitination and ERK activation were completely abolished. Cells expressing kinase impaired IGF-1R, exhibited both receptor ubiquitination and ERK phosphorylation, however failed to activate Akt. While IGF-1R mutants with impaired PI3K/Akt signaling were degraded mainly by the proteasomes, the C-terminal truncated one was exclusively degraded through the lysosomal pathway. Conclusions. Our data suggest important roles of ubiquitination in mediating IGF-1R signaling and degradation. Ubiquitination of IGF-1R requires receptor tyrosine kinase activity, but is not involved in Akt activation. In addition we show that the C-terminal domain of IGF-1R is a necessary requisite for ubiquitination and ERK phosphorylation as well as for proteasomal degradation of the receptor.	[Larsson, Olle] Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden; Karolinska Univ Hosp Solna, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Larsson, O (corresponding author), Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden.	olle.larsson@ki.se	Girnita, Leonard/A-4168-2008	Girnita, Leonard/0000-0003-0280-9500	Swedish Cancer Society; Cancer Society in Stockholm; Swedish Research Council; Swedish Children Cancer Society; Gustaf V Jubilee Foundation; Ingabritt and Arne Lundberg's research Foundation; Alex and Eva Wallstrom's Foundation; Karolinska Institute	Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children Cancer Society(Swedish Cancer Society); Gustaf V Jubilee Foundation; Ingabritt and Arne Lundberg's research Foundation; Alex and Eva Wallstrom's Foundation; Karolinska Institute(Karolinska Institutet)	The Swedish Cancer Society, the Cancer Society in Stockholm, the Swedish Research Council, the Swedish Children Cancer Society, The Gustaf V Jubilee Foundation, Ingabritt and Arne Lundberg's research Foundation, Alex and Eva Wallstrom's Foundation and the Karolinska Institute.	Alexander A, 1998, Front Biosci, V3, pd729; Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Authier F, 1999, J BIOL CHEM, V274, P33723, DOI 10.1074/jbc.274.47.33723; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Baserga R, 2000, GROWTH HORM IGF RES, V10, pS43, DOI 10.1016/S1096-6374(00)90021-2; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; Colombo MG, 2001, CARDIOVASC DRUG THER, V15, P25, DOI 10.1023/A:1011154616992; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Furlanetto RW, 1997, BIOCHEM J, V327, P765; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Girnita L, 2000, CANCER RES, V60, P5278; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LeRoith D, 1995, ANN NY ACAD SCI, V766, P402, DOI 10.1111/j.1749-6632.1995.tb26689.x; LI SW, 1994, J BIOL CHEM, V269, P32558; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Oli MW, 2006, EUKARYOT CELL, V5, P132, DOI 10.1128/EC.5.1.132-139.2006; Park DS, 2003, BIOCHEMISTRY-US, V42, P15124, DOI 10.1021/bi0356348; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; Rubini M, 1997, EXP CELL RES, V230, P284, DOI 10.1006/excr.1996.3430; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; TARTAREDECKERT S, 1995, J BIOL CHEM, V270, P23456, DOI 10.1074/jbc.270.40.23456; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu D, 2003, J BIOL CHEM, V278, P6702, DOI 10.1074/jbc.M209809200; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zaiss DMW, 2002, P NATL ACAD SCI USA, V99, P14344, DOI 10.1073/pnas.212257299; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	46	57	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e340	10.1371/journal.pone.0000340	http://dx.doi.org/10.1371/journal.pone.0000340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406664	Green Published, gold			2022-12-27	WOS:000207445300002
J	Murakami, H; Goto, DB; Toda, T; Chen, ES; Grewal, SI; Martienssen, RA; Yanagida, M				Murakami, Hiroaki; Goto, Derek B.; Toda, Takashi; Chen, Ee Sin; Grewal, Shiv I.; Martienssen, Robert A.; Yanagida, Mitsuhiro			Ribonuclease Activity of Dis3 Is Required for Mitotic Progression and Provides a Possible Link between Heterochromatin and Kinetochore Function	PLOS ONE			English	Article								Background. Cellular RNA metabolism has a broad range of functional aspects in cell growth and division, but its role in chromosome segregation during mitosis is only poorly understood. The Dis3 ribonuclease is a key component of the RNA-processing exosome complex. Previous isolation of the dis3-54 cold-sensitive mutant of fission yeast Schizosaccharomyces pombe suggested that Dis3 is also required for correct chromosome segregation. Methodology/Principal Findings. We show here that the progression of mitosis is arrested in dis3-54, and that segregation of the chromosomes is blocked by activation of the mitotic checkpoint control. This block is dependent on the Mad2 checkpoint protein. Double mutant and inhibitor analyses revealed that Dis3 is required for correct kinetochore formation and function, and that this activity is monitored by the Mad2 checkpoint. Dis3 is a member of the highly conserved RNase II family and is known to be an essential subunit of the exosome complex. The dis3-54 mutation was found to alter the RNaseII domain of Dis3, which caused a reduction in ribonuclease activity in vitro. This was associated with loss of silencing of an ura4(+) reporter gene inserted into the outer repeats (otr) and central core (cnt and imr) regions of the centromere. On the other hand, centromeric siRNA maturation and formation of the RITS RNAi effector complex was normal in the dis3-54 mutant. Micrococcal nuclease assay also suggested the overall chromatin structure of the centromere was not affected in dis3-54 mutant. Conclusions/Significance. RNase activity of Dis3, a core subunit of exosome, was found to be required for proper kinetochore formation and establishment of kinetochore-microtubule interactions. Moreover, Dis3 was suggested to contribute to kinetochore formation through an involvement in heterochromatic silencing at both outer centromeric repeats and within the central core region. This activity is likely monitored by the mitotic checkpoint, and distinct from that of RNAi-mediated heterochromatin formation directly targeting outer centromeric repeats.	[Murakami, Hiroaki; Yanagida, Mitsuhiro] Kyoto Univ, Grad Sch Biostudies, Japan Sci & Technol Corp, CREST Res Program,Dept Gene Mech,Sakyo Ku, Kyoto, Japan; [Goto, Derek B.; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Toda, Takashi] Lincolns Inn Fields Labs, London Res Inst, Canc Res UK, Lab Cell Regulat, London, England; [Chen, Ee Sin; Grewal, Shiv I.] NIH, Mol Cell Biol Lab, Bethesda, MD 20892 USA	Japan Science & Technology Agency (JST); Kyoto University; Cold Spring Harbor Laboratory; Cancer Research UK; National Institutes of Health (NIH) - USA	Yanagida, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Japan Sci & Technol Corp, CREST Res Program,Dept Gene Mech,Sakyo Ku, Kyoto, Japan.	yanagida@kozo.lif.kyoto-u.ac.jp	Goto, Derek B/B-7053-2009	Murakami, Hiroaki/0000-0002-6646-6263	Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Corporation (JST); National Institutes of Health [R01-GM067014]; Life Sciences Research Foundation; Cancer Research UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396, R01GM067014] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Specially Promoted Center of Excellence (COE) grant from the Ministry of Education, Culture, Sports, Science and Technology to M. Y., a Core Research for Evolutional Science and Technology (CREST) research grant from the Japan Science and Technology Corporation (JST) to M. Y., and a grant from the National Institutes of Health (R01-GM067014) to R. M. D. G. was a DOE-Energy Biosciences Research Fellow of the Life Sciences Research Foundation. T. T. is supported by Cancer Research UK.	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Aoki K, 2006, CURR BIOL, V16, P1627, DOI 10.1016/j.cub.2006.06.065; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Coburn GA, 1996, J BIOL CHEM, V271, P1048, DOI 10.1074/jbc.271.2.1048; Ding DQ, 1998, J CELL SCI, V111, P701; Doe CL, 1998, NUCLEIC ACIDS RES, V26, P4222, DOI 10.1093/nar/26.18.4222; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Garcia MA, 2002, EMBO J, V21, P6015, DOI 10.1093/emboj/cdf611; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; HAGAN IM, 1988, J CELL SCI, V89, P343; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jin QW, 2002, MOL CELL BIOL, V22, P7168, DOI 10.1128/MCB.22.20.7168-7183.2002; Kadura S, 2005, MOL BIOL CELL, V16, P385, DOI 10.1091/mbc.E04-07-0558; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; KINOSHITA N, 1991, MOL CELL BIOL, V11, P5839, DOI 10.1128/MCB.11.12.5839; KLAR AJS, 1991, GENETICS, V129, P1033; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lim JT, 1997, CANCER RES, V57, P921; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Minoda A, 2005, MOL BIOL CELL, V16, P316, DOI 10.1091/mbc.E04-06-0519; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; NIWA O, 1989, EMBO J, V8, P3045, DOI 10.1002/j.1460-2075.1989.tb08455.x; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; PATRIDGE JF, 2000, GENE DEV, V14, P783; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; POLIZZI C, 1991, J CELL BIOL, V112, P191, DOI 10.1083/jcb.112.2.191; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Shiomi T, 1998, J BIOCHEM-TOKYO, V123, P883; Shobuike T, 2001, NUCLEIC ACIDS RES, V29, P1326, DOI 10.1093/nar/29.6.1326; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tange Y, 2002, J CELL SCI, V115, P4375, DOI 10.1242/jcs.00135; TODA T, 1983, J MOL BIOL, V168, P251, DOI 10.1016/S0022-2836(83)80017-5; Toyoda Y, 2002, CURR BIOL, V12, P347, DOI 10.1016/S0960-9822(02)00692-9; UMESONO K, 1983, J MOL BIOL, V168, P271, DOI 10.1016/S0022-2836(83)80018-7; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang SW, 2005, MOL CELL BIOL, V25, P2288, DOI 10.1128/MCB.25.6.2288-2296.2005; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; WOODS A, 1989, J CELL SCI, V93, P491; YAMANO H, 1994, EMBO J, V13, P5310, DOI 10.1002/j.1460-2075.1994.tb06865.x; Yanagida M, 2005, PHILOS T R SOC B, V360, P609, DOI 10.1098/rstb.2004.1615; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	65	65	68	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e317	10.1371/journal.pone.0000317	http://dx.doi.org/10.1371/journal.pone.0000317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17380189	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000207445100019
J	Kimura, R; Fujimoto, A; Tokunaga, K; Ohashi, J				Kimura, Ryosuke; Fujimoto, Akihiro; Tokunaga, Katsushi; Ohashi, Jun			A Practical Genome Scan for Population-Specific Strong Selective Sweeps That Have Reached Fixation	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; NATURAL-SELECTION; LINKAGE DISEQUILIBRIUM; ARTIFICIAL SELECTION; RACIAL-DIFFERENCES; SIGNATURES; HITCHHIKING; DENSITY; TISSUE; RACE	Phenotypic divergences between modern human populations have developed as a result of genetic adaptation to local environments over the past 100,000 years. To identify genes involved in population-specific phenotypes, it is necessary to detect signatures of recent positive selection in the human genome. Although detection of elongated linkage disequilibrium (LD) has been a powerful tool in the field of evolutionary genetics, current LD-based approaches are not applicable to already fixed loci. Here, we report a method of scanning for population-specific strong selective sweeps that have reached fixation. In this method, genome-wide SNP data is used to analyze differences in the haplotype frequency, nucleotide diversity, and LD between populations, using the ratio of haplotype homozygosity between populations. To estimate the detection power of the statistics used in this study, we performed computer simulations and found that these tests are relatively robust against the density of typed SNPs and demographic parameters if the advantageous allele has reached fixation. Therefore, we could determine the threshold for maintaining high detection power, regardless of SNP density and demographic history. When this method was applied to the HapMap data, it was able to identify the candidates of population-specific strong selective sweeps more efficiently than the outlier approach that depends on the empirical distribution. This study, confirming strong positive selection on genes previously reported to be associated with specific phenotypes, also identifies other candidates that are likely to contribute to phenotypic differences between human populations.	[Kimura, Ryosuke; Fujimoto, Akihiro; Tokunaga, Katsushi; Ohashi, Jun] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Kimura, Ryosuke] Japan Soc Promot Sci, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science	Kimura, R (corresponding author), Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan.	rkimura@m.u-tokyo.ac.jp	OHASHI, JUN/G-5907-2015; Kimura, Ryosuke/B-3354-2015		Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Ettinger B, 1997, J CLIN ENDOCR METAB, V82, P429, DOI 10.1210/jc.82.2.429; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hanchard NA, 2006, AM J HUM GENET, V78, P153, DOI 10.1086/499252; Harris EF, 2001, AM J PHYS ANTHROPOL, V115, P223, DOI 10.1002/ajpa.1077; Hill JO, 1999, AM J CLIN NUTR, V69, P381; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Kayser M, 2003, MOL BIOL EVOL, V20, P893, DOI 10.1093/molbev/msg092; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Kim Y, 2002, GENETICS, V160, P765; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Morrison JA, 1996, J PEDIATR-US, V129, P637, DOI 10.1016/S0022-3476(96)70142-7; NEEL JV, 1962, AM J HUM GENET, V14, P353; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Payseur BA, 2002, MOL BIOL EVOL, V19, P1143, DOI 10.1093/oxfordjournals.molbev.a004172; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saltin B, 1995, Scand J Med Sci Sports, V5, P315; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; STEVENS J, 1994, J CLIN EPIDEMIOL, V47, P495, DOI 10.1016/0895-4356(94)90296-8; Storz JF, 2004, MOL BIOL EVOL, V21, P1800, DOI 10.1093/molbev/msh192; Taaffe DR, 2001, J BONE MINER RES, V16, P1343, DOI 10.1359/jbmr.2001.16.7.1343; TAJIMA F, 1989, GENETICS, V123, P585; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yanovski JA, 1996, AM J CLIN NUTR, V64, P833, DOI 10.1093/ajcn/64.6.833; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733; Zhang YY, 2005, AM J HUM BIOL, V17, P568, DOI 10.1002/ajhb.20427	48	66	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e286	10.1371/journal.pone.0000286	http://dx.doi.org/10.1371/journal.pone.0000286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356696	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444800009
J	Akhras, MS; Thiyagarajan, S; Villablanca, AC; Davis, RW; Nyren, P; Pourmand, N				Akhras, Michael S.; Thiyagarajan, Sreedevi; Villablanca, Andrea C.; Davis, Ronald W.; Nyren, Pal; Pourmand, Nader			PathogenMip Assay: A Multiplex Pathogen Detection Assay	PLOS ONE			English	Article								The Molecular Inversion Probe (MIP) assay has been previously applied to a large-scale human SNP detection. Here we describe the PathogenMip Assay, a complete protocol for probe production and applied approaches to pathogen detection. We have demonstrated the utility of this assay with an initial set of 24 probes targeting the most clinically relevant HPV genotypes associated with cervical cancer progression. Probe construction was based on a novel, cost-effective, ligase-based protocol. The assay was validated by performing pyrosequencing and Microarray chip detection in parallel experiments. HPV plasmids were used to validate sensitivity and selectivity of the assay. In addition, 20 genomic DNA extracts from primary tumors were genotyped with the PathogenMip Assay results and were in 100% agreement with conventional sequencing using an L1-based HPV genotyping protocol. The PathogenMip Assay is a widely accessible protocol for producing and using highly discriminating probes, with experimentally validated results in pathogen genotyping, which could potentially be applied to the detection and characterization of any microbe.	[Akhras, Michael S.; Thiyagarajan, Sreedevi; Villablanca, Andrea C.; Davis, Ronald W.; Pourmand, Nader] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Akhras, Michael S.; Nyren, Pal] Royal Inst Technol, Dept Biotechnol, Stockholm, Sweden	Stanford University; Royal Institute of Technology	Pourmand, N (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	pourmand@stanford.edu		Pourmand, Nader/0000-0003-0251-9060	National Institutes of Health [PO1-HG000205]; The Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt; The Fulbright Commission; Hans Werthen Foundation; Sixten Gemzeus Scholarship Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt; The Fulbright Commission; Hans Werthen Foundation; Sixten Gemzeus Scholarship Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by a grant from National Institutes of Health (PO1-HG000205). Michael S. Akhras was supported by: The Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt, The Fulbright Commission, Hans Werthen Foundation and Sixten Gemzeus Scholarship Foundation.	Bissonnette L, 2006, EXPERT REV MOL DIAGN, V6, P433, DOI 10.1586/14737159.6.3.433; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; Csako G, 2006, CLIN CHIM ACTA, V363, P6, DOI 10.1016/j.cccn.2005.07.009; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Dufva M, 2005, BIOMOL ENG, V22, P173, DOI 10.1016/j.bioeng.2005.09.003; Eason RG, 2004, P NATL ACAD SCI USA, V101, P11046, DOI 10.1073/pnas.0403672101; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; Gharizadeh B, 2005, INT J ANTIMICROB AG, V26, P486, DOI 10.1016/j.ijantimicag.2005.08.017; GHARIZADEH B, 2006, J BIOTECHNOL; GHARIZADEH B, 2006, MOL CELL PROBES; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Gustafsdottir SM, 2006, CLIN CHEM, V52, P1152, DOI 10.1373/clinchem.2005.065847; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Ji HL, 2006, CANCER RES, V66, P7910, DOI 10.1158/0008-5472.CAN-06-0595; Klaassen CHW, 2004, J CLIN MICROBIOL, V42, P2152, DOI 10.1128/JCM.42.5.2152-2160.2004; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; LANDEGREN U, 1988, SCIENCE, V242, P229, DOI 10.1126/science.3051381; LANDEGREN U, 1993, BIOESSAYS, V15, P761, DOI 10.1002/bies.950151112; Latorra D, 2003, MOL CELL PROBE, V17, P253, DOI 10.1016/S0890-8508(03)00062-8; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058; Nielsen CB, 1999, J BIOMOL STRUCT DYN, V17, P175, DOI 10.1080/07391102.1999.10508352; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Nilsson M, 1997, NAT GENET, V16, P252, DOI 10.1038/ng0797-252; Pettersson E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl103; Pierce SE, 2006, NAT METHODS, V3, P601, DOI 10.1038/NMETH905; Schaeffer AJ, 2004, CANCER RES, V64, P538, DOI 10.1158/0008-5472.CAN-03-0124; Szemes M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni069; Thiyagarajan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-500; Wang YK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni177	35	22	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2007	2	2							e223	10.1371/journal.pone.0000223	http://dx.doi.org/10.1371/journal.pone.0000223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DK	17311101	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444500004
J	Liu, CM; Lin, SH; Chen, YC; Lin, KCM; Wu, TSJ; King, CC				Liu, Chung-Ming; Lin, Shu-Hua; Chen, Ying-Chen; Lin, Katherine Chun-Min; Wu, Tsung-Shu Joseph; King, Chwan-Chuen			Temperature Drops and the Onset of Severe Avian Influenza A H5N1 Virus Outbreaks	PLOS ONE			English	Article								Global influenza surveillance is one of the most effective strategies for containing outbreaks and preparing for a possible pandemic influenza. Since the end of 2003, highly pathogenic avian influenza viruses (HPAI) H5N1 have caused many outbreaks in poultries and wild birds from East Asia and have spread to at least 48 countries. For such a fast and wide-spreading virulent pathogen, prediction based on changes of micro-and macro-environment has rarely been evaluated. In this study, we are developing a new climatic approach by investigating the conditions that occurred before the H5N1 avian influenza outbreaks for early predicting future HPAI outbreaks and preventing pandemic disasters. The results show a temperature drop shortly before these outbreaks in birds in each of the Eurasian regions stricken in 2005 and 2006. Dust storms, like those that struck near China's Lake Qinghai around May 4, 2005, exacerbated the spread of this HPAI H5N1 virus, causing the deaths of a record number of wild birds and triggering the subsequent spread of H5N1. Weather monitoring could play an important role in the early warning of outbreaks of this potentially dangerous virus.	[Liu, Chung-Ming; Lin, Shu-Hua; Chen, Ying-Chen] Natl Taiwan Univ, Global Change Res Ctr, Taipei 10764, Taiwan; [Liu, Chung-Ming] Natl Taiwan Univ, Dept Atmospher Sci, Coll Sci, Taipei 10764, Taiwan; [Lin, Katherine Chun-Min] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Wu, Tsung-Shu Joseph; King, Chwan-Chuen] Natl Taiwan Univ, Inst Epidemiol, Coll Publ Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Liu, CM (corresponding author), Natl Taiwan Univ, Global Change Res Ctr, Taipei 10764, Taiwan.	liucm@ntu.edu.tw; cc_king99@hotmail.com	Wu, Tsung Shu Joseph/K-6138-2018	Wu, Tsung Shu Joseph/0000-0001-6155-9340; King, Chwan-Chuen/0000-0002-6078-2601	National Science Council (NSC) of Republic of China [NSC-95-2621-Z002-004, NSC-95-EPA-Z-002-004, NSC-94-2621-Z002-013, NSC-95-2815-C-002-162-B]	National Science Council (NSC) of Republic of China(Ministry of Science and Technology, Taiwan)	The study was supported by funding grants NSC-95-2621-Z002-004, NSC-95-EPA-Z-002-004, NSC-94-2621-Z002-013 and NSC-95-2815-C-002-162-B from the National Science Council (NSC) of Republic of China.	BROWN IH, 2006, FAO OIE INT SCI C AV; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chretien JP, 2006, LANCET INFECT DIS, V6, P538, DOI 10.1016/S1473-3099(06)70556-4; DOMENECH J, 2006, FAO OIE INT SCI C AV; *FAO, 2006, AVIAN INFLUENZA DIS, V40, P1; FOUCHIER R, 2006, FAO OIE INT SCI C AV; Hangalapura BN, 2006, DEV COMP IMMUNOL, V30, P503, DOI 10.1016/j.dci.2005.07.001; Hangalapura BN, 2004, POULTRY SCI, V83, P1644, DOI 10.1093/ps/83.10.1644; KARESH W, 2006, FAO OIE INT SCI C AV; Liu CM, 2004, TERR ATMOS OCEAN SCI, V15, P999, DOI 10.3319/TAO.2004.15.5.999(ADSE); Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Steensels M, 2006, Verh K Acad Geneeskd Belg, V68, P103; *XFN VIA FORB COM, 2006, CHIN REP 2 NEW AV FL	14	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e191	10.1371/journal.pone.0000191	http://dx.doi.org/10.1371/journal.pone.0000191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17297505	Green Published, Green Submitted, gold			2022-12-27	WOS:000207444300004
J	Pas, ABT; Lopriore, E; Engbers, MJ; Walther, FJ				Pas, Arjan B. te; Lopriore, Enrico; Engbers, Marissa J.; Walther, Frans J.			Early Respiratory Management of Respiratory Distress Syndrome in Very Preterm Infants and Bronchopulmonary Dysplasia: A Case-Control Study	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; BIRTH-WEIGHT INFANTS; DELIVERY ROOM; EXPIRATORY PRESSURE; MANUAL VENTILATION; LUNG INJURY; CHEST-WALL; SURFACTANT; IMPROVE; TRIAL	Background. In the period immediately after birth, preterm infants are highly susceptible to lung injury. Early nasal continuous positive airway pressure (ENCPAP) is an attempt to avoid intubation and may minimize lung injury. In contrast, ENCPAP can fail, and at that time surfactant rescue can be less effective. Objective. To compare the pulmonary clinical course and outcome of very preterm infants (gestational age 25-32 weeks) with respiratory distress syndrome (RDS) who started with ENCPAP and failed (ECF group), with a control group of infants matched for gestational age, who were directly intubated in the delivery room (DRI group). Primary outcome consisted of death during admission or bronchopulmonary dysplasia (BPD). Results. 25 infants were included in the ECF group and 50 control infants matched for gestational age were included in the DRI group. Mean gestational age and birth weight in the ECF group were 29.7 weeks and 1,393 g and in the DRI group 29.1 weeks and 1,261 g (p = NS). The incidence of BPD was significantly lower in the ECF group than in the DRI group (4% vs. 35%; P < 0.004; OR 12.6 (95% CI 1.6-101)). Neonatal mortality was similar in both groups (4%). The incidence of neonatal morbidities such as severe cerebral injury, patent ductus arteriosus, necrotizing enterocolitis and retinopathy of prematurity, was not significantly different between the two groups. Conclusion. A trial of ENCPAP at birth may reduce the incidence of BPD and does not seem to be detrimental in very preterm infants. Randomized controlled trials are needed to test whether early respiratory management of preterm infants with RDS plays an important role in the development of BPD.	[Pas, Arjan B. te; Lopriore, Enrico; Engbers, Marissa J.; Walther, Frans J.] Leiden Univ, Med Ctr, Div Neonatol, Dept Pediat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Pas, ABT (corresponding author), Leiden Univ, Med Ctr, Div Neonatol, Dept Pediat, Leiden, Netherlands.	a.b.te_pas@lumc.nl	Lopriore, Enrico/ABE-3576-2021; pas, arjan te/AAA-9019-2020	Lopriore, Enrico/0000-0002-3513-5066; pas, arjan te/0000-0001-7831-8797; Walther, Frans/0000-0003-1931-159X				Aly H, 2005, PEDIATRICS, V115, P1660, DOI 10.1542/peds.2004-2493; Aly H, 2004, PEDIATRICS, V114, P697, DOI 10.1542/peds.2003-0572-L; Ammari A, 2005, J PEDIATR-US, V147, P341, DOI 10.1016/j.jpeds.2005.04.062; AVERY ME, 1987, PEDIATRICS, V79, P26; BEVILACQUA G, 1993, J PERINAT MED, V21, P329, DOI 10.1515/jpme.1993.21.5.329; Bjorklund LJ, 1997, PEDIATR RES, V42, P348; Bjorklund LJ, 2001, ACTA ANAESTH SCAND, V45, P986, DOI 10.1034/j.1399-6576.2001.450811.x; Donn Steven M, 2003, Semin Neonatol, V8, P441, DOI 10.1016/S1084-2756(03)00124-6; Finer NN, 2004, PEDIATRICS, V114, P651, DOI 10.1542/peds.2004-0394; GERHARDT T, 1980, ACTA PAEDIATR SCAND, V69, P359, DOI 10.1111/j.1651-2227.1980.tb07093.x; Gittermann MK, 1997, EUR J PEDIATR, V156, P384, DOI 10.1007/s004310050620; HELDT GP, 1987, J APPL PHYSIOL, V62, P170, DOI 10.1152/jappl.1987.62.1.170; Hussey SG, 2004, ARCH DIS CHILD-FETAL, V89, pF490, DOI 10.1136/adc.2003.047712; Ikegami M, 2000, PEDIATR RES, V47, P398, DOI 10.1203/00006450-200003000-00019; Ingimarsson J, 2004, INTENS CARE MED, V30, P1446, DOI 10.1007/s00134-004-2227-3; Jobe AH, 2005, J PEDIATR-US, V147, P284, DOI 10.1016/j.jpeds.2005.05.003; Jobe AH, 2002, PEDIATR RES, V52, P387, DOI 10.1203/01.PDR.0000025341.25481.42; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Lindner W, 1999, PEDIATRICS, V103, P961, DOI 10.1542/peds.103.5.961; Morley CJ, 2001, PEDIATRICS, V108, P1383, DOI 10.1542/peds.108.6.1383; ODONNELL CP, 2005, ARCH DIS CHILD FETAL; Perlman JM, 2006, PEDIATRICS, V117, pE978, DOI 10.1542/ped.2006-0350; SOLL RF, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000510, 10.1002/14651858.CD000510]; STEVENS TP, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003063; SUBRAMANIAM P, 2000, COCHRANE DB SYST REV; te Pas AB, 2006, CURR PEDIATR REV, V2, P187, DOI 10.2174/157339606778019693; Thomson MA, 2004, AM J RESP CRIT CARE, V169, P1054, DOI 10.1164/rccm.200309-1276OC; Thomson MA, 2002, BIOL NEONATE, V81, P16, DOI 10.1159/000056766; Van Marter LJ, 2000, PEDIATRICS, V105, P1194, DOI 10.1542/peds.105.6.1194; Verder H, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.2.e24; Wada K, 1997, J APPL PHYSIOL, V83, P1054, DOI 10.1152/jappl.1997.83.4.1054; Yost CC, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001456	32	16	17	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e192	10.1371/journal.pone.0000192	http://dx.doi.org/10.1371/journal.pone.0000192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17285145	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444300005
J	de Wit, H; Cornelisse, LN; Toonen, RFG; Verhage, M				de Wit, Heidi; Cornelisse, L. Niels; Toonen, Ruud F. G.; Verhage, Matthijs			Docking of Secretory Vesicles Is Syntaxin Dependent	PLOS ONE			English	Article								Secretory vesicles dock at the plasma membrane before they undergo fusion. Molecular docking mechanisms are poorly defined but believed to be independent of SNARE proteins. Here, we challenged this hypothesis by acute deletion of the target SNARE, syntaxin, in vertebrate neurons and neuroendocrine cells. Deletion resulted in fusion arrest in both systems. No docking defects were observed in synapses, in line with previous observations. However, a drastic reduction in morphologically docked secretory vesicles was observed in chromaffin cells. Syntaxin-deficient chromaffin cells showed a small reduction in total and plasma membrane staining for the docking factor Munc18-1, which appears insufficient to explain the drastic reduction in docking. The sub-membrane cortical actin network was unaffected by syntaxin deletion. These observations expose a docking role for syntaxin in the neuroendocrine system. Additional layers of regulation may have evolved to make syntaxin redundant for docking in highly specialized systems like synaptic active zones.	[Verhage, Matthijs] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Funct Genom, Amsterdam, Netherlands; Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Verhage, M (corresponding author), Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Funct Genom, Amsterdam, Netherlands.	matthijs@cncr.vu.nl		Toonen, Ruud/0000-0002-9900-4233; Cornelisse, Lennart Niels/0000-0001-9425-2935; verhage, matthijs/0000-0002-6085-7503	Netherlands Organization for Scientific Research (ZonMW Veni) [016-066-101, 970-10-036, 916-036-043, MW-PIO 900-01-001]; NeuroBsik Mouse Phenomics Consortium [BSIK03053]; European Commission (EU) [LSHM-CT-2005-019055]	Netherlands Organization for Scientific Research (ZonMW Veni)(Netherlands Organization for Scientific Research (NWO)); NeuroBsik Mouse Phenomics Consortium; European Commission (EU)(European CommissionEuropean Commission Joint Research Centre)	This research was supported by grants from the Netherlands Organization for Scientific Research (ZonMW Veni grant 016-066-101 to RFGT, GpD 970-10-036 to MV and HdW, ZonMW Veni Grant 916-036-043 to HdW, ZonMW Pionier MW-PIO 900-01-001 to MV), the NeuroBsik Mouse Phenomics Consortium (BSIK03053) and by the European Commission (EU Synapse project, LSHM-CT-2005-019055).	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Capogna M, 1997, J NEUROSCI, V17, P7190; Chieregatti E, 2002, TRAFFIC, V3, P496, DOI 10.1034/j.1600-0854.2002.30706.x; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Marsal J, 1997, P NATL ACAD SCI USA, V94, P14871, DOI 10.1073/pnas.94.26.14871; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Raciborska DA, 1998, EUR J NEUROSCI, V10, P2617, DOI 10.1046/j.1460-9568.1998.00270.x; Reist NE, 1998, J NEUROSCI, V18, P7662; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SCHIAVO G, 1995, J BIOL CHEM, V270, P10566, DOI 10.1074/jbc.270.18.10566; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schutz D, 2005, EUR J NEUROSCI, V21, P2419, DOI 10.1111/j.1460-9568.2005.04095.x; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	48	88	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e126	10.1371/journal.pone.0000126	http://dx.doi.org/10.1371/journal.pone.0000126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205130	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443700020
J	McAllister, BF; Evans, AL				McAllister, Bryant F.; Evans, Amy L.			Increased Nucleotide Diversity with Transient Y Linkage in Drosophila americana	PLOS ONE			English	Article							SEXUALLY ANTAGONISTIC GENES; BACKGROUND SELECTION; GENOME EVOLUTION; SEX-CHROMOSOMES; X-CHROMOSOME; RECOMBINATION; HITCHHIKING; POLYMORPHISM; PATTERNS; MELANOGASTER	Recombination shapes nucleotide variation within genomes. Patterns are thought to arise from the local recombination landscape, influencing the degree to which neutral variation experiences hitchhiking with selected variation. This study examines DNA polymorphism along Chromosome 4 (element B) of Drosophila americana to identify effects of hitchhiking arising as a consequence of Y-linked transmission. A centromeric fusion between the X and 4(th) chromosomes segregates in natural populations of D. americana. Frequency of the X-4 fusion exhibits a strong positive correlation with latitude, which has explicit consequences for unfused 4(th) chromosomes. Unfused Chromosome 4 exists as a non-recombining Y chromosome or as an autosome proportional to the frequency of the X-4 fusion. Furthermore, Y linkage along the unfused 4 is disrupted as a function of the rate of recombination with the centromere. Inter-population and intra-chromosomal patterns of nucleotide diversity were assayed using six regions distributed along unfused 4(th) chromosomes derived from populations with different frequencies of the X-4 fusion. No difference in overall level of nucleotide diversity was detected among populations, yet variation along the chromosome exhibits a distinct pattern in relation to the X-4 fusion. Sequence diversity is inflated at loci experiencing the strongest Y linkage. These findings are inconsistent with the expected reduction in nucleotide diversity resulting from hitchhiking due to background selection or selective sweeps. In contrast, excessive polymorphism is accruing in association with transient Y linkage, and furthermore, hitchhiking with sexually antagonistic alleles is potentially responsible.	[McAllister, Bryant F.] Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Iowa, Roy J Carver Ctr Comparat Genom, Iowa City, IA USA	University of Iowa; University of Iowa	McAllister, BF (corresponding author), Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA.	bryant-mcallister@uiowa.edu	McAllister, Bryant/A-3015-2008		National Science Foundation [DEB-0075295/0228832]; Roy J. Carver Charitable Trust [05-2045]	National Science Foundation(National Science Foundation (NSF)); Roy J. Carver Charitable Trust	This article is based upon work supported by the National Science Foundation under grant Nos. DEB-0075295/0228832 and the Roy J. Carver Charitable Trust under grant No. 05-2045.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bachtrog D, 2000, CURR BIOL, V10, P1025, DOI 10.1016/S0960-9822(00)00656-4; Bachtrog D, 2004, NAT GENET, V36, P518, DOI 10.1038/ng1347; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Barton NH, 2002, GENET RES, V79, P129, DOI 10.1017/S0016672301005493; Baudry E, 2001, GENETICS, V158, P1725; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Berlin S, 2004, P NATL ACAD SCI USA, V101, P15967, DOI 10.1073/pnas.0405126101; BLIGHT WC, 1955, THESIS WASHINGTON U; Charlesworth B, 1997, GENETICS, V145, P989; Charlesworth B, 1996, GENET RES, V68, P131, DOI 10.1017/S0016672300034029; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Cutter AD, 2003, MOL BIOL EVOL, V20, P665, DOI 10.1093/molbev/msg072; ENDLER JA, 1973, SCIENCE, V179, P243, DOI 10.1126/science.179.4070.243; Fay JC, 2000, GENETICS, V155, P1405; FELSENSTEIN J, 1974, GENETICS, V78, P737; Filatov DA, 2000, NATURE, V404, P388, DOI 10.1038/35006057; Filatov DA, 2001, MOL BIOL EVOL, V18, P1442, DOI 10.1093/oxfordjournals.molbev.a003930; FU YX, 1993, GENETICS, V133, P693; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; Greenberg AJ, 2006, MOL BIOL EVOL, V23, P401, DOI 10.1093/molbev/msj045; GUBENKO IS, 1984, GENETICA, V65, P127, DOI 10.1007/BF00135277; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; Haukoos JS, 2005, ACAD EMERG MED, V12, P360, DOI 10.1197/j.aem.2004.11.018; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1995, GENETICS, V141, P1605; HUDSON RR, 1988, GENETICS, V120, P831; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; Innan H, 2003, GENETICS, V165, P2307; Jensen MA, 2002, GENETICS, V160, P493; Kennison J, 2000, DROSOPHILA PROTOCOLS, P111; KIKKAWA H., 1935, CYTOLOGIA, V6, P190, DOI 10.1508/cytologia.6.190; Kim Y, 2000, GENETICS, V155, P1415; KREITMAN M, 1991, GENETICS, V127, P565; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LOZOVSKAYA ER, 1993, CHROMOSOMA, V102, P253, DOI 10.1007/BF00352399; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; McAllister BF, 1999, GENETICS, V153, P221; McAllister BF, 2000, GENETICS, V154, P1711; McAllister BF, 2003, GENETICS, V165, P1317; McAllister BF, 2002, GENOME, V45, P13, DOI 10.1139/g01-112; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Navarro A, 2002, GENETICS, V161, P849; Nordborg M, 1996, GENET RES, V67, P159, DOI 10.1017/S0016672300033619; Nordborg M, 1997, GENETICS, V146, P1501; Nurminsky DI, 1996, MOL BIOL EVOL, V13, P132, DOI 10.1093/oxfordjournals.molbev.a025551; Rice WR, 1998, P NATL ACAD SCI USA, V95, P6217, DOI 10.1073/pnas.95.11.6217; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; RICE WR, 1987, GENETICS, V116, P161; RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.1111/j.1558-5646.1987.tb05864.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schafer MA, 2006, HEREDITY, V97, P291, DOI 10.1038/sj.hdy.6800860; Schlotterer C, 2002, GENETICS, V160, P753; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Scotti I, 2006, EVOLUTION, V60, P1793; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stephan W, 1998, P NATL ACAD SCI USA, V95, P5649, DOI 10.1073/pnas.95.10.5649; Stokes ME, 2000, CATEGORICAL DATA ANA; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TOMINAGA H, 1995, GENETICA, V96, P293, DOI 10.1007/BF01439583; Vieira J, 1997, CHROMOSOMA, V106, P99, DOI 10.1007/s004120050229; Vieira J, 2001, GENETICS, V158, P279; Wang W, 2004, GENETICS, V166, P1783, DOI 10.1534/genetics.166.4.1783; Wang W, 2002, SCIENCE, V295, P134, DOI 10.1126/science.1064521; WIEHE THE, 1993, MOL BIOL EVOL, V10, P842, DOI 10.1093/oxfordjournals.molbev.a040046; Yi SJ, 2000, MOL BIOL EVOL, V17, P703, DOI 10.1093/oxfordjournals.molbev.a026349; Zurovcova M, 1999, GENETICS, V153, P1709	76	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2006	1	2							e112	10.1371/journal.pone.0000112	http://dx.doi.org/10.1371/journal.pone.0000112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DC	17205116	gold, Green Published			2022-12-27	WOS:000207443700006
J	Nilsson, RH; Ryberg, M; Kristiansson, E; Abarenkov, K; Larsson, KH; Koljalg, U				Nilsson, R. Henrik; Ryberg, Martin; Kristiansson, Erik; Abarenkov, Kessy; Larsson, Karl-Henrik; Koljalg, Urmas			Taxonomic Reliability of DNA Sequences in Public Sequence Databases: A Fungal Perspective	PLOS ONE			English	Article							DIVERSITY; IDENTIFICATION; EXAMPLE	Background. DNA sequences are increasingly seen as one of the primary information sources for species identification in many organism groups. Such approaches, popularly known as barcoding, are underpinned by the assumption that the reference databases used for comparison are sufficiently complete and feature correctly and informatively annotated entries. Methodology/Principal Findings. The present study uses a large set of fungal DNA sequences from the inclusive International Nucleotide Sequence Database to show that the taxon sampling of fungi is far from complete, that about 20% of the entries may be incorrectly identified to species level, and that the majority of entries lack descriptive and up-to-date annotations. Conclusions. The problems with taxonomic reliability and insufficient annotations in public DNA repositories form a tangible obstacle to sequence-based species identification, and it is manifest that the greatest challenges to biological barcoding will be of taxonomical, rather than technical, nature.	[Nilsson, R. Henrik; Ryberg, Martin; Larsson, Karl-Henrik] Univ Gothenburg, Dept Plant & Environm Sci, Gothenburg, Sweden; [Kristiansson, Erik] Chalmers Univ Technol, Dept Math Stat, S-41296 Gothenburg, Sweden; [Abarenkov, Kessy; Koljalg, Urmas] Univ Tartu, Inst Bot & Ecol, EE-50090 Tartu, Estonia	University of Gothenburg; Chalmers University of Technology; University of Tartu	Nilsson, RH (corresponding author), Univ Gothenburg, Dept Plant & Environm Sci, Gothenburg, Sweden.	henrik.nilsson@botany.gu.se	Kõljalg, Urmas/H-6925-2015; Kõljalg, Urmas/AAM-7828-2020; Nilsson, R. Henrik/A-6062-2009; Khor, Beesym/B-2832-2010; 赵, 鹏/B-8401-2009; Ryberg, Martin/AHA-1804-2022; Abarenkov, Kessy/H-9611-2015	Kõljalg, Urmas/0000-0002-5171-1668; Nilsson, R. Henrik/0000-0002-8052-0107; Ryberg, Martin/0000-0002-6795-4349; Abarenkov, Kessy/0000-0001-5526-4845	Helge Ax:son Johnson; Wilhelm and Martina Lundgren; Lars Hierta	Helge Ax:son Johnson; Wilhelm and Martina Lundgren; Lars Hierta	This work was supported by the foundations of Helge Ax:son Johnson, Wilhelm and Martina Lundgren, and Lars Hierta.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Bridge PD, 2003, NEW PHYTOL, V160, P43, DOI 10.1046/j.1469-8137.2003.00861.x; Bruns TD, 2004, CAN J BOT, V82, P1122, DOI [10.1139/B04-021, 10.1139/b04-021]; Clapp JP, 2002, MYCORRHIZA, V12, P269, DOI 10.1007/s00572-002-0175-8; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hibbett DS, 2005, SYST BIOL, V54, P660, DOI 10.1080/10635150590947104; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Izzo A, 2005, NEW PHYTOL, V166, P619, DOI 10.1111/j.1469-8137.2005.01354.x; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nilsson RH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-178; Nilsson RH, 2004, BIOINFORMATICS, V20, P1447, DOI 10.1093/bioinformatics/bth119; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schussler A, 2003, MYCORRHIZA, V13, P233, DOI 10.1007/s00572-003-0250-9; Steinke D, 2005, PHILOS T R SOC B, V360, P1975, DOI 10.1098/rstb.2005.1729; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	25	439	461	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e59	10.1371/journal.pone.0000059	http://dx.doi.org/10.1371/journal.pone.0000059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183689	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600059
J	Ralser, M; Heeren, G; Breitenbach, M; Lehrach, H; Krobitsch, S				Ralser, Markus; Heeren, Gino; Breitenbach, Michael; Lehrach, Hans; Krobitsch, Sylvia			Triose Phosphate Isomerase Deficiency Is Caused by Altered Dimerization-Not Catalytic Inactivity-of the Mutant Enzymes	PLOS ONE			English	Article								Triosephosphate isomerase (TPI) deficiency is an autosomal recessive disorder caused by various mutations in the gene encoding the key glycolytic enzyme TPI. A drastic decrease in TPI activity and an increased level of its substrate, dihydroxyacetone phosphate, have been measured in unpurified cell extracts of affected individuals. These observations allowed concluding that the different mutations in the TPI alleles result in catalytically inactive enzymes. However, despite a high occurrence of TPI null alleles within several human populations, the frequency of this disorder is exceptionally rare. In order to address this apparent discrepancy, we generated a yeast model allowing us to perform comparative in vivo analyses of the enzymatic and functional properties of the different enzyme variants. We discovered that the majority of these variants exhibit no reduced catalytic activity per se. Instead, we observed, the dimerization behavior of TPI is influenced by the particular mutations investigated, and by the use of a potential alternative translation initiation site in the TPI gene. Additionally, we demonstrated that the overexpression of the most frequent TPI variant, Glu104Asp, which displays altered dimerization features, results in diminished endogenous TPI levels in mammalian cells. Thus, our results reveal that enzyme deregulation attributable to aberrant dimerization of TPI, rather than direct catalytic inactivation of the enzyme, underlies the pathogenesis of TPI deficiency. Finally, we discovered that yeast cells expressing a TPI variant exhibiting reduced catalytic activity are more resistant against oxidative stress caused by the thiol-oxidizing reagent diamide. This observed advantage might serve to explain the high allelic frequency of TPI null alleles detected among human populations.	[Ralser, Markus; Lehrach, Hans; Krobitsch, Sylvia] Max Planck Inst Mol Genet, Berlin, Germany; [Heeren, Gino; Breitenbach, Michael] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria	Max Planck Society; Salzburg University	Krobitsch, S (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	krobitsc@molgen.mpg.de		Ralser, Markus/0000-0001-9535-7413	FWF [S9302-B05]; European Community [512020]; Max Planck Society	FWF(Austrian Science Fund (FWF)); European Community(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funding: We are grateful to the FWF (Vienna, Austria; project S9302-B05 to M. B.), the European Community (for project MIMAGE, contr. no. 512020; to M. B.), and the Max Planck Society for providing financial support for this project.	Arya R, 1997, HUM MUTAT, V10, P290; Brachmann CB, 1998, YEAST, V14, P115; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; CHANG ML, 1993, AM J HUM GENET, V52, P1260; CIRIACY M, 1979, J BACTERIOL, V139, P152, DOI 10.1128/JB.139.1.152-160.1979; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Compagno C, 1996, BIOTECHNOL PROGR, V12, P591, DOI 10.1021/bp960043c; Concepcion GP, 2005, MED HYPOTHESES, V65, P865, DOI 10.1016/j.mehy.2005.06.006; Costa WMV, 2002, FREE RADICAL BIO MED, V33, P1507, DOI 10.1016/S0891-5849(02)01086-9; DAAR IO, 1986, P NATL ACAD SCI USA, V83, P7903, DOI 10.1073/pnas.83.20.7903; EBER SW, 1991, EUR J PEDIATR, V150, P761, DOI 10.1007/BF02026706; EBER SW, 1984, HUM GENET, V67, P336, DOI 10.1007/BF00291364; EBER SW, 1979, EUR J CLIN INVEST, V9, P195, DOI 10.1111/j.1365-2362.1979.tb00923.x; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gonzalez CI, 2001, GENE, V274, P15, DOI 10.1016/S0378-1119(01)00552-2; Grant CM, 1999, MOL CELL BIOL, V19, P2650; HAMMOND KB, 1991, NEW ENGL J MED, V325, P769, DOI 10.1056/NEJM199109123251104; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Heeren G, 2004, FEMS YEAST RES, V5, P157, DOI 10.1016/j.femsyr.2004.05.008; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Hollan S, 1997, P NATL ACAD SCI USA, V94, P10362, DOI 10.1073/pnas.94.19.10362; HOLLAN S, 1993, HUM GENET, V92, P486, DOI 10.1007/BF00216456; HOLLAN S, 1995, P NATL ACAD SCI USA, V92, P268, DOI 10.1073/pnas.92.1.268; Hollan Susan, 1998, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V192, P929; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Jung JH, 2002, J BIOL CHEM, V277, P48931, DOI 10.1074/jbc.M208806200; Kinoshita T, 2005, ACTA CRYSTALLOGR F, V61, P346, DOI 10.1107/S1744309105008341; Kochetov AV, 2005, MOL GENET GENOMICS, V273, P491, DOI 10.1007/s00438-005-1152-7; Kochetov AV, 2004, MOL GENET GENOMICS, V270, P442, DOI 10.1007/s00438-003-0941-0; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; KOZAK M, 1995, P NATL ACAD SCI USA, V92, P2662, DOI 10.1073/pnas.92.7.2662; KREMS B, 1995, CURR GENET, V27, P427, DOI 10.1007/BF00311211; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Liu JS, 2000, ONCOGENE, V19, P2767, DOI 10.1038/sj.onc.1203599; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; MAITRA PK, 1971, J BIOL CHEM, V246, P475; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; MERKLE S, 1989, GENETICS, V123, P837; MOHRENWEISER HW, 1987, ANN HUM GENET, V51, P303, DOI 10.1111/j.1469-1809.1987.tb01065.x; MOHRENWEISER HW, 1981, P NATL ACAD SCI-BIOL, V78, P5046, DOI 10.1073/pnas.78.8.5046; MOHRENWEISER HW, 1982, PEDIATR RES, V16, P960, DOI 10.1203/00006450-198211000-00012; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NEEL JV, 1988, AM J HUM GENET, V42, P663; Olah J, 2005, BIOCHEM J, V392, P675, DOI 10.1042/BJ20050993; Olah J, 2002, BIOCHEM SOC T, V30, P30, DOI 10.1042/bst0300030; Orosz F, 2000, P NATL ACAD SCI USA, V97, P1026, DOI 10.1073/pnas.97.3.1026; Orosz F, 2001, BLOOD, V98, P3106, DOI 10.1182/blood.V98.10.3106; Orosz F, 1996, J THEOR BIOL, V182, P437, DOI 10.1006/jtbi.1996.0184; Overkamp KM, 2002, APPL ENVIRON MICROB, V68, P2814, DOI 10.1128/AEM.68.6.2814-2821.2002; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; PERRY BA, 1992, HUM GENET, V88, P634, DOI 10.1007/BF02265287; Ralser M, 2005, HUM MOL GENET, V14, P2893, DOI 10.1093/hmg/ddi321; Ralser M, 2005, BIOTECHNIQUES, V39, P165, DOI 10.2144/05392BM01; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; RAVICHANDRAN V, 1994, J BIOL CHEM, V269, P25010; SAWYER TH, 1972, J BIOL CHEM, V247, P6499; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schneider A, 1996, BLOOD CELL MOL DIS, V22, P82, DOI 10.1006/bcmd.1996.0011; SCHNEIDER AS, 1965, NEW ENGL J MED, V272, P229, DOI 10.1056/NEJM196502042720503; Schneider AS, 2000, BEST PRACT RES CL HA, V13, P119, DOI 10.1053/beha.2000.0061; SCHUPPEKOISTINEN I, 1994, EUR J BIOCHEM, V221, P1033, DOI 10.1111/j.1432-1033.1994.tb18821.x; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Shi YH, 2005, J BIOL CHEM, V280, P41805, DOI 10.1074/jbc.M505181200; SNAPKA RM, 1974, COMP BIOCHEM PHYSIOL, V49, P733, DOI 10.1016/0305-0491(74)90259-4; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Valentin C, 2000, BLOOD, V96, P1130; Watanabe M, 1996, AM J HUM GENET, V58, P308; Yamaji R, 2004, ARCH BIOCHEM BIOPHYS, V423, P332, DOI 10.1016/j.abb.2004.01.003	73	61	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e30	10.1371/journal.pone.0000030	http://dx.doi.org/10.1371/journal.pone.0000030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183658	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600030
J	Levine, MT; Begun, DJ				Levine, Mia T.; Begun, David J.			Comparative Population Genetics of the Immunity Gene, Relish: Is Adaptive Evolution Idiosyncratic?	PLOS ONE			English	Article							GLAND PROTEIN GENES; DROSOPHILA; ADH	The frequency of adaptive evolution acting on common loci in distant lineages remains an outstanding question in evolutionary biology. We asked whether the immunity factor, Relish, a gene with a history of directional selection in Drosophila simulans, shows evidence of a similar selective history in other Drosophila species. We found only weak evidence of recurrent adaptive protein evolution at the Relish locus in three sister species pairs, suggesting that this key component of the insect immune system has an idiosyncratic evolutionary history in Drosophila.	[Levine, Mia T.; Begun, David J.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Levine, MT (corresponding author), Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA.	mialevine@ucdavis.edu		Levine, Mia/0000-0003-4311-7535	National Science Foundation [DEB0327049]; National Institute of Health [GM071926]; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071926] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation grant DEB0327049 and National Institute of Health grant GM071926. MTL was supported by a National Science Foundation Graduate Research Fellowship.	AGUADE M, 1989, GENETICS, V122, P607; AGUADE M, 1997, MOL BIOL EVOL, V14, P544; Begun DJ, 2000, GENETICS, V154, P1231; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Charlesworth D, 1998, HEREDITY, V81, P1, DOI 10.1038/sj.hdy.6884000; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; HUDSON RR, 1987, GENETICS, V116, P153; Hughes A, 1999, ADAPTIVE EVOLUTION G, P54; Lindmark H, 2001, J IMMUNOL, V167, P6920, DOI 10.4049/jimmunol.167.12.6920; Llopart A, 2005, GENETICS, V171, P197, DOI 10.1534/genetics.104.033597; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; PERUTZ MF, 1983, MOL BIOL EVOL, V1, P1; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; SCHAEFFER SW, 1991, P NATL ACAD SCI USA, V88, P6097, DOI 10.1073/pnas.88.14.6097; Schaeffer SW, 2001, GENETICS, V159, P673; Soong TW, 2006, TRENDS GENET, V22, P621, DOI 10.1016/j.tig.2006.08.010; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Wagstaff BJ, 2005, GENETICS, V171, P1083, DOI 10.1534/genetics.105.043372; Wagstaff BJ, 2005, MOL BIOL EVOL, V22, P818, DOI 10.1093/molbev/msi067; Yokoyama S, 1996, ANNU REV ECOL SYST, V27, P543, DOI 10.1146/annurev.ecolsys.27.1.543	23	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2007	2	5							e442	10.1371/journal.pone.0000442	http://dx.doi.org/10.1371/journal.pone.0000442			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DY	17505533	Green Published, gold			2022-12-27	WOS:000207445900002
J	Cyrklaff, M; Linaroudis, A; Boicu, M; Chlanda, P; Baumeister, W; Griffiths, G; Krijnse-Locker, J				Cyrklaff, Marek; Linaroudis, Alexandros; Boicu, Marius; Chlanda, Petr; Baumeister, Wolfgang; Griffiths, Gareth; Krijnse-Locker, Jacomine			Whole Cell Cryo-Electron Tomography Reveals Distinct Disassembly Intermediates of Vaccinia Virus	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; INTRACELLULAR CORES; MEMBRANE; ENTRY; DNA; ENVELOPE; RECEPTOR; MODE	At each round of infection, viruses fall apart to release their genome for replication, and then reassemble into stable particles within the same host cell. For most viruses, the structural details that underlie these disassembly and assembly reactions are poorly understood. Cryo-electron tomography (cryo-ET), a unique method to investigate large and asymmetric structures at the near molecular resolution, was previously used to study the complex structure of vaccinia virus (VV). Here we study the disassembly of VV by cryo-ET on intact, rapidly frozen, mammalian cells, infected for up to 60 minutes. Binding to the cell surface induced distinct structural rearrangements of the core, such as a shape change, the rearrangement of its surface spikes and de-condensation of the viral DNA. We propose that the cell surface induced changes, in particular the decondensation of the viral genome, are a prerequisite for the subsequent release of the vaccinia DNA into the cytoplasm, which is followed by its cytoplasmic replication. Generally, this is the first study that employs whole cell cryo-ET to address structural details of pathogen-host cell interaction.	[Cyrklaff, Marek; Linaroudis, Alexandros; Boicu, Marius; Chlanda, Petr; Baumeister, Wolfgang] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Griffiths, Gareth; Krijnse-Locker, Jacomine] European Mol Biol Lab, Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Cyrklaff, M (corresponding author), Max Planck Inst Biochem, Dept Mol Struct Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	cyrklaff@biochem.mpg.de; Krijnse@embl.de	Chlanda, Petr/AAK-6368-2021; Locker, Jacomine Krijnse/E-1009-2016; Locker, Jacomine Krijnse/AAX-1185-2020	Chlanda, Petr/0000-0002-7782-2139; 	EU; DFG [SPP1175]	EU(European Commission); DFG(German Research Foundation (DFG))	JKL is supported by a fifth framework EU grant, MC and JKL by the DFG priority program SPP1175.	ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; ARMSTRONG JA, 1973, J GEN VIROL, V21, P533, DOI 10.1099/0022-1317-21-3-533; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Baumeister W, 2005, PROTEIN SCI, V14, P257, DOI 10.1110/ps.041148605; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; CHANG A, 1976, J GEN VIROL, V32, P275, DOI 10.1099/0022-1317-32-2-275; Cudmore S, 1996, J VIROL, V70, P6909, DOI 10.1128/JVI.70.10.6909-6921.1996; Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102; CYRKLAFF M, 1990, J ELECTRON MICR TECH, V16, P351, DOI 10.1002/jemt.1060160407; DALES S, 1968, VIROLOGY, V35, P564, DOI 10.1016/0042-6822(68)90286-9; Fernandez JJ, 2003, J STRUCT BIOL, V144, P152, DOI 10.1016/j.jsb.2003.09.010; Griffiths G, 2001, J VIROL, V75, P11056, DOI 10.1128/JVI.75.22.11056-11070.2001; Griffiths G, 2001, J VIROL, V75, P11034, DOI 10.1128/JVI.75.22.11034-11055.2001; Grimm R, 1998, BIOPHYS J, V74, P1031, DOI 10.1016/S0006-3495(98)74028-7; Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006; Henderson DA, 1999, SCIENCE, V283, P1279, DOI 10.1126/science.283.5406.1279; Heuser J, 2005, J CELL BIOL, V169, P269, DOI 10.1083/jcb.200412169; Hollinshead M, 1999, J VIROL, V73, P1503, DOI 10.1128/JVI.73.2.1503-1517.1999; HOLOWCZAK JA, 1972, VIROLOGY, V50, P216, DOI 10.1016/0042-6822(72)90362-5; Jensen ON, 1996, J VIROL, V70, P7485, DOI 10.1128/JVI.70.11.7485-7497.1996; JOKLIK WK, 1964, J MOL BIOL, V8, P263, DOI 10.1016/S0022-2836(64)80136-4; KRIJNSELOCKER J, 1999, J CELL BIOL, V144, P267; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497; Mallardo M, 2002, J VIROL, V76, P5167, DOI 10.1128/JVI.76.10.5167-5183.2002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Moss B, 2006, VIROLOGY, V344, P48, DOI 10.1016/j.virol.2005.09.037; MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.biochem.59.1.661; Moss B, 2001, FIELDS VIROLOGY, P2849; Pedersen K, 2000, J VIROL, V74, P3525, DOI 10.1128/JVI.74.8.3525-3536.2000; Roos N, 1996, EMBO J, V15, P2343, DOI 10.1002/j.1460-2075.1996.tb00590.x; Rossmann MG, 2002, TRENDS MICROBIOL, V10, P324, DOI 10.1016/S0966-842X(02)02383-1; SAROV I, 1972, VIROLOGY, V50, P593, DOI 10.1016/0042-6822(72)90410-2; Schramm B, 2006, TRAFFIC, V7, P1352, DOI 10.1111/j.1600-0854.2006.00470.x; Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Sodeik B, 2002, TRENDS MICROBIOL, V10, P15, DOI 10.1016/S0966-842X(01)02256-9; SODEIK B, 1993, J CELL BIOL, V121, P521, DOI 10.1083/jcb.121.3.521; Stewart PL, 2003, ADV PROTEIN CHEM, V64, P455; Tolonen N, 2001, MOL BIOL CELL, V12, P2031, DOI 10.1091/mbc.12.7.2031	42	51	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2007	2	5							e420	10.1371/journal.pone.0000420	http://dx.doi.org/10.1371/journal.pone.0000420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DX	17487274	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445800002
J	Blethrow, JD; Tang, C; Deng, CH; Krutchinsky, AN				Blethrow, Justin D.; Tang, Chao; Deng, Changhui; Krutchinsky, Andrew N.			Modular Mass Spectrometric Tool for Analysis of Composition and Phosphorylation of Protein Complexes	PLOS ONE			English	Article								The combination of high accuracy, sensitivity and speed of single and multiple-stage mass spectrometric analyses enables the collection of comprehensive sets of data containing detailed information about complex biological samples. To achieve these properties, we combined two high-performance matrix-assisted laser desorption ionization mass analyzers in one modular mass spectrometric tool, and applied this tool for dissecting the composition and post-translational modifications of protein complexes. As an example of this approach, we here present studies of the Saccharomyces cerevisiae anaphase-promoting complexes (APC) and elucidation of phosphorylation sites on its components. In general, the modular concept we describe could be useful for assembling mass spectrometers operating with both matrix-assisted laser desorption ionization (MALDI) and electrospray ionization (ESI) ion sources into powerful mass spectrometric tools for the comprehensive analysis of complex biological samples.	[Deng, Changhui; Krutchinsky, Andrew N.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Blethrow, Justin D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Tang, Chao] XProteo Inc, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Krutchinsky, AN (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	krutcha@picasso.ucsf.edu	Deng, Changhui/A-1010-2012		National Institute of Health; Sandler Family Fund	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Fund	This work was supported in part by funding from National Institute of Health and by the Sandler Family Fund. No sponsors or funders were involved in the design and conduct of the study.	Annan RS, 1996, ANAL CHEM, V68, P3413, DOI 10.1021/ac960221g; BASSMANN C, 2006, Patent No. 20060289; Chang EJ, 2004, ANAL CHEM, V76, P4472, DOI 10.1021/ac049637h; Chernushevich IV, 2001, J MASS SPECTROM, V36, P849, DOI 10.1002/jms.207; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ens W, 2005, METHOD ENZYMOL, V402, P49, DOI 10.1016/S0076-6879(05)02002-1; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; Garrett TJ, 2006, ANAL CHEM, V78, P2465, DOI 10.1021/ac0522761; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hager JW, 2002, RAPID COMMUN MASS SP, V16, P512, DOI 10.1002/rcm.607; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Krutchinsky AN, 2000, J AM SOC MASS SPECTR, V11, P493, DOI 10.1016/S1044-0305(00)00114-8; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; Loboda AV, 2003, RAPID COMMUN MASS SP, V17, P2508, DOI 10.1002/rcm.1241; Makarov A, 2006, ANAL CHEM, V78, P2113, DOI 10.1021/ac0518811; Martin RL, 2003, RAPID COMMUN MASS SP, V17, P1358, DOI 10.1002/rcm.1044; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; Odegrip R, 2004, P NATL ACAD SCI USA, V101, P2806, DOI 10.1073/pnas.0400219101; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Purves RW, 1997, J AM SOC MASS SPECTR, V8, P1085, DOI 10.1016/S1044-0305(97)00146-3; Qin J, 1997, ANAL CHEM, V69, P4002, DOI 10.1021/ac970489n; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robeva AS, 1996, BIOCHEM PHARMACOL, V51, P545, DOI 10.1016/0006-2952(95)02235-X; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Sadygov RG, 2004, NAT METHODS, V1, P195, DOI 10.1038/NMETH725; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Schwartz JC, 2002, J AM SOC MASS SPECTR, V13, P659, DOI 10.1016/S1044-0305(02)00384-7; Stafford G, 2002, J AM SOC MASS SPECTR, V13, P589, DOI 10.1016/S1044-0305(02)00385-9; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Vestal ML, 2005, METHOD ENZYMOL, V402, P79, DOI 10.1016/S0076-6879(05)02003-3; Wu JT, 1996, ANAL CHEM, V68, P3388, DOI 10.1021/ac960405v; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; YOST RA, 1978, J AM CHEM SOC, V100, P2274, DOI 10.1021/ja00475a072; YOST RA, 1990, METHOD ENZYMOL, V193, P154, DOI 10.1016/0076-6879(90)93415-H; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015	44	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2007	2	4							e358	10.1371/journal.pone.0000358	http://dx.doi.org/10.1371/journal.pone.0000358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DS	17406682	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445300020
J	Schacherer, J; Ruderfer, DM; Gresham, D; Dolinski, K; Botstein, D; Kruglyak, L				Schacherer, Joseph; Ruderfer, Douglas M.; Gresham, David; Dolinski, Kara; Botstein, David; Kruglyak, Leonid			Genome-Wide Analysis of Nucleotide-Level Variation in Commonly Used Saccharomyces cerevisiae Strains	PLOS ONE			English	Article								Ten years have passed since the genome of Saccharomyces cerevisiae-more precisely, the S288c strain-was completely sequenced. However, experimental work in yeast is commonly performed using strains that are of unknown genetic relationship to S288c. Here, we characterized the nucleotide-level similarity between S288c and seven commonly used lab strains (A364A, W303, FL100, CEN.PK, Sigma 1278b, SK1 and BY4716) using 25mer oligonucleotide microarrays that provide complete and redundant coverage of the similar to 12 Mb Saccharomyces cerevisiae genome. Using these data, we assessed the frequency and distribution of nucleotide variation in comparison to the sequenced reference genome. These data allow us to infer the relationships between experimentally important strains of yeast and provide insight for experimental designs that are sensitive to sequence variation. We propose a rational approach for near complete sequencing of strains related to the reference using these data and directed re-sequencing. These data and new visualization tools are accessible online in a new resource: the Yeast SNPs Browser (YSB; http://gbrowse.princeton.edu/cgi-bin/gbrowse/yeast_strains_snps) that is available to all researchers.	[Schacherer, Joseph; Ruderfer, Douglas M.; Gresham, David; Dolinski, Kara; Botstein, David; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Schacherer, Joseph; Ruderfer, Douglas M.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Gresham, David; Dolinski, Kara; Botstein, David] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu	Ruderfer, Douglas M/M-5795-2016; Dolinski, Kara/GPP-4026-2022	Ruderfer, Douglas M/0000-0002-2365-386X; Dolinski, Kara/0000-0002-7010-0264	National Institute of General Medical Sciences [R01 GM046406, P50 GM071508]; NIH [R37 MH059520]; James S. McDonnell Foundation [99-11T]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046406, P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of General Medical Sciences grant R01 GM046406 and center grant P50 GM071508 (D. B.), NIH grant R37 MH059520 and James S. McDonnell Foundation grant 99-11T (L. K.).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; Brachmann CB, 1998, YEAST, V14, P115; CHARRON MJ, 1986, MOL CELL BIOL, V6, P3891, DOI 10.1128/MCB.6.11.3891; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Gagiano M, 2002, FEMS YEAST RES, V2, P433, DOI 10.1016/S1567-1356(02)00133-2; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HARTWELL LH, 1967, J BACTERIOL, V93, P1662, DOI 10.1128/JB.93.5.1662-1670.1967; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; LACROUTE F, 1968, J BACTERIOL, V95, P824, DOI 10.1128/JB.95.3.824-832.1968; LAMBIE EJ, 1988, CELL, V52, P863, DOI 10.1016/0092-8674(88)90428-X; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; LOUIS EJ, 1990, GENETICS, V124, P533; MORTIMER RK, 1986, GENETICS, V113, P35; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; THOMAS BJ, 1989, GENETICS, V123, P725; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Winzeler EA, 2003, GENETICS, V163, P79; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004	34	84	88	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2007	2	3							e322	10.1371/journal.pone.0000322	http://dx.doi.org/10.1371/journal.pone.0000322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DR	17389913	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445200005
J	Hsiao, CD; You, MS; Guh, YJ; Ma, M; Jiang, YJ; Hwang, PP				Hsiao, Chung-Der; You, May-Su; Guh, Ying-Jey; Ma, Ming; Jiang, Yun-Jin; Hwang, Pung-Pung			A Positive Regulatory Loop between foxi3a and foxi3b Is Essential for Specification and Differentiation of Zebrafish Epidermal Ionocytes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXI1; BRANCHIAL CHLORIDE CELLS; MITOCHONDRIA-RICH CELLS; ACID-BASE REGULATION; XENOPUS-EMBRYOS; DANIO-RERIO; SOMITE DEVELOPMENT; NEURAL INDUCTION; NOTCH LIGANDS; JAGGED GENES	Background. Epidermal ionocytes play essential roles in the transepithelial transportation of ions, water, and acid-base balance in fish embryos before their branchial counterparts are fully functional. However, the mechanism controlling epidermal ionocyte specification and differentiation remains unknown. Methodology/Principal Findings. In zebrafish, we demonstrated that Delta-Notch-mediated lateral inhibition plays a vital role in singling out epidermal ionocyte progenitors from epidermal stem cells. The entire epidermal ionocyte domain of genetic mutants and morphants, which failed to transmit the DeltaC-Notch1a/Notch3 signal from sending cells (epidermal ionocytes) to receiving cells (epidermal stem cells), differentiates into epidermal ionocytes. The low Notch activity in epidermal ionocyte progenitors is permissive for activating winged helix/forkhead box transcription factors of foxi3a and foxi3b. Through gain-and loss-of-function assays, we show that the foxi3a-foxi3b regulatory loop functions as a master regulator to mediate a dual role of specifying epidermal ionocyte progenitors as well as of subsequently promoting differentiation of Na+,K+-ATPase-rich cells and H+-ATPase-rich cells in a concentration-dependent manner. Conclusions/Significance. This study provides a framework to show the molecular mechanism controlling epidermal ionocyte specification and differentiation in a low vertebrate for the first time. We propose that the positive regulatory loop between foxi3a and foxi3b not only drives early ionocyte differentiation but also prevents the complete blockage of ionocyte differentiation when the master regulator of foxi3 function is unilaterally compromised.	[Hsiao, Chung-Der; You, May-Su; Ma, Ming; Jiang, Yun-Jin] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Hsiao, Chung-Der; Guh, Ying-Jey; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Guh, Ying-Jey] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Academia Sinica - Taiwan; National Defense Medical Center	Jiang, YJ (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	yjjiang@imcb.a-star.edu.sg; pphwang@gate.sinica.edu.tw	Jiang, Yun-Jin/E-3995-2010; MA, MING/E-7811-2012; Hsiao, Chung-Der/W-4535-2019; Hwang, Pung-Pung/AAH-1538-2022; Hwang, Pung-Pung/AEQ-4633-2022; hwang, pp/A-3641-2011	Jiang, Yun-Jin/0000-0003-0499-7306; Hsiao, Chung-Der/0000-0002-6398-8672; 	Academia Sinica; National Science Council	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	Visiting scientist schloarship from A-Star and distinguished postdoctoral schloarship from Academia Sinica to CDH; grants from National Science Council and Academia Sinica to PPH.	Ackermann GE, 2003, FRONT BIOSCI-LANDMRK, V8, pD1227, DOI 10.2741/1092; Al-Awqati Q, 2004, J CLIN INVEST, V113, P1528, DOI 10.1172/JCI200422029; Appel B, 1998, DEVELOPMENT, V125, P371; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Briggs JP, 2002, AM J PHYSIOL-REG I, V282, pR3, DOI 10.1152/ajpregu.00589.2001; Canfield VA, 2002, MECH DEVELOP, V116, P51, DOI 10.1016/S0925-4773(02)00135-1; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chang IC, 2001, PHYSIOL BIOCHEM ZOOL, V74, P111, DOI 10.1086/319304; Chen E, 2004, CURR PHARM BIOTECHNO, V5, P409, DOI 10.2174/1389201043376652; COULY G, 1990, DEVELOPMENT, V108, P543; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Dang ZC, 2000, J EXP BIOL, V203, P379; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Deblandre GA, 1999, DEVELOPMENT, V126, P4715; Dornseifer P, 1997, MECH DEVELOP, V63, P159, DOI 10.1016/S0925-4773(97)00037-3; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; GHYSEN A, 1993, BIOESSAYS, V15, P293, DOI 10.1002/bies.950150502; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; GRECO AM, 1995, J EXP BIOL, V198, P2557; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Haddon C, 1998, DEVELOPMENT, V125, P4637; Hans S, 2004, DEVELOPMENT, V131, P5091, DOI 10.1242/dev.01346; Hansen A, 2002, DEV DYNAM, V223, P483, DOI 10.1002/dvdy.10074; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Heitzler P, 1996, DEVELOPMENT, V122, P161; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Herzog W, 2003, DEV BIOL, V254, P36, DOI 10.1016/S0012-1606(02)00124-0; Hiroi J, 2005, J EXP BIOL, V208, P2023, DOI 10.1242/jeb.01611; Hsiao CD, 2002, MECH DEVELOP, V119, pS161, DOI 10.1016/S0925-4773(03)00110-2; Hulander M, 2003, DEVELOPMENT, V130, P2013, DOI 10.1242/dev.00376; HWANG PP, 1985, J EXP ZOOL, V236, P115, DOI 10.1002/jez.1402360202; Imai Y, 2001, GENESIS, V30, P160, DOI 10.1002/gene.1055; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kaneko T, 2002, FISHERIES SCI, V68, P1, DOI 10.1046/j.1444-2906.2002.00382.x; Katoh F, 2003, J EXP BIOL, V206, P793, DOI 10.1242/jeb.00159; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kotrschal K, 1997, CHEM SENSES, V22, P111, DOI 10.1093/chemse/22.2.111; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lantz KA, 2005, CLIN SCI, V108, P195, DOI 10.1042/CS20040309; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Lorent K, 2004, DEVELOPMENT, V131, P5753, DOI 10.1242/dev.01411; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Matsuda Y, 2005, DEVELOPMENT, V132, P2783, DOI 10.1242/dev.01853; Matsuo-Takasaki M, 2005, DEVELOPMENT, V132, P3885, DOI 10.1242/dev.01959; Pan TC, 2005, AM J PHYSIOL-REG I, V289, pR1202, DOI 10.1152/ajpregu.00816.2004; Perry SF, 2003, J EXP ZOOL PART A, V300A, P53, DOI 10.1002/jez.a.10309; Perry SF, 1998, COMP BIOCHEM PHYS A, V119, P9, DOI 10.1016/S1095-6433(97)00411-X; Pujic Z, 2006, DEV BIOL, V293, P330, DOI 10.1016/j.ydbio.2005.12.056; Read EM, 1998, INT J DEV BIOL, V42, P763; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Sakuragui MM, 2003, J COMP PHYSIOL B, V173, P309, DOI 10.1007/s00360-003-0337-9; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 1996, DEVELOPMENT, V123, P165; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Solomon KS, 2003, DEV DYNAM, V228, P301, DOI 10.1002/dvdy.10373; Solomon KS, 2003, DEVELOPMENT, V130, P929, DOI 10.1242/dev.00308; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Takke C, 1999, DEVELOPMENT, V126, P3005; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Varsamos S, 2005, COMP BIOCHEM PHYS A, V141, P401, DOI 10.1016/j.cbpb.2005.01.013; Wall SM, 2005, CURR OPIN NEPHROL HY, V14, P480, DOI 10.1097/01.mnh.0000168390.04520.06; Westin J, 1997, DEV GENES EVOL, V207, P51, DOI 10.1007/s004270050091; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041; Zecchin E, 2005, DEV DYNAM, V233, P638, DOI 10.1002/dvdy.20366	83	114	115	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2007	2	3							e302	10.1371/journal.pone.0000302	http://dx.doi.org/10.1371/journal.pone.0000302			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DQ	17375188	Green Published, Green Submitted, gold			2022-12-27	WOS:000207445100004
J	Nicholls, B; Racey, PA				Nicholls, Barry; Racey, Paul A.			Bats Avoid Radar Installations: Could Electromagnetic Fields Deter Bats from Colliding with Wind Turbines?	PLOS ONE			English	Article							AUDITORY SYSTEM RESPONSE; THRESHOLDS; HEARING; THERMOREGULATION; SENSATIONS; MICROWAVES	Large numbers of bats are killed by collisions with wind turbines, and there is at present no direct method of reducing or preventing this mortality. We therefore determine whether the electromagnetic radiation associated with radar installations can elicit an aversive behavioural response in foraging bats. Four civil air traffic control (ATC) radar stations, three military ATC radars and three weather radars were selected, each surrounded by heterogeneous habitat. Three sampling points matched for habitat type and structure, dominant vegetation species, altitude and surrounding land class were located at increasing distances from each station. A portable electromagnetic field meter measured the field strength of the radar at three distances from the source: in close proximity (<200 m) with a high electromagnetic field (EMF) strength>2 volts/metre, an intermediate point within line of sight of the radar (200-400 m) and with an EMF strength<2 v/m, and a control site out of sight of the radar (>400 m) and registering an EMF of zero v/m. At each radar station bat activity was recorded three times with three independent sampling points monitored on each occasion, resulting in a total of 90 samples, 30 of which were obtained within each field strength category. At these sampling points, bat activity was recorded using an automatic bat recording station, operated from sunset to sunrise. Bat activity was significantly reduced in habitats exposed to an EMF strength of greater than 2 v/m when compared to matched sites registering EMF levels of zero. The reduction in bat activity was not significantly different at lower levels of EMF strength within 400 m of the radar. We predict that the reduction in bat activity within habitats exposed to electromagnetic radiation may be a result of thermal induction and an increased risk of hyperthermia.	[Nicholls, Barry; Racey, Paul A.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	University of Aberdeen	Nicholls, B (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland.	b.nicholls@abdn.ac.uk			Mammals Trust UK (MTUK); Department for Environment, Food and Rural Affairs (DEFRA)	Mammals Trust UK (MTUK); Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA))	Funding for this project was provided by The Mammals Trust UK (MTUK), and the Department for Environment, Food and Rural Affairs (DEFRA).	ADAIR ER, 1983, MICROWAVES THERMOREG, P359; Ahlen I, 2003, WIND TURBINES BATS P; Alcalde J., 2003, BARBASTELLA, V2, P3; Arnett E.B., 2005, RELATIONSHIPS UNPUB; Bach L, 2002, AUSWIRKUNGEN WINDENE; Balmori A, 2005, ELECTROMAGN BIOL MED, V24, P109, DOI 10.1080/15368370500205472; Barlow J, 2003, MAR MAMMAL SCI, V19, P265, DOI 10.1111/j.1748-7692.2003.tb01108.x; Blick DW, 1997, BIOELECTROMAGNETICS, V18, P403, DOI 10.1002/(SICI)1521-186X(1997)18:6<403::AID-BEM1>3.0.CO;2-6; BROWN DO, 1994, BIOELECTROMAGNETICS, V15, P143, DOI 10.1002/bem.2250150206; Burchard JF, 1996, J DAIRY SCI, V79, P1549, DOI 10.3168/jds.S0022-0302(96)76516-5; Curry RC, 2000, P NAT AV WIND POW PL, P18; D'Andrea JA, 2003, BIOELECTROMAGNETICS, pS39, DOI 10.1002/bem.10169; Davydov AF, 2004, J EVOL BIOCHEM PHYS+, V40, P241, DOI 10.1023/B:JOEY.0000042626.18724.9d; DOWNS NC, 1999, BAT RES NEWS, V40, P41; Elder JA, 2003, BIOELECTROMAGNETICS, pS162, DOI 10.1002/bem.10163; ENDL P, 2005, UNTERSUCHUNGEN UNPUB; Erickson W., 2002, SYNTHESIS COMP BASEL; FENTON MB, 1970, CAN J ZOOLOG, V48, P847, DOI 10.1139/z70-148; FOSTER KR, 1974, SCIENCE, V185, P256, DOI 10.1126/science.185.4147.256; FREY AH, 1963, AM J MED ELECTRON, V2, P28; FREY AH, 1962, J APPL PHYSIOL, V17, P689, DOI 10.1152/jappl.1962.17.4.689; FREY AH, 1961, AEROSPACE MED, V32, P1140; GREENBERG B, 1981, BIOELECTROMAGNETICS, V2, P315, DOI 10.1002/bem.2250020404; HENDLER E, 1963, TEMP ITS MEAS, P211; HENSHAW RE, 1966, PHYSIOL ZOOL, V39, P223, DOI 10.1086/physzool.39.3.30152849; HODOS W, 2001, NAT AV WIND POW PLAN, P88; Humphrey SR, 1976, SPECIAL PUBLICATION, V4, P1; Johnson GD, 2003, AM MIDL NAT, V150, P332, DOI 10.1674/0003-0031(2003)150[0332:MOBAAL]2.0.CO;2; Johnson Gregory D., 2005, Bat Research News, V46, P45; Jones G, 2005, CURR BIOL, V15, pR484, DOI 10.1016/j.cub.2005.06.051; JUSTESEN DR, 1979, B NEW YORK ACAD MED, V55, P1058; JUSTESEN DR, 1982, BIOELECTROMAGNETICS, V3, P117, DOI 10.1002/bem.2250030115; Kerns Jessica, 2004, STUDY BIRD BAT COLLI; Kraus SD, 1997, NATURE, V388, P525, DOI 10.1038/41451; Kunz TH, 2003, BAT ECOLOGY, P3; LIN J C, 1976, Journal of Microwave Power, V11, P295; LIN JC, 1977, RADIO SCI, V12, P237, DOI 10.1029/RS012i06Sp00237; Lin JC, 2001, IEEE ANTENN PROPAG M, V43, P166, DOI 10.1109/74.979546; LIN JC, 1990, BIOL EFFECTS MED APP, P275; LIN JC, 2002, MOBILE COMPUT COMMUN, V6, P9; NEUWEILER G, 2000, PHYSIOL ZOOL, V39, P223; REEDER WG, 1951, J MAMMAL, V32, P389, DOI 10.2307/1375787; Ryan BF, 1994, MINITAB HDB; SOMMER HC, 1964, AEROSPACE MED, V35, P834; SPEAKMAN JR, 1994, J THEOR BIOL, V171, P325, DOI 10.1006/jtbi.1994.1235; Timm R.M., 1989, Bulletin of the Chicago Academy of Sciences, V14, P1; TRAXLER A., 2004, VOGELSCHLAG MEIDEVER; Trippel EA, 1999, CAN J FISH AQUAT SCI, V56, P113, DOI 10.1139/cjfas-56-1-113; *UNEP EUROBATS, 2006, AGR CONS POP EUR BAT; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; Wickramasinghe LP, 2004, CONSERV BIOL, V18, P1283, DOI 10.1111/j.1523-1739.2004.00152.x; Zar JH, 1999, BIOSTATISTICAL ANAL	52	24	29	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e297	10.1371/journal.pone.0000297	http://dx.doi.org/10.1371/journal.pone.0000297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17372629	gold, Green Published, Green Submitted			2022-12-27	WOS:000207444800020
J	Smemo, S; Borevitz, JO				Smemo, Scott; Borevitz, Justin O.			Redundancy in Genotyping Arrays	PLOS ONE			English	Article								Despite their unprecedented density, current SNP genotyping arrays contain large amounts of redundancy, with up to 40 oligonucleotide features used to query each SNP. By using publicly available reference genotype data from the International HapMap, we show that 93.6% sensitivity at <5% false positive rate can be obtained with only four probes per SNP, compared with 98.3% with the full data set. Removal of this redundancy will allow for more comprehensive whole-genome association studies with increased SNP density and larger sample sizes.	[Borevitz, Justin O.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Smemo, Scott] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Borevitz, JO (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	borevitz@uchicago.edu	Borevitz, Justin/B-5423-2012	Borevitz, Justin/0000-0001-8408-3699	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; CARVALHO B, 2006, BIOSTATISTICS; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Meaburn E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj027; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741	10	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2007	2	3							e287	10.1371/journal.pone.0000287	http://dx.doi.org/10.1371/journal.pone.0000287			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DN	17356697	Green Published, gold, Green Submitted			2022-12-27	WOS:000207444800010
J	Dorfberger, S; Adi-Japha, E; Karni, A				Dorfberger, Shoshi; Adi-Japha, Esther; Karni, Avi			Reduced Susceptibility to Interference in the Consolidation of Motor Memory before Adolescence	PLOS ONE			English	Article								Are children superior to adults in consolidating procedural memory? This notion has been tied to "critical,'' early life periods of increased brain plasticity. Here, using a motor sequence learning task, we show, in experiment 1, that a) the rate of learning during a training session, b) the gains accrued, without additional practice, within a 24 hours post-training interval (delayed consolidation gains), and c) the long-term retention of these gains, were as effective in 9, 12 and 17-year-olds and comparable to those reported for adults. However, a follow-up experiment showed that the establishment of a memory trace for the trained sequence of movements was significantly more susceptible to interference by a subsequent motor learning experience (practicing a reversed movement sequence) in the 17-year-olds compared to the 9 and 12-year-olds. Unlike the 17-year-olds, the younger age-groups showed significant delayed gains even after interference training. Altogether, our results indicate the existence of an effective consolidation phase in motor learning both before and after adolescence, with no childhood advantage in the learning or retention of a motor skill. However, the ability to co-consolidate different, successive motor experiences, demonstrated in both the 9 and 12-year-olds, diminishes after puberty, suggesting that a more selective memory consolidation process takes over from the childhood one. Only the adult consolidation process is gated by a recency effect, and in situations of multiple, clashing, experiences occurring within a short time-interval, adults may less effectively establish in memory experiences superseded by newer ones.	[Adi-Japha, Esther] Bar Ilan Univ, Sch Educ, Ramat Gan, Israel; [Dorfberger, Shoshi; Karni, Avi] Univ Haifa, Brain Behav Res Ctr, Lab Funct Brain Imaging & Learning Res, IL-31999 Haifa, Israel	Bar Ilan University; University of Haifa	Adi-Japha, E (corresponding author), Bar Ilan Univ, Sch Educ, Ramat Gan, Israel.	esther.japha@gmail.com	/GLU-1786-2022; Adi-Japha, Esther/O-9945-2019	/0000-0001-9757-0031; Adi-Japha, Esther/0000-0001-9757-0031	Wolf Foundation	Wolf Foundation	SD was supported in part by a stipend from the Wolf Foundation.	BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Gaudreau H, 2001, J SLEEP RES, V10, P165, DOI 10.1046/j.1365-2869.2001.00252.x; Gleissner U, 2002, EPILEPSY RES, V51, P287, DOI 10.1016/S0920-1211(02)00158-4; Harrison RV, 2005, DEV PSYCHOBIOL, V46, P252, DOI 10.1002/dev.20052; Hauptmann B, 2002, COGNITIVE BRAIN RES, V13, P313, DOI 10.1016/S0926-6410(01)00124-0; Helmstaedter C, 2002, ANN NEUROL, V52, P89, DOI 10.1002/ana.10260; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; KNUDSEN EI, 1989, J NEUROSCI, V9, P3306; Korman M, 2006, J SLEEP RES, V15, P231; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Maquet P, 2003, LEARN MEMORY, V10, P237, DOI 10.1101/lm.64303; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Meulemans T, 1998, J EXP CHILD PSYCHOL, V69, P199, DOI 10.1006/jecp.1998.2442; Perez LA, 1998, J EXP CHILD PSYCHOL, V70, P167, DOI 10.1006/jecp.1998.2449; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; Robertson EM, 2004, CURR BIOL, V14, pR1061, DOI 10.1016/j.cub.2004.11.048; Roth DAE, 2005, LEARN MEMORY, V12, P159, DOI 10.1101/87505; Sengpiel F, 2001, CURR BIOL, V11, pR647, DOI 10.1016/S0960-9822(01)00383-9; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Siegel DJ, 2001, J AM ACAD CHILD PSY, V40, P997, DOI 10.1097/00004583-200109000-00008; STELMACH GE, 1996, ACQUISITION MOTOR BE, P392; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; Verwey WB, 2004, PSYCHOL RES-PSYCH FO, V68, P64, DOI 10.1007/s00426-003-0144-7; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	38	76	77	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e240	10.1371/journal.pone.0000240	http://dx.doi.org/10.1371/journal.pone.0000240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327907	gold, Green Submitted, Green Published			2022-12-27	WOS:000207444600002
J	Mutschler, I; Schulze-Bonhage, A; Glauche, V; Demandt, E; Speck, O; Ball, T				Mutschler, Isabella; Schulze-Bonhage, Andreas; Glauche, Volkmar; Demandt, Evariste; Speck, Oliver; Ball, Tonio			A Rapid Sound-Action Association Effect in Human Insular Cortex	PLOS ONE			English	Article								Background. Learning to play a musical piece is a prime example of complex sensorimotor learning in humans. Recent studies using electroencephalography (EEG) and transcranial magnetic stimulation (TMS) indicate that passive listening to melodies previously rehearsed by subjects on a musical instrument evokes differential brain activation as compared with unrehearsed melodies. These changes were already evident after 20-30 minutes of training. The exact brain regions involved in these differential brain responses have not yet been delineated. Methodology/Principal Finding. Using functional MRI (fMRI), we investigated subjects who passively listened to simple piano melodies from two conditions: In the 'actively learned melodies' condition subjects learned to play a piece on the piano during a short training session of a maximum of 30 minutes before the fMRI experiment, and in the 'passively learned melodies' condition subjects listened passively to and were thus familiarized with the piece. We found increased fMRI responses to actively compared with passively learned melodies in the left anterior insula, extending to the left fronto-opercular cortex. The area of significant activation overlapped the insular sensorimotor hand area as determined by our meta-analysis of previous functional imaging studies. Conclusions/Significance. Our results provide evidence for differential brain responses to action-related sounds after short periods of learning in the human insular cortex. As the hand sensorimotor area of the insular cortex appears to be involved in these responses, re-activation of movement representations stored in the insular sensorimotor cortex may have contributed to the observed effect. The insular cortex may therefore play a role in the initial learning phase of action-perception associations.	[Mutschler, Isabella; Schulze-Bonhage, Andreas; Ball, Tonio] Univ Hosp Freiburg, Epilepsy Ctr, Freiburg, Germany; [Mutschler, Isabella; Ball, Tonio] Heidelberg Acad Sci & Humanities, Heidelberg, Germany; [Schulze-Bonhage, Andreas; Ball, Tonio] Bernstein Ctr Computat Neurosci Freiburg, Freiburg, Germany; [Demandt, Evariste] Univ Freiburg, Inst Biol 1, D-7800 Freiburg, Germany; [Speck, Oliver] Univ Hosp Freiburg, Dept Diagnost Radiol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Ball, T (corresponding author), Univ Hosp Freiburg, Epilepsy Ctr, Freiburg, Germany.	tonio.ball@uniklinik-freiburg.de	Schulze-Bonhage, Andreas/AAJ-3107-2020; Speck, Oliver/F-1406-2013	Speck, Oliver/0000-0002-6019-5597; Mutschler Collins, Isabella/0000-0003-2738-5943	Heidelberg Academy of Science and Humanities	Heidelberg Academy of Science and Humanities	This research was supported by the Heidelberg Academy of Science and Humanities. The "YAMAHA Stiftung 100 Jahre e. V.'' provided the piano used in the experiments.	Aramaki Y, 2006, CEREB CORTEX, V16, P1338, DOI 10.1093/cercor/bhj075; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Blank SC, 2002, BRAIN, V125, P1829, DOI 10.1093/brain/awf191; Bohning DE, 2001, J NEURAL TRANSM, V108, P35, DOI 10.1007/s007020170095; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Costantini M, 2005, CEREB CORTEX, V15, P1761, DOI 10.1093/cercor/bhi053; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; D'Ausilio A, 2006, EUR J NEUROSCI, V24, P955, DOI 10.1111/j.1460-9568.2006.04960.x; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gerardin E, 2004, NEUROREPORT, V15, P2327, DOI 10.1097/00001756-200410250-00005; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Indovina I, 2001, EXP BRAIN RES, V140, P265, DOI 10.1007/s002210100796; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jantzen KJ, 2002, NEUROSCI LETT, V332, P205, DOI 10.1016/S0304-3940(02)00956-4; Johansen-Berg H, 2002, EXP BRAIN RES, V142, P13, DOI 10.1007/s00221-001-0905-8; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kawashima R, 2000, J NEUROPHYSIOL, V83, P1079, DOI 10.1152/jn.2000.83.2.1079; Kiehl KA, 2005, NEUROIMAGE, V25, P899, DOI 10.1016/j.neuroimage.2004.12.035; Kim JA, 2005, J NEUROPHYSIOL, V94, P2504, DOI 10.1152/jn.01047.2004; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Lamm C, 2001, NEUROIMAGE, V14, P268, DOI 10.1006/nimg.2001.0850; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; LITLE P, 1986, PERS INDIV DIFFER, V7, P575, DOI 10.1016/0191-8869(86)90136-4; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Macar F, 2004, COGNITIVE BRAIN RES, V21, P206, DOI 10.1016/j.cogbrainres.2004.01.005; Maeda F, 2003, PSYCHOPHARMACOLOGY, V168, P359, DOI 10.1007/s00213-002-1216-x; Martin RE, 2004, J NEUROPHYSIOL, V92, P2428, DOI 10.1152/jn.01144.2003; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; MUTSCHLER I, 2005, NEUROFORUM S, V1; MUTSCHLER I, 2006, NEUROIMAGE S1, V31; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; POLLATOS O, 2006, HUM BRAIN MAPP; Saini S, 2004, J NEUROL NEUROSUR PS, V75, P840, DOI 10.1136/jnnp.2003.016782; Stancak A, 2006, NEUROIMAGE, V33, P660, DOI 10.1016/j.neuroimage.2006.06.049; Toma K, 2003, NEUROSCI LETT, V344, P177, DOI 10.1016/S0304-3940(03)00417-8; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Vaillancourt DE, 2003, J NEUROPHYSIOL, V90, P3330, DOI 10.1152/jn.00394.2003; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Wiese H, 2005, NEUROIMAGE, V28, P691, DOI 10.1016/j.neuroimage.2005.06.044; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261	52	73	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2007	2	2							e259	10.1371/journal.pone.0000259	http://dx.doi.org/10.1371/journal.pone.0000259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DL	17327919	Green Published, Green Accepted, gold			2022-12-27	WOS:000207444600019
J	Martin, GR; Wilson, KJ; Wild, JM; Parsons, S; Kubke, MF; Corfield, J				Martin, Graham R.; Wilson, Kerry-Jayne; Wild, J. Martin; Parsons, Stuart; Kubke, M. Fabiana; Corfield, Jeremy			Kiwi Forego Vision in the Guidance of Their Nocturnal Activities	PLOS ONE			English	Article								Background. In vision, there is a trade-off between sensitivity and resolution, and any eye which maximises information gain at low light levels needs to be large. This imposes exacting constraints upon vision in nocturnal flying birds. Eyes are essentially heavy, fluid-filled chambers, and in flying birds their increased size is countered by selection for both reduced body mass and the distribution of mass towards the body core. Freed from these mass constraints, it would be predicted that in flightless birds nocturnality should favour the evolution of large eyes and reliance upon visual cues for the guidance of activity. Methodology/Principal Findings. We show that in Kiwi (Apterygidae), flightlessness and nocturnality have, in fact, resulted in the opposite outcome. Kiwi show minimal reliance upon vision indicated by eye structure, visual field topography, and brain structures, and increased reliance upon tactile and olfactory information. Conclusions/Significance. This lack of reliance upon vision and increased reliance upon tactile and olfactory information in Kiwi is markedly similar to the situation in nocturnal mammals that exploit the forest floor. That Kiwi and mammals evolved to exploit these habitats quite independently provides evidence for convergent evolution in their sensory capacities that are tuned to a common set of perceptual challenges found in forest floor habitats at night and which cannot be met by the vertebrate visual system. We propose that the Kiwi visual system has undergone adaptive regressive evolution driven by the trade-off between the relatively low rate of gain of visual information that is possible at low light levels, and the metabolic costs of extracting that information.	[Martin, Graham R.] Univ Birmingham, Ctr Ornithol, Sch Biosci, Edgbaston, England; [Wilson, Kerry-Jayne] Lincoln Univ, Bioprotect & Ecol Div, Lincoln, NE, New Zealand; [Wild, J. Martin; Kubke, M. Fabiana; Corfield, Jeremy] Univ Auckland, Dept Anat, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Parsons, Stuart; Corfield, Jeremy] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Birmingham; Lincoln University - New Zealand; University of Auckland; University of Auckland	Martin, GR (corresponding author), Univ Birmingham, Ctr Ornithol, Sch Biosci, Edgbaston, England.	g.r.martin@bham.ac.uk	Kubke, Maria Fabiana/E-2472-2011; Kubke, M Fabiana/H-3320-2012	Kubke, Maria Fabiana/0000-0002-3351-5225; Parsons, Stuart/0000-0003-1025-5616	The Royal Society	The Royal Society(Royal Society of London)	The study was funded in part by a grant from The Royal Society to G. R. M.	[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Brooke MD, 1999, P ROY SOC B-BIOL SCI, V266, P405, DOI 10.1098/rspb.1999.0652; Craigie EH, 1930, J COMP NEUROL, V49, P223, DOI 10.1002/cne.900490202; CUNNINGHAM SJ, 2006, FORAGING SIGN BILL M; Davies M.N.O., 1994, P339; DUBBELDAM JL, 1990, NETH J ZOOL, V40, P241; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Gottschaldt K.-M., 1985, P375; GREEN DG, 1980, VISION RES, V20, P827, DOI 10.1016/0042-6989(80)90063-2; Guillemain M, 2002, FUNCT ECOL, V16, P522, DOI 10.1046/j.1365-2435.2002.00652.x; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; HOWLAND HC, 1992, J COMP PHYSIOL A, V170, P687; Iwaniuk AN, 2006, J COMP PHYSIOL A, V192, P1313, DOI 10.1007/s00359-006-0161-2; Jeffery WR, 2005, J HERED, V96, P185, DOI 10.1093/jhered/esi028; Karten H.J., 1967, STEREOTAXIC ATLAS BR; KARTEN HJ, 1973, J COMP NEUROL, V150, P253, DOI 10.1002/cne.901500303; King AS, 1980, FORM FUNCTION BIRDS, P10; Land MF, 2002, ANIMAL EYES; Laughlin SB, 2001, ECOLOGY SENSING, P170; Leys R, 2005, BIOL LETTERS, V1, P496, DOI 10.1098/rsbl.2005.0358; Lythgoe J.N., 1979, ECOLOGY VISION; MARCHANT S, 1990, HDB AUSTR NZ ANTAR 1, V1; Martin G, 2004, NATURWISSENSCHAFTEN, V91, P26, DOI 10.1007/s00114-003-0495-3; Martin GR, 2004, ORNITOL NEOTROP, V15, P233; Martin GR, 2005, NATURWISSENSCHAFTEN, V92, P351, DOI 10.1007/s00114-005-0010-0; Martin GR, 2001, BRAIN BEHAV EVOLUT, V58, P115, DOI 10.1159/000047265; MARTIN GR, 1986, IBIS, V128, P266, DOI 10.1111/j.1474-919X.1986.tb02674.x; Martin GR, 1999, IBIS, V141, P444, DOI 10.1111/j.1474-919X.1999.tb04413.x; Nachtigall P. E., 1988, ANIMAL SONAR PROCESS; Nebel S, 2005, ANIM BIOL, V55, P235, DOI 10.1163/1570756054472818; Piersma T, 1998, P ROY SOC B-BIOL SCI, V265, P1377, DOI 10.1098/rspb.1998.0445; Tennyson Alan J. D., 2003, Records of the Auckland Museum, V40, P55; WENZEL BM, 1968, NATURE, V220, P1133, DOI 10.1038/2201133a0; Wilson K. J., 2004, FLIGHT HUIA ECOLOGY; Worthy T. H., 2002, LOST WORLD MOA PREHI	36	80	81	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2007	2	2							e198	10.1371/journal.pone.0000198	http://dx.doi.org/10.1371/journal.pone.0000198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DI	17332846	Green Submitted, Green Published, gold			2022-12-27	WOS:000207444300010
J	Valdivia, ER; Wu, Y; Li, LC; Cosgrove, DJ; Stephenson, AG				Valdivia, Elene R.; Wu, Yajun; Li, Lian-Chao; Cosgrove, Daniel J.; Stephenson, Andrew G.			A Group-1 Grass Pollen Allergen Influences the Outcome of Pollen Competition in Maize	PLOS ONE			English	Article							IGE-EPITOPES; PERFORMANCE; TUBE; CLONING; GENE; GERMINATION; POPULATION; EXPRESSION; EXPANSINS; PROTEINS	Worldwide, 400 million people suffer from hay fever and seasonal asthma. The major causative agents of these allergies are pollen specific proteins called the group-1 grass pollen allergens. Although details of their antigenicity have been studied for 40 years with an eye towards immunotherapy, their function in the plant has drawn scant attention. Zea m 1 constitutes a class of abundant grass pollen allergens coded for by several genes that loosen the walls of grass cells, including the maize stigma and style. We have examined the impact of a transposon insertion into one of these genes (EXPB1, the most abundant isoform of Zea m 1) on the production of Zea m 1 protein, pollen viability, and pollen tube growth, both in vitro and in vivo. We also examined the effect of the insertional mutation on the competitive ability of the pollen by experimentally varying the sizes of the pollen load deposited onto stigmas using pollen from heterozygous plants and then screening the progeny for the presence of the transposon using PCR. We found that the insertional mutation reduced the levels of Zea m 1 in maize pollen, but had no effect on pollen viability, in vitro pollen tube growth or the proportion of progeny sired when small pollen loads are deposited onto stigmas. However, when large pollen loads are deposited onto the stigmas, the transposon mutation is vastly underrepresented in the progeny, indicating that this major pollen allergen has a large effect on pollen tube growth rates in vivo, and plays an important role in determining the outcome of the pollen-pollen competition for access to the ovules. We propose that the extraordinary abundance (4% of the extractable protein in maize pollen) of this major pollen allergen is the result of selection for a trait that functions primarily in providing differential access to ovules.	[Valdivia, Elene R.; Wu, Yajun; Cosgrove, Daniel J.; Stephenson, Andrew G.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Valdivia, Elene R.; Wu, Yajun; Cosgrove, Daniel J.; Stephenson, Andrew G.] Penn State Univ, Plant Physiol Grad Program, University Pk, PA 16802 USA; [Li, Lian-Chao] Penn State Univ, Huck Inst Life Sci, Prote & Mass Spectrometry Core Facil, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Stephenson, AG (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	as4@psu.edu	/AAE-9630-2019	Valdivia, Elene/0000-0001-6773-0583	NSF [DEB 02-35217]; USDA [2005-35320-15251]; NIH [GM060397]; DOE [DE-FG02-84ER13179]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060397] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by an NSF grant DEB 02-35217 and USDA grant 2005-35320-15251 to A. G. S. and by NIH grant GM060397 and DOE grant DE-FG02-84ER13179 to D.J.C.; E. R. V. was supported in part by an NSF Graduate Research Training grant to D.J.C.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; Arthur KM, 2003, GENETICS, V165, P2137; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Ball T, 2005, FEBS J, V272, P217, DOI 10.1111/j.1432-1033.2004.04403.x; BARNABAS B, 1984, ACTA BOT HUNG, V30, P329; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bernasconi G, 2004, PERSPECT PLANT ECOL, V6, P149, DOI 10.1078/1433-8319-00075; Bernasconi G, 2004, SCIENCE, V303, P971, DOI 10.1126/science.1092180; Brutnell TP, 2002, FUNCT INTEGR GENOMIC, V2, P4, DOI 10.1007/s10142-001-0044-0; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; COSTANUNES JD, 2003, GENOME BIOL, V5; Delph LF, 1997, ECOLOGY, V78, P1632, DOI 10.1890/0012-9658(1997)078[1632:HEFAPP]2.0.CO;2; Falque M, 2005, GENETICS, V170, P1957, DOI 10.1534/genetics.104.040204; GORLA MS, 1994, POLLEN PISTIL INTERA, P230; GRIFFITH IJ, 1991, FEBS LETT, V279, P210, DOI 10.1016/0014-5793(91)80151-R; JOHNSON P, 1965, NATURE, V206, P935, DOI 10.1038/206935b0; JOHNSON P, 1965, EUR POLYM J, V1, P63; Knox B, 1996, TRENDS PLANT SCI, V1, P156, DOI 10.1016/S1360-1385(96)80051-3; KNOX RB, 1993, MOLECULAR BIOLOGY AND IMMUNOLOGY OF ALLERGENS, P31; Laffer S, 1996, MOL IMMUNOL, V33, P417, DOI 10.1016/0161-5890(95)00152-2; Li LC, 2003, PLANT PHYSIOL, V132, P2073, DOI 10.1104/pp.103.020024; MALLEY A, 1962, J ALLERGY, V33, P84, DOI 10.1016/0021-8707(62)90067-9; MARTIN FW, 1959, STAIN TECHNOL, V34, P125, DOI 10.3109/10520295909114663; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; Meeley B., 1995, Maize Genetics Cooperation Newsletter, P82; OTTAVIANO E, 1988, THEOR APPL GENET, V76, P601, DOI 10.1007/BF00260915; Petersen A, 1996, J ALLERGY CLIN IMMUN, V98, P805, DOI 10.1016/S0091-6749(96)70130-6; QUESADA M, 1993, AM NAT, V142, P694, DOI 10.1086/285564; RICH PM, 1989, MANUAL MICROCOMPUTER; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; SCHIEFELBEIN J, 1993, PLANT PHYSIOL, V103, P979, DOI 10.1104/pp.103.3.979; Schreiber S, 2003, Z GASTROENTEROL, V41, P21, DOI 10.1055/s-2003-36662; SHCHERBAN TY, 1995, P NATL ACAD SCI USA, V92, P9245, DOI 10.1073/pnas.92.20.9245; SNOW AA, 1993, ANNU REV ECOL SYST, V24, P331, DOI 10.1146/annurev.es.24.110193.001555; STEPHENSON AG, 1992, ECOLOGY AND EVOLUTION OF PLANT REPRODUCTION, P119; Stephenson AG, 2001, SEX PLANT REPROD, V14, P77, DOI 10.1007/s004970100081; Stephenson AG, 2003, PHILOS T R SOC B, V358, P1009, DOI 10.1098/rstb.2003.1290; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Travers SE, 2000, AM J BOT, V87, P1091, DOI 10.2307/2656645; VALDIVIA ER, 2005, THESIS PENNSYLVANIA; Vejlupkova Z., 2003, Maize Genetics Cooperation Newsletter, P24; Wang W, 2004, SEX PLANT REPROD, V17, P41, DOI 10.1007/s00497-004-0207-y; WILLING RP, 1988, THEOR APPL GENET, V75, P751, DOI 10.1007/BF00265600; Winsor JA, 2000, AM J BOT, V87, P527, DOI 10.2307/2656596; Wu YJ, 2001, PLANT PHYSIOL, V126, P222, DOI 10.1104/pp.126.1.222; Xu ZN, 2006, GENETICS, V172, P1251, DOI 10.1534/genetics.105.050237; ZAMIR D, 1982, GENETICS, V101, P129; ZAMIR D, 1981, THEOR APPL GENET, V59, P235, DOI 10.1007/BF00265501	54	38	41	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2007	2	1							e154	10.1371/journal.pone.0000154	http://dx.doi.org/10.1371/journal.pone.0000154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DF	17225858	Green Published, gold			2022-12-27	WOS:000207444000005
J	Eger, KA; Sundrud, MS; Motsinger, AA; Tseng, M; Van Kaer, L; Unutmaz, D				Eger, Karla A.; Sundrud, Mark S.; Motsinger, Alison A.; Tseng, Michelle; Van Kaer, Luc; Unutmaz, Derya			Human Natural Killer T Cells Are Heterogeneous in Their Capacity to Reprogram Their Effector Functions	PLOS ONE			English	Article								Background. Natural killer T (NKT) cells are a subset of T cells that help potentiate and regulate immune responses. Although human NKT cell subsets with distinct effector functions have been identified, it is unclear whether the effector functions of these subsets are imprinted during development or can be selectively reprogrammed in the periphery. Results. We found that neonatal NKT cells are predominantly CD4+ and express higher levels of CCR7 and CD62L and lower levels of CD94 and CD161 than adult CD4+ or CD4- NKT cell subsets. Accordingly, neonatal NKT cells were more flexible than adult CD4+ NKT cells in their capacity to acquire Th1- or Th2-like functions upon either cytokine-mediated polarization or ectopic expression of the Th1 or Th2 transcription factors T-bet and GATA-3, respectively. Consistent with their more differentiated phenotype, CD4- NKT cells were predominantly resistant to functional reprogramming and displayed higher cytotoxic function. In contrast to conventional T cells, neither the expression of CXCR3 nor the cytotoxic capacity of neonatal NKT cells could be reprogrammed. Conclusions and Significance. Together, these results suggest that neonatal CD4+, adult CD4+, and adult CD4- NKT may represent unique states of maturation and that some functions of human NKT cells may be developmentally imprinted, while others are acquired similar to conventional T cell subsets during peripheral maturation and differentiation. Given the potent immuno-regulatory functions of NKT cells, these findings have important implications for the development of novel NKT cell-based therapeutics and vaccines.	[Eger, Karla A.; Sundrud, Mark S.; Tseng, Michelle; Van Kaer, Luc; Unutmaz, Derya] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Motsinger, Alison A.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Unutmaz, D (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Derya.Unutmaz@med.nyu.edu	Van Kaer, Luc/H-1033-2015; Motsinger-Reif, Alison/I-4167-2018	Van Kaer, Luc/0000-0001-5275-2309; Motsinger-Reif, Alison/0000-0003-1346-2493	National Institutes of Health [AI50953, NS44044, HL68744, GM62758, T32 HL069765, AI054206]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068744, T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This work was supported by National Institutes of Health grants AI50953, NS44044, HL68744 to LVK, GM62758 to AAM, T32 HL069765 to KAE, and AI054206 to DU.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Baev DV, 2004, BLOOD, V104, P4150, DOI 10.1182/blood-2004-04-1629; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Bezbradica JS, 2005, J IMMUNOL, V174, P4696, DOI 10.4049/jimmunol.174.8.4696; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Couedel C, 1998, EUR J IMMUNOL, V28, P4391, DOI 10.1002/(SICI)1521-4141(199812)28:12<4391::AID-IMMU4391>3.0.CO;2-2; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; D'Andrea A, 2000, EUR J IMMUNOL, V30, P1544, DOI 10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO;2-I; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; EMOTO M, 1995, INT IMMUNOL, V7, P1729, DOI 10.1093/intimm/7.11.1729; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; HAHN S, 1995, IMMUNOL REV, V146, P57, DOI 10.1111/j.1600-065X.1995.tb00684.x; Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Joyce S, 2001, CELL MOL LIFE SCI, V58, P442, DOI 10.1007/PL00000869; Kadowaki N, 2001, J EXP MED, V193, P1221, DOI 10.1084/jem.193.10.1221; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Laouar A, 2005, NAT IMMUNOL, V6, P698, DOI 10.1038/ni1212; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Loza MJ, 2002, EUR J IMMUNOL, V32, P3453, DOI 10.1002/1521-4141(200212)32:12<3453::AID-IMMU3453>3.0.CO;2-D; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Matsumoto G, 2004, J IMMUNOL, V173, P4976, DOI 10.4049/jimmunol.173.8.4976; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Metelitsa LS, 2001, J IMMUNOL, V167, P3114, DOI 10.4049/jimmunol.167.6.3114; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Motsinger A, 2003, J VIROL, V77, P8153, DOI 10.1128/JVI.77.14.8153-8158.2003; Nuti S, 1998, EUR J IMMUNOL, V28, P3448, DOI 10.1002/(SICI)1521-4141(199811)28:11<3448::AID-IMMU3448>3.0.CO;2-5; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; Ortaldo JR, 2004, J IMMUNOL, V172, P943, DOI 10.4049/jimmunol.172.2.943; Parekh VV, 2004, J IMMUNOL, V173, P3693, DOI 10.4049/jimmunol.173.6.3693; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Porcelli S, 1996, HUM IMMUNOL, V48, P63, DOI 10.1016/0198-8859(96)00090-0; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sandberg JK, 2004, P NATL ACAD SCI USA, V101, P7058, DOI 10.1073/pnas.0305986101; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Seino K, 2004, FRONT BIOSCI-LANDMRK, V9, P2577, DOI 10.2741/1418; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takahashi T, 2002, J IMMUNOL, V168, P3140, DOI 10.4049/jimmunol.168.7.3140; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Taniguchi M, 2000, SEMIN IMMUNOL, V12, P543, DOI 10.1006/smim.2000.0270; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; van der Vliet HJJ, 2003, CANCER RES, V63, P4101; Van Kaer L, 2005, CURR BIOL, V15, pR429, DOI 10.1016/j.cub.2005.05.032; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Yu KOA, 2005, IMMUNOL LETT, V100, P42, DOI 10.1016/j.imlet.2005.06.010; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	70	35	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e50	10.1371/journal.pone.0000050	http://dx.doi.org/10.1371/journal.pone.0000050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183680	Green Submitted, Green Published, gold			2022-12-27	WOS:000207443600050
J	Kapralov, MV; Filatov, DA				Kapralov, Maxim V.; Filatov, Dmitry A.			Molecular Adaptation during Adaptive Radiation in the Hawaiian Endemic Genus Schiedea	PLOS ONE			English	Article							EVOLUTION; SELECTION; RUBISCO; HYBRIDIZATION; SEQUENCES; SOFTWARE; MATK	Background. "Explosive'' adaptive radiations on islands remain one of the most puzzling evolutionary phenomena. The rate of phenotypic and ecological adaptations is extremely fast during such events, suggesting that many genes may be under fairly strong selection. However, no evidence for adaptation at the level of protein coding genes was found, so it has been suggested that selection may work mainly on regulatory elements. Here we report the first evidence that positive selection does operate at the level of protein coding genes during rapid adaptive radiations. We studied molecular adaptation in Hawaiian endemic plant genus Schiedea (Caryophyllaceae), which includes closely related species with a striking range of morphological and ecological forms, varying from rainforest vines to woody shrubs growing in desert-like conditions on cliffs. Given the remarkable difference in photosynthetic performance between Schiedea species from different habitats, we focused on the "photosynthetic'' Rubisco enzyme, the efficiency of which is known to be a limiting step in plant photosynthesis. Results. We demonstrate that the chloroplast rbcL gene, encoding the large subunit of Rubisco enzyme, evolved under strong positive selection in Schiedea. Adaptive amino acid changes occurred in functionally important regions of Rubisco that interact with Rubisco activase, a chaperone which promotes and maintains the catalytic activity of Rubisco. Interestingly, positive selection acting on the rbcL might have caused favorable cytotypes to spread across several Schiedea species. Significance. We report the first evidence for adaptive changes at the DNA and protein sequence level that may have been associated with the evolution of photosynthetic performance and colonization of new habitats during a recent adaptive radiation in an island plant genus. This illustrates how small changes at the molecular level may change ecological species performance and helps us to understand the molecular bases of extremely fast rate of adaptation during island adaptive radiations.	[Kapralov, Maxim V.; Filatov, Dmitry A.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Filatov, DA (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	D.Filatov@bham.ac.uk		Filatov, Dmitry/0000-0001-8077-5452; Kapralov, Maxim/0000-0001-7966-0295	BBSRC; Biotechnology and Biological Sciences Research Council [BB/C512310/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant from the BBSRC.	ARNOLD ML, 1997, NATURAL HYBRIDISATIO; Avise J, 2004, MOL MARKERS NATURAL; Barrier M, 2001, P NATL ACAD SCI USA, V98, P10208, DOI 10.1073/pnas.181257698; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; DEAN C, 1989, ANNU REV PLANT PHYS, V40, P415, DOI 10.1146/annurev.pp.40.060189.002215; Doiron S, 2002, MOL BIOL EVOL, V19, P1902, DOI 10.1093/oxfordjournals.molbev.a004014; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; Filatov DA, 2004, HEREDITY, V92, P452, DOI 10.1038/sj.hdy.6800440; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hollocher H, 1996, PHILOS T R SOC B, V351, P735, DOI 10.1098/rstb.1996.0068; Kadereit G, 2003, INT J PLANT SCI, V164, P959, DOI 10.1086/378649; Kellogg EA, 1997, AM J BOT, V84, P413, DOI 10.2307/2446015; Kimura M., 1983, NEUTRAL THEORY MOL E; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEWONTIN RC, 1966, EVOLUTION, V20, P315, DOI 10.1111/j.1558-5646.1966.tb03369.x; Machado CA, 2003, P ROY SOC B-BIOL SCI, V270, P1193, DOI 10.1098/rspb.2003.2333; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Morjan CL, 2004, MOL ECOL, V13, P1341, DOI 10.1111/j.1365-294X.2004.02164.x; Nelson D.L., 2005, LEHNINGER PRINCIPLES, DOI DOI 10.1002/BMB.2005.494033010419; Neshich G, 2005, NUCLEIC ACIDS RES, V33, pD269, DOI 10.1093/nar/gki111; NEUHAUS H, 1987, CURR GENET, V11, P251, DOI 10.1007/BF00355398; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Remington DL, 2002, MOL BIOL EVOL, V19, P1563, DOI 10.1093/oxfordjournals.molbev.a004218; ROY II, 2000, PHOTOSYNTHESIS PHYSL, P53; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Satagopan S, 2004, J BIOL CHEM, V279, P14240, DOI 10.1074/jbc.M313215200; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Slatkin M., 1976, P767; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Vogel J, 1997, J MOL BIOL, V270, P179, DOI 10.1006/jmbi.1997.1115; Wagner W.L., 2005, SYST BOT MONOGR, V72, P1; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	47	41	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e8	10.1371/journal.pone.0000008	http://dx.doi.org/10.1371/journal.pone.0000008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183712	Green Published, Green Submitted, gold			2022-12-27	WOS:000207443600008
J	Rachman, H; Kim, N; Ulrichs, T; Baumann, S; Pradl, L; Eddine, AN; Bild, M; Rother, M; Kuban, RJ; Lee, JS; Hurwitz, R; Brinkmann, V; Kosmiadi, GA; Kaufmann, SHE				Rachman, Helmy; Kim, Nayoung; Ulrichs, Timo; Baumann, Sven; Pradl, Lydia; Eddine, Ali Nasser; Bild, Matthias; Rother, Marion; Kuban, Ralf-Juergen; Lee, Jong Seok; Hurwitz, Robert; Brinkmann, Volker; Kosmiadi, George A.; Kaufmann, Stefan H. E.			Critical Role of Methylglyoxal and AGE in Mycobacteria-Induced Macrophage Apoptosis and Activation	PLOS ONE			English	Article								Apoptosis and activation of macrophages play an important role in the host response to mycobacterial infection involving TNF-alpha as a critical autocrine mediator. The underlying mechanisms are still ill-defined. Here, we demonstrate elevated levels of methylglyoxal (MG), a small and reactive molecule that is usually a physiological product of various metabolic pathways, and advanced glycation end products (AGE) during mycobacterial infection of macrophages, leading to apoptosis and activation of macrophages. Moreover, we demonstrate abundant AGE in pulmonary lesions of tuberculosis (TB) patients. Global gene expression profiling of MG-treated macrophages revealed a diverse spectrum of functions induced by MG, including apoptosis and immune response. Our results not only provide first evidence for the involvement of MG and AGE in TB, but also form a basis for novel intervention strategies against infectious diseases in which MG and AGE play critical roles.	[Rachman, Helmy; Kim, Nayoung; Ulrichs, Timo; Baumann, Sven; Pradl, Lydia; Eddine, Ali Nasser; Bild, Matthias; Lee, Jong Seok; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Rother, Marion] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Kuban, Ralf-Juergen] Univ Med Berlin, Charite, Lab Funct Genom, Berlin, Germany; [Hurwitz, Robert; Brinkmann, Volker] Max Planck Inst Infect Biol, Core Facil, Berlin, Germany; [Kosmiadi, George A.] Cent TB Res Inst, Dept Immunol 2, Moscow, Russia	Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Brinkmann, Volker/A-6015-2009; Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268	German Ministry for Science and Technology	German Ministry for Science and Technology	Funding: This work received financial support to SHEK from the German Ministry for Science and Technology (Competence Networks "Pathogenomics" and "Structural Genomics of MTB").	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Abordo EA, 1997, IMMUNOL LETT, V58, P139, DOI 10.1016/S0165-2478(97)00080-1; Akhand AA, 2001, FREE RADICAL BIO MED, V31, P20, DOI 10.1016/S0891-5849(01)00550-0; Chaplen FWR, 1998, P NATL ACAD SCI USA, V95, P5533, DOI 10.1073/pnas.95.10.5533; Chiu BC, 2002, MECH AGEING DEV, V123, P313, DOI 10.1016/S0047-6374(01)00372-4; Davidson SD, 2002, UROL RES, V30, P116, DOI 10.1007/s00240-002-0244-7; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Du J, 2000, J CELL BIOCHEM, V77, P333, DOI 10.1002/(SICI)1097-4644(20000501)77:2<333::AID-JCB15>3.0.CO;2-Q; Du J, 2001, FREE RADICAL BIO MED, V31, P469, DOI 10.1016/S0891-5849(01)00611-6; Fairbairn IP, 2004, BIOCHEM SOC T, V32, P496, DOI 10.1042/BST0320496; Heidland A, 2001, AM J KIDNEY DIS, V38, pS100, DOI 10.1053/ajkd.2001.27414; HEIJST JW, 2005, CANC LETT; Humeny A, 2002, J AGR FOOD CHEM, V50, P2153, DOI 10.1021/jf011349o; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kalapos MP, 1999, BBA-GEN SUBJECTS, V1426, P1, DOI 10.1016/S0304-4165(98)00141-X; Kaneko H, 1999, LAB INVEST, V79, P379; Kang YB, 1996, LEUKEMIA RES, V20, P397, DOI 10.1016/0145-2126(95)00162-X; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Kaufmann SHE, 2002, ANN RHEUM DIS, V61, P54; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Lal MA, 2002, KIDNEY INT, V61, P2006, DOI 10.1046/j.1523-1755.2002.00367.x; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; Law K, 1996, AM J RESP CRIT CARE, V153, P799, DOI 10.1164/ajrccm.153.2.8564135; Mandl-Weber S, 2001, PERITON DIALYSIS INT, V21, P487; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; Mogga SJ, 2002, SCAND J IMMUNOL, V56, P383, DOI 10.1046/j.1365-3083.2002.01140.x; Okado A, 1996, BIOCHEM BIOPH RES CO, V225, P219, DOI 10.1006/bbrc.1996.1157; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Rodriguez- Iturbe B, 2005, J PHARMACOL EXP THER, V315, P51, DOI 10.1124/jpet.105.088062; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; THORNALLEY PJ, 1988, BIOCHEM J, V254, P751, DOI 10.1042/bj2540751; Turner NA, 1998, J MOL CELL CARDIOL, V30, P1789, DOI 10.1006/jmcc.1998.0743; Ulrichs T, 2005, J PATHOL, V205, P633, DOI 10.1002/path.1728; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; YIM HS, 1995, J BIOL CHEM, V270, P28228; Yim MB, 2001, ANN NY ACAD SCI, V928, P48, DOI 10.1111/j.1749-6632.2001.tb05634.x; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291; Zhang YX, 1999, EXP CELL RES, V247, P233, DOI 10.1006/excr.1998.4350	47	55	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e29	10.1371/journal.pone.0000029	http://dx.doi.org/10.1371/journal.pone.0000029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183656	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600029
J	Stubbe, JH; Boomsma, DI; Vink, JM; Cornes, BK; Martin, NG; Skytthe, A; Kyvik, KO; Rose, RJ; Kujala, UM; Kaprio, J; Harris, JR; Pedersen, NL; Hunkin, J; Spector, TD; de Geus, EJC				Stubbe, Janine H.; Boomsma, Dorret I.; Vink, Jacqueline M.; Cornes, Belinda K.; Martin, Nicholas G.; Skytthe, Axel; Kyvik, Kirsten O.; Rose, Richard J.; Kujala, Urho M.; Kaprio, Jaakko; Harris, Jennifer R.; Pedersen, Nancy L.; Hunkin, Janice; Spector, Tim D.; de Geus, Eco J. C.			Genetic Influences on Exercise Participation in 37.051 Twin Pairs from Seven Countries	PLOS ONE			English	Article								Background. A sedentary lifestyle remains a major threat to health in contemporary societies. To get more insight in the relative contribution of genetic and environmental influences on individual differences in exercise participation, twin samples from seven countries participating in the GenomEUtwin project were used. Methodology. Self-reported data on leisure time exercise behavior from Australia, Denmark, Finland, Norway, the Netherlands, Sweden and United Kingdom were used to create a comparable index of exercise participation in each country (60 minutes weekly at a minimum intensity of four metabolic equivalents). Principal Findings. Modest geographical variation in exercise participation was revealed in 85,198 subjects, aged 19-40 years. Modeling of monozygotic and dizygotic twin resemblance showed that genetic effects play an important role in explaining individual differences in exercise participation in each country. Shared environmental effects played no role except for Norwegian males. Heritability of exercise participation in males and females was similar and ranged from 48% to 71% (excluding Norwegian males). Conclusions. Genetic variation is important in individual exercise behavior and may involve genes influencing the acute mood effects of exercise, high exercise ability, high weight loss ability, and personality. This collaborative study suggests that attempts to find genes influencing exercise participation can pool exercise data across multiple countries and different instruments.	[Stubbe, Janine H.; Boomsma, Dorret I.; Vink, Jacqueline M.; Hunkin, Janice; Spector, Tim D.; de Geus, Eco J. C.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Rose, Richard J.; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Skytthe, Axel; Kyvik, Kirsten O.] Univ So Denmark, Inst Publ Hlth, Odense, Denmark; [Cornes, Belinda K.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Harris, Jennifer R.] Norwegian Inst Publ Hlth, Oslo, Norway; St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London, England; [Kaprio, Jaakko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; [Rose, Richard J.] Indiana Univ, Dept Psychol, Bloomington, IN USA; [Kujala, Urho M.] Univ Jyaskyla, Dept Hlth Sci, Jyaskyla, Finland	Vrije Universiteit Amsterdam; University of Helsinki; University of Southern Denmark; QIMR Berghofer Medical Research Institute; Karolinska Institutet; Norwegian Institute of Public Health (NIPH); Guy's & St Thomas' NHS Foundation Trust; Finland National Institute for Health & Welfare; Indiana University System; Indiana University Bloomington; University of Jyvaskyla	Stubbe, JH (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands.	jh.stubbe@psy.vu.nl	de Geus, Eco J.C./M-9318-2015; Spector, Tim D/F-6533-2012; Atkins, Janice L/R-5886-2019; Kyvik, Kirsten O/K-5680-2016; Skytthe, Axel E/G-4820-2019; Boomsma, Dorret I/AAX-4470-2020; Kujala, Urho/AAP-2547-2020; Kaprio, Jaakko/A-1820-2008; Vink, Jacqueline/A-7648-2012	de Geus, Eco J.C./0000-0001-6022-2666; Atkins, Janice L/0000-0003-4919-9068; Kyvik, Kirsten O/0000-0003-2981-0245; Skytthe, Axel E/0000-0002-8629-4913; Kaprio, Jaakko/0000-0002-3716-2455; Kujala, Urho/0000-0002-9262-1992; Martin, Nicholas/0000-0003-4069-8020	Netherlands Organization for Scientific Research [NWO-MW 904-61-193]; European Commission [QLG2-CT-2002-01254]; NIAA (USA) [AA07535, AA013320, AA013326]; NHMRC (Australia) [941177, 951023, 950998, 981339, 241916, 941944]; National Institute on Alcohol Abuse and Alcoholism [AA08315, AA12502]; Academy of Finland [44069, 100499]; Wellcome Trust; Arthritis & Rheumatism Campaign; Norwegian Research Council; Norwegian Foundation for Health and Rehabilitation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA012502, R01AA013326, R01AA013320, R01AA012502, R01AA007535, R01AA008315] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); NIAA (USA); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Academy of Finland(Academy of Finland); Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis & Rheumatism Campaign; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Foundation for Health and Rehabilitation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by the Netherlands Organization for Scientific Research (NWO-MW 904-61-193) and the European Commission under 'Quality of Life and Management of the Living Resources' of the Fifth Framework Program (GenomEUtwin QLG2-CT-2002-01254). The Australian work was carried out in corporation with the Australian Twin Registry, and was supported in part by grants from NIAA (USA) AA07535, AA013320, AA013326, NHMRC (Australia) 941177, 951023, 950998, 981339, 241916 and 941944. The Finnish Twin Cohort has been supported by the National Institute on Alcohol Abuse and Alcoholism (grants AA08315 & AA12502) and the Academy of Finland (grants 44069 & 100499). The British TwinsUK study is supported by the Wellcome Trust and the Arthritis & Rheumatism Campaign. The Norwegian Institute of Public Health program of twin research is supported by grants from the Norwegian Research Council and the Norwegian Foundation for Health and Rehabilitation.	Aarnio M, 1997, INT J SPORTS MED, V18, P549, DOI 10.1055/s-2007-972680; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Beunen G, 1999, INT J OBESITY, V23, pS55, DOI 10.1038/sj.ijo.0800885; BLAIR SN, 1995, B WORLD HEALTH ORGAN, V73, P135; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Boomsma DI, 2002, TWIN RES, V5, P401, DOI 10.1375/twin.5.5.401; BOOMSMA DI, 1989, BEHAV GENET, V19, P123, DOI 10.1007/BF01065888; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; CAMACHO TC, 1991, AM J EPIDEMIOL, V134, P220, DOI 10.1093/oxfordjournals.aje.a116074; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Davis JM, 1997, MED SCI SPORT EXER, V29, P45, DOI 10.1097/00005768-199701000-00008; DISHMAN RK, 1985, PUBLIC HEALTH REP, V100, P158; Etnier JL, 1997, J SPORT EXERCISE PSY, V19, P249, DOI 10.1123/jsep.19.3.249; FALCONER DS, 1996, INTRO QUANTITATIVE G, P311; FARMER ME, 1988, AM J EPIDEMIOL, V128, P1340, DOI 10.1093/oxfordjournals.aje.a115087; Gauvin L, 1996, NUTR REV, V54, pS53; Haase A, 2004, PREV MED, V39, P182, DOI 10.1016/j.ypmed.2004.01.028; Halliwill J R, 2001, Exerc Sport Sci Rev, V29, P65, DOI 10.1097/00003677-200104000-00005; Harris JR, 2002, TWIN RES, V5, P415, DOI 10.1375/136905202320906192; Hillman CH, 2004, RES Q EXERCISE SPORT, V75, P176, DOI 10.1080/02701367.2004.10609149; KAPLAN GA, 1991, AM J PREV MED, V7, P12, DOI 10.1016/S0749-3797(18)30959-0; Kaplan GA, 1996, AM J EPIDEMIOL, V144, P793, DOI 10.1093/oxfordjournals.aje.a009003; Kaprio J, 2002, TWIN RES, V5, P366, DOI 10.1375/136905202320906101; Kaprio J, 1981, Prog Clin Biol Res, V69 Pt C, P37; Kesaniemi YA, 2001, MED SCI SPORT EXER, V33, pS351; KING AC, 1992, MED SCI SPORT EXER, V24, pS221; Koopmans J. R., 1994, GENETIC FACTORS CORO, P217, DOI [DOI 10.1007/978-94-011-1130-0, 10.1007/978-94-011-1130-0]; Kujala UM, 2002, AM J EPIDEMIOL, V156, P985, DOI 10.1093/aje/kwf151; Kupper N, 2005, PSYCHOPHYSIOLOGY, V42, P202, DOI 10.1111/j.1469-8986.2005.00276.x; Lauderdale DS, 1997, MED SCI SPORT EXER, V29, P1062, DOI 10.1097/00005768-199708000-00012; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Maia JAR, 2002, AM J PREV MED, V23, P87, DOI 10.1016/S0749-3797(02)00478-6; Martinez-Gonzalez MA, 2001, MED SCI SPORT EXER, V33, P1142, DOI 10.1097/00005768-200107000-00011; Matson-Koffman DM, 2005, AM J HEALTH PROMOT, V19, P167, DOI 10.4278/0890-1171-19.3.167; Mulder EJ, 2003, TWIN RES, V6, P422, DOI 10.1375/twin.6.5.422; NEALE MC, 1992, METHODOLOGY GENETICS; Orleans CT, 2003, ANN BEHAV MED, V25, P77, DOI 10.1207/S15324796ABM2502_02; Payne N, 2005, BRIT J HEALTH PSYCH, V10, P115, DOI 10.1348/135910704X14636; PERUSSE L, 1989, AM J EPIDEMIOL, V129, P1012, DOI 10.1093/oxfordjournals.aje.a115205; Plomin R., 2000, BEHAV GENETICS; Rankinen T, 2004, MED SCI SPORT EXER, V36, P1451, DOI 10.1249/01.MSS.0000139902.42385.5F; Richards M, 2003, SOC SCI MED, V56, P785, DOI 10.1016/S0277-9536(02)00075-8; Rowland TW, 1998, MED SCI SPORT EXER, V30, P392, DOI 10.1097/00005768-199803000-00009; SALLIS JF, 1988, J BEHAV MED, V11, P31, DOI 10.1007/BF00846167; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Seefeldt V, 2002, SPORTS MED, V32, P143, DOI 10.2165/00007256-200232030-00001; SHEPHARD RJ, 1985, SPORTS MED, V2, P348, DOI 10.2165/00007256-198502050-00004; Sherwood NE, 2000, ANNU REV NUTR, V20, P21, DOI 10.1146/annurev.nutr.20.1.21; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Simonen R, 2004, MED SCI SPORT EXER, V36, P1559, DOI 10.1249/01.MSS.0000074670.03001.98; Simonen RL, 2003, PHYSIOL BEHAV, V78, P751, DOI 10.1016/S0031-9384(03)00084-2; Simonen RL, 2002, MED SCI SPORT EXER, V34, P1137, DOI 10.1097/00005768-200207000-00014; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Steptoe A, 1996, LANCET, V347, P1789, DOI 10.1016/S0140-6736(96)91616-5; Stubbe JH, 2005, MED SCI SPORT EXER, V37, P563, DOI 10.1249/01.MSS.0000158181.75442.8B; Tergerson JL, 2002, J SCHOOL HEALTH, V72, P374, DOI 10.1111/j.1746-1561.2002.tb03562.x; Thomis MA, 1997, J APPL PHYSIOL, V82, P959, DOI 10.1152/jappl.1997.82.3.959; Thorburn A W, 2000, Obes Rev, V1, P87, DOI 10.1046/j.1467-789x.2000.00018.x; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; van Loon AJM, 2000, INT J EPIDEMIOL, V29, P785, DOI 10.1093/ije/29.5.785; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; WEYERER S, 1992, INT J SPORTS MED, V13, P492, DOI 10.1055/s-2007-1021304; Wilmore JH, 1999, AM J CLIN NUTR, V70, P346; Wolfarth B, 2005, MED SCI SPORT EXER, V37, P881, DOI 10.1249/01.mss.0000168663.55604.1d; Yeung RR, 1996, J PSYCHOSOM RES, V40, P123, DOI 10.1016/0022-3999(95)00554-4	66	185	189	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e22	10.1371/journal.pone.0000022	http://dx.doi.org/10.1371/journal.pone.0000022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183649	Green Published, gold			2022-12-27	WOS:000207443600022
J	Van Bocxlaer, I; Roelants, K; Biju, SD; Nagaraju, J; Bossuyt, F				Van Bocxlaer, Ines; Roelants, Kim; Biju, S. D.; Nagaraju, J.; Bossuyt, Franky			Late Cretaceous Vicariance in Gondwanan Amphibians	PLOS ONE			English	Article							BIOGEOGRAPHY; DISPERSAL; RADIATION; DIVERSIFICATION; EVOLUTION; TIME; DNA	Overseas dispersals are often invoked when Southern Hemisphere terrestrial and freshwater organism phylogenies do not fit the sequence or timing of Gondwana fragmentation. We used dispersal-vicariance analyses and molecular timetrees to show that two species-rich frog groups, Microhylidae and Natatanura, display congruent patterns of spatial and temporal diversification among Gondwanan plates in the Late Cretaceous, long after the presumed major tectonic break-up events. Because amphibians are notoriously salt-intolerant, these analogies are best explained by simultaneous vicariance, rather than by oceanic dispersal. Hence our results imply Late Cretaceous connections between most adjacent Gondwanan landmasses, an essential concept for biogeographic and palaeomap reconstructions.	[Van Bocxlaer, Ines; Roelants, Kim; Biju, S. D.; Bossuyt, Franky] Vrije Univ Brussel, Dept Biol, Unit Ecol & Systemat, Brussels, Belgium; [Biju, S. D.] Univ Delhi, Sch Environm Studies, CEMDE, Delhi 110007, India; [Nagaraju, J.] Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Hyderabad, Andhra Pradesh, India	Vrije Universiteit Brussel; University of Delhi; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Bossuyt, F (corresponding author), Vrije Univ Brussel, Dept Biol, Unit Ecol & Systemat, Brussels, Belgium.	fbossuyt@vub.ac.be	Van Bocxlaer, Ines/L-4852-2015	Bossuyt, Franky/0000-0001-6804-9271; Roelants, Kim/0000-0001-5367-5958	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen;  [FWO 1.5.039.03N];  [FWO G. 0056.03];  [FWO G. 0307.04];  [VUB OZR834]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); ; ; ; 	Ines Van Bocxlaer is supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). Franky Bossuyt receives a postdoctoral fellowship from the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. This work was supported by research grants FWO 1.5.039.03N, FWO G. 0056.03, FWO G. 0307.04 and VUB OZR834.	[Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Bossuyt F, 2001, SCIENCE, V292, P93, DOI 10.1126/science.1058875; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Briggs JC, 2003, J BIOGEOGR, V30, P381, DOI 10.1046/j.1365-2699.2003.00809.x; Chatterjee S, 1999, P INDIAN NATL SCI A, V65, P397; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Dubois Alain, 2006, Alytes (Paris), V24, P1; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hay W.W., 1999, GEOL SOC AM SPEC PAP, V332, P1, DOI 10.1130/0-8137-2332-9.1; Hill RV, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)395<0001:ANSOPG>2.0.CO;2; Karanth KP, 2006, CURR SCI INDIA, V90, P789; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; McCarthy D, 2005, J BIOGEOGR, V32, P2161, DOI 10.1111/j.1365-2699.2005.01355.x; Parker H. W., 1934, MONOGRAPH FROGS FAMI, P1; PATRIAT P, 1988, TECTONOPHYSICS, V155, P211, DOI 10.1016/0040-1951(88)90267-3; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Rage JC, 2003, ACTA PALAEONTOL POL, V48, P661; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Savage J.M., 1973, EVOLUTIONARY BIOL AN, P351; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Upchurch P, 2002, GEOBIOS-LYON, V35, P277, DOI 10.1016/S0016-6995(02)00065-7; van der Meijden A, 2005, MOL PHYLOGENET EVOL, V37, P674, DOI 10.1016/j.ympev.2005.05.001; Vences M, 2003, P ROY SOC B-BIOL SCI, V270, P2435, DOI 10.1098/rspb.2003.2516; MAT METHODS AVAILABL	39	118	124	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2006	1	1							e74	10.1371/journal.pone.0000074	http://dx.doi.org/10.1371/journal.pone.0000074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DB	17183706	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443600074
J	Chen, L; Jha, P; Stirling, B; Sgaier, SK; Daid, T; Kaul, R; Nagelkerke, N				Chen, Li; Jha, Prabhat; Stirling, Bridget; Sgaier, Sema K.; Daid, Tina; Kaul, Rupert; Nagelkerke, Nico		Int Studies HIV AIDS ISHA Investig	Sexual Risk Factors for HIV Infection in Early and Advanced HIV Epidemics in Sub-Saharan Africa: Systematic Overview of 68 Epidemiological Studies	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX VIRUS-2; DAR-ES-SALAAM; REPRODUCTIVE-TRACT INFECTIONS; DISTANCE TRUCK-DRIVERS; GENITAL-ULCER-DISEASE; BASE-LINE SURVEY; TRANSMITTED-DISEASES; MALE CIRCUMCISION; PREGNANT-WOMEN	Background. It is commonly assumed that sexual risk factors for heterosexual HIV transmission in sub-Saharan Africa, such as multi-partner sex, paid sex and co-infections, become less important as HIV epidemics mature and prevalence increases. Methods and Findings. We conducted a systematic review of 68 African epidemiological studies from 1986 to 2006 involving 17,000 HIV positive adults and 73,000 controls. We used random-effects methods and stratified results by gender, time, background HIV prevalence rates and other variables. The number of sex partners, history of paid sex, and infection with herpes simplex virus (HSV-2) or other sexually-transmitted infections (STIs) each showed significant associations with HIV infection. Among the general population, the odds ratio (OR) of HIV infection for women reporting 3+ sex partners versus 0-2 was 3.64 (95% CI [2.87-4.62]), with similar risks for men. About 9% of infected women reported ever having been paid for sex, versus 4% of control women (OR = 2.29, [1.45-3.62]). About 31% of infected men reported ever paying for sex versus 18% of uninfected men (OR = 1.75, [1.30-2.36]). HSV-2 infection carried the largest risk of HIV infection: OR = 4.62, [2.85-7.47] in women, and OR = 6.97, [4.68-10.38] in men. These risks changed little over time and stratification by lower and higher HIV background prevalence showed that risk ratios for most variables were larger in high prevalence settings. Among uninfected controls, the male-female differences in the number of sex partners and in paid sex were more extreme in the higher HIV prevalence settings than in the lower prevalence settings. Significance. Multi-partner sex, paid sex, STIs and HSV-2 infection are as important to HIV transmission in advanced as in early HIV epidemics. Even in high prevalence settings, prevention among people with high rates of partner change, such as female sex workers and their male clients, is likely to reduce transmission overall.	[Chen, Li; Jha, Prabhat; Stirling, Bridget; Sgaier, Sema K.; Daid, Tina] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Stirling, Bridget] Univ Victoria, Div Med Sci, Isl Med Program, Victoria, BC, Canada; [Kaul, Rupert] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Kaul, Rupert] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada; [Nagelkerke, Nico] Al Ain Univ, Dept Community Med, Al Ain, U Arab Emirates	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Victoria; University of Nairobi; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	prabhat.jha@utoronto.ca		Kaul, Rupert/0000-0002-1586-4093; Wang, Yu/0000-0001-7935-9902	Canadian Institutes of Health Research [123821]; Bill and Melinda Gates Foundation [39922]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Supported in part by research grants from the Canadian Institutes of Health Research (no 123821), and the Bill and Melinda Gates Foundation (no 39922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams KR, 2000, METHODS METAANALYSIS; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; ALLEN S, 1991, JAMA-J AM MED ASSOC, V266, P1657, DOI 10.1001/jama.266.12.1657; Ao TTH, 2006, SEX TRANSM DIS, V33, P163, DOI 10.1097/01.olq.0000187204.57006.b3; Aseffa A, 1998, EPIDEMIOL INFECT, V120, P171, DOI 10.1017/S0950268897008595; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, P885, DOI 10.1097/00002030-200105040-00009; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; BASSETT MT, 1992, J ACQ IMMUN DEF SYND, V5, P556; Bassett MT, 1996, J ACQ IMMUN DEF SYND, V13, P287, DOI 10.1097/00042560-199611010-00012; BERKLEY SF, 1989, J INFECT DIS, V160, P22, DOI 10.1093/infdis/160.1.22; Boerma JT, 2003, SEX TRANSM DIS, V30, P779, DOI 10.1097/01.OLQ.0000078820.62897.A6; Bogaerts J, 1998, INT J STD AIDS, V9, P706, DOI 10.1258/0956462981921242; Breslow NE, 1980, IARC SCI PUBL, V32; BULTERYS M, 1994, AIDS, V8, P1585, DOI 10.1097/00002030-199411000-00010; BWAYO J, 1994, ARCH INTERN MED, V154, P1391, DOI 10.1001/archinte.154.12.1391; BWAYO JJ, 1991, E AFR MED J, V68, P425; CARAEL M, 1988, AIDS, V2, P201; Carpenter LM, 2002, J ACQ IMMUN DEF SYND, V29, P174, DOI 10.1097/00042560-200202010-00011; CARSWELL JW, 1989, AIDS, V3, P759, DOI 10.1097/00002030-198911000-00013; CHAO A, 1994, INT J EPIDEMIOL, V23, P371, DOI 10.1093/ije/23.2.371; Chen CY, 2000, SEX TRANSM DIS, V27, P21, DOI 10.1097/00007435-200001000-00005; Cleland J, 2004, SEX TRANSM INFECT, V80, P1, DOI 10.1136/sti.2004.013151; Clift S, 2003, SEX TRANSM INFECT, V79, P307, DOI 10.1136/sti.79.4.307; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; COSSA HA, 1994, INT J STD AIDS, V5, P117, DOI 10.1177/095646249400500208; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; Cowan FM, 2005, JAIDS-J ACQ IMM DEF, V40, P371, DOI 10.1097/01.qai.0000162420.93243.ff; DIALLO MO, 1992, AIDS, V6, P581, DOI 10.1097/00002030-199206000-00010; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M., 2008, SYSTEMATIC REV HLTH; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gomo E., 1997, Central African Journal of Medicine, V43, P350; GREENBLATT RM, 1988, AIDS, V2, P47, DOI 10.1097/00002030-198802000-00008; GROSSKURTH H, 1995, AIDS, V9, P927, DOI 10.1097/00002030-199508000-00015; Gwanzura L, 1998, J INFECT DIS, V177, P481, DOI 10.1086/517381; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P793, DOI 10.1046/j.1365-3156.2002.00943.x; Hearst N, 1997, AIDS, V11, pS1; HIRA SK, 1990, J INFECT DIS, V161, P584, DOI 10.1093/infdis/161.3.584; HUDSON CP, 1988, AIDS, V2, P255, DOI 10.1097/00002030-198808000-00003; HUNTER DJ, 1994, AIDS, V8, P93, DOI 10.1097/00002030-199401000-00014; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Kapiga S H, 2000, Afr J Reprod Health, V4, P88, DOI 10.2307/3583246; Kapiga SH, 2003, SEX TRANSM DIS, V30, P187, DOI 10.1097/00007435-200303000-00001; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; KAPIGA SH, 1994, J ACQ IMMUN DEF SYND, V7, P301; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Kelly R, 1999, AIDS, V13, P399, DOI 10.1097/00002030-199902250-00013; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Keou FXM, 1999, AIDS, V13, P536, DOI 10.1097/00002030-199903110-00021; Korenromp EL, 2001, SEX TRANSM DIS, V28, P613, DOI 10.1097/00007435-200111000-00001; Kumwenda NI, 2002, SEX TRANSM DIS, V29, P366, DOI 10.1097/00007435-200206000-00010; Lagarde E, 2004, INT J STD AIDS, V15, P395, DOI 10.1258/095646204774195254; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Langeland N, 1998, INT J STD AIDS, V9, P104, DOI 10.1258/0956462981921765; Lankoande S, 1998, INT J STD AIDS, V9, P146, DOI 10.1258/0956462981921909; LEROY V, 1995, GENITOURIN MED, V71, P207; LINDAN C, 1991, AIDS, V5, P993, DOI 10.1097/00002030-199108000-00011; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; MacDonald KS, 2001, AIDS, V15, P635, DOI 10.1097/00002030-200103300-00014; MAGGWA BN, 1993, AIDS, V7, P733, DOI 10.1097/00002030-199305000-00019; MANN JM, 1988, AIDS, V2, P249, DOI 10.1097/00002030-198808000-00002; Marcelin AG, 2002, J MED VIROL, V68, P164, DOI 10.1002/jmv.10184; Mbizvo EM, 2002, INT J STD AIDS, V13, P343, DOI 10.1258/0956462021925171; Mbizvo EM, 2001, INT J STD AIDS, V12, P524, DOI 10.1258/0956462011923624; Mbizvo M. T., 1996, Central African Journal of Medicine, V42, P14; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; MCCARTHY MC, 1989, AIDS, V3, P725, DOI 10.1097/00002030-198911000-00006; MCCARTHY MC, 1995, J MED VIROL, V46, P18, DOI 10.1002/jmv.1890460105; McFarland W, 1999, J INFECT DIS, V180, P1459, DOI 10.1086/315076; MEDA N, 1995, INT J STD AIDS, V6, P273, DOI 10.1177/095646249500600410; Mihret W, 2002, SEX TRANSM DIS, V29, P175, DOI 10.1097/00007435-200203000-00008; MIOTTI PG, 1990, AIDS, V4, P733, DOI 10.1097/00002030-199008000-00003; Mnyika KS, 1996, J ACQ IMMUN DEF SYND, V11, P484, DOI 10.1097/00042560-199604150-00009; Msuya SE, 2003, SEX TRANSM DIS, V30, P588, DOI 10.1097/00007435-200307000-00011; Msuya SE, 2002, ACTA OBSTET GYN SCAN, V81, P886, DOI 10.1034/j.1600-0412.2002.810916.x; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; Nagot N, 2005, JAIDS-J ACQ IMM DEF, V39, P454, DOI 10.1097/01.qai.0000152399.54648.b9; NdinyaAchola JO, 1997, INT J STD AIDS, V8, P506, DOI 10.1258/0956462971920668; NSUBUGA P, 1990, J ACQ IMMUN DEF SYND, V3, P1002; Nunn AJ, 1996, INT J STD AIDS, V7, P123, DOI 10.1258/0956462961917320; Nyambi P, 2002, JAIDS-J ACQ IMM DEF, V31, P506, DOI 10.1097/00126334-200212150-00008; NZILA N, 1991, AIDS, V5, P715, DOI 10.1097/00002030-199106000-00011; Obisesan KA, 1997, INT J GYNECOL OBSTET, V56, P271, DOI 10.1016/S0020-7292(96)02821-4; Petry KU, 1996, INT J STD AIDS, V7, P265, DOI 10.1258/0956462961917942; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; PLOURDE PJ, 1992, J INFECT DIS, V166, P86, DOI 10.1093/infdis/166.1.86; PUJADES RMM, 2002, AIDS, V16, P451; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; Quigley MA, 2000, J ACQ IMMUN DEF SYND, V23, P418, DOI 10.1097/00042560-200004150-00009; Ramjee G, 2005, JAIDS-J ACQ IMM DEF, V39, P333, DOI 10.1097/01.qai.0000144445.44518.ea; Riedner G, 2003, SEX TRANSM INFECT, V79, P382, DOI 10.1136/sti.79.5.382; RYDER RW, 1990, AIDS, V4, P725, DOI 10.1097/00002030-199008000-00002; Sagay AS, 2005, INT J GYNECOL OBSTET, V90, P61, DOI 10.1016/j.ijgo.2005.03.030; SAMOAHADU C, 2001, J ACQ IMMUN DEF SYND, V28, P358; SassanMorokro M, 1996, J ACQ IMMUN DEF SYND, V11, P183, DOI 10.1097/00042560-199602010-00010; Seber G., 2003, LINEAR REGRESSION AN; SEED J, 1995, J ACQ IMMUN DEF SYND, V8, P83; Sentjens REJH, 2002, EPIDEMIOL INFECT, V128, P221, DOI 10.1017/S0950268801006604; SERWADDA D, 1992, AIDS, V6, P983, DOI 10.1097/00002030-199209000-00012; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; Siegfried N, 2005, BRIT MED J, V331, P742, DOI 10.1136/bmj.331.7519.742; SIMONSEN JN, 1988, NEW ENGL J MED, V319, P274, DOI 10.1056/NEJM198808043190504; Simooya OO, 2001, AIDS, V15, P1741, DOI 10.1097/00002030-200109070-00023; Sinei SKA, 1996, INT J STD AIDS, V7, P65, DOI 10.1258/0956462961917104; Siziya S., 1996, Central African Journal of Medicine, V42, P114; Smith J, 1999, INT J STD AIDS, V10, P452, DOI 10.1258/0956462991914456; Stringer EM, 2004, JAIDS-J ACQ IMM DEF, V35, P60, DOI 10.1097/00126334-200401010-00009; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutcliffe S, 2002, JAIDS-J ACQ IMM DEF, V31, P90, DOI 10.1097/00126334-200209010-00012; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Tengia-Kessy A, 1998, E AFR MED J, V75, P528; TERMEULEN J, 1992, E AFR MED J, V69, P688; Thior I, 1997, Afr J Reprod Health, V1, P26, DOI 10.2307/3583374; Todd J, 2006, J INFECT DIS, V193, P458, DOI 10.1086/499313; *UNAIDS, 2006, AIDS EP UPD; *UNAIDS, 2005, AIDS EP UPD SPEC SEC; Urassa M, 1997, AIDS, V11, P73, DOI 10.1097/00002030-199701000-00011; VANDEPERRE P, 1987, AIDS, V1, P207; Wawer M., 2005, 12 C RETR OPP INF BO; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; *WHO UNAIDS, 2002, 13 WHOUNAIDS; *WHO UNAIDS, CONS STI IN IN PRESS; Zaba BW, 2000, AIDS, V14, P2741, DOI 10.1097/00002030-200012010-00014; Zuma K, 2003, INT J STD AIDS, V14, P814, DOI 10.1258/095646203322556147	130	199	208	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2007	2	10							e1001	10.1371/journal.pone.0001001	http://dx.doi.org/10.1371/journal.pone.0001001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HU	17912340	Green Published, gold			2022-12-27	WOS:000207455900037
J	Chen, SX; Wang, Y; Chen, FY; Yang, HC; Gan, MH; Zheng, SJ				Chen, Shixi; Wang, Yu; Chen, Fuyong; Yang, Hanchun; Gan, Menghou; Zheng, Shijun J.			A Highly Pathogenic Strain of Staphylococcus sciuri Caused Fatal Exudative Epidermitis in Piglets	PLOS ONE			English	Article							HYICUS SUBSP HYICUS; EXFOLIATIVE TOXIN; MOLECULAR CHARACTERIZATION; MEMBERS; PIGS; SKIN; IDENTIFICATION; MASTITIS	Staphylococcus sciuri are important human pathogens responsible for endocarditis, peritonitis, septic shock, urinary tract infection, pelvic inflammatory disease and wound infections. However, little information is known regarding the pathogenicity of S. sciuri to animals. From the pericardial fluid of a diseased piglet with exudative epidermitis (EE), we isolated a strain of Staphylococcus in pure culture. Surprisingly, this isolate was a member of S. sciuri rather than S. hyicus as identified by its biochemical traits and also by analysis of 23S ribosomal DNA using Internal Transcribed Spacer PCR. In addition, inoculation of newborn piglets with 1x10(10) CFU of the isolate by oral feeding or intra-muscular injection successfully reproduced EE in piglets, which suggested that the oral intake of the pathogen by the animals is one of the major routes of exposure. These unexpected findings prioritized S. sciuri as important zoonotic agents, which may have ramifications for human medicine.	[Chen, Shixi; Wang, Yu; Chen, Fuyong; Yang, Hanchun; Gan, Menghou; Zheng, Shijun J.] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Prevent Vet Med, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Zheng, SJ (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Prevent Vet Med, Beijing 100094, Peoples R China.	sjzheng@cau.edu.cn		Kaul, Rupert/0000-0002-1586-4093; Wang, Yu/0000-0001-7935-9902	National Basic Research Program (Project 973) of China [2006CB504300]	National Basic Research Program (Project 973) of China(National Basic Research Program of China)	This work was supported by a grant from the National Basic Research Program (Project 973) of China (Grant 2006CB504300).	Ahrens P, 2004, J BACTERIOL, V186, P1833, DOI 10.1128/JB.186.6.1833-1837.2004; Amtsberg G, 1973, Dtsch Tierarztl Wochenschr, V80, P496; Andresen LO, 1998, FEMS IMMUNOL MED MIC, V20, P301, DOI 10.1111/j.1574-695X.1998.tb01140.x; Andresen LO, 2005, VET REC, V157, P376, DOI 10.1136/vr.157.13.376; Andresen LO, 2005, VET MICROBIOL, V105, P291, DOI 10.1016/j.vetmic.2004.12.006; Andresen LO, 2004, J APPL MICROBIOL, V96, P1265, DOI 10.1111/j.1365-2672.2004.02258.x; ANDRESEN LO, 1993, MICROB PATHOGENESIS, V15, P217, DOI 10.1006/mpat.1993.1072; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; Couto I, 2000, J CLIN MICROBIOL, V38, P1136, DOI 10.1128/JCM.38.3.1136-1143.2000; Couto I, 2001, J CLIN MICROBIOL, V39, P3099, DOI 10.1128/JCM.39.9.3099-3103.2001; Dakic I, 2005, J CLIN MICROBIOL, V43, P4875, DOI 10.1128/JCM.43.9.4875-4876.2005; Gianneechini R, 2002, ACTA VET SCAND, V43, P221, DOI 10.1186/1751-0147-43-221; Hanakawa Y, 2002, J CLIN INVEST, V110, P53, DOI 10.1172/JCI200215766; Hedin G, 1998, EUR J CLIN MICROBIOL, V17, P673, DOI 10.1007/s100960050157; Hill BD, 1996, AUST VET J, V73, P179, DOI 10.1111/j.1751-0813.1996.tb10022.x; Horii T, 2001, SCAND J INFECT DIS, V33, P930, DOI 10.1080/00365540110076750; LAMMLER C, 1990, BERL MUNCH TIERARZTL, V103, P60; ONET GE, 1991, J AM VET MED ASSOC, V199, P362; PHILLIPS WE, 1980, AM J VET RES, V41, P274; POUTREL B, 1984, AM J VET RES, V45, P2084; Rahman MT, 2005, MICROB DRUG RESIST, V11, P205, DOI 10.1089/mdr.2005.11.205; Sato H, 1990, Kitasato Arch Exp Med, V63, P119; Sato H, 2000, J BACTERIOL, V182, P4096, DOI 10.1128/JB.182.14.4096-4100.2000; SCHULZ W, 1969, Archiv fuer Experimentelle Veterinaermedizin, V23, P415; Shittu A, 2004, J MED MICROBIOL, V53, P51, DOI 10.1099/jmm.0.05294-0; Stepanovic S, 2005, INT J STD AIDS, V16, P452, DOI 10.1258/0956462054093999; Stepanovic S, 2005, SYST APPL MICROBIOL, V28, P353, DOI 10.1016/j.syapm.2005.02.001; Stepanovic S, 2005, J CLIN MICROBIOL, V43, P956, DOI 10.1128/JCM.43.2.956-958.2005; Stepanovic S, 2003, J CLIN MICROBIOL, V41, P5262, DOI 10.1128/JCM.41.11.5262-5264.2003; Stepanovic S, 2002, SCAND J INFECT DIS, V34, P685, DOI 10.1080/00365540110076949; Stepanovic S, 2001, VET MICROBIOL, V82, P177, DOI 10.1016/S0378-1135(01)00377-7; Stepanovic S, 2001, FEMS MICROBIOL LETT, V199, P47, DOI 10.1016/S0378-1097(01)00150-1; TAKEUCHI S, 1987, VET MICROBIOL, V14, P47, DOI 10.1016/0378-1135(87)90051-4; Waage S, 1999, J DAIRY SCI, V82, P712, DOI 10.3168/jds.S0022-0302(99)75288-4; Wallet F, 2000, SCAND J INFECT DIS, V32, P697, DOI 10.1080/003655400459667; Zheng SJ, 2004, J IMMUNOL, V173, P5652, DOI 10.4049/jimmunol.173.9.5652	36	199	208	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2007	2	1							e147	10.1371/journal.pone.0000147	http://dx.doi.org/10.1371/journal.pone.0000147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10DE	17912340	Green Published, gold, Green Submitted			2022-12-27	WOS:000207443900001
